PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Soto, A; Solari, L; Diaz, J; Mantilla, A; Matthys, F; van der Stuyft, P				Soto, Alonso; Solari, Lely; Diaz, Javier; Mantilla, Alberto; Matthys, Francine; van der Stuyft, Patrick			Validation of a Clinical-Radiographic Score to Assess the Probability of Pulmonary Tuberculosis in Suspect Patients with Negative Sputum Smears	PLOS ONE			English	Article							HIV-INFECTION; DIAGNOSIS; ALGORITHM; VALIDITY	Background: Clinical suspects of pulmonary tuberculosis in which the sputum smears are negative for acid fast bacilli represent a diagnostic challenge in resource constrained settings. Our objective was to validate an existing clinical-radiographic score that assessed the probability of smear-negative pulmonary tuberculosis (SNPT) in high incidence settings in Peru. Methodology/Principal Findings: We included in two referral hospitals in Lima patients with clinical suspicion of pulmonary tuberculosis and two or more negative sputum smears. Using a published but not externally validated score, patients were classified as having low, intermediate or high probability of pulmonary tuberculosis. The reference standard for the diagnosis of tuberculosis was a positive sputum culture in at least one of 2 liquid (MGIT or Middlebrook 7H9) and 1 solid (Ogawa) media. Prevalence of tuberculosis was calculated in each of the three probability groups. 684 patients were included. 184 (27.8%) had a diagnosis of pulmonary tuberculosis. The score did not perform well in patients with a previous history of pulmonary tuberculosis. In patients without, the prevalence of tuberculosis was 5.1%, 31.7% and 72% in the low, intermediate and high probability group respectively. The area under de ROC curve was 0.76 (95% CI 0.72-0.80) and scores >= 6 had a positive LR of 10.9. Conclusions/Significance: In smear negative suspects without previous history of tuberculosis, the clinical-radiographic score can be used as a tool to assess the probability of pulmonary tuberculosis and to guide the decision to initiate or defer treatment or to requesting additional tests.	[Soto, Alonso; Mantilla, Alberto] Hosp Nacl Hipolito Unanue, Dept Med, Lima, Peru; [Solari, Lely; Matthys, Francine; van der Stuyft, Patrick] Inst Trop Med, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Diaz, Javier] Hosp Nacl Cayetano Heredia, Dept Med, Lima, Peru	Institute of Tropical Medicine (ITM)	Soto, A (corresponding author), Hosp Nacl Hipolito Unanue, Dept Med, Lima, Peru.	sotosolari@yahoo.com	Solari, Lely/ABH-2674-2020; Soto, Alonso/ABB-7707-2021	Solari, Lely/0000-0002-8041-8807; Soto, Alonso/0000-0001-8648-8032	Damien Foundation [85561/2005]	Damien Foundation	Funding was provided by the Damien Foundation (www.damienfoundation.org/), grant 85561/2005. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JO, 2003, AIDS, V17, P613, DOI 10.1097/00002030-200303070-00017; Altman D.G., 1991, PRACTICAL STATISTIC; Aris EA, 1999, E AFR MED J, V76, P630; Barrera L., 2007, TUBERCULOSIS 2007 BA, P93; Bergman N. J., 1995, Central African Journal of Medicine, V41, P1; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Enarson D.A., 2000, MANAGEMENT TUBERCULO; Finch D, 1997, CHEST, V111, P1174, DOI 10.1378/chest.111.5.1174; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Gilpin C, 2007, INT J TUBERC LUNG D, V11, P946; Kanaya AM, 2001, CHEST, V120, P349, DOI 10.1378/chest.120.2.349; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; LUSTED LB, 1971, SCIENCE, V171, P1217, DOI 10.1126/science.171.3977.1217; Matthys F, 2009, T ROY SOC TROP MED H, V103, P52, DOI 10.1016/j.trstmh.2008.07.021; Mello FCD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-43; Pegues CF, 1996, INFECT CONT HOSP EP, V17, P412; Samb B, 1999, INT J TUBERC LUNG D, V3, P330; Samb B, 1997, INT J TUBERC LUNG D, V1, P25; Saranchuk P, 2007, SAMJ S AFR MED J, V97, P517; Scherer LC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-356; Shi Su-hong, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P984; Siddiqi K, 2006, TROP MED INT HEALTH, V11, P323, DOI 10.1111/j.1365-3156.2006.01559.x; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; *STATACORP LP, 2004, STAT STAT SOFTW REAL; Tattevin P, 1999, CHEST, V115, P1248, DOI 10.1378/chest.115.5.1248; Tessema TA, 2001, SCAND J INFECT DIS, V33, P355, DOI 10.1080/003655401750173986; WHO, 2007, IMPR DIAGN TREATM SM; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; 2008, ESTRATEGIA SANITARIA	31	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18486	10.1371/journal.pone.0018486	http://dx.doi.org/10.1371/journal.pone.0018486			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483690	Green Published, gold, Green Submitted			2022-12-27	WOS:000289191300025
J	Zaravinos, A; Lambrou, GI; Volanis, D; Delakas, D; Spandidos, DA				Zaravinos, Apostolos; Lambrou, George I.; Volanis, Dimitrios; Delakas, Dimitris; Spandidos, Demetrios A.			Spotlight on Differentially Expressed Genes in Urinary Bladder Cancer	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TRANSITIONAL-CELL-CARCINOMA; KINASE INHIBITOR PROTEIN; METASTASIS SUPPRESSOR GENE; HUMAN NASAL POLYPOSIS; PROSTATE-CANCER; MATRIX METALLOPROTEINASES; FACTOR RECEPTOR; IN-SITU; PREDICTING RECURRENCE	Introduction: We previously identified common differentially expressed (DE) genes in bladder cancer (BC). In the present study we analyzed in depth, the expression of several groups of these DE genes. Materials and Methods: Samples from 30 human BCs and their adjacent normal tissues were analyzed by whole genome cDNA microarrays, qRT-PCR and Western blotting. Our attention was focused on cell-cycle control and DNA damage repair genes, genes related to apoptosis, signal transduction, angiogenesis, as well as cellular proliferation, invasion and metastasis. Four publicly available GEO Datasets were further analyzed, and the expression data of the genes of interest (GOIs) were compared to those of the present study. The relationship among the GOI was also investigated. GO and KEGG molecular pathway analysis was performed to identify possible enrichment of genes with specific biological themes. Results: Unsupervised cluster analysis of DNA microarray data revealed a clear distinction in BC vs. control samples and low vs. high grade tumors. Genes with at least 2-fold differential expression in BC vs. controls, as well as in non-muscle invasive vs. muscle invasive tumors and in low vs. high grade tumors, were identified and ranked. Specific attention was paid to the changes in osteopontin (OPN, SPP1) expression, due to its multiple biological functions. Similarly, genes exhibiting equal or low expression in BC vs. the controls were scored. Significant pair-wise correlations in gene expression were scored. GO analysis revealed the multi-facet character of the GOIs, since they participate in a variety of mechanisms, including cell proliferation, cell death, metabolism, cell shape, and cytoskeletal re-organization. KEGG analysis revealed that the most significant pathway was that of Bladder Cancer (p = 1.5x10(-31)). Conclusions: The present work adds to the current knowledge on molecular signature identification of BC. Such works should progress in order to gain more insight into disease molecular mechanisms.	[Zaravinos, Apostolos; Volanis, Dimitrios; Spandidos, Demetrios A.] Univ Crete, Sch Med, Virol Lab, Iraklion, Crete, Greece; [Lambrou, George I.] Univ Athens, Dept Pediat 1, Choremeio Res Lab, Athens, Greece; [Volanis, Dimitrios; Delakas, Dimitris] Asklipieio Gen Hosp, Dept Urol, Athens, Greece	University of Crete; National & Kapodistrian University of Athens	Zaravinos, A (corresponding author), Univ Crete, Sch Med, Virol Lab, Iraklion, Crete, Greece.	spandidos@spandidos.gr	Zaravinos, Apostolos/B-2528-2019; Lambrou, George/F-9674-2011	Zaravinos, Apostolos/0000-0003-4625-5562; Spandidos, Demetrios/0000-0002-1146-931X; Lambrou, George/0000-0001-8389-1360				Al-Abbasi DS, 2009, APPL IMMUNOHISTO M M, V17, P307, DOI 10.1097/PAI.0b013e3181941794; Altman NS, 2006, GENET RES, V88, P153, DOI 10.1017/S0016672307008476; Askham JM, 2010, ONCOGENE, V29, P150, DOI 10.1038/onc.2009.315; Boulalas I, 2009, J UROLOGY, V181, P2312, DOI 10.1016/j.juro.2009.01.011; Boulalas I, 2009, INT J BIOL MARKER, V24, P17, DOI 10.1177/172460080902400103; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Campbell SC, 1998, CANCER RES, V58, P1298; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chaffer CL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-53; Chikazawa M, 2008, PATHOBIOLOGY, V75, P335, DOI 10.1159/000164218; Choi YD, 2007, J UROLOGY, V177, P1174, DOI 10.1016/j.juro.2006.10.031; Chow NH, 1997, ANTICANCER RES, V17, P1293; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Colquhoun AJ, 2007, J RADIAT RES, V48, P351, DOI 10.1269/jrr.07014; Coppola D, 2004, CLIN CANCER RES, V10, P184, DOI 10.1158/1078-0432.CCR-1405-2; CORDONCARDO C, 1995, AM J PATHOL, V147, P545; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DeBoer WI, 1997, INT J CANCER, V71, P284, DOI 10.1002/(SICI)1097-0215(19970410)71:2<284::AID-IJC25>3.0.CO;2-G; del Rey J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-280; Dominguez-Escrig JL, 2004, CLIN CANCER RES, V10, P4874, DOI 10.1158/1078-0432.CCR-04-0034; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Eder IE, 1997, BRIT J CANCER, V75, P1753, DOI 10.1038/bjc.1997.299; Eissa S, 2007, EUR UROL, V52, P1388, DOI 10.1016/j.eururo.2007.04.006; FEINBERG AP, 1983, SCIENCE, V220, P1175, DOI 10.1126/science.6304875; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Fu Z, 2006, PROSTATE, V66, P248, DOI 10.1002/pros.20319; FUJITA J, 1984, NATURE, V309, P464, DOI 10.1038/309464a0; Gan YB, 2006, PHARM RES-DORDR, V23, P1324, DOI 10.1007/s11095-006-0136-6; Gerhards S, 2001, UROLOGY, V57, P675, DOI 10.1016/S0090-4295(00)01087-6; GORSCH SM, 1992, CANCER RES, V52, P6949; Gravas S, 2004, UROL INT, V73, P173, DOI 10.1159/000079700; Guo Zheng-Hui, 2003, Ai Zheng, V22, P307; Halimi M, 2009, INDIAN J PATHOL MICR, V52, P155; Hanemaaijer R, 1999, ANN NY ACAD SCI, V878, P141, DOI 10.1111/j.1749-6632.1999.tb07680.x; Helmy Amira, 2007, MedGenMed, V9, P34; Herrera R, 2002, TRENDS MOL MED, V8, pS27, DOI 10.1016/S1471-4914(02)02307-9; Hung TT, 2008, CANCER LETT, V265, P27, DOI 10.1016/j.canlet.2008.02.034; Inoue K, 2000, CLIN CANCER RES, V6, P4866; Izadifar V, 1999, HUM PATHOL, V30, P372, DOI 10.1016/S0046-8177(99)90110-7; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Ke H.L., 2009, UROL ONCOL; Keller ET, 2004, CANCER LETT, V207, P131, DOI 10.1016/j.canlet.2004.02.006; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; LEVIDOU G, J CANC RES CLIN ONCO, V36, P1563; Li B, 1998, Int J Urol, V5, P317, DOI 10.1111/j.1442-2042.1998.tb00358.x; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; LLENA FRV, 2006, ACTAS UROL ESP, V30, P754; Lopez-Beltran A, 2004, EUR UROL, V46, P170, DOI 10.1016/j.eururo.2004.03.017; MARGULIES IMK, 1992, CANCER EPIDEM BIOMAR, V1, P467; Maslyukova Ye. A., 2006, Voprosy Onkologii (St. Petersburg), V52, P643; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; Mellon JK, 1996, J UROLOGY, V155, P321, DOI 10.1016/S0022-5347(01)66653-9; MELLON K, 1995, J UROLOGY, V153, P919, DOI 10.1016/S0022-5347(01)67604-3; Mengual L, 2009, J UROLOGY, V182, P741, DOI 10.1016/j.juro.2009.03.084; Mitra AP, 2006, CLIN GENITOURIN CANC, V5, P67, DOI 10.3816/CGC.2006.n.020; MOCH H, 1993, VIRCHOWS ARCH A, V423, P329, DOI 10.1007/BF01607144; Monzon FA, 2009, J CLIN ONCOL, V27, P2503, DOI 10.1200/JCO.2008.17.9762; Morimoto I, 2002, GENE CHROMOSOME CANC, V33, P270, DOI 10.1002/gcc.10020; MURPHY G, 1991, BIOCHEM J, V277, P277, DOI 10.1042/bj2770277; Nakazawa K, 2009, AM J CLIN PATHOL, V132, P776, DOI 10.1309/AJCP61KNVHJVHAFN; Nakopoulou L, 1998, HUM PATHOL, V29, P146, DOI 10.1016/S0046-8177(98)90225-8; NEAL DE, 1990, CANCER, V65, P1619, DOI 10.1002/1097-0142(19900401)65:7<1619::AID-CNCR2820650728>3.0.CO;2-Q; NEAL DE, 1985, LANCET, V1, P366; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Nutt JE, 2003, BJU INT, V91, P99, DOI 10.1046/j.1464-410X.2003.04020.x; Oates AJ, 1997, INVAS METAST, V17, P1; Odabaei G, 2004, ADV CANCER RES, V91, P169, DOI 10.1016/S0065-230X(04)91005-6; Ozdemir E, 1999, J UROLOGY, V161, P1359, DOI 10.1016/S0022-5347(01)61684-7; Park S, 2005, ONCOGENE, V24, P3535, DOI 10.1038/sj.onc.1208435; Pfister C, 1999, CLIN CANCER RES, V5, P4079; Quentin T, 2004, ANTICANCER RES, V24, P1011; Raspollini Maria Rosaria, 2006, Arch Ital Urol Androl, V78, P97; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Ria R, 2002, EUR J CLIN INVEST, V32, P199, DOI 10.1046/j.1365-2362.2002.00960.x; ROBERTS AB, 1990, PHILOS T R SOC B, V327, P145, DOI 10.1098/rstb.1990.0050; Rusanescu G, 2001, MOL CELL BIOL, V21, P2650, DOI 10.1128/MCB.21.8.2650-2658.2001; Saito S, 1997, Int J Urol, V4, P178, DOI 10.1111/j.1442-2042.1997.tb00167.x; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SHARIAT SF, J UROL, V183, P1744; Sier CFM, 2000, CLIN CANCER RES, V6, P2333; Simister PC, 2002, ACTA CRYSTALLOGR D, V58, P1077, DOI 10.1107/S090744490200522X; Staack Andrea, 2006, BMC Urol, V6, P19, DOI 10.1186/1471-2490-6-19; STEINER MS, 1994, ENDOCRINOLOGY, V135, P2240, DOI 10.1210/en.135.5.2240; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storey John D, 2003, Methods Mol Biol, V224, P149; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Symvoulakis EK, 2007, INT J BIOL MARKER, V22, P12, DOI 10.1177/172460080702200102; Townsend JP, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-41; Underwood MA, 1996, BRIT J UROL, V77, P659, DOI 10.1046/j.1464-410X.1996.09386.x; van Rhijn BWG, 2009, EUR UROL, V56, P430, DOI 10.1016/j.eururo.2009.06.028; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasala K, 2007, CLIN BIOCHEM, V40, P640, DOI 10.1016/j.clinbiochem.2007.01.021; Villares GJ, 2007, WORLD J UROL, V25, P573, DOI 10.1007/s00345-007-0202-7; VISVANATHAN KV, 1988, ONCOGENE RES, V3, P77; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; WILLIAMS NG, 1994, CANCER METAST REV, V13, P105, DOI 10.1007/BF00690421; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Wolff EM, 2005, NAT CLIN PRACT UROL, V2, P502, DOI 10.1038/ncpuro0318; Wood M, 1997, CLIN EXP METASTAS, V15, P246, DOI 10.1023/A:1018421431388; YE DW, 1993, UROL RES, V21, P223; Yin M, 2008, HUM PATHOL, V39, P527, DOI 10.1016/j.humpath.2007.08.005; Zaravinos A, 2010, BRIT J DERMATOL, V162, P325, DOI 10.1111/j.1365-2133.2009.09480.x; ZARAVINOS A, PATHOL ONCOL RES; ZARAVINOS A, 2011, PLOS ONE; Zaravinos A, 2008, CANCER LETT, V264, P288, DOI 10.1016/j.canlet.2008.01.046; Zaravinos A, 2008, ONCOL REP, V19, P385; Zaravinos A, 2007, INT J ONCOL, V31, P1051; Zaravinos A, 2009, CELL CYCLE, V8, P1402, DOI 10.4161/cc.8.9.8308; Zhang GJ, 2005, UROL ONCOL-SEMIN ORI, V23, P413, DOI 10.1016/j.urolonc.2005.05.029	116	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18255	10.1371/journal.pone.0018255	http://dx.doi.org/10.1371/journal.pone.0018255			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483670	Green Submitted, Green Published, gold			2022-12-27	WOS:000289191300014
J	Hren, D; Marusic, M; Marusic, A				Hren, Darko; Marusic, Matko; Marusic, Ana			Regression of Moral Reasoning during Medical Education: Combined Design Study to Evaluate the Effect of Clinical Study Years	PLOS ONE			English	Article							DIFFICULTIES; DILEMMAS; ETHICS	Background: Moral reasoning is important for developing medical professionalism but current evidence for the relationship between education and moral reasoning does not clearly apply to medical students. We used a combined study design to test the effect of clinical teaching on moral reasoning. Methods: We used the Defining Issues Test-2 as a measure of moral judgment, with 3 general moral schemas: Personal Interest, Maintaining Norms, and Postconventional Schema. The test was applied to 3 consecutive cohorts of second year students in 2002 (n = 207), 2003 (n = 192), and 2004 (n = 139), and to 707 students of all 6 study years in 2004 cross-sectional study. We also tested 298 age-matched controls without university education. Results: In the cross-sectional study, there was significant main effect of the study year for Postconventional (F(5,679) = 3.67, P = 0.003) and Personal Interest scores (F(5,679) = 3.38, P = 0.005). There was no effect of the study year for Maintaining Norms scores. 3(rd) year medical students scored higher on Postconventional schema score than all other study years (p < 0.001). There were no statistically significant differences among 3 cohorts of 2(nd) year medical students, demonstrating the absence of cohort or point-of-measurement effects. Longitudinal study of 3 cohorts demonstrated that students regressed from Postconventional to Maintaining Norms schema-based reasoning after entering the clinical part of the curriculum. Interpretation: Our study demonstrated direct causative relationship between the regression in moral reasoning development and clinical teaching during medical curriculum. The reasons may include hierarchical organization of clinical practice, specific nature of moral dilemmas faced by medical students, and hidden medical curriculum.	[Hren, Darko] Univ Split, Fac Philosophy, Split, Croatia; [Marusic, Matko; Marusic, Ana] Univ Split, Sch Med, Dept Res Biomed & Hlth, Split, Croatia	University of Split; University of Split	Hren, D (corresponding author), Univ Split, Fac Philosophy, Split, Croatia.	dhren@ffst.hr	Marusic, Ana/E-7683-2013; Hren, Darko/H-1819-2017; Marusic, Matko/E-1834-2017	Marusic, Ana/0000-0001-6272-0917; Hren, Darko/0000-0001-6465-6568; Marusic, Matko/0000-0001-5562-1777	Croatian Ministry of Science, Education and Sports [216-1080314-0245]	Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia)	This research was supported by the grant No. 216-1080314-0245 from the Croatian Ministry of Science, Education and Sports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin D C Jr, 1996, Am J Orthop (Belle Mead NJ), V25, P481; Bebeau MJ, 2003, GUIDE DIT 2; Becker Howard, 1961, BOYS WHITE STUDENT C; BLASI A, 1980, PSYCHOL BULL, V88, P1, DOI 10.1037/0033-2909.88.1.1; BRANCH W, 1993, NEW ENGL J MED, V329, P1130, DOI 10.1056/NEJM199310073291518; Branch WT, 2000, J GEN INTERN MED, V15, P503, DOI 10.1046/j.1525-1497.2000.06298.x; Branch WT, 1998, ACAD MED, V73, P360, DOI 10.1097/00001888-199804000-00007; Campbell D. T., 1966, EXPT QUASIEXPERIMENT; CANDEE D, 1982, PEDIATR RES, V16, P846, DOI 10.1203/00006450-198210000-00009; CHRISTAKIS DA, 1993, ACAD MED, V68, P249, DOI 10.1097/00001888-199304000-00003; Christie R., 1970, STUDIES MACHIAVELLIA; Fleisher WP, 2003, CAN MED ASSOC J, V169, P1145; HAFFERTY FW, 1994, ACAD MED, V69, P861, DOI 10.1097/00001888-199411000-00001; Helkama Klaus, 2003, SCAND J EDUC RES, V47, P399, DOI DOI 10.1080/00313830308589; Hren D, 2006, MED EDUC, V40, P269, DOI 10.1111/j.1365-2929.2006.02391.x; Hurst SA, 2007, J MED ETHICS, V33, P51, DOI 10.1136/jme.2005.014266; King PM, 2002, J MORAL EDUC, V31, P247, DOI 10.1080/0305724022000008106; Klemenc-Ketis Z, 2008, CROAT MED J, V49, P799, DOI 10.3325/cmj.2008.49.799; KOLLEMORTEN I, 1981, J MED ETHICS, V7, P67, DOI 10.1136/jme.7.2.67; Lempp H, 2004, BMJ-BRIT MED J, V329, P770, DOI 10.1136/bmj.329.7469.770; Lind G., 2000, REV BRASILEIRA EDUCA, V24, P24; Marinovic D, 2009, CROAT MED J, V50, P492, DOI 10.3325/cmj.2009.50.492; Morton KR, 1996, ACAD MED, V71, P5, DOI 10.1097/00001888-199601000-00008; Offenbach SI, 2001, SCI ENG ETHICS, V7, P589, DOI 10.1007/s11948-001-0015-9; Pascarella E. T., 2005, COLL AFFECTS STUDENT; Patenaude J, 2003, CAN MED ASSOC J, V168, P840; Rest James, 1999, POSTCONVENTIONAL MOR; Rest JR, 2000, J MORAL EDUC, V29, P381, DOI 10.1080/713679390; SCHAIE K W, 1965, Psychol Bull, V64, P92, DOI 10.1037/h0022371; Self DJ, 1998, ACAD MED, V73, P517, DOI 10.1097/00001888-199805000-00018; Self DJ, 1994, MORAL DEV PROFESSION; SHEEHAN TJ, 1985, EVAL HEALTH PROF, V8, P379, DOI 10.1177/016327878500800401; WALKER LJ, 1991, HDB MORAL BEHAV DEV, V2	33	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17406	10.1371/journal.pone.0017406	http://dx.doi.org/10.1371/journal.pone.0017406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YK	21479204	Green Published, gold, Green Submitted			2022-12-27	WOS:000289055700012
J	Warmuth, V; Eriksson, A; Bower, MA; Canon, J; Cothran, G; Distl, O; Glowatzki-Mullis, ML; Hunt, H; Luis, C; Oom, MD; Yupanqui, IT; Zabek, T; Manica, A				Warmuth, Vera; Eriksson, Anders; Bower, Mim A.; Canon, Javier; Cothran, Gus; Distl, Ottmar; Glowatzki-Mullis, Marie-Louise; Hunt, Harriet; Luis, Cristina; Oom, Maria do Mar; Tupac Yupanqui, Isabel; Zabek, Tomasz; Manica, Andrea			European Domestic Horses Originated in Two Holocene Refugia	PLOS ONE			English	Article							INFERRING ADMIXTURE PROPORTIONS; GENETIC DIVERSITY; MICROSATELLITE LOCI; WILD HORSES; BREEDS; CATTLE; GEOGRAPHY	The role of European wild horses in horse domestication is poorly understood. While the fossil record for wild horses in Europe prior to horse domestication is scarce, there have been suggestions that wild populations from various European regions might have contributed to the gene pool of domestic horses. To distinguish between regions where domestic populations are mainly descended from local wild stock and those where horses were largely imported, we investigated patterns of genetic diversity in 24 European horse breeds typed at 12 microsatellite loci. The distribution of high levels of genetic diversity in Europe coincides with the distribution of predominantly open landscapes prior to domestication, as suggested by simulation-based vegetation reconstructions, with breeds from Iberia and the Caspian Sea region having significantly higher genetic diversity than breeds from central Europe and the UK, which were largely forested at the time the first domestic horses appear there. Our results suggest that not only the Eastern steppes, but also the Iberian Peninsula provided refugia for wild horses in the Holocene, and that the genetic contribution of these wild populations to local domestic stock may have been considerable. In contrast, the consistently low levels of diversity in central Europe and the UK suggest that domestic horses in these regions largely derive from horses that were imported from the Eastern refugium, the Iberian refugium, or both.	[Warmuth, Vera; Eriksson, Anders; Manica, Andrea] Univ Cambridge, Dept Zool, Cambridge, England; [Warmuth, Vera; Bower, Mim A.; Hunt, Harriet] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England; [Canon, Javier; Tupac Yupanqui, Isabel] Univ Complutense, Fac Vet, Dept Anim Prod, E-28040 Madrid, Spain; [Cothran, Gus] Texas A&M Univ, CVM, VIBS, Anim Genet Lab, College Stn, TX USA; [Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Glowatzki-Mullis, Marie-Louise] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Luis, Cristina] Univ Lisbon, Museus Politecn MNHN & MCUL, P-1699 Lisbon, Portugal; [Oom, Maria do Mar] Univ Lisbon, Ctr Biol Ambiental, P-1699 Lisbon, Portugal; [Zabek, Tomasz] Natl Res Inst Anim Prod, Lab Genom, Balice, Poland	University of Cambridge; University of Cambridge; Complutense University of Madrid; Texas A&M University System; Texas A&M University College Station; University of Veterinary Medicine Hannover, Foundation; University of Bern; Universidade de Lisboa; Universidade de Lisboa; National Research Institute of Animal Production	Warmuth, V (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	vmw23@cam.ac.uk; am315@cam.ac.uk	Eriksson, Anders/C-9767-2010; Luís, Cristina/AFF-4315-2022; do Mar Oom, Maria/B-9423-2011; Ząbek, Tomasz/AAS-8092-2021; Luís, Cristina/H-8324-2013; Manica, Andrea/N-9013-2019; Warmuth, Vera/H-6876-2012; Manica, Andrea/B-5497-2008; Luís, Cristina/AAE-9871-2022; Canon Ferreras, Francisco Javier/M-5704-2018	Eriksson, Anders/0000-0003-3436-3726; Luís, Cristina/0000-0001-8005-9624; do Mar Oom, Maria/0000-0002-1715-4108; Ząbek, Tomasz/0000-0002-9795-3232; Luís, Cristina/0000-0001-8005-9624; Manica, Andrea/0000-0003-1895-450X; Manica, Andrea/0000-0003-1895-450X; Luís, Cristina/0000-0001-8005-9624; Canon Ferreras, Francisco Javier/0000-0003-1137-0958	Biotechnology and Biological Sciences Research Council [BB/E527604/1]; German Academic Exchange Service [D/07/44562]; Leverhulme Trust [F/09757/B]; Biotechnology and Biological Sciences Research Council [BB/H005854/1] Funding Source: researchfish; BBSRC [BB/H005854/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partially supported by a research studentship from the Biotechnology and Biological Sciences Research Council (BB/E527604/1) and a PhD studentship from the German Academic Exchange Service (D/07/44562) to VW, and a Leverhulme Trust project grant (F/09757/B) to MAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle KS, 2004, ANIM GENET, V35, P270, DOI 10.1111/j.1365-2052.2004.01166.x; Allen M, 1998, J FORENSIC SCI, V43, P453; Ammerman A.J., 1973, EXPLANATION CULTURE, P343; [Anonymous], 2010, R LANG ENV STAT COMP; ANTHONY DW, 1986, CURR ANTHROPOL, V27, P291, DOI 10.1086/203441; Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; BINNS MM, 1995, BRIT VET J, V151, P9, DOI 10.1016/S0007-1935(05)80057-0; Boyle K.V., 2006, P10; Breen M, 1997, MAMM GENOME, V8, P267, DOI 10.1007/s003359900407; Canon J, 2006, ANIM GENET, V37, P327, DOI 10.1111/j.1365-2052.2006.01461.x; Canon J, 2000, ANIM GENET, V31, P39, DOI 10.1046/j.1365-2052.2000.00591.x; Chapman R., 1990, EMERGING COMPLEXITY; Childe V.G., 1925, DAWN EUROPEAN CIVILI; Cieslak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015311; Cymbron T, 2005, P ROY SOC B-BIOL SCI, V272, P1837, DOI 10.1098/rspb.2005.3138; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; ELLEGREN H, 1992, ANIM GENET, V23, P133, DOI 10.1111/j.1365-2052.1992.tb00032.x; Freeman AR, 2006, ANIM GENET, V37, P1, DOI 10.1111/j.1365-2052.2005.01363.x; Gallimore R, 2005, CLIM DYNAM, V25, P755, DOI 10.1007/s00382-005-0054-z; Glowatzki-Mullis ML, 2006, ANIM GENET, V37, P33, DOI 10.1111/j.1365-2052.2005.01376.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GUERIN G, 1994, ANIM GENET, V25, P62; Handley LJL, 2007, HEREDITY, V99, P620, DOI 10.1038/sj.hdy.6801039; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; Hendricks Bonnie, 1995, INT ENCY HORSE BREED; Huntley B, 1988, VEGETATION HIST; Lewis PO, 2001, GENETIC DATA ANAL GD; Linklater WL, 2000, NEW ZEAL J ECOL, V24, P139; Lira J, 2010, MOL ECOL, V19, P64, DOI 10.1111/j.1365-294X.2009.04430.x; Loftus RT, 1999, MOL ECOL, V8, P2015, DOI 10.1046/j.1365-294x.1999.00805.x; Ludwig A, 2009, SCIENCE, V324, P485, DOI 10.1126/science.1172750; Luis C, 2007, ANIM GENET, V38, P20, DOI 10.1111/j.1365-2052.2006.01545.x; Manica A, 2005, HUM GENET, V118, P366, DOI 10.1007/s00439-005-0039-3; MARKLUND S, 1994, ANIM GENET, V25, P19, DOI 10.1111/j.1365-2052.1994.tb00050.x; Medugorac I, 2009, MOL ECOL, V18, P3394, DOI 10.1111/j.1365-294X.2009.04286.x; Mitchell FJG, 2005, J ECOL, V93, P168, DOI 10.1111/j.1365-2745.2004.00964.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; Pantaleon-Cano J, 2003, HOLOCENE, V13, P109, DOI 10.1191/0959683603hl598rp; Peter C, 2007, ANIM GENET, V38, P37, DOI 10.1111/j.1365-2052.2007.01561.x; PREECE RC, 1991, J BIOGEOGR, V18, P409, DOI 10.2307/2845483; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Royo LJ, 2005, J HERED, V96, P663, DOI 10.1093/jhered/esi116; Stewart John R., 2007, Acta Zoologica Cracoviensia Ser. A - Vertebrata, V50A, P93, DOI 10.3409/000000007783995372; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; VANHAERINGEN H, 1994, ANIM GENET, V25, P207, DOI 10.1111/j.1365-2052.1994.tb00129.x; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Zabek Tomasz, 2005, Journal of Applied Genetics, V46, P299; [No title captured]; [No title captured]; [No title captured]; [No title captured]	52	51	55	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18194	10.1371/journal.pone.0018194	http://dx.doi.org/10.1371/journal.pone.0018194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479181	Green Published, Green Submitted, gold			2022-12-27	WOS:000289055700038
J	Franck, C; Maskarinec, SA; Tirrell, DA; Ravichandran, G				Franck, Christian; Maskarinec, Stacey A.; Tirrell, David A.; Ravichandran, Guruswami			Three-Dimensional Traction Force Microscopy: A New Tool for Quantifying Cell-Matrix Interactions	PLOS ONE			English	Article							DIGITAL VOLUME CORRELATION; FOCAL ADHESIONS; LOCOMOTING CELLS; SUBSTRATE; ELASTICITY; MIGRATION; MOVEMENT; STRESSES; PHYSICS	The interactions between biochemical processes and mechanical signaling play important roles during various cellular processes such as wound healing, embryogenesis, metastasis, and cell migration. While traditional traction force measurements have provided quantitative information about cell matrix interactions in two dimensions, recent studies have shown significant differences in the behavior and morphology of cells when placed in three-dimensional environments. Hence new quantitative experimental techniques are needed to accurately determine cell traction forces in three dimensions. Recently, two approaches both based on laser scanning confocal microscopy have emerged to address this need. This study highlights the details, implementation and advantages of such a three-dimensional imaging methodology with the capability to compute cellular traction forces dynamically during cell migration and locomotion. An application of this newly developed three-dimensional traction force microscopy (3D TFM) technique to single cell migration studies of 3T3 fibroblasts is presented to show that this methodology offers a new quantitative vantage point to investigate the three-dimensional nature of cell-ECM interactions.	[Franck, Christian] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Maskarinec, Stacey A.; Tirrell, David A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Ravichandran, Guruswami] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA	Brown University; California Institute of Technology; California Institute of Technology	Franck, C (corresponding author), Brown Univ, Sch Engn, Providence, RI 02912 USA.	franck@brown.edu	Franck, Christian/C-6077-2012	Franck, Christian/0000-0002-2347-620X; Maskarinec, Stacey/0000-0002-1716-8374	National Science Foundation (DMR) through the Center for Science and Engineering of Materials (CSEM) at the California Institute of Technology [0520565]; National Institutes of Health	National Science Foundation (DMR) through the Center for Science and Engineering of Materials (CSEM) at the California Institute of Technology(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Science Foundation (DMR \# 0520565) through the Center for Science and Engineering of Materials (CSEM) at the California Institute of Technology. S. A. M. had additional support from a predoctoral National Research Service Award fellowship from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303; Bay BK, 2008, J STRAIN ANAL ENG, V43, P745, DOI 10.1243/03093247JSA436; Bay BK, 1999, EXP MECH, V39, P217, DOI 10.1007/BF02323555; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186; CHEN DJ, 1993, APPL OPTICS, V32, P1839, DOI 10.1364/AO.32.001839; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; del Alamo JC, 2007, P NATL ACAD SCI USA, V104, P13343, DOI 10.1073/pnas.0705815104; Dembo M, 1996, BIOPHYS J, V70, P2008, DOI 10.1016/S0006-3495(96)79767-9; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; di Scalea FL, 1998, EXP MECH, V38, P55, DOI 10.1007/BF02321268; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Franck C, 2007, EXP MECH, V47, P427, DOI 10.1007/s11340-007-9037-9; FRANCK C, 2008, THESIS CALTECH; Fung YC., 1993, 1 COURSE CONTINUUM M, V3rd ed.; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gjorevski N, 2010, INTEGR BIOL-UK, V2, P424, DOI 10.1039/c0ib00040j; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Hur SS, 2009, CELL MOL BIOENG, V2, P425, DOI 10.1007/s12195-009-0082-6; Ingber DE, 2008, SEMIN CANCER BIOL, V18, P356, DOI 10.1016/j.semcancer.2008.03.016; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; LEE J, 1994, J CELL BIOL, V127, P1957, DOI 10.1083/jcb.127.6.1957; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Maloney JM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041923; Maskarinec SA, 2009, P NATL ACAD SCI USA, V106, P22108, DOI 10.1073/pnas.0904565106; Merkel R, 2007, BIOPHYS J, V93, P3314, DOI 10.1529/biophysj.107.111328; OLIVER T, 1995, CELL MOTIL CYTOSKEL, V31, P225, DOI 10.1002/cm.970310306; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Reinhart-King CA, 2003, LANGMUIR, V19, P1573, DOI 10.1021/la026142j; ROEDER B, 2004, T ASME, V126, P669; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Safran SA, 2005, PHYSICA A, V352, P171, DOI 10.1016/j.physa.2004.12.035; Schwarz US, 2003, MAT SCI ENG C-BIO S, V23, P387, DOI 10.1016/S0928-4931(02)00309-0; Schwarz US, 2002, BIOPHYS J, V83, P1380, DOI 10.1016/S0006-3495(02)73909-X; Takita K, 2003, IEICE T FUND ELECTR, VE86A, P1925; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Wang JHC, 2007, BIOMECH MODEL MECHAN, V6, P361, DOI 10.1007/s10237-006-0068-4; WARD M, 1994, BIOPHYS J, V6, P2522; WARD MD, 1993, BIOPHYS J, V64, P936, DOI 10.1016/S0006-3495(93)81456-5; YANG JT, 1995, DEVELOPMENT, V121, P549; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723	46	202	206	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17833	10.1371/journal.pone.0017833	http://dx.doi.org/10.1371/journal.pone.0017833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21468318	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000289054600018
J	Kenerson, HL; Yeh, MM; Yeung, RS				Kenerson, Heidi L.; Yeh, Matthew M.; Yeung, Raymond S.			Tuberous Sclerosis Complex-1 Deficiency Attenuates Diet-Induced Hepatic Lipid Accumulation	PLOS ONE			English	Article							INSULIN-RESISTANCE; CELL-GROWTH; MAMMALIAN TARGET; INDUCED OBESITY; ADIPOSE-TISSUE; FATTY LIVER; STEATOSIS; MICE; MTOR; GENE	Non-alcoholic fatty liver disease (NAFLD) is causally linked to type 2 diabetes, insulin resistance and dyslipidemia. In a normal liver, insulin suppresses gluconeogenesis and promotes lipogenesis. In type 2 diabetes, the liver exhibits selective insulin resistance by failing to inhibit hepatic glucose production while maintaining triglyceride synthesis. Evidence suggests that the insulin pathway bifurcates downstream of Akt to regulate these two processes. Specifically, mTORC1 has been implicated in lipogenesis, but its role on hepatic steatosis has not been examined. Here, we generated mice with hepatocyte-specific deletion of Tsc1 to study the effects of constitutive mTORC1 activation in the liver. These mice developed normally but displayed mild hepatomegaly and insulin resistance without obesity. Unexpectedly, the Tsc1-null livers showed minimal signs of steatosis even under high-fat diet condition. This 'resistant' phenotype was reversed by rapamycin and could be overcome by the expression of Myr-Akt. Moreover, rapamycin failed to reduce hepatic triglyceride levels in models of steatosis secondary to Pten ablation in hepatocytes or high-fat diet in wild-type mice. These observations suggest that mTORC1 is neither necessary nor sufficient for steatosis. Instead, Akt and mTORC1 have opposing effects on hepatic lipid accumulation such that mTORC1 protects against diet-induced steatosis. Specifically, mTORC1 activity induces a metabolic shift towards fat utilization and glucose production in the liver. These findings provide novel insights into the role of mTORC1 in hepatic lipid metabolism.	[Kenerson, Heidi L.; Yeung, Raymond S.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Yeh, Matthew M.; Yeung, Raymond S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kenerson, HL (corresponding author), Univ Washington, Dept Surg, Seattle, WA 98195 USA.	ryeung@u.washington.edu			NIH [CA77882, CA102662]; NATIONAL CANCER INSTITUTE [R01CA077882, R01CA102662] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from NIH (CA77882 and CA102662). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengoechea-Alonso MT, 2009, J BIOL CHEM, V284, P5885, DOI 10.1074/jbc.M807906200; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Capeau J, 2008, DIABETES METAB, V34, P649, DOI 10.1016/S1262-3636(08)74600-7; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Chakrabarti P, 2009, J BIOL CHEM, V284, P13296, DOI 10.1074/jbc.C800241200; Chang GR, 2009, BASIC CLIN PHARMACOL, V105, P188, DOI 10.1111/j.1742-7843.2009.00427.x; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Gross DN, 2009, CURR DIABETES REP, V9, P208, DOI 10.1007/s11892-009-0034-5; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931; Hill MM, 2002, PHARMACOL THERAPEUT, V93, P243, DOI 10.1016/S0163-7258(02)00193-6; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Korsheninnikova E, 2006, DIABETOLOGIA, V49, P3049, DOI 10.1007/s00125-006-0439-5; Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Mauvoisin D, 2007, J CELL COMMUN SIGNAL, V1, P113, DOI 10.1007/s12079-007-0011-1; Nellist M, 1999, J BIOL CHEM, V274, P35647, DOI 10.1074/jbc.274.50.35647; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Wickenden JA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2558; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004129; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; ZHENG Y, 2009, J ENDOCRINOL; Zick Y, 2004, BIOCHEM SOC T, V32, P812, DOI 10.1042/BST0320812	52	51	52	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18075	10.1371/journal.pone.0018075	http://dx.doi.org/10.1371/journal.pone.0018075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479224	Green Published, gold, Green Submitted			2022-12-27	WOS:000289054600026
J	Sato, H; Hunt, ML; Weiner, JJ; Hansen, AT; Frank, DW				Sato, Hiromi; Hunt, Meredith L.; Weiner, Joshua J.; Hansen, Andrew T.; Frank, Dara W.			Modified Needle-Tip PcrV Proteins Reveal Distinct Phenotypes Relevant to the Control of Type III Secretion and Intoxication by Pseudomonas aeruginosa	PLOS ONE			English	Article							PESTIS V-ANTIGEN; HOST-CELL MEMBRANES; EXOENZYME S REGULON; SHIGELLA-FLEXNERI; YERSINIA-PESTIS; SYSTEM NEEDLE; DEPENDENT TRANSLOCATION; ADENYLATE-CYCLASE; ESCHERICHIA-COLI; APPARATUS NEEDLE	The type III secretion system (T3SS) is employed to deliver effector proteins to the cytosol of eukaryotic hosts by multiple species of Gram-negative bacteria, including Pseudomonas aeruginosa. Translocation of effectors is dependent on the proteins encoded by the pcrGVHpopBD operon. These proteins form a T3S translocator complex, composed of a needle-tip complex (PcrV), translocons (PopB and PopD), and chaperones (PcrG and PcrH). PcrV mediates the folding and insertion of PopB/PopD in host plasmic membranes, where assembled translocons form a translocation channel. Assembly of this complex and delivery of effectors through this machinery is tightly controlled by PcrV, yet the multifunctional aspects of this molecule have not been defined. In addition, PcrV is a protective antigen for P. aeruginosa infection as is the ortholog, LcrV, for Yersinia. We constructed PcrV derivatives containing in-frame linker insertions and site-specific mutations. The expression of these derivatives was regulated by a T3S-specific promoter in a pcrV-null mutant of PA103. Nine derivatives disrupted the regulation of effector secretion and constitutively released an effector protein into growth medium. Three of these regulatory mutants, in which the linker was inserted in the N-terminal globular domain, were competent for the translocation of a cytotoxin, ExoU, into eukaryotic host cells. We also isolated strains expressing a delayed-toxicity phenotype, which secrete translocators slowly despite the normal level of effector secretion. Most of the cytotoxic translocation-competent strains retained the protective epitope of PcrV derivatives, and Mab166 was able to protect erythrocytes during infection with these strains. The use of defined PcrV derivatives possessing distinct phenotypes may lead to a better understanding of the functional aspects of T3 needle-tip proteins and the development of therapeutic agents or vaccines targeting T3SS-mediated intoxication.	[Sato, Hiromi; Hunt, Meredith L.; Weiner, Joshua J.; Hansen, Andrew T.; Frank, Dara W.] Med Coll Wisconsin, Ctr Infect Dis Res, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Sato, H (corresponding author), Med Coll Wisconsin, Ctr Infect Dis Res, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA.	hsato@mcw.edu			National Institute of Allergy and Infectious Diseases, NIH [AI49577]; Center for Infectious Disease Research; Advancing a Healthier Wisconsin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049577] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for Infectious Disease Research; Advancing a Healthier Wisconsin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI49577 from the National Institute of Allergy and Infectious Diseases, the Center for Infectious Disease Research, and the Advancing a Healthier Wisconsin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.niaid.nih.gov/Pages/default.aspx http://www.mcw.edu/display/router.aspx?docid = 16723& http://www.mcw.edu/display/router.aspx? docid = 16994&	Baer M, 2009, INFECT IMMUN, V77, P1083, DOI 10.1128/IAI.00815-08; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Blocker AJ, 2008, P NATL ACAD SCI USA, V105, P6507, DOI 10.1073/pnas.0708344105; Botteaux A, 2009, MOL MICROBIOL, V71, P449, DOI 10.1111/j.1365-2958.2008.06537.x; Bridge DR, 2010, MICROBIOL-SGM, V156, P356, DOI 10.1099/mic.0.033241-0; Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x; Brubaker RR, 2003, INFECT IMMUN, V71, P3673, DOI 10.1128/IAI.71.7.3673-3681.2003; Burr SE, 2003, J BACTERIOL, V185, P6583, DOI 10.1128/JB.185.22.6583-6591.2003; Caroline G, 2008, J BIOL CHEM, V283, P23940, DOI 10.1074/jbc.M803146200; Cisz M, 2008, J BACTERIOL, V190, P2726, DOI 10.1128/JB.01553-07; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; CROUCH BS, 1996, CHEST, V109, P1019, DOI DOI 10.1378/CHEST.109.4.1019; Dacheux D, 2001, INFECT IMMUN, V69, P538, DOI 10.1128/IAI.69.1.538-542.2001; Davis AJ, 2007, J BACTERIOL, V189, P83, DOI 10.1128/JB.01396-06; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; DeBord KL, 2001, J BACTERIOL, V183, P4588, DOI 10.1128/JB.183.15.4588-4598.2001; Derewenda U, 2004, STRUCTURE, V12, P301, DOI 10.1016/j.str.2004.01.010; Epler CR, 2009, INFECT IMMUN, V77, P2754, DOI 10.1128/IAI.00190-09; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Faure Karine, 2003, J Immune Based Ther Vaccines, V1, P2, DOI 10.1186/1476-8518-1-2; FRANK DW, 1994, INFECT IMMUN, V62, P554, DOI 10.1128/IAI.62.2.554-563.1994; Frank DW, 1997, MOL MICROBIOL, V26, P621, DOI 10.1046/j.1365-2958.1997.6251991.x; Frank DW, 2002, J INFECT DIS, V186, P64, DOI 10.1086/341069; Frithz-Lindsten E, 1998, MOL MICROBIOL, V29, P1155, DOI 10.1046/j.1365-2958.1998.00994.x; FrithzLindsten E, 1997, MOL MICROBIOL, V25, P1125, DOI 10.1046/j.1365-2958.1997.5411905.x; FU H, 1993, P NATL ACAD SCI USA, V90, P2320, DOI 10.1073/pnas.90.6.2320; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Ganesan AK, 1999, J BIOL CHEM, V274, P21823, DOI 10.1074/jbc.274.31.21823; Giamarellou H, 2000, INT J ANTIMICROB AG, V16, P103, DOI 10.1016/S0924-8579(00)00212-0; Goehring UM, 1999, J BIOL CHEM, V274, P36369, DOI 10.1074/jbc.274.51.36369; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamad MA, 2007, ADV EXP MED BIOL, V603, P225; Hill J, 1997, INFECT IMMUN, V65, P4476, DOI 10.1128/IAI.65.11.4476-4482.1997; Holder IA, 2001, INFECT IMMUN, V69, P5908, DOI 10.1128/IAI.69.9.5908-5910.2001; Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200; La Ragione RM, 2006, MICROBES INFECT, V8, P426, DOI 10.1016/j.micinf.2005.07.009; Lee PC, 2010, MOL MICROBIOL, V75, P924, DOI 10.1111/j.1365-2958.2009.07027.x; Lee VT, 2000, J BIOL CHEM, V275, P36869, DOI 10.1074/jbc.M002467200; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Marenne MN, 2003, MICROB PATHOGENESIS, V35, P243, DOI 10.1016/S0882-4010(03)00154-2; MARTINEZARGUDO I, 2010, MOL MICROBIOL   1011, DOI DOI 10.1111/J.1365-2958.2010.07413.X; McCaw ML, 2002, MOL MICROBIOL, V46, P1123, DOI 10.1046/j.1365-2958.2002.03228.x; MENARD R, 1993, J BACTERIOL, V175, P5899; MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x; Moriyama K, 2009, MICROBIOL IMMUNOL, V53, P587, DOI 10.1111/j.1348-0421.2009.00165.x; MOTIN VL, 1994, INFECT IMMUN, V62, P4192, DOI 10.1128/IAI.62.10.4192-4201.1994; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Overheim KA, 2005, INFECT IMMUN, V73, P5152, DOI 10.1128/IAI.73.8.5152-5159.2005; Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001; Quenee LE, 2010, VACCINE, V28, P1870, DOI 10.1016/j.vaccine.2009.11.076; Quinaud M, 2007, P NATL ACAD SCI USA, V104, P7803, DOI 10.1073/pnas.0610098104; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sato H, 2006, BIOCHEMISTRY-US, V45, P10368, DOI 10.1021/bi060788j; Sawa T, 1999, NAT MED, V5, P392, DOI 10.1038/7391; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Schulert GS, 2003, J INFECT DIS, V188, P1695, DOI 10.1086/379372; SKRZYPEK E, 1995, J BACTERIOL, V177, P2530, DOI 10.1128/jb.177.9.2530-2542.1995; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Stensrud KF, 2008, J BIOL CHEM, V283, P18646, DOI 10.1074/jbc.M802799200; Sun JJ, 2003, J BIOL CHEM, V278, P32794, DOI 10.1074/jbc.M304290200; Sundin C, 2002, MICROB PATHOGENESIS, V33, P265, DOI 10.1006/mpat.2002.0534; Torruellas J, 2005, MOL MICROBIOL, V57, P1719, DOI 10.1111/j.1365-2958.2005.04790.x; Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005; Veenendaal AKJ, 2009, J BACTERIOL, V191, P563, DOI 10.1128/JB.01004-08; Vernazza C, 2009, VACCINE, V27, P2775, DOI 10.1016/j.vaccine.2009.03.011; Viboud GI, 2001, EMBO J, V20, P5373, DOI 10.1093/emboj/20.19.5373; Vidal F, 1996, ARCH INTERN MED, V156, P2121, DOI 10.1001/archinte.156.18.2121; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; YAHR TL, 1995, J BACTERIOL, V177, P1169, DOI 10.1128/jb.177.5.1169-1178.1995; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Yahr TL, 1997, J BACTERIOL, V179, P7165, DOI 10.1128/jb.179.22.7165-7168.1997	76	23	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18356	10.1371/journal.pone.0018356	http://dx.doi.org/10.1371/journal.pone.0018356			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479247	gold, Green Published, Green Submitted			2022-12-27	WOS:000289054600048
J	Amsalem, E; Hefetz, A				Amsalem, Etya; Hefetz, Abraham			The Effect of Group Size on the Interplay between Dominance and Reproduction in Bombus terrestris	PLOS ONE			English	Article							DIVISION-OF-LABOR; WORKER REPRODUCTION; OVARIAN DEVELOPMENT; JUVENILE-HORMONE; HIERARCHY LENGTH; COLONY SIZE; CONFLICT; BEHAVIOR; HYMENOPTERA; ASSOCIATIONS	Social insects provide good model systems for testing trade-offs in decision-making because of their marked reproductive skew and the dilemma workers face when to reproduce. Attaining reproductive skew requires energy investment in aggression or fertility signaling, creating a trade-off between reproduction and dominance. This may be density-dependent because the cost of achieving dominance may be higher in larger groups. We investigated the effect of group-size in B. terrestris queenless workers on two major reproduction-dominance correlates: between-worker aggression, and pheromone production, aiming at mimicking decision-making during the transition of worker behavior from cooperation and sterility to aggressive reproductive competition in whole colonies. Despite the competition, reproductive division of labor in colonies can be maintained even during this phase through the production of a sterility signal by sterile workers that has an appeasement effect on dominant nestmates. Worker-worker aggression, ovary activation, and production of sterility-appeasement signals may therefore constitute components of a trade-off affecting worker reproduction decisions. By constructing queenless groups of different size and measuring how this affected the parameters above, we found that in all groups aggression was not evenly distributed with the alpha-worker performing most of the aggressive acts. Moreover, aggression by the alpha-worker increased proportionally with group-size. However, while in small groups the alpha-worker monopolized reproduction, in larger groups several workers shared reproduction, creating two worker groups: reproductives and helpers. It appears that despite the increase of aggression, this was evidently not sufficient for the alpha-worker to monopolize reproduction. If we compare the alpha-worker to the queen in full-sized colonies it can be hypothesized that worker reproduction in B. terrestris colonies starts due to a gradual increase in the worker population and the queen's inability to physically inhibit worker oviposition. This may shift the trade-off between cost and benefit of worker reproduction and trigger the competition phase.	[Amsalem, Etya; Hefetz, Abraham] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, Ramat Aviv, Israel	Tel Aviv University	Amsalem, E (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, Ramat Aviv, Israel.	amsaleme@post.tau.ac.il	Hefetz, Abraham/I-3853-2015		Israel Science Foundation (ISF) [535/08]	Israel Science Foundation (ISF)(Israel Science Foundation)	The work was supported by a grant from The Israel Science Foundation founded by the Israel Academy of Sciences (ISF grant no. 535/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2004, INSECT SOC, V51, P287, DOI 10.1007/s00040-004-0741-5; Alaux C, 2005, BEHAV ECOL SOCIOBIOL, V59, P270, DOI 10.1007/s00265-005-0035-6; Alaux C, 2006, BEHAV ECOL SOCIOBIOL, V60, P439, DOI 10.1007/s00265-006-0184-2; Amsalem E, 2010, BEHAV ECOL SOCIOBIOL, V64, P1685, DOI 10.1007/s00265-010-0982-4; Amsalem E, 2009, P R SOC B, V276, P1295, DOI 10.1098/rspb.2008.1688; Bloch G, 1999, BEHAV ECOL SOCIOBIOL, V45, P125, DOI 10.1007/s002650050546; Bloch G, 1996, PHYSIOL ENTOMOL, V21, P257, DOI 10.1111/j.1365-3032.1996.tb00863.x; Bloch G, 1999, P ROY SOC B-BIOL SCI, V266, P2465, DOI 10.1098/rspb.1999.0947; Bloch G, 2000, J COMP PHYSIOL A, V186, P261, DOI 10.1007/s003590050426; Bloch G, 2000, J INSECT PHYSIOL, V46, P47, DOI 10.1016/S0022-1910(99)00101-8; Bortolotti L, 2001, ENTOMOL EXP APPL, V101, P143, DOI 10.1023/A:1019234709744; Bourke AFG, 1999, J EVOLUTION BIOL, V12, P245, DOI 10.1046/j.1420-9101.1999.00028.x; Bourke AFG, 2001, P ROY SOC B-BIOL SCI, V268, P347, DOI 10.1098/rspb.2000.1381; BULMER MG, 1983, AM NAT, V121, P540, DOI 10.1086/284081; Cant MA, 2000, AM NAT, V155, P406, DOI 10.1086/303328; Cant MA, 2006, AM NAT, V167, P837, DOI 10.1086/503445; Cant MA, 2006, BEHAV ECOL, V17, P560, DOI 10.1093/beheco/arj065; Cnaani J, 2002, INSECT SOC, V49, P164, DOI 10.1007/s00040-002-8297-8; Cnaani J, 2007, ENTOMOL GEN, V29, P305; Cumber R. A., 1949, Transactions of the Royal Entomological Society of London, V100, P1; DUCHATEAU MJ, 1989, J ETHOL, V7, P141, DOI 10.1007/BF02350036; DUCHATEAU MJ, 1989, ENTOMOL EXP APPL, V51, P199, DOI 10.1007/BF00347883; Duchateau MJ, 2004, BEHAV ECOL, V15, P71, DOI 10.1093/beheco/arg087; DUCHATEAU MJ, 1988, BEHAVIOUR, V107, P186, DOI 10.1163/156853988X00340; Fanelli D, 2008, ANIM BEHAV, V75, P879, DOI 10.1016/j.anbehav.2007.07.009; Field J, 1998, AM NAT, V151, P545, DOI 10.1086/286140; FREE J.B, 1958, BEHAVIOUR, V12, P233, DOI 10.1163/156853957X00128; Geva S, 2005, J INSECT PHYSIOL, V51, P811, DOI 10.1016/j.jinsphys.2005.03.009; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Heinze J, 2008, NATURWISSENSCHAFTEN, V95, P757, DOI 10.1007/s00114-008-0375-y; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; MICHENER CD, 1974, SOCIAL BEHAV BEES; Molet M, 2005, INSECT SOC, V52, P247, DOI 10.1007/s00040-005-0801-5; Monnin T, 2003, BEHAV ECOL SOCIOBIOL, V54, P71, DOI 10.1007/s00265-003-0600-9; Monnin T, 1999, BEHAV ECOL SOCIOBIOL, V46, P413, DOI 10.1007/s002650050637; OWEN RE, 1982, BEHAV ECOL SOCIOBIOL, V11, P91, DOI 10.1007/BF00300097; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; Reeve HK, 2001, ANNU REV ENTOMOL, V46, P347, DOI 10.1146/annurev.ento.46.1.347; Reeve HK, 2000, AM NAT, V155, P365, DOI 10.1086/303322; ROSELER PF, 1981, EXPERIENTIA, V37, P348, DOI 10.1007/BF01959856; Seppa P, 2002, BEHAV ECOL, V13, P531, DOI 10.1093/beheco/13.4.531; Stearns S.C., 1992, pi; VANDERBLOM J, 1986, BEHAVIOUR, V97, P37, DOI 10.1163/156853986X00306; VANDOORN A, 1989, PHYSIOL ENTOMOL, V14, P211, DOI 10.1111/j.1365-3032.1989.tb00954.x; VANDOORN A, 1987, NETH J ZOOL, V37, P255, DOI 10.1163/002829687X00080; VANDOORN A, 1986, INSECT SOC, V33, P3, DOI 10.1007/BF02224031; VANHONK CGJ, 1981, BEHAV ECOL SOCIOBIOL, V9, P9, DOI 10.1007/BF00299847; [No title captured]	48	44	44	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18238	10.1371/journal.pone.0018238	http://dx.doi.org/10.1371/journal.pone.0018238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464893	Green Submitted, Green Published, gold			2022-12-27	WOS:000289053800031
J	Gunapala, KM; Gallardo, CM; Hsu, CT; Steele, AD				Gunapala, Keith M.; Gallardo, Christian M.; Hsu, Cynthia T.; Steele, Andrew D.			Single Gene Deletions of Orexin, Leptin, Neuropeptide Y, and Ghrelin Do Not Appreciably Alter Food Anticipatory Activity in Mice	PLOS ONE			English	Article							ENTRAINED CIRCADIAN-RHYTHMS; BODY-WEIGHT; ZUCKER RAT; DROSOPHILA-MELANOGASTER; SUPRACHIASMATIC NUCLEI; GLUCOSE-HOMEOSTASIS; ENERGY HOMEOSTASIS; ARCUATE NUCLEUS; DEFICIENT MICE; MUTANT MICE	Timing activity to match resource availability is a widely conserved ability in nature. Scheduled feeding of a limited amount of food induces increased activity prior to feeding time in animals as diverse as fish and rodents. Typically, food anticipatory activity (FAA) involves temporally restricting unlimited food access (RF) to several hours in the middle of the light cycle, which is a time of day when rodents are not normally active. We compared this model to calorie restriction (CR), giving the mice 60% of their normal daily calorie intake at the same time each day. Measurement of body temperature and home cage behaviors suggests that the RF and CR models are very similar but CR has the advantage of a clearly defined food intake and more stable mean body temperature. Using the CR model, we then attempted to verify the published result that orexin deletion diminishes food anticipatory activity (FAA) but observed little to no diminution in the response to CR and, surprisingly, that orexin KO mice are refractory to body weight loss on a CR diet. Next we tested the orexigenic neuropeptide Y (NPY) and ghrelin and the anorexigenic hormone, leptin, using mouse mutants. NPY deletion did not alter the behavior or physiological response to CR. Leptin deletion impaired FAA in terms of some activity measures, such as walking and rearing, but did not substantially diminish hanging behavior preceding feeding time, suggesting that leptin knockout mice do anticipate daily meal time but do not manifest the full spectrum of activities that typify FAA. Ghrelin knockout mice do not have impaired FAA on a CR diet. Collectively, these results suggest that the individual hormones and neuropepetides tested do not regulate FAA by acting individually but this does not rule out the possibility of their concerted action in mediating FAA.	[Gunapala, Keith M.; Gallardo, Christian M.; Hsu, Cynthia T.; Steele, Andrew D.] CALTECH, Div Biol, Broad Fellows Program Brain Circuitry, Pasadena, CA 91125 USA	California Institute of Technology	Gunapala, KM (corresponding author), CALTECH, Div Biol, Broad Fellows Program Brain Circuitry, Pasadena, CA 91125 USA.	steelea@caltech.edu		Gallardo, Christian/0000-0001-5702-0852	Broad Fellow Program in Brain Circuitry at Caltech; Ellison Medical Foundation; Klarman Family Foundation	Broad Fellow Program in Brain Circuitry at Caltech; Ellison Medical Foundation(Lawrence Ellison Foundation); Klarman Family Foundation	These studies were funded by the Broad Fellow Program in Brain Circuitry at Caltech, the Ellison Medical Foundation, and the Klarman Family Foundation Grants Program in Eating Disorders Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2004, EUR J NEUROSCI, V20, P3054, DOI 10.1111/j.1460-9568.2004.03749.x; Antle MC, 2009, EUR J NEUROSCI, V30, P1643, DOI 10.1111/j.1460-9568.2009.06959.x; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; BARGIELLO TA, 1984, NATURE, V312, P752, DOI 10.1038/312752a0; Blum ID, 2009, NEUROSCIENCE, V164, P351, DOI 10.1016/j.neuroscience.2009.08.009; Challet E, 2009, EUR J NEUROSCI, V30, P1676, DOI 10.1111/j.1460-9568.2009.06962.x; CHOI DL, NEUROSCIENCE, V167, P11; Clark EL, 2009, NEUROSCIENCE, V161, P970, DOI 10.1016/j.neuroscience.2009.04.007; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Goulding EH, 2008, P NATL ACAD SCI USA, V105, P20575, DOI 10.1073/pnas.0809053106; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Hillebrand JJG, 2005, BIOL PSYCHIAT, V58, P165, DOI 10.1016/j.biopsych.2005.03.011; Hsu CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012903; Hsu JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011802; Iida M, 1996, BIOCHEM BIOPH RES CO, V224, P597, DOI 10.1006/bbrc.1996.1070; Iijima M, 2005, NEUROSCI RES, V52, P166, DOI 10.1016/j.neures.2005.03.003; Jackson WS, 2009, NEURON, V63, P438, DOI 10.1016/j.neuron.2009.07.026; Kaur S, 2008, BRAIN RES, V1205, P47, DOI 10.1016/j.brainres.2008.02.026; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Marchant EG, 1997, BRAIN RES, V765, P273, DOI 10.1016/S0006-8993(97)00571-4; Mercer JG, 1996, J NEUROENDOCRINOL, V8, P733, DOI 10.1046/j.1365-2826.1996.05161.x; MISTLBERGER RE, 1992, BEHAV NEUROSCI, V106, P192, DOI 10.1037/0735-7044.106.1.192; Mistlberger RE, 2003, BRAIN RES, V980, P161, DOI 10.1016/S0006-8993(03)02755-0; Mistlberger RE, 1999, PHYSIOL BEHAV, V66, P329, DOI 10.1016/S0031-9384(98)00311-4; Mistlberger RE, 1998, APPETITE, V30, P255, DOI 10.1006/appe.1997.0134; Moon BC, 1997, GENOMICS, V42, P152, DOI 10.1006/geno.1997.4701; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Pitts SN, 2003, AM J PHYSIOL-REG I, V285, pR57, DOI 10.1152/ajpregu.00023.2003; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Seeley RJ, 1996, HORM METAB RES, V28, P664, DOI 10.1055/s-2007-979874; Seoane LM, 2003, ENDOCRINOLOGY, V144, P544, DOI 10.1210/en.2002-220795; STANLEY BG, 1993, BRAIN RES, V604, P304; STANLEY BG, 1993, PEPTIDES, V14, P475, DOI 10.1016/0196-9781(93)90135-4; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; Szentirmai E, 2010, AM J PHYSIOL-REG I, V298, pR467, DOI 10.1152/ajpregu.00557.2009; Tomaszuk A, 1996, HORM RES, V46, P53, DOI 10.1159/000184996; Verhagen LA, 2010, EUR NEUROPSYCHOPHARM; White BD, 1997, P SOC EXP BIOL MED, V214, P222, DOI 10.3181/00379727-214-44090; Wortley KE, 2004, P NATL ACAD SCI USA, V101, P8227, DOI 10.1073/pnas.0402763101; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; ZEHRING WA, 1984, CELL, V39, P369, DOI 10.1016/0092-8674(84)90015-1	54	45	47	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18377	10.1371/journal.pone.0018377	http://dx.doi.org/10.1371/journal.pone.0018377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464907	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000289053800045
J	Montoto, LG; Magana, C; Tourmente, M; Martin-Coello, J; Crespo, C; Luque-Larena, JJ; Gomendio, M; Roldan, ERS				Gomez Montoto, Laura; Magana, Concepcion; Tourmente, Maximiliano; Martin-Coello, Juan; Crespo, Cristina; Jose Luque-Larena, Juan; Gomendio, Montserrat; Roldan, Eduardo R. S.			Sperm Competition, Sperm Numbers and Sperm Quality in Muroid Rodents	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; TESTIS SIZE; CYTOCHROME-B; PRIMARY DETERMINANT; EJACULATE QUALITY; SEXUAL SELECTION; MALE-FERTILITY; IN-VIVO; EVOLUTION; SPERMATOZOA	Sperm competition favors increases in relative testes mass and production efficiency, and changes in sperm phenotype that result in faster swimming speeds. However, little is known about its effects on traits that contribute to determine the quality of a whole ejaculate (i.e., proportion of motile, viable, morphologically normal and acrosome intact sperm) and that are key determinants of fertilization success. Two competing hypotheses lead to alternative predictions: (a) sperm quantity and quality traits co-evolve under sperm competition because they play complementary roles in determining ejaculate's competitive ability, or (b) energetic constraints force trade-offs between traits depending on their relevance in providing a competitive advantage. We examined relationships between sperm competition levels, sperm quantity, and traits that determine ejaculate quality, in a comparative study of 18 rodent species using phylogenetically controlled analyses. Total sperm numbers were positively correlated to proportions of normal sperm, acrosome integrity and motile sperm; the latter three were also significantly related among themselves, suggesting no trade-offs between traits. In addition, testes mass corrected for body mass (i.e., relative testes mass), showed a strong association with sperm numbers, and positive significant associations with all sperm traits that determine ejaculate quality with the exception of live sperm. An "overall sperm quality" parameter obtained by principal component analysis (which explained 85% of the variance) was more strongly associated with relative testes mass than any individual quality trait. Overall sperm quality was as strongly associated with relative testes mass as sperm numbers. Thus, sperm quality traits improve under sperm competition in an integrated manner suggesting that a combination of all traits is what makes ejaculates more competitive. In evolutionary terms this implies that a complex network of genetic and developmental pathways underlying processes of sperm formation, maturation, transport in the female reproductive tract, and preparation for fertilization must all evolve in concert.	[Gomez Montoto, Laura; Magana, Concepcion; Tourmente, Maximiliano; Martin-Coello, Juan; Crespo, Cristina; Gomendio, Montserrat; Roldan, Eduardo R. S.] CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain; [Jose Luque-Larena, Juan] Univ Valladolid, Dept Ciencias Agroforest ETS Ingn Agr, Area Zool, Palencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Universidad de Valladolid	Montoto, LG (corresponding author), CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain.	roldane@mncn.csic.es	Roldan, Eduardo R.S./M-7947-2014; Luque-Larena, Juan Jose/D-6454-2014; Tourmente, Maximiliano/I-2852-2019	Roldan, Eduardo R.S./0000-0002-7545-4248; Luque-Larena, Juan Jose/0000-0001-6425-637X; Tourmente, Maximiliano/0000-0002-5833-9117	Spanish Ministry of Science and Innovation; Spanish Ministry of Education and Science; Spanish Ministry of Education	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of Education(Spanish Government)	This work was supported by the Spanish Ministry of Science and Innovation. L. G. M. and J.M.C. were supported by predoctoral studentships from the Spanish Ministry of Education and Science. M. T. is a postdoctoral researcher funded by the Programa Nacional de Movilidad de Recursos Humanos de Investigacion of the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2005, J ZOOL, V267, P135, DOI 10.1017/S0952836905007284; Anderson MJ, 2002, NATURE, V416, P496, DOI 10.1038/416496a; Bannikova AA, 2010, BIOL J LINN SOC, V99, P595, DOI 10.1111/j.1095-8312.2009.01378.x; BARTKE A, 1972, J HERED, V63, P172, DOI 10.1093/oxfordjournals.jhered.a108263; Birkhead TR, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P1; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; BIRKHEAD TR, 1998, SPERM COMPETITION SE, P826; Birkhead TR, 1992, SPERM COMPETITION BI; BRISKIE JV, 1992, P ROY SOC B-BIOL SCI, V247, P89, DOI 10.1098/rspb.1992.0013; Buzan EV, 2008, BIOL J LINN SOC, V94, P825, DOI 10.1111/j.1095-8312.2008.01024.x; CUMMINS JM, 1982, GAMETE RES, V5, P239, DOI 10.1002/mrd.1120050304; CUMMINS JM, 1986, GAMETE RES, V15, P187, DOI 10.1002/mrd.1120150302; CUMMINS JM, 1985, J REPROD FERTIL, V75, P153, DOI 10.1530/jrf.0.0750153; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Firman RC, 2010, EVOLUTION, V64, P1245, DOI 10.1111/j.1558-5646.2009.00894.x; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Florman HM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P55; Foote RH, 2003, ANIM REPROD SCI, V75, P119, DOI 10.1016/S0378-4320(02)00233-6; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Froman DP, 1999, BIOL REPROD, V61, P400, DOI 10.1095/biolreprod61.2.400; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Gage MJG, 2003, P ROY SOC B-BIOL SCI, V270, P625, DOI 10.1098/rspb.2002.2258; Gage MJG, 2002, J FISH BIOL, V61, P1528, DOI [10.1006/jfbi.2002.2171, 10.1111/j.1095-8649.2002.tb02495.x]; Gage MJG, 1998, J FISH BIOL, V53, P835, DOI 10.1111/j.1095-8649.1998.tb01836.x; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; GARRETT C, 2007, SPERMATOLOGY, P357; Golas A, 2008, INT J DEV BIOL, V52, P287, DOI 10.1387/ijdb.072333ag; GOMENDIO M, 1991, P ROY SOC B-BIOL SCI, V243, P181, DOI 10.1098/rspb.1991.0029; Gomendio M, 2000, P ROY SOC B-BIOL SCI, V267, P875, DOI 10.1098/rspb.2000.1084; Gomendio M, 2008, INT J DEV BIOL, V52, P439, DOI 10.1387/ijdb.082595mg; Gomendio M, 2006, P NATL ACAD SCI USA, V103, P15113, DOI 10.1073/pnas.0605795103; Gomenido Montserrat, 1998, P667, DOI 10.1016/B978-012100543-6/50041-6; Gotoh H, 2010, REPROD FERT DEVELOP, V22, P1066, DOI 10.1071/RD09295; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; Hosken DJ, 1997, P ROY SOC B-BIOL SCI, V264, P385, DOI 10.1098/rspb.1997.0055; Hosken DJ, 2001, ECOL LETT, V4, P10, DOI 10.1046/j.1461-0248.2001.00198.x; HOWARD J, 1991, J ANDROL, V12, P36; Hunter FM, 2002, CURR BIOL, V12, P121, DOI 10.1016/S0960-9822(01)00647-9; Immler S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000170; Jaarola M, 2004, MOL PHYLOGENET EVOL, V33, P647, DOI 10.1016/j.ympev.2004.07.015; JENNIONS MD, 1993, BIOL J LINN SOC, V50, P211; Jurewicz J, 2009, INT J OCCUP MED ENV, V22, P305, DOI 10.2478/v10001-009-0036-1; KENAGY GJ, 1986, J MAMMAL, V67, P1, DOI 10.2307/1380997; KOT MC, 1987, GAMETE RES, V18, P57, DOI 10.1002/mrd.1120180107; KRZANOWSKA H, 1974, J REPROD FERTIL, V38, P81, DOI 10.1530/jrf.0.0380081; Larson JL, 1999, MOL REPROD DEV, V52, P445, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;445::AID-MRD14&gt;3.0.CO;2-6; Lessells CM, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P43, DOI 10.1016/B978-0-12-372568-4.00002-1; Levitan DR, 2000, P ROY SOC B-BIOL SCI, V267, P531, DOI 10.1098/rspb.2000.1032; Lupold S, 2009, EVOLUTION, V63, P391, DOI 10.1111/j.1558-5646.2008.00571.x; Lundrigan BL, 2002, SYST BIOL, V51, P410, DOI 10.1080/10635150290069878; Malo AF, 2005, BIOL REPROD, V72, P822, DOI 10.1095/biolreprod.104.036368; Malo AF, 2005, P ROY SOC B-BIOL SCI, V272, P149, DOI 10.1098/rspb.2004.2933; Martin Y, 2000, MOL PHYLOGENET EVOL, V16, P37, DOI 10.1006/mpev.1999.0760; Martin-Coello J, 2009, P ROY SOC B-BIOL SCI, V276, P2427, DOI 10.1098/rspb.2009.0257; MOLLER AP, 1989, FUNCT ECOL, V3, P91, DOI 10.2307/2389679; MOLLER AP, 1988, J HUM EVOL, V17, P479, DOI 10.1016/0047-2484(88)90037-1; Moore H, 2002, NATURE, V418, P174, DOI 10.1038/nature00832; Moore PJ, 2004, EVOLUTION, V58, P1773, DOI 10.1111/j.0014-3820.2004.tb00460.x; NAKATSURU K, 1982, SCIENCE, V216, P753, DOI 10.1126/science.216.4547.753; Olsson M, 1997, P ROY SOC B-BIOL SCI, V264, P455, DOI 10.1098/rspb.1997.0065; Pagel M., 1991, COMP METHOD EVOLUTIO, P248; PARKER GA, 1982, J THEOR BIOL, V96, P281, DOI 10.1016/0022-5193(82)90225-9; PARKER GA, 1993, P ROY SOC B-BIOL SCI, V253, P245, DOI 10.1098/rspb.1993.0110; PARKER GA, 1993, P ROY SOC B-BIOL SCI, V253, P255, DOI 10.1098/rspb.1993.0111; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; PARKER GA, 2010, BIOL REV IN PRESS; Pfunder M, 2004, MOL ECOL, V13, P1277, DOI 10.1111/j.1365-294X.2004.02126.x; Pitnick S, 1996, AM NAT, V148, P57, DOI 10.1086/285911; Pitnick S, 2001, P ROY SOC B-BIOL SCI, V268, P1071, DOI 10.1098/rspb.2001.1621; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P247, DOI 10.1016/B978-0-12-372568-4.00007-0; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; Pukazhenthi BS, 2006, THERIOGENOLOGY, V66, P112, DOI 10.1016/j.theriogenology.2006.03.020; PURSEL VG, 1972, J ANIM SCI, V34, P278; Robinson M, 1997, MOL PHYLOGENET EVOL, V8, P423, DOI 10.1006/mpev.1997.0424; Robovsky J, 2008, ZOOL SCR, V37, P571, DOI 10.1111/j.1463-6409.2008.00342.x; ROLDAN ERS, 1992, BIOL REV, V67, P551, DOI 10.1111/j.1469-185X.1992.tb01193.x; Scott MA, 2000, ANIM REPROD SCI, V60, P337, DOI 10.1016/S0378-4320(00)00130-5; SHI QX, 1995, BIOL REPROD, V52, P540, DOI 10.1095/biolreprod52.3.540; Simmons L. W., 2001, MG BEH ECOL; SMITH TT, 1990, BIOL REPROD, V42, P450, DOI 10.1095/biolreprod42.3.450; Soulsbury CD, 2010, PLOS ONE, V5, pA152, DOI 10.1371/journal.pone.0009581; Stockley P, 1997, AM NAT, V149, P933, DOI 10.1086/286031; Suarez S.S., 1990, P111; Suarez SS, 2008, INT J DEV BIOL, V52, P455, DOI 10.1387/ijdb.072527ss; Suzuki H, 2004, MOL PHYLOGENET EVOL, V33, P626, DOI 10.1016/j.ympev.2004.08.003; TAMULI MK, 1994, ANIM REPROD SCI, V35, P247, DOI 10.1016/0378-4320(94)90040-X; TANNENBAUM LV, 2010, ARCH ENV CONTAM TOXI, V60, P173; Tomkins JL, 2002, ANIM BEHAV, V63, P1009, DOI 10.1006/anbe.2001.1994; Tougard C, 2008, BIOL J LINN SOC, V93, P309, DOI 10.1111/j.1095-8312.2007.00926.x; Tourmente M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-12	90	87	88	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18173	10.1371/journal.pone.0018173	http://dx.doi.org/10.1371/journal.pone.0018173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464956	Green Submitted, gold, Green Published			2022-12-27	WOS:000288813900046
J	Palmer, SM; Flake, GP; Kelly, FL; Zhang, HL; Nugent, JL; Kirby, PJ; Foley, JF; Gwinn, WM; Morgan, DL				Palmer, Scott M.; Flake, Gordon P.; Kelly, Fran L.; Zhang, Helen L.; Nugent, Julia L.; Kirby, Patrick J.; Foley, Julie F.; Gwinn, William M.; Morgan, Dan L.			Severe Airway Epithelial Injury, Aberrant Repair and Bronchiolitis Obliterans Develops after Diacetyl Instillation in Rats	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; SECRETORY PROTEIN CC16; LUNG TRANSPLANTATION; BASEMENT-MEMBRANE; DECREASED SERUM; WORKERS; TENASCIN; UPDATE; ASTHMA; PLANT	Background: Bronchiolitis obliterans (BO) is a fibrotic lung disease that occurs in a variety of clinical settings, including toxin exposures, autoimmunity and lung or bone marrow transplant. Despite its increasing clinical importance, little is known regarding the underlying disease mechanisms due to a lack of adequate small animal BO models. Recent epidemiological studies have implicated exposure to diacetyl (DA), a volatile component of artificial butter flavoring, as a cause of BO in otherwise healthy factory workers. Our overall hypothesis is that DA induces severe epithelial injury and aberrant repair that leads to the development of BO. Therefore, the objectives of this study were 1) to determine if DA, delivered by intratracheal instillation (ITI), would lead to the development of BO in rats and 2) to characterize epithelial regeneration and matrix repair after ITI of DA. Methods and Main Results: Male Sprague-Dawley rats were treated with a single dose of DA (125 mg/kg) or sterile water (vehicle control) by ITI. Instilled DA resulted in airway specific injury, followed by rapid epithelial regeneration, and extensive intraluminal airway fibrosis characteristic of BO. Increased airway resistance and lung fluid neutrophilia occurred with the development of BO, similar to human disease. Despite rapid epithelial regeneration after DA treatment, expression of the normal phenotypic markers, Clara cell secretory protein and acetylated tubulin, were diminished. In contrast, expression of the matrix component Tenascin C was significantly increased, particularly evident within the BO lesions. Conclusions: We have established that ITI of DA results in BO, creating a novel chemical-induced animal model that replicates histological, biological and physiological features of the human disease. Furthermore, we demonstrate that dysregulated epithelial repair and excessive matrix Tenacin C deposition occur in BO, providing new insights into potential disease mechanisms and therapeutic targets.	[Palmer, Scott M.; Kelly, Fran L.; Zhang, Helen L.; Nugent, Julia L.] Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Durham, NC 27706 USA; [Flake, Gordon P.; Kirby, Patrick J.; Foley, Julie F.; Gwinn, William M.; Morgan, Dan L.] NIEHS, Res Triangle Pk, NC 27709 USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Palmer, SM (corresponding author), Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Durham, NC 27706 USA.	palme002@mc.duke.edu		Palmer, Scott/0000-0002-1370-3771	U.S. National Institutes of Health at the National Institute of Environmental Health Sciences (NIEHS); National Heart Lung Blood Institute [HL91140-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL091140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101578, ZIGES102505, ZIAES101865] Funding Source: NIH RePORTER	U.S. National Institutes of Health at the National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was funded the U.S. National Institutes of Health through Intramural Research grants to DLM at the National Institute of Environmental Health Sciences (NIEHS) and SMP from National Heart Lung Blood Institute (grant HL91140-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afessa B, 2001, BONE MARROW TRANSPL, V28, P425, DOI 10.1038/sj.bmt.1703142; Agostini Carlo, 2006, Proc Am Thorac Soc, V3, P357, DOI 10.1513/pats.200601-010TK; Akpinar-Elci M, 2005, CHEST, V128, P991, DOI 10.1378/chest.128.2.991; Akpinar-Elci M, 2004, EUR RESPIR J, V24, P298, DOI 10.1183/09031936.04.00013903; Antonov J, 2005, LAB INVEST, V85, P1040, DOI 10.1038/labinvest.3700303; Appel JZ, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-87; Chan A, 2004, CURR OPIN PULM MED, V10, P133, DOI 10.1097/00063198-200403000-00008; Chen Huaiyong, 2009, Proc Am Thorac Soc, V6, P602, DOI 10.1513/pats.200907-078RM; Costa CLB, 2005, RESPIRATION, V72, P642, DOI 10.1159/000087363; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Glaab T, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-63; Hubbs AF, 2008, TOXICOL PATHOL, V36, P330, DOI 10.1177/0192623307312694; Karjalainen EM, 2003, RESP MED, V97, P1045, DOI 10.1016/S0954-6111(03)00136-7; KIM TJ, AM J IND MED, V53, P857; Kreiss K, 2002, NEW ENGL J MED, V347, P330, DOI 10.1056/NEJMoa020300; Laitinen A, 1997, AM J RESP CRIT CARE, V156, P951, DOI 10.1164/ajrccm.156.3.9610084; Lockey JE, 2009, EUR RESPIR J, V34, P63, DOI 10.1183/09031936.00050808; Mattsson J, 2005, TRANSPLANTATION, V79, P1411, DOI 10.1097/01.TP.0000158354.39635.AB; McDyer John F, 2007, Proc Am Thorac Soc, V4, P37, DOI 10.1513/pats.200605-107JG; Morgan DL, 2008, TOXICOL SCI, V103, P169, DOI 10.1093/toxsci/kfn016; Morris JB, 2009, TOXICOL SCI, V108, P173, DOI 10.1093/toxsci/kfn222; Nakahara H, 2006, EUR J IMMUNOL, V36, P3334, DOI 10.1002/eji.200636271; Nord M, 2002, TRANSPLANTATION, V73, P1264, DOI 10.1097/00007890-200204270-00013; Ryu JH, 2003, AM J RESP CRIT CARE, V168, P1277, DOI 10.1164/rccm.200301-053SO; Snyder JC, 2009, AM J RESP CELL MOL, V40, P633, DOI 10.1165/rcmb.2008-0334OC; van Rooy FGBGJ, 2007, AM J RESP CRIT CARE, V176, P498, DOI 10.1164/rccm.200611-1620OC; Vanaudenaerde BM, 2008, EUR RESPIR J, V32, P832, DOI 10.1183/09031936.00134307; Verleden GM, 2009, TRANSPL INT, V22, P771, DOI 10.1111/j.1432-2277.2009.00872.x	28	63	68	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17644	10.1371/journal.pone.0017644	http://dx.doi.org/10.1371/journal.pone.0017644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464978	Green Published, Green Submitted, gold			2022-12-27	WOS:000288813900004
J	von Kleist, M; Menz, S; Stocker, H; Arasteh, K; Schutte, C; Huisinga, W				von Kleist, Max; Menz, Stephan; Stocker, Hartmut; Arasteh, Keikawus; Schuette, Christof; Huisinga, Wilhelm			HIV Quasispecies Dynamics during Pro-Active Treatment Switching: Impact on Multi-Drug Resistance and Resistance Archiving in Latent Reservoirs	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; COMBINATION ANTIRETROVIRAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; IN-VIVO; TREATMENT-NAIVE; REVERSE-TRANSCRIPTASE; VIRAL SUPPRESSION; DRUG REGIMENS; INFECTION	The human immunodeficiency virus (HIV) can be suppressed by highly active anti-retroviral therapy (HAART) in the majority of infected patients. Nevertheless, treatment interruptions inevitably result in viral rebounds from persistent, latently infected cells, necessitating lifelong treatment. Virological failure due to resistance development is a frequent event and the major threat to treatment success. Currently, it is recommended to change treatment after the confirmation of virological failure. However, at the moment virological failure is detected, drug resistant mutants already replicate in great numbers. They infect numerous cells, many of which will turn into latently infected cells. This pool of cells represents an archive of resistance, which has the potential of limiting future treatment options. The objective of this study was to design a treatment strategy for treatment-naive patients that decreases the likelihood of early treatment failure and preserves future treatment options. We propose to apply a single, pro-active treatment switch, following a period of treatment with an induction regimen. The main goal of the induction regimen is to decrease the abundance of randomly generated mutants that confer resistance to the maintenance regimen, thereby increasing subsequent treatment success. Treatment is switched before the overgrowth and archiving of mutant strains that carry resistance against the induction regimen and would limit its future re-use. In silico modelling shows that an optimal trade-off is achieved by switching treatment at & 80 days after the initiation of antiviral therapy. Evaluation of the proposed treatment strategy demonstrated significant improvements in terms of resistance archiving and virological response, as compared to conventional HAART. While continuous pro-active treatment alternation improved the clinical outcome in a randomized trial, our results indicate that a similar improvement might also be reached after a single pro-active treatment switch. The clinical validity of this finding, however, remains to be shown by a corresponding trial.	[von Kleist, Max; Menz, Stephan; Schuette, Christof] Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany; [Stocker, Hartmut; Arasteh, Keikawus] Vivantes Auguste Viktoria Klinikum, Dept Gastroenterol & Infect Dis, Berlin, Germany; [Huisinga, Wilhelm] Natl Univ Ireland, Hamilton Inst, Maynooth, Kildare, Ireland; [Huisinga, Wilhelm] Univ Potsdam, Inst Math, Potsdam, Germany	Free University of Berlin; Maynooth University; University of Potsdam	von Kleist, M (corresponding author), Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany.	vkleist@zedat.fu-berlin.de	von Kleist, Max/K-3023-2016; Stoecker, Horst/F-8382-2012	von Kleist, Max/0000-0001-6587-6394; Stoecker, Horst/0000-0002-3282-3664	BMBF; DFG	BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	MvK acknowledges financial support by BMBF funding. SM acknowledges financial support by DFG funding, provided through the Dahlem Research School of Freie Universitat Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFONSI A, 2005, ESAIM P, V14, P1, DOI DOI 10.1051/PROC:2005001; Archer J, 2009, AIDS, V23, P1209, DOI 10.1097/QAD.0b013e32832b4399; Arora P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000305; Bartlett JA, 2002, J ACQ IMMUN DEF SYND, V29, pS2, DOI 10.1097/00126334-200202011-00002; Blankson JN, 2000, J INFECT DIS, V182, P1636, DOI 10.1086/317615; Blumberg HM, 2005, JAMA-J AM MED ASSOC, V293, P2776, DOI 10.1001/jama.293.22.2776; Callaway DS, 2002, B MATH BIOL, V64, P29, DOI 10.1006/bulm.2001.0266; Carr A, 2003, NAT REV DRUG DISCOV, V2, P624, DOI 10.1038/nrd1151; Carter CC, 2010, NAT MED, V16, P446, DOI 10.1038/nm.2109; Catanzaro Linda M, 2004, Curr HIV/AIDS Rep, V1, P89, DOI 10.1007/s11904-004-0013-z; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Clavel Francois, 2009, Eur J Med Res, V14 Suppl 3, P47; COFFIN J, 2006, 13 C RETR OPP INF 5; Coovadia A, 2010, JAMA-J AM MED ASSOC, V304, P1082, DOI 10.1001/jama.2010.1278; Curlin ME, 2007, PLOS COMPUT BIOL, V3, P1239, DOI 10.1371/journal.pcbi.0030133; D'Amato RM, 1998, ANTIVIR THER, V3, P147; DeJesus E, 2006, JAIDS-J ACQ IMM DEF, V43, P1, DOI 10.1097/01.qai.0000233308.82860.2f; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; Fabbiani M, 2009, J ANTIMICROB CHEMOTH, V64, P109, DOI 10.1093/jac/dkp132; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fondere JM, 2004, J CLIN VIROL, V29, P33, DOI 10.1016/S1386-6532(03)00083-0; Ghosn J, 2006, AIDS, V20, P159, DOI 10.1097/01.aids.0000199820.47703.a0; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Horstkotte D, 2004, EUR HEART J, V25, P267, DOI 10.1016/j.ehj.2003.11.008; Ji HZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009263; KLOPFENSTEIN RW, 1971, RCA REV, V32, P447; Koelsch KK, 2008, J INFECT DIS, V197, P411, DOI 10.1086/525283; Lambotte O, 2004, AIDS, V18, P1147, DOI 10.1097/00002030-200405210-00008; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Lennox JL, 2010, JAIDS-J ACQ IMM DEF, V55, P39, DOI 10.1097/QAI.0b013e3181da1287; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Markowitz M, 2003, J VIROL, V77, P5037, DOI 10.1128/JVI.77.8.5037-5038.2003; Martinez-Picado J, 2003, ANN INTERN MED, V139, P81, DOI 10.7326/0003-4819-139-2-200307150-00007; Martinez-Picado J, 2008, VIRUS RES, V134, P104, DOI 10.1016/j.virusres.2007.12.021; Murray JM, 2007, AIDS, V21, P2315, DOI 10.1097/QAD.0b013e3282f12377; Negredo E, 2004, ANTIVIR THER, V9, P889; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; Reekie J, 2010, HIV MED, V11, P469, DOI 10.1111/j.1468-1293.2009.00816.x; Ribeiro RM, 1998, AIDS, V12, P461, DOI 10.1097/00002030-199805000-00006; Richman DD, 2000, ANTIVIR THER, V5, P27; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Sedaghat AR, 2008, P NATL ACAD SCI USA, V105, P4832, DOI 10.1073/pnas.0711372105; Sedaghat AR, 2009, ANTIVIR THER, V14, P263; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; Sherr L, 2007, INT J STD AIDS, V18, P700, DOI 10.1258/095646207782193821; Siliciano JD, 2004, J ANTIMICROB CHEMOTH, V54, P6, DOI 10.1093/jac/dkh292; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; US Department of Health and Human Services US Food and Drug Administration Center for Drug Evaluation and Research Center for Biologics Evaluation and Research Center for Devices and Radiological Health, 2009, PAN ANT GUID AD AD G, P1; von Kleist M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000720; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005; Zimmerli W, 2003, INFECTION, V31, P99, DOI 10.1007/s15010-002-3079-9	69	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18204	10.1371/journal.pone.0018204	http://dx.doi.org/10.1371/journal.pone.0018204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455303	Green Submitted, Green Published, gold			2022-12-27	WOS:000288811500028
J	Mermel, LA; Machan, JT; Parenteau, S				Mermel, Leonard A.; Machan, Jason T.; Parenteau, Stephen			Seasonality of MRSA Infections	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS INFECTIONS; GENERAL-PRACTICE; IMPETIGO; CARRIAGE; 3-YEAR	Using MRSA isolates submitted to our hospital microbiology laboratory January 2001-March 2010 and the number of our emergency department (ED) visits, quarterly community-associated (CA) and hospital-associated (HA) MRSA infections were modeled using Poisson regressions. For pediatric patients, approximately 1.85x (95% CI 1.45x-2.36x, adj. p < 0.0001) as many CA-MRSA infections per ED visit occurred in the second two quarters as occurred in the first two quarters. For adult patients, 1.14x (95% CI 1.01x-1.29x, adj. p = 0.03) as many infections per ED visit occurred in the second two quarters as in the first two quarters. Approximately 2.94x (95% CI 1.39x-6.21x, adj. p = 0.015) as many HA-MRSA infections per hospital admission occurred in the second two quarters as occurred in the first two quarters for pediatric patients. No seasonal variation was observed among adult HA-MRSA infections per hospital admission. We demonstrated seasonality of MRSA infections and provide a summary table of similar observations in other studies.	[Mermel, Leonard A.; Parenteau, Stephen] Rhode Isl Hosp, Dept Epidemiol & Infect Control, Providence, RI 02903 USA; [Mermel, Leonard A.] Brown Univ, Dept Med, Warren Alpert Med Sch, Providence, RI 02912 USA; [Machan, Jason T.] Brown Univ, Dept Orthopaed, Warren Alpert Med Sch, Providence, RI USA; [Machan, Jason T.] Brown Univ, Dept Surg, Warren Alpert Med Sch, Providence, RI 02912 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Brown University	Mermel, LA (corresponding author), Rhode Isl Hosp, Dept Epidemiol & Infect Control, Providence, RI 02903 USA.	lmermel@lifespan.org	Mermel, Leonard/Z-1475-2019; Machan, Jason/D-3897-2013	Machan, Jason/0000-0003-2048-4914				Bassetti S, 2005, INFECT CONT HOSP EP, V26, P196, DOI 10.1086/502526; Chi Chih-Yu, 2004, J Microbiol Immunol Infect, V37, P16; Cluff L E, 1968, Trans Am Clin Climatol Assoc, V79, P205; Dailiana ZH, 2008, MED SCI MONITOR, V14, pCR511; Dietrich DW, 2004, PEDIATRICS, V113, pE347, DOI 10.1542/peds.113.4.e347; DILLON HC, 1968, AM J DIS CHILD, V115, P530, DOI 10.1001/archpedi.1968.02100010532002; EHRENKRANTZ NJ, 1964, NEW ENGL J MED, V271, P225, DOI 10.1056/NEJM196407302710503; ELEGBE IA, 1983, J ROY SOC HEALTH, V103, P118, DOI 10.1177/146642408310300308; Elliot AJ, 2006, FAM PRACT, V23, P490, DOI 10.1093/fampra/cml042; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; Harrison LM, 1999, FEMS IMMUNOL MED MIC, V25, P19, DOI 10.1111/j.1574-695X.1999.tb01323.x; Kaimal S, 2009, INT J DERMATOL, V48, P1082, DOI 10.1111/j.1365-4632.2009.04156.x; Kakar Nirupama, 1999, Journal of Dermatology (Tokyo), V26, P288; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Koning S, 2006, BRIT J DERMATOL, V154, P239, DOI 10.1111/j.1365-2133.2005.06766.x; KRISTENSEN JK, 1991, INT J DERMATOL, V30, P699, DOI 10.1111/j.1365-4362.1991.tb02612.x; Levy RM, 2005, CLIN MICROBIOL INFEC, V11, P153, DOI 10.1111/j.1469-0691.2004.01042.x; Loffeld A, 2005, CLIN EXP DERMATOL, V30, P512, DOI 10.1111/j.1365-2230.2005.01847.x; Luby S, 2002, AM J TROP MED HYG, V67, P430, DOI 10.4269/ajtmh.2002.67.430; Monnet DL, 2004, EMERG INFECT DIS, V10, P1432, DOI 10.3201/eid1008.020694; Morin CA, 2001, J INFECT DIS, V184, P1029, DOI 10.1086/323459; Morrison-Rodriguez SM, 2010, EPIDEMIOL INFECT, V138, P721, DOI 10.1017/S0950268810000142; NOBLE WC, 1967, J HYG-CAMB, V65, P567, DOI 10.1017/S002217240004609X; Perencevich EN, 2008, INFECT CONT HOSP EP, V29, P1124, DOI 10.1086/592698; ROGERS M, 1987, MED J AUSTRALIA, V147, P63, DOI 10.5694/j.1326-5377.1987.tb133260.x; Sdougkos G, 2008, CLIN MICROBIOL INFEC, V14, P995, DOI 10.1111/j.1469-0691.2008.02064.x; SINGH G, 1973, DERMATOLOGICA, V147, P342, DOI 10.1159/000251891; Skinner D, 1941, ARCH INTERN MED, V68, P851, DOI 10.1001/archinte.1941.00200110003001; Solberg C O, 1965, Acta Med Scand Suppl, V436, P1; Szczesiul JM, 2007, PEDIATR INFECT DIS J, V26, P852, DOI 10.1097/INF.0b013e318124aa5c; TAPLIN D, 1965, ARCH ENVIRON HEALTH, V11, P546, DOI 10.1080/00039896.1965.10664255; Tveten Y, 2002, J ANTIMICROB CHEMOTH, V50, P873, DOI 10.1093/jac/dkf217; Van De Griend P, 2009, EMERG INFECT DIS, V15, P1582, DOI 10.3201/eid1510.080877; WHITE A, 1961, J LAB CLIN MED, V58, P273; Wiersma P, 2009, EPIDEMIOL INFECT, V137, P1674, DOI 10.1017/S0950268809002490	35	46	47	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17925	10.1371/journal.pone.0017925	http://dx.doi.org/10.1371/journal.pone.0017925			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21468350	Green Submitted, Green Published, gold			2022-12-27	WOS:000288810500022
J	Lauridsen, H; Hansen, K; Wang, T; Agger, P; Andersen, JL; Knudsen, PS; Rasmussen, AS; Uhrenholt, L; Pedersen, M				Lauridsen, Henrik; Hansen, Kasper; Wang, Tobias; Agger, Peter; Andersen, Jonas L.; Knudsen, Peter S.; Rasmussen, Anne S.; Uhrenholt, Lars; Pedersen, Michael			Inside Out: Modern Imaging Techniques to Reveal Animal Anatomy	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; PERFUSION; MRI; CT	Animal anatomy has traditionally relied on detailed dissections to produce anatomical illustrations, but modern imaging modalities, such as MRI and CT, now represent an enormous resource that allows for fast non-invasive visualizations of animal anatomy in living animals. These modalities also allow for creation of three-dimensional representations that can be of considerable value in the dissemination of anatomical studies. In this methodological review, we present our experiences using MRI, CT and mu CT to create advanced representation of animal anatomy, including bones, inner organs and blood vessels in a variety of animals, including fish, amphibians, reptiles, mammals, and spiders. The images have a similar quality to most traditional anatomical drawings and are presented together with interactive movies of the anatomical structures, where the object can be viewed from different angles. Given that clinical scanners found in the majority of larger hospitals are fully suitable for these purposes, we encourage biologists to take advantage of these imaging techniques in creation of three-dimensional graphical representations of internal structures.	[Lauridsen, Henrik; Hansen, Kasper; Rasmussen, Anne S.; Pedersen, Michael] Aarhus Univ, Hosp Skejby, MR Res Ctr, Aarhus, Denmark; [Lauridsen, Henrik; Hansen, Kasper; Wang, Tobias; Andersen, Jonas L.; Knudsen, Peter S.] Aarhus Univ, Dept Biol Sci, Aarhus, Denmark; [Agger, Peter; Pedersen, Michael] Aarhus Univ, Hosp Skejby, Inst Clin Med, Aarhus, Denmark; [Uhrenholt, Lars] Aarhus Univ, Dept Forens Med, Sect Forens Pathol, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Lauridsen, H (corresponding author), Aarhus Univ, Hosp Skejby, MR Res Ctr, Aarhus, Denmark.	michael@mr.au.dk	Agger, Peter/H-5122-2019; Wang, Tobias/I-7946-2013	Wang, Tobias/0000-0002-4350-3682; Lauridsen, Henrik/0000-0002-8833-4456; Uhrenholt, Lars/0000-0002-2823-3995; Rasmussen, Anne Staub/0000-0002-6562-0572; Agger, Peter/0000-0002-7338-6624; Hansen, Kasper/0000-0002-8669-8897	The Danish Agency for Science, Technology and Innovation	The Danish Agency for Science, Technology and Innovation	The study was supported by The Danish Agency for Science, Technology and Innovation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2003, CAN J EARTH SCI, V40, P1071, DOI 10.1139/E03-023; Baker M, 2010, NATURE, V463, P977, DOI 10.1038/463977a; Beuf O, 2006, MAGN RESON MATER PHY, V19, P202, DOI 10.1007/s10334-006-0048-9; BOJANUS LH, 1776, ANATOMETESTUDINIS EU; Cozzone PJ, 2004, MAGN RESON MATER PHY, V17, P101, DOI 10.1007/s10334-004-0091-3; De Iuliis G., 2007, DISSECTION VERTEBRAT; Dierick M, 2007, NUCL INSTRUM METH A, V580, P641, DOI 10.1016/j.nima.2007.05.030; *DIG FISH LIB, COLL PROJ U CAL; Dinley J, 2010, J MICROSC-OXFORD, V238, P123, DOI 10.1111/j.1365-2818.2009.03335.x; Drake R., 2007, GRAYS ATLAS ANATOMY; Ellis H, 1999, HUMAN SECTIONAL ANAT; Garland MR, 2002, RADIOGRAPHICS, V22, P55, DOI 10.1148/radiographics.22.1.g02ja1155; Gumpenberger M, 2001, SEMIN AVIAN EXOT PET, V10, P174, DOI 10.1053/saep.2001.24674; HAACKE EM, 1999, MAGNETIC RESONANCE I, V331, P669; Haackes EM, 1999, MAGNETIC RESONANCE I, P331; KENT GC, 2001, COMP ANATOMY VERTEBR; O'Malley B., 2007, CLIN ANATOMY PHYSL E; Pees M, 2009, VET RADIOL ULTRASOUN, V50, P487, DOI 10.1111/j.1740-8261.2009.01569.x; Pohlmann A, 2007, MAGN RESON IMAGING, V25, P129, DOI 10.1016/j.mri.2006.08.019; Pough F.H., 1996, VERTEBRATE LIFE; Raiti P, 1997, J ZOO WILDLIFE MED, V28, P189; Randall DJ, 2002, ECKERT ANIMAL PHYSL, V5; Rasmussen Anne S., 2010, BMC Physiology, V10, P3, DOI 10.1186/1472-6793-10-3; Rieppel O, 2008, ZOOL J LINN SOC-LOND, V152, P131, DOI 10.1111/j.1096-3642.2007.00337.x; Rosen D.E., 1976, Bulletin Am Mus nat Hist, V157, P1; Samii VF, 1998, VET RADIOL ULTRASOUN, V39, P504, DOI 10.1111/j.1740-8261.1998.tb01640.x; Secor SM, 2008, J EXP BIOL, V211, P3767, DOI 10.1242/jeb.023754; SMITH DG, 1976, CELL TISSUE RES, V165, P199; Valente ALS, 2007, VET J, V174, P362, DOI 10.1016/j.tvjl.2006.08.018; Walter T, 2010, NAT METHODS, V7, pS26, DOI [10.1038/nmeth.1431, 10.1038/NMETH.1431]; YOUNG JAMES, 1929, PROC ROY SOC MED, V23, P1; Zhou YQ, 2004, LAB INVEST, V84, P385, DOI 10.1038/labinvest.3700038; Ziegler A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-313; Ziegler A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-45; Ziegler A, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-10; Ziegler A, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-33	36	61	63	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17879	10.1371/journal.pone.0017879	http://dx.doi.org/10.1371/journal.pone.0017879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445356	Green Submitted, gold, Green Published			2022-12-27	WOS:000288809100013
J	Lee, BK; Lessler, J; Stuart, EA				Lee, Brian K.; Lessler, Justin; Stuart, Elizabeth A.			Weight Trimming and Propensity Score Weighting	PLOS ONE			English	Article							DEMYSTIFYING DOUBLE ROBUSTNESS; ALTERNATIVE STRATEGIES; CAUSAL INFERENCE; DEPRESSION	Propensity score weighting is sensitive to model misspecification and outlying weights that can unduly influence results. The authors investigated whether trimming large weights downward can improve the performance of propensity score weighting and whether the benefits of trimming differ by propensity score estimation method. In a simulation study, the authors examined the performance of weight trimming following logistic regression, classification and regression trees (CART), boosted CART, and random forests to estimate propensity score weights. Results indicate that although mis-specified logistic regression propensity score models yield increased bias and standard errors, weight trimming following logistic regression can improve the accuracy and precision of final parameter estimates. In contrast, weight trimming did not improve the performance of boosted CART and random forests. The performance of boosted CART and random forests without weight trimming was similar to the best performance obtainable by weight trimmed logistic regression estimated propensity scores. While trimming may be used to optimize propensity score weights estimated using logistic regression, the optimal level of trimming is difficult to determine. These results indicate that although trimming can improve inferences in some settings, in order to consistently improve the performance of propensity score weighting, analysts should focus on the procedures leading to the generation of weights (i. e., proper specification of the propensity score model) rather than relying on ad-hoc methods such as weight trimming.	[Lee, Brian K.] Drexel Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Lessler, Justin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Stuart, Elizabeth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Stuart, Elizabeth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA	Drexel University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lee, BK (corresponding author), Drexel Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Philadelphia, PA 19104 USA.	bklee@drexel.edu		Lessler, Justin/0000-0002-9741-8109; Lee, Brian/0000-0002-3635-8034; Stuart, Elizabeth/0000-0002-9042-8611	National Institute of Mental Health [K25MH083846]; NATIONAL INSTITUTE OF MENTAL HEALTH [K25MH083846] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Award Number K25MH083846 from the National Institute of Mental Health ( PI: Stuart). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2009, MED DECIS MAKING, V29, P661, DOI 10.1177/0272989X09341755; Bang H, 2005, BIOMETRICS, V61, P962, DOI 10.1111/j.1541-0420.2005.00377.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BREIMAN L, 2008, RANDOMFOREST BREIMAN; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Do DP, 2008, AM J EPIDEMIOL, V168, P611, DOI 10.1093/aje/kwn182; DRAKE C, 1993, BIOMETRICS, V49, P1231, DOI 10.2307/2532266; Elliott M. R., 2000, J OFF STAT, V16, P191; Elliott MR, 2008, J OFF STAT, V24, P517; Freedman DA, 2008, EVALUATION REV, V32, P392, DOI 10.1177/0193841X08317586; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Harder VS, 2008, AM J EPIDEMIOL, V168, P592, DOI 10.1093/aje/kwn184; Harder VS, 2006, ADDICTION, V101, P1463, DOI 10.1111/j.1360-0443.2006.01545.x; LEE BK, 2009, STAT MED; Lee BK, 2010, STAT MED, V29, P337, DOI 10.1002/sim.3782; Luellen JK, 2005, EVALUATION REV, V29, P530, DOI 10.1177/0193841X05275596; Ma S, 2008, AM J PUBLIC HEALTH, V98, P2285, DOI 10.2105/AJPH.2007.117127; McCaffrey DF, 2004, PSYCHOL METHODS, V9, P403, DOI 10.1037/1082-989X.9.4.403; Petersen JL, 2010, AM HEART J, V159, P462, DOI 10.1016/j.ahj.2009.11.031; Potter F. J., 1993, EFFECT WEIGHT TRIMMI; Ridgeway G, 2006, TWANG TOOLKIT WEIGHT; Ridgeway G, 2007, STAT SCI, V22, P540, DOI 10.1214/07-STS227C; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; RUBIN DB, 2001, HLTH SERVICES OUTCOM, V2; Schafer JL, 2008, PSYCHOL METHODS, V13, P279, DOI 10.1037/a0014268; Setoguchi S, 2008, PHARMACOEPIDEM DR S, V17, P546, DOI 10.1002/pds.1555; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; THERNEAU TM, 2007, RPART RECURSIVE PART; Trojano M, 2007, ANN NEUROL, V61, P300, DOI 10.1002/ana.21102; WESTREICH D, J CLIN EPID IN PRESS; ZADOR P, 2001, P SECT SURV RES METH	34	248	250	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18174	10.1371/journal.pone.0018174	http://dx.doi.org/10.1371/journal.pone.0018174			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YU	21483818	gold, Green Submitted, Green Published			2022-12-27	WOS:000289057200038
J	Lee, KM; Yang, JS; Kim, G; Lee, J; Goh, KI; Kim, IM				Lee, Kyu-Min; Yang, Jae-Suk; Kim, Gunn; Lee, Jaesung; Goh, Kwang-Il; Kim, In-mook			Impact of the Topology of Global Macroeconomic Network on the Spreading of Economic Crises	PLOS ONE			English	Article							FINANCIAL CONTAGION; TRADE; FLUCTUATIONS	Throughout economic history, the global economy has experienced recurring crises. The persistent recurrence of such economic crises calls for an understanding of their generic features rather than treating them as singular events. The global economic system is a highly complex system and can best be viewed in terms of a network of interacting macroeconomic agents. In this regard, from the perspective of collective network dynamics, here we explore how the topology of the global macroeconomic network affects the patterns of spreading of economic crises. Using a simple toy model of crisis spreading, we demonstrate that an individual country's role in crisis spreading is not only dependent on its gross macroeconomic capacities, but also on its local and global connectivity profile in the context of the world economic network. We find that on one hand clustering of weak links at the regional scale can significantly aggravate the spread of crises, but on the other hand the current network structure at the global scale harbors higher tolerance of extreme crises compared to more "globalized" random networks. These results suggest that there can be a potential hidden cost in the ongoing globalization movement towards establishing less-constrained, trans-regional economic links between countries, by increasing vulnerability of the global economic system to extreme crises.	[Lee, Kyu-Min; Goh, Kwang-Il; Kim, In-mook] Korea Univ, Dept Phys, Seoul 136701, South Korea; [Yang, Jae-Suk] Columbia Univ, Sanford C Bernstein & Co, Ctr Leadership & Eth, Columbia Business Sch, New York, NY USA; [Kim, Gunn] Sejong Univ, Dept Phys, Seoul, South Korea; [Lee, Jaesung] Sogang Univ, Dept Math, Seoul, South Korea	Korea University; Columbia University; Sejong University; Sogang University	Lee, KM (corresponding author), Korea Univ, Dept Phys, Seoul 136701, South Korea.	kgoh@korea.ac.kr	Yang, Jae-Suk/F-2332-2015	Yang, Jae-Suk/0000-0001-9595-5229	MEST [2009-0080801]; Lotte Scholarship Foundation; Sanford C. Benstein & Co. Center for Leadership and Ethics;  [NRF-2010-356-B00016]	MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Lotte Scholarship Foundation; Sanford C. Benstein & Co. Center for Leadership and Ethics; 	This work was supported by Mid-career Researcher Program through NRF grant funded by the MEST (No. 2009-0080801). K-ML acknowledges support from the Lotte Scholarship Foundation. J-SY was supported by NRF-2010-356-B00016 grant and is grateful to the Sanford C. Benstein & Co. Center for Leadership and Ethics for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allen F, 2000, J POLIT ECON, V108, P1, DOI 10.1086/262109; Allen F, 2007, UNDERSTANDING FINANC; Arvai Z, 2009, FINANC UVER, V59, P522; Bak P., 1996, NATURE WORKS SCI SEL; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Boss M, 2004, QUANT FINANC, V4, P677, DOI 10.1080/14697680400020325; Caldarelli G., 2007, SCALE FREE NETWORKS; Bohorquez JC, 2009, NATURE, V462, P911, DOI 10.1038/nature08631; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Daley DJ, 1999, EPIDEMIC MODELING; Forbes KJ, 2002, NBER CONF R, P77; Garas A, 2008, EUR PHYS J B, V63, P265, DOI 10.1140/epjb/e2008-00237-3; Garas A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113043; Garlaschelli D, 2005, PHYSICA A, V350, P491, DOI 10.1016/j.physa.2004.11.040; Gatti DD, 2009, J ECON INTERACT COOR, V4, P195, DOI 10.1007/s11403-009-0054-x; Glick R, 1999, J INT MONEY FINANC, V18, P603, DOI 10.1016/S0261-5606(99)00023-6; Goh KI, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.148701; Gopikrishnan P, 1999, PHYS REV E, V60, P5305, DOI 10.1103/PhysRevE.60.5305; HALDANE A, RETHINKING FINANCIAL; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Iori G, 2008, J ECON DYN CONTROL, V32, P259, DOI 10.1016/j.jedc.2007.01.032; Kali R, 2007, J INT BUS STUD, V38, P595, DOI 10.1057/palgrave.jibs.8400286; Kali R, 2010, ECON INQ, V48, P1072, DOI 10.1111/j.1465-7295.2009.00249.x; Kaminsky GL, 2000, J INT ECON, V51, P145, DOI 10.1016/S0022-1996(99)00040-9; Kindleberger CP, 2005, MANIAS, PANICS AND CRASHES: A HISTORY OF FINANCIAL CRISES, 5TH EDITION, P1, DOI 10.1057/9780230628045; Kinney R, 2005, EUR PHYS J B, V46, P101, DOI 10.1140/epjb/e2005-00237-9; Kwon O, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/68003; LELAND WE, 1994, IEEE ACM T NETWORK, V2, P1, DOI 10.1109/90.282603; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; Motter AE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098701; Motter AE, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.065102; Onnela JP, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.056110; ONNELA JP, 2006, P NIKKEI ECONOPHYSIC, V3; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Paul G, 2006, PHYSICA A, V370, P854, DOI 10.1016/j.physa.2006.02.044; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Serrano M. A., 2007, J ECON INTERACT COOR, V2, P111, DOI DOI 10.1007/S11403-007-0026-Y; Serrano MA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.015101; SMITH DA, 1992, SOC FORCES, V70, P857, DOI 10.2307/2580193; STANLEY HE, 2008, AM PHYS SOC NEWS, V17, P8; UN Conference on Trade and Development, 2009, GLOB EC CRIS SYST FA; WALLACE I, 1990, GLOBAL EC SYSTEM; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Zlatic V, 2009, EUR PHYS J B, V67, P271, DOI 10.1140/epjb/e2009-00007-9	47	66	71	9	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18443	10.1371/journal.pone.0018443	http://dx.doi.org/10.1371/journal.pone.0018443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YU	21483794	Green Submitted, Green Published, gold			2022-12-27	WOS:000289057200080
J	Sengupta, S; Ulasov, IV; Thaci, B; Ahmed, AU; Lesniak, MS				Sengupta, Sadhak; Ulasov, Ilya V.; Thaci, Bart; Ahmed, Atique U.; Lesniak, Maciej S.			Enhanced Transduction and Replication of RGD-Fiber Modified Adenovirus in Primary T Cells	PLOS ONE			English	Article							MEDIATED GENE DELIVERY; COXSACKIE B VIRUSES; ONCOLYTIC ADENOVIRUS; DENDRITIC CELLS; IN-VIVO; INTRACRANIAL GLIOMA; MALIGNANT GLIOMA; NATURAL-KILLER; LYMPHOCYTES; VECTORS	Background: Adenoviruses are often used as vehicles to mediate gene delivery for therapeutic purposes, but their research scope in hematological cells remains limited due to a narrow choice of host cells that express the adenoviral receptor (CAR). T cells, which are attractive targets for gene therapy of numerous diseases, remain resistant to adenoviral infection because of the absence of CAR expression. Here, we demonstrate that this resistance can be overcome when murine or human T cells are transduced with an adenovirus incorporating the RGD-fiber modification (Ad-RGD). Methodology/Principal Finding: A luciferase-expressing replication-deficient Ad-RGD infected 3-fold higher number of activated primary T cells than an adenovirus lacking the RGD-fiber modification in vitro. Infection with replication-competent Ad-RGD virus also caused increased cell cycling, higher E1A copy number and enriched hexon antigen expression in both human and murine T cells. Transduction with oncolytic Ad-RGD also resulted in higher titers of progeny virus and enhanced the killing of T cells. In vivo, 35-45% of splenic T cells were transduced by Ad-RGD. Conclusions: Collectively, our results prove that a fiber modified Ad-RGD successfully transduces and replicates in primary T cells of both murine and human origin.	[Sengupta, Sadhak; Ulasov, Ilya V.; Thaci, Bart; Ahmed, Atique U.; Lesniak, Maciej S.] Univ Chicago, Brain Tumor Ctr, Chicago, IL 60637 USA	University of Chicago	Sengupta, S (corresponding author), Univ Chicago, Brain Tumor Ctr, Chicago, IL 60637 USA.	mlesniak@surgery.bsd.uchicago.edu	Ulasov, Ilya/A-2352-2014; Sengupta, Sadhak/D-2526-2009	Ulasov, Ilya/0000-0002-0818-0363; Thaci, Bart/0000-0001-5392-7174	NCI [R01CA122930, R01CA138587]; National Institute of Neurological Disorders and Stroke [U01NS069997]; American Cancer Society [RSG-07-276-01-MGO]; NATIONAL CANCER INSTITUTE [R01CA122930, R01CA138587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS069997] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the NCI (R01CA122930, R01CA138587), the National Institute of Neurological Disorders and Stroke (U01NS069997), and the American Cancer Society (RSG-07-276-01-MGO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 1996, BIOCHEM BIOPH RES CO, V218, P164, DOI 10.1006/bbrc.1996.0029; Ahmed AU, 2010, MOL THER, V18, P1846, DOI 10.1038/mt.2010.131; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bergelson JM, 1998, J VIROL, V72, P415, DOI 10.1128/JVI.72.1.415-419.1998; Bobisse S, 2009, CANCER RES, V69, P9385, DOI 10.1158/0008-5472.CAN-09-0494; Chen Z, 2002, J IMMUNOL METHODS, V260, P79, DOI 10.1016/S0022-1759(01)00521-X; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Coughlan L, 2009, J VIROL, V83, P6416, DOI 10.1128/JVI.00445-09; Di Nicola M, 1999, HUM GENE THER, V10, P1875; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Evans J. D., 2002, ADENOVIRAL VECTORS G, P39; Fueyo J, 2000, ONCOGENE, V19, P2, DOI 10.1038/sj.onc.1203251; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; Harui A, 2006, J IMMUNOL METHODS, V312, P94, DOI 10.1016/j.jim.2006.02.014; Harui A, 2006, J LEUKOCYTE BIOL, V79, P1271, DOI 10.1189/jlb.1105694; HUANG SA, 1995, J VIROL, V69, P2257, DOI 10.1128/JVI.69.4.2257-2263.1995; Hurez Vincent, 2002, BMC Immunol, V3, P4, DOI 10.1186/1471-2172-3-4; Kennedy-Nasser AA, 2007, CURR OPIN HEMATOL, V14, P616, DOI 10.1097/MOH.0b013e3282ef615a; Lecoeur H, 1997, J IMMUNOL METHODS, V209, P111, DOI 10.1016/S0022-1759(97)00138-5; Liu YZ, 2004, HUM GENE THER, V15, P637, DOI 10.1089/1043034041361181; McNees AL, 2004, J VIROL, V78, P6955, DOI 10.1128/JVI.78.13.6955-6966.2004; Miller G, 2002, CANCER RES, V62, P5260; NAKAMURA Y, 1994, CANCER RES, V54, P5757; Nandi S, 2009, J GENE MED, V11, P1005, DOI 10.1002/jgm.1385; Nevins JR, 1997, METHOD ENZYMOL, V283, P205; Okada N, 2005, CANCER GENE THER, V12, P72, DOI 10.1038/sj.cgt.7700772; Okada N, 2003, CANCER GENE THER, V10, P421, DOI 10.1038/sj.cgt.7700586; Rein DT, 2004, INT J CANCER, V111, P698, DOI 10.1002/ijc.20295; Schmidt MR, 2000, J IMMUNOL, V165, P4112, DOI 10.4049/jimmunol.165.7.4112; Schroers R, 2004, EXP HEMATOL, V32, P536, DOI 10.1016/j.exphem.2004.03.010; Sengupta S, 2005, IMMUNOBIOLOGY, V210, P647, DOI 10.1016/j.imbio.2005.06.003; Sengupta S, 2007, J IMMUNOL, V178, P6083, DOI 10.4049/jimmunol.178.10.6083; Sonabend AM, 2009, CANCER GENE THER, V16, P362, DOI 10.1038/cgt.2008.80; Sonabend AM, 2008, STEM CELLS, V26, P831, DOI 10.1634/stemcells.2007-0758; Tekant Y, 2005, SURGERY, V137, P527, DOI 10.1016/j.surg.2004.12.014; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Tyler MA, 2006, MOL CANCER THER, V5, P2408, DOI 10.1158/1535-7163.MCT-06-0187; Ulasov IV, 2007, HUM GENE THER, V18, P589, DOI 10.1089/hum.2007.002; Vera JF, 2009, CURR GENE THER, V9, P396, DOI 10.2174/156652309789753338; Wattel E, 1996, LEUKEMIA, V10, P171; Wickham TJ, 1997, J VIROL, V71, P7663, DOI 10.1128/JVI.71.10.7663-7669.1997; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wu HJ, 2002, HUM GENE THER, V13, P1647, DOI 10.1089/10430340260201734; YANG YP, 1995, J IMMUNOL, V155, P2564; Ye Z, 2007, CANCER GENE THER, V14, P661, DOI 10.1038/sj.cgt.7701039; Yotnda P, 2004, BLOOD, V104, P2272, DOI 10.1182/blood-2003-11-3803; Zhang YG, 2010, J VIROL, V84, P8799, DOI 10.1128/JVI.00562-10; Zheng S, 2007, J GENE MED, V9, P151, DOI 10.1002/jgm.1008	48	12	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18091	10.1371/journal.pone.0018091	http://dx.doi.org/10.1371/journal.pone.0018091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464908	Green Published, gold, Green Submitted			2022-12-27	WOS:000289053800023
J	Wyatt, CM; Shi, QH; Novak, JE; Hoover, DR; Szczech, L; Mugabo, JS; Binagwaho, A; Cohen, M; Mutimura, E; Anastos, K				Wyatt, Christina M.; Shi, Qiuhu; Novak, James E.; Hoover, Donald R.; Szczech, Lynda; Mugabo, Jules Semahore; Binagwaho, Agnes; Cohen, Mardge; Mutimura, Eugene; Anastos, Kathryn			Prevalence of Kidney Disease in HIV-Infected and Uninfected Rwandan Women	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; ANTIRETROVIRAL THERAPY; SEROPOSITIVE PATIENTS; AFRICAN-AMERICANS; SERUM CREATININE; COCKCROFT-GAULT; RISK-FACTORS; ADULTS; ASSOCIATION	Background: In the United States, HIV-related kidney disease disproportionately affects individuals of African descent; however, there are few estimates of kidney disease prevalence in Africa. We evaluated the prevalence of kidney disease among HIV-infected and uninfected Rwandan women. Methods: The Rwandan Women's Interassociation Study and Assessment prospectively enrolled 936 women. Associations with estimated glomerular filtration rate (eGFR)<60 mL/min/1.73 m(2) and proteinuria were assessed in separate logistic regression models. Results: Among 891 non-pregnant women with available data, 2.4% had an eGFR<60 mL/min/1.73 m(2) (calculated by the Modification of Diet in Renal Disease equation, MDRD eGFR) and 8.7% had proteinuria >= 1+. The prevalence of decreased eGFR varied markedly depending on the estimating method used, with the highest prevalence by Cockcroft-Gault. Regardless of the method used to estimate GFR, the proportion with decreased eGFR or proteinuria did not differ significantly between HIV-infected and -uninfected women in unadjusted analysis. After adjusting for age and blood pressure, HIV infection was associated with significantly higher odds of decreased MDRD eGFR but not proteinuria. Conclusion: In a well-characterized cohort of Rwandan women, HIV infection was associated with decreased MDRD eGFR. The prevalence of decreased eGFR among HIV-infected women in our study was lower than that previously reported in African-Americans and in other Central and East African HIV populations, although there was substantial variability depending on the equation used to estimate GFR. Future studies are needed to optimize GFR estimates and to determine the impact of antiretroviral therapy on kidney disease in this population.	[Wyatt, Christina M.] Mt Sinai Sch Med, New York, NY 10029 USA; [Shi, Qiuhu] New York Med Coll, Sch Publ Hlth, Valhalla, NY 10595 USA; [Novak, James E.] Henry Ford Hlth Syst, Detroit, MI USA; [Hoover, Donald R.] Rutgers State Univ, New Brunswick, NJ 08903 USA; [Szczech, Lynda] Duke Univ, Med Ctr, Dept Med, Div Nephrol, Durham, NC 27710 USA; [Mugabo, Jules Semahore] Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA; [Binagwaho, Agnes] Minist Hlth, Kigali, Rwanda; [Binagwaho, Agnes] Harvard Univ, Sch Med, Boston, MA USA; [Cohen, Mardge] Cook Cty Bur Hlth Serv, CORE Ctr, Chicago, IL USA; [Mutimura, Eugene] Womens Equ Access Care & Treatment, Kigali, Rwanda; [Anastos, Kathryn] Montefiore Med Ctr, Bronx, NY 10467 USA; [Anastos, Kathryn] Albert Einstein Coll Med, Bronx, NY 10467 USA	Icahn School of Medicine at Mount Sinai; New York Medical College; Henry Ford Health System; Henry Ford Hospital; Rutgers State University New Brunswick; Duke University; University System of Maryland; University of Maryland Baltimore; Harvard University; Harvard Medical School; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Wyatt, CM (corresponding author), Mt Sinai Sch Med, New York, NY 10029 USA.	kanastos@verizon.net			National Institute of Allergy and Infectious Diseases [UO1-AI-35004]; Fogarty International Center [NIH D43-TW001403]; National Institutes of Health [NIH AI-51519]; National Institute of Diabetes and Digestive and Kidney Disease [DK54615]; Chicago WIHS [U01-AI-34993]; National Institute of Diabetes and Digestive and Kidney Diseases [K23DK077568]; FOGARTY INTERNATIONAL CENTER [D43TW001403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519, U01AI035004, U01AI034993, K22AI134993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054615, K23DK077568] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Chicago WIHS; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by supplements from the National Institute of Allergy and Infectious Diseases to the Bronx/Manhattan Women's Interagency HIV Study (WIHS), which is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004). This work was also supported in part by the AIDS International Training and Research Program (Fogarty International Center, NIH D43-TW001403) and the Center for AIDS Research of the Albert Einstein College of Medicine and Montefiore Medical Center funded by the National Institutes of Health (NIH AI-51519) and by the National Institute of Diabetes and Digestive and Kidney Disease (DK54615), and the Chicago WIHS (U01-AI-34993). CMW is supported by a career development award from the National Institute of Diabetes and Digestive and Kidney Diseases (K23DK077568). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, PAT MON GUID HIV CAR; Arendse CG, 2010, KIDNEY INT, V78, P239, DOI 10.1038/ki.2010.155; Choi AI, 2007, J AM SOC NEPHROL, V18, P2968, DOI 10.1681/ASN.2007040402; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Eastwood JB, 2010, NEPHROL DIAL TRANSPL, V25, P2178, DOI 10.1093/ndt/gfp765; Emem CP, 2008, NEPHROL DIAL TRANSPL, V23, P741, DOI 10.1093/ndt/gfm836; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257; Han TM, 2006, KIDNEY INT, V69, P2243, DOI 10.1038/sj.ki.5000339; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kotler Donald P., 1996, American Journal of Clinical Nutrition, V64, p489S, DOI 10.1093/ajcn/64.3.489S; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lucas GM, 2008, J INFECT DIS, V197, P1548, DOI 10.1086/587994; Lucas GM, 2010, JAIDS-J ACQ IMM DEF, V55, P491, DOI 10.1097/QAI.0b013e3181e8d5a8; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Mulenga LB, 2008, AIDS, V22, P1821, DOI 10.1097/QAD.0b013e328307a051; Peters PJ, 2008, KIDNEY INT, V74, P925, DOI 10.1038/ki.2008.305; Reid A, 2008, CLIN INFECT DIS, V46, P1271, DOI 10.1086/533468; Stohr W, 2008, ANTIVIR THER, V13, P761; Szczech LA, 2004, CLIN INFECT DIS, V39, P1199, DOI 10.1086/424013; UNAIDS and WHO, 2008, UNAIDS WHO AIDS EP U; van Deventer HE, 2008, CLIN CHEM, V54, P1197, DOI 10.1373/clinchem.2007.099085; Wools-Kaloustian K, 2007, NEPHROL DIAL TRANSPL, V22, P2208, DOI 10.1093/ndt/gfm223; Wyatt CM, 2007, AIDS, V21, P2101, DOI 10.1097/QAD.0b013e3282ef1bb4; Wyatt CM, 2010, JAIDS-J ACQ IMM DEF, V55, P73, DOI 10.1097/QAI.0b013e3181cc1070; WYATT CM, 2011, ANTIVIR THE IN PRESS	28	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18352	10.1371/journal.pone.0018352	http://dx.doi.org/10.1371/journal.pone.0018352			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464937	Green Submitted, gold, Green Published			2022-12-27	WOS:000289053800043
J	Zhang, L; Valdez, JM; Zhang, BY; Wei, L; Chang, JA; Xin, L				Zhang, Li; Valdez, Joseph M.; Zhang, Boyu; Wei, Lei; Chang, Jiang; Xin, Li			ROCK Inhibitor Y-27632 Suppresses Dissociation-Induced Apoptosis of Murine Prostate Stem/Progenitor Cells and Increases Their Cloning Efficiency	PLOS ONE			English	Article							STEM-CELLS; PTEN; PHOSPHORYLATION; SUBPOPULATION; SURVIVAL; DELETION; ISOFORM; KINASES; ACTS; RHOA	Activation of the RhoA/ROCK signaling pathway has been shown to contribute to dissociation-induced apoptosis of embryonic and neural stem cells. We previously demonstrated that approximately 1 out of 40 Lin(-)Sca-1(+)CD49f(high) (LSC) prostate basal epithelial cells possess the capacities of stem cells for self-renewal and multi-lineage differentiation. We show here that treating LSC cells with the ROCK kinase inhibitor Y-27632 increases their cloning efficiency by 8 fold in an in vitro prostate colony assay. Y-27632 treatment allows prostate colony cells to replate efficiently, which does not occur otherwise. Y-27632 also increases the cloning efficiency of prostate stem cells in a prostate sphere assay and a dissociated prostate cell regeneration assay. The increased cloning efficiency is due to the suppression of the dissociation-induced, RhoA/ROCK activation-mediated apoptosis of prostate stem cells. Dissociation of prostate epithelial cells from extracellular matrix increases PTEN activity and attenuates AKT activity. Y-27632 treatment alone is sufficient to suppress cell dissociation-induced activation of PTEN activity. However, this does not contribute to the increased cloning efficiency, because Y-27632 treatment increases the sphere-forming unit of wild type and Pten null prostate cells to a similar extent. Finally, knocking down expression of both ROCK kinases slightly increases the replating efficiency of prostate colony cells, corroborating that they play a major role in the Y-27632 mediated increase in cloning efficiency. Our study implies that the numbers of prostate cells with stem/progenitor activity may be underestimated based on currently employed assays, supports that dissociation-induced apoptosis is a common feature of embryonic and somatic stem cells with an epithelial phenotype, and highlights the significance of environmental cues for the maintenance of stem cells.	[Zhang, Li; Valdez, Joseph M.; Zhang, Boyu; Xin, Li] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA; [Wei, Lei] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Chang, Jiang] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Xin, Li] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Xin, Li] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Indiana University System; Indiana University-Purdue University Indianapolis; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor College of Medicine; Baylor College of Medicine	Zhang, L (corresponding author), Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA.	xin@bcm.edu		Chang, Jiang/0000-0003-3707-7557	NIH [CA125937, CA141497, HL102314]; Baylor College of Medicine; NATIONAL CANCER INSTITUTE [R00CA125937, U01CA141497] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL098956, R01HL102314, R21HL094844, P01HL085098] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH CA125937, NIH CA141497, NIH HL102314, and a Junior Faculty Seed Award from the Baylor College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Chang J, 2006, P NATL ACAD SCI USA, V103, P14495, DOI 10.1073/pnas.0601911103; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; CHEN G, CELL STEM CELL, V7, P240; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; GOLDSTEIN AS, 2008, P NATL ACAD SCI US; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hudson DL, 2000, LAB INVEST, V80, P1243, DOI 10.1038/labinvest.3780132; Hudson DL, 2001, J HISTOCHEM CYTOCHEM, V49, P271, DOI 10.1177/002215540104900214; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Krawetz RJ, 2009, BIOESSAYS, V31, P336, DOI 10.1002/bies.200800157; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Litvinov IV, 2006, CANCER RES, V66, P8598, DOI 10.1158/0008-5472.CAN-06-1228; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Man JH, 2010, J CLIN INVEST, V120, P2829, DOI 10.1172/JCI42542; Matusik RJ, 2008, DIFFERENTIATION, V76, P682, DOI 10.1111/j.1432-0436.2008.00276.x; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Ming XF, 2002, MOL CELL BIOL, V22, P8467, DOI 10.1128/MCB.22.24.8467-8477.2002; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Pelosi M, 2007, MOL CELL BIOL, V27, P6163, DOI 10.1128/MCB.01735-06; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sawicki JA, 2002, PROSTATE, V50, P46, DOI 10.1002/pros.10031; TERUNUMA A, TISSUE ENG A, V16, P1363; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uzgare AR, 2004, CANCER RES, V64, P6190, DOI 10.1158/0008-5472.CAN-04-0968; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; XIE D, P NATL ACAD SCI US, V107, P2485; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Zhang YM, 2006, FASEB J, V20, P916, DOI 10.1096/fj.05-5129com	49	67	74	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18271	10.1371/journal.pone.0018271	http://dx.doi.org/10.1371/journal.pone.0018271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464902	gold, Green Submitted, Green Published			2022-12-27	WOS:000289053800035
J	Ding, H; Tsai, CG; Zhou, F; Buchy, P; Deubel, V; Zhou, P				Ding, Heng; Tsai, Cheguo; Zhou, Fan; Buchy, Philippe; Deubel, Vincent; Zhou, Paul			Heterosubtypic Antibody Response Elicited with Seasonal Influenza Vaccine Correlates Partial Protection against Highly Pathogenic H5N1 Virus	PLOS ONE			English	Article							AVIAN INFLUENZA; A H5N1; CROSS-PROTECTION; GENE DELIVERY; T-CELLS; INFECTION; IMMUNITY; INDUCTION	Background: The spread of highly pathogenic avian influenza (HPAI) H5N1 virus in human remains a global health concern. Heterosubtypic antibody response between seasonal influenza vaccine and potential pandemic influenza virus has important implications for public health. Previous studies by Corti et al. and by Gioia et al. demonstrate that heterosubtypic neutralizing antibodies against the highly pathogenic H5N1 virus can be elicited with a seasonal influenza vaccine in humans. However, whether such response offers immune protection against highly pathogenic H5N1 virus remained to be determined. Methodology/Principal Findings: In this study, using a sensitive influenza HA (hemagglutinin) and NA (neuraminidase) pseudotype-based neutralization (PN) assay we first confirmed that low levels of heterosubtypic neutralizing antibody response against H5N1 virus were indeed elicited with seasonal influenza vaccine in humans. We then immunized mice with the seasonal influenza vaccine and challenged them with lethal doses of highly pathogenic H5N1 virus. As controls, we immunized mice with homosubtypic H5N1 virus like particles (VLP) or PBS and challenged them with the same H5N1 virus. Here we show that low levels of heterosubtypic neutralizing antibody response were elicited with seasonal influenza vaccine in mice, which were significantly higher than those in PBS control. Among them 2 out of 27 whose immune sera exhibited similar levels of neutralizing antibody response as VLP controls actually survived from highly pathogenic H5N1 virus challenge. Conclusions/Significance: Therefore, we conclude that low levels of heterosubtypic neutralizing antibody response are indeed elicited with seasonal influenza vaccine in humans and mice and at certain levels such response offers immune protection against severity of H5N1 virus infection.	[Ding, Heng; Tsai, Cheguo; Zhou, Fan; Zhou, Paul] Chinese Acad Sci, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Buchy, Philippe; Deubel, Vincent] Inst Pasteur Cambodia, Phnom Penh, Cambodia	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia	Ding, H (corresponding author), Chinese Acad Sci, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai, Peoples R China.	blzhou@sibs.ac.cn	Cai, Cheguo/K-3747-2019	BUCHY, Philippe/0000-0003-1372-3008; Zhou, Fan/0000-0001-9918-3422	French Ministry of Health; Chinese National Science Foundation [30671922]; National Science and Technology Major Projects [2008ZX10001-010, 2009ZX10004-105, 2009ZX10004-016]; Li Kai-Shing Foundation of Hong Kong	French Ministry of Health; Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects; Li Kai-Shing Foundation of Hong Kong	This work was supported by research grants from the French Ministry of Health, the Chinese National Science Foundation (#30671922), National Science and Technology Major Projects (#2008ZX10001-010, #2009ZX10004-105, #2009ZX10004-016), and the Li Kai-Shing Foundation of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsharifi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005336; BIDDISON WE, 1979, J IMMUNOL, V122, P660; Boon ACM, 2004, J IMMUNOL, V172, P2453, DOI 10.4049/jimmunol.172.4.2453; Buchy P, 2007, J CLIN VIROL, V39, P164, DOI 10.1016/j.jcv.2007.04.010; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Cheng X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004436; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Couch RB, 2008, VACCINE, V26, pD5, DOI 10.1016/j.vaccine.2008.05.076; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Garcia JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007918; Gillim-Ross L, 2007, PLOS MED, V4, P226, DOI 10.1371/journal.pmed.0040091; Gioia C, 2008, EMERG INFECT DIS, V14, P121, DOI 10.3201/eid1401.061283; Ichinohe T, 2007, J INFECT DIS, V196, P1313, DOI 10.1086/521304; Jameson J, 1998, J VIROL, V72, P8682, DOI 10.1128/JVI.72.11.8682-8689.1998; Kositanont U, 2010, VIRAL IMMUNOL, V23, P329, DOI 10.1089/vim.2009.0082; Kreijtz JHCM, 2009, VACCINE, V27, P4983, DOI 10.1016/j.vaccine.2009.05.079; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; MCMICHAEL AJ, 1978, EUR J IMMUNOL, V8, P705, DOI 10.1002/eji.1830081007; Monto AS, 2009, EXPERT REV VACCINES, V8, P383, DOI [10.1586/erv.09.9, 10.1586/ERV.09.9]; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Tang JW, 2008, J MED VIROL, V80, P1992, DOI 10.1002/jmv.21321; Tsai CG, 2009, VACCINE, V27, P6777, DOI 10.1016/j.vaccine.2009.08.056; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; van Maurik A, 2010, VACCINE, V28, P1778, DOI 10.1016/j.vaccine.2009.12.008; World Health Organization, CUM NUMB CONF HUM CA; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	31	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17821	10.1371/journal.pone.0017821	http://dx.doi.org/10.1371/journal.pone.0017821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464977	Green Published, gold			2022-12-27	WOS:000288813900011
J	Toldo, S; Bogaard, HJ; Van Tassell, BW; Mezzaroma, E; Seropian, IM; Robati, R; Salloum, FN; Voelkel, NF; Abbate, A				Toldo, Stefano; Bogaard, Herman J.; Van Tassell, Benjamin W.; Mezzaroma, Eleonora; Seropian, Ignacio M.; Robati, Roshanak; Salloum, Fadi N.; Voelkel, Norbert F.; Abbate, Antonio			Right Ventricular Dysfunction following Acute Myocardial Infarction in the Absence of Pulmonary Hypertension in the Mouse	PLOS ONE			English	Article							HEART-FAILURE; APOPTOSIS	Background: Cardiac remodelling after AMI is characterized by molecular and cellular mechanisms involving both the ischemic and non-ischemic myocardium. The extent of right ventricular (RV) dilatation and dysfunction and its relation to pulmonary hypertension (PH) following AMI are unknown. The aim of the current study was to evaluate changes in dimensions and function of the RV following acute myocardial infarction (AMI) involving the left ventricle (LV). Methods: We assessed changes in RV dimensions and function 1 week following experimental AMI involving the LV free wall in 10 mice and assessed for LV and RV dimensions and function and for the presence and degree of PH. Results: RV fractional area change and tricuspidal annular plane systolic excursion significantly declined by 33% (P = 0.021) and 28% (P = 0.001) respectively. Right ventricular systolic pressure measured invasively in the mouse was within the normal values and unchanged following AMI. Conclusion: AMI involving the LV and sparing the RV induces a significant acute decline in RV systolic function in the absence of pulmonary hypertension in the mouse indicating that RV dysfunction developed independent of changes in RV afterload.	[Toldo, Stefano] Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA 23284 USA; Virginia Commonwealth Univ, Victoria Johnson Res Ctr, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Toldo, S (corresponding author), Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA 23284 USA.	abbatea@yahoo.com	Salloum, Fadi N/C-2391-2008; Abbate, Antonio/E-3405-2014; Abbate, Antonio/G-8805-2016	Salloum, Fadi N/0000-0002-8947-9315; Abbate, Antonio/0000-0002-1930-785X; Seropian, Ignacio Miguel/0000-0002-6823-4001; Bogaard, Harm Jan/0000-0001-5371-0346; Toldo, Stefano/0000-0002-1588-4019	VCU Pauley Heart Center; Victoria Johnson Research Laboratories; American Heart Association; institutional NIH [1KL2RR031989-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058, KL2TR000057] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031989] Funding Source: NIH RePORTER	VCU Pauley Heart Center; Victoria Johnson Research Laboratories; American Heart Association(American Heart Association); institutional NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study was supported by funds deriving from the VCU Pauley Heart Center and Victoria Johnson Research Laboratories, and in part by an American Heart Association Beginning Grant in Aid to Dr. Abbate. Dr. Van Tassell is supported by an institutional NIH 1KL2RR031989-01 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2008, AM J CARDIOL, V102, P658, DOI 10.1016/j.amjcard.2008.05.007; Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Anavekar NS, 2008, AM J CARDIOL, V101, P607, DOI 10.1016/j.amjcard.2007.09.115; ANTONI ML, 2010, CIRC CARDIOVASC IMAG; ANVERSA P, 1991, AM J CARDIOL, V68, P7; BAKOS AUGUSTUS C. P., 1950, CIRCULATION, V1, P724; Bussani R, 2003, J CLIN PATHOL, V56, P672, DOI 10.1136/jcp.56.9.672; Daniels MCG, 2001, AM J PHYSIOL-HEART C, V281, pH2150, DOI 10.1152/ajpheart.2001.281.5.H2150; DISALVO TG, 1995, J AM COLL CARDIOL, V25, P1143, DOI 10.1016/0735-1097(94)00511-N; Gardin JM, 2002, J AM SOC ECHOCARDIOG, V15, P275, DOI 10.1067/mje.2002.121536; Haddad F, 2008, CIRCULATION, V117, P1436, DOI 10.1161/CIRCULATIONAHA.107.653576; Larose E, 2007, J AM COLL CARDIOL, V49, P855, DOI 10.1016/j.jacc.2006.10.056; OAKLEY C, 1988, AM J CARDIOL, V62, pA14, DOI 10.1016/S0002-9149(88)80079-1; Patten RD, 1998, AM J PHYSIOL-HEART C, V274, pH1812, DOI 10.1152/ajpheart.1998.274.5.H1812; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Quaife RA, 1998, AM J CARDIOL, V81, P247, DOI 10.1016/S0002-9149(97)00874-6; SANTAMORE WP, 1976, J APPL PHYSIOL, V41, P925, DOI 10.1152/jappl.1976.41.6.925; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Zornoff LAM, 2002, J AM COLL CARDIOL, V39, P1450, DOI 10.1016/S0735-1097(02)01804-1	19	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18102	10.1371/journal.pone.0018102	http://dx.doi.org/10.1371/journal.pone.0018102			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455304	Green Published, Green Submitted, gold			2022-12-27	WOS:000288811500021
J	Nevo, Y; Aga-Mizrachi, S; Elmakayes, E; Yanay, N; Ettinger, K; Elbaz, M; Brunschwig, Z; Dadush, O; Elad-Sfadia, G; Haklai, R; Kloog, Y; Chapman, J; Reif, S				Nevo, Yoram; Aga-Mizrachi, Shlomit; Elmakayes, Edva; Yanay, Nurit; Ettinger, Keren; Elbaz, Moran; Brunschwig, Zivia; Dadush, Oshrat; Elad-Sfadia, Galit; Haklai, Roni; Kloog, Yoel; Chapman, Joab; Reif, Shimon			The Ras Antagonist, Farnesylthiosalicylic Acid (FTS), Decreases Fibrosis and Improves Muscle Strength in dy(2J)/dy(2J) Mouse Model of Muscular Dystrophy	PLOS ONE			English	Article							INDUCED LIVER-CIRRHOSIS; DEPENDENT CELL-GROWTH; GTP-BINDING PROTEINS; MATRIX METALLOPROTEINASES; SKELETAL-MUSCLE; INFLAMMATORY MYOPATHIES; DY(2J) MICE; INHIBITION; ACTIVATION; EXPRESSION	The Ras superfamily of guanosine-triphosphate (GTP)-binding proteins regulates a diverse spectrum of intracellular processes involved in inflammation and fibrosis. Farnesythiosalicylic acid (FTS) is a unique and potent Ras inhibitor which decreased inflammation and fibrosis in experimentally induced liver cirrhosis and ameliorated inflammatory processes in systemic lupus erythematosus, neuritis and nephritis animal models. FTS effect on Ras expression and activity, muscle strength and fibrosis was evaluated in the dy 2J/dy 2J mouse model of merosin deficient congenital muscular dystrophy. The dy 2J/dy 2J mice had significantly increased RAS expression and activity compared with the wild type mice. FTS treatment significantly decreased RAS expression and activity. In addition, phosphorylation of ERK, a Ras downstream protein, was significantly decreased following FTS treatment in the dy 2J/dy 2J mice. Clinically, FTS treated mice showed significant improvement in hind limb muscle strength measured by electronic grip strength meter. Significant reduction of fibrosis was demonstrated in the treated group by quantitative Sirius Red staining and lower muscle collagen content. FTS effect was associated with significantly inhibition of both MMP-2 and MMP-9 activities. We conclude that active RAS inhibition by FTS was associated with attenuated fibrosis and improved muscle strength in the dy 2J/dy 2J mouse model of congenital muscular dystrophy.	[Nevo, Yoram; Aga-Mizrachi, Shlomit; Elmakayes, Edva; Yanay, Nurit; Ettinger, Keren; Elbaz, Moran; Brunschwig, Zivia; Dadush, Oshrat] Hadassah Hebrew Univ Hosp, Pediat Neuromuscular Lab, Jerusalem, Israel; [Nevo, Yoram; Aga-Mizrachi, Shlomit; Elmakayes, Edva; Yanay, Nurit; Ettinger, Keren; Elbaz, Moran; Brunschwig, Zivia; Dadush, Oshrat] Hadassah Hebrew Univ Hosp, Neuropediat Unit, Jerusalem, Israel; [Elad-Sfadia, Galit; Haklai, Roni; Kloog, Yoel] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel; [Chapman, Joab] Tel Aviv Univ, Dept Neurol, Sheba Med Ctr, IL-69978 Tel Aviv, Israel; [Reif, Shimon] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dana Childrens Hosp, Dept Pediat, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Tel Aviv University; Chaim Sheba Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Nevo, Y (corresponding author), Hadassah Hebrew Univ Hosp, Pediat Neuromuscular Lab, Jerusalem, Israel.	nevo@hadassah.org.il	Chapman, Joab/E-4598-2010	Chapman, Joab/0000-0002-2161-9764				BALLIN M, 1988, BIOCHEM BIOPH RES CO, V154, P832, DOI 10.1016/0006-291X(88)90215-X; Bani C, 2008, MUSCLE NERVE, V37, P583, DOI 10.1002/mus.20970; Blum R, 2008, RECENT PAT ANTI-CANC, V3, P31; BOKOCH GM, 1993, FASEB J, V7, P750, DOI 10.1096/fasebj.7.9.8330683; Carmeli E, 2004, MUSCLE NERVE, V29, P191, DOI 10.1002/mus.10529; Choi YC, 2000, NEUROLOGY, V54, P65, DOI 10.1212/WNL.54.1.65; Clarke HC, 2003, J AM SOC NEPHROL, V14, P848, DOI 10.1097/01.ASN.0000057543.55318.8B; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Colognato H, 1999, CURR BIOL, V9, P1327, DOI 10.1016/S0960-9822(00)80056-1; Dadush O, 2010, NEUROMUSCULAR DISORD, V20, P267, DOI 10.1016/j.nmd.2010.02.002; Downward J, 2006, SCIENCE, V314, P433, DOI 10.1126/science.1134727; Egozi Y, 1999, INT J CANCER, V80, P911, DOI 10.1002/(SICI)1097-0215(19990315)80:6<911::AID-IJC18>3.0.CO;2-4; Elad G, 1999, BBA-MOL CELL RES, V1452, P228, DOI 10.1016/S0167-4889(99)00144-5; Elad-Sfadia G, 2002, J BIOL CHEM, V277, P37169, DOI 10.1074/jbc.M205698200; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Guo LT, 2003, NEUROMUSCULAR DISORD, V13, P207, DOI 10.1016/s0960-8966(02)00266-3; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; Jimenez-Mallebrera C, 2005, CELL MOL LIFE SCI, V62, P809, DOI 10.1007/s00018-004-4510-4; Kafri M, 2005, J NEUROIMMUNOL, V168, P46, DOI 10.1016/j.jneuroim.2005.07.008; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Katzav A, 2001, CLIN EXP IMMUNOL, V126, P570, DOI 10.1046/j.1365-2249.2001.01674.x; Kherif S, 1999, DEV BIOL, V205, P158, DOI 10.1006/dbio.1998.9107; Kloog, 1999, Expert Opin Investig Drugs, V8, P2121, DOI 10.1517/13543784.8.12.2121; Kloog Y, 2000, MOL MED TODAY, V6, P398, DOI 10.1016/S1357-4310(00)01789-5; Lattanzi G, 2000, BIOCHEM BIOPH RES CO, V277, P639, DOI 10.1006/bbrc.2000.3735; Le DT, 2002, CURR OPIN HEMATOL, V9, P308, DOI 10.1097/00062752-200207000-00008; Li H, 2009, HUM MOL GENET, V18, P2584, DOI 10.1093/hmg/ddp191; Lisi MT, 2007, BBA-MOL BASIS DIS, V1772, P159, DOI 10.1016/j.bbadis.2006.09.006; MARCIANO D, 1995, J MED CHEM, V38, P1267, DOI 10.1021/jm00008a004; MAROM M, 1995, J BIOL CHEM, V270, P22263, DOI 10.1074/jbc.270.38.22263; MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705; Miyagoe-Suzuki Y, 2000, MICROSC RES TECHNIQ, V48, P181, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO;2-Q; Muntoni F, 2004, NEUROMUSCULAR DISORD, V14, P635, DOI 10.1016/j.nmd.2004.06.009; Nevo Y, 2010, MUSCLE NERVE, V42, P218, DOI 10.1002/mus.21706; Pahan K, 2000, J NEUROCHEM, V74, P2288, DOI 10.1046/j.1471-4159.2000.0742288.x; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Reif S, 2004, J HEPATOL, V41, P235, DOI 10.1016/j.jhep.2004.04.010; Reif S, 1999, J HEPATOL, V31, P1053, DOI 10.1016/S0168-8278(99)80318-3; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Rubio N, 2008, J NEUROCHEM, V104, P100, DOI 10.1111/j.1471-4159.2007.05020.x; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schessl Joachim, 2006, Semin Pediatr Neurol, V13, P80, DOI 10.1016/j.spen.2006.06.003; Schoser BGH, 2002, ACTA NEUROL SCAND, V105, P309, DOI 10.1034/j.1600-0404.2002.1o104.x; SHORER Z, 1995, J CHILD NEUROL, V10, P472, DOI 10.1177/088307389501000610; Vainzof M, 2008, J MOL NEUROSCI, V34, P241, DOI 10.1007/s12031-007-9023-9; VanSaun Michael N., 2006, Birth Defects Research, V78, P69, DOI 10.1002/bdrc.20061; Vilquin JT, 2000, NEUROMUSCULAR DISORD, V10, P59, DOI 10.1016/S0960-8966(99)00056-5; Weijzen S, 1999, LEUKEMIA, V13, P502, DOI 10.1038/sj.leu.2401367; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297	49	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18049	10.1371/journal.pone.0018049	http://dx.doi.org/10.1371/journal.pone.0018049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445359	Green Published, Green Submitted, gold			2022-12-27	WOS:000288809100025
J	Cortez, BD; Quassollo, G; Caceres, A; Machado-Santelli, GM				Cortez, Beatriz de Araujo; Quassollo, Gonzalo; Caceres, Alfredo; Machado-Santelli, Glaucia Maria			The Fate of Chrysotile-Induced Multipolar Mitosis and Aneuploid Population in Cultured Lung Cancer Cells	PLOS ONE			English	Article							PLEURAL MESOTHELIAL CELLS; CENTROSOME AMPLIFICATION; MITOTIC CHECKPOINT; DNA-DAMAGE; CHROMOSOME INSTABILITY; MAMMALIAN-CELLS; ASBESTOS FIBERS; STRAND BREAKS; IN-VITRO; INDUCTION	Chrysotile is one of the six types of asbestos, and it is the only one that can still be commercialized in many countries. Exposure to other types of asbestos has been associated with serious diseases, such as lung carcinomas and pleural mesotheliomas. The association of chrysotile exposure with disease is controversial. However, in vitro studies show the mutagenic potential of chrysotile, which can induce DNA and cell damage. The present work aimed to analyze alterations in lung small cell carcinoma cultures after 48 h of chrysotile exposure, followed by 2, 4 and 8 days of recovery in fiber-free culture medium. Some alterations, such as aneuploid cell formation, increased number of cells in G2/M phase and cells in multipolar mitosis were observed even after 8 days of recovery. The presence of chrysotile fibers in the cell cultures was detected and cell morphology was observed by laser scanning confocal microscopy. After 4 and 8 days of recovery, only a few chrysotile fragments were present in some cells, and the cellular morphology was similar to that of control cells. Cells transfected with the GFP-tagged alpha-tubulin plasmid were treated with chrysotile for 24 or 48 h and cells in multipolar mitosis were observed by time-lapse microscopy. Fates of these cells were established: retention in metaphase, cell death, progression through M phase generating more than two daughter cells or cell fusion during telophase or cytokinesis. Some of them were related to the formation of aneuploid cells and cells with abnormal number of centrosomes.	[Cortez, Beatriz de Araujo; Machado-Santelli, Glaucia Maria] Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, BR-05508 Sao Paulo, Brazil; [Cortez, Beatriz de Araujo] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, BR-05508 Sao Paulo, Brazil; [Quassollo, Gonzalo; Caceres, Alfredo] INIMEC CONICET, Inst Invest Med Mercedes & Martin Ferreyra, Cordoba, Argentina	Universidade de Sao Paulo; Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Cortez, BD (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, BR-05508 Sao Paulo, Brazil.	glaucia.usp@gmail.com	Machado-Santelli, Glaucia M/C-6775-2013; Cortez, Beatriz Araujo/G-6858-2015	Machado-Santelli, Glaucia M/0000-0003-2046-9693; Quassollo, Gonzalo/0000-0003-3298-9688	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Brazil; Agencia Cordoba Ciencia; MINCyT, Argentina [PICT 815, PME]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Agencia Cordoba Ciencia; MINCyT, Argentina	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Brazil and by grants from Agencia Cordoba Ciencia and MINCyT (PICT 815 and PME), Argentina. BAC was a fellow from Red de MacroUniversidades de America Latina y el Caribe, during her stay in Argentina. GQ is a doctoral fellow of FONCyT (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JC, 2009, J CELL SCI, V122, P1990, DOI 10.1242/jcs.039115; Bernstein DM, 2005, INHAL TOXICOL, V17, P1, DOI 10.1080/08958370590885663; BONALDO MD, 1991, CELL BIOL INT REP, V15, P229; Borojerdi JP, 2009, MUTAT RES-FUND MOL M, V665, P67, DOI 10.1016/j.mrfmmm.2009.03.004; Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962; Brody A R, 1989, IARC Sci Publ, P93; Brody AR, 1997, ENVIRON HEALTH PERSP, V105, P1165, DOI 10.2307/3433527; Burmeister B, 2004, MUTAT RES-GEN TOX EN, V558, P81, DOI 10.1016/j.mrgentox.2003.11.003; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Cassiola F, 2005, COLLOID SURFACE B, V41, P277, DOI 10.1016/j.colsurfb.2004.12.006; Cortez BA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-181; Dopp E, 1997, MUTAT RES-FUND MOL M, V377, P77, DOI 10.1016/S0027-5107(97)00062-6; Dopp E, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-9; Duesberg P, 2006, CONTRIB MICROBIOL, V13, P16, DOI 10.1159/000092963; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Hede K, 2005, J NATL CANCER I, V97, P87, DOI 10.1093/jnci/97.2.87; Jensen CG, 1999, CELL BIOL INT, V23, P829, DOI 10.1006/cbir.1999.0479; Kawamura K, 2004, CANCER RES, V64, P4800, DOI 10.1158/0008-5472.CAN-03-3908; Kuriyama R, 2007, J CELL SCI, V120, P2444, DOI 10.1242/jcs.008938; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Levresse V, 2000, MUTAGENESIS, V15, P239, DOI 10.1093/mutage/15.3.239; Levresse V, 1997, AM J RESP CELL MOL, V17, P660, DOI 10.1165/ajrcmb.17.6.2854; Li RH, 2000, P NATL ACAD SCI USA, V97, P3236, DOI 10.1073/pnas.040529797; Liu ST, 2003, CURR TOP DEV BIOL, V58, P27, DOI 10.1016/S0070-2153(03)58002-4; MACHADOSANTELLI GM, 1994, ANAL CELL PATHOL, V7, P321; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; MOSSMAN BT, 1990, SCIENCE, V247, P294, DOI 10.1126/science.2153315; Okayasu R, 1999, CANCER RES, V59, P298; PATHAK S, 2006, ANEUPLOIDY STEM CELL, P49; QUINLAN TR, 1995, AM J PATHOL, V147, P728; Sargent LM, 2010, NANOTOXICOLOGY, V4, P396, DOI 10.3109/17435390.2010.500444; Suzuki K, 1996, CARCINOGENESIS, V17, P661, DOI 10.1093/carcin/17.4.661; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Xu A, 1999, CANCER RES, V59, P5922; Xu A, 2007, ENVIRON HEALTH PERSP, V115, P87, DOI 10.1289/ehp.9425	38	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18600	10.1371/journal.pone.0018600	http://dx.doi.org/10.1371/journal.pone.0018600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483691	Green Published, Green Submitted, gold			2022-12-27	WOS:000289191300032
J	Kaneda, K; Kasahara, H; Matsui, R; Katoh, T; Mizukami, H; Ozawa, K; Watanabe, D; Isa, T				Kaneda, Katsuyuki; Kasahara, Hironori; Matsui, Ryosuke; Katoh, Tomoko; Mizukami, Hiroaki; Ozawa, Keiya; Watanabe, Dai; Isa, Tadashi			Selective Optical Control of Synaptic Transmission in the Subcortical Visual Pathway by Activation of Viral Vector-Expressed Halorhodopsin	PLOS ONE			English	Article							CAT SUPERIOR COLLICULUS; RECEPTIVE-FIELD PROPERTIES; PHOTORECEPTOR DEGENERATION; ECTOPIC EXPRESSION; NEURAL CIRCUITRY; STRIATE CORTEX; RESPONSES; MOUSE; INTERROGATION; ORGANIZATION	The superficial layer of the superior colliculus (sSC) receives visual inputs via two different pathways: from the retina and the primary visual cortex. However, the functional significance of each input for the operation of the sSC circuit remains to be identified. As a first step toward understanding the functional role of each of these inputs, we developed an optogenetic method to specifically suppress the synaptic transmission in the retino-tectal pathway. We introduced enhanced halorhodopsin (eNpHR), a yellow light-sensitive, membrane-targeting chloride pump, into mouse retinal ganglion cells (RGCs) by intravitreously injecting an adeno-associated virus serotype-2 vector carrying the CMV-eNpHR-EYFP construct. Several weeks after the injection, whole-cell recordings made from sSC neurons in slice preparations revealed that yellow laser illumination of the eNpHR-expressing retino-tectal axons, putatively synapsing onto the recorded cells, effectively inhibited EPSCs evoked by electrical stimulation of the optic nerve layer. We also showed that sSC spike activities elicited by visual stimulation were significantly reduced by laser illumination of the sSC in anesthetized mice. These results indicate that photo-activation of eNpHR expressed in RGC axons enables selective blockade of retino-tectal synaptic transmission. The method established here can most likely be applied to a variety of brain regions for studying the function of individual inputs to these regions.	[Kaneda, Katsuyuki; Katoh, Tomoko; Isa, Tadashi] Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 444, Japan; [Kaneda, Katsuyuki; Isa, Tadashi] Grad Univ Adv Studies, Hayama, Japan; [Kasahara, Hironori; Matsui, Ryosuke; Watanabe, Dai] Kyoto Univ, Fac Med, Dept Biol Sci, Kyoto, Japan; [Watanabe, Dai] Kyoto Univ, Grad Sch Biostudies, Dept Mol & Syst Biol, Kyoto, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Kyoto University; Kyoto University	Kaneda, K (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido, Japan.	kkaneda@pharm.hokudai.ac.jp	Kaneda, Katsuyuki/A-8443-2012; Mizukami, Hiroaki/D-7674-2013	Mizukami, Hiroaki/0000-0001-8954-874X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [22700419] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Strategic Research Program of Brain Sciences (SRPBS) of the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; BERENDSE HW, 1990, J COMP NEUROL, V299, P187, DOI 10.1002/cne.902990206; Bereshpolova Y, 2006, J NEUROSCI, V26, P2250, DOI 10.1523/JNEUROSCI.4402-05.2006; BERSON DM, 1988, J NEUROPHYSIOL, V60, P1861, DOI 10.1152/jn.1988.60.6.1861; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; BINNS KE, 1994, EUR J NEUROSCI, V6, P161, DOI 10.1111/j.1460-9568.1994.tb00257.x; Binns KE, 1996, VISUAL NEUROSCI, V13, P683, DOI 10.1017/S0952523800008579; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Ding J, 2008, J NEUROSCI, V28, P6483, DOI 10.1523/JNEUROSCI.0435-08.2008; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Harvey AR, 2002, MOL CELL NEUROSCI, V21, P141, DOI 10.1006/mcne.2002.1168; HUANG XG, 1993, J NEUROPHYSIOL, V70, P723, DOI 10.1152/jn.1993.70.2.723; Isa T, 1998, J NEUROSCI, V18, P8496; Kaneda K, 2008, J NEUROSCI, V28, P816, DOI 10.1523/JNEUROSCI.4666-07.2008; MANGINI NJ, 1980, J COMP NEUROL, V193, P203, DOI 10.1002/cne.901930114; Martin KRG, 2002, METHODS, V28, P267, DOI 10.1016/S1046-2023(02)00232-3; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; MCILWAIN JT, 1973, J NEUROPHYSIOL, V36, P690, DOI 10.1152/jn.1973.36.4.690; METIN C, 1988, EXP BRAIN RES, V69, P594; MOHLER CW, 1977, J NEUROPHYSIOL, V40, P74, DOI 10.1152/jn.1977.40.1.74; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; RHOADES RW, 1978, J COMP NEUROL, V180, P617, DOI 10.1002/cne.901800312; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Schoonheim PJ, 2010, J NEUROSCI, V30, P7111, DOI 10.1523/JNEUROSCI.5193-09.2010; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang Y, 2009, J NEUROSCI, V29, P9186, DOI 10.1523/JNEUROSCI.0184-09.2009; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7	39	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18452	10.1371/journal.pone.0018452	http://dx.doi.org/10.1371/journal.pone.0018452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483674	Green Published, Green Submitted, gold			2022-12-27	WOS:000289191300022
J	Amaral, AJ; Ferretti, L; Megens, HJ; Crooijmans, RPMA; Nie, HS; Ramos-Onsins, SE; Perez-Enciso, M; Schook, LB; Groenen, MAM				Amaral, Andreia J.; Ferretti, Luca; Megens, Hendrik-Jan; Crooijmans, Richard P. M. A.; Nie, Haisheng; Ramos-Onsins, Sebastian E.; Perez-Enciso, Miguel; Schook, Lawrence B.; Groenen, Martien A. M.			Genome-Wide Footprints of Pig Domestication and Selection Revealed through Massive Parallel Sequencing of Pooled DNA	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; RECENT POSITIVE SELECTION; CLASS-I REGION; LINKAGE DISEQUILIBRIUM; GENETIC DIVERSITY; BREEDS; GENERATION; SIGNATURES; CHIMPANZEE; MUTATION	Background: Artificial selection has caused rapid evolution in domesticated species. The identification of selection footprints across domesticated genomes can contribute to uncover the genetic basis of phenotypic diversity. Methodology/Main Findings: Genome wide footprints of pig domestication and selection were identified using massive parallel sequencing of pooled reduced representation libraries (RRL) representing,2% of the genome from wild boar and four domestic pig breeds (Large White, Landrace, Duroc and Pietrain) which have been under strong selection for muscle development, growth, behavior and coat color. Using specifically developed statistical methods that account for DNA pooling, low mean sequencing depth, and sequencing errors, we provide genome-wide estimates of nucleotide diversity and genetic differentiation in pig. Widespread signals suggestive of positive and balancing selection were found and the strongest signals were observed in Pietrain, one of the breeds most intensively selected for muscle development. Most signals were population-specific but affected genomic regions which harbored genes for common biological categories including coat color, brain development, muscle development, growth, metabolism, olfaction and immunity. Genetic differentiation in regions harboring genes related to muscle development and growth was higher between breeds than between a given breed and the wild boar. Conclusions/Significance: These results, suggest that although domesticated breeds have experienced similar selective pressures, selection has acted upon different genes. This might reflect the multiple domestication events of European breeds or could be the result of subsequent introgression of Asian alleles. Overall, it was estimated that approximately 7% of the porcine genome has been affected by selection events. This study illustrates that the massive parallel sequencing of genomic pools is a cost-effective approach to identify footprints of selection.	[Amaral, Andreia J.; Megens, Hendrik-Jan; Crooijmans, Richard P. M. A.; Nie, Haisheng; Groenen, Martien A. M.] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands; [Ferretti, Luca; Ramos-Onsins, Sebastian E.; Perez-Enciso, Miguel] Univ Autonoma Barcelona, Dept Anim Sci & Food Technol, Bellaterra, Spain; [Ferretti, Luca; Ramos-Onsins, Sebastian E.; Perez-Enciso, Miguel] Ctr Res Agr Genom, Dept Anim Sci, Bellaterra, Spain; [Perez-Enciso, Miguel] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Schook, Lawrence B.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	Wageningen University & Research; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); ICREA; University of Illinois System; University of Illinois Urbana-Champaign	Amaral, AJ (corresponding author), Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands.	andreia.fonseca@gmail.com	Perez-Enciso, Miguel/H-6057-2015; Groenen, Martien/D-8408-2012; Megens, Hendrik-Jan/M-5300-2019; Ramos-Onsins, Sebastian/B-4822-2015; Crooijmans, Richard PMA/E-2492-2012; Amaral, Andreia/O-8168-2015; Ferretti, Luca/B-4340-2019; Megens, Hendrik-Jan/E-9676-2010	Perez-Enciso, Miguel/0000-0003-3524-995X; Groenen, Martien/0000-0003-0484-4545; Megens, Hendrik-Jan/0000-0002-3619-7533; Ramos-Onsins, Sebastian/0000-0002-1776-140X; Amaral, Andreia/0000-0003-0958-5570; Ferretti, Luca/0000-0001-7578-7301; Megens, Hendrik-Jan/0000-0002-3619-7533; Schook, Lawrence/0000-0002-6580-8364	European Commission; USDA [AG 2008-34480-19328, AG 2007-04315]; USDA-ARS [538 AG58-5438-7-3171]; EU [FOOD-CT-2006-01625]; Centre for Research in Agrigenomics [CSD2007-00036]; MICINN (Spain) [AGC2007-65563-C02-01/GAN, CGL2009-09346/BOS]; CSIC (Spain); ICREA Funding Source: Custom	European Commission(European CommissionEuropean Commission Joint Research Centre); USDA(United States Department of Agriculture (USDA)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); EU(European Commission); Centre for Research in Agrigenomics; MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC (Spain); ICREA(ICREA)	This work was conducted as part of the SABRETRAIN Project funded by the Marie Curie Host Fellowships for Early Stage Research Training and as part of the 6th Framework Programme of the European Commission. This work was supported by USDA AG 2008-34480-19328, USDA-ARS 538 AG58-5438-7-3171, USDA AG 2007-04315, EU SABRE project FOOD-CT-2006-01625 and Consolider-Ingenio Programme CSD2007-00036 "Centre for Research in Agrigenomics". MP-E is funded by a MICINN grant AGC2007-65563-C02-01/GAN (Spain). SER-O is recipient of a Ramon y Cajal position and is funded by a MICINN grant CGL2009-09346/BOS (Spain). LF holds a JAEdoc post doc fellowship from CSIC (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achat G, 2008, GENETICS, V179, P1409, DOI 10.1534/genetics.107.082198; Alonso S, 2008, MOL BIOL EVOL, V25, P997, DOI 10.1093/molbev/msn049; Amaral AJ, 2008, GENETICS, V179, P569, DOI 10.1534/genetics.107.084277; Amaral AJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-374; Angles JM, 2005, TISSUE ANTIGENS, V66, P173, DOI 10.1111/j.1399-0039.2005.00461.x; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Birch J, 2006, IMMUNOGENETICS, V58, P670, DOI 10.1007/s00251-006-0137-y; Bonetta L, 2006, NAT METHODS, V3, P141, DOI 10.1038/nmeth0206-141; Chen GK, 2009, GENOME RES, V19, P136, DOI 10.1101/gr.083634.108; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Darwin CR., 1868, VARIATION ANIMALS PL, DOI DOI 10.1371/journal.pbio.0040088; Driscoll CA, 2009, P NATL ACAD SCI USA, V106, P9971, DOI 10.1073/pnas.0901586106; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Evans PD, 2005, SCIENCE, V309, P1717, DOI 10.1126/science.1113722; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fang MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000341; Farnir F, 2000, GENOME RES, V10, P220, DOI 10.1101/gr.10.2.220; FRANK H, 1980, Z TIERPSYCHOL, V53, P389; Gilad Y, 2005, GENOME RES, V15, P224, DOI 10.1101/gr.2846405; Giuffra E, 2000, GENETICS, V154, P1785; Hellmann I, 2008, GENOME RES, V18, P1020, DOI 10.1101/gr.074187.107; Hemmer H, 1990, DOMESTICATION; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Jiang R, 2009, GENETICS, V181, P187, DOI 10.1534/genetics.107.080630; LANCET D, 1994, NATURE, V372, P321, DOI 10.1038/372321a0; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Laval G, 2000, GENET SEL EVOL, V32, P187, DOI 10.1051/gse:2000113; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lu J, 2005, P NATL ACAD SCI USA, V102, P4063, DOI 10.1073/pnas.0500436102; Lynch M, 2008, MOL BIOL EVOL, V25, P2409, DOI 10.1093/molbev/msn185; MARKLUND S, 1996, MAMM GENOME, V7, P822; McRae AF, 2002, GENETICS, V160, P1113; Megens HJ, 2008, GENET SEL EVOL, V40, P103, DOI 10.1051/gse:2007039; Meyer D, 2006, GENETICS, V173, P2121, DOI 10.1534/genetics.105.052837; Meyer-Lindenberg A, 2007, J CLIN INVEST, V117, P672, DOI 10.1172/JCI30413; Miltiadou D, 2005, IMMUNOGENETICS, V57, P499, DOI 10.1007/s00251-005-0008-y; MOREY DF, 1994, AM SCI, V82, P336; Muira WM, 2008, P NATL ACAD SCI USA, V105, P17312, DOI 10.1073/pnas.0806569105; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Ojeda A, 2008, ANIM GENET, V39, P468, DOI 10.1111/j.1365-2052.2008.01752.x; Ollivier L, 2009, ANIMAL, V3, P915, DOI 10.1017/S1751731109004297; Otting N, 2005, P NATL ACAD SCI USA, V102, P1626, DOI 10.1073/pnas.0409084102; Pages H C M., ANNOTATIONDBI ANNOTA; Paszek A, 1998, J MOL EVOL, V46, P121, DOI 10.1007/PL00006279; Porter V., 1993, PIGS HDB BREEDS WORL; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; PRICE EO, 1969, ADAPTATION DOMESTIC, P34; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Roos C, 2005, IMMUNOGENETICS, V56, P773, DOI 10.1007/s00251-004-0744-4; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; VOLIS S, 2008, POPULATION GENETICS, P279; Wakeley J., 2008, COALESCENT THEORY IN	57	98	107	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e14782	10.1371/journal.pone.0014782	http://dx.doi.org/10.1371/journal.pone.0014782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483733	Green Published, Green Submitted, gold			2022-12-27	WOS:000289058700001
J	Shanaube, K; Hargreaves, J; Fielding, K; Schaap, A; Lawrence, KA; Hensen, B; Sismanidis, C; Menezes, A; Beyers, N; Ayles, H; Godfrey-Faussett, P				Shanaube, Kwame; Hargreaves, James; Fielding, Katherine; Schaap, Ab; Lawrence, Katherine-Anne; Hensen, Bernadette; Sismanidis, Charalambos; Menezes, Angela; Beyers, Nulda; Ayles, Helen; Godfrey-Faussett, Peter			Risk Factors Associated with Positive QuantiFERON-TB Gold In-Tube and Tuberculin Skin Tests Results in Zambia and South Africa	PLOS ONE			English	Article							BLOOD INTERFERON-GAMMA; CELL-BASED ASSAY; LATENT TUBERCULOSIS; RELEASE ASSAYS; INFECTION; DIAGNOSIS; TRANSMISSION; HIV; PREVALENCE; INDIVIDUALS	Introduction: The utility of T-cell based interferon-gamma release assays for the diagnosis of latent tuberculosis infection remains unclear in settings with a high burden of tuberculosis. Objectives: To determine risk factors associated with positive QuantiFERON-TB Gold In-Tube (QFT-GIT) and tuberculin skin test (TST) results and the level of agreement between the tests; to explore the hypotheses that positivity in QFT-GIT is more related to recent infection and less affected by HIV than the TST. Methods: Adult household contacts of tuberculosis patients were invited to participate in a cross-sectional study across 24 communities in Zambia and South Africa. HIV, QFT-GIT and TST tests were done. A questionnaire was used to assess risk factors. Results: A total of 2,220 contacts were seen. 1,803 individuals had interpretable results for both tests, 1,147 (63.6%) were QFT-GIT positive while 725 (40.2%) were TST positive. Agreement between the tests was low (kappa=0.24). QFT-GIT and TST results were associated with increasing age (adjusted OR [aOR] for each 10 year increase for QFT-GIT 1.15; 95% CI: 1.06-1.25, and for TST aOR: 1.10; 95% CI 1.01-1.20). HIV positivity was less common among those with positive results on QFT-GIT (aOR: 0.51; 95% CI: 0.39-0.67) and TST (aOR: 0.61; 95% CI: 0.46-0.82). Smear positivity of the index case was associated with QFT-GIT (aOR: 1.25; 95% CI: 0.90-1.74) and TST (aOR: 1.39; 95% CI: 0.98-1.98) results. We found little evidence in our data to support our hypotheses. Conclusion: QFT-GIT may not be more sensitive than the TST to detect risk factors associated with tuberculous infection. We found little evidence to support the hypotheses that positivity in QFT-GIT is more related to recent infection and less affected by HIV than the TST.	[Shanaube, Kwame; Schaap, Ab; Ayles, Helen] Univ Zambia, ZAMBART Project, Lusaka, Zambia; [Hargreaves, James; Fielding, Katherine; Schaap, Ab] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Hensen, Bernadette; Ayles, Helen; Godfrey-Faussett, Peter] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Lawrence, Katherine-Anne; Menezes, Angela; Beyers, Nulda] Univ Stellenbosch, Desmond Tutu TB Ctr, ZA-7600 Stellenbosch, South Africa; [Sismanidis, Charalambos] WHO, Stop TB Dept, Monitoring & Evaluat Unit, CH-1211 Geneva, Switzerland	University of Zambia; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Stellenbosch University; World Health Organization	Shanaube, K (corresponding author), Univ Zambia, ZAMBART Project, Lusaka, Zambia.	kshanaube@zambart.org.zm		Ayles, Helen/0000-0003-4108-2842; Hensen, Bernadette/0000-0001-6719-6720; Hargreaves, James/0000-0002-3509-3572; Shanaube, Kwame/0000-0001-7899-0890	Foundation for Innovative New Diagnostics (FIND); Johns Hopkins University; Bill and Melinda Gates Foundation via the CREATE (Consortium to Respond Effectively to AIDS and Tuberculosis Epidemic) consortium [19790.01]; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: researchfish	Foundation for Innovative New Diagnostics (FIND); Johns Hopkins University(Johns Hopkins University); Bill and Melinda Gates Foundation via the CREATE (Consortium to Respond Effectively to AIDS and Tuberculosis Epidemic) consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This manuscript/work was supported by the Foundation for Innovative New Diagnostics (FIND). Further support was provided by a subcontract from Johns Hopkins University with funds provided (Grant No. 19790.01) from the Bill and Melinda Gates Foundation via the CREATE (Consortium to Respond Effectively to AIDS and Tuberculosis Epidemic) consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122; [Anonymous], 2011, GUID INT TUB CAS FIN; Ayles HM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-63; Balcells ME, 2008, INT J INFECT DIS, V12, P645, DOI 10.1016/j.ijid.2008.03.005; Boccia D, 2009, AM J TROP MED HYG, V80, P1004, DOI 10.4269/ajtmh.2009.80.1004; Canadian Tuberculosis Committee, 2007, Can Commun Dis Rep, V33, P1; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; *CDCP, 2000, MMWR, V49; *CELL LTD, 2007, 142 CELL LTD; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Classen CN, 1999, THORAX, V54, P136, DOI 10.1136/thx.54.2.136; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; Davidow AL, 2008, INT J TUBERC LUNG D, V12, P152; del Corral H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008257; *DEP HLTH REP S AF, 2010, GUID TUB PREV THER H; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; DUNCAN LE, 1995, T ROY SOC TROP MED H, V89, P37, DOI 10.1016/0035-9203(95)90649-5; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962; GUELAR A, 1993, AIDS, V7, P1345, DOI 10.1097/00002030-199310000-00007; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Hesseling AC, 2009, THORAX, V64, P840, DOI 10.1136/thx.2007.085340; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Lalvani A, 2010, ENFERM INFEC MICR CL, V28, P245, DOI 10.1016/j.eimc.2009.05.012; Lee JY, 2006, EUR RESPIR J, V28, P24, DOI 10.1183/09031936.06.00016906; Lewinsohn DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003407; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Mahomed H, 2006, INT J TUBERC LUNG D, V10, P310; *MOH TDRC CSO U ZA, 2009, ZAMB DEM HLTH SURV 2; Mutsvangwa J, 2010, THORAX, V65, P315, DOI 10.1136/thx.2009.124891; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2008, INT J TUBERC LUNG D, V12, P895; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Raby E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002489; Rieder HL, 2011, INT J TUBERC LUNG D, V15, pS1; Schaaf HS, 2003, INT J TUBERC LUNG D, V7, P426; Shanaube K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007749; Sismanidis C, 2008, CLIN TRIALS, V5, P316, DOI 10.1177/1740774508094747; Thomas TA, 2010, PEDIATRICS, V126, pE1522, DOI 10.1542/peds.2010-0885; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; WHO, 2009, WHOHTMTB2009411; Zellweger JP, 2005, INT J TUBERC LUNG D, V9, P1242	46	33	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18206	10.1371/journal.pone.0018206	http://dx.doi.org/10.1371/journal.pone.0018206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483746	Green Published, gold, Green Accepted			2022-12-27	WOS:000289058700013
J	Hultberg, A; Temperton, NJ; Rosseels, V; Koenders, M; Gonzalez-Pajuelo, M; Schepens, B; Ibanez, LI; Vanlandschoot, P; Schillemans, J; Saunders, M; Weiss, RA; Saelens, X; Melero, JA; Verrips, CT; Van Gucht, S; de Haard, HJ				Hultberg, Anna; Temperton, Nigel J.; Rosseels, Valerie; Koenders, Mireille; Gonzalez-Pajuelo, Maria; Schepens, Bert; Ibanez, Lorena Itati; Vanlandschoot, Peter; Schillemans, Joris; Saunders, Michael; Weiss, Robin A.; Saelens, Xavier; Melero, Jose A.; Verrips, C. Theo; Van Gucht, Steven; de Haard, Hans J.			Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MONOCLONAL-ANTIBODY; RABIES VIRUS; IN-VITRO; ANTIGENIC STRUCTURE; F-GLYCOPROTEIN; ESCAPE MUTANTS; FRAGMENTS; MICE; VARIANTS	For efficient prevention of viral infections and cross protection, simultaneous targeting of multiple viral epitopes is a powerful strategy. Llama heavy chain antibody fragments (VHH) against the trimeric envelope proteins of Respiratory Syncytial Virus (Fusion protein), Rabies virus (Glycoprotein) and H5N1 Influenza (Hemagglutinin 5) were selected from llama derived immune libraries by phage display. Neutralizing VHH recognizing different epitopes in the receptor binding sites on the spikes with affinities in the low nanomolar range were identified for all the three viruses by viral neutralization assays. By fusion of VHH with variable linker lengths, multimeric constructs were made that improved neutralization potencies up to 4,000-fold for RSV, 1,500-fold for Rabies virus and 75-fold for Influenza H5N1. The potencies of the VHH constructs were similar or better than best performing monoclonal antibodies. The cross protection capacity against different viral strains was also improved for all three viruses, both by multivalent (two or three identical VHH) and biparatopic (two different VHH) constructs. By combining a VHH neutralizing RSV subtype A, but not subtype B with a poorly neutralizing VHH with high affinity for subtype B, a biparatopic construct was made with low nanomolar neutralizing potency against both subtypes. Trivalent anti-H5N1 VHH neutralized both Influenza H5N1 clade1 and 2 in a pseudotype assay and was very potent in neutralizing the NIBRG-14 Influenza H5N1 strain with IC(50) of 9 picomolar. Bivalent and biparatopic constructs against Rabies virus cross neutralized both 10 different Genotype 1 strains and Genotype 5. The results show that multimerization of VHH fragments targeting multiple epitopes on a viral trimeric spike protein is a powerful tool for anti-viral therapy to achieve "best-in-class" and broader neutralization capacity.	[Hultberg, Anna; Koenders, Mireille; Verrips, C. Theo; de Haard, Hans J.] Univ Utrecht, Dept Biol Cellular Architecture & Dynam, Utrecht, Netherlands; [Temperton, Nigel J.; Weiss, Robin A.] UCL, Div Infect & Immun, MRC, Ctr Med Mol Virol, London, England; [Temperton, Nigel J.] Univ Kent, Medway Sch Pharm, Chatham, Kent, England; [Rosseels, Valerie; Van Gucht, Steven] Sci Inst Publ Hlth, Rabies Lab, Brussels, Belgium; [Gonzalez-Pajuelo, Maria; Vanlandschoot, Peter; Saunders, Michael] Ablynx NV, Ghent, Belgium; [Schepens, Bert; Ibanez, Lorena Itati; Saelens, Xavier] VIB, Dept Mol Biomed Res, Ghent, Belgium; [Schepens, Bert; Ibanez, Lorena Itati; Saelens, Xavier] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Schillemans, Joris] Univ Utrecht, Dept Pharmaceut, UIPS, Utrecht, Netherlands; [Melero, Jose A.] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Melero, Jose A.] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain	Utrecht University; University of London; University College London; University of Greenwich; University of Kent; Flanders Institute for Biotechnology (VIB); Ghent University; Utrecht University; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Hultberg, A (corresponding author), Univ Utrecht, Dept Biol Cellular Architecture & Dynam, Utrecht, Netherlands.	peter.vanlandschoot@ablynx.com; J.J.W.deHaard@uu.nl	Temperton, Nigel James/M-1164-2019; Temperton, Nigel James/K-5158-2013; Saelens, Xavier/N-5728-2015	Temperton, Nigel James/0000-0002-7978-3815; Temperton, Nigel James/0000-0002-7978-3815; Melero, Jose A./0000-0001-8148-6521; , Xavier/0000-0002-3861-6965	Flemish government [IWT70050]; Ablynx NV; MRC [G0801176, G0600369] Funding Source: UKRI; Medical Research Council [G0600369, G0801176] Funding Source: researchfish	Flemish government(European Commission); Ablynx NV(Ablynx); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by an IWT grant (Institute for the Promotion of Innovation by Science and Technology in Flanders, IWT70050) from the Flemish government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding was also provided by Ablynx NV which had a significant input on the design and execution of the research.	Bakker ABH, 2005, J VIROL, V79, P9062, DOI 10.1128/JVI.79.14.9062-9068.2005; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; BOURHY H, 1992, J CLIN MICROBIOL, V30, P2419, DOI 10.1128/JCM.30.9.2419-2426.1992; Colman PM, 2009, ANNU REV BIOCHEM, V78, P95, DOI 10.1146/annurev.biochem.78.082207.084029; Conrath KE, 2001, J BIOL CHEM, V276, P7346, DOI 10.1074/jbc.M007734200; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Corral T, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-17; Crowe JE, 1998, VIROLOGY, V252, P373, DOI 10.1006/viro.1998.9462; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; DeVincenzo JP, 2004, J INFECT DIS, V190, P975, DOI 10.1086/423213; Fooks AR, 2003, EPIDEMIOL INFECT, V131, P1029, DOI 10.1017/S0950268803001481; Forsman A, 2008, J VIROL, V82, P12069, DOI 10.1128/JVI.01379-08; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; GARCIABARRENO B, 1989, J VIROL, V63, P925; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Klein JS, 2009, P NATL ACAD SCI USA, V106, P7385, DOI 10.1073/pnas.0811427106; LEROUX I, 2008, WHO RABIES B, V32; Lopez JA, 1998, J VIROL, V72, P6922; MONTANOHIROSE JA, 1993, VACCINE, V11, P1259, DOI 10.1016/0264-410X(93)90052-Y; Roovers RC, 2007, CANCER IMMUNOL IMMUN, V56, P303, DOI 10.1007/s00262-006-0180-4; Rudge JS, 2007, P NATL ACAD SCI USA, V104, P18363, DOI 10.1073/pnas.0708865104; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Schofield DJ, 1997, J GEN VIROL, V78, P2431, DOI 10.1099/0022-1317-78-10-2431; Serruys B, 2009, HEPATOLOGY, V49, P39, DOI 10.1002/hep.22609; Sheldon J, 2008, J ANTIMICROB CHEMOTH, V61, P766, DOI 10.1093/jac/dkn014; Temperton NJ, 2007, INFLUENZA OTHER RESP, V1, P105, DOI 10.1111/j.1750-2659.2007.00016.x; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; van der Vaart JM, 2006, VACCINE, V24, P4130, DOI 10.1016/j.vaccine.2006.02.045; Wandeler A.I., 1993, Revue Scientifique et Technique Office International des Epizooties, V12, P51; Wu H, 2005, J MOL BIOL, V350, P126, DOI 10.1016/j.jmb.2005.04.049; Wu SJ, 2007, J GEN VIROL, V88, P2719, DOI 10.1099/vir.0.82753-0	35	116	134	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e17665	10.1371/journal.pone.0017665	http://dx.doi.org/10.1371/journal.pone.0017665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483777	Green Published, Green Accepted, gold			2022-12-27	WOS:000289058300003
J	Wielinga, PY; Yakala, GK; Heeringa, P; Kleemann, R; Kooistra, T				Wielinga, Peter Y.; Yakala, Gopala K.; Heeringa, Peter; Kleemann, Robert; Kooistra, Teake			Beneficial Effects of Alternate Dietary Regimen on Liver Inflammation, Atherosclerosis and Renal Activation	PLOS ONE			English	Article							CALORIE RESTRICTION; TRANSGENIC MICE; CHOLESTEROL; DISEASE	Background: Alternate day calorie restriction (CR) has been shown to be almost as beneficial as daily CR. The question arises whether this concept is also applicable to alternating dietary composition. Objective: To seek evidence that alternating high cholesterol (HC) - cholesterol-free (CON) Western diet can effectively diminish hepatic and renal inflammation and cardiovascular risk factors as compared with daily HC-supplemented Western diet. Design: Four groups of ApoE*3Leiden mice, a humanized model for atherosclerosis, were subjected to different feeding treatments for 16 weeks. Mice were fed CON diet; CON diet with 1% w/w cholesterol (HC); alternate (ALT) diet regimen of CON (4 days) and HC (3 days); or CON diet supplemented with 0.43% (w/w) cholesterol (MC), with overall dietary cholesterol intake equal to ALT. Plasma was analyzed for cardiovascular risk factors, aorta for atherosclerotic lesion formation, and liver and kidney for inflammation. Results: ALT diet but not MC was almost as effective as daily CON feeding in preventing disease development. Compared to HC, the ALT group showed 62% lower hepatic nuclear factor kappa B (NF-kappa B) activity (P < 0.001), a reduction of the circulating inflammatory markers E-selectin (-20%; P < 0.05), vascular cell adhesion molecule 1 (VCAM-1; -15%; P < 0.05) and Serum Amyloid A (SAA; -31%; P < 0.05), smaller atherosclerotic lesion sizes (-51%; 46497 +/- 10791 mu m(2) vs. 94664 +/- 16470 mu m(2); P < 0.05) and diminished renal expression of specific inflammation and activation markers (VCAM-1, -27%; P < 0.05; monocyte chemotactic protein-1 (MCP-1); -37%; P < 0.01). Conclusion: Alternate HC-CON feeding reproduced most of the beneficial effects of daily cholesterol-free diet, including strongly diminished hepatic, vascular and renal activation and inflammation; also atherosclerosis was reduced by half as compared to HC, albeit still higher compared to the CON group.	[Wielinga, Peter Y.; Kleemann, Robert; Kooistra, Teake] TNO Metab Hlth Res, Leiden, Netherlands; [Yakala, Gopala K.; Heeringa, Peter] Univ Groningen, Med Biol Sect, Dept Pathol & Med Biol, Univ Med Ctr Groningen, Groningen, Netherlands; [Wielinga, Peter Y.; Yakala, Gopala K.; Heeringa, Peter; Kleemann, Robert] Top Inst Food & Nutr, Wageningen, Netherlands	Netherlands Organization Applied Science Research; University of Groningen; Top Institute Food & Nutrition	Wielinga, PY (corresponding author), TNO Metab Hlth Res, Leiden, Netherlands.	Peter.Wielinga@tno.nl	Heeringa, Peter/A-6008-2009	Heeringa, Peter/0000-0001-8684-763X	Top Institute Food and Nutrition [A1004]; TNO	Top Institute Food and Nutrition; TNO	The study was funded by the Top Institute Food and Nutrition (www.tifn.nl), research program A1004 and the TNO (www.tno.nl), research program Personalized Health. PYW, GKY, PH and RK are employed by Top Institute Food and Nutrition and PYW, RK and TK by TNO-BioSciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fontana L, 2008, EUR J CARDIOV PREV R, V15, P3, DOI 10.1097/HJR.0b013e3282f17bd4; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Jiang T, 2005, J AM SOC NEPHROL, V16, P2385, DOI 10.1681/ASN.2004080701; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Kooistra T, 2006, ARTERIOSCL THROM VAS, V26, P2322, DOI 10.1161/01.ATV.0000238348.05028.14; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Rein D, 2006, J NUTR, V136, P2331, DOI 10.1093/jn/136.9.2331; Turk MW, 2009, J CARDIOVASC NURS, V24, P58, DOI 10.1097/01.JCN.0000317471.58048.32; VANLIEW JB, 1992, AM J PHYSIOL, V263, pF554, DOI 10.1152/ajprenal.1992.263.3.F554; Varady KA, 2008, FASEB J, V22, P2090, DOI 10.1096/fj.07-098178; Varady KA, 2010, J NUTR BIOCHEM, V21, P188, DOI 10.1016/j.jnutbio.2008.11.001; Varady KA, 2009, AM J CLIN NUTR, V90, P1138, DOI 10.3945/ajcn.2009.28380; Verschuren L, 2005, ARTERIOSCL THROM VAS, V25, P161, DOI 10.1161/01.ATV.0000148866.29829.19; Wiggins JE, 2010, J AM SOC NEPHROL, V21, P587, DOI 10.1681/ASN.2009060663; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	17	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18432	10.1371/journal.pone.0018432	http://dx.doi.org/10.1371/journal.pone.0018432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483792	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200077
J	Schulzke, JD; Andres, S; Amasheh, M; Fromm, A; Gunzel, D				Schulzke, Joerg D.; Andres, Susanne; Amasheh, Maren; Fromm, Anja; Guenzel, Dorothee			Anti-Diarrheal Mechanism of the Traditional Remedy Uzara via Reduction of Active Chloride Secretion	PLOS ONE			English	Article							EPITHELIAL-CELL LINE; CL-SECRETION; COLON; TRANSPORT; BARRIER; STIMULATION; CARBACHOL; CHANNEL; CHOLERA; CONDUCTANCE	Background and Purpose: The root extract of the African Uzara plant is used in traditional medicine as anti-diarrheal drug. It is known to act via inhibition of intestinal motility, but malabsorptive or antisecretory mechanisms are unknown yet. Experimental Approach: HT-29/B6 cells and human colonic biopsies were studied in Ussing experiments in vitro. Uzara was tested on basal as well as on forskolin- or cholera toxin-induced Cl(-) secretion by measuring short-circuit current (I(SC)) and tracer fluxes of (22)Na(+) and (36)Cl(-). Para- and transcellular resistances were determined by two-path impedance spectroscopy. Enzymatic activity of the Na(+)/K(+)-ATPase and intracellular cAMP levels (ELISA) were measured. Key Results: In HT-29/B6 cells, Uzara inhibited forskolin- as well as cholera toxin-induced I(SC) within 60 minutes indicating reduced active chloride secretion. Similar results were obtained in human colonic biopsies pre-stimulated with forskolin. In HT-29/B6, the effect of Uzara on the forskolin- induced I(SC) was time- and dose-dependent. Analyses of the cellular mechanisms of this Uzara effect revealed inhibition of the Na(+)/K(+)-ATPase, a decrease in forskolin-induced cAMP production and a decrease in paracellular resistance. Tracer flux experiments indicate that the dominant effect is the inhibition of the Na(+)/K(+)-ATPase. Conclusion and Implications: Uzara exerts anti-diarrheal effects via inhibition of active chloride secretion. This inhibition is mainly due to an inhibition of the Na(+)/K(+)-ATPase and to a lesser extent to a decrease in intracellular cAMP responses and paracellular resistance. The results imply that Uzara is suitable for treating acute secretory diarrhea.	[Schulzke, Joerg D.; Andres, Susanne; Amasheh, Maren] Free Univ Berlin, Charite, Sect Gen Med & Nutr, Dept Gastroenterol, D-1000 Berlin, Germany; [Schulzke, Joerg D.; Andres, Susanne; Amasheh, Maren; Fromm, Anja; Guenzel, Dorothee] Humboldt Univ, Berlin, Germany; [Fromm, Anja; Guenzel, Dorothee] Free Univ Berlin, Charite, Inst Clin Physiol, D-1000 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schulzke, JD (corresponding author), Free Univ Berlin, Charite, Sect Gen Med & Nutr, Dept Gastroenterol, D-1000 Berlin, Germany.	joerg.schulzke@charite.de		Gunzel, Dorothee/0000-0002-7998-7164; Fromm, Anja/0000-0003-4091-9612	German Research Foundation; DFG Research Unit [FOR 721/2]	German Research Foundation(German Research Foundation (DFG)); DFG Research Unit(German Research Foundation (DFG))	This study was funded by the German Research Foundation, DFG Research Unit FOR 721/2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott AJ, 1998, BIOCHEM BIOPH RES CO, V251, P256, DOI 10.1006/bbrc.1998.9453; BAJNATH RB, 1991, J MEMBRANE BIOL, V122, P239, DOI 10.1007/BF01871424; BRAYDEN DJ, 1993, AM J PHYSIOL, V264, pG325, DOI 10.1152/ajpgi.1993.264.2.G325; BRIDGES RJ, 1983, N-S ARCH PHARMACOL, V323, P355, DOI 10.1007/BF00512476; BROWN L, 1983, BIOCHEM PHARMACOL, V32, P2767, DOI 10.1016/0006-2952(83)90090-4; Desjeux JF, 1997, BAILLIERE CLIN GASTR, V11, P509, DOI 10.1016/S0950-3528(97)90029-4; DHARMSATHAPHORN K, 1986, J CLIN INVEST, V77, P348, DOI 10.1172/JCI112311; Epple HJ, 1997, PFLUG ARCH EUR J PHY, V433, P638, DOI 10.1007/s004240050325; Flores CA, 2007, J PHYSIOL-LONDON, V583, P705, DOI 10.1113/jphysiol.2007.134387; Gessner O, 1930, N-S ARCH EX PATH PH, V148, P353; Ghorbani M, 1997, PLANTA MED, V63, P343, DOI 10.1055/s-2006-957697; KIMBERG DV, 1971, J CLIN INVEST, V50, P1218, DOI 10.1172/JCI106599; KREUSEL KM, 1991, AM J PHYSIOL, V261, pC574, DOI 10.1152/ajpcell.1991.261.4.C574; Krug SM, 2009, BIOPHYS J, V97, P2202, DOI 10.1016/j.bpj.2009.08.003; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Lencer WI, 2001, AM J PHYSIOL-GASTR L, V280, pG781, DOI 10.1152/ajpgi.2001.280.5.G781; Mall M, 1998, AM J PHYSIOL-GASTR L, V275, pG1274, DOI 10.1152/ajpgi.1998.275.6.G1274; Mandal A, 2008, AM J PHYSIOL-CELL PH, V295, pC100, DOI 10.1152/ajpcell.90636.2007; Preston P, 2010, J BIOL CHEM, V285, P7165, DOI 10.1074/jbc.M109.047829; Raymond-Hamet, 1930, CR HEBD ACAD SCI, V190, P821; RITTER A, 2006, INT J CLIN PHARM TH, V44, P529; Rosenthal R, 2010, J CELL SCI, V123, P1913, DOI 10.1242/jcs.060665; SADRZADEH SMH, 1993, J PHARMACOL TOXICOL, V30, P103, DOI 10.1016/1056-8719(93)90013-5; SCHMIEDL S, 2006, INT J CLIN PHARM TH, V44, P526; Schmitz H, 2002, AIDS, V16, P983, DOI 10.1097/00002030-200205030-00004; Schulz V., 2004, RATIONAL PHYTOTHERAP, P1; SMITH PL, 1986, AM J PHYSIOL, V250, pG44, DOI 10.1152/ajpgi.1986.250.1.G44; Stockmann M, 1998, AIDS, V12, P43, DOI 10.1097/00002030-199801000-00006; STRABEL D, 1995, EUR J PHARMACOL, V274, P181, DOI 10.1016/0014-2999(94)00728-P; Thurmann PA, 2004, INT J CLIN PHARM TH, V42, P281; van Wyk BE, 2008, J ETHNOPHARMACOL, V119, P342, DOI 10.1016/j.jep.2008.05.029; WEYMER A, 1985, J CLIN INVEST, V76, P1828, DOI 10.1172/JCI112175; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632	33	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18107	10.1371/journal.pone.0018107	http://dx.doi.org/10.1371/journal.pone.0018107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479205	Green Published, Green Submitted, gold			2022-12-27	WOS:000289055700026
J	Buch, PK; Mihelec, M; Cottrill, P; Wilkie, SE; Pearson, RA; Duran, Y; West, EL; Michaelides, M; Ali, RR; Hunt, DM				Buch, Prateek K.; Mihelec, Marija; Cottrill, Phillippa; Wilkie, Susan E.; Pearson, Rachael A.; Duran, Yanai; West, Emma L.; Michaelides, Michel; Ali, Robin R.; Hunt, David M.			Dominant Cone-Rod Dystrophy: A Mouse Model Generated by Gene Targeting of the GCAP1/Guca1a Gene	PLOS ONE			English	Article							CYCLASE-ACTIVATING PROTEIN-1; CALCIUM-CHANNEL BLOCKER; D-CIS-DILTIAZEM; GUANYLYL CYCLASE; RETINAL DEGENERATION; RETINITIS-PIGMENTOSA; PHOTORECEPTOR RESCUE; DEPENDENT CHANNEL; RECOVERY KINETICS; PROGRESSIVE CONE	Cone dystrophy 3 (COD3) is a severe dominantly inherited retinal degeneration caused by missense mutations in GUCA1A, the gene encoding Guanylate Cyclase Activating Protein 1 (GCAP1). The role of GCAP1 in controlling cyclic nucleotide levels in photoreceptors has largely been elucidated using knock-out mice, but the disease pathology in these mice cannot be extrapolated directly to COD3 as this involves altered, rather than loss of, GCAP1 function. Therefore, in order to evaluate the pathology of this dominant disorder, we have introduced a point mutation into the murine Guca1a gene that causes an E155G amino acid substitution; this is one of the disease-causing mutations found in COD3 patients. Disease progression in this novel mouse model of cone dystrophy was determined by a variety of techniques including electroretinography (ERG), retinal histology, immunohistochemistry and measurement of cGMP levels. It was established that although retinal development was normal up to 3 months of age, there was a subsequent progressive decline in retinal function, with a far greater alteration in cone than rod responses, associated with a corresponding loss of photoreceptors. In addition, we have demonstrated that accumulation of cyclic GMP precedes the observed retinal degeneration and is likely to contribute to the disease mechanism. Importantly, this knock-in mutant mouse has many features in common with the human disease, thereby making it an excellent model to further probe disease pathogenesis and investigate therapeutic interventions.	[Buch, Prateek K.; Mihelec, Marija; Cottrill, Phillippa; Wilkie, Susan E.; Pearson, Rachael A.; Duran, Yanai; West, Emma L.; Michaelides, Michel; Ali, Robin R.; Hunt, David M.] UCL, Inst Ophthalmol, London, England; [Hunt, David M.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia	University of London; University College London; University of Western Australia	Buch, PK (corresponding author), UCL, Inst Ophthalmol, London, England.	r.ali@ucl.ac.uk; david.hunt@uwa.edu.au	Pearson, Rachael/Y-3339-2018; Hunt, David M/K-6024-2012; West, Emma L/C-5252-2013	Pearson, Rachael/0000-0002-1107-1969; Hunt, David M/0000-0002-9264-3948; Ali, Robin/0000-0003-3126-6517; West, Emma/0000-0002-7006-3686	UK Medical Research Council; Wellcome Trust; Fight for Sight UK; Foundation Fighting Blindness USA; Royal Society; National Institute for Health Research USA; Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital; Moorfields Special Trustees; UCL Institute of Ophthalmology; Medical Research Council [G0801004] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10130] Funding Source: researchfish; MRC [G0801004] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Fight for Sight UK; Foundation Fighting Blindness USA; Royal Society(Royal Society of London); National Institute for Health Research USA; Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital; Moorfields Special Trustees; UCL Institute of Ophthalmology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from the UK Medical Research Council (Hunt and Ali), the Wellcome Trust (Hunt), Fight for Sight UK (Ali), Foundation Fighting Blindness USA (Hunt), the Royal Society (Pearson) and the National Institute for Health Research USA (Ali and Michaelides). The authors also acknowledge support from the Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital, Moorfields Special Trustees and UCL Institute of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; BIRCH DG, 1995, INVEST OPHTH VIS SCI, V36, P1603; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; COOK NJ, 1987, P NATL ACAD SCI USA, V84, P585, DOI 10.1073/pnas.84.2.585; Cuenca N, 1998, INVEST OPHTH VIS SCI, V39, P1243; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; FARBER DB, 1976, J CYCLIC NUCL PROT, V2, P139; Frasson M, 1999, NAT MED, V5, P1183, DOI 10.1038/13508; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; HANKE W, 1988, P NATL ACAD SCI USA, V85, P94, DOI 10.1073/pnas.85.1.94; He LH, 2000, J BIOL CHEM, V275, P12175, DOI 10.1074/jbc.275.16.12175; Hetling JR, 1999, J PHYSIOL-LONDON, V516, P593, DOI 10.1111/j.1469-7793.1999.0593v.x; Howes K, 1998, INVEST OPHTH VIS SCI, V39, P867; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Hunt DM, 2010, MOL CELL BIOCHEM, V334, P157, DOI 10.1007/s11010-009-0331-y; Jiang L, 2005, MOL VIS, V11, P143; Jiang L, 2008, VISION RES, V48, P2425, DOI 10.1016/j.visres.2008.07.016; Kachi S, 1999, EXP EYE RES, V68, P465, DOI 10.1006/exer.1998.0629; Kitiratschky VBD, 2009, HUM MUTAT, V30, pE782, DOI 10.1002/humu.21055; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Lyubarsky A, 2001, MOL VIS, V7, P71; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Michaelides M, 2005, OPHTHALMOLOGY, V112, P1442, DOI 10.1016/j.ophtha.2005.02.024; Michaelides M, 2006, SURV OPHTHALMOL, V51, P232, DOI 10.1016/j.survophthal.2006.02.007; Naash MI, 2004, J COMP NEUROL, V478, P149, DOI 10.1002/cne.20283; Nishiguchi KM, 2004, INVEST OPHTH VIS SCI, V45, P3863, DOI 10.1167/iovs.04-0590; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; OttoBruc A, 1997, P NATL ACAD SCI USA, V94, P4727, DOI 10.1073/pnas.94.9.4727; Pawlyk BS, 2002, INVEST OPHTH VIS SCI, V43, P1912; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Pearce-Kelling SE, 2001, MOL VIS, V7, P42; Pennesi ME, 2003, P NATL ACAD SCI USA, V100, P6783, DOI 10.1073/pnas.1130102100; Pepperberg DR, 1996, J OPT SOC AM A, V13, P586, DOI 10.1364/JOSAA.13.000586; Pepperberg DR, 2000, METHOD ENZYMOL, V316, P202; Pepperberg DR, 1997, VISUAL NEUROSCI, V14, P73, DOI 10.1017/S0952523800008774; Samardzija M, 2008, HUM MOL GENET, V17, P281, DOI 10.1093/hmg/ddm304; Small KW, 1996, AM J OPHTHALMOL, V121, P1; Sokal I, 1998, MOL CELL, V2, P129, DOI 10.1016/S1097-2765(00)80121-5; Sokal I, 2005, INVEST OPHTH VIS SCI, V46, P1124, DOI 10.1167/iovs.04-1431; Tan MH, 2009, HUM MOL GENET, V18, P2099, DOI 10.1093/hmg/ddp133; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; van de Pavert SA, 2007, J NEUROSCI, V27, P564, DOI 10.1523/JNEUROSCI.3496-06.2007; Vasireddy V, 2006, INVEST OPHTH VIS SCI, V47, P4558, DOI 10.1167/iovs.06-0353; Wilkie SE, 2001, AM J HUM GENET, V69, P471, DOI 10.1086/323265; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999	50	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18089	10.1371/journal.pone.0018089	http://dx.doi.org/10.1371/journal.pone.0018089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464903	Green Published, Green Submitted, gold			2022-12-27	WOS:000289053800022
J	Goncalves-Pimentel, C; Rita, G; Jozsef, M; Sanchez-Soriano, N; Prokop, A				Goncalves-Pimentel, Catarina; Rita Gombos; Jozsef Mihaly; Sanchez-Soriano, Natalia; Prokop, Andreas			Dissecting Regulatory Networks of Filopodia Formation in a Drosophila Growth Cone Model	PLOS ONE			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; ABL TYROSINE KINASE; ARP2/3 COMPLEX; AXON GUIDANCE; ACTIN; PROFILIN; ROLES; MUTATIONS; MECHANISM; PROTEIN	F-actin networks are important structural determinants of cell shape and morphogenesis. They are regulated through a number of actin-binding proteins. The function of many of these proteins is well understood, but very little is known about how they cooperate and integrate their activities in cellular contexts. Here, we have focussed on the cellular roles of actin regulators in controlling filopodial dynamics. Filopodia are needle-shaped, actin-driven cell protrusions with characteristic features that are well conserved amongst vertebrates and invertebrates. However, existing models of filopodia formation are still incomplete and controversial, pieced together from a wide range of different organisms and cell types. Therefore, we used embryonic Drosophila primary neurons as one consistent cellular model to study filopodia regulation. Our data for loss-of-function of capping proteins, enabled, different Arp2/3 complex components, the formin DAAM and profilin reveal characteristic changes in filopodia number and length, providing a promising starting point to study their functional relationships in the cellular context. Furthermore, the results are consistent with effects reported for the respective vertebrate homologues, demonstrating the conserved nature of our Drosophila model system. Using combinatorial genetics, we demonstrate that different classes of nucleators cooperate in filopodia formation. In the absence of Arp2/3 or DAAM filopodia numbers are reduced, in their combined absence filopodia are eliminated, and in genetic assays they display strong functional interactions with regard to filopodia formation. The two nucleators also genetically interact with enabled, but not with profilin. In contrast, enabled shows strong genetic interaction with profilin, although loss of profilin alone does not affect filopodia numbers. Our genetic data support a model in which Arp2/ 3 and DAAM cooperate in a common mechanism of filopodia formation that essentially depends on enabled, and is regulated through profilin activity at different steps.	[Goncalves-Pimentel, Catarina; Sanchez-Soriano, Natalia; Prokop, Andreas] Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester, Lancs, England; [Goncalves-Pimentel, Catarina] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Rita Gombos; Jozsef Mihaly] Hungarian Acad Sci, Inst Genet, Biol Res Ctr, Szeged, Hungary	University of Manchester; Universidade de Coimbra; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Goncalves-Pimentel, C (corresponding author), Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester, Lancs, England.	NSanchez@manchester.ac.uk; Andreas.Prokop@manchester.ac.uk	Gonçalves-Pimentel, Catarina/E-6277-2013; Pimentel, Catarina/I-6095-2015	Gonçalves-Pimentel, Catarina/0000-0003-1181-3907; Pimentel, Catarina/0000-0003-1181-3907; Mihaly, Jozsef/0000-0003-3399-2424; Sanchez-Soriano, Natalia/0000-0002-6667-2817; Prokop, Andreas/0000-0001-8482-3298	Wellcome Trust [087742/Z/08/Z]; NSS [077748/Z/05/Z, 092403/Z/10/Z]; Hungarian Scientific Research Foundation (OTKA) [K82039]; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/15891/2005]; Hungarian Academy of Sciences; BBSRC; University of Manchester	Wellcome Trust(Wellcome TrustEuropean Commission); NSS; Hungarian Scientific Research Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Hungarian Academy of Sciences(Hungarian Academy of Sciences); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Manchester	This work was funded through grants by the Wellcome Trust to AP and NSS (077748/Z/05/Z and 092403/Z/10/Z), a support from the Hungarian Scientific Research Foundation (OTKA grant K82039) to JM, a studentship from the Fundacao para a Ciencia e a Tecnologia to CGP (SFRH/BD/15891/2005), and a studentship from the Hungarian Academy of Sciences to RG. The Bioimaging Facility used for live imaging is supported by grants from the BBSRC, The Wellcome Trust and the University of Manchester Strategic Fund. The Drosophila core facility is supported by grants of the Wellcome Trust (087742/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern-Djamali SM, 1999, P NATL ACAD SCI USA, V96, P4977, DOI 10.1073/pnas.96.9.4977; Ahern-Djamali SM, 1998, MOL BIOL CELL, V9, P2157, DOI 10.1091/mbc.9.8.2157; Alves-Silva J, 2008, MOL BIOL CELL, V19, P4287, DOI 10.1091/mbc.E08-02-0182; Barko S, 2010, J BIOL CHEM, V285, P13154, DOI 10.1074/jbc.M109.093914; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Block J, 2008, J MICROSC-OXFORD, V231, P506, DOI 10.1111/j.1365-2818.2008.02063.x; Bottenberg W, 2009, MECH DEVELOP, V126, P489, DOI 10.1016/j.mod.2009.04.004; Budnik V, 2006, INT REV NEUROBIOL, V75, P323, DOI 10.1016/S0074-7742(06)75015-2; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Delalle I, 2005, GENETICS, V171, P1757, DOI 10.1534/genetics.105.049213; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; DUBENDORFER A, 1980, INVERTEBRATE SYSTEMS, P169; Dwivedy A, 2007, DEVELOPMENT, V134, P2137, DOI 10.1242/dev.002345; FAIX J, 2009, INT J BIOCHEM CELL B, DOI DOI 10.1016/J.BIOCEL.2009.1002.1012; Gates J, 2007, DEVELOPMENT, V134, P2027, DOI 10.1242/dev.02849; Gates J, 2009, DEV BIOL, V333, P90, DOI 10.1016/j.ydbio.2009.06.030; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8; GUPTON SL, 2007, SCI STKE, pRE5, DOI DOI 10.1126/STKE.4002007RE5; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; HOMEM CC, 2009, MOL BIOL CELL; Hudson AM, 2002, J CELL BIOL, V156, P677, DOI 10.1083/jcb.200109065; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Kuppers B, 2003, J NEUROCHEM, V84, P939, DOI 10.1046/j.1471-4159.2003.01554.x; Kuppers-Munther B, 2004, DEV BIOL, V269, P459, DOI 10.1016/j.ydbio.2004.01.038; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; Matusek T, 2008, J NEUROSCI, V28, P13310, DOI 10.1523/JNEUROSCI.2727-08.2008; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; MELLOR H, 2009, BIOCHIM BIOPHYS ACTA, DOI DOI 10.1016/J.BBAMCR.2008.1012.1018; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; PROKOP A, 2011, MAKING UNMA IN PRESS; Sanchez-Soriano N, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-9; Sanchez-Soriano N, 2010, DEV NEUROBIOL, V70, P58, DOI 10.1002/dneu.20762; Sanchez-Soriano N, 2009, J CELL SCI, V122, P2534, DOI 10.1242/jcs.046268; Schenck A, 2004, DEV BIOL, V274, P260, DOI 10.1016/j.ydbio.2004.07.009; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; SCHNEIDER I, 1964, J EXP ZOOL, V156, P91, DOI 10.1002/jez.1401560107; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Yarmola EG, 2006, TRENDS BIOCHEM SCI, V31, P197, DOI 10.1016/j.tibs.2006.02.006	57	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18340	10.1371/journal.pone.0018340	http://dx.doi.org/10.1371/journal.pone.0018340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464901	Green Published, Green Submitted, gold			2022-12-27	WOS:000289053800042
J	Irish, J; Blair, S; Carter, DA				Irish, Julie; Blair, Shona; Carter, Dee A.			The Antibacterial Activity of Honey Derived from Australian Flora	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; GLUCOSE-OXIDASE; STRAINS; IDENTIFICATION; METHYLGLYOXAL; SENSITIVITY; INHIBINE; ORIGIN	Chronic wound infections and antibiotic resistance are driving interest in antimicrobial treatments that have generally been considered complementary, including antimicrobially active honey. Australia has unique native flora and produces honey with a wide range of different physicochemical properties. In this study we surveyed 477 honey samples, derived from native and exotic plants from various regions of Australia, for their antibacterial activity using an established screening protocol. A level of activity considered potentially therapeutically useful was found in 274 (57%) of the honey samples, with exceptional activity seen in samples derived from marri (Corymbia calophylla), jarrah (Eucalyptus marginata) and jellybush (Leptospermum polygalifolium). In most cases the antibacterial activity was attributable to hydrogen peroxide produced by the bee-derived enzyme glucose oxidase. Non-hydrogen peroxide activity was detected in 80 (16.8%) samples, and was most consistently seen in honey produced from Leptospermum spp. Testing over time found the hydrogen peroxide-dependent activity in honey decreased, in some cases by 100%, and this activity was more stable at 4 degrees C than at 25 degrees C. In contrast, the non-hydrogen peroxide activity of Leptospermum honey samples increased, and this was greatest in samples stored at 25 degrees C. The stability of non-peroxide activity from other honeys was more variable, suggesting this activity may have a different cause. We conclude that many Australian honeys have clinical potential, and that further studies into the composition and stability of their active constituents are warranted.	[Irish, Julie; Blair, Shona; Carter, Dee A.] Univ Sydney, Sch Mol Biosci, Camperdown, NSW, Australia	University of Sydney	Irish, J (corresponding author), Univ Sydney, Sch Mol Biosci, Camperdown, NSW, Australia.	dee.carter@sydney.edu.au	Carter, Dee/C-1331-2010	Carter, Dee/0000-0002-4638-0059; Blair, Shona/0000-0002-4425-6775	Rural Industries Research and Development Corporation grant [US-128A]; Australian Postgraduate Award	Rural Industries Research and Development Corporation grant(Rural Industries R&D Corp); Australian Postgraduate Award(Australian Government)	This project was financially supported by a Rural Industries Research and Development Corporation grant (Project No. US-128A), and an Australian Postgraduate Award to JI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CJ, 2008, CARBOHYD RES, V343, P651, DOI 10.1016/j.carres.2007.12.011; Adams CJ, 2009, CARBOHYD RES, V344, P1050, DOI 10.1016/j.carres.2009.03.020; Allen K.L., 1991, APIACTA, V26, P114, DOI [10.1080/ 0005772X.1992.11099118, DOI 10.1080/0005772X.1992.11099118]; ALLEN KL, 1991, J PHARM PHARMACOL, V43, P817, DOI 10.1111/j.2042-7158.1991.tb03186.x; Allen KL, 1997, NEW ZEAL J AGR RES, V40, P537, DOI 10.1080/00288233.1997.9513276; *AUSTR NAT BOT GAR, 2008, AUSTR PLANT COMM NAM; Bang LM, 2003, J ALTERN COMPLEM MED, V9, P267, DOI 10.1089/10755530360623383; Blair SE, 2009, EUR J CLIN MICROBIOL, V28, P1199, DOI 10.1007/s10096-009-0763-z; Brady N, 2004, J APICULT RES, V43, P47, DOI 10.1080/00218839.2004.11101109; Brady N. F., 1996, Pharmaceutical Sciences, V2, P471; Brooker M.I.H., 2001, FIELD GUIDE EUCALYPT, VII; Brooker M.I.H., 2006, FIELD GUIDE EUCALYPT, V1; Brooker MIH, 2004, FIELD GUIDE EUCALYPT, V3; Cabrera L, 2006, REV CIENT-FAC CIEN V, V16, P556; Castro-Vazquez L, 2008, J AGR FOOD CHEM, V56, P1999, DOI 10.1021/jf072227k; Clemson A.A., 1985, HONEY POLLEN FLORA; Cooper R, 1999, J Wound Care, V8, P161; Cooper RA, 2000, LETT APPL MICROBIOL, V31, P20, DOI 10.1046/j.1472-765x.2000.00756.x; Cooper RA, 2002, J APPL MICROBIOL, V93, P857, DOI 10.1046/j.1365-2672.2002.01761.x; Cooper RA, 2002, J BURN CARE REHABIL, V23, P366, DOI 10.1097/00004630-200211000-00002; Cooper RA, 1999, J ROY SOC MED, V92, P283, DOI 10.1177/014107689909200604; COOPER RA, 2009, COMP MED GRADE HONEY; *CTR PLANT BIOD RE, 2008, AUSTR PLANT NAM IND; *CTR PLANT BIOD RE, 2008, AUSTR VIRT HERB MAP; Dag A, 2003, APIDOLOGIE, V34, P299, DOI 10.1051/apido:2003022; Flores MJ, 2002, MOL MICROBIOL, V44, P783, DOI 10.1046/j.1365-2958.2002.02913.x; French VM, 2005, J ANTIMICROB CHEMOTH, V56, P228, DOI 10.1093/jac/dki193; Gallardo-Chacon JJ, 2008, J APICULT RES, V47, P131, DOI 10.1080/00218839.2008.11101439; Henriques A, 2005, J APICULT RES, V44, P119, DOI 10.1080/00218839.2005.11101161; Irish J, 2006, MED MYCOL, V44, P289, DOI 10.1080/13693780500417037; Janmaat AF, 2000, BEHAV ECOL SOCIOBIOL, V47, P171, DOI 10.1007/s002650050008; Kwakman PHS, 2010, FASEB J, V24, P2576, DOI 10.1096/fj.09-150789; Mattila HR, 2006, ENVIRON ENTOMOL, V35, P708, DOI 10.1603/0046-225X-35.3.708; Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282; MOLAN PC, 1988, J APICULT RES, V27, P252, DOI 10.1080/00218839.1988.11100811; MOLAN PC, 1988, J APICULT RES, V27, P62, DOI 10.1080/00218839.1988.11100783; Molan PC, 1996, J PHARM PHARMACOL, V48, P1206, DOI 10.1111/j.2042-7158.1996.tb03922.x; MOLAN PC, 1992, BEE WORLD, V73, P5, DOI 10.1080/0005772X.1992.11099109; Mundo MA, 2004, INT J FOOD MICROBIOL, V97, P1, DOI 10.1016/j.ijfoodmicro.2004.03.025; Ohashi K, 1999, EUR J BIOCHEM, V265, P127, DOI 10.1046/j.1432-1327.1999.00696.x; Price JN, 2006, ECOGRAPHY, V29, P623, DOI 10.1111/j.0906-7590.2006.04645.x; SOMERVILLE DC, 2008, RURAL IND RES DEV CO, V8060; Stephens JM, 2010, FOOD CHEM, V120, P78, DOI 10.1016/j.foodchem.2009.09.074; WHITE JW, 1963, BIOCHIM BIOPHYS ACTA, V73, P57; WHITE JW, 1964, J FOOD SCI, V29, P819, DOI 10.1111/j.1365-2621.1964.tb00455.x; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102	46	131	137	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18229	10.1371/journal.pone.0018229	http://dx.doi.org/10.1371/journal.pone.0018229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464891	Green Submitted, gold, Green Published			2022-12-27	WOS:000289053800030
J	Ahlehoff, O; Gislason, GH; Lindhardsen, J; Charlot, MG; Jorgensen, CH; Olesen, JB; Bretler, DM; Skov, L; Torp-Pedersen, C; Hansen, PR				Ahlehoff, Ole; Gislason, Gunnar Hilmar; Lindhardsen, Jesper; Charlot, Mette Gitz; Jorgensen, Casper Haslund; Olesen, Jonas Bjerring; Bretler, Ditte-Marie; Skov, Lone; Torp-Pedersen, Christian; Hansen, Peter Riis			Psoriasis Carries an Increased Risk of Venous Thromboembolism: A Danish Nationwide Cohort Study	PLOS ONE			English	Article							CORONARY-ARTERY; CARDIOVASCULAR MORTALITY; PLATELET ACTIVATION; VASCULAR-DISEASES; ATHEROSCLEROSIS; INFLAMMATION; MECHANISMS; CANCER	Background: Psoriasis is an immunoinflammatory disease associated with cardiovascular risk factors, atherothrombotic events, and hypercoagulability. Venous thromboembolism (VTE) is potentially lethal and shares risk factors with psoriasis, but the risk of VTE associated with psoriasis is unknown. The present study investigated the potential association between psoriasis and VTE. Methods and Findings: Information from nationwide prospectively recorded registers of hospitalization, drug dispensing from pharmacies, socio-economic data, and causes of death was linked on an individual level. In an unselected nationwide cohort, we used multivariate Poisson regression models controlling for age, gender, comorbidity, concomitant medication, socio-economic data, and calendar year, to assess the risk of VTE associated with psoriasis. A total of 35,138 patients with mild and 3,526 patients with severe psoriasis were identified and compared with 4,126,075 controls. Patients with psoriasis had higher incidence rates per 1000 person-years of VTE than controls (1.29, 1.92, and 3.20 for controls, mild psoriasis, and severe psoriasis, respectively). The rate ratio (RR) of VTE was elevated in all patients with psoriasis with RR 1.35 (95% confidence interval [CI] 1.21-1.49) and RR 2.06 (CI 1.63-2.61) for mild and severe psoriasis, respectively. Exclusion of patients with malignancies, and censoring of patients undergoing surgery did not alter the results. Conclusion: This nationwide cohort study indicates that patients with psoriasis are at increased risk of VTE. The risk was highest in young patients with severe psoriasis. Physicians should be aware that patients with psoriasis may be at increased risk of both venous and arterial thromboembolic events.	[Ahlehoff, Ole; Gislason, Gunnar Hilmar; Lindhardsen, Jesper; Charlot, Mette Gitz; Jorgensen, Casper Haslund; Olesen, Jonas Bjerring; Bretler, Ditte-Marie; Torp-Pedersen, Christian; Hansen, Peter Riis] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hellerup, Denmark; [Skov, Lone] Univ Copenhagen, Gentofte Hosp, Dept Dermatol, Hellerup, Denmark; [Skov, Lone; Torp-Pedersen, Christian] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Ahlehoff, O (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hellerup, Denmark.	olahha01@geh.regionh.dk	Skov, Lone/W-3575-2018; Gislason, Gunnar/B-7561-2009; Hansen, Peter Riis/AAR-7659-2020	Gislason, Gunnar/0000-0002-0548-402X; Hansen, Peter Riis/0000-0002-9056-535X; Skov, Lone/0000-0002-4784-9680	Department of Cardiology, Copenhagen University Hospital Gentofte	Department of Cardiology, Copenhagen University Hospital Gentofte	The study was supported by the Department of Cardiology, Copenhagen University Hospital Gentofte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlehoff O, 2011, J INTERN MED, V270, P147, DOI 10.1111/j.1365-2796.2010.02310.x; Alexandroff AB, 2009, BRIT J DERMATOL, V161, P1, DOI 10.1111/j.1365-2133.2009.09281.x; BERRETTINI M, 1985, THROMB HAEMOSTASIS, V53, P195; Brauchli YB, 2009, J INVEST DERMATOL, V129, P2604, DOI 10.1038/jid.2009.113; Friedewald VE, 2008, AM J CARDIOL, V102, P1631, DOI 10.1016/j.amjcard.2008.10.004; Gelfand JM, 2007, ARCH DERMATOL, V143, P1493, DOI 10.1001/archderm.143.12.1493; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gelfand JM, 2009, J INVEST DERMATOL, V129, P2411, DOI 10.1038/jid.2009.112; Gisondi P, 2009, SEMIN THROMB HEMOST, V35, P313, DOI 10.1055/s-0029-1222610; Goldhaber SZ, 2010, J AM COLL CARDIOL, V56, P1, DOI 10.1016/j.jacc.2010.01.057; Grainge MJ, 2010, LANCET, V375, P657, DOI 10.1016/S0140-6736(09)61963-2; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Holst AG, 2010, CIRCULATION, V121, P1896, DOI 10.1161/CIRCULATIONAHA.109.921460; Karabudak O, 2008, ACTA DERM-VENEREOL, V88, P337, DOI 10.2340/00015555-0456; Kimball AB, 2008, DERMATOLOGY, V217, P27, DOI 10.1159/000121333; LIPPI G, 2010, CLIN CHEM LAB MED; Mallbris L, 2004, EUR J EPIDEMIOL, V19, P225, DOI 10.1023/B:EJEP.0000020447.59150.f9; MCDONALD CJ, 1978, BRIT J DERMATOL, V99, P469, DOI 10.1111/j.1365-2133.1978.tb02012.x; Mehta NN, 2010, EUR HEART J, V31, P1000, DOI 10.1093/eurheartj/ehp567; Menter A, 2007, LANCET, V370, P272, DOI 10.1016/S0140-6736(07)61129-5; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nuttall M, 2006, J CLIN EPIDEMIOL, V59, P265, DOI 10.1016/j.jclinepi.2005.07.015; Prodanovich S, 2009, ARCH DERMATOL, V145, P700, DOI 10.1001/archdermatol.2009.94; Prodanowich S, 2005, J AM ACAD DERMATOL, V52, P262, DOI 10.1016/j.jaad.2004.06.017; SALEH T, 2010, CLIN APPL THROMB HEM; Severinsen MT, 2010, J CLIN EPIDEMIOL, V63, P223, DOI 10.1016/j.jclinepi.2009.03.018; Shirinsky IV, 2007, J AM ACAD DERMATOL, V57, P529, DOI 10.1016/j.jaad.2007.05.040; Sorensen HT, 2007, LANCET, V370, P1773, DOI 10.1016/S0140-6736(07)61745-0; Squizzato A, 2010, EUR HEART J, V31, P1248, DOI 10.1093/eurheartj/ehp556; Tamagawa-Mineoka R, 2010, J AM ACAD DERMATOL, V62, P621, DOI 10.1016/j.jaad.2009.06.053; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wakkee M, 2007, ATHEROSCLEROSIS, V190, P1, DOI 10.1016/j.atherosclerosis.2006.07.011; Zacho J, 2010, ARTERIOSCL THROM VAS, V30, P1672, DOI 10.1161/ATVBAHA.109.198473	33	72	72	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18125	10.1371/journal.pone.0018125	http://dx.doi.org/10.1371/journal.pone.0018125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464995	Green Published, Green Submitted, gold			2022-12-27	WOS:000288813900042
J	Liebau, S; Steinestel, J; Linta, L; Kleger, A; Storch, A; Schoen, M; Steinestel, K; Proepper, C; Bockmann, J; Schmeisser, MJ; Boeckers, TM				Liebau, Stefan; Steinestel, Julie; Linta, Leonhard; Kleger, Alexander; Storch, Alexander; Schoen, Michael; Steinestel, Konrad; Proepper, Christian; Bockmann, Juergen; Schmeisser, Michael J.; Boeckers, Tobias M.			An SK3 Channel/nWASP/Abi-1 Complex Is Involved in Early Neurogenesis	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTIVATED POTASSIUM CHANNEL; NEURAL STEM-CELLS; SMALL-CONDUCTANCE; INTERMEDIATE-CONDUCTANCE; DENDRITIC SPINES; POSTSYNAPTIC DENSITY; N-WASP; FUNCTIONAL EXPRESSION; EXCITATORY SYNAPSES	Background: The stabilization or regulated reorganization of the actin cytoskeleton is essential for cellular structure and function. Recently, we could show that the activation of the SK3-channel that represents the predominant SK-channel in neural stem cells, leads to a rapid local outgrowth of long filopodial processes. This observation indicates that the rearrangement of the actin based cytoskeleton via membrane bound SK3-channels might selectively be controlled in defined micro compartments of the cell. Principal Findings: We found two important proteins for cytoskeletal rearrangement, the Abelson interacting protein 1, Abi-1 and the neural Wiskott Aldrich Syndrome Protein, nWASP, to be in complex with SK3-channels in neural stem cells (NSCs). Moreover, this interaction is also found in spines and postsynaptic compartments of developing primary hippocampal neurons and regulates neurite outgrowth during early phases of differentiation. Overexpression of the proteins or pharmacological activation of SK3 channels induces obvious structural changes in NSCs and hippocampal neurons. In both neuronal cell systems SK3 channels and nWASP act synergistic by strongly inducing filopodial outgrowth while Abi-1 behaves antagonistic to its interaction partners. Conclusions: Our results give good evidence for a functional interplay of a trimeric complex that transforms incoming signals via SK3-channel activation into the local rearrangement of the cytoskeleton in early steps of neuronal differentiation involving nWASP and Abi-1 actin binding proteins.	[Liebau, Stefan; Steinestel, Julie; Linta, Leonhard; Schoen, Michael; Steinestel, Konrad; Proepper, Christian; Bockmann, Juergen; Schmeisser, Michael J.; Boeckers, Tobias M.] Univ Ulm, Inst Anat & Cell Biol, Ulm, Germany; [Kleger, Alexander] Univ Ulm, Dept Internal Med 1, D-7900 Ulm, Germany; [Kleger, Alexander] Inst Mol Med, Ulm, Germany; [Kleger, Alexander] Max Planck Res Grp Stem Cell Aging, Ulm, Germany; [Storch, Alexander] Tech Univ Dresden, Dept Neurol, D-8027 Dresden, Germany; [Storch, Alexander] Tech Univ Dresden, CRTD, D-8027 Dresden, Germany	Ulm University; Ulm University; Max Planck Society; Technische Universitat Dresden; Technische Universitat Dresden	Liebau, S (corresponding author), Univ Ulm, Inst Anat & Cell Biol, Ulm, Germany.	tobias.boeckers@uni-ulm.de	Liebau, Stefan/C-3374-2015; Schmeisser, Michael/S-6347-2019	Liebau, Stefan/0000-0003-0721-8187; Kleger, Alexander/0000-0003-0592-5232; Steinestel, Konrad/0000-0002-6549-9848	Deutsche Forschungsgemeinschaft (DFG) [BO1718/3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (DFG) URL: www.dfg.de (BO1718/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Boeckers TM, 2005, J NEUROCHEM, V92, P519, DOI 10.1111/j.1471-4159.2004.02910.x; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; CHICCHI GG, 1988, J BIOL CHEM, V263, P10192; DesMarais V, 2009, CELL MOTIL CYTOSKEL, V66, P303, DOI 10.1002/cm.20361; El-Hussein AE, 2000, SCIENCE, V290, P1364; Espinosa L, 2002, J CELL SCI, V115, P3837, DOI 10.1242/jcs.00062; Gavrilova-Ruch O, 2002, J MEMBRANE BIOL, V188, P137, DOI 10.1007/s00232-001-0181-3; GilPerotin S, 2009, ADV ANAT EMBRYOL CEL, V203, P1, DOI 10.1007/978-3-540-88719-5; GILPEROTIN S, 2009, ANAT EMBRYOL CELL BI, V203, pR9; Guan JQ, 2005, BIOCHEMISTRY-US, V44, P3166, DOI 10.1021/bi048021j; Hartig SM, 2009, J CELL SCI, V122, P2283, DOI 10.1242/jcs.041343; Hofer SB, 2010, CURR BIOL, V20, pR157, DOI 10.1016/j.cub.2009.12.040; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Howard J, 2009, ANNU REV BIOPHYS, V38, P217, DOI 10.1146/annurcv.biophys.050708.133732; Ichigotani Y, 2002, INT J MOL MED, V9, P591; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jager H, 2004, TOXICON, V43, P951, DOI 10.1016/j.toxicon.2004.03.025; Jager H, 2004, MOL PHARMACOL, V65, P630, DOI 10.1124/mol.65.3.630; Jensen BS, 2001, CURR DRUG TARGETS, V2, P401, DOI 10.2174/1389450013348173; Ji HF, 2009, EUR J NEUROSCI, V29, P1883, DOI 10.1111/j.1460-9568.2009.06735.x; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kleger A, 2010, CIRCULATION, V122, P1823, DOI 10.1161/CIRCULATIONAHA.110.971721; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Lee S. H., 2010, MOL CELLS, V29, P311, DOI DOI 10.1007/s10059-010-0053-8; Liebau S, 2007, STEM CELLS, V25, P1720, DOI 10.1634/stemcells.2006-0823; Liebau S, 2007, J NEUROCHEM, V101, P1338, DOI 10.1111/j.1471-4159.2006.04437.x; Liebau S, 2009, BIOCHEM BIOPH RES CO, V385, P460, DOI 10.1016/j.bbrc.2009.05.098; Lujan R, 2009, NAT REV NEUROSCI, V10, P475, DOI 10.1038/nrn2668; Mattson MP, 1999, J NEUROSCI RES, V57, P577, DOI 10.1002/(SICI)1097-4547(19990901)57:5<577::AID-JNR1>3.0.CO;2-H; Maurer Martin H, 2003, Proteome Sci, V1, P4, DOI 10.1186/1477-5956-1-4; Maurer MH, 2004, NEUROCHEM RES, V29, P1129, DOI 10.1023/B:NERE.0000023600.25994.11; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Obermair GJ, 2003, EUR J NEUROSCI, V17, P721, DOI 10.1046/j.1460-9568.2003.02488.x; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Pedarzani P, 2001, J BIOL CHEM, V276, P9762, DOI 10.1074/jbc.M010001200; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Sailer CA, 2004, MOL CELL NEUROSCI, V26, P458, DOI 10.1016/j.mcn.2004.03.002; Sailer CA, 2002, J NEUROSCI, V22, P9698; Sarpal D, 2004, SYNAPSE, V53, P104, DOI 10.1002/syn.20042; Schmeisser MJ, 2009, J BIOL CHEM, V284, P29146, DOI 10.1074/jbc.M109.020628; Schwab A, 1999, CELL PHYSIOL BIOCHEM, V9, P126, DOI 10.1159/000016309; Sekerkova G, 2007, NEUROSCIENCE, V145, P116, DOI 10.1016/j.neuroscience.2006.11.061; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Shao DM, 2009, INT J BIOCHEM CELL B, V41, P1471, DOI 10.1016/j.biocel.2009.01.016; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Strassmaier T, 2005, J BIOL CHEM, V280, P21231, DOI 10.1074/jbc.M413125200; Suzuki T, 1999, BRAIN RES, V840, P36, DOI 10.1016/S0006-8993(99)01762-X; Takenawa T, 2001, J CELL SCI, V114, P1801; Tani K, 2003, J BIOL CHEM, V278, P21685, DOI 10.1074/jbc.M301447200; Tao R, 2008, AM J PHYSIOL-CELL PH, V295, pC1409, DOI 10.1152/ajpcell.00268.2008; Tzounopoulos T, 2003, NEUROSCIENTIST, V9, P434, DOI 10.1177/1073858403259282; Vick KA, 2010, NEUROPHARMACOLOGY, V58, P650, DOI 10.1016/j.neuropharm.2009.11.008; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wolfart J, 2001, J NEUROSCI, V21, P3443, DOI 10.1523/JNEUROSCI.21-10-03443.2001; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758	65	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18148	10.1371/journal.pone.0018148	http://dx.doi.org/10.1371/journal.pone.0018148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464958	Green Submitted, gold, Green Published			2022-12-27	WOS:000288813900043
J	Nandagopal, S; Wu, D; Lin, F				Nandagopal, Saravanan; Wu, Dan; Lin, Francis			Combinatorial Guidance by CCR7 Ligands for T Lymphocytes Migration in Co-Existing Chemokine Fields	PLOS ONE			English	Article							IN-VIVO; LYMPHOID NEOGENESIS; NEURONAL MIGRATION; ACTIVE MOVEMENT; CELL CHEMOTAXIS; DENDRITIC CELLS; CCL21; EXPRESSION; INFLAMMATION; GRADIENTS	Chemokines mediate the trafficking and positioning of lymphocytes in lymphoid tissues that is crucial for immune surveillance and immune responses. In particular, a CCR7 ligand, CCL21, plays important roles in recruiting T cells to secondary lymphoid tissues (SLT). Furthermore, CCL21 together with another CCR7 ligand, CCL19, direct the navigation and compartmentation of T cells within SLT. However, the distinct roles of these two chemokines for regulating cell trafficking and positioning are not clear. In this study, we explore the effect of co-existing CCL19 and CCL21 concentration fields on guiding T cell migration. Using microfluidic devices that can configure single and superimposed chemokine fields we show that under physiological gradient conditions, human peripheral blood T cells chemotax to CCL21 but not CCL19. Furthermore, T cells migrate away from the CCL19 gradient in a uniform background of CCL21. This repulsive migratory response is predicted by mathematical modeling based on the competition of CCL19 and CCL21 for CCR7 signaling and the differential ability of the two chemokines for desensitizing CCR7. These results suggest a new combinatorial guiding mechanism by CCL19 and CCL21 for the migration and trafficking of CCR7 expressing leukocytes.	[Nandagopal, Saravanan; Wu, Dan; Lin, Francis] Univ Manitoba, Dept Phys & Astron, Winnipeg, MB, Canada; [Nandagopal, Saravanan; Lin, Francis] Univ Manitoba, Dept Biosyst Engn, Winnipeg, MB, Canada; [Lin, Francis] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Lin, Francis] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Nandagopal, S (corresponding author), Univ Manitoba, Dept Phys & Astron, Winnipeg, MB, Canada.	flin@physics.umanitoba.ca		Lin, Francis/0000-0003-1736-193X; Andalur Nandagopal, Saravanan/0000-0002-1787-3356	Natural Sciences and Engineering Research Council of Canada (NSERC); Manitoba Health Research Council (MHRC); University of Manitoba	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Health Research Council (MHRC); University of Manitoba	This study is supported by grants from Natural Sciences and Engineering Research Council of Canada (NSERC), Manitoba Health Research Council (MHRC) and the University of Manitoba. The authors would like to acknowledge the products and services provided by CMC Microsystems (www.cmc.ca) that facilitated this research. CMC is a non-profit corporation funded by NSERC, with matching contributions from industries. S.N. thanks MHRC for a fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; BEHAR TN, 1994, J NEUROSCI, V14, P29; Britschgi MR, 2010, EUR J IMMUNOL, V40, P1266, DOI 10.1002/eji.200939921; Britschgi MR, 2008, J IMMUNOL, V181, P7681, DOI 10.4049/jimmunol.181.11.7681; Brown MN, 2010, J IMMUNOL, V185, P4873, DOI 10.4049/jimmunol.1000676; Carlsen HS, 2005, BLOOD, V106, P444, DOI 10.1182/blood-2004-11-4353; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Dekker LV, 2000, SCIENCE, V287, P982, DOI 10.1126/science.287.5455.982; Dustin ML, 2008, IMMUNITY, V28, P15, DOI 10.1016/j.immuni.2008.01.001; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Foxman EF, 1999, J CELL BIOL, V147, P577, DOI 10.1083/jcb.147.3.577; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Knapp DM, 1999, EXP CELL RES, V247, P543, DOI 10.1006/excr.1998.4364; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; LAUFFENBURGER DA, 1981, J IMMUNOL METHODS, V40, P45, DOI 10.1016/0022-1759(81)90079-X; LAUFFENBURGER DA, 1982, CELL BIOPHYS, V4, P177, DOI 10.1007/BF02918312; Lin F, 2008, J IMMUNOL, V181, P2465, DOI 10.4049/jimmunol.181.4.2465; Lin F, 2006, LAB CHIP, V6, P1462, DOI 10.1039/b607071j; Lin F, 2008, J IMMUNOL, V181, P8335, DOI 10.4049/jimmunol.181.12.8335; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Manzo A, 2007, AM J PATHOL, V171, P1549, DOI 10.2353/ajpath.2007.061275; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Ngo VN, 1998, J EXP MED, V188, P181, DOI 10.1084/jem.188.1.181; Otero C, 2006, J IMMUNOL, V177, P2314, DOI 10.4049/jimmunol.177.4.2314; Ott TR, 2006, BIOCHEM BIOPH RES CO, V348, P1089, DOI 10.1016/j.bbrc.2006.07.165; Poznansky MC, 2002, J CLIN INVEST, V109, P1101, DOI 10.1172/JCI200213853; Raffaghello L, 2009, J LEUKOCYTE BIOL, V86, P1271, DOI 10.1189/jlb.0409283; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Shankaran H, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-48; Tharp WG, 2006, J LEUKOCYTE BIOL, V79, P539, DOI 10.1189/jlb.0905516; TRANQUILLO RT, 1988, J CELL BIOL, V106, P303, DOI 10.1083/jcb.106.2.303; Vianello F, 2005, J MOL MED, V83, P752, DOI 10.1007/s00109-005-0675-z; Weninger W, 2003, SEMIN IMMUNOL, V15, P257, DOI 10.1016/j.smim.2003.08.007; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706	43	52	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18183	10.1371/journal.pone.0018183	http://dx.doi.org/10.1371/journal.pone.0018183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464944	Green Published, gold, Green Submitted			2022-12-27	WOS:000288813900048
J	Morris, MJ; Liu, D; Weaver, LM; Board, PG; Casarotto, MG				Morris, Melanie J.; Liu, Dan; Weaver, Llara M.; Board, Philip G.; Casarotto, Marco G.			A Structural Basis for Cellular Uptake of GST-Fold Proteins	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; CRYSTAL-STRUCTURE; CHANNEL; PORE; MEMBRANES; TOXIN; CELLS; INTERMEDIATE; EXPRESSION; STABILITY	It has recently emerged that glutathione transferase enzymes (GSTs) and other structurally related molecules can be translocated from the external medium into many different cell types. In this study we aim to explore in detail, the structural features that govern cell translocation and by dissecting the human GST enzyme GSTM2-2 we quantatively demonstrate that the alpha-helical C-terminal domain (GST-C) is responsible for this property. Attempts to further examine the constituent helices within GST-C resulted in a reduction in cell translocation efficiency, indicating that the intrinsic GST-C domain structure is necessary for maximal cell translocation capacity. In particular, it was noted that the alpha-6 helix of GST-C plays a stabilising role in the fold of this domain. By destabilising the conformation of GST-C, an increase in cell translocation efficiency of up to similar to 2-fold was observed. The structural stability profiles of these protein constructs have been investigated by circular dichroism and differential scanning fluorimetry measurements and found to impact upon their cell translocation efficiency. These experiments suggest that the globular, helical domain in the 'GST-fold' structural motif plays a role in influencing cellular uptake, and that changes that affect the conformational stability of GST-C can significantly influence cell translocation efficiency.	[Morris, Melanie J.; Liu, Dan; Weaver, Llara M.; Board, Philip G.; Casarotto, Marco G.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Morris, MJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	Marco.Casarotto@anu.edu.au	Casarotto, Marco/D-8704-2011	Casarotto, Marco/0000-0002-0571-7671	Australian Research Council [DP0558315]	Australian Research Council(Australian Research Council)	This work was supported by Grant DP0558315 Australian Research Council (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branden C., 1999, INTRO PROTEIN STRUCT; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Cromer BA, 2002, EUR BIOPHYS J BIOPHY, V31, P356, DOI 10.1007/s00249-002-0219-1; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Elkins P, 1997, STRUCTURE, V5, P443, DOI 10.1016/S0969-2126(97)00200-1; Elmquist A, 2001, EXP CELL RES, V269, P237, DOI 10.1006/excr.2001.5316; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Grimsley JK, 1997, BIOCHEMISTRY-US, V36, P14366, DOI 10.1021/bi971596e; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Knubovets T, 1999, P NATL ACAD SCI USA, V96, P1262, DOI 10.1073/pnas.96.4.1262; Lakey JH, 2001, CURR TOP MICROBIOL, V257, P131; Le Trong I, 2002, PROTEINS, V48, P618, DOI 10.1002/prot.10162; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Morris MJ, 2009, BBA-BIOMEMBRANES, V1788, P676, DOI 10.1016/j.bbamem.2008.10.018; Namiki S, 2003, BIOCHEM BIOPH RES CO, V305, P592, DOI 10.1016/S0006-291X(03)00807-6; NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; ORLANDI PA, 1993, J BIOL CHEM, V268, P12010; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; ROSS VL, 1993, BIOCHEM J, V294, P373, DOI 10.1042/bj2940373; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Schendel SL, 1998, CELL DEATH DIFFER, V5, P372, DOI 10.1038/sj.cdd.4400365; Shield AJ, 2006, BIOCHEM BIOPH RES CO, V347, P859, DOI 10.1016/j.bbrc.2006.06.189; Szpikowska BK, 1996, ARCH BIOCHEM BIOPHYS, V335, P173, DOI 10.1006/abbi.1996.0495; Tetlow N, 2004, PHARMACOGENETICS, V14, P359, DOI 10.1097/00008571-200406000-00005; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Zhou HN, 2011, J BIOL CHEM, V286, P4271, DOI 10.1074/jbc.M110.197822	32	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17864	10.1371/journal.pone.0017864	http://dx.doi.org/10.1371/journal.pone.0017864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455499	Green Published, gold			2022-12-27	WOS:000288811500011
J	Lundstrom, E; Hartshorne, T; Li, K; Lindblad, S; Wick, MC; Bengtsson, C; Alfredsson, L; Klareskog, L; Padyukov, L				Lundstrom, Emeli; Hartshorne, Toinette; Li, Kelly; Lindblad, Staffan; Wick, Marius C.; Bengtsson, Camilla; Alfredsson, Lars; Klareskog, Lars; Padyukov, Leonid			Effects of GSTM1 in Rheumatoid Arthritis; Results from the Swedish EIRA study	PLOS ONE			English	Article							S-TRANSFERASE M1; AMERICAN PATIENTS; T1 POLYMORPHISMS; DISEASE-ACTIVITY; RISK-FACTOR; FOLLOW-UP; SMOKING; GENE; HLA-DRB1; SUSCEPTIBILITY	Objective: Glutathione-S-transferases (GSTs) play an important role in tobacco smoke detoxification, interestingly approximately 50% of individuals in most human populations lack the gene GSTM1 due to copy number variation (CNV). We aimed to investigate GSTM1 CNV in Rheumatoid Arthritis (RA) in relation to smoking and HLA-DRB1 shared epitope; the two best known risk factors for RA and in addition, to perform subanalyses in patients where relations between variations in GSTM1 and RA have previously been described. Methods: qPCR was performed using TaqMan Copy Number assays (Applied Biosystems) for 2426 incident RA cases and 1257 controls from the Swedish EIRA. Odds ratio (OR) together with 95% confidence intervals (CI) was calculated and used as a measure of the relative risk of developing RA. Results: No association between RA and GSTM1 CNV was observed when analyzing whole EIRA. However, >= 1 copy of GSTM1 appears to be a significant risk factor for autoantibody positive RA in non-smoking females >= 60 years (OR: 2.00 95% CI: 1.07-3.74), a population where such relationships have previously been described. Our data further suggest a protective effect of GSTM1 in ACPA-negative smoking men (OR: 0.56 95% CI: 0.35-0.90). Conclusion: We assessed the exact number of GSTM1 gene copies in relation to development and severity of RA. Our data provide support for the notion that variations in copy numbers of GSTM1 may influence risk in certain subsets of RA, but do not support a role for GSTM1 CNV as a factor that more generally modifies the influence of smoking on RA.	[Lundstrom, Emeli; Lindblad, Staffan; Wick, Marius C.; Klareskog, Lars; Padyukov, Leonid] Karolinska Inst, Dept Rheumatol, Stockholm, Sweden; [Hartshorne, Toinette; Li, Kelly] Appl Biosyst Inc, Foster City, CA 94404 USA; [Wick, Marius C.] Innsbruck Med Univ, Dept Radiol, Innsbruck, Austria; [Bengtsson, Camilla; Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Karolinska Institutet; Thermo Fisher Scientific; Applied Biosystems; Medical University of Innsbruck; Karolinska Institutet	Lundstrom, E (corresponding author), Karolinska Inst, Dept Rheumatol, Stockholm, Sweden.	emeli.lundstrom@ki.se	Alfredsson, Lars/AAC-9007-2019; Padyukov, Leonid/A-4890-2009	Alfredsson, Lars/0000-0003-1688-6697; Padyukov, Leonid/0000-0003-2950-5670; Klareskog, Lars/0000-0001-9601-6186	Swedish Research Council [521-2006-5752]; Swedish Rheumatism Foundation; AFA insurance company; Swedish Combine program; EUFp6	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Foundation; AFA insurance company; Swedish Combine program; EUFp6(European Commission)	This study was supported in part by the Swedish Research Council, the Swedish Rheumatism Foundation, the AFA insurance company, the Swedish Combine program, and the EUFp6 funded Autocure program. LP is supported by the Swedish Research Council grant 521-2006-5752. Applied Biosystems provided reagents for genotyping of GSTM1 for this study. No additional external funding was received for this study.	Bekris LM, 2005, AUTOIMMUNITY, V38, P567, DOI 10.1080/08916930500407238; CHENEVIXTRENCH G, 1995, CARCINOGENESIS, V16, P1655, DOI 10.1093/carcin/16.7.1655; Criswell LA, 2006, ANN RHEUM DIS, V65, P1163, DOI 10.1136/ard.2005.049676; Grabar PB, 2009, CLIN EXP RHEUMATOL, V27, P229; Holla LI, 2006, ALLERGY, V61, P265, DOI 10.1111/j.1398-9995.2006.01000.x; KEENAN BT, 2010, ARTHRITIS RHEUM; LARSEN A, 1977, ACTA RADIOL DIAGN, V18, P481, DOI 10.1177/028418517701800415; Linn-Rasker SP, 2006, ANN RHEUM DIS, V65, P366, DOI 10.1136/ard.2005.041079; Mattey DL, 1999, ANN RHEUM DIS, V58, P164, DOI 10.1136/ard.58.3.164; Mattey DL, 2002, ARTHRITIS RHEUM, V46, P640, DOI 10.1002/art.10174; MCDANIEL DO, 1995, ANN INTERN MED, V123, P181, DOI 10.7326/0003-4819-123-3-199508010-00004; McLellan RA, 1997, MOL PHARMACOL, V52, P958, DOI 10.1124/mol.52.6.958; MIL AHV, 2008, ARTHRITIS RES THER, V10, P205; Morinobu S, 2006, CLIN EXP RHEUMATOL, V24, P268; Norskov MS, 2009, CLIN BIOCHEM, V42, P201, DOI 10.1016/j.clinbiochem.2008.10.020; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; Padyukov L, 2004, ARTHRITIS RHEUM, V50, P3085, DOI 10.1002/art.20553; Pedersen M, 2007, ARTHRITIS RHEUM-US, V56, P1446, DOI 10.1002/art.22597; Perricone C, 2009, AUTOIMMUN REV, V8, P697, DOI 10.1016/j.autrev.2009.02.020; Ronnelid J, 2005, ANN RHEUM DIS, V64, P1744, DOI 10.1136/ard.2004.033571; SEIDEGARD J, 1990, CARCINOGENESIS, V11, P33, DOI 10.1093/carcin/11.1.33; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; Teller K, 1996, J RHEUMATOL, V23, P1363; van der Helm-van Mil AHM, 2006, ARTHRITIS RHEUM-US, V54, P1117, DOI 10.1002/art.21739; van der Helm-van Mil AHM, 2005, CURR OPIN RHEUMATOL, V17, P299, DOI 10.1097/01.bor.0000160780.13012.be; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM, V56, P425, DOI 10.1002/art.22373; Verpoort KN, 2007, ARTHRITIS RHEUM-US, V56, P2913, DOI 10.1002/art.22845; Wick M, 2003, ANN RHEUM DIS, V62, P579, DOI 10.1136/ard.62.6.579; Yun BR, 2005, J RHEUMATOL, V32, P992	29	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17880	10.1371/journal.pone.0017880	http://dx.doi.org/10.1371/journal.pone.0017880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445357	Green Published, gold, Green Submitted			2022-12-27	WOS:000288809100014
J	Sneddon, LU; Schmidt, R; Fang, YX; Cossins, AR				Sneddon, Lynne U.; Schmidt, Rupert; Fang, Yongxiang; Cossins, Andrew R.			Molecular Correlates of Social Dominance: A Novel Role for Ependymin in Aggression	PLOS ONE			English	Article							SUBORDINATE RELATIONSHIPS; MEMORY CONSOLIDATION; GENE-EXPRESSION; RAINBOW-TROUT; CELL-ADHESION; BROWN TROUT; CARP BRAIN; STRESS; HIERARCHIES; PLASTICITY	Theoretical and empirical studies have sought to explain the formation and maintenance of social relationships within groups. The resulting dominance hierarchies have significant fitness and survival consequences dependent upon social status. We hypothesised that each position or rank within a group has a distinctive brain gene expression profile that correlates with behavioural phenotype. Furthermore, transitions in rank position should determine which genes shift in expression concurrent with the new dominance status. We used a custom cDNA microarray to profile brain transcript expression in a model species, the rainbow trout, which forms tractable linear hierarchies. Dominant, subdominant and submissive individuals had distinctive transcript profiles with 110 gene probes identified using conservative statistical analyses. By removing the dominant, we characterised the changes in transcript expression in sub-dominant individuals that became dominant demonstrating that the molecular transition occurred within 48 hours. A strong, novel candidate gene, ependymin, which was highly expressed in both the transcript and protein in subdominants relative to dominants, was tested further. Using antibody injection to inactivate ependymin in pairs of dominant and subdominant zebrafish, the subdominant fish exhibited a substantial increase in aggression in parallel with an enhanced competitive ability. This is the first study to characterise the molecular signatures of dominance status within groups and the first to implicate ependymin in control of aggressive behaviour. It also provides evidence for indirect genetic effect models in which genotype/phenotype of an individual is influenced by conspecific interactions within a group. The variation in the molecular profile of each individual within a group may offer a new explanation of intraspecific variation in gene expression within undefined groups of animals and provides new candidates for empirical study.	[Sneddon, Lynne U.; Fang, Yongxiang; Cossins, Andrew R.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Sneddon, Lynne U.; Fang, Yongxiang; Cossins, Andrew R.] Univ Liverpool, Ctr Genom Res, Liverpool L69 3BX, Merseyside, England; [Schmidt, Rupert] Univ Giessen, Zentrale Biotech Betriebseinheit, Giessen, Germany	University of Liverpool; University of Liverpool; Justus Liebig University Giessen	Sneddon, LU (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	lsneddon@liverpool.ac.uk	Sneddon, Lynne/A-8795-2012	Sneddon, Lynne/0000-0001-9787-3948; Cossins, Andrew/0000-0002-0813-5212	Natural Environment Research Council (NERC); Royal Society of London; NERC [NBAF010002, NE/F001320/1] Funding Source: UKRI; Natural Environment Research Council [NBAF010002, NE/C000889/1, NE/F001320/1] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society of London(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a Fellowship from the Natural Environment Research Council (NERC) and a Royal Society of London Travel Grant awarded to LS, and long-term support to ARC from NERC for the Liverpool node of their Biomolecular Analysis Facility. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Alaux C, 2009, P NATL ACAD SCI USA, V106, P15400, DOI 10.1073/pnas.0907043106; Aubin-Horth N, 2005, P ROY SOC B-BIOL SCI, V272, P1655, DOI 10.1098/rspb.2005.3125; Ben-Shahar Y, 2005, J COMP PHYSIOL A, V191, P987, DOI 10.1007/s00359-005-0025-1; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buitenhuis B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-544; Cavallaro S, 2002, P NATL ACAD SCI USA, V99, P16279, DOI 10.1073/pnas.242597199; Cherek DR, 2004, PSYCHOPHARMACOLOGY, V171, P405, DOI 10.1007/s00213-003-1590-z; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Feder ME, 2005, J EVOLUTION BIOL, V18, P901, DOI 10.1111/j.1420-9101.2005.00921.x; Frost AJ, 2007, P ROY SOC B-BIOL SCI, V274, P333, DOI 10.1098/rspb.2006.3751; Gilmour KM, 2005, INTEGR COMP BIOL, V45, P263, DOI 10.1093/icb/45.2.263; Gracey AY, 2004, P NATL ACAD SCI USA, V101, P16970, DOI 10.1073/pnas.0403627101; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Larson ET, 2006, BEHAV BRAIN RES, V167, P94, DOI 10.1016/j.bbr.2005.08.020; Leil TA, 2002, J NEUROSCI RES, V68, P127, DOI 10.1002/jnr.10184; METCALFE NB, 1986, J FISH BIOL, V28, P525, DOI 10.1111/j.1095-8649.1986.tb05190.x; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Mukai M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008182; Olsen EM, 2001, N AM J FISH MANAGE, V21, P967, DOI 10.1577/1548-8675(2001)021&lt;0967:AEOVIE&gt;2.0.CO;2; Pottinger TG, 2001, HORM BEHAV, V40, P419, DOI 10.1006/hbeh.2001.1707; Pradel G, 1999, J NEUROBIOL, V39, P197, DOI 10.1002/(SICI)1097-4695(199905)39:2<197::AID-NEU4>3.0.CO;2-9; Pradel G, 2000, J NEUROBIOL, V43, P389, DOI 10.1002/1097-4695(20000615)43:4<389::AID-NEU7>3.0.CO;2-X; Renn SCP, 2008, J EXP BIOL, V211, P3041, DOI 10.1242/jeb.018242; ROTHER S, 1995, J NEUROCHEM, V65, P1456; Schmidt JT, 1998, J NEUROBIOL, V37, P659, DOI 10.1002/(SICI)1097-4695(199812)37:4<659::AID-NEU13>3.0.CO;2-3; Sloman KA, 2000, FISH PHYSIOL BIOCHEM, V22, P11, DOI 10.1023/A:1007837400713; Sloman KA, 2002, CAN J ZOOL, V80, P1221, DOI [10.1139/z02-105, 10.1139/Z02-105]; Sloman KA, 2001, PHYSIOL BIOCHEM ZOOL, V74, P383, DOI 10.1086/320426; Smith RW, 2009, PROTEOMICS, V9, P2217, DOI 10.1002/pmic.200800662; Sneddon LU, 2006, ETHOLOGY, V112, P437, DOI 10.1111/j.1439-0310.2005.01192.x; Sneddon LU, 2005, PHYSIOL BIOCHEM ZOOL, V78, P695, DOI 10.1086/432141; Sneddon LU, 2004, J FISH BIOL, V64, P799, DOI 10.1111/j.1095-8649.2004.00361.x; Sneddon LU, 2000, J EXP BIOL, V203, P537; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Suarez-Castillo EC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-23; Tang SJ, 1999, FEBS LETT, V459, P95, DOI 10.1016/S0014-5793(99)01229-6; Thomas JB, 2006, COMP BIOCHEM PHYS A, V143, P162, DOI 10.1016/j.cbpa.2005.11.008; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Weir LK, 2004, J ANIM ECOL, V73, P1069, DOI 10.1111/j.0021-8790.2004.00876.x; Williams TD, 2003, AQUAT TOXICOL, V65, P141, DOI 10.1016/S0166-445X(03)00119-X; WILSON AJ, 2008, P ROY SOC LOND B BIO, V276, P533; Wit E, 2005, J R STAT SOC C-APPL, V54, P817, DOI 10.1111/j.1467-9876.2005.00519.x	44	40	42	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18181	10.1371/journal.pone.0018181	http://dx.doi.org/10.1371/journal.pone.0018181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483679	gold, Green Published, Green Submitted			2022-12-27	WOS:000289191300009
J	Bohm, SM; Wells, K; Kalko, EKV				Boehm, Stefan M.; Wells, Konstans; Kalko, Elisabeth K. V.			Top-Down Control of Herbivory by Birds and Bats in the Canopy of Temperate Broad-Leaved Oaks (Quercus robur)	PLOS ONE			English	Article							WHITE OAK; SPECIES RICHNESS; LEAF TANNINS; ARTHROPODS; PREDATION; FOREST; DAMAGE; DIVERSITY; ABUNDANCE; INSECTS	The intensive foraging of insectivorous birds and bats is well known to reduce the density of arboreal herbivorous arthropods but quantification of collateral leaf damage remains limited for temperate forest canopies. We conducted exclusion experiments with nets in the crowns of young and mature oaks, Quercus robur, in south and central Germany to investigate the extent to which aerial vertebrates reduce herbivory through predation. We repeatedly estimated leaf damage throughout the vegetation period. Exclusion of birds and bats led to a distinct increase in arthropod herbivory, emphasizing the prominent role of vertebrate predators in controlling arthropods. Leaf damage (e. g., number of holes) differed strongly between sites and was 59% higher in south Germany, where species richness of vertebrate predators and relative oak density were lower compared with our other study site in central Germany. The effects of bird and bat exclusion on herbivory were 19% greater on young than on mature trees in south Germany. Our results support previous studies that have demonstrated clear effects of insectivorous vertebrates on leaf damage through the control of herbivorous arthropods. Moreover, our comparative approach on quantification of leaf damage highlights the importance of local attributes such as tree age, forest composition and species richness of vertebrate predators for control of arthropod herbivory.	[Boehm, Stefan M.; Wells, Konstans] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Wells, Konstans] Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Kalko, Elisabeth K. V.] Smithsonian Trop Res Inst, Balboa, Panama	Ulm University; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Smithsonian Institution; Smithsonian Tropical Research Institute	Bohm, SM (corresponding author), Univ Ulm, Inst Expt Ecol, Ulm, Germany.	stefan.boehm@uni-ulm.de	Wells, Konstans/A-7232-2010	Wells, Konstans/0000-0003-0377-2463	German Research Foundation [1374, KA 1241/151]	German Research Foundation(German Research Foundation (DFG))	This work was funded by the German Research Foundation (www.dfg.de) Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (KA 1241/151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTEGRIM O, 1989, OECOLOGIA, V79, P136; ANDERSON ME, 1991, ANIM BEHAV, V42, P489, DOI 10.1016/S0003-3472(05)80048-X; Barber NA, 2009, AM MIDL NAT, V162, P169, DOI 10.1674/0003-0031-162.1.169; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Bohm SM, 2009, J ORNITHOL, V150, P799, DOI 10.1007/s10336-009-0401-7; Bridgeland WT, 2010, ECOLOGY, V91, P73, DOI 10.1890/08-1821.1; Brossa R, 2009, TREES-STRUCT FUNCT, V23, P401, DOI 10.1007/s00468-008-0289-5; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; COLEY PD, 1986, OECOLOGIA, V70, P238, DOI 10.1007/BF00379246; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; FEENY PP, 1968, J INSECT PHYSIOL, V14, P805, DOI 10.1016/0022-1910(68)90191-1; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Forkner RE, 2000, ECOLOGY, V81, P1588, DOI 10.1890/0012-9658(2000)081[1588:WGUMCD]2.0.CO;2; Gil-Tena A, 2007, FOREST ECOL MANAG, V242, P470, DOI 10.1016/j.foreco.2007.01.080; Goerlitz HR, 2010, CURR BIOL, V20, P1568, DOI 10.1016/j.cub.2010.07.046; GRADWOHL J, 1982, ECOLOGY, V63, P581, DOI 10.2307/1938974; Greenberg R, 2000, ECOLOGY, V81, P1750, DOI 10.1890/0012-9658(2000)081[1750:TIOAIO]2.0.CO;2; Gunnarsson B, 1996, J ANIM ECOL, V65, P389, DOI 10.2307/5885; Gunnarsson B, 2004, BIODIVERS CONSERV, V13, P685, DOI 10.1023/B:BIOC.0000011720.18889.f7; Gunnarsson B, 2009, FOREST ECOL MANAG, V257, P619, DOI 10.1016/j.foreco.2008.09.055; Gunnarsson B, 2007, J ARACHNOL, V35, P509, DOI 10.1636/RT07-64.1; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Hochwender CG, 2003, AM MIDL NAT, V150, P246, DOI 10.1674/0003-0031(2003)150[0246:FCOHOQ]2.0.CO;2; HOLMES RT, 1979, SCIENCE, V206, P462, DOI 10.1126/science.206.4417.462; Kalcounis MC, 1999, J MAMMAL, V80, P673, DOI 10.2307/1383311; Kalka MB, 2008, SCIENCE, V320, P71, DOI 10.1126/science.1153352; Knoot TG, 2010, ENVIRON MANAGE, V45, P155, DOI 10.1007/s00267-009-9404-7; Koh LP, 2008, ECOL APPL, V18, P821, DOI 10.1890/07-1650.1; Lanham JD, 2002, FOREST ECOL MANAG, V155, P143, DOI 10.1016/S0378-1127(01)00554-0; Lichtenberg JS, 2002, AM MIDL NAT, V148, P338, DOI 10.1674/0003-0031(2002)148[0338:WTIABI]2.0.CO;2; Lill JT, 2003, ECOLOGY, V84, P682, DOI 10.1890/0012-9658(2003)084[0682:EEBCII]2.0.CO;2; Mantyla E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002832; MARQUIS RJ, 1994, ECOLOGY, V75, P2007, DOI 10.2307/1941605; Marquis RJ, 2004, SCIENCE, V305, P619, DOI 10.1126/science.1101848; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Mols CMM, 2002, J APPL ECOL, V39, P888, DOI 10.1046/j.1365-2664.2002.00761.x; Mooney KA, 2010, P NATL ACAD SCI USA, V107, P7335, DOI 10.1073/pnas.1001934107; MOORE R, 1991, J APPL ECOL, V28, P305, DOI 10.2307/2404131; Murakami M, 2000, P ROY SOC B-BIOL SCI, V267, P1597, DOI 10.1098/rspb.2000.1184; PAINE RT, 1980, J ANIM ECOL, V49, P667; Philpott SM, 2009, ECOL APPL, V19, P1858, DOI 10.1890/08-1928.1; PRESZLER RW, 1994, OECOLOGIA, V100, P66, DOI 10.1007/BF00317131; Recher HF, 2006, AUSTRAL ECOL, V31, P349, DOI 10.1111/j.1442-9993.2006.01555.x; Sanz JJ, 2001, ECOL RES, V16, P387, DOI 10.1046/j.1440-1703.2001.00403.x; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Schwenk WS, 2010, J AVIAN BIOL, V41, P367, DOI 10.1111/j.1600-048X.2009.04963.x; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Southwood TRE, 2004, EUR J ENTOMOL, V101, P43, DOI 10.14411/eje.2004.011; Strong AM, 2000, OECOLOGIA, V125, P370, DOI 10.1007/s004420000467; Suwa T, 2008, AM J BOT, V95, P434, DOI 10.3732/ajb.95.4.434; Swift SM, 2002, BEHAV ECOL SOCIOBIOL, V52, P408, DOI 10.1007/s00265-002-0531-x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Utsumi S, 2009, OIKOS, V118, P1805, DOI 10.1111/j.1600-0706.2009.17580.x; Van Bael SA, 2005, OECOLOGIA, V145, P658, DOI 10.1007/s00442-005-0134-0; Van Bael SA, 2008, ECOLOGY, V89, P928, DOI 10.1890/06-1976.1; Vehvilainen H, 2007, OECOLOGIA, V152, P287, DOI 10.1007/s00442-007-0673-7; Whelan CJ, 2008, ANN NY ACAD SCI, V1134, P25, DOI 10.1196/annals.1439.003; Williams-Guillen K, 2008, SCIENCE, V320, P70, DOI 10.1126/science.1152944; Wold EN, 1997, ECOLOGY, V78, P1356, DOI 10.1890/0012-9658(1997)078[1356:IDIWOE]2.0.CO;2; Wright DM, 2010, FUNCT ECOL, V24, P52, DOI 10.1111/j.1365-2435.2009.01597.x; Zuur Alain F., 2009, P1	64	61	64	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e17857	10.1371/journal.pone.0017857	http://dx.doi.org/10.1371/journal.pone.0017857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483739	Green Published, Green Submitted, gold			2022-12-27	WOS:000289058700003
J	Suzuki, M; Kimura, T; Ogawa, H; Hotta, K; Oka, K				Suzuki, Mamiko; Kimura, Tetsuya; Ogawa, Hiroto; Hotta, Kohji; Oka, Kotaro			Chromatophore Activity during Natural Pattern Expression by the Squid Sepioteuthis lessoniana: Contributions of Miniature Oscillation	PLOS ONE			English	Article							LOLIGO-VULGARIS; BODY PATTERNS; ULTRASTRUCTURE; MOTONEURONS; RESPONSES; BEHAVIOR; BRAIN; STIMULATION; INFORMATION; OPALESCENS	Squid can rapidly change the chromatic patterns on their body. The patterns are created by the expansion and retraction of chromatophores. The chromatophore consists of a central pigment-containing cell surrounded by radial muscles that are controlled by motor neurons located in the central nervous system (CNS). In this study we used semi-intact squid (Sepioteuthis lessoniana) displaying centrally controlled natural patterns to analyze spatial and temporal activities of chromatophores located on the dorsal mantle skin. We found that chromatophores oscillated with miniature expansions/retractions at various frequencies, even when the chromatic patterns appear macroscopically stable. The frequencies of this miniature oscillation differed between "feature" and "background" areas of chromatic patterns. Higher frequencies occurred in feature areas, whereas lower frequencies were detected in background areas. We also observed synchronization of the oscillation during chromatic pattern expression. The expansion size of chromatophores oscillating at high frequency correlated with the number of synchronized chromatophores but not the oscillation frequency. Miniature oscillations were not observed in denervated chromatophores. These results suggest that miniature oscillations of chromatophores are driven by motor neuronal activities in the CNS and that frequency and synchrony of this oscillation determine the chromatic pattern and the expansion size, respectively.	[Suzuki, Mamiko; Hotta, Kohji; Oka, Kotaro] Keio Univ, Grad Sch Sci & Technol, Kanagawa, Japan; [Kimura, Tetsuya] RIKEN Brain Sci Inst, Lab Alzheimer Dis, Wako, Saitama, Japan; [Ogawa, Hiroto] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan	Keio University; RIKEN; Hokkaido University	Suzuki, M (corresponding author), Keio Univ, Grad Sch Sci & Technol, Kanagawa, Japan.	oka@bio.keio.ac.jp	Oka, Kotaro/C-4918-2014; Hotta, Kohji/D-1162-2014	Hotta, Kohji/0000-0003-4614-7473	Ministry of Education, Culture, Sports, Science and Technology; Keio University	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Keio University	This work was funded by the Ministry of Education, Culture, Sports, Science and Technology, Grant-in-Aid for the 21st Century Center of Excellence (COE) Program titled "Understanding and Control of Life's Function via Systems Biology" (Keio University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arshavsky YI, 1998, ANN NY ACAD SCI, V860, P51, DOI 10.1111/j.1749-6632.1998.tb09038.x; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; CLONEY RA, 1968, Z ZELLFORSCH MIK ANA, V89, P250, DOI 10.1007/BF00347297; DUBAS F, 1986, J EXP BIOL, V121, P1; DUBAS F, 1986, BRAIN RES, V374, P21, DOI 10.1016/0006-8993(86)90390-2; FLOREY E, 1966, COMP BIOCHEM PHYSIOL, V18, P305, DOI 10.1016/0010-406X(66)90189-7; FLOREY E, 1969, AM ZOOL, V9, P429; FLOREY E, 1969, Z VERGL PHYSIOL, V65, P98, DOI 10.1007/BF00297991; Gaston Michelle R., 2006, Invertebrate Neuroscience, V6, P81, DOI 10.1007/s10158-006-0021-3; GILBERT DL, 1990, SQUID EXPT ANIMALS; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; HANLON RT, 1994, BIOL BULL, V187, P363, DOI 10.2307/1542293; Hanlon RT, 1999, BIOL BULL-US, V197, P49, DOI 10.2307/1542996; HANLON RT, 1988, PHILOS T ROY SOC B, V320, P437, DOI 10.1098/rstb.1988.0087; Hanlon RT, 1996, CEPHALOPOD BEHAV; Iwama A, 1999, ZOOL SCI, V16, P407, DOI 10.2108/zsj.16.407; Jantzen TM, 2003, BIOL BULL-US, V204, P305, DOI 10.2307/1543601; Kay LM, 2006, SEMIN CELL DEV BIOL, V17, P433, DOI 10.1016/j.semcdb.2006.04.012; Kimura T, 1998, LEARN MEMORY, V4, P365, DOI 10.1101/lm.4.5.365; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; MESSENGER JB, 1986, J EXP BIOL, V125, P395; MIROW S, 1972, CELL TISSUE RES, V125, P176; Miyan J.A., 1995, P415; PACKARD A, 1971, ANIM BEHAV, V19, P780, DOI 10.1016/S0003-3472(71)80181-1; PACKARD A, 1992, J PHYSIOL-LONDON, V446, pP164; PACKARD A, 1993, J PHYSIOL-LONDON, V459, pP429; PACKARD A, 1995, J PHYSIOL-LONDON, V489P, pP134; Packard A., 1988, P89; Packard A., 1995, BEHAV BRAIN RES NATU, P105; Packard A., 2001, INT SCH BIOCYBERNETI, P397; Packard Andrew, 1995, P331; Packard A, 2011, OPT LASER TECHNOL, V43, P302, DOI 10.1016/j.optlastec.2008.12.017; REED CM, 1995, CELL TISSUE RES, V282, P503, DOI 10.1007/s004410050501; Sakurai Y, 1999, NEUROSCI BIOBEHAV R, V23, P785, DOI 10.1016/S0149-7634(99)00017-2; SANDERS GD, 1974, PROC R SOC SER B-BIO, V186, P1, DOI 10.1098/rspb.1974.0031; Sekiguchi T, 2010, LEARN MEMORY, V17, P372, DOI 10.1101/lm.1867110	38	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18244	10.1371/journal.pone.0018244	http://dx.doi.org/10.1371/journal.pone.0018244			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483763	gold, Green Submitted, Green Published			2022-12-27	WOS:000289058300009
J	Cerqueira, FM; Laurindo, FRM; Kowaltowski, AJ				Cerqueira, Fernanda M.; Laurindo, Francisco R. M.; Kowaltowski, Alicia J.			Mild Mitochondrial Uncoupling and Calorie Restriction Increase Fasting eNOS, Akt and Mitochondrial Biogenesis	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; LIFE-SPAN; INSULIN SENSITIVITY; DIETARY RESTRICTION; GENE-EXPRESSION; RHESUS-MONKEYS; BLOOD-GLUCOSE; PHOSPHORYLATION; METABOLISM; MIMETICS	Enhanced mitochondrial biogenesis promoted by eNOS activation is believed to play a central role in the beneficial effects of calorie restriction (CR). Since treatment of mice with dinitrophenol (DNP) promotes health and lifespan benefits similar to those observed in CR, we hypothesized that it could also impact biogenesis. We found that DNP and CR increase citrate synthase activity, PGC-1 alpha, cytochrome c oxidase and mitofusin-2 expression, as well as fasting plasma levels of NO center dot products. In addition, eNOS and Akt phosphorylation in skeletal muscle and visceral adipose tissue was activated in fasting CR and DNP animals. Overall, our results indicate that systemic mild uncoupling activates eNOS and Akt-dependent pathways leading to mitochondrial biogenesis.	[Cerqueira, Fernanda M.; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Laurindo, Francisco R. M.] Univ Sao Paulo, Inst Coracao, Fac Med, BR-01498 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Cerqueira, FM (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	alicia@iq.usp.br	Laurindo, Francisco R/J-6575-2015; cerqueira, fernanda/C-8326-2014; Kowaltowski, Alicia J/H-8698-2012		Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); The John Simon Guggenhein Memorial Foundation	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); The John Simon Guggenhein Memorial Foundation	This work was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma) and The John Simon Guggenhein Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews ZB, 2009, AM J PHYSIOL-ENDOC M, V296, pE621, DOI 10.1152/ajpendo.90903.2008; Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; Baylis C, 1998, CURR OPIN NEPHROL HY, V7, P59, DOI 10.1097/00041552-199801000-00010; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Boden G, 2005, ANN INTERN MED, V142, P403, DOI 10.7326/0003-4819-142-6-200503150-00006; BODKIN NL, 1995, J GERONTOL A-BIOL, V50, pB142, DOI 10.1093/gerona/50A.3.B142; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Cerqueira FM, 2010, AGEING RES REV, V9, P424, DOI 10.1016/j.arr.2010.05.002; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; da Silva CCC, 2008, AGING CELL, V7, P552, DOI 10.1111/j.1474-9726.2008.00407.x; Escriva F, 2007, J ENDOCRINOL, V194, P131, DOI 10.1677/joe.1.07043; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Hu ZL, 2008, J BIOL CHEM, V283, P25256, DOI 10.1074/jbc.M802455200; Humphrey DM, 2009, EXP GERONTOL, V44, P316, DOI 10.1016/j.exger.2009.02.001; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; KEMNITZ JW, 1994, AM J PHYSIOL, V266, pE540, DOI 10.1152/ajpendo.1994.266.4.E540; Lambert AJ, 2004, AM J PHYSIOL-REG I, V286, pR71, DOI 10.1152/ajpregu.00341.2003; LANE MA, 1995, AM J PHYSIOL-ENDOC M, V268, pE941, DOI 10.1152/ajpendo.1995.268.5.E941; Lanza IR, 2010, PFLUG ARCH EUR J PHY, V459, P277, DOI 10.1007/s00424-009-0724-5; Lemire BD, 2009, MECH AGEING DEV, V130, P461, DOI 10.1016/j.mad.2009.05.001; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Masoro EJ, 2009, BBA-GEN SUBJECTS, V1790, P1040, DOI 10.1016/j.bbagen.2009.02.011; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; MONTAGNANI M, 2001, J BIOL CHEM, V12, P597; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Padalko VI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P986, DOI 10.1007/s10541-005-0213-1; Rashid G, 2007, NEPHROL DIAL TRANSPL, V22, P2831, DOI 10.1093/ndt/gfm269; Ritchie SA, 2010, BIOCHEM J, V426, P85, DOI 10.1042/BJ20091580; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Severin FF, 2010, P NATL ACAD SCI USA, V107, P663, DOI 10.1073/pnas.0910216107; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Tainter ML, 1938, J PHARMACOL EXP THER, V63, P51; van Diepeningen AD, 2010, EXP GERONTOL, V45, P516, DOI 10.1016/j.exger.2010.01.002; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zheng YB, 2009, J ENDOCRINOL, V203, P337, DOI 10.1677/JOE-09-0181; Zhou XS, 2009, AM J PHYSIOL-HEART C, V297, pH2227, DOI 10.1152/ajpheart.00325.2009; Zorzano A, 2009, CURR OPIN DRUG DISC, V12, P597	46	58	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18433	10.1371/journal.pone.0018433	http://dx.doi.org/10.1371/journal.pone.0018433			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483800	Green Submitted, Green Published, gold			2022-12-27	WOS:000289057200078
J	Martinez, JP; Bocharov, G; Ignatovich, A; Reiter, J; Dittmar, MT; Wain-Hobson, S; Meyerhans, A				Martinez, Javier P.; Bocharov, Gennady; Ignatovich, Anna; Reiter, Jochen; Dittmar, Matthias T.; Wain-Hobson, Simon; Meyerhans, Andreas			Fitness Ranking of Individual Mutants Drives Patterns of Epistatic Interactions in HIV-1	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE; DELETERIOUS MUTATIONS; RNA VIRUS; POSITIVE EPISTASIS; NUCLEOSIDE ANALOGS; GENETIC ROBUSTNESS; DRUG-RESISTANCE; VIRAL FITNESS; EVOLUTION	Fitness interactions between mutations, referred to as epistasis, can strongly impact evolution. For RNA viruses and retroviruses with their high mutation rates, epistasis may be particularly important to overcome fitness losses due to the accumulation of deleterious mutations and thus could influence the frequency of mutants in a viral population. As human immunodeficiency virus type 1 (HIV-1) resistance to azidothymidine (AZT) requires selection of sequential mutations, it is a good system to study the impact of epistasis. Here we present a thorough analysis of a classical AZT-resistance pathway (the 41-215 cluster) of HIV-1 variants by fitness measurements in single round infection assays covering physiological drug concentrations ex vivo. The sign and value of epistasis varied and did not predict the epistatic effect on the mutant frequency. This complex behavior is explained by the fitness ranking of the variants that strongly depends on environmental factors, i.e., the presence and absence of drugs and the host cells used. Although some interactions compensate fitness losses, the observed small effect on the relative mutant frequencies suggests that epistasis might be inefficient as a buffering mechanism for fitness losses in vivo. While the use of epistasis-based hypotheses to make general assumptions on the evolutionary dynamics of viral populations is appealing, our data caution their interpretation without further knowledge on the characteristics of the viral mutant spectrum under different environmental conditions.	[Martinez, Javier P.; Reiter, Jochen; Meyerhans, Andreas] Univ Saarland, Dept Virol, D-6650 Homburg, Germany; [Bocharov, Gennady; Ignatovich, Anna] Russian Acad Sci, Inst Numer Math, Moscow, Russia; [Dittmar, Matthias T.] Barts & London Queen Marys Sch Med & Dent, Ctr Immunol & Infect Dis, London, England; [Wain-Hobson, Simon] Inst Pasteur, Mol Retrovirol Unit, Paris, France; [Meyerhans, Andreas] Univ Pompeu Fabra, Dept Expt & Hlth Sci, ICREA Infect Biol Lab, Barcelona, Spain	Saarland University; Russian Academy of Sciences; University of London; Queen Mary University London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; ICREA; Pompeu Fabra University	Martinez, JP (corresponding author), Univ Saarland, Dept Virol, D-6650 Homburg, Germany.	andreas.meyerhans@upf.edu	Meyerhans, Andreas/D-3382-2014; Bocharov, Gennady/H-1832-2016; Bocharov, Gennady/GSN-1705-2022; Bocharov, Gennady/T-1322-2017; Meyerhans, Andreas/S-2559-2019; Bocharov, Gennady/AGA-7312-2022; Bocharov, Gennady/AAN-7508-2020	Meyerhans, Andreas/0000-0003-0620-5317; Bocharov, Gennady/0000-0002-5049-0656; Bocharov, Gennady/0000-0002-5049-0656; Meyerhans, Andreas/0000-0003-0620-5317; Bocharov, Gennady/0000-0002-5049-0656; Bocharov, Gennady/0000-0002-5049-0656; Martinez Vesga, Javier Pablo/0000-0003-3333-5272	Deutsche Forschungsgemeinschaft; Deutsche Akademische Austauschdienst (DAAD); Russian Foundation for Basic Research; Russian Academy of Sciences; ICREA Funding Source: Custom	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Akademische Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); ICREA(ICREA)	This work was supported by grants from the Deutsche Forschungsgemeinschaft, the Deutsche Akademische Austauschdienst (DAAD), and the Russian Foundation for Basic Research and by the Program of the Russian Academy of Sciences "Basic Research for Medicine". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus CL, 2005, J VIROL, V79, P13572, DOI 10.1128/JVI.79.21.13572-13578.2005; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Armitage P., 2002, STAT METHODS MED RES; Arts EJ, 1998, DRUG RESIST UPDATE, V1, P21, DOI 10.1016/S1368-7646(98)80211-2; Arts EJ, 1996, J VIROL, V70, P712, DOI 10.1128/JVI.70.2.712-720.1996; ARTS EJ, 1994, ANTIMICROB AGENTS CH, V38, P1008, DOI 10.1128/AAC.38.5.1008; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Bateson W, 1909, MENDELS PRINCIPLES H; Beerenwinkel N, 2005, J INFECT DIS, V191, P1953, DOI 10.1086/430005; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Boyer PL, 2006, PLOS PATHOG, V2, P101, DOI 10.1371/journal.ppat0020010; Burch CL, 2004, GENETICS, V167, P559, DOI 10.1534/genetics.103.021196; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; da Silva J, 2010, GENETICS, V185, P293, DOI 10.1534/genetics.109.112458; de Visser JAGM, 2007, NAT REV GENET, V8, P139, DOI 10.1038/nrg1985; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Elena SF, 2010, CHAOS, V20, DOI 10.1063/1.3449300; Elena SF, 2006, EMBO REP, V7, P168, DOI 10.1038/sj.embor.7400636; Elena SF, 1999, J MOL EVOL, V49, P703, DOI 10.1007/PL00000082; Fletcher CV, 2000, AIDS, V14, P2137, DOI 10.1097/00002030-200009290-00010; Gavrilets S, 2004, FITNESS LANDSCAPES O; Gelderblom HC, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-60; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gregersen JW, 2006, NATURE, V443, P574, DOI 10.1038/nature05133; Harrigan PR, 1998, J VIROL, V72, P3773, DOI 10.1128/JVI.72.5.3773-3778.1998; Havlir DV, 1996, J VIROL, V70, P7894, DOI 10.1128/JVI.70.11.7894-7899.1996; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu ZX, 2006, J VIROL, V80, P7020, DOI 10.1128/JVI.02747-05; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; Kouyos RD, 2007, TRENDS ECOL EVOL, V22, P308, DOI 10.1016/j.tree.2007.02.014; Kouyos RD, 2006, GENETICS, V173, P589, DOI 10.1534/genetics.105.053108; LACEY SF, 1994, J VIROL, V68, P3421, DOI 10.1128/JVI.68.5.3421-3424.1994; Maeda Y, 1998, J INFECT DIS, V177, P1207, DOI 10.1086/515282; Michalakis Y, 2004, SCIENCE, V306, P1492, DOI 10.1126/science.1106677; Montville R, 2005, PLOS BIOL, V3, P1939, DOI 10.1371/journal.pbio.0030381; Neumann T, 2005, VIROLOGY, V333, P251, DOI 10.1016/j.virol.2004.12.035; NOWAK AMM, 2000, VIRUS DYNAMICS; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Otto SP, 2006, BIOCHEM SOC T, V34, P519, DOI 10.1042/BST0340519; Parera M, 2007, MOL BIOL EVOL, V24, P382, DOI 10.1093/molbev/msl168; Parera M, 2009, J MOL BIOL, V392, P243, DOI 10.1016/j.jmb.2009.07.015; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; RICHMAN D, 1991, P NATL ACAD SCI USA, V88, P11241, DOI 10.1073/pnas.88.24.11241; Rolland M, 2007, NAT REV MICROBIOL, V5, P2006, DOI 10.1038/nrmicro1594-C1; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Silander OK, 2007, PLOS BIOL, V5, P922, DOI 10.1371/journal.pbio.0050094; Sluis-Cremer N, 2000, CELL MOL LIFE SCI, V57, P1408, DOI 10.1007/PL00000626; SLUSHER JT, 1992, ANTIMICROB AGENTS CH, V36, P2473, DOI 10.1128/AAC.36.11.2473; Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835; van Opijnen T, 2006, J VIROL, V80, P6678, DOI 10.1128/JVI.02547-05; van Opijnen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000271; Wang K, 2006, SCIENCE, V312, DOI 10.1126/science.1109904; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002	57	20	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18375	10.1371/journal.pone.0018375	http://dx.doi.org/10.1371/journal.pone.0018375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483787	gold, Green Published			2022-12-27	WOS:000289057200067
J	Colijn, C; Cohen, T; Ganesh, A; Murray, M				Colijn, Caroline; Cohen, Ted; Ganesh, Ayalvadi; Murray, Megan			Spontaneous Emergence of Multiple Drug Resistance in Tuberculosis before and during Therapy	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IN-VITRO; PROBABILITY-DISTRIBUTION; MUTATION FREQUENCIES; BEIJING-GENOTYPE; MUTANTS; EVOLUTION; GENE; TRANSMISSION; CHEMOTHERAPY	The emergence of drug resistance in M. tuberculosis undermines the efficacy of tuberculosis (TB) treatment in individuals and of TB control programs in populations. Multiple drug resistance is often attributed to sequential functional monotherapy, and standard initial treatment regimens have therefore been designed to include simultaneous use of four different antibiotics. Despite the widespread use of combination therapy, highly resistant M. tb strains have emerged in many settings. Here we use a stochastic birth-death model to estimate the probability of the emergence of multidrug resistance during the growth of a population of initially drug sensitive TB bacilli within an infected host. We find that the probability of the emergence of resistance to the two principal anti-TB drugs before initiation of therapy ranges from 10(-5) to 10(-4); while rare, this is several orders of magnitude higher than previous estimates. This finding suggests that multidrug resistant M. tb may not be an entirely "man-made" phenomenon and may help explain how highly drug resistant forms of TB have independently emerged in many settings.	[Colijn, Caroline] Univ Bristol, Dept Engn Math, Bristol, Avon, England; [Cohen, Ted; Murray, Megan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Cohen, Ted] Harvard Univ, Sch Med, Div Global Hlth Equ, Boston, MA USA; [Ganesh, Ayalvadi] Univ Bristol, Sch Math, Bristol, Avon, England	University of Bristol; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; University of Bristol	Colijn, C (corresponding author), Univ Bristol, Dept Engn Math, Bristol, Avon, England.	tcohen@hsph.harvard.edu	Cohen, Ted/G-8101-2011	Cohen, Ted/0000-0002-8091-7198	Office Of The Director, NIH [DP2OD006663]; NIAID, NIH [U19AI076217]; Ellison Medical Foundation [ID-SS-0693-04]; Bristol Centre for Complexity Sciences; EPSRC [EP/5011214]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI076217] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006663] Funding Source: NIH RePORTER	Office Of The Director, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ellison Medical Foundation(Lawrence Ellison Foundation); Bristol Centre for Complexity Sciences; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	TC was supported by DP2OD006663 from the Office Of The Director, NIH and both TC and MM were supported by U19AI076217 from NIAID, NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Office of the Director, NIH or the NIH (http://nih.gov). MM was supported by the Ellison Medical Foundation ID-SS-0693-04 (www.ellisonfoundation.org). AG was supported by the Bristol Centre for Complexity Sciences (http://bccs.bristol.ac.uk) and EPSRC grant EP/5011214 (www.epsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerer WP, 2001, J MATH BIOL, V42, P145, DOI 10.1007/s002850000053; Bergval IL, 2009, J ANTIMICROB CHEMOTH, V64, P515, DOI 10.1093/jac/dkp237; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Bottger EC, 2008, EUR J PEDIATR, V167, P141, DOI 10.1007/s00431-007-0606-9; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Turrientes MC, 2010, APPL ENVIRON MICROB, V76, P1746, DOI 10.1128/AEM.02817-09; Cohen T, 2004, MICROB DRUG RESIST, V10, P280, DOI 10.1089/mdr.2004.10.280; DAVID HL, 1970, APPL MICROBIOL, V20, P810, DOI 10.1128/AEM.20.5.810-814.1970; Dye C, 2009, NAT REV MICROBIOL, V7, P81, DOI 10.1038/nrmicro2048; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Gillespie SH, 2007, BIOCHEM SOC T, V35, P1317, DOI 10.1042/BST0351317; Gillespie SH, 2002, ANTIMICROB AGENTS CH, V46, P267, DOI 10.1128/AAC.46.2.267-274.2002; Gillespie SH, 2001, INT J ANTIMICROB AG, V17, P171, DOI 10.1016/S0924-8579(00)00340-X; Ioerger TR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-670; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Komarova N, 2006, J THEOR BIOL, V239, P351, DOI 10.1016/j.jtbi.2005.08.003; Kornarova NL, 2007, MATH BIOSCI, V210, P253, DOI 10.1016/j.mbs.2007.04.007; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lipsitch M, 1998, INT J TUBERC LUNG D, V2, P187; Luria SE, 1943, GENETICS, V28, P491; MA WT, 1992, J APPL PROBAB, V29, P255, DOI 10.2307/3214564; Machowski EE, 2007, J BACTERIOL, V189, P2190, DOI 10.1128/JB.01647-06; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; Mitchison DA, 1998, INT J TUBERC LUNG D, V2, P10; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; PAKES AG, 1993, J APPL PROBAB, V30, P991, DOI 10.2307/3214530; Perdigao J, 2010, J ANTIMICROB CHEMOTH, V65, P224, DOI 10.1093/jac/dkp452; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; SHCHERBAKOV D, 2010, MOL MICROBIOL; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Shimao T, 1987, Tubercle, V68, P5, DOI 10.1016/0041-3879(87)90014-6; STEWART FM, 1990, GENETICS, V124, P175; TAN WY, 1982, SIAM J APPL MATH, V42, P719, DOI 10.1137/0142050; van Soolingen D, 2000, J INFECT DIS, V182, P1788, DOI 10.1086/317598; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05; Werngren J, 2003, J CLIN MICROBIOL, V41, P1520, DOI 10.1128/JCM.41.4.1520-1524.2003; *WHO STOP TB DEP, 2009, COUNTR HAD REP LEAST; Wrande M, 2008, P NATL ACAD SCI USA, V105, P11863, DOI 10.1073/pnas.0804739105; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320; Zheng Q, 2003, GENETICS, V164, P373; Zheng Q, 1999, MATH BIOSCI, V162, P1, DOI 10.1016/S0025-5564(99)00045-0	44	62	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18327	10.1371/journal.pone.0018327	http://dx.doi.org/10.1371/journal.pone.0018327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479171	Green Submitted, Green Published, gold			2022-12-27	WOS:000289055700047
J	Gouws, EJ; Gaston, KJ; Chown, SL				Gouws, E. Jeanne; Gaston, Kevin J.; Chown, Steven L.			Intraspecific Body Size Frequency Distributions of Insects	PLOS ONE			English	Article							INDIVIDUAL-LEVEL SELECTION; WORKER CASTE POLYMORPHISM; EVOLUTION; ECOLOGY; ANT; DIMORPHISM; ALLOMETRIES; PERFORMANCE; PHYSIOLOGY; ONTOGENY	Although interspecific body size frequency distributions are well documented for many taxa, including the insects, intraspecific body size frequency distributions (IaBSFDs) are more poorly known, and their variation among mass-based and linear estimates of size has not been widely explored. Here we provide IaBSFDs for 16 species of insects based on both mass and linear estimates and large sample sizes (n >= 100). In addition, we review the published IaBSFDs for insects, though doing so is complicated by their under-emphasis in the literature. The form of IaBSFDs can differ substantially between mass-based and linear measures. Nonetheless, in non-social insects they tend to be normally distributed (18 of 27 species) or in fewer instances positively skewed. Negatively skewed distributions are infrequently reported and log transformation readily removes the positive skew. Sexual size dimorphism does not generally cause bimodality in IaBSFDs. The available information on IaBSFDs in the social insects suggests that these distributions are usually positively skewed or bimodal (24 of 30 species). However, only c. 15% of ant genera are polymorphic, suggesting that normal distributions are probably more common, but less frequently investigated. Although only 57 species, representing seven of the 29 orders of insects, have been considered here, it appears that whilst IaBSFDs are usually normal, other distribution shapes can be found in several species, though most notably among the social insects. By contrast, the interspecific body size frequency distribution is typically right-skewed in insects and in most other taxa.	[Gouws, E. Jeanne; Chown, Steven L.] Univ Stellenbosch, Dept Bot & Zool, Ctr Invas Biol, ZA-7600 Stellenbosch, South Africa; [Gaston, Kevin J.] Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England	Stellenbosch University; University of Sheffield	Gouws, EJ (corresponding author), Sci Serv, Western Cape Nat Conservat Board, Stellenbosch, South Africa.	slchown@sun.ac.za	Chown, Steven L/H-3347-2011; Chown, Steven/ABD-7646-2021	Chown, Steven L/0000-0001-6069-5105; Gaston, Kevin J./0000-0002-7235-7928	National Research Foundation of South Africa; Royal Society	National Research Foundation of South Africa(National Research Foundation - South Africa); Royal Society(Royal Society of London)	EJG and SLC were supported by the National Research Foundation of South Africa via a grant to the DST-NRF Centre of Excellence for Invasion Biology. KJG holds a Royal Society-Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOCK J, 1984, EVOLUTION, V38, P220, DOI [10.2307/2408560, 10.1111/j.1558-5646.1984.tb00274.x]; Babin-Fenske J, 2008, ECOL ENTOMOL, V33, P646, DOI 10.1111/j.1365-2311.2008.01018.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Billick I, 2007, INSECT SOC, V54, P113, DOI 10.1007/s00040-007-0918-9; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; BROWN JH, 1991, AM NAT, V138, P1478, DOI 10.1086/285297; Chown SL, 1997, FUNCT ECOL, V11, P365, DOI 10.1046/j.1365-2435.1997.00096.x; Chown SL, 1999, BIOL REV, V74, P87, DOI 10.1017/S000632319800526X; CHOWN SL, 1993, OECOLOGIA, V96, P508, DOI 10.1007/BF00320508; Chown SL, 2001, POLAR BIOL, V24, P706, DOI 10.1007/s003000100281; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; COOPER WE, 1989, AM NAT, V133, P729, DOI 10.1086/284948; Couvillon MJ, 2010, ECOL ENTOMOL, V35, P424, DOI 10.1111/j.1365-2311.2010.01198.x; de Jong Gerdien, 2008, P523; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Feener DH, 1988, FUNCT ECOL, V2, P509, DOI 10.2307/2389394; Fraser VS, 2000, BEHAV ECOL SOCIOBIOL, V47, P188, DOI 10.1007/s002650050010; FRUMHOFF PC, 1992, AM NAT, V139, P559, DOI 10.1086/285344; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Gaston KJ, 2008, J BIOGEOGR, V35, P483, DOI 10.1111/j.1365-2699.2007.01772.x; Greve M, 2008, GLOBAL ECOL BIOGEOGR, V17, P514, DOI 10.1111/j.1466-8238.2008.00388.x; Hanks LM, 2005, ENTOMOL EXP APPL, V114, P25, DOI 10.1111/j.0013-8703.2005.00225.x; Hughes WOH, 2003, P NATL ACAD SCI USA, V100, P9394, DOI 10.1073/pnas.1633701100; Kingsolver JG, 2004, EVOLUTION, V58, P1608; Koons DN, 2009, HERPETOL CONSERV BIO, V4, P221; Kozlowski J, 2004, INTEGR COMP BIOL, V44, P480, DOI 10.1093/icb/44.6.480; Kozlowski J, 2002, FUNCT ECOL, V16, P419, DOI 10.1046/j.1365-2435.2002.00646.x; Kozlowski J, 1997, AM NAT, V149, P352; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Loder N, 1997, OIKOS, V78, P195, DOI 10.2307/3545817; LOUNIBOS LP, 1994, ECOL ENTOMOL, V19, P138, DOI 10.1111/j.1365-2311.1994.tb00403.x; MACHIN J, 1991, J EXP BIOL, V161, P439; May RM, 1981, THEORETICAL ECOLOGY, P5; Mercer RD, 2001, ANTARCT SCI, V13, P135, DOI 10.1017/S0954102001000219; Moczek Armin P., 2008, P81; Osmundson DB, 2006, J FISH BIOL, V68, P1563, DOI 10.1111/j.0022-1112.2006.001043.x; Oster G.F., 1978, Monographs in Population Biology, pi; Peat J, 2005, ECOL ENTOMOL, V30, P176, DOI 10.1111/j.0307-6946.2005.00676.x; PIELOU E C, 1969, P286; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Powell S, 2006, FUNCT ECOL, V20, P1105, DOI 10.1111/j.1365-2435.2006.01184.x; Roulston TH, 2000, J KANSAS ENTOMOL SOC, V73, P129; Schoning C, 2005, OIKOS, V110, P231, DOI 10.1111/j.0030-1299.2005.13672.x; Shingleton AW, 2008, P ROY SOC B-BIOL SCI, V275, P1875, DOI 10.1098/rspb.2008.0227; Smith FA, 2004, AM NAT, V163, P672, DOI 10.1086/382898; Stergiou KI, 1999, ENVIRON BIOL FISH, V54, P151, DOI 10.1023/A:1007594719450; Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500; Strobbe F, 2004, BIOL J LINN SOC, V83, P187, DOI 10.1111/j.1095-8312.2004.00379.x; Teder T, 2008, AM NAT, V172, P223, DOI 10.1086/589896; TSCHINKEL WR, 1988, BEHAV ECOL SOCIOBIOL, V22, P103, DOI 10.1007/BF00303545; WADDINGTON KD, 1986, J KANSAS ENTOMOL SOC, V59, P95; WHEELER DE, 1991, AM NAT, V138, P1218, DOI 10.1086/285279; WILSON EO, 1953, Q REV BIOL, V28, P136, DOI 10.1086/399512; Yang AS, 2004, CURR BIOL, V14, P514, DOI 10.1016/j.cub.2004.03.005	55	41	41	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e16606	10.1371/journal.pone.0016606	http://dx.doi.org/10.1371/journal.pone.0016606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479214	Green Published, gold			2022-12-27	WOS:000289055700005
J	Leonard, H; Glasson, E; Nassar, N; Whitehouse, A; Bebbington, A; Bourke, J; Jacoby, P; Dixon, G; Malacova, E; Bower, C; Stanley, F				Leonard, Helen; Glasson, Emma; Nassar, Natasha; Whitehouse, Andrew; Bebbington, Ami; Bourke, Jenny; Jacoby, Peter; Dixon, Glenys; Malacova, Eva; Bower, Carol; Stanley, Fiona			Autism and Intellectual Disability Are Differentially Related to Sociodemographic Background at Birth	PLOS ONE			English	Article							PERINATAL RISK-FACTORS; OLDER REPRODUCTIVE AGE; MENTAL-RETARDATION; PATERNAL AGE; WESTERN-AUSTRALIA; SPECTRUM DISORDERS; SOCIOECONOMIC-STATUS; INFANTILE-AUTISM; CHILDREN; POPULATION	Background: Research findings investigating the sociodemographics of autism spectrum disorder (ASD) have been inconsistent and rarely considered the presence of intellectual disability (ID). Methods: We used population data on Western Australian singletons born from 1984 to 1999 (n = 398,353) to examine the sociodemographic characteristics of children diagnosed with ASD with or without ID, or ID without ASD compared with non-affected children. Results: The profiles for the four categories examined, mild-moderate ID, severe ID, ASD without ID and ASD with ID varied considerably and we often identified a gradient effect where the risk factors for mild-moderate ID and ASD without ID were at opposite extremes while those for ASD with ID were intermediary. This was demonstrated clearly with increased odds of ASD without ID amongst older mothers aged 35 years and over (odds ratio (OR) = 1.69 [CI: 1.18, 2.43]), first born infants (OR = 2.78; [CI: 1.67, 4.54]), male infants (OR = 6.57 [CI: 4.87, 8.87]) and increasing socioeconomic advantage. In contrast, mild-moderate ID was associated with younger mothers aged less than 20 years (OR = 1.88 [CI: 1.57, 2.25]), paternal age greater than 40 years (OR = 1.59 [CI: 1.36, 1.86]), Australian-born and Aboriginal mothers (OR = 1.60 [CI: 1.41, 1.82]), increasing birth order and increasing social disadvantage (OR = 2.56 [CI: 2.27, 2.97]). Mothers of infants residing in regional or remote areas had consistently lower risk of ASD or ID and may be linked to reduced access to services or under-ascertainment rather than a protective effect of location. Conclusions: The different risk profiles observed between groups may be related to aetiological differences or ascertainment factors or both. Untangling these pathways is challenging but an urgent public health priority in view of the supposed autism epidemic.	[Leonard, Helen; Glasson, Emma; Nassar, Natasha; Whitehouse, Andrew; Bebbington, Ami; Bourke, Jenny; Jacoby, Peter; Dixon, Glenys; Malacova, Eva; Bower, Carol; Stanley, Fiona] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA, Australia; [Glasson, Emma] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Nassar, Natasha] Univ Sydney, Kolling Inst Med Res, Perinatal Res, Sydney, NSW 2006, Australia; [Malacova, Eva] Curtin Univ Technol, Natl Drug Res Inst, Perth, WA, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Sydney; Kolling Institute of Medical Research; Curtin University	Leonard, H (corresponding author), Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA, Australia.	hleonard@ichr.uwa.edu.au	Dixon, Glenys/J-2144-2015; Glasson, Emma/H-5339-2013; Whitehouse, Andrew J.O./AGJ-2519-2022; Nassar, Natasha/K-3918-2019; Leonard, Helen/A-1010-2013	Dixon, Glenys/0000-0002-1716-076X; Glasson, Emma/0000-0003-3996-9049; Whitehouse, Andrew J.O./0000-0001-8722-1575; Leonard, Helen/0000-0001-6405-5834; , Emma/0000-0001-5547-8595; Nassar, Natasha/0000-0002-3720-9655	Australian National Health and Medical Research Council (NHMRC) [353514, 572742]; NHMRC [353628, 572568, 632955]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033123, R01NS058500] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by the Australian National Health and Medical Research Council (NHMRC, http://www.nhmrc.gov.au/) Program Grants (353514 and 572742), NHMRC Research Fellowship (353628 to CB), NHMRC Research Fellowship (572568) (to HL) and NHMRC Career Development Fellowship (632955 to NN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anello A, 2009, J AUTISM DEV DISORD, V39, P1487, DOI 10.1007/s10803-009-0755-y; *AUSTR BUR STAT, 1998, INF PAP 1996 CENS SO; Australian Bureau of Statistics, 2008, STAND AUSTR CLASS CO; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Begeer S, 2009, J AUTISM DEV DISORD, V39, P142, DOI 10.1007/s10803-008-0611-5; Bhasin TK, 2007, J AUTISM DEV DISORD, V37, P667, DOI 10.1007/s10803-006-0194-y; Blair Eve M, 2005, BMC Pediatr, V5, P13, DOI 10.1186/1471-2431-5-13; Cantor RM, 2007, MOL PSYCHIATR, V12, P419, DOI 10.1038/sj.mp.4001966; Chapman DA, 2002, AM J MENT RETARD, V107, P46, DOI 10.1352/0895-8017(2002)107<0046:ERFFMR>2.0.CO;2; Coo H, 2008, J AUTISM DEV DISORD, V38, P1036, DOI 10.1007/s10803-007-0478-x; Croen LA, 2002, J AUTISM DEV DISORD, V32, P217, DOI 10.1023/A:1015405914950; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Currenti SA, 2010, CELL MOL NEUROBIOL, V30, P161, DOI 10.1007/s10571-009-9453-8; Decoufle Pierre, 1995, Annals of Epidemiology, V5, P347, DOI 10.1016/1047-2797(95)00031-2; DREWS CD, 1995, AM J PUBLIC HEALTH, V85, P329, DOI 10.2105/AJPH.85.3.329; Durkin MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011551; Durkin MS, 2010, AM J PUBLIC HEALTH, V100, P389, DOI 10.2105/AJPH.2009.184101; Durkin MS, 2008, AM J EPIDEMIOL, V168, P1268, DOI 10.1093/aje/kwn250; Eaton WW, 2001, J AUTISM DEV DISORD, V31, P279, DOI 10.1023/A:1010743203048; Eyles DW, 2010, ACTA PAEDIATR, V99, P645, DOI 10.1111/j.1651-2227.2010.01797.x; Fernell E, 2010, ACTA PAEDIATR, V99, P743, DOI 10.1111/j.1651-2227.2010.01755.x; Gee A, 2010, LANCET, V376, P1451, DOI 10.1016/S0140-6736(10)61977-0; GILLBERG C, 1995, J INTELL DISABIL RES, V39, P141, DOI 10.1111/j.1365-2788.1995.tb00482.x; Glasson EJ, 2004, ARCH GEN PSYCHIAT, V61, P618, DOI 10.1001/archpsyc.61.6.618; Glasson EJ, 2008, MED J AUSTRALIA, V188, P288, DOI 10.5694/j.1326-5377.2008.tb01623.x; Grether JK, 2009, AM J EPIDEMIOL, V170, P1118, DOI 10.1093/aje/kwp247; HEBER R, 1961, AM J MENT DEFIC, V64; Herbert MR, 2006, NEUROTOXICOLOGY, V27, P671, DOI 10.1016/j.neuro.2006.03.017; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Hultman CM, 2002, EPIDEMIOLOGY, V13, P417, DOI 10.1097/00001648-200207000-00009; Hultman CM, 2010, MOL PSYCHIAT; Keen DV, 2010, BRIT J PSYCHIAT, V196, P274, DOI 10.1192/bjp.bp.109.065490; King M, 2009, INT J EPIDEMIOL, V38, P1224, DOI 10.1093/ije/dyp261; King MD, 2009, AM J PUBLIC HEALTH, V99, P1673, DOI 10.2105/AJPH.2008.149021; Kinney DK, 2010, MED HYPOTHESES, V74, P102, DOI 10.1016/j.mehy.2009.07.052; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; Lauritsen MB, 2005, J CHILD PSYCHOL PSYC, V46, P963, DOI 10.1111/j.1469-7610.2004.00391.x; Leonard H, 2005, SOC SCI MED, V60, P1499, DOI 10.1016/j.socscimed.2004.08.014; Leonard H, 2008, AM J EPIDEMIOL, V167, P103, DOI 10.1093/aje/kwm245; Leonard H, 2010, RES AUTISM SPECT DIS, V4, P548, DOI 10.1016/j.rasd.2010.01.003; Liu KY, 2010, AM J SOCIOL, V115, P1387, DOI 10.1086/651448; Liu K, 2010, DEMOGRAPHY, V47, P327, DOI 10.1353/dem.0.0101; Loesch DZ, 2000, AM J PHYS ANTHROPOL, V111, P545, DOI 10.1002/(SICI)1096-8644(200004)111:4<545::AID-AJPA9>3.0.CO;2-X; Maimburg RD, 2006, ACTA PSYCHIAT SCAND, V114, P257, DOI 10.1111/j.1600-0447.2006.00805.x; Mandell DS, 2009, AM J PUBLIC HEALTH, V99, P493, DOI 10.2105/AJPH.2007.131243; Moraine C, 2009, WORLD J BIOL PSYCHIA, V10, P1030, DOI 10.1080/15622970802627455; Nassar N, 2009, INT J EPIDEMIOL, V38, P1245, DOI 10.1093/ije/dyp260; Palmer RF, 2010, AM J PUBLIC HEALTH, V100, P270, DOI 10.2105/AJPH.2008.150565; Petterson B, 2005, ANN HUM BIOL, V32, P237, DOI 10.1080/03014460500075035; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Rutter M, 2009, INT J EPIDEMIOL, V38, P1238, DOI 10.1093/ije/dyp257; Shelton JF, 2010, AUTISM RES, V3, P30, DOI 10.1002/aur.116; StataCorp, 2007, STAT STAT SOFTW REL; Statistics Canada, 2020, IND REM; Stromme P, 2000, SOC PSYCH PSYCH EPID, V35, P12, DOI 10.1007/s001270050003; Tanner JM., 1986, HUMAN GROWTH MULTIDI, P3; Tsuchiya KJ, 2008, BRIT J PSYCHIAT, V193, P316, DOI 10.1192/bjp.bp.107.045120; YearginAllsopp M, 1997, DEV MED CHILD NEUROL, V39, P142	62	79	81	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17875	10.1371/journal.pone.0017875	http://dx.doi.org/10.1371/journal.pone.0017875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YK	21479223	Green Published, gold, Green Submitted			2022-12-27	WOS:000289055700017
J	Mulrooney, TJ; Marsh, J; Urits, I; Seyfried, TN; Mukherjee, P				Mulrooney, Tiernan J.; Marsh, Jeremy; Urits, Ivan; Seyfried, Thomas N.; Mukherjee, Purna			Influence of Caloric Restriction on Constitutive Expression of NF-kappa B in an Experimental Mouse Astrocytoma	PLOS ONE			English	Article							INFLAMMATORY FACTOR-I; ENDOTHELIAL-GROWTH-FACTOR; DIETARY RESTRICTION; MALIGNANT GLIOMAS; GENE-EXPRESSION; KETOGENIC DIET; MESSENGER-RNA; KETONE-BODIES; UP-REGULATION; BRAIN-TUMORS	Background: Many of the current standard therapies employed for the management of primary malignant brain cancers are largely viewed as palliative, ultimately because these conventional strategies have been shown, in many instances, to decrease patient quality of life while only offering a modest increase in the length of survival. We propose that caloric restriction (CR) is an alternative metabolic therapy for brain cancer management that will not only improve survival but also reduce the morbidity associated with disease. Although we have shown that CR manages tumor growth and improves survival through multiple molecular and biochemical mechanisms, little information is known about the role that CR plays in modulating inflammation in brain tumor tissue. Methodology/Principal Findings: Phosphorylation and activation of nuclear factor kappa B (NF-kappa B) results in the transactivation of many genes including those encoding cycloxygenase-2 (COX-2) and allograft inflammatory factor-1 (AIF-1), both of which are proteins that are primarily expressed by inflammatory and malignant cancer cells. COX-2 has been shown to enhance inflammation and promote tumor cell survival in both in vitro and in vivo studies. In the current report, we demonstrate that the p65 subunit of NF-kappa B was expressed constitutively in the CT-2A tumor compared with contra-lateral normal brain tissue, and we also show that CR reduces (i) the phosphorylation and degree of transcriptional activation of the NF-kappa B-dependent genes COX-2 and AIF-1 in tumor tissue, as well as (ii) the expression of proinflammatory markers lying downstream of NF-kappa B in the CT-2A malignant mouse astrocytoma, [e. g. macrophage inflammatory protein-2 (MIP-2)]. On the whole, our date indicate that the NF-kappa B inflammatory pathway is constitutively activated in the CT-2A astrocytoma and that CR targets this pathway and inflammation. Conclusion: CR could be effective in reducing malignant brain tumor growth in part by inhibiting inflammation in the primary brain tumor.	[Mulrooney, Tiernan J.] Georgetown Univ, Med Ctr, Tumor Biol Program, Washington, DC 20007 USA; [Marsh, Jeremy] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Urits, Ivan; Seyfried, Thomas N.; Mukherjee, Purna] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA	Georgetown University; Yeshiva University; Albert Einstein College of Medicine; Boston College	Mulrooney, TJ (corresponding author), Georgetown Univ, Med Ctr, Tumor Biol Program, Washington, DC 20007 USA.	mukherjp@bc.edu		Seyfried, Thomas/0000-0003-1491-3989	National Institutes of Health [NS 055195, CA102135]; Boston College; NATIONAL CANCER INSTITUTE [R01CA102135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS055195, R01NS055195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston College; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants NS 055195 and CA102135 and the Boston College research expense fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Angileri FF, 2008, CANCER-AM CANCER SOC, V112, P2258, DOI 10.1002/cncr.23407; Annabi B, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-8; Armstrong DA, 2004, J LEUKOCYTE BIOL, V75, P641, DOI 10.1189/jlb.0803370; Atkinson GP, 2009, ONCOGENE, V28, P3735, DOI 10.1038/onc.2009.232; Autieri MV, 1996, BIOCHEM BIOPH RES CO, V228, P29, DOI 10.1006/bbrc.1996.1612; Badie B, 2003, CLIN CANCER RES, V9, P872; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Carlson MRJ, 2007, CLIN CANCER RES, V13, P2592, DOI 10.1158/1078-0432.CCR-06-2772; Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572; Chung HY, 2001, ANN NY ACAD SCI, V928, P327; Clement K, 2004, FASEB J, V18, P1657, DOI 10.1096/fj.04-2204com; Csiszar A, 2009, MECH AGEING DEV, V130, P518, DOI 10.1016/j.mad.2009.06.004; Derr RL, 2009, J CLIN ONCOL, V27, P1082, DOI 10.1200/JCO.2008.19.1098; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028; Dong WM, 1998, AM J RESP CELL MOL, V19, P462, DOI 10.1165/ajrcmb.19.3.3114; Fenton JI, 2009, DIABETES OBES METAB, V11, P343, DOI 10.1111/j.1463-1326.2008.00974.x; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Fisher PG, 2005, JAMA-J AM MED ASSOC, V293, P615, DOI 10.1001/jama.293.5.615; FLAVIN HJ, 1991, J NEUROCHEM, V56, P1007, DOI 10.1111/j.1471-4159.1991.tb02021.x; GUSTAFSON MP, NEURO ONCOL; Hagemann T, 2004, CARCINOGENESIS, V25, P1543, DOI 10.1093/carcin/bgh146; HARVEY AE, 2010, CANC PREVENTION RE S, V3, pB54; Hayashi S, 2001, NEUROL MED-CHIR, V41, P187, DOI 10.2176/nmc.41.187; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; HOLNESS CL, 1993, BLOOD, V81, P1607; HUANG S, 1992, AM J PATHOL, V141, P981; Hursting SD, 2007, CANCER RES, V67, P2391, DOI 10.1158/0008-5472.CAN-06-4237; Hursting SD, 2010, CARCINOGENESIS, V31, P83, DOI 10.1093/carcin/bgp280; Huysentruyt LC, 2008, INT J CANCER, V123, P73, DOI 10.1002/ijc.23492; Ikeda S, 2001, ARCH SURG-CHICAGO, V136, P297, DOI 10.1001/archsurg.136.3.297; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; JENKS S, J NATL CANC I, V102, P519; Jia J, 2010, PEDIATR RES, V67, P29, DOI 10.1203/PDR.0b013e3181bf572b; Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005; Jukich PJ, 2001, NEURO-ONCOLOGY, V3, P141, DOI 10.1093/neuonc/3.3.141; Jung KJ, 2009, INFLAMM RES, V58, P143, DOI 10.1007/s00011-008-7227-2; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim DS, 2003, MOL IMMUNOL, V40, P633, DOI 10.1016/j.molimm.2003.07.001; Kimura M, 2007, J IMMUNOL, V178, P3316, DOI 10.4049/jimmunol.178.5.3316; Kobayashi Hanako, 2009, V511, P185, DOI 10.1007/978-1-59745-447-6_8; Korkolopoulou P, 2008, HUM PATHOL, V39, P1143, DOI 10.1016/j.humpath.2008.01.020; Krebs H.A., 1971, ADV ENZYME REGUL, V9, P387, DOI [10.1016/S0065-2571(71)80055-9, DOI 10.1016/S0065-2571(71)80055-9]; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li J, 2010, AM J PATHOL, V176, P699, DOI 10.2353/ajpath.2010.090502; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu S, 2008, CANCER SCI, V99, P952, DOI 10.1111/j.1349-7006.2008.00787.x; Lowry JK, 1998, ARCH NEUROL-CHICAGO, V55, P922, DOI 10.1001/archneur.55.7.922; Lu S, 2004, RADIOLOGY, V232, P221, DOI 10.1148/radiol.2321030653; Ludwig HC, 2000, ANTICANCER RES, V20, P299; Lukins MB, 2005, ANESTH ANALG, V100, P1129, DOI 10.1213/01.ANE.0000146943.45445.55; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Mancardi S, 2003, IMMUNOLOGY, V108, P523, DOI 10.1046/j.1365-2567.2003.01613.x; MANCINO A, CLIN CANC RES, V16, P784; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Marsh J, 2008, CLIN CANCER RES, V14, P7751, DOI 10.1158/1078-0432.CCR-08-0213; Martinez-Murillo R, 2007, HISTOL HISTOPATHOL, V22, P1309, DOI 10.14670/HH-22.1309; Matzer SP, 2004, INT IMMUNOL, V16, P1675, DOI 10.1093/intimm/dxh169; McMillan DC, 2006, BRIT MED J, V333, P1109, DOI 10.1136/bmj.39042.565035.BE1; Mitchell JR, 2010, AGING CELL, V9, P40, DOI 10.1111/j.1474-9726.2009.00532.x; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Mukherjee P, 1999, JNCI-J NATL CANCER I, V91, P512, DOI 10.1093/jnci/91.6.512; Mukherjee P, 2004, CLIN CANCER RES, V10, P5622, DOI 10.1158/1078-0432.CCR-04-0308; Mukherjee P, 2002, BRIT J CANCER, V86, P1615, DOI 10.1038/sj.bjc.6600298; Mukherjee P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-37; NABEL GJ, 1993, GENE DEV, V7, P2063, DOI 10.1101/gad.7.11.2063; Nicholson HS, 2007, CANCER, V110, P1542, DOI 10.1002/cncr.22961; Nozell S, 2008, MOL CELL BIOL, V28, P6632, DOI 10.1128/MCB.00697-08; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; Pashenkov M, 2000, SCAND J IMMUNOL, V52, P117; Pope WB, 2005, AM J NEURORADIOL, V26, P2466; Portnow J, 2002, NEURO-ONCOLOGY, V4, P22, DOI 10.1093/neuonc/4.1.22; Ranes MK, 2001, BRIT J CANCER, V84, P1107, DOI 10.1054/bjoc.2000.1713; Ruskin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008349; Rutz HP, 2005, CANCER BIOL THER, V4, P1186, DOI 10.4161/cbt.4.11.2232; Rutz HP, 2005, CANCER, V103, P2656, DOI 10.1002/cncr.21067; Seyfried Thomas N, 2005, Nutr Metab (Lond), V2, P30, DOI 10.1186/1743-7075-2-30; Seyfried TN, 2003, BRIT J CANCER, V89, P1375, DOI 10.1038/sj.bjc.6601269; Seyfried TN, 2001, PERSPECT BIOL MED, V44, P263, DOI 10.1353/pbm.2001.0035; SEYFRIED TN, 1992, MOL CHEM NEUROPATHOL, V17, P147, DOI 10.1007/BF03159989; SEYFRIED TN, NUTR METAB LOND, V7, P7; SEYFRIED TN, BIOCH BIOPHYS ACTA; Shelton LM, 2010, ASN NEURO, V2, DOI 10.1042/AN20100002; SHELTON LM, J NEUROONCOL; Shono T, 2001, CANCER RES, V61, P4375; Smith JS, 2000, FRONT BIOSCI-LANDMRK, V5, pD213, DOI 10.2741/Smith; STAUDT LM, COLD SPRING HARB PER, V2; Temel SG, 2009, J MOL HISTOL, V40, P369, DOI 10.1007/s10735-009-9250-1; Tsunoda Keishi, 2005, Brain Tumor Pathol, V22, P79, DOI 10.1007/s10014-005-0186-1; UTANS U, 1995, J CLIN INVEST, V95, P2954, DOI 10.1172/JCI118003; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; WANG H, CURR CANC DRUG TARGE; Wang HM, 2004, LAB INVEST, V84, P941, DOI 10.1038/labinvest.3700123; WILLIAMSON DH, 1962, BIOCHEM J, V82, P90, DOI 10.1042/bj0820090; WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612; Xie TX, 2010, ONCOL REP, V23, P725, DOI 10.3892/or_00000690; Yang ZF, 2005, INT IMMUNOL, V17, P1391, DOI 10.1093/intimm/dxh316; Zampetaki A, 2004, FASEB J, V18, P1090, DOI 10.1096/fj.03-0991fje; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5	103	46	49	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18085	10.1371/journal.pone.0018085	http://dx.doi.org/10.1371/journal.pone.0018085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479220	Green Published, Green Submitted, gold			2022-12-27	WOS:000289055700024
J	Ananiadou, S; Sullivan, D; Black, W; Levow, GA; Gillespie, JJ; Mao, CH; Pyysalo, S; Kolluru, B; Tsujii, J; Sobral, B				Ananiadou, Sophia; Sullivan, Dan; Black, William; Levow, Gina-Anne; Gillespie, Joseph J.; Mao, Chunhong; Pyysalo, Sampo; Kolluru, BalaKrishna; Tsujii, Junichi; Sobral, Bruno			Named Entity Recognition for Bacterial Type IV Secretion Systems	PLOS ONE			English	Article							LEGIONELLA-PNEUMOPHILA; CONJUGATION; ONTOLOGY; DNA	Research on specialized biological systems is often hampered by a lack of consistent terminology, especially across species. In bacterial Type IV secretion systems genes within one set of orthologs may have over a dozen different names. Classifying research publications based on biological processes, cellular components, molecular functions, and microorganism species should improve the precision and recall of literature searches allowing researchers to keep up with the exponentially growing literature, through resources such as the Pathosystems Resource Integration Center (PATRIC, patricbrc.org). We developed named entity recognition (NER) tools for four entities related to Type IV secretion systems: 1) bacteria names, 2) biological processes, 3) molecular functions, and 4) cellular components. These four entities are important to pathogenesis and virulence research but have received less attention than other entities, e. g., genes and proteins. Based on an annotated corpus, large domain terminological resources, and machine learning techniques, we developed recognizers for these entities. High accuracy rates (>80%) are achieved for bacteria, biological processes, and molecular function. Contrastive experiments highlighted the effectiveness of alternate recognition strategies; results of term extraction on contrasting document sets demonstrated the utility of these classes for identifying T4SS-related documents.	[Ananiadou, Sophia; Levow, Gina-Anne; Kolluru, BalaKrishna; Tsujii, Junichi] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Ananiadou, Sophia; Black, William; Kolluru, BalaKrishna; Tsujii, Junichi] Univ Manchester, Manchester Interdisciplinary Bioctr, Natl Ctr Text Min, Manchester, Lancs, England; [Sullivan, Dan; Gillespie, Joseph J.; Mao, Chunhong; Sobral, Bruno] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA; [Pyysalo, Sampo; Tsujii, Junichi] Univ Tokyo, Dept Comp Sci, Sch Informat Sci & Technol, Tokyo, Japan	University of Manchester; University of Manchester; Virginia Polytechnic Institute & State University; University of Tokyo	Ananiadou, S (corresponding author), Univ Manchester, Sch Comp Sci, Manchester, Lancs, England.	dsulliva@vbi.vt.edu	Sobral, Bruno/GVU-7637-2022	Sobral, Bruno/0000-0003-3908-577X; Gillespie, Joseph/0000-0002-5447-7264	National Institutes of Health [HHSN272200900040C, HHSN266200400035C]; Biotechnology and Biological Sciences Research Council [BBS/B/13640, BB/F006039/1]; BBSRC [BB/G53025X/1, BB/F006039/1, BB/G013160/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G53025X/1, BB/G013160/1] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This was supported by the National Institutes of Health (http://www.nih.gov/) [grant numbers HHSN272200900040C and HHSN266200400035C] to BWSS. Sophia Ananiadou and Gina-Anne Levow acknowledge support by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) through grant numbers BBS/B/13640, BB/F006039/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Ananiadou S, 2006, TRENDS BIOTECHNOL, V24, P571, DOI 10.1016/j.tibtech.2006.10.002; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Collier N, 2006, LANG RESOUR EVAL, V40, P405, DOI 10.1007/s10579-007-9019-7; Collier N, 2008, BIOINFORMATICS, V24, P2940, DOI 10.1093/bioinformatics/btn534; CONWAY M, 2008, P 3 INT S SEM MIN BI; Doms A, 2005, NUCLEIC ACIDS RES, V33, pW783, DOI 10.1093/nar/gki470; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Finkel J, 2004, P JOINT WORKSH NAT L, P88; Frantzi K., 2000, INT J DIGITAL LIB, V3, P117, DOI DOI 10.1007/S007999900023; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Gillespie JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004833; Gillespie JJ, 2010, INFECT IMMUN, V78, P1809, DOI 10.1128/IAI.01384-09; GUYON P, 1980, P NATL ACAD SCI-BIOL, V77, P2693, DOI 10.1073/pnas.77.5.2693; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S1; Jin Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-492; Jones KM, 2007, J BACTERIOL, V189, P2133, DOI 10.1128/JB.00116-06; Juhas M, 2007, J BACTERIOL, V189, P761, DOI 10.1128/JB.01327-06; KAWAZOE A, 2006, P INT WORKSH BIOM ON, P77; KORVES T, 2009, CONTROLLED VOCABULAR, P279; Kutter S, 2008, J BACTERIOL, V190, P2161, DOI 10.1128/JB.01341-07; LAFFERTY, 2001, P 18 INT C MACH LEAR; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; Lee KJ, 2004, J BIOMED INFORM, V37, P436, DOI 10.1016/j.jbi.2004.08.012; Leser U, 2005, BRIEF BIOINFORM, V6, P357, DOI 10.1093/bib/6.4.357; Li LS, 2009, COMPUT BIOL CHEM, V33, P334, DOI 10.1016/j.compbiolchem.2009.07.004; Miyao Y, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P1017; Nenadic G., 2004, COLING 2004 P 20 INT, P604; Okanohara D, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P465; OKAZAKI N, 2008, P C EMP METH NAT LAN, P447; Okazaki N, 2006, BIOINFORMATICS, V22, P3089, DOI 10.1093/bioinformatics/btl534; PYYSALO TOS, 2010, P 2010 WORKSH BIOM N, P132; SANG EFT, 2000, P CONLL 2000 LLL 200; SASAKI Y, 2008, MAKE MOST NE DICT ST, P63; SCHROEDER GN, J BACTERIOL JB; Segal G, 2005, FEMS MICROBIOL REV, V29, P65, DOI 10.1016/j.femsre.2004.07.001; Tsuruoka, 2004, P INT JOINT WORKSH N, P70, DOI DOI 10.3115/1567594.1567610; TSURUOKA JIT, 2009, EACL 2009 12 C EUR C, P790; Tsuruoka Y, 2005, LECT NOTES COMPUT SC, V3746, P382; TSURUOKA Y, 2006, GENIA TAGGER 3 0; Tsuruoka Y, 2007, BIOINFORMATICS, V23, P2768, DOI 10.1093/bioinformatics/btm393; Wilbur J., 2007, P 2 BIOCREATIVE CHAL, P7; Zupan J, 2000, PLANT J, V23, P11, DOI 10.1046/j.1365-313x.2000.00808.x	46	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e14780	10.1371/journal.pone.0014780	http://dx.doi.org/10.1371/journal.pone.0014780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21468321	gold, Green Published, Green Submitted			2022-12-27	WOS:000289054600002
J	Delogu, G; Chiacchio, T; Vanini, V; Butera, O; Cuzzi, G; Bua, A; Molicotti, P; Zanetti, S; Lauria, FN; Grisetti, S; Magnavita, N; Fadda, G; Girardi, E; Goletti, D				Delogu, Giovanni; Chiacchio, Teresa; Vanini, Valentina; Butera, Ornella; Cuzzi, Gilda; Bua, Alessandra; Molicotti, Paola; Zanetti, Stefania; Lauria, Francesco Nicola; Grisetti, Susanna; Magnavita, Nicola; Fadda, Giovanni; Girardi, Enrico; Goletti, Delia			Methylated HBHA Produced in M. smegmatis Discriminates between Active and Non-Active Tuberculosis Disease among RD1-Responders	PLOS ONE			English	Article							HEPARIN-BINDING HEMAGGLUTININ; MYCOBACTERIUM-TUBERCULOSIS; LATENT TUBERCULOSIS; T-CELL; IMMUNE-RESPONSES; INFECTION; ANTIGENS; SPECTRUM	Background: A challenge in tuberculosis (TB) research is to develop a new immunological test that can help distinguish, among subjects responsive to QuantiFERON TB Gold In tube (QFT-IT), those who are able to control Mtb replication (remote LTBI, recent infection and past TB) from those who cannot (active TB disease). IFN-gamma response to the Heparin-binding-hemagglutinin (HBHA) of Mtb has been associated with LTBI, but the cumbersome procedures of purifying the methylated and immunological active form of the protein from Mtb or M. bovis Bacillus Calmette et Guerin (BCG) have prevented its implementation in a diagnostic test. Therefore, the aim of the present study was to evaluate the IFN-gamma response to methylated HBHA of Mtb produced in M. smegmatis (rHBHAms) in individuals at different stages of TB who scored positive to QFT-IT. Methodology/Principal Findings: 87 individuals at different stages of TB who scored positive to QFT-IT were selected. IFN-gamma response to in vitro whole blood stimulation with rHBHAms was evaluated by short-term and long-term tests and detected by ELISA or flow cytometry. We demonstrated that the IFN-gamma response to rHBHAms is mediated by CD4(+) T-cells with an effector-memory phenotype. This response, evaluated by short-term-tests, is significantly lower in active TB than in remote LTBI (p=0.0010) and past TB (p=0.0152). These results were confirmed by long-term tests. The qualitative data confirmed that IFN-gamma responses higher than the cut-off point identified by ROC analysis are associated with the status of non-active disease. Conclusions: In this study we show that the T-cell response to a recombinant and methylated HBHA of Mtb produced in M. smegmatis is useful to discriminate between active and non-active TB disease among those responsive to QFT-IT in a whole blood system. Further studies are needed to improve the accuracy of the assay.	[Delogu, Giovanni; Fadda, Giovanni] Univ Cattolica Sacro Cuore, Ist Microbiol, Rome, Italy; [Chiacchio, Teresa; Vanini, Valentina; Butera, Ornella; Cuzzi, Gilda; Goletti, Delia] L Spallanzani Natl Inst Infect Dis INMI, Translat Res Unit, Dept Epidemiol & Preclin Res, Rome, Italy; [Bua, Alessandra; Molicotti, Paola; Zanetti, Stefania] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Lauria, Francesco Nicola] INMI, Div Infect Dis Resp Tract, Dept Clin Res, Rome, Italy; [Grisetti, Susanna] INMI, Div Clin 3, Dept Clin Res, Rome, Italy; [Magnavita, Nicola] Univ Cattolica Sacro Cuore, Ist Med Lavoro, Rome, Italy; [Girardi, Enrico] INMI, Dept Epidemiol & Preclin Res, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Lazzaro Spallanzani; University of Sassari; IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Lazzaro Spallanzani	Delogu, G (corresponding author), Univ Cattolica Sacro Cuore, Ist Microbiol, Rome, Italy.	delia.goletti@inmi.it	molicotti, Paola/AAB-3217-2019; Delogu, Giovanni/I-3701-2012; goletti, delia/AAM-6577-2020; Vanini, Valentina/K-4475-2016; Magnavita, Nicola/J-6074-2014; Fadda, Giovanni/K-6224-2012	Delogu, Giovanni/0000-0003-0182-8267; Vanini, Valentina/0000-0001-8476-964X; Magnavita, Nicola/0000-0002-0988-7344; Goletti, Delia/0000-0001-8360-4376; MOLICOTTI, PAOLA/0000-0001-8127-1627; Girardi, Enrico/0000-0001-8182-5896	Italian Ministry of Health [06.76.1, 07.103]	Italian Ministry of Health(Ministry of Health, Italy)	The study was supported by grants from the Italian Ministry of Health "Ricerca Corrente" and "Ricerca Finalizzata" 06.76.1 and 07.103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Butera O, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-182; Delogu G, 2006, INFECT IMMUN, V74, P3006, DOI 10.1128/IAI.74.5.3006-3011.2006; Delogu G, 2004, FEMS MICROBIOL LETT, V239, P33, DOI 10.1016/j.femsle.2004.08.015; Delogu G, 1999, J BACTERIOL, V181, P7464, DOI 10.1128/JB.181.24.7464-7469.1999; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Goletti D, 2010, EUR RESPIR J, V36, P135, DOI 10.1183/09031936.00140009; Goletti D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-5; Goletti D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003417; Hougardy JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000926; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Lawn SD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-99; Lawn SD, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/980594; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Masungi C, 2002, J INFECT DIS, V185, P513, DOI 10.1086/338833; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Menozzi FD, 1998, P NATL ACAD SCI USA, V95, P12625, DOI 10.1073/pnas.95.21.12625; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2010, NAT REV MICROBIOL, V8, P242, DOI 10.1038/nrmicro2236-c1; Pethe K, 2002, P NATL ACAD SCI USA, V99, P10759, DOI 10.1073/pnas.162246899; Place S, 2010, AM J RESP CRIT CARE, V182, P848, DOI 10.1164/rccm.201001-0083OC; Savolainen L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003272; Shin AR, 2006, CLIN VACCINE IMMUNOL, V13, P869, DOI 10.1128/CVI.00103-06; Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510; Temmerman S, 2004, NAT MED, V10, P935, DOI 10.1038/nm1090; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; World Health Organization, 2010, GLOB TUB CONTR SURV; Yang CS, 2008, RESP MED, V102, P280, DOI 10.1016/j.rmed.2007.08.016; Zanetti S, 2005, CLIN DIAGN LAB IMMUN, V12, P1135, DOI 10.1128/CDLI.12.9.1135-1138.2005	30	64	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18315	10.1371/journal.pone.0018315	http://dx.doi.org/10.1371/journal.pone.0018315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479248	Green Published, gold, Green Submitted			2022-12-27	WOS:000289054600044
J	Markwardt, ML; Kremers, GJ; Kraft, CA; Ray, K; Cranfill, PJC; Wilson, KA; Day, RN; Wachter, RM; Davidson, MW; Rizzo, MA				Markwardt, Michele L.; Kremers, Gert-Jan; Kraft, Catherine A.; Ray, Krishanu; Cranfill, Paula J. C.; Wilson, Korey A.; Day, Richard N.; Wachter, Rebekka M.; Davidson, Michael W.; Rizzo, Mark A.			An Improved Cerulean Fluorescent Protein with Enhanced Brightness and Reduced Reversible Photoswitching	PLOS ONE			English	Article							GREEN; FRET; CYAN; CHROMOPHORE; GFP; ACQUISITION; DYNAMICS; VARIANT	Cyan fluorescent proteins (CFPs), such as Cerulean, are widely used as donor fluorophores in Forster resonance energy transfer (FRET) experiments. Nonetheless, the most widely used variants suffer from drawbacks that include low quantum yields and unstable flurorescence. To improve the fluorescence properties of Cerulean, we used the X-ray structure to rationally target specific amino acids for optimization by site-directed mutagenesis. Optimization of residues in strands 7 and 8 of the beta-barrel improved the quantum yield of Cerulean from 0.48 to 0.60. Further optimization by incorporating the wild-type T65S mutation in the chromophore improved the quantum yield to 0.87. This variant, mCerulean3, is 20% brighter and shows greatly reduced fluorescence photoswitching behavior compared to the recently described mTurquoise fluorescent protein in vitro and in living cells. The fluorescence lifetime of mCerulean3 also fits to a single exponential time constant, making mCerulean3 a suitable choice for fluorescence lifetime microscopy experiments. Furthermore, inclusion of mCerulean3 in a fusion protein with mVenus produced FRET ratios with less variance than mTurquoise-containing fusions in living cells. Thus, mCerulean3 is a bright, photostable cyan fluorescent protein which possesses several characteristics that are highly desirable for FRET experiments.	[Markwardt, Michele L.; Kraft, Catherine A.; Rizzo, Mark A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Kremers, Gert-Jan] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Ray, Krishanu] Univ Maryland, Sch Med, Ctr Fluorescence Spect, Baltimore, MD 21201 USA; [Ray, Krishanu] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Cranfill, Paula J. C.; Wilson, Korey A.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Cranfill, Paula J. C.; Wilson, Korey A.; Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Day, Richard N.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN USA; [Wachter, Rebekka M.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA	University System of Maryland; University of Maryland Baltimore; Vanderbilt University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Indiana University System; Indiana University Bloomington; Arizona State University; Arizona State University-Tempe	Markwardt, ML (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	mrizz001@umaryland.edu			National Science Foundation [MCB-061593]; National Institutes of Health [GM72048, DK47301, DK47301-15S2, DK077140, DK077140-02S1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, R01DK077140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM072048] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Science Foundation grant to R. M. W. (MCB-061593), and National Institutes of Health grants GM72048, which provided support to G.J.K. (D. W. Piston, PI), DK47301 and DK47301-15S2 to R.N.D., and DK077140 and DK077140-02S1 to M. A. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Allen MD, 2006, ACS CHEM BIOL, V1, P371, DOI 10.1021/cb600202f; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Caiolfa VR, 2007, J CELL BIOL, V179, P1067, DOI 10.1083/jcb.200702151; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; CODY CW, 1993, BIOCHEMISTRY-US, V32, P1212, DOI 10.1021/bi00056a003; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Cubitt AB, 1999, METHOD CELL BIOL, V58, P19; Day RN, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2939094; Demachy I, 2005, J PHYS CHEM B, V109, P24121, DOI 10.1021/jp054656w; Dickinson ME, 2001, BIOTECHNIQUES, V31, P1272, DOI 10.2144/01316bt01; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Ding SY, 2010, MOL ENDOCRINOL, V24, P171, DOI 10.1210/me.2009-0138; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Forster T., 1948, ANN PHYS, V6, P54; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hodgson L, 2006, METHOD ENZYMOL, V406, P140, DOI 10.1016/S0076-6879(06)06012-5; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Kremers GJ, 2007, BIOCHEMISTRY-US, V46, P3775, DOI 10.1021/bi0622874; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lelimousin M, 2009, BIOCHEMISTRY-US, V48, P10038, DOI 10.1021/bi901093w; LEW D, 1993, GENE DEV, V7, P683, DOI 10.1101/gad.7.4.683; Malo GD, 2007, BIOCHEMISTRY-US, V46, P9865, DOI 10.1021/bi602664c; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Piston DW, 2008, METHOD CELL BIOL, V85, P415, DOI 10.1016/S0091-679X(08)85018-2; Pouwels LJ, 2008, BIOCHEMISTRY-US, V47, P10111, DOI 10.1021/bi8007164; Redford GI, 2005, J FLUORESC, V15, P805, DOI 10.1007/s10895-005-2990-8; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Rizzo Mark A, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.top64; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Tramier M, 2002, BIOPHYS J, V83, P3570, DOI 10.1016/S0006-3495(02)75357-5; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vallverdu G, 2010, PROTEINS, V78, P1040, DOI 10.1002/prot.22628; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Wachter RM, 2007, ACCOUNTS CHEM RES, V40, P120, DOI 10.1021/ar040086r; Wachter RM, 2010, BIOCHEMISTRY-US, V49, P7417, DOI 10.1021/bi100901h; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; Zal T, 2004, CURR OPIN IMMUNOL, V16, P418, DOI 10.1016/j.coi.2004.05.019; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	49	190	202	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17896	10.1371/journal.pone.0017896	http://dx.doi.org/10.1371/journal.pone.0017896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479270	Green Submitted, gold, Green Published			2022-12-27	WOS:000289054600019
J	Dewaard, JR; Hebert, PDN; Humble, LM				deWaard, Jeremy R.; Hebert, Paul D. N.; Humble, Leland M.			A Comprehensive DNA Barcode Library for the Looper Moths (Lepidoptera: Geometridae) of British Columbia, Canada	PLOS ONE			English	Article							IDENTIFICATION; LIFE; DIVERSITY; DIPTERA; GENUS	Background: The construction of comprehensive reference libraries is essential to foster the development of DNA barcoding as a tool for monitoring biodiversity and detecting invasive species. The looper moths of British Columbia (BC), Canada present a challenging case for species discrimination via DNA barcoding due to their considerable diversity and limited taxonomic maturity. Methodology/Principal Findings: By analyzing specimens held in national and regional natural history collections, we assemble barcode records from representatives of 400 species from BC and surrounding provinces, territories and states. Sequence variation in the barcode region unambiguously discriminates over 93% of these 400 geometrid species. However, a final estimate of resolution success awaits detailed taxonomic analysis of 48 species where patterns of barcode variation suggest cases of cryptic species, unrecognized synonymy as well as young species. Conclusions/Significance: A catalog of these taxa meriting further taxonomic investigation is presented as well as the supplemental information needed to facilitate these investigations.	[deWaard, Jeremy R.; Humble, Leland M.] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada; [deWaard, Jeremy R.] Royal British Columbia Museum, Victoria, BC, Canada; [Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Humble, Leland M.] Nat Resources Canada, Canadian Forest Serv, Victoria, BC, Canada	University of British Columbia; University of Guelph; Natural Resources Canada; Canadian Forest Service	Dewaard, JR (corresponding author), Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada.	jdewaard@interchange.ubc.ca	deWaard, Jeremy R/G-8112-2014; Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700	Forest Investment Account - Forest Science Program Student Grant; NSERC; Canadian Barcode of Life Network through funding from Genome Canada through the Ontario Genomics Institute	Forest Investment Account - Forest Science Program Student Grant; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Barcode of Life Network through funding from Genome Canada through the Ontario Genomics Institute	Funding was provided by a Forest Investment Account - Forest Science Program Student Grant and an NSERC Graduate Scholarship (to JRD) and by the Canadian Barcode of Life Network through funding from Genome Canada through the Ontario Genomics Institute and from NSERC (to LMH and PDNH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Bolte K. B., 1990, Memoirs of the Entomological Society of Canada; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; deWaard JR, 2009, BIODIVERS CONSERV, V18, P3825, DOI 10.1007/s10531-009-9682-7; DeWaard Jeremy R., 2008, V410, P275; Doak P, 2000, ECOLOGY, V81, P1828, DOI 10.1890/0012-9658(2000)081[1828:PCORDF]2.0.CO;2; Elias-Gutierrez M, 2008, HIDROBIOLOGICA, V18, P63; Ferguson D.C., 1983, CHECK LIST LEPIDOPTE, p88 ; Ferguson DC, 2008, MOTHS AM N MEXICO; Ferris CD, 2010, ZOOTAXA, P1; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Gibbs J, 2009, ZOOTAXA, P1; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hausmann A, 2009, ZOOTAXA, P1; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Huemer P, 2009, ZOOTAXA, P1; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Locke SA, 2010, INT J PARASITOL, V40, P333, DOI 10.1016/j.ijpara.2009.08.012; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Marshall I.B., 1999, NATL ECOLOGICAL FRAM; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Mitchell A, 2008, AUST J ENTOMOL, V47, P169, DOI 10.1111/j.1440-6055.2008.00645.x; Nieminen M, 1996, OECOLOGIA, V108, P643, DOI 10.1007/BF00329038; Packer L, 2009, MOL ECOL RESOUR, V9, P42, DOI 10.1111/j.1755-0998.2009.02631.x; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Penev L, 2008, ZOOKEYS, P1, DOI 10.3897/zookeys.1.11; Pohl GR, 2010, ZOOKEYS, P1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Rivera J, 2009, MOL ECOL RESOUR, V9, P224, DOI 10.1111/j.1755-0998.2009.02648.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Scoble M, ONLINE LIST VALID AV; SCOBLE M. J., 1992, LEPIDOPTERA FORM FUN; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-31; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TOMON TT, 2007, REVISION GENUS PROBO; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Wilson A. D., 2010, Journal of Entomology, V7, P60, DOI 10.3923/je.2010.60.79; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x; Zhou X, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-30	54	45	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18290	10.1371/journal.pone.0018290	http://dx.doi.org/10.1371/journal.pone.0018290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464900	Green Published, Green Submitted, gold			2022-12-27	WOS:000289053800038
J	Kerr, SC; Azzouz, N; Fuchs, SM; Collart, MA; Strahl, BD; Corbett, AH; Laribee, RN				Kerr, Shana C.; Azzouz, Nowel; Fuchs, Stephen M.; Collart, Martine A.; Strahl, Brian D.; Corbett, Anita H.; Laribee, R. Nicholas			The Ccr4-Not Complex Interacts with the mRNA Export Machinery	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; SACCHAROMYCES-CEREVISIAE; BINDING PROTEIN; ARGININE METHYLATION; GENE-EXPRESSION; POLY(A) RNA; IN-VIVO; TRANSCRIPTION FACTOR; HISTONE METHYLATION; STATISTICAL-MODEL	Background: The Ccr4-Not complex is a key eukaryotic regulator of gene transcription and cytoplasmic mRNA degradation. Whether this complex also affects aspects of post-transcriptional gene regulation, such as mRNA export, remains largely unexplored. Human Caf1 (hCaf1), a Ccr4-Not complex member, interacts with and regulates the arginine methyltransferase PRMT1, whose targets include RNA binding proteins involved in mRNA export. However, the functional significance of this regulation is poorly understood. Methodology/Principal Findings: Here we demonstrate using co-immunoprecipitation approaches that Ccr4-Not subunits interact with Hmt1, the budding yeast ortholog of PRMT1. Furthermore, using genetic and biochemical approaches, we demonstrate that Ccr4-Not physically and functionally interacts with the heterogenous nuclear ribonucleoproteins (hnRNPs) Nab2 and Hrp1, and that the physical association depends on Hmt1 methyltransferase activity. Using mass spectrometry, co-immunoprecipitation and genetic approaches, we also uncover physical and functional interactions between Ccr4-Not subunits and components of the nuclear pore complex (NPC) and we provide evidence that these interactions impact mRNA export. Conclusions/Significance: Taken together, our findings suggest that Ccr4-Not has previously unrealized functional connections to the mRNA processing/export pathway that are likely important for its role in gene expression. These results shed further insight into the biological functions of Ccr4-Not and suggest that this complex is involved in all aspects of mRNA biogenesis, from the regulation of transcription to mRNA export and turnover.	[Kerr, Shana C.] Emory Univ, Sch Med, Dept Biochem, Cell & Dev Biol Grad Program, Atlanta, GA 30322 USA; [Azzouz, Nowel; Collart, Martine A.] Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Fuchs, Stephen M.; Strahl, Brian D.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Laribee, R. Nicholas] Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, Memphis, TN USA; [Laribee, R. Nicholas] Univ Tennessee, Hlth Sci Ctr, Ctr Canc Res, Memphis, TN USA	Emory University; University of Geneva; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Kerr, SC (corresponding author), Emory Univ, Sch Med, Dept Biochem, Cell & Dev Biol Grad Program, Atlanta, GA 30322 USA.	rlaribee@uthsc.edu	Strahl, Brian/C-7601-2012; Fuchs, Stephen/I-7251-2012; Corbett, Anita/AAH-6106-2021	Strahl, Brian/0000-0002-4947-6259; Corbett, Anita/0000-0002-0461-6895; Collart, Martine/0000-0001-6955-1773; Laribee, R. Nicholas/0000-0003-4519-4470; Fuchs, Stephen/0000-0001-7261-9214	National Institutes of Health [GM58728, GM068088]; Swiss National Science Foundation [3100A0-120419/1]; University of Tennessee; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, R01GM068088, R01GM058728, F32GM080896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Tennessee; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health grants GM58728 (to AHC) and GM068088 (to BDS), Swiss National Science Foundation grant 3100A0-120419/1 (to MAC), and start-up funding from the University of Tennessee (to RNL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Aguilera A, 2005, CURR OPIN CELL BIOL, V17, P242, DOI 10.1016/j.ceb.2005.03.001; Ahmed S, 2007, TRENDS GENET, V23, P396, DOI 10.1016/j.tig.2007.05.009; Aitchison JD, 1995, J CELL BIOL, V131, P1659, DOI 10.1083/jcb.131.6.1659; Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Azzouz N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006760; Azzouz N, 2009, RNA, V15, P377, DOI 10.1261/rna.1348209; Belanger KD, 2005, GENETICS, V171, P935, DOI 10.1534/genetics.104.036319; Benson JD, 1998, EMBO J, V17, P6714, DOI 10.1093/emboj/17.22.6714; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; BOGERD AM, 1994, J CELL BIOL, V127, P319, DOI 10.1083/jcb.127.2.319; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Chang MP, 1999, MOL CELL BIOL, V19, P1056; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; COLLART MA, 2004, PROGR NUCL ACID RES; Cui Y, 2008, MOL GENET GENOMICS, V279, P323, DOI 10.1007/s00438-007-0314-1; Deluen C, 2002, MOL CELL BIOL, V22, P6735, DOI 10.1128/MCB.22.19.6735-6749.2002; Dermody JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003273; Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Duncan K, 2000, CURR BIOL, V10, P687, DOI 10.1016/S0960-9822(00)00527-3; Erkmann JA, 2004, EXP CELL RES, V296, P12, DOI 10.1016/j.yexcr.2004.03.015; FABRE E, 1994, CELL, V78, P275, DOI 10.1016/0092-8674(94)90297-6; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Green DM, 2003, P NATL ACAD SCI USA, V100, P1010, DOI 10.1073/pnas.0336594100; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Gwizdek C, 2006, P NATL ACAD SCI USA, V103, P16376, DOI 10.1073/pnas.0607941103; Heath CV, 1995, J CELL BIOL, V131, P1677, DOI 10.1083/jcb.131.6.1677; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; Henry MF, 1996, MOL CELL BIOL, V16, P3668; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Kessler MM, 1997, GENE DEV, V11, P2545, DOI 10.1101/gad.11.19.2545; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kress TL, 2008, MOL CELL, V32, P727, DOI 10.1016/j.molcel.2008.11.013; Lange A, 2008, J BIOL CHEM, V283, P12926, DOI 10.1074/jbc.M800898200; Laribee RN, 2007, P NATL ACAD SCI USA, V104, P5836, DOI 10.1073/pnas.0607996104; Lau NC, 2009, BIOCHEM J, V422, P443, DOI 10.1042/BJ20090500; Lee MS, 1996, GENE DEV, V10, P1233, DOI 10.1101/gad.10.10.1233; Lemaire M, 2000, J BIOL CHEM, V275, P26925; Lenssen E, 2007, EUKARYOT CELL, V6, P2251, DOI 10.1128/EC.00327-06; Lim RYH, 2008, HISTOCHEM CELL BIOL, V129, P105, DOI 10.1007/s00418-007-0371-x; LOEB JDJ, 1995, P NATL ACAD SCI USA, V92, P7647, DOI 10.1073/pnas.92.17.7647; Marfatia KA, 2003, J BIOL CHEM, V278, P6731, DOI 10.1074/jbc.M207571200; McBride AE, 2000, J BIOL CHEM, V275, P3128, DOI 10.1074/jbc.275.5.3128; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Mulder KW, 2007, GENETICS, V176, P181, DOI 10.1534/genetics.106.060640; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Panasenko O, 2006, J BIOL CHEM, V281, P31389, DOI 10.1074/jbc.M604986200; Pulliam KF, 2009, GENETICS, V181, P105, DOI 10.1534/genetics.108.097303; Robin-Lespinasse Y, 2007, J CELL SCI, V120, P638, DOI 10.1242/jcs.03357; Rodriguez MS, 2004, BIOL CELL, V96, P639, DOI 10.1016/j.biolcel.2004.04.014; Rodriguez MS, 2003, TRAFFIC, V4, P566, DOI 10.1034/j.1600-0854.2003.00115.x; Sambrook J., 2002, MOL CLONING LAB MANU; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Siebel CW, 1996, P NATL ACAD SCI USA, V93, P13641, DOI 10.1073/pnas.93.24.13641; SIKORSKI RS, 1989, GENETICS, V122, P19; Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903; SINGLETON DR, 1995, J CELL SCI, V108, P265; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Strawn LA, 2001, J BIOL CHEM, V276, P6445, DOI 10.1074/jbc.M008311200; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Swanson MJ, 2003, MOL CELL BIOL, V23, P2800, DOI 10.1128/MCB.23.8.2800-2820.2003; Taura T, 1998, P NATL ACAD SCI USA, V95, P7427, DOI 10.1073/pnas.95.13.7427; Terry LJ, 2007, J CELL BIOL, V178, P1121, DOI 10.1083/jcb.200704174; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Vinciguerra P, 2004, CURR OPIN CELL BIOL, V16, P285, DOI 10.1016/j.ceb.2004.03.013; Vinciguerra P, 2005, EMBO J, V24, P813, DOI 10.1038/sj.emboj.7600527; Viswanathan P, 2004, J BIOL CHEM, V279, P23988, DOI 10.1074/jbc.M402803200; WENTE SR, 1993, J CELL BIOL, V123, P275, DOI 10.1083/jcb.123.2.275; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wong DH, 1997, MOL CELL BIOL, V17, P3755, DOI 10.1128/MCB.17.7.3755; Xu C, 2003, RNA, V9, P746, DOI 10.1261/rna.5020803; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416	90	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18302	10.1371/journal.pone.0018302	http://dx.doi.org/10.1371/journal.pone.0018302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464899	gold, Green Published, Green Submitted			2022-12-27	WOS:000289053800039
J	Kuzmova, E; Bartos, L; Kotrba, R; Bubenik, GA				Kuzmova, Erika; Bartos, Ludek; Kotrba, Radim; Bubenik, George A.			Effect of Different Factors on Proliferation of Antler Cells, Cultured In Vitro	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; BONE-MARROW; DEER ANTLERS; IGF-I; GROWTH; TESTOSTERONE; REGENERATION; EXPRESSION; CHONDROCYTES	Antlers as a potential model for bone growth and development have become an object of rising interest. To elucidate processes explaining how antler growth is regulated, in vitro cultures have been established. However, until now, there has been no standard method to cultivate antler cells and in vitro results are often opposite to those reported in vivo. In addition, many factors which are often not taken into account under in vitro conditions may play an important role in the development of antler cells. In this study we investigated the effects of the antler growth stage, the male individuality, passaged versus primary cultures and the effect of foetal calf serum concentrations on proliferative potential of mixed antler cell cultures in vitro, derived from regenerating antlers of red deer males (Cervus elaphus). The proliferation potential of antler cells was measured by incorporation of H-3 thymidine. Our results demonstrate that there is no significant effect of the antler growth stage, whereas male individuality and all other examined factors significantly affected antler cell proliferation. Furthermore, our results suggest that primary cultures may better represent in vivo conditions and processes occurring in regenerating antlers. In conclusion, before all main factors affecting antler cell proliferation in vitro will be satisfactorily investigated, results of in vitro studies focused on hormonal regulation of antler growth should be taken with extreme caution.	[Kuzmova, Erika; Bartos, Ludek; Kotrba, Radim] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Kuzmova, Erika] Charles Univ Prague, Dept Ecol, Prague, Czech Republic; [Bubenik, George A.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Czech Research Institute of Animal Science; Charles University Prague; University of Guelph	Kuzmova, E (corresponding author), Inst Anim Sci, Dept Ethol, Prague, Czech Republic.	kuzmovae@gmail.com	Kužmová, Erika/H-1520-2014	Kuzmova, Erika/0000-0002-0728-9578; Kotrba, Radim/0000-0001-5009-8454	Czech Science Foundation [523/08/0808]; Ministry of Agriculture of the Czech Republic [MZe 00027014020002701404]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This study was supported by the Czech Science Foundation (grant number 523/08/0808) and the Ministry of Agriculture of the Czech Republic (grant number MZe 00027014020002701404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SP, 2002, DEV BIOL, V251, P409, DOI 10.1006/dbio.2002.0816; BARTOS L, 1987, ACTA THERIOL, V32, P403, DOI 10.4098/AT.arch.87-28; Bartos L, 1997, CAN J ZOOL, V75, P1934, DOI 10.1139/z97-823; Bartos L, 2000, J ENDOCRINOL, V164, P87, DOI 10.1677/joe.0.1640087; Bartos L., 2004, ANTLER SCI PRODUCT T, P45; Bartos L, 2009, BONE, V44, P691, DOI 10.1016/j.bone.2008.12.004; Beales MP, 1999, INVEST OPHTH VIS SCI, V40, P1658; Berg DK, 2007, BIOL REPROD, V77, P384, DOI 10.1095/biolreprod.106.058172; Cegielski M, 2006, B VET I PULAWY, V50, P247; Ciapetti G, 2006, BIOMATERIALS, V27, P6150, DOI 10.1016/j.biomaterials.2006.08.025; Ciba P, 2009, ANN ANAT, V191, P94, DOI 10.1016/j.aanat.2008.07.012; Colitti M, 2005, J ANAT, V207, P339, DOI 10.1111/j.1469-7580.2005.00464.x; Faucheux C, 2001, J EXP BIOL, V204, P443; Hiorns LR, 2004, BRIT J CANCER, V90, P476, DOI 10.1038/sj.bjc.6601405; Itaya T, 2009, J PERIODONTAL RES, V44, P425, DOI 10.1111/j.1600-0765.2008.01137.x; Kierdorf U, 2007, J MORPHOL, V268, P726, DOI 10.1002/jmor.10546; Kierdorf U, 2009, SEMIN CELL DEV BIOL, V20, P535, DOI 10.1016/j.semcdb.2008.11.011; KUZMOVA E, 2011, ANIM PROD S IN PRESS; Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118; Li C, 2001, GEN COMP ENDOCR, V124, P75, DOI 10.1006/gcen.2001.7681; Li CY, 2007, CELL TISSUE RES, V328, P65, DOI 10.1007/s00441-006-0333-y; Li CY, 2001, ANAT EMBRYOL, V204, P375, DOI 10.1007/s004290100204; Li CY, 1999, J EXP ZOOL, V284, P82, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;82::AID-JEZ11&gt;3.0.CO;2-K; Lutz MB, 2007, IMMUNOBIOLOGY, V212, P855, DOI 10.1016/j.imbio.2007.09.001; Matich J, 2003, CELL BIOL INT, V27, P625, DOI 10.1016/S1065-6995(03)00118-5; MUIR PD, 1987, NEW ZEAL J AGR RES, V30, P305; Patel M, 2009, ARCH ORAL BIOL, V54, P898, DOI 10.1016/j.archoralbio.2009.06.008; Pochampally RR, 2004, BLOOD, V103, P1647, DOI 10.1182/blood-2003-06-1967; Pradel W, 2008, J PHYSIOL PHARMACOL, V59, P47; Price J, 2005, CURR TOP DEV BIOL, V67, P1, DOI 10.1016/S0070-2153(05)67001-9; Price JS, 2005, J ANAT, V207, P603, DOI 10.1111/j.1469-7580.2005.00478.x; Rhodes NP, 2004, J MATER SCI-MATER M, V15, P397, DOI 10.1023/B:JMSM.0000021109.21807.f0; Riekstina U, 2008, CYTOTECHNOLOGY, V58, P153, DOI 10.1007/s10616-009-9183-2; Rolf HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002064; ROLF HJ, 2006, OSTEOLOGY, V15, P245; SADIGHI M, 1994, J ENDOCRINOL, V143, P461, DOI 10.1677/joe.0.1430461; Sadighi M, 2001, GROWTH HORM IGF RES, V11, P240, DOI 10.1054/ghir.2001.0232; Solchaga LA, 1999, CELL TRANSPLANT, V8, P511, DOI 10.1177/096368979900800506; Thibeault SL, 2002, ANN OTO RHINOL LARYN, V111, P8, DOI 10.1177/000348940211100102; Uchida K, 2007, J ORTHOP SCI, V12, P484, DOI 10.1007/s00776-007-1159-5; Vackova I, 2003, ANIM REPROD SCI, V77, P235, DOI 10.1016/S0378-4320(03)00034-4; Werren C, 2008, PFERDEHEILKUNDE, V24, P193; Yokoyama M, 2008, J BIOSCI BIOENG, V106, P46, DOI 10.1263/jbb.106.46	43	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18053	10.1371/journal.pone.0018053	http://dx.doi.org/10.1371/journal.pone.0018053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464927	Green Submitted, Green Published, gold			2022-12-27	WOS:000289053800017
J	Mays, CE; Yeom, J; Kang, HE; Bian, JF; Khaychuk, V; Kim, Y; Bartz, JC; Telling, GC; Ryou, C				Mays, Charles E.; Yeom, Jihyun; Kang, Hae-Eun; Bian, Jifeng; Khaychuk, Vadim; Kim, Younghwan; Bartz, Jason C.; Telling, Glenn C.; Ryou, Chongsuk			In Vitro Amplification of Misfolded Prion Protein Using Lysate of Cultured Cells	PLOS ONE			English	Article							CYCLIC AMPLIFICATION; PRPSC; CONVERSION; STRAINS; LINE; NEUROBLASTOMA; INFECTIVITY; PROPAGATION; GENERATION; COMPLEXES	Protein misfolding cyclic amplification (PMCA) recapitulates the prion protein (PrP) conversion process under cell-free conditions. PMCA was initially established with brain material and then with further simplified constituents such as partially purified and recombinant PrP. However, availability of brain material from some species or brain material from animals with certain mutations or polymorphisms within the PrP gene is often limited. Moreover, preparation of native PrP from mammalian cells and tissues, as well as recombinant PrP from bacterial cells, involves time-consuming purification steps. To establish a convenient and versatile PMCA procedure unrestricted to the availability of substrate sources, we attempted to conduct PMCA with the lysate of cells that express cellular PrP (PrPC). PrPSc was efficiently amplified with lysate of rabbit kidney epithelial RK13 cells stably transfected with the mouse or Syrian hamster PrP gene. Furthermore, PMCA was also successful with lysate of other established cell lines of neuronal or non-neuronal origins. Together with the data showing that the abundance of PrPC in cell lysate was a critical factor to drive efficient PrPSc amplification, our results demonstrate that cell lysate in which PrPC is present abundantly serves as an excellent substrate source for PMCA.	[Mays, Charles E.; Khaychuk, Vadim; Telling, Glenn C.; Ryou, Chongsuk] Univ Kentucky, Coll Med, Dept Microbiol Mol Genet & Immunol, Lexington, KY USA; [Yeom, Jihyun; Kang, Hae-Eun; Bian, Jifeng; Kim, Younghwan; Telling, Glenn C.; Ryou, Chongsuk] Univ Kentucky, Coll Med, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Bartz, Jason C.] Creighton Univ, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA	University of Kentucky; University of Kentucky; Creighton University	Mays, CE (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.	cryou2@email.uky.edu	Bian, Jifeng/AAE-6262-2019; Telling, Glenn C/G-1217-2019	Bian, Jifeng/0000-0001-6838-9938; Telling, Glenn C/0000-0002-6294-1805; Bartz, Jason/0000-0003-4081-7886	Sanders-Brown Center on Aging; Department of Microbiology, Immunology, and Molecular Genetics, University of Kentucky College of Medicine	Sanders-Brown Center on Aging; Department of Microbiology, Immunology, and Molecular Genetics, University of Kentucky College of Medicine	This work was supported in part by funds from the Sanders-Brown Center on Aging and the Department of Microbiology, Immunology, and Molecular Genetics, University of Kentucky College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abid K, 2010, FEBS LETT, V584, P2409, DOI 10.1016/j.febslet.2010.04.040; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; BALKEMABUSCHMAN.A, 2010, J GEN VIROL, DOI DOI 10.1099/VIR.1090.025387-025380; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; BEALE AJ, 1963, LANCET, V2, P640; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; Birkett CR, 2001, EMBO J, V20, P3351, DOI 10.1093/emboj/20.13.3351; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Geoghegan JC, 2007, J BIOL CHEM, V282, P36341, DOI 10.1074/jbc.M704447200; Geoghegan JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000535; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619; Graham JF, 2010, J BIOL CHEM, V285, P9868, DOI 10.1074/jbc.M109.093484; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; Jones M, 2007, J PATHOL, V213, P21, DOI 10.1002/path.2204; Jones M, 2009, TRANSFUSION, V49, P376, DOI 10.1111/j.1537-2995.2008.01954.x; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Kim JI, 2009, FEBS LETT, V583, P3671, DOI 10.1016/j.febslet.2009.10.049; Kim NH, 2005, FASEB J, V19, P783, DOI 10.1096/fj.04-2117fje; KLEBE RJ, 1969, J CELL BIOL, V43, pA69; Kurt TD, 2007, J VIROL, V81, P9605, DOI 10.1128/JVI.00635-07; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Leblanc P, 2006, EMBO J, V25, P2674, DOI 10.1038/sj.emboj.7601162; Lucassen R, 2003, BIOCHEMISTRY-US, V42, P4127, DOI 10.1021/bi027218d; Mays CE, 2008, BRAIN RES, V1208, P170, DOI 10.1016/j.brainres.2008.02.103; Mays CE, 2010, FASEB J, V24, P5102, DOI 10.1096/fj.10-163600; Mays CE, 2009, BIOCHEM BIOPH RES CO, V388, P306, DOI 10.1016/j.bbrc.2009.07.163; Meyerett C, 2008, VIROLOGY, V382, P267, DOI 10.1016/j.virol.2008.09.023; Murayama Y, 2007, NEUROSCI LETT, V413, P270, DOI 10.1016/j.neulet.2006.11.056; Murayama Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013152; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; Nishina K, 2004, BIOCHEMISTRY-US, V43, P2613, DOI 10.1021/bi035889l; Nishina KA, 2006, BIOCHEMISTRY-US, V45, P14129, DOI 10.1021/bi061526k; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rubenstein R, 2010, J GEN VIROL, V91, P1883, DOI 10.1099/vir.0.020164-0; Ryou Chongsuk, 2008, Int J Med Sci, V5, P347; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Saborio GP, 1999, BIOCHEM BIOPH RES CO, V258, P470, DOI 10.1006/bbrc.1999.0660; Shi S, 2009, VIRUS RES, V141, P26, DOI 10.1016/j.virusres.2008.12.010; Shikiya RA, 2010, J VIROL, V84, P5706, DOI 10.1128/JVI.00243-10; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; Tattum MH, 2010, TRANSFUSION, V50, P996, DOI 10.1111/j.1537-2995.2010.02595.x; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Weber P, 2007, VET MICROBIOL, V123, P346, DOI 10.1016/j.vetmic.2007.04.004; Yanai A, 1999, FEBS LETT, V460, P11, DOI 10.1016/S0014-5793(99)01316-2	61	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18047	10.1371/journal.pone.0018047	http://dx.doi.org/10.1371/journal.pone.0018047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464935	Green Published, Green Submitted, gold			2022-12-27	WOS:000289053800015
J	Catanzaro, D; Labbe, M; Porretta, L				Catanzaro, Daniele; Labbe, Martine; Porretta, Luciano			A Class Representative Model for Pure Parsimony Haplotyping under Uncertain Data	PLOS ONE			English	Article							GENE; SUSCEPTIBILITY; INFERENCE; RISK; POPULATIONS; ASSOCIATION; ALGORITHMS; COMPLEXITY; MUTATION	The Pure Parsimony Haplotyping (PPH) problem is a NP-hard combinatorial optimization problem that consists of finding the minimum number of haplotypes necessary to explain a given set of genotypes. PPH has attracted more and more attention in recent years due to its importance in analysis of many fine-scale genetic data. Its application fields range from mapping complex disease genes to inferring population histories, passing through designing drugs, functional genomics and pharmacogenetics. In this article we investigate, for the first time, a recent version of PPH called the Pure Parsimony Haplotype problem under Uncertain Data (PPH-UD). This version mainly arises when the input genotypes are not accurate, i.e., when some single nucleotide polymorphisms are missing or affected by errors. We propose an exact approach to solution of PPH-UD based on an extended version of Catanzaro et al. [1] class representative model for PPH, currently the state-of-the-art integer programming model for PPH. The model is efficient, accurate, compact, polynomial-sized, easy to implement, solvable with any solver for mixed integer programming, and usable in all those cases for which the parsimony criterion is well suited for haplotype estimation.	[Catanzaro, Daniele; Labbe, Martine; Porretta, Luciano] Univ Libre Bruxelles, Dept Comp Sci, Brussels, Belgium	Universite Libre de Bruxelles	Catanzaro, D (corresponding author), Univ Libre Bruxelles, Dept Comp Sci, CP 210-01, Brussels, Belgium.	dacatanz@ulb.ac.be	Catanzaro, Daniele/L-2486-2017	Catanzaro, Daniele/0000-0001-9427-1562; Labbe, Martine/0000-0001-7471-2308	Belgian National Fund for Scientific Research; Belgian American Education Foundation; Communaute Francaise de Belgique | Actions de Recherche Concertees (ARC); Ministerio de Ciencia e Innovacion [MTM2009-14039-C06]	Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Belgian American Education Foundation; Communaute Francaise de Belgique | Actions de Recherche Concertees (ARC); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	DC acknowledges support from the Belgian National Fund for Scientific Research (F.N.R.S.), of which he is Charge de Recherches and from the Belgian American Education Foundation (B. A. E. F.). DC and ML also acknowledge support from Communaute Francaise de Belgique | Actions de Recherche Concertees (ARC). ML acknowledges support from "Ministerio de Ciencia e Innovacion" through the research project MTM2009-14039-C06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Brown DG, 2006, IEEE ACM T COMPUT BI, V3, P141, DOI 10.1109/TCBB.2006.24; Catanzaro D, 2010, HUMAN IMMUN IN PRESS; Catanzaro D, 2009, INT T OPER RES, V16, P561, DOI 10.1111/j.1475-3995.2009.00716.x; Catanzaro D, 2010, INFORMS J COMPUT, V22, P195, DOI 10.1287/ijoc.1090.0333; Clark VJ, 2001, HUM GENET, V108, P484, DOI 10.1007/s004390100512; Dahlback B, 1997, THROMB HAEMOSTASIS, V78, P483; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; DORMAN JS, 1990, P NATL ACAD SCI USA, V87, P7370, DOI 10.1073/pnas.87.19.7370; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gusfield D, 2003, LECT NOTES COMPUT SC, V2676, P144; Gusfield D, 2001, J COMPUT BIOL, V8, P305, DOI 10.1089/10665270152530863; Halldorsson BV, 2003, LECT NOTE COMPUTER S, V2731; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Lancia G, 2006, OPER RES LETT, V34, P289, DOI 10.1016/j.orl.2005.05.007; Lancia G, 2004, INFORMS J COMPUT, V16, P348, DOI 10.1287/ijoc.1040.0085; LI WH, 1991, GENETICS, V129, P513; Lu X, 2003, GENOME RES, V13, P2112, DOI 10.1101/gr.586803; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Wang LS, 2003, BIOINFORMATICS, V19, P1773, DOI 10.1093/bioinformatics/btg239; Zhang XS, 2006, CURR BIOINFORM, V1, P105, DOI 10.2174/157489306775330570	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17937	10.1371/journal.pone.0017937	http://dx.doi.org/10.1371/journal.pone.0017937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464966	gold, Green Submitted, Green Published			2022-12-27	WOS:000288813900021
J	Holder, BP; Simon, P; Liao, LE; Abed, Y; Bouhy, X; Beauchemin, CAA; Boivin, G				Holder, Benjamin P.; Simon, Philippe; Liao, Laura E.; Abed, Yacine; Bouhy, Xavier; Beauchemin, Catherine A. A.; Boivin, Guy			Assessing the In Vitro Fitness of an Oseltamivir-Resistant Seasonal A/H1N1 Influenza Strain Using a Mathematical Model	PLOS ONE			English	Article							A VIRUS-INFECTION; NEURAMINIDASE INHIBITOR; VIRAL DYNAMICS; H274Y MUTATION; NS1 PROTEIN; H1N1 VIRUS; MDCK CELLS; VIVO; REPLICATION; APOPTOSIS	In 2007, the A/Brisbane/59/2007 (H1N1) seasonal influenza virus strain acquired the oseltamivir-resistance mutation H275Y in its neuraminidase (NA) gene. Although previous studies had demonstrated that this mutation impaired the replication capacity of the influenza virus in vitro and in vivo, the A/Brisbane/59/2007 H275Y oseltamivir-resistant mutant completely out-competed the wild-type (WT) strain and was, in the 2008-2009 influenza season, the primary A/H1N1 circulating strain. Using a combination of plaque and viral yield assays, and a simple mathematical model, approximate values were extracted for two basic viral kinetics parameters of the in vitro infection. In the ST6GalI-MDCK cell line, the latent infection period (i.e., the time for a newly infected cell to start releasing virions) was found to be 1-3 h for the WT strain and more than 7 h for the H275Y mutant. The infecting time (i.e., the time for a single infectious cell to cause the infection of another one) was between 30 and 80 min for the WT, and less than 5 min for the H275Y mutant. Single-cycle viral yield experiments have provided qualitative confirmation of these findings. These results, though preliminary, suggest that the increased fitness success of the A/Brisbane/59/2007 H275Y mutant may be due to increased infectivity compensating for an impaired or delayed viral release, and are consistent with recent evidence for the mechanistic origins of fitness reduction and recovery in NA expression. The method applied here can reconcile seemingly contradictory results from the plaque and yield assays as two complementary views of replication kinetics, with both required to fully capture a strain's fitness.	[Holder, Benjamin P.; Liao, Laura E.; Beauchemin, Catherine A. A.] Ryerson Univ, Dept Phys, Toronto, ON, Canada; [Simon, Philippe; Abed, Yacine; Bouhy, Xavier; Boivin, Guy] CHUQ CHUL, Infect Dis Res Ctr, Quebec City, PQ, Canada; [Simon, Philippe; Abed, Yacine; Bouhy, Xavier; Boivin, Guy] Univ Laval, Quebec City, PQ, Canada	Toronto Metropolitan University; Laval University; Laval University	Holder, BP (corresponding author), Ryerson Univ, Dept Phys, Toronto, ON, Canada.	cbeau@ryerson.ca; Guy.Boivin@crchul.ulaval.ca	Beauchemin, Catherine AA/G-4619-2011; SIMON, Philippe/GXZ-4688-2022	Beauchemin, Catherine AA/0000-0003-0599-0069; Liao, Laura/0000-0001-6069-2633; Boivin, Guy/0000-0003-3027-4662	Canadian Institutes for Health Research [86937]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institutes for Health Research [www.cihr-irsc.gc.ca; funding reference number 86937] (GB and CAAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2004, ANTIVIR THER, V9, P577; Aoki FY, 2007, ANTIVIR THER, V12, P603; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Baz M, 2010, J INFECT DIS, V201, P740, DOI 10.1086/650464; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; BOCHAROV GA, 1994, J THEOR BIOL, V167, P323, DOI 10.1006/jtbi.1994.1074; Carr J, 2000, ANTIVIR RES, V46, pA59; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Collin N, 2009, VACCINE, V27, P5184, DOI 10.1016/j.vaccine.2009.06.034; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Correia V, 2010, ANTIVIR RES, V86, P128, DOI 10.1016/j.antiviral.2010.01.002; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; DULBECCO R, 1952, P NATL ACAD SCI USA, V38, P747, DOI 10.1073/pnas.38.8.747; Efron B., 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Fort J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.178101; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Handel A, 2010, J R SOC INTERFACE, V7, P35, DOI 10.1098/rsif.2009.0067; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Hayden FG, 1996, ANTIVIRAL DRUG RESIS, P59; HERLOCHER M, 2002, ANTIVIR RES, V55, P307; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Herzog P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-138; HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HOLDER BP, 2011, BMC PUBLIC IN PRESS; HOLDER BP, 2011, AUTOIMMUNIT IN PRESS; HUANG AS, 1970, NATURE, V226, P325, DOI 10.1038/226325a0; Hurt AC, 2010, J VIROL, V84, P9427, DOI 10.1128/JVI.00373-10; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; KAVERIN NV, 1995, J VIROL, V69, P2700, DOI 10.1128/JVI.69.4.2700-2703.1995; KOCH AL, 1964, J THEOR BIOL, V6, P413, DOI 10.1016/0022-5193(64)90056-6; Lackenby A, 2008, CURR OPIN INFECT DIS, V21, P626, DOI 10.1097/QCO.0b013e3283199797; Marcus PI, 2009, J VIROL, V83, P8122, DOI 10.1128/JVI.02680-08; Marriott AC, 2010, REV MED VIROL, V20, P51, DOI 10.1002/rmv.641; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; MCCASKILL J, 1991, BIOPHYS J, V61, P1540; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Mohler L, 2005, BIOTECHNOL BIOENG, V90, P46, DOI 10.1002/bit.20363; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Mossong J, 2009, ANTIVIR RES, V84, P91, DOI 10.1016/j.antiviral.2009.08.001; NAGAI T, 1995, ANTIVIR RES, V26, P11, DOI 10.1016/0166-3542(94)00062-D; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Noah JW, 2007, ANTIVIR RES, V73, P50, DOI 10.1016/j.antiviral.2006.07.006; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; Rasband W., 2006, IMAGEJ; Schirmer P, 2009, EXPERT OPIN DRUG SAF, V8, P357, DOI [10.1517/14740330902840519, 10.1517/14740330902840519 ]; Sidorenko Y, 2004, BIOTECHNOL BIOENG, V88, P1, DOI 10.1002/bit.20096; Sieuwerts S, 2008, LETT APPL MICROBIOL, V47, P275, DOI 10.1111/j.1472-765X.2008.02417.x; SIMON P, 2010, J CLIN MICROBIOL; Smith AM, 2010, J MATH BIOL, V60, P711, DOI 10.1007/s00285-009-0281-8; TAKIZAWA T, 1993, J GEN VIROL, V74, P2347, DOI 10.1099/0022-1317-74-11-2347; Triana-Baltzer GB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007838; VANKLEY A, 2003, ADV BIOCH PROTEIN PR; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Wu HL, 2008, B MATH BIOL, V70, P785, DOI 10.1007/s11538-007-9279-9; Yen HL, 2005, ANTIMICROB AGENTS CH, V49, P4075, DOI 10.1128/AAC.49.10.4075-4084.2005; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07; Zaraket H, 2010, J CLIN MICROBIOL, V48, P1085, DOI 10.1128/JCM.01532-09; Zhirnov OP, 2002, J VIROL, V76, P1617, DOI 10.1128/JVI.76.4.1617-1625.2002	69	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e14767	10.1371/journal.pone.0014767	http://dx.doi.org/10.1371/journal.pone.0014767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455300	Green Submitted, Green Published, gold			2022-12-27	WOS:000288811500001
J	Ismail, Y; McCormick, S; Hijri, M				Ismail, Youssef; McCormick, Susan; Hijri, Mohamed			A Fungal Symbiont of Plant-Roots Modulates Mycotoxin Gene Expression in the Pathogen Fusarium sambucinum	PLOS ONE			English	Article							GLOMUS-INTRARADICES; HEAD BLIGHT; TRICHOTHECENE 3-O-ACETYLTRANSFERASE; SECONDARY METABOLISM; SPOROTRICHIOIDES; BIOSYNTHESIS; GRAMINEARUM; VOLATILES; GROWTH; TRI101	Fusarium trichothecenes are fungal toxins that cause disease on infected plants and, more importantly, health problems for humans and animals that consume infected fruits or vegetables. Unfortunately, there are few methods for controlling mycotoxin production by fungal pathogens. In this study, we isolated and characterized sixteen Fusarium strains from naturally infected potato plants in the field. Pathogenicity tests were carried out in the greenhouse to evaluate the virulence of the strains on potato plants as well as their trichothecene production capacity, and the most aggressive strain was selected for further studies. This strain, identified as F. sambucinum, was used to determine if trichothecene gene expression was affected by the symbiotic Arbuscular mycorrhizal fungus (AMF) Glomus irregulare. AMF form symbioses with plant roots, in particular by improving their mineral nutrient uptake and protecting plants against soil-borne pathogens. We found that that G. irregulare significantly inhibits F. sambucinum growth. We also found, using RT-PCR assays to assess the relative expression of trichothecene genes, that in the presence of the AMF G. irregulare, F. sambucinum genes TRI5 and TRI6 were up-regulated, while TRI4, TRI13 and TRI101 were down-regulated. We conclude that AMF can modulate mycotoxin gene expression by a plant fungal pathogen. This previously undescribed effect may be an important mechanism for biological control and has fascinating implications for advancing our knowledge of plant-microbe interactions and controlling plant pathogens.	[Ismail, Youssef; Hijri, Mohamed] Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, Montreal, PQ H3C 3J7, Canada; [Ismail, Youssef] Desert Res Ctr, Dept Plant Protect, Plant Pathol Unit, Cairo, Egypt; [McCormick, Susan] USDA, Bacterial Foodborne Pathogens & Mycol Res Unit, NCAUR, Peoria, IL USA	Universite de Montreal; Egyptian Knowledge Bank (EKB); Desert Research Center (DRC); United States Department of Agriculture (USDA)	Ismail, Y (corresponding author), Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, CP 6128, Montreal, PQ H3C 3J7, Canada.	Mohamed.Hijri@umontreal.ca	Hijri, Mohamed/ABC-5969-2021; Hijri, Mohamed/AAL-5737-2021	Hijri, Mohamed/0000-0001-6112-8372; McCormick, Susan/0000-0002-7824-6372	NSERC; Ministry of Higher Education of Egypt	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ministry of Higher Education of Egypt(Ministry of Higher Education & Scientific Research (MHESR))	This research is supported by an NSERC Discovery grant to MH. YI received a grant and scholarship from the Ministry of Higher Education of Egypt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NJ, 2008, CAN J MICROBIOL, V54, P1023, DOI 10.1139/W08-100; Angelard C, 2010, CURR BIOL, V20, P1216, DOI 10.1016/j.cub.2010.05.031; AYERS G. W., 1956, American Potato Journal, V33, P1, DOI 10.1007/BF02846537; Boon E, 2010, J EVOLUTION BIOL, V23, P1519, DOI 10.1111/j.1420-9101.2010.02019.x; Brown DW, 2002, FUNGAL GENET BIOL, V36, P224, DOI 10.1016/S1087-1845(02)00021-X; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Choudhary DK, 2008, CURR SCI INDIA, V94, P595; Cooney JM, 2001, J AGR FOOD CHEM, V49, P522, DOI 10.1021/jf0006372; Desjardins AE, 1997, MOL PLANT MICROBE IN, V10, P147, DOI 10.1094/MPMI.1997.10.2.147; Edwards SG, 2001, APPL ENVIRON MICROB, V67, P1575, DOI 10.1128/AEM.67.4.1575-1580.2001; Filion M, 1999, NEW PHYTOL, V141, P525, DOI 10.1046/j.1469-8137.1999.00366.x; Garvey GS, 2008, J BIOL CHEM, V283, P1660, DOI 10.1074/jbc.M705752200; Hijri M, 2005, NATURE, V433, P160, DOI 10.1038/nature03069; Hijri M, 2004, FUNGAL GENET BIOL, V41, P253, DOI 10.1016/j.fgb.2003.10.011; Hijri M, 2007, FUNGAL GENET BIOL, V44, P1380, DOI 10.1016/j.fgb.2007.03.004; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Lecomte J, 2011, FEMS MICROBIOL LETT, V317, P43, DOI 10.1111/j.1574-6968.2011.02209.x; Leslie J F, 2006, Mycotoxin Res, V22, P73, DOI 10.1007/BF02956766; Lioussanne L, 2009, MYCORRHIZA, V19, P443, DOI 10.1007/s00572-009-0257-y; McCormick SP, 2010, APPL ENVIRON MICROB, V76, P136, DOI 10.1128/AEM.02017-09; McCormick SP, 1999, APPL ENVIRON MICROB, V65, P5252; MILLER JD, 1986, CAN J BOT, V64, P1, DOI 10.1139/b86-001; Nielsen Carina, 2009, Mycotoxin Res, V25, P77, DOI 10.1007/s12550-009-0011-5; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Piesik D, 2007, J PHYTOPATHOL, V155, P488, DOI 10.1111/j.1439-0434.2007.01266.x; Pirgozliev SR, 2003, EUR J PLANT PATHOL, V109, P731, DOI 10.1023/A:1026034509247; PROCTOR RH, 1995, APPL ENVIRON MICROB, V61, P1923, DOI 10.1128/AEM.61.5.1923-1930.1995; Proctor RH, 2009, MOL MICROBIOL, V74, P1128, DOI 10.1111/j.1365-2958.2009.06927.x; Roze LV, 2007, APPL ENVIRON MICROB, V73, P7268, DOI 10.1128/AEM.00801-07; Seo JA, 2001, FUNGAL GENET BIOL, V34, P155, DOI 10.1006/fgbi.2001.1299; St-Arnaud M., 2007, MYCORRHIZAE CROP PRO, P67; STARNAUD M, 1995, MYCORRHIZA, V5, P431, DOI 10.1007/s005720050093; TURNER WB, 1975, INT J ENVIRON STUD, V8, P159, DOI 10.1080/00207237508709727; Ward TJ, 2002, P NATL ACAD SCI USA, V99, P9278, DOI 10.1073/pnas.142307199	34	30	30	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17990	10.1371/journal.pone.0017990	http://dx.doi.org/10.1371/journal.pone.0017990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455305	Green Published, gold, Green Submitted			2022-12-27	WOS:000288811500017
J	Muttukrishna, S; Swer, M; Suri, S; Jamil, A; Calleja-Agius, J; Gangooly, S; Ludlow, H; Jurkovic, D; Jauniaux, E				Muttukrishna, Shanthi; Swer, Michelle; Suri, Sangeeta; Jamil, Amna; Calleja-Agius, Jean; Gangooly, Subrata; Ludlow, Helen; Jurkovic, Davor; Jauniaux, Eric			Soluble Flt-1 and PlGF: New Markers of Early Pregnancy Loss?	PLOS ONE			English	Article							MATERNO-EMBRYONIC INTERFACE; ENDOTHELIAL GROWTH-FACTOR; OXIDATIVE STRESS; INTERVILLOUS CIRCULATION; THREATENED MISCARRIAGE; BLOOD-FLOW; EXPRESSION; PREECLAMPSIA; CYTOKINES; OXYGEN	Recent data have indicated a relationship between placental oxygen and angiogenic protein levels in the first trimester of normal pregnancies. Our objective was to investigate if maternal serum levels of angiogenic factors Soluble vascular endothelial growth factor (VEGF) receptor 1 (sFlt-1), soluble Endoglin and placental growth factor (PlGF) are altered in women with symptoms of threatened miscarriage (TM) and if they are predictive of a subsequent miscarriage. Blood samples were collected at 6-10 weeks from women presenting with TM (n = 40), from asymptomatic controls (n = 32) and from non-pregnant women in their luteal phase (n = 14). All samples were assayed for serum level of sFLT-1, PlGF, sEndoglin and HSP70 using commercial ELISAs. Samples were analysed retrospectively on the basis of pregnancy outcome. TM group included 21 women with a normal pregnancy outcome and 19 with subsequent complete miscarriage. The latter subgroup had significantly lower mean maternal serum (MS) sFlt-1 (83%, P < 0.001) and PlGF (44%, P < 0.001) compared to those with a normal pregnancy outcome. Asymptomatic control pregnant women had similar MS levels of sFlt-1 and PlGF compared to the TM patients with a normal outcome. The mean MS sFlt-1 (> 10 fold) and MS PlGF (similar to 2 fold) levels were significantly (P < 0.001) higher in control pregnant women compared to the non-pregnant group in the luteal phase of the menstrual cycle. Soluble Endoglin was not altered in the normal pregnant women compared to non pregnant women, although lower in the TM subgroup with a subsequent miscarriage (similar to 25%, P < 0.001) compared to TM with a live birth. There was no significant difference in the mean MS HSP 70 levels between the different groups. This study shows that sFlt1 and PlGF MS levels are increased by several folds in early pregnancy and that MS sFlt-1 and MS PlGF are markedly decreased in threatened miscarriage patients who subsequently have a miscarriage suggesting these proteins are sensitive predictive markers of subsequent pregnancy loss.	[Muttukrishna, Shanthi] Univ Coll Cork, Cork Univ Matern Hosp, Anu Res Ctr, Dept Obstet & Gynaecol, Cork, Ireland; [Swer, Michelle; Suri, Sangeeta; Jamil, Amna; Calleja-Agius, Jean; Gangooly, Subrata; Ludlow, Helen; Jurkovic, Davor; Jauniaux, Eric] UCL, Inst Womens Hlth, London, England	University College Cork; University of London; University College London	Muttukrishna, S (corresponding author), Univ Coll Cork, Cork Univ Matern Hosp, Anu Res Ctr, Dept Obstet & Gynaecol, Cork, Ireland.	S.Muttukrishna@ucc.ie		Calleja Agius, Jean/0000-0001-6369-0297	UCLH charities for early pregnancy research; Anu Research Centre	UCLH charities for early pregnancy research; Anu Research Centre	Funding was provided by UCLH charities for early pregnancy research and Anu Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter N, 2001, CLIN EXP IMMUNOL, V126, P529, DOI 10.1046/j.1365-2249.2001.01663.x; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Choi HK, 2003, MOL REPROD DEV, V66, P24, DOI 10.1002/mrd.10331; DUAN L, 2010, ARCH GYNECOL OBSTET, V404, P1367; Gastrich MD, 2010, J MATERN-FETAL NEO M, V23, P751, DOI 10.3109/14767058.2010.481316; Greenwold N, 2003, FERTIL STERIL, V79, P1373, DOI 10.1016/S0015-0282(03)00364-9; Hasan R, 2009, OBSTET GYNECOL, V114, P860, DOI 10.1097/AOG.0b013e3181b79796; HUSTIN J, 1990, PLACENTA, V11, P477, DOI 10.1016/S0143-4004(05)80193-6; JAUNIAUX E, 1992, HISTOPATHOLOGY, V21, P409, DOI 10.1111/j.1365-2559.1992.tb00424.x; Jauniaux E, 2005, PLACENTA, V26, P114, DOI 10.1016/j.placenta.2004.05.011; Jauniaux E, 2003, PLACENTA, V24, pS86, DOI 10.1053/plac.2002.0932; Jauniaux E, 2003, FERTIL STERIL, V79, P100, DOI 10.1016/S0015-0282(02)04568-5; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; JAUNIAUX E, 1994, HUM REPROD, V9, P2432, DOI 10.1093/oxfordjournals.humrep.a138465; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Jauniaux E, 2010, CURR OPIN OBSTET GYN, V22, P452, DOI 10.1097/GCO.0b013e3283404e44; Jenkins C, 2000, ANTIOXID REDOX SIGN, V2, P623, DOI 10.1089/15230860050192369; Johns J, 2003, OBSTET GYNECOL, V102, P483, DOI 10.1016/S0029-7844(03)00580-5; Johns J, 2006, OBSTET GYNECOL, V107, P845, DOI 10.1097/01.AOG.0000206186.91335.9a; Makhseed M, 2000, HUM REPROD, V15, P2011, DOI 10.1093/humrep/15.9.2011; Molvarec A, 2010, CELL STRESS CHAPERON, V15, P237, DOI 10.1007/s12192-009-0146-5; MUTTUKRISHNA S, 2008, PLOS ONE, V31, P1; Muttukrishna S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002302; Plaisier M, 2007, FERTIL STERIL, V88, P176, DOI 10.1016/j.fertnstert.2006.11.102; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Reddy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004453; Silver RK, 2005, OBSTET GYNECOL, V105, P587, DOI 10.1097/01.AOG.0000152343.08096.c3; Smith GCS, 2007, OBSTET GYNECOL, V109, P1316, DOI 10.1097/01.AOG.0000265804.09161.0d; Venkatesha S, 2006, NAT MED, V12, P862, DOI 10.1038/nm0706-862c; von Wolff M, 2000, MOL HUM REPROD, V6, P627; Vuorela P, 1997, BIOL REPROD, V56, P489, DOI 10.1095/biolreprod56.2.489; Xing YN, 2001, PROTEIN SCI, V10, P226, DOI 10.1110/ps.25901	34	44	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18041	10.1371/journal.pone.0018041	http://dx.doi.org/10.1371/journal.pone.0018041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448460	Green Published, gold			2022-12-27	WOS:000288810500030
J	Pontiroli, A; Travis, ER; Sweeney, FP; Porter, D; Gaze, WH; Mason, S; Hibberd, V; Holden, J; Courtenay, O; Wellington, EMH				Pontiroli, Alessandra; Travis, Emma Rachel; Sweeney, Francis Patrick; Porter, David; Gaze, William Hugo; Mason, Sam; Hibberd, Victoria; Holden, Jennifer; Courtenay, Orin; Wellington, Elizabeth Margaret Helen			Pathogen Quantitation in Complex Matrices: A Multi-Operator Comparison of DNA Extraction Methods with a Novel Assessment of PCR Inhibition	PLOS ONE			English	Article							REAL-TIME PCR; MYCOBACTERIUM-BOVIS; MOLECULAR-DETECTION; POSSUM POPULATIONS; RIBOSOMAL-RNA; RAPID METHOD; SOIL; TUBERCULOSIS; SAMPLES; RECOVERY	Background: Mycobacterium bovis is the aetiological agent of bovine tuberculosis (bTB), an important recrudescent zoonosis, significantly increasing in British herds in recent years. Wildlife reservoirs have been identified for this disease but the mode of transmission to cattle remains unclear. There is evidence that viable M. bovis cells can survive in soil and faeces for over a year. Methodology/Principal Findings: We report a multi-operator blinded trial for a rigorous comparison of five DNA extraction methods from a variety of soil and faecal samples to assess recovery of M. bovis via real-time PCR detection. The methods included four commercial kits: the QIAamp Stool Mini kit with a pre-treatment step, the FastDNA (R) Spin kit, the UltraClean (TM) and PowerSoil (TM) soil kits and a published manual method based on phenol: chloroform purification, termed Griffiths. M. bovis BCG Pasteur spiked samples were extracted by four operators and evaluated using a specific real-time PCR assay. A novel inhibition control assay was used alongside spectrophotometric ratios to monitor the level of inhibitory compounds affecting PCR, DNA yield, and purity. There were statistically significant differences in M. bovis detection between methods of extraction and types of environmental samples; no significant differences were observed between operators. Processing times and costs were also evaluated. To improve M. bovis detection further, the two best performing methods, FastDNA (R) Spin kit and Griffiths, were optimised and the ABI TaqMan environmental PCR Master mix was adopted, leading to improved sensitivities. Conclusions: M. bovis was successfully detected in all environmental samples; DNA extraction using FastDNA (R) Spin kit was the most sensitive method with highest recoveries from all soil types tested. For troublesome faecal samples, we have used and recommend an improved assay based on a reduced volume, resulting in detection limits of 4.25 x 10(5) cells g(-1) using Griffiths and 4.25 x 10(6) cells g(-1) using FastDNA (R) Spin kit.	[Pontiroli, Alessandra; Travis, Emma Rachel; Sweeney, Francis Patrick; Porter, David; Gaze, William Hugo; Mason, Sam; Hibberd, Victoria; Holden, Jennifer; Courtenay, Orin; Wellington, Elizabeth Margaret Helen] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Pontiroli, A (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	A.Pontiroli@warwick.ac.uk	Gaze, William/HCH-3571-2022	Gaze, William/0000-0002-9345-6204; Wellington, ELizabeth/0000-0002-4329-0699	Biotechnology and Biological Sciences Research Council [BBSRCBB/E020925/1]; Department for Environment, Food and Rural Affairs [DEFRA SE3231]; BBSRC [BB/E020925/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E020925/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council BBSRCBB/E020925/1 grant to OC and EMHW, and Department for Environment, Food and Rural Affairs, DEFRA SE3231 grant to EMHW and OC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous WK, 2005, J CLIN MICROBIOL, V43, P2471, DOI 10.1128/JCM.43.5.2471-2473.2005; Artz RRE, 2006, CAN J MICROBIOL, V52, P482, DOI 10.1139/W05-149; Caley P, 1999, NEW ZEAL VET J, V47, P133, DOI 10.1080/00480169.1999.36130; Chen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011963; Coleman JD, 2006, NEW ZEAL VET J, V54, P52, DOI 10.1080/00480169.2006.36612; Courtenay O, 2008, CATTLE PRACT, V16, P122; Courtenay O, 2006, BIOL LETT-UK, V2, P460, DOI 10.1098/rsbl.2006.0468; Dineen SM, 2010, J APPL MICROBIOL, V109, P1886, DOI 10.1111/j.1365-2672.2010.04816.x; Dokoupil S., 1964, Vedecke Prace Vyzkumneho Ustavu Veterinarni CSAZV v Brne, V3, P49; Dong DX, 2006, J MICROBIOL METH, V66, P217, DOI 10.1016/j.mimet.2005.11.010; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Durnez L, 2009, J MICROBIOL METH, V76, P152, DOI 10.1016/j.mimet.2008.10.002; Genov I., 1965, Veterinarmedizin, V2, P97; Ghosh J, 2009, P NATL ACAD SCI USA, V106, P10781, DOI 10.1073/pnas.0904104106; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hartman LJ, 2005, MOL CELL PROBE, V19, P51, DOI 10.1016/j.mcp.2004.07.006; HIROSHI A, 2007, ENVIRON MICROBIOL, V9, P869; HOLLAND BS, 1987, BIOMETRICS, V43, P417, DOI 10.2307/2531823; INOUE M, 2010, EUR J CLIN MICROBIOL, P1; Kaser M, 2009, APPL ENVIRON MICROB, V75, P414, DOI 10.1128/AEM.01358-08; Lantz PG, 1997, J MICROBIOL METH, V28, P159, DOI 10.1016/S0167-7012(97)00979-2; Maddock ECG, 1933, J HYG-CAMBRIDGE, V33, P103, DOI 10.1017/S002217240001843X; Obika S, 1998, TETRAHEDRON LETT, V39, P5401, DOI 10.1016/S0040-4039(98)01084-3; Purdy KJ, 1996, APPL ENVIRON MICROB, V62, P3905, DOI 10.1128/AEM.62.10.3905-3907.1996; Queipo-Ortuno MI, 2008, EUR J CLIN MICROBIOL, V27, P109, DOI 10.1007/s10096-007-0409-y; Reilly LA, 2007, PREV VET MED, V80, P129, DOI 10.1016/j.prevetmed.2007.02.002; Sagova-Mareckova M, 2008, APPL ENVIRON MICROB, V74, P2902, DOI 10.1128/AEM.02161-07; Simeonov A, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf090; Sweeney FP, 2007, APPL ENVIRON MICROB, V73, P7471, DOI 10.1128/AEM.00978-07; Sweeney FP, 2006, LETT APPL MICROBIOL, V43, P364, DOI 10.1111/j.1472-765X.2006.01983.x; TSAI YL, 1991, APPL ENVIRON MICROB, V57, P1070, DOI 10.1128/AEM.57.4.1070-1074.1991; Whitehouse CA, 2007, MOL CELL PROBE, V21, P92, DOI 10.1016/j.mcp.2006.08.003; Williams RS, 1930, J HYG-CAMBRIDGE, V30, P413, DOI 10.1017/S0022172400010561; Young JS, 2005, APPL ENVIRON MICROB, V71, P1946, DOI 10.1128/AEM.71.4.1946-1952.2005	34	50	50	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17916	10.1371/journal.pone.0017916	http://dx.doi.org/10.1371/journal.pone.0017916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448453	Green Published, gold, Green Submitted			2022-12-27	WOS:000288810500021
J	Klompas, M; Khan, Y; Kleinman, K; Evans, RS; Lloyd, JF; Stevenson, K; Samore, M; Platt, R				Klompas, Michael; Khan, Yosef; Kleinman, Kenneth; Evans, R. Scott; Lloyd, James F.; Stevenson, Kurt; Samore, Matthew; Platt, Richard		CDC Prevention Epictr Program	Multicenter Evaluation of a Novel Surveillance Paradigm for Complications of Mechanical Ventilation	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; BRONCHOALVEOLAR LAVAGE; NOSOCOMIAL PNEUMONIA; DIAGNOSTIC-ACCURACY; VALIDATION; INFECTION; CRITERIA; RISK; BENCHMARKING; STANDARD	Background: Ventilator-associated pneumonia (VAP) surveillance is time consuming, subjective, inaccurate, and inconsistently predicts outcomes. Shifting surveillance from pneumonia in particular to complications in general might circumvent the VAP definition's subjectivity and inaccuracy, facilitate electronic assessment, make interfacility comparisons more meaningful, and encourage broader prevention strategies. We therefore evaluated a novel surveillance paradigm for ventilator-associated complications (VAC) defined by sustained increases in patients' ventilator settings after a period of stable or decreasing support. Methods: We assessed 600 mechanically ventilated medical and surgical patients from three hospitals. Each hospital contributed 100 randomly selected patients ventilated 2-7 days and 100 patients ventilated > 7 days. All patients were independently assessed for VAP and for VAC. We compared incidence-density, duration of mechanical ventilation, intensive care and hospital lengths of stay, hospital mortality, and time required for surveillance for VAP and for VAC. A subset of patients with VAP and VAC were independently reviewed by a physician to determine possible etiology. Results: Of 597 evaluable patients, 9.3% had VAP (8.8 per 1,000 ventilator days) and 23% had VAC (21.2 per 1,000 ventilator days). Compared to matched controls, both VAP and VAC prolonged days to extubation (5.8, 95% CI 4.2-8.0 and 6.0, 95% CI 5.1-7.1 respectively), days to intensive care discharge (5.7, 95% CI 4.2-7.7 and 5.0, 95% CI 4.1-5.9), and days to hospital discharge (4.7, 95% CI 2.6-7.5 and 3.0, 95% CI 2.1-4.0). VAC was associated with increased mortality (OR 2.0, 95% CI 1.3-3.2) but VAP was not (OR 1.1, 95% CI 0.5-2.4). VAC assessment was faster (mean 1.8 versus 39 minutes per patient). Both VAP and VAC events were predominantly attributable to pneumonia, pulmonary edema, ARDS, and atelectasis. Conclusions: Screening ventilator settings for VAC captures a similar set of complications to traditional VAP surveillance but is faster, more objective, and a superior predictor of outcomes.	[Klompas, Michael; Kleinman, Kenneth; Platt, Richard] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA; [Klompas, Michael; Kleinman, Kenneth; Platt, Richard] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Klompas, Michael; Platt, Richard] Brigham & Womens Hosp, Infect Control Dept, Boston, MA 02115 USA; [Khan, Yosef; Stevenson, Kurt] Ohio State Univ, Dept Med, Med Ctr, Columbus, OH 43210 USA; [Evans, R. Scott; Samore, Matthew] Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT USA; [Evans, R. Scott; Lloyd, James F.] Intermt Healthcare, Dept Med Informat, Salt Lake City, UT USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Brigham & Women's Hospital; University System of Ohio; Ohio State University; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center	Klompas, M (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA.	mklompas@partners.org	Klompas, Michael/Z-2415-2019	Kleinman, Ken/0000-0002-5600-5834	Centers for Disease Control and Prevention Epicenters Program [1U01CI000344]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000344] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention Epicenters Program(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by the Centers for Disease Control and Prevention Epicenters Program (grant #1U01CI000344). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balthazar AB, 2001, BRAZ J MED BIOL RES, V34, P993, DOI 10.1590/S0100-879X2001000800004; Berriel-Cass D, 2006, JT COMM J QUAL PATIE, V32, P612, DOI 10.1016/S1553-7250(06)32079-X; Beyersmann J, 2006, INFECT CONT HOSP EP, V27, P493, DOI 10.1086/503375; Blamoun J, 2009, AM J INFECT CONTROL, V37, P172, DOI 10.1016/j.ajic.2008.05.010; Bregeon F, 2000, EUR RESPIR J, V16, P969, DOI 10.1183/09031936.00.16596900; Brown H., 1999, APPL MIXED MODELS ME; Burger CD, 2006, MAYO CLIN PROC, V81, P849, DOI 10.4065/81.6.849; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Fabregas N, 1999, THORAX, V54, P867, DOI 10.1136/thx.54.10.867; FAGON JY, 1993, CHEST, V103, P547, DOI 10.1378/chest.103.2.547; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kirtland SH, 1997, CHEST, V112, P445, DOI 10.1378/chest.112.2.445; Klompas M, 2008, CLIN INFECT DIS, V46, P1443, DOI 10.1086/587103; Klompas M, 2008, INFECT CONT HOSP EP, V29, P31, DOI 10.1086/524332; Klompas M, 2007, ANN INTERN MED, V147, P803, DOI 10.7326/0003-4819-147-11-200712040-00013; Klompas M, 2009, CRIT CARE, V13, DOI 10.1186/cc8036; MARQUETTE CH, 1995, AM J RESP CRIT CARE, V151, P1878, DOI 10.1164/ajrccm.151.6.7767535; Marra AR, 2009, AM J INFECT CONTROL, V37, P619, DOI 10.1016/j.ajic.2009.03.009; MEDURI GU, 1994, CHEST, V106, P221, DOI 10.1378/chest.106.1.221; Morris AC, 2009, THORAX, V64, P516, DOI 10.1136/thx.2008.110239; PAPAZIAN L, 1995, AM J RESP CRIT CARE, V152, P1982, DOI 10.1164/ajrccm.152.6.8520766; Petersen IS, 1999, SCAND J INFECT DIS, V31, P299, DOI 10.1080/00365549950163617; Resar R, 2005, JT COMM J QUAL PATIE, V31, P243, DOI 10.1016/S1553-7250(05)31031-2; Rich-Edwards JW, 2005, BMJ-BRIT MED J, V330, P1115, DOI 10.1136/bmj.38434.629630.E0; ROUBY JJ, 1992, AM REV RESPIR DIS, V146, P1059, DOI 10.1164/ajrccm/146.4.1059; ROUBY JJ, 1989, ANESTHESIOLOGY, V71, P679, DOI 10.1097/00000542-198911000-00010; Schurink CAM, 2004, INTENS CARE MED, V30, P217, DOI 10.1007/s00134-003-2018-2; Tejerina E, 2010, J CRIT CARE, V25, P62, DOI 10.1016/j.jcrc.2009.05.008; TORRES A, 1994, AM J RESP CRIT CARE, V149, P324, DOI 10.1164/ajrccm.149.2.8306025; Uckay I, 2008, CLIN INFECT DIS, V46, P557, DOI 10.1086/526534; Youngquist P, 2007, JT COMM J QUAL PATIE, V33, P219, DOI 10.1016/S1553-7250(07)33026-2; Zahar JR, 2009, CRIT CARE MED, V37, P2545, DOI 10.1097/CCM.0b013e3181a38109	33	137	139	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18062	10.1371/journal.pone.0018062	http://dx.doi.org/10.1371/journal.pone.0018062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445364	Green Published, gold			2022-12-27	WOS:000288809100027
J	Mima, A; Abe, H; Nagai, K; Arai, H; Matsubara, T; Araki, M; Torikoshi, K; Tominaga, T; Iehara, N; Fukatsu, A; Kita, T; Doi, T				Mima, Akira; Abe, Hideharu; Nagai, Kojiro; Arai, Hidenori; Matsubara, Takeshi; Araki, Makoto; Torikoshi, Kazuo; Tominaga, Tatsuya; Iehara, Noriyuki; Fukatsu, Atsushi; Kita, Toru; Doi, Toshio			Activation of Src Mediates PDGF-Induced Smad1 Phosphorylation and Contributes to the Progression of Glomerulosclerosis in Glomerulonephritis	PLOS ONE			English	Article							MESANGIAL CELL-PROLIFERATION; GROWTH-FACTOR; C-SRC; SIGNALING PATHWAY; MATRIX EXPANSION; TYROSINE PHOSPHORYLATION; PROTEIN-SYNTHESIS; BETA; KINASE; EXPRESSION	Platelet-derived growth factor (PDGF) plays critical roles in mesangial cell (MC) proliferation in mesangial proliferative glomerulonephritis. We showed previously that Smad1 contributes to PDGF-dependent proliferation of MCs, but the mechanism by which Smad1 is activated by PDGF is not precisely known. Here we examined the role of c-Src tyrosine kinase in the proliferative change of MCs. Experimental mesangial proliferative glomerulonephritis (Thy1 GN) was induced by a single intravenous injection of anti-rat Thy-1.1 monoclonal antibody. In Thy1 GN, MC proliferation and type IV collagen (Col4) expression peaked on day 6. Immunohistochemical staining for the expression of phospho-Src (pSrc), phospho-Smad1 (pSmad1), Col4, and smooth muscle alpha-actin (SMA) revealed that the activation of c-Src and Smad1 signals in glomeruli peaked on day 6, consistent with the peak of mesangial proliferation. When treated with PP2, a Src inhibitor, both mesangial proliferation and sclerosis were significantly reduced. PP2 administration also significantly reduced pSmad1, Col4, and SMA expression. PDGF induced Col4 synthesis in association with increased expression of pSrc and pSmad1 in cultured MCs. In addition, PP2 reduced Col4 synthesis along with decreased pSrc and pSmad1 protein expression in vitro. Moreover, the addition of siRNA against c-Src significantly reduced the phosphorylation of Smad1 and the overproduction of Col4. These results provide new evidence that the activation of Src/Smad1 signaling pathway plays a key role in the development of glomerulosclerosis in experimental glomerulonephritis.	[Mima, Akira; Abe, Hideharu; Nagai, Kojiro; Tominaga, Tatsuya; Doi, Toshio] Univ Tokushima, Dept Nephrol, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan; [Arai, Hidenori] Kyoto Univ, Grad Sch Med, Dept Geriatr Med, Kyoto, Japan; [Mima, Akira; Matsubara, Takeshi; Araki, Makoto; Torikoshi, Kazuo; Iehara, Noriyuki; Fukatsu, Atsushi] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan; [Kita, Toru] Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Kyoto, Japan	Tokushima University; Kyoto University; Kyoto University; Kyoto University	Mima, A (corresponding author), Univ Tokushima, Dept Nephrol, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan.	abeabe@clin.med.tokushima-u.ac.jp	Arai, Hidenori/P-9816-2017; FUKATSU, ATSUSHI/R-7941-2019	Arai, Hidenori/0000-0002-9000-6849; Araki, Makoto/0000-0003-0854-4064	Japan Society for the Promotion [21591033, 19590973]	Japan Society for the Promotion(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research is supported by Grants-in-Aid for Scientific Research of the Japan Society for the Promotion (no. 21591033 and 19590973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2004, J BIOL CHEM, V279, P14201, DOI 10.1074/jbc.M310427200; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Catapano F, 2008, AM J KIDNEY DIS, V52, P475, DOI 10.1053/j.ajkd.2008.03.008; DOI T, 1992, P NATL ACAD SCI USA, V89, P2873, DOI 10.1073/pnas.89.7.2873; FLOEGE J, 1993, J CLIN INVEST, V92, P2952, DOI 10.1172/JCI116918; FLOEGE J, 1995, MINER ELECTROL METAB, V21, P271; Floege J, 2008, J AM SOC NEPHROL, V19, P12, DOI 10.1681/ASN.2007050532; FOGO A, 1989, SEMIN NEPHROL, V9, P329; GOLDEN A, 1986, P NATL ACAD SCI USA, V83, P852, DOI 10.1073/pnas.83.4.852; Huang WC, 2003, J IMMUNOL, V170, P4767, DOI 10.4049/jimmunol.170.9.4767; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; JOHNSON RJ, 1993, J AM SOC NEPHROL, V4, P119; JOHNSON RJ, 1992, J EXP MED, V175, P1413, DOI 10.1084/jem.175.5.1413; KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lindahl P, 1998, DEVELOPMENT, V125, P3313; LOWE C, 1993, P NATL ACAD SCI USA, V90, P4485, DOI 10.1073/pnas.90.10.4485; MACKAY K, 1988, KIDNEY INT, V33, P677, DOI 10.1038/ki.1988.53; Makibayashi K, 2001, AM J PATHOL, V158, P1733, DOI 10.1016/S0002-9440(10)64129-6; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; Matsubara T, 2006, LAB INVEST, V86, P357, DOI 10.1038/labinvest.3700400; Mima A, 2008, DIABETES, V57, P1712, DOI 10.2337/db07-1726; Mima A, 2006, LAB INVEST, V86, P927, DOI 10.1038/labinvest.3700445; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Pan DB, 2007, BIOCHEM CELL BIOL, V85, P606, DOI 10.1139/O07-064; Peters H, 1998, KIDNEY INT, V54, P1570, DOI 10.1046/j.1523-1755.1998.00164.x; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Severgnini M, 2004, AM J PHYSIOL-LUNG C, V286, pL1282, DOI 10.1152/ajplung.00349.2003; Severgnini M, 2005, AM J RESP CRIT CARE, V171, P858, DOI 10.1164/rccm.200407-981OC; SILVER BJ, 1989, P NATL ACAD SCI USA, V86, P1056, DOI 10.1073/pnas.86.3.1056; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Spreafico A, 2008, FASEB J, V22, P1560, DOI 10.1096/fj.07-9873com; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; STRIKER LJ, 1989, SEMIN NEPHROL, V9, P318; Takahashi T, 2005, J BIOL CHEM, V280, P7100, DOI 10.1074/jbc.M411064200; Takikita-Suzuki M, 2003, AM J PATHOL, V163, P277, DOI 10.1016/S0002-9440(10)63651-6; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; THROCKMORTON DC, 1995, KIDNEY INT, V48, P111, DOI 10.1038/ki.1995.274; Trevino JG, 2006, AM J PATHOL, V168, P962, DOI 10.2353/ajpath.2006.050570; Waters CM, 2005, CELL SIGNAL, V17, P263, DOI 10.1016/j.cellsig.2004.07.011; Yamamoto Y, 2001, J CLIN INVEST, V108, P261, DOI 10.1172/JCI11771	46	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17929	10.1371/journal.pone.0017929	http://dx.doi.org/10.1371/journal.pone.0017929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445358	Green Published, Green Submitted, gold			2022-12-27	WOS:000288809100017
J	Cattepoel, S; Hanenberg, M; Kulic, L; Nitsch, RM				Cattepoel, Susann; Hanenberg, Michael; Kulic, Luka; Nitsch, Roger M.			Chronic Intranasal Treatment with an Anti-A beta(30-42) scFv Antibody Ameliorates Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CHAIN VARIABLE FRAGMENTS; BLOOD-BRAIN-BARRIER; A-BETA BURDEN; COGNITIVE DEFICITS; PRECURSOR-PROTEIN; IN-VIVO; MEMORY DEFICITS; INTERFERON-BETA; PEPTIDE	Amyloid-beta peptide (A beta)-directed active and passive immunization therapeutic strategies reduce brain levels of A beta, decrease the severity of beta-amyloid plaque pathology and reverse cognitive deficits in mouse models of Alzheimer's disease (AD). As an alternative approach to passive immunization with full IgG molecules, single-chain variable fragment (scFv) antibodies can modulate or neutralize A beta-related neurotoxicity and inhibit its aggregation in vitro. In this study, we characterized a scFv derived from a full IgG antibody raised against the C-terminus of A beta, and studied its passage into the brains of APP transgenic mice, as well as its potential to reduce A beta-related pathology. We found that the scFv entered the brain after intranasal application, and that it bound to beta-amyloid plaques in the cortex and hippocampus of APP transgenic mice. Moreover, the scFv inhibited A beta fibril formation and A beta-mediated neurotoxicity in vitro. In a preventative therapeutic approach chronic intranasal treatment with scFv reduced congophilic amyloid angiopathy (CAA) and beta-amyloid plaque numbers in the cortex of APPswe/PS1dE9 mice. This reduction of CAA and plaque pathology was associated with a redistribution of brain A beta from the insoluble fraction to the soluble peptide pool. Due to their lack of the effector domain of full IgG, scFv may represent an alternative tool for the treatment of A beta-related pathology without triggering Fc-mediated effector functions. Additionally, our observations support the possibility that A beta-directed immunotherapy can reduce A beta deposition in brain vessels in transgenic mice.	[Cattepoel, Susann; Hanenberg, Michael; Kulic, Luka; Nitsch, Roger M.] Univ Zurich, Div Psychiat Res, Zurich, Switzerland	University of Zurich	Cattepoel, S (corresponding author), Univ Zurich, Div Psychiat Res, Zurich, Switzerland.	nitsch@bli.uzh.ch			Swiss National Science Foundation [3200B-112626/1]; Swiss Commission of Technology and Innovation; Swiss National Center for Competence in Research (NCCR)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Commission of Technology and Innovation; Swiss National Center for Competence in Research (NCCR)(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science Foundation Grant 3200B-112626/1, the Swiss Commission of Technology and Innovation and the Swiss National Center for Competence in Research (NCCR) on "Neural Plasticity and Repair". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacskai BJ, 2002, J NEUROSCI, V22, P7873; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bayer AJ, 2005, NEUROLOGY, V64, P94, DOI 10.1212/01.WNL.0000148604.77591.67; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; BRODY DL, ANN REV NEUROSCI, V31, P175; Burmester J, 2001, J MOL BIOL, V309, P671, DOI 10.1006/jmbi.2001.4663; Buttini M, 2005, J NEUROSCI, V25, P9096, DOI 10.1523/JNEUROSCI.1697-05.2005; Chen Xue-Qing, 1998, J Alzheimers Dis, V1, P35; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; Deadwyler SA, 2007, J NEUROSCI, V27, P14239, DOI 10.1523/JNEUROSCI.3878-07.2007; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; der Maur AA, 2001, FEBS LETT, V508, P407, DOI 10.1016/S0014-5793(01)03101-5; Dhuria SV, 2009, J PHARM SCI-US, V98, P2501, DOI 10.1002/jps.21604; Dickstein DL, 2006, FASEB J, V20, P426, DOI 10.1096/fj.05-3956com; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Frenkel D, 2000, J NEUROIMMUNOL, V106, P23, DOI 10.1016/S0165-5728(99)00232-5; Fu HJ, 2010, CNS NEUROL DISORD-DR, V9, P197, DOI 10.2174/187152710791012017; Fukuchi KI, 2006, BIOCHEM BIOPH RES CO, V344, P79, DOI 10.1016/j.bbrc.2006.03.145; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Gaugler MNM, 2005, FEBS LETT, V579, P753, DOI 10.1016/j.febslet.2005.01.002; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Graff CL, 2005, J PHARM SCI-US, V94, P1187, DOI 10.1002/jps.20318; Graff CL, 2005, PHARM RES-DORDR, V22, P235, DOI 10.1007/s11095-004-1191-5; HANSON LR, 2004, DRUG DELIVERY TECHNO, V4, P66; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Hock C, 2002, NAT MED, V8, P1270, DOI 10.1038/nm783; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Illum L, 2004, J PHARM PHARMACOL, V56, P3, DOI 10.1211/0022357022539; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Knobloch M, 2007, NEUROBIOL AGING, V28, P1297, DOI 10.1016/j.neurobiolaging.2006.06.019; Kumar-Singh S, 2008, GENES BRAIN BEHAV, V7, P67, DOI 10.1111/j.1601-183X.2007.00380.x; Lawrence D, 2002, LANCET, V359, P1674, DOI 10.1016/S0140-6736(02)08601-4; Lemere CA, 2001, DNA CELL BIOL, V20, P705, DOI 10.1089/10445490152717569; Levites Y, 2006, FASEB J, V20, P2576, DOI 10.1096/fj.06-6463fje; Levites Y, 2006, J NEUROSCI, V26, P11923, DOI 10.1523/JNEUROSCI.2795-06.2006; Liu RT, 2004, BIOCHEMISTRY-US, V43, P6959, DOI 10.1021/bi049933o; Maier M, 2006, J NEUROSCI, V26, P4717, DOI 10.1523/JNEUROSCI.0381-06.2006; Maur AAD, 2002, J BIOL CHEM, V277, P45075, DOI 10.1074/jbc.M205264200; Mohajeri MH, 2004, NEURODEGENER DIS, V1, P160, DOI 10.1159/000080981; Mohajeri MH, 2002, J BIOL CHEM, V277, P33012, DOI 10.1074/jbc.M203193200; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nitsch RM, 2008, NEUROTHERAPEUTICS, V5, P415, DOI 10.1016/j.nurt.2008.05.013; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Prada CM, 2007, J NEUROSCI, V27, P1973, DOI 10.1523/JNEUROSCI.5426-06.2007; Racke MM, 2005, J NEUROSCI, V25, P629, DOI 10.1523/JNEUROSCI.4337-04.2005; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Ross TM, 2004, J NEUROIMMUNOL, V151, P66, DOI 10.1016/j.jneuroim.2004.02.011; ROZGA M, BIOCH BIOPHYS RES CO, V364, P714; SAKANE T, 1995, J PHARM PHARMACOL, V47, P379, DOI 10.1111/j.2042-7158.1995.tb05814.x; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schroeter S, 2008, J NEUROSCI, V28, P6787, DOI 10.1523/JNEUROSCI.2377-07.2008; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Solorzano-Vargas RS, 2008, MOL IMMUNOL, V45, P881, DOI 10.1016/j.molimm.2007.08.008; Thorne RG, 2008, NEUROSCIENCE, V152, P785, DOI 10.1016/j.neuroscience.2008.01.013; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Town T, 2005, NEUROMOL MED, V7, P255, DOI 10.1385/NMM:7:3:255; Town T, 2009, CNS NEUROL DISORD-DR, V8, P114, DOI 10.2174/187152709787847306; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N; Wilcock DM, 2004, J NEUROSCI, V24, P6144, DOI 10.1523/JNEUROSCI.1090-04.2004; Wilcock DM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-24; Wilcock DM, 2006, J NEUROSCI, V26, P5340, DOI 10.1523/JNEUROSCI.0695-06.2006; Yue S, 2008, LIFE SCI, V82, P1249, DOI 10.1016/j.lfs.2008.04.009; Zameer A, 2006, BIOCHEMISTRY-US, V45, P11532, DOI 10.1021/bi060601o	69	57	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18296	10.1371/journal.pone.0018296	http://dx.doi.org/10.1371/journal.pone.0018296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483675	gold, Green Submitted, Green Published			2022-12-27	WOS:000289191300017
J	Blakely, BD; Bye, CR; Fernando, CV; Horne, MK; Macheda, ML; Stacker, SA; Arenas, E; Parish, CL				Blakely, Brette D.; Bye, Christopher R.; Fernando, Chathurini V.; Horne, Malcolm K.; Macheda, Maria L.; Stacker, Steven A.; Arenas, Ernest; Parish, Clare L.			Wnt5a Regulates Midbrain Dopaminergic Axon Growth and Guidance	PLOS ONE			English	Article							UNBIASED STEREOLOGICAL ESTIMATION; NEURAL STEM-CELLS; INT-1 PROTOONCOGENE; NEURITE OUTGROWTH; BETA-CATENIN; TOTAL NUMBER; NEURONS; RECEPTOR; POLARITY; MICE	During development, precise temporal and spatial gradients are responsible for guiding axons to their appropriate targets. Within the developing ventral midbrain (VM) the cues that guide dopaminergic (DA) axons to their forebrain targets remain to be fully elucidated. Wnts are morphogens that have been identified as axon guidance molecules. Several Wnts are expressed in the VM where they regulate the birth of DA neurons. Here, we describe that a precise temporo-spatial expression of Wnt5a accompanies the development of nigrostriatal projections by VM DA neurons. In mice at E11.5, Wnt5a is expressed in the VM where it was found to promote DA neurite and axonal growth in VM primary cultures. By E14.5, when DA axons are approaching their striatal target, Wnt5a causes DA neurite retraction in primary cultures. Co-culture of VM explants with Wnt5a-overexpressing cell aggregates revealed that Wnt5a is capable of repelling DA neurites. Antagonism experiments revealed that the effects of Wnt5a are mediated by the Frizzled receptors and by the small GTPase, Rac1 (a component of the non-canonical Wnt planar cell polarity pathway). Moreover, the effects were specific as they could be blocked by Wnt5a antibody, sFRPs and RYK-Fc. The importance of Wnt5a in DA axon morphogenesis was further verified in Wnt5a(-/-) mice, where fasciculation of the medial forebrain bundle (MFB) as well as the density of DA neurites in the MFB and striatal terminals were disrupted. Thus, our results identify a novel role of Wnt5a in DA axon growth and guidance.	[Blakely, Brette D.; Bye, Christopher R.; Fernando, Chathurini V.; Horne, Malcolm K.; Parish, Clare L.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia; [Blakely, Brette D.; Horne, Malcolm K.; Parish, Clare L.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia; [Horne, Malcolm K.] St Vincents Hosp, Fitzroy, Vic 3065, Australia; [Macheda, Maria L.; Stacker, Steven A.] Royal Melbourne Hosp, Ludwig Inst Canc Res, Parkville, Vic 3050, Australia; [Arenas, Ernest] Karolinska Inst, Mol Neurobiol Lab, Dept Biochem & Biophys, Stockholm, Sweden	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; Ludwig Institute for Cancer Research; Royal Melbourne Hospital; Karolinska Institutet	Blakely, BD (corresponding author), Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia.	clare.parish@florey.edu.au	Horne, Malcolm/AAL-5214-2020; Bye, Chris R/D-6406-2011; Parish, Clare/A-3380-2014; Arenas, Ernest/AAO-5231-2020	Horne, Malcolm/0000-0001-9427-2100; Bye, Chris R/0000-0003-1714-5954; Arenas, Ernest/0000-0003-0197-6577; Stacker, Steven/0000-0003-4096-9273; Parish, Clare/0000-0001-8212-9884; Blakely, Brette/0000-0002-8420-7396; Macheda, Maria/0000-0002-8460-2046	Australian National Health and Medical Research Council (NHMRC) [566740]; Bethlehem Griffith Research Foundation (BGRF), Australia; Human Frontiers Science Program; NHMRC; Australian Postgraduate Award; Swedish Research Council [VR2008:2811]; Norwegian Research Council; Karolinska Institutet	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Bethlehem Griffith Research Foundation (BGRF), Australia; Human Frontiers Science Program(Human Frontier Science Program); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Swedish Research Council(Swedish Research CouncilEuropean Commission); Norwegian Research Council(Research Council of NorwayEuropean Commission); Karolinska Institutet(Karolinska Institutet)	This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC #566740) and the Bethlehem Griffith Research Foundation (BGRF), Australia. C. L. P. was supported by a Human Frontiers Science Program Long-Term Training Fellowship, NHMRC CJ Martin Fellowship, and NHMRC Career Development Award. B. D. B. is supported by an Australian Postgraduate Award. S. A. S. is supported by an NHMRC Senior Research Fellowship. The work of E. A. was supported by grants from the Swedish Research Council (VR2008:2811 and DBRM), Norwegian Research Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberi L, 2004, DEVELOPMENT, V131, P3229, DOI 10.1242/dev.01128; Andersson ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003517; BJORKLUND A, 1984, DOPAMINE CONTAINING, P55; Bodmer D, 2009, J NEUROSCI, V29, P7569, DOI 10.1523/JNEUROSCI.1445-09.2009; Bovolenta P, 2006, DEVELOPMENT, V133, P4399, DOI 10.1242/dev.02592; BRAENDGAARD H, 1990, J MICROSC-OXFORD, V157, P285, DOI 10.1111/j.1365-2818.1990.tb02967.x; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; Castelo-Branco GA, 2006, MOL CELL NEUROSCI, V31, P251, DOI 10.1016/j.mcn.2005.09.014; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Castelo-Branco G, 2006, NEURODEGENER DIS, V3, P5, DOI 10.1159/000092086; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; Endo Y, 2007, CANCER SCI, V98, P1311, DOI 10.1111/j.1349-7006.2007.00536.x; FALLON JH, 1978, J COMP NEUROL, V180, P545, DOI 10.1002/cne.901800310; Fenstermaker AG, 2010, J NEUROSCI, V30, P16053, DOI 10.1523/JNEUROSCI.4508-10.2010; Fuentes EO, 2008, J BRACHIAL PLEX PERI, V3, DOI 10.1186/1749-7221-3-19; Garcia C, 2008, J CLIN INVEST, V118, P2291, DOI [10.1172/JC134508, 10.1172/JCI34508]; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hammond R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007007; HERNANDEZ CMA, 2007, REV ALERG MEX, V54, P162; Hernandez-Montiel HL, 2008, J COMP NEUROL, V506, P387, DOI 10.1002/cne.21503; Ille F, 2005, CELL MOL LIFE SCI, V62, P1100, DOI 10.1007/s00018-005-4552-2; Kawano H, 2003, EXP NEUROL, V182, P103, DOI 10.1016/S0014-4886(03)00030-X; Keeble TR, 2006, INT J BIOCHEM CELL B, V38, P2011, DOI 10.1016/j.biocel.2006.07.005; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kolk SM, 2009, J NEUROSCI, V29, P12542, DOI 10.1523/JNEUROSCI.2521-09.2009; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Lin L, 2005, MOL CELL NEUROSCI, V28, P547, DOI 10.1016/j.mcn.2004.11.009; Lin L, 2006, STEM CELLS, V24, P2504, DOI 10.1634/stemcells.2006-0119; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Nakamura S, 2000, J NEUROSCI, V20, P4112; Parish CL, 2001, J NEUROSCI, V21, P5147, DOI 10.1523/JNEUROSCI.21-14-05147.2001; Parish CL, 2008, J CLIN INVEST, V118, P149, DOI 10.1172/JCI32273; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032; Richards AB, 2007, EUR J NEUROSCI, V25, P2619, DOI 10.1111/j.1460-9568.2007.05523.x; SANCHEZCAMACHO C, 2009, BIOESSAYS; Saueressig H, 1999, DEVELOPMENT, V126, P4201; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Schulte G, 2005, J NEUROCHEM, V92, P1550, DOI 10.1111/j.1471-4159.2004.03022.x; Sieber BA, 2004, MOL CELL NEUROSCI, V26, P418, DOI 10.1016/j.mcn.2004.03.009; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; STUEBNER S, 2009, DEV DYN; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Turner BJ, 2009, NEUROBIOL DIS, V34, P511, DOI 10.1016/j.nbd.2009.03.005; Van den Heuvel DMA, 2008, PROG NEUROBIOL, V85, P75, DOI 10.1016/j.pneurobio.2008.01.003; Wagner J, 1999, NAT BIOTECHNOL, V17, P653, DOI 10.1038/10862; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang YS, 2006, J NEUROSCI, V26, P355, DOI 10.1523/JNEUROSCI.3221-05.2006; Wang YS, 2002, J NEUROSCI, V22, P8563; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yue Y, 1999, J NEUROSCI, V19, P2090; Zou YM, 2007, CURR OPIN NEUROBIOL, V17, P22, DOI 10.1016/j.conb.2007.01.006; Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015	66	75	78	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18373	10.1371/journal.pone.0018373	http://dx.doi.org/10.1371/journal.pone.0018373			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483795	Green Published, gold			2022-12-27	WOS:000289057200066
J	Watkins, JD; Siddappa, NB; Lakhashe, SK; Humbert, M; Sholukh, A; Hemashettar, G; Wong, YL; Yoon, JK; Wang, W; Novembre, FJ; Villinger, F; Ibegbu, C; Patel, K; Corti, D; Agatic, G; Vanzetta, F; Bianchi, S; Heeney, JL; Sallusto, F; Lanzavecchia, A; Ruprecht, RM				Watkins, Jennifer D.; Siddappa, Nagadenahalli B.; Lakhashe, Samir K.; Humbert, Michael; Sholukh, Anton; Hemashettar, Girish; Wong, Yin Ling; Yoon, John K.; Wang, Wendy; Novembre, Francis J.; Villinger, Francois; Ibegbu, Chris; Patel, Kalpana; Corti, Davide; Agatic, Gloria; Vanzetta, Fabrizia; Bianchi, Siro; Heeney, Jonathan L.; Sallusto, Federica; Lanzavecchia, Antonio; Ruprecht, Ruth M.			An Anti-HIV-1 V3 Loop Antibody Fully Protects Cross-Clade and Elicits T-Cell Immunity in Macaques Mucosally Challenged with an R5 Clade C SHIV	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; CHIMERIC VIRUS; HIV-1 VACCINE; TRANSMISSION; IMMUNIZATION; INFECTION; GP120; TRIAL	Neutralizing antibodies have been shown to protect macaques against SHIV challenge. However, genetically diverse HIV-1 clades have evolved, and a key question left unanswered is whether neutralizing antibodies can confer cross-clade protection in vivo. The novel human monoclonal antibody HGN194 was isolated from an individual infected with an HIV-1 clade AG recombinant circulating recombinant form (CRF). HGN194 targets an epitope in the third hypervariable loop (V3) of HIV-1 gp120 and neutralizes a range of relatively neutralization-sensitive and resistant viruses. We evaluated the potential of HGN194 to protect infant rhesus monkeys against a SHIV encoding a primary CCR5-tropic HIV-1 clade C envelope. After high-dose mucosal challenge, all untreated controls became highly viremic while all HGN194-treated animals (50 mg/kg) were completely protected. When HGN194 was given at 1 mg/kg, one out of two monkeys remained aviremic, whereas the other had delayed, lower peak viremia. Interestingly, all protected monkeys given high-dose HGN194 developed Gagspecific proliferative responses of both CD4+ and CD8+ T cells. To test whether generation of the latter involved cryptic infection, we ablated CD8+ cells after HGN194 clearance. No viremia was detected in any protected monkeys, thus ruling out virus reservoirs. Thus, induction of CD8 T-cell immunity may have resulted from transient `` Hit and Run'' infection or cross priming via Ag-Ab-mediated cross-presentation. Together, our data identified the HGN194 epitope as protective and provide proof-of-concept that this anti-V3 loop mAb can prevent infection with sterilizing immunity after challenge with virus of a different clade, implying that V3 is a potential vaccine target.	[Watkins, Jennifer D.; Siddappa, Nagadenahalli B.; Lakhashe, Samir K.; Humbert, Michael; Sholukh, Anton; Hemashettar, Girish; Wong, Yin Ling; Yoon, John K.; Wang, Wendy; Ruprecht, Ruth M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Watkins, Jennifer D.; Siddappa, Nagadenahalli B.; Lakhashe, Samir K.; Humbert, Michael; Sholukh, Anton; Ruprecht, Ruth M.] Harvard Univ, Sch Med, Boston, MA USA; [Novembre, Francis J.; Villinger, Francois; Ibegbu, Chris; Patel, Kalpana] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Novembre, Francis J.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Villinger, Francois] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Corti, Davide; Agatic, Gloria; Vanzetta, Fabrizia; Bianchi, Siro] Humabs SAGL, Bellinzona, Switzerland; [Heeney, Jonathan L.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Sallusto, Federica; Lanzavecchia, Antonio] Inst Res Biomed, Bellinzona, Switzerland	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Emory University; Emory University; Emory University; University of Cambridge; Universita della Svizzera Italiana	Watkins, JD (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	ruth_ruprecht@dfci.harvard.edu	Sholukh, Anton/AAU-2338-2021; Lakhashe, Samir/F-1150-2014	Sholukh, Anton/0000-0003-0498-9162; Bianchi, Siro/0000-0002-5100-8905; Byrareddy, Siddappa/0000-0002-7423-1763; Heeney, Jonathan/0000-0003-2702-1621; Zatta, Fabrizia/0000-0003-4945-8058	National Institutes of Health [R37 AI34266, P01 AI48240]; Bill and Melinda Gates Foundation [38637]; Center For AIDS Research Immunology Core [P30 A01050409];  [RR-00165]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034266, P01AI048240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Center For AIDS Research Immunology Core; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grant R37 AI34266 and P01 AI48240 to RMR, by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) UCL-VDC (Weiss) grant 38637, and by Center For AIDS Research Immunology Core P30 A01050409. Base grant RR-00165 provided support to the Yerkes National Primate Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Boyer JD, 2007, P NATL ACAD SCI USA, V104, P18648, DOI 10.1073/pnas.0709198104; Brady LJ, 2005, INFECT IMMUN, V73, P671, DOI 10.1128/IAI.73.2.671-678.2005; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Ferrantelli F, 2004, J INFECT DIS, V189, P2167, DOI 10.1086/420833; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hofmann-Lehmann R, 2000, AIDS RES HUM RETROV, V16, P1247, DOI 10.1089/08892220050117014; Humbert M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003937; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Kitabwalla M, 2003, AIDS RES HUM RETROV, V19, P125, DOI 10.1089/088922203762688630; Kramer VG, 2007, CURR HIV RES, V5, P642, DOI 10.2174/157016207782418506; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Siddappa NB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011689; Song RJ, 2006, J VIROL, V80, P8729, DOI 10.1128/JVI.00558-06; Tan RCH, 1999, J MED PRIMATOL, V28, P164, DOI 10.1111/j.1600-0684.1999.tb00265.x; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	26	67	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18207	10.1371/journal.pone.0018207	http://dx.doi.org/10.1371/journal.pone.0018207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483815	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200043
J	Sankey, C; Henry, S; Andre, N; Richard-Yris, MA; Hausberger, M				Sankey, Carol; Henry, Severine; Andre, Nicolas; Richard-Yris, Marie-Annick; Hausberger, Martine			Do Horses Have a Concept of Person?	PLOS ONE			English	Article							DOGS CANIS-FAMILIARIS; BEHAVIOR; HEARING; FACE; ME	Background: Animals' ability for cross-modal recognition has recently received much interest. Captive or domestic animals seem able to perceive cues of human attention and appear to have a multisensory perception of humans. Methodology/Principal Findings: Here, we used a task where horses have to remain immobile under a vocal order to test whether they are sensitive to the attentional state of the experimenter, but also whether they behave and respond differently to the familiar order when tested by a familiar or an unknown person. Horses' response varied according to the person's attentional state when the order was given by an unknown person: obedience levels were higher when the person giving the order was looking at the horse than when he was not attentive. More interesting is the finding that whatever the condition, horses monitored much more and for longer times the unknown person, as if they were surprised to hear the familiar order given by an unknown voice. Conclusion/Significance: These results suggest that recognition of humans may lie in a global, integrated, multisensory representation of specific individuals, that includes visual and vocal identity, but also expectations on the individual's behaviour in a familiar situation.	[Sankey, Carol; Henry, Severine; Andre, Nicolas; Richard-Yris, Marie-Annick; Hausberger, Martine] Univ Rennes 1, CNRS, Lab Eethol Anim & Humaine, Biol Stn,UMR 6552, Paimpont, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Sankey, C (corresponding author), Univ Rennes 1, CNRS, Lab Eethol Anim & Humaine, Biol Stn,UMR 6552, Paimpont, France.	carol.sankey@univ-rennes1.fr		Sankey, Carol/0000-0001-9890-9287	COST of the "Haras Nationaux"; region Bretagne	COST of the "Haras Nationaux"; region Bretagne(Region Bretagne)	This work was supported by the COST of the "Haras Nationaux" and the region Bretagne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I, 2007, ANIM COGN, V10, P17, DOI 10.1007/s10071-006-0025-8; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Engh AL, 2006, ANIM BEHAV, V71, P381, DOI 10.1016/j.anbehav.2005.05.009; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Hare B., 1998, EVOL COMMUN, V2, P137; Hattori Y, 2007, ANIM COGN, V10, P141, DOI 10.1007/s10071-006-0049-0; Hinde R.A., 1979, UNDERSTANDING RELATI; Kaminski J, 2004, ANIM COGN, V7, P216, DOI 10.1007/s10071-004-0214-2; Miklosi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016; Proops L, 2010, ANIM COGN, V13, P197, DOI 10.1007/s10071-009-0257-5; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Sankey C, 2010, ANIM BEHAV, V79, P869, DOI 10.1016/j.anbehav.2009.12.037; Schwab C, 2006, J COMP PSYCHOL, V120, P169, DOI 10.1037/0735-7036.120.3.169; Seyfarth RM, 2009, P NATL ACAD SCI USA, V106, P669, DOI 10.1073/pnas.0811894106; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Waring G.H., 2003, HORSE BEHAV, V2; Xitco MJ, 2004, ANIM COGN, V7, P231, DOI 10.1007/s10071-004-0217-z; [No title captured]	19	42	44	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18331	10.1371/journal.pone.0018331	http://dx.doi.org/10.1371/journal.pone.0018331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479184	Green Submitted, gold, Green Published			2022-12-27	WOS:000289055700048
J	Gomez, I; Pena, C; Herrera, M; Munoz, C; Larriba, MJ; Garcia, V; Dominguez, G; Silva, J; Rodriguez, R; de Herreros, AG; Bonilla, F; Garcia, JM				Gomez, Irene; Pena, Cristina; Herrera, Mercedes; Munoz, Concepcion; Jesus Larriba, Maria; Garcia, Vanesa; Dominguez, Gemma; Silva, Javier; Rodriguez, Rufo; Garcia de Herreros, Antonio; Bonilla, Felix; Garcia, Jose M.			TWIST1 Is Expressed in Colorectal Carcinomas and Predicts Patient Survival	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; BREAST-CANCER CELLS; COLON-CANCER; GENE-EXPRESSION; TUMOR-CELLS; METASTASIS; OVEREXPRESSION; INDUCTION	TWIST1 is a transcription factor that belongs to the family of basic helix-loop-helix proteins involved in epithelial-to-mesenchymal transition and invasion processes. The TWIST1 protein possesses oncogenic, drug-resistant, angiogenic and invasive properties, and has been related with several human tumors and other pathologies. Colorectal cancer is one of the tumors in which TWIST1 is over-expressed, but its involvement in the clinical outcome of the disease is still unclear. We tested, by RT-PCR, the expression levels of TWIST1 in normal and tumor paired-sample tissues from a series of 151 colorectal cancer patients, in order to investigate its prognostic value as a tumor marker. TWIST1 expression was restricted to tumor tissues (86.1%) and correlated with lymph node metastasis (LNM). Adjusted analysis showed that the expression levels of TWIST1 correlated with overall survival (OS) and disease-free survival (DFS). Importantly, TWIST1 expression levels predicted OS specifically at stages I and II. Moreover, patients with stage II tumors and high TWIST1 levels showed even shorter survival than patients with stage III tumors. These results suggest that TWIST1 expression levels could be a tumor indicator in stage II patients and help select patients at greater risk of poor prognosis who might benefit from adjuvant chemotherapy.	[Gomez, Irene; Pena, Cristina; Herrera, Mercedes; Garcia, Vanesa; Dominguez, Gemma; Silva, Javier; Bonilla, Felix; Garcia, Jose M.] Hosp Univ Puerta de Hierro Majadahonda, Dept Med Oncol, Madrid, Spain; [Garcia de Herreros, Antonio] Univ Pompeu Fabra, Inst Municipal Invest Med, Unitat Biol Cellular & Mol, Barcelona, Spain; [Munoz, Concepcion] Hosp Virgen de la Salud, Dept Gastroenterol, Toledo, Spain; [Rodriguez, Rufo] Hosp Virgen de la Salud, Dept Pathol, Toledo, Spain; [Jesus Larriba, Maria] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, CSIC, Madrid, Spain	Hospital Puerta de Hierro-Majadahonda; Pompeu Fabra University; Complejo Hospitalario de Toledo; Complejo Hospitalario de Toledo; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Gomez, I (corresponding author), Hosp Univ Puerta de Hierro Majadahonda, Dept Med Oncol, Madrid, Spain.	fbonilla.hpth@salud.madrid.org; jgarciar.hpth@salud.madrid.org	LARRIBA, MARIA JESUS/O-4652-2014; de Herreros, A Garcia/H-3104-2014	LARRIBA, MARIA JESUS/0000-0001-9035-7414; de Herreros, A Garcia/0000-0001-5270-0808; Garcia-Barberan, Vanesa/0000-0002-2531-0203	Foundation AECC [S-GEN/0266/2006, RD06/0020/0020, SAF2010-20750, RD06/0020/0040];  [ISCIII-CP08/00217]	Foundation AECC; 	This study was supported by grants from: Foundation AECC, S-GEN/0266/2006, RD06/0020/0020, SAF2010-20750 and RD06/0020/0040. JMG is supported by ISCIII-CP08/00217. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; DEANS GT, 1992, BRIT J SURG, V79, P608, DOI 10.1002/bjs.1800790706; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; ELIAS MC, 2005, TWIST IS EXPRESSED H, P824; Entz-Werle N, 2005, INT J CANCER, V117, P349, DOI 10.1002/ijc.21068; Erlichman C, 1999, J CLIN ONCOL, V17, P1356, DOI 10.1200/JCO.1999.17.5.1356; Fackler MJ, 2003, INT J CANCER, V107, P970, DOI 10.1002/ijc.11508; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hong Ran, 2009, BASIC APPL PATHOLOGY, V2, P15, DOI DOI 10.1111/j.1755-9294.2009.01030.x; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Mamounas E, 1999, J CLIN ONCOL, V17, P1349, DOI 10.1200/JCO.1999.17.5.1349; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Okada T, 2010, GENE CHROMOSOME CANC, V49, P452, DOI 10.1002/gcc.20755; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Sasaki K, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-158; Shibata K, 2008, ANN ONCOL, V19, P81, DOI 10.1093/annonc/mdm344; Taal BG, 2001, BRIT J CANCER, V85, P1437, DOI 10.1054/bjoc.2001.2117; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; TOMITA N, 1992, CANCER RES, V52, P6840; Valdes-Mora F, 2009, ANN SURG ONCOL, V16, P78, DOI 10.1245/s10434-008-0166-x; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; van Doorn R, 2004, CANCER RES, V64, P5578, DOI 10.1158/0008-5472.CAN-04-1253; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XH, 2004, ONCOGENE, V23, P474, DOI 10.1038/sj.onc.1207128; Watanabe O, 2004, ANTICANCER RES, V24, P3851; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yu QC, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-119	46	56	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18023	10.1371/journal.pone.0018023	http://dx.doi.org/10.1371/journal.pone.0018023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464926	Green Published, Green Submitted, gold			2022-12-27	WOS:000289053800013
J	Miller, JH				Miller, Joshua H.			Ghosts of Yellowstone: Multi-Decadal Histories of Wildlife Populations Captured by Bones on a Modern Landscape	PLOS ONE			English	Article							MOLLUSCAN DEATH ASSEMBLAGES; ECOLOGICAL FIDELITY; FAUNAL ASSEMBLAGES; MOUNTAIN GOATS; HABITAT; ORIGIN	Natural accumulations of skeletal material (death assemblages) have the potential to provide historical data on species diversity and population structure for regions lacking decades of wildlife monitoring, thereby contributing valuable baseline data for conservation and management strategies. Previous studies of the ecological and temporal resolutions of death assemblages from terrestrial large-mammal communities, however, have largely focused on broad patterns of community composition in tropical settings. Here, I expand the environmental sampling of large-mammal death assemblages into a temperate biome and explore more demanding assessments of ecological fidelity by testing their capacity to record past population fluctuations of individual species in the well-studied ungulate community of Yellowstone National Park (Yellowstone). Despite dramatic ecological changes following the 1988 wildfires and 1995 wolf re-introduction, the Yellowstone death assemblage is highly faithful to the living community in species richness and community structure. These results agree with studies of tropical death assemblages and establish the broad capability of vertebrate remains to provide high-quality ecological data from disparate ecosystems and biomes. Importantly, the Yellowstone death assemblage also correctly identifies species that changed significantly in abundance over the last 20 to,80 years and the directions of those shifts (including local invasions and extinctions). The relative frequency of fresh versus weathered bones for individual species is also consistent with documented trends in living population sizes. Radiocarbon dating verifies the historical source of bones from Equus caballus (horse): a functionally extinct species. Bone surveys are a broadly valuable tool for obtaining population trends and baseline shifts over decadal-to-centennial timescales.	Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA	University of Chicago	Miller, JH (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	millerjh@uchicago.edu			National Science Foundation; Doctoral Dissertation Improvement Grant; Department of Education; Geological Society of America; American Society of Mammalogists; American Museum of Natural History; The Paleontological Society; Sigma Xi; Lawrence Livermore National Laboratory; University of Chicago	National Science Foundation(National Science Foundation (NSF)); Doctoral Dissertation Improvement Grant; Department of Education(US Department of Education); Geological Society of America; American Society of Mammalogists; American Museum of Natural History; The Paleontological Society; Sigma Xi; Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); University of Chicago(University of Chicago)	Support for this project was generously provided by the National Science Foundation (Predoctoral Fellowship Program [http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=6201] and a Doctoral Dissertation Improvement Grant [http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5234]), the Department of Education (GAANN Fellowship in Evolutionary Ecology [http://www2.ed.gov/programs/gaann/index.html]), the Geological Society of America (Student Research Grant [http://www.geosociety.org/grants/gradgrants.htm]), the American Society of Mammalogists (Grants-in-Aid Program [http://www.mammalsociety.org/applications/]), the American Museum of Natural History (Theodore Roosevelt Fund [http://rggs.amnh.org/pages/academics_and_research/fellowship_and_grant_opportunities#grants]), the Explorer's Club (The Exploration Fund [http://www.explorers.org/index.php/expeditions/funding/expedition_grants]), The Paleontological Society (Steven J. Gould Award [http://www.paleosoc.org/grantin.html]), Sigma Xi (Grant-in-Aid of Research [http://www.sigmaxi.org/programs/giar/]), Lawrence Livermore National Laboratory and The University of Chicago (Berkmann Fellowship, Goodfriend Fund for Paleoecology, and Gurley Fund [http://geosci.uchicago.edu/]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS P, 1983, PALEOBIOLOGY, V9, P289, DOI 10.1017/S0094837300007703; ANDREWS P, 1995, J ARCHAEOL SCI, V22, P147, DOI 10.1006/jasc.1995.0016; Behrensmeyer A.K., 1980, P72; Behrensmeyer A.K., 1993, NATL GEOGRAPHIC RES, V9, P402; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; BEHRENSMEYER AK, 1979, PALEOBIOLOGY, V5, P12, DOI 10.1017/S0094837300006254; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; EBERHARDT LL, 1992, J WILDLIFE MANAGE, V56, P603, DOI 10.2307/3808878; Feldhamer G.A., 2003, WILD MAMMALS N AM BI; Gates CC, 2005, ECOLOGY BISON MOVEME; Gotelli NJ, 2013, ECOSIMR 1 00; Grayson DK, 1981, J ETHNOBIOL, V1, P28; GRIFFITH B, 2002, ARCTIC REFUGE COASTA, P8; Hadly EA, 1999, PALAEOGEOGR PALAEOCL, V149, P389, DOI 10.1016/S0031-0182(98)00214-4; Hadly EA, 2004, PLOS BIOL, V2, P1600, DOI 10.1371/journal.pbio.0020290; Houston D.B., 1982, NO YELLOWSTONE ELK E; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Kidwell SM, 2002, GEOLOGY, V30, P803, DOI 10.1130/0091-7613(2002)030<0803:TAMDAP>2.0.CO;2; Kidwell SM, 2008, LETHAIA, V41, P199, DOI 10.1111/j.1502-3931.2007.00050.x; Kidwell SM, 2007, P NATL ACAD SCI USA, V104, P17701, DOI 10.1073/pnas.0707194104; Kidwell SM, 2010, PALEOBIOLOGY, V36, P615, DOI 10.1666/09004.1; Largo E, 2008, WILDLIFE BIOL, V14, P489, DOI 10.2981/0909-6396-14.4.489; Lemke TO, 2004, WILDLIFE SOC B, V32, P532, DOI 10.2193/0091-7648(2004)32[532:OEASOM]2.0.CO;2; Liebig PM, 2003, PALAIOS, V18, P168, DOI 10.1669/0883-1351(2003)18<168:BOTBMM>2.0.CO;2; McGill BJ, 2005, P NATL ACAD SCI USA, V102, P16701, DOI 10.1073/pnas.0504225102; Meldgaard M., 1986, Meddelelser om Gronland Bioscience, V20, P1; NRC, 2005, GEOL REC EC DYN UND; Plumb GE, 2009, BIOL CONSERV, V142, P2377, DOI 10.1016/j.biocon.2009.05.019; Porder S, 2003, PALEOBIOLOGY, V29, P197, DOI 10.1666/0094-8373(2003)029<0197:MTOOFA>2.0.CO;2; Pyenson ND, 2010, PALEOBIOLOGY, V36, P453, DOI 10.1666/09018.1; Reed DN, 2007, VERTEBR PALEOBIOL PA, P217, DOI 10.1007/978-1-4020-3098-7_9; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Saenz-Arroyo A, 2005, P ROY SOC B-BIOL SCI, V272, P1957, DOI 10.1098/rspb.2005.3175; Schullery P, 2001, WEST N AM NATURALIST, V61, P289; SEPT JM, 1994, J ARCHAEOL SCI, V21, P217, DOI 10.1006/jasc.1994.1023; Smith DW, 2003, BIOSCIENCE, V53, P330, DOI 10.1641/0006-3568(2003)053[0330:YAW]2.0.CO;2; Sokal R. R., 2000, BIOMETRY; Sutcliffe Antony J., 2000, Polar Record, V36, P233; TAPPEN M, 1995, CURR ANTHROPOL, V36, P223, DOI 10.1086/204353; Terry RC, 2010, P ROY SOC B-BIOL SCI, V277, P1193, DOI 10.1098/rspb.2009.1984; Terry RC, 2010, PALEOBIOLOGY, V36, P137, DOI 10.1666/0094-8373-36.1.137; Tyers Daniel B., 2006, Alces, V42, P133; Tyers DB, 1995, ALCES N AM, V31, P35; VANVALEN L, 1964, AM NAT, V98, P109, DOI 10.1086/282307; Western D, 2009, SCIENCE, V324, P1061, DOI 10.1126/science.1171155; White PJ, 2008, WILDLIFE BIOL, V14, P138, DOI 10.2981/0909-6396(2008)14[138:IEORWC]2.0.CO;2; White PJ, 2005, WILDLIFE SOC B, V33, P942, DOI 10.2193/0091-7648(2005)33[942:NYEAWR]2.0.CO;2; Yellowstone National Park, 1997, YELL NO RANG COMPL C; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	61	36	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18057	10.1371/journal.pone.0018057	http://dx.doi.org/10.1371/journal.pone.0018057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464921	gold, Green Published, Green Submitted			2022-12-27	WOS:000289053800018
J	Ryu, HS; Park, SY; Ma, DA; Zhang, J; Lee, W				Ryu, Hyun Su; Park, Seung-Yoon; Ma, Duan; Zhang, Jin; Lee, Wan			The Induction of MicroRNA Targeting IRS-1 Is Involved in the Development of Insulin Resistance under Conditions of Mitochondrial Dysfunction in Hepatocytes	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; PHOSPHATIDYLINOSITOL 3-KINASE; WEIGHT-LOSS; RECEPTOR SUBSTRATE-1; GLUCOSE-UTILIZATION; DEPLETION; GROWTH; DNA; SENSITIVITY; METABOLISM	Background: Mitochondrial dysfunction induces insulin resistance in myocytes via a reduction of insulin receptor substrate-1 (IRS-1) expression. However, the effect of mitochondrial dysfunction on insulin sensitivity is not understood well in hepatocytes. Although research has implicated the translational repression of target genes by endogenous non-coding microRNAs (miRNA) in the pathogenesis of various diseases, the identity and role of the miRNAs that are involved in the development of insulin resistance also remain largely unknown. Methodology: To determine whether mitochondrial dysfunction induced by genetic or metabolic inhibition causes insulin resistance in hepatocytes, we analyzed the expression and insulin-stimulated phosphorylation of insulin signaling intermediates in SK-Hep1 hepatocytes. We used qRT-PCR to measure cellular levels of selected miRNAs that are thought to target IRS-1 3' untranslated regions (3'UTR). Using overexpression of miR-126, we determined whether IRS-1-targeting miRNA causes insulin resistance in hepatocytes. Principal Findings: Mitochondrial dysfunction resulting from genetic (mitochondrial DNA depletion) or metabolic inhibition (Rotenone or Antimycin A) induced insulin resistance in hepatocytes via a reduction in the expression of IRS-1 protein. In addition, we observed a significant up-regulation of several miRNAs presumed to target IRS-1 39UTR in hepatocytes with mitochondrial dysfunction. Using reporter gene assay we confirmed that miR-126 directly targeted to IRS-1 39UTR. Furthermore, the overexpression of miR-126 in hepatocytes caused a substantial reduction in IRS-1 protein expression, and a consequent impairment in insulin signaling. Conclusions/Significance: We demonstrated that miR-126 was actively involved in the development of insulin resistance induced by mitochondrial dysfunction. These data provide novel insights into the molecular basis of insulin resistance, and implicate miRNA in the development of metabolic disease.	[Ryu, Hyun Su; Park, Seung-Yoon; Lee, Wan] Dongguk Univ, Coll Med, Dept Biochem, Kyungju, South Korea; [Ma, Duan; Zhang, Jin] Fudan Univ, Key Lab Mol Med, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200433, Peoples R China	Dongguk University; Fudan University	Ryu, HS (corresponding author), Dongguk Univ, Coll Med, Dept Biochem, Kyungju, South Korea.	wanlee@dongguk.ac.kr	Lee, Wan/B-6252-2013; Ma, Duan/I-8330-2014	Lee, Wan/0000-0002-5181-2135; 	Ministry of Health Welfare [A100370]; Ministry of Education, Science and Technology [M108KM010008-08K1301-00810]; National Research Foundation of Korea, Republic of Korea [2009-006791]	Ministry of Health Welfare; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea, Republic of Korea(National Research Foundation of Korea)	This study was supported by grant of the Korea Healthcare R&D Project, Ministry of Health & Welfare (A100370); 21C Frontier Functional Proteomics Project from Ministry of Education, Science and Technology (M108KM010008-08K1301-00810); National Research Foundation of Korea Grant (2009-006791), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910; Anai O, 1998, J BIOL CHEM, V273, P29686, DOI 10.1074/jbc.273.45.29686; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berggren JR, 2008, AM J PHYSIOL-ENDOC M, V294, pE726, DOI 10.1152/ajpendo.00354.2007; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Brozinick JT, 2003, DIABETES, V52, P935, DOI 10.2337/diabetes.52.4.935; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Carvalho Eugenia, 2001, FASEB Journal, V15, P1101; Catalano PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE522, DOI 10.1152/ajpendo.00124.2001; CHEN LB, 1989, METHOD CELL BIOL, V29, P103; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; Gallagher IJ, 2010, GENOME MED, V2, DOI 10.1186/gm130; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Hennessy Erica, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000781; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kelley DE, 2001, DIABETES CARE, V24, P933, DOI 10.2337/diacare.24.5.933; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lim JH, 2006, DIABETOLOGIA, V49, P1924, DOI 10.1007/s00125-006-0278-4; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Marx J, 2004, SCIENCE, V306, P592, DOI 10.1126/science.306.5696.592b; Park KS, 2001, AM J PHYSIOL-ENDOC M, V280, pE1007, DOI 10.1152/ajpendo.2001.280.6.E1007; Park SY, 2005, J BIOL CHEM, V280, P9855, DOI 10.1074/jbc.M409399200; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Rondinone CM, 1997, P NATL ACAD SCI USA, V94, P4171, DOI 10.1073/pnas.94.8.4171; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Schenk S, 2009, J PHYSIOL-LONDON, V587, P4949, DOI 10.1113/jphysiol.2009.175489; Shen WF, 2008, MOL CELL BIOL, V28, P4609, DOI 10.1128/MCB.01652-07; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; SIMONEAU JA, 1995, FASEB J, V9, P273, DOI 10.1096/fasebj.9.2.7781930; Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166; Szendroedi J, 2007, PLOS MED, V4, P858, DOI 10.1371/journal.pmed.0040154; Toledo FGS, 2008, DIABETES, V57, P987, DOI 10.2337/db07-1429; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089	43	121	130	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17343	10.1371/journal.pone.0017343	http://dx.doi.org/10.1371/journal.pone.0017343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464990	Green Published, gold, Green Submitted			2022-12-27	WOS:000288813900002
J	Wark, AR; Greenwood, AK; Taylor, EM; Yoshida, K; Peichel, CL				Wark, Abigail R.; Greenwood, Anna K.; Taylor, Elspeth M.; Yoshida, Kohta; Peichel, Catherine L.			Heritable Differences in Schooling Behavior among Threespine Stickleback Populations Revealed by a Novel Assay	PLOS ONE			English	Article							GUPPY POECILIA-RETICULATA; GASTEROSTEUS-ACULEATUS; 3-SPINED STICKLEBACKS; SYMPATRIC STICKLEBACKS; REPRODUCTIVE ISOLATION; ANTIPREDATOR BEHAVIOR; EMERGENT PROPERTIES; SHOALING DECISIONS; MINNOW SHOALS; SPECIES-PAIR	Identifying the proximate and ultimate mechanisms of social behavior remains a major goal of behavioral biology. In particular, the complex social interactions mediating schooling behavior have long fascinated biologists, leading to theoretical and empirical investigations that have focused on schooling as a group-level phenomenon. However, methods to examine the behavior of individual fish within a school are needed in order to investigate the mechanisms that underlie both the performance and the evolution of schooling behavior. We have developed a technique to quantify the schooling behavior of an individual in standardized but easily manipulated social circumstances. Using our model school assay, we show that threespine sticklebacks (Gasterosteus aculeatus) from alternative habitats differ in behavior when tested in identical social circumstances. Not only do marine sticklebacks show increased association with the model school relative to freshwater benthic sticklebacks, they also display a greater degree of parallel swimming with the models. Taken together, these data indicate that marine sticklebacks exhibit a stronger tendency to school than benthic sticklebacks. We demonstrate that these population-level differences in schooling tendency are heritable and are shared by individuals within a population even when they have experienced mixed-population housing conditions. Finally, we begin to explore the stimuli that elicit schooling behavior in these populations. Our data suggest that the difference in schooling tendency between marine and benthic sticklebacks is accompanied by differential preferences for social vs. non-social and moving vs. stationary shelter options. Our study thus provides novel insights into the evolution of schooling behavior, as well as a new experimental approach to investigate the genetic and neural mechanisms that underlie this complex social behavior.	[Wark, Abigail R.; Greenwood, Anna K.; Taylor, Elspeth M.; Yoshida, Kohta; Peichel, Catherine L.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Wark, Abigail R.] Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Wark, AR (corresponding author), Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA.	akg@stanfordalumni.org; cpeichel@fhcrc.org	Yoshida, Kohta/AGI-9520-2022	Yoshida, Kohta/0000-0002-5896-7383	National Institutes of Health [P50 HG002568]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by National Institutes of Health grant P50 HG002568 (CLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Boulcott P, 2007, EVOL ECOL, V21, P601, DOI 10.1007/s10682-006-9138-4; BREDEN F, 1987, ANIM BEHAV, V35, P618, DOI 10.1016/S0003-3472(87)80297-X; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; CRONLYDILLON J, 1968, J EXP BIOL, V49, P679; Faria JJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1211, DOI 10.1007/s00265-010-0988-y; Frommen JG, 2004, BEHAVIOUR, V141, P1401, DOI 10.1163/1568539042948196; Frommen JG, 2009, BEHAV ECOL SOCIOBIOL, V63, P1141, DOI 10.1007/s00265-009-0767-9; Huntingford FA, 2009, J FISH BIOL, V75, P1943, DOI 10.1111/j.1095-8649.2009.02420.x; Imada H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011248; Kitano J, 2007, BIOL J LINN SOC, V91, P671, DOI 10.1111/j.1095-8312.2007.00824.x; Kozak GM, 2008, BEHAV ECOL, V19, P667, DOI 10.1093/beheco/arn022; Krause J, 2002, LIVING GROUPS; LARSON GL, 1976, CAN J ZOOL, V54, P107, DOI 10.1139/z76-012; MAGURRAN AE, 1986, BEHAV ECOL SOCIOBIOL, V19, P267, DOI 10.1007/BF00300641; MAGURRAN AE, 1990, ANIM BEHAV, V39, P834, DOI 10.1016/S0003-3472(05)80947-9; MAGURRAN AE, 1991, BEHAVIOUR, V118, P214, DOI 10.1163/156853991X00292; MAGURRAN AE, 1987, PROC R SOC SER B-BIO, V229, P439, DOI 10.1098/rspb.1987.0004; MCPHAIL JD, 1992, CAN J ZOOL, V70, P361, DOI 10.1139/z92-054; Milinski M, 1997, P ROY SOC B-BIOL SCI, V264, P831, DOI 10.1098/rspb.1997.0116; Modarressie R, 2006, P ROY SOC B-BIOL SCI, V273, P849, DOI 10.1098/rspb.2005.3397; Parrish JK, 2002, BIOL BULL-US, V202, P296, DOI 10.2307/1543482; PITCHER T, 1979, ANIM BEHAV, V27, P126, DOI 10.1016/0003-3472(79)90133-7; PITCHER TJ, 1983, ANIM BEHAV, V31, P611, DOI 10.1016/S0003-3472(83)80087-6; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; ROWLAND WJ, 1989, BEHAV ECOL SOCIOBIOL, V24, P433, DOI 10.1007/BF00293272; ROWLAND WJ, 1979, BEHAV RES METH INSTR, V11, P564, DOI 10.3758/BF03201381; SEGHERS BH, 1974, EVOLUTION, V28, P486, DOI 10.1111/j.1558-5646.1974.tb00774.x; SHAW E, 1965, ANIM BEHAV, V13, P330, DOI 10.1016/0003-3472(65)90052-7; Soria M, 2007, J FISH BIOL, V71, P1257, DOI 10.1111/j.1095-8649.2007.01554.x; Taylor EB, 2000, P ROY SOC B-BIOL SCI, V267, P2375, DOI 10.1098/rspb.2000.1294; TINBERGEN N, 1951, STUDY INSTINCT, P221; Vamosi SM, 2002, ANN ZOOL FENN, V39, P237; Viscido SV, 2004, MAR ECOL PROG SER, V273, P239, DOI 10.3354/meps273239; Ward AJW, 2004, P ROY SOC B-BIOL SCI, V271, pS328, DOI 10.1098/rsbl.2004.0178; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Wark AR, 2011, BEHAV ECOL SOCIOBIOL, V65, P1147, DOI 10.1007/s00265-010-1130-x; Wootton R.J., 1976, BIOL STICKLEBACKS; Wright D, 2006, NAT PROTOC, V1, P1828, DOI 10.1038/nprot.2006.287	40	45	45	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18316	10.1371/journal.pone.0018316	http://dx.doi.org/10.1371/journal.pone.0018316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464914	Green Submitted, Green Published, gold			2022-12-27	WOS:000288813900058
J	Su, JL; Li, SA; Hu, XD; Yu, XL; Wang, YY; Liu, PP; Lu, XS; Zhang, GZ; Hu, XY; Liu, D; Li, XX; Su, WL; Lu, H; Mok, NS; Wang, PY; Wang, M; Tian, KG; Gao, GF				Su, Jingliang; Li, Shuang; Hu, Xudong; Yu, Xiuling; Wang, Yongyue; Liu, Peipei; Lu, Xishan; Zhang, Guozhong; Hu, Xueying; Liu, Di; Li, Xiaoxia; Su, Wenliang; Lu, Hao; Mok, Ngai Shing; Wang, Peiyi; Wang, Ming; Tian, Kegong; Gao, George F.			Duck Egg-Drop Syndrome Caused by BYD Virus, a New Tembusu-Related Flavivirus	PLOS ONE			English	Article							EQUINE ENCEPHALITIS-VIRUS; ANSER-ANSER-DOMESTICUS; WEST-NILE-VIRUS; GENUS FLAVIVIRUS; GEESE; TRANSMISSION; ANTIBODIES; MOSQUITO; SERA	Since April 2010, a severe outbreak of duck viral infection, with egg drop, feed uptake decline and ovary-oviduct disease, has spread around the major duck-producing regions in China. A new virus, named BYD virus, was isolated in different areas, and a similar disease was reproduced in healthy egg-producing ducks, infecting with the isolated virus. The virus was re-isolated from the affected ducks and replicated well in primary duck embryo fibroblasts and Vero cells, causing the cytopathic effect. The virus was identified as an enveloped positive-stranded RNA virus with a size of approximately 55 nm in diameter. Genomic sequencing of the isolated virus revealed that it is closely related to Tembusu virus (a mosquito-borne Ntaya group flavivirus), with 87-91% nucleotide identity of the partial E (envelope) proteins to that of Tembusu virus and 72% of the entire genome coding sequence with Bagaza virus, the most closely related flavivirus with an entirely sequenced genome. Collectively our systematic studies fulfill Koch's postulates, and therefore, the causative agent of the duck egg drop syndrome occurring in China is a new flavivirus. Flavivirus is an emerging and re-emerging zoonotic pathogen and BYD virus that causes severe egg-drop, could be disastrous for the duck industry. More importantly its public health concerns should also be evaluated, and its epidemiology should be closely watched due to the zoonotic nature of flaviviruses.	[Su, Jingliang; Li, Shuang; Hu, Xudong; Wang, Yongyue; Lu, Xishan; Zhang, Guozhong; Su, Wenliang; Wang, Ming] China Agr Univ, Coll Vet Med, Key Lab Zoonosis, Minist Agr, Beijing 100094, Peoples R China; [Hu, Xudong; Liu, Peipei; Lu, Xishan; Liu, Di; Lu, Hao; Mok, Ngai Shing; Wang, Peiyi; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Yu, Xiuling; Li, Xiaoxia; Tian, Kegong] China Anim Dis Control Ctr, Beijing, Peoples R China; [Liu, Peipei; Gao, George F.] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Hu, Xueying] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China; [Liu, Di] Chinese Acad Sci, Network Informat Ctr, Inst Microbiol, Beijing, Peoples R China; [Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Huazhong Agricultural University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences	Su, JL (corresponding author), China Agr Univ, Coll Vet Med, Key Lab Zoonosis, Minist Agr, Beijing 100094, Peoples R China.	jinglsu@yahoo.com; tiankg@263.net; gaof@im.ac.cn	Liu, Di/ABD-2729-2021; Gao, George Fu/ABD-5229-2021; Liu, Di/G-6135-2014	Liu, Di/0000-0003-3693-2726; Liu, Di/0000-0003-3693-2726	China Ministry of Science and Technology (MOST) [2010CB530301, 2010CB530303]; Natural Science Foundation of China (NSFC) [30800640]; NSFC Innovative Research Group [81021003]	China Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC Innovative Research Group	The work is supported by the China Ministry of Science and Technology (MOST) Project 973 (Grant No. 2010CB530301 and 2010CB530303). DL is partly supported by the Natural Science Foundation of China (NSFC, Grant No. 30800640). GFG is a leading principal investigator of the NSFC Innovative Research Group (Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAIR BM, 2008, DIS POULTRY, P266; Austin RJ, 2004, CAN VET J, V45, P117; Barnard B.J., 1950, ONDERSTEPOORT J VET, V47, P89; Beckwith WH, 2002, AM J TROP MED HYG, V66, P422, DOI 10.4269/ajtmh.2002.66.422; Bondre VP, 2009, J GEN VIROL, V90, P2644, DOI 10.1099/vir.0.012336-0; BOWEN ETW, 1975, T ROY SOC TROP MED H, V69, P182, DOI 10.1016/0035-9203(75)90151-0; Digoutte J.P., 1978, AM J TROP MED HYG, V27, P376, DOI [10.4269/ajtmh.1978.27.376, DOI 10.4269/AJTMH.1978.27.376]; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Dobler G, 2010, VET MICROBIOL, V140, P221, DOI 10.1016/j.vetmic.2009.08.024; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X; Gubler D.J., 2007, FIELDS VIROLOGY, VVolume 1; HASE T, 1987, ARCH VIROL, V92, P273, DOI 10.1007/BF01317484; HEINZ FX, 2000, VIRUS TAXONOMY, P859; Hlinak A, 1998, J WILDLIFE DIS, V34, P479, DOI 10.7589/0090-3558-34.3.479; Karabatsos N., 1985, INT CATALOGUE ARBOVI; Kono Y, 2000, AM J TROP MED HYG, V63, P94, DOI 10.4269/ajtmh.2000.63.94; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; LUKERT PD, 1989, LAB MANUAL ISOLATION, P182; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687; Swayne DE, 2001, EMERG INFECT DIS, V7, P751; TRAORELAMIZANA M, 1994, J MED ENTOMOL, V31, P934, DOI 10.1093/jmedent/31.6.934; WAGES DP, 1993, AVIAN DIS, V37, P1163, DOI 10.2307/1591931; WALLACE HG, 1977, MOSQ NEWS, V37, P35; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310; WOOLCOCK PR, 2008, DISEASES POULTRY, P414; WOOLHOUSE MEJ, 2006, T16 QUANTITATIVE ANA	30	250	328	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18106	10.1371/journal.pone.0018106	http://dx.doi.org/10.1371/journal.pone.0018106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455312	gold, Green Published, Green Submitted			2022-12-27	WOS:000288811500023
J	Yoder, KE; Espeseth, A; Wang, XH; Fang, QM; Russo, MT; Lloyd, RS; Hazuda, D; Sobol, RW; Fishel, R				Yoder, Kristine E.; Espeseth, Amy; Wang, Xiao-hong; Fang, Qingming; Russo, Maria Teresa; Lloyd, R. Stephen; Hazuda, Daria; Sobol, Robert W.; Fishel, Richard			The Base Excision Repair Pathway Is Required for Efficient Lentivirus Integration	PLOS ONE			English	Article							DNA-POLYMERASE-BETA; PREINTEGRATION COMPLEXES; VIRUS INTEGRATION; HIV-1 INTEGRATION; IN-VITRO; GENE; PROTEIN; DAMAGE; CELLS; VECTORS	An siRNA screen has identified several proteins throughout the base excision repair (BER) pathway of oxidative DNA damage as important for efficient HIV infection. The proteins identified included early repair factors such as the base damage recognition glycosylases OGG1 and MYH and the late repair factor POL beta, implicating the entire BER pathway. Murine cells with deletions of the genes Ogg1, Myh, Neil1 and Pol beta recapitulate the defect of HIV infection in the absence of BER. Defective infection in the absence of BER proteins was also seen with the lentivirus FIV, but not the gammaretrovirus MMLV. BER proteins do not affect HIV infection through its accessory genes nor the central polypurine tract. HIV reverse transcription and nuclear entry appear unaffected by the absence of BER proteins. However, HIV integration to the host chromosome is reduced in the absence of BER proteins. Pre-integration complexes from BER deficient cell lines show reduced integration activity in vitro. Integration activity is restored by addition of recombinant BER protein POL beta. Lentiviral infection and integration efficiency appears to depend on the presence of BER proteins.	[Yoder, Kristine E.; Fishel, Richard] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; [Yoder, Kristine E.; Fishel, Richard] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Fishel, Richard] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Espeseth, Amy; Hazuda, Daria] Merck Res Labs, Dept Antiviral Res, West Point, PA USA; [Russo, Maria Teresa] Ist Super Sanita, Dept Environm & Primary Prevent, I-00161 Rome, Italy; [Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Dept Mol & Med Genet, Portland, OR 97201 USA; [Sobol, Robert W.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Wang, Xiao-hong; Fang, Qingming; Sobol, Robert W.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA USA; [Sobol, Robert W.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Merck & Company; Istituto Superiore di Sanita (ISS); Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yoder, KE (corresponding author), Ohio State Univ, Med Ctr, Columbus, OH 43210 USA.	yoder.176@osu.edu; rfishel@osu.edu	Fang, Qingming/B-6839-2008; Sobol, Robert W./E-4125-2013; Yoder, Kristine/E-4353-2011	Fang, Qingming/0000-0002-4006-0636; Sobol, Robert W./0000-0001-7385-3563; Yoder, Kristine/0000-0002-5598-9018; Lloyd, R. Stephen/0000-0001-7273-372X	NIH [AI82422, DK075974, CA148629]; Associazione Italiana Ricerca sul Cancro; Merck Research Laboratories; NATIONAL CANCER INSTITUTE [R01CA148629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK075974, R01DK075974] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Merck Research Laboratories(Merck & Company); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants AI82422 (KY and RF), DK075974 (RSL), CA148629 (RWS), a grant from Associazione Italiana Ricerca sul Cancro (MTR), and Merck Research Laboratories (AE and DH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTTS J, 1988, BIOCHEMISTRY-US, V27, P901, DOI 10.1021/bi00403a010; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Beitzel B, 2003, NUCLEIC ACIDS RES, V31, P5025, DOI 10.1093/nar/gkg684; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cannon PM, 1996, J VIROL, V70, P8234, DOI 10.1128/JVI.70.11.8234-8240.1996; Chen HM, 1998, P NATL ACAD SCI USA, V95, P15270, DOI 10.1073/pnas.95.26.15270; Coffin J, 1997, RETROVIRUSES; ELLISON V, 1990, J VIROL, V64, P2711, DOI 10.1128/JVI.64.6.2711-2715.1990; ESPESETH AS, 2010, SIRNA SCREENIN UNPUB; FARNET CM, 1990, P NATL ACAD SCI USA, V87, P4164, DOI 10.1073/pnas.87.11.4164; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedberg EC, 2006, DNA REPAIR, V5, P189, DOI 10.1016/j.dnarep.2005.09.009; Hansen MST, 1999, NAT BIOTECHNOL, V17, P578, DOI 10.1038/9886; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Karolewski BA, 2003, HUM GENE THER, V14, P1287, DOI 10.1089/104303403322319372; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; McCurrach ME, 2001, METHOD CELL BIOL, V66, P197; Poeschla EM, 1998, NAT MED, V4, P354, DOI 10.1038/nm0398-354; Puebla-Osorio N, 2006, MOL CELL BIOL, V26, P3935, DOI 10.1128/MCB.26.10.3935-3941.2006; Rumbaugh JA, 1998, J BIOL CHEM, V273, P28740, DOI 10.1074/jbc.273.44.28740; Russo MT, 2009, CANCER RES, V69, P4372, DOI 10.1158/0008-5472.CAN-08-3292; Russo MT, 2004, CANCER RES, V64, P4411, DOI 10.1158/0008-5472.CAN-04-0355; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2007, J VIROL, V81, P166, DOI 10.1128/JVI.01953-06; Sobol RW, 2007, DNA REPAIR, V6, P3, DOI 10.1016/j.dnarep.2006.08.005; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Svilar D, 2010, ANTIOXID REDOX SIGNA; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Xie YL, 2008, CARCINOGENESIS, V29, P722, DOI 10.1093/carcin/bgn033; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834; Yan N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000327; Yoder KE, 2000, J VIROL, V74, P11191, DOI 10.1128/JVI.74.23.11191-11200.2000; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	50	24	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17862	10.1371/journal.pone.0017862	http://dx.doi.org/10.1371/journal.pone.0017862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448280	Green Published, gold, Green Accepted			2022-12-27	WOS:000288810500019
J	Li, QA; Li, XD; Li, CH; Chen, LR; Song, J; Tang, YL; Xu, XJ				Li, Qian; Li, Xudong; Li, Canghai; Chen, Lirong; Song, Jun; Tang, Yalin; Xu, Xiaojie			A Network-Based Multi-Target Computational Estimation Scheme for Anticoagulant Activities of Compounds	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; FACTOR XA; 3-DIMENSIONAL STRUCTURE; THROMBIN INHIBITORS; DRUG-THERAPY; FACTOR IXA; BINDING; DESIGN; PERFORMANCE; DISCOVERY	Background: Traditional virtual screening method pays more attention on predicted binding affinity between drug molecule and target related to a certain disease instead of phenotypic data of drug molecule against disease system, as is often less effective on discovery of the drug which is used to treat many types of complex diseases. Virtual screening against a complex disease by general network estimation has become feasible with the development of network biology and system biology. More effective methods of computational estimation for the whole efficacy of a compound in a complex disease system are needed, given the distinct weightiness of the different target in a biological process and the standpoint that partial inhibition of several targets can be more efficient than the complete inhibition of a single target. Methodology: We developed a novel approach by integrating the affinity predictions from multi-target docking studies with biological network efficiency analysis to estimate the anticoagulant activities of compounds. From results of network efficiency calculation for human clotting cascade, factor Xa and thrombin were identified as the two most fragile enzymes, while the catalytic reaction mediated by complex IXa:VIIIa and the formation of the complex VIIIa: IXa were recognized as the two most fragile biological matter in the human clotting cascade system. Furthermore, the method which combined network efficiency with molecular docking scores was applied to estimate the anticoagulant activities of a serial of argatroban intermediates and eight natural products respectively. The better correlation (r = 0.671) between the experimental data and the decrease of the network deficiency suggests that the approach could be a promising computational systems biology tool to aid identification of anticoagulant activities of compounds in drug discovery. Conclusions: This article proposes a network-based multi-target computational estimation method for anticoagulant activities of compounds by combining network efficiency analysis with scoring function from molecular docking.	[Li, Qian; Li, Xudong; Chen, Lirong; Xu, Xiaojie] Peking Univ, Beijing Natl Lab Mol Sci, State Key Lab Rare Earth Mat Chem & Applicat, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Li, Qian; Tang, Yalin] Chinese Acad Sci, Inst Chem, State Key Lab Struct Chem Unstable & Stable Speci, Beijing Natl Lab Mol Sci,Ctr Mol Sci, Beijing 100080, Peoples R China; [Li, Canghai; Song, Jun] China Acad Chinese Med Sci, Expt Res Ctr, Beijing, Peoples R China; [Li, Qian] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Peking University; Chinese Academy of Sciences; Institute of Chemistry, CAS; China Academy of Chinese Medical Sciences; Experimental Research Center, CACMS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, QA (corresponding author), Peking Univ, Beijing Natl Lab Mol Sci, State Key Lab Rare Earth Mat Chem & Applicat, Coll Chem & Mol Engn, Beijing 100871, Peoples R China.	lirongchen@pku.edu.cn; tangyl@iccas.ac.cn; xiaojxu@pku.edu.cn			National Science and Technology Major Project [2008ZX09401-006, 2008ZX09202-007]	National Science and Technology Major Project	This project was supported by the National Science and Technology Major Project 2008ZX09401-006 and 2008ZX09202-007 (http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2002, BIOCHEMISTRY-US, V41, P15514, DOI 10.1021/bi0264061; Agoston V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051909; Auffray C, 2009, GENOME MED, V1, DOI 10.1186/gm2; Bender A, 2004, J CHEM INF COMP SCI, V44, P1708, DOI 10.1021/ci0498719; Bender A, 2008, CURR OPIN DRUG DISC, V11, P327; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Davidson BL, 2003, J THROMB THROMBOLYS, V16, P49, DOI 10.1023/B:THRO.0000014593.16147.bf; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Di Nisio M, 2005, NEW ENGL J MED, V353, P1028, DOI 10.1056/NEJMra044440; Dullweber F, 2001, J MOL BIOL, V313, P593, DOI 10.1006/jmbi.2001.5062; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Everse SJ, 1999, BIOCHEMISTRY-US, V38, P2941, DOI 10.1021/bi982626w; Geppert H, 2010, J CHEM INF MODEL, V50, P205, DOI 10.1021/ci900419k; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guertin KR, 2007, CURR MED CHEM, V14, P2471, DOI 10.2174/092986707782023659; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hopfner KP, 1999, STRUCTURE, V7, P989, DOI 10.1016/S0969-2126(99)80125-7; Huang MD, 1998, J MOL BIOL, V275, P873, DOI 10.1006/jmbi.1997.1512; Jenkins JL, 2003, PROTEINS, V50, P81, DOI 10.1002/prot.10270; Jenwitheesuk E, 2008, TRENDS PHARMACOL SCI, V29, P62, DOI 10.1016/j.tips.2007.11.007; Jiang RW, 2005, CURR MED CHEM, V12, P237, DOI 10.2174/0929867053363397; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Kontijevskis A, 2007, PLOS COMPUT BIOL, V3, P424, DOI 10.1371/journal.pcbi.0030048; Korcsmaros T, 2007, EXPERT OPIN DRUG DIS, V2, P799, DOI 10.1517/17460441.2.6.799; Kranjc A, 2004, CURR MED CHEM, V11, P2535, DOI 10.2174/0929867043364432; Krupinski Kazimierz, 1995, Materia Medica Polona, V27, P39; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li XD, 2005, ACTA PHYS-CHIM SIN, V21, P504, DOI 10.3866/PKU.WHXB20050509; Li Y, 2005, J ETHNOPHARMACOL, V98, P329, DOI 10.1016/j.jep.2005.01.020; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; Mestres J, 2002, BIOCHEM SOC T, V30, P797, DOI 10.1042/bst0300797; Mitsos A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000591; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Nishio H, 2008, EXPERT OPIN PHARMACO, V9, P2509, DOI [10.1517/14656566.9.14.2509, 10.1517/14656566.9.14.2509 ]; Olivero AG, 2005, J BIOL CHEM, V280, P9160, DOI 10.1074/jbc.M409068200; ORTOLANI O, 1995, TRANSPLANT P, V27, P2877; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Papagrigoriou E, 2006, NAT STRUCT MOL BIOL, V13, P557, DOI 10.1038/nsmb1095; Park H, 2006, PROTEINS, V65, P549, DOI 10.1002/prot.21183; Qiao XB, 2002, J CHEM INF COMP SCI, V42, P481, DOI 10.1021/ci010113h; Rai R, 2001, CURR MED CHEM, V8, P101, DOI 10.2174/0929867013373822; Rester U, 2008, CURR OPIN DRUG DISC, V11, P559; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Sakharkar MK, 2008, INT J BIOL SCI, V4, P15; Satoh Y, 1996, YAKUGAKU ZASSHI, V116, P244, DOI 10.1248/yakushi1947.116.3_244; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Shi CS, 2007, THROMB RES, V119, P769, DOI 10.1016/j.thromres.2006.06.008; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Spiro Zoltan, 2008, J Biol, V7, P20, DOI 10.1186/jbiol81; Stephanou A, 2005, MATH COMPUT MODEL, V41, P1137, DOI 10.1016/j.mcm.2005.05.008; Stephen P, 2008, J COMPUT AID MOL DES, V22, P647, DOI 10.1007/s10822-007-9130-2; Sun HM, 2008, CURR MED CHEM, V15, P1018, DOI 10.2174/092986708784049630; Tan F, 2002, ACTA BOT SIN, V44, P795; Tang J, 2005, J BIOL CHEM, V280, P41077, DOI 10.1074/jbc.M506766200; Tucker TJ, 1998, J MED CHEM, V41, P3210, DOI 10.1021/jm9801713; Wei LP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000020; Wishart DS, 2008, PHARMACOGENOMICS, V9, P1155, DOI 10.2217/14622416.9.8.1155; Wist AD, 2009, GENOME MED, V1, DOI 10.1186/gm11; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zbinden KG, 2005, BIOORG MED CHEM LETT, V15, P817, DOI 10.1016/j.bmcl.2004.10.092	65	23	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e14774	10.1371/journal.pone.0014774	http://dx.doi.org/10.1371/journal.pone.0014774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445339	Green Published, gold, Green Submitted			2022-12-27	WOS:000288809100001
J	Deeds, JR; Handy, SM; White, KD; Reimer, JD				Deeds, Jonathan R.; Handy, Sara M.; White, Kevin D.; Reimer, James D.			Palytoxin Found in Palythoa sp Zoanthids (Anthozoa, Hexacorallia) Sold in the Home Aquarium Trade	PLOS ONE			English	Article							PUTATIVE PALYTOXIN; MOLECULAR EVIDENCE; OSTREOPSIS-OVATA; PHYLOGENIES; SKIN	Zoanthids (Anthozoa, Hexacorallia) are colonial anemones that contain one of the deadliest toxins ever discovered, palytoxin (LD50 in mice 300 ng/kg), but it is generally believed that highly toxic species are not sold in the home aquarium trade. We previously showed that an unintentionally introduced zoanthid in a home aquarium contained high concentrations of palytoxin and was likely responsible for a severe respiratory reaction when an individual attempted to eliminate the contaminant colonies using boiling water. To assess the availability and potential exposure of palytoxin to marine aquarium hobbyists, we analyzed zoanthid samples collected from local aquarium stores for palytoxin using liquid chromatography and high resolution mass spectrometry and attempted to identify the specimens through genetic analysis of 16S and cytochrome c oxidase 1 (COI) markers. We found four specimens of the same apparent species of zoanthid, that we described previously to be responsible for a severe respiratory reaction in a home aquarium, to be available in three aquarium stores in the Washington D. C. area. We found all of these specimens (n = 4) to be highly toxic with palytoxin or palytoxin-like compounds (range 0.5-3.5 mg crude toxin/g zoanthid). One of the most potent non-protein compounds ever discovered is present in dangerous quantities in a select species of zoanthid commonly sold in the home aquarium trade.	[Deeds, Jonathan R.; Handy, Sara M.; White, Kevin D.] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA; [Reimer, James D.] Univ Ryukyus, Dept Chem Biol & Marine Sci, Okinawa, Japan	US Food & Drug Administration (FDA); University of the Ryukyus	Deeds, JR (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.	jonathan.deeds@fda.hhs.gov	Reimer, James Davis/AAP-1331-2020; Handy, Sara/C-6195-2008		United States Food and Drug Administration Center for Food Safety and Applied Nutrition	United States Food and Drug Administration Center for Food Safety and Applied Nutrition	This study was funded by the United States Food and Drug Administration Center for Food Safety and Applied Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BORNEMAN EH, 2004, AQUARIUM CORALS SELE, P464; Burnett WJ, 1997, CORAL REEFS, V16, P55, DOI 10.1007/s003380050060; Ciminiello P, 2008, J AM SOC MASS SPECTR, V19, P111, DOI 10.1016/j.jasms.2007.11.001; Ciminiello P, 2006, ANAL CHEM, V78, P6153, DOI 10.1021/ac060250j; Ciminiello P, 2010, RAPID COMMUN MASS SP, V24, P2735, DOI 10.1002/rcm.4696; Ciminiello P, 2009, CHEM RES TOXICOL, V22, P1851, DOI 10.1021/tx900259v; Cohen NJ, 2009, J FOOD PROTECT, V72, P810, DOI 10.4315/0362-028X-72.4.810; Daly JW, 2005, J NAT PROD, V68, P1556, DOI 10.1021/np0580560; Deeds JR, 2010, TOXICON, V56, P150, DOI 10.1016/j.toxicon.2009.05.035; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halstead B.W., 1988, POISONOUS VENOMOUS M; Hoffmann K, 2008, TOXICON, V51, P1535, DOI 10.1016/j.toxicon.2008.03.009; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lewis RJ, 2001, TOXICON, V39, P97, DOI 10.1016/S0041-0101(00)00161-6; MAJLESI N, 2008, CLIN TOXICOL, V46, P637; MOORE RE, 1971, SCIENCE, V172, P495, DOI 10.1126/science.172.3982.495; MOORE RE, 1982, OCEANUS, V25, P54; MOORE RE, 1981, J AM CHEM SOC, V103, P2491, DOI 10.1021/ja00399a093; MURATA M, 1994, J AM CHEM SOC, V116, P7098, DOI 10.1021/ja00095a013; Nordt SP, 2011, J EMERG MED, V40, P397, DOI 10.1016/j.jemermed.2009.05.004; Reimer JD, 2007, ZOOL SCI, V24, P346, DOI 10.2108/zsj.24.346; Reimer James Davis, 2010, Marine Biodiversity, V40, P237, DOI 10.1007/s12526-010-0044-1; Reimer JD, 2004, ZOOL SCI, V21, P517, DOI 10.2108/zsj.21.517; Riobo P, 2008, FOOD CHEM TOXICOL, V46, P2639, DOI 10.1016/j.fct.2008.04.020; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rossi R, 2010, TOXICON, V56, P1381, DOI 10.1016/j.toxicon.2010.08.003; Ryland JS, 2003, INVERTEBR SYST, V17, P407, DOI 10.1071/IS02008; Sinniger F, 2005, MAR BIOL, V147, P1121, DOI 10.1007/s00227-005-0016-3; Sinniger F, 2008, ZOOL SCI, V25, P1253, DOI 10.2108/zsj.25.1253; Tubaro A, 2011, TOXICON, V57, P478, DOI 10.1016/j.toxicon.2011.01.005; UEMURA D, 1981, TETRAHEDRON LETT, V22, P2781, DOI 10.1016/S0040-4039(01)90551-9; UEMURA D, 1985, TETRAHEDRON, V41, P1007, DOI 10.1016/S0040-4020(01)96468-3; Ukena T, 2001, BIOSCI BIOTECH BIOCH, V65, P2585, DOI 10.1271/bbb.65.2585; WALSH GE, 1971, ZOOL J LINN SOC-LOND, V50, P161, DOI 10.1111/j.1096-3642.1971.tb00757.x; WILES JS, 1974, TOXICON, V12, P427, DOI 10.1016/0041-0101(74)90011-7	39	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18235	10.1371/journal.pone.0018235	http://dx.doi.org/10.1371/journal.pone.0018235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483745	Green Submitted, Green Published, gold			2022-12-27	WOS:000289058700015
J	Schneider, KA; Peischl, S				Schneider, Kristan A.; Peischl, Stephan			Evolution of Assortative Mating in a Population Expressing Dominance	PLOS ONE			English	Article							DEPENDENT INTRASPECIFIC COMPETITION; AFRICAN FINCH PYRENESTES; BILL SIZE POLYMORPHISM; LONG-TERM EVOLUTION; DISRUPTIVE SELECTION; SYMPATRIC SPECIATION; REPRODUCTIVE ISOLATION; ADAPTIVE-DYNAMICS; NICHE WIDTH; MODEL	In this article, we study the influence of dominance on the evolution of assortative mating. We perform a population-genetic analysis of a two-locus two-allele model. We consider a quantitative trait that is under a mixture of frequency-independent stabilizing selection and density-and frequency-dependent selection caused by intraspecific competition for a continuum of resources. The trait is determined by a single (ecological) locus and expresses intermediate dominance. The second (modifier) locus determines the degree of assortative mating, which is expressed in females only. Assortative mating is based on similarities in the quantitative trait ('magic trait' model). Analytical conditions for the invasion of assortment modifiers are derived in the limit of weak selection and weak assortment. For the full model, extensive numerical iterations are performed to study the global dynamics. This allows us to gain a better understanding of the interaction of the different selective forces. Remarkably, depending on the size of modifier effects, dominance can have different effects on the evolution of assortment. We show that dominance hinders the evolution of assortment if modifier effects are small, but promotes it if modifier effects are large. These findings differ from those in previous work based on adaptive dynamics.	[Schneider, Kristan A.; Peischl, Stephan] Univ Vienna, Dept Math, Vienna, Austria	University of Vienna	Schneider, KA (corresponding author), Univ Vienna, Dept Math, Vienna, Austria.	kristan.schneider@univie.ac.at	Peischl, Stephan/AAT-3078-2020	Peischl, Stephan/0000-0002-0474-6104; Schneider, Kristan/0000-0003-4138-1180	Austrian Science Foundation (FWF) [P21305-N13]; Vienna Science and Technology Fund (WWTF); Austrian Science Fund (FWF) [P 21305] Funding Source: researchfish	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Vienna Science and Technology Fund (WWTF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants of the Austrian Science Foundation (FWF) (P21305-N13) to R. Burger and the Vienna Science and Technology Fund (WWTF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2004, EVOLUTION, V58, P2599; Barton NH, 2009, EVOLUTION, V63, P1171, DOI 10.1111/j.1558-5646.2009.00622.x; Bolnick DI, 2006, J THEOR BIOL, V241, P734, DOI 10.1016/j.jtbi.2006.01.009; Burger R, 2006, EVOLUTION, V60, P2185; BULMER MG, 1974, AM NAT, V108, P45, DOI 10.1086/282884; Bulmer MG, 1980, MATH THEORY QUANTITA; Burger R, 2005, J MATH BIOL, V50, P355, DOI 10.1007/s00285-004-0294-2; Burger R, 2006, AM NAT, V167, P190, DOI 10.1086/499375; CHRISTIANSEN FB, 1980, THEOR POPUL BIOL, V18, P297, DOI 10.1016/0040-5809(80)90056-8; CROSBY JL, 1970, HEREDITY, V25, P253, DOI 10.1038/hdy.1970.30; De Cara MAR, 2008, AM NAT, V171, P580, DOI 10.1086/587062; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Doebeli M, 1996, J EVOLUTION BIOL, V9, P893, DOI 10.1046/j.1420-9101.1996.9060893.x; Doebeli M, 2005, J EVOLUTION BIOL, V18, P1194, DOI 10.1111/j.1420-9101.2005.00912.x; Doebeli M, 2007, P ROY SOC B-BIOL SCI, V274, P347, DOI 10.1098/rspb.2006.3725; DURINX M, 2008, ASSORTATIVE MATE CHO; EPSTEIN E, 1984, SOC BIOL, V31, P243; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; GARRISON RJ, 1968, EUGEN QUART, V15, P113, DOI 10.1080/19485565.1968.9987762; Gavrilets S, 1998, AM NAT, V152, P706, DOI 10.1086/286201; GAVRILETS S, 2004, MONOGRAPHS POPULATIO, V41; HO HZ, 1986, SOC BIOL, V33, P77; Kondrashov AS, 1999, NATURE, V400, P351, DOI 10.1038/22514; Kopp M, 2008, J EVOLUTION BIOL, V21, P1005, DOI 10.1111/j.1420-9101.2008.01547.x; Kopp M, 2006, EVOLUTION, V60, P1537; Leimar O, 2005, AM NAT, V165, P669, DOI 10.1086/429566; Matessi C, 2006, THEOR POPUL BIOL, V69, P283, DOI 10.1016/j.tpb.2005.08.007; Matessi C, 2001, SELECTION, V2, P41, DOI DOI 10.1556/SELECT.2.2001.1-2.4); MOORE WS, 1979, HEREDITY, V42, P173, DOI 10.1038/hdy.1979.21; O'DONALD P., 1960, HEREDITY, V15, P389, DOI 10.1038/hdy.1960.104; Otto SP, 2008, GENETICS, V179, P2091, DOI 10.1534/genetics.107.084418; Peischl S, 2008, J THEOR BIOL, V251, P210, DOI 10.1016/j.jtbi.2007.11.014; Peischl S, 2010, EVOLUTION, V64, P561, DOI 10.1111/j.1558-5646.2009.00839.x; Pennings PS, 2008, AM NAT, V171, pE44, DOI 10.1086/523952; RETTELBACH A, 2010, THEORETICAL IN PRESS; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; Rueffler C, 2006, TRENDS ECOL EVOL, V21, P238, DOI 10.1016/j.tree.2006.03.003; Schneider KA, 2006, J EVOLUTION BIOL, V19, P570, DOI 10.1111/j.1420-9101.2005.01001.x; Schneider KA, 2006, J MATH BIOL, V52, P483, DOI 10.1007/s00285-005-0355-1; Schneider KA, 2007, THEOR POPUL BIOL, V71, P342, DOI 10.1016/j.tpb.2006.11.003; Slabbekoorn H, 2000, BIOL J LINN SOC, V71, P737, DOI 10.1006/bijl.2000.0472; SLATKIN M, 1979, GENETICS, V93, P755; SMITH TB, 1993, NATURE, V363, P618, DOI 10.1038/363618a0; SMITH TB, 1990, ECOLOGY, V71, P1246, DOI 10.2307/1938261; SPUHLER JN, 1968, EUGEN QUART, V15, P128, DOI 10.1080/19485565.1968.9987763; UDOVIC D, 1980, AM NAT, V116, P621, DOI 10.1086/283654; Van Dooren TJM, 2004, EVOL ECOL RES, V6, P857; Van Doorn GS, 2006, EVOLUTION, V60, P2226, DOI 10.1554/06-291.1; Waxman D, 2005, J EVOLUTION BIOL, V18, P1214, DOI 10.1111/j.1420-9101.2005.00953.x; WILSON DS, 1986, AM NAT, V127, P835, DOI 10.1086/284528	50	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e16821	10.1371/journal.pone.0016821	http://dx.doi.org/10.1371/journal.pone.0016821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483775	Green Published, Green Submitted, gold			2022-12-27	WOS:000289058300001
J	Yang, WY; Cheng, TC; Ye, MQ; Deng, XJ; Yi, HY; Huang, YD; Tan, XA; Han, D; Wang, B; Xiang, ZH; Cao, Y; Xia, QY				Yang, Wanying; Cheng, Tingcai; Ye, Mingqiang; Deng, Xiaojuan; Yi, Huiyu; Huang, Yadong; Tan, Xiang; Han, Dong; Wang, Bo; Xiang, Zhonghuai; Cao, Yang; Xia, Qingyou			Functional Divergence among Silkworm Antimicrobial Peptide Paralogs by the Activities of Recombinant Proteins and the Induced Expression Profiles	PLOS ONE			English	Article							DROSOPHILA IMMUNE-RESPONSE; GENOME-WIDE ANALYSIS; ANTIBACTERIAL PEPTIDE; GENE-EXPRESSION; INSECT IMMUNITY; DIFFERENTIAL DISPLAY; ANTIFUNGAL PEPTIDE; HOST-DEFENSE; EVOLUTION; GLOVERIN	Antimicrobial peptides are small-molecule proteins that are usually encoded by multiple-gene families. They play crucial roles in the innate immune response, but reports on the functional divergence of antimicrobial peptide gene families are rare. In this study, 14 paralogs of antimicrobial peptides belonging to cecropin, moricin and gloverin families were recombinantly expressed in pET expression systems. By antimicrobial activity tests, peptides representing paralogs in the same family of cecropin and moricin families, displayed remarkable differences against 10 tested bacteria. The evolutionary rates were relatively fast in the two families, which presented obvious functional divergence among paralogs of each family. Four peptides of gloverin family had similar antimicrobial spectrum and activity against tested bacteria. The gloverin family showed similar antimicrobial function and slow evolutionary rates. By induced transcriptional activity, genes encoding active antimicrobial peptides were upregulated at obviously different levels when silkworm pupae were infected by three types of microbes. Association analysis of antimicrobial activities and induced transcriptional activities indicated that the antimicrobial activities might be positively correlated with induced transcriptional activities in the cecropin and moricin families. These results suggest that representative BmcecB6, BmcecD and Bmmor as the major effector genes have broad antimicrobial spectrum, strong antimicrobial activity and high microbe-induced expression among each family and maybe play crucial roles in eliminating microbial infection.	[Yang, Wanying; Ye, Mingqiang; Deng, Xiaojuan; Yi, Huiyu; Han, Dong; Cao, Yang] S China Agr Univ, Lab Insect Mol Biol & Biotechnol, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Cheng, Tingcai; Xia, Qingyou] Chongqing Univ, Inst Agr & Life Sci, Chongqing 630044, Peoples R China; [Tan, Xiang; Wang, Bo; Xiang, Zhonghuai; Xia, Qingyou] Southwest Univ, Inst Sericulture & Syst Biol, Chongqing, Peoples R China; [Huang, Yadong] Jinan Univ, Biopharmaceut Res & Dev Ctr, Guangzhou, Guangdong, Peoples R China; [Ye, Mingqiang] Guangdong Acad Agr Sci, Sericulture & Agri Food Res Inst, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Chongqing University; Southwest University - China; Jinan University; Guangdong Academy of Agricultural Sciences	Yang, WY (corresponding author), S China Agr Univ, Lab Insect Mol Biol & Biotechnol, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China.	caoyang@scau.edu.cn; xiaqy@swu.edu.cn		cheng, tingcai/0000-0002-3862-0817	Fund for Foreign Scholars in University Research and Teaching programs [B07045]; National Basic Research Program of China [2005CB121002]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0750]; National Natural Science Foundation [31001034]; Chongqing Natural Science Foundation [2009BB1368]	Fund for Foreign Scholars in University Research and Teaching programs; National Basic Research Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing)	This work was supported by grants from the Fund for Foreign Scholars in University Research and Teaching programs (No. B07045, to ZX), the National Basic Research Program of China (No. 2005CB121002, to YC), the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT0750, to QX), National Natural Science Foundation (No. 31001034, to TC), and the Chongqing Natural Science Foundation (2009BB1368, to TC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLING B, 1995, INSECT BIOCHEM MOLEC, V25, P511, DOI 10.1016/0965-1748(94)00091-C; Axen A, 1997, EUR J BIOCHEM, V247, P614, DOI 10.1111/j.1432-1033.1997.00614.x; BULET P, 1993, J BIOL CHEM, V268, P14893; Cheng TC, 2006, GENOMICS, V87, P356, DOI 10.1016/j.ygeno.2005.11.018; Dai HE, 2008, J PEPT SCI, V14, P855, DOI 10.1002/psc.1016; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Deng XJ, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/315423; DIMARCQ JL, 1994, EUR J BIOCHEM, V221, P201, DOI 10.1111/j.1432-1033.1994.tb18730.x; Duda TF, 2002, MOL BIOL EVOL, V19, P858, DOI 10.1093/oxfordjournals.molbev.a004143; Ekengren S, 1999, INSECT BIOCHEM MOLEC, V29, P965, DOI 10.1016/S0965-1748(99)00071-5; FEHLBAUM P, 1994, J BIOL CHEM, V269, P33159; Furukawa S, 1999, BIOCHEM J, V340, P265, DOI 10.1042/0264-6021:3400265; HARA S, 1995, J BIOL CHEM, V270, P29923, DOI 10.1074/jbc.270.50.29923; Hemmi H, 2002, FEBS LETT, V518, P33, DOI 10.1016/S0014-5793(02)02637-6; Hetru C, 2003, J INFECT DIS, V187, pS327, DOI 10.1086/374758; HULTMARK D, 1980, EUR J BIOCHEM, V106, P7, DOI 10.1111/j.1432-1033.1980.tb05991.x; Jiggins FM, 2005, GENETICS, V171, P1847, DOI 10.1534/genetics.105.045435; Kang C, 2008, J MICROBIOL, V46, P656, DOI 10.1007/s12275-008-0214-z; KATO Y, 1993, INSECT BIOCHEM MOLEC, V23, P285, DOI 10.1016/0965-1748(93)90009-H; Kawaoka S, 2008, ARCH INSECT BIOCHEM, V67, P87, DOI 10.1002/arch.20223; Kuimelis R G, 1997, Nucleic Acids Symp Ser, P255; Lee WH, 2005, EUR J IMMUNOL, V35, P1220, DOI 10.1002/eji.200425615; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LEVASHINA EA, 1995, EUR J BIOCHEM, V233, P694, DOI 10.1111/j.1432-1033.1995.694_2.x; Lundstrom A, 2002, INSECT BIOCHEM MOLEC, V32, P795, DOI 10.1016/S0965-1748(01)00162-X; Mackintosh JA, 1998, DEV COMP IMMUNOL, V22, P387, DOI 10.1016/S0145-305X(98)00025-1; MORISHIMA I, 1990, COMP BIOCHEM PHYS B, V95, P551, DOI 10.1016/0305-0491(90)90019-P; Mrinal N, 2008, J BIOL CHEM, V283, P23376, DOI 10.1074/jbc.M801080200; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Oizumi Y, 2005, BBA-PROTEINS PROTEOM, V1752, P83, DOI 10.1016/j.bbapap.2005.07.013; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; SAMAKOVLIS C, 1990, EMBO J, V9, P2969, DOI 10.1002/j.1460-2075.1990.tb07489.x; Seitz V, 2003, DEV COMP IMMUNOL, V27, P207, DOI 10.1016/S0145-305X(02)00097-6; Silva JLC, 2010, BRAZ J MED BIOL RES, V43, P431, DOI 10.1590/S0100-879X2010005000010; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Tennessen JA, 2005, J MOL EVOL, V61, P445, DOI 10.1007/s00239-004-0330-2; Tennessen JA, 2007, J MOL EVOL, V65, P605, DOI 10.1007/s00239-007-9045-5; Tian CH, 2008, MOL IMMUNOL, V45, P3909, DOI 10.1016/j.molimm.2008.06.025; Uttenweiler-Joseph S, 1998, P NATL ACAD SCI USA, V95, P11342, DOI 10.1073/pnas.95.19.11342; WICKER C, 1990, J BIOL CHEM, V265, P22493; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yang J, 1999, COMP BIOCHEM PHYS B, V122, P409, DOI 10.1016/S0305-0491(99)00015-2; Yang WY, 2006, GENE, V379, P26, DOI 10.1016/j.gene.2006.03.017; Zhu Y, 2003, INSECT BIOCHEM MOLEC, V33, P541, DOI 10.1016/S0965-1748(03)00028-6	48	24	35	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18109	10.1371/journal.pone.0018109	http://dx.doi.org/10.1371/journal.pone.0018109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479226	gold, Green Submitted, Green Published			2022-12-27	WOS:000289054600028
J	Marchi, N; Granata, T; Freri, E; Ciusani, E; Ragona, F; Puvenna, V; Teng, QS; Alexopolous, A; Janigro, D				Marchi, Nicola; Granata, Tiziana; Freri, Elena; Ciusani, Emilio; Ragona, Francesca; Puvenna, Vikram; Teng, Quingshan; Alexopolous, Andreas; Janigro, Damir			Efficacy of Anti-Inflammatory Therapy in a Model of Acute Seizures and in a Population of Pediatric Drug Resistant Epileptics	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; TEMPORAL-LOBE EPILEPSY; IN-VITRO; RASMUSSENS-SYNDROME; INFANTILE SPASMS; HMPAO SPECT; DISRUPTION; PILOCARPINE; EPILEPTOGENESIS; CHILDHOOD	Targeting pro-inflammatory events to reduce seizures is gaining momentum. Experimentally, antagonism of inflammatory processes and of blood-brain barrier (BBB) damage has been demonstrated to be beneficial in reducing status epilepticus (SE). Clinically, a role of inflammation in the pathophysiology of drug resistant epilepsies is suspected. However, the use anti-inflammatory drug such as glucocorticosteroids (GCs) is limited to selected pediatric epileptic syndromes and spasms. Lack of animal data may be one of the reasons for the limited use of GCs in epilepsy. We evaluated the effect of the CG dexamethasone in reducing the onset and the severity of pilocarpine SE in rats. We assessed BBB integrity by measuring serum S100 beta and Evans Blue brain extravasation. Electrophysiological monitoring and hematologic measurements (WBCs and IL-1 beta) were performed. We reviewed the effect of add on dexamethasone treatment on a population of pediatric patients affected by drug resistant epilepsy. We excluded subjects affected by West, Landau-Kleffner or Lennox-Gastaut syndromes and Rasmussen encephalitis, known to respond to GCs or adrenocorticotropic hormone (ACTH). The effect of two additional GCs, methylprednisolone and hydrocortisone, was also reviewed in this population. When dexamethasone treatment preceded exposure to the convulsive agent pilocarpine, the number of rats developing status epilepticus (SE) was reduced. When SE developed, the time-to-onset was significantly delayed compared to pilocarpine alone and mortality associated with pilocarpine-SE was abolished. Dexamethasone significantly protected the BBB from damage. The clinical study included pediatric drug resistant epileptic subjects receiving add on GC treatments. Decreased seizure frequency (>= 50%) or interruption of status epilepticus was observed in the majority of the subjects, regardless of the underlying pathology. Our experimental results point to a seizure-reducing effect of dexamethasone. The mechanism encompasses improvement of BBB integrity. Our results also suggest that add on GCs could be of efficacy in controlling pediatric drug resistant seizures.	[Teng, Quingshan; Janigro, Damir] Cleveland Clin Fdn, Dept Neurol Surg, Cleveland, OH 44195 USA; [Janigro, Damir] Cleveland Clin Fdn, Dept Mol Med, Cleveland, OH 44195 USA; [Marchi, Nicola; Puvenna, Vikram; Janigro, Damir] Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA; [Alexopolous, Andreas] Cleveland Clin Fdn, Epilepsy Ctr, Cleveland, OH 44195 USA; [Granata, Tiziana; Freri, Elena; Ciusani, Emilio; Ragona, Francesca] Ist Neurol Besta, Milan, Italy	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; IRCCS Istituto Neurologico Besta	Marchi, N (corresponding author), Cleveland Clin Fdn, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	janigrd@ccf.org	Ciusani, Emilio/J-9822-2016; Granata, Tiziana/J-9012-2016; Marchi, Nicola/J-8607-2016; Ragona, Francesca/K-9699-2016; Freri, Elena/J-8341-2016	Ciusani, Emilio/0000-0002-7285-123X; Granata, Tiziana/0000-0002-0170-6836; Marchi, Nicola/0000-0001-9124-0226; Ragona, Francesca/0000-0003-1399-8271; Freri, Elena/0000-0002-2293-8687; Janigro, Damir/0000-0003-2165-5826	Cleveland Clinic-Swedish Satellite Laboratory Feasibility Project, Federal Appropriation Washington State;  [RO1 NS43284];  [RO1 NS38195];  [R21 HD057256]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043284, R01NS038195] Funding Source: NIH RePORTER	Cleveland Clinic-Swedish Satellite Laboratory Feasibility Project, Federal Appropriation Washington State; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by RO1 NS43284, RO1 NS38195, R21 HD057256 to DJ. Also supported by the Cleveland Clinic-Swedish Satellite Laboratory Feasibility Project, Federal Appropriation Washington State. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez V, 2010, EPILEPSY BEHAV, V17, P302, DOI 10.1016/j.yebeh.2009.12.025; Amato C, 2001, EUR J RADIOL, V38, P50, DOI 10.1016/S0720-048X(00)00284-9; Araki T, 2006, EPILEPSIA, V47, P176, DOI 10.1111/j.1528-1167.2006.00384.x; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; Blair RE, 2009, NEUROSCI LETT, V453, P233, DOI 10.1016/j.neulet.2009.02.035; CARMEN J, 1993, J NATL MED ASSOC, V85, P301; Cornford E M, 1999, Adv Neurol, V79, P845; Cornford EM, 2000, AM J PHYSIOL-HEART C, V279, pH1346, DOI 10.1152/ajpheart.2000.279.3.H1346; Cucullo L, 2004, BRAIN RES, V997, P147, DOI 10.1016/j.brainres.2003.09.079; Elkassabany NM, 2008, J NEUROSURG ANESTH, V20, P45, DOI 10.1097/ANA.0b013e31815d5f1f; Fabene PF, 2008, NAT MED, V14, P1377, DOI 10.1038/nm.1878; Granata T, 2003, NEUROL SCI, V24, pS239, DOI 10.1007/s10072-003-0086-2; Granata T, 2003, NEUROLOGY, V60, P422, DOI 10.1212/WNL.60.3.422; Grosso S, 2008, EPILEPSY RES, V81, P80, DOI 10.1016/j.eplepsyres.2008.04.016; Gutin P H, 1975, Semin Oncol, V2, P49; Hermsen CC, 1998, J INFECT DIS, V178, P1225, DOI 10.1086/515691; HUANG CC, 1995, EUR NEUROL, V35, P199, DOI 10.1159/000117128; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Ivens S, 2010, J NEUROL, V257, P615, DOI 10.1007/s00415-009-5384-z; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; KWAN P, 2009, EPILEPSIA; Lansberg MG, 1999, NEUROLOGY, V52, P1021, DOI 10.1212/WNL.52.5.1021; LEITE JP, 1995, EPILEPSY RES, V20, P93, DOI 10.1016/0920-1211(94)00070-D; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; MARCHI N, 2010, BRAIN RES; Marchi N, 2007, EPILEPSIA, V48, P1934, DOI 10.1111/j.1528-1167.2007.01185.x; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi N, 2009, NEUROBIOL DIS, V33, P171, DOI 10.1016/j.nbd.2008.10.002; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Paladin F, 1998, ITAL J NEUROL SCI, V19, P217, DOI 10.1007/BF02427604; Paladin F, 1999, ITAL J NEUROL SCI, V20, P237, DOI 10.1007/s100720050037; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Razani-Boroujerdi S, 2008, J NEUROIMMUNOL, V194, P83, DOI 10.1016/j.jneuroim.2007.11.019; Riazi K, 2010, EPILEPSY RES, V89, P34, DOI 10.1016/j.eplepsyres.2009.09.004; Rogawski MA, 2002, INT REV NEUROBIOL, V49, P199; Rook GAW, 1999, BEST PRACT RES CL EN, V13, P567, DOI 10.1053/beem.1999.0044; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Sevilla-Castillo RA, 2009, NEUROPEDIATRICS, V40, P265, DOI 10.1055/s-0030-1249653; SIEMES H, 1984, EPILEPSIA, V25, P368, DOI 10.1111/j.1528-1157.1984.tb04202.x; Sinclair DB, 2003, PEDIATR NEUROL, V28, P194, DOI 10.1016/S0887-8994(02)00513-1; SNEAD OC, 1983, NEUROLOGY, V33, P966, DOI 10.1212/WNL.33.8.966; Stefan H, 2006, ACTA NEUROL SCAND, V113, P139, DOI 10.1111/j.1600-0404.2005.00561.x; Tan KM, 2008, EPILEPSY RES, V82, P190, DOI 10.1016/j.eplepsyres.2008.08.007; Tomkins O, 2007, NEUROBIOL DIS, V25, P367, DOI 10.1016/j.nbd.2006.10.006; Uva L, 2008, NEUROSCIENCE, V151, P303, DOI 10.1016/j.neuroscience.2007.10.037; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Verhelst H, 2005, SEIZURE-EUR J EPILEP, V14, P412, DOI 10.1016/j.seizure.2005.07.002; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2010, CURR OPIN INVEST DR, V11, P43	51	111	118	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18200	10.1371/journal.pone.0018200	http://dx.doi.org/10.1371/journal.pone.0018200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464890	gold, Green Submitted, Green Published			2022-12-27	WOS:000289053800028
J	Nojima, S; Kiemle, DJ; Webster, FX; Apperson, CS; Schal, C				Nojima, Satoshi; Kiemle, David J.; Webster, Francis X.; Apperson, Charles S.; Schal, Coby			Nanogram-Scale Preparation and NMR Analysis for Mass-Limited Small Volatile Compounds	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; MULTIDIMENSIONAL GAS-CHROMATOGRAPHY; PROBE; IDENTIFICATION	Semiochemicals are often produced in infinitesimally small quantities, so their isolation requires large amounts of starting material, not only requiring significant effort in sample preparation, but also resulting in a complex mixture of compounds from which the bioactive compound needs to be purified and identified. Often, compounds cannot be unambiguously identified by their mass spectra alone, and NMR analysis is required for absolute chemical identification, further exacerbating the situation because NMR is relatively insensitive and requires large amounts of pure analyte, generally more than several micrograms. We developed an integrated approach for purification and NMR analysis of <1 mu g of material. Collections from high performance preparative gas-chromatography are directly eluted with minimal NMR solvent into capillary NMR tubes. With this technique, (1)H-NMR spectra were obtained on 50 ng of geranyl acetate, which served as a model compound, and reasonable H-H COSY NMR spectra were obtained from 250 ng of geranyl acetate. This simple off-line integration of preparative GC and NMR will facilitate the purification and chemical identification of novel volatile compounds, such as insect pheromones and other semiochemicals, which occur in minute (sub-nanogram), and often limited, quantities.	[Nojima, Satoshi; Apperson, Charles S.; Schal, Coby] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Nojima, Satoshi; Apperson, Charles S.; Schal, Coby] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Kiemle, David J.; Webster, Francis X.] SUNY Coll Environm Sci & Forestry, Dept Chem, Syracuse, NY 13210 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Nojima, S (corresponding author), Shin Etsu Chem Co Ltd, Tokyo, Japan.	coby_schal@ncsu.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358	NIH-NIAID [1 U01 AI058303-01]; North Carolina State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI058303] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); North Carolina State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a grant from NIH-NIAID (1 U01 AI058303-01) and the Blanton J. Whitmire Endowment at North Carolina State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brey WW, 2006, J MAGN RESON, V179, P290, DOI 10.1016/j.jmr.2005.12.008; Dossey AT, 2006, ACS CHEM BIOL, V1, P511, DOI 10.1021/cb600318u; Eldridge SL, 2008, ADV CHROMATOGR, V46, P351; Eyres GT, 2008, ANAL CHEM, V80, P6293, DOI 10.1021/ac8007847; Eyres GT, 2008, J CHROMATOGR A, V1215, P168, DOI 10.1016/j.chroma.2008.10.102; Grynbaum MD, 2007, ANAL CHEM, V79, P2708, DOI 10.1021/ac0617767; Hu JF, 2005, PHYTOCHEM ANALYSIS, V16, P127, DOI 10.1002/pca.831; Kuhnle M, 2009, J SEP SCI, V32, P719, DOI 10.1002/jssc.200800661; Maguire Y, 2007, P NATL ACAD SCI USA, V104, P9198, DOI 10.1073/pnas.0703001104; Massin C, 2003, J MAGN RESON, V164, P242, DOI 10.1016/S1090-7807(03)00151-4; Nojima S, 2005, SCIENCE, V307, P1104, DOI 10.1126/science.1107163; Nojima S, 2004, J CHEM ECOL, V30, P2153, DOI 10.1023/B:JOEC.0000048780.26118.c0; Nojima S, 2008, J CHEM ECOL, V34, P418, DOI 10.1007/s10886-008-9437-z; Schlotterbeck G, 2002, ANAL CHEM, V74, P4464, DOI 10.1021/ac025556e; Schroeder FC, 2006, ANGEW CHEM INT EDIT, V45, P7122, DOI 10.1002/anie.200601789; WEBSTER FX, 1998, METHODS CHEM ECOLOGY, P153	16	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18178	10.1371/journal.pone.0018178	http://dx.doi.org/10.1371/journal.pone.0018178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464906	Green Submitted, Green Published, gold			2022-12-27	WOS:000289053800025
J	de Vries, SJ; Bonvin, AMJJ				de Vries, Sjoerd J.; Bonvin, Alexandre M. J. J.			CPORT: A Consensus Interface Predictor and Its Performance in Prediction-Driven Docking with HADDOCK	PLOS ONE			English	Article							PROTEIN-PROTEIN DOCKING; INTERACTION-SITE PREDICTION; SUPPORT VECTOR MACHINES; BIOMOLECULAR COMPLEXES; BLIND PREDICTIONS; BINDING-SITES; WEB SERVER; CAPRI; SURFACE; RECOGNITION	Background: Macromolecular complexes are the molecular machines of the cell. Knowledge at the atomic level is essential to understand and influence their function. However, their number is huge and a significant fraction is extremely difficult to study using classical structural methods such as NMR and X-ray crystallography. Therefore, the importance of large-scale computational approaches in structural biology is evident. This study combines two of these computational approaches, interface prediction and docking, to obtain atomic-level structures of protein-protein complexes, starting from their unbound components. Methodology/Principal Findings: Here we combine six interface prediction web servers into a consensus method called CPORT (Consensus Prediction Of interface Residues in Transient complexes). We show that CPORT gives more stable and reliable predictions than each of the individual predictors on its own. A protocol was developed to integrate CPORT predictions into our data-driven docking program HADDOCK. For cases where experimental information is limited, this prediction-driven docking protocol presents an alternative to ab initio docking, the docking of complexes without the use of any information. Prediction-driven docking was performed on a large and diverse set of protein-protein complexes in a blind manner. Our results indicate that the performance of the HADDOCK-CPORT combination is competitive with ZDOCK-ZRANK, a state-of-the-art ab initio docking/scoring combination. Finally, the original interface predictions could be further improved by interface post-prediction (contact analysis of the docking solutions). Conclusions/Significance: The current study shows that blind, prediction-driven docking using CPORT and HADDOCK is competitive with ab initio docking methods. This is encouraging since prediction-driven docking represents the absolute bottom line for data-driven docking: any additional biological knowledge will greatly improve the results obtained by prediction-driven docking alone. Finally, the fact that original interface predictions could be further improved by interface post-prediction suggests that prediction-driven docking has not yet been pushed to the limit. A web server for CPORT is freely available at http://haddock.chem.uu.nl/services/CPORT.	[de Vries, Sjoerd J.; Bonvin, Alexandre M. J. J.] Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Utrecht, Netherlands	Utrecht University	de Vries, SJ (corresponding author), Tech Univ Munich, Munich, Germany.	a.m.j.j.bonvin@uu.nl	Bonvin, Alexandre M.J.J./A-5420-2009	Bonvin, Alexandre M.J.J./0000-0001-7369-1322	Netherlands Organization for Scientific Research [700.56.442]; European Community [032220, 213010]; European Commission Capacities Area - Research Infrastructures Initiative [228398]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission); European Commission Capacities Area - Research Infrastructures Initiative	This work was supported by the Netherlands Organization for Scientific Research (VICI grant # 700.56.442 to AMJJB) and by the European Community (Integrated Project SPINE2-COMPLEX contract no. 032220 and FP7 e-Infrastructure grant, contract no. 213010 - e-NMR). The work was carried out under the HPC-EUROPA2 project (project number: 228398) with the support of the European Commission Capacities Area - Research Infrastructures Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; de Vries SJ, 2006, PROTEINS, V63, P479, DOI 10.1002/prot.20842; de Vries SJ, 2008, CURR PROTEIN PEPT SC, V9, P394, DOI 10.2174/138920308785132712; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; de Vries SJ, 2010, PROTEINS, V78, P3242, DOI 10.1002/prot.22814; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fernandez-Recio J, 2004, J MOL BIOL, V335, P843, DOI 10.1016/j.jmb.2003.10.069; Huang B, 2008, GENE, V422, P14, DOI 10.1016/j.gene.2008.06.014; Hubbard S. J., 1993, NACCESS; HWANG H, PROTEINS, V78, P3104; Hwang H, 2008, PROTEINS, V73, P705, DOI 10.1002/prot.22106; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kufareva I, 2007, PROTEINS, V67, P400, DOI 10.1002/prot.21233; Lensink MF, 2007, PROTEINS, V69, P704, DOI 10.1002/prot.21804; Lensink MF, 2010, PROTEINS, V78, P3085, DOI 10.1002/prot.22850; Lensink MF, 2010, PROTEINS, V78, P3073, DOI 10.1002/prot.22818; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; Liang SD, 2009, PROTEINS, V75, P397, DOI 10.1002/prot.22252; Martin O, 2008, PROTEINS, V70, P1367, DOI 10.1002/prot.21603; MELQUIOND ASJ, 2010, PROTEIN PROTEIN COMP, P183; Mendez R, 2003, PROTEINS, V52, P51, DOI 10.1002/prot.10393; Mintseris J, 2005, PROTEINS, V60, P214, DOI 10.1002/prot.20560; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Pierce B, 2008, PROTEINS, V72, P270, DOI 10.1002/prot.21920; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Qin S, 2007, BIOINFORMATICS, V23, P3386, DOI 10.1093/bioinformatics/btm434; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; van Dijk ADJ, 2005, FEBS J, V272, P293, DOI 10.1111/j.1742-4658.2004.04473.x; Wiehe K, 2007, PROTEINS, V69, P719, DOI 10.1002/prot.21747; Zhou HX, 2007, BIOINFORMATICS, V23, P2203, DOI 10.1093/bioinformatics/btm323	40	189	192	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17695	10.1371/journal.pone.0017695	http://dx.doi.org/10.1371/journal.pone.0017695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464987	gold, Green Submitted, Green Published			2022-12-27	WOS:000288813900005
J	Saupe, EE; Papes, M; Selden, PA; Vetter, RS				Saupe, Erin E.; Papes, Monica; Selden, Paul A.; Vetter, Richard S.			Tracking a Medically Important Spider: Climate Change, Ecological Niche Modeling, and the Brown Recluse (Loxosceles reclusa)	PLOS ONE			English	Article							GEOGRAPHIC DISTRIBUTIONS; SPECIES DISTRIBUTIONS; CHAGAS-DISEASE; AREAS; CONSERVATISM; SICARIIDAE; PREDICTION; RESPONSES; ARANEAE; HABITAT	Most spiders use venom to paralyze their prey and are commonly feared for their potential to cause injury to humans. In North America, one species in particular, Loxosceles reclusa (brown recluse spider, Sicariidae), causes the majority of necrotic wounds induced by the Araneae. However, its distributional limitations are poorly understood and, as a result, medical professionals routinely misdiagnose brown recluse bites outside endemic areas, confusing putative spider bites for other serious conditions. To address the issue of brown recluse distribution, we employ ecological niche modeling to investigate the present and future distributional potential of this species. We delineate range boundaries and demonstrate that under future climate change scenarios, the spider's distribution may expand northward, invading previously unaffected regions of the USA. At present, the spider's range is centered in the USA, from Kansas east to Kentucky and from southern Iowa south to Louisiana. Newly influenced areas may include parts of Nebraska, Minnesota, Wisconsin, Michigan, South Dakota, Ohio, and Pennsylvania. These results illustrate a potential negative consequence of climate change on humans and will aid medical professionals in proper bite identification/treatment, potentially reducing bite misdiagnoses.	[Saupe, Erin E.; Selden, Paul A.] Univ Kansas, Inst Paleontol, Lawrence, KS 66045 USA; [Saupe, Erin E.; Selden, Paul A.] Univ Kansas, Dept Geol, Lawrence, KS 66045 USA; [Papes, Monica] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Selden, Paul A.] Nat Hist Museum, London SW7 5BD, England; [Vetter, Richard S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of Kansas; University of Kansas; University of Wisconsin System; University of Wisconsin Madison; Natural History Museum London; University of California System; University of California Riverside	Saupe, EE (corresponding author), Univ Kansas, Inst Paleontol, Lawrence, KS 66045 USA.	eesaupe@ku.edu	Selden, Paul/C-7530-2009	Selden, Paul/0000-0001-7454-4260; Saupe, Erin/0000-0002-0370-9897	University of Kansas; Paleontological Society; Geological Society of America	University of Kansas; Paleontological Society; Geological Society of America	The authors acknowledge a University of Kansas Self Graduate Fellowship (http://www2.ku.edu/similar to selfpro/), a Paleontological Society Caster Research Grant (http://www.paleosoc.org/grantin.html), and a Geological Society of America Student Research Grant (http://www.geosociety.org/grants/gradgrants.htm) for financial support to EES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], BIODIVERSITY INFORM, DOI DOI 10.1111/jbi.12227; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Binford GJ, 2005, TOXICON, V45, P547, DOI 10.1016/j.toxicon.2004.11.011; Brooker S, 2002, TRENDS PARASITOL, V18, P70, DOI 10.1016/S1471-4922(01)02223-1; Costa J, 2002, AM J TROP MED HYG, V67, P516, DOI 10.4269/ajtmh.2002.67.516; Cramer KL, 2008, J ARACHNOL, V36, P136, DOI 10.1636/Sh06-29.1; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Evangelista PH, 2008, DIVERS DISTRIB, V14, P808, DOI 10.1111/j.1472-4642.2008.00486.x; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Foley DH, 2008, J MED ENTOMOL, V45, P852, DOI 10.1603/0022-2585(2008)45[852:PDOTSI]2.0.CO;2; FUTRELL JM, 1992, AM J MED SCI, V304, P261, DOI 10.1097/00000441-199210000-00008; Gaston JK, 2003, STRUCTURE DYNAMICS G; GERTSCH WJ, 1983, B AM MUS NAT HIST, V175, P265; Giovanelli JGR, 2010, ECOL MODEL, V221, P215, DOI 10.1016/j.ecolmodel.2009.10.009; Glenn JB, 2003, CLIN PEDIATR, V42, P567, DOI 10.1177/000992280304200615; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guralnick RP, 2006, PLOS BIOL, V4, P1908, DOI 10.1371/journal.pbio.0040381; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HITE JM, 1966, AGR EXP STA B, V711, P1; HOLT RD, 1992, EVOL ECOL, V6, P433, DOI 10.1007/BF02270702; HOUGHTON JT, 2001, IPCC 3 ASSESSMENT RE; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Joyner TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009596; Kearney M, 2006, OIKOS, V115, P186, DOI 10.1111/j.2006.0030-1299.14908.x; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Maher SP, 2010, AM J TROP MED HYG, V83, P736, DOI 10.4269/ajtmh.2010.10-0042; Mak S, 2010, J MED ENTOMOL, V47, P99, DOI 10.1603/033.047.0114; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; Neerinckx S, 2010, AM J TROP MED HYG, V82, P492, DOI 10.4269/ajtmh.2010.09-0426; Neerinckx SB, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-54; Ortega-Huerta MA, 2008, REV MEX BIODIVERS, V79, P205; Papes M., 2003, J WUHAN BOT RES, V21, P137; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2008, EVOLUTION, V62, P173, DOI 10.1111/j.1558-5646.2007.00258.x; Peterson AT, 2007, J MAMMAL, V88, P1544, DOI 10.1644/06-MAMM-A-280R1.1; Peterson AT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-59; Peterson AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002441; Peterson AT, 1999, ECOL MODEL, V117, P159, DOI 10.1016/S0304-3800(99)00023-X; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2002, EMERG INFECT DIS, V8, P662, DOI 10.3201/eid0807.010454; Peterson AT, 2001, ECOL MODEL, V144, P21, DOI 10.1016/S0304-3800(01)00345-3; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; PRESSEY RL, 1994, CONSERV BIOL, V8, P662, DOI 10.1046/j.1523-1739.1994.08030662.x; Price Jeff, 2000, Bird Observer (Arlington), V28, P224; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Roura-Pascual N, 2009, BIOL INVASIONS, V11, P1017, DOI 10.1007/s10530-008-9313-3; Rushton SP, 2004, J APPL ECOL, V41, P193, DOI 10.1111/j.0021-8901.2004.00903.x; Sandidge Jamel S., 2005, Transactions of the Kansas Academy of Science, V108, P99, DOI 10.1660/0022-8443(2005)108[0099:BRSARO]2.0.CO;2; SCACHETTIPEREIR.R, 2003, DESKTOPGARP; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Swanson DL, 2005, NEW ENGL J MED, V352, P700, DOI 10.1056/NEJMra041184; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200; Vetter RS, 2008, J ARACHNOL, V36, P150, DOI 10.1636/RSt08-06.1; Vetter RS, 2000, WESTERN J MED, V173, P357, DOI 10.1136/ewjm.173.5.357; Vetter RS, 2005, J MED ENTOMOL, V42, P512, DOI 10.1603/0022-2585(2005)042[0512:ASASBR]2.0.CO;2; Walther GR, 2005, P ROY SOC B-BIOL SCI, V272, P1427, DOI 10.1098/rspb.2005.3119; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wieczorek J, 2004, INT J GEOGR INF SCI, V18, P745, DOI 10.1080/13658810412331280211; Williams P, 1996, CONSERV BIOL, V10, P155, DOI 10.1046/j.1523-1739.1996.10010155.x	85	43	45	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17731	10.1371/journal.pone.0017731	http://dx.doi.org/10.1371/journal.pone.0017731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464985	gold, Green Submitted, Green Published			2022-12-27	WOS:000288813900008
J	Thorup, K; Ortvad, TE; Rabol, J; Holland, RA; Tottrup, AP; Wikelski, M				Thorup, Kasper; Ortvad, Troels Eske; Rabol, Jorgen; Holland, Richard A.; Tottrup, Anders P.; Wikelski, Martin			Juvenile Songbirds Compensate for Displacement to Oceanic Islands during Autumn Migration	PLOS ONE			English	Article							SEA-TURTLES; ANIMAL NAVIGATION; BIRD MIGRATION; MAGNETIC CUES; ORIENTATION; MIGRANTS; PASSERINES; COMPASS; SYSTEM; TIME	To what degree juvenile migrant birds are able to correct for orientation errors or wind drift is still largely unknown. We studied the orientation of passerines on the Faroe Islands far off the normal migration routes of European migrants. The ability to compensate for displacement was tested in naturally occurring vagrants presumably displaced by wind and in birds experimentally displaced 1100 km from Denmark to the Faroes. The orientation was studied in orientation cages as well as in the free-flying birds after release by tracking departures using small radio transmitters. Both the naturally displaced and the experimentally displaced birds oriented in more easterly directions on the Faroes than was observed in Denmark prior to displacement. This pattern was even more pronounced in departure directions, perhaps because of wind influence. The clear directional compensation found even in experimentally displaced birds indicates that first-year birds can also possess the ability to correct for displacement in some circumstances, possibly involving either some primitive form of true navigation, or 'sign posts', but the cues used for this are highly speculative. We also found some indications of differences between species in the reaction to displacement. Such differences might be involved in the diversity of results reported in displacement studies so far.	[Thorup, Kasper; Ortvad, Troels Eske; Rabol, Jorgen] Univ Copenhagen, Zool Museum, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen, Denmark; [Holland, Richard A.; Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Tottrup, Anders P.] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen, Denmark	University of Copenhagen; Max Planck Society; University of Copenhagen	Thorup, K (corresponding author), Univ Copenhagen, Zool Museum, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen, Denmark.	kthorup@snm.ku.dk	Holland, Richard A/A-6107-2010; Tøttrup, Anders P/N-3836-2013; Thorup, Kasper/A-4835-2013	Holland, Richard A/0000-0003-4495-8061; Tøttrup, Anders P/0000-0001-8776-9629; Thorup, Kasper/0000-0002-0320-0601	Danish Council for Independent Research; Division Of Integrative Organismal Systems [0744704] Funding Source: National Science Foundation	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	K. Thorup was supported by a grant from the Danish Council for Independent Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson S, 2005, CURR BIOL, V15, P1591, DOI 10.1016/j.cub.2005.07.027; AKESSON S, 1993, ORNIS SCAND, V24, P87, DOI 10.2307/3676357; Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; Alerstam T, 2006, SCIENCE, V313, P791, DOI 10.1126/science.1129048; Batschelet E, 1981, CIRCULAR STAT BIOL; Beck W., 1988, P1955; Berthold P, 1996, CONTROL BIRD MIGRATI; Bingman VP, 2005, ETHOL ECOL EVOL, V17, P295; Bostrom J, 2010, BEHAV ECOL SOCIOBIOL, V64, P1725, DOI 10.1007/s00265-010-0985-1; Chernetsov N, 2008, CURR BIOL, V18, P188, DOI 10.1016/j.cub.2008.01.018; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Fair J., 2010, ORNITHOLOGICAL COUNC; Fischer JH, 2003, AVIAN MIGRATION, P423; Fitzgerald TM, 2008, BEHAV ECOL SOCIOBIOL, V62, P1499, DOI 10.1007/s00265-008-0579-3; Fransson T, 2001, NATURE, V414, P35, DOI 10.1038/35102115; Gauthreaux SA, 1978, ANIMAL MIGRATION NAV, P219; Gould JL, 2008, CURR BIOL, V18, pR214, DOI 10.1016/j.cub.2008.01.011; Gschweng M, 2008, P ROY SOC B-BIOL SCI, V275, P2887, DOI 10.1098/rspb.2008.0575; Gwinner E., 1972, ANIMAL ORIENTATION N, P321; Holland RA, 2010, J R SOC INTERFACE, V7, P1617, DOI 10.1098/rsif.2010.0159; Kullberg C, 2003, P ROY SOC B-BIOL SCI, V270, P373, DOI 10.1098/rspb.2002.2273; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; Lohmann KJ, 1996, J EXP BIOL, V199, P73; LOHMANN KJ, 1994, J EXP BIOL, V194, P23; MOORE FR, 1990, AUK, V107, P245; Mouritsen H, 1998, J EXP BIOL, V201, P2927; Mouritsen H, 2001, J EXP BIOL, V204, P3855; PERDECK A. C., 1958, ARDEA, V46, P1; RABOL J, 1985, Dansk Ornitologisk Forenings Tidsskrift, V79, P133; RABOL J, 1979, ORNIS SCAND, V10, P69, DOI 10.2307/3676346; Reilly JR, 2009, J ANIM ECOL, V78, P990, DOI 10.1111/j.1365-2656.2009.01576.x; Thorup K, 2001, J AVIAN BIOL, V32, P111, DOI 10.1034/j.1600-048X.2001.320203.x; Thorup K, 2007, P NATL ACAD SCI USA, V104, P18115, DOI 10.1073/pnas.0704734104; Thorup K, 2007, BEHAV ECOL SOCIOBIOL, V61, P825, DOI 10.1007/s00265-006-0306-x; Thorup K, 2010, INTEGR COMP BIOL, V50, P315, DOI 10.1093/icb/icq065; Thorup Kasper, 2000, Animal Behaviour Forum, V60, pF3; Wallraff HG., 2005, AVIAN NAVIGATION PIG; WIEDNER DS, 1992, AUK, V109, P500; Wikelski M, 2007, J EXP BIOL, V210, P181, DOI 10.1242/jeb.02629	39	32	33	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17903	10.1371/journal.pone.0017903	http://dx.doi.org/10.1371/journal.pone.0017903			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464975	Green Published, gold, Green Submitted			2022-12-27	WOS:000288813900016
J	Todaro, MA; Kanneby, T; Dal Zotto, M; Jondelius, U				Todaro, M. Antonio; Kanneby, Tobias; Dal Zotto, Matteo; Jondelius, Ulf			Phylogeny of Thaumastodermatidae (Gastrotricha: Macrodasyida) Inferred from Nuclear and Mitochondrial Sequence Data	PLOS ONE			English	Article							TETRANCHYRODERMA GASTROTRICHA; MARINE GASTROTRICHS; 18S; TREE; EVOLUTION; POSITION; BASAL; GNATHOSTOMULIDA; ULTRASTRUCTURE; MORPHOLOGY	Background: Phylogenetic relationships within Gastrotricha are poorly known. Attempts to shed light on this subject using morphological traits have led to hypotheses lacking satisfactory statistical support; it seemed therefore that a different approach was needed. Methodology/Principal Findings: In this paper we attempt to elucidate the relationships within the taxonomically vast family Thaumastodermatidae (Macrodasyida) using molecular sequence data. The study includes representatives of all the extant genera of the family and for the first time uses a multi-gene approach to infer evolutionary liaisons within Gastrotricha. The final data set comprises sequences of three genes (18S, 28S rDNA and COI mtDNA) from 41 species, including 29 thaumastodermatids, 11 non-thaumastodermatid macrodasyidans and a single chaetonotidan. Molecular data was analyzed as a combined set of 3 genes and as individual genes, using Bayesian and maximum likelihood approaches. Two different outgroups were used: Xenotrichula intermedia (Chaetonotida) and members of the putative basal Dactylopodola (Macrodasyida). Thaumastodermatidae and all other sampled macrodasyidan families were found monophyletic except for Cephalodasyidae. Within Thaumastodermatidae Diplodasyinae and Thaumastodermatinae are monophyletic and so are most genera. Oregodasys turns out to be the most basal group within Thaumastodermatinae in analyses of the concatenated data set as well as in analyses of the nuclear genes. Thaumastoderma appears as the sister taxon to the remaining species. Surprisingly, Tetranchyroderma is non-monophyletic in our analyses as one group of species clusters with Ptychostomella while another appears as the sister group of Pseudostomella. Conclusions/Significance: Results in general agree with the current classification; however, a revision of the more derived thaumastodermatid taxa seems necessary. We also found that the ostensible COI sequences from several species do not conform to the general invertebrate or any other published mitochondrial genetic code; they may be mitochondrially derived nuclear genes (numts), or one or more modifications of the mitochondrial genetic code within Gastrotricha.	[Todaro, M. Antonio; Dal Zotto, Matteo] Univ Modena & Reggio Emilia, Dept Biol, Modena, Italy; [Kanneby, Tobias; Jondelius, Ulf] Swedish Museum Nat Hist, Dept Invertebrate Zool, S-10405 Stockholm, Sweden	Universita di Modena e Reggio Emilia; Swedish Museum of Natural History	Todaro, MA (corresponding author), Univ Modena & Reggio Emilia, Dept Biol, Modena, Italy.	antonio.todaro@unimore.it	Jondelius, Ulf/A-4992-2009; Jondelius, Ulf/AAF-7943-2020; Todaro, M. Antonio/H-1311-2013	Jondelius, Ulf/0000-0003-2847-2192; Jondelius, Ulf/0000-0003-2847-2192; Todaro, M. Antonio/0000-0002-6353-7281; Kanneby, Tobias/0000-0001-7151-5915; Dal Zotto, Matteo/0000-0003-1386-7626	MIUR; Swedish Taxonomy Initiative (STI)	MIUR(Ministry of Education, Universities and Research (MIUR)); Swedish Taxonomy Initiative (STI)	This study benefited from a MIUR grants to MAT (PRIN-2004 "Contributo della meiofauna alla biodiversiti marina italiana" and PRIN-2007 "Approccio integrato all'identificazione dei Gastrotrichi marini") and from a grant to UJ by the Swedish Taxonomy Initiative (STI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; [Anonymous], HIV SEQUENCE DATABAS; Claparede E., 1867, ANN SCI NAT ZOOL, V8, P16; Dal Zotto Matteo, 2010, Meiofauna Marina, V18, P41; Dujardin F, 1841, HIST NATURELLE ZOOPH, P684; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EHRENBERG CG, 1838, BLICK TIEFERE ORG LE, P386; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gerlach S. A., 1953, Zoologischer Anzeiger, V150, P203; Giribet G, 2000, SYST BIOL, V49, P539, DOI 10.1080/10635159950127385; Guidi L, 2003, ZOOMORPHOLOGY, V122, P135, DOI 10.1007/s00435-003-0079-y; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Hochberg R, 2000, BIOL BULL, V198, P299, DOI 10.2307/1542532; Hochberg R, 2001, INVERTEBR BIOL, V120, P124, DOI 10.1111/j.1744-7410.2001.tb00116.x; Hochberg R, 2010, ZOOTAXA, P1; Huelsenbeck JP, 2005, STAT BIOL HEALTH, P183, DOI 10.1007/0-387-27733-1_7; HUMMON WD, 1993, B ZOOL, V60, P109, DOI 10.1080/11250009309355798; Hummon WD, 2010, ZOOTAXA, P1; Hummon WD, 2009, ZOOTAXA, P47, DOI 10.11646/zootaxa.2278.1.3; Hyman LH, 1951, INVERTEBRATES, V3, P53; Kieneke A, 2008, ZOOL SCR, V37, P429, DOI 10.1111/j.1463-6409.2008.00334.x; Leasi F, 2010, J MAR BIOL ASSOC UK, V90, P645, DOI 10.1017/S0025315409991068; Lee JM, 2003, ZOOL SCI, V20, P481, DOI 10.2108/zsj.20.481; Levi C., 1950, Archives de Zoologie Experimentale et Generale Paris, V87, P31; Littlewood DTJ, 1998, MOL PHYLOGENET EVOL, V9, P72, DOI 10.1006/mpev.1997.0448; Ludwig H., 1875, Z WISS ZOOL, V26, P193; LUPORINI P, 1970, PUBBL STAZ ZOOL NAPO, V38, P267; Maddison W., 2018, MESQUITE MODULAR SYS; Manylov OG, 2004, MOL PHYLOGENET EVOL, V30, P850, DOI 10.1016/S1055-7903(03)00251-3; Marotta Roberto, 2005, Meiofauna Marina, V14, P9; Noren M, 1999, CLADISTICS, V15, P103, DOI 10.1111/j.1096-0031.1999.tb00252.x; Peterson KJ, 2001, EVOL DEV, V3, P170, DOI 10.1046/j.1525-142x.2001.003003170.x; Petrov NB, 2007, MOL BIOL+, V41, P445, DOI 10.1134/S0026893307030107; RAMBAUT A, 2006, FIGTREE V1 1 2; REMANE A, 1927, TIERWELT NORD OSTSEE, P1; RIEGER GE, 1977, Z ZOOL SYST EVOL, V15, P81; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rothe Birgen H., 2010, Meiofauna Marina, V18, P49; Ruppert E.E., 1991, P41; RUPPERT EE, 1982, ZOOMORPHOLOGY, V99, P181, DOI 10.1007/BF00312295; RUPPERT EE, 1978, ZOOL SCR, V7, P93, DOI 10.1111/j.1463-6409.1978.tb00592.x; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schmidt-Rhaesa A, 1998, J MORPHOL, V238, P263, DOI 10.1002/(SICI)1097-4687(199812)238:3<263::AID-JMOR1>3.0.CO;2-L; Schultze M, 1853, MULLERS ARCH ANATOMI, V6, P241; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stamatakis A., 2006, P INT PAR DISTR PROC; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Telford MJ, 2003, P ROY SOC B-BIOL SCI, V270, P1077, DOI 10.1098/rspb.2003.2342; Todaro MA, 2006, ZOOL SCR, V35, P251, DOI 10.1111/j.1463-6409.2006.00228.x; Todaro M. Antonio, 2008, Meiofauna Marina, V16, P3; Todaro MA, 2002, J MAR BIOL ASSOC UK, V82, P555, DOI 10.1017/S0025315402005878; TODARO MA, 1992, B ZOOL, V59, P471, DOI 10.1080/11250009209386709; TONGIORGI P, 1984, B ZOOL, V51, P335, DOI 10.1080/11250008409439471; TRAVIS PB, 1983, Z ZOOL SYST EVOL, V21, P52; Wallberg A, 2007, ZOOL SCR, V36, P509, DOI 10.1111/j.1463-6409.2007.00295.x; Willems W. R., 2009, Meiofauna Marina, V17, P1; WINNEPENNINCKX B, 1995, MOL BIOL EVOL, V12, P1132; Wirz A, 1999, MOL PHYLOGENET EVOL, V13, P314, DOI 10.1006/mpev.1999.0650; Zrzavy J, 2003, ZOOL SCR, V32, P61, DOI 10.1046/j.1463-6409.2003.00104.x	62	42	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17892	10.1371/journal.pone.0017892	http://dx.doi.org/10.1371/journal.pone.0017892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455302	Green Submitted, Green Published, gold			2022-12-27	WOS:000288811500013
J	Enblom, A; Lekander, M; Hammar, M; Johnsson, A; Onelov, E; Ingvar, M; Steineck, G; Borjeson, S				Enblom, Anna; Lekander, Mats; Hammar, Mats; Johnsson, Anna; Onelov, Erik; Ingvar, Martin; Steineck, Gunnar; Borjeson, Sussanne			Getting the Grip on Nonspecific Treatment Effects: Emesis in Patients Randomized to Acupuncture or Sham Compared to Patients Receiving Standard Care	PLOS ONE			English	Article							CHEMOTHERAPY-INDUCED NAUSEA; CANCER-PATIENTS; CONTROLLED-TRIAL; PAIN; PROPHYLAXIS; MULTICENTER; ACUPRESSURE; SICKNESS; P6	Background: It is not known whether or not delivering acupuncture triggers mechanisms cited as placebo and if acupuncture or sham reduces radiotherapy-induced emesis more than standard care. Methodology/Principal Findings: Cancer patients receiving radiotherapy over abdominal/pelvic regions were randomized to verum (penetrating) acupuncture (n = 109; 99 provided data) in the alleged antiemetic acupuncture point PC6 or sham acupuncture (n = 106; 101 provided data) performed with a telescopic non-penetrating needle at a sham point 2-3 times/week during the whole radiotherapy period. The acupuncture cohort was compared to a reference cohort receiving standard care (n = 62; 62 provided data). The occurrence of emesis in each group was compared after a mean dose of 27 Gray. Nausea and vomiting were experienced during the preceding week by 37 and 8% in the verum acupuncture group, 38 and 7% in the sham acupuncture group and 63 and 15% in the standard care group, respectively. The lower occurrence of nausea in the acupuncture cohort (verum and sham) compared to patients receiving standard care (37% versus 63%, relative risk (RR) 0.6, 95 % confidence interval (CI) 0.5-0.8) was also true after adjustment for potential confounding factors for nausea (RR 0.8, CI 0.6 to 0.9). Nausea intensity was lower in the acupuncture cohort (78% no nausea, 13% a little, 8% moderate, 1% much) compared to the standard care cohort (52% no nausea, 32% a little, 15% moderate, 2% much) (p = 0.002). The acupuncture cohort expected antiemetic effects from their treatment (95%). Patients who expected nausea had increased risk for nausea compared to patients who expected low risk for nausea (RR 1.6; Cl 1.2-2.4). Conclusions/Significance: Patients treated with verum or sham acupuncture experienced less nausea and vomiting compared to patients receiving standard care, possibly through a general care effect or due to the high level of patient expectancy.	[Enblom, Anna; Borjeson, Sussanne] Linkoping Univ, Div Nursing Sci, Dept Med & Hlth Sci, Linkoping, Sweden; [Enblom, Anna] Vardal Inst, Lund, Sweden; [Enblom, Anna; Lekander, Mats; Ingvar, Martin] Karolinska Inst, Dept Clin Neurosci, Osher Ctr Integrat Med, Stockholm, Sweden; [Lekander, Mats] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Hammar, Mats] Linkoping Univ, Dept Clin & Expt Med Obstet & Gynecol, Linkoping, Sweden; [Johnsson, Anna] Univ Lund Hosp, Dept Oncol, Div Physiotherapy, S-22185 Lund, Sweden; [Onelov, Erik; Steineck, Gunnar] Karolinska Inst, Dept Oncol, Div Clin Canc Epidemiol, Stockholm, Sweden; [Steineck, Gunnar] Sahlgrens Acad, Dept Oncol, Div Clin Canc Epidemiol, Gothenburg, Sweden; [Borjeson, Sussanne] Linkoping Univ Hosp, Ctr Surg & Oncol, S-58185 Linkoping, Sweden	Linkoping University; Karolinska Institutet; Stockholm University; Linkoping University; Lund University; Skane University Hospital; Karolinska Institutet; University of Gothenburg; Linkoping University	Enblom, A (corresponding author), Linkoping Univ, Div Nursing Sci, Dept Med & Hlth Sci, Linkoping, Sweden.	anna.enblom@ki.se	Hammar, Mats/R-7908-2019; Steineck, Gunnar/W-1515-2019	Hammar, Mats/0000-0002-4593-7273; Steineck, Gunnar/0000-0002-0787-3969; Ingvar, Martin/0000-0002-9041-5714; Johnsson, Anna/0000-0001-9347-5336	Swedish Cancer Society; Vardal Institute; County Council of Ostergotland; University of Linkoping; Cancer and Traffic Injury Fund; Vardal Foundation for Health Care Sciences and Allergy Research; Vinnova; Swedish Strategic Research Foundation	Swedish Cancer Society(Swedish Cancer Society); Vardal Institute; County Council of Ostergotland; University of Linkoping; Cancer and Traffic Injury Fund; Vardal Foundation for Health Care Sciences and Allergy Research; Vinnova(Vinnova); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research)	This study was supported by The Swedish Cancer Society, The Vardal Institute, The County Council of Ostergotland, The University of Linkoping, Cancer and Traffic Injury Fund and The Vardal Foundation for Health Care Sciences and Allergy Research. Mats Lekander and Martin Ingvar are members of Stockholm Brain Institute funded by Vinnova and The Swedish Strategic Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGLIETTI L, 1990, CANCER CHEMOTH PHARM, V26, P239, DOI 10.1007/BF02897209; Arving Cecilia, 2007, Cancer Nurs, V30, pE10, DOI 10.1097/01.NCC.0000270709.64790.05; Borjeson S, 2002, J PAIN SYMPTOM MANAG, V24, P345, DOI 10.1016/S0885-3924(02)00543-2; Borjeson S, 1997, CANCER NURS, V20, P260; Dibble S L, 2000, Oncol Nurs Forum, V27, P41; DUNDEE JW, 1989, J ROY SOC MED, V82, P268, DOI 10.1177/014107688908200508; ENBLOM A, 2008, 1088 LINK U MED DISS; Enblom A, 2009, SUPPORT CARE CANCER, V17, P23, DOI 10.1007/s00520-008-0445-x; Ezzo JM, 2006, COCHRANE DB SYST REV, V19, P2285, DOI DOI 10.1002/14651858.CD002285.PUB2; FEYER PC, 2009, SUPPORT CAR IN PRESS; Goldman RH, 2008, CLIN J PAIN, V24, P211, DOI 10.1097/AJP.0b013e31815ec20f; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Higgins SC, 2007, SUPPORT CARE CANCER, V15, P171, DOI 10.1007/s00520-006-0113-y; Hui KKS, 2005, NEUROIMAGE, V27, P479, DOI 10.1016/j.neuroimage.2005.04.037; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Linde K, 2007, PAIN, V128, P264, DOI 10.1016/j.pain.2006.12.006; Lu Weidong, 2005, Semin Oncol Nurs, V21, P190, DOI 10.1016/j.soncn.2005.04.008; Luebbert K, 2001, PSYCHO-ONCOLOGY, V10, P490, DOI 10.1002/pon.537; Maranzano E, 1999, INT J RADIAT ONCOL, V44, P619, DOI 10.1016/S0360-3016(99)00055-3; Molassiotis A, 2007, COMPLEMENT THER MED, V15, P3, DOI 10.1016/j.ctim.2006.07.005; Myers Cynthia D, 2008, J Soc Integr Oncol, V6, P19; Mystakidou K, 2006, MED ONCOL, V23, P251, DOI 10.1385/MO:23:2:251; Pariente J, 2005, NEUROIMAGE, V25, P1161, DOI 10.1016/j.neuroimage.2005.01.016; Park J, 1999, ACUPUNCT MED, V17, P110, DOI DOI 10.1136/AIM.17.2.110; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Roscoe JA, 2003, J PAIN SYMPTOM MANAG, V26, P731, DOI 10.1016/S0885-3924(03)00254-9; Shen JN, 2000, JAMA-J AM MED ASSOC, V284, P2755, DOI 10.1001/jama.284.21.2755; Shin YH, 2004, CANCER NURS, V27, P267, DOI 10.1097/00002820-200407000-00002; Shun SC, 2008, SUPPORT CARE CANCER, V16, P1059, DOI 10.1007/s00520-007-0384-y; Steineck G, 2006, ACTA ONCOL, V45, P421, DOI 10.1080/02841860600649293; Streitberger K, 2003, CLIN CANCER RES, V9, P2538; Xia Y. S., 2000, INT J CLIN ACUPUNCTU, V11, P145; Young SD, 2007, IEEE T VIS COMPUT GR, V13, P422, DOI 10.1109/TVCG.2007.1029; Zachariae R, 2007, PSYCHOTHER PSYCHOSOM, V76, P376, DOI 10.1159/000107566	34	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e14766	10.1371/journal.pone.0014766	http://dx.doi.org/10.1371/journal.pone.0014766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448267	Green Published, Green Submitted, gold			2022-12-27	WOS:000288810500001
J	Gallo, M; Park, D; Luciani, DS; Kida, K; Palmieri, F; Blacque, OE; Johnson, JD; Riddle, DL				Gallo, Marco; Park, Donha; Luciani, Dan S.; Kida, Katarzyna; Palmieri, Ferdinando; Blacque, Oliver E.; Johnson, James D.; Riddle, Donald L.			MISC-1/OGC Links Mitochondrial Metabolism, Apoptosis and Insulin Secretion	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; PERMEABILITY TRANSITION PORE; NEMATODE CAENORHABDITIS-ELEGANS; BCL-2-LIKE PROTEIN CED-9; C-ELEGANS; CYTOCHROME-C; 2-OXOGLUTARATE CARRIERS; GERMLINE PROLIFERATION; SIGNALING LIGAND; GENETIC-CONTROL	We identified MISC-1 (Mitochondrial Solute Carrier) as the C. elegans orthologue of mammalian OGC (2-oxoglutarate carrier). OGC was originally identified for its ability to transfer alpha-ketoglutarate across the inner mitochondrial membrane. However, we found that MISC-1 and OGC are not solely involved in metabolic control. Our data show that these orthologous proteins participate in phylogenetically conserved cellular processes, like control of mitochondrial morphology and induction of apoptosis. We show that MISC-1/OGC is required for proper mitochondrial fusion and fission events in both C. elegans and human cells. Transmission electron microscopy reveals that loss of MISC-1 results in a decreased number of mitochondrial cristae, which have a blebbed appearance. Furthermore, our pull-down experiments show that MISC-1 and OGC interact with the anti-apoptotic proteins CED-9 and Bcl-x(L), respectively, and with the pro-apoptotic protein ANT. Knock-down of misc-1 in C. elegans and OGC in mouse cells induces apoptosis through the caspase cascade. Genetic analysis suggests that MISC-1 controls apoptosis through the physiological pathway mediated by the LIN-35/Rb-like protein. We provide genetic and molecular evidence that absence of MISC-1 increases insulin secretion and enhances germline stem cell proliferation in C. elegans. Our study suggests that the mitochondrial metabolic protein MISC-1/OGC integrates metabolic, apoptotic and insulin secretion functions. We propose a novel mechanism by which mitochondria integrate metabolic and cell survival signals. Our data suggest that MISC-1/OGC functions by sensing the metabolic status of mitochondria and directly activate the apoptotic program when required. Our results suggest that controlling MISC-1/OGC function allows regulation of mitochondrial morphology and cell survival decisions by the metabolic needs of the cell.	[Gallo, Marco; Riddle, Donald L.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Park, Donha; Riddle, Donald L.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Luciani, Dan S.; Johnson, James D.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Kida, Katarzyna; Blacque, Oliver E.] Univ Coll Dublin, UCD Conway Inst, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Palmieri, Ferdinando] Univ Bari, Dept Pharmacobiol, Biochem Lab, Bari, Italy; [Palmieri, Ferdinando] CNR, Unit Study Mitochondria & Bioenerget, I-70126 Bari, Italy	University of British Columbia; University of British Columbia; University of British Columbia; University College Dublin; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR)	Gallo, M (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	mgallo@msl.ubc.ca	Blacque, Oliver/AAL-8860-2021; Johnson, James/B-3919-2008	Johnson, James/0000-0002-7523-9433; Gallo, Marco/0000-0002-8451-8207; Blacque, Oliver/0000-0003-1598-2695; Luciani, Dan/0000-0002-4318-4159	Canadian Institutes of Health Research [MOP 79458]; Natural Sciences and Engineering Research Council of Canada CGS; Michael Smith Foundation for Health Research; Izaak Walton Killam Memorial Pre-Doctoral Fellowship; William and Dorothy Gilbert Graduate Scholarship in Bio-Medical Sciences; Juvenile Diabetes Research Foundation; Canadian Diabetes Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada CGS; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Izaak Walton Killam Memorial Pre-Doctoral Fellowship; William and Dorothy Gilbert Graduate Scholarship in Bio-Medical Sciences; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Canadian Diabetes Association	This work was supported by a Canadian Institutes of Health Research grant (MOP 79458; http://www.cihr-irsc.gc.ca/e/193.html) to DLR and a Natural Sciences and Engineering Research Council of Canada CGS (http://www.nserc-crsng.gc.ca/), Michael Smith Foundation for Health Research Senior Graduate Studentship (http://www.msfhr.org/), Izaak Walton Killam Memorial Pre-Doctoral Fellowship (http://www.killamtrusts.ca/) and a William and Dorothy Gilbert Graduate Scholarship in Bio-Medical Sciences to MG. JDJ and DSL were supported by the Juvenile Diabetes Research Foundation (http://www.jdrf.ca/), the Canadian Institutes of Health Research and the Canadian Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajiro K, 1996, J BIOL CHEM, V271, P13197, DOI 10.1074/jbc.271.22.13197; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Berry LW, 1997, DEVELOPMENT, V124, P925; BISACCIA F, 1985, BIOCHIM BIOPHYS ACTA, V810, P362, DOI 10.1016/0005-2728(85)90222-1; BRENNER S, 1974, GENETICS, V77, P71; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Chen ZF, 1998, J PHARMACOL EXP THER, V285, P608; Chen ZF, 2000, ARCH BIOCHEM BIOPHYS, V373, P193, DOI 10.1006/abbi.1999.1527; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; del Peso L, 1998, J BIOL CHEM, V273, P33495, DOI 10.1074/jbc.273.50.33495; Gems D, 1998, GENETICS, V150, P129; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Halestrap AP, 1997, MOL CELL BIOCHEM, V174, P167, DOI 10.1023/A:1006879618176; Henderson ST, 1997, MOL BIOL CELL, V8, P1751, DOI 10.1091/mbc.8.9.1751; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Horvitz HR, 1999, CANCER RES, V59, p1701S; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kawano T, 2000, BIOCHEM BIOPH RES CO, V273, P431, DOI 10.1006/bbrc.2000.2971; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; LAM M, 1994, P NATL ACAD SCI USA, V91, P6569, DOI 10.1073/pnas.91.14.6569; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Marzo I, 1998, J EXP MED, V187, P1261, DOI 10.1084/jem.187.8.1261; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Michaelson D, 2010, DEVELOPMENT, V137, P671, DOI 10.1242/dev.042523; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nadarajan S, 2009, DEVELOPMENT, V136, P2223, DOI 10.1242/dev.034603; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; Navarro RE, 2001, DEVELOPMENT, V128, P3221; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Park D, 2010, DEVELOPMENT, V137, P477, DOI 10.1242/dev.043752; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Rolland SG, 2009, J CELL BIOL, V186, P525, DOI 10.1083/jcb.200905070; Schertel C, 2007, DEVELOPMENT, V134, P3691, DOI 10.1242/dev.004606; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Shen QF, 2009, MOL CELL BIOL, V29, P3881, DOI 10.1128/MCB.01509-08; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Spector MS, 1997, NATURE, V385, P653, DOI 10.1038/385653a0; Timmons L, 1994, SCIENCE, V263, P802; Wang XD, 2001, GENE DEV, V15, P2922; Woodfield KY, 1997, BBA-GENE STRUCT EXPR, V1351, P27, DOI 10.1016/S0167-4781(97)00017-1; Xu F, 2006, J PHARMACOL EXP THER, V316, P1175, DOI 10.1124/jpet.105.094599; YUAN JY, 1992, DEVELOPMENT, V116, P309; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zhou YP, 2000, AM J PHYSIOL-ENDOC M, V278, pE340, DOI 10.1152/ajpendo.2000.278.2.E340; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	73	22	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17827	10.1371/journal.pone.0017827	http://dx.doi.org/10.1371/journal.pone.0017827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448454	Green Submitted, gold, Green Published			2022-12-27	WOS:000288810500014
J	Wang, HJ; Ding, Y; Tang, J; Dong, XA; He, B; Qiu, J; Wild, DJ				Wang, Huijun; Ding, Ying; Tang, Jie; Dong, Xiao; He, Bing; Qiu, Judy; Wild, David J.			Finding Complex Biological Relationships in Recent PubMed Articles Using Bio-LDA	PLOS ONE			English	Article								The overwhelming amount of available scholarly literature in the life sciences poses significant challenges to scientists wishing to keep up with important developments related to their research, but also provides a useful resource for the discovery of recent information concerning genes, diseases, compounds and the interactions between them. In this paper, we describe an algorithm called Bio-LDA that uses extracted biological terminology to automatically identify latent topics, and provides a variety of measures to uncover putative relations among topics and bio-terms. Relationships identified using those approaches are combined with existing data in life science datasets to provide additional insight. Three case studies demonstrate the utility of the Bio-LDA model, including association predication, association search and connectivity map generation. This combined approach offers new opportunities for knowledge discovery in many areas of biology including target identification, lead hopping and drug repurposing.	[Wang, Huijun; Dong, Xiao; Wild, David J.] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA; [Ding, Ying; He, Bing] Indiana Univ, Sch Lib & Informat Sci, Bloomington, IN 47401 USA; [Tang, Jie] Tsinghua Univ, Dept Comp Sci, Beijing 100084, Peoples R China; [Qiu, Judy] Indiana Univ, Pervas Technol Inst, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Tsinghua University; Indiana University System; Indiana University Bloomington	Wang, HJ (corresponding author), Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA.	djwild@indiana.edu	He, Bing/H-8271-2016; wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022	Ding, Ying/0000-0003-2567-2009				Alako BTF, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-51; Anyanwu K, 2002, SIGMOD REC, V31, P42, DOI 10.1145/637411.637418; Belleau F, 2008, J BIOMED INFORM, V41, P706, DOI 10.1016/j.jbi.2008.03.004; BIZER C, 2006, 5 INT SEM WEB C ATH; Blei DM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-250; Blei D. M., 2010, SUPERVISED TOPIC MOD, V06, P11; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Chen B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-255; Cohen KB, 2004, COMPU BIOL, V5, P147; FELDMAN R, 2003, MINING BIOMEDICAL LI, V1, P69; Frijters R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000943; HOFMANN T, 2009, PROBABILISTIC LATENT, P50; JENTZSCH A, 2009, LINKING OPEN DRUG DA; Morchen F., 2008, P 14 ACM SIGKDD INT, P954, DOI DOI 10.1145/1401890.1402004; MUIN M, 2006, AMIA ANN S P AMIA S, P1089; Newman D., 2007, ADV NEURAL INFORM PR, P1081; Rosen-Zvi M., 2004, AUTHOR TOPIC MODEL A, P487, DOI DOI 10.5555/1036843.1036902; Si X., 2009, J COMPUTATIONAL INFO; Steyvers M., 2004, P 10 ACM SIGKDD INT, P306, DOI [10.1145/1014052.1014087, DOI 10.1145/1014052.1014087, 10.1145/1014052, DOI 10.1145/1014052]; Tang J., 2008, PROC ACM SIGKDD INT, P990, DOI DOI 10.1145/1401890.1402008; WANG X, 2007, TRACTOGRAPHY SEGMENT; WANG X, 2006, TOPICS TIME NONMARKO, P424; Wang Y, 2009, LECT NOTES COMPUT SC, V5564, P301, DOI 10.1007/978-3-642-02158-9_26; Wild DJ, 2009, EXPERT OPIN DRUG DIS, V4, P995, DOI 10.1517/17460440903233738; XU H, 2009, TAG REFINEMENT REGUL, P573; Zheng B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-58	26	60	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17243	10.1371/journal.pone.0017243	http://dx.doi.org/10.1371/journal.pone.0017243			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448266	gold, Green Submitted, Green Published			2022-12-27	WOS:000288810500005
J	Ennes-Vidal, V; Menna-Barreto, RFS; Santos, ALS; Branquinha, MH; d'Avila-Levy, CM				Ennes-Vidal, Vitor; Menna-Barreto, Rubem F. S.; Santos, Andre L. S.; Branquinha, Marta H.; d'Avila-Levy, Claudia M.			MDL28170, a Calpain Inhibitor, Affects Trypanosoma cruzi Metacyclogenesis, Ultrastructure and Attachment to Rhodnius prolixus Midgut	PLOS ONE			English	Article							CYSTEINE PROTEINASE; KINETOPLASTID PARASITES; EPIMASTIGOTE FORMS; IN-VITRO; DIFFERENTIATION; MEMBRANE; DISEASE; LOCALIZATION; RESERVOSOMES; DROSOPHILA	Background: Trypanosoma cruzi is the etiological agent of Chagas' disease. During the parasite life cycle, many molecules are involved in the differentiation process and infectivity. Peptidases are relevant for crucial steps of T. cruzi life cycle; as such, it is conceivable that they may participate in the metacyclogenesis and interaction with the invertebrate host. Methodology/Principal Findings: In this paper, we have investigated the effect of the calpain inhibitor MDL28170 on the attachment of T. cruzi epimastigotes to the luminal midgut surface of Rhodnius prolixus, as well as on the metacyclogenesis process and ultrastructure. MDL28170 treatment was capable of significantly reducing the number of bound epimastigotes to the luminal surface midgut of the insect. Once the cross-reactivity of the anti-Dm-calpain was assessed, it was possible to block calpain molecules by the antibody, leading to a significant reduction in the capacity of adhesion to the insect guts by T. cruzi. However, the antibodies were unable to interfere in metacyclogenesis, which was impaired by the calpain inhibitor presenting a significant reduction in the number of metacyclic trypomastigotes. The calpain inhibitor also promoted a direct effect against bloodstream trypomastigotes. Ultrastructural analysis of epimastigotes treated with the calpain inhibitor revealed disorganization in the reservosomes, Golgi and plasma membrane disruption. Conclusions/Significance: The presence of calpain and calpain-like molecules in a wide range of organisms suggests that these proteins could be necessary for basic cellular functions. Herein, we demonstrated the effects of MDL28170 in crucial steps of the T. cruzi life cycle, such as attachment to the insect midgut and metacyclogenesis, as well as in parasite viability and morphology. Together with our previous findings, these results help to shed some light on the functions of T. cruzi calpains. Considering the potential roles of these molecules on the interaction with both invertebrate and vertebrate hosts, it is interesting to improve knowledge on these molecules in T. cruzi.	[Ennes-Vidal, Vitor; d'Avila-Levy, Claudia M.] Fundacao Oswaldo Cruz Fiocruz, Lab Biol Mol & Doencas Endem, IOC, Rio De Janeiro, Brazil; [Menna-Barreto, Rubem F. S.] Fiocruz MS, Lab Biol Celular, IOC, BR-21045900 Rio De Janeiro, Brazil; [Santos, Andre L. S.] Univ Fed Rio de Janeiro, Lab Estudos Integrados Bioquim Microbiana, Dept Microbiol Geral, IMPPG, Rio de Janeiro, Brazil; [Branquinha, Marta H.] Univ Fed Rio de Janeiro, Lab Bioquim Proteases, Dept Microbiol Geral, IMPPG, Rio de Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Ennes-Vidal, V (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Lab Biol Mol & Doencas Endem, IOC, Rio De Janeiro, Brazil.	davila.levy@ioc.fiocruz.br	Santos, André/Z-5853-2019; Menna-Barreto, Rubem/O-7325-2019; Branquinha, Marta/AAA-3084-2019; d'Avila-Levy, Claudia M/O-7192-2014	Santos, André/0000-0003-0821-8592; Menna-Barreto, Rubem/0000-0002-1352-0641; d'Avila-Levy, Claudia M/0000-0001-8042-4695	MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FUJB (Fundacao Universitaria Jose Bonifacio); CEPG/UFRJ; FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro); Fundacao Oswaldo Cruz (FIOCRUZ)	MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FUJB (Fundacao Universitaria Jose Bonifacio); CEPG/UFRJ; FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Oswaldo Cruz (FIOCRUZ)	This study was supported by MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), FUJB (Fundacao Universitaria Jose Bonifacio), CEPG/UFRJ, FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro) and Fundacao Oswaldo Cruz (FIOCRUZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azambuja P, 2005, AN ACAD BRAS CIENC, V77, P397, DOI 10.1590/S0001-37652005000300004; Azambuja P. de, 1997, The molecular biology of insect disease vectors: a methods manual., P56; Beyette JR, 1997, ARCH BIOCHEM BIOPHYS, V337, P232, DOI 10.1006/abbi.1996.9758; BONALDO MC, 1988, J CELL BIOL, V106, P1349, DOI 10.1083/jcb.106.4.1349; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; Cazzulo JJ, 2001, CURR PHARM DESIGN, V7, P1143, DOI 10.2174/1381612013397528; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Cordero EM, 2009, J PROTEOME RES, V8, P3642, DOI 10.1021/pr800887u; Couto LA, 2004, J NEUROSCI RES, V77, P410, DOI 10.1002/jnr.20170; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Cunha-e-Silva N, 2006, PARASITOL RES, V99, P325, DOI 10.1007/s00436-006-0190-3; d'Avila-Levy CM, 2006, INT J ANTIMICROB AG, V28, P138, DOI 10.1016/j.ijantimicag.2006.03.021; d'Avila-Levy CM, 2003, ARCH BIOCHEM BIOPHYS, V420, P1, DOI 10.1016/j.abb.2003.09.033; de Souza W, 2009, PROG HISTOCHEM CYTO, V44, P67, DOI 10.1016/j.proghi.2009.01.001; DESOUZA W, 1984, INT REV CYTOL, V86, P197, DOI 10.1016/S0074-7696(08)60180-1; Drugs for Neglected Diseases initiative, 2010, NEW AGR SIGN JOIN FO; Duschak VG, 2006, PARASITOLOGY, V132, P345, DOI 10.1017/S0031182005009030; EMORI Y, 1994, J BIOL CHEM, V269, P25137; Engel JC, 1998, J CELL SCI, V111, P597; Ennes-Vidal V, 2010, J ANTIMICROB CHEMOTH, V65, P1395, DOI 10.1093/jac/dkq154; Ersfeld K, 2005, J MOL EVOL, V61, P742, DOI 10.1007/s00239-004-0272-8; FIGUEIREDO RCBQ, 1994, PARASITOL RES, V80, P517, DOI 10.1007/BF00932700; Figueiredo RCBQ, 2000, J PARASITOL, V86, P1213, DOI 10.1645/0022-3395(2000)086[1213:DOTCEM]2.0.CO;2; Giese V, 2008, MEM I OSWALDO CRUZ, V103, P598, DOI 10.1590/S0074-02762008000600015; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Grynspan F, 1997, BRAIN RES, V763, P145, DOI 10.1016/S0006-8993(97)00384-3; Hertz-Fowler C, 2001, MOL BIOCHEM PARASIT, V116, P25, DOI 10.1016/S0166-6851(01)00296-1; Kumagai T, 2005, EXP PARASITOL, V109, P53, DOI 10.1016/j.exppara.2004.11.001; Lescop C, 2005, BIOORG MED CHEM LETT, V15, P5176, DOI 10.1016/j.bmcl.2005.08.064; MEIRELLES MNL, 1992, MOL BIOCHEM PARASIT, V52, P175, DOI 10.1016/0166-6851(92)90050-T; MEIRELLES RMS, 2001, ACTA MICROSC, V10, P19; Mellgren RL, 2010, J BIOL CHEM, V285, P36597, DOI 10.1074/jbc.M110.110015; Nogueira NFS, 2007, EXP PARASITOL, V116, P120, DOI 10.1016/j.exppara.2006.12.014; Olego-Fernandez S, 2009, PROTIST, V160, P576, DOI 10.1016/j.protis.2009.05.003; Pereira FM, 2009, PARASITOLOGY, V136, P45, DOI 10.1017/S0031182008005209; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Rami A, 1997, NEUROSCI RES, V27, P93, DOI 10.1016/S0168-0102(96)01123-6; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Sangenito LS, 2009, PARASITOLOGY, V136, P433, DOI 10.1017/S0031182009005629; Sant'Anna C, 2009, PROTEOMICS, V9, P1782, DOI 10.1002/pmic.200800730; Santos ALS, 2006, AN ACAD BRAS CIENC, V78, P687, DOI 10.1590/S0001-37652006000400006; Tonami K, 2007, MOL CELL BIOL, V27, P2548, DOI 10.1128/MCB.00992-06; Tull D, 2004, MOL BIOL CELL, V15, P4775, DOI 10.1091/mbc.E04-06-0457; Vermelrio A.B., 2007, CURR ENZYME INHIB, V3, P19; Yu XL, 2003, J EXP BIOL, V206, P561, DOI 10.1242/jeb.00097	46	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18371	10.1371/journal.pone.0018371	http://dx.doi.org/10.1371/journal.pone.0018371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483751	Green Published, gold, Green Submitted			2022-12-27	WOS:000289058700021
J	Herman-Roloff, A; Llewellyn, E; Obiero, W; Agot, K; Ndinya-Achola, J; Muraguri, N; Bailey, RC				Herman-Roloff, Amy; Llewellyn, Emma; Obiero, Walter; Agot, Kawango; Ndinya-Achola, Jeckoniah; Muraguri, Nicholas; Bailey, Robert C.			Implementing Voluntary Medical Male Circumcision for HIV Prevention in Nyanza Province, Kenya: Lessons Learned during the First Year	PLOS ONE			English	Article								Background: In 2007, the World Health Organization endorsed male circumcision as an effective HIV prevention strategy. In 2008, the Government of Kenya (GoK) launched the national voluntary medical male circumcision (VMMC) program in Nyanza Province, the geographic home to the Luo, the largest non-circumcising ethnic group in Kenya. Currently, several other African countries are in the early stages of implementing this intervention. Methods and Results: This paper uses data from a health facility needs assessment (n = 81 facilities) and a study to evaluate the implementation of VMMC services in 16 GoK facilities (n = 2,675 VMMC clients) to describe Kenya's experience in implementing the national program. The needs assessment revealed that no health facility was prepared to offer the minimum package of services as outlined by the national guidelines, and partner organizations were called upon to fill this gap. The findings concerning human resource shortages facilitated the GoK's decision to endorse trained nurses to provide VMMCs, enabling more facilities to offer the service. Findings from the evaluation study resulted in replacing voluntary counseling and testing (VCT) with provider-initiated testing and counseling (PITC) and subsequently doubling the proportion of VMMC clients tested for HIV. Conclusions: This paper outlines how certain challenges, like human resource shortages and low HIV test rates, were addressed through national policy changes, while other challenges, like large fluctuations in demand, were addressed locally. Currently, the program requires significant support from partner organizations, but a strategic plan is under development to continue to build capacity in GoK staff and facilities. Coordination between all parties was essential and was facilitated through the formation of national, provincial, and district VMMC task forces. The lessons learned from Kenya's VMMC implementation experience are likely generalizable to other African countries.	[Herman-Roloff, Amy; Bailey, Robert C.] Univ Illinois, Div Epidemiol & Biostat, Chicago, IL 60637 USA; [Herman-Roloff, Amy; Llewellyn, Emma; Obiero, Walter; Bailey, Robert C.] Nyanza Reprod Hlth Soc, Kisumu, Kenya; [Agot, Kawango] Impact Res & Dev Org, Kisumu, Kenya; [Ndinya-Achola, Jeckoniah] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Muraguri, Nicholas] Natl AIDS & STI Control Programme, Nairobi, Kenya	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Nairobi	Herman-Roloff, A (corresponding author), Univ Illinois, Div Epidemiol & Biostat, Chicago, IL 60637 USA.	aherma2@uic.edu			Bill & Melinda Gates Foundation; President's Emergency Plan for AIDS Relief [U62PS024508]; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U62PS024508] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Support for this study was provided by a grant to Family Health International (FHI) from the Bill & Melinda Gates Foundation to support the Male Circumcision Consortium (MCC), a partnership between FHI, University of Illinois at Chicago working closely with the Nyanza Reproductive Health Society, and EngenderHealth. The views expressed in this publication do not necessarily reflect those of the Bill & Melinda Gates Foundation or the MCC partners Grant number: 47394; (http://www.gatesfoundation.org/Pages/home.aspx). Additional funding for service provision came from Impact Research and Development Organization, which received funding from the President's Emergency Plan for AIDS Relief, administered through the Centers for Disease Control and Prevention (Cooperative Agreement U62PS024508; http://www.pepfar.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; *MIN HLTH NAT AIDS, 2008, GUID SAF VOL MED MAL; *MIN PUBL HLTH SAN, 2009, NAT STRAT VOL MED MA; National AIDS and STI Programme Ministry of Health Kenya, 2008, KEN AIDS IND SURV 20; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; *WHO UN JOINT PROG, 2007, NEW DAT MAL CIRC HIV	9	38	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18299	10.1371/journal.pone.0018299	http://dx.doi.org/10.1371/journal.pone.0018299			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483697	Green Published, Green Submitted, gold			2022-12-27	WOS:000289058700017
J	Kaspersen, MD; Larsen, PB; Ingerslev, HJ; Fedder, J; Petersen, GB; Bonde, J; Hollsberg, P				Kaspersen, Maja D.; Larsen, Peter B.; Ingerslev, Hans Jakob; Fedder, Jens; Petersen, Gert Bruun; Bonde, Jesper; Hollsberg, Per			Identification of Multiple HPV Types on Spermatozoa from Human Sperm Donors	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS DNA; DEOXYRIBONUCLEIC-ACID; SEMEN; MEN; PREVALENCE; INFECTION; ASSOCIATION; VIRUS; WOMEN	Human papillomaviruses (HPV) may cause sexually transmitted disease. High-risk types of HPV are involved in the development of cervical cell dysplasia, whereas low-risk types may cause genital condyloma. Despite the association between HPV and cancer, donor sperm need not be tested for HPV according to European regulations. Consequently, the potential health risk of HPV transmission by donor bank sperm has not been elucidated, nor is it known how HPV is associated with sperm. The presence of 35 types of HPV was examined on DNA from semen samples of 188 Danish sperm donors using a sensitive HPV array. To examine whether HPV was associated with the sperm, in situ hybridization were performed with HPV-6, HPV-16 and -18, and HPV-31-specific probes. The prevalence of HPV-positive sperm donors was 16.0% and in 66.7% of these individuals high-risk types of HPV were detected. In 5.3% of sperm donors, two or more HPV types were detected. Among all identified HPV types, 61.9% were high-risk types. In situ hybridization experiments identified HPV genomes particularly protruding from the equatorial segment and the tail of the sperm. Semen samples from more than one in seven healthy Danish donors contain HPV, most of them of high-risk types binding to the equatorial segment of the sperm cell. Most HPV-positive sperm showed decreased staining with DAPI, indicative of reduced content of DNA. Our data demonstrate that oncogenic HPV types are frequent in men.	[Kaspersen, Maja D.; Hollsberg, Per] Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark; [Larsen, Peter B.; Petersen, Gert Bruun] Cryos Int Sperm Bank, Aarhus, Denmark; [Ingerslev, Hans Jakob] Aarhus Univ Hosp, Fertil Clin, DK-8000 Aarhus, Denmark; [Fedder, Jens] Reg Hosp Horsens, Reprod Biol Lab, Sci Unit, Horsens, Denmark; [Fedder, Jens] Reg Hosp Horsens, Fertil Clin, Horsens, Denmark; [Bonde, Jesper] Univ Copenhagen, Hvidovre Hosp, Div Pathol, Clin Res Ctr, DK-2650 Hvidovre, Denmark	Aarhus University; Aarhus University; University of Copenhagen	Kaspersen, MD (corresponding author), Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark.	ph@microbiology.au.dk	Bonde, Jesper/AAN-5930-2020; Bonde, Jesper H/F-1478-2013	Bonde, Jesper/0000-0003-4853-6747	University Hospital of Aarhus; Lundbeck Foundation; Faculty of Health Sciences, Aarhus University	University Hospital of Aarhus; Lundbeck Foundation(Lundbeckfonden); Faculty of Health Sciences, Aarhus University	This study was supported by The University Hospital of Aarhus; The Lundbeck Foundation; The Faculty of Health Sciences, Aarhus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezold G, 2007, FERTIL STERIL, V87, P1087, DOI 10.1016/j.fertnstert.2006.08.109; Brossfield JE, 1999, J ASSIST REPROD GEN, V16, P325, DOI 10.1023/A:1020458100382; CHAN PJ, 1994, FERTIL STERIL, V61, P982; Chan PJ, 1996, J ASSIST REPROD GEN, V13, P516, DOI 10.1007/BF02066536; Connelly DA, 2001, AM J OBSTET GYNECOL, V184, P1068, DOI 10.1067/mob.2001.115226; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Didelot-Rousseau MN, 2007, J CLIN VIROL, V39, P153, DOI 10.1016/j.jcv.2007.03.003; FORESTA C, 2010, INT J ANDROL; Giatromanolaki A, 2007, Infect Dis Obstet Gynecol, V2007, P60549, DOI 10.1155/2007/60549; Giuliano AR, 2007, J INFECT DIS, V196, P1146, DOI 10.1086/521629; Goodman A, 2000, CURR OPIN OBSTET GYN, V12, P11, DOI 10.1097/00001703-200002000-00002; GREEN J, 1991, GENITOURIN MED, V67, P207; Hernandez BY, 2008, J INFECT DIS, V197, P787, DOI 10.1086/528379; Kapranos N, 2003, FERTIL STERIL, V79, P1566, DOI 10.1016/S0015-0282(03)00370-4; Kjaer SK, 2008, INT J CANCER, V123, P1864, DOI 10.1002/ijc.23712; KYO S, 1994, J INFECT DIS, V170, P682, DOI 10.1093/infdis/170.3.682; Lai YM, 1997, FERTIL STERIL, V67, P1152, DOI 10.1016/S0015-0282(97)81454-9; Lai YM, 1996, FERTIL STERIL, V65, P1026, DOI 10.1016/S0015-0282(16)58281-8; Lee CA, 2002, GYNECOL ONCOL, V85, P511, DOI 10.1006/gyno.2002.6662; Mejlhede N, 2009, APMIS, V117, P108, DOI 10.1111/j.1600-0463.2008.00019.x; Olatunbosun O, 2001, OBSTET GYNECOL, V97, P357, DOI 10.1016/S0029-7844(00)01183-2; OSTROW RS, 1986, SCIENCE, V231, P731, DOI 10.1126/science.3003908; Perez-Andino J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005847; Rintala MAM, 2004, INT J STD AIDS, V15, P740, DOI 10.1258/0956462042395122; Rohde V, 1999, FERTIL STERIL, V72, P814, DOI 10.1016/S0015-0282(99)00363-5; Sherwood JB, 1997, GYNECOL ONCOL, V66, P141, DOI 10.1006/gyno.1997.4731; Spandorfer SD, 2006, FERTIL STERIL, V86, P765, DOI 10.1016/j.fertnstert.2006.01.051; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	28	47	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18095	10.1371/journal.pone.0018095	http://dx.doi.org/10.1371/journal.pone.0018095			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479232	gold, Green Published, Green Submitted			2022-12-27	WOS:000289054600027
J	Lundequist, A; Boyce, JA				Lundequist, Anders; Boyce, Joshua A.			LPA5 Is Abundantly Expressed by Human Mast Cells and Important for Lysophosphatidic Acid Induced MIP-1 beta Release	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; MOLECULAR-CLONING; OVARIAN-CANCER; ORPHAN GPCR; IDENTIFICATION; GROWTH; ACTIVATION; GENERATION; ROLES; GPR92	Background: Lysophosphatidic acid (LPA) is a bioactive lipid inducing proliferation, differentiation as well as cytokine release by mast cells through G-protein coupled receptors. Recently GPR92/LPA5 was identified as an LPA receptor highly expressed by cells of the immune system, which prompted us to investigate its presence and influence on mast cells. Principal Findings: Transcript analysis using quantitative real-time PCR revealed that LPA5 is the most prevalent LPA-receptor in human mast cells. Reduction of LPA5 levels using shRNA reduced calcium flux and abolished MIP-1 beta release in response to LPA. Conclusions: LPA5 is a bona fide LPA receptor on human mast cells responsible for the majority of LPA induced MIP-1 beta release.	[Lundequist, Anders; Boyce, Joshua A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Lundequist, Anders; Boyce, Joshua A.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Lundequist, Anders] Swedish Univ Agr Sci, Uppsala, Sweden	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Swedish University of Agricultural Sciences	Lundequist, A (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.	Anders.Lundequist@slu.se			National Institutes of Health [AI-52353, AI-31599, HL-36110, AI078908]; Consul Th C Bergh's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052353, U01AI031599, R01AI052353, R56AI052353, P01AI031599, R01AI078908, U19AI031599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consul Th C Bergh's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI-52353, AI-31599, HL-36110, and AI078908, by Consul Th C Bergh's Foundation, and by a generous contribution from the Vinik Family. The Viniks are private donors who contributed generously to establish an endowment; there are no industry ties. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2000, J IMMUNOL, V165, P7215, DOI 10.4049/jimmunol.165.12.7215; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; An SZ, 1997, BIOCHEM BIOPH RES CO, V231, P619, DOI 10.1006/bbrc.1997.6150; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Bagga S, 2004, BLOOD, V104, P4080, DOI 10.1182/blood-2004-03-1166; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Boyce JA, 2003, J ALLERGY CLIN IMMUN, V111, P24, DOI 10.1067/mai.2003.60; Fang XJ, 2000, ANN NY ACAD SCI, V905, P188; Hashimoto T, 2006, J PHARMACOL SCI, V100, P82, DOI 10.1254/jphs.FPJ05030X; Jin YX, 2003, EUR J IMMUNOL, V33, P2083, DOI 10.1002/eji.200323711; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lin DA, 2005, J IMMUNOL, V175, P5430, DOI 10.4049/jimmunol.175.8.5430; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Murakami M, 2008, BIOCHEM BIOPH RES CO, V371, P707, DOI 10.1016/j.bbrc.2008.04.145; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Ochi H, 2000, P NATL ACAD SCI USA, V97, P10509, DOI 10.1073/pnas.180318697; Ochi H, 1999, J EXP MED, V190, P267, DOI 10.1084/jem.190.2.267; Paruchuri S, 2008, J BIOL CHEM, V283, P16477, DOI 10.1074/jbc.M705822200; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; RADINGER M, 2001, GENERATION ISOLATION; Schwartz BM, 2001, GYNECOL ONCOL, V81, P291, DOI 10.1006/gyno.2001.6124; Supajatura V, 2001, J IMMUNOL, V167, P2250, DOI 10.4049/jimmunol.167.4.2250; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; TOKUMURA A, 1994, AM J PHYSIOL, V267, pC204, DOI 10.1152/ajpcell.1994.267.1.C204; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Varadaradjalou S, 2003, EUR J IMMUNOL, V33, P899, DOI 10.1002/eji.200323830; Zhao YT, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-114	29	36	36	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18192	10.1371/journal.pone.0018192	http://dx.doi.org/10.1371/journal.pone.0018192			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464938	Green Published, gold, Green Submitted			2022-12-27	WOS:000289053800026
J	Radl, DB; Ferraris, J; Boti, V; Seilicovich, A; Sarkar, DK; Pisera, D				Betiana Radl, Daniela; Ferraris, Jimena; Boti, Valeria; Seilicovich, Adriana; Sarkar, Dipak Kumar; Pisera, Daniel			Dopamine-Induced Apoptosis of Lactotropes Is Mediated by the Short Isoform of D2 Receptor	PLOS ONE			English	Article							PITUITARY-TUMORS; MESSENGER-RNA; ACTIVATION; EXPRESSION; BROMOCRIPTINE; CABERGOLINE; RESISTANT; PROLIFERATION; INHIBIT; AGONIST	Dopamine, through D2 receptor (D2R), is the major regulator of lactotrope function in the anterior pituitary gland. Both D2R isoforms, long (D2L) and short (D2S), are expressed in lactotropes. Although both isoforms can transduce dopamine signal, they differ in the mechanism that leads to cell response. The administration of D2R agonists, such as cabergoline, is the main pharmacological treatment for prolactinomas, but resistance to these drugs exists, which has been associated with alterations in D2R expression. We previously reported that dopamine and cabergoline induce apoptosis of lactotropes in primary culture in an estrogen-dependent manner. In this study we used an in vivo model to confirm the permissive action of estradiol in the apoptosis of anterior pituitary cells induced by D2R agonists. Administration of cabergoline to female rats induced apoptosis, measured by Annexin-V staining, in anterior pituitary gland from estradiol-treated rats but not from ovariectomized rats. To evaluate the participation of D2R isoforms in the apoptosis induced by dopamine we used lactotrope-derived PR1 cells stably transfected with expression vectors encoding D2L or D2S receptors. In the presence of estradiol, dopamine induced apoptosis, determined by ELISA and TUNEL assay, only in PR1-D2S cells. To study the role of p38 MAPK in apoptosis induced by D2R activation, anterior pituitary cells from primary culture or PR1-D2S were incubated with an inhibitor of the p38 MAPK pathway (SB203850). SB203580 blocked the apoptotic effect of D2R activation in lactotropes from primary cultures and PR1-D2S cells. Dopamine also induced p38 MAPK phosphorylation, determined by western blot, in PR1-D2S cells and estradiol enhanced this effect. These data suggest that, in the presence of estradiol, D2R agonists induce apoptosis of lactotropes by their interaction with D2S receptors and that p38 MAPK is involved in this process.	[Betiana Radl, Daniela; Ferraris, Jimena; Boti, Valeria; Seilicovich, Adriana; Pisera, Daniel] Univ Buenos Aires, Inst Invest Reprod, Fac Med, Buenos Aires, DF, Argentina; [Sarkar, Dipak Kumar] State Univ New Jersey, Dept Anim Sci, Endocrine Program, New Brunswick, NJ USA	University of Buenos Aires; Rutgers State University New Brunswick	Radl, DB (corresponding author), Univ Buenos Aires, Inst Invest Reprod, Fac Med, Buenos Aires, DF, Argentina.	dpisera@fmed.uba.ar	Sarkar, Dipak K/O-7942-2017	Sarkar, Dipak K/0000-0003-3237-9871; Pisera, Daniel/0000-0001-8795-1551; Ferraris, Jimena/0000-0001-7472-0439	ANPCyT [PICT 2006-92]; UBA [UBACyT 2008-2010 M057]; CONICET; NIH [R01 AA11591, 5R37 AA08757]	ANPCyT(ANPCyT); UBA(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by ANPCyT (PICT 2006-92), UBA (UBACyT 2008-2010 M057), CONICET, NIH (R01 AA11591, 5R37 AA08757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JJ, 2003, MOL CELL ENDOCRINOL, V206, P49, DOI 10.1016/S0303-7207(03)00236-3; Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; Bonci A, 2005, NEURON, V47, P335, DOI 10.1016/j.neuron.2005.07.015; CACCAVELLI L, 1994, NEUROENDOCRINOLOGY, V60, P314, DOI 10.1159/000126764; Candolfi M, 2002, ENDOCRINOLOGY, V143, P3611, DOI 10.1210/en.2002-220377; Choi EY, 1999, BIOCHEM BIOPH RES CO, V256, P33, DOI 10.1006/bbrc.1999.0286; Choi WS, 2004, J BIOL CHEM, V279, P20451, DOI 10.1074/jbc.M311164200; Colao A, 2009, BEST PRACT RES CL EN, V23, P575, DOI 10.1016/j.beem.2009.05.003; De Mei C, 2009, CURR OPIN PHARMACOL, V9, P53, DOI 10.1016/j.coph.2008.12.002; EGUCHI K, 1995, ENDOCR J, V42, P153, DOI 10.1507/endocrj.42.153; EGUCHI K, 1995, ENDOCR J, V42, P413, DOI 10.1507/endocrj.42.413; EUSUNG J, 2001, J NEUROCHEM, V78, P374; Gillam MP, 2006, ENDOCR REV, V27, P485, DOI 10.1210/er.2005-9998; GUIRAMAND J, 1995, J BIOL CHEM, V270, P7354, DOI 10.1074/jbc.270.13.7354; Guivarc'H D, 1998, ENDOCRINOLOGY, V139, P4213, DOI 10.1210/en.139.10.4213; GUIVARCH D, 1995, NEUROSCIENCE, V69, P159, DOI 10.1016/0306-4522(95)00228-B; Hashi A, 1996, ENDOCRINOLOGY, V137, P3246, DOI 10.1210/en.137.8.3246; Hnasko TS, 2007, NEUROENDOCRINOLOGY, V86, P48, DOI 10.1159/000105242; Hofland LJ, 2010, MOL CELL ENDOCRINOL, V326, P89, DOI 10.1016/j.mce.2010.04.020; Iaccarino C, 2002, P NATL ACAD SCI USA, V99, P14530, DOI 10.1073/pnas.222319599; Jaita G, 2005, ENDOCRINOLOGY, V146, P4737, DOI 10.1210/en.2005-0279; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; MCCHESNEY R, 1991, MOL CELL ENDOCRINOL, V79, pR1, DOI 10.1016/0303-7207(91)90110-E; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Molitch ME, 2008, J CLIN ENDOCR METAB, V93, P4643, DOI 10.1210/jc.2008-2244; MONTMAYEUR JP, 1991, P NATL ACAD SCI USA, V88, P3135, DOI 10.1073/pnas.88.8.3135; Oomizu S, 2003, ALCOHOL CLIN EXP RES, V27, P975, DOI 10.1097/01.ALC.0000071743.57855.BE; Passos VQ, 2009, NEUROENDOCRINOLOGY, V89, P163, DOI 10.1159/000156116; PASTORCIC M, 1995, CANCER RES, V55, P4892; Pisera D, 2004, AM J PHYSIOL-ENDOC M, V287, pE767, DOI 10.1152/ajpendo.00052.2004; Radl DB, 2008, NEUROENDOCRINOLOGY, V88, P43, DOI 10.1159/000116117; Saiardi A, 1997, NEURON, V19, P115, DOI 10.1016/S0896-6273(00)80352-9; Sarkar DK, 2005, ENDOCRINOLOGY, V146, P4179, DOI 10.1210/en.2005-0430; SENOGLES SE, 1994, J BIOL CHEM, V269, P23120; Takeuchi Y, 2003, J NEUROCHEM, V85, P1064, DOI 10.1046/j.1471-4159.2003.01763.x; Van-Ham II, 2007, J NEUROCHEM, V102, P1796, DOI 10.1111/j.1471-4159.2007.04650.x; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; Wu ZB, 2010, J NEURO-ONCOL, V99, P25, DOI 10.1007/s11060-009-0107-y; XUA A, 2002, BRAIN RES, V939, P95; Ying CW, 2000, ENDOCR J, V47, P1, DOI 10.1507/endocrj.47.1; Zaldivar V, 2009, NEUROENDOCRINOLOGY, V90, P292, DOI 10.1159/000235618; Zatelli MC, 2010, J CLIN ENDOCR METAB, V95, P968, DOI 10.1210/jc.2009-1641	42	30	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18097	10.1371/journal.pone.0018097	http://dx.doi.org/10.1371/journal.pone.0018097			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464994	Green Published, Green Submitted, gold			2022-12-27	WOS:000288813900038
J	Jadhav, S; Hussain, A; Devi, S; Kumar, A; Parveen, S; Gandham, N; Wieler, LH; Ewers, C; Ahmed, N				Jadhav, Savita; Hussain, Arif; Devi, Savita; Kumar, Ashutosh; Parveen, Sana; Gandham, Nageshwari; Wieler, Lothar H.; Ewers, Christa; Ahmed, Niyaz			Virulence Characteristics and Genetic Affinities of Multiple Drug Resistant Uropathogenic Escherichia coli from a Semi Urban Locality in India	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; REPETITIVE DNA-SEQUENCES; SPECTRUM-BETA-LACTAMASE; PATHOGENS; STRAINS; SUSCEPTIBILITY; EPIDEMIOLOGY; PREVALENCE; EMERGENCE; CLONE	Extraintestinal pathogenic Escherichia coli (ExPEC) are of significant health concern. The emergence of drug resistant E. coli with high virulence potential is alarming. Lack of sufficient data on transmission dynamics, virulence spectrum and antimicrobial resistance of certain pathogens such as the uropathogenic E. coli (UPEC) from countries with high infection burden, such as India, hinders the infection control and management efforts. In this study, we extensively genotyped and phenotyped a collection of 150 UPEC obtained from patients belonging to a semi-urban, industrialized setting near Pune, India. The isolates representing different clinical categories were analyzed in comparison with 50 commensal E. coli isolates from India as well as 50 ExPEC strains from Germany. Virulent strains were identified based on hemolysis, haemagglutination, cell surface hydrophobicity, serum bactericidal activity as well as with the help of O serotyping. We generated antimicrobial resistance profiles for all the clinical isolates and carried out phylogenetic analysis based on repetitive extragenic palindromic (rep)-PCR. E. coli from urinary tract infection cases expressed higher percentages of type I (45%) and P fimbriae (40%) when compared to fecal isolates (25% and 8% respectively). Hemolytic group comprised of 60% of UPEC and only 2% of E. coli from feces. Additionally, we found that serum resistance and cell surface hydrophobicity were not significantly (p = 0.16/p = 0.51) associated with UPEC from clinical cases. Moreover, clinical isolates exhibited highest resistance against amoxicillin (67.3%) and least against nitrofurantoin (57.3%). We also observed that 31.3% of UPEC were extended-spectrum beta-lactamase (ESBL) producers belonging to serotype O25, of which four were also positive for O25b subgroup that is linked to B2-O25b-ST131-CTX-M-15 virulent/multiresistant type. Furthermore, isolates from India and Germany (as well as global sources) were found to be genetically distinct with no evidence to espouse expansion of E. coli from India to the west or vice-versa.	[Jadhav, Savita; Gandham, Nageshwari] Dr D Y Patil Med Coll & Hosp, Dept Microbiol, Pune, Maharashtra, India; [Hussain, Arif; Devi, Savita; Kumar, Ashutosh; Parveen, Sana; Ahmed, Niyaz] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India; [Wieler, Lothar H.; Ewers, Christa] Free Univ Berlin, Inst Microbiol & Epizoot, Fac Vet, Berlin, Germany; [Ahmed, Niyaz] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia; [Ahmed, Niyaz] Univ Hyderabad Campus, Inst Life Sci, Hyderabad, Andhra Pradesh, India	Dr DY Patil Vidyapeeth Pune; Dr D Y Patil Medical College, Hospital & Research Centre; University of Hyderabad; Free University of Berlin; Universiti Malaya	Jadhav, S (corresponding author), Dr D Y Patil Med Coll & Hosp, Dept Microbiol, Pune, Maharashtra, India.	niyazSL@uohyd.ernet.in	Ahmed, Niyaz/D-2589-2010; Ewers, Christa/AAL-9186-2020; Jadhav, Dr. Savita Vivekanand/AGY-8516-2022	Ahmed, Niyaz/0000-0001-6425-7583; Jadhav, Dr. Savita Vivekanand/0000-0003-3439-9462; Ewers, Christa/0000-0001-6167-1340; Wieler, Lothar H./0000-0003-4365-3717	University of Hyderabad	University of Hyderabad(University of Hyderabad)	This study was funded by the University of Hyderabad through intramural, startup grants to Niyaz Ahmed and was carried out as part of the Indo-German Research Training Group - Internationales Graduiertenkolleg (GRK1673) - Functional Molecular Infection Epidemiology, an initiative of the German Research Foundation (DFG) and the University of Hyderabad (India), of which Niyaz Ahmed and Lothar Wieler are Speakers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babypadmini S, 2004, Indian J Med Microbiol, V22, P172; BLANCO J, 1992, FEMS MICROBIOL LETT, V99, P131, DOI 10.1016/0378-1097(92)90014-F; Blanco M, 1995, Enferm Infecc Microbiol Clin, V13, P236; Clermont O, 2009, J ANTIMICROB CHEMOTH, V64, P274, DOI 10.1093/jac/dkp194; *CLIN LAB STAND I, 2006, MS45A CLIN LAB STAND; Collee JG, 1996, MACKIE MCCARTNEY PRA, P53; Dobrindt U, 2005, INT J MED MICROBIOL, V295, P357, DOI 10.1016/j.ijmm.2005.07.009; Dombek PE, 2000, APPL ENVIRON MICROB, V66, P2572, DOI 10.1128/AEM.66.6.2572-2577.2000; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Ewers C, 2010, J ANTIMICROB CHEMOTH, V65, P651, DOI 10.1093/jac/dkq004; FOWLER JE, 1977, J UROLOGY, V117, P472, DOI 10.1016/S0022-5347(17)58501-8; Gales AC, 2002, DIAGN MICR INFEC DIS, V44, P289, DOI 10.1016/S0732-8893(02)00470-4; Hagan EC, 2007, INFECT IMMUN, V75, P3941, DOI 10.1128/IAI.00337-07; Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042; HUGHES C, 1983, INFECT IMMUN, V39, P546, DOI 10.1128/IAI.39.2.546-551.1983; Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07; Johnson JR, 2005, INT J MED MICROBIOL, V295, P383, DOI 10.1016/j.ijmm.2005.07.005; Johnson JR, 2003, INFECT DIS CLIN N AM, V17, P261, DOI 10.1016/S0891-5520(03)00027-8; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Karlowsky JA, 2001, INT J ANTIMICROB AG, V18, P121, DOI 10.1016/S0924-8579(01)00369-7; LEFFLER H, 1981, INFECT IMMUN, V34, P920, DOI 10.1128/IAI.34.3.920-929.1981; Mathai D, 2001, DIAGN MICR INFEC DIS, V40, P129, DOI 10.1016/S0732-8893(01)00254-1; MINSHEW BH, 1978, J INFECT DIS, V137, P648, DOI 10.1093/infdis/137.5.648; Najar GA, 2007, RES PHARM SCI, V2, P99; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; PEZZLO M, 2004, CLIN MICROBIOLOGY PR, P31211; PUZOVA H, 1994, FEMS IMMUNOL MED MIC, V9, P223, DOI 10.1111/j.1574-695X.1994.tb00497.x; QUACKENBUSH RL, 1979, INFECT IMMUN, V24, P562, DOI 10.1128/IAI.24.2.562-564.1979; Rademaker JLW, 1997, DNA MARKERS, P151; Sahm DF, 2001, ANTIMICROB AGENTS CH, V45, P1402, DOI 10.1128/AAC.45.5.1402-1406.2001; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; SIEGFRIED L, 1994, J MED MICROBIOL, V41, P127, DOI 10.1099/00222615-41-2-127; Tambekar DH, 2006, AFR J BIOTECHNOL, V5, P1562; Tankhiwale SS, 2004, INDIAN J MED RES, V120, P553; Ulleryd P, 2003, INT J ANTIMICROB AG, V22, pS89, DOI 10.1016/S0924-8579(03)00228-0; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007	37	80	89	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18063	10.1371/journal.pone.0018063	http://dx.doi.org/10.1371/journal.pone.0018063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464963	Green Published, gold, Green Submitted			2022-12-27	WOS:000288813900032
J	Miranda, JJ; Bernabe-Ortiz, A; Stanojevic, S; Malaga, G; Gilman, RH; Smeeth, L				Jaime Miranda, J.; Bernabe-Ortiz, Antonio; Stanojevic, Sanja; Malaga, German; Gilman, Robert H.; Smeeth, Liam			A1C as a Diagnostic Criteria for Diabetes in Low- and Middle-Income Settings: Evidence from Peru	PLOS ONE			English	Article							HEMOGLOBIN A(1C); GLUCOSE	Objectives: To determine the prevalence of type 2 diabetes mellitus, in three groups of Peruvian adults, using fasting glucose and glycosylated hemoglobin (A1C). Methodology/Principal Findings: This study included adults from the PERU MIGRANT Study who had fasted >= 8 h. Fasting glucose >= 126 mg/dL and A1C >= 6.5% were used, separately, to define diabetes. Subjects with a current diagnosis of diabetes were excluded. 964 of 988 subjects were included in this analysis. Overall, 0.9% (95% CI 0.3-1.5) and 3.5% (95% CI 2.4-4.7) had diabetes using fasting glucose and A1C criteria, respectively. Compared to those classified as having diabetes using fasting glucose, newly classified subjects with diabetes using A1C (n = 25), were older, poorer, thinner and more likely to come from rural areas. Of these, 40% (10/25) had impaired fasting glucose (IFG). Conclusions: This study shows that the use of A1C as diagnostic criteria for type 2 diabetes mellitus identifies people of different characteristics than fasting glucose. In the PERU MIGRANT population using A1C to define diabetes tripled the prevalence; the increase was more marked among poorer and rural populations. More than half the newly diagnosed people with diabetes using A1C had normal fasting glucose.	[Jaime Miranda, J.; Bernabe-Ortiz, Antonio; Stanojevic, Sanja; Malaga, German; Gilman, Robert H.; Smeeth, Liam] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Jaime Miranda, J.; Malaga, German] Univ Peruana Cayetano Heredia, Sch Med, Dept Med, Lima, Peru; [Jaime Miranda, J.; Smeeth, Liam] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Bernabe-Ortiz, Antonio] Univ Peruana Cayetano Heredia, Sch Publ Hlth, Epidemiol Unit, Lima, Peru; [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Gilman, Robert H.] A B PRISMA, Area Invest & Desarrollo, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Miranda, JJ (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.	Jaime.Miranda@upch.pe	Miranda, J. Jaime/A-8482-2008; Stanojevic, Sanja/A-4243-2010; Smeeth, Liam/X-5862-2018	Miranda, J. Jaime/0000-0002-4738-5468; Smeeth, Liam/0000-0002-9168-6022; Stanojevic, Sanja/0000-0001-7931-8051; Malaga, German/0000-0002-7828-300X; Bernabe-Ortiz, Antonio/0000-0002-6834-1376	Wellcome Trust [GR074833MA]; National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services [HHSN268200900033C]; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded in whole by the Wellcome Trust (GR074833MA). LS is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science. The CRONICAS Center of Excellence in Chronic Diseases at UPCH is funded by the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services, under contract No. HHSN268200900033C. The funder had no role in study design, data collection, analysis, or interpretation, in writing the report, or in the decision to submit the article for publication. The researchers are all independent from the funding source.	Borch-Johnsen K, 1998, BMJ-BRIT MED J, V317, P371; Borch-Johnsen K, 1999, LANCET, V354, P617; Carson AP, 2010, DIABETES CARE, V33, P95, DOI 10.2337/dc09-1227; Gama R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5648; Gavin JR, 1997, DIABETES CARE, V20, P1183; Genuth S, 2003, DIABETES CARE, V26, P3160; Gilchrist JM, 2009, J CLIN EPIDEMIOL, V62, P1045, DOI 10.1016/j.jclinepi.2008.11.012; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; International Diabetes Federation, 2009, DIAB ATL; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Miranda JJ, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-23; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Qiao Q, 2003, DIABETES CARE, V26, P688; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	21	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18069	10.1371/journal.pone.0018069	http://dx.doi.org/10.1371/journal.pone.0018069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464957	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000288813900034
J	Velpula, KK; Dasari, VR; Tsung, AJ; Gondi, CS; Klopfenstein, JD; Mohanam, S; Rao, JS				Velpula, Kiran Kumar; Dasari, Venkata Ramesh; Tsung, Andrew J.; Gondi, Christopher S.; Klopfenstein, Jeffrey D.; Mohanam, Sanjeeva; Rao, Jasti S.			Regulation of Glioblastoma Progression by Cord Blood Stem Cells Is Mediated by Downregulation of Cyclin D1	PLOS ONE			English	Article							BETA-CATENIN; DEPENDENT KINASE; BREAST-CANCER; BRAIN-TUMORS; GENE-THERAPY; BONE-MARROW; IN-VIVO; GLIOMA; GROWTH; AMPLIFICATION	Background: The normal progression of the cell cycle requires sequential expression of cyclins. Rapid induction of cyclin D1 and its associated binding with cyclin-dependent kinases, in the presence or absence of mitogenic signals, often is considered a rate-limiting step during cell cycle progression through the G(1) phase. Methodology/Principal Findings: In the present study, human umbilical cord blood stem cells (hUCBSC) in co-cultures with glioblastoma cells (U251 and 5310) not only induced G(0)-G(1) phase arrest, but also reduced the number of cells at S and G(2)-M phases of cell cycle. Cell cycle regulatory proteins showed decreased expression levels upon treatment with hUCBSC as revealed by Western and FACS analyses. Inhibition of cyclin D1 activity by hUCBSC treatment is sufficient to abolish the expression levels of Cdk 4, Cdk 6, cyclin B1, beta-Catenin levels. Our immuno precipitation experiments present evidence that, treatment of glioma cells with hUCBSC leads to the arrest of cell-cycle progression through inactivation of both cyclin D1/Cdk 4 and cyclin D1/Cdk 6 complexes. It is observed that hUCBSC, when co-cultured with glioma cells, caused an increased G(0)-G(1) phase despite the reduction of G(0)-G(1) regulatory proteins cyclin D1 and Cdk 4. We found that this reduction of G(0)-G(1) regulatory proteins, cyclin D1 and Cdk 4 may be in part compensated by the expression of cyclin E1, when co-cultured with hUCBSC. Co-localization experiments under in vivo conditions in nude mice brain xenografts with cyclin D1 and CD81 antibodies demonstrated, decreased expression of cyclin D1 in the presence of hUCBSC. Conclusions/Significance: This paper elucidates a model to regulate glioma cell cycle progression in which hUCBSC acts to control cyclin D1 induction and in concert its partner kinases, Cdk 4 and Cdk 6 by mediating cell cycle arrest at G(0)-G(1) phase.	[Velpula, Kiran Kumar; Dasari, Venkata Ramesh; Gondi, Christopher S.; Mohanam, Sanjeeva; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA; [Tsung, Andrew J.; Klopfenstein, Jeffrey D.; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Neurosurg, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Velpula, KK (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA.	jsrao@uic.edu	Dasari, Venkata Ramesh/B-3098-2009	Dasari, Venkata Ramesh/0000-0003-0819-2935; Gondi, Christopher/0000-0002-3036-9920	National Institute of Neurological Disorders and Stroke (NINDS) [NS057529]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057529] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The project was supported by Award Number NS057529 (J.S.R.) from the National Institute of Neurological Disorders and Stroke (NINDS). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Arber N, 1997, CANCER RES, V57, P1569; BARTKOVA J, 1994, INT J CANCER, V58, P568, DOI 10.1002/ijc.2910580420; Benedetti S, 2000, NAT MED, V6, P447, DOI 10.1038/74710; Bowe DB, 2002, ONCOGENE, V21, P291, DOI 10.1038/sj/onc/1205025; Buschges R, 1999, BRAIN PATHOL, V9, P435; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Chen Z, 2005, J NEUROCHEM, V92, P1281, DOI 10.1111/j.1471-4159.2004.02934.x; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010350; Dasari VR, 2008, NEUROBIOL DIS, V32, P486, DOI 10.1016/j.nbd.2008.09.005; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Donato V, 2007, TUMORI, V93, P248; Ehtesham M, 2002, CANCER RES, V62, P7170; Ehtesham M, 2002, CANCER RES, V62, P5657; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Feng B, 2009, CANCER BIOTHER RADIO, V24, P717, DOI 10.1089/cbr.2009.0652; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gillett C, 1996, INT J CANCER, V69, P92, DOI 10.1002/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.3.CO;2-I; GILLETT C, 1994, CANCER RES, V54, P1812; Gondi CS, 2010, INT J ONCOL, V36, P1165, DOI 10.3892/ijo_00000599; Guo Y, 2005, ONCOGENE, V24, P2599, DOI 10.1038/sj.onc.1208326; Guo Y, 2005, ONCOGENE, V24, P1032, DOI 10.1038/sj.onc.1208299; Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8; Han L, 2010, BRAIN RES, V1366, P9, DOI 10.1016/j.brainres.2010.09.097; James CG, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-30; Jeon YT, 2005, CANCER LETT, V223, P259, DOI 10.1016/j.canlet.2004.12.024; Kang SG, 2005, NEUROL MED-CHIR, V45, P232, DOI 10.2176/nmc.45.232; Kong SM, 2000, CANCER RES, V60, P249; Lang FF, 2003, J CLIN ONCOL, V21, P2508, DOI 10.1200/JCO.2003.21.13.2508; LI G, 2010, MOL CELL BIOCH  1224; Lu YR, 2008, CANCER BIOL THER, V7, P245, DOI 10.4161/cbt.7.2.5296; Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406; Molenaar JJ, 2008, CANCER RES, V68, P2599, DOI 10.1158/0008-5472.CAN-07-5032; Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713; Monteiro E, 2004, CANCER DETECT PREV, V28, P237, DOI 10.1016/j.cdp.2004.04.005; Pu P, 2009, CANCER GENE THER, V16, P351, DOI 10.1038/cgt.2008.78; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Soni R, 2000, BIOCHEM BIOPH RES CO, V275, P877, DOI 10.1006/bbrc.2000.3349; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Surawicz TS, 1998, J NEURO-ONCOL, V40, P151, DOI 10.1023/A:1006091608586; Takahashi M, 2007, DEV BIOL, V303, P549, DOI 10.1016/j.ydbio.2006.11.031; Takayama S, 2006, J BIOL CHEM, V281, P17856, DOI 10.1074/jbc.M602290200; Tocci Angelo, 2003, Hematol J, V4, P92, DOI 10.1038/sj.thj.6200232; WALKER AE, 1985, NEUROLOGY, V35, P219, DOI 10.1212/WNL.35.2.219; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; Williams B, 1996, CANCER GENET CYTOGEN, V91, P77, DOI 10.1016/S0165-4608(96)00155-0; Zheng YL, 2010, BIOMED PHARMACOTHER, V64, P527, DOI 10.1016/j.biopha.2009.04.046	49	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18017	10.1371/journal.pone.0018017	http://dx.doi.org/10.1371/journal.pone.0018017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455311	gold, Green Published			2022-12-27	WOS:000288811500019
J	Banks, SML; Cho, B; Eun, SH; Lee, JH; Windler, SL; Xie, XH; Bilder, D; Fischer, JA				Banks, Susan M. L.; Cho, Bomsoo; Eun, Suk Ho; Lee, Ji-Hoon; Windler, Sarah L.; Xie, Xuanhua; Bilder, David; Fischer, Janice A.			The Functions of Auxilin and Rab11 in Drosophila Suggest That the Fundamental Role of Ligand Endocytosis in Notch Signaling Cells Is Not Recycling	PLOS ONE			English	Article							UBIQUITIN LIGASE; FAT-FACETS; MIND BOMB; DELTA-ENDOCYTOSIS; PATTERN-FORMATION; PLANAR POLARITY; EPSIN; PATHWAY; ACTIVATION; EYE	Notch signaling requires ligand internalization by the signal sending cells. Two endocytic proteins, epsin and auxilin, are essential for ligand internalization and signaling. Epsin promotes clathrin-coated vesicle formation, and auxilin uncoats clathrin from newly internalized vesicles. Two hypotheses have been advanced to explain the requirement for ligand endocytosis. One idea is that after ligand/receptor binding, ligand endocytosis leads to receptor activation by pulling on the receptor, which either exposes a cleavage site on the extracellular domain, or dissociates two receptor subunits. Alternatively, ligand internalization prior to receptor binding, followed by trafficking through an endosomal pathway and recycling to the plasma membrane may enable ligand activation. Activation could mean ligand modification or ligand transcytosis to a membrane environment conducive to signaling. A key piece of evidence supporting the recycling model is the requirement in signaling cells for Rab11, which encodes a GTPase critical for endosomal recycling. Here, we use Drosophila Rab11 and auxilin mutants to test the ligand recycling hypothesis. First, we find that Rab11 is dispensable for several Notch signaling events in the eye disc. Second, we find that Drosophila female germline cells, the one cell type known to signal without clathrin, also do not require auxilin to signal. Third, we find that much of the requirement for auxilin in Notch signaling was bypassed by overexpression of both clathrin heavy chain and epsin. Thus, the main role of auxilin in Notch signaling is not to produce uncoated ligand-containing vesicles, but to maintain the pool of free clathrin. Taken together, these results argue strongly that at least in some cell types, the primary function of Notch ligand endocytosis is not for ligand recycling.	[Banks, Susan M. L.; Cho, Bomsoo; Eun, Suk Ho; Lee, Ji-Hoon; Xie, Xuanhua; Fischer, Janice A.] Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Banks, Susan M. L.; Cho, Bomsoo; Eun, Suk Ho; Lee, Ji-Hoon; Xie, Xuanhua; Fischer, Janice A.] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Windler, Sarah L.; Bilder, David] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of California System; University of California Berkeley	Banks, SML (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA.	jaf@mail.utexas.edu	Tsai, Yu-Chen/B-5852-2008; Xie, xuanhua Peter/C-5267-2012	Xie, xuanhua Peter/0000-0001-8032-4715; Bilder, David/0000-0002-1842-4966; Banks, Susan/0000-0001-7088-4487	National Institutes of Health (NIH), Texas [R01HD30680]; NIH [R01GM068675]; ACS, California [RSG0704001]; California Cancer Research Coordinating Committee; NIH; University of Texas at Austin; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD030680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068675, R01GM090150] Funding Source: NIH RePORTER	National Institutes of Health (NIH), Texas(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS, California(American Cancer Society); California Cancer Research Coordinating Committee; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas at Austin; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Janice Fischer is the PI on National Institutes of Health (NIH) grant R01HD30680 that funded the work in Texas. David Bilder is the PI on NIH grant R01GM068675 and ACS grant RSG0704001 that funded the work in California. Sarah Windler also had funding from a California Cancer Research Coordinating Committee Fellowship and an NIH Training Grant. Ji-Hoon Lee also received funding from a Continuing Fellowship from The University of Texas at Austin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alone DP, 2005, INT J DEV BIOL, V49, P873, DOI 10.1387/ijdb.051986da; Bai T, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-7; Baker NE, 1997, CURR BIOL, V7, P122, DOI 10.1016/S0960-9822(06)00056-X; Benhra N, 2010, MOL BIOL CELL, V21, P2078, DOI 10.1091/mbc.E09-11-0926; Bogard N, 2007, DEVELOPMENT, V134, P3413, DOI 10.1242/dev.008466; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cadavid ALM, 2000, DEVELOPMENT, V127, P1727; Carthew RW, 2007, CURR OPIN GENET DEV, V17, P309, DOI 10.1016/j.gde.2007.05.001; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Chen H, 2009, P NATL ACAD SCI USA, V106, P13838, DOI 10.1073/pnas.0907008106; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Deblandre GA, 2001, DEV CELL, V1, P795, DOI 10.1016/S1534-5807(01)00091-0; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Eun SH, 2008, DEVELOPMENT, V135, P1089, DOI 10.1242/dev.009530; Eun SH, 2007, GENETICS, V175, P1163, DOI 10.1534/genetics.106.067959; Fanto M, 1999, NATURE, V397, P523, DOI 10.1038/17389; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Furthauer M, 2009, TRAFFIC, V10, P792, DOI 10.1111/j.1600-0854.2009.00914.x; Gall WE, 2000, CURR BIOL, V10, P1349, DOI 10.1016/S0960-9822(00)00771-5; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Hagedorn EJ, 2006, J CELL BIOL, V173, P443, DOI 10.1083/jcb.200602054; HEUSS SF, 2008, J CELL SCI, V112, P3289; Horvath CAJ, 2007, INT J BIOCHEM CELL B, V39, P1765, DOI 10.1016/j.biocel.2006.12.004; Huang YZ, 1996, DEVELOPMENT, V122, P3207; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; Kandachar V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-50; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lai EC, 2005, DEVELOPMENT, V132, P2319, DOI 10.1242/dev.01825; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; Matsuda M, 2009, DEVELOPMENT, V136, P197, DOI 10.1242/dev.027938; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Parks AL, 2000, DEVELOPMENT, V127, P1373; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Pishvaee B, 2000, NAT CELL BIOL, V2, P958, DOI 10.1038/35046619; Pitsouli C, 2005, DEVELOPMENT, V132, P4041, DOI 10.1242/dev.01979; Rajan A, 2009, NAT CELL BIOL, V11, P815, DOI 10.1038/ncb1888; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sun X, 1997, DEVELOPMENT, V124, P3439; Tian XL, 2004, DEVELOPMENT, V131, P5807, DOI 10.1242/dev.01459; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; Tomlinson A, 1999, DEVELOPMENT, V126, P5725; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Windler SL, 2010, CURR BIOL, V20, P538, DOI 10.1016/j.cub.2010.01.049; Wolff Tanya, 1993, P1277; Yeh E, 2001, CURR BIOL, V11, P1675, DOI 10.1016/S0960-9822(01)00527-9	61	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18259	10.1371/journal.pone.0018259	http://dx.doi.org/10.1371/journal.pone.0018259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448287	Green Published, Green Submitted, gold			2022-12-27	WOS:000288810500049
J	He, T; Wang, QO; Feng, GH; Hu, YO; Wang, L; Wang, YM				He, Tao; Wang, Qiong; Feng, Guihai; Hu, Yaou; Wang, Li; Wang, Yumin			Computational Detection and Functional Analysis of Human Tissue-Specific A-to-I RNA Editing	PLOS ONE			English	Article							SYSTEMATIC IDENTIFICATION; ADENOSINE DEAMINASES; PREDICTION; EXPRESSION; PROTEIN; CANCER; DISCOVERY; CLEAVAGE; TARGETS; SITES	A-to-I RNA editing is a widespread post-transcriptional modification event in vertebrates. It could increase transcriptome and proteome diversity through recoding the genomic information and cross-linking other regulatory events, such as those mediated by alternative splicing, RNAi and microRNA (miRNA). Previous studies indicated that RNA editing can occur in a tissue-specific manner in response to the requirements of the local environment. We set out to systematically detect tissue-specific A-to-I RNA editing sites in 43 human tissues using bioinformatics approaches based on the Fisher's exact test and the Benjamini & Hochberg false discovery rate (FDR) multiple testing correction. Twenty-three sites in total were identified to be tissue-specific. One of them resulted in an altered amino acid residue which may prevent the phosphorylation of PARP-10 and affect its activity. Eight and two tissue-specific A-to-I RNA editing sites were predicted to destroy putative exonic splicing enhancers (ESEs) and exonic splicing silencers (ESSs), respectively. Brain-specific and ovary-specific A-to-I RNA editing sites were further verified by comparing the cDNA sequences with their corresponding genomic templates in multiple cell lines from brain, colon, breast, bone marrow, lymph, liver, ovary and kidney tissue. Our findings help to elucidate the role of A-to-I RNA editing in the regulation of tissue-specific development and function, and the approach utilized here can be broadened to study other types of tissue-specific substitution editing.	[He, Tao; Feng, Guihai; Hu, Yaou; Wang, Li; Wang, Yumin] Beijing Inst Biotechnol, Beijing, Peoples R China; [Wang, Qiong] Beijing Inst Radiat Med, Beijing, Peoples R China	Academy of Military Medical Sciences - China	He, T (corresponding author), Beijing Inst Biotechnol, Beijing, Peoples R China.	liwang@tsinghua.edu.cn; wym66@vip.sina.com	Feng, Guihai/A-5105-2019	Feng, Guihai/0000-0002-8726-1734	National High-Tech RD Program (863) [2007AA022204]; National Key Technologies RD Program [2003A08-4-6]; Chinese Key Program for Drug Invention [2009ZX09501-027]; National Natural Science Foundation of China [30800644]	National High-Tech RD Program (863)(National High Technology Research and Development Program of China); National Key Technologies RD Program(National Key Technology R&D Program); Chinese Key Program for Drug Invention; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants of the National High-Tech R&D Program (863) (2007AA022204), the National Key Technologies R&D Program (2003A08-4-6), Chinese Key Program for Drug Invention (2009ZX09501-027), and National Natural Science Foundation of China (30800644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Gallo A, 2008, RNA BIOL, V5, P135, DOI 10.4161/rna.5.3.6739; Gott JM, 2003, CR BIOL, V326, P901, DOI 10.1016/j.crvi.2003.09.004; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grohmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008956; GUIGO R, 1992, J MOL BIOL, V226, P141, DOI 10.1016/0022-2836(92)90130-C; Guryev V, 2006, GENOME RES, V16, P491, DOI 10.1101/gr.4791006; He SM, 2008, NUCLEIC ACIDS RES, V36, pD170, DOI 10.1093/nar/gkm1011; Howad W, 1997, P NATL ACAD SCI USA, V94, P11090, DOI 10.1073/pnas.94.20.11090; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Jacobs MM, 2009, DEV NEUROSCI-BASEL, V31, P223, DOI 10.1159/000210185; Jin YF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-98; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Julenius K, 2007, GLYCOBIOLOGY, V17, P868, DOI 10.1093/glycob/cwm050; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Laurencikiene J, 2006, EMBO REP, V7, P303, DOI 10.1038/sj.embor.7400621; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Maas Stefan, 2006, RNA Biol, V3, P1; Neeman Y, 2005, TRENDS GENET, V21, P544, DOI 10.1016/j.tig.2005.08.005; Nielsen KB, 2007, AM J HUM GENET, V80, P416, DOI 10.1086/511992; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Osenberg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011173; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Picardi E, 2010, NUCLEIC ACIDS RES, V38, P4755, DOI 10.1093/nar/gkq202; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Schaub M, 2002, BIOCHIMIE, V84, P791, DOI 10.1016/S0300-9084(02)01446-3; Schmitt AO, 1999, NUCLEIC ACIDS RES, V27, P4251, DOI 10.1093/nar/27.21.4251; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Song WZ, 2004, J BIOL CHEM, V279, P32554, DOI 10.1074/jbc.M402392200; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Xu Q, 2003, NUCLEIC ACIDS RES, V31, P5635, DOI 10.1093/nar/gkg786; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yu M, 2005, ONCOGENE, V24, P1982, DOI 10.1038/sj.onc.1208410; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	52	15	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18129	10.1371/journal.pone.0018129	http://dx.doi.org/10.1371/journal.pone.0018129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448465	Green Published, Green Submitted, gold			2022-12-27	WOS:000288810500042
J	Landgren, S; Simms, JA; Thelle, DS; Strandhagen, E; Bartlett, SE; Engel, JA; Jerlhag, E				Landgren, Sara; Simms, Jeffrey A.; Thelle, Dag S.; Strandhagen, Elisabeth; Bartlett, Selena E.; Engel, Jorgen A.; Jerlhag, Elisabet			The Ghrelin Signalling System Is Involved in the Consumption of Sweets	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; STIMULATES LOCOMOTOR-ACTIVITY; CONDITIONED PLACE PREFERENCE; ETHANOL-CONSUMPTION; ALCOHOL-CONSUMPTION; 20-PERCENT ETHANOL; DOPAMINE-OVERFLOW; NUCLEUS-ACCUMBENS; LONG-EVANS; RATS	The gastric-derived orexigenic peptide ghrelin affects brain circuits involved in energy balance as well as in reward. Indeed, ghrelin activates an important reward circuit involved in natural-as well as drug-induced reward, the cholinergic-dopaminergic reward link. It has been hypothesized that there is a common reward mechanism for alcohol and sweet substances in both animals and humans. Alcohol dependent individuals have higher craving for sweets than do healthy controls and the hedonic response to sweet taste may, at least in part, depend on genetic factors. Rat selectively bred for high sucrose intake have higher alcohol consumption than non-sucrose preferring rats and vice versa. In the present study a group of alcohol-consuming individuals selected from a population cohort was investigated for genetic variants of the ghrelin signalling system in relation to both their alcohol and sucrose consumption. Moreover, the effects of GHS-R1A antagonism on voluntary sucrose-intake and operant self-administration, as well as saccharin intake were investigated in preclinical studies using rodents. The effects of peripheral grelin administration on sucrose intake were also examined. Here we found associations with the ghrelin gene haplotypes and increased sucrose consumption, and a trend for the same association was seen in the high alcohol consumers. The preclinical data show that a GHS-R1A antagonist reduces the intake and self-administration of sucrose in rats as well as saccharin intake in mice. Further, ghrelin increases the intake of sucrose in rats. Collectively, our data provide a clear indication that the GHS-R1A antagonists reduces and ghrelin increases the intake of rewarding substances and hence, the central ghrelin signalling system provides a novel target for the development of drug strategies to treat addictive behaviours.	[Landgren, Sara; Engel, Jorgen A.; Jerlhag, Elisabet] Univ Gothenburg, Sahlgrenska Acad, Dept Pharmacol, Gothenburg, Sweden; [Simms, Jeffrey A.; Bartlett, Selena E.] Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA USA; [Simms, Jeffrey A.; Engel, Jorgen A.] Univ Calif San Francisco, Res Ctr, Emeryville, CA USA; [Thelle, Dag S.] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Strandhagen, Elisabeth] Univ Gothenburg, Sahlgrenska Acad, Sch Publ Hlth & Community Med, Gothenburg, Sweden	University of Gothenburg; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of Oslo; University of Gothenburg	Landgren, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Pharmacol, Gothenburg, Sweden.	elisabet.jerlhag@pharm.gu.se	Bartlett, Selena/J-1345-2012; Thelle, Dag Steinar/ABD-1867-2020	Bartlett, Selena/0000-0002-1741-3958; Thelle, Dag Steinar/0000-0002-4417-5967	Swedish Research Council [K2006-21X-04247-33-3, 2009-2782]; Alcohol Research Council of the Swedish Alcohol Retailing Monopoly; Swedish Brain Foundation; Swedish Council for Tobacco Research; LUA/ALF, Sahlgrenska University Hospital [7341, 148251]; foundations of Signe; Olof Wallenius; Goljes Memory; Adlerbertska; Fredrik and Ingrid Thuring; Tore Nilsson; Langmanska; Torsten and Ragnar Soderberg; Wilhelm and Martina Lundgren; Knut and Alice Wallenberg; Magnus Bergvall; Swedish Council for Working Life and Social Research (EpiLife); Swedish Society of Medicine; State of California for Medical Research through UCSF; Department of Defense [W81XWH-07-1-0075]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Alcohol Research Council of the Swedish Alcohol Retailing Monopoly; Swedish Brain Foundation; Swedish Council for Tobacco Research; LUA/ALF, Sahlgrenska University Hospital; foundations of Signe; Olof Wallenius; Goljes Memory; Adlerbertska; Fredrik and Ingrid Thuring; Tore Nilsson; Langmanska; Torsten and Ragnar Soderberg; Wilhelm and Martina Lundgren; Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Magnus Bergvall; Swedish Council for Working Life and Social Research (EpiLife)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Society of Medicine; State of California for Medical Research through UCSF; Department of Defense(United States Department of Defense)	This work was supported by grants from the Swedish Research Council (grant no. K2006-21X-04247-33-3 and 2009-2782), the Alcohol Research Council of the Swedish Alcohol Retailing Monopoly, the Swedish Brain Foundation, Swedish Council for Tobacco Research, LUA/ALF (grant no. 7341, 148251) from the Sahlgrenska University Hospital, and the foundations of Signe and Olof Wallenius, Goljes Memory, Adlerbertska, Fredrik and Ingrid Thuring, Tore Nilsson, Langmanska, Torsten and Ragnar Soderberg, Wilhelm and Martina Lundgren, Knut and Alice Wallenberg, Magnus Bergvall, the Swedish Council for Working Life and Social Research (EpiLife), the Swedish Society of Medicine, the State of California for Medical Research through UCSF and the Department of Defense (grant no. W81XWH-07-1-0075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; BELKNAP JK, 1993, PSYCHOPHARMACOLOGY, V112, P503, DOI 10.1007/BF02244901; Berg C, 2009, APPETITE, V52, P21, DOI 10.1016/j.appet.2008.07.008; Berg CM, 2008, AM J CLIN NUTR, V88, P289; Carroll ME, 2008, BEHAV PHARMACOL, V19, P435, DOI 10.1097/FBP.0b013e32830c3632; Davis KW, 2007, REGUL PEPTIDES, V140, P148, DOI 10.1016/j.regpep.2006.12.003; Disse E, 2010, PHYSIOL BEHAV, V101, P277, DOI 10.1016/j.physbeh.2010.05.017; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; JERLHAG E, 2010, ALCOHOL IN PRESS, DOI DOI 10.1016/J.ALCOHOL.2010.10.002; Jerlhag E, 2008, ADDICT BIOL, V13, P358, DOI 10.1111/j.1369-1600.2008.00125.x; Jerlhag E, 2008, EUR NEUROPSYCHOPHARM, V18, P508, DOI 10.1016/j.euroneuro.2008.02.006; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; Jerlhag E, 2006, ALCOHOL ALCOHOLISM, V41, P486, DOI 10.1093/alcalc/agl049; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Jerlhag E, 2010, PSYCHOPHARMACOLOGY, V211, P415, DOI 10.1007/s00213-010-1907-7; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; Jiang H, 2006, MOL ENDOCRINOL, V20, P1772, DOI 10.1210/me.2005-0084; Kampov-Polevoy AB, 2004, ALCOHOL CLIN EXP RES, V28, P1291, DOI 10.1097/01.ALC.0000137808.69482.75; Kampov-Polevoy AB, 2003, ALCOHOL CLIN EXP RES, V27, P1929, DOI 10.1097/01.ALC.0000099265.60216.23; Kampov-Polevoy AB, 2003, ALCOHOL CLIN EXP RES, V27, P1743, DOI 10.1097/01.ALC.0000093739.05809.DD; Kampov-Polevoy AB, 1999, ALCOHOL ALCOHOLISM, V34, P386, DOI 10.1093/alcalc/34.3.386; KampovPolevoy A, 1997, AM J PSYCHIAT, V154, P269, DOI 10.1176/ajp.154.2.269; Kaur S, 2010, ALCOHOL CLIN EXP RES, V34, P1525, DOI 10.1111/j.1530-0277.2010.01237.x; Keen-Rhinehart K, 2005, AM J PHYSIOL-REG I, V288, pR716, DOI 10.1152/ajpregu.00705.2004; Keskitalo K, 2007, AM J CLIN NUTR, V86, P1663; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Landgren S, 2008, ALCOHOL CLIN EXP RES, V32, P2054, DOI 10.1111/j.1530-0277.2008.00793.x; Landgren S, 2012, ADDICT BIOL, V17, P86, DOI 10.1111/j.1369-1600.2010.00280.x; Landgren S, 2010, ALCOHOL CLIN EXP RES, V34, P1519, DOI 10.1111/j.1530-0277.2010.01236.x; Larsson A, 2004, ALCOHOL, V34, P239, DOI 10.1016/j.alcohol.2004.10.002; Larsson A, 2004, NEUROSCI BIOBEHAV R, V27, P713, DOI 10.1016/j.neubiorev.2003.11.010; Lemon CH, 2004, J NEUROPHYSIOL, V92, P536, DOI 10.1152/jn.00097.2004; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Malik S, 2008, CELL METAB, V7, P400, DOI 10.1016/j.cmet.2008.03.007; MCCALLUM SE, 2011, PSYCHOPHARMA IN PRES, DOI DOI 10.1007/S00213-010-2132-0; Moulin A, 2007, J MED CHEM, V50, P5790, DOI 10.1021/jm0704550; RAMIREZ I, 1978, PHYSIOL BEHAV, V20, P257, DOI 10.1016/0031-9384(78)90218-4; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Simms JA, 2010, NEUROPSYCHOPHARMACOL, V35, P1453, DOI 10.1038/npp.2010.15; SINCLAIR JD, 1992, ALCOHOL, V9, P155, DOI 10.1016/0741-8329(92)90027-8; Skibicka KP, 2012, ADDICT BIOL, V17, P95, DOI 10.1111/j.1369-1600.2010.00294.x; Steensland P, 2007, P NATL ACAD SCI USA, V104, P12518, DOI 10.1073/pnas.0705368104; Strandhagen E, 2010, EUR J EPIDEMIOL, V25, P163, DOI 10.1007/s10654-010-9427-7; Tessari M, 2007, ADDICT BIOL, V12, P22, DOI 10.1111/j.1369-1600.2007.00052.x; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Volkow ND, 2003, INT J EAT DISORDER, V33, P136, DOI 10.1002/eat.10118; Wellman PJ, 2005, REGUL PEPTIDES, V125, P151, DOI 10.1016/j.regpep.2004.08.013	51	59	61	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18170	10.1371/journal.pone.0018170	http://dx.doi.org/10.1371/journal.pone.0018170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448464	Green Submitted, gold, Green Published			2022-12-27	WOS:000288810500047
J	Fang, Z; Rajewsky, N				Fang, Zhuo; Rajewsky, Nikolaus			The Impact of miRNA Target Sites in Coding Sequences and in 3 ' UTRs	PLOS ONE			English	Article							MICRORNA TARGETS; PROTEIN; IDENTIFICATION; DETERMINANTS; MAMMALS; SIRNAS	Animal miRNAs are a large class of small regulatory RNAs that are known to directly and negatively regulate the expression of a large fraction of all protein encoding genes. The identification and characterization of miRNA targets is thus a fundamental problemin biology. miRNAs regulate target genes by binding to 39 untranslated regions (3 ' UTRs) of target mRNAs, and multiple binding sites for the same miRNA in 3'UTRs can strongly enhance the degree of regulation. Recent experiments have demonstrated that a large fraction of miRNA binding sites reside in coding sequences. Overall, miRNA binding sites in coding regions were shown to mediate smaller regulation than 3'UTR binding. However, possible interactions between target sites in coding sequences and 3'UTRs have not been studied. Using transcriptomics and proteomics data of ten miRNA mis-expression experiments as well as transcriptome-wide experimentally identified miRNA target sites, we found that mRNA and protein expression of genes containing target sites both in coding regions and 3'UTRs were in general mildly but significantly more regulated than those containing target sites in 3'UTRs only. These effects were stronger for conserved target sites of length 7-8 nt in coding regions compared to non-conserved sites. Combined with our other finding that miRNA target sites in coding regions are under negative selection, our results shed light on the functional importance of miRNA targeting in coding regions.	[Fang, Zhuo; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Fang, Z (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	rajewsky@mdc-berlin.de		Rajewsky, Nikolaus/0000-0002-4785-4332	Federal Ministry for Education and Research	Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	Zhuo Fang is funded by the Federal Ministry for Education and Research through a FORSYS-Partner project (FORSYS, 0315267C; http://forsys.drfz.de/index.php/home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	17	195	202	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18067	10.1371/journal.pone.0018067	http://dx.doi.org/10.1371/journal.pone.0018067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445367	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000288809100028
J	Khanna, A; Okkeri, J; Bilgen, T; Tiirikka, T; Vihinen, M; Visakorpi, T; Westermarck, J				Khanna, Anchit; Okkeri, Juha; Bilgen, Turker; Tiirikka, Timo; Vihinen, Mauno; Visakorpi, Tapio; Westermarck, Jukka			ETS1 Mediates MEK1/2-Dependent Overexpression of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) in Human Cancer Cells	PLOS ONE			English	Article							ONCOGENIC ACTIVITY; GASTRIC-CANCER; GENE; PATHWAY; EGFR; FAMILY	EGFR-MEK-ERK signaling pathway has an established role in promoting malignant growth and disease progression in human cancers. Therefore identification of transcriptional targets mediating the oncogenic effects of the EGFR-MEK-ERK pathway would be highly relevant. Cancerous inhibitor of protein phosphatase 2A (CIP2A) is a recently characterized human oncoprotein. CIP2A promotes malignant cell growth and is over expressed at high frequency (40-80%) in most of the human cancer types. However, the mechanisms inducing its expression in cancer still remain largely unexplored. Here we present systematic analysis of contribution of potential gene regulatory mechanisms for high CIP2A expression in cancer. Our data shows that evolutionary conserved CpG islands at the proximal CIP2A promoter are not methylated both in normal and cancer cells. Furthermore, sequencing of the active CIP2A promoter region from altogether seven normal and malignant cell types did not reveal any sequence alterations that would increase CIP2A expression specifically in cancer cells. However, treatment of cancer cells with various signaling pathway inhibitors revealed that CIP2A mRNA expression was sensitive to inhibition of EGFR activity as well as inhibition or activation of MEK-ERK pathway. Moreover, MEK1/2-specific siRNAs decreased CIP2A protein expression. Series of CIP2A promoter-luciferase constructs were created to identify proximal 227 to 2107 promoter region responsible for MEK-dependent stimulation of CIP2A expression. Additional mutagenesis and chromatin immunoprecipitation experiments revealed ETS1 as the transcription factor mediating stimulation of CIP2A expression through EGFR-MEK pathway. Thus, ETS1 is probably mediating high CIP2A expression in human cancers with increased EGFR-MEK1/2-ERK pathway activity. These results also suggest that in addition to its established role in invasion and angiogenesis, ETS1 may support malignant cellular growth via regulation of CIP2A expression and protein phosphatase 2A inhibition.	[Khanna, Anchit; Bilgen, Turker; Tiirikka, Timo; Vihinen, Mauno; Visakorpi, Tapio; Westermarck, Jukka] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Khanna, Anchit; Bilgen, Turker; Tiirikka, Timo; Vihinen, Mauno; Visakorpi, Tapio; Westermarck, Jukka] Tampere Univ Hosp, Tampere, Finland; [Khanna, Anchit] Univ Tampere, TGPBB, FIN-33101 Tampere, Finland; [Okkeri, Juha; Bilgen, Turker; Westermarck, Jukka] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Okkeri, Juha; Bilgen, Turker; Westermarck, Jukka] Abo Akad Univ, Turku, Finland; [Bilgen, Turker] Akdeniz Univ, Fac Med, Dept Med Biol & Genet, TR-07058 Antalya, Turkey; [Westermarck, Jukka] Univ Turku, Dept Pathol, Turku, Finland	Tampere University; Tampere University; Tampere University Hospital; Tampere University; University of Turku; Abo Akademi University; Akdeniz University; University of Turku	Khanna, A (corresponding author), Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland.	jukwes@utu.fi	Vihinen, Mauno/A-8452-2012; Westermarck, Jukka/AAL-6464-2020; Bilgen, Turker/N-6376-2018	Vihinen, Mauno/0000-0002-9614-7976; Westermarck, Jukka/0000-0001-7478-3018; Bilgen, Turker/0000-0002-3015-0929; Visakorpi, Tapio/0000-0002-5004-0364	Academy of Finland [217676, 217675]; Association for International Cancer Research [08-0614]; Foundation for the Finnish Cancer Institute; Emil Aaltonen Foundation; Sigrid Juselius Foundation; Competitive Research Funding of the Pirkanmaa Hospital District [9K152, 9L115]; Tampere Graduate Program in Biomedicine and Biotechnology; The Scientific and Technological Research Council of Turkey	Academy of Finland(Academy of Finland); Association for International Cancer Research; Foundation for the Finnish Cancer Institute; Emil Aaltonen Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Competitive Research Funding of the Pirkanmaa Hospital District; Tampere Graduate Program in Biomedicine and Biotechnology; The Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by Academy of Finland ( projects: 217676 and 217675), Association for International Cancer Research ( project 08-0614), Foundation for the Finnish Cancer Institute (J.W.), Emil Aaltonen Foundation, Sigrid Juselius Foundation, Competitive Research Funding of the Pirkanmaa Hospital District ( projects: 9K152 and 9L115), Tampere Graduate Program in Biomedicine and Biotechnology ( A. K.), and The Scientific and Technological Research Council of Turkey ( T. B.). The funders had no role in study design, data collection or analysis, decision to publish or preparation of the manuscript.	CHEN KF, 2010, ONCOGENE; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; Dent P, 2009, DRUG RESIST UPDATE, V12, P65, DOI 10.1016/j.drup.2009.03.001; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Dong Q.Z., 2010, ANN SURG ONCOL; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hahne JC, 2005, ONCOGENE, V24, P5384, DOI 10.1038/sj.onc.1208761; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Holterman CE, 2010, CANCER RES, V70, P730, DOI 10.1158/0008-5472.CAN-09-2090; Hoo LS, 2002, ONCOGENE, V21, P5006, DOI 10.1038/sj.onc.1205625; Johnson AC, 2000, MOL MED, V6, P17, DOI 10.1007/BF03401931; Junttila MR, 2008, CELL CYCLE, V7, P592, DOI 10.4161/cc.7.5.5492; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Li WJ, 2008, CLIN CANCER RES, V14, P3722, DOI 10.1158/1078-0432.CCR-07-4137; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Normanno N, 2006, J CELL PHYSIOL, V207, P420, DOI 10.1002/jcp.20588; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rutter JL, 1998, CANCER RES, V58, P5321; Seth A, 2001, Expert Opin Ther Targets, V5, P87, DOI 10.1517/14728222.5.1.87; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; SETH A, 1990, ONCOGENE, V5, P1761; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; WANG J, 2011, INT J LAB HEMATOL; WATSON DK, 1985, P NATL ACAD SCI USA, V82, P7294, DOI 10.1073/pnas.82.21.7294; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Yang BS, 1996, MOL CELL BIOL, V16, P538; Yoon YK, 2009, MOL CANCER THER, V8, P2526, DOI 10.1158/1535-7163.MCT-09-0300; Zhao JJ, 2004, TRENDS MOL MED, V10, P344, DOI 10.1016/j.molmed.2004.05.005	39	51	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17979	10.1371/journal.pone.0017979	http://dx.doi.org/10.1371/journal.pone.0017979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445343	Green Submitted, gold, Green Published			2022-12-27	WOS:000288809100020
J	Schmidt, J; Musken, M; Becker, T; Magnowska, Z; Bertinetti, D; Moller, S; Zimmermann, B; Herberg, FW; Jansch, L; Haussler, S				Schmidt, Juliane; Muesken, Mathias; Becker, Tanja; Magnowska, Zofia; Bertinetti, Daniela; Moeller, Stefan; Zimmermann, Bastian; Herberg, Friedrich W.; Jaensch, Lothar; Haeussler, Susanne			The Pseudomonas aeruginosa Chemotaxis Methyltransferase CheR1 Impacts on Bacterial Surface Sampling	PLOS ONE			English	Article							BIOFILM FORMATION; TWITCHING MOTILITY; PROTEIN METHYLTRANSFERASE; CELL POLES; IV PILI; METHYLATION; SEQUENCE; RECEPTOR; SYSTEM; ROLES	The characterization of factors contributing to the formation and development of surface-associated bacterial communities known as biofilms has become an area of intense interest since biofilms have a major impact on human health, the environment and industry. Various studies have demonstrated that motility, including swimming, swarming and twitching, seems to play an important role in the surface colonization and establishment of structured biofilms. Thereby, the impact of chemotaxis on biofilm formation has been less intensively studied. Pseudomonas aeruginosa has a very complex chemosensory system with two Che systems implicated in flagella-mediated motility. In this study, we demonstrate that the chemotaxis protein CheR1 is a methyltransferase that binds S-adenosylmethionine and transfers a methyl group from this methyl donor to the chemoreceptor PctA, an activity which can be stimulated by the attractant serine but not by glutamine. We furthermore demonstrate that CheR1 does not only play a role in flagella-mediated chemotaxis but that its activity is essential for the formation and maintenance of bacterial biofilm structures. We propose a model in which motility and chemotaxis impact on initial attachment processes, dispersion and reattachment and increase the efficiency and frequency of surface sampling in P. aeruginosa.	[Schmidt, Juliane; Muesken, Mathias; Becker, Tanja; Magnowska, Zofia; Jaensch, Lothar; Haeussler, Susanne] Helmholtz Ctr Infect Res, Dept Cell Biol, Braunschweig, Germany; [Muesken, Mathias; Becker, Tanja; Haeussler, Susanne] Ctr Expt & Clin Infect Res, TWINCORE, Hannover, Germany; [Muesken, Mathias; Becker, Tanja; Haeussler, Susanne] Hannover Med Sch, D-3000 Hannover, Germany; [Bertinetti, Daniela; Moeller, Stefan; Herberg, Friedrich W.] Univ Kassel, Dept Biochem, Kassel, Germany; [Zimmermann, Bastian] Biaffin GmbH & Co KG, Kassel, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Universitat Kassel	Schmidt, J (corresponding author), Helmholtz Ctr Infect Res, Dept Cell Biol, Braunschweig, Germany.	susanne.haeussler@twincore.de	Häussler, Susanne/I-2605-2014; Herberg, Friedrich W/B-5572-2015; Pohl, Sarah/B-3102-2016; Bertinetti, Daniela/B-5655-2015	Häussler, Susanne/0000-0001-6141-9102; Herberg, Friedrich W/0000-0001-7117-7653; Pohl, Sarah/0000-0003-2655-7037; Bertinetti, Daniela/0000-0003-1150-3765; Musken, Mathias/0000-0002-5624-1378	German Research Foundation (DFG) [SFB900]; EU [222635]	German Research Foundation (DFG)(German Research Foundation (DFG)); EU(European Commission)	Financial support from the German Research Foundation (DFG) (SFB900) and of the Helmholtz-Gemeinschaft is gratefully acknowledged. Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FWH and BZ are supported by the grant "Affinity Proteome" from EU (222635). The commercial company Biaffin GmbH & Co KG contributed to analysis tools.	ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; Armitage JP, 1997, MICROBIOL-UK, V143, P3671, DOI 10.1099/00221287-143-12-3671; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; BLAIR DF, 1995, ANNU REV MICROBIOL, V49, P489, DOI 10.1146/annurev.mi.49.100195.002421; Boin MA, 2004, FEMS MICROBIOL LETT, V239, P1, DOI 10.1016/j.femsle.2004.08.039; Bourret RB, 2002, J BIOL CHEM, V277, P9625, DOI 10.1074/jbc.R100066200; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; DARZINS A, 1994, MOL MICROBIOL, V11, P137, DOI 10.1111/j.1365-2958.1994.tb00296.x; DeLange PA, 2007, CURR MICROBIOL, V55, P389, DOI 10.1007/s00284-007-9008-5; Djordjevic S, 1998, NAT STRUCT BIOL, V5, P446, DOI 10.1038/nsb0698-446; Dotsch A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-29; Ferrandez A, 2002, J BACTERIOL, V184, P4374, DOI 10.1128/JB.184.16.4374-4383.2002; GUTTLER A, 1998, THESIS; Guvener ZT, 2006, MOL MICROBIOL, V61, P106, DOI 10.1111/j.1365-2958.2006.05218.x; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kato J, 1999, BIOSCI BIOTECH BIOCH, V63, P155, DOI 10.1271/bbb.63.155; Kato J, 2008, J BIOSCI BIOENG, V106, P1, DOI 10.1263/jbb.106.1; Kirby JR, 2009, ANNU REV MICROBIOL, V63, P45, DOI 10.1146/annurev.micro.091208.073221; Kirov SM, 2004, INFECT IMMUN, V72, P1939, DOI 10.1128/IAI.72.4.1939-1945.2004; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Klockgether J, 2010, J BACTERIOL, V192, P1113, DOI 10.1128/JB.01515-09; KURODA A, 1995, J BACTERIOL, V177, P7019, DOI 10.1128/jb.177.24.7019-7025.1995; Lemon KP, 2007, J BACTERIOL, V189, P4418, DOI 10.1128/JB.01967-06; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; LIN LN, 1994, BIOCHEMISTRY-US, V33, P6564, DOI 10.1021/bi00187a025; LUPAS A, 1989, J BIOL CHEM, V264, P17337; MASDUKI A, 1995, J BACTERIOL, V177, P948, DOI 10.1128/jb.177.4.948-952.1995; Merritt PM, 2007, J BACTERIOL, V189, P8005, DOI 10.1128/JB.00566-07; Moorthy S, 2004, MOL MICROBIOL, V52, P573, DOI 10.1111/j.1365-2958.2004.04000.x; Morgan R, 2006, J BACTERIOL, V188, P7335, DOI 10.1128/JB.00599-06; Musken M, 2010, MICROBIOL-SGM, V156, P431, DOI 10.1099/mic.0.033290-0; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Okumura H, 1998, J BACTERIOL, V180, P1862, DOI 10.1128/JB.180.7.1862-1868.1998; Pamp SJ, 2007, J BACTERIOL, V189, P2531, DOI 10.1128/JB.01515-06; Perez E, 2004, BIOCHEMISTRY-US, V43, P953, DOI 10.1021/bi035455q; Perez E, 2007, MOL MICROBIOL, V63, P363, DOI 10.1111/j.1365-2958.2006.05518.x; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Rao CV, 2009, CONTRIB MICROBIOL, V16, P33, DOI 10.1159/000219372; RICE MS, 1991, J BIOL CHEM, V266, P9746; Shiomi D, 2002, J BIOL CHEM, V277, P42325, DOI 10.1074/jbc.M202001200; SIMMS SA, 1991, J BIOL CHEM, V266, P12741; SIMMS SA, 1987, J BIOL CHEM, V262, P8537; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SPRINGER WR, 1977, P NATL ACAD SCI USA, V74, P533, DOI 10.1073/pnas.74.2.533; STOCK JB, 1978, P NATL ACAD SCI USA, V75, P3659, DOI 10.1073/pnas.75.8.3659; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Taguchi K, 1997, MICROBIOL-UK, V143, P3223, DOI 10.1099/00221287-143-10-3223; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Whitchurch CB, 2004, MOL MICROBIOL, V52, P873, DOI 10.1111/j.1365-2958.2004.04026.x; Winsor GL, 2005, NUCLEIC ACIDS RES, V33, pD338, DOI 10.1093/nar/gki047; WOLFE AJ, 1988, P NATL ACAD SCI USA, V85, P6711, DOI 10.1073/pnas.85.18.6711; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; Wu JG, 1996, BIOCHEMISTRY-US, V35, P4984, DOI 10.1021/bi9530189; Yeung ATY, 2009, J BACTERIOL, V191, P5592, DOI 10.1128/JB.00157-09; Zusman DR, 2007, NAT REV MICROBIOL, V5, P862, DOI 10.1038/nrmicro1770	63	44	44	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18184	10.1371/journal.pone.0018184	http://dx.doi.org/10.1371/journal.pone.0018184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445368	Green Published, gold, Green Submitted			2022-12-27	WOS:000288809100033
J	Streb, JW; Long, XC; Lee, TH; Sun, QA; Kitchen, CM; Georger, MA; Slivano, OJ; Blaner, WS; Carr, DW; Gelman, IH; Miano, JM				Streb, Jeffrey W.; Long, Xiaochun; Lee, Ting-Hein; Sun, Qiang; Kitchen, Chad M.; Georger, Mary A.; Slivano, Orazio J.; Blaner, William S.; Carr, Daniel W.; Gelman, Irwin H.; Miano, Joseph M.			Retinoid-Induced Expression and Activity of an Immediate Early Tumor Suppressor Gene in Vascular Smooth Muscle Cells	PLOS ONE			English	Article							PROLIFERATION IN-VITRO; SERUM RESPONSE FACTOR; KINASE-C SUBSTRATE; PROTEIN-KINASE; INTIMAL HYPERPLASIA; NEOINTIMA FORMATION; ANGIOTENSIN-II; CYTOSKELETAL ARCHITECTURE; BALLOON ANGIOPLASTY; NUCLEAR RECEPTORS	Retinoids are used clinically to treat a number of hyper-proliferative disorders and have been shown in experimental animals to attenuate vascular occlusive diseases, presumably through nuclear receptors bound to retinoic acid response elements (RARE) located in target genes. Here, we show that natural or synthetic retinoids rapidly induce mRNA and protein expression of a specific isoform of A-Kinase Anchoring Protein 12 (AKAP12 beta) in cultured smooth muscle cells (SMC) as well as the intact vessel wall. Expression kinetics and actinomycin D studies indicate Akap12 beta is a retinoid-induced, immediate-early gene. Akap12 beta promoter analyses reveal a conserved RARE mildly induced with atRA in a region that exhibits hyperacetylation. Immunofluorescence microscopy and protein kinase A (PKA) regulatory subunit overlay assays in SMC suggest a physical association between AKAP12 beta and PKA following retinoid treatment. Consistent with its designation as a tumor suppressor, inducible expression of AKAP12 beta attenuates SMC growth in vitro. Further, immunohistochemistry studies establish marked decreases in AKAP12 expression in experimentally-injured vessels of mice as well as atheromatous lesions in humans. Collectively, these results demonstrate a novel role for retinoids in the induction of an AKAP tumor suppressor that blocks vascular SMC growth thus providing new molecular insight into how retiniods may exert their anti-proliferative effects in the injured vessel wall.	[Streb, Jeffrey W.; Long, Xiaochun; Lee, Ting-Hein; Sun, Qiang; Kitchen, Chad M.; Georger, Mary A.; Slivano, Orazio J.; Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14627 USA; [Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY USA; [Blaner, William S.] Columbia Univ, Dept Med, New York, NY USA; [Carr, Daniel W.] Portland VA Med Ctr, Portland, OR USA; [Gelman, Irwin H.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	University of Rochester; University of Rochester; Columbia University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Roswell Park Cancer Institute	Streb, JW (corresponding author), Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14627 USA.	j.m.miano@rochester.edu	; Miano, Joseph/L-5634-2018	Long, Xiaochun/0000-0001-9714-0023; Miano, Joseph/0000-0001-7522-3207	National Institutes of Health [HL070077, CA094108, DK079221, DK068437, T32HL07949]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Service; NATIONAL CANCER INSTITUTE [R01CA094108, R55CA094108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070077, T32HL007949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068437, R01DK079221, R56DK068437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Service(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health grants HL070077 to JMM; CA094108 to IHG; DK079221 and DK068437 to WSB; and Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Service to DWC. JWS was funded through an NIH training grant (#T32HL07949). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura S, 2008, CANCER RES, V68, P5096, DOI 10.1158/0008-5472.CAN-07-5619; Bu Y, 2007, J BIOL CHEM, V282, P26725, DOI 10.1074/jbc.M702885200; CARR DW, 1992, J BIOL CHEM, V267, P13376; Chen JY, 1999, CHINESE MED J-PEKING, V112, P121; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chen JY, 2001, BIOCHEM BIOPH RES CO, V281, P475, DOI 10.1006/bbrc.2001.4362; Choi MC, 2004, ONCOGENE, V23, P7095, DOI 10.1038/sj.onc.1207932; Coats SR, 2000, J MOL CELL CARDIOL, V32, P2207, DOI 10.1006/jmcc.2000.1246; DeRose JJ, 1999, CARDIOVASC SURG, V7, P633, DOI 10.1016/S0967-2109(99)00041-1; Firulli AB, 1998, IN VITRO CELL DEV-AN, V34, P217; Firulli AB, 1996, CIRC RES, V78, P196, DOI 10.1161/01.RES.78.2.196; Flotho C, 2007, BRIT J HAEMATOL, V138, P644, DOI 10.1111/j.1365-2141.2007.06709.x; Fujiu K, 2005, CIRC RES, V97, P1132, DOI 10.1161/01.RES.0000190613.22565.13; Gelman IH, 2000, HISTOCHEM J, V32, P13, DOI 10.1023/A:1003950027529; Gelman IH, 2002, FRONT BIOSCI-LANDMRK, V7, pD1782, DOI 10.2741/gelman; Goeppert B, 2010, HEPATOLOGY, V52, P2023, DOI 10.1002/hep.23939; GORDON T, 1992, J CLIN INVEST, V90, P992, DOI 10.1172/JCI115976; Haraguchi G, 2006, J MOL CELL CARDIOL, V41, P885, DOI 10.1016/j.yjmcc.2006.07.022; Haxsen V, 2001, CIRC RES, V88, P637, DOI 10.1161/01.RES.88.6.637; Ichiki T, 2006, ARTERIOSCL THROM VAS, V26, P449, DOI 10.1161/01.ATV.0000196747.79349.d1; Indolfi C, 2001, CIRC RES, V88, P319, DOI 10.1161/01.RES.88.3.319; Indolfi C, 1997, NAT MED, V3, P775, DOI 10.1038/nm0797-775; Indolfi C, 2000, J AM COLL CARDIOL, V36, P288, DOI 10.1016/S0735-1097(00)00679-3; Jo Ukhyun, 2006, Cancer Res Treat, V38, P144, DOI 10.4143/crt.2006.38.3.144; Korshunov VA, 2003, ARTERIOSCL THROM VAS, V23, P2185, DOI 10.1161/01.ATV.0000103120.06092.14; Kosaka C, 2001, HYPERTENS RES, V24, P579, DOI 10.1291/hypres.24.579; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Leville CD, 2000, J SURG RES, V90, P183, DOI 10.1006/jsre.2000.5887; Lin XY, 1996, J BIOL CHEM, V271, P28430, DOI 10.1074/jbc.271.45.28430; LIPPMAN SM, 1995, J CELL BIOCHEM, P1; Liu HO, 2009, BRAIN RES, V1265, P1, DOI 10.1016/j.brainres.2009.01.050; Liu YZ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-105; Long XC, 2007, J BIOL CHEM, V282, P15941, DOI 10.1074/jbc.R700010200; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Miano JM, 2000, CIRC RES, V87, P355; Miano JM, 1996, CIRCULATION, V93, P1886, DOI 10.1161/01.CIR.93.10.1886; Miano JM, 1998, CIRCULATION, V98, P1219, DOI 10.1161/01.CIR.98.12.1219; Nagpal S, 2004, J INVEST DERMATOL, V123, pXX, DOI 10.1111/j.0022-202X.2004.23533.x; Namimatsu S, 2005, J HISTOCHEM CYTOCHEM, V53, P3, DOI 10.1369/jhc.4C6466.2005; Neuville P, 1999, ARTERIOSCL THROM VAS, V19, P1430, DOI 10.1161/01.ATV.19.6.1430; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pakala R, 2000, J CARDIOVASC PHARM, V35, P302, DOI 10.1097/00005344-200002000-00019; Quelo I, 2000, BIOCHEM BIOPH RES CO, V271, P481, DOI 10.1006/bbrc.2000.2654; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Stolle K, 2004, J HISTOCHEM CYTOCHEM, V52, P1511, DOI 10.1369/jhc.4A6289.2004; Streb Jeffrey W., 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P31, DOI 10.2174/1568006033337393; Streb JW, 2005, J BIOL CHEM, V280, P4125, DOI 10.1074/jbc.M412466200; Streb JW, 2004, J BIOL CHEM, V279, P56014, DOI 10.1074/jbc.M408828200; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tao JC, 2006, J BIOL CHEM, V281, P23932, DOI 10.1074/jbc.M601813200; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; VENANCE SL, 1993, CAN J PHYSIOL PHARM, V71, P800, DOI 10.1139/y93-119; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang HY, 2006, EUR J CELL BIOL, V85, P643, DOI 10.1016/j.ejcb.2005.12.003; Wang S, 1997, PFLUG ARCH EUR J PHY, V434, P669, DOI 10.1007/s004240050450; Wiegman PJ, 2000, ARTERIOSCL THROM VAS, V20, P89, DOI 10.1161/01.ATV.20.1.89; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wright G, 1996, AM J PHYSIOL-HEART C, V270, pH1363, DOI 10.1152/ajpheart.1996.270.4.H1363; Xia W, 2001, CANCER RES, V61, P5644; Yan XH, 2009, EXP CELL RES, V315, P1247, DOI 10.1016/j.yexcr.2008.12.026	60	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18538	10.1371/journal.pone.0018538	http://dx.doi.org/10.1371/journal.pone.0018538			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483686	gold, Green Published, Green Submitted			2022-12-27	WOS:000289191300028
J	Fiamegos, YC; Kastritis, PL; Exarchou, V; Han, H; Bonvin, AMJJ; Vervoort, J; Lewis, K; Hamblin, MR; Tegos, GP				Fiamegos, Yiannis C.; Kastritis, Panagiotis L.; Exarchou, Vassiliki; Han, Haley; Bonvin, Alexandre M. J. J.; Vervoort, Jacques; Lewis, Kim; Hamblin, Michael R.; Tegos, George P.			Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against Gram-Positive Pathogenic Bacteria	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; ANTIBIOTIC-ACTIVITY; CHLOROGENIC ACID; NORA; TRANSPORTER; DERIVATIVES; BERBERINE; ANALOGS; PLANT; IDENTIFICATION	Background: Traditional antibiotics are increasingly suffering from the emergence of multidrug resistance amongst pathogenic bacteria leading to a range of novel approaches to control microbial infections being investigated as potential alternative treatments. One plausible antimicrobial alternative could be the combination of conventional antimicrobial agents/antibiotics with small molecules which block multidrug efflux systems known as efflux pump inhibitors. Bioassay-driven purification and structural determination of compounds from plant sources have yielded a number of pump inhibitors which acted against gram positive bacteria. Methodology/Principal Findings: In this study we report the identification and characterization of 4',5'-O-dicaffeoylquinic acid (4',5'-ODCQA) from Artemisia absinthium as a pump inhibitor with a potential of targeting efflux systems in a wide panel of Gram-positive human pathogenic bacteria. Separation and identification of phenolic compounds (chlorogenic acid, 3',5'-ODCQA, 4',5'-ODCQA) was based on hyphenated chromatographic techniques such as liquid chromatography with post column solid-phase extraction coupled with nuclear magnetic resonance spectroscopy and mass spectroscopy. Microbial susceptibility testing and potentiation of well know pump substrates revealed at least two active compounds; chlorogenic acid with weak antimicrobial activity and 4',5'-ODCQA with pump inhibitory activity whereas 3',5'-ODCQA was ineffective. These intitial findings were further validated with checkerboard, berberine accumulation efflux assays using efflux-related phenotypes and clinical isolates as well as molecular modeling methodology. Conclusions/Significance: These techniques facilitated the direct analysis of the active components from plant extracts, as well as dramatically reduced the time needed to analyze the compounds, without the need for prior isolation. The calculated energetics of the docking poses supported the biological information for the inhibitory capabilities of 4',5'-ODCQA and furthermore contributed evidence that CQAs show a preferential binding to Major Facilitator Super family efflux systems, a key multidrug resistance determinant in gram-positive bacteria.	[Fiamegos, Yiannis C.] Univ Ioannina, Analyt Chem Lab, GR-45110 Ioannina, Greece; [Kastritis, Panagiotis L.; Bonvin, Alexandre M. J. J.] Univ Utrecht, Bijvoet Ctr Biomol Res, Fac Sci, Utrecht, Netherlands; [Exarchou, Vassiliki] Univ Ioannina, NMR Ctr, GR-45110 Ioannina, Greece; [Han, Haley; Hamblin, Michael R.; Tegos, George P.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Vervoort, Jacques] Wageningen NMR Ctr, Biophys Lab, Wageningen, Netherlands; [Lewis, Kim] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Lewis, Kim] Northeastern Univ, Antimicrobial Drug Discovery Ctr, Boston, MA 02115 USA; [Hamblin, Michael R.; Tegos, George P.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Hamblin, Michael R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	University of Ioannina; Utrecht University; University of Ioannina; Harvard University; Massachusetts General Hospital; Wageningen University & Research; Northeastern University; Northeastern University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT)	Fiamegos, YC (corresponding author), Univ Ioannina, Analyt Chem Lab, GR-45110 Ioannina, Greece.	gtegos@salud.unm.edu	Hamblin, Mike/AAB-2511-2022; Han, Hye Sung/AAQ-3621-2021; Tegos, George/C-8830-2011; Kastritis, Panagiotis/AAL-7029-2021; Hamblin, Michael R/H-2758-2019; Bonvin, Alexandre M.J.J./A-5420-2009; Kastritis, Panagiotis L/F-2498-2010	Han, Hye Sung/0000-0002-3556-0740; Kastritis, Panagiotis/0000-0002-1463-8422; Hamblin, Michael R/0000-0001-6431-4605; Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Kastritis, Panagiotis L/0000-0002-1463-8422	E.U. [HPRI-CT-2001-00178, 2002-31, 2003-011]; National Institutes of Health (NIH) [5U54MH084690-02, R01GM59903R01AI050875]; Massachusetts Technology Transfer Center (MTTC); Netherlands Organization for Scientific Research [700.56.442]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690] Funding Source: NIH RePORTER	E.U.(European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Technology Transfer Center (MTTC); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for Y. Fiamegos was provided by E.U. Large Scale Facilities program, contracts HPRI-CT-2001-00178, 'LC-NMR analysis of traditional herbal pharmaceuticals' (project no 2002-31) and 'On line LC-SPE-NMR system in analyzing the bioactive constituents of Artemisia extract', (Project no 2003-011) of the Wageningen NMR center. Funding was provided for G. Tegos by the National Institutes of Health (NIH, 5U54MH084690-02, Center Driven Initiative 1) and Massachusetts Technology Transfer Center (MTTC), by the National Institutes of Health for K. Lewis (NIH, R01GM59903) and M. R. Hamblin (NIH, R01AI050875). Funding for P. Kastritis was provided by the Netherlands Organization for Scientific Research through a VICI grant (700.56.442) to A. Bonvin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Azuma K, 1999, J AGR FOOD CHEM, V47, P3963, DOI 10.1021/jf990347p; Ball AR, 2006, ACS CHEM BIOL, V1, P594, DOI 10.1021/cb600238x; Bandyopadhyay G, 2004, BLOOD, V104, P2514, DOI 10.1182/blood-2003-11-4065; Belofsky G, 2006, J NAT PROD, V69, P261, DOI 10.1021/np058057s; Belofsky G, 2004, J NAT PROD, V67, P481, DOI 10.1021/np030409c; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cherigo L, 2008, J NAT PROD, V71, P1037, DOI 10.1021/np800148w; Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005; Clifford MN, 2003, J AGR FOOD CHEM, V51, P2900, DOI 10.1021/jf026187q; *CLIN LAB STAND I, 2008, M39A329 CLSI; CLSI, 1908, M27A3 CLSI; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eliopoulos G.M., 1991, ANTIBIOTICS LAB MED, V3rd Edn, P432; Exarchou V, 2003, ANAL CHEM, V75, P6288, DOI 10.1021/ac0347819; Falcao-Silva VS, 2009, PHYTOTHER RES, V23, P1367, DOI 10.1002/ptr.2695; German N, 2008, EUR J MED CHEM, V43, P2453, DOI 10.1016/j.ejmech.2008.01.042; Gibbons S, 2004, PLANTA MED, V70, P1240, DOI 10.1055/s-2004-835860; Hisamoto M, 2003, J AGR FOOD CHEM, V51, P5255, DOI 10.1021/jf0262458; [黄象艳 Huang Xiangyan], 2003, [中国抗生素杂志, Chinese Journal of Antibiotics], V28, P718; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jonas BM, 2001, ANTIMICROB AGENTS CH, V45, P3574, DOI 10.1128/AAC.45.12.3574-3579.2001; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Juteau F, 2003, PLANTA MED, V69, P158, DOI 10.1055/s-2003-37714; Kaatz GW, 2000, ANTIMICROB AGENTS CH, V44, P1404, DOI 10.1128/AAC.44.5.1404-1406.2000; Kastritis PL, 2010, J PROTEOME RES, V9, P2216, DOI 10.1021/pr9009854; Lechner D, 2008, J ANTIMICROB CHEMOTH, V62, P345, DOI 10.1093/jac/dkn178; Lewis K, 2006, NAT BIOTECHNOL, V24, P1504, DOI 10.1038/nbt1206-1504; Lomovskaya O, 2001, J MOL MICROB BIOTECH, V3, P225; Lomovskaya O, 2007, NAT REV DRUG DISCOV, V6, P56, DOI 10.1038/nrd2200; Markham PN, 1999, ANTIMICROB AGENTS CH, V43, P2404, DOI 10.1128/AAC.43.10.2404; Michalet S, 2007, BIOORG MED CHEM LETT, V17, P1755, DOI 10.1016/j.bmcl.2006.12.059; Mohtar M, 2009, CURR MICROBIOL, V59, P181, DOI 10.1007/s00284-009-9416-9; Morel C, 2003, J AGR FOOD CHEM, V51, P5677, DOI 10.1021/jf0302714; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; OHNISHI M, 1994, PHYTOCHEMISTRY, V36, P579, DOI 10.1016/S0031-9422(00)89778-2; PAULSEN IT, 2002, MICROBIAL MULTIDRUG, P5; Pereda-Miranda R, 2006, J NAT PROD, V69, P406, DOI 10.1021/np050227d; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Reinke RA, 2002, J MED CHEM, V45, P3669, DOI 10.1021/jm010359d; Rodrigues L, 2008, J ANTIMICROB CHEMOTH, V61, P1076, DOI 10.1093/jac/dkn070; Sabatini S, 2008, J MED CHEM, V51, P4321, DOI 10.1021/jm701623q; Samosorn S, 2006, BIOORGAN MED CHEM, V14, P857, DOI 10.1016/j.bmc.2005.09.019; Sangwan PL, 2008, BIOORGAN MED CHEM, V16, P9847, DOI 10.1016/j.bmc.2008.09.042; Schram K, 2004, J MASS SPECTROM, V39, P384, DOI 10.1002/jms.600; Singh N, 2008, CHEM-BIOL INTERACT, V173, P97, DOI 10.1016/j.cbi.2008.03.008; Stavri M, 2007, J ANTIMICROB CHEMOTH, V59, P1247, DOI 10.1093/jac/dkl460; Stermitz FR, 2000, P NATL ACAD SCI USA, V97, P1433, DOI 10.1073/pnas.030540597; Stermitz FR, 2002, PLANTA MED, V68, P1140, DOI 10.1055/s-2002-36347; Stermitz FR, 2003, BIOORG MED CHEM LETT, V13, P1915, DOI 10.1016/S0960-894X(03)00316-0; Tegos G, 2002, ANTIMICROB AGENTS CH, V46, P3133, DOI 10.1128/AAC.46.10.3133-3141.2002; TEGOS G, 2006, SUBSTRATES INHIBITOR; Thota N, 2008, BIOORGAN MED CHEM, V16, P6535, DOI 10.1016/j.bmc.2008.05.030; Truong-Bolduc QC, 2003, J BACTERIOL, V185, P3127, DOI 10.1128/JB.185.10.3127-3138.2003; Tsuchiya T, 1996, BIOSCI BIOTECH BIOCH, V60, P765, DOI 10.1271/bbb.60.765; Wei P, 2004, BIOORG MED CHEM LETT, V14, P3093, DOI 10.1016/j.bmcl.2004.04.018	62	114	120	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18127	10.1371/journal.pone.0018127	http://dx.doi.org/10.1371/journal.pone.0018127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483731	Green Published, gold, Green Submitted			2022-12-27	WOS:000289058700009
J	Archer, SK; Inchaustegui, D; Queiroz, R; Clayton, C				Archer, Stuart K.; Inchaustegui, Diana; Queiroz, Rafael; Clayton, Christine			The Cell Cycle Regulated Transcriptome of Trypanosoma brucei	PLOS ONE			English	Article							MESSENGER-RNA ABUNDANCE; POLO-LIKE KINASE; CRITHIDIA-FASCICULATA; CHROMATIN IMMUNOPRECIPITATION; LEISHMANIA-MEXICANA; BINDING-PROTEINS; DNA-REPLICATION; EXPRESSED GENES; AURORA KINASE; IDENTIFICATION	Progression of the eukaryotic cell cycle requires the regulation of hundreds of genes to ensure that they are expressed at the required times. Integral to cell cycle progression in yeast and animal cells are temporally controlled, progressive waves of transcription mediated by cell cycle-regulated transcription factors. However, in the kinetoplastids, a group of early-branching eukaryotes including many important pathogens, transcriptional regulation is almost completely absent, raising questions about the extent of cell-cycle regulation in these organisms and the mechanisms whereby regulation is achieved. Here, we analyse gene expression over the Trypanosoma brucei cell cycle, measuring changes in mRNA abundance on a transcriptome-wide scale. We developed a "double-cut" elutriation procedure to select unperturbed, highly synchronous cell populations from log-phase cultures, and compared this to synchronization by starvation. Transcriptome profiling over the cell cycle revealed the regulation of at least 430 genes. While only a minority were homologous to known cell cycle regulated transcripts in yeast or human, their functions correlated with the cellular processes occurring at the time of peak expression. We searched for potential target sites of RNA-binding proteins in these transcripts, which might earmark them for selective degradation or stabilization. Over-represented sequence motifs were found in several co-regulated transcript groups and were conserved in other kinetoplastids. Furthermore, we found evidence for cell-cycle regulation of a flagellar protein regulon with a highly conserved sequence motif, bearing similarity to consensus PUF-protein binding motifs. RNA sequence motifs that are functional in cell-cycle regulation were more widespread than previously expected and conserved within kinetoplastids. These findings highlight the central importance of post-transcriptional regulation in the proliferation of parasitic kinetoplastids.	[Archer, Stuart K.; Inchaustegui, Diana; Clayton, Christine] DKFZ ZMBH Allianz, Zentrum Mol Biol Heidelberg, Heidelberg, Germany; [Queiroz, Rafael] DKFZ ZMBH Allianz, Deutsch Krebsforschungszentrum, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Archer, SK (corresponding author), DKFZ ZMBH Allianz, Zentrum Mol Biol Heidelberg, Heidelberg, Germany.	s.archer@victorchang.edu.au	Clayton, Christine/K-7700-2019	Archer, Stuart/0000-0003-0450-1243; Clayton, Christine/0000-0002-6384-0731	DFG [CL112/14-1]	DFG(German Research Foundation (DFG))	This work was supported by DFG grant CL112/14-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2004, MOL BIOCHEM PARASIT, V136, P71, DOI 10.1016/j.molbiopara.2004.03.002; ARCHER SK, 2008, MOL BIOCH PARASITOL; Archer SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000565; Avliyakulov NK, 2003, EUKARYOT CELL, V2, P671, DOI 10.1128/EC.2.4.671-677.2003; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Banfalvi G, 2008, NAT PROTOC, V3, P663, DOI 10.1038/nprot.2008.34; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Benz C, 2005, MOL BIOCHEM PARASIT, V143, P125, DOI 10.1016/j.molbiopara.2005.05.008; Brown LM, 1997, NUCLEIC ACIDS RES, V25, P3281, DOI 10.1093/nar/25.16.3281; Bucerius F, 2011, MOL BIOCHEM PARASIT, V175, P205, DOI 10.1016/j.molbiopara.2010.10.001; BULLARD J, GENOMINATOR ANAL GEN; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chowdhury AR, 2008, EUKARYOT CELL, V7, P425, DOI 10.1128/EC.00369-07; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; de Lichtenberg U, 2005, YEAST, V22, P1191, DOI 10.1002/yea.1302; Downey N, 2005, EUKARYOT CELL, V4, P765, DOI 10.1128/EC.4.4.765-774.2005; Ersfeld K, 1996, MOL BIOCHEM PARASIT, V81, P201, DOI 10.1016/0166-6851(96)02709-0; Ettwiller L, 2007, NAT METHODS, V4, P563, DOI 10.1038/NMETH1061; Forsythe GR, 2009, MOL BIOCHEM PARASIT, V164, P131, DOI 10.1016/j.molbiopara.2008.12.008; GALANTI N, 1994, EXP CELL RES, V214, P225, DOI 10.1006/excr.1994.1252; GALE M, 1994, J CELL SCI, V107, P1825; Gauthier NP, 2008, NUCLEIC ACIDS RES, V36, pD854, DOI 10.1093/nar/gkm729; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; HARRIS ME, 1991, MOL CELL BIOL, V11, P2416, DOI 10.1128/MCB.11.5.2416; Haudry Y, 2010, NAT PROTOC, V5, P323, DOI 10.1038/nprot.2009.158; Hines JC, 2010, MOL CELL BIOL, V30, P1319, DOI 10.1128/MCB.01231-09; Ho HH, 2006, P NATL ACAD SCI USA, V103, P7676, DOI 10.1073/pnas.0602595103; Holzer TR, 2008, MOL BIOCHEM PARASIT, V157, P54, DOI 10.1016/j.molbiopara.2007.10.001; Kabani S, 2010, MOL BIOCHEM PARASIT, V169, P59, DOI 10.1016/j.molbiopara.2009.08.008; Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li Z, 2007, J CELL SCI, V120, P3883, DOI 10.1242/jcs.007955; Mahmood R, 2001, MOL CELL BIOL, V21, P4453, DOI 10.1128/MCB.21.14.4453-4459.2001; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; Mishra KK, 2003, EUKARYOT CELL, V2, P1009, DOI 10.1128/EC.2.5.1009-1017.2003; Mittra B, 2004, EUKARYOT CELL, V3, P1185, DOI 10.1128/EC.3.5.1185-1197.2004; Mittra B, 2003, J BIOL CHEM, V278, P26564, DOI 10.1074/jbc.M304322200; Pasion SG, 1996, MOL CELL BIOL, V16, P6724; Portman N, 2009, J BIOL CHEM, V284, P5610, DOI 10.1074/jbc.M808859200; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; Siegel TN, 2010, NUCL ACIDS RES; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tu XM, 2006, J BIOL CHEM, V281, P9677, DOI 10.1074/jbc.M511504200; Umeyama T, 2008, EUKARYOT CELL, V7, P1582, DOI 10.1128/EC.00150-08; URBANI L, 1995, EXP CELL RES, V219, P159, DOI 10.1006/excr.1995.1216; Van den Abbeele J, 1999, PARASITOLOGY, V118, P469, DOI 10.1017/S0031182099004217; Vaughan PS, 1998, J BIOL CHEM, V273, P194, DOI 10.1074/jbc.273.1.194; Vaughan S, 2010, CURR OPIN MICROBIOL, V13, P453, DOI 10.1016/j.mib.2010.05.006; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wurst M, 2009, MOL BIOCHEM PARASIT, V163, P61, DOI 10.1016/j.molbiopara.2008.09.001; Zhou Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009660; Zick A, 2005, NUCLEIC ACIDS RES, V33, P4235, DOI 10.1093/nar/gki742	65	72	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18425	10.1371/journal.pone.0018425	http://dx.doi.org/10.1371/journal.pone.0018425			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483801	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200074
J	Rolland, M; Frahm, N; Nickle, DC; Jojic, N; Deng, WJ; Allen, TM; Brander, C; Heckerman, DE; Mullins, JI				Rolland, Morgane; Frahm, Nicole; Nickle, David C.; Jojic, Nebojsa; Deng, Wenjie; Allen, Todd M.; Brander, Christian; Heckerman, David E.; Mullins, James I.			Increased Breadth and Depth of Cytotoxic T Lymphocytes Responses against HIV-1-B Nef by Inclusion of Epitope Variant Sequences	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELLULAR IMMUNE-RESPONSES; RECOGNITION; VIREMIA	Different vaccine approaches cope with HIV-1 diversity, ranging from centralized(1-4) to variability-encompassing(5-7) antigens. For all these strategies, a concern remains: how does HIV-1 diversity impact epitope recognition by the immune system? We studied the relationship between HIV-1 diversity and CD8(+) T Lymphocytes (CTL) targeting of HIV-1 subtype B Nef using 944 peptides (10-mers overlapping by nine amino acids (AA)) that corresponded to consensus peptides and their most common variants in the HIV-1-B virus population. IFN-gamma ELISpot assays were performed using freshly isolated PBMC from 26 HIV-1-infected persons. Three hundred and fifty peptides elicited a response in at least one individual. Individuals targeted a median of 7 discrete regions. Overall, 33% of responses were directed against viral variants but not elicited against consensus-based test peptides. However, there was no significant relationship between the frequency of a 10-mer in the viral population and either its frequency of recognition (Spearman's correlation coefficient rho = 0.24) or the magnitude of the responses (rho = 0.16). We found that peptides with a single mutation compared to the consensus were likely to be recognized (especially if the change was conservative) and to elicit responses of similar magnitude as the consensus peptide. Our results indicate that cross-reactivity between rare and frequent variants is likely to play a role in the expansion of CTL responses, and that maximizing antigenic diversity in a vaccine may increase the breadth and depth of CTL responses. However, since there are few obvious preferred pathways to virologic escape, the diversity that may be required to block all potential escape pathways may be too large for a realistic vaccine to accommodate. Furthermore, since peptides were not recognized based on their frequency in the population, it remains unclear by which mechanisms variability-inclusive antigens (i.e., constructs enriched with frequent variants) expand CTL recognition.	[Rolland, Morgane; Nickle, David C.; Deng, Wenjie; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Frahm, Nicole; Allen, Todd M.; Brander, Christian] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Jojic, Nebojsa; Brander, Christian] Hosp Badalona Germans Trias & Pujol, AIDS Res Inst IrsiCaixa HIVACAT, Barcelona, Spain; [Brander, Christian] ICREA, Barcelona, Spain; [Heckerman, David E.] Microsoft Res, Redmond, WA USA	University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Massachusetts General Hospital; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; ICREA; Microsoft	Rolland, M (corresponding author), Henry M Jackson Fdn, Mil HIV Res Program, Rockville, MD 20852 USA.	mrolland@hivresearch.org	Allen, Todd/F-5473-2011; Nickle, David/ABF-2727-2020	Allen, Todd/0000-0002-6609-1318; Brander, Christian/0000-0002-0548-5778	Microsoft Research; Bill and Melinda Gates Foundation [43437]; amfAR [107005-43-RFNT]; Computational Biology Core of the University of Washington Centers for AIDS Research and STD (National Institutes of Health) [AI27757]; University of Washington Center for AIDS Research [P30 AI27757]; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, P30AI027757] Funding Source: NIH RePORTER	Microsoft Research(Microsoft); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); amfAR; Computational Biology Core of the University of Washington Centers for AIDS Research and STD (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Center for AIDS Research; ICREA(ICREA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an unrestricted gift from Microsoft Research, the Bill and Melinda Gates Foundation (43437) and by grants to MR from amfAR (Mathilde Krim Fellowship - 107005-43-RFNT), the Computational Biology Core of the University of Washington Centers for AIDS Research and STD (National Institutes of Health AI27757), and a grant to JIM from the University of Washington Center for AIDS Research (P30 AI27757)(bioinformatics core). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DEH is an employee of Microsoft Research and MR is currently employed by the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) (this study was completed prior to MR's employment at HJF).	Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Buseyne F, 2001, INT IMMUNOL, V13, P941, DOI 10.1093/intimm/13.7.941; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; DAYHOFF MO, 1965, J THEOR BIOL, V8, P97, DOI 10.1016/0022-5193(65)90096-2; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Frahm N, 2005, J VIROL, V79, P10218, DOI 10.1128/JVI.79.16.10218-10225.2005; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kent SJ, 1997, J INFECT DIS, V176, P1188, DOI 10.1086/514112; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KLEIN MR, 1995, TRENDS MICROBIOL, V3, P386, DOI 10.1016/S0966-842X(00)88984-2; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McKinney DM, 2004, J IMMUNOL, V173, P1941, DOI 10.4049/jimmunol.173.3.1941; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Nickle DC, 2007, PLOS COMPUT BIOL, V3, P754, DOI 10.1371/journal.pcbi.0030075; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rolland M, 2007, J VIROL, V81, P8507, DOI 10.1128/JVI.02683-06; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Yerly D, 2008, J IMMUNOL, V181, P6361, DOI 10.4049/jimmunol.181.9.6361	24	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17969	10.1371/journal.pone.0017969	http://dx.doi.org/10.1371/journal.pone.0017969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464919	gold, Green Published, Green Submitted			2022-12-27	WOS:000289053800009
J	Stegmaier, P; Voss, N; Meier, T; Kel, A; Wingender, E; Borlak, J				Stegmaier, Philip; Voss, Nico; Meier, Tatiana; Kel, Alexander; Wingender, Edgar; Borlak, Juergen			Advanced Computational Biology Methods Identify Molecular Switches for Malignancy in an EGF Mouse Model of Liver Cancer	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; TRANSCRIPTION FACTORS; STEM-CELLS; TUMOR-SUPPRESSOR; HUMAN BREAST; PROTEIN-1; PROMOTER; IDENTIFICATION; APOPTOSIS; BIOINFORMATICS	The molecular causes by which the epidermal growth factor receptor tyrosine kinase induces malignant transformation are largely unknown. To better understand EGFs' transforming capacity whole genome scans were applied to a transgenic mouse model of liver cancer and subjected to advanced methods of computational analysis to construct de novo gene regulatory networks based on a combination of sequence analysis and entrained graph-topological algorithms. Here we identified transcription factors, processes, key nodes and molecules to connect as yet unknown interacting partners at the level of protein-DNA interaction. Many of those could be confirmed by electromobility band shift assay at recognition sites of gene specific promoters and by western blotting of nuclear proteins. A novel cellular regulatory circuitry could therefore be proposed that connects cell cycle regulated genes with components of the EGF signaling pathway. Promoter analysis of differentially expressed genes suggested the majority of regulated transcription factors to display specificity to either the pre-tumor or the tumor state. Subsequent search for signal transduction key nodes upstream of the identified transcription factors and their targets suggested the insulin-like growth factor pathway to render the tumor cells independent of EGF receptor activity. Notably, expression of IGF2 in addition to many components of this pathway was highly upregulated in tumors. Together, we propose a switch in autocrine signaling to foster tumor growth that was initially triggered by EGF and demonstrate the knowledge gain form promoter analysis combined with upstream key node identification.	[Stegmaier, Philip; Voss, Nico; Kel, Alexander; Wingender, Edgar] BIOBASE GmbH, Wolfenbuettel, Germany; [Meier, Tatiana; Borlak, Juergen] Fraunhofer Inst Toxicol & Expt Med, Dept Mol Med & Med Biotechnol, Hannover, Germany; [Meier, Tatiana; Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, D-3000 Hannover, Germany; [Kel, Alexander; Wingender, Edgar] GeneXplain GmbH, Wolfenbuettel, Germany; [Kel, Alexander] Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Wingender, Edgar] Univ Gottingen, Dept Bioinformat, Gottingen, Germany	Fraunhofer Gesellschaft; Hannover Medical School; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; University of Gottingen	Stegmaier, P (corresponding author), BIOBASE GmbH, Wolfenbuettel, Germany.	juergen.borlak@item.fraunhofer.de	Kel, Alexander E/I-7284-2013	Wingender, Edgar/0000-0002-7729-8453	EU [LSHM-CT-2006-518153, LSHB-CT-2007-037590]; ETB; Russian Ministry Sciences and Education; Ministry of Science and Culture, Lower Saxony, Germany [25A.5-76251-99-3/00]	EU(European Commission); ETB; Russian Ministry Sciences and Education; Ministry of Science and Culture, Lower Saxony, Germany	Parts of the work were funded by EU grants "EuroDia" (LSHM-CT-2006-518153) and Net2Drug (LSHB-CT-2007-037590) and the ETB grant GlobCell and BMBF project TcellTalk as well as the program of intenational collaboration of the Russian Ministry Sciences and Education and Ministry of Science and Culture, Lower Saxony, Germany; Grant number: 25A.5-76251-99-3/00 to Juergen Borlak. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PS, NV, AK, EW are employees of BIOBASE GmbH, Wolfenbuettel, Germany. AK is also an employee of Institute of Systems Biology Ltd., Novosibirsk, Russia.	Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Borlak J, 2005, ONCOGENE, V24, P1809, DOI 10.1038/sj.onc.1208196; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Desbois-Mouthon C, 2006, INT J CANCER, V119, P2557, DOI 10.1002/ijc.22221; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; FIGUEROA JA, 1995, J CLIN ENDOCR METAB, V80, P3476, DOI 10.1210/jc.80.12.3476; Fu VX, 2004, J BIOL CHEM, V279, P52218, DOI 10.1074/jbc.M405015200; Fu YC, 2007, J BIOL CHEM, V282, P31525, DOI 10.1074/jbc.M701132200; GALSON DL, 1995, MOL CELL BIOL, V15, P2135; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guo Y, 2002, P NATL ACAD SCI USA, V99, P3663, DOI 10.1073/pnas.062041099; Hayashida K, 2000, J IMMUNOL, V164, P1110, DOI 10.4049/jimmunol.164.2.1110; Hosui A, 2009, J EXP MED, V206, P819, DOI 10.1084/jem.20080003; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jiang JT, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-4; Jones HE, 2004, ENDOCR-RELAT CANCER, V11, P793, DOI 10.1677/erc.1.00799; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kel A, 2008, SAR QSAR ENVIRON RES, V19, P481, DOI 10.1080/10629360802083806; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kel AE, 2001, J MOL BIOL, V309, P99, DOI 10.1006/jmbi.2001.4650; Kel A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S13; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Krull M, 2006, NUCLEIC ACIDS RES, V34, pD546, DOI 10.1093/nar/gkj107; Lopes EC, 2008, CANCER RES, V68, P7258, DOI 10.1158/0008-5472.CAN-08-0344; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Michael H, 2008, BRIEF BIOINFORM, V9, P518, DOI 10.1093/bib/bbn038; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Nioi P, 2008, CHEM-BIOL INTERACT, V176, P252, DOI 10.1016/j.cbi.2008.09.005; Otaegi G, 2006, J CELL SCI, V119, P2739, DOI 10.1242/jcs.03012; Pham-Gia T, 2000, COMMUN STAT-THEOR M, V29, P2693, DOI 10.1080/03610920008832632; RAHMANN S, 2003, STAT APPL GENET MOL; Riedemann J, 2007, BIOCHEM BIOPH RES CO, V355, P700, DOI 10.1016/j.bbrc.2007.02.041; Sala A, 2005, EUR J CANCER, V41, P2479, DOI 10.1016/j.ejca.2005.08.004; Schmid CD, 2006, NUCLEIC ACIDS RES, V34, pD82, DOI 10.1093/nar/gkj146; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Shah JJ, 2009, LEUKEMIA, V23, P1964, DOI 10.1038/leu.2009.173; Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; van Roy FM, 2005, NAT REV CANCER, V5, P956, DOI 10.1038/nrc1752; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wingender E, 2007, J BIOSCIENCES, V32, P169, DOI 10.1007/s12038-007-0015-2; Yamashita R, 2010, NUCLEIC ACIDS RES, V38, pD98, DOI 10.1093/nar/gkp1017; Yang CQ, 2003, CANCER RES, V63, P8312; Yeh LCC, 2000, ENDOCRINOLOGY, V141, P3278, DOI 10.1210/en.141.9.3278; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002	49	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17738	10.1371/journal.pone.0017738	http://dx.doi.org/10.1371/journal.pone.0017738			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464922	gold, Green Published			2022-12-27	WOS:000289053800002
J	Power, BD; Alfonso, H; Flicker, L; Hankey, GJ; Yeap, BB; Almeida, OP				Power, Brian D.; Alfonso, Helman; Flicker, Leon; Hankey, Graeme J.; Yeap, Bu B.; Almeida, Osvaldo P.			Body Adiposity in Later Life and the Incidence of Dementia: The Health in Men Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; MASS INDEX; WAIST CIRCUMFERENCE; ALZHEIMER-DISEASE; LEPTIN LEVELS; FOLLOW-UP; OBESITY; ASSOCIATION; MIDLIFE; WEIGHT	Objective: To determine if adiposity in later life increases dementia hazard. Methods: Cohort study of 12,047 men aged 65-84 years living in Perth, Australia. Adiposity exposures were baseline body mass index (BMI), waist circumference (WC) and waist-to-hip ratio (WHR). We used the Western Australian Data Linkage System (WADLS) to establish the presence of new cases of dementia between 1996 and 2009 according to the International Classification of Diseases (ICD). Crude and adjusted hazard ratio (HR, 95% confidence interval, 95% CI) of dementia for each adiposity marker was calculated using Cox regression models. Other measured factors included age, marital status, education, alcohol use, smoking, diet, physical activity, and prevalent hypertension, diabetes, dyslipidaemia and cardiovascular disease. Results: Compared with men with BMI < 25, participants with BMI between 25-30 had lower adjusted HR of dementia (HR = 0.82, 95% CI = 0.70-0.95). The HR of dementia for men with BMI >= 30 was comparable to men with BMI, 25 (HR = 0.82, 95% CI = 0.67-1.01). Waist circumference showed no obvious association with dementia hazard. Men with WHR >= 0.9 had lower adjusted HR of dementia than men with WHR < 0.9 (HR = 0.82, 95% CI = 0.69-0.98). We found a "J" shape association between measures of obesity and the hazard of dementia, with the nadir of risk being in the overweight range of BMI and about 1 for WHR. Conclusions: Higher adiposity is not associated with incident dementia in this Australian cohort of older men. Overweight men and those with WHR >= 0.9 have lower hazard of dementia than men with normal weight and with WHR < 0.9.	[Power, Brian D.; Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA, Australia; [Power, Brian D.; Alfonso, Helman; Flicker, Leon; Almeida, Osvaldo P.] Univ Western Australia, Western Australian Ctr Hlth & Ageing, Med Res Ctr, Perth, WA 6009, Australia; [Power, Brian D.; Alfonso, Helman; Almeida, Osvaldo P.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Flicker, Leon; Hankey, Graeme J.; Yeap, Bu B.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Flicker, Leon] Royal Perth Hosp, Dept Geriatr Med, Perth, WA, Australia; [Hankey, Graeme J.] Royal Perth Hosp, Dept Neurol, Perth, WA, Australia; [Yeap, Bu B.] Fremantle Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia	Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; University of Western Australia	Power, BD (corresponding author), Royal Perth Hosp, Dept Psychiat, Perth, WA, Australia.	osvaldo.almeida@uwa.edu.au	Hankey, Graeme J/H-4968-2014; Almeida, Osvaldo P./A-4925-2008; Flicker, Leon/AAE-1530-2022	Hankey, Graeme J/0000-0002-6044-7328; Almeida, Osvaldo P./0000-0002-8689-6199; Flicker, Leon/0000-0002-3650-0475	National Health and Medical Research Council of Australia (NHMRC) [279408, 379600, 403963]; BUPA Foundation of Australia [DS 080608]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); BUPA Foundation of Australia	This work was funded by competitive project grants from the National Health and Medical Research Council of Australia (NHMRC) numbers 279408, 379600, and 403963 to Hankey, Flicker, and Almeida (http://www.nhmrc.gov.au), and from the BUPA Foundation of Australia number DS 080608 to Almeida (http://www.bupa.com.au/Bupa/about-us/bupa-health-foundation/about). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atti AR, 2008, J AM GERIATR SOC, V56, P111, DOI 10.1111/j.1532-5415.2007.01458.x; Australian Institute of Health and Welfare, 2004, OB TRENDS OLD AUSTR; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Bradshaw PJ, 2000, MED J AUSTRALIA, V172, P566, DOI 10.5694/j.1326-5377.2000.tb124115.x; Davidson TL, 2005, PHYSIOL BEHAV, V86, P731, DOI 10.1016/j.physbeh.2005.09.004; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Flicker L, 2010, J AM GERIATR SOC, V58, P234, DOI 10.1111/j.1532-5415.2009.02677.x; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Gustafson DR, 2009, NEUROLOGY, V73, P1559, DOI 10.1212/WNL.0b013e3181c0d4b6; Harvey J, 2005, BIOCHEM SOC T, V33, P1029, DOI 10.1042/BST0331029; Harvey J, 2006, PROG LIPID RES, V45, P369, DOI 10.1016/j.plipres.2006.03.001; Hayden KM, 2006, ALZ DIS ASSOC DIS, V20, P93, DOI 10.1097/01.wad.0000213814.43047.86; Heiat A, 2001, ARCH INTERN MED, V161, P1194, DOI 10.1001/archinte.161.9.1194; Heinzl H, 1997, COMPUT METH PROG BIO, V54, P201, DOI 10.1016/S0169-2607(97)00043-6; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Klein S, 2007, DIABETES CARE, V30, P1647, DOI 10.2337/dc07-9921; Lieb W, 2009, JAMA-J AM MED ASSOC, V302, P2565, DOI 10.1001/jama.2009.1836; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P392, DOI 10.1001/archneur.64.3.392; Luchsinger JA, 2009, CURR OPIN CLIN NUTR, V12, P15, DOI 10.1097/MCO.0b013e32831c8c71; Norman PE, 2009, INT J EPIDEMIOL, V38, P48, DOI 10.1093/ije/dyn041; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Nourhashemi F, 2003, NEUROLOGY, V60, P117, DOI 10.1212/01.WNL.0000038910.46217.AA; Okosun IS, 1998, DIABETES CARE, V21, P1836, DOI 10.2337/diacare.21.11.1836; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Power DA, 2001, DEMENT GERIATR COGN, V12, P167, DOI 10.1159/000051252; Quesenberry CP, 1998, ARCH INTERN MED, V158, P466, DOI 10.1001/archinte.158.5.466; Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929; Rosengren A, 2005, ARCH INTERN MED, V165, P321, DOI 10.1001/archinte.165.3.321; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Zhu SK, 2004, OBES RES, V12, P633, DOI 10.1038/oby.2004.73	37	40	42	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17902	10.1371/journal.pone.0017902	http://dx.doi.org/10.1371/journal.pone.0017902			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464984	gold, Green Published			2022-12-27	WOS:000288813900015
J	de Paula, MR; Ravetti, MG; Berretta, R; Moscato, P				de Paula, Mateus Rocha; Ravetti, Martin Gomez; Berretta, Regina; Moscato, Pablo			Differences in Abundances of Cell-Signalling Proteins in Blood Reveal Novel Biomarkers for Early Detection Of Clinical Alzheimer's Disease	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; AMYLOID PRECURSOR PROTEIN; MITOCHONDRIAL-FUNCTION; CEREBROSPINAL-FLUID; FAS ANTIGEN; BETA; BRAIN; EXPRESSION; GENE; APOPTOSIS	Background: In November 2007 a study published in Nature Medicine proposed a simple test based on the abundance of 18 proteins in blood to predict the onset of clinical symptoms of Alzheimer's Disease (AD) two to six years before these symptoms manifest. Later, another study, published in PLoS ONE, showed that only five proteins (IL-1 alpha, IL-3, EGF, TNF-alpha and G-CSF) have overall better prediction accuracy. These classifiers are based on the abundance of 120 proteins. Such values were standardised by a Z-score transformation, which means that their values are relative to the average of all others. Methodology: The original datasets from the Nature Medicine paper are further studied using methods from combinatorial optimisation and Information Theory. We expand the original dataset by also including all pair-wise differences of z-score values of the original dataset ("metafeatures"). Using an exact algorithm to solve the resulting (alpha, beta)-k Feature Set problem, used to tackle the feature selection problem, we found signatures that contain either only features, metafeatures or both, and evaluated their predictive performance on the independent test set. Conclusions: It was possible to show that a specific pattern of cell signalling imbalance in blood plasma has valuable information to distinguish between NDC and AD samples. The obtained signatures were able to predict AD in patients that already had a Mild Cognitive Impairment (MCI) with up to 84% of sensitivity, while maintaining also a strong prediction accuracy of 90% on a independent dataset with Non Demented Controls (NDC) and AD samples. The novel biomarkers uncovered with this method now confirms ANG-2, IL-11, PDGF-BB, CCL15/MIP-1 delta; and supports the joint measurement of other signalling proteins not previously discussed: GM-CSF, NT-3, IGFBP-2 and VEGF-B.	[de Paula, Mateus Rocha; Berretta, Regina; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia; [Ravetti, Martin Gomez] Univ Fed Minas Gerais UFMG, Dept Engn Prod, Belo Horizonte, MG, Brazil	University of Newcastle; Universidade Federal de Minas Gerais	de Paula, MR (corresponding author), Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia.	Pablo.Moscato@newcastle.edu.au	MOSCATO, PABLO ALBERTO/G-7668-2013; Ravetti, Martin/K-1108-2012	Ravetti, Martin/0000-0001-7781-0034; Moscato, Pablo/0000-0003-2570-5966; Berretta, Regina/0000-0002-4420-3446	Australian Research Council (ARC) Centre for Bioinformatics, Australia	Australian Research Council (ARC) Centre for Bioinformatics, Australia(Australian Research Council)	The authors acknowledge partial support from the Australian Research Council (ARC) Centre for Bioinformatics, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED A, 2009, CIRC RES, P1333; Andreoli V, 2007, NEUROCHEM RES, V32, P1445, DOI 10.1007/s11064-007-9329-6; Angelova A, 2005, PROC CVPR IEEE, P494; ARENAS E, 1994, NATURE, V367, P368, DOI 10.1038/367368a0; Baker CA, 2002, J VIROL, V76, P10905, DOI 10.1128/JVI.76.21.10905-10913.2002; Bauer E, 1999, MACH LEARN, V36, P105, DOI 10.1023/A:1007515423169; Bengoechea TG, 2009, P NATL ACAD SCI USA, V106, P7870, DOI 10.1073/pnas.0901533106; Berretta R, 2007, J RES PRACT INF TECH, V39, P287; Berretta Regina, 2008, V453, P363, DOI 10.1007/978-1-60327-429-6_19; Cao CH, 2009, NEUROBIOL DIS, V34, P63, DOI 10.1016/j.nbd.2008.12.015; CHENPLOTKIN A, 2009, ANN NEUROLOGY; Chiappelli M, 2006, DEMENT GERIATR COGN, V22, P296, DOI 10.1159/000095160; Chiarini Anna, 2006, Italian Journal of Anatomy and Embryology, V111, P221; Cole GM, 2007, EXP GERONTOL, V42, P10, DOI 10.1016/j.exger.2006.08.009; Cotta C, 2004, LECT NOTES COMPUT SC, V3005, P21; Cotta C, 2003, J COMPUT SYST SCI, V67, P686, DOI 10.1016/S0022-0000(03)00081-3; COTTA C, 2007, HDB APPROXIMATION AL; Coulson EJ, 2009, NEUROSCIENTIST, V15, P317, DOI 10.1177/1073858408331376; Coulson EJ, 2006, J NEUROCHEM, V98, P654, DOI 10.1111/j.1471-4159.2006.03905.x; DANIELVAN L, 2010, REJUV RES, P541; de la Monte SM, 2003, LAB INVEST, V83, P287, DOI 10.1097/01.LAB.0000056995.07053.C0; de la Monte SM, 2001, J NEUROPATH EXP NEUR, V60, P195, DOI 10.1093/jnen/60.2.195; Diarra Adama, 2009, Biochem Biophys Res Commun, V390, P352, DOI 10.1016/j.bbrc.2009.09.116; Durany N, 2000, INT J DEV NEUROSCI, V18, P807, DOI 10.1016/S0736-5748(00)00046-0; Falk T, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-49; FAYYAD UM, 1993, 13 INT JOINT C ART I; Festa ED, 2009, MULT SCLER J, V15, P1271, DOI 10.1177/1352458509107017; Feuk L, 2000, HUM GENET, V107, P391, DOI 10.1007/s004390000383; FEUK L, 2002, HUM MUTAT, V21, P53; Fiala M, 2005, J ALZHEIMERS DIS, V7, P221, DOI 10.3233/jad-2005-7304; Fombonne J, 2009, ANN NEUROL, V65, P294, DOI 10.1002/ana.21578; Frey C, 2006, J NEURAL TRANSM, V113, P1753, DOI 10.1007/s00702-006-0481-y; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; He XM, 2006, BRAIN RES, V1082, P192, DOI 10.1016/j.brainres.2006.01.086; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Hock C, 2000, MOL PSYCHIATR, V5, P510, DOI 10.1038/sj.mp.4000743; Hourani Mou'ath, 2008, V453, P379, DOI 10.1007/978-1-60327-429-6_20; Iarlori C, 2005, EXP GERONTOL, V40, P605, DOI 10.1016/j.exger.2005.04.007; Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009; Lesne S, 2005, J BIOL CHEM, V280, P24941, DOI 10.1074/jbc.M413495200; Lombardi VRM, 2004, METHOD FIND EXP CLIN, V26, P523, DOI 10.1358/mf.2004.26.7.863735; Longo FM, 2007, CURR ALZHEIMER RES, V4, P503, DOI 10.2174/156720507783018316; Manczak M, 2009, HUM MOL GENET, V18, P3876, DOI 10.1093/hmg/ddp331; Masoudi R, 2009, J BIOL CHEM, V284, P18424, DOI 10.1074/jbc.M109.007104; Mirnics ZK, 2005, NEUROBIOL DIS, V20, P969, DOI 10.1016/j.nbd.2005.06.004; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Moscato P, 2007, BIOSYSTEMS, V88, P56, DOI 10.1016/j.biosystems.2006.04.005; Moscato P., 2005, ACSC 05, P371; Murphy GM, 1998, J BIOL CHEM, V273, P20967, DOI 10.1074/jbc.273.33.20967; NarisawaSaito M, 1996, NEUROREPORT, V7, P2925, DOI 10.1097/00001756-199611250-00024; NISHIMURA T, 1995, BRAIN RES, V695, P137, DOI 10.1016/0006-8993(95)00699-Q; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P1077, DOI 10.1001/archneurol.2010.215; Poesen K, 2008, J NEUROSCI, V28, P10451, DOI 10.1523/JNEUROSCI.1092-08.2008; POON WW, 2009, NEUROBIOLOG IN PRESS; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; RAVETTI MG, 2009, FDN COMPUTATIONAL IN, V4, P149; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reale M, 2008, J ALZHEIMERS DIS, V14, P147; Richartz E, 2002, DEMENT GERIATR COGN, V13, P178, DOI 10.1159/000048650; Riemer C, 2000, J VIROL, V74, P10245, DOI 10.1128/JVI.74.21.10245-10248.2000; Rosenmann H, 2004, DEMENT GERIATR COGN, V17, P143, DOI 10.1159/000076347; Rosso OA, 2009, J NEUROSCI METH, V181, P257, DOI 10.1016/j.jneumeth.2009.04.028; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Saragovi HU, 2009, CURR ALZHEIMER RES, V6, P419, DOI 10.2174/156720509789207912; Schulte-Herbruggen O, 2008, CURR ALZHEIMER RES, V5, P38; Soares HD, 2009, ANN NY ACAD SCI, V1180, P56, DOI 10.1111/j.1749-6632.2009.05066.x; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Su JH, 2003, NEUROBIOL DIS, V12, P182, DOI 10.1016/S0969-9961(02)00019-0; Tarkowski E, 1999, J CLIN IMMUNOL, V19, P223, DOI 10.1023/A:1020568013953; THAM A, 1993, J NEURAL TRANSM-PARK, V5, P165, DOI 10.1007/BF02257671; Thirumangalakudi L, 2006, J ALZHEIMERS DIS, V10, P111; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tripathy D, 2010, NEUROBIOL AGING, V31, P8, DOI 10.1016/j.neurobiolaging.2008.03.009; Vezhnevets A, 2007, LECT NOTES ARTIF INT, V4701, P430; WALKER JM, 2008, METHODS MOL MED, V141, P131; Weiss N, 2010, J NEUROIMMUNOL, V223, P131, DOI 10.1016/j.jneuroim.2010.03.009; Witten I. H., 2005, DATA MINING PRACTICA; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Xiyang YB, 2009, J NEUROTRAUM, V26, P275, DOI 10.1089/neu.2007.0374; Yaar M, 1997, J CLIN INVEST, V100, P2333, DOI 10.1172/JCI119772; Yew DT, 2004, NEUROSCI LETT, V367, P113, DOI 10.1016/j.neulet.2004.05.091	82	23	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17481	10.1371/journal.pone.0017481	http://dx.doi.org/10.1371/journal.pone.0017481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21479255	Green Submitted, Green Published, gold			2022-12-27	WOS:000288811500004
J	Alli, R; Zhang, ZM; Nguyen, P; Zheng, JJ; Geiger, TL				Alli, Rajshekhar; Zhang, Ziwei M.; Phuong Nguyen; Zheng, Jie J.; Geiger, Terrence L.			Rational Design of T Cell Receptors with Enhanced Sensitivity for Antigen	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; REGION DISEASE HYPOTHESIS; HIGH-AFFINITY; SELF-REACTIVITY; PHAGE DISPLAY; SPECIFICITY; MICE; TCRS; LYMPHOCYTES	Enhancing the affinity of therapeutic T cell receptors (TCR) without altering their specificity is a significant challenge for adoptive immunotherapy. Current efforts have primarily relied on empirical approaches. Here, we used structural analyses to identify a glycine-serine variation in the TCR that modulates antigen sensitivity. A G at position 107 within the CDR3 beta stalk is encoded within a single mouse and human TCR, TRBV13-2 and TRBV12-5 respectively. Most TCR bear a S107. The S hydroxymethyl side chain intercalates into the core of the CDR3 beta loop, stabilizing it. G107 TRBV possess a gap in their CDR3 beta where this S hydroxymethyl moiety would fit. We predicted based on modeling and molecular dynamics simulations that a G107S substitution would increase CDR3 beta stability and thereby augment receptor sensitivity. Experimentally, a G107S replacement led to an similar to 10-1000 fold enhanced antigen sensitivity in 3 of 4 TRBV13-2(+) TCR tested. Analysis of fine specificity indicated a preserved binding orientation. These results support the feasibility of developing high affinity antigen specific TCR for therapeutic purposes through the identification and manipulation of critical framework residues. They further indicate that amino acid variations within TRBV not directly involved in ligand contact can program TCR sensitivity, and suggest a role for CDR3 stability in this programming.	[Alli, Rajshekhar; Phuong Nguyen; Geiger, Terrence L.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Zhang, Ziwei M.; Zheng, Jie J.] St Jude Childrens Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Geiger, Terrence L.] Univ Tennessee, Ctr Hlth Sci, Dept Pathol, Memphis, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Alli, R (corresponding author), St Jude Childrens Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	terrence.geiger@stjude.org	Geiger, Terrence/M-4516-2018	Geiger, Terrence/0000-0001-8290-5732; Zheng, Jie/0000-0001-6524-6800	National Institutes of Health [R01 AI056153]; American Lebanese Syrian Associated Charities (ALSAC)/St. Jude Children's Research Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)/St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant R01 AI056153 (to TLG) and by the American Lebanese Syrian Associated Charities (ALSAC)/St. Jude Children's Research Hospital (to all authors). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; Alli R, 2008, J IMMUNOL, V181, P136, DOI 10.4049/jimmunol.181.1.136; Andricioaei I, 2001, J CHEM PHYS, V115, P6289, DOI 10.1063/1.1401821; Benichou G, 1999, J INVEST DERM SYMP P, V4, P224, DOI 10.1038/sj.jidsp.5640216; Berry LJ, 2009, TISSUE ANTIGENS, V74, P277, DOI 10.1111/j.1399-0039.2009.01336.x; Brusko TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011726; Burton AR, 2008, DIABETES, V57, P1321, DOI 10.2337/db07-1129; CIBOTTI R, 1994, J EXP MED, V180, P861, DOI 10.1084/jem.180.3.861; DEKERLERO RNM, 1996, EUR J IMMUNOL, V26, P2470; Donermeyer DL, 2006, J IMMUNOL, V177, P6911, DOI 10.4049/jimmunol.177.10.6911; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fasso M, 2000, J EXP MED, V192, P1719, DOI 10.1084/jem.192.12.1719; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; HAQQI TM, 1992, P NATL ACAD SCI USA, V89, P1253, DOI 10.1073/pnas.89.4.1253; Hare BJ, 1999, NAT STRUCT BIOL, V6, P574; HEBERKATZ E, 1989, IMMUNOL TODAY, V10, P164, DOI 10.1016/0167-5699(89)90174-6; Holler PD, 2004, MOL IMMUNOL, V40, P1027, DOI 10.1016/j.molimm.2003.11.013; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Jackola DR, 2008, MOL IMMUNOL, V45, P1494, DOI 10.1016/j.molimm.2007.08.023; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; JOHNSON NA, 1989, J IMMUNOL, V142, P3298; Kieback E, 2010, EXPERT OPIN BIOL TH, V10, P749, DOI 10.1517/14712591003689998; Kumar V, 1997, J EXP MED, V185, P1725, DOI 10.1084/jem.185.10.1725; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Masuda K, 1997, J IMMUNOL, V158, P2076; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Mongan J, 2007, J CHEM THEORY COMPUT, V3, P156, DOI 10.1021/ct600085e; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Nguyen P, 2010, J IMMUNOL, V185, P3895, DOI 10.4049/jimmunol.1001550; OSMAN GE, 1993, J EXP MED, V177, P387, DOI 10.1084/jem.177.2.387; Richman SA, 2007, BIOMOL ENG, V24, P361, DOI 10.1016/j.bioeng.2007.02.009; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Thielges MC, 2008, BIOCHEMISTRY-US, V47, P7237, DOI 10.1021/bi800374q; Thorpe IF, 2007, P NATL ACAD SCI USA, V104, P8821, DOI 10.1073/pnas.0610064104; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Udyavar A, 2009, J IMMUNOL, V182, P4439, DOI 10.4049/jimmunol.0804377; Weber KS, 2005, P NATL ACAD SCI USA, V102, P19033, DOI 10.1073/pnas.0507554102; WILSON DB, 1993, IMMUNOL TODAY, V14, P376, DOI 10.1016/0167-5699(93)90136-9; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Yang Y, 1996, IMMUNITY, V4, P189, DOI 10.1016/S1074-7613(00)80683-4; Zhao Y, 2007, J IMMUNOL, V179, P5845, DOI 10.4049/jimmunol.179.9.5845	43	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18027	10.1371/journal.pone.0018027	http://dx.doi.org/10.1371/journal.pone.0018027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21455495	Green Published, gold, Green Submitted			2022-12-27	WOS:000288810500029
J	Hribova, E; Cizkova, J; Christelova, P; Taudien, S; de Langhe, E; Dolezel, J				Hribova, Eva; Cizkova, Jana; Christelova, Pavla; Taudien, Stefan; de Langhe, Edmond; Dolezel, Jaroslav			The ITS1-5.8S-ITS2 Sequence Region in the Musaceae: Structure, Diversity and Use in Molecular Phylogeny	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; NUCLEAR RIBOSOMAL DNA; CONCERTED EVOLUTION; GENETIC DIVERSITY; ALLOPOLYPLOID SPECIATION; NRDNA POLYMORPHISM; HYBRID ORIGIN; RNA GENES; RDNA; GENOME	Genes coding for 45S ribosomal RNA are organized in tandem arrays of up to several thousand copies and contain 18S, 5.8S and 26S rRNA units separated by internal transcribed spacers ITS1 and ITS2. While the rRNA units are evolutionary conserved, ITS show high level of interspecific divergence and have been used frequently in genetic diversity and phylogenetic studies. In this work we report on the structure and diversity of the ITS region in 87 representatives of the family Musaceae. We provide the first detailed information on ITS sequence diversity in the genus Musa and describe the presence of more than one type of ITS sequence within individual species. Both Sanger sequencing of amplified ITS regions and whole genome 454 sequencing lead to similar phylogenetic inferences. We show that it is necessary to identify putative pseudogenic ITS sequences, which may have negative effect on phylogenetic reconstruction at lower taxonomic levels. Phylogenetic reconstruction based on ITS sequence showed that the genus Musa is divided into two distinct clades Callimusa and Australimusa and Eumusa and Rhodochlamys. Most of the intraspecific banana hybrids analyzed contain conserved parental ITS sequences, indicating incomplete concerted evolution of rDNA loci. Independent evolution of parental rDNA in hybrids enables determination of genomic constitution of hybrids using ITS. The observation of only one type of ITS sequence in some of the presumed interspecific hybrid clones warrants further study to confirm their hybrid origin and to unravel processes leading to evolution of their genomes.	[Hribova, Eva; Cizkova, Jana; Christelova, Pavla; Dolezel, Jaroslav] Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Olomouc, Czech Republic; [Taudien, Stefan] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [de Langhe, Edmond] Katholieke Univ Leuven, Lab Trop Crop Improvement, Leuven, Belgium	Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); KU Leuven	Hribova, E (corresponding author), Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Olomouc, Czech Republic.	dolezel@ueb.cas.cz	Dolezel, Jaroslav/B-7716-2008; hribova, eva/F-7291-2014; Cizkova, Jana/F-7673-2014	Dolezel, Jaroslav/0000-0002-6263-0492; Hribova, Eva/0000-0002-6868-4344; Cizkova, Jana/0000-0001-7787-1849	Grant Agency of the Academy of Sciences of the Czech Republic [IAA600380703, KJB 500380901]; International Atomic Energy Agency [13192]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); International Atomic Energy Agency(International Atomic Energy Agency)	This work has been supported by the Grant Agency of the Academy of Sciences of the Czech Republic [grant awards no. IAA600380703 and KJB 500380901] and was performed in collaboration with the International Atomic Energy Agency [Research Agreement no. 13192]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Amorim EP, 2009, GENET MOL BIOL, V32, P96, DOI 10.1590/S1415-47572009005000024; Bailey CD, 2003, MOL PHYLOGENET EVOL, V29, P435, DOI 10.1016/j.ympev.2003.08.021; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Barkman TJ, 2002, SYST BOT, V27, P209; Bartos J, 2005, CYTOGENET GENOME RES, V109, P50, DOI 10.1159/000082381; BENNETT RI, 1991, PLANT MOL BIOL, V16, P685, DOI 10.1007/BF00023432; Buhariwalla HK, 2005, MOL ECOL NOTES, V5, P327, DOI 10.1111/j.1471-8286.2005.00916.x; Cheesman E. E, 1947, KEW BULL, P106, DOI DOI 10.2307/4109207; Christelova P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-103; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Dadejova M, 2007, NEW PHYTOL, V174, P658, DOI 10.1111/j.1469-8137.2007.02034.x; De Langhe E, 2010, ANN BOT-LONDON, V106, P849, DOI 10.1093/aob/mcq187; DOVER GA, 1982, SCIENCE, V218, P1069, DOI 10.1126/science.7146895; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELDER JF, 1995, Q REV BIOL, V70, P297, DOI 10.1086/419073; Francisco-Ortega J, 2001, AM J BOT, V88, P161, DOI 10.2307/2657136; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GAWEL NJ, 1992, THEOR APPL GENET, V84, P286, DOI 10.1007/BF00229484; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hakkinen Markku, 2005, APG Acta Phytotaxonomica et Geobotanica, V56, P27; Hakkinen Markku, 2004, APG Acta Phytotaxonomica et Geobotanica, V55, P79; Harpke D, 2008, J PLANT RES, V121, P261, DOI 10.1007/s10265-008-0156-x; Harpke D, 2008, BOTANY, V86, P300, DOI 10.1139/B07-134; Hershkovitz MA, 1996, NUCLEIC ACIDS RES, V24, P2857, DOI 10.1093/nar/24.15.2857; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jobes DV, 1997, PLANT MOL BIOL REP, V15, P326, DOI 10.1023/A:1007462330699; Kim ST, 2008, P NATL ACAD SCI USA, V105, P12370, DOI 10.1073/pnas.0805141105; Kovarik A, 2005, GENETICS, V169, P931, DOI 10.1534/genetics.104.032839; Kovarik A, 2004, BIOL J LINN SOC, V82, P615, DOI 10.1111/j.1095-8312.2004.00345.x; Kress WJ, 2001, SYST BIOL, V50, P926, DOI 10.1080/106351501753462885; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; LANAUD C, 1992, HEREDITY, V68, P147, DOI 10.1038/hdy.1992.23; Li LF, 2010, MOL PHYLOGENET EVOL, V57, P1, DOI 10.1016/j.ympev.2010.06.021; Lim KY, 2004, BIOL J LINN SOC, V82, P599, DOI 10.1111/j.1095-8312.2004.00344.x; Liu AZ, 2010, TAXON, V59, P20, DOI 10.1002/tax.591003; Liu QL, 2006, NEW PHYTOL, V170, P411, DOI 10.1111/j.1469-8137.2006.01665.x; Macas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-427; Manos PS, 1999, MOL PHYLOGENET EVOL, V12, P333, DOI 10.1006/mpev.1999.0614; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mayol M, 2001, MOL PHYLOGENET EVOL, V19, P167, DOI 10.1006/mpev.2001.0934; Meyer M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1095; Nwakanma DC, 2003, THEOR APPL GENET, V108, P154, DOI 10.1007/s00122-003-1402-1; Ochieng JW, 2007, MOL PHYLOGENET EVOL, V44, P752, DOI 10.1016/j.ympev.2007.04.017; OKane SL, 1996, SYST BOT, V21, P559, DOI 10.2307/2419615; Pettengill JB, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-264; Popp M, 2001, MOL PHYLOGENET EVOL, V20, P474, DOI 10.1006/mpev.2001.0977; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Renner SS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-58; Risterucci AM, 2009, THEOR APPL GENET, V119, P1093, DOI 10.1007/s00122-009-1111-5; Ritz CM, 2005, J HERED, V96, P4, DOI 10.1093/jhered/esi011; ROGERS SO, 1987, PLANT MOL BIOL, V9, P509, DOI 10.1007/BF00015882; Safar J, 2004, GENOME, V47, P1182, DOI 10.1139/G04-062; Samuel R, 1998, PLANT SYST EVOL, V211, P129, DOI 10.1007/BF00984917; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Shepherd K., 1988, P INT WORKSH HELD LO, P158; SIMMOND NW, 1962, EVOLUTION BANANAS; SIMMONDS N. W., 1955, JOUR LINNEAN SOC BOT, V55, P302; SIMMONDS N. W., 1960, Kew Bulletin, V14, P198, DOI 10.2307/4114778; Smit A, 1996, REPEATMASKER OPEN 30; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Sun K, 2002, PLANT SYST EVOL, V235, P121, DOI 10.1007/s00606-002-0206-0; TOMLINSON PB, 1962, EVOLUTION, V16, P192, DOI 10.2307/2406197; Ude G, 2002, THEOR APPL GENET, V104, P1239, DOI 10.1007/s00122-001-0802-3; Volkov RA, 1999, MOL BIOL EVOL, V16, P311, DOI 10.1093/oxfordjournals.molbev.a026112; Votkov RA, 2007, SYST BIODIVERS, V5, P261, DOI 10.1017/S1477200007002447; Wang QD, 2007, PLANT SYST EVOL, V267, P65, DOI 10.1007/s00606-006-0499-5; Wang XL, 2007, GENET RESOUR CROP EV, V54, P1125, DOI 10.1007/s10722-006-9004-9; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Wissemann V, 2002, J APPL BOT-ANGEW BOT, V76, P176; Wolf M, 2005, RNA, V11, P1616, DOI 10.1261/rna.2144205; Wong C, 2002, ANN BOT-LONDON, V90, P231, DOI 10.1093/aob/mcf170; Wuyts J, 2001, NUCLEIC ACIDS RES, V29, P175, DOI 10.1093/nar/29.1.175; Xiao LQ, 2010, MOL PHYLOGENET EVOL, V55, P168, DOI 10.1016/j.ympev.2009.11.020; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	83	69	77	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17863	10.1371/journal.pone.0017863	http://dx.doi.org/10.1371/journal.pone.0017863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445344	Green Submitted, gold, Green Published			2022-12-27	WOS:000288809100011
J	Kennedy, L; Pauriah, M; Godfrey, V; Howie, J; Dennis, H; Crowther, D; Struthers, A; Goddard, C; Feuerstein, G; Lang, C; Miele, G				Kennedy, Laura; Pauriah, Mahesh; Godfrey, Valerie; Howie, Jacqueline; Dennis, Helen; Crowther, Daniel; Struthers, Allan; Goddard, Catharine; Feuerstein, Giora; Lang, Chim; Miele, Gino			Global Array-Based Transcriptomics from Minimal Input RNA Utilising an Optimal RNA Isolation Process Combined with SPIA cDNA Probes	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; FINE-NEEDLE-ASPIRATION; BREAST-CANCER; SINGLE-CELL; ENDOTHELIAL FUNCTION; NANOGRAM AMOUNTS; MICROARRAY; AMPLIFICATION; SAMPLES; REPRODUCIBILITY	Background: Technical advances in the collection of clinical material, such as laser capture microdissection and cell sorting, provide the advantage of yielding more refined and homogenous populations of cells. However, these attractive advantages are counter balanced by the significant difficultly in obtaining adequate nucleic acid yields to allow transcriptomic analyses. Established technologies are available to carry out global transcriptomics using nanograms of input RNA, however, many clinical samples of low cell content would be expected to yield RNA within the picogram range. To fully exploit these clinical samples the challenge of isolating adequate RNA yield directly and generating sufficient microarray probes for global transcriptional profiling from this low level RNA input has been addressed in the current report. We have established an optimised RNA isolation workflow specifically designed to yield maximal RNA from minimal cell numbers. This procedure obtained RNA yield sufficient for carrying out global transcriptional profiling from vascular endothelial cell biopsies, clinical material not previously amenable to global transcriptomic approaches. In addition, by assessing the performance of two linear isothermal probe generation methods at decreasing input levels of good quality RNA we demonstrated robust detection of a class of low abundance transcripts (GPCRs) at input levels within the picogram range, a lower level of RNA input (50 pg) than previously reported for global transcriptional profiling and report the ability to interrogate the transcriptome from only 10 pg of input RNA. By exploiting an optimal RNA isolation workflow specifically for samples of low cell content, and linear isothermal RNA amplification methods for low level RNA input we were able to perform global transcriptomics on valuable and potentially informative clinically derived vascular endothelial biopsies here for the first time. These workflows provide the ability to robustly exploit ever more common clinical samples yielding extremely low cell numbers and RNA yields for global transcriptomics.	[Kennedy, Laura; Crowther, Daniel; Goddard, Catharine; Miele, Gino] Ninewells Hosp, TMRC Lab, Translat Med Res Collaborat, Dundee DD1 9SY, Scotland; [Pauriah, Mahesh; Godfrey, Valerie; Howie, Jacqueline; Dennis, Helen; Struthers, Allan; Lang, Chim] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Ctr Cardiovasc & Lung Biol, Dundee DD1 9SY, Scotland; [Crowther, Daniel; Goddard, Catharine; Feuerstein, Giora; Miele, Gino] Pfizer Global Res & Dev, Collegeville, PA USA; [Crowther, Daniel; Feuerstein, Giora; Miele, Gino] Pfizer Global Res & Dev, Dundee, Scotland	University of Dundee; University of Dundee; Pfizer; Pfizer	Kennedy, L (corresponding author), Ninewells Hosp, TMRC Lab, Translat Med Res Collaborat, Dundee DD1 9SY, Scotland.	c.c.lang@dundee.ac.uk; g.miele@dundee.ac.uk		Struthers, Allan/0000-0002-2926-2528; Lang, Chim/0000-0002-4530-3078	Translational Medicine Research Collaboration	Translational Medicine Research Collaboration	This study was funded by the Translational Medicine Research Collaboration. GM, CG, DC & GF were employees of Wyeth Research/PGRD and were involved in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Assersohn L, 2002, CLIN CANCER RES, V8, P794; Bai XY, 2008, AM J HEMATOL, V83, P26, DOI 10.1002/ajh.20953; Bak M, 2006, ANAL BIOCHEM, V358, P111, DOI 10.1016/j.ab.2006.08.023; Barker CS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-57; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Clarkson P, 2001, ATHEROSCLEROSIS, V154, P171, DOI 10.1016/S0021-9150(00)00455-X; Clement-Ziza M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-246; Cobleigh MA, 2005, CLIN CANCER RES, V11, P8623, DOI 10.1158/1078-0432.CCR-05-0735; Colombo PC, 2005, CIRCULATION, V111, P58, DOI 10.1161/01.CIR.0000151611.89232.3B; Colombo PC, 2002, J APPL PHYSIOL, V92, P1331, DOI 10.1152/japplphysiol.00680.2001; Dobson AT, 2004, HUM MOL GENET, V13, P1461, DOI 10.1093/hmg/ddh157; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Guglielmelli P, 2007, STEM CELLS, V25, P165, DOI 10.1634/stemcells.2006-0351; HAN SH, 2009, ATHEROSCLEROSIS; Hansen A, 2007, NAT METHODS, V4, P35, DOI 10.1038/NMETH977; Hunter SM, 2008, J BIOCHEM BIOPH METH, V70, P1048, DOI 10.1016/j.jprot.2007.11.011; Kim C, 2006, MOL VIS, V12, P1640; King CL, 2005, J MOL DIAGN, V7, P57, DOI 10.1016/S1525-1578(10)60009-8; Klur S, 2004, GENOMICS, V83, P508, DOI 10.1016/j.ygeno.2003.09.005; Kurn N, 2005, CLIN CHEM, V51, P1973, DOI 10.1373/clinchem.2005.053694; Lang JE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-326; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Marcus JS, 2006, ANAL CHEM, V78, P3084, DOI 10.1021/ac0519460; Nygaard V, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-147; Onat D, 2007, J APPL PHYSIOL, V103, P1873, DOI 10.1152/japplphysiol.00367.2007; Oudes AJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-92; Peterkova M, 2009, FOLIA BIOL-PRAGUE, V55, P53; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shearstone JR, 2006, GENOMICS, V88, P111, DOI 10.1016/j.ygeno.2006.03.004; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Singh R, 2005, AM J PHYSIOL-CELL PH, V288, pC1179, DOI 10.1152/ajpcell.00258.2004; Sotiriou C, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr433; Symmans WF, 2003, CANCER, V97, P2960, DOI 10.1002/cncr.11435; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Toriello NM, 2008, P NATL ACAD SCI USA, V105, P20173, DOI 10.1073/pnas.0806355106; Viale Agnes, 2007, J Biomol Tech, V18, P150	40	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17625	10.1371/journal.pone.0017625	http://dx.doi.org/10.1371/journal.pone.0017625			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445340	gold, Green Published, Green Submitted			2022-12-27	WOS:000288809100005
J	Elling, L; Steinberg, C; Brockelmann, AK; Dobel, C; Bolte, J; Junghofer, M				Elling, Ludger; Steinberg, Christian; Broeckelmann, Ann-Kathrin; Dobel, Christan; Boelte, Jens; Junghofer, Markus			Acute Stress Alters Auditory Selective Attention in Humans Independent of HPA: A Study of Evoked Potentials	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; CORTICOTROPIN-RELEASING-FACTOR; MESOLIMBIC DOPAMINE NEURONS; WORKING-MEMORY; PREFRONTAL CORTEX; LOCUS-COERULEUS; NUCLEUS-ACCUMBENS; PERCEPTUAL LOAD; DISCHARGE RATE; ACTH 4-10	Background: Acute stress is a stereotypical, but multimodal response to a present or imminent challenge overcharging an organism. Among the different branches of this multimodal response, the consequences of glucocorticoid secretion have been extensively investigated, mostly in connection with long-term memory (LTM). However, stress responses comprise other endocrine signaling and altered neuronal activity wholly independent of pituitary regulation. To date, knowledge of the impact of such "paracorticoidal" stress responses on higher cognitive functions is scarce. We investigated the impact of an ecological stressor on the ability to direct selective attention using event-related potentials in humans. Based on research in rodents, we assumed that a stress-induced imbalance of catecholaminergic transmission would impair this ability. Methodology/Principal Findings: The stressor consisted of a single cold pressor test. Auditory negative difference (Nd) and mismatch negativity (MMN) were recorded in a tonal dichotic listening task. A time series of such tasks confirmed an increased distractibility occuring 4-7 minutes after onset of the stressor as reflected by an attenuated Nd. Salivary cortisol began to rise 8-11 minutes after onset when no further modulations in the event-related potentials (ERP) occurred, thus precluding a causal relationship. This effect may be attributed to a stress-induced activation of mesofrontal dopaminergic projections. It may also be attributed to an activation of noradrenergic projections. Known characteristics of the modulation of ERP by different stress-related ligands were used for further disambiguation of causality. The conjuncture of an attenuated Nd and an increased MMN might be interpreted as indicating a dopaminergic influence. The selective effect on the late portion of the Nd provides another tentative clue for this. Conclusions/Significance: Prior studies have deliberately tracked the adrenocortical influence on cognition, as it has proven most influential with respect to LTM. However, current cortisol-optimized study designs would have failed to detect the present findings regarding attention.	[Elling, Ludger; Steinberg, Christian; Broeckelmann, Ann-Kathrin; Dobel, Christan; Junghofer, Markus] Univ Hosp Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Boelte, Jens] Univ Munster, Inst Psychol, Munster, Germany	University of Munster; University of Munster	Elling, L (corresponding author), Univ Hosp Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany.	ellingl@uni-muenster.de	Junghoefer, Markus/AAA-2892-2021	Junghoefer, Markus/0000-0002-8532-2986; Bolte, Jens/0000-0002-8128-0520	Deutsche Forschungsgemeinschaft [FOR 751]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was funded by the Deutsche Forschungsgemeinschaft, grant number FOR 751 (http://gepris.dfg.de/gepris/octopus/gepris/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE ED, 1989, J NEUROCHEM, V52, P1655, DOI 10.1111/j.1471-4159.1989.tb09224.x; Ahveninen J, 2003, NEUROSCI LETT, V340, P181, DOI 10.1016/S0304-3940(03)00102-2; Al'Absi M, 2002, PSYCHOPHYSIOLOGY, V39, P95, DOI 10.1017/S0048577202001543; Alexander JK, 2007, J COGNITIVE NEUROSCI, V19, P468, DOI 10.1162/jocn.2007.19.3.468; Arnsten AFT, 1998, ARCH GEN PSYCHIAT, V55, P362, DOI 10.1001/archpsyc.55.4.362; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; BARTLETT EJ, 1994, AM J PSYCHIAT, V151, P681; BERGER B, 1991, TRENDS NEUROSCI, V14, P21, DOI 10.1016/0166-2236(91)90179-X; Biondi M, 1999, PSYCHOTHER PSYCHOSOM, V68, P114, DOI 10.1159/000012323; BORN J, 1987, EXP BRAIN RES, V67, P85, DOI 10.1007/BF00269456; BORN J, 1987, PSYCHOPHYSIOLOGY, V24, P286, DOI 10.1111/j.1469-8986.1987.tb00297.x; BORN J, 1990, NEUROENDOCRINOLOGY, V52, P169, DOI 10.1159/000125569; BORN J, 1985, LIFE SCI, V36, P2117, DOI 10.1016/0024-3205(85)90308-X; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Braunstein-Bercovitz H, 2003, ANXIETY STRESS COPIN, V16, P345, DOI 10.1080/10615800310000112560; Braunstein-Bercovitz H, 2001, EMOTION, V1, P182, DOI 10.1037//1528-3542.1.2.182; Butler A. B., 1996, COMP VERTEBRATE NEUR, DOI DOI 10.1002/0471733849.CH19; CENCI MA, 1992, BRAIN RES, V581, P217, DOI 10.1016/0006-8993(92)90711-H; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Cook CJ, 2004, PHYSIOL BEHAV, V82, P751, DOI 10.1016/j.physbeh.2004.06.013; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; COX T, 1985, ERGONOMICS, V28, P1155, DOI 10.1080/00140138508963238; Curtis AL, 1997, J PHARMACOL EXP THER, V281, P163; de Kloet ER, 2008, EUR J PHARMACOL, V585, P473, DOI 10.1016/j.ejphar.2008.03.011; de Kloet ER, 2008, FRONT NEUROENDOCRIN, V29, P268, DOI 10.1016/j.yfrne.2007.10.002; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; DEUTCH AY, 1990, BRAIN RES, V521, P311, DOI 10.1016/0006-8993(90)91557-W; DEWIED D, 1980, P ROY SOC LOND B BIO, P183; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Duncko R, 2009, NEUROBIOL LEARN MEM, V91, P377, DOI 10.1016/j.nlm.2009.01.006; Elzinga BM, 2005, BEHAV NEUROSCI, V119, P98, DOI 10.1037/0735-7044.119.1.98; Erickson K, 2003, NEUROSCI BIOBEHAV R, V27, P233, DOI 10.1016/S0149-7634(03)00033-2; Finlay JM, 1997, NEUROCHEM RES, V22, P1387, DOI 10.1023/A:1022075324164; GOLDMANRACIC PS, 1999, PRIMATE NERVOUS SYST, V15, P403; GRESCH PJ, 1994, J NEUROCHEM, V63, P575; HERD JA, 1991, PHYSIOL REV, V71, P305, DOI 10.1152/physrev.1991.71.1.305; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Hoffman R, 2004, ARCH CLIN NEUROPSYCH, V19, P497, DOI 10.1016/j.acn.2003.07.005; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; Jemel B, 2003, BRAIN TOPOGR, V15, P249, DOI 10.1023/A:1023915730566; Joels M, 1997, FRONT NEUROENDOCRIN, V18, P2, DOI 10.1006/frne.1996.0144; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Kahkonen S, 2002, METHOD FIND EXP CLIN, V24, P27; Kahkonen S, 2001, NEUROPSYCHOPHARMACOL, V25, P498, DOI 10.1016/S0893-133X(01)00255-X; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Kok A, 2000, BIOL PSYCHOL, V54, P107, DOI 10.1016/S0301-0511(00)00054-5; Koob GF, 1999, BIOL PSYCHIAT, V46, P1167, DOI 10.1016/S0006-3223(99)00164-X; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; Lightman SL, 2008, J NEUROENDOCRINOL, V20, P880, DOI 10.1111/j.1365-2826.2008.01711.x; MANTZ J, 1989, BRAIN RES, V476, P377, DOI 10.1016/0006-8993(89)91263-8; Martins JM, 1996, NEUROENDOCRINOLOGY, V63, P338; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; Molle M, 1997, PSYCHOSOM MED, V59, P497, DOI 10.1097/00006842-199709000-00006; Morrow BA, 2000, BRAIN RES BULL, V52, P519, DOI 10.1016/S0361-9230(00)00290-2; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Nater UM, 2005, INT J PSYCHOPHYSIOL, V55, P333, DOI 10.1016/j.ijpsycho.2004.09.009; Oei NYL, 2006, STRESS, V9, P133, DOI 10.1080/10253890600965773; PREUSS TM, 1995, J COGNITIVE NEUROSCI, V7, P1, DOI 10.1162/jocn.1995.7.1.1; Qin SZ, 2009, BIOL PSYCHIAT, V66, P25, DOI 10.1016/j.biopsych.2009.03.006; Robbins TW, 2005, HAND CHEM N, V21, P395; Rohleder N, 2006, PSYCHOPHYSIOLOGY, V43, P645, DOI 10.1111/j.1469-8986.2006.00457.x; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Schoofs D, 2008, PSYCHONEUROENDOCRINO, V33, P643, DOI 10.1016/j.psyneuen.2008.02.004; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Shelley AM, 1997, NEUROPSYCHOPHARMACOL, V16, P202, DOI 10.1016/S0893-133X(96)00190-X; Simoens VL, 2007, PSYCHOPHYSIOLOGY, V44, P30, DOI 10.1111/j.1469-8986.2006.00476.x; Skosnik PD, 2000, INT J PSYCHOPHYSIOL, V36, P59, DOI 10.1016/S0167-8760(99)00100-2; Smolnik R, 1999, NEUROENDOCRINOLOGY, V70, P63, DOI 10.1159/000054460; Steciuk M, 2000, Stress, V3, P195, DOI 10.3109/10253890009001123; Strahler J, 2010, PSYCHOPHYSIOLOGY, V47, P587, DOI 10.1111/j.1469-8986.2009.00957.x; Streff A, 2010, EUR J PAIN, V14, P266, DOI 10.1016/j.ejpain.2009.05.011; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; THIERRY AM, 1976, NATURE, V263, P242, DOI 10.1038/263242a0; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; van Marle HJF, 2009, BIOL PSYCHIAT, V66, P649, DOI 10.1016/j.biopsych.2009.05.014; van Stegeren AH, 2008, INT J PSYCHOPHYSIOL, V69, P33, DOI 10.1016/j.ijpsycho.2008.02.008; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321; Yoshioka M, 1996, NEUROSCI LETT, V209, P201, DOI 10.1016/0304-3940(96)12631-8; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106; ZLOKOVIC BV, 1990, BIOCHIM BIOPHYS ACTA, V1025, P191, DOI 10.1016/0005-2736(90)90097-8	88	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18009	10.1371/journal.pone.0018009	http://dx.doi.org/10.1371/journal.pone.0018009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745UD	21483666	Green Published, gold, Green Submitted			2022-12-27	WOS:000289191300005
J	Al-Daghri, NM; Al-Attas, OS; Alokail, MS; Alkharfy, KM; Yakout, SM; Sabico, SB; Gibson, GC; Chrousos, GP; Kumar, S				Al-Daghri, Nasser M.; Al-Attas, Omar S.; Alokail, Majed S.; Alkharfy, Khalid M.; Yakout, Sobhy M.; Sabico, Shaun B.; Gibson, Greg C.; Chrousos, George P.; Kumar, Sudhesh			Parent-Offspring Transmission of Adipocytokine Levels and Their Associations with Metabolic Traits	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; CHILDHOOD OVERWEIGHT; INSULIN-RESISTANCE; OBESITY; ADIPONECTIN; CHILDREN; PREVALENCE; TRENDS; HERITABILITY; ADOLESCENTS	Adipose tissue secreted cytokines (adipocytokines) have significant effects on the physiology and pathology of human metabolism relevant to diabetes and cardiovascular disease. We determined the relationship of the pattern of these circulating hormones with obesity-related phenotypes and whether such pattern is transmitted from parent to offspring. A combined total of 403 individuals from 156 consenting Saudi families divided into initial (119 families with 123 adults and 131 children) and replication (37 families with 58 adults and 91 children) cohorts were randomly selected from the RIYADH Cohort study. Anthropometrics were evaluated and metabolic measures such as fasting serum glucose, lipid profiles, insulin, leptin, adiponectin, resistin, tumor necrosis factor alpha (TNF alpha), activated plasminogen activator inhibitor 1 (aPAI1), high sensitivity C-reactive protein (hsCRP) and angiotensin II were also assessed. Parent-offspring regressions revealed that with the exception of hsCRP, all hormones measured showed evidence for significant inheritance. Principal component (PC) analysis of standardized hormone levels demonstrated surprising heritability of the three most common axes of variation. PC1, which explained 21% of the variation, was most strongly loaded on levels of leptin, TNF alpha, insulin, and aPAI1, and inversely with adiponectin. It was significantly associated with body mass index (BMI) and phenotypically stronger in children, and showed a heritability of similar to 50%, after adjustment for age, gender and generational effects. We conclude that adipocytokines are highly heritable and their pattern of co-variation significantly influences BMI as early as the pre-teen years. Investigation at the genomic scale is required to determine the variants affecting the regulation of the hormones studied.	[Al-Daghri, Nasser M.; Al-Attas, Omar S.; Alokail, Majed S.; Yakout, Sobhy M.; Sabico, Shaun B.; Chrousos, George P.] King Saud Univ, Coll Med, Biomarkers Res Program, Dept Biochem, Riyadh 11461, Saudi Arabia; [Alkharfy, Khalid M.] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh 11461, Saudi Arabia; [Gibson, Greg C.] Georgia Inst Technol, Sch Biol, Ctr Integrat Genom, Atlanta, GA 30332 USA; [Chrousos, George P.] Univ Athens, Sch Med, Aghia Sophia Childrens Hosp, Div Endocrinol Metab & Diabet, GR-11527 Athens, Greece; [Kumar, Sudhesh] Univ Warwick, Diabet & Metab Unit, Clin Sci Res Inst, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	King Saud University; King Saud University; University System of Georgia; Georgia Institute of Technology; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; University of Warwick	Al-Daghri, NM (corresponding author), King Saud Univ, Coll Med, Biomarkers Res Program, Dept Biochem, Riyadh 11461, Saudi Arabia.	ndaghri@ksu.edu.sa	Sabico, Shaun/C-9086-2011; Al-okail, Majed S/E-5565-2016; Al-Daghri, Nasser/A-8360-2011; yakout, sobhy/E-7509-2019; Al-Daghri, Nasser/G-7736-2011; kumar, sudhesh/D-6945-2013	Sabico, Shaun/0000-0002-5248-2350; Al-okail, Majed S/0000-0001-8147-3499; Al-Daghri, Nasser/0000-0001-5472-1725; Al-Daghri, Nasser/0000-0001-5472-1725; kumar, sudhesh/0000-0003-4326-5941	King Saud University, Riyadh, KSA	King Saud University, Riyadh, KSA(King Saud University)	The study was funded internally by King Saud University, Riyadh, KSA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daghri N, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-10; Al-Daghri NM, 2010, EUR J CLIN INVEST, V40, P1063, DOI 10.1111/j.1365-2362.2010.02341.x; Al-Daghri NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012159; Alvarez-Aguilar C, 2007, EXP MOL MED, V39, P327, DOI 10.1038/emm.2007.36; Ayatollahi SMT, 2010, OBES REV, V11, P335, DOI 10.1111/j.1467-789X.2010.00725.x; Beardsall K, 2009, J CLIN ENDOCR METAB, V94, P3708, DOI 10.1210/jc.2009-0757; Benson L, 2009, PEDIATRICS, V123, pE153, DOI 10.1542/peds.2008-1408; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Comuzzie AG, 2001, J CLIN ENDOCR METAB, V86, P4321, DOI 10.1210/jc.86.9.4321; COOPER R, AM J CLIN NUTR, V92, P946; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Davis MM, 2008, J AM BOARD FAM MED, V21, P549, DOI 10.3122/jabfm.2008.06.070140; de Kloet AD, 2010, PHYSIOL BEHAV, V100, P525, DOI 10.1016/j.physbeh.2010.03.018; de Luis DA, 2010, DIABETES RES CLIN PR, V89, P110, DOI 10.1016/j.diabres.2010.03.031; El Mouzan MI, 2010, ANN SAUDI MED, V30, P203, DOI 10.4103/0256-4947.62833; Elhadd TA, 2007, ANN SAUDI MED, V27, P241; Friedlander Y, 2009, OBESITY, V17, P1458, DOI 10.1038/oby.2008.672; Gilardini L, 2006, ATHEROSCLEROSIS, V189, P401, DOI 10.1016/j.atherosclerosis.2005.12.021; Harte A, 2005, CIRCULATION, V111, P1954, DOI 10.1161/01.CIR.0000161954.17870.5D; Haworth CMA, 2008, OBESITY, V16, P1585, DOI 10.1038/oby.2008.240; Hou XH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-389; Kaprio J, 2001, INT J OBESITY, V25, P132, DOI 10.1038/sj.ijo.0801526; Lim Lynette Ly, 2009, Popul Health Metr, V7, P15, DOI 10.1186/1478-7954-7-15; Lissner L, 2010, OBES REV, V11, P553, DOI 10.1111/j.1467-789X.2009.00696.x; Luo BF, 2010, J MED GENET, V47, P415, DOI 10.1136/jmg.2009.068932; Martin LJ, 2010, OBESITY, V18, P1378, DOI 10.1038/oby.2009.394; McTernan CL, 2002, LANCET, V359, P46, DOI 10.1016/S0140-6736(02)07281-1; Menzaghi C, 2010, J INTERN MED, V267, P287, DOI 10.1111/j.1365-2796.2009.02141.x; Menzaghi C, 2006, J CLIN ENDOCR METAB, V91, P2792, DOI 10.1210/jc.2005-2715; Olds TS, 2010, INT J OBESITY, V34, P57, DOI 10.1038/ijo.2009.211; Pearson S, 2010, ACTA PAEDIATR, V99, P1675, DOI 10.1111/j.1651-2227.2010.01897.x; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Schnabel RB, 2009, CIRC-CARDIOVASC GENE, V2, P229, DOI 10.1161/CIRCGENETICS.108.804245; Schoppen S, 2010, CLIN CHEM LAB MED, V48, P707, DOI 10.1515/CCLM.2010.142; Speakman JR, 2004, J NUTR, V134, p2090S, DOI 10.1093/jn/134.8.2090S; Tejero ME, 2007, INT J OBESITY, V31, P535, DOI 10.1038/sj.ijo.0803436; Umeda M, 2001, AM J HYPERTENS, V14, P206, DOI 10.1016/S0895-7061(00)01253-X; Whitaker KL, 2010, AM J CLIN NUTR, V91, P1560, DOI 10.3945/ajcn.2009.28838; Yvan-Charvet L, 2007, ARTERIOSCL THROM VAS, V27, P1340, DOI 10.1161/ATVBAHA.106.136382; Zhang LX, 2010, J AM SOC NEPHROL, V21, P1185, DOI 10.1681/ASN.2009101053	41	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18182	10.1371/journal.pone.0018182	http://dx.doi.org/10.1371/journal.pone.0018182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483749	Green Published, gold, Green Submitted			2022-12-27	WOS:000289058700012
J	Ganesh, BS; Chintala, SK				Ganesh, Bhagyalaxmi S.; Chintala, Shravan K.			Inhibition of Reactive Gliosis Attenuates Excitotoxicity-Mediated Death of Retinal Ganglion Cells	PLOS ONE			English	Article							OPTIC-NERVE HEAD; ELEVATED INTRAOCULAR-PRESSURE; MOUSE MODEL; ASTROCYTES; GLAUCOMA; RESPONSES; DAMAGE; EXPRESSION; NEUROPATHY; LIGATION	Reactive gliosis is a hallmark of many retinal neurodegenerative conditions, including glaucoma. Although a majority of studies to date have concentrated on reactive gliosis in the optic nerve head, very few studies have been initiated to investigate the role of reactive gliosis in the retina. We have previously shown that reactive glial cells synthesize elevated levels of proteases, and these proteases, in turn, promote the death of retinal ganglion cells (RGCs). In this investigation, we have used two glial toxins to inhibit reactive gliosis and have evaluated their effect on protease-mediated death of RGCs. Kainic acid was injected into the vitreous humor of C57BL/6 mice to induce reactive gliosis and death of RGCs. C57BL/6 mice were also treated with glial toxins, alpha-aminoadipic acid (AAA) or Neurostatin, along with KA. Reactive gliosis was assessed by immunostaining of retinal cross sections and retinal flat-mounts with glial fibrillary acidic protein (GFAP) and vimentin antibodies. Apoptotic cell death was assessed by TUNEL assays. Loss of RGCs was determined by immunostaining of flat-mounted retinas with Brn3a antibodies. Proteolytic activities of matrix metalloproteinase-9 (MMP-9), tissue plasminogen activator (tPA), and urokinase plasminogen activator (uPA) were assessed by zymography assays. GFAP-immunoreactivity indicated that KA induced reactive gliosis in both retinal astrocytes and in Muller cells. AAA alone or in combination with KA decreased GFAP and vimentin-immunoreactivity in Mller cells, but not in astrocytes. In addition AAA failed to decrease KA-mediated protease levels and apoptotic death of RGCs. In contrast, Neurostatin either alone or in combination with KA, decreased reactive gliosis in both astrocytes and Mller cells. Furthermore, Neurostatin decreased protease levels and prevented apoptotic death of RGCs. Our findings, for the first time, indicate that inhibition of reactive gliosis decreases protease levels in the retina, prevents apoptotic death of retinal neurons, and provides substantial neuroprotection.	[Ganesh, Bhagyalaxmi S.; Chintala, Shravan K.] Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA	Oakland University	Ganesh, BS (corresponding author), Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA.	Chintala@oakland.edu			National Eye Institutes [EY017853-01A2]; Vision Research Infrastructure Development Grant [EY014803]; NATIONAL EYE INSTITUTE [R24EY014803, R01EY017853] Funding Source: NIH RePORTER	National Eye Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Vision Research Infrastructure Development Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in part, by National Eye Institutes Project grant EY017853-01A2 (to SKC) and Vision Research Infrastructure Development Grant EY014803. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Rodriguez J, 2000, J NEUROCHEM, V74, P2547, DOI 10.1046/j.1471-4159.2000.0742547.x; Anderson D R, 1967, Trans Am Ophthalmol Soc, V65, P275; BELLIVEAU DJ, 1994, GLIA, V12, P24, DOI 10.1002/glia.440120104; Chintala SK, 2002, J BIOL CHEM, V277, P47461, DOI 10.1074/jbc.M204824200; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Halassa MM, 2009, NEUROPHARMACOLOGY, V57, P343, DOI 10.1016/j.neuropharm.2009.06.031; Harvey R, 2007, INVEST OPHTH VIS SCI, V48, P1884, DOI 10.1167/iovs.06-0990; HEFTI F, 1985, J NEUROSCI, V5, P2086; Hernandez MR, 2008, PROG BRAIN RES, V173, P353, DOI 10.1016/S0079-6123(08)01125-4; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; Inman DM, 2007, GLIA, V55, P942, DOI 10.1002/glia.20516; ISHIKAWA Y, 1983, JPN J OPHTHALMOL, V27, P107; Johnson EC, 2000, INVEST OPHTH VIS SCI, V41, P431; Johnson EC, 2009, J GLAUCOMA, V18, P341, DOI 10.1097/IJG.0b013e31818c6ef6; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P960, DOI 10.1167/iovs.09-3884; Kim JH, 2006, J BIOCHEM MOL BIOL, V39, P339; Kuehn MH, 2006, EXP EYE RES, V83, P620, DOI 10.1016/j.exer.2006.03.002; Kumada M, 2004, TOXICOL APPL PHARM, V200, P48, DOI 10.1016/j.taap.2004.03.017; Mali RS, 2005, FASEB J, V19, P1280, DOI 10.1096/fj.04-3403com; MILLER RH, 1989, EUR J NEUROSCI, V1, P172, DOI 10.1111/j.1460-9568.1989.tb00785.x; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nakazawa T, 2006, MOL VIS, V12, P867; Neufeld AH, 2003, NEUROSCIENTIST, V9, P485, DOI 10.1177/1073858403253460; Pena JDO, 2001, INVEST OPHTH VIS SCI, V42, P2303; Prasanna G, 2002, INVEST OPHTH VIS SCI, V43, P2704; RADANY EH, 1992, P NATL ACAD SCI USA, V89, P6467, DOI 10.1073/pnas.89.14.6467; Steele MR, 2006, INVEST OPHTH VIS SCI, V47, P977, DOI 10.1167/iovs.05-0865; West EL, 2008, EXP EYE RES, V86, P601, DOI 10.1016/j.exer.2008.01.004; Yorio T, 2002, J GLAUCOMA, V11, P259, DOI 10.1097/00061198-200206000-00016; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V; Zhang X, 2004, INVEST OPHTH VIS SCI, V45, P2374, DOI 10.1167/iovs.03-1239; Zhang X, 2004, NEUROSCI LETT, V356, P140, DOI 10.1016/j.neulet.2003.10.084; Zhang X, 2003, MOL VIS, V9, P238	33	63	68	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18305	10.1371/journal.pone.0018305	http://dx.doi.org/10.1371/journal.pone.0018305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483783	gold, Green Published, Green Submitted			2022-12-27	WOS:000289057200055
J	Chu, T; Lingelbach, K; Przyborski, JM				Trang Chu; Lingelbach, Klaus; Przyborski, Jude M.			Genetic Evidence Strongly Support an Essential Role for PfPV1 in Intra-Erythrocytic Growth of P. falciparum	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; MALARIA PARASITES; PARASITOPHOROUS VACUOLE; INFECTED ERYTHROCYTES; PROTEINS; VIRULENCE; TRANSFECTION; PROTEASES; REVEALS; SIGNAL	Upon invading the host erythrocyte, the human malaria parasite P. falciparum lives and replicates within a membrane bound compartment referred to as the parasitophorous vacuole. Recently, interest in this compartment and its protein content has grown, due to the important roles these play in parasite egress and protein traffic to the host cell. Surprisingly, the function of many proteins within this compartment has not been experimentally addressed. Here, we study the importance of one of these proteins, termed PfPV1, for intra-erythrocytic parasite survival. Despite numerous attempts to inactivate the gene encoding PfPV1, we were unable to recover deletion mutants. Control experiments verified that the pv1 gene locus was per se open for gene targeting experiments, allowing us to exclude technical limitations in our experimental strategy. Our data provide strong genetic evidence that PfPV1 is essential for survival of blood stage P. falciparum, and further highlight the importance of parasitophorous vacuole proteins in this part of the parasite's life cycle.	[Trang Chu; Lingelbach, Klaus; Przyborski, Jude M.] Univ Marburg, Dept Parasitol, Fac Biol, Marburg, Germany	Philipps University Marburg	Chu, T (corresponding author), Univ Marburg, Dept Parasitol, Fac Biol, Marburg, Germany.	przybors@staff.uni-marburg.de	Przyborski, Jude/ABC-9498-2021	Przyborski, Jude/0000-0002-3494-7767	SFB [SFB 593]; International Max Planck Research School (IMPRS)	SFB(Austrian Science Fund (FWF)); International Max Planck Research School (IMPRS)	K.L. and T.C. are supported by the SFB 593. T. C was the recipient of a Doctoral Scholarship of the International Max Planck Research School (IMPRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Cowman A F, 1984, Mol Biol Med, V2, P207; Crabb BS, 2004, METH MOL B, V270, P263; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; GUNTHER K, 1991, MOL BIOCHEM PARASIT, V46, P149, DOI 10.1016/0166-6851(91)90208-N; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; KEMP DJ, 1987, ANNU REV MICROBIOL, V41, P181, DOI 10.1146/annurev.mi.41.100187.001145; Lingelbach K, 1998, J CELL SCI, V111, P1467; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Nyalwidhe J, 2006, PROTEOMICS, V6, P1563, DOI 10.1002/pmic.200500379; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; RAGGE K, 1990, MOL BIOCHEM PARASIT, V42, P93, DOI 10.1016/0166-6851(90)90116-4; Rossner M, 2004, J CELL BIOL, V166, P11, DOI 10.1083/jcb.200406019; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840	21	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18396	10.1371/journal.pone.0018396	http://dx.doi.org/10.1371/journal.pone.0018396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483790	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200068
J	Wu, ZQ; Li, YZ; Li, XL; Ti, DD; Zhao, YL; Si, YL; Mei, QA; Zhao, P; Fu, XB; Han, WD				Wu, Zhiqiang; Li, Yazhuo; Li, Xiaolei; Ti, Dongdong; Zhao, Yali; Si, Yiling; Mei, Qian; Zhao, Po; Fu, Xiaobing; Han, Weidong			LRP16 Integrates into NF-kappa B Transcriptional Complex and Is Required for Its Functional Activation	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; DEPENDENT GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; BREAST-CANCER; CLINICOPATHOLOGICAL SIGNIFICANCE; GASTRIC-CARCINOMA; ANDROGEN RECEPTOR; PROGNOSTIC VALUE; PROSTATE-CANCER; MACRO DOMAIN	Background: Nuclear factor kappa B (NF-kappa B)-mediated pathways have been widely implicated in cell survival, development and tumor progression. Although the molecular events of determining NF-kappa B translocation from cytoplasm to nucleus have been extensively documented, the regulatory mechanisms of NF-kappa B activity inside the nucleus are still poorly understood. Being a special member of macro domain proteins, LRP16 was previously identified as a coactivator of both estrogen receptor and androgen receptor, and as an interactor of NF-kappa B coactivator UXT. Here, we investigated the regulatory role of LRP16 on NF-kappa B activation. Methodology: GST pull-down and coimmunoprecipitation (CoIP) assays assessed protein-protein interactions. The functional activity of NF-kappa B was assessed by luciferase assays, changes in expression of its target genes, and its DNA binding ability. Annexin V staining and flow cytometry analysis were used to evaluate cell apoptosis. Immunohistochemical staining of LRP16 and enzyme-linked immunosorbent assay-based evaluation of active NF-kappa B were performed on primary human gastric carcinoma samples. Results: We demonstrate that LRP16 integrates into NF-kappa B transcriptional complex through associating with its p65 component. RNA interference knockdown of the endogenous LRP16 in cells leads to impaired NF-kappa B activity and significantly attenuated NF-kappa B-dependent gene expression. Mechanistic analysis revealed that knockdown of LRP16 did not affect tumor necrosis factor a (TNF-alpha)-induced nuclear translocation of NF-kappa B, but blunted the formation or stabilization of functional NF-kappa B/p300/CREB-binding protein transcription complex in the nucleus. In addition, knockdown of LRP16 also sensitizes cells to apoptosis induced by TNF-alpha. Finally, a positive link between LRP16 expression intensity in nuclei of tumor cells and NF-kappa B activity was preliminarily established in human gastric carcinoma specimens. Conclusions: Our findings not only indicate that LRP16 is a crucial regulator for NF-kappa B activation inside the nucleus, but also suggest that LRP16 may be an important contributor to the aberrant activation of NF-kappa B in tumors.	[Wu, Zhiqiang; Li, Xiaolei; Ti, Dongdong; Zhao, Yali; Si, Yiling; Mei, Qian; Fu, Xiaobing; Han, Weidong] Chinese Peoples Liberat Army Gen Hosp, Dept Mol Biol, Inst Basic Med, Beijing, Peoples R China; [Li, Yazhuo; Zhao, Po] Chinese Peoples Liberat Army Gen Hosp, Dept Pathol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Wu, ZQ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Mol Biol, Inst Basic Med, Beijing, Peoples R China.	hanwdrsw69@yahoo.com	li, Xiaolei/V-1383-2019	li, Xiaolei/0000-0002-2697-6496	National Natural Science Foundation of China [81071617, 81001184, 81072109]; Ministry of Science and Technology of China [2010CB912802]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work is supported by the grants from the National Natural Science Foundation of China (website is http://www.nsfc.gov.cn/Portal0/default124.htm) (No. 81071617, 81001184 and 81072109) and is partially supported by the grant from the Ministry of Science and Technology of China (the website is http://www.most.gov.cn/) (No. 2010CB912802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Aguiar RCT, 2005, J BIOL CHEM, V280, P33756, DOI 10.1074/jbc.M505408200; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Allen MD, 2003, J MOL BIOL, V330, P503, DOI 10.1016/S0022-2836(03)00473-X; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Baselga J, 2002, CANCER CELL, V1, P319, DOI 10.1016/S1535-6108(02)00066-1; Chan HM, 2001, J CELL SCI, V114, P2363; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; De Bosscher K, 2006, ONCOGENE, V25, P6868, DOI 10.1038/sj.onc.1209935; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goenka S, 2006, P NATL ACAD SCI USA, V103, P4210, DOI 10.1073/pnas.0506981103; Han WD, 2007, ENDOCR-RELAT CANCER, V14, P741, DOI 10.1677/ERC-06-0082; Han WD, 2003, ENDOCR-RELAT CANCER, V10, P217, DOI 10.1677/erc.0.0100217; Han WD, 2008, J STEROID BIOCHEM, V109, P47, DOI 10.1016/j.jsbmb.2007.12.009; Han WD, 2009, NUCLEIC ACIDS RES, V37, P3996, DOI 10.1093/nar/gkp332; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Isaacs W, 2002, CANCER CELL, V2, P113, DOI 10.1016/S1535-6108(02)00103-4; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Ko S, 2008, MOL ENDOCRINOL, V22, P273, DOI 10.1210/me.2007-0332; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lee DF, 2008, CLIN CANCER RES, V14, P5656, DOI 10.1158/1078-0432.CCR-08-0123; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li YZ, 2009, WORLD J GASTROENTERO, V15, P4833, DOI 10.3748/wjg.15.4833; Meng YG, 2007, CELL RES, V17, P869, DOI 10.1038/cr.2007.79; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Neuvonen M, 2009, J MOL BIOL, V385, P212, DOI 10.1016/j.jmb.2008.10.045; O'Malley BW, 2008, CURR OPIN CELL BIOL, V20, P310, DOI 10.1016/j.ceb.2008.04.005; PEHRSON JR, 1992, SCIENCE, V257, P1398; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Sasaki N, 2001, CLIN CANCER RES, V7, P4136; Sui SG, 2007, J CELL BIOL, V178, P231, DOI 10.1083/jcb.200611081; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tian LY, 2009, J ENDOCRINOL, V202, P167, DOI 10.1677/JOE-09-0054; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wolf IM, 2008, J CELL BIOCHEM, V104, P1580, DOI 10.1002/jcb.21755; Xi HQ, 2010, WORLD J GASTROENTERO, V16, P1644, DOI 10.3748/wjg.v16.i13.1644; Yamanaka N, 2004, ANTICANCER RES, V24, P1071; Yang J, 2009, ENDOCR-RELAT CANCER, V16, P139, DOI 10.1677/ERC-08-0150; Zhao P, 2010, CANCER SCI, V101, P2262, DOI 10.1111/j.1349-7006.2010.01658.x; Zhao YL, 2005, J MOL ENDOCRINOL, V34, P77, DOI 10.1677/jme.1.01628; Zhou Y, 2005, ENDOCR-RELAT CANCER, V12, pS37, DOI 10.1677/erc.1.00977; Zhou YM, 2005, INT J BIOCHEM CELL B, V37, P1130, DOI 10.1016/j.biocel.2004.09.006	53	31	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18157	10.1371/journal.pone.0018157	http://dx.doi.org/10.1371/journal.pone.0018157			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483817	Green Submitted, Green Published, gold			2022-12-27	WOS:000289057200034
J	Davis, CJ; Bowers, JS; Memon, A				Davis, Colin J.; Bowers, Jeffrey S.; Memon, Amina			Social Influence in Televised Election Debates: A Potential Distortion of Democracy	PLOS ONE			English	Article							CAMPAIGN; SUSCEPTIBILITY; IMPACT	A recent innovation in televised election debates is a continuous response measure (commonly referred to as the "worm") that allows viewers to track the response of a sample of undecided voters in real-time. A potential danger of presenting such data is that it may prevent people from making independent evaluations. We report an experiment with 150 participants in which we manipulated the worm and superimposed it on a live broadcast of a UK election debate. The majority of viewers were unaware that the worm had been manipulated, and yet we were able to influence their perception of who won the debate, their choice of preferred prime minister, and their voting intentions. We argue that there is an urgent need to reconsider the simultaneous broadcast of average response data with televised election debates.	[Davis, Colin J.; Memon, Amina] Royal Holloway Univ London, Dept Psychol, London, England; [Bowers, Jeffrey S.] Univ Bristol, Dept Expt Psychol, Bristol, Avon, England	University of London; Royal Holloway University London; University of Bristol	Davis, CJ (corresponding author), Royal Holloway Univ London, Dept Psychol, London, England.	c.davis@rhul.ac.uk		Bowers, Jeffrey/0000-0001-9558-5010; Davis, Colin/0000-0001-5814-5104				ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; Benoit WL, 2002, J COMMUN, V52, P316, DOI 10.1111/j.1460-2466.2002.tb02547.x; Berger J, 2008, P NATL ACAD SCI USA, V105, P8846, DOI 10.1073/pnas.0711988105; Blais A, 1999, CAN PUBLIC POL, V25, P197, DOI 10.2307/3551888; Blais A, 1996, BRIT J POLIT SCI, V26, P143, DOI 10.1017/S0007123400000405; CHAKRABARTI R, 2010, TV ELECTION DEBATES; COOKE D, 2007, AGE             1022; DAVIES D, 2008, DONT SCRAP SQUIGGLE; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; DIVESTA FJ, 1959, J ABNORM SOC PSYCH, V59, P204, DOI 10.1037/h0042945; Fein S, 2007, POLIT PSYCHOL, V28, P165, DOI 10.1111/j.1467-9221.2007.00561.x; Festinger L., 1957, THEORY COGNITIVE DIS, V2; FINKEL SE, 1995, BRIT J POLIT SCI, V25, P349, DOI 10.1017/S0007123400007249; Fournier P, 2004, ELECT STUD, V23, P661, DOI 10.1016/j.electstud.2003.09.001; Gabbert F, 2003, APPL COGNITIVE PSYCH, V17, P533, DOI 10.1002/acp.885; Hoffman HG, 2001, MEM COGNITION, V29, P394, DOI 10.3758/BF03196390; KROSNICK JA, 1994, POLIT COMMUN, V11, P391, DOI 10.1080/10584609.1994.9963047; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; NOSANCHUK TA, 1974, J PERS SOC PSYCHOL, V29, P153, DOI 10.1037/h0035737; PENNY T, 2010, BUSINESS WEEK   0430; Petty R.E., 1986, ADV EXPT SOCIAL PSYC, V19, P123, DOI [10.1016/S0065-2601(08)60214-2, DOI 10.1016/S0065-2601(08)60214-2, https://doi.org/10.1016/S0065-2601(08)60214-2]; SCHILL KR, 2009, REAL TIME RESPONSE M, P155; SCHROTT PR, 1990, PUBLIC OPIN QUART, V54, P567, DOI 10.1086/269228; Philip S, 2008, AUST J POLIT SCI, V43, P443, DOI 10.1080/10361140802267241; Sherif M., 1936, PSYCHOL SOCIAL NORMS; Tormala ZL, 2002, J PERS SOC PSYCHOL, V83, P1298, DOI 10.1037//0022-3514.83.6.1298; Weaver JB, 2009, COMPUT HUM BEHAV, V25, P50, DOI 10.1016/j.chb.2008.06.004; Yawn M, 1998, POLIT BEHAV, V20, P155, DOI 10.1023/A:1024832830083; 1992, SUN             0411	30	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18154	10.1371/journal.pone.0018154	http://dx.doi.org/10.1371/journal.pone.0018154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YK	21479191	Green Published, gold			2022-12-27	WOS:000289055700034
J	Yin, A; Korzh, S; Winata, CL; Korzh, V; Gong, ZY				Yin, Ao; Korzh, Svitlana; Winata, Cecilia L.; Korzh, Vladimir; Gong, Zhiyuan			Wnt Signaling Is Required for Early Development of Zebrafish Swimbladder	PLOS ONE			English	Article							LUNG MORPHOGENESIS; BETA-CATENIN; SWIM BLADDER; DANIO-RERIO; EXPRESSION; GENE; HEDGEHOG; SPECIFICATION; PATHWAY; ROLES	Background: Wnt signaling plays critical roles in mammalian lung development. However, Wnt signaling in the development of the zebrafish swimbladder, which is considered as a counterpart of mammalian lungs, have not been explored. To investigate the potential conservation of signaling events in early development of the lung and swimbladder, we wish to address the question whether Wnt signaling plays a role in swimbladder development. Methodology/Principal Findings: For analysis of zebrafish swimbladder development, we first identified, by whole-mount in situ hybridization (WISH), has2 as a mesenchymal marker, sox2 as the earliest epithelial marker, as well as hprt1l and elovl1a as the earliest mesothelial markers. We also demonstrated that genes encoding Wnt signaling members Wnt5b, Fz2, Fz7b, Lef1, Tcf3 were expressed in different layers of swimbladder. Then we utilized the heat-shock inducible transgenic lines hs: Dkk1-GFP and hs: Delta Tcf-GFP to temporarily block canonical Wnt signaling. Inhibition of canonical Wnt signaling at various time points disturbed precursor cells specification, organization, anterioposterior patterning, and smooth muscle differentiation in all three tissue layers of swimbladder. These observations were also confirmed by using a chemical inhibitor (IWR-1) of Wnt signaling. In addition, we found that Hedgehog (Hh) signaling was activated by canonical Wnt signaling and imposed a negative feedback on the latter. Significance/Conclusion: We first provided a new set of gene markers for the three tissue layers of swimbladder in zebrafish and demonstrated the expression of several key genes of Wnt signaling pathway in developing swimbladder. Our functional analysis data indicated that Wnt/beta-catenin signaling is required for swimbladder early development and we also provided evidence for the crosstalk between Wnt and Hh signaling in early swimbladder development.	[Yin, Ao; Korzh, Svitlana; Winata, Cecilia L.; Korzh, Vladimir; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Korzh, Vladimir] Natl Univ Singapore, Inst Mol & Cell Biol, Lab Fish Dev Biol, Genes & Dev Div, Singapore 117548, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Yin, A (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	vlad@imcb.a-star.edu.sg; dbsgzy@nus.edu.sg	Korzh, Vladimir P/H-1596-2011; Gong, Zhiyuan/H-8794-2012	Korzh, Vladimir P/0000-0002-6580-7986; Gong, Zhiyuan/0000-0002-9660-5260; winata, cecilia/0000-0002-7718-5248	Ministry of Education of Singapore; Agency for Science, Technology and Research of Singapore	Ministry of Education of Singapore(Ministry of Education, Singapore); Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR))	This work was funded by the Ministry of Education of Singapore. VK's lab in the IMCB was supported by the grant from the Agency for Science, Technology and Research of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or reparation of the manuscript.	Alexa K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008261; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Burke ZD, 2006, CURR BIOL, V16, pR688, DOI 10.1016/j.cub.2006.08.011; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; De Langhe SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001516; Farber SA, 2003, GENOME RES, V13, P1082, DOI 10.1101/gr.479603; Finney JL, 2006, J COMP NEUROL, V495, P587, DOI 10.1002/cne.20948; Georgijevic S, 2007, DEV DYNAM, V236, P1623, DOI 10.1002/dvdy.21165; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Hong SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003736; Jia LW, 2008, CELL BIOL INT, V32, P807, DOI 10.1016/j.cellbi.2008.03.011; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; Lako M, 1998, GENE, V219, P101, DOI 10.1016/S0378-1119(98)00393-X; Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007; Li CG, 2005, DEV BIOL, V287, P86, DOI 10.1016/j.ydbio.2005.08.035; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Li YH, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011014, 10.1371/journal.pone.0015219]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Muller II, 2006, DEV DYNAM, V235, P2881, DOI 10.1002/dvdy.20925; Perry SF, 2001, COMP BIOCHEM PHYS A, V129, P37, DOI 10.1016/S1095-6433(01)00304-X; Rajagopal J, 2008, DEVELOPMENT, V135, P1625, DOI 10.1242/dev.015495; Reiter JF, 2001, DEVELOPMENT, V128, P125; Roy S, 2001, CURR BIOL, V11, P1358, DOI 10.1016/S0960-9822(01)00402-X; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Shu WG, 2002, DEVELOPMENT, V129, P4831; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; STRAHLE U, 1993, GENE DEV, V7, P1436, DOI 10.1101/gad.7.7b.1436; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Teoh PH, 2010, DEV DYNAM, V239, P865, DOI 10.1002/dvdy.22221; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Winata CL, 2009, DEV BIOL, V331, P222, DOI 10.1016/j.ydbio.2009.04.035; Yin A, 2010, GENE EXPR PATTERNS, V10, P338, DOI 10.1016/j.gep.2010.07.005; Yin Y, 2008, DEV BIOL, V319, P426, DOI 10.1016/j.ydbio.2008.04.009	41	57	60	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18431	10.1371/journal.pone.0018431	http://dx.doi.org/10.1371/journal.pone.0018431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479192	gold, Green Submitted, Green Published			2022-12-27	WOS:000289055700057
J	Lindstedt, F; Berrebi, J; Greayer, E; Lonsdorf, TB; Schalling, M; Ingvar, M; Kosek, E				Lindstedt, Fredrik; Berrebi, Jonathan; Greayer, Erik; Lonsdorf, Tina B.; Schalling, Martin; Ingvar, Martin; Kosek, Eva			Conditioned Pain Modulation Is Associated with Common Polymorphisms in the Serotonin Transporter Gene	PLOS ONE			English	Article							NOXIOUS INHIBITORY CONTROLS; NOCICEPTIVE FLEXION REFLEX; 5-HTTLPR POLYMORPHISM; NFR THRESHOLD; ISCHEMIC PAIN; PERCEPTION; ANALGESIA; NEURONS; FIBROMYALGIA; STIMULATION	Background: Variation in the serotonin transporter (5-HTT) gene (SLC6A4) has been shown to influence a wide range of affective processes. Low 5-HTT gene-expression has also been suggested to increase the risk of chronic pain. Conditioned pain modulation (CPM) - i.e. 'pain inhibits pain' - is impaired in chronic pain states and, reciprocally, aberrations of CPM may predict the development of chronic pain. Therefore we hypothesized that a common variation in the SLC6A4 is associated with inter-individual variation in CPM. Forty-five healthy subjects recruited on the basis of tri-allelic 5-HTTLPR genotype, with inferred high or low 5-HTT-expression, were included in a double-blind study. A submaximal-effort tourniquet test was used to provide a standardized degree of conditioning ischemic pain. Individualized noxious heat and pressure pain thresholds (PPTs) were used as subjective test-modalities and the nociceptive flexion reflex (NFR) was used to provide an objective neurophysiological window into spinal processing. Results: The low, as compared to the high, 5-HTT-expressing group exhibited significantly reduced CPM-mediated pain inhibition for PPTs (p = 0.02) and heat-pain (p = 0.02). The CPM-mediated inhibition of the NFR, gauged by increases in NFR-threshold, did not differ significantly between groups (p = 0.75). Inhibition of PPTs and heat-pain were correlated (Spearman's rho = 0.35, p = 0.02), whereas the NFR-threshold increase was not significantly correlated with degree of inhibition of these subjectively reported modalities. Conclusions: Our results demonstrate the involvement of the tri-allelic 5-HTTLPR genotype in explaining clinically relevant inter-individual differences in pain perception and regulation. Our results also illustrate that shifts in NFR-thresholds do not necessarily correlate to the modulation of experienced pain. We discuss various possible mechanisms underlying these findings and suggest a role of regulation of 5-HT receptors along the neuraxis as a function of differential 5-HTT-expression.	[Lindstedt, Fredrik; Berrebi, Jonathan; Greayer, Erik; Lonsdorf, Tina B.; Ingvar, Martin; Kosek, Eva] Karolinska Inst, Stockholm Brain Inst, Osher Ctr Integrat Med, Dept Clin Neurosci, Stockholm, Sweden; [Lonsdorf, Tina B.] Univ Hosp Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Lonsdorf, Tina B.; Schalling, Martin] Karolinska Inst, Neurogenet Unit, Dept Mol Med & Surg, Stockholm, Sweden; [Lonsdorf, Tina B.; Schalling, Martin] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden	Karolinska Institutet; University of Hamburg; University Medical Center Hamburg-Eppendorf; Karolinska Institutet; Karolinska Institutet	Lindstedt, F (corresponding author), Karolinska Inst, Stockholm Brain Inst, Osher Ctr Integrat Med, Dept Clin Neurosci, Stockholm, Sweden.	fredrik.lindstedt@ki.se	Schalling, Martin/F-1518-2015; Lonsdorf, Tina/K-8657-2017	Schalling, Martin/0000-0001-5011-2922; Lonsdorf, Tina/0000-0003-1501-4846; Kosek, Eva/0000-0003-0488-8177; Ingvar, Martin/0000-0002-9041-5714	Osher foundation; Swedish Research Council [2009-2322, 2008-3307]; Karolinska Institutet; Karolinska University Hospital	Osher foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Karolinska University Hospital(Karolinska Institutet)	This study was funded by the Osher foundation (www.osherfoundation.org) and the Swedish Research Council (www.vr.se), grant nr 2009-2322 (MI) and 2008-3307 (MS). The study was further supported by funds from Karolinska Institutet and Karolinska University Hospital (MS). The funders had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript.	Ablin JN, 2009, CURR PAIN HEADACHE R, V13, P343, DOI 10.1007/s11916-009-0056-3; Arendt-Nielsen L, 2008, PAIN, V140, P465, DOI 10.1016/j.pain.2008.09.027; Arnold LM, 2004, ARTHRITIS RHEUM-US, V50, P944, DOI 10.1002/art.20042; Bardin L, 2004, EUR J PAIN, V8, P253, DOI 10.1016/j.ejpain.2003.09.002; Bardin L, 2003, PHARMACOLOGY, V67, P182, DOI 10.1159/000068404; BARS DL, 1979, PAIN, V6, P305; Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008; Boettger MK, 2007, EUR J PAIN, V11, P819, DOI 10.1016/j.ejpain.2006.12.004; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; Bouhassira D, 2003, BRAIN, V126, P1068, DOI 10.1093/brain/awg106; Brenner B, 2007, J NEUROCHEM, V102, P206, DOI 10.1111/j.1471-4159.2007.04542.x; Buskila D, 2007, BEST PRACT RES CL RH, V21, P535, DOI 10.1016/j.berh.2007.02.011; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; CHITOUR D, 1982, BRAIN RES, V236, P329, DOI 10.1016/0006-8993(82)90718-1; Christidis N, 2007, CLIN J PAIN, V23, P467, DOI 10.1097/AJP.0b013e318058abb1; Cohen H, 2002, ARTHRITIS RHEUM, V46, P845, DOI 10.1002/art.10103; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Danziger N, 1998, PAIN, V75, P85, DOI 10.1016/S0304-3959(97)00208-X; DICKENSON AH, 1980, BRAIN RES, V200, P293, DOI 10.1016/0006-8993(80)90921-X; DICKENSON AH, 1981, BRAIN RES, V216, P313, DOI 10.1016/0006-8993(81)90133-5; France CR, 2009, PAIN, V145, P211, DOI 10.1016/j.pain.2009.06.022; Goffaux P, 2007, PAIN, V130, P137, DOI 10.1016/j.pain.2006.11.011; Golimbet VE, 2010, MOL BIOL+, V44, P223, DOI 10.1134/S0026893310020068; Holden JE, 2005, NEUROSCIENCE, V135, P1255, DOI 10.1016/j.neuroscience.2005.07.023; Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62; Jensen KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006016; Karg K., 2011, ARCH GEN PSYCHIAT; Kayser V, 2007, PAIN, V130, P235, DOI 10.1016/j.pain.2006.11.015; Kosek E, 2000, PAIN, V88, P69, DOI 10.1016/S0304-3959(00)00310-9; Kosek E, 1997, PAIN, V70, P41, DOI 10.1016/S0304-3959(96)03295-2; Kosek E, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-37; KRAUS E, 1982, BRAIN RES, V231, P461, DOI 10.1016/0006-8993(82)90384-5; LaCroix-Fralish ML, 2009, ANNU REV PHARMACOL, V49, P97, DOI 10.1146/annurev-pharmtox-061008-103222; LANNERSTEN L, 2010, PAIN IN PRESS; Lariviere M, 2007, CLIN J PAIN, V23, P506, DOI 10.1097/AJP.0b013e31806a23e8; Le Bars D, 2002, BRAIN RES REV, V40, P29, DOI 10.1016/S0165-0173(02)00186-8; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Leonard G, 2009, PAIN, V147, P217, DOI 10.1016/j.pain.2009.09.009; LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Marks DM, 2009, CURR NEUROPHARMACOL, V7, P331, DOI 10.2174/157015909790031201; Millan MJ, 1995, BEHAV BRAIN RES, V73, P69; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; MOORE PA, 1979, PAIN, V6, P375, DOI 10.1016/0304-3959(79)90055-1; Nahmias F, 2009, PAIN, V147, P224, DOI 10.1016/j.pain.2009.09.016; NISHIOKA K, 1995, LIFE SCI, V56, P485, DOI 10.1016/0024-3205(94)00477-A; Noskova T, 2008, PROG NEURO-PSYCHOPH, V32, P1735, DOI 10.1016/j.pnpbp.2008.07.012; Nussbaum EL, 1998, PHYS THER, V78, P160, DOI 10.1093/ptj/78.2.160; Offenbaecher M, 1999, ARTHRITIS RHEUM-US, V42, P2482, DOI 10.1002/1529-0131(199911)42:11<2482::AID-ANR27>3.0.CO;2-B; Phillips Ceri J, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P591, DOI 10.1586/14737167.6.5.591; Pinerua-Shuhaibar L, 1999, J AFFECT DISORDERS, V56, P119, DOI 10.1016/S0165-0327(99)00051-8; Potvin S, 2010, EUR J PAIN, V14, P742, DOI 10.1016/j.ejpain.2009.12.004; Price DD, 2003, PAIN, V106, P215, DOI 10.1016/j.pain.2003.10.016; Pud D, 2009, PAIN, V144, P16, DOI 10.1016/j.pain.2009.02.015; Rhudy JL, 2007, PAIN, V128, P244, DOI 10.1016/j.pain.2006.09.024; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; Sandrini G, 2006, CEPHALALGIA, V26, P782, DOI 10.1111/j.1468-2982.2006.01130.x; Sandrini G, 2005, PROG NEUROBIOL, V77, P353, DOI 10.1016/j.pneurobio.2005.11.003; Serretti A, 2006, CURR DRUG TARGETS, V7, P1659, DOI 10.2174/138945006779025419; Simmons AN, 2009, INT J NEUROPSYCHOPH, V12, P1009, DOI 10.1017/S1461145709990149; Skljarevski V, 2002, PAIN, V96, P3, DOI 10.1016/S0304-3959(02)00018-0; Spaeth M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2715; Sur C, 1996, EUR J NEUROSCI, V8, P2753, DOI 10.1111/j.1460-9568.1996.tb01570.x; Szilagyi A, 2006, HEADACHE, V46, P478, DOI 10.1111/j.1526-4610.2006.00379.x; Wei F, 2010, J NEUROSCI, V30, P8624, DOI 10.1523/JNEUROSCI.5389-09.2010; Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789; WILLEIT M, NEUROIMAGE IN PRESS; WILLER JC, 1984, BRAIN, V107, P1095, DOI 10.1093/brain/107.4.1095; WILLER JC, 1989, J NEUROPHYSIOL, V62, P1028, DOI 10.1152/jn.1989.62.5.1028; Yarnitsky D, 2008, PAIN, V138, P22, DOI 10.1016/j.pain.2007.10.033; Yarnitsky D, 2010, EUR J PAIN, V14, P339, DOI 10.1016/j.ejpain.2010.02.004	72	76	78	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18252	10.1371/journal.pone.0018252	http://dx.doi.org/10.1371/journal.pone.0018252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464942	Green Published, gold, Green Submitted			2022-12-27	WOS:000289053800034
J	Liu, XH; Xu, WQ; Russ, J; Eiden, LE; Eiden, MV				Liu, Xiu-Huai; Xu, Wenqin; Russ, Jill; Eiden, Lee E.; Eiden, Maribeth V.			The Host Range of Gammaretroviruses and Gammaretroviral Vectors Includes Post-Mitotic Neural Cells	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; IMMUNODEFICIENCY-VIRUS TYPE-1; MURINE LEUKEMIA-VIRUS; CEREBRAL CORTICAL-NEURONS; PC12 CELLS; NUCLEAR IMPORT; PREINTEGRATION COMPLEX; FLUORESCENT PROTEIN; GENE-THERAPY; RETROVIRUS	Background: Gammaretroviruses and gammaretroviral vectors, in contrast to lentiviruses and lentiviral vectors, are reported to be restricted in their ability to infect growth-arrested cells. The block to this restriction has never been clearly defined. The original assessment of the inability of gammaretroviruses and gammaretroviral vectors to infect growth-arrested cells was carried out using established cell lines that had been growth-arrested by chemical means, and has been generalized to neurons, which are post-mitotic. We re-examined the capability of gammaretroviruses and their derived vectors to efficiently infect terminally differentiated neuroendocrine cells and primary cortical neurons, a target of both experimental and therapeutic interest. Methodology/Principal Findings: Using GFP expression as a marker for infection, we determined that both growth-arrested (NGF-differentiated) rat pheochromocytoma cells (PC12 cells) and primary rat cortical neurons could be efficiently transduced, and maintained long-term protein expression, after exposure to murine leukemia virus (MLV) and MLV-based retroviral vectors. Terminally differentiated PC12 cells transduced with a gammaretroviral vector encoding the antiapoptotic protein Bcl-xL were protected from cell death induced by withdrawal of nerve growth factor (NGF), demonstrating gammaretroviral vector-mediated delivery and expression of genes at levels sufficient for therapeutic effect in non-dividing cells. Post-mitotic rat cortical neurons were also shown to be susceptible to transduction by murine replication-competent gammaretroviruses and gammaretroviral vectors. Conclusions/Significance: These findings suggest that the host range of gammaretroviruses includes post-mitotic and other growth-arrested cells in mammals, and have implications for re-direction of gammaretroviral gene therapy to neurological disease.	[Liu, Xiu-Huai; Eiden, Lee E.] NIMH, Mol Neurosci Sect, Lab Cellular & Mol Regulat, NIH, Bethesda, MD 20892 USA; [Xu, Wenqin; Russ, Jill; Eiden, Maribeth V.] NIMH, Sect Directed Gene Transfer, Lab Cellular & Mol Regulat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Liu, XH (corresponding author), NIMH, Mol Neurosci Sect, Lab Cellular & Mol Regulat, NIH, Bethesda, MD 20892 USA.	eidenm@mail.nih.gov		Eiden, Lee/0000-0001-7524-944X	National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002592, ZIAMH002386] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the National Institute of Mental Health Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Bacsi A, 2005, CELL MOL NEUROBIOL, V25, P1123, DOI 10.1007/s10571-005-8222-6; Blomer U, 1998, P NATL ACAD SCI USA, V95, P2603, DOI 10.1073/pnas.95.5.2603; BOWERMAN B, 1989, GENE DEV, V3, P469, DOI 10.1101/gad.3.4.469; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen J, 2001, VIROLOGY, V282, P186, DOI 10.1006/viro.2001.0826; Depienne C, 2000, EXP CELL RES, V260, P387, DOI 10.1006/excr.2000.5016; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; EZZEDDINE ZD, 1991, NEW BIOL, V3, P608; FARNET CM, 1991, J VIROL, V65, P1910, DOI 10.1128/JVI.65.4.1910-1915.1991; FARNET CM, 1990, P NATL ACAD SCI USA, V87, P4164, DOI 10.1073/pnas.87.11.4164; Galla M, 2004, MOL CELL, V16, P309, DOI 10.1016/j.molcel.2004.09.023; GALLAY P, 1995, CELL, V83, P569, DOI 10.1016/0092-8674(95)90097-7; Goff SP, 2001, J GENE MED, V3, P517, DOI 10.1002/1521-2254(200111)3:6<517::AID-JGM234>3.0.CO;2-E; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Guenechea G, 2000, MOL THER, V1, P566, DOI 10.1006/mthe.2000.0077; Haffar OK, 2000, J MOL BIOL, V299, P359, DOI 10.1006/jmbi.2000.3768; Hahn AT, 2009, CELL CYCLE, V8, P1044, DOI 10.4161/cc.8.7.8042; HAREL J, 1981, VIROLOGY, V110, P202, DOI 10.1016/0042-6822(81)90022-2; Hashimoto R, 2002, J NEUROCHEM, V80, P589, DOI 10.1046/j.0022-3042.2001.00728.x; Hossle JP, 2002, NEWS PHYSIOL SCI, V17, P87, DOI 10.1152/nips.01343.2001; Iordanskiy S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-4; Jarrosson-Wuilleme L, 2006, J VIROL, V80, P1152, DOI 10.1128/JVI.80.3.1152-1159.2006; Kamau SW, 2001, ANTIMICROB AGENTS CH, V45, P3654, DOI 10.1128/AAC.45.12.3654-3656.2001; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; LANDER MR, 1984, J VIROL, V52, P695, DOI 10.1128/JVI.52.2.695-698.1984; Li L, 2000, J VIROL, V74, P10965, DOI 10.1128/JVI.74.23.10965-10974.2000; Liu XH, 2001, J BIOL CHEM, V276, P46326, DOI 10.1074/jbc.M108930200; Logg CR, 2007, J MOL BIOL, V369, P1214, DOI 10.1016/j.jmb.2007.04.026; Logg CR, 2001, J VIROL, V75, P6989, DOI 10.1128/JVI.75.15.6989-6998.2001; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; MESNER PW, 1992, J CELL BIOL, V119, P1669, DOI 10.1083/jcb.119.6.1669; MILLER AD, 1990, HUM GENE THER, V1, P5, DOI 10.1089/hum.1990.1.1-5; MILLER DG, 1990, MOL CELL BIOL, V10, P4239, DOI 10.1128/MCB.10.8.4239; Persengiev SP, 2001, ONCOGENE, V20, P5124, DOI 10.1038/sj.onc.1204663; RAUSCH DM, 1990, CELL MOL NEUROBIOL, V10, P237, DOI 10.1007/BF00734577; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; SPRINGETT GM, 1989, J VIROL, V63, P3865, DOI 10.1128/JVI.63.9.3865-3869.1989; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Thornhill SI, 2008, MOL THER, V16, P590, DOI 10.1038/sj.mt.6300393; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; vanGrunsven LA, 1996, ONCOGENE, V12, P1347; vanGrunsven LA, 1996, ONCOGENE, V12, P855; WILSON CA, 1995, J VIROL, V69, P534, DOI 10.1128/JVI.69.1.534-537.1995; WILSON CA, 1994, J VIROL, V68, P7697, DOI 10.1128/JVI.68.12.7697-7703.1994; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Zhang YZ, 2006, CELL BIOL INT, V30, P777, DOI 10.1016/j.cellbi.2006.05.010	52	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18072	10.1371/journal.pone.0018072	http://dx.doi.org/10.1371/journal.pone.0018072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464894	gold, Green Published, Green Submitted			2022-12-27	WOS:000289053800021
J	Weaver, EA; Rubrum, AM; Webby, RJ; Barry, MA				Weaver, Eric A.; Rubrum, Adam M.; Webby, Richard J.; Barry, Michael A.			Protection against Divergent Influenza H1N1 Virus by a Centralized Influenza Hemagglutinin	PLOS ONE			English	Article							CONSENSUS SEQUENCE; IMMUNE-RESPONSES; AVIAN INFLUENZA; DNA VACCINES; MICE; AIDS; IMMUNOGENICITY; IMMUNIZATION; INTRANASAL; ADAPTATION	Influenza poses a persistent worldwide threat to the human population. As evidenced by the 2009 H1N1 pandemic, current vaccine technologies are unable to respond rapidly to this constantly diverging pathogen. We tested the utility of adenovirus (Ad) vaccines expressing centralized consensus influenza antigens. Ad vaccines were produced within 2 months and protected against influenza in mice within 3 days of vaccination. Ad vaccines were able to protect at doses as low as 10 7 virus particles/kg indicating that approximately 1,000 human doses could be rapidly generated from standard Ad preparations. To generate broadly cross-reactive immune responses, centralized consensus antigens were constructed against H1 influenza and against H1 through H5 influenza. Twenty full-length H1 HA sequences representing the main branches of the H1 HA phylogenetic tree were used to create a synthetic centralized gene, HA1-con. HA1-con minimizes the degree of sequence dissimilarity between the vaccine and existing circulating viruses. The centralized H1 gene, HA1-con, induced stronger immune responses and better protection against mismatched virus challenges as compared to two wildtype H1 genes. HA1-con protected against three genetically diverse lethal influenza challenges. When mice were challenged with 1934 influenza A/PR/8/34, HA1-con protected 100% of mice while vaccine generated from 2009 A/TX/05/09 only protected 40%. Vaccination with 1934 A/PR/8/34 and 2009 A/TX/05/09 protected 60% and 20% against 1947 influenza A/FM/1/47, respectively, whereas 80% of mice vaccinated with HA1-con were protected. Notably, 80% of mice challenged with 2009 swine flu isolate A/California/4/09 were protected by HA1-con vaccination. These data show that HA1-con in Ad has potential as a rapid and universal vaccine for H1N1 influenza viruses.	[Weaver, Eric A.; Barry, Michael A.] Mayo Clin, Dept Internal Med, Div Infect Dis, Rochester, MN 55905 USA; [Rubrum, Adam M.; Webby, Richard J.] St Jude Childrens Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Barry, Michael A.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Translat Immunovirol & Biodef Program, Rochester, MN USA	Mayo Clinic; St Jude Children's Research Hospital; Mayo Clinic; Mayo Clinic; Mayo Clinic	Weaver, EA (corresponding author), Mayo Clin, Dept Internal Med, Div Infect Dis, Rochester, MN 55905 USA.	weaver.eric@mayo.edu	Webby, Richard J/N-5657-2018		US National Institute of Allergy and Infectious Diseases, National Institutes of Health [HHSN266200700005C]	US National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work conducted at St Jude Children's Research Hospital was funded by the US National Institute of Allergy and Infectious Diseases, National Institutes of Health, under Contract No. HHSN266200700005C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casimiro DR, 2003, J VIROL, V77, P7663, DOI 10.1128/JVI.77.13.7663-7668.2003; CDC, 2009, H1N1 FLU VACC WHY DE; CDC, 2009, FIST GLOB EST 2009 H; Chen MW, 2008, P NATL ACAD SCI USA, V105, P13538, DOI 10.1073/pnas.0806901105; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; Ellenberger DL, 2002, VIROLOGY, V302, P155, DOI 10.1006/viro.2002.1577; Ennis FA, 1999, VIROLOGY, V259, P256, DOI 10.1006/viro.1999.9765; Fiers W, 2009, VACCINE, V27, P6280, DOI 10.1016/j.vaccine.2009.07.007; Gao Feng, 2004, Expert Rev Vaccines, V3, pS161, DOI 10.1586/14760584.3.4.S161; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; GITELMAN AK, 1984, VIROLOGY, V134, P230, DOI 10.1016/0042-6822(84)90288-5; Hirota Y, 1997, VACCINE, V15, P962, DOI 10.1016/S0264-410X(96)00302-7; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Kilbourne ED, 2002, P NATL ACAD SCI USA, V99, P10748, DOI 10.1073/pnas.162366899; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Laddy DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002517; Laddy DJ, 2007, VACCINE, V25, P2984, DOI 10.1016/j.vaccine.2007.01.063; Mok H, 2005, MOL THER, V11, P66, DOI 10.1016/j.ymthe.2004.09.015; Muszkat M, 2003, VACCINE, V21, P1180, DOI 10.1016/S0264-410X(02)00481-4; Muszkat M, 2000, VACCINE, V18, P1696, DOI 10.1016/S0264-410X(99)00509-5; Muthumani K, 2008, VACCINE, V26, P5128, DOI 10.1016/j.vaccine.2008.03.060; Nicholson KG, 2003, PEDIATR INFECT DIS J, V22, pS228, DOI 10.1097/01.inf.0000092193.91306.2f; Nickle DC, 2003, SCIENCE, V299, P1515; Novitsky V, 2002, J VIROL, V76, P5435, DOI 10.1128/JVI.76.11.5435-5451.2002; Potter C W, 1977, Dev Biol Stand, V39, P323; Rimmelzwaan GF, 2001, VACCINE, V20, P158, DOI 10.1016/S0264-410X(01)00262-6; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Rimmelzwaan Guus F., 2001, Current Opinion in Pharmacology, V1, P491, DOI 10.1016/S1471-4892(01)00085-6; SCHILD GC, 1983, NATURE, V303, P706, DOI 10.1038/303706a0; Subbarao K, 1999, ADV VIRUS RES, V54, P349, DOI 10.1016/S0065-3527(08)60371-1; Weaver EA, 2006, J VIROL, V80, P6745, DOI 10.1128/JVI.02484-05; Weaver EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005059; WEBSTER RG, 1980, EUR J IMMUNOL, V10, P396, DOI 10.1002/eji.1830100515; World Health Organization, 2009, INFL FACT SHEET; 1998, MMWR MORB MORTAL WKL, V47, P280; 2004, MMWR MORB MORTAL WKL, V53, P547; 2001, MMWR MORB MORTAL WKL, V50, P466; 2003, MMWR MORB MORTAL WKL, V52, P26	40	47	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18314	10.1371/journal.pone.0018314	http://dx.doi.org/10.1371/journal.pone.0018314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464940	Green Published, gold, Green Submitted			2022-12-27	WOS:000289053800040
J	Chou, CW; Wu, MS; Huang, WC; Chen, CC				Chou, Chia-Wei; Wu, Ming-Shiang; Huang, Wei-Chien; Chen, Ching-Chow			HDAC Inhibition Decreases the Expression of EGFR in Colorectal Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; HISTONE DEACETYLASE INHIBITOR; COLON-CANCER; GENE-EXPRESSION; TYROSINE KINASE; LUNG-CANCER; TRANSCRIPTION; SURVIVAL; APOPTOSIS; CETUXIMAB	Epidermal growth factor receptor (EGFR), a receptor tyrosine kinase which promotes cell proliferation and survival, is abnormally overexpressed in numerous tumors of epithelial origin, including colorectal cancer (CRC). EGFR monoclonal antibodies have been shown to increase the median survival and are approved for the treatment of colorectal cancer. Histone deacetylases (HDACs), frequently overexpressed in colorectal cancer and several malignancies, are another attractive targets for cancer therapy. Several inhibitors of HDACs (HDACi) are developed and exhibit powerful antitumor abilities. In this study, human colorectal cancer cells treated with HDACi exhibited reduced EGFR expression, thereby disturbed EGF-induced ERK and Akt phosphorylation. HDACi also decreased the expression of SGLT1, an active glucose transporter found to be stabilized by EGFR, and suppressed the glucose uptake of cancer cells. HDACi suppressed the transcription of EGFR and class I HDACs were proved to be involved in this event. Chromatin immunoprecipitation analysis showed that HDACi caused the dissociation of SP1, HDAC3 and CBP from EGFR promoter. Our data suggested that HDACi could serve as a single agent to block both EGFR and HDAC, and may bring more benefits to the development of CRC therapy.	[Chou, Chia-Wei; Chen, Ching-Chow] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei 10764, Taiwan; [Wu, Ming-Shiang] Natl Taiwan Univ, Coll Med, Dept Internal Med & Primary Care Med, Div Gastroenterol, Taipei 10764, Taiwan; [Wu, Ming-Shiang] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Huang, Wei-Chien] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Huang, Wei-Chien] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chou, CW (corresponding author), Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei 10764, Taiwan.	chingchowchen@ntu.edu.tw	Huang, Wei-Chien/D-1740-2012; Huang, Wei-Chien/H-3126-2019	Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716; Wu, Ming-Shiang/0000-0002-1940-6428; CHEN, CHING-CHOW/0000-0002-7810-0939	National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a research grant from National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Banck MS, 2009, CLIN CANCER RES, V15, P7492, DOI 10.1158/1078-0432.CCR-09-0188; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; BLAIS A, 1991, AM J PHYSIOL, V260, pC1245, DOI 10.1152/ajpcell.1991.260.6.C1245; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brandt B, 2006, CLIN CANCER RES, V12, P7252, DOI 10.1158/1078-0432.CCR-06-0626; Casneuf VF, 2008, CANCER INVEST, V26, P852, DOI 10.1080/07357900801956363; Chen CJ, 2008, EUR J PHARMACOL, V591, P36, DOI 10.1016/j.ejphar.2008.06.041; Chou CW, 2008, FEBS LETT, V582, P4059, DOI 10.1016/j.febslet.2008.10.048; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Engelman JA, 2008, CANCER CELL, V13, P375, DOI 10.1016/j.ccr.2008.04.008; Ewald JA, 2003, EXP CELL RES, V282, P121, DOI 10.1016/S0014-4827(02)00014-9; Fakih MG, 2009, CLIN CANCER RES, V15, P3189, DOI 10.1158/1078-0432.CCR-08-2999; Fazzone W, 2009, INT J CANCER, V125, P463, DOI 10.1002/ijc.24403; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Harari PM, 2004, INT J RADIAT ONCOL, V58, P976, DOI 10.1016/j.ijrobp.2003.09.097; Heerdt BG, 1997, CELL GROWTH DIFFER, V8, P523; Helmke BM, 2004, ORAL ONCOL, V40, P28, DOI 10.1016/S1368-8375(03)00129-5; Ishikawa N, 2001, JPN J CANCER RES, V92, P874, DOI 10.1111/j.1349-7006.2001.tb01175.x; Jepsen K, 2002, J CELL SCI, V115, P689; Johnson AC, 2000, MOL MED, V6, P17, DOI 10.1007/BF03401931; KAGEYAMA R, 1988, J BIOL CHEM, V263, P6329; Kobayashi H, 2003, NUTR CANCER, V46, P202, DOI 10.1207/S15327914NC4602_14; Koshiji M, 2005, MOL CELL, V17, P793, DOI 10.1016/j.molcel.2005.02.015; Lai CJ, 2010, CANCER RES, V70, P3647, DOI 10.1158/0008-5472.CAN-09-3360; Lin YC, 2008, CANCER RES, V68, P2375, DOI 10.1158/0008-5472.CAN-07-5807; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; MAHRAOUI L, 1994, BIOCHEM J, V298, P629, DOI 10.1042/bj2980629; Mariadason JM, 2008, EPIGENETICS-US, V3, P28, DOI 10.4161/epi.3.1.5736; Levy EM, 2009, INNATE IMMUN-LONDON, V15, P91, DOI 10.1177/1753425908101404; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Ritter CA, 2003, SEMIN ONCOL, V30, P3, DOI 10.1053/sonc.2003.50027; Rossig L, 2002, CIRC RES, V91, P837, DOI 10.1161/01.RES.0000037983.07158.B1; Sasakawa Y, 2003, BIOCHEM PHARMACOL, V66, P897, DOI 10.1016/S0006-2952(03)00411-8; Schwartz B, 1998, MOL CELL BIOCHEM, V188, P21, DOI 10.1023/A:1006831330340; Tong X, 2004, BIOCHEM BIOPH RES CO, V317, P463, DOI 10.1016/j.bbrc.2004.03.066; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Waby JS, 2008, CURR GENOMICS, V9, P301, DOI 10.2174/138920208785133244; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; WILSON PM, 2010, CANCER CHEMOTH PHARM, P979; Xu WS, 2005, CANCER RES, V65, P7832, DOI 10.1158/0008-5472.CAN-04-4608; Yu CR, 2007, CLIN CANCER RES, V13, P1140, DOI 10.1158/1078-0432.CCR-06-1751; Yu XD, 2007, CANCER J, V13, P105, DOI 10.1097/PPO.0b013e318046eedc; Zhou Q, 2009, BREAST CANCER RES TR, V117, P443, DOI 10.1007/s10549-008-0148-5	51	79	83	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18087	10.1371/journal.pone.0018087	http://dx.doi.org/10.1371/journal.pone.0018087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464950	Green Published, gold, Green Submitted			2022-12-27	WOS:000288813900037
J	Inderbitzin, P; Davis, RM; Bostock, RM; Subbarao, KV				Inderbitzin, Patrik; Davis, R. Michael; Bostock, Richard M.; Subbarao, Krishna V.			The Ascomycete Verticillium longisporum Is a Hybrid and a Plant Pathogen with an Expanded Host Range	PLOS ONE			English	Article							VEGETATIVE COMPATIBILITY GROUPS; INTERSPECIFIC HYBRIDIZATION; FUNGAL ENDOPHYTES; ALBO-ATRUM; VERTICAL TRANSMISSION; NATURAL HYBRID; V-LONGISPORUM; OILSEED RAPE; MATING-TYPE; DNA-CONTENT	Hybridization plays a central role in plant evolution, but its overall importance in fungi is unknown. New plant pathogens are thought to arise by hybridization between formerly separated fungal species. Evolution of hybrid plant pathogens from non-pathogenic ancestors in the fungal-like protist Phytophthora has been demonstrated, but in fungi, the most important group of plant pathogens, there are few well-characterized examples of hybrids. We focused our attention on the hybrid and plant pathogen Verticillium longisporum, the causal agent of the Verticillium wilt disease in crucifer crops. In order to address questions related to the evolutionary origin of V. longisporum, we used phylogenetic analyses of seven nuclear loci and a dataset of 203 isolates of V. longisporum, V. dahliae and related species. We confirmed that V. longisporum was diploid, and originated three different times, involving four different lineages and three different parental species. All hybrids shared a common parent, species A1, that hybridized respectively with species D1, V. dahliae lineage D2 and V. dahliae lineage D3, to give rise to three different lineages of V. longisporum. Species A1 and species D1 constituted as yet unknown taxa. Verticillium longisporum likely originated recently, as each V. longisporum lineage was genetically homogenous, and comprised species A1 alleles that were identical across lineages.	[Inderbitzin, Patrik; Davis, R. Michael; Bostock, Richard M.; Subbarao, Krishna V.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	University of California System; University of California Davis	Inderbitzin, P (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	kvsubbarao@ucdavis.edu	Subbarao, Krishna/X-3870-2019	Subbarao, Krishna/0000-0002-2075-1835	California Leafy Greens Board, United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) [2007-51100-03846]; Hatch funds [CA-D*-PPA-5681-H]	California Leafy Greens Board, United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA); Hatch funds	Financial support was provided by the California Leafy Greens Board (2008-10, 2008-11, 2009-10, and 2009-11), United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) (2007-51100-03846), and the Hatch funds allocated to University of California Agricultural Experiment Station Project CA-D*-PPA-5681-H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babadoost M, 2004, PLANT PATHOL, V53, P669, DOI 10.1111/j.1365-3059.2004.01070.x; Barbara DJ, 2003, MOL PLANT PATHOL, V4, P297, DOI 10.1046/J.1364-3703.2003.00172.X; Beser J, 2007, J CLIN MICROBIOL, V45, P881, DOI 10.1128/JCM.02245-06; Bhat RG, 1999, PHYTOPATHOLOGY, V89, P1218, DOI 10.1094/PHYTO.1999.89.12.1218; Brady B.L., 2002, VERTICILLIUM WILTS, P552; Brasier C, 2000, NATURE, V405, P134, DOI 10.1038/35012193; Brasier CM, 1999, P NATL ACAD SCI USA, V96, P5878, DOI 10.1073/pnas.96.10.5878; Brasier CM, 1998, MYCOL RES, V102, P45, DOI 10.1017/S0953756297004541; Brasier CM, 2001, BIOSCIENCE, V51, P123, DOI 10.1641/0006-3568(2001)051[0123:REOIPP]2.0.CO;2; CHRISTEN AA, 1979, PHYTOPATHOLOGY, V69, P263, DOI 10.1094/Phyto-69-263; CLARKSON JM, 1985, PLANT PATHOL, V34, P129, DOI 10.1111/j.1365-3059.1985.tb02769.x; Clewes E, 2008, PLANT PATHOL, V57, P1047, DOI 10.1111/j.1365-3059.2008.01897.x; Clewes E, 2008, NEW PHYTOL, V177, P583, DOI 10.1111/j.1469-8137.2007.02327.x; Collado-Romero M, 2008, PHYTOPATHOLOGY, V98, P1019, DOI 10.1094/PHYTO-98-9-1019; Collado-Romero M, 2010, FUNGAL BIOL-UK, V114, P209, DOI 10.1016/j.funbio.2009.12.005; Collins A, 2003, PHYTOPATHOLOGY, V93, P364, DOI 10.1094/PHYTO.2003.93.3.364; Eynck C, 2007, EUR J PLANT PATHOL, V118, P259, DOI 10.1007/s10658-007-9144-6; Flor HH, 1932, J AGRIC RES, V44, P0049; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gonthier P, 2007, MOL ECOL, V16, P1389, DOI 10.1111/j.1365-294X.2007.03250.x; HASTIE AC, 1964, GENET RES, V5, P305, DOI 10.1017/S0016672300001245; HASTIE AC, 1973, T BRIT MYCOL SOC, V60, P511, DOI 10.1016/S0007-1536(73)80035-X; HEAL J, 2000, P ARISTOTELIAN SOC S, P1; Heale JB, 1999, CAN J PLANT PATHOL, V21, P1; Hegarty MJ, 2005, NEW PHYTOL, V165, P411, DOI 10.1111/j.1469-8137.2004.01253.x; Hernandez-Bello MA, 2006, PHYTOPATHOLOGY, V96, P1148, DOI 10.1094/PHYTO-96-1148; HORIUCHI S, 1990, BIOLOGICAL CONTROL OF SOIL-BORNE PLANT PATHOGENS, P285; INGRAM R, 1968, T BRIT MYCOL SOC, V51, P339, DOI 10.1016/S0007-1536(68)80073-7; JACKSON CW, 1985, J GEN MICROBIOL, V131, P3229; Johansson A, 2006, EUR J PLANT PATHOL, V114, P139, DOI 10.1007/s10658-005-2333-2; Joly DL, 2006, PLANT DIS, V90, P1552, DOI 10.1094/PD-90-1552A; Karapapa VK, 1997, MYCOL RES, V101, P1281, DOI 10.1017/S0953756297003985; Kauserud H, 2007, MOL ECOL, V16, P389, DOI 10.1111/j.1365-294X.2006.03129.x; Lin X, 2007, PLOS GENET, V3, P1975, DOI 10.1371/journal.pgen.0030186; Ma XF, 2008, ANN BOT-LONDON, V101, P825, DOI 10.1093/aob/mcm331; MANINTVELD WA, 2006, EUR J PLANT PATHOL, V117, P25; Masneuf I, 1998, APPL ENVIRON MICROB, V64, P3887; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; Moon CD, 2004, MOL ECOL, V13, P1455, DOI 10.1111/j.1365-294X.2004.02138.x; Moon CD, 2002, MYCOLOGIA, V94, P694, DOI 10.2307/3761720; Moon CD, 2007, MYCOLOGIA, V99, P895, DOI 10.3852/mycologia.99.6.895; Morin L, 2009, MYCOL RES, V113, P725, DOI 10.1016/j.mycres.2009.02.008; Newcombe G, 2000, MYCOL RES, V104, P261, DOI 10.1017/S0953756299001665; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; O'Donnell K, 1998, MYCOLOGIA, V90, P465, DOI 10.2307/3761407; Oliver SG., 1981, FUNGAL NUCLEUS, P191; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Pantou MP, 2005, MYCOL RES, V109, P889, DOI 10.1017/S0953756205003345; Pantou MP, 2005, FEMS MICROBIOL LETT, V245, P213, DOI 10.1016/j.femsle.2005.03.011; Paun O, 2007, TAXON, V56, P649, DOI 10.2307/25065850; Pethybridge GH., 1919, T BRIT MYCOL SOC, V6, P104; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PUHALLA JE, 1983, PHYTOPATHOLOGY, V73, P1305, DOI 10.1094/Phyto-73-1305; Qin QM, 2006, PHYTOPATHOLOGY, V96, P582, DOI 10.1094/PHYTO-96-0582; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAMBROOK J, MOLECULAR CLONING; Schardl CL, 2003, MOL ECOL, V12, P2861, DOI 10.1046/j.1365-294X.2003.01965.x; Selosse MA, 2007, NEW PHYTOL, V173, P452, DOI 10.1111/j.1469-8137.2007.01978.x; SOLTIS DE, 1993, CRIT REV PLANT SCI, V12, P243, DOI 10.1080/713608048; SPIERS AG, 1994, MYCOL RES, V98, P889, DOI 10.1016/S0953-7562(09)80260-8; Staats M, 2005, MOL BIOL EVOL, V22, P333, DOI 10.1093/molbev/msi020; STARK C., 1961, Gartenbauwissenschaft, V26, P493; Steventon LA, 2002, MYCOL RES, V106, P570, DOI 10.1017/S0953756202005865; SUBBARAO KV, 1995, PHYTOPATHOLOGY, V85, P1105, DOI 10.1094/Phyto-85-1105; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taylor JW, 1999, CLIN MICROBIOL REV, V12, P126, DOI 10.1128/CMR.12.1.126; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; TSAI HF, 1994, P NATL ACAD SCI USA, V91, P2542, DOI 10.1073/pnas.91.7.2542; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; TYPAS MA, 1980, J GEN MICROBIOL, V121, P231; Usami T, 2008, J GEN PLANT PATHOL, V74, P61, DOI 10.1007/s10327-007-0043-7; Usami T, 2009, J GEN PLANT PATHOL, V75, P422, DOI 10.1007/s10327-009-0197-6; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zeise K, 2002, J PHYTOPATHOL, V150, P112, DOI 10.1046/j.1439-0434.2002.00730.x; Zeise K, 2002, J PHYTOPATHOL, V150, P557, DOI 10.1046/j.1439-0434.2002.00799.x; ZOLAN ME, 1995, MICROBIOL REV, V59, P686, DOI 10.1128/MMBR.59.4.686-698.1995	76	114	118	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18260	10.1371/journal.pone.0018260	http://dx.doi.org/10.1371/journal.pone.0018260			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455321	Green Published, Green Submitted, gold			2022-12-27	WOS:000288811500034
J	Silver, J; Mei, YF				Silver, Jim; Mei, Ya-Fang			Transduction and Oncolytic Profile of a Potent Replication-Competent Adenovirus 11p Vector (RCAd11pGFP) in Colon Carcinoma Cells	PLOS ONE			English	Article							GENE-TRANSFER VECTOR; CARCINOEMBRYONIC ANTIGEN; NUCLEOTIDE-SEQUENCE; COLORECTAL-CANCER; CELLULAR RECEPTOR; CD46 RECEPTOR; THERAPY; VIRUS; EXPRESSION; SEROTYPE-3	Replication-competent adenovirus type 5 (Ad5) vectors promise to be more efficient gene delivery vehicles than their replication-deficient counterparts, and chimeric Ad5 vectors that are capable of targeting CD46 are more effective than Ad5 vectors with native fibers. Although several strategies have been used to improve gene transduction and oncolysis, either by modifying their tropism or enhancing their replication capacity, some tumor cells are still relatively refractory to infection by chimeric Ad5. The oncolytic effects of the vectors are apparent in certain tumors but not in others. Here, we report the biological and oncolytic profiles of a replication-competent adenovirus 11p vector (RCAd11pGFP) in colon carcinoma cells. CD46 was abundantly expressed in all cells studied; however, the transduction efficiency of RCAd11pGFP varied. RCAd11pGFP efficiently transduced HT-29, HCT-8, and LS174T cells, but it transduced T84 cells, derived from a colon cancer metastasis in the lung, less efficiently. Interestingly, RCAd11p replicated more rapidly in the T84 cells than in HCT-8 and LS174T cells and as rapidly as in HT-29 cells. Cell toxicity and proliferation assays indicated that RCAd11pGFP had the highest cell-killing activities in HT29 and T84 cells, the latter of which also expressed the highest levels of glycoproteins of the carcinoma embryonic antigen (CEA) family. In vivo experiments showed significant growth inhibition of T84 and HT-29 tumors in xenograft mice treated with either RCAd11pGFP or Ad11pwt compared to untreated controls. Thus, RCAd11pGFP has a potent cytotoxic effect on colon carcinoma cells.	[Silver, Jim; Mei, Ya-Fang] Umea Univ, Dept Clin Microbiol Virol, Umea, Sweden	Umea University	Silver, J (corresponding author), Umea Univ, Dept Clin Microbiol Virol, Umea, Sweden.	mei.ya-fang@climi.umu.se			Swedish Society of Medicine [2006-18791]; Cancer Research Foundation in Northern Sweden [AMP 08-571, AMP 08-6009, AMP 09-637]; Lion's Cancer Research Foundation at Umea University, Magn [LP 10-1855]; Umea University	Swedish Society of Medicine; Cancer Research Foundation in Northern Sweden; Lion's Cancer Research Foundation at Umea University, Magn; Umea University	This work was supported by a Swedish Society of Medicine grant 2006-18791 (Dr. YF Mei); Cancer Research Foundation in Northern Sweden: grants AMP 08-571 (Dr. YF Mei), AMP 08-6009 (Dr. YF Mei), AMP 09-637(Dr. YF Mei); Lion's Cancer Research Foundation at Umea University, grant LP 10-1855 (Dr. YF Mei); Magn. Bergvalls Stifitelse 2008 (Dr. YF Mei); and by Umea University, Medical Faculty's Insamligsstifteser grant 2009 and 2010 (Dr. YF Mei). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BD, 2004, CANCER RES, V64, P4919, DOI 10.1158/0008-5472.CAN-04-0884; Bakalakos EA, 1999, AM J SURG, V177, P2, DOI 10.1016/S0002-9610(98)00303-1; Blumenthal RD, 2005, CANCER RES, V65, P8809, DOI 10.1158/0008-5472.CAN-05-0420; Brouwer E, 2007, CANCER GENE THER, V14, P211, DOI 10.1038/sj.cgt.7701010; CAWKWELL L, 1994, BRIT J CANCER, V70, P813, DOI 10.1038/bjc.1994.404; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Chung-Faye GA, 2000, BRIT MED J, V321, P1397, DOI 10.1136/bmj.321.7273.1397; Douglas JT, 1999, NAT BIOTECHNOL, V17, P470, DOI 10.1038/8647; Fleischli C, 2007, J GEN VIROL, V88, P2925, DOI 10.1099/vir.0.83142-0; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hoffmann D, 2006, MOL CANCER THER, V5, P374, DOI 10.1158/1535-7163.MCT-05-0374; Holterman L, 2004, J VIROL, V78, P13207, DOI 10.1128/JVI.78.23.13207-13215.2004; Huarte E, 2006, MOL THER, V14, P129, DOI 10.1016/j.ymthe.2006.02.015; Kawakami Y, 2003, CANCER RES, V63, P1262; Kim M, 2003, BRIT J CANCER, V88, P1411, DOI 10.1038/sj.bjc.6600932; Mei YF, 2002, VIROLOGY, V295, P30, DOI 10.1006/viro.2002.1359; MEI YF, 1993, VIROLOGY, V194, P453, DOI 10.1006/viro.1993.1284; Mel YF, 1998, VIROLOGY, V240, P254, DOI 10.1006/viro.1997.8904; Nemerow GR, 1999, MICROBIOL MOL BIOL R, V63, P725, DOI 10.1128/MMBR.63.3.725-734.1999; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rea D, 2001, J IMMUNOL, V166, P5236, DOI 10.4049/jimmunol.166.8.5236; Sandberg L, 2009, HUM GENE THER, V20, P361, DOI 10.1089/hum.2007.124; Segerman A, 2003, J VIROL, V77, P9183, DOI 10.1128/JVI.77.17.9183-9191.2003; Segerman A, 2003, J VIROL, V77, P1157, DOI 10.1128/JVI.77.2.1157-1162.2003; Short JJ, 2006, VIRUS RES, V122, P144, DOI 10.1016/j.virusres.2006.07.009; Sirena D, 2005, VIROLOGY, V343, P283, DOI 10.1016/j.virol.2005.08.024; Skog J, 2002, J GEN VIROL, V83, P1299, DOI 10.1099/0022-1317-83-6-1299; Stevenson SC, 1997, J VIROL, V71, P4782, DOI 10.1128/JVI.71.6.4782-4790.1997; Stone D, 2005, J VIROL, V79, P5090, DOI 10.1128/JVI.79.8.5090-5104.2005; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Tomlinson I, 1997, CANCER METAST REV, V16, P67, DOI 10.1023/A:1005744323215; VELCICH A, 1995, CELL GROWTH DIFFER, V6, P749; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; Wang J, 1998, MOL MICROBIOL, V30, P657, DOI 10.1046/j.1365-2958.1998.01102.x; Wang YH, 2009, J CLIN INVEST, V119, P1604, DOI 10.1172/JCI37905; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wildner O, 1999, CANCER RES, V59, P410; Wilson JM, 1996, NEW ENGL J MED, V334, P1185, DOI 10.1056/NEJM199605023341809; Zwacka RM, 1998, HEMATOL ONCOL CLIN N, V12, P595, DOI 10.1016/S0889-8588(05)70010-1	42	11	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17532	10.1371/journal.pone.0017532	http://dx.doi.org/10.1371/journal.pone.0017532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455297	Green Published, gold, Green Submitted			2022-12-27	WOS:000288811500005
J	Delvenne, JF; Castronovo, J; Demeyere, N; Humphreys, GW				Delvenne, Jean-Francois; Castronovo, Julie; Demeyere, Nele; Humphreys, Glyn W.			Bilateral Field Advantage in Visual Enumeration	PLOS ONE			English	Article							MAGIC NUMBER 4; INTERHEMISPHERIC INTERACTION; NEUROPSYCHOLOGICAL EVIDENCE; HEMISPHERES; CAPACITY; SYSTEMS; SPECIALIZATION; INFORMATION; INTEGRATION; HEMIFIELDS	A number of recent studies have demonstrated superior visual processing when the information is distributed across the left and right visual fields than if the information is presented in a single hemifield (the bilateral field advantage). This effect is thought to reflect independent attentional resources in the two hemifields and the capacity of the neural responses to the left and right hemifields to process visual information in parallel. Here, we examined whether a bilateral field advantage can also be observed in a high-level visual task that requires the information from both hemifields to be combined. To this end, we used a visual enumeration task-a task that requires the assimilation of separate visual items into a single quantity-where the to-be-enumerated items were either presented in one hemifield or distributed between the two visual fields. We found that enumerating large number (> 4 items), but not small number (< 4 items), exhibited the bilateral field advantage: enumeration was more accurate when the visual items were split between the left and right hemifields than when they were all presented within the same hemifield. Control experiments further showed that this effect could not be attributed to a horizontal alignment advantage of the items in the visual field, or to a retinal stimulation difference between the unilateral and bilateral displays. These results suggest that a bilateral field advantage can arise when the visual task involves inter-hemispheric integration. This is in line with previous research and theory indicating that, when the visual task is attentionally demanding, parallel processing by the neural responses to the left and right hemifields can expand the capacity of visual information processing.	[Delvenne, Jean-Francois; Castronovo, Julie] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England; [Castronovo, Julie] Univ Louvain, Louvain, Belgium; [Demeyere, Nele; Humphreys, Glyn W.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England	University of Leeds; University of Birmingham	Delvenne, JF (corresponding author), Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England.	j.f.delvenne@leeds.ac.uk	Delvenne, Jean-Francois/B-4646-2008; Demeyere, Nele/G-3974-2015	Delvenne, Jean-Francois/0000-0002-1990-9738; Demeyere, Nele/0000-0003-0416-5147	Belgian National Fund for Scientific Research	Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS)	This research was supported by the Belgian National Fund for Scientific Research (www.frs-fnrs.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Alvarez GA, 2005, PSYCHOL SCI, V16, P637, DOI 10.1111/j.1467-9280.2005.01587.x; ATKINSON J, 1976, PERCEPTION, V5, P335, DOI 10.1068/p050335; BANICH MT, 1990, CORTEX, V26, P77, DOI 10.1016/S0010-9452(13)80076-7; Banich MT, 1998, BRAIN COGNITION, V36, P128, DOI 10.1006/brcg.1997.0950; BELGER A, 1992, NEUROPSYCHOLOGIA, V30, P923, DOI 10.1016/0028-3932(92)90036-L; Castronovo J, 2007, J EXP PSYCHOL HUMAN, V33, P1089, DOI 10.1037/0096-1523.33.5.1089; Colvin MK, 2005, BRAIN COGNITION, V57, P43, DOI 10.1016/j.bandc.2004.08.019; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; DEHAENE S, 1994, J EXP PSYCHOL HUMAN, V20, P958, DOI 10.1037/0096-1523.20.5.958; Delvenne JF, 2005, COGNITION, V96, pB79, DOI 10.1016/j.cognition.2004.12.007; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; FRIEDMAN A, 1981, J EXP PSYCHOL HUMAN, V7, P1031, DOI 10.1037/0096-1523.7.5.1031; Humphreys GW, 2000, VISION RES, V40, P1569, DOI 10.1016/S0042-6989(00)00042-0; Jackson N, 2004, LATERALITY, V9, P53, DOI 10.1080/13576500244000256; KAUFMAN EL, 1949, AM J PSYCHOL, V62, P498, DOI 10.2307/1418556; Kimura D, 1966, NEUROPSYCHOLOGIA, V16, P593; Large ME, 2008, EUR J NEUROSCI, V27, P3299, DOI 10.1111/j.1460-9568.2008.06270.x; LUCK SJ, 1989, NATURE, V342, P543, DOI 10.1038/342543a0; Murray MM, 2001, NEUROPSYCHOLOGIA, V39, P828, DOI 10.1016/S0028-3932(01)00004-5; MYERS RE, 1958, ARCH NEURO PSYCHIATR, V80, P298, DOI 10.1001/archneurpsyc.1958.02340090034004; Pasini M, 2001, PSYCHOL RES-PSYCH FO, V65, P57, DOI 10.1007/s004260000036; Piazza M, 2002, NEUROIMAGE, V15, P435, DOI 10.1006/nimg.2001.0980; Pillow J, 2002, NEURON, V33, P805, DOI 10.1016/S0896-6273(02)00605-0; Ratinckx E, 2001, NEUROPSYCHOLOGIA, V39, P335, DOI 10.1016/S0028-3932(00)00143-3; Ratinckx E, 2007, CORTEX, V43, P207, DOI 10.1016/S0010-9452(08)70476-3; Reardon KM, 2009, VISION RES, V49, P691, DOI 10.1016/j.visres.2009.01.005; Reynvoet B, 2004, NEUROPSYCHOLOGIA, V42, P713, DOI 10.1016/j.neuropsychologia.2003.11.013; Reynvoet B, 2008, CORTEX, V44, P728, DOI 10.1016/j.cortex.2007.12.005; Sathian K, 1999, J COGNITIVE NEUROSCI, V11, P36, DOI 10.1162/089892999563238; Scalf PE, 2007, J EXP PSYCHOL HUMAN, V33, P298, DOI 10.1037/0096-1523.33.2.298; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; Watson DG, 2006, PERCEPT PSYCHOPHYS, V68, P319, DOI 10.3758/BF03193679; Watson DG, 1999, COGNITIVE NEUROPSYCH, V16, P609, DOI 10.1080/026432999380663; Weissman DH, 2000, NEUROPSYCHOLOGY, V14, P41, DOI 10.1037/0894-4105.14.1.41; Whalen J, 1999, PSYCHOL SCI, V10, P130, DOI 10.1111/1467-9280.00120	38	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17743	10.1371/journal.pone.0017743	http://dx.doi.org/10.1371/journal.pone.0017743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	740QW	21448271	Green Published, gold			2022-12-27	WOS:000288810500011
J	Krefis, AC; Schwarz, NG; Nkrumah, B; Acquah, S; Loag, W; Oldeland, J; Sarpong, N; Adu-Sarkodie, Y; Ranft, U; May, J				Krefis, Anne Caroline; Schwarz, Norbert Georg; Nkrumah, Bernard; Acquah, Samuel; Loag, Wibke; Oldeland, Jens; Sarpong, Nimako; Adu-Sarkodie, Yaw; Ranft, Ulrich; May, Juergen			Spatial Analysis of Land Cover Determinants of Malaria Incidence in the Ashanti Region, Ghana	PLOS ONE			English	Article							WESTERN KENYAN HIGHLANDS; ANOPHELES-ARABIENSIS; SATELLITE IMAGERY; ENVIRONMENTAL-CHANGE; LARVAL HABITATS; RAIN-FOREST; CHILDREN; RISK; AREA; TRANSMISSION	Malaria belongs to the infectious diseases with the highest morbidity and mortality worldwide. As a vector-borne disease malaria distribution is strongly influenced by environmental factors. The aim of this study was to investigate the association between malaria risk and different land cover classes by using high-resolution multispectral Ikonos images and Poisson regression analyses. The association of malaria incidence with land cover around 12 villages in the Ashanti Region, Ghana, was assessed in 1,988 children < 15 years of age. The median malaria incidence was 85.7 per 1,000 inhabitants and year (range 28.4-272.7). Swampy areas and banana/plantain production in the proximity of villages were strong predictors of a high malaria incidence. An increase of 10% of swampy area coverage in the 2 km radius around a village led to a 43% higher incidence (relative risk [RR] = 1.43, p < 0.001). Each 10% increase of area with banana/plantain production around a village tripled the risk for malaria (RR = 3.25, p < 0.001). An increase in forested area of 10% was associated with a 47% decrease of malaria incidence (RR = 0.53, p = 0.029). Distinct cultivation in the proximity of homesteads was associated with childhood malaria in a rural area in Ghana. The analyses demonstrate the usefulness of satellite images for the prediction of malaria endemicity. Thus, planning and monitoring of malaria control measures should be assisted by models based on geographic information systems.	[Krefis, Anne Caroline; Schwarz, Norbert Georg; Loag, Wibke; May, Juergen] Bernhard Nocht Inst Trop Med, Hamburg, Germany; [Ranft, Ulrich] Univ Dusseldorf, IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Nkrumah, Bernard; Acquah, Samuel; Sarpong, Nimako] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Adu-Sarkodie, Yaw] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; [Oldeland, Jens] Univ Hamburg, Bioctr Klein Flottbek, Hamburg, Germany; [Oldeland, Jens] Univ Hamburg, Bot Garden, Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; University of Hamburg; University of Hamburg	Krefis, AC (corresponding author), Bernhard Nocht Inst Trop Med, Hamburg, Germany.	krefis@bni-hamburg.de	Oldeland, Jens/A-1587-2012; May, Jürgen/E-7857-2011; Schwarz, Norbert G/C-8797-2012	Schwarz, Norbert G/0000-0002-8387-2837; Oldeland, Jens/0000-0002-7833-4903; May, Jurgen/0000-0001-7831-8420; Acquah, Samuel/0000-0002-3896-2665	Swiss Foundation	Swiss Foundation(Swiss National Science Foundation (SNSF))	This work was supported by a Swiss Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2007, AM J TROP MED HYG, V77, P660, DOI 10.4269/ajtmh.2007.77.660; Anosike JC, 2007, ANN AGR ENV MED, V14, P31; BECK LR, 1994, AM J TROP MED HYG, V51, P271, DOI 10.4269/ajtmh.1994.51.271; Bogh C, 2007, AM J TROP MED HYG, V76, P875; Brooker S, 2004, TROP MED INT HEALTH, V9, P757, DOI 10.1111/j.1365-3156.2004.01272.x; Browne ENL, 2000, ANN TROP MED PARASIT, V94, P15, DOI 10.1080/00034980057572; CABRERA B D, 1978, Southeast Asian Journal of Tropical Medicine and Public Health, V9, P398; De Jong S. M., 2004, REMOTE SENSING IMAGE; de Souza D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009927; de-Graft Aikins Ama, 2007, Ghana Med J, V41, P154; Edillo FE, 2002, J MED ENTOMOL, V39, P70, DOI 10.1603/0022-2585-39.1.70; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hay SI, 1997, INT J REMOTE SENS, V18, P2899, DOI 10.1080/014311697217125; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Hopkins GHE, 1952, MOSQUITOES ETHIOPIAN, V2nd; Kalyani S., 2010, INT J ENG SCI TECH, V2, P175, DOI DOI 10.4314/IJEST.V2I3.59189; KERR J. A., 1933, BULL ENT RES [LONDON], V24, P493, DOI 10.1017/S0007485300035458; Krefis AC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-201; Krefis AC, 2011, AM J TROP MED HYG, V84, P285, DOI 10.4269/ajtmh.2011.10-0381; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Kulkarni MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009396; Lawrence R, 2006, PHOTOGRAMM ENG REM S, V72, P169, DOI 10.14358/PERS.72.2.169; Leonardo L. R., 2005, Parassitologia (Rome), V47, P105; Marks F, 2010, EMERG INFECT DIS, V16, P1796, DOI 10.3201/eid1611.100388; Minakawa N, 2002, J MED ENTOMOL, V39, P833, DOI 10.1603/0022-2585-39.6.833; Minakawa N, 2005, AM J TROP MED HYG, V73, P157, DOI 10.4269/ajtmh.2005.73.157; Munga S, 2006, AM J TROP MED HYG, V74, P69, DOI 10.4269/ajtmh.2006.74.69; Mushinzimana E, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-13; Nihei N, 2002, JPN J INFECT DIS, V55, P160; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Peterson I, 2009, AM J TROP MED HYG, V80, P103, DOI 10.4269/ajtmh.2009.80.103; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Roberts DR, 1996, AM J TROP MED HYG, V54, P304, DOI 10.4269/ajtmh.1996.54.304; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Russell P. F., 1934, American Journal of Tropical Medicine, V14, P139; RUSSELL PAUL F., 1934, AMER JOUR TROP MED, V14, P407; Sharma V. P., 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P834; Shililu J, 2003, J MED ENTOMOL, V40, P921, DOI 10.1603/0022-2585-40.6.921; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P181, DOI 10.1016/0035-9203(85)90329-3; Uguru NP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-7; WARREL DA, 2002, ESSENTIAL MALARIOLOG; *WHO, 2009, WHO WORLD MALARIA RE; *WHO, 1982, MANUAL ENV MANAGEMEN, V66; WIE W, 2008, ISPRS, V37, P667; Ye-Ebiyo Y, 2000, AM J TROP MED HYG, V63, P90, DOI 10.4269/ajtmh.2000.63.90; 2002, HI STAR HLTH IMPROVE; 2010, INFORM ALL DISTRICTS	47	21	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17905	10.1371/journal.pone.0017905	http://dx.doi.org/10.1371/journal.pone.0017905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448277	gold, Green Published			2022-12-27	WOS:000288810500020
J	Stern, CM; Luoma, JI; Meitzen, J; Mermelstein, PG				Stern, Christopher M.; Luoma, Jessie I.; Meitzen, John; Mermelstein, Paul G.			Corticotropin Releasing Factor-Induced CREB Activation in Striatal Neurons Occurs via a Novel G beta gamma Signaling Pathway	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; CENTRAL-NERVOUS-SYSTEM; MEMBRANE ESTROGEN-RECEPTORS; ADENYLATE-CYCLASE ACTIVITY; NUCLEUS-ACCUMBENS; RAT-BRAIN; GENE-EXPRESSION; DOPAMINE NEURONS; DRUG-ADDICTION; CRF RECEPTORS	The peptide corticotropin-releasing factor (CRF) was initially identified as a critical component of the stress response. CRF exerts its cellular effects by binding to one of two cognate G-protein coupled receptors (GPCRs), CRF receptor 1 (CRFR1) or 2 (CRFR2). While these GPCRs were originally characterized as being coupled to G alpha(s), leading to downstream activation of adenylyl cyclase (AC) and subsequent increases in cAMP, it has since become clear that CRFRs couple to and activate numerous other downstream signaling cascades. In addition, CRF signaling influences the activity of many diverse brain regions, affecting a variety of behaviors. One of these regions is the striatum, including the nucleus accumbens (NAc). CRF exerts profound effects on striatal-dependent behaviors such as drug addiction, pair-bonding, and natural reward. Recent data indicate that at least some of these behaviors regulated by CRF are mediated through CRF activation of the transcription factor CREB. Thus, we aimed to elucidate the signaling pathway by which CRF activates CREB in striatal neurons. Here we describe a novel neuronal signaling pathway whereby CRF leads to a rapid G beta gamma- and MEK-dependent increase in CREB phosphorylation. These data are the first descriptions of CRF leading to activation of a G beta gamma-dependent signaling pathway in neurons, as well as the first description of G beta gamma activation leading to downstream CREB phosphorylation in any cellular system. Additionally, these data provide additional insight into the mechanisms by which CRF can regulate neuronal function.	[Stern, Christopher M.; Luoma, Jessie I.; Mermelstein, Paul G.] Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA; [Stern, Christopher M.; Luoma, Jessie I.; Meitzen, John; Mermelstein, Paul G.] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Stern, CM (corresponding author), Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA.	pmerm@umn.edu			National Institutes of Health (NIH) [NS41302];  [DA07234]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041302] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grant NS41302 to PGM. CMS was supported by the training grant DA07234. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgoz M, 2006, CELL SIGNAL, V18, P1758, DOI 10.1016/j.cellsig.2006.01.016; Bale TL, 2005, HORM BEHAV, V48, P1, DOI 10.1016/j.yhbeh.2005.01.009; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; BATTAGLIA G, 1987, SYNAPSE, V1, P572, DOI 10.1002/syn.890010610; Bayatti N, 2003, ENDOCRINOLOGY, V144, P4051, DOI 10.1210/en.2003-0168; Beckstead MJ, 2009, NEUROPSYCHOPHARMACOL, V34, P1926, DOI 10.1038/npp.2009.25; Behan DP, 1997, J NEUROCHEM, V68, P2053; Blank T, 2003, J NEUROSCI, V23, P700, DOI 10.1523/JNEUROSCI.23-02-00700.2003; Boulware MI, 2007, J NEUROSCI, V27, P9941, DOI 10.1523/JNEUROSCI.1647-07.2007; Boulware MI, 2005, J NEUROSCI, V25, P5066, DOI 10.1523/JNEUROSCI.1427-05.2005; Briand LA, 2010, BRAIN RES, V1314, P219, DOI 10.1016/j.brainres.2009.11.002; BROWN SA, 1995, J STUD ALCOHOL, V56, P538, DOI 10.15288/jsa.1995.56.538; Brunzell DH, 2009, NEUROPSYCHOPHARMACOL, V34, P1993, DOI 10.1038/npp.2009.11; Butchbach MER, 2004, J BIOL CHEM, V279, P34388, DOI 10.1074/jbc.M403938200; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; CHALMERS DT, 1995, J NEUROSCI, V15, P6340; CHEN FM, 1986, BRAIN RES, V381, P49; Cleck JN, 2008, J CLIN INVEST, V118, P454, DOI 10.1172/JCI33946; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; DESOUZA EB, 1987, J NEUROSCI, V7, P88; DESOUZA EB, 1987, BRAIN RES, V437, P355, DOI 10.1016/0006-8993(87)91651-9; DiNieri JA, 2009, J NEUROSCI, V29, P1855, DOI 10.1523/JNEUROSCI.5104-08.2009; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Facci L, 2003, NEUROPHARMACOLOGY, V45, P623, DOI 10.1016/S0028-3908(03)00211-9; Farrow B, 2003, SURGERY, V134, P197, DOI 10.1067/msy.2003.220; Freitag A, 1998, EUR J PHARMACOL, V354, P67, DOI 10.1016/S0014-2999(98)00439-7; Fu Y, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-26; GLASS DB, 1989, J BIOL CHEM, V264, P14579; GOEDERS NE, 1994, PSYCHOPHARMACOLOGY, V114, P63, DOI 10.1007/BF02245445; Groth RD, 2008, EUR J NEUROSCI, V27, P31, DOI 10.1111/j.1460-9568.2007.05980.x; Groth RD, 2003, J NEUROSCI, V23, P8125; Grove-Strawser D, 2010, NEUROSCIENCE, V170, P1045, DOI 10.1016/j.neuroscience.2010.08.012; Guan XW, 2010, J NEUROCHEM, V115, P795, DOI 10.1111/j.1471-4159.2010.06981.x; Gutknecht E, 2009, MOL PHARMACOL, V75, P648, DOI 10.1124/mol.108.050427; HANEY M, 1995, BRAIN RES, V698, P46, DOI 10.1016/0006-8993(95)00788-R; Hara M, 2010, J NEUROCHEM, V113, P1046, DOI 10.1111/j.1471-4159.2010.06668.x; HARRIS DN, 1979, J CYCLIC NUCL PROT, V5, P125; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Holahan MR, 1997, PSYCHOPHARMACOLOGY, V130, P189, DOI 10.1007/s002130050228; Iredale PA, 2000, J NEUROCHEM, V74, P199, DOI 10.1046/j.1471-4159.2000.0740199.x; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Koob GF, 2010, BRAIN RES, V1314, P3, DOI 10.1016/j.brainres.2009.11.008; Kralisch S, 2005, J ENDOCRINOL, V185, pR1, DOI 10.1677/joe.1.06211; Kreibich AS, 2009, NEUROPSYCHOPHARMACOL, V34, P2609, DOI 10.1038/npp.2009.91; Lawrence AJ, 2002, BRIT J PHARMACOL, V136, P896, DOI 10.1038/sj.bjp.0704783; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Lim MM, 2007, HORM BEHAV, V51, P508, DOI 10.1016/j.yhbeh.2007.01.006; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Magalhaes AC, 2010, NAT NEUROSCI, V13, P622, DOI 10.1038/nn.2529; Meitzen J, 2011, J NEUROCHEM, V116, P984, DOI 10.1111/j.1471-4159.2010.07137.x; MERCHENTHALER I, 1984, PEPTIDES, V5, P53, DOI 10.1016/0196-9781(84)90265-1; Miczek KA, 1996, PSYCHOPHARMACOLOGY, V128, P256, DOI 10.1007/s002130050133; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pecina S, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-8; PERRIN MH, 1993, ENDOCRINOLOGY, V133, P3058, DOI 10.1210/en.133.6.3058; Perrin MH, 1999, J PHARMACOL EXP THER, V288, P729; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; Primus RJ, 1997, NEUROPSYCHOPHARMACOL, V17, P308, DOI 10.1016/S0893-133X(97)00071-7; RAMSEY NF, 1993, BRAIN RES, V608, P216, DOI 10.1016/0006-8993(93)91461-Z; Refojo D, 2005, P NATL ACAD SCI USA, V102, P6183, DOI 10.1073/pnas.0502070102; Riegel AC, 2008, NEURON, V57, P559, DOI 10.1016/j.neuron.2007.12.029; Ruhmann A, 1998, P NATL ACAD SCI USA, V95, P15264, DOI 10.1073/pnas.95.26.15264; Saini DK, 2007, J BIOL CHEM, V282, P24099, DOI 10.1074/jbc.M701191200; Sarnyai Z, 1998, ANN NY ACAD SCI, V851, P371, DOI 10.1111/j.1749-6632.1998.tb09011.x; Sarnyai Z, 2001, PHARMACOL REV, V53, P209; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; SHAHAM Y, 1994, PSYCHOPHARMACOLOGY, V114, P523, DOI 10.1007/BF02249346; Sheng H, 2008, ENDOCRINOLOGY, V149, P1389, DOI 10.1210/en.2007-1378; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Stern CM, 2010, CELL MOL LIFE SCI, V67, P3785, DOI 10.1007/s00018-010-0447-y; Tamura M, 2005, BBA-PROTEINS PROTEOM, V1754, P245, DOI 10.1016/j.bbapap.2005.06.015; Tao J, 2008, MOL PHARMACOL, V73, P1596, DOI 10.1124/mol.107.043612; Teli T, 2005, MOL ENDOCRINOL, V19, P474, DOI 10.1210/me.2004-0275; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Tu HJ, 2007, CELL SIGNAL, V19, P1996, DOI 10.1016/j.cellsig.2007.05.004; Ungless MA, 2003, NEURON, V39, P401, DOI 10.1016/S0896-6273(03)00461-6; Walters CL, 2005, NEURON, V46, P933, DOI 10.1016/j.neuron.2005.05.005; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; Wasylyk C, 2008, CANCER RES, V68, P1275, DOI 10.1158/0008-5472.CAN-07-2674; Weick JP, 2003, J NEUROSCI, V23, P3446; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Yu JZ, 2009, J BIOL CHEM, V284, P10462, DOI 10.1074/jbc.M809166200; Zheng XL, 2000, J BIOL CHEM, V275, P31747, DOI 10.1074/jbc.M000621200	88	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18114	10.1371/journal.pone.0018114	http://dx.doi.org/10.1371/journal.pone.0018114			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448293	Green Published, gold, Green Submitted			2022-12-27	WOS:000288810500038
J	Baugh, LR; Kurhanewicz, N; Sternberg, PW				Baugh, L. Ryan; Kurhanewicz, Nicole; Sternberg, Paul W.			Sensitive and Precise Quantification of Insulin-Like mRNA Expression in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; LIFE-SPAN; TRANSCRIPTION FACTOR; DAUER LARVA; DAF-2; LONGEVITY; RECEPTOR; GENE; MEMBER; DIAPAUSE	Insulin-like signaling regulates developmental arrest, stress resistance and lifespan in the nematode Caenorhabditis elegans. However, the genome encodes 40 insulin-like peptides, and the regulation and function of individual peptides is largely uncharacterized. We used the nCounter platform to measure mRNA expression of all 40 insulin-like peptides as well as the insulin-like receptor daf-2, its transcriptional effector daf-16, and the daf-16 target gene sod-3. We validated the platform using 53 RNA samples previously characterized by high density oligonucleotide microarray analysis. For this set of genes and the standard nCounter protocol, sensitivity and precision were comparable between the two platforms. We optimized conditions of the nCounter assay by varying the mass of total RNA used for hybridization, thereby increasing sensitivity up to 50-fold and reducing the median coefficient of variation as much as 4-fold. We used deletion mutants to demonstrate specificity of the assay, and we used optimized conditions to assay insulin-like gene expression throughout the C. elegans life cycle. We detected expression for nearly all insulin-like genes and find that they are expressed in a variety of distinct patterns suggesting complexity of regulation and specificity of function. We identified insulin-like genes that are specifically expressed during developmental arrest, larval development, adulthood and embryogenesis. These results demonstrate that the nCounter platform provides a powerful approach to analyzing insulin-like gene expression dynamics, and they suggest hypotheses about the function of individual insulin-like genes.	[Baugh, L. Ryan; Kurhanewicz, Nicole] Duke Univ, Dept Biol, Durham, NC 27706 USA; [Baugh, L. Ryan; Kurhanewicz, Nicole] Duke Univ, IGSP Ctr Syst Biol, Durham, NC USA; [Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Sternberg, Paul W.] CALTECH, Div Biol, Pasadena, CA 91125 USA	Duke University; Duke University; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Baugh, LR (corresponding author), Duke Univ, Dept Biol, Durham, NC 27706 USA.	ryan.baugh@duke.edu	Baugh, L. Ryan/GRS-0507-2022	Baugh, L. Ryan/0000-0003-2148-5492; Sternberg, Paul/0000-0002-7699-0173; Kurhanewicz, Nicole/0000-0003-2023-9310	Howard Hughes Medical Institute; American Cancer Society [PF-06-028-01-DDC]; Duke University	Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Cancer Society(American Cancer Society); Duke University	his work was funded by the Howard Hughes Medical Institute (P.W.S.), the American Cancer Society (L.R.B. PF-06-028-01-DDC) and start up funds from Duke University (L.R.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip.	Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; BAUGH LR, 2009, SCIENCE; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Gems D, 1998, GENETICS, V150, P129; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hristova M, 2005, MOL CELL BIOL, V25, P11059, DOI 10.1128/MCB.25.24.11059-11072.2005; Hu P.J., 2007, WORMBOOK, P1, DOI [10.1895/wormbook.1.144.1, DOI 10.1895/WORMBOOK.1.144.1]; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; LEWIS JA, 1995, CAENORHABDITIS ELEGA, P4; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Malkov Vladislav A, 2009, BMC Res Notes, V2, P80, DOI 10.1186/1756-0500-2-80; Materna SC, 2010, GENE EXPR PATTERNS, V10, P177, DOI 10.1016/j.gep.2010.04.002; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Michaelson D, 2010, DEVELOPMENT, V137, P671, DOI 10.1242/dev.042523; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Patel DS, 2008, GENETICS, V178, P931, DOI 10.1534/genetics.107.070813; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; SWANSON MM, 1981, DEV BIOL, V84, P27, DOI 10.1016/0012-1606(81)90367-5; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011	27	33	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18086	10.1371/journal.pone.0018086	http://dx.doi.org/10.1371/journal.pone.0018086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445366	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000288809100030
J	Custodio, G; Taques, GR; Figueiredo, BC; Gugelmin, ES; Figueiredo, MMO; Watanabe, F; Pontarolo, R; Lalli, E; Torres, LFB				Custodio, Gislaine; Taques, Guilherme R.; Figueiredo, Bonald C.; Gugelmin, Elizabeth S.; Oliveira Figueiredo, Mirna M.; Watanabe, Flora; Pontarolo, Roberto; Lalli, Enzo; Bleggi Torres, Luiz Fernando			Increased Incidence of Choroid Plexus Carcinoma Due to the Germline TP53 R337H Mutation in Southern Brazil	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; LI-FRAUMENI SYNDROME; ADRENOCORTICAL TUMORS; CANCER; CHILDHOOD; EXPERIENCE; CHILDREN; GENE	Background: Choroid plexus carcinomas (CPC) are rare tumors predominantly found in children. Given the high frequency of the germline R337H mutation in the TP53 gene in southern Brazil, we have evaluated the frequency of the R337H mutation in families with CPC in children. Methodology/Principal Findings: The present series included 29 patients that were admitted to the same institution from 1992 to 2010, including 22 children with CPC (0.08-13.6 years of age at diagnosis) and 7 children with papilloma of the choroid plexus (Pp; 0.5-9.8 years of age). Surgical resection was possible in 28 children. Blood and/or tumor DNA was extracted and analyzed using PCR-RFLP and results were confirmed by sequencing 240 bp of the TP53 exon 10. The patients, all parents, and some relatives submitted samples for blood DNA analysis. In addition, we have also examined the presence of the mutation in DNA from paraffin-embedded tumor samples to evaluate loss of heterozygosity. We found 63.3% (14/22) of the CPC patients positive for the germline R337H mutation; CPC samples were either heterozygous (n = 7), lost only the wild-type (n = 4), or only the R337H copy (n = 2). One CPC sample was not available. All Pp cases (7/7, 100%) were negative for R337H. Cure (. 5 years survival free of disease) was observed in 18.1% of the CPC cases with the R337H mutation (2/11), 71.4% of the Pp (5/7), and 25% of CPC cases negative for the R337H mutation (2/8). Family history of cancer (with 2 or more cancer cases) was exclusively identified on the parental side segregating the R337H mutation, and 50% (7/14) of them were compatible with Li-Fraumeni-like syndrome. Significance: Our results show for the first time that the R337H TP53 mutation is responsible for 63% of the CPC cases in children, suggesting a higher incidence of CPC in southern Brazil.	[Custodio, Gislaine; Taques, Guilherme R.; Figueiredo, Bonald C.; Gugelmin, Elizabeth S.; Oliveira Figueiredo, Mirna M.; Bleggi Torres, Luiz Fernando] Pele Pequeno Principe Res Inst, Curitiba, Parana, Brazil; [Figueiredo, Bonald C.] Fac Pequeno Principe, Curitiba, Parana, Brazil; [Watanabe, Flora] Pequeno Principe Hosp, Curitiba, Parana, Brazil; [Pontarolo, Roberto] Univ Fed Parana, Dept Pharmaceut Sci, BR-80060000 Curitiba, Parana, Brazil; [Lalli, Enzo] CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, Alpes Maritimes, France; [Lalli, Enzo] Univ Nice, Valbonne, Alpes Maritimes, France	Hospital Pequeno Principe; Hospital Pequeno Principe; Hospital Pequeno Principe; Universidade Federal do Parana; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Custodio, G (corresponding author), Pele Pequeno Principe Res Inst, Curitiba, Parana, Brazil.	bonaldf@pelepequenoprincipe.org.br	Pontarolo, Roberto/G-6948-2014; de Figueiredo, Bonald Cavalcante/AAD-6672-2021; Lalli, Enzo/F-7052-2013	Pontarolo, Roberto/0000-0002-7049-4363; de Figueiredo, Bonald Cavalcante/0000-0002-1051-2056; Lalli, Enzo/0000-0002-0584-5681	CNPQ Brazil [302841/2009-1]; Fundacao Araucaria, PR - Brazil [398/2009]; CNRS - France	CNPQ Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria, PR - Brazil(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); CNRS - France(Centre National de la Recherche Scientifique (CNRS))	This work was funded by CNPQ Brazil (302841/2009-1), Fundacao Araucaria, PR - Brazil (398/2009) and CNRS - France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUZZI A, 2000, CHOROID PLEXUS TUMOR; ANG LC, 1990, CANCER, V32, P131; Assumpcao JG, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-357; Berger C, 1998, NEUROSURGERY, V42, P470, DOI 10.1097/00006123-199803000-00006; BERGSAGEL DJ, 1992, NEW ENGL J MED, V326, P988, DOI 10.1056/NEJM199204093261504; BIRCH JM, 1994, CANCER RES, V54, P1298; BLEGGITORRES LF, 2004, ARQ NEURO-PSIQUIAT, V62, P127; Chow E, 1999, INT J RADIAT ONCOL, V44, P249, DOI 10.1016/S0360-3016(98)00560-4; DiGiammarino EL, 2002, NAT STRUCT BIOL, V9, P12, DOI 10.1038/nsb730; Farrugia A, 2010, FORENSIC SCI INT, V194, pE25, DOI 10.1016/j.forsciint.2009.09.004; Figueiredo BC, 2006, J MED GENET, V43, P91, DOI 10.1136/jmg.2004.030551; Gessl M, 2003, BRAIN PATHOL, V13, P409; GOTTSCHALK J, 1993, CANCER, V72, P1343, DOI 10.1002/1097-0142(19930815)72:4<1343::AID-CNCR2820720432>3.0.CO;2-G; Heymann S, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-104; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Latronico AC, 2001, J CLIN ENDOCR METAB, V86, P4970, DOI 10.1210/jc.86.10.4970; Levine AJ, 2009, VIROLOGY, V384, P285, DOI 10.1016/j.virol.2008.09.034; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; McEvoy AW, 2000, PEDIATR NEUROSURG, V32, P192, DOI 10.1159/000028933; McManamy CS, 2007, BRAIN PATHOL, V17, P151, DOI 10.1111/j.1750-3639.2007.00058.x; Melo Ernesto Lima Araújo, 2003, Radiol Bras, V36, P379, DOI 10.1590/S0100-39842003000600010; Mitchel REJ, 2004, RADIAT RES, V162, P20, DOI 10.1667/RR3190; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; PARKIN DM, 1988, INT J CANCER, V42, P511, DOI 10.1002/ijc.2910420408; Pianovski MAD, 2006, PEDIATR BLOOD CANCER, V47, P56, DOI 10.1002/pbc.20624; PIERGA JY, 1993, MED PEDIATR ONCOL, V21, P480, DOI 10.1002/mpo.2950210705; Pinto EM, 2005, J CLIN ENDOCR METAB, V90, P2976, DOI 10.1210/jc.2004-0963; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; Tabori U, 2010, J CLIN ONCOL, V28, P1995, DOI 10.1200/JCO.2009.26.8169; Tinat J, 2009, J CLIN ONCOL, V27, pE108, DOI 10.1200/JCO.2009.22.7967; Wolff JEA, 2002, BRIT J CANCER, V87, P1086, DOI 10.1038/sj.bjc.6600609	32	45	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18015	10.1371/journal.pone.0018015	http://dx.doi.org/10.1371/journal.pone.0018015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445348	Green Submitted, gold, Green Published			2022-12-27	WOS:000288809100024
J	Hoogendijk, AJ; Diks, SH; van der Poll, T; Peppelenbosch, MP; Wieland, CW				Hoogendijk, Arie J.; Diks, Sander H.; van der Poll, Tom; Peppelenbosch, Maikel P.; Wieland, Catharina W.			Kinase Activity Profiling of Pneumococcal Pneumonia	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; ACTIVATED PROTEIN-KINASE; STREPTOCOCCUS-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; INFLAMMATORY RESPONSE; DOWN-REGULATION; R-ROSCOVITINE; INFECTION; INHIBITION; BETA	Background: Pneumonia represents a major health burden. Previous work demonstrated that although the induction of inflammation is important for adequate host defense against pneumonia, an inability to regulate the host's inflammatory response within the lung later during infection can be detrimental. Intracellular signaling pathways commonly rely on activation of kinases, and kinases play an essential role in the regulation of the inflammatory response of immune cells. Methodology/Principal Findings: Pneumonia was induced in mice via intranasal instillation of Streptococcus ( S.) pneumoniae. Kinomics peptide arrays, exhibiting 1024 specific consensus sequences for protein kinases, were used to produce a systems biology analysis of cellular kinase activity during the course of pneumonia. Several differences in kinase activity revealed by the arrays were validated in lung homogenates of individual mice using western blot. We identified cascades of activated kinases showing that chemotoxic stress and a T helper 1 response were induced during the course of pneumococcal pneumonia. In addition, our data point to a reduction in WNT activity in lungs of S. pneumoniae infected mice. Moreover, this study demonstrated a reduction in overall CDK activity implying alterations in cell cycle biology. Conclusions/Significance: This study utilizes systems biology to provide insight into the signaling events occurring during lung infection with the common cause of community acquired pneumonia, and may assist in identifying novel therapeutic targets in the treatment of bacterial pneumonia.	[Hoogendijk, Arie J.; van der Poll, Tom; Wieland, Catharina W.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Hoogendijk, Arie J.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Diks, Sander H.] Univ Med Ctr Groningen, Dept Cell Biol, Immunol Sect, Groningen, Netherlands; [Diks, Sander H.] Univ Groningen, Groningen, Netherlands; [Peppelenbosch, Maikel P.] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Wieland, Catharina W.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam	Hoogendijk, AJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.j.hoogendijk@amc.uva.nl	Peppelenbosch, Maikel P./U-5304-2019	Peppelenbosch, Maikel/0000-0001-9112-6028	Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from The Netherlands Organization for Scientific Research to C.W. Wieland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Dessing MC, 2007, AM J RESP CRIT CARE, V175, P604, DOI 10.1164/rccm.200606-824OC; Dessing MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007993; Diks SH, 2004, J BIOL CHEM, V279, P49206, DOI 10.1074/jbc.M405028200; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; Duffin R, 2009, FEBS LETT, V583, P2540, DOI 10.1016/j.febslet.2009.07.017; Ferreira DM, 2009, MICROB PATHOGENESIS, V47, P157, DOI 10.1016/j.micpath.2009.05.005; Gao Y, 2006, J BIOL CHEM, V281, P18394, DOI 10.1074/jbc.M601112200; Hammerlein A, 2005, CELL MOL LIFE SCI, V62, P606, DOI 10.1007/s00018-005-4507-7; Hanage WP, 2009, SCIENCE, V324, P1454, DOI 10.1126/science.1171908; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Ho PL, 2009, CHEST, V136, P1119, DOI 10.1378/chest.09-0285; Hu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006640; Huang YP, 2008, BLOOD, V112, P111, DOI 10.1182/blood-2007-10-118232; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kang MJ, 2008, FEBS J, V275, P5969, DOI 10.1111/j.1742-4658.2008.06725.x; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Knapp S, 2008, J IMMUNOL, V180, P3478, DOI 10.4049/jimmunol.180.5.3478; Koedel U, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000461; Liu L, 2008, J IMMUNOL, V180, P1808, DOI 10.4049/jimmunol.180.3.1808; Lowenberg M, 2006, ENDOCRINOLOGY, V147, P3555, DOI 10.1210/en.2005-1602; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Parikh K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006440; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Raje N, 2005, BLOOD, V106, P1042, DOI 10.1182/blood-2005-01-0320; Ratner AJ, 2007, CELL MICROBIOL, V9, P1343, DOI 10.1111/j.1462-5822.2006.00878.x; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; RIETHER C, 2009, BRAIN BEHAV IN PRESS; Ripoll VM, 2010, J LEUKOCYTE BIOL, V87, P735, DOI 10.1189/jlb.0509359; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Tasken K, 2006, BIOCHEM SOC T, V34, P476, DOI 10.1042/BST0340476; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Taylor AW, 2009, J LEUKOCYTE BIOL, V85, P29, DOI 10.1189/jlb.0708415; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; van Baal JWPM, 2006, CANCER RES, V66, P11605, DOI 10.1158/0008-5472.CAN-06-1370; van den Blink B, 2001, J IMMUNOL, V166, P582, DOI 10.4049/jimmunol.166.1.582; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; van Zoelen MAD, 2009, J IMMUNOL, V182, P4349, DOI 10.4049/jimmunol.0801199; Weber SE, 2011, J IMMUNOL, V186, P432, DOI 10.4049/jimmunol.1001963; Yinnon AM, 1996, QJM-MON J ASSOC PHYS, V89, P933; YUSKAITIS CJ, 2008, CELLULAR SI IN PRESS; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang P, 2009, MOL IMMUNOL, V46, P677, DOI 10.1016/j.molimm.2008.08.281	50	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18519	10.1371/journal.pone.0018519	http://dx.doi.org/10.1371/journal.pone.0018519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483672	Green Published, gold, Green Submitted			2022-12-27	WOS:000289191300027
J	Kessels, RPC; van Doormaal, A; Janzen, G				Kessels, Roy P. C.; van Doormaal, Amy; Janzen, Gabriele			Landmark Recognition in Alzheimer's Dementia: Spared Implicit Memory for Objects Relevant for Navigation	PLOS ONE			English	Article							SPATIAL MEMORY; NEURAL REPRESENTATION; DISEASE; LOCATION; DISORIENTATION; ATTENTION; ATROPHY; TASK	Background: In spatial navigation, landmark recognition is crucial. Specifically, memory for objects placed at decision points on a route is relevant. Previous fMRI research in healthy adults showed higher medial-temporal lobe (MTL) activation for objects placed at decision points compared to non-decision points, even at an implicit level. Since there is evidence that implicit learning is intact in amnesic patients, the current study examined memory for objects relevant for navigation in patients with Alzheimer's dementia (AD). Methodology/Principal Findings: 21 AD patients participated with MTL atrophy assessed on MRI (mean MMSE=21.2, SD=4.0), as well as 20 age- and education-matched non-demented controls. All participants watched a 5-min video showing a route through a virtual museum with 20 objects placed at intersections (decision points) and 20 at simple turns (non-decision points). The instruction was to pay attention to the toys (half of the objects) for which they were supposedly tested later. Subsequently, a recognition test followed with the 40 previously presented objects among 40 distracter items (both toys and non-toys). Results showed a better performance for the non-toy objects placed at decision points than non-decision points, both for AD patients and controls. Conclusion/Significance: Our findings indicate that AD patients with MTL damage have implicit memory for object information relevant for navigation. No decision point effect was found for the attended items. Possibly, focusing attention on the items occurred at the cost of the context information in AD, whereas the controls performed at an optimal level due to intact memory function.	[Kessels, Roy P. C.; van Doormaal, Amy; Janzen, Gabriele] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6525 ED Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Med Ctr, Dept Geriatr Med, NL-6525 ED Nijmegen, Netherlands; [Janzen, Gabriele] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Kessels, RPC (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	r.kessels@donders.ru.nl	Kessels, Roy P.C./D-1902-2010; Janzen, Gabriele/G-2058-2012	Kessels, Roy P.C./0000-0001-9500-9793; Kessels, Roy/0000-0002-7107-8900	Netherlands Organisation for Scientific Research (NWO) [452-08-005, 452-07-015]; ERC [204643]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission)	RPCK was funded by a VIDI innovational grant from the Netherlands Organisation for Scientific Research (NWO, http://www.nwo.nl; no. 452-08-005); GJ was supported by a VIDI innovational grant from NWO (no. 452-07-015) and by an ERC Starting Independent Researcher Grant (no. 204643; http://erc.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett V., 1994, OUTLIERS STAT DATA; Bird CM, 2010, HIPPOCAMPUS, V20, P1154, DOI 10.1002/hipo.20715; Bresciani L, 2005, AGING CLIN EXP RES, V17, P8, DOI 10.1007/BF03337714; Bucks RS, 1997, CLIN NEUROPSYCHOL, V11, P273, DOI 10.1080/13854049708400456; Cherrier MM, 2001, NEUROPSY NEUROPSY BE, V14, P159; Cushman LA, 2008, NEUROLOGY, V71, P888, DOI 10.1212/01.wnl.0000326262.67613.fe; Deipolyi AR, 2007, NEUROLOGY, V69, P986, DOI 10.1212/01.wnl.0000271376.19515.c6; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HANNAY HJ, 1986, EXPT TECHNIQUES HUMA, P45; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Holdstock JS, 1999, CORTEX, V35, P479, DOI 10.1016/S0010-9452(08)70814-1; Hort J, 2007, P NATL ACAD SCI USA, V104, P4042, DOI 10.1073/pnas.0611314104; Janzen G, 2006, Q J EXP PSYCHOL, V59, P493, DOI 10.1080/02724980443000746; Janzen G, 2004, NAT NEUROSCI, V7, P673, DOI 10.1038/nn1257; Janzen G, 2008, HIPPOCAMPUS, V18, P40, DOI 10.1002/hipo.20364; Janzen G, 2007, CEREB CORTEX, V17, P975, DOI 10.1093/cercor/bhl008; Janzen G, 2010, NEUROIMAGE, V52, P364, DOI 10.1016/j.neuroimage.2010.03.083; Jheng SS, 2009, BEHAV BRAIN RES, V200, P42, DOI 10.1016/j.bbr.2008.12.029; Kalova E, 2005, BEHAV BRAIN RES, V159, P175, DOI 10.1016/j.bbr.2004.10.016; Kavcic V, 2003, BRAIN, V126, P1173, DOI 10.1093/brain/awg105; Kessels RPC, 2010, J INT NEUROPSYCH SOC, V16, P200, DOI 10.1017/S1355617709990944; Kessels RPC, 2005, DEMENT GERIATR COGN, V20, P184, DOI 10.1159/000087233; Kessels RPC, 2001, BRAIN RES REV, V35, P295, DOI 10.1016/S0165-0173(01)00058-3; Kilb A, 2007, MEM COGNITION, V35, P1162, DOI 10.3758/BF03193486; Laczo J, 2009, BEHAV BRAIN RES, V202, P252, DOI 10.1016/j.bbr.2009.03.041; Luck D, 2010, BRAIN COGNITION, V72, P255, DOI 10.1016/j.bandc.2009.09.009; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Milner B, 1997, PHILOS T R SOC B, V352, P1469, DOI 10.1098/rstb.1997.0133; Monacelli AM, 2003, NEUROLOGY, V61, P1491, DOI 10.1212/WNL.61.11.1491; NEBES RD, 1992, J CLIN EXP NEUROPSYC, V14, P317, DOI 10.1080/01688639208402831; OKEEFE J, 1978, HIPPOCAMPUS COGNITIV, P584; Piekema C, 2006, NEUROIMAGE, V33, P374, DOI 10.1016/j.neuroimage.2006.06.035; Postle BR, 1996, LEARN MEMORY, V3, P305, DOI 10.1101/lm.3.4.305; Postma A, 2008, NEUROSCI BIOBEHAV R, V32, P1339, DOI 10.1016/j.neubiorev.2008.05.001; Schinazi VR, 2010, NEUROIMAGE, V53, P725, DOI 10.1016/j.neuroimage.2010.06.065; Schmand B., 1992, NEDERLANDSE LEESTEST; Simone PM, 1997, ALZ DIS ASSOC DIS, V11, P140, DOI 10.1097/00002093-199709000-00006; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; van De Pol LA, 2006, J NEUROL NEUROSUR PS, V77, P439, DOI 10.1136/jnnp.2005.075341; Zakzanis KK, 2009, MED SCI MONITOR, V15, pCR140	42	30	31	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18611	10.1371/journal.pone.0018611	http://dx.doi.org/10.1371/journal.pone.0018611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743ZC	21483699	gold, Green Published, Green Submitted			2022-12-27	WOS:000289058700033
J	Hegde, VL; Nagarkatti, PS; Nagarkatti, M				Hegde, Venkatesh L.; Nagarkatti, Prakash S.; Nagarkatti, Mitzi			Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol	PLOS ONE			English	Article							CONSTITUENT CANNABIDIOL; MULTIPLE-SCLEROSIS; IMMUNE-RESPONSES; LIVER-INJURY; INFLAMMATION; IDENTIFICATION; INVOLVEMENT; SUBSETS; MICE; CANNABINOIDS	Background: Myeloid-derived suppressor cells (MDSCs) are getting increased attention as one of the main regulatory cells of the immune system. They are induced at sites of inflammation and can potently suppress T cell functions. In the current study, we demonstrate how activation of TRPV1 vanilloid receptors can trigger MDSCs, which in turn, can inhibit inflammation and hepatitis. Methodology/Principal Findings: Polyclonal activation of T cells, following injection of concanavalin A (ConA), in C57BL/6 mice caused acute hepatitis, characterized by significant increase in aspartate transaminase (AST), induction of inflammatory cytokines, and infiltration of mononuclear cells in the liver, leading to severe liver injury. Administration of cannabidiol (CBD), a natural non-psychoactive cannabinoid, after ConA challenge, inhibited hepatitis in a dose-dependent manner, along with all of the associated inflammation markers. Phenotypic analysis of liver infiltrating cells showed that CBD-mediated suppression of hepatitis was associated with increased induction of arginase-expressing CD11b(+)Gr-1(+) MDSCs. Purified CBD-induced MDSCs could effectively suppress T cell proliferation in vitro in arginase-dependent manner. Furthermore, adoptive transfer of purified MDSCs into naive mice conferred significant protection from ConA-induced hepatitis. CBD failed to induce MDSCs and suppress hepatitis in the livers of vanilloid receptor-deficient mice (TRPV1(-/-)) thereby suggesting that CBD primarily acted via this receptor to induce MDSCs and suppress hepatitis. While MDSCs induced by CBD in liver consisted of granulocytic and monocytic subsets at a ratio of similar to 2:1, the monocytic MDSCs were more immunosuppressive compared to granulocytic MDSCs. The ability of CBD to induce MDSCs and suppress hepatitis was also demonstrable in Staphylococcal enterotoxin B-induced liver injury. Conclusions/Significance: This study demonstrates for the first time that MDSCs play a critical role in attenuating acute inflammation in the liver, and that agents such as CBD, which trigger MDSCs through activation of TRPV1 vanilloid receptors may constitute a novel therapeutic modality to treat inflammatory diseases.	[Hegde, Venkatesh L.; Nagarkatti, Prakash S.; Nagarkatti, Mitzi] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Hegde, VL (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	mnagark@uscmed.sc.edu	Hegde, Venkatesh/E-8519-2014	Hegde, Venkatesh/0000-0002-0949-919X; Nagarkatti, Prakash/0000-0003-2663-0759	National Institutes of Health, USA [R01-DA016545, P01-AT003961]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016545] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The research was funded by National Institutes of Health, USA grant awards, R01-DA016545 and P01-AT003961 to MN and PSN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisogno T, 2001, BRIT J PHARMACOL, V134, P845, DOI 10.1038/sj.bjp.0704327; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bronte V, 2009, EUR J IMMUNOL, V39, P2670, DOI 10.1002/eji.200939892; Chen DW, 2001, J IMMUNOL, V166, P5889, DOI 10.4049/jimmunol.166.10.5889; CONSROE P, 1991, PHARMACOL BIOCHEM BE, V40, P701, DOI 10.1016/0091-3057(91)90386-G; Costa B, 2004, BRIT J PHARMACOL, V143, P247, DOI 10.1038/sj.bjp.0705920; Costa B, 2004, N-S ARCH PHARMACOL, V369, P294, DOI 10.1007/s00210-004-0871-3; Costa B, 2007, EUR J PHARMACOL, V556, P75, DOI 10.1016/j.ejphar.2006.11.006; Croxford JL, 2005, J NEUROIMMUNOL, V166, P3, DOI 10.1016/j.jneuroim.2005.04.023; CUNHA JM, 1980, PHARMACOLOGY, V21, P175, DOI 10.1159/000137430; Czaja AJ, 2002, HEPATOLOGY, V36, P479, DOI 10.1053/jhep.2002.34944; De Wilde V, 2009, AM J TRANSPLANT, V9, P2034, DOI 10.1111/j.1600-6143.2009.02757.x; Dugast AS, 2008, J IMMUNOL, V180, P7898, DOI 10.4049/jimmunol.180.12.7898; EGGINK HF, 1982, CLIN EXP IMMUNOL, V50, P17; Fushimi S, 2009, CLIN IMMUNOL, V133, P437, DOI 10.1016/j.clim.2009.08.015; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Greifenberg V, 2009, EUR J IMMUNOL, V39, P2865, DOI 10.1002/eji.200939486; Haile LA, 2008, GASTROENTEROLOGY, V135, P871, DOI 10.1053/j.gastro.2008.06.032; Hegde VL, 2008, MOL PHARMACOL, V74, P20, DOI 10.1124/mol.108.047035; Hegde VL, 2010, EUR J IMMUNOL, V40, P3358, DOI 10.1002/eji.201040667; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Knolle PA, 1996, HEPATOLOGY, V24, P824, DOI 10.1002/hep.510240413; Li BF, 2006, HEPATOLOGY, V43, P1211, DOI 10.1002/hep.21174; Liou GI, 2008, INVEST OPHTH VIS SCI, V49, P5526, DOI 10.1167/iovs.08-2196; Luxon Bruce A, 2006, Curr Gastroenterol Rep, V8, P83, DOI 10.1007/s11894-006-0068-7; Malfait AM, 2000, P NATL ACAD SCI USA, V97, P9561, DOI 10.1073/pnas.160105897; Manns MP, 2006, HEPATOLOGY, V43, pS132, DOI 10.1002/hep.21059; Mechoulam R, 2002, J CLIN PHARMACOL, V42, p11S, DOI 10.1002/j.1552-4604.2002.tb05998.x; Mechoulam R, 2002, CHEM PHYS LIPIDS, V121, P35, DOI 10.1016/S0009-3084(02)00144-5; Mechoulam R, 2007, CHEM BIODIVERS, V4, P1678, DOI 10.1002/cbdv.200790147; Mizuhara H, 1996, HEPATOLOGY, V23, P1608, DOI 10.1002/hep.510230643; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nakaya M, 2009, J IMMUNOL, V183, P7047, DOI 10.4049/jimmunol.0900547; Pan H, 2009, J PHARMACOL EXP THER, V328, P708, DOI 10.1124/jpet.108.147181; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rog DJ, 2007, CLIN THER, V29, P2068, DOI 10.1016/j.clinthera.2007.09.013; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Satoh M, 1996, TOHOKU J EXP MED, V180, P139, DOI 10.1620/tjem.180.139; Scuderi C, 2009, PHYTOTHER RES, V23, P597, DOI 10.1002/ptr.2625; Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Tiegs G, 1997, ACTA GASTRO-ENT BELG, V60, P176; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Tomihara K, 2010, J IMMUNOL, V184, P6151, DOI 10.4049/jimmunol.0903519; Wade DT, 2004, MULT SCLER, V10, P434, DOI 10.1191/1352458504ms1082oa; Wahl C, 2009, J IMMUNOL, V182, P4521, DOI 10.4049/jimmunol.0802810; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zuardi AW, 2006, J PSYCHOPHARMACOL, V20, P683, DOI 10.1177/0269881106060967	54	85	88	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18281	10.1371/journal.pone.0018281	http://dx.doi.org/10.1371/journal.pone.0018281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483776	Green Published, gold, Green Submitted			2022-12-27	WOS:000289058300010
J	Le Bert, N; Chain, BM; Rook, G; Noursadeghi, M				Le Bert, Nina; Chain, Benjamin M.; Rook, Graham; Noursadeghi, Mahdad			DC Priming by M. vaccae Inhibits Th2 Responses in Contrast to Specific TLR2 Priming and Is Associated with Selective Activation of the CREB Pathway	PLOS ONE			English	Article							KILLED MYCOBACTERIUM-VACCAE; CHRONIC INFLAMMATORY DISORDERS; TOLL-LIKE RECEPTOR-2; REGULATORY T-CELLS; DENDRITIC CELLS; ATOPIC-DERMATITIS; BINDING PROTEIN; MACROPHAGE ACTIVATION; IMMUNE-RESPONSES; MITE ALLERGEN	The environmental mycobacterium, M. vaccae has been used in mouse models to support the contemporary hygiene hypothesis that non-pathogenic microorganisms reduce allergy associated T helper (Th)2 responses and inflammatory diseases by augmenting regulatory T cells. However, data for human models and possible mechanisms are limited. We tested the effect of innate immune interactions between human DC and M. vaccae on DC-dependent T cell responses. M. vaccae activation of DC via Toll like receptor (TLR)2 was compared to a specific TLR2 ligand (Pam(3)CSK4) and alternative stimulation with a TLR4 ligand (LPS). M. vaccae induced DC dependent inhibition of Th2 responses, in contrast to Pam(3)CSK4, which had the opposite effect and LPS, which had no polarizing effect. DC maturation, gene expression and cytokine production, in response to each stimulus did not correlate with the specific functional effects. Comparable DC transcriptional responses to M. vaccae and Pam(3)CSK4 suggested that TLR2 mediated transcriptional regulation was not sufficient for inhibition of Th2 responses. Transcription factor enrichment analysis and assessment of signaling events, implicated a role for selective early activation of the CREB pathway by M. vaccae. Further study of the CREB pathway may provide novel insight into the molecular mechanisms of DC-dependent T cell polarization.	[Le Bert, Nina; Chain, Benjamin M.; Rook, Graham; Noursadeghi, Mahdad] UCL, London, England	University of London; University College London	Le Bert, N (corresponding author), UCL, London, England.	m.noursadeghi@ucl.ac.uk		Rook, Graham/0000-0002-8041-8110; Chain, Benny/0000-0002-7417-3970; Le Bert, Nina/0000-0003-0502-2527; Noursadeghi, Mahdad/0000-0002-4774-0853	EC [MEST-CT-2005-020524]; Wellcome Trust [WT077161MA]; National Institute for Health Research UCLH/UCL Comprehensive Biomedical Research Centre; Medical Research Council [G9721629, G0900950B, G0900950, G9721629B] Funding Source: researchfish; MRC [G0900950, G9721629] Funding Source: UKRI	EC(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research UCLH/UCL Comprehensive Biomedical Research Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by an EC grant through the Marie Curie Early Stage Training Site GALTRAIN (project MEST-CT-2005-020524), supported by a Wellcome Trust fellowship (WT077161MA) to MN and the National Institute for Health Research UCLH/UCL Comprehensive Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VC, 2004, EUR J IMMUNOL, V34, P631, DOI 10.1002/eji.200324659; Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; Arkwright PD, 2003, BRIT J DERMATOL, V149, P1029, DOI 10.1111/j.1365-2133.2003.05557.x; Arkwright PD, 2001, J ALLERGY CLIN IMMUN, V107, P531, DOI 10.1067/mai.2001.113081; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bhatt K, 2007, J CLIN IMMUNOL, V27, P347, DOI 10.1007/s10875-007-9084-0; Brothers S, 2009, CLIN EXP DERMATOL, V34, P770, DOI 10.1111/j.1365-2230.2008.03153.x; Camporota L, 2003, EUR RESPIR J, V21, P287, DOI 10.1183/09031936.03.00042103; Chain B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-344; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Drage MG, 2009, CELL IMMUNOL, V258, P29, DOI 10.1016/j.cellimm.2009.03.008; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fedele G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008734; Ferwerda G, 2007, J LEUKOCYTE BIOL, V82, P1011, DOI 10.1189/jlb.0307147; Floto RA, 2006, SCIENCE, V314, P454, DOI 10.1126/science.1133515; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fukushima A, 2006, BIOCHEM BIOPH RES CO, V339, P1048, DOI 10.1016/j.bbrc.2005.11.114; Gutzwiller MER, 2007, VET DERMATOL, V18, P87, DOI 10.1111/j.1365-3164.2007.00579.x; Hernandez-Pando R, 2000, IMMUNOLOGY, V100, P391, DOI 10.1046/j.1365-2567.2000.00054.x; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Krutzik SR, 2003, NAT MED, V9, P525, DOI 10.1038/nm864; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lombardi V, 2008, CLIN EXP ALLERGY, V38, P1819, DOI 10.1111/j.1365-2222.2008.03056.x; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Nigou J, 2001, J IMMUNOL, V166, P7477, DOI 10.4049/jimmunol.166.12.7477; Noursadeghi M, 2009, J IMMUNOL, V182, P319, DOI 10.4049/jimmunol.182.1.319; Ozdemir C, 2003, CLIN EXP ALLERGY, V33, P266, DOI 10.1046/j.1365-2222.2003.01595.x; PANDO RH, 2008, CLIN VACCIN IN PRESS; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Rasaiyaah J, 2009, IMMUNOLOGY, V127, P429, DOI 10.1111/j.1365-2567.2008.03018.x; Retra K, 2008, PARASITE IMMUNOL, V30, P39, DOI 10.1111/j.1365-3024.2007.01000.x; Roach SK, 2005, INFECT IMMUN, V73, P514, DOI 10.1128/IAI.73.1.514-522.2005; Rook GAW, 2010, CLIN EXP IMMUNOL, V160, P70, DOI 10.1111/j.1365-2249.2010.04133.x; Rook GAW, 2007, T ROY SOC TROP MED H, V101, P1072, DOI 10.1016/j.trstmh.2007.05.014; Samten B, 2005, J IMMUNOL, V174, P6357, DOI 10.4049/jimmunol.174.10.6357; Shirtcliffe PM, 2003, RESPIROLOGY, V8, P497, DOI 10.1046/j.1440-1843.2003.00510.x; Skinner MA, 1997, INFECT IMMUN, V65, P4525, DOI 10.1128/IAI.65.11.4525-4530.1997; Smit JJ, 2003, EUR J PHARMACOL, V470, P193, DOI 10.1016/S0014-2999(03)01794-1; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Sweet L, 2006, J LEUKOCYTE BIOL, V80, P415, DOI 10.1189/jlb.1205702; Taylor RC, 2006, J ALLERGY CLIN IMMUN, V117, P1148, DOI 10.1016/j.jaci.2006.02.014; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; van Riet E, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-9; von Reyn CF, 2010, AIDS, V24, P675, DOI 10.1097/QAD.0b013e3283350f1b; Wang CC, 1998, IMMUNOLOGY, V93, P307; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406; Zhou C, 2008, J ZHEJIANG UNIV-SC B, V9, P279, DOI 10.1631/jzus.B0730029; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154; Zuany-Amorim C, 2002, J IMMUNOL, V169, P1492, DOI 10.4049/jimmunol.169.3.1492; Zuany-Amorim C, 2002, NAT MED, V8, P625, DOI 10.1038/nm0602-625	57	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18346	10.1371/journal.pone.0018346	http://dx.doi.org/10.1371/journal.pone.0018346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483768	gold, Green Published, Green Submitted			2022-12-27	WOS:000289058300013
J	Luo, YZ; Spurlock, F; Deng, X; Gill, S; Goh, K				Luo, Yuzhou; Spurlock, Frank; Deng, Xin; Gill, Sheryl; Goh, Kean			Use-Exposure Relationships of Pesticides for Aquatic Risk Assessment	PLOS ONE			English	Article							SURFACE WATERS; TRANSPORT; BEHAVIOR; MODEL; FATE	Field-scale environmental models have been widely used in aquatic exposure assessments of pesticides. Those models usually require a large set of input parameters and separate simulations for each pesticide in evaluation. In this study, a simple use-exposure relationship is developed based on regression analysis of stochastic simulation results generated from the Pesticide Root-Zone Model (PRZM). The developed mathematical relationship estimates edge-of-field peak concentrations of pesticides from aerobic soil metabolism half-life (AERO), organic carbon-normalized soil sorption coefficient (KOC), and application rate (RATE). In a case study of California crop scenarios, the relationships explained 90-95% of the variances in the peak concentrations of dissolved pesticides as predicted by PRZM simulations for a 30-year period. KOC was identified as the governing parameter in determining the relative magnitudes of pesticide exposures in a given crop scenario. The results of model application also indicated that the effects of chemical fate processes such as partitioning and degradation on pesticide exposure were similar among crop scenarios, while the cross-scenario variations were mainly associated with the landscape characteristics, such as organic carbon contents and curve numbers. With a minimum set of input data, the use-exposure relationships proposed in this study could be used in screening procedures for potential water quality impacts from the off-site movement of pesticides.	[Luo, Yuzhou; Spurlock, Frank; Deng, Xin; Gill, Sheryl; Goh, Kean] Calif Environm Protect Agcy, Dept Pesticide Regulat, Sacramento, CA 95812 USA	California Environmental Protection Agency	Luo, YZ (corresponding author), Calif Environm Protect Agcy, Dept Pesticide Regulat, Sacramento, CA 95812 USA.	yluo@cdpr.ca.gov; xdeng@cdpr.ca.gov	Luo, Yuzhou/A-7223-2010	Luo, Yuzhou/0000-0003-0879-9622				AHUJA LR, ROOT ZONE WATER QUAL; [Anonymous], [No title captured]; Capel PD, 2001, ENVIRON SCI TECHNOL, V35, P648, DOI 10.1021/es001220f; Capel PD, 2001, HYDROL PROCESS, V15, P1251, DOI 10.1002/hyp.212; *CDWR, 2002, 2001 STAT IRR METH S; *CEPA, 2010, SURF WAT DAT; Chapra SC, 1997, SURFACE WATER QUALIT; Chen WL, 2002, ENVIRON TOXICOL CHEM, V21, P298, DOI [10.1897/1551-5028(2002)021&lt;0298:APSWMI&gt;2.0.CO;2, 10.1002/etc.5620210211]; Cryer SA, 2001, ENVIRON MODEL ASSESS, V6, P195, DOI 10.1023/A:1011978420760; Dasgupta S, 2008, SYNTHETIC PYRETHROID; DOMAGALSKI JL, 2003, 034088 US GEOL SURV; Domagalski JL, 2010, ENVIRON TOXICOL CHEM, V29, P813, DOI 10.1002/etc.106; DON DF, 1992, WEED TECHNOL, V6, P716; Dubrovsky N.M., 1998, US GEOLOGICAL SURVEY, V1159; FOCUS (Forum for the Co-ordination of Pesticide Fate Models and their Use), 2001, SANCO48022001REV2 FO; GOSS DW, 1992, WEED TECHNOL, V6, P701, DOI 10.1017/S0890037X00036083; Kellogg RL, 2000, ENV INDICATORS PESTI; KRATZER CR, 2002, 024103 US GEOL SURV; Luo YZ, 2007, CHEMOSPHERE, V66, P1396, DOI 10.1016/j.chemosphere.2006.09.026; Luo YZ, 2010, ENVIRON POLLUT, V158, P1629, DOI 10.1016/j.envpol.2009.12.008; Luo YZ, 2009, J ENVIRON QUAL, V38, P664, DOI 10.2134/jeq2008.0216; Nolan B. T., 2005, 20051196 US GEOL SUR; ROSS LJ, 1999, EH9901 CAL DEP PEST; Russell M, 2001, FINAL REPORT FIFRA E; Siepmann S, 2000, 003 CAL DEP FISH GAM; Singh P, 2002, ENVIRON TOXICOL CHEM, V21, P1545, DOI 10.1897/1551-5028(2002)021&lt;1545:COPRZM&gt;2.0.CO;2; Spurlock F, 2008, ENVIRON TOXICOL CHEM, V27, P1683, DOI 10.1897/07-600.1; United States Environmental Protection Agency (US EPA), 2006, ORG PEST REV CUM RIS; *USEPA, 2010, WAT EXP MOD US OFF P; *USEPA, 1999, EPA600R99064 OFF RES; *USEPA, 2006, EPA600R05111 CTR EXP; *USEPA, 2008, USEPA TIER 2 CROP SC; USEPA, 2005, EPA822R05006 OFF WAT; *USEPA, 2010, PEST ROOT ZON MOD PR; *USEPA, 2010, EFF DET CAL RED LEGG; [USEPA] US Environmental Protection Agency, 2002, GUID SEL INP PAR MOD; *USGS, 2005, 20051196 USGS; Villeneuve J. P., 1988, Journal of Contaminant Hydrology, V3, P77, DOI 10.1016/0169-7722(88)90018-6; Wolt J, 2002, ENVIRON TOXICOL CHEM, V21, P1558, DOI [10.1897/1551-5028(2002)021<1558:SAFVEO>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;1558:SAFVEO&gt;2.0.CO;2]	39	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18234	10.1371/journal.pone.0018234	http://dx.doi.org/10.1371/journal.pone.0018234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483772	gold, Green Published, Green Submitted			2022-12-27	WOS:000289058300008
J	Chou, KC; Wu, ZC; Xiao, XA				Chou, Kuo-Chen; Wu, Zhi-Cheng; Xiao, Xuan			iLoc-Euk: A Multi-Label Classifier for Predicting the Subcellular Localization of Singleplex and Multiplex Eukaryotic Proteins	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SUPPORT VECTOR MACHINES; APOPTOSIS PROTEINS; GENE ONTOLOGY; LOCATION PREDICTION; HYBRID APPROACH; MARCH-INSIDE; SEQUENCES; NETWORKS; REPRESENTATION	Predicting protein subcellular localization is an important and difficult problem, particularly when query proteins may have the multiplex character, i.e., simultaneously exist at, or move between, two or more different subcellular location sites. Most of the existing protein subcellular location predictor can only be used to deal with the single-location or "singleplex" proteins. Actually, multiple-location or "multiplex" proteins should not be ignored because they usually posses some unique biological functions worthy of our special notice. By introducing the "multi-labeled learning" and "accumulation-layer scale", a new predictor, called iLoc-Euk, has been developed that can be used to deal with the systems containing both singleplex and multiplex proteins. As a demonstration, the jackknife cross-validation was performed with iLoc-Euk on a benchmark dataset of eukaryotic proteins classified into the following 22 location sites: (1) acrosome, (2) cell membrane, (3) cell wall, (4) centriole, (5) chloroplast, (6) cyanelle, (7) cytoplasm, (8) cytoskeleton, (9) endoplasmic reticulum, (10) endosome, (11) extracellular, (12) Golgi apparatus, (13) hydrogenosome, (14) lysosome, (15) melanosome, (16) microsome (17) mitochondrion, (18) nucleus, (19) peroxisome, (20) spindle pole body, (21) synapse, and (22) vacuole, where none of proteins included has >= 25% pairwise sequence identity to any other in a same subset. The overall success rate thus obtained by iLoc-Euk was 79%, which is significantly higher than that by any of the existing predictors that also have the capacity to deal with such a complicated and stringent system. As a user-friendly web-server, iLoc-Euk is freely accessible to the public at the web-site http://icpr.jci.edu.cn/bioinfo/iLoc-Euk. It is anticipated that iLoc-Euk may become a useful bioinformatics tool for Molecular Cell Biology, Proteomics, System Biology, and Drug Development Also, its novel approach will further stimulate the development of predicting other protein attributes.	[Chou, Kuo-Chen; Xiao, Xuan] Gordon Life Sci Inst, San Diego, CA 92130 USA; [Wu, Zhi-Cheng; Xiao, Xuan] Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China	Jingdezhen Ceramic Institute	Chou, KC (corresponding author), Gordon Life Sci Inst, San Diego, CA 92130 USA.	kcchou@gordonlifescience.org	Chou, Kuo-Chen/A-8340-2009		National Natural Science Foundation of China [60961003]; Chinese Ministry of Education [210116]; Province National Natural Science Foundation of Jiangxi [2009GZS0064]; Department of Education of Jiangxi Province [GJJ09271]; plan for training youth scientists (stars of Jing-Gang) of Jiangxi Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Province National Natural Science Foundation of Jiangxi; Department of Education of Jiangxi Province; plan for training youth scientists (stars of Jing-Gang) of Jiangxi Province	This work was supported by the grants from the National Natural Science Foundation of China (No. 60961003), the Key Project of Chinese Ministry of Education (No. 210116), the Province National Natural Science Foundation of Jiangxi (2009GZS0064), the Department of Education of Jiangxi Province (No. GJJ09271), and the plan for training youth scientists (stars of Jing-Gang) of Jiangxi Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P31, DOI 10.1093/nar/25.1.31; Cai YD, 2010, PROTEIN PEPTIDE LETT, V17, P464, DOI 10.2174/092986610790963654; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Chen YL, 2007, J THEOR BIOL, V248, P377, DOI 10.1016/j.jtbi.2007.05.019; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; CHOU KC, 1995, FEBS LETT, V363, P123, DOI 10.1016/0014-5793(95)00240-A; Chou KC, 2003, BIOCHEM BIOPH RES CO, V311, P743, DOI 10.1016/j.bbrc.2003.10.062; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 1999, PROTEIN ENG, V12, P107, DOI 10.1093/protein/12.2.107; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1994, J BIOL CHEM, V269, P22014; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Ding YS, 2008, PATTERN RECOGN LETT, V29, P1887, DOI 10.1016/j.patrec.2008.06.007; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Feng Zhi-Ping, 2002, In Silico Biology, V2, P291; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Gerstein M, 2003, CURR OPIN STRUC BIOL, V13, P341, DOI 10.1016/S0959-440X(03)00080-0; Glory E, 2007, DEV CELL, V12, P7, DOI 10.1016/j.devcel.2006.12.007; Gonzalez-Diaz H, 2008, PROTEOMICS, V8, P750, DOI 10.1002/pmic.200700638; Gonzalez-Diaz H, 2007, CURR TOP MED CHEM, V7, P1015, DOI 10.2174/156802607780906771; Gonzalez-Diaz H, 2010, CURR DRUG METAB, V11, P379, DOI 10.2174/138920010791514225; Gonzalez-Diaz H, 2008, CURR TOP MED CHEM, V8, P1676, DOI 10.2174/156802608786786543; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Jahandideh S, 2009, J THEOR BIOL, V259, P517, DOI 10.1016/j.jtbi.2009.04.016; Jiang XY, 2008, PROTEIN PEPTIDE LETT, V15, P392, DOI 10.2174/092986608784246443; Jin YH, 2008, PROTEIN PEPTIDE LETT, V15, P286; Joshi RR, 2010, PROTEIN PEPTIDE LETT, V17, P1198; Kandaswamy KK, 2010, PROTEIN PEPTIDE LETT, V17, P1473; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2011, J THEOR BIOL, V269, P64, DOI 10.1016/j.jtbi.2010.10.019; Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4; Liu LJ, 2010, PROTEIN PEPTIDE LETT, V17, P246, DOI 10.2174/092986610790226085; Liu T, 2010, PROTEIN PEPTIDE LETT, V17, P1263, DOI 10.2174/092986610792231528; Loewenstein Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-207; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Mardia K.V., 1979, MULTIVARIATE ANAL, P322; Masso M, 2010, J THEOR BIOL, V266, P560, DOI 10.1016/j.jtbi.2010.07.026; Matsuda S, 2005, PROTEIN SCI, V14, P2804, DOI 10.1110/ps.051597405; Millar AH, 2009, PLANT CELL, V21, P1625, DOI 10.1105/tpc.109.066019; Mundra P, 2007, PATTERN RECOGN LETT, V28, P1610, DOI 10.1016/j.patrec.2007.04.001; Munteanu CR, 2009, J PROTEOME RES, V8, P5219, DOI 10.1021/pr900556g; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; Nakai K, 2000, ADV PROTEIN CHEM, V54, P277, DOI 10.1016/S0065-3233(00)54009-1; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Pan YX, 2003, J PROTEIN CHEM, V22, P395, DOI 10.1023/A:1025350409648; Park KJ, 2003, BIOINFORMATICS, V19, P1656, DOI 10.1093/bioinformatics/btg222; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Pillai KCS, 1985, ENCY STATISTICAL SCI, P176; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Rodriguez-Soca Y, 2010, J PROTEOME RES, V9, P1182, DOI 10.1021/pr900827b; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; SMITH C, 2008, SUBCELLULAR TARGETIN; Tantoso E, 2008, AMINO ACIDS, V35, P345, DOI 10.1007/s00726-007-0616-y; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Xiao X, 2006, AMINO ACIDS, V30, P49, DOI 10.1007/s00726-005-0225-6; Yang XY, 2010, PROTEIN PEPTIDE LETT, V17, P899, DOI 10.2174/092986610791306670; Zakeri P, 2011, J THEOR BIOL, V269, P208, DOI 10.1016/j.jtbi.2010.10.026; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251	73	305	307	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18258	10.1371/journal.pone.0018258	http://dx.doi.org/10.1371/journal.pone.0018258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21483473	Green Submitted, Green Published, gold			2022-12-27	WOS:000289055700042
J	Mizuno, H; Nakamura, A; Aoki, Y; Ito, N; Kishi, S; Yamamoto, K; Sekiguchi, M; Takeda, S; Hashido, K				Mizuno, Hideya; Nakamura, Akinori; Aoki, Yoshitsugu; Ito, Naoki; Kishi, Soichiro; Yamamoto, Kazuhiro; Sekiguchi, Masayuki; Takeda, Shin'ichi; Hashido, Kazuo			Identification of Muscle-Specific MicroRNAs in Serum of Muscular Dystrophy Animal Models: Promising Novel Blood-Based Markers for Muscular Dystrophy	PLOS ONE			English	Article							CREATINE-KINASE; CIRCULATING MICRORNAS; DIFFERENTIATION; REGENERATION; EXPRESSION; INJURY; FIBERS	Duchenne muscular dystrophy (DMD) is a lethal X-linked disorder caused by mutations in the dystrophin gene, which encodes a cytoskeletal protein, dystrophin. Creatine kinase (CK) is generally used as a blood-based biomarker for muscular disease including DMD, but it is not always reliable since it is easily affected by stress to the body, such as exercise. Therefore, more reliable biomarkers of muscular dystrophy have long been desired. MicroRNAs (miRNAs) are small,,22 nucleotide, noncoding RNAs which play important roles in the regulation of gene expression at the post-transcriptional level. Recently, it has been reported that miRNAs exist in blood. In this study, we hypothesized that the expression levels of specific serum circulating miRNAs may be useful to monitor the pathological progression of muscular diseases, and therefore explored the possibility of these miRNAs as new biomarkers for muscular diseases. To confirm this hypothesis, we quantified the expression levels of miRNAs in serum of the dystrophin-deficient muscular dystrophy mouse model, mdx, and the canine X-linked muscular dystrophy in Japan dog model (CXMDJ), by real-time PCR. We found that the serum levels of several muscle-specific miRNAs (miR-1, miR-133a and miR-206) are increased in both mdx and CXMDJ. Interestingly, unlike CK levels, expression levels of these miRNAs in mdx serum are little influenced by exercise using treadmill. These results suggest that serum miRNAs are useful and reliable biomarkers for muscular dystrophy.	[Mizuno, Hideya; Kishi, Soichiro; Hashido, Kazuo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Adm Sect Radiat Protect, Tokyo, Japan; [Nakamura, Akinori; Aoki, Yoshitsugu; Ito, Naoki; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Tokyo, Japan; [Yamamoto, Kazuhiro; Sekiguchi, Masayuki] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Tokyo, Japan; [Aoki, Yoshitsugu] Tokyo Med & Dent Sch Univ Grad Sch, Med Res Inst, Dept Syst Neurosci, Tokyo, Japan; [Ito, Naoki] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 227, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Tokyo Institute of Technology	Mizuno, H (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Adm Sect Radiat Protect, Tokyo, Japan.	hashido@ncnp.go.jp	Kishi, Soichiro/C-7712-2011; Ito, Naoki/K-9327-2018	Ito, Naoki/0000-0002-1884-8494; Aoki, MD, PhD, Yoshitsugu/0000-0002-9038-7506	ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [21300149] Funding Source: KAKEN	ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Health and Labour Sciences Research Grants for Translational research from the ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; CULLEN MJ, 1980, BRIT MED BULL, V36, P145, DOI 10.1093/oxfordjournals.bmb.a071630; EBASHI S, 1959, J BIOCHEM-TOKYO, V46, P103; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; FLORENCE JM, 1985, NEUROLOGY, V35, P758, DOI 10.1212/WNL.35.5.758; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; MOSER H, 1984, HUM GENET, V66, P17, DOI 10.1007/BF00275183; NICHOLSON GA, 1986, MUSCLE NERVE, V9, P820, DOI 10.1002/mus.880090905; Shimatsu Y, 2003, EXP ANIM TOKYO, V52, P93, DOI 10.1538/expanim.52.93; Shimatsu Yoshiki, 2005, Acta Myol, V24, P145; Urasawa N, 2008, CIRCULATION, V117, P2437, DOI 10.1161/CIRCULATIONAHA.107.739326; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; VASSELLA F, 1965, PEDIATRICS, V35, P322; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022; Yugeta Naoko, 2006, BMC Cardiovasc Disord, V6, P47, DOI 10.1186/1471-2261-6-47	25	136	146	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18388	10.1371/journal.pone.0018388	http://dx.doi.org/10.1371/journal.pone.0018388			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479190	gold, Green Published, Green Submitted			2022-12-27	WOS:000289055700054
J	Pino-Yanes, M; Corrales, A; Basaldua, S; Hernandez, A; Guerra, L; Villar, J; Flores, C				Pino-Yanes, Maria; Corrales, Almudena; Basaldua, Santiago; Hernandez, Alexis; Guerra, Luisa; Villar, Jesus; Flores, Carlos			North African Influences and Potential Bias in Case-Control Association Studies in the Spanish Population	PLOS ONE			English	Article							CANARY-ISLANDS; Y-CHROMOSOME; IBERIAN PENINSULA; GENETIC-STRUCTURE; PATERNAL LINEAGES; GENOTYPE DATA; NEAR-EASTERN; DIVERSITY; EUROPE; STRATIFICATION	Background: Despite the limited genetic heterogeneity of Spanish populations, substantial evidences support that historical African influences have not affected them uniformly. Accounting for such population differences might be essential to reduce spurious results in association studies of genetic factors with disease. Using ancestry informative markers (AIMs), we aimed to measure the African influences in Spanish populations and to explore whether these might introduce statistical bias in population-based association studies. Methodology/Principal Findings: We genotyped 93 AIMs in Spanish (from the Canary Islands and the Iberian Peninsula) and Northwest Africans, and conducted population and individual-based clustering analyses along with reference data from the HapMap, HGDP-CEPH, and other sources. We found significant differences for the Northwest African influence among Spanish populations from as low as approximate to 5% in Spanish from the Iberian Peninsula to as much as approximate to 17% in Canary Islanders, whereas the sub-Saharan African influence was negligible. Strikingly, the Northwest African ancestry showed a wide inter-individual variation in Canary Islanders ranging from 0% to 96%, reflecting the violent way the Islands were conquered and colonized by the Spanish in the XV century. As a consequence, a comparison of allele frequencies between Spanish samples from the Iberian Peninsula and the Canary Islands evidenced an excess of markers with significant differences. However, the inflation of p-values for the differences was adequately controlled by correcting for genetic ancestry estimates derived from a reduced number of AIMs. Conclusions/Significance: Although the African influences estimated might be biased due to marker ascertainment, these results confirm that Northwest African genetic footprints are recognizable nowadays in the Spanish populations, particularly in Canary Islanders, and that the uneven African influences existing in these populations might increase the risk for false positives in association studies. Adjusting for population stratification assessed with a few dozen AIMs would be sufficient to control this effect.	[Pino-Yanes, Maria; Corrales, Almudena; Villar, Jesus; Flores, Carlos] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Pino-Yanes, Maria; Corrales, Almudena; Basaldua, Santiago; Flores, Carlos] Hosp Univ NS Candelaria, Res Unit, Tenerife, Spain; [Hernandez, Alexis] Inst Nacl Toxicol & Ciencias Forenses, Tenerife, Spain; [Guerra, Luisa] Hosp Univ Dr Negrin, Hematol Serv, Las Palmas Gran Canaria, Spain; [Villar, Jesus] Hosp Univ Dr Negrin, Multidisciplinary Organ Dysfunct Evaluat Res Netw, Res Unit, Las Palmas Gran Canaria, Spain; [Villar, Jesus] St Michaels Hosp, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Pino-Yanes, M (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.	cflores@ull.es	Pino-Yanes, Maria/C-8498-2017; Corrales, Almudena/G-5391-2017; Flores, Carlos/R-1159-2019; Villar, Jesús/R-4526-2019	Pino-Yanes, Maria/0000-0003-0332-437X; Corrales, Almudena/0000-0002-2207-5463; Villar, Jesús/0000-0001-5687-3562; Flores, Carlos/0000-0001-5352-069X	Instituto de Salud Carlos III [PI081383, EMER07/001]; Fundacion Canaria de Investigacion y Salud (FUNCIS) [23/07]; Gobierno de Canarias [EMER07/001]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Canaria de Investigacion y Salud (FUNCIS); Gobierno de Canarias	This work was funded by grants to CF from Instituto de Salud Carlos III (PI081383) and Fundacion Canaria de Investigacion y Salud (FUNCIS, 23/07), and by a specific agreement between Instituto de Salud Carlos III and Gobierno de Canarias (EMER07/001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SM, 2008, AM J HUM GENET, V83, P725, DOI 10.1016/j.ajhg.2008.11.007; Alonso S, 2005, EUR J HUM GENET, V13, P1293, DOI 10.1038/sj.ejhg.5201482; Athanasiadis G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-84; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barbujani G, 2004, ANNU REV GENOM HUM G, V5, P119, DOI 10.1146/annurev.genom.5.061903.180021; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Boronat M, 2006, DIABETIC MED, V23, P148, DOI 10.1111/j.1464-5491.2005.01739.x; Bosch E, 2000, EUR J HUM GENET, V8, P360, DOI 10.1038/sj.ejhg.5200464; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Capelli C, 2009, EUR J HUM GENET, V17, P848, DOI 10.1038/ejhg.2008.258; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; CHEJNE AG, 1974, MUSLIM SPAIN HIST CU; de Pablos-Velasco P, 2002, J HYPERTENS, V20, P1965, DOI 10.1097/00004872-200210000-00015; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flores C, 2004, EUR J HUM GENET, V12, P855, DOI 10.1038/sj.ejhg.5201225; Flores C, 2003, ANN HUM GENET, V67, P138, DOI 10.1046/j.1469-1809.2003.00015.x; Flores C, 2001, CURR ANTHROPOL, V42, P749, DOI 10.1086/323819; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fregel R, 2005, IMMUNOGENETICS, V57, P572, DOI 10.1007/s00251-005-0029-6; Fregel R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-181; Gonzalez AM, 2003, AM J PHYS ANTHROPOL, V120, P391, DOI 10.1002/ajpa.10168; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Laayouni H, 2010, HUM GENET, V127, P455, DOI 10.1007/s00439-010-0798-3; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Maca-Meyer N, 2004, ANN HUM GENET, V68, P600, DOI 10.1046/j.1529-8817.2003.00125.x; Maca-Meyer N, 2003, ANN HUM GENET, V67, P329, DOI 10.1046/j.1469-1809.2003.00045.x; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pereira L, 2005, HUM BIOL, V77, P213, DOI 10.1353/hub.2005.0041; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Rando JC, 1999, ANN HUM GENET, V63, P413, DOI 10.1046/j.1469-1809.1999.6350413.x; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; ROBERTS DF, 1965, HUM BIOL, V37, P38; Rodriguez-Ezpeleta N, 2010, HUM GENET, V128, P113, DOI 10.1007/s00439-010-0833-4; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Serda GJ, 2005, J ASTHMA, V42, P507, DOI 10.1081/JAS-200067621; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Wang JL, 2003, GENETICS, V164, P747; Wang PL, 2006, BIOINFORMATICS, V22, pE523, DOI 10.1093/bioinformatics/btl241; WEIR B, 1996, GENETIC DADTA ANAL, V2; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864	51	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18389	10.1371/journal.pone.0018389	http://dx.doi.org/10.1371/journal.pone.0018389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479138	gold, Green Published			2022-12-27	WOS:000289055700055
J	Velez, JM; Miriyala, S; Nithipongvanitch, R; Noel, T; Plabplueng, CD; Oberley, T; Jungsuwadee, P; Van Remmen, H; Vore, M; Clair, DKS				Velez, Joyce M.; Miriyala, Sumitra; Nithipongvanitch, Ramaneeya; Noel, Teresa; Plabplueng, Chotiros D.; Oberley, Terry; Jungsuwadee, Paiboon; Van Remmen, Holly; Vore, Mary; Clair, Daret K. St.			p53 Regulates Oxidative Stress-Mediated Retrograde Signaling: A Novel Mechanism for Chemotherapy-Induced Cardiac Injury	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; GLUTATHIONE TRANSFERASE; LIPID-PEROXIDATION; NITRIC-OXIDE; CELL-DEATH; ACTIVATION; MICE; AUTOPHAGY; PROTEINS; HEART	The side effects of cancer therapy on normal tissues limit the success of therapy. Generation of reactive oxygen species (ROS) has been implicated for numerous chemotherapeutic agents including doxorubicin (DOX), a potent cancer chemotherapeutic drug. The production of ROS by DOX has been linked to DNA damage, nuclear translocation of p53, and mitochondrial injury; however, the causal relationship and molecular mechanisms underlying these events are unknown. The present study used wild-type (WT) and p53 homozygous knock-out (p53(-/-)) mice to investigate the role of p53 in the crosstalk between mitochondria and nucleus. Injecting mice with DOX (20 mg/kg) causes oxidative stress in cardiac tissue as demonstrated by immunogold analysis of the levels of 4-hydroxy-2'-nonenal (4HNE)-adducted protein, a lipid peroxidation product bound to proteins. 4HNE levels increased in both nuclei and mitochondria of WT DOX-treated mice but only in nuclei of DOX-treated p53((-/-)) mice, implicating a critical role for p53 in causing DOX-induced oxidative stress in mitochondria. The stress-activated protein c-Jun amino-terminal kinase (JNKs) was activated in response to increased 4HNE in WT mice but not p53((-/-)) mice receiving DOX treatment, as determined by co-immunoprecipitation of HNE and pJNK. The activation of JNK in DOX treated WT mice was accompanied by Bcl-2 dissociation from Beclin in mitochondria and induction of type II cell death (autophagic cell death), as evidenced by an increase in LC3-I/LC-3-II ratio and gamma-H2AX, a biomarker for DNA damage. The absence of p53 significantly reduces mitochondrial injury, assessed by quantitative morphology, and decline in cardiac function, assessed by left ventricular ejection fraction and fraction shortening. These results demonstrate that p53 plays a critical role in DOX-induced cardiac toxicity, in part, by the induction of oxidative stress mediated retrograde signaling.	[Velez, Joyce M.; Miriyala, Sumitra; Noel, Teresa; Jungsuwadee, Paiboon; Vore, Mary; Clair, Daret K. St.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40526 USA; [Oberley, Terry] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Oberley, Terry] Univ Wisconsin Hosp & Clin, William S Middleton Mem Vet Adm Hosp, Pathol & Lab Med Serv, Madison, WI 53792 USA; [Nithipongvanitch, Ramaneeya; Plabplueng, Chotiros D.] Mahidol Univ, Fac Med Technol, Bangkok 10700, Thailand; [Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Kentucky; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; Mahidol University; University of Texas System; University of Texas Health San Antonio	Velez, JM (corresponding author), Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40526 USA.	DSTCL00@uky.edu	Jungsuwadee, Paiboon/AAE-4038-2020; Vore, Mary/E-2177-2012	Jungsuwadee, Paiboon/0000-0002-5430-6887; Miriyala, Sumitra/0000-0001-7158-9295	National Institutes of Health [CA 139483, CA 139484, T32 HL072743]; Interdisciplinary Cardiovascular Training Program; NATIONAL CANCER INSTITUTE [R01CA139843] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interdisciplinary Cardiovascular Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by National Institutes of Health grants CA 139483, CA 139484 and T32 HL072743, Interdisciplinary Cardiovascular Training Program (Joyce M. Velez). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; ALIN P, 1985, FEBS LETT, V179, P267, DOI 10.1016/0014-5793(85)80532-9; Awasthi YC, 2005, METHOD ENZYMOL, V401, P379, DOI 10.1016/S0076-6879(05)01024-4; BLOOM KR, 1978, CANCER, V41, P1265, DOI 10.1002/1097-0142(197804)41:4<1265::AID-CNCR2820410408>3.0.CO;2-R; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Chaiswing L, 2005, MOL CANCER THER, V4, P1056, DOI 10.1158/1535-7163.MCT-04-0322; Chaiswing L, 2004, TOXICOL PATHOL, V32, P536, DOI 10.1080/01926230490502601; Cole MP, 2006, CARDIOVASC RES, V69, P186, DOI 10.1016/j.cardiores.2005.07.012; Daosukho C, 2007, FREE RADICAL BIO MED, V42, P1818, DOI 10.1016/j.freeradbiomed.2007.03.007; ISHIKAWA T, 1986, J BIOL CHEM, V261, P1576; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Jungsuwadee P, 2006, MOL CANCER THER, V5, P2851, DOI 10.1158/1535-7163.MCT-06-0297; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liu W, 2000, J CELL SCI, V113, P635; Liu W, 1999, J CELL SCI, V112, P2409; Lucas DT, 1999, P NATL ACAD SCI USA, V96, P6689, DOI 10.1073/pnas.96.12.6689; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Mela L, 1979, Methods Enzymol, V55, P39; Nedergaard J, 1979, Methods Enzymol, V55, P3; Nishida Kazuhiko, 2008, Circ J, V72 Suppl A, pA17, DOI 10.1253/circj.CJ-08-0669; NITHIPONGVANITC.R, 2007, J HISTOCHEM CYTOCHEM; Oberley TD, 2002, METHOD ENZYMOL, V352, P373; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Raza H, 2008, TOXICOL APPL PHARM, V226, P161, DOI 10.1016/j.taap.2007.09.002; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Seimiya H, 1997, J BIOL CHEM, V272, P4631, DOI 10.1074/jbc.272.7.4631; Shizukuda Y, 2005, MOL CELL BIOCHEM, V273, P25, DOI 10.1007/s11010-005-5905-8; Srivastava S, 1998, J BIOL CHEM, V273, P10893, DOI 10.1074/jbc.273.18.10893; Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234; Yen HC, 1999, ARCH BIOCHEM BIOPHYS, V362, P59, DOI 10.1006/abbi.1998.1011; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zainal TA, 2000, FASEB J, V14, P1825, DOI 10.1096/fj.99-0881com; Zainal TA, 1999, FREE RADICAL BIO MED, V26, P1181, DOI 10.1016/S0891-5849(98)00312-8; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835	37	52	54	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18005	10.1371/journal.pone.0018005	http://dx.doi.org/10.1371/journal.pone.0018005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479164	Green Published, gold, Green Submitted			2022-12-27	WOS:000289055700021
J	Vidwans, SJ; Flaherty, KT; Fisher, DE; Tenenbaum, JM; Travers, MD; Shrager, J				Vidwans, Smruti J.; Flaherty, Keith T.; Fisher, David E.; Tenenbaum, Jay M.; Travers, Michael D.; Shrager, Jeff			A Melanoma Molecular Disease Model	PLOS ONE			English	Article							P16 PROTEIN EXPRESSION; METASTATIC MELANOMA; SIGNALING PATHWAYS; BRAF MUTATIONS; CYCLIN D1; COMBINED INHIBITION; MALIGNANT-MELANOMA; COMPLETE RESPONSE; LINEAGE SURVIVAL; MUCOSAL MELANOMA	While advanced melanoma remains one of the most challenging cancers, recent developments in our understanding of the molecular drivers of this disease have uncovered exciting opportunities to guide personalized therapeutic decisions. Genetic analyses of melanoma have uncovered several key molecular pathways that are involved in disease onset and progression, as well as prognosis. These advances now make it possible to create a "Molecular Disease Model" (MDM) for melanoma that classifies individual tumors into molecular subtypes (in contrast to traditional histological subtypes), with proposed treatment guidelines for each subtype including specific assays, drugs, and clinical trials. This paper describes such a Melanoma Molecular Disease Model reflecting the latest scientific, clinical, and technological advances.	[Vidwans, Smruti J.; Tenenbaum, Jay M.; Travers, Michael D.; Shrager, Jeff] CollabRx Inc, Palo Alto, CA 94301 USA; [Flaherty, Keith T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Fisher, David E.] Massachusetts Gen Hosp, Dept Dermatol, Cutaneous Biol Res Ctr, Boston, MA 02114 USA; [Fisher, David E.] Massachusetts Gen Hosp, Melanoma Program, Boston, MA 02114 USA; [Shrager, Jeff] Stanford Univ, Symbol Syst Program Consulting, Stanford, CA 94305 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Stanford University	Vidwans, SJ (corresponding author), CollabRx Inc, Palo Alto, CA 94301 USA.	jshrager@stanford.edu	Fisher, David/AAH-2878-2019		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR043369] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aziz SA, 2007, J CLIN ONCOL, V25; Beadling C, 2008, CLIN CANCER RES, V14, P6821, DOI 10.1158/1078-0432.CCR-08-0575; Bedikian AY, 2006, J CLIN ONCOL, V24, P4738, DOI 10.1200/JCO.2006.06.0483; Bedogni B, 2004, CANCER RES, V64, P2552, DOI 10.1158/0008-5472.CAN-03-3327; Bennett DC, 2008, PIGM CELL MELANOMA R, V21, P27, DOI 10.1111/j.1755-148X.2007.00433.x; Board RE, 2009, BRIT J CANCER, V101, P1724, DOI 10.1038/sj.bjc.6605371; Borner C, 1999, MELANOMA RES, V9, P347, DOI 10.1097/00008390-199908000-00002; BOS JL, 1989, CANCER RES, V49, P4682; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Carvajal RD, 2009, J CLIN ONCOL S, V27; Celebi JT, 2000, J MED GENET, V37, P653, DOI 10.1136/jmg.37.9.653; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Edlundh-Rose E, 2006, MELANOMA RES, V16, P471, DOI 10.1097/01.cmr.0000232300.22032.86; Falasca M, 2010, CURR PHARM DESIGN, V16, P1410, DOI 10.2174/138161210791033950; Fisher D E, 2010, Pigment Cell Melanoma Res, V23, P14, DOI 10.1111/j.1755-148X.2009.00655.x; FLAHERTY K, 2009, J CLIN ONCOL S, V27, pNIL18; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gajewski TF, 2006, J CLIN ONCOL, V24, p456S; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gautschi O, 2001, J NATL CANCER I, V93, P463, DOI 10.1093/jnci/93.6.463; Goel VK, 2006, J INVEST DERMATOL, V126, P154, DOI 10.1038/sj.jid.5700026; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Grover R, 1998, MELANOMA RES, V8, P267, DOI 10.1097/00008390-199806000-00010; Harland M, 2005, GENE CHROMOSOME CANC, V43, P128, DOI 10.1002/gcc.20177; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hocker T, 2007, HUM MUTAT, V28, P578, DOI 10.1002/humu.20481; Hocker TL, 2008, J INVEST DERMATOL, V128, P2575, DOI 10.1038/jid.2008.226; Hodi FS, 2008, J CLIN ONCOL, V26, P2046, DOI 10.1200/JCO.2007.14.0707; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Jaiswal BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005717; Jansen B, 1998, NAT MED, V4, P232, DOI 10.1038/nm0298-232; Jonsson G, 2007, ONCOGENE, V26, P4738, DOI 10.1038/sj.onc.1210252; Kefford R., 2010, J CLIN ONCOL S, V28; Keller-Melchior R, 1998, J INVEST DERMATOL, V110, P932, DOI 10.1046/j.1523-1747.1998.00211.x; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Lamba S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006833; Lasithiotakis KG, 2008, J INVEST DERMATOL, V128, P2013, DOI 10.1038/jid.2008.44; Lennartsson J., 2005, CANC THER, V3, P5; LERNER AB, 1986, J INVEST DERMATOL, V87, P299, DOI 10.1111/1523-1747.ep12524353; Li G, 1998, MELANOMA RES, V8, P17, DOI 10.1097/00008390-199802000-00004; Li G, 2000, J INVEST DERMATOL, V114, P514, DOI 10.1046/j.1523-1747.2000.00867.x; Lutzky J, 2008, PIGM CELL MELANOMA R, V21, P492, DOI 10.1111/j.1755-148X.2008.00475.x; MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marini A, 2006, J INVEST DERMATOL, V126, P422, DOI 10.1038/sj.jid.5700073; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Meier F, 2007, BRIT J DERMATOL, V156, P1204, DOI 10.1111/j.1365-2133.2007.07821.x; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Meier F, 2009, J AM ACAD DERMATOL, V60, P863, DOI 10.1016/j.jaad.2008.09.053; Mikhail M, 2005, CLIN CANCER RES, V11, P5153, DOI 10.1158/1078-0432.CCR-05-0397; Molhoek KR, 2008, CANCER RES, V68, P4392, DOI 10.1158/0008-5472.CAN-07-5844; OLA MS, 2011, MOL CELL BIOCH; Pavlick AC, 2009, J CLIN ONCOL, V27; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Przybojewska B, 2000, CANCER GENET CYTOGEN, V121, P73, DOI 10.1016/S0165-4608(00)00223-5; Quinlan MP, 2009, FUTURE ONCOL, V5, P105, DOI 10.2217/14796694.5.1.105; Quintas-Cardama A, 2008, NAT CLIN PRACT ONCOL, V5, P737, DOI 10.1038/ncponc1251; Rizos H, 2001, J BIOL CHEM, V276, P41424, DOI 10.1074/jbc.M105299200; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V338, P1307, DOI 10.1016/j.bbrc.2005.09.150; Roskoski R, 2010, BIOCHEM BIOPH RES CO, V399, P313, DOI 10.1016/j.bbrc.2010.07.092; Satzger I, 2010, DERMATOLOGY, V220, P77, DOI 10.1159/000265558; Sauter ER, 2002, CANCER RES, V62, P3200; Schwartz GK, 2009, J CLIN ONCOL, V27; Selzer E, 1998, MELANOMA RES, V8, P197, DOI 10.1097/00008390-199806000-00001; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Slipicevic A, 2005, AM J CLIN PATHOL, V124, P528, DOI 10.1309/YT58WWMTA6YR1PRV; Smalley KSM, 2008, MOL CANCER THER, V7, P2876, DOI 10.1158/1535-7163.MCT-08-0431; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Soufir N, 1998, HUM MOL GENET, V7, P209, DOI 10.1093/hmg/7.2.209; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Straume O, 2000, CLIN CANCER RES, V6, P1845; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Woodman SE, 2009, MOL CANCER THER, V8, P2079, DOI 10.1158/1535-7163.MCT-09-0459; WOODMAN SE, 2010, BIOCH PHARM     0508; Yokoyama S, 2008, PIGM CELL MELANOMA R, V21, P457, DOI 10.1111/j.1755-148X.2008.00480.x	92	66	70	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18257	10.1371/journal.pone.0018257	http://dx.doi.org/10.1371/journal.pone.0018257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479172	Green Submitted, Green Published, gold			2022-12-27	WOS:000289055700041
J	Farias, AS; Talaisys, RL; Blanco, YC; Lopes, SCP; Longhini, ALF; Pradella, F; Santos, LMB; Costa, FTM				Farias, Alessandro S.; Talaisys, Rafael L.; Blanco, Yara C.; Lopes, Stefanie C. P.; Longhini, Ana Leda F.; Pradella, Fernando; Santos, Leonilda M. B.; Costa, Fabio T. M.			Regulatory T Cell Induction during Plasmodium chabaudi Infection Modifies the Clinical Course of Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; TGF-BETA; SELF-TOLERANCE; IMMUNE EVASION; TH17 CELLS; MALARIA; EFFECTOR; DISEASE; INFLAMMATION	Background: Experimental autoimmune encephalomyelitis (EAE) is used as an animal model for human multiple sclerosis (MS), which is an inflammatory demyelinating autoimmune disease of the central nervous system characterized by activation of Th1 and/or Th17 cells. Human autoimmune diseases can be either exacerbated or suppressed by infectious agents. Recent studies have shown that regulatory T cells play a crucial role in the escape mechanism of Plasmodium spp. both in humans and in experimental models. These cells suppress the Th1 response against the parasite and prevent its elimination. Regulatory T cells have been largely associated with protection or amelioration in several autoimmune diseases, mainly by their capacity to suppress proinflammatory response. Methodology/Principal Findings: In this study, we verified that CD4(+)CD25(+) regulatory T cells (T regs) generated during malaria infection (6 days after EAE induction) interfere with the evolution of EAE. We observed a positive correlation between the reduction of EAE clinical symptoms and an increase of parasitemia levels. Suppression of the disease was also accompanied by a decrease in the expression of IL-17 and IFN-gamma and increases in the expression of IL-10 and TGF-beta 1 relative to EAE control mice. The adoptive transfer of CD4(+)CD25(+) cells from P. chabaudi-infected mice reduced the clinical evolution of EAE, confirming the role of these T regs. Conclusions/Significance: These data corroborate previous findings showing that infections interfere with the prevalence and evolution of autoimmune diseases by inducing regulatory T cells, which regulate EAE in an apparently non-specific manner.	[Farias, Alessandro S.; Talaisys, Rafael L.; Blanco, Yara C.; Lopes, Stefanie C. P.; Longhini, Ana Leda F.; Pradella, Fernando; Santos, Leonilda M. B.; Costa, Fabio T. M.] Univ Estadual Campinas UNICAMP, Dept Genet Evolucao & Bioagentes, Campinas, SP, Brazil	Universidade Estadual de Campinas	Farias, AS (corresponding author), Univ Estadual Campinas UNICAMP, Dept Genet Evolucao & Bioagentes, Campinas, SP, Brazil.	asfarias@unicamp.br; costaftm@unicamp.br	Farias, Alessandro/AAH-2228-2020; Costa, Fabio/E-1181-2012; Lopes, Stefanie/A-8314-2012; Farias, Alessandro/C-6879-2012	Farias, Alessandro/0000-0001-6759-1819; Costa, Fabio/0000-0001-9969-7300; Farias, Alessandro/0000-0001-6759-1819; Lopes, Stefanie/0000-0002-6981-2192	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/15620-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Academy of Sciences for the Developing World (TWAS) [05-049 RG/BIO/LA]; National Institute for Vaccine Development and Technology (CNPq-INCTV); Rede de Malaria (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Academy of Sciences for the Developing World (TWAS); National Institute for Vaccine Development and Technology (CNPq-INCTV); Rede de Malaria (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported financially by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and The Academy of Sciences for the Developing World (TWAS; Grant # 05-049 RG/BIO/LA), The National Institute for Vaccine Development and Technology (CNPq-INCTV) and Rede de Malaria (CNPq). ASF was supported by a FAPESP fellowship (# 2009/15620-9). RLT, YCB and ALFL received a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship and SCPL was supported by CNPq. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderton SM, 2008, CURR OPIN NEUROL, V21, P248, DOI 10.1097/WCO.0b013e3282febf58; Bach JF, 2001, J AUTOIMMUN, V16, P347, DOI 10.1006/jaut.2000.0478; Bettini M, 2009, CURR OPIN IMMUNOL, V21, P612, DOI 10.1016/j.coi.2009.09.011; Blanco YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003126; BROCKE S, 1993, NATURE, V365, P642, DOI 10.1038/365642a0; BUENO LL, PLOS ONE, V5, pE9623; Cambos M, 2008, INT J PARASITOL, V38, P229, DOI 10.1016/j.ijpara.2007.07.006; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Farias AS, 2007, NEUROIMMUNOMODULAT, V14, P32, DOI 10.1159/000107286; Feger U, 2007, CLIN EXP IMMUNOL, V147, P412, DOI 10.1111/j.1365-2249.2006.03271.x; Finney OC, 2009, EUR J IMMUNOL, V39, P1288, DOI 10.1002/eji.200839112; Furtado GD, 2001, IMMUNOL REV, V182, P122; Hafler DA, 2005, IMMUNOL REV, V204, P208, DOI 10.1111/j.0105-2896.2005.00240.x; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hisaeda H, 2005, INT J BIOCHEM CELL B, V37, P700, DOI 10.1016/j.biocel.2004.10.009; Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; LEHMANN D, 1992, J AUTOIMMUN, V5, P675, DOI 10.1016/0896-8411(92)90185-S; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Minigo G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000402; Nie CQ, 2007, INFECT IMMUN, V75, P2275, DOI 10.1128/IAI.01783-06; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; O'Connor RA, 2008, J NEUROIMMUNOL, V193, P1, DOI 10.1016/j.jneuroim.2007.11.016; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Omer FM, 2003, J EXP MED, V198, P1817, DOI 10.1084/jem.20030713; Peacock JW, 2003, EUR J IMMUNOL, V33, P1849, DOI 10.1002/eji.200323148; Riley EM, 2006, PARASITE IMMUNOL, V28, P35, DOI 10.1111/j.1365-3024.2006.00775.x; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Scholzen A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000543; Strauch UG, 2005, GUT, V54, P1546, DOI 10.1136/gut.2004.059451; Tadokoro CE, 2004, J AUTOIMMUN, V23, P103, DOI 10.1016/j.jaut.2004.05.003; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Todryk SM, 2009, EUR J IMMUNOL, V39, P3042, DOI 10.1002/eji.200939434; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818	38	24	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17849	10.1371/journal.pone.0017849	http://dx.doi.org/10.1371/journal.pone.0017849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464982	Green Published, gold, Green Submitted			2022-12-27	WOS:000288813900014
J	Braeckman, U; Provoost, P; Moens, T; Soetaert, K; Middelburg, JJ; Vincx, M; Vanaverbeke, J				Braeckman, Ulrike; Provoost, Pieter; Moens, Tom; Soetaert, Karline; Middelburg, Jack J.; Vincx, Magda; Vanaverbeke, Jan			Biological vs. Physical Mixing Effects on Benthic Food Web Dynamics	PLOS ONE			English	Article							DEEP-SEA NEMATODES; ESTUARINE TIDAL FLAT; LANICE-CONCHILEGA; ORGANIC-MATTER; VERTICAL-DISTRIBUTION; NORTH-SEA; SEDIMENTS; BACTERIA; CARBON; PHYTOPLANKTON	Biological particle mixing (bioturbation) and solute transfer (bio-irrigation) contribute extensively to ecosystem functioning in sediments where physical mixing is low. Macrobenthos transports oxygen and organic matter deeper into the sediment, thereby likely providing favourable niches to lower trophic levels (i.e., smaller benthic animals such as meiofauna and bacteria) and thus stimulating mineralisation. Whether this biological transport facilitates fresh organic matter assimilation by the metazoan lower part of the food web through niche establishment (i.e., ecosystem engineering) or rather deprives them from food sources, is so far unclear. We investigated the effects of the ecosystem engineers Lanice conchilega (bio-irrigator) and Abra alba (bioturbator) compared to abiotic physical mixing events on survival and food uptake of nematodes after a simulated phytoplankton bloom. The C-13 labelled diatom Skeletonema costatum was added to 4 treatments: (1) microcosms containing the bioturbator, (2) microcosms containing the bio-irrigator, (3) control microcosms and (4) microcosms with abiotic manual surface mixing. Nematode survival and subsurface peaks in nematode density profiles were most pronounced in the bio-irrigator treatment. However, nematode specific uptake (Delta delta C-13) of the added diatoms was highest in the physical mixing treatment, where macrobenthos was absent and the diatom C-13 was homogenised. Overall, nematodes fed preferentially on bulk sedimentary organic material rather than the added diatoms. The total C budget (mu g C m(-2)), which included (TOC)-C-13 remaining in the sediment, respiration, nematode and macrobenthic uptake, highlighted the limited assimilation by the metazoan benthos and the major role of bacterial respiration. In summary, bioturbation and especially bio-irrigation facilitated the lower trophic levels mainly over the long-term through niche establishment. Since the freshly added diatoms represented only a limited food source for nematodes, the macrobenthic effect was more pronounced in niche establishment than the negative structuring effects such as competition.	[Braeckman, Ulrike; Moens, Tom; Vincx, Magda; Vanaverbeke, Jan] Univ Ghent, Marine Biol Sect, Dept Biol, B-9000 Ghent, Belgium; [Provoost, Pieter; Soetaert, Karline; Middelburg, Jack J.] Netherlands Inst Ecol NIOO KNAW, Ctr Estuarine & Marine Ecol, Yerseke, Netherlands; [Middelburg, Jack J.] Univ Utrecht, Fac Geosci, Utrecht, Netherlands	Ghent University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Utrecht University	Braeckman, U (corresponding author), Univ Ghent, Marine Biol Sect, Dept Biol, B-9000 Ghent, Belgium.	Ulrike.Braeckman@UGent.be	Braeckman, Ulrike/AAJ-4801-2021; Vanaverbeke, jan/A-1118-2012; Soetaert, Karline E/A-9839-2011; Moens, Tom/AAB-8701-2019; Middelburg, Jack/B-4951-2011	Soetaert, Karline E/0000-0003-4603-7100; Middelburg, Jack/0000-0003-3601-9072; Braeckman, Ulrike/0000-0002-7558-6363	Research Foundation - Flanders (FWO); Belgian Science Policy (BelSPO) [SD/BN/01A, GOA 01600705, G.0041.08]; European Union Network of Excellence MarBEF [GOCE-CT-2003-505446]	Research Foundation - Flanders (FWO)(FWO); Belgian Science Policy (BelSPO)(Belgian Federal Science Policy Office); European Union Network of Excellence MarBEF	Support was given to U.B. by the Research Foundation - Flanders (FWO). This paper contributes to the Westbanks project (www.vliz.be/projects/westbanks), which is supported by the Belgian Science Policy (BelSPO, contract no. SD/BN/01A) to the Ghent University BBSea Project (GOA 01600705), FWO project (G.0041.08) and the European Union Network of Excellence MarBEF (GOCE-CT-2003-505446). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle N, 2003, MAR ECOL PROG SER, V251, P37, DOI 10.3354/meps251037; AMOUROUX JM, 1989, MAR ECOL PROG SER, V51, P87, DOI 10.3354/meps051087; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2004, J EXP MAR BIOL ECOL, V305, P191, DOI 10.1016/j.jembe.2003.12.011; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Bouchet VMP, 2009, J EXP MAR BIOL ECOL, V371, P20, DOI 10.1016/j.jembe.2008.12.012; Braeckman U, 2011, MAR ECOL PROG SER, V422, P179, DOI 10.3354/meps08910; Braeckman U, 2010, MAR ECOL PROG SER, V399, P173, DOI 10.3354/meps08336; Dashfield SL, 2008, J EXP MAR BIOL ECOL, V365, P46, DOI 10.1016/j.jembe.2008.07.039; Degraer S., 2006, MACROBENTHOS ATLAS B; FORSTER S, 1995, MAR BIOL, V123, P335, DOI 10.1007/BF00353625; Franco MA, 2008, J EXP MAR BIOL ECOL, V362, P1, DOI 10.1016/j.jembe.2008.04.010; Franco MA, 2008, MAR ECOL PROG SER, V358, P51, DOI 10.3354/meps07361; Friedrichs M, 2000, MAR ECOL PROG SER, V192, P219, DOI 10.3354/meps192219; Gallucci F, 2008, MAR ECOL PROG SER, V367, P173, DOI 10.3354/meps07537; Gorley C.K., 2006, GETTING STARTED PRIM; GRAF G, 1992, OCEANOGR MAR BIOL, V30, P149; Guilini K, 2010, LIMNOL OCEANOGR, V55, P1977, DOI 10.4319/lo.2010.55.5.1977; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; HARGRAVE BT, 1973, J FISH RES BOARD CAN, V30, P1317, DOI 10.1139/f73-212; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Ingels J, 2010, MAR ECOL PROG SER, V406, P121, DOI 10.3354/meps08535; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kamp A, 2005, MAR ECOL PROG SER, V297, P61, DOI 10.3354/meps297061; KRISTENSEN E, 2005, INTERACTIONS MACRO M, P125, DOI DOI 10.1029/CE060P0125; KRISTENSEN E, 1987, J MARINE RES JMMRAO, V45; Lancelot C, 2005, MAR ECOL PROG SER, V289, P63, DOI 10.3354/meps289063; Levin L, 1997, J MAR RES, V55, P595, DOI 10.1357/0022240973224337; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Middelburg JJ, 2000, LIMNOL OCEANOGR, V45, P1224, DOI 10.4319/lo.2000.45.6.1224; Moens T, 2002, MAR ECOL PROG SER, V234, P127, DOI 10.3354/meps234127; Moodley L, 2002, MAR ECOL PROG SER, V236, P23, DOI 10.3354/meps236023; Olafsson E, 2003, VIE MILIEU, V53, P249; Posey M, 1996, B MAR SCI, V59, P523; Rabaut M., 2009, THESIS GHENT U; Rabaut M, 2007, ESTUAR COAST SHELF S, V75, P525, DOI 10.1016/j.ecss.2007.05.041; Rabaut M, 2009, HELGOLAND MAR RES, V63, P37, DOI 10.1007/s10152-008-0137-4; REISE K, 1983, MAR ECOL PROG SER, V12, P229, DOI 10.3354/meps012229; REISE K, 1985, ECOLOGICAL STUDIES A, V54, P119; Rousseau V, 2002, MAR ECOL PROG SER, V236, P61, DOI 10.3354/meps236061; SOLAN M, 2005, INTERACTIONS MACRO M, P105; Steyaert M, 2001, MAR ECOL PROG SER, V224, P299, DOI 10.3354/meps224299; Steyaert M., 2005, ELECT KEY FREE LIVIN; Sun MY, 2005, MAR CHEM, V96, P201, DOI 10.1016/j.marchem.2004.11.003; Sun MY, 2002, ORG GEOCHEM, V33, P445, DOI 10.1016/S0146-6380(02)00005-0; Van Hoey G, 2005, ESTUAR COAST SHELF S, V64, P751, DOI 10.1016/j.ecss.2005.03.022; Van Hoey G, 2004, ESTUAR COAST SHELF S, V59, P599, DOI 10.1016/j.ecss.2003.11.005; Van Hoey G, 2008, MAR BIOL, V154, P1009, DOI 10.1007/s00227-008-0992-1; van Nugteren P, 2009, LIMNOL OCEANOGR, V54, P1413, DOI 10.4319/lo.2009.54.5.1413; van Oevelen D, 2006, LIMNOL OCEANOGR, V51, P1302, DOI 10.4319/lo.2006.51.3.1302; van Oevelen D, 2009, MAR ECOL PROG SER, V380, P19, DOI 10.3354/meps07921; Vanaverbeke J, 2008, CURRENT STATUS EUTRO, P73; Warwick R.M., 1998, SYNOPSES BRIT FAUNA, P53; Wetzel MA, 1995, MAR BIOL, V124, P301, DOI 10.1007/BF00347134; Witte U, 2003, MAR ECOL PROG SER, V251, P27, DOI 10.3354/meps251027; Wright S., 1997, PHYTOPLANKTON PIGMEN, P327; ZIEGELMEIER E, 1969, HELGOLAND WISS MEER, V19, P216, DOI 10.1007/BF01625607; Ziegelmeier E., 1954, Helgolander Wissenschaftliche Meeresuntersuchungen, V4, P107, DOI 10.1007/BF02178540	58	35	35	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18078	10.1371/journal.pone.0018078	http://dx.doi.org/10.1371/journal.pone.0018078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455308	Green Published, gold, Green Submitted			2022-12-27	WOS:000288811500020
J	Bousquet, SM; Monet, M; Boulay, G				Bousquet, Simon M.; Monet, Michael; Boulay, Guylain			The Serine 814 of TRPC6 Is Phosphorylated under Unstimulated Conditions	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; RECEPTOR POTENTIAL TRP; SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE CK2; CALCIUM-ENTRY; CA2+ ENTRY; DEPENDENT PHOSPHORYLATION; STATISTICAL-MODEL; CHANNEL ACTIVITY; STORE DEPLETION	TRPC are nonselective cation channels involved in calcium entry. Their regulation by phosphorylation has been shown to modulate their routing and activity. TRPC6 activity increases following phosphorylation by Fyn, and is inhibited by protein kinase G and protein kinase C. A previous study by our group showed that TRPC6 is phosphorylated under unstimulated conditions in a human embryonic kidney cells line (HEK293). To investigate the mechanism responsible for this phosphorylation, we used a MS/MS approach combined with metabolic labeling and showed that the serine at position 814 is phosphorylated in unstimulated cells. The mutation of Ser(814) into Ala decreased basal phosphorylation but did not modify TRPC6 activity. Even though Ser(814) is within a consensus site for casein kinase II (CK2), we showed that CK2 is not involved in the phosphorylation of TRPC6 and does not modify its activity. In summary, we identified a new basal phosphorylation site (Ser(814)) on TRPC6 and showed that CK2 is not responsible for the phosphorylation of this site.	[Bousquet, Simon M.; Monet, Michael; Boulay, Guylain] Univ Sherbrooke, Dept Pharmacol, Sherbrooke, PQ, Canada	University of Sherbrooke	Bousquet, SM (corresponding author), Univ Sherbrooke, Dept Pharmacol, Sherbrooke, PQ, Canada.	Guylain.Boulay@USherbrooke.ca	Boulay, Guylain/D-9773-2010	MONET, Michael/0000-0002-7864-862X	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Quebec Heart & Stroke Foundation; Fonds de Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Quebec Heart & Stroke Foundation; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, and the Quebec Heart & Stroke Foundation. GB is the recipient of a scholarship from the Fonds de Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSUBEL FM, 2002, CURRENT PROTOCOLS MO; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; BOUSQUET S, 2010, J BIOL CHEM; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Jung S, 2002, AM J PHYSIOL-CELL PH, V282, pC347, DOI 10.1152/ajpcell.00283.2001; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Mani BK, 2009, CELL CALCIUM, V45, P400, DOI 10.1016/j.ceca.2009.01.004; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Sambrook J, 2001, MOL CLONING LAB MAN; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sinkins WG, 2004, J BIOL CHEM, V279, P34521, DOI 10.1074/jbc.M401156200; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Takahashi S, 2008, J PHYSIOL-LONDON, V586, P4209, DOI 10.1113/jphysiol.2008.156083; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Voolstra O, 2010, J BIOL CHEM, V285, P14275, DOI 10.1074/jbc.M110.102053; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	38	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18121	10.1371/journal.pone.0018121	http://dx.doi.org/10.1371/journal.pone.0018121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448286	Green Published, Green Submitted, gold			2022-12-27	WOS:000288810500041
J	Elkan-Miller, T; Ulitsky, I; Hertzano, R; Rudnicki, A; Dror, AA; Lenz, DR; Elkon, R; Irmler, M; Beckers, J; Shamir, R; Avraham, KB				Elkan-Miller, Tal; Ulitsky, Igor; Hertzano, Ronna; Rudnicki, Anya; Dror, Amiel A.; Lenz, Danielle R.; Elkon, Ran; Irmler, Martin; Beckers, Johannes; Shamir, Ron; Avraham, Karen B.			Integration of Transcriptomics, Proteomics, and MicroRNA Analyses Reveals Novel MicroRNA Regulation of Targets in the Mammalian Inner Ear	PLOS ONE			English	Article							GROWTH-FACTOR LEDGF/P75; PROGRESSIVE HEARING-LOSS; GENE-EXPRESSION; SENSORY EPITHELIA; CANCER CELLS; HAIR-CELLS; MOUSE; IDENTIFICATION; ACTIVATION; MUTATIONS	We have employed a novel approach for the identification of functionally important microRNA (miRNA)-target interactions, integrating miRNA, transcriptome and proteome profiles and advanced in silico analysis using the FAME algorithm. Since miRNAs play a crucial role in the inner ear, demonstrated by the discovery of mutations in a miRNA leading to human and mouse deafness, we applied this approach to microdissected auditory and vestibular sensory epithelia. We detected the expression of 157 miRNAs in the inner ear sensory epithelia, with 53 miRNAs differentially expressed between the cochlea and vestibule. Functionally important miRNAs were determined by searching for enriched or depleted targets in the transcript and protein datasets with an expression consistent with the dogma of miRNA regulation. Importantly, quite a few of the targets were detected only in the protein datasets, attributable to regulation by translational suppression. We identified and experimentally validated the regulation of PSIP1-P75, a transcriptional co-activator previously unknown in the inner ear, by miR-135b, in vestibular hair cells. Our findings suggest that miR-135b serves as a cellular effector, involved in regulating some of the differences between the cochlear and vestibular hair cells.	[Elkan-Miller, Tal; Hertzano, Ronna; Rudnicki, Anya; Dror, Amiel A.; Lenz, Danielle R.; Elkon, Ran; Avraham, Karen B.] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Ulitsky, Igor; Shamir, Ron] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Irmler, Martin; Beckers, Johannes] Helmholtz Ctr Munich, German Res Ctr Environm Hlth GmbH, Inst Expt Genet, Neuherberg, Germany; [Beckers, Johannes] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, D-8050 Freising Weihenstephan, Germany	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Elkan-Miller, T (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	karena@post.tau.ac.il	Dror, Amiel/AAB-7522-2020; Ulitsky, Igor/HCH-7453-2022; Dror, Amiel/AAD-3348-2022; Irmler, Martin/B-3317-2013; Hertzano, Ronna P/Y-8304-2019; Beckers, Johannes/K-7237-2012	Ulitsky, Igor/0000-0003-0555-6561; Dror, Amiel/0000-0002-7178-6771; Irmler, Martin/0000-0003-3169-479X; Beckers, Johannes/0000-0001-7874-3822; Avraham, Karen B/0000-0002-4913-251X; Shamir, Ron/0000-0003-1889-9870	Israel Science Foundation [1486/07, 802/08]; European Commission [LSHG-CT-2004-512063, HEALTH-F4-2009-223575]; Eumodic [037188]; Helmholtz Alliance CoReNe; Tel Aviv University; Legacy Heritage Fund	Israel Science Foundation(Israel Science Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Eumodic; Helmholtz Alliance CoReNe; Tel Aviv University; Legacy Heritage Fund	This work was supported by the Israel Science Foundation (Grant number 1486/07), European Commission FP6 Integrated Projects EuroHear (Grant number LSHG-CT-2004-512063) and Eumodic (Grant number 037188) (to K.B.A.); Helmholtz Alliance CoReNe (to J.B.); Israel Science Foundation (Grant number 802/08) and the European Union 7th framework programme (project HEALTH-F4-2009-223575, TRIREME) (to R.S.). I.U. was supported in part by the Edmond J. Safra Bioinformatics program at Tel Aviv University and the Legacy Heritage Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Beer I, 2004, PROTEOMICS, V4, P950, DOI 10.1002/pmic.200300652; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Chen YR, 2006, J PROTEOME RES, V5, P2727, DOI 10.1021/pr060212g; Cheng C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r90; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Chylack LT, 2004, EXP EYE RES, V79, P941, DOI 10.1016/j.exer.2004.08.022; Denman-Johnson K, 1999, J NEUROCYTOL, V28, P821, DOI 10.1023/A:1007061819934; Dror AA, 2010, J BIOL CHEM, V285, P21724, DOI 10.1074/jbc.M110.120188; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; GIOANNI J, 1990, BRIT J CANCER, V62, P8, DOI 10.1038/bjc.1990.219; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Grosshans H, 2008, CELL, V134, P560, DOI 10.1016/j.cell.2008.08.008; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; HACKNEY CM, 1995, AM J PHYSIOL-CELL PH, V268, pC1, DOI 10.1152/ajpcell.1995.268.1.C1; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hertzano R, 2004, HUM MOL GENET, V13, P2143, DOI 10.1093/hmg/ddh218; Hertzano R, 2010, JARO-J ASSOC RES OTO, V11, P407, DOI 10.1007/s10162-010-0211-x; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Irmler M, 2008, PROTEOMICS, V8, P1165, DOI 10.1002/pmic.200700741; Kawamoto K, 2009, HEARING RES, V247, P17, DOI 10.1016/j.heares.2008.08.010; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kelly M, 2007, INT J DEV BIOL, V51, P535, DOI 10.1387/ijdb.072344mk; Kircher M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-346; Kosik KS, 2005, NEURON, V47, P779, DOI 10.1016/j.neuron.2005.08.019; Kubo E, 2003, HISTOCHEM CELL BIOL, V119, P289, DOI 10.1007/s00418-003-0518-3; Kubo E, 2002, J MOL BIOL, V320, P1053, DOI 10.1016/S0022-2836(02)00551-X; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Navarro F, 2010, J IMMUNOL, V184, P5939, DOI 10.4049/jimmunol.0902567; Nishizawa Y, 2001, CELL TISSUE RES, V305, P107, DOI 10.1007/s004410100398; Oshima A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.034397; Robertson NG, 1998, NAT GENET, V20, P299, DOI 10.1038/3118; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shinohara T, 2002, PROG RETIN EYE RES, V21, P341, DOI 10.1016/S1350-9462(02)00007-1; Singh DP, 2000, BIOCHEM BIOPH RES CO, V267, P373, DOI 10.1006/bbrc.1999.1979; Singh DP, 2000, GENE, V242, P265, DOI 10.1016/S0378-1119(99)00506-5; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sutherland HG, 2006, MOL CELL BIOL, V26, P7201, DOI 10.1128/MCB.00459-06; Takacs CM, 2010, SEMIN CELL DEV BIOL, V21, P760, DOI 10.1016/j.semcdb.2010.02.003; Tunnacliffe A, 1996, MAMM GENOME, V7, P784, DOI 10.1007/s003359900234; Ulitsky I, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq570; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Voorhoeve PM, 2007, ADV EXP MED BIOL, V604, P17, DOI 10.1007/978-0-387-69116-9_2; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; Yang Y, 2010, MOL BIOSYST, V6, P1873, DOI 10.1039/c004401f; Yang Y, 2009, PROTEOMICS, V9, P1374, DOI 10.1002/pmic.200800551	60	63	69	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18195	10.1371/journal.pone.0018195	http://dx.doi.org/10.1371/journal.pone.0018195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483685	Green Published, gold			2022-12-27	WOS:000289191300010
J	Savas, S; Azorsa, DO; Jarjanazi, H; Ibrahim-Zada, I; Gonzales, IM; Arora, S; Henderson, MC; Choi, YH; Briollais, L; Ozcelik, H; Tuzmen, S				Savas, Sevtap; Azorsa, David O.; Jarjanazi, Hamdi; Ibrahim-Zada, Irada; Gonzales, Irma M.; Arora, Shilpi; Henderson, Meredith C.; Choi, Yun Hee; Briollais, Laurent; Ozcelik, Hilmi; Tuzmen, Sukru			NCI60 Cancer Cell Line Panel Data and RNAi Analysis Help Identify EAF2 as a Modulator of Simvastatin and Lovastatin Response in HCT-116 Cells	PLOS ONE			English	Article							PROSTATE-CANCER; COLORECTAL-CANCER; STATINS INHIBIT; STEM-CELLS; PROTEIN; ADENOCARCINOMA; CHOLESTEROL; APOPTOSIS; SURVIVAL; PATHWAY	Simvastatin and lovastatin are statins traditionally used for lowering serum cholesterol levels. However, there exists evidence indicating their potential chemotherapeutic characteristics in cancer. In this study, we used bioinformatic analysis of publicly available data in order to systematically identify the genes involved in resistance to cytotoxic effects of these two drugs in the NCI60 cell line panel. We used the pharmacological data available for all the NCI60 cell lines to classify simvastatin or lovastatin resistant and sensitive cell lines, respectively. Next, we performed whole-genome single marker case-control association tests for the lovastatin and simvastatin resistant and sensitive cells using their publicly available Affymetrix 125K SNP genomic data. The results were then evaluated using RNAi methodology. After correction of the p-values for multiple testing using False Discovery Rate, our results identified three genes (NRP1, COL13A1, MRPS31) and six genes (EAF2, ANK2, AKAP7, STEAP2, LPIN2, PARVB) associated with resistance to simvastatin and lovastatin, respectively. Functional validation using RNAi confirmed that silencing of EAF2 expression modulated the response of HCT-116 colon cancer cells to both statins. In summary, we have successfully utilized the publicly available data on the NCI60 cell lines to perform whole-genome association studies for simvastatin and lovastatin. Our results indicated genes involved in the cellular response to these statins and siRNA studies confirmed the role of the EAF2 in response to these drugs in HCT-116 colon cancer cells.	[Savas, Sevtap; Jarjanazi, Hamdi; Ibrahim-Zada, Irada; Ozcelik, Hilmi] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; [Savas, Sevtap; Jarjanazi, Hamdi; Ibrahim-Zada, Irada; Ozcelik, Hilmi] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Savas, Sevtap; Jarjanazi, Hamdi; Ibrahim-Zada, Irada; Ozcelik, Hilmi] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Azorsa, David O.; Gonzales, Irma M.; Arora, Shilpi; Henderson, Meredith C.; Tuzmen, Sukru] Translat Genom Res Inst TGen, Pharmaceut Genom Div, Scottsdale, AZ USA; [Azorsa, David O.; Gonzales, Irma M.; Henderson, Meredith C.] Translat Genom Res Inst TGen, Clin Translat Res Div, Scottsdale, AZ USA; [Choi, Yun Hee; Briollais, Laurent] Mt Sinai Hosp, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Translational Genomics Research Institute; Translational Genomics Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Savas, S (corresponding author), Mem Univ, Discipline Genet, Fac Med, St John, NF, Canada.	dazorsa@tgen.org	Jarjanazi, Hamdi/B-6221-2011; Briollais, Laurent/A-2941-2013; Tüzmen, Şükrü/AAH-9916-2021; Tuzmen, Sukru/I-5663-2013	Jarjanazi, Hamdi/0000-0001-8652-2560; Tüzmen, Şükrü/0000-0003-4822-396X; Tuzmen, Sukru/0000-0003-4822-396X; Savas, Sevtap/0000-0002-7324-938X	Canadian Breast Cancer Foundation - Ontario Chapter; TGen institutional research funds; prostate cancer foundation	Canadian Breast Cancer Foundation - Ontario Chapter; TGen institutional research funds; prostate cancer foundation	This study was supported by TGen institutional research funds and a grant from the prostate cancer foundation (H. Ozcelik). Y.H. Choi is supported by a fellowship from the Canadian Breast Cancer Foundation - Ontario Chapter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2006, BBA-REV CANCER, V1766, P168, DOI 10.1016/j.bbcan.2006.10.003; Al-Mosawi ZS, 2007, ARTHRITIS RHEUM, V56, P960, DOI 10.1002/art.22431; Arden SD, 1996, J CLIN INVEST, V97, P551, DOI 10.1172/JCI118448; Azorsa DO, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-43; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; Cascorbi I, 2006, PHARMACOL THERAPEUT, V112, P457, DOI 10.1016/j.pharmthera.2006.04.009; Eng L, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-18; Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI 10.1007/978-1-4757-1647-4_5; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; Fuchs D, 2008, BIOCHEM BIOPH RES CO, V374, P309, DOI 10.1016/j.bbrc.2008.07.012; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gauthaman K, 2009, BRIT J PHARMACOL, V157, P962, DOI 10.1111/j.1476-5381.2009.00241.x; Gauthaman K, 2009, J CELL BIOCHEM, V106, P975, DOI 10.1002/jcb.22092; Gbelcova H, 2008, INT J CANCER, V122, P1214, DOI 10.1002/ijc.23242; Gray PC, 1998, CURR OPIN NEUROBIOL, V8, P330, DOI 10.1016/S0959-4388(98)80057-3; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Hager MH, 2006, CURR OPIN CLIN NUTR, V9, P379, DOI 10.1097/01.mco.0000232896.66791.62; Hahn J, 2007, PROSTATE, V67, P146, DOI 10.1002/pros.20481; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Jarjanazi H, 2008, HUM MUTAT, V29, P461, DOI 10.1002/humu.20732; Kang S, 2009, ONCOL REP, V21, P1317, DOI 10.3892/or_00000357; Kim WS, 2001, INVEST NEW DRUG, V19, P81, DOI 10.1023/A:1006481423298; Kodach LL, 2007, GASTROENTEROLOGY, V133, P1272, DOI 10.1053/j.gastro.2007.08.021; Korenbaum E, 2001, GENE, V279, P69, DOI 10.1016/S0378-1119(01)00743-0; Lennernas H, 1997, CLIN PHARMACOKINET, V32, P403, DOI 10.2165/00003088-199732050-00005; Lewis KA, 2005, LEUKEMIA RES, V29, P527, DOI 10.1016/j.leukres.2004.10.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzi PL, 2006, MOL CANCER THER, V5, P2613, DOI 10.1158/1535-7163.MCT-06-0447; Martirosyan A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-103; Maurus D, 2005, EMBO J, V24, P1181, DOI 10.1038/sj.emboj.7600603; Mohler PJ, 2006, J CARDIOVASC ELECTR, V17, P1153, DOI 10.1111/j.1540-8167.2006.00540.x; Mongroo PS, 2004, ONCOGENE, V23, P8959, DOI 10.1038/sj.onc.1208112; Ogunwobi OO, 2008, AM J GASTROENTEROL, V103, P825, DOI 10.1111/j.1572-0241.2007.01773.x; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Porkka KP, 2002, LAB INVEST, V82, P1573, DOI 10.1097/01.LAB.0000038554.26102.C6; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Savas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012601; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Tomiyama N, 2008, BIOL PHARM BULL, V31, P369, DOI 10.1248/bpb.31.369; Tuzmen Sukru, 2007, Methods Mol Biol, V353, P177; Vree Tom B, 2003, ScientificWorldJournal, V3, P1332; Wheeler DL, 2002, NUCLEIC ACIDS RES, V30, P13, DOI 10.1093/nar/30.1.13; Xiao W, 2008, ONCOGENE, V27, P1536, DOI 10.1038/sj.onc.1210786; Ylonen R, 2005, J BONE MINER RES, V20, P1381, DOI 10.1359/JBMR.050319; Zhuang LY, 2002, CANCER RES, V62, P2227	49	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18306	10.1371/journal.pone.0018306	http://dx.doi.org/10.1371/journal.pone.0018306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483694	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000289058700018
J	Trevino, V; Tadesse, MG; Vannucci, M; Al-Shahrour, F; Antczak, P; Durant, S; Bikfalvi, A; Dopazo, J; Campbell, MJ; Falciani, F				Trevino, Victor; Tadesse, Mahlet G.; Vannucci, Marina; Al-Shahrour, Fatima; Antczak, Philipp; Durant, Sarah; Bikfalvi, Andreas; Dopazo, Joaquin; Campbell, Moray J.; Falciani, Francesco			Analysis of Normal-Tumour Tissue Interaction in Tumours: Prediction of Prostate Cancer Features from the Molecular Profile of Adjacent Normal Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; II RECEPTOR BLOCKER; NF-KAPPA-B; GENE-EXPRESSION; LYSYL OXIDASE; BREAST-CANCER; MICROARRAY ANALYSIS; SIGNALING PATHWAYS; VARIABLE SELECTION; METASTASIS	Statistical modelling, in combination with genome-wide expression profiling techniques, has demonstrated that the molecular state of the tumour is sufficient to infer its pathological state. These studies have been extremely important in diagnostics and have contributed to improving our understanding of tumour biology. However, their importance in in-depth understanding of cancer patho-physiology may be limited since they do not explicitly take into consideration the fundamental role of the tissue microenvironment in specifying tumour physiology. Because of the importance of normal cells in shaping the tissue microenvironment we formulate the hypothesis that molecular components of the profile of normal epithelial cells adjacent the tumour are predictive of tumour physiology. We addressed this hypothesis by developing statistical models that link gene expression profiles representing the molecular state of adjacent normal epithelial cells to tumour features in prostate cancer. Furthermore, network analysis showed that predictive genes are linked to the activity of important secreted factors, which have the potential to influence tumor biology, such as IL1, IGF1, PDGF BB, AGT, and TGF beta.	[Trevino, Victor; Antczak, Philipp; Durant, Sarah; Falciani, Francesco] Univ Birmingham, Sch Biosci, Edgbaston, England; [Trevino, Victor; Antczak, Philipp; Durant, Sarah; Falciani, Francesco] Univ Birmingham, IBR, Edgbaston, England; [Tadesse, Mahlet G.] Univ Penn, Sch Med, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Vannucci, Marina] Rice Univ, Houston, TX USA; [Al-Shahrour, Fatima; Dopazo, Joaquin] Ctr Invest Principe Felipe, Bioinformat Dept, Valencia, Spain; [Campbell, Moray J.] Univ Birmingham, Sch Med, Inst Biomed Res, Birmingham, W Midlands, England; [Trevino, Victor] Inst Tecnol & Estudios Super Monterrey, Dept Comp Sci, Nuevo Leon, Mexico; [Trevino, Victor] Inst Tecnol & Estudios Super Monterrey, Biomed Engn Program, Nuevo Leon, Mexico; [Campbell, Moray J.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Bikfalvi, Andreas] INSERM, U920, Talence, France; [Bikfalvi, Andreas] Univ Bordeaux 1, F-33405 Talence, France	University of Birmingham; University of Birmingham; University of Pennsylvania; Rice University; Prince Felipe Research Center; University of Birmingham; Tecnologico de Monterrey; Tecnologico de Monterrey; Roswell Park Cancer Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Trevino, V (corresponding author), Univ Birmingham, Sch Biosci, Edgbaston, England.	ffalciani@googlemail.com	Antczak, Philipp/L-5879-2019; Trevino, Victor/C-9219-2009; Vannucci, Marina/I-8439-2014; Campbell, Moray/ABF-1264-2021; Dopazo, Joaquin/A-9270-2014; Campbell, Moray J/A-1311-2013	Antczak, Philipp/0000-0001-9600-7757; Trevino, Victor/0000-0002-7472-9844; Vannucci, Marina/0000-0002-7360-5321; Campbell, Moray/0000-0002-3355-0928; Dopazo, Joaquin/0000-0003-3318-120X; 	Darwin Trust; CONACyT; CRUK [C8504/A9488]; Spanish Ministry of Science and Innovation [BIO2008-04212]; GVA-FEDER [PROMETEO/2010/001]; National Institute of Bioinformatics; RTICC [RD06/0020/1019]; NIH-NHGRI [R01-HG003319]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003319] Funding Source: NIH RePORTER	Darwin Trust; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CRUK(Cancer Research UK); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); GVA-FEDER; National Institute of Bioinformatics; RTICC(Instituto de Salud Carlos III); NIH-NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Victor Trevino was a recipient of a Darwin Trust Fellowship and CONACyT. This work is in part funded by grants from the CRUK (C8504/A9488), Spanish Ministry of Science and Innovation (BIO2008-04212), GVA-FEDER (PROMETEO/2010/001). The authors also thank the support of the National Institute of Bioinformatics (www.inab.org) and the RTICC (grant RD06/0020/1019) both initiatives of the Instituto de Salud Carlos III (MICINN). Marina Vannucci is partially supported by NIH-NHGRI R01-HG003319. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti C, 2006, INT J BIOL MARKER, V21, P88, DOI 10.1177/172460080602100204; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008; BORNFELDT KE, 1994, J CLIN INVEST, V93, P1266, DOI 10.1172/JCI117081; Bose SK, 2009, PROSTATE, V69, P1334, DOI 10.1002/pros.20980; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; Chandran UR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-45; Chow L, 2009, MOL CELL ENDOCRINOL, V302, P219, DOI 10.1016/j.mce.2008.08.032; Cianfrocca M, 2009, CA-CANCER J CLIN, V59, P303, DOI 10.3322/caac.20029; Ding Q, 2010, AM J MED SCI, V339, P425, DOI 10.1097/MAJ.0b013e3181d7c9db; Dupont J, 2001, ENDOCRINOLOGY, V142, P4969, DOI 10.1210/en.142.11.4969; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Ghadjar P, 2008, J CANCER RES CLIN, V134, P1181, DOI 10.1007/s00432-008-0403-5; Gonzalez-Moreno O, 2010, EXP CELL RES, V316, P554, DOI 10.1016/j.yexcr.2009.11.020; Gregg JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-165; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Hinz M, 2002, J EXP MED, V196, P605, DOI 10.1084/jem.20020062; Jeay S, 2003, MOL CELL BIOL, V23, P2251, DOI 10.1128/MCB.23.7.2251-2263.2003; Joshi A, 2010, FRONT BIOSCI-LANDMRK, V15, P180, DOI 10.2741/3614; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; Lindmark F, 2005, BRIT J CANCER, V93, P493, DOI 10.1038/sj.bjc.6602729; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Min CY, 2009, CANCER RES, V69, P6685, DOI 10.1158/0008-5472.CAN-08-4818; Monnier Y, 2008, CANCER RES, V68, P7323, DOI 10.1158/0008-5472.CAN-08-0841; Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Ooi CH, 2003, BIOINFORMATICS, V19, P37, DOI 10.1093/bioinformatics/19.1.37; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Palamakumbura AH, 2009, ONCOGENE, V28, P3390, DOI 10.1038/onc.2009.203; Quackenbush J, 2006, NEW ENGL J MED, V354, P2463, DOI 10.1056/NEJMra042342; REDNER A, 1986, ANN NY ACAD SCI, V468, P241, DOI 10.1111/j.1749-6632.1986.tb42043.x; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Rollins BJ, 2006, EUR J CANCER, V42, P760, DOI 10.1016/j.ejca.2006.01.002; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sakamoto S, 2004, PROSTATE, V61, P305, DOI 10.1002/pros.20098; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; Schroder FH, 2009, J UROLOGY, V181, P69, DOI 10.1016/j.juro.2008.09.012; Sha NJ, 2004, BIOMETRICS, V60, P812, DOI 10.1111/j.0006-341X.2004.00233.x; Shulby SA, 2004, CANCER RES, V64, P4693, DOI 10.1158/0008-5472.CAN-03-3437; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Sun YJ, 2009, PROSTATE, V69, P1119, DOI 10.1002/pros.20961; Sun ZJ, 2008, BRIT J CANCER, V99, P1656, DOI 10.1038/sj.bjc.6604712; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Trevino V, 2006, BIOINFORMATICS, V22, P1154, DOI 10.1093/bioinformatics/btl074; Tsai MS, 2002, ONCOGENE, V21, P8178, DOI 10.1038/sj.onc.1205682; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; Uemura H, 2008, MOL CANCER RES, V6, P250, DOI 10.1158/1541-7786.MCR-07-0289; Uemura H, 2008, INT J UROL, V15, P19, DOI 10.1111/j.1442-2042.2007.01937.x; Uemura H, 2006, MINI-REV MED CHEM, V6, P835, DOI 10.2174/138955706777698633; VLAHOS CJ, 1993, J CELL BIOCHEM, V52, P404, DOI 10.1002/jcb.240520405; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Wang WQ, 2009, INT J CANCER, V124, P521, DOI 10.1002/ijc.23961	57	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e16492	10.1371/journal.pone.0016492	http://dx.doi.org/10.1371/journal.pone.0016492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479216	Green Published, Green Submitted, gold			2022-12-27	WOS:000289055700004
J	Gilot, D; Le Meur, N; Giudicelli, F; Le Vee, M; Lagadic-Gossmann, D; Theret, N; Fardel, O				Gilot, David; Le Meur, Nolwenn; Giudicelli, Fanny; Le Vee, Marc; Lagadic-Gossmann, Dominique; Theret, Nathalie; Fardel, Olivier			RNAi-Based Screening Identifies Kinases Interfering with Dioxin-Mediated Up-Regulation of CYP1A1 Activity	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; CELL-CYCLE PROGRESSION; BREAST-CANCER CELLS; AH RECEPTOR; PROTEIN-KINASE; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; INOSITOL 1,4,5-TRISPHOSPHATE; ACTIVATION; PHOSPHORYLATION; INHIBITOR	Background: The aryl hydrocarbon receptor (AhR) is a transcription factor activated by several environmental pollutants, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), and involved in carcinogenesis and various physiological processes, including immune response and endocrine functions. Characterization of kinases-related AhR transduction pathway remains an important purpose. Results: We performed a kinome-wide siRNA screen in human mammary MCF-7 cells to identify non redundant protein kinases implicated in the up-regulation of cytochrome P-450 (CYP) 1A1 activity, an AhR referent target, in response to TCDD exposure. To this aim, we monitored CYP1A1-related ethoxyresorufin-O-deethylase (EROD) activity and quantified cell density. This normalization was crucial since it allowed us to focus only on siRNA affecting EROD activity and discard siRNA affecting cell density. Analyses of the cell density data allowed us to identify several hits already well-characterized as effectors of the cell cycle and original hits. Collectively, these data fully validated the protocol and the siRNA library. Next, 22 novel candidates were identified as kinases potentially implicated in the up-regulation of CYP1A1 in response to TCDD, without alteration of cell survival or cell proliferation. The siRNA library screen gave a limited number of hits (approximately 3%). Interestingly, four of them are able to bind calmodulin among which the IP3 kinase A (ITPKA) and pregnancy up-regulated non-ubiquitously expressed CaM kinase (PNCK, also named CaMKI beta). Remarkably, for both proteins, their kinase activity depends on the calmodulin binding. Involvement of ITPKA and PNCK in TCDD-mediated CYP1A1 up-regulation was further validated by screening-independent expression knock-down. PNCK was finally shown to regulate activation of CaMKI alpha, a CaMKI isoform previously reported to interplay with the AhR pathway. Conclusions: These data fully support a role for both IP3-related kinase and CaMK isoforms in the AhR signaling cascade. More generally, this study also highlights the interest of large scale loss-of-function screens for characterizing the molecular mechanism of action of environmental contaminants.	[Gilot, David; Le Meur, Nolwenn; Giudicelli, Fanny; Le Vee, Marc; Lagadic-Gossmann, Dominique; Theret, Nathalie; Fardel, Olivier] Univ Rennes 1, EA Signalisat & Reponse Agents Infectieux & Chim, Inst Rech Sante Environm & Travail, Rennes, France; [Gilot, David; Le Meur, Nolwenn; Giudicelli, Fanny; Le Vee, Marc; Lagadic-Gossmann, Dominique; Theret, Nathalie; Fardel, Olivier] Inst Federatif Rech 140, Rennes, France; [Fardel, Olivier] CHU Rennes, Dept Hematol Immunol & Therapie Cellulaire, Hop Pontchaillou, Rennes, France	Universite de Rennes; CHU Rennes	Gilot, D (corresponding author), Inst Genet & Dev Rennes, CNRS, UMR 6061, Equipe Regulat Transcript & Oncogenese, Rennes, France.	david.gilot@univ-rennes1.fr	Le Meur, Nolwenn/M-3039-2013; Theret, Nathalie/I-2871-2015; Le Vee, Marc/U-8843-2019; LAGADIC-GOSSMANN, Dominique/I-5079-2015; theret, nathalie/ABG-6780-2020; Fardel, Olivier/J-8560-2015; LE VÉE, Marc/AAP-6961-2020	Le Meur, Nolwenn/0000-0001-8451-4014; Theret, Nathalie/0000-0002-5857-7828; LAGADIC-GOSSMANN, Dominique/0000-0002-4888-236X; theret, nathalie/0000-0002-5857-7828; 	Ministere de l'Ecologie, de l'Energie, du Developpement Durable et de la Mer	Ministere de l'Ecologie, de l'Energie, du Developpement Durable et de la Mer	This work was supported by the Programme National de Recherche sur les Perturbateurs Endocriniens (PNRPE) from the Ministere de l'Ecologie, de l'Energie, du Developpement Durable et de la Mer (http://www.developpement-durable.gouv.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHULETA MM, 1993, P NATL ACAD SCI USA, V90, P6105, DOI 10.1073/pnas.90.13.6105; Barhoover MA, 2010, MOL PHARMACOL, V77, P195, DOI 10.1124/mol.109.059675; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Braeuning A, 2009, DRUG METAB DISPOS, V37, P1576, DOI 10.1124/dmd.109.027821; Chen SJ, 2005, J BIOL CHEM, V280, P4350, DOI 10.1074/jbc.M411554200; Condon JC, 2002, ENDOCRINOLOGY, V143, P3651, DOI 10.1210/en.2001-211359; Davila DR, 1999, J TOXICOL ENV HEAL A, V56, P249, DOI 10.1080/009841099158097; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Enan E, 1996, BIOCHEM PHARMACOL, V52, P1599, DOI 10.1016/S0006-2952(96)00566-7; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Gardner HP, 2000, GENOMICS, V63, P279, DOI 10.1006/geno.1999.6091; Giet R, 2005, TRENDS CELL BIOL, V15, P241, DOI 10.1016/j.tcb.2005.03.004; GILOT D, 2010, CHEM BIOL INTERACT; Han EH, 2009, TOXICOLOGY, V266, P38, DOI 10.1016/j.tox.2009.10.013; Howard S, 2009, J MED CHEM, V52, P379, DOI 10.1021/jm800984v; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Lin CH, 2008, J NEUROCHEM, V104, P1415, DOI 10.1111/j.1471-4159.2007.05098.x; Mahajan S, 1999, J BIOL CHEM, V274, P9587, DOI 10.1074/jbc.274.14.9587; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matsumura F, 2009, BIOCHEM PHARMACOL, V77, P608, DOI 10.1016/j.bcp.2008.10.013; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Micheau O, 1997, J NATL CANCER I, V89, P783, DOI 10.1093/jnci/89.11.783; Monteiro P, 2008, MOL PHARMACOL, V73, P769, DOI 10.1124/mol.107.043125; Monteiro P, 2008, DRUG METAB DISPOS, V36, P2556, DOI 10.1124/dmd.108.023333; Mullenders J, 2009, ONCOGENE, V28, P4409, DOI 10.1038/onc.2009.295; N'Diaye M, 2006, J BIOL CHEM, V281, P19906, DOI 10.1074/jbc.M601192200; Naito Y, 1997, J BIOL CHEM, V272, P32704, DOI 10.1074/jbc.272.51.32704; Oesch-Bartlomowicz B, 2005, BIOCHEM BIOPH RES CO, V338, P446, DOI 10.1016/j.bbrc.2005.08.092; Oesch-Bartlomowicz B, 2009, BIOCHEM PHARMACOL, V77, P627, DOI 10.1016/j.bcp.2008.10.017; OKEY AB, 1994, TOXICOL LETT, V70, P1, DOI 10.1016/0378-4274(94)90139-2; Pelz O, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-185; Piva R, 2006, BLOOD, V107, P689, DOI 10.1182/blood-2005-05-2125; Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031; Rodriguez-Mora OG, 2005, CANCER RES, V65, P5408, DOI 10.1158/0008-5472.CAN-05-0271; Schwarz M, 2005, REGUL TOXICOL PHARM, V43, P19, DOI 10.1016/j.yrtph.2005.05.008; Swanson HI, 2002, CHEM-BIOL INTERACT, V141, P63, DOI 10.1016/S0009-2797(02)00066-2; Tan ZQ, 2004, TOXICOL SCI, V82, P80, DOI 10.1093/toxsci/kfh228; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Wang YQ, 2009, J BIOL CHEM, V284, P5671, DOI 10.1074/jbc.M806104200; Xia HJ, 2005, CELL RES, V15, P83, DOI 10.1038/sj.cr.7290270; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675	42	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18261	10.1371/journal.pone.0018261	http://dx.doi.org/10.1371/journal.pone.0018261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479225	Green Published, gold			2022-12-27	WOS:000289054600039
J	Gregory, MS; Hackett, CG; Abernathy, EF; Lee, KS; Saff, RR; Hohlbaum, AM; Moody, KSL; Hobson, MW; Jones, A; Kolovou, P; Karray, S; Giani, A; John, SWM; Chen, DF; Marshak-Rothstein, A; Ksander, BR				Gregory, Meredith S.; Hackett, Caroline G.; Abernathy, Emma F.; Lee, Karen S.; Saff, Rebecca R.; Hohlbaum, Andreas M.; Moody, Krishna-sulayman L.; Hobson, Maura W.; Jones, Alexander; Kolovou, Paraskevi; Karray, Saoussen; Giani, Andrea; John, Simon W. M.; Chen, Dong Feng; Marshak-Rothstein, Ann; Ksander, Bruce R.			Opposing Roles for Membrane Bound and Soluble Fas Ligand in Glaucoma-Associated Retinal Ganglion Cell Death	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; FIBER LAYER THICKNESS; OCULAR IMMUNE PRIVILEGE; OPEN-ANGLE GLAUCOMA; INFLAMMATORY RESPONSES; INDUCED APOPTOSIS; GENE-EXPRESSION; DBA/2J MICE; ALPHA; ACTIVATION	Glaucoma, the most frequent optic neuropathy, is a leading cause of blindness worldwide. Death of retinal ganglion cells (RGCs) occurs in all forms of glaucoma and accounts for the loss of vision, however the molecular mechanisms that cause RGC loss remain unclear. The pro-apoptotic molecule, Fas ligand, is a transmembrane protein that can be cleaved from the cell surface by metalloproteinases to release a soluble protein with antagonistic activity. Previous studies documented that constitutive ocular expression of FasL maintained immune privilege and prevented neoangeogenesis. We now show that FasL also plays a major role in retinal neurotoxicity. Importantly, in both TNF alpha triggered RGC death and a spontaneous model of glaucoma, gene-targeted mice that express only full-length FasL exhibit accelerated RGC death. By contrast, FasL-deficiency, or administration of soluble FasL, protected RGCs from cell death. These data identify membrane-bound FasL as a critical effector molecule and potential therapeutic target in glaucoma.	[Gregory, Meredith S.; Hackett, Caroline G.; Abernathy, Emma F.; Hobson, Maura W.; Jones, Alexander; Kolovou, Paraskevi; Chen, Dong Feng; Ksander, Bruce R.] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02163 USA; [Lee, Karen S.; Hohlbaum, Andreas M.; Moody, Krishna-sulayman L.; Hobson, Maura W.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Saff, Rebecca R.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Moody, Krishna-sulayman L.; Marshak-Rothstein, Ann] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Karray, Saoussen] Hop Necker Enfants Malad, INSERM, U580, Paris, France; [Giani, Andrea] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA; [John, Simon W. M.] Jackson Lab, Howard Hughes Med Inst, Bar Harbor, ME 04609 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Boston University; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Howard Hughes Medical Institute; Jackson Laboratory	Gregory, MS (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02163 USA.	ann.rothstein@umassmed.edu; bruce.ksander@schepens.harvard.edu	Gregory-Ksander, Meredith/AAG-1413-2019; Giani, Andrea/L-5926-2017	Gregory-Ksander, Meredith/0000-0002-7193-0032; Giani, Andrea/0000-0003-0682-1945; Karray, Saoussen/0000-0003-0107-4039	Lions Research Foundation; American Health Assistance Foundation; NEI [EY016486, EY016145]; NCI [CA90691]; Glaucoma Foundation;  [EY11721]; NATIONAL CANCER INSTITUTE [R01CA090691] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011721, R29EY011721, R01EY016145, R01EY016486] Funding Source: NIH RePORTER	Lions Research Foundation; American Health Assistance Foundation(BrightFocus Foundation); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Glaucoma Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding sources: Lions Research Foundation (BRK), American Health Assistance Foundation (MSG), NEI EY016486 (BRK), NEI EY016145 (MSG), NCI CA90691 (AMR), EY11721 (SWMJ), the Glaucoma Foundation (BRK) and SWMJ is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapova OA, 2001, GLIA, V33, P205, DOI 10.1002/1098-1136(200103)33:3<205::AID-GLIA1019>3.0.CO;2-D; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Anderson MG, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-20; Aoki K, 2001, NAT IMMUNOL, V2, P333, DOI 10.1038/86336; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Bossi G, 2005, SEMIN IMMUNOL, V17, P87, DOI 10.1016/j.smim.2004.09.007; Dace DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007121; Ferguson TA, 2008, SEMIN IMMUNOPATHOL, V30, P111, DOI 10.1007/s00281-008-0113-8; Funayama T, 2004, INVEST OPHTH VIS SCI, V45, P4359, DOI 10.1167/iovs.03-1403; Gregory MS, 2002, J IMMUNOL, V169, P2727, DOI 10.4049/jimmunol.169.5.2727; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; He JS, 2007, J IMMUNOL, V179, P2339, DOI 10.4049/jimmunol.179.4.2339; Hohlbaum AM, 2001, J IMMUNOL, V167, P6217, DOI 10.4049/jimmunol.167.11.6217; Hohlbaum AM, 2000, J EXP MED, V191, P1209, DOI 10.1084/jem.191.7.1209; Hu MS, 1999, INFECT IMMUN, V67, P928, DOI 10.1128/IAI.67.2.928-935.1999; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Jodo S, 2001, J BIOL CHEM, V276, P39938, DOI 10.1074/jbc.M107005200; Ju KR, 2006, BRAIN RES, V1122, P209, DOI 10.1016/j.brainres.2006.09.022; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Karray S, 2004, J IMMUNOL, V172, P2118, DOI 10.4049/jimmunol.172.4.2118; Kavurma MM, 2003, CELL DEATH DIFFER, V10, P36, DOI 10.1038/sj.cdd.4401179; Kim JS, 2009, BRIT J OPHTHALMOL, V93, P1057, DOI 10.1136/bjo.2009.157875; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lee HO, 2003, CYTOKINE GROWTH F R, V14, P325, DOI 10.1016/S1359-6101(03)00028-5; Lei Y, 2008, INVEST OPHTH VIS SCI, V49, P1940, DOI 10.1167/iovs.07-0735; Letellier E, 2010, IMMUNITY, V32, P240, DOI 10.1016/j.immuni.2010.01.011; Lin HJ, 2003, EYE, V17, P31, DOI 10.1038/sj.eye.6700227; Martinez-Lorenzo MJ, 1998, EUR J IMMUNOL, V28, P2714, DOI 10.1002/(SICI)1521-4141(199809)28:09<2714::AID-IMMU2714>3.0.CO;2-9; McKinnon S J, 1997, Curr Opin Ophthalmol, V8, P28, DOI 10.1097/00055735-199704000-00006; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; NEMAZEE D, 1991, J IMMUNOL, V147, P2536; Ohta K, 2000, INVEST OPHTH VIS SCI, V41, P2591; Park SM, 2005, CURR OPIN CELL BIOL, V17, P610, DOI 10.1016/j.ceb.2005.09.010; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Rescigno M, 2000, J EXP MED, V192, P1661, DOI 10.1084/jem.192.11.1661; Sano Y, 2002, EXP EYE RES, V75, P475, DOI 10.1006/exer.2002.2044; Sawada H, 2010, INVEST OPHTH VIS SCI, V51, P903, DOI 10.1167/iovs.09-4247; SCHUMAN JS, 1995, ARCH OPHTHALMOL-CHIC, V113, P586, DOI 10.1001/archopht.1995.01100050054031; SHERRY B, 1988, J CELL BIOL, V107, P1269, DOI 10.1083/jcb.107.4.1269; Shudo K, 2001, EUR J IMMUNOL, V31, P2504, DOI 10.1002/1521-4141(200108)31:8<2504::AID-IMMU2504>3.0.CO;2-C; Sotozono C, 2000, CURR EYE RES, V20, P54, DOI 10.1076/0271-3683(200001)20:1;1-H;FT054; Stuart PM, 2003, INVEST OPHTH VIS SCI, V44, P93, DOI 10.1167/iovs.02-0299; Stuart PM, 1997, J CLIN INVEST, V99, P396, DOI 10.1172/JCI119173; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; Sugita S, 2000, BRIT J OPHTHALMOL, V84, P1130, DOI 10.1136/bjo.84.10.1130; TANAKA M, 1995, EMBO J, V14, P1129, DOI 10.1002/j.1460-2075.1995.tb07096.x; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Taylor DL, 2005, J NEUROSCI, V25, P2952, DOI 10.1523/JNEUROSCI.4456-04.2005; Tchedre KT, 2008, INVEST OPHTH VIS SCI, V49, P2577, DOI 10.1167/iovs.07-1101; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; THEOFILOPOULOS AN, 1985, J EXP MED, V162, P1, DOI 10.1084/jem.162.1.1; Vargo-Gogola T, 2002, ARCH BIOCHEM BIOPHYS, V408, P155, DOI 10.1016/S0003-9861(02)00525-8; Wax MB, 2008, J NEUROSCI, V28, P12085, DOI 10.1523/JNEUROSCI.3200-08.2008; Wollstein G, 2005, ARCH OPHTHALMOL-CHIC, V123, P464, DOI 10.1001/archopht.123.4.464; Yang ZY, 2007, INVEST OPHTH VIS SCI, V48, P5539, DOI 10.1167/iovs.07-0542	61	81	83	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17659	10.1371/journal.pone.0017659	http://dx.doi.org/10.1371/journal.pone.0017659			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479271	Green Published, gold, Green Submitted			2022-12-27	WOS:000289054600014
J	Held, N; Smits, BMG; Gockeln, R; Schubert, S; Nave, H; Northrup, E; Cuppen, E; Hedrich, HJ; Wedekind, D				Held, Nadine; Smits, Bart M. G.; Gockeln, Roland; Schubert, Stephanie; Nave, Heike; Northrup, Emily; Cuppen, Edwin; Hedrich, Hans J.; Wedekind, Dirk			A Mutation in Myo15 Leads to Usher-Like Symptoms in LEW/Ztm-ci2 Rats	PLOS ONE			English	Article							UNCONVENTIONAL MYOSIN; RETINITIS-PIGMENTOSA; HEARING-LOSS; CIRCLING BEHAVIOR; DEAFNESS DFNB3; HAIR-CELLS; GENE; WHIRLIN; MOUSE; MODEL	The LEW/Ztm-ci2 rat is an animal model for syndromal deafness that arose from a spontaneous mutation. Homozygous animals show locomotor abnormalities like lateralized circling behavior. Additionally, an impaired vision can be observed in some animals through behavioral studies. Syndromal deafness as well as retinal degeneration are features of the Usher syndrome in humans. In the present study, the mutation was identified as a base substitution (T->C) in exon 56 of Myo15, leading to an amino acid exchange from leucine (Leu) to proline (Pro) within the carboxy-terminal MyTH4 domain in the proteins' tail region. Myo15 mRNA was expressed in the retina as demonstrated for the first time with the help of in-situ hybridization and PCR. To characterize the visual phenotype, rats were examined by scotopic and photopic electroretinography and, additionally, histological analyses of the retinas were conducted. The complete loss of sight was detected along with a severe degeneration of photoreceptor cells. Interestingly, the manifestation of the disease does not solely depend on the mutation, but also on environmental factors. Since the LEW/Ztm-ci2 rat features the entire range of symptoms of the human Usher syndrome we think that this strain is an appropriate model for this disease. Our findings display that mutations in binding domains of myosin XV do not only cause non-syndromic hearing loss but can also lead to syndromic disorders including retinal dysfunction.	[Held, Nadine; Northrup, Emily; Hedrich, Hans J.; Wedekind, Dirk] Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany; [Smits, Bart M. G.; Cuppen, Edwin] KNAW, Hubrecht Inst, Utrecht, Netherlands; [Smits, Bart M. G.; Cuppen, Edwin] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Gockeln, Roland] Hannover Med Sch, Clin Ophthalmol, D-3000 Hannover, Germany; [Schubert, Stephanie] Hannover Med Sch, Inst Human Genet, D-3000 Hannover, Germany; [Nave, Heike] Hannover Med Sch, Inst Funct & Appl Anat, D-3000 Hannover, Germany	Hannover Medical School; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Hannover Medical School; Hannover Medical School; Hannover Medical School	Held, N (corresponding author), Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany.		Kielstein, Heike/GNW-4839-2022; Cuppen, Edwin/H-2389-2016; Cuppen, Edwin/F-5696-2011	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Schubert, Stephanie/0000-0001-8634-7299	Deutsche Forschungsgemeinschaft (DFG) [GRK705-II]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (DFG), GRK705-II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham KB, 1997, HUM MOL GENET, V6, P1225, DOI 10.1093/hmg/6.8.1225; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Baker JP, 1998, CURR OPIN CELL BIOL, V10, P80, DOI 10.1016/S0955-0674(98)80089-6; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Chwalisz WT, 2003, MAMM GENOME, V14, P620, DOI 10.1007/s00335-003-3009-x; DAVENPORT SLH, 1977, MONTR 5 INT C BIRTH; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; Ebermann I, 2007, HUM GENET, V121, P203, DOI 10.1007/s00439-006-0304-0; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Gockeln R, 2003, INVEST OPHTH VIS SCI, V44, pU431; HECKENLIVELY JR, 1988, AM J OPHTHALMOL, V105, P504, DOI 10.1016/0002-9394(88)90242-5; Kaiser A, 2001, EUR J NEUROSCI, V14, P1129, DOI 10.1046/j.0953-816x.2001.01726.x; Karl T, 2003, PHYSIOL BEHAV, V80, P123, DOI 10.1016/S0031-9384(03)00229-4; Kremer H, 2006, HUM MOL GENET, V15, pR262, DOI 10.1093/hmg/ddl205; Liang Y, 1999, GENOMICS, V61, P243, DOI 10.1006/geno.1999.5976; Liburd N, 2001, HUM GENET, V109, P535, DOI 10.1007/s004390100604; Liu XQ, 2007, P NATL ACAD SCI USA, V104, P4413, DOI 10.1073/pnas.0610950104; Liu XZ, 1999, AM J HUM GENET, V64, P1221, DOI 10.1086/302332; Loscher W, 2010, NEUROMETHODS, V44, P33, DOI 10.1007/978-1-60761-474-6_3; Loscher W, 2010, NEUROSCI BIOBEHAV R, V34, P31, DOI 10.1016/j.neubiorev.2009.07.001; Loscher W, 1996, NEUROSCIENCE, V74, P1135; Marmor MF, 2004, DOC OPHTHALMOL, V108, P107, DOI 10.1023/B:DOOP.0000036793.44912.45; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Mburu Philomena, 1997, Genes and Function, V1, P191; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Nal N, 2007, HUM MUTAT, V28, P1014, DOI 10.1002/humu.20556; NARAYAN O, 1983, J INFECT DIS, V148, P305, DOI 10.1093/infdis/148.2.305; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Noell W K, 1966, Invest Ophthalmol, V5, P450; Paige AJW, 2000, MAMM GENOME, V11, P51, DOI 10.1007/s003350010010; Petit C, 2001, ANNU REV GENOM HUM G, V2, P271, DOI 10.1146/annurev.genom.2.1.271; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Redowicz MJ, 2002, ACTA BIOCHIM POL, V49, P789; ROBBINS SG, 1990, LAB INVEST, V62, P417; Rogers MJC, 1999, MAMM GENOME, V10, P513, DOI 10.1007/s003359901032; Schwartz SB, 2005, INVEST OPHTH VIS SCI, V46, P734, DOI 10.1167/iovs.04-1136; Shearer AE, 2009, LARYNGOSCOPE, V119, P727, DOI 10.1002/lary.20116; Smits BMG, 2005, GENETICS, V170, P1887, DOI 10.1534/genetics.105.044222; Tlili Abdelaziz, 2005, Hum Mutat, V25, P503, DOI 10.1002/humu.9333; Tuxworth RI, 2000, TRAFFIC, V1, P11, DOI 10.1034/j.1600-0854.2000.010103.x; Urbach YK, 2010, METHODS MOL BIOL, V597, P333, DOI 10.1007/978-1-60327-389-3_24; Usher C. H., 1914, ROY LOND OPHTHAL HOS, V19, P130; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; WILLIAMS TP, 1983, INVEST OPHTH VIS SCI, V24, P285	47	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e15669	10.1371/journal.pone.0015669	http://dx.doi.org/10.1371/journal.pone.0015669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479269	gold, Green Published, Green Submitted			2022-12-27	WOS:000289054600006
J	Irving, AD; Connell, SD; Russell, BD				Irving, Andrew D.; Connell, Sean D.; Russell, Bayden D.			Restoring Coastal Plants to Improve Global Carbon Storage: Reaping What We Sow	PLOS ONE			English	Article							CLIMATE-CHANGE; CO2; IMPACTS	Long-term carbon capture and storage (CCS) is currently considered a viable strategy for mitigating rising levels of atmospheric CO2 and associated impacts of global climate change. Until recently, the significant below-ground CCS capacity of coastal vegetation such as seagrasses, salt marshes, and mangroves has largely gone unrecognized in models of global carbon transfer. However, this reservoir of natural, free, and sustainable carbon storage potential is increasingly jeopardized by alarming trends in coastal habitat loss, totalling 30-50% of global abundance over the last century alone. Human intervention to restore lost habitats is a potentially powerful solution to improve natural rates of global CCS, but data suggest this approach is unlikely to substantially improve long-term CCS unless current restoration efforts are increased to an industrial scale. Failure to do so raises the question of whether resources currently used for expensive and time-consuming restoration projects would be more wisely invested in arresting further habitat loss and encouraging natural recovery.	[Irving, Andrew D.; Connell, Sean D.; Russell, Bayden D.] Univ Adelaide, So Seas Ecol Labs, Sch Earth & Environm Sci, Adelaide, SA, Australia	University of Adelaide	Irving, AD (corresponding author), Univ Adelaide, So Seas Ecol Labs, Sch Earth & Environm Sci, Adelaide, SA, Australia.	andrew.irving@adelaide.edu.au	Connell, Sean D/A-8874-2008; Russell, Bayden D./A-9942-2008; Russell, Bayden D./R-9325-2019	Connell, Sean D/0000-0002-5350-6852; Russell, Bayden D./0000-0003-1282-9978; Russell, Bayden D./0000-0003-1282-9978; Irving, Andrew/0000-0002-9763-2148	Australian Research Council	Australian Research Council(Australian Research Council)	Funding support was provided by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Bachu S, 2008, PROG ENERG COMBUST, V34, P254, DOI 10.1016/j.pecs.2007.10.001; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Cebrian J, 2002, LIMNOL OCEANOGR, V47, P11, DOI 10.4319/lo.2002.47.1.0011; Chalmers H, 2010, P I MECH ENG C-J MEC, V224, P505, DOI 10.1243/09544062JMES1516; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Fonseca M.S., 1998, GUIDELINES CONSERVAT; Goldenheim W, 2008, OECOLOGIA, V158, P473, DOI 10.1007/s00442-008-1157-0; Green E.P., 2003, WORLD ATLAS SEAGRASS; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Irving AD, 2010, J APPL ECOL, V47, P1119, DOI 10.1111/j.1365-2664.2010.01852.x; Kennedy D, 2005, SCIENCE, V309, P75, DOI 10.1126/science.309.5731.75; Kennish MJ, 2001, J COASTAL RES, V17, P731; KIRKMAN H, 1990, AQUAT BOT, V37, P367, DOI 10.1016/0304-3770(90)90022-D; Laffoley D., 2009, MANAGEMENT NATURAL C; Lal R, 2008, PHILOS T R SOC B, V363, P815, DOI 10.1098/rstb.2007.2185; Mcalpine CA, 2009, GLOBAL CHANGE BIOL, V15, P2206, DOI 10.1111/j.1365-2486.2009.01939.x; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Orth RJ, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P111; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Palacios SL, 2007, MAR ECOL PROG SER, V344, P1, DOI 10.3354/meps07084; Pidgeon E., 2009, MANAGEMENT NATURAL C, P47; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Rogelj J, 2010, NATURE, V464, P1126, DOI 10.1038/4641126a; Russell BD, 2010, SCIENCE, V327, P144, DOI 10.1126/science.327.5962.144-c; Russell BD, 2009, GLOBAL CHANGE BIOL, V15, P2153, DOI 10.1111/j.1365-2486.2009.01886.x; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WALSH B, 2009, CAN GEOENGINEERING H; Watzin M. C., 1992, FRAGILE FRINGE COAST; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wigley TML, 2006, SCIENCE, V314, P452, DOI 10.1126/science.1131728	34	58	64	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18311	10.1371/journal.pone.0018311	http://dx.doi.org/10.1371/journal.pone.0018311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479244	Green Submitted, Green Published, gold			2022-12-27	WOS:000289054600043
J	Leonard, MK; Torres, C; Travis, KE; Brown, TT; Hagler, DJ; Dale, AM; Elman, JL; Halgren, E				Leonard, Matthew K.; Torres, Christina; Travis, Katherine E.; Brown, Timothy T.; Hagler, Donald J., Jr.; Dale, Anders M.; Elman, Jeffrey L.; Halgren, Eric			Language Proficiency Modulates the Recruitment of Non-Classical Language Areas in Bilinguals	PLOS ONE			English	Article							SPANISH-ENGLISH BILINGUALS; DEPTH-RECORDED POTENTIALS; SPATIOTEMPORAL DYNAMICS; 2ND-LANGUAGE ACQUISITION; WORD; BRAIN; AGE; FMRI; REPRESENTATION; MEMORY	Bilingualism provides a unique opportunity for understanding the relative roles of proficiency and order of acquisition in determining how the brain represents language. In a previous study, we combined magnetoencephalography (MEG) and magnetic resonance imaging (MRI) to examine the spatiotemporal dynamics of word processing in a group of Spanish-English bilinguals who were more proficient in their native language. We found that from the earliest stages of lexical processing, words in the second language evoke greater activity in bilateral posterior visual regions, while activity to the native language is largely confined to classical left hemisphere fronto-temporal areas. In the present study, we sought to examine whether these effects relate to language proficiency or order of language acquisition by testing Spanish-English bilingual subjects who had become dominant in their second language. Additionally, we wanted to determine whether activity in bilateral visual regions was related to the presentation of written words in our previous study, so we presented subjects with both written and auditory words. We found greater activity for the less proficient native language in bilateral posterior visual regions for both the visual and auditory modalities, which started during the earliest word encoding stages and continued through lexico-semantic processing. In classical left fronto-temporal regions, the two languages evoked similar activity. Therefore, it is the lack of proficiency rather than secondary acquisition order that determines the recruitment of non-classical areas for word processing.	[Leonard, Matthew K.; Elman, Jeffrey L.] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; [Leonard, Matthew K.; Torres, Christina; Travis, Katherine E.; Brown, Timothy T.; Hagler, Donald J., Jr.; Dale, Anders M.; Halgren, Eric] Univ Calif San Diego, Multimodal Imaging Lab, La Jolla, CA 92093 USA; [Torres, Christina; Hagler, Donald J., Jr.; Dale, Anders M.; Halgren, Eric] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Travis, Katherine E.; Brown, Timothy T.; Dale, Anders M.; Halgren, Eric] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Elman, Jeffrey L.; Halgren, Eric] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Leonard, MK (corresponding author), Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA.	mkleonard@cogsci.ucsd.edu	Dale, Anders M/A-5180-2010; Elman, Jeffrey/A-9858-2008	Leonard, Matthew/0000-0002-8530-880X; Travis, Katherine/0000-0002-0050-911X; Elman, Jeffrey/0000-0002-8072-2294	NSF [BCS-0924539]; Kavli Institute for Brain and Mind at UCSD; NIH [R01 NS18741, T32 MH20002, T32 DC00041, K32 NS05609, HD53136]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000041] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [0924539] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Kavli Institute for Brain and Mind at UCSD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	NSF grant BCS-0924539 (http://www.nsf.gov/), Innovative research grant from the Kavli Institute for Brain and Mind at UCSD (http://kibm.ucsd.edu/), NIH grant R01 NS18741, NIH Training grant T32 MH20002 to the UCSD Institute for Neural Computation, NIH Training grant T32 DC00041 to the UCSD Center for Research in Language, NIH award K32 NS05609, and NIH grant HD53136 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutalebi J., 2001, BILING-LANG COGN, V4, P179, DOI [DOI 10.1017/S136672890100027X, 10.1017/S136672890100027, DOI 10.1017/S136672890100027]; Albert M.L., 1978, BILINGUAL BRAIN NEUR; ARDAL S, 1990, BRAIN LANG, V39, P187, DOI 10.1016/0093-934X(90)90011-5; Basnight-Brown DM, 2007, MEM COGNITION, V35, P953, DOI 10.3758/BF03193468; Brown TT, 2005, CEREB CORTEX, V15, P275, DOI 10.1093/cercor/bhh129; Chee MWL, 2004, P NATL ACAD SCI USA, V101, P15265, DOI 10.1073/pnas.0403703101; Chee MWL, 2001, NEUROIMAGE, V13, P1155, DOI 10.1006/nimg.2001.0781; Costa A, 2004, J MEM LANG, V50, P491, DOI 10.1016/j.jml.2004.02.002; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dale AM, 2001, CURR OPIN NEUROBIOL, V11, P202, DOI 10.1016/S0959-4388(00)00197-5; Dehaene S, 1997, NEUROREPORT, V8, P3809, DOI 10.1097/00001756-199712010-00030; DIMITROPOULOU M, MEMORY COGI IN PRESS; Dunabeitia JA, 2010, EXP PSYCHOL, V57, P98, DOI 10.1027/1618-3169/a000013; GENTNER D, 1988, CHILD DEV, V59, P47, DOI 10.2307/1130388; Gollan TH, 2002, NEUROPSYCHOLOGY, V16, P562, DOI 10.1037//0894-4105.16.4.562; Gough P. B., 1980, B ORTON SOC, V30, P179, DOI [10.1007/ BF02653717, DOI 10.3389/fpsyg.2018.02393]; Halgren E, 2006, NEUROIMAGE, V30, P1401, DOI 10.1016/j.neuroimage.2005.10.053; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P51, DOI 10.1016/0928-4257(94)90093-0; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P1, DOI 10.1016/0928-4257(94)90092-2; Hernandez AE, 2007, PSYCHOL BULL, V133, P638, DOI 10.1037/0033-2909.133.4.638; Hull R, 2007, NEUROPSYCHOLOGIA, V45, P1987, DOI 10.1016/j.neuropsychologia.2007.03.002; KROLL JF, 1994, J MEM LANG, V33, P149, DOI 10.1006/jmla.1994.1008; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Leonard MK, 2010, NEUROIMAGE, V49, P3286, DOI 10.1016/j.neuroimage.2009.12.009; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; Marinkovic K, 2004, NEUROSCIENTIST, V10, P142, DOI 10.1177/1073858403261018; Marion V, 2007, J SPEECH LANG HEAR R, V50, P940, DOI 10.1044/1092-4388(2007/067); Maurer U, 2005, J COGNITIVE NEUROSCI, V17, P1532, DOI 10.1162/089892905774597218; Mayberry RI, 2003, BRAIN LANG, V87, P369, DOI 10.1016/S0093-934X(03)00137-8; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; McDonald CR, 2010, NEUROIMAGE, V53, P707, DOI 10.1016/j.neuroimage.2010.06.069; Meschyan G, 2006, NEUROIMAGE, V29, P1135, DOI 10.1016/j.neuroimage.2005.08.055; Meschyan G, 2002, MEM COGNITION, V30, P262, DOI 10.3758/BF03195287; Meschyan G, 2002, J EDUC PSYCHOL, V94, P14, DOI 10.1037//0022-0663.94.1.14; Moreno EM, 2005, COGNITIVE BRAIN RES, V22, P205, DOI 10.1016/j.cogbrainres.2004.08.010; Namy LL, 2002, J EXP PSYCHOL GEN, V131, P5, DOI 10.1037//0096-3445.131.1.5; Perani D, 2005, CURR OPIN NEUROBIOL, V15, P202, DOI 10.1016/j.conb.2005.03.007; Perani D, 1996, NEUROREPORT, V7, P2439, DOI 10.1097/00001756-199611040-00007; Perani D, 1998, BRAIN, V121, P1841, DOI 10.1093/brain/121.10.1841; PIERCE KA, 1994, DEV PSYCHOL, V30, P724, DOI 10.1037/0012-1649.30.5.724; POTTER MC, 1984, J VERB LEARN VERB BE, V23, P23, DOI 10.1016/S0022-5371(84)90489-4; Price CJ, 2003, BRAIN LANG, V86, P272, DOI 10.1016/S0093-934X(02)00544-8; SALTZ E, 1972, CHILD DEV, V43, P1191, DOI 10.2307/1127507; Silverberg S, 2004, J MEM LANG, V51, P381, DOI 10.1016/j.jml.2004.05.003; STORCK PA, 1973, J EDUC PSYCHOL, V65, P192, DOI 10.1037/h0034907; Tagamets MA, 2000, J COGNITIVE NEUROSCI, V12, P281, DOI 10.1162/089892900562101; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Wartenburger I, 2003, NEURON, V37, P159, DOI 10.1016/S0896-6273(02)01150-9; Xue G, 2004, NEUROIMAGE, V22, P1, DOI 10.1016/j.neuroimage.2004.01.013	50	42	47	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18240	10.1371/journal.pone.0018240	http://dx.doi.org/10.1371/journal.pone.0018240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	740RG	21455315	Green Submitted, Green Published, gold			2022-12-27	WOS:000288811500031
J	White, MJ; Savaryn, JP; Bretl, DJ; He, HJ; Penoske, RM; Terhune, SS; Zahrt, TC				White, Mark J.; Savaryn, John P.; Bretl, Daniel J.; He, Hongjun; Penoske, Renee M.; Terhune, Scott S.; Zahrt, Thomas C.			The HtrA-Like Serine Protease PepD Interacts with and Modulates the Mycobacterium tuberculosis 35-kDa Antigen Outer Envelope Protein	PLOS ONE			English	Article							PHAGE-SHOCK; STRESS-RESPONSE; 2-COMPONENT SYSTEM; DELETION MUTANT; SIGMA-FACTOR; EXPRESSION; MPRAB; GENE; PSPA; DOMAIN	Mycobacterium tuberculosis remains a significant global health concern largely due to its ability to persist for extended periods within the granuloma of the host. While residing within the granuloma, the tubercle bacilli are likely to be exposed to stress that can result in formation of aberrant proteins with altered structures. Bacteria encode stress responsive determinants such as proteases and chaperones to deal with misfolded or unfolded proteins. pepD encodes an HtrA-like serine protease and is thought to process proteins altered following exposure of M. tuberculosis to extra-cytoplasmic stress. PepD functions both as a protease and chaperone in vitro, and is required for aspects of M. tuberculosis virulence in vivo. pepD is directly regulated by the stress-responsive two-component signal transduction system MprAB and indirectly by extracytoplasmic function (ECF) sigma factor SigE. Loss of PepD also impacts expression of other stress-responsive determinants in M. tuberculosis. To further understand the role of PepD in stress adaptation by M. tuberculosis, a proteomics approach was taken to identify binding proteins and possible substrates of this protein. Using subcellular fractionation, the cellular localization of wild-type and PepD variants was determined. Purified fractions as well as whole cell lysates from Mycobacterium smegmatis or M. tuberculosis strains expressing a catalytically compromised PepD variant were immunoprecipitated for PepD and subjected to LC-MS/MS analyses. Using this strategy, the 35-kDa antigen encoding a homolog of the PspA phage shock protein was identified as a predominant binding partner and substrate of PepD. We postulate that proteolytic cleavage of the 35-kDa antigen by PepD helps maintain cell wall homeostasis in Mycobacterium and regulates specific stress response pathways during periods of extracytoplasmic stress.	[White, Mark J.; Savaryn, John P.; Bretl, Daniel J.; He, Hongjun; Penoske, Renee M.; Terhune, Scott S.; Zahrt, Thomas C.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [White, Mark J.; Bretl, Daniel J.; He, Hongjun; Penoske, Renee M.; Zahrt, Thomas C.] Med Coll Wisconsin, Ctr Infect Dis Res, Milwaukee, WI 53226 USA; [Savaryn, John P.; Terhune, Scott S.] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	White, MJ (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA.	tzahrt@mcw.edu			National Institutes of Health and Infectious Disease [RO1 AI51669]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051669] Funding Source: NIH RePORTER	National Institutes of Health and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by RO1 AI51669 from the National Institutes of Health and Infectious Disease and an Investigator in Pathogenesis award from the Burroughs Wellcome Fund to T.C.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Amaral L, 2008, CURR DRUG TARGETS, V9, P816, DOI 10.2174/138945008785747798; Amaral L, 2007, J ANTIMICROB CHEMOTH, V59, P1237, DOI 10.1093/jac/dkl500; [Anonymous], GLOB TUB CONTR SURV; Barik S, 2010, MOL MICROBIOL, V75, P592, DOI 10.1111/j.1365-2958.2009.07008.x; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Dahl JL, 2001, INFECT IMMUN, V69, P4295, DOI 10.1128/IAI.69.7.4295-4302.2001; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; Dona V, 2008, J BACTERIOL, V190, P5963, DOI 10.1128/JB.00622-08; Dutta NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010069; Elderkin S, 2002, J MOL BIOL, V320, P23, DOI 10.1016/S0022-2836(02)00404-7; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Estorninho M, 2010, MICROBIOL-SGM, V156, P3445, DOI 10.1099/mic.0.042275-0; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; Hankamer BD, 2004, J BIOL CHEM, V279, P8862, DOI 10.1074/jbc.M307889200; He HJ, 2006, J BACTERIOL, V188, P2134, DOI 10.1128/JB.188.6.2134-2143.2006; He HJ, 2005, J BACTERIOL, V187, P202, DOI 10.1128/JB.187.1.202-212.2005; Isaac DD, 2005, P NATL ACAD SCI USA, V102, P17775, DOI 10.1073/pnas.0508936102; JACOBS WR, 1991, METHOD ENZYMOL, V204, P537; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; Kim DY, 2005, J BIOCHEM MOL BIOL, V38, P266; KOBAYASHI H, 1985, J BIOL CHEM, V260, P72; Kobayashi R, 2007, MOL MICROBIOL, V66, P100, DOI 10.1111/j.1365-2958.2007.05893.x; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; LEE BY, 1995, J CLIN INVEST, V96, P245, DOI 10.1172/JCI118028; Lyon WR, 2004, INFECT IMMUN, V72, P1618, DOI 10.1128/IAI.72.3.1618-1625.2004; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Mehra S, 2010, J INFECT DIS, V202, P943, DOI 10.1086/654820; Miller JH., 1972, EXPT MOL GENETICS; MohamedMohaideen NN, 2008, BIOCHEMISTRY-US, V47, P6092, DOI 10.1021/bi701929m; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Murwantoko, 2004, BIOCHEM J, V381, P895, DOI 10.1042/BJ20040435; Pang XH, 2007, J BACTERIOL, V189, P6213, DOI 10.1128/JB.00492-07; Pang XH, 2007, MICROBIOL-SGM, V153, P1229, DOI 10.1099/mic.0.29281-0; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Skeiky YAW, 1999, INFECT IMMUN, V67, P3998, DOI 10.1128/IAI.67.8.3998-4007.1999; Stack HM, 2005, APPL ENVIRON MICROB, V71, P4241, DOI 10.1128/AEM.71.8.4241-4247.2005; Standar K, 2008, FEBS LETT, V582, P3585, DOI 10.1016/j.febslet.2008.09.002; Sureka K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001771; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; TAKAYAMA K, 1975, J LIPID RES, V16, P308; TILLY K, 1983, CELL, V34, P641, DOI 10.1016/0092-8674(83)90396-3; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; WEINER L, 1991, GENE DEV, V5, P1912, DOI 10.1101/gad.5.10.1912; Westphal S, 2001, P NATL ACAD SCI USA, V98, P4243, DOI 10.1073/pnas.061501198; White MJ, 2010, J BACTERIOL, V192, P1498, DOI 10.1128/JB.01167-09; Wilson RL, 2006, INFECT IMMUN, V74, P765, DOI 10.1128/IAI.74.1.765-768.2006; Wolf D, 2010, J BACTERIOL, V192, P4680, DOI 10.1128/JB.00543-10; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Zahrt TC, 2001, P NATL ACAD SCI USA, V98, P12706, DOI 10.1073/pnas.221272198	54	36	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18175	10.1371/journal.pone.0018175	http://dx.doi.org/10.1371/journal.pone.0018175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445360	gold, Green Published, Green Submitted			2022-12-27	WOS:000288809100032
J	Lou, YQ; Liu, JL; Li, Y; Liu, Y; Wang, ZG; Liu, K; Wu, H; Niu, QL; Gu, W; Guo, YH; Li, ZZ; Wen, SJ				Lou, Yuqing; Liu, Jielin; Li, Yao; Liu, Ya; Wang, Zuoguang; Liu, Kuo; Wu, Hai; Niu, Qiuli; Gu, Wei; Guo, Yanhong; Li, Zhizhong; Wen, Shaojun			Association Study of the beta 2-Adrenergic Receptor Gene Polymorphisms and Hypertension in the Northern Han Chinese	PLOS ONE			English	Article							BETA(2)-ADRENERGIC RECEPTOR; HAPLOTYPE INFERENCE; BLOOD-PRESSURE; ADRB2 GENE; OBESITY; COMBINATION; PREVALENCE; ALGORITHM; PROTEIN; ASTHMA	Background: The beta 2-adrenergic receptor (ADRB2) gene has been widely researched as a candidate gene for essential hypertension (EH), but no consensus has been reached in different ethnicities. The aim of the present study was to evaluate the possible association between the ADRB2 gene polymorphisms and the EH risk in the Northern Han Chinese population. Methodology/Principal Findings: This study included 747 hypertensive subjects and 390 healthy volunteers as control subjects in the Northern Han Chinese. Genotyping was performed to identify the C-47T, A46G and C79G polymorphisms of the ADRB2 gene. G allelic frequency of A46G polymorphism was significantly higher in hypertensive subjects (P = 0.011, OR = 1.287, 95% CI [1.059-1.565]) than that in controls. Significant association could also be found in dominant genetic model (GG+AG vs. AA, P = 0.006, OR = 1.497, 95% CI [1.121-1.998]), in homozygote comparison (GG vs. AA, P = 0.025, OR = 1.568, 95% CI [1.059-2.322]), and in additive genetic model (GG vs. AG vs. AA, P = 0.012, OR = 1.282, 95% CI [1.056-1.555]). Subgroup analyses performed by gender suggested that this association could be found in male, but not in female. Stratification analyses by obesity showed that A46G polymorphism was related to the prevalence of hypertension in the obese population (GG vs. AG vs. AA, P<0.001, OR = 1.645, 95% CI [1.258-2.151]). Significant interaction was found between A46G genotypes and body mass index on EH risk. No significant association could be found between C-47T or C79G polymorphism and EH risk. Linkage disequilibrium was detected between the C-47T, A46G and C79G polymorphisms. Haplotype analyses observed that the T-47-A46-C79 haplotype was a protective haplotype for EH, while the T-47-G46-C79 haplotype increased the risk. Conclusions/Significances: We revealed that the ADRB2 A46G polymorphism might increase the risk for EH in the Northern Han Chinese population.	[Lou, Yuqing; Liu, Jielin; Liu, Ya; Wang, Zuoguang; Liu, Kuo; Niu, Qiuli; Gu, Wei; Wen, Shaojun] Capital Med Univ, Beijing Anzhen Hosp, Dept Hypertens Res, Beijing, Peoples R China; [Lou, Yuqing; Liu, Jielin; Liu, Ya; Wang, Zuoguang; Liu, Kuo; Niu, Qiuli; Gu, Wei; Wen, Shaojun] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Li, Yao; Wu, Hai] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Guo, Yanhong] Peking Univ, Hosp 3, Dept Cardiol, Beijing 100871, Peoples R China; [Li, Zhizhong] Capital Med Univ, Beijing Anzhen Hosp, Emergency Ctr Heart Lung & Blood Vessel Dis, Beijing, Peoples R China	Capital Medical University; Fudan University; Peking University; Capital Medical University	Lou, YQ (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Hypertens Res, Beijing, Peoples R China.	dr_lizhizhong@yahoo.com.cn; wenshaojun@yahoo.com.cn	GUO, Yanhong/B-5325-2012; Guo, Yanhong/D-9764-2012	Liu, Ya/0000-0002-7816-684X; Wang, Zuoguang/0000-0002-0230-1611	National High Technology Research and Development Program [2008AA02Z441]; Ministry of Science and Technology of the People's Republic of China [2008BAI52B03]	National High Technology Research and Development Program(National High Technology Research and Development Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was funded by grants 2008AA02Z441 of the National High Technology Research and Development Program (http://program.most.gov.cn/page/pds/mian1_AA.htm?planId=AA), and grants 2008BAI52B03 of the National Eleventh Five-year Plan Program from the Ministry of Science and Technology (http://program.most.gov.cn/page/pds/mian1_BA.htm?planId=BA) of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartels NK, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-1; Brodde OE, 2005, PHARMACOGENET GENOM, V15, P267, DOI 10.1097/01213011-200505000-00001; Busjahn A, 2000, HYPERTENSION, V35, P555, DOI 10.1161/01.HYP.35.2.555; Candy G, 2000, J HYPERTENS, V18, P167, DOI 10.1097/00004872-200018020-00006; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Cockcroft JR, 2000, HYPERTENSION, V36, P371, DOI 10.1161/01.HYP.36.3.371; Deng W, 2004, J HUM GENET, V49, P339, DOI 10.1007/s10038-004-0154-3; Dishy V, 2001, NEW ENGL J MED, V345, P1030, DOI 10.1056/NEJMoa010819; Feldman RD, 1998, TRENDS CARDIOVAS MED, V8, P297, DOI 10.1016/S1050-1738(98)00022-X; Ge D, 2005, ANN HUM GENET, V69, P36, DOI 10.1046/j.1529-8817.2003.00093.x; Gjesing AP, 2007, DIABETOLOGIA, V50, P563, DOI 10.1007/s00125-006-0578-8; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Gu DF, 2006, HYPERTENSION, V47, P1147, DOI 10.1161/01.HYP.0000219041.66702.45; Hawkins GA, 2006, AM J RESP CRIT CARE, V174, P1101, DOI 10.1164/rccm.200509-1405OC; Herrmann SM, 2002, J HYPERTENS, V20, P229, DOI 10.1097/00004872-200202000-00012; Herrmann V, 2000, AM J HYPERTENS, V13, P1021, DOI 10.1016/S0895-7061(00)01188-2; Hu CJ, 2007, CLIN CHEM LAB MED, V45, P20, DOI 10.1515/CCLM.2007.014; Jia HY, 2000, J HYPERTENS, V18, P687, DOI 10.1097/00004872-200018060-00005; Kao WHL, 2009, CIRCULATION, V119, P940, DOI 10.1161/CIRCULATIONAHA.108.791723; Kato N, 2001, HYPERTENSION, V37, P286, DOI 10.1161/01.HYP.37.2.286; Kirstein SL, 2004, PHARMACOL REV, V56, P31, DOI 10.1124/pr.56.1.2; Leineweber K, 2004, N-S ARCH PHARMACOL, V369, P1, DOI 10.1007/s00210-003-0824-2; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Lima JJ, 2007, METABOLISM, V56, P757, DOI 10.1016/j.metabol.2007.01.007; Lou YQ, 2010, HYPERTENS RES, V33, P1114, DOI 10.1038/hr.2010.151; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; McGraw DW, 1998, J CLIN INVEST, V102, P1927, DOI 10.1172/JCI4862; Misono M, 2009, J HYPERTENS, V27, P1377, DOI 10.1097/HJH.0b013e32832b7ead; Mo W, 2007, CLIN CHEM LAB MED, V45, P493, DOI 10.1515/CCLM.2007.089; Petrone A, 2006, EUR J HUM GENET, V14, P94, DOI 10.1038/sj.ejhg.5201521; Pojoga L, 2006, HYPERTENSION, V48, P892, DOI 10.1161/01.HYP.0000244688.45472.95; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Scott MGH, 1999, BRIT J PHARMACOL, V126, P841, DOI 10.1038/sj.bjp.0702385; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Small KM, 2003, ANNU REV PHARMACOL, V43, P381, DOI 10.1146/annurev.pharmtox.43.100901.135823; Smith SC, 2005, CIRCULATION, V111, pE134, DOI 10.1161/01.CIR.0000157743.54710.04; STEIN CM, 1995, J CLIN INVEST, V96, P579, DOI 10.1172/JCI118070; Szczepankiewicz A, 2009, J APPL GENET, V50, P275, DOI 10.1007/BF03195683; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; *WHO, 2000, WHO REG OFF W PAC IN; Wu HY, 2006, J HYPERTENS, V24, P1041, DOI 10.1097/01.hjh.0000226193.21311.e1; Xie HG, 2000, CLIN PHARMACOL THER, V67, P670, DOI 10.1067/mcp.2000.106293; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yu SF, 2008, BIOMED ENVIRON SCI, V21, P239, DOI 10.1016/S0895-3988(08)60036-7; Zhang HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008783	48	13	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18590	10.1371/journal.pone.0018590	http://dx.doi.org/10.1371/journal.pone.0018590			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483652	gold, Green Published, Green Submitted			2022-12-27	WOS:000289191300031
J	Mine-Hattab, J; Fleury, G; Prevost, C; Dutreix, M; Viovy, JL				Mine-Hattab, Judith; Fleury, Genevieve; Prevost, Chantal; Dutreix, Marie; Viovy, Jean-Louis			Optimizing the Design of Oligonucleotides for Homology Directed Gene Targeting	PLOS ONE			English	Article							SINGLE-STRANDED OLIGONUCLEOTIDES; RECA-PROTEIN; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; NUCLEOPROTEIN FILAMENTS; MULTIPLE PATHWAYS; RAD51 PROTEIN; DNA; RECOMBINATION; EXCHANGE	Background: Gene targeting depends on the ability of cells to use homologous recombination to integrate exogenous DNA into their own genome. A robust mechanistic model of homologous recombination is necessary to fully exploit gene targeting for therapeutic benefit. Methodology/Principal Findings: In this work, our recently developed numerical simulation model for homology search is employed to develop rules for the design of oligonucleotides used in gene targeting. A Metropolis Monte-Carlo algorithm is used to predict the pairing dynamics of an oligonucleotide with the target double-stranded DNA. The model calculates the base-alignment between a long, target double-stranded DNA and a probe nucleoprotein filament comprised of homologous recombination proteins (Rad51 or RecA) polymerized on a single strand DNA. In this study, we considered different sizes of oligonucleotides containing 1 or 3 base heterologies with the target; different positions on the probe were tested to investigate the effect of the mismatch position on the pairing dynamics and stability. We show that the optimal design is a compromise between the mean time to reach a perfect alignment between the two molecules and the stability of the complex. Conclusion and Significance: A single heterology can be placed anywhere without significantly affecting the stability of the triplex. In the case of three consecutive heterologies, our modeling recommends using long oligonucleotides (at least 35 bases) in which the heterologous sequences are positioned at an intermediate position. Oligonucleotides should not contain more than 10% consecutive heterologies to guarantee a stable pairing with the target dsDNA. Theoretical modeling cannot replace experiments, but we believe that our model can considerably accelerate optimization of oligonucleotides for gene therapy by predicting their pairing dynamics with the target dsDNA.	[Mine-Hattab, Judith; Fleury, Genevieve; Viovy, Jean-Louis] Inst Curie, CNRS, Lab Phys Chim Curie, UMR 168, F-75231 Paris, France; [Dutreix, Marie] Hosp Orsay, Inst Curie, Translat Res Dept, Lab Recombinat Repair & Canc, Orsay, France; [Prevost, Chantal] CNRS, IBPC, Lab Biochim Theor, UMR 9080, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Mine-Hattab, J (corresponding author), Inst Curie, CNRS, Lab Phys Chim Curie, UMR 168, F-75231 Paris, France.	Jean-Louis.Viovy@curie.fr	Fleury, Geneviève/E-6184-2013	Viovy, Jean-Louis/0000-0002-8223-4040; Chantal, Prevost/0000-0003-3516-6687	IMPBio ANR; Institute Curie-PIC	IMPBio ANR(French National Research Agency (ANR)); Institute Curie-PIC	This work was partly supported by the IMPBio ANR programme, by the Institute Curie-PIC "Physics at the Cell Level". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzuma K, 1998, J BIOL CHEM, V273, P31565, DOI 10.1074/jbc.273.47.31565; Barzel A, 2008, NAT REV GENET, V9, P27, DOI 10.1038/nrg2224; Bazemore LR, 1997, P NATL ACAD SCI USA, V94, P11863, DOI 10.1073/pnas.94.22.11863; Bertucat G, 1998, J BIOMOL STRUCT DYN, V16, P535, DOI 10.1080/07391102.1998.10508268; Bertucat G, 1999, BIOPHYS J, V77, P1562, DOI 10.1016/S0006-3495(99)77004-9; BIANCHI ME, 1983, CELL, V35, P511, DOI 10.1016/0092-8674(83)90185-X; Biet E, 2003, PIGM CELL RES, V16, P133, DOI 10.1034/j.1600-0749.2003.00021.x; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cizeau P, 1997, BIOPOLYMERS, V42, P383, DOI 10.1002/(SICI)1097-0282(19971005)42:4<383::AID-BIP1>3.0.CO;2-M; Cluzel P, 1996, SCIENCE, V271, P792, DOI 10.1126/science.271.5250.792; DORFMAN K, 2004, PHYS REV LETT, V93, P1; DUTREIX D, 2003, COMPLEXUS, V1, P89; Fulconis R, 2005, BIOPHYS J, V88, P3770, DOI 10.1529/biophysj.104.055269; Gamper HB, 2000, BIOCHEMISTRY-US, V39, P5808, DOI 10.1021/bi9921891; Gendrel CG, 2000, GENE DEV, V14, P1261; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; HONIGBERG SM, 1985, J BIOL CHEM, V260, P1845; Igoucheva O, 2001, GENE THER, V8, P391, DOI 10.1038/sj.gt.3301414; JWANG BR, 1992, P NATL ACAD SCI USA, V89, P7596, DOI 10.1073/pnas.89.16.7596; Klapstein K, 2004, BIOPHYS J, V87, P1466, DOI 10.1529/biophysj.104.039578; Lavery R, 1999, GENETICA, V106, P75, DOI 10.1023/A:1003776827836; Leger JF, 1998, P NATL ACAD SCI USA, V95, P12295, DOI 10.1073/pnas.95.21.12295; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Liu L, 2002, NUCLEIC ACIDS RES, V30, P2742, DOI 10.1093/nar/gkf397; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; McLachlan J, 2009, DNA REPAIR, V8, P1424, DOI 10.1016/j.dnarep.2009.09.014; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Mine J, 2007, NUCLEIC ACIDS RES, V35, P7171, DOI 10.1093/nar/gkm752; MOREL P, 1994, J BIOL CHEM, V269, P19830; Nishinaka T, 1998, P NATL ACAD SCI USA, V95, P11071, DOI 10.1073/pnas.95.19.11071; Ohbayashi F, 2005, P NATL ACAD SCI USA, V102, P13628, DOI 10.1073/pnas.0506598102; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Parekh-Olmedo H, 2007, GENE THER, V14, P1675, DOI 10.1038/sj.gt.3303053; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Sagi D, 2006, NUCLEIC ACIDS RES, V34, P5021, DOI 10.1093/nar/gkl586; Savir Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000468; Sawitzke JA, 2007, METHOD ENZYMOL, V421, P171, DOI 10.1016/S0076-6879(06)21015-2; SHEN P, 1986, GENETICS, V112, P441; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P5100, DOI 10.1073/pnas.76.10.5100; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; WATT VM, 1985, P NATL ACAD SCI USA, V82, P4768, DOI 10.1073/pnas.82.14.4768; Xiao J, 2006, CHEMBIOCHEM, V7, P1265, DOI 10.1002/cbic.200600038; Yanez RJ, 1999, GENE THER, V6, P1282, DOI 10.1038/sj.gt.3300945; Yin WX, 2005, BIOCHEM BIOPH RES CO, V334, P1032, DOI 10.1016/j.bbrc.2005.06.193	49	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e14795	10.1371/journal.pone.0014795	http://dx.doi.org/10.1371/journal.pone.0014795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483664	Green Published, Green Submitted, gold			2022-12-27	WOS:000289191300003
J	Itzhaki, I; Rapoport, S; Huber, I; Mizrahi, I; Zwi-Dantsis, L; Arbel, G; Schiller, J; Gepstein, L				Itzhaki, Ilanit; Rapoport, Sophia; Huber, Irit; Mizrahi, Itzhak; Zwi-Dantsis, Limor; Arbel, Gil; Schiller, Jackie; Gepstein, Lior			Calcium Handling in Human Induced Pluripotent Stem Cell Derived Cardiomyocytes	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM; CARDIAC MYOCYTES; RELEASE; CONTRACTION; EXPRESSION; INDUCTION; CHANNELS	Background: The ability to establish human induced pluripotent stem cells (hiPSCs) by reprogramming of adult fibroblasts and to coax their differentiation into cardiomyocytes opens unique opportunities for cardiovascular regenerative and personalized medicine. In the current study, we investigated the Ca2+-handling properties of hiPSCs derived-cardiomyocytes (hiPSC-CMs). Methodology/Principal Findings: RT-PCR and immunocytochemistry experiments identified the expression of key Ca2+-handling proteins. Detailed laser confocal Ca2+ imaging demonstrated spontaneous whole-cell [Ca2+](i) transients. These transients required Ca2+ influx via L-type Ca2+ channels, as demonstrated by their elimination in the absence of extracellular Ca2+ or by administration of the L-type Ca2+ channel blocker nifedipine. The presence of a functional ryanodine receptor (RyR)-mediated sarcoplasmic reticulum (SR) Ca2+ store, contributing to [Ca2+](i) transients, was established by application of caffeine (triggering a rapid increase in cytosolic Ca2+) and ryanodine (decreasing [Ca2+](i)). Similarly, the importance of Ca2+ reuptake into the SR via the SR Ca2+ ATPase (SERCA) pump was demonstrated by the inhibiting effect of its blocker (thapsigargin), which led to [Ca2+](i) transients elimination. Finally, the presence of an IP3-releasable Ca2+ pool in hiPSC-CMs and its contribution to whole-cell [Ca2+](i) transients was demonstrated by the inhibitory effects induced by the IP3-receptor blocker 2-Aminoethoxydiphenyl borate (2-APB) and the phosopholipase C inhibitor U73122. Conclusions/Significance: Our study establishes the presence of a functional, SERCA-sequestering, RyR-mediated SR Ca2+ store in hiPSC-CMs. Furthermore, it demonstrates the dependency of whole-cell [Ca2+](i) transients in hiPSC-CMs on both sarcolemmal Ca2+ entry via L-type Ca2+ channels and intracellular store Ca2+ release.	[Itzhaki, Ilanit; Huber, Irit; Mizrahi, Itzhak; Zwi-Dantsis, Limor; Arbel, Gil; Gepstein, Lior] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Sohnis Family Res Lab Cardiac Electrophysiol & Re, IL-31096 Haifa, Israel; [Rapoport, Sophia; Schiller, Jackie] Technion Israel Inst Technol, Dept Physiol Biophys, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Itzhaki, I (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Sohnis Family Res Lab Cardiac Electrophysiol & Re, POB 9649, IL-31096 Haifa, Israel.	mdlior@tx.technion.ac.il	Gepstein, Lior/H-9458-2012		Israel Science Foundation [1781/07]; Legacy Heritage Foundation [1225/09]; European Research Council [ERC-2010-StG-260830-Cardio-iPS]; Lorry Lokey research fund; Nancy and Stephen Grand Philanthropic Fund	Israel Science Foundation(Israel Science Foundation); Legacy Heritage Foundation; European Research Council(European Research Council (ERC)European Commission); Lorry Lokey research fund; Nancy and Stephen Grand Philanthropic Fund	This study was supported in part by the Israel Science Foundation and Legacy Heritage Foundation (no. 1225/09), by the Israel Science Foundation Converging Technologies Program (1781/07), by the Ideas Program of the European Research Council (ERC-2010-StG-260830-Cardio-iPS), by the Lorry Lokey research fund, and by the Nancy and Stephen Grand Philanthropic Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DR, 1999, CARDIOVASC RES, V42, P339, DOI 10.1016/S0008-6363(99)00038-3; CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; Dolnikov K, 2006, STEM CELLS, V24, P236, DOI 10.1634/stemcells.2005-0036; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; Fu JD, 2005, FASEB J, V19, P181, DOI 10.1096/fj.05-4501fje; Fu JD, 2006, ACTA PHARMACOL SIN, V27, P901, DOI 10.1111/j.1745-7254.2006.00380.x; Galli GLJ, 2006, AM J PHYSIOL-REG I, V291, pR1781, DOI 10.1152/ajpregu.00421.2006; GERMANGUZ I, 2009, J CELL MOL MED; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; ITZHAKI I, 2011, NATURE; Jaconi M, 2000, MOL BIOL CELL, V11, P1845, DOI 10.1091/mbc.11.5.1845; Kapur N, 2007, J PHYSIOL-LONDON, V581, P1113, DOI 10.1113/jphysiol.2006.125955; Katz G, 2009, CURR PROB CARDIOLOGY, V34, P1, DOI 10.1016/j.cpcardiol.2008.09.002; Li J, 1997, AM J PHYSIOL-HEART C, V273, pH2481, DOI 10.1152/ajpheart.1997.273.5.H2481; Liu J, 2007, STEM CELLS, V25, P3038, DOI 10.1634/stemcells.2007-0549; Liu WR, 2002, LIFE SCI, V71, P1279, DOI 10.1016/S0024-3205(02)01826-X; Marks AR, 2000, CIRC RES, V87, P8, DOI 10.1161/01.RES.87.1.8; Mery A, 2005, MOL BIOL CELL, V16, P2414, DOI 10.1091/mbc.E04-10-0883; MORAD M, 1983, NATURE, V304, P635, DOI 10.1038/304635a0; MOSCHELLA MC, 1993, J CELL BIOL, V120, P1137, DOI 10.1083/jcb.120.5.1137; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Poindexter BJ, 2001, CELL CALCIUM, V30, P373, DOI 10.1054/ceca.2001.0249; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Priori SG, 2005, CIRC RES, V97, P1077, DOI 10.1161/01.RES.0000194556.41865.e2; Rosemblit N, 1999, DEV BIOL, V206, P163, DOI 10.1006/dbio.1998.9120; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; Sauer H, 2001, AM J PHYSIOL-HEART C, V281, pH411, DOI 10.1152/ajpheart.2001.281.1.H411; Sedan O, 2008, STEM CELLS, V26, P3130, DOI 10.1634/stemcells.2008-0777; Shannon TR, 2000, BIOPHYS J, V78, P334, DOI 10.1016/S0006-3495(00)76596-9; Snir M, 2003, AM J PHYSIOL-HEART C, V285, pH2355, DOI 10.1152/ajpheart.00020.2003; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Viatchenko-Karpinski S, 1999, P NATL ACAD SCI USA, V96, P8259, DOI 10.1073/pnas.96.14.8259; WEBER A, 1968, J GEN PHYSIOL, V52, P750, DOI 10.1085/jgp.52.5.750; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhu WZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005407; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	44	131	133	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18037	10.1371/journal.pone.0018037	http://dx.doi.org/10.1371/journal.pone.0018037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483779	gold, Green Published, Green Submitted			2022-12-27	WOS:000289058300006
J	Santarelli, L; Strafella, E; Staffolani, S; Amati, M; Emanuelli, M; Sartini, D; Pozzi, V; Carbonari, D; Bracci, M; Pignotti, E; Mazzanti, P; Sabbatini, A; Ranaldi, R; Gasparini, S; Neuzil, J; Tomasetti, M				Santarelli, Lory; Strafella, Elisabetta; Staffolani, Sara; Amati, Monica; Emanuelli, Monica; Sartini, Davide; Pozzi, Valentina; Carbonari, Damiano; Bracci, Massimo; Pignotti, Elettra; Mazzanti, Paola; Sabbatini, Armando; Ranaldi, Renzo; Gasparini, Stefano; Neuzil, Jiri; Tomasetti, Marco			Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma	PLOS ONE			English	Article							PLEURAL MESOTHELIOMA; CIRCULATING MICRORNAS; HUMAN CANCERS; LUNG-CANCER; DIAGNOSIS; SERUM; DISEASES; BIOMARKERS; PROFILES; EXPOSURE	Background: Improved detection methods for diagnosis of malignant pleural mesothelioma (MPM) are essential for early and reliable detection as well as treatment. Since recent data point to abnormal levels of microRNAs (miRNAs) in tumors, we hypothesized that a profile of deregulated miRNAs may be a marker of MPM and that the levels of specific miRNAs may be used for monitoring its progress. Methods and Results: miRNAs isolated from fresh-frozen biopsies of MPM patients were tested for the expression of 88 types of miRNA involved in cancerogenesis. Most of the tested miRNAs were downregulated in the malignant tissues compared with the normal tissues. Of eight significantly downregulated, three miRNAs were assayed in cancerous tissue and adjacent non-cancerous tissue sample pairs collected from 27 formalin-fixed, paraffin-embedded MPM tissues by quantitative RT-PCR. Among the miRNAs tested, only miR-126 significantly remained downregulated in the malignant tissues. Furthermore, the performance of the selected miR-126 as biomarker was evaluated in serum samples of asbestos-exposed subjects and MPM patients and compared with controls. MiR-126 was not affected by asbestos exposure, whereas it was found strongly associated with VEGF serum levels. Levels of miR-126 in serum, and its levels in patients' serum in association with a specific marker of MPM, SMRPs, correlate with subjects at high risk to develop MPM. Conclusions and Significance: We propose miR-126, in association with SMRPs, as a marker for early detection of MPM. The identification of tumor biomarkers used alone or, in particular, in combination could greatly facilitate the surveillance procedure for cohorts of subjects exposed to asbestos.	[Santarelli, Lory; Strafella, Elisabetta; Staffolani, Sara; Amati, Monica; Carbonari, Damiano; Bracci, Massimo; Tomasetti, Marco] Polytech Univ Marche, Dept Mol Pathol & Innovat Therapies, Ancona, Italy; [Emanuelli, Monica; Sartini, Davide; Pozzi, Valentina] Polytech Univ Marche, Dept Biochem Biol & Genet, Ancona, Italy; [Pignotti, Elettra] Univ Bologna, Dept Stat Sci, Bologna, Italy; [Mazzanti, Paola] Hosp Univ Ancona, Dept Med Oncol, Ancona, Italy; [Sabbatini, Armando] Hosp Univ Ancona, Thorac Surg Unit, Ancona, Italy; [Ranaldi, Renzo] Hosp Univ Ancona, Anat Pathol Unit, Ancona, Italy; [Gasparini, Stefano] Hosp Univ Ancona, Pneumol Unit, Ancona, Italy; [Neuzil, Jiri] Griffith Univ, Apoptosis Res Grp, Sch Med Sci, Southport, Qld 4215, Australia; [Neuzil, Jiri] Griffith Univ, Griffith Hlth Inst, Southport, Qld 4215, Australia; [Neuzil, Jiri] Acad Sci Czech Republic, Inst Biotechnol, Mol Therapy Grp, Prague, Czech Republic	Marche Polytechnic University; Marche Polytechnic University; University of Bologna; Griffith University; Griffith University; Menzies Health Institute Queensland; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences	Santarelli, L (corresponding author), Polytech Univ Marche, Dept Mol Pathol & Innovat Therapies, Ancona, Italy.	m.tomasetti@univpm.it	Neuzil, Jiri/H-7204-2014; santarelli, lory/I-7429-2012; Bracci, Massimo/K-1192-2018; Santarelli, Lory/AAU-4494-2020	Neuzil, Jiri/0000-0002-2478-2460; Bracci, Massimo/0000-0003-3901-5376; santarelli, lory/0000-0003-1015-7098	National Institute against Occupational Injury Insurance (INAIL); Australian Research Council; Grant Agency of the Czech Republic [204/08/0811]	National Institute against Occupational Injury Insurance (INAIL); Australian Research Council(Australian Research Council); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	The study was supported by a grant from the National Institute against Occupational Injury Insurance (INAIL) to L.S. and M.T. The INAIL is not a commercial company. J.N. was supported in part by grants from the Australian Research Council and the Grant Agency of the Czech Republic (204/08/0811). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	AISNER J, 1995, CHEST, V108, P1122; Amati M, 2008, CANCER EPIDEM BIOMAR, V17, P163, DOI 10.1158/1055-9965.EPI-07-0607; Barbato C, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/871313; Blenkiron C, 2007, HUM MOL GENET, V16, pR106, DOI 10.1093/hmg/ddm056; Busacca S, 2010, AM J RESP CELL MOL, V42, P312, DOI 10.1165/rcmb.2009-0060OC; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Ellis P, 2006, J THORAC ONCOL, V1, P591, DOI 10.1097/01243894-200607000-00017; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fennell DA, 2008, NAT CLIN PRACT ONCOL, V5, P136, DOI 10.1038/ncponc1039; GEE GV, 2010, INT J CANC; Grigoriu BD, 2009, AM J RESP CRIT CARE, V179, P950, DOI 10.1164/rccm.200807-1125OC; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Hansen J, 1998, AM J RESP CRIT CARE, V157, P69, DOI 10.1164/ajrccm.157.1.96-11086; Heneghan HM, 2010, OBES REV, V11, P354, DOI 10.1111/j.1467-789X.2009.00659.x; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Liu B, 2009, LUNG CANCER, V66, P169, DOI 10.1016/j.lungcan.2009.01.010; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo L, 2010, RESP MED, V104, P149, DOI 10.1016/j.rmed.2009.05.017; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; MURPHY RLH, 1971, NEW ENGL J MED, V285, P1271, DOI 10.1056/NEJM197112022852301; Ortholan C, 2009, CURR MED CHEM, V16, P1047, DOI 10.2174/092986709787581833; Pass HI, 2009, SEMIN THORAC CARDIOV, V21, P97, DOI 10.1053/j.semtcvs.2009.06.007; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Robinson BWS, 2003, LANCET, V362, P1612, DOI 10.1016/S0140-6736(03)14794-0; Romero S, 1996, EUR RESPIR J, V9, P17, DOI 10.1183/09031936.96.09010017; Scagliotti GV, 2007, ONCOL REV, V1, P91, DOI 10.1007/s12156-007-0011-7; Scherpereel A, 2006, AM J RESP CRIT CARE, V173, P1155, DOI 10.1164/rccm.200511-1789OC; Shah PP, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-11; Tomasetti Marco, 2009, Curr Mol Pharmacol, V2, P190; Waller DA, 2003, CURR OPIN ONCOL, V15, P139, DOI 10.1097/00001622-200303000-00004; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang CX, 2009, CELL CYCLE, V8, P3469, DOI 10.4161/cc.8.21.9837	42	76	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18232	10.1371/journal.pone.0018232	http://dx.doi.org/10.1371/journal.pone.0018232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483773	Green Published, gold			2022-12-27	WOS:000289058300007
J	Zhou, GL; Isoe, J; Day, WA; Miesfeld, RL				Zhou, Guoli; Isoe, Jun; Day, W. Antony; Miesfeld, Roger L.			Alpha-COPI Coatomer Protein Is Required for Rough Endoplasmic Reticulum Whorl Formation in Mosquito Midgut Epithelial Cells	PLOS ONE			English	Article							AEDES-AEGYPTI L; BLOOD DIGESTION; L INSECTA; DIPTERA; TRYPSIN; ULTRASTRUCTURE; CULICIDAE; MEAL; P100	Background: One of the early events in midgut epithelial cells of Aedes aegypti mosquitoes is the dynamic reorganization of rough endoplasmic reticulum (RER) whorl structures coincident with the onset of blood meal digestion. Based on our previous studies showing that feeding on an amino acid meal induces TOR signaling in Ae. aegypti, we used proteomics and RNAi to functionally identify midgut epithelial cell proteins that contribute to RER whorl formation. Methodology/Principal Findings: Adult female Ae. aegypti mosquitoes were maintained on sugar alone (unfed), or fed an amino acid meal, and then midgut epithelial cells were analyzed by electron microscopy and protein biochemistry. The size and number of RER whorls in midgut epithelial cells were found to decrease significantly after feeding, and several KDEL-containing proteins were shown to have altered expression levels. LC-MS/MS mass spectrometry was used to analyze midgut microsomal proteins isolated from unfed and amino acid fed mosquitoes, and of the 127 proteins identified, 8 were chosen as candidate whorl forming proteins. Three candidate proteins were COPI coatomer subunits (alpha, beta, beta'), all of which appeared to be present at higher levels in microsomal fractions from unfed mosquitoes. Using RNAi to knockdown alpha-COPI expression, electron microscopy revealed that both the size and number of RER whorls were dramatically reduced in unfed mosquitoes, and moreover, that extended regions of swollen RER were prevalent in fed mosquitoes. Lastly, while a deficiency in alpha-COPI had no effect on early trypsin protein synthesis or secretion 3 hr post blood meal (PBM), expression of late phase proteases at 24 hr PBM was completely blocked. Conclusions: alpha-COPI was found to be required for the formation of RER whorls in midgut epithelial cells of unfed Aa. aegypti mosquitoes, as well as for the expression of late phase midgut proteases.	[Zhou, Guoli; Isoe, Jun; Miesfeld, Roger L.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA; [Day, W. Antony] Univ Arizona, Arizona Res Labs, Tucson, AZ USA	University of Arizona; University of Arizona	Zhou, GL (corresponding author), Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA.	rlm@email.arizona.edu			National Institutes of Health [R01AI31951]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grant R01AI31951 to RLM (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Saraiva KLA, 2008, MICRON, V39, P580, DOI 10.1016/j.micron.2007.06.003; Andrade-Coelho CA, 2001, MEM I OSWALDO CRUZ, V96, P1141, DOI 10.1590/S0074-02762001000800020; Attardo GM, 2006, J EXP BIOL, V209, P3071, DOI 10.1242/jeb.02349; BAUER P, 1977, CELL TISSUE RES, V177, P215, DOI 10.1007/BF00221082; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; BERTRAM D. S., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P404, DOI 10.1016/0035-9203(61)90085-2; BILLINGSLEY PF, 1990, ANNU REV ENTOMOL, V35, P219, DOI 10.1146/annurev.en.35.010190.001251; Brandon MC, 2008, INSECT BIOCHEM MOLEC, V38, P916, DOI 10.1016/j.ibmb.2008.07.003; Briegel H, 2003, J VECTOR ECOL, V28, P1; Callebaut I, 1997, BIOCHEM J, V321, P125, DOI 10.1042/bj3210125; Dickhout JG, 2007, CIRCULATION, V116, P1214, DOI 10.1161/CIRCULATIONAHA.107.728378; Dykstra KM, 2010, MOL BIOL CELL, V21, P1556, DOI 10.1091/mbc.E09-12-1002; GRAF R, 1986, CELL TISSUE RES, V245, P19, DOI 10.1007/BF00218082; Hecker H., 1971, Acta Tropica, V28, P80; HECKER H, 1977, CELL TISSUE RES, V184, P321, DOI 10.1007/BF00219894; HOUK EJ, 1977, TISSUE CELL, V9, P103, DOI 10.1016/0040-8166(77)90052-0; Hsu VW, 2009, NAT REV MOL CELL BIO, V10, P360, DOI 10.1038/nrm2663; HWANG KM, 1974, J CELL BIOL, V62, P20, DOI 10.1083/jcb.62.1.20; Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P903, DOI 10.1016/j.ibmb.2009.10.008; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; KOGAN PH, 1990, J MED ENTOMOL, V27, P709, DOI 10.1093/jmedent/27.4.709; Lingwood D, 2009, J BIOL CHEM, V284, P12041, DOI 10.1074/jbc.M900220200; Marquardt W. C., 2005, BIOL DIS VECTORS; Noriega FG, 1999, J INSECT PHYSIOL, V45, P613, DOI 10.1016/S0022-1910(99)00052-9; Noriega FG, 1999, INSECT BIOCHEM MOLEC, V29, P243, DOI 10.1016/S0965-1748(98)00132-5; Okuda K, 2005, J INSECT PHYSIOL, V51, P769, DOI 10.1016/j.jinsphys.2005.03.010; Okuda K, 2002, TISSUE CELL, V34, P210, DOI 10.1016/S0040-8166(02)00032-0; Popova-Butler A, 2009, J INSECT PHYSIOL, V55, P264, DOI 10.1016/j.jinsphys.2008.12.008; RUDIN W, 1976, TISSUE CELL, V8, P459, DOI 10.1016/0040-8166(76)90006-9; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Styers ML, 2008, AM J PHYSIOL-CELL PH, V294, pC1485, DOI 10.1152/ajpcell.00010.2008; Yang J, 2007, NUCLEIC ACIDS RES, V35, P4485, DOI 10.1093/nar/gkm470; Zhou GL, 2004, J INSECT PHYSIOL, V50, P337, DOI 10.1016/j.jinsphys.2004.02.003; Zhou Guoli, 2009, Open Access Insect Physiology, V1, P1; Zhou HX, 2010, J VIROL, V84, P3542, DOI 10.1128/JVI.02570-09	35	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18150	10.1371/journal.pone.0018150	http://dx.doi.org/10.1371/journal.pone.0018150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483820	gold, Green Published, Green Submitted			2022-12-27	WOS:000289057200033
J	Heidt, T; Deininger, F; Peter, K; Goldschmidt, J; Pethe, A; Hagemeyer, CE; Neudorfer, I; Zirlik, A; Weber, WA; Bode, C; Meyer, PT; Behe, M; von zur Muhlen, C				Heidt, Timo; Deininger, Friederike; Peter, Karlheinz; Goldschmidt, Juergen; Pethe, Annette; Hagemeyer, Christoph E.; Neudorfer, Irene; Zirlik, Andreas; Weber, Wolfgang A.; Bode, Christoph; Meyer, Philipp T.; Behe, Martin; von zur Muehlen, Constantin			Activated Platelets in Carotid Artery Thrombosis in Mice Can Be Selectively Targeted with a Radiolabeled Single-Chain Antibody	PLOS ONE			English	Article							MAGNETIC-RESONANCE; GLYCOPROTEIN IIB/IIIA; CONTRAST AGENT; ATHEROSCLEROTIC PLAQUES; VASCULAR INFLAMMATION; PULMONARY EMBOLI; GPIIB/IIIA; ATHEROGENESIS; ANTAGONIST; RESOLUTION	Background: Activated platelets can be found on the surface of inflamed, rupture-prone and ruptured plaques as well as in intravascular thrombosis. They are key players in thrombosis and atherosclerosis. In this study we describe the construction of a radiolabeled single-chain antibody targeting the LIBS-epitope of activated platelets to selectively depict platelet activation and wall-adherent non-occlusive thrombosis in a mouse model with nuclear imaging using in vitro and ex vivo autoradiography as well as small animal SPECT-CT for in vivo analysis. Methodology/Principal Findings: LIBS as well as an unspecific control single-chain antibody were labeled with (111)Indium ((111)In) via bifunctional DTPA (=(111)In-LIBS/(111)In-control). Autoradiography after incubation with (111)In-LIBS on activated platelets in vitro (mean 3866+/-28 DLU/mm(2), 4010+/-630 DLU/mm(2) and 4520+/-293 DLU/mm(2)) produced a significantly higher ligand uptake compared to (111)In-control (2101+/-76 DLU/mm(2), 1181+/-96 DLU/mm(2) and 1866+/-246 DLU/mm(2)) indicating a specific binding to activated platelets; P < 0.05. Applying these findings to an ex vivo mouse model of carotid artery thrombosis revealed a significant increase in ligand uptake after injection of (111)In-LIBS in the presence of small thrombi compared to the non-injured side, as confirmed by histology (49630+/-10650 DLU/mm(2) vs. 17390+/-7470 DLU/mm(2); P < 0.05). These findings could also be reproduced in vivo. SPECT-CT analysis of the injured carotid artery with (111)In-LIBS resulted in a significant increase of the target-to-background ratio compared to (111)In-control (1.99+/-0.36 vs. 1.1+/-0.24; P<0.01). Conclusions/Significance: Nuclear imaging with (111)In-LIBS allows the detection of platelet activation in vitro and ex vivo with high sensitivity. Using SPECT-CT, wall-adherent activated platelets in carotid arteries could be depicted in vivo. These results encourage further studies elucidating the role of activated platelets in plaque pathology and atherosclerosis and might be of interest for further developments towards clinical application.	[Heidt, Timo; Neudorfer, Irene; Zirlik, Andreas; Bode, Christoph; von zur Muehlen, Constantin] Univ Freiburg, Dept Cardiol & Angiol, Freiburg, Germany; [Deininger, Friederike; Weber, Wolfgang A.; Meyer, Philipp T.; Behe, Martin] Univ Freiburg, Dept Nucl Med, Freiburg, Germany; [Peter, Karlheinz; Hagemeyer, Christoph E.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Goldschmidt, Juergen] Leibniz Inst Neurobiol, Magdeburg, Germany; [Pethe, Annette] Univ Magdeburg, Dept Nucl Med, D-39106 Magdeburg, Germany	University of Freiburg; University of Freiburg; Baker Heart and Diabetes Institute; Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University	Heidt, T (corresponding author), Univ Freiburg, Dept Cardiol & Angiol, Freiburg, Germany.	timo.heidt@uniklinik-freiburg.de	Peter, Karlheinz/E-8772-2010; /S-2765-2019; Hagemeyer, Christoph/E-8958-2011; Zirlik, Andreas/A-6400-2011; Behe, Martin/E-2941-2013	Peter, Karlheinz/0000-0002-8040-2258; /0000-0002-8040-2258; Hagemeyer, Christoph/0000-0002-7114-4023; Zirlik, Andreas/0000-0001-6290-3297; 	German Research Foundation (DFG) [MU2727/3-1]; Australian National Health and Medical Research Council; Australian Research Council [FT0992210]; Australian National Health and Medical Research Council [472668]	German Research Foundation (DFG)(German Research Foundation (DFG)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the German Research Foundation (DFG, grant number MU2727/3-1: CvzM, DvE, IN) and by the Australian National Health and Medical Research Council (www.nhmrc.gov.au); Australian Research Council Future Fellowship FT0992210 to K. P. and Australian National Health and Medical Research Council Career Development Award 472668 to C. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates SM, 2003, ARCH INTERN MED, V163, P452, DOI 10.1001/archinte.163.4.452; BREITLING F, 1999, RECOMBINANT ANTIBODI; Choudhury RP, 2009, ARTERIOSCL THROM VAS, V29, P983, DOI 10.1161/ATVBAHA.108.165498; Choudhury RP, 2004, NAT REV DRUG DISCOV, V3, P913, DOI 10.1038/nrd1548; Ehrenreich H, 2004, MOL PSYCHIATR, V9, P42, DOI 10.1038/sj.mp.4001442; Fujimoto S, 2008, J AM COLL CARDIOL, V52, P1847, DOI 10.1016/j.jacc.2008.08.048; Gawaz M, 2008, J THROMB HAEMOST, V6, P235, DOI 10.1111/j.1538-7836.2007.02867.x; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Haider N, 2009, J NUCL CARDIOL, V16, P753, DOI 10.1007/s12350-009-9107-8; Hallouard F, 2010, BIOMATERIALS, V31, P6249, DOI 10.1016/j.biomaterials.2010.04.066; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Klem JA, 2000, J NUCL CARDIOL, V7, P359, DOI 10.1067/mnc.2000.106967; LARSON SM, 1985, J NUCL MED, V26, P538; Li D, 2010, CIRC-CARDIOVASC IMAG, V3, P464, DOI 10.1161/CIRCIMAGING.109.896654; McAteer MA, 2010, ATHEROSCLEROSIS, V209, P18, DOI 10.1016/j.atherosclerosis.2009.10.009; Morris TA, 2010, SEMIN NUCL MED, V40, P474, DOI 10.1053/j.semnuclmed.2010.08.002; Nahrendorf M, 2006, CIRCULATION, V114, P1504, DOI 10.1161/CIRCULATIONAHA.106.646380; Nahrendorf M, 2009, CIRC-CARDIOVASC IMAG, V2, P56, DOI 10.1161/CIRCIMAGING.108.839092; Rudd JHF, 2008, NAT CLIN PRACT CARD, V5, pS11, DOI 10.1038/ncpcardio1160; Schambach SJ, 2009, STROKE, V40, P1444, DOI 10.1161/STROKEAHA.108.521740; Schmidt KC, 2005, NUCL MED BIOL, V32, P719, DOI 10.1016/j.nucmedbio.2005.04.020; Schwarz M, 2004, J PHARMACOL EXP THER, V308, P1002, DOI 10.1124/jpet.103.058883; Schwarz M, 2006, CIRC RES, V99, P25, DOI 10.1161/01.RES.0000232317.84122.0c; Sinusas AJ, 2008, CIRC-CARDIOVASC IMAG, V1, P244, DOI 10.1161/CIRCIMAGING.108.824359; Spuentrup E, 2005, CIRCULATION, V111, P1377, DOI 10.1161/01.CIR.0000158478.29668.9B; Stoll P, 2007, ARTERIOSCL THROM VAS, V27, P1206, DOI 10.1161/ATVBAHA.106.138875; von zur Muhlen C, 2008, CIRCULATION, V118, P258, DOI 10.1161/CIRCULATIONAHA.107.753657; von zur Muhlen C, 2008, MOL IMAGING, V7, P59, DOI 10.2310/7290.2008.0008; von zur Muhlen C, 2009, J VASC RES, V46, P6, DOI 10.1159/000135660; Wang XK, 2005, THROMB RES, V115, P95, DOI 10.1016/j.thromres.2004.07.009; Westrick RJ, 2007, ARTERIOSCL THROM VAS, V27, P2079, DOI 10.1161/ATVBAHA.107.142810; Zhang JS, 2008, CIRCULATION, V118, P1953, DOI 10.1161/CIRCULATIONAHA.108.789743	32	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18446	10.1371/journal.pone.0018446	http://dx.doi.org/10.1371/journal.pone.0018446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479193	gold, Green Published, Green Submitted			2022-12-27	WOS:000289055700058
J	Kerry, PS; Ayllon, J; Taylor, MA; Hass, C; Lewis, A; Garcia-Sastre, A; Randall, RE; Hale, BG; Russell, RJ				Kerry, Philip S.; Ayllon, Juan; Taylor, Margaret A.; Hass, Claudia; Lewis, Andrew; Garcia-Sastre, Adolfo; Randall, Richard E.; Hale, Benjamin G.; Russell, Rupert J.			A Transient Homotypic Interaction Model for the Influenza A Virus NS1 Protein Effector Domain	PLOS ONE			English	Article							X-RAY-STRUCTURE; RNA-BINDING; NONSTRUCTURAL PROTEIN-1; STRUCTURAL BASIS; INFECTED-CELLS; INTERFERON; ACTIVATION; MOTIF; DIMERIZATION; RECOGNITION	Influenza A virus NS1 protein is a multifunctional virulence factor consisting of an RNA binding domain (RBD), a short linker, an effector domain (ED), and a C-terminal 'tail'. Although poorly understood, NS1 multimerization may autoregulate its actions. While RBD dimerization seems functionally conserved, two possible apo ED dimers have been proposed (helix-helix and strand-strand). Here, we analyze all available RBD, ED, and full-length NS1 structures, including four novel crystal structures obtained using EDs from divergent human and avian viruses, as well as two forms of a monomeric ED mutant. The data reveal the helix-helix interface as the only strictly conserved ED homodimeric contact. Furthermore, a mutant NS1 unable to form the helix-helix dimer is compromised in its ability to bind dsRNA efficiently, implying that ED multimerization influences RBD activity. Our bioinformatical work also suggests that the helix-helix interface is variable and transient, thereby allowing two ED monomers to twist relative to one another and possibly separate. In this regard, we found a mAb that recognizes NS1 via a residue completely buried within the ED helix-helix interface, and which may help highlight potential different conformational populations of NS1 (putatively termed 'helix-closed' and 'helix-open') in virus-infected cells. 'Helix-closed' conformations appear to enhance dsRNA binding, and 'helix-open' conformations allow otherwise inaccessible interactions with host factors. Our data support a new model of NS1 regulation in which the RBD remains dimeric throughout infection, while the ED switches between several quaternary states in order to expand its functional space. Such a concept may be applicable to other small multifunctional proteins.	[Kerry, Philip S.; Taylor, Margaret A.; Hass, Claudia; Lewis, Andrew; Randall, Richard E.; Russell, Rupert J.] Univ St Andrews, St Andrews, Fife, Scotland; [Ayllon, Juan; Garcia-Sastre, Adolfo; Hale, Benjamin G.] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Div Infect Dis, Dept Med, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY USA	University of St Andrews; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Kerry, PS (corresponding author), Univ St Andrews, Biomed Sci Res Complex, St Andrews, Fife, Scotland.	ben.hale@mssm.edu; rjmr@st-andrews.ac.uk	Barasoain, Juan Ayllón/AAA-3899-2019; Hale, Benjamin G./D-4958-2015	Barasoain, Juan Ayllón/0000-0002-7556-8106; Hale, Benjamin G./0000-0002-3891-9480; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Randall, Richard/0000-0002-9304-6678	Medical Research Council, UK; Scottish Funding Council; CRIP, a National Institute of Allergy and Infectious Diseases (NIAID) [HHSN266200700010C]; NIAID [RO1AI46954, U19AI83025, PO1AI58113]; National Institutes of Health-National Cancer Institute (NIH-NCI) [5R24 CA095823-04]; NSF [DBI-9724504]; NIH [1 S10 RR0 9145-01]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058113, U19AI083025, R01AI046954] Funding Source: NIH RePORTER; MRC [G0601126] Funding Source: UKRI; Medical Research Council [G0601126] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Funding Council; CRIP, a National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health-National Cancer Institute (NIH-NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Work in St. Andrews was supported by the Medical Research Council, UK (RER and RJR), and the Scottish Funding Council (RJR). Work performed at MSSM was partially supported by CRIP, a National Institute of Allergy and Infectious Diseases (NIAID) funded Center for Research in Influenza Pathogenesis (contract number HHSN266200700010C), and by NIAID grants RO1AI46954, U19AI83025 and PO1AI58113 (to AG-S). Confocal laser scanning microscopy was performed at the MSSM-Microscopy Shared Resource Facility, supported with funding from National Institutes of Health-National Cancer Institute (NIH-NCI) shared resources grant (5R24 CA095823-04), NSF Major Research Instrumentation grant (DBI-9724504) and NIH shared instrumentation grant (1 S10 RR0 9145-01). The University of St. Andrews is a charity registered in Scotland (No. SC013532). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; Bornholdt ZA, 2008, NATURE, V456, P985, DOI 10.1038/nature07444; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; Cheng A, 2009, CELL RES, V19, P187, DOI 10.1038/cr.2008.288; Chien CY, 1997, NAT STRUCT BIOL, V4, P891, DOI 10.1038/nsb1197-891; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; Dey S, 2010, J MOL BIOL, V398, P146, DOI 10.1016/j.jmb.2010.02.020; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2008, VIROLOGY, V378, P1, DOI 10.1016/j.virol.2008.05.026; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Hale BG, 2010, J VIROL, V84, P6909, DOI 10.1128/JVI.00081-10; Hale BG, 2010, P NATL ACAD SCI USA, V107, P1954, DOI 10.1073/pnas.0910715107; Hale BG, 2009, VIROLOGY, V383, P6, DOI 10.1016/j.virol.2008.10.002; Hayman A, 2006, VIROLOGY, V347, P52, DOI 10.1016/j.virol.2005.11.024; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keiner B, 2010, J VIROL, V84, P11858, DOI 10.1128/JVI.01011-10; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Liu HB, 2010, J VIROL, V84, P11164, DOI 10.1128/JVI.01278-10; Liu JS, 1997, NAT STRUCT BIOL, V4, P896, DOI 10.1038/nsb1197-896; Long JX, 2008, VIRUS GENES, V36, P471, DOI 10.1007/s11262-007-0187-8; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miknis ZJ, 2009, J VIROL, V83, P3007, DOI 10.1128/JVI.01505-08; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; NEMEROFF ME, 1995, VIROLOGY, V212, P422, DOI 10.1006/viro.1995.1499; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Qian XY, 1995, RNA, V1, P948; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Saha RP, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-11; Schrodinger L., 2020, PYMOL; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Steidle S, 2010, J VIROL, V84, P12761, DOI 10.1128/JVI.00701-10; Twu KY, 2007, J VIROL, V81, P8112, DOI 10.1128/JVI.00006-07; Volmer R, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-63; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Wang XY, 2002, J VIROL, V76, P12951, DOI 10.1128/JVI.76.24.12951-12962.2002; Xia SL, 2010, ARCH BIOCHEM BIOPHYS, V494, P198, DOI 10.1016/j.abb.2009.12.008; Xia SL, 2009, ACTA CRYSTALLOGR D, V65, P11, DOI 10.1107/S0907444908032186; Xu K, 2011, J VIROL, V85, P1086, DOI 10.1128/JVI.00877-10; Xu QF, 2011, NUCLEIC ACIDS RES, V39, pD761, DOI 10.1093/nar/gkq1059; Yin CF, 2007, J BIOL CHEM, V282, P20584, DOI 10.1074/jbc.M611619200; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zhao C, 2010, P NATL ACAD SCI USA, V107, P2253, DOI 10.1073/pnas.0909144107	58	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17946	10.1371/journal.pone.0017946	http://dx.doi.org/10.1371/journal.pone.0017946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464929	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000289053800008
J	Tsalatsanis, A; Barnes, L; Hozo, I; Skvoretz, J; Djulbegovic, B				Tsalatsanis, Athanasios; Barnes, Laura; Hozo, Iztok; Skvoretz, John; Djulbegovic, Benjamin			A Social Network Analysis of Treatment Discoveries in Cancer	PLOS ONE			English	Article							PHYSICIANS; BREAST; TRIAL	Controlled clinical trials are widely considered to be the vehicle to treatment discovery in cancer that leads to significant improvements in health outcomes including an increase in life expectancy. We have previously shown that the pattern of therapeutic discovery in randomized controlled trials (RCTs) can be described by a power law distribution. However, the mechanism generating this pattern is unknown. Here, we propose an explanation in terms of the social relations between researchers in RCTs. We use social network analysis to study the impact of interactions between RCTs on treatment success. Our dataset consists of 280 phase III RCTs conducted by the NCI from 1955 to 2006. The RCT networks are formed through trial interactions formed i) at random, ii) based on common characteristics, or iii) based on treatment success. We analyze treatment success in terms of survival hazard ratio as a function of the network structures. Our results show that the discovery process displays power law if there are preferential interactions between trials that may stem from researchers' tendency to interact selectively with established and successful peers. Furthermore, the RCT networks are "small worlds": trials are connected through a small number of ties, yet there is much clustering among subsets of trials. We also find that treatment success (improved survival) is proportional to the network centrality measures of closeness and betweenness. Negative correlation exists between survival and the extent to which trials operate within a limited scope of information. Finally, the trials testing curative treatments in solid tumors showed the highest centrality and the most influential group was the ECOG. We conclude that the chances of discovering life-saving treatments are directly related to the richness of social interactions between researchers inherent in a preferential interaction model.	[Tsalatsanis, Athanasios; Barnes, Laura; Djulbegovic, Benjamin] Univ S Florida, Ctr Evidence Based Med & Hlth Outcomes Res, Tampa, FL 33606 USA; [Hozo, Iztok] Indiana Univ NW, Dept Math, Gary, IN USA; [Skvoretz, John] Univ S Florida, Dept Sociol, Tampa, FL USA; [Djulbegovic, Benjamin] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; Indiana University System; Indiana University Northwest; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Tsalatsanis, A (corresponding author), Univ S Florida, Ctr Evidence Based Med & Hlth Outcomes Res, Tampa, FL 33606 USA.	atsalats@health.usf.edu	Djulbegovic, Benjamin/I-3661-2012; Tsalatsanis, Athanasios/A-8742-2009; Hozo, ihozo@iun.edu/R-3498-2016	Djulbegovic, Benjamin/0000-0003-0671-1447; Tsalatsanis, Athanasios/0000-0003-3818-8283; Hozo, ihozo@iun.edu/0000-0003-2349-5707	Office of Research Integrity and National Institutes of Health [1R01NS044417-01, 1R01NS052956-01, 1R01CA133594-01 NIH/ORI]; NATIONAL CANCER INSTITUTE [R01CA133594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052956, R01NS044417] Funding Source: NIH RePORTER	Office of Research Integrity and National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research has been supported by: Research program on research integrity, Office of Research Integrity and National Institutes of Health (grants: No 1R01NS044417-01, 1R01NS052956-01 and 1R01CA133594-01 NIH/ORI); PI: Dr. Djulbegovic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; [Anonymous], 1676, COMMUNICATION; Barabasi A, 1999, EMERGENCE SCALING RA, P509; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Burt RS, 2004, AM J SOCIOL, V110, P349, DOI 10.1086/421787; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; Cullen R, 1997, B MED LIBR ASSOC, V85, P348; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Djulbegovic B, 2001, Curr Oncol Rep, V3, P389, DOI 10.1007/s11912-001-0024-5; Djulbegovic B, 2009, CANCER CONTROL, V16, P158, DOI 10.1177/107327480901600208; Djulbegovic B, 2008, ARCH INTERN MED, V168, P632, DOI 10.1001/archinte.168.6.632; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; FISHER B, 1980, CANCER, V15, P4; Grann A, 2005, JAMA-J AM MED ASSOC, V293, P1001, DOI 10.1001/jama.293.8.1001; Haug JD, 1997, B MED LIBR ASSOC, V85, P223; Hyams DM, 1997, DIS COLON RECTUM, V40, P131, DOI 10.1007/BF02054976; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; JADAD A, 1998, RANDOMIZED CONTROLLE; Keating NL, 2007, J GEN INTERN MED, V22, P794, DOI 10.1007/s11606-007-0190-8; Kleinberg J.M., 1998, P 9 ANN ACM SIAM S D, P668; Klemm K, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.057102; Kuhn TS, 1962, STRUCTURE SCI REVOLU; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; NEWMAN MEJ, 2005, POWER LAWS PARETO DI, P323; Popper, 1972, OBJECTIVE KNOWLEDGE; Popper K, 1945, ECONOMICA-NEW SER, V12, P69, DOI 10.2307/2549898; Reaman Gregory H, 2004, J Pediatr Oncol Nurs, V21, P123, DOI 10.1177/1043454204264406; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	30	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18060	10.1371/journal.pone.0018060	http://dx.doi.org/10.1371/journal.pone.0018060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743XV	21464896	Green Submitted, Green Published, gold			2022-12-27	WOS:000289053800020
J	Sipola-Leppanen, M; Hovi, P; Andersson, S; Wehkalampi, K; Vaarasmaki, M; Strang-Karlsson, S; Jarvenpaa, AL; Makitie, O; Eriksson, JG; Kajantie, E				Sipola-Leppanen, Marika; Hovi, Petteri; Andersson, Sture; Wehkalampi, Karoliina; Vaarasmaki, Marja; Strang-Karlsson, Sonja; Jarvenpaa, Anna-Liisa; Makitie, Outi; Eriksson, Johan G.; Kajantie, Eero			Resting Energy Expenditure in Young Adults Born Preterm-The Helsinki Study of Very Low Birth Weight Adults	PLOS ONE			English	Article							FAT-FREE MASS; X-RAY ABSORPTIOMETRY; CARDIOVASCULAR RISK-FACTORS; BASAL METABOLIC-RATE; BODY-COMPOSITION; BLOOD-PRESSURE; FETAL-GROWTH; DISEASE; AGE; VALIDATION	Background: Adults born preterm with very low birth weight (VLBW; < 1500g) have higher levels of cardiovascular and metabolic risk factors than their counterparts born at term. Resting energy expenditure (REE) could be one factor contributing to, or protecting from, these risks. We studied the effects of premature birth with VLBW on REE. Methodology/Principal Findings: We used indirect calorimetry to measure REE and dual x-ray absorptiometry (DXA) to measure lean body mass (LBM) in 116 VLBW and in 118 term-born control individuals (mean age: 22.5 years, SD 2.2) participating in a cohort study. Compared with controls VLBW adults had 6.3% lower REE (95% CI 3.2, 9.3) adjusted for age and sex, but 6.1% higher REE/LBM ratio (95% CI 3.4, 8.6). These differences remained similar when further adjusted for parental education, daily smoking, body fat percentage and self-reported leisure time exercise intensity, duration and frequency. Conclusions/Significance: Adults born prematurely with very low birth weight have higher resting energy expenditure per unit lean body mass than their peers born at term. This is not explained by differences in childhood socio-economic status, current fat percentage, smoking or leisure time physical activity. Presence of metabolically more active tissue could protect people with very low birth weight from obesity and subsequent risk of chronic disease.	[Sipola-Leppanen, Marika] Natl Inst Hlth & Welf, Diabet Prevent Unit, Dept Chron Dis Prevent, Oulu, Finland; [Sipola-Leppanen, Marika] Univ Oulu, Dept Pediat & Adolescence, Oulu, Finland; [Hovi, Petteri; Wehkalampi, Karoliina; Strang-Karlsson, Sonja; Eriksson, Johan G.; Kajantie, Eero] Natl Inst Hlth & Welf, Diabet Prevent Unit, Dept Chron Dis Prevent, Helsinki, Finland; [Hovi, Petteri; Andersson, Sture; Wehkalampi, Karoliina; Strang-Karlsson, Sonja; Jarvenpaa, Anna-Liisa; Makitie, Outi; Kajantie, Eero] Helsinki Univ Cent Hosp, Hosp Children & Adolescents, Helsinki, Finland; [Vaarasmaki, Marja] Oulu Univ Hosp, Dept Obstet & Gynaecol, Oulu, Finland; [Vaarasmaki, Marja] Natl Inst Hlth & Welf, Dept Children Young People & Families, Oulu, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.] Folkhalsan Res Inst, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Helsinki Univ Cent Hosp, Unit Gen Practice, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Oulu; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Oulu; Finland National Institute for Health & Welfare; University of Helsinki; Vaasa Central Hospital; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital	Sipola-Leppanen, M (corresponding author), Natl Inst Hlth & Welf, Diabet Prevent Unit, Dept Chron Dis Prevent, Oulu, Finland.	eero.kajantie@helsinki.fi	Paalanne, Marika/ABE-5008-2020	Paalanne, Marika/0000-0003-1626-9410; Vaarasmaki, Marja/0000-0002-8234-4434; Makitie, Outi/0000-0002-4547-001X; Eriksson, Johan/0000-0002-2516-2060	Academy of Finland [135252, 132700, 132894, 126775, 129255, 129907, 135072, 127437, 129306, 130326, 134791]; Biomedicum Helsinki Foundation; Finnish Concordia Foundation; Finska Lakaresallskapet; Finnish Medical Society Duodecim; Finnish Foundation for Pediatric Research; Finnish Pediatric Society; Finnish Special Governmental Subsidy for Health Sciences; Finnish National Graduate School of Clinical Investigation; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Novo Nordisk Foundation; Paivikki and Sakari Sohlberg Foundation; Pediatric Graduate School and the Clinical Graduate School in Paediatrics and Obstetrics/Gynaecology, University of Helsinki; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Vasa Nation and Wiipurilainen osakunta at Helsinki University; Wilhelm and Else Stockmann Foundation; Yrjo Jahnsson Foundation	Academy of Finland(Academy of Finland); Biomedicum Helsinki Foundation; Finnish Concordia Foundation; Finska Lakaresallskapet; Finnish Medical Society Duodecim; Finnish Foundation for Pediatric Research; Finnish Pediatric Society; Finnish Special Governmental Subsidy for Health Sciences; Finnish National Graduate School of Clinical Investigation; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Paivikki and Sakari Sohlberg Foundation; Pediatric Graduate School and the Clinical Graduate School in Paediatrics and Obstetrics/Gynaecology, University of Helsinki; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Vasa Nation and Wiipurilainen osakunta at Helsinki University; Wilhelm and Else Stockmann Foundation; Yrjo Jahnsson Foundation	Grant support: Academy of Finland (grants 135252 to SA; 132700 to KW; 132894 to OM; 126775, 129255, 129907, 135072 to JGE; 127437, 129306, 130326, 134791 to EK) the Biomedicum Helsinki Foundation; the Finnish Concordia Foundation; Finska Lakaresallskapet; the Finnish Medical Society Duodecim; the Finnish Foundation for Pediatric Research; the Finnish Pediatric Society; the Finnish Special Governmental Subsidy for Health Sciences; the Finnish National Graduate School of Clinical Investigation; the Jalmari and Rauha Ahokas Foundation; the Juho Vainio Foundation; the Novo Nordisk Foundation; the Paivikki and Sakari Sohlberg Foundation; the Pediatric Graduate School and the Clinical Graduate School in Paediatrics and Obstetrics/Gynaecology, University of Helsinki; the Signe and Ane Gyllenberg Foundation; the Sigrid Juselius Foundation; Vasa Nation and Wiipurilainen osakunta at Helsinki University; the Wilhelm and Else Stockmann Foundation; and the Yrjo Jahnsson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008192; Astrup A, 1999, AM J CLIN NUTR, V69, P1117; Au-Yong ITH, 2009, DIABETES, V58, P2583, DOI 10.2337/db09-0833; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009; Doyle LW, 2003, PEDIATRICS, V111, P252, DOI 10.1542/peds.111.2.252; Dulloo AG, 1998, AM J CLIN NUTR, V68, P599, DOI 10.1093/ajcn/68.3.599; Eriksson J, 2002, HORM METAB RES, V34, P72, DOI 10.1055/s-2002-20518; Evensen KAI, 2009, EARLY HUM DEV, V85, P239, DOI 10.1016/j.earlhumdev.2008.10.008; Glickman SG, 2004, J APPL PHYSIOL, V97, P509, DOI 10.1152/japplphysiol.01234.2003; HAARBO J, 1991, CLIN PHYSIOL, V11, P331, DOI 10.1111/j.1475-097X.1991.tb00662.x; Hack M, 2005, PEDIATR RES, V58, P677, DOI 10.1203/01.PDR.0000180551.93470.56; Hack M, 2003, PEDIATRICS, V112, pE30, DOI 10.1542/peds.112.1.e30; Hack M, 2007, J PEDIATR-US, V151, P635, DOI 10.1016/j.jpeds.2007.04.063; Heymsfield SB, 2002, AM J PHYSIOL-ENDOC M, V282, pE132, DOI 10.1152/ajpendo.2002.282.1.E132; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Hovi P, 2010, J PEDIATR-US, V156, P54, DOI 10.1016/j.jpeds.2009.07.022; Hovi P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000135; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; Irving RJ, 2000, LANCET, V355, P2135, DOI 10.1016/S0140-6736(00)02384-9; JARVENPAA AL, 1991, ANN MED, V23, P699, DOI 10.3109/07853899109148106; Johnstone AM, 2005, AM J CLIN NUTR, V82, P941, DOI 10.1093/ajcn/82.5.941; Jorgensen JOL, 1998, METABOLISM, V47, P1134, DOI 10.1016/S0026-0495(98)90289-X; Kajantie E, 2010, J PEDIAT; Kajantie E, 2008, PEDIATRICS, V122, pE62, DOI 10.1542/peds.2007-3858; Kensara OA, 2006, AM J PHYSIOL-ENDOC M, V291, pE365, DOI 10.1152/ajpendo.00599.2005; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Martinussen M, 2009, J PEDIAT, V155, P848; National Center for Health Statistics, 2008, FIN NAT DAT VER LOW; NELSON KM, 1992, AM J CLIN NUTR, V56, P848, DOI 10.1093/ajcn/56.5.848; Philip AGS, 2005, PEDIATR RES, V58, P799, DOI 10.1203/01.PDR.0000151693.46655.66; Pihkala J, 1989, Duodecim, V105, P1540; Pyhala R, 2009, PEDIATRICS, V123, P731, DOI 10.1542/peds.2008-0277; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; Rogers M, 2005, PEDIATRICS, V116, pE58, DOI 10.1542/peds.2004-1603; Saigal S, 2007, PEDIATRICS, V119, pE562, DOI 10.1542/peds.2006-2328; Sophie A, 2008, 2008 EUROPERISTAT SC, P12; SVENDSEN OL, 1993, METABOLISM, V42, P1588, DOI 10.1016/0026-0495(93)90155-H; SVENDSEN OL, 1993, AM J CLIN NUTR, V57, P605, DOI 10.1093/ajcn/57.5.605; Taylor HG, 2011, DEV NEUROPSYCHOL, V36, P96, DOI 10.1080/87565641.2011.540544; TISSOT S, 1995, INTENS CARE MED, V21, P149, DOI 10.1007/BF01726538; Wang ZM, 2010, AM J CLIN NUTR, V92, P1369, DOI 10.3945/ajcn.2010.29885; Wang ZM, 2000, AM J PHYSIOL-ENDOC M, V279, pE539, DOI 10.1152/ajpendo.2000.279.3.E539; Weitz G, 2003, J HYPERTENS, V21, P943, DOI 10.1097/00004872-200305000-00019; Wells JCK, 1998, EUR J CLIN NUTR, V52, P536, DOI 10.1038/sj.ejcn.1600604; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886	48	17	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17700	10.1371/journal.pone.0017700	http://dx.doi.org/10.1371/journal.pone.0017700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464981	gold, Green Published, Green Submitted			2022-12-27	WOS:000288813900007
J	Bottomly, D; Walter, NAR; Hunter, JE; Darakjian, P; Kawane, S; Buck, KJ; Searles, RP; Mooney, M; McWeeney, SK; Hitzemann, R				Bottomly, Daniel; Walter, Nicole A. R.; Hunter, Jessica Ezzell; Darakjian, Priscila; Kawane, Sunita; Buck, Kari J.; Searles, Robert P.; Mooney, Michael; McWeeney, Shannon K.; Hitzemann, Robert			Evaluating Gene Expression in C57BL/6J and DBA/2J Mouse Striatum Using RNA-Seq and Microarrays	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; ALCOHOL-DRINKING; CANDIDATE GENES; TRANSCRIPTOME; QTL; MOUSE-CHROMOSOME-1; IDENTIFICATION; NORMALIZATION; LOCI; RATS	C57BL/6J (B6) and DBA/2J (D2) are two of the most commonly used inbred mouse strains in neuroscience research. However, the only currently available mouse genome is based entirely on the B6 strain sequence. Subsequently, oligonucleotide microarray probes are based solely on this B6 reference sequence, making their application for gene expression profiling comparisons across mouse strains dubious due to their allelic sequence differences, including single nucleotide polymorphisms (SNPs). The emergence of next-generation sequencing (NGS) and the RNA-Seq application provides a clear alternative to oligonucleotide arrays for detecting differential gene expression without the problems inherent to hybridization-based technologies. Using RNA-Seq, an average of 22 million short sequencing reads were generated per sample for 21 samples (10 B6 and 11 D2), and these reads were aligned to the mouse reference genome, allowing 16,183 Ensembl genes to be queried in striatum for both strains. To determine differential expression, 'digital mRNA counting' is applied based on reads that map to exons. The current study compares RNA-Seq (Illumina GA IIx) with two microarray platforms (Illumina MouseRef-8 v2.0 and Affymetrix MOE 430 2.0) to detect differential striatal gene expression between the B6 and D2 inbred mouse strains. We show that by using stringent data processing requirements differential expression as determined by RNA-Seq is concordant with both the Affymetrix and Illumina platforms in more instances than it is concordant with only a single platform, and that instances of discordance with respect to direction of fold change were rare. Finally, we show that additional information is gained from RNA-Seq compared to hybridization-based techniques as RNA-Seq detects more genes than either microarray platform. The majority of genes differentially expressed in RNA-Seq were only detected as present in RNA-Seq, which is important for studies with smaller effect sizes where the sensitivity of hybridization-based techniques could bias interpretation.	[Bottomly, Daniel; Kawane, Sunita; McWeeney, Shannon K.] Oregon Hlth & Sci Univ, Oregon Clin & Translat Res Inst, Portland, OR 97201 USA; [Walter, Nicole A. R.; Buck, Kari J.; Hitzemann, Robert] Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Res Serv, Portland, OR 97201 USA; [Walter, Nicole A. R.; Hunter, Jessica Ezzell; Darakjian, Priscila; Hitzemann, Robert] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Searles, Robert P.] Oregon Hlth & Sci Univ, Massively Parallel Sequencing Shared Resource, Portland, OR 97201 USA; [Mooney, Michael; McWeeney, Shannon K.] Oregon Hlth & Sci Univ, Div Bioinformat & Computat Biol Med Informat & Cl, Portland, OR 97201 USA; [McWeeney, Shannon K.] Oregon Hlth & Sci Univ, Div Biostat Publ Hlth & Preventat Med, Portland, OR 97201 USA; [McWeeney, Shannon K.] Oregon Hlth & Sci Univ, OHSU Knight Canc Inst, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Bottomly, D (corresponding author), Oregon Hlth & Sci Univ, Oregon Clin & Translat Res Inst, Portland, OR 97201 USA.	bottomly@ohsu.edu		McWeeney, Shannon/0000-0001-8333-6607; Mooney, Michael/0000-0003-1372-8722; Walter, Nicole/0000-0003-0431-8078; Hunter, Jessica/0000-0002-1117-1097	Veterans Affairs Research Service; MJ Murdock Charitable Trust;  [DA005228];  [AA011114];  [AA011034];  [AA013484];  [AA010760];  [T32AA07468];  [T32DA07262];  [MH051372];  [5UL1RR024140];  [5P30CA069533-13];  [5T15LM007088]; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA010760, P50AA010760, T32AA007468, R01AA011034, R01AA011114, R29AA011114, U01AA013484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007262, R01DA005228] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007088] Funding Source: NIH RePORTER	Veterans Affairs Research Service(US Department of Veterans Affairs); MJ Murdock Charitable Trust; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grants DA005228 (KB and NW), AA011114 (KB and NW), AA011034 (RH), AA013484 (RH), AA010760 (RH, KB, SKM, PD and NW), T32AA07468 (JH and DO), T32DA07262 (DO), MH051372 (RH), 5UL1RR024140 (DB and SKM), 5P30CA069533-13 (SKM), 5T15LM007088 (MM), the Veterans Affairs Research Service, and a grant from the MJ Murdock Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bice PJ, 2010, ALCOHOL, V44, P477, DOI 10.1016/j.alcohol.2010.06.004; Bice PJ, 2006, BEHAV GENET, V36, P248, DOI 10.1007/s10519-005-9019-6; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Denmark DL, 2008, GENES BRAIN BEHAV, V7, P599, DOI 10.1111/j.1601-183X.2008.00396.x; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fagnani M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r108; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hitzemann R, 1995, INT REV NEUROBIOL, V38, P43, DOI 10.1016/S0074-7742(08)60524-3; Hitzemann R, 2003, MAMM GENOME, V14, P733, DOI 10.1007/s00335-003-2277-9; Hofstetter JR, 2008, GENES BRAIN BEHAV, V7, P214, DOI 10.1111/j.1601-183X.2007.00340.x; Iancu OD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-585; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim H, 2004, NAT GENET, V36, P915, DOI 10.1038/ng0904-915; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000299; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Malmanger B, 2006, MAMM GENOME, V17, P1193, DOI 10.1007/s00335-006-0070-2; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mulligan MK, 2006, P NATL ACAD SCI USA, V103, P6368, DOI 10.1073/pnas.0510188103; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; *OR HLTH SCI U, OR HLTH SCI U MASS P; *OR HLTH SCI U, GEN MICR SHAR RES; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Peirce JL, 2006, MAMM GENOME, V17, P643, DOI 10.1007/s00335-005-0187-8; Pozhitkov AE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1122; *R DEV COR TEAM WO, 2010, TITL R FDN STAT COMP; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosen GD, 2003, NEUROINFORMATICS, V1, P327, DOI 10.1385/NI:1:4:327; Rosen Glenn D, 2007, Methods Mol Biol, V401, P287, DOI 10.1007/978-1-59745-520-6_16; Rosen GD, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-5; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Sikela JM, 2006, ALCOHOL CLIN EXP RES, V30, P700, DOI 10.1111/j.1530-0277.2006.00081.x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tabakoff B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-70; Venables WN., 2002, MODERN APPL STAT S 4; Walter NAR, 2007, NAT METHODS, V4, P679, DOI 10.1038/nmeth0907-679; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang H, 2003, EXP BRAIN RES, V149, P413, DOI 10.1007/s00221-002-1369-1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016	50	148	150	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17820	10.1371/journal.pone.0017820	http://dx.doi.org/10.1371/journal.pone.0017820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455293	Green Published, gold, Green Submitted			2022-12-27	WOS:000288811500010
J	Haberlandt, C; Derouiche, A; Wyczynski, A; Haseleu, J; Pohle, J; Karram, K; Trotter, J; Seifert, G; Frotscher, M; Steinhauser, C; Jabs, R				Haberlandt, Christian; Derouiche, Amin; Wyczynski, Alexandra; Haseleu, Julia; Pohle, Joerg; Karram, Khalad; Trotter, Jacqueline; Seifert, Gerald; Frotscher, Michael; Steinhaeuser, Christian; Jabs, Ronald			Gray Matter NG2 Cells Display Multiple Ca2+-Signaling Pathways and Highly Motile Processes	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; OLIGODENDROCYTE PRECURSOR CELLS; PROTEIN DISULFIDE-ISOMERASE; HIPPOCAMPAL GLIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; MOUSE HIPPOCAMPUS; ENDOPLASMIC-RETICULUM; SYNAPTIC-TRANSMISSION; NA+/CA2+ EXCHANGE; CALCIUM-CHANNELS	NG2 cells, the fourth type of glia in the mammalian CNS, receive synaptic input from neurons. The function of this innervation is unknown yet. Postsynaptic changes in intracellular Ca2+-concentration ([Ca2+](i)) might be a possible consequence. We employed transgenic mice with fluorescently labeled NG2 cells to address this issue. To identify Ca2+-signaling pathways we combined patch-clamp recordings, Ca2+-imaging, mRNA-transcript analysis and focal pressure-application of various substances to identified NG2-cells in acute hippocampal slices. We show that activation of voltage-gated Ca2+-channels, Ca2+-permeable AMPA-receptors, and group I metabotropic glutamate-receptors provoke [Ca2+](i-) elevations in NG2 cells. The Ca2+-influx is amplified by Ca2+-induced Ca2+-release. Minimal electrical stimulation of presynaptic neurons caused postsynaptic currents but no somatic [Ca2+](i) elevations, suggesting that [Ca2+](i) elevations in NG2 cells might be restricted to their processes. Local Ca2+-signaling might provoke transmitter release or changes in cell motility. To identify structural prerequisites for such a scenario, we used electron microscopy, immunostaining, mRNA-transcript analysis, and time lapse imaging. We found that NG2 cells form symmetric and asymmetric synapses with presynaptic neurons and show immunoreactivity for vesicular glutamate transporter 1. The processes are actin-based, contain ezrin but not glial filaments, microtubules or endoplasmic reticulum. Furthermore, we demonstrate that NG2 cell processes in situ are highly motile. Our findings demonstrate that gray matter NG2 cells are endowed with the cellular machinery for two-way communication with neighboring cells.	[Haberlandt, Christian; Derouiche, Amin; Wyczynski, Alexandra; Haseleu, Julia; Pohle, Joerg; Seifert, Gerald; Steinhaeuser, Christian; Jabs, Ronald] Univ Bonn, Inst Cellular Neurosci, D-5300 Bonn, Germany; [Derouiche, Amin; Frotscher, Michael] Univ Freiburg, Inst Anat & Cell Biol, Freiburg, Germany; [Derouiche, Amin] Goethe Univ Frankfurt, Inst Anat 2, Frankfurt, Germany; [Pohle, Joerg] Univ Basel, Inst Physiol, Dept Biomed, Basel, Switzerland; [Karram, Khalad; Trotter, Jacqueline] Johannes Gutenberg Univ Mainz, Mainz, Germany	University of Bonn; University of Freiburg; Goethe University Frankfurt; University of Basel; Johannes Gutenberg University of Mainz	Haberlandt, C (corresponding author), Univ Bonn, Inst Cellular Neurosci, D-5300 Bonn, Germany.	christian.steinhaeuser@ukb.uni-bonn.de; ronald.jabs@ukb.uni-bonn.de	Derouiche, Amin/G-7390-2015; Jabs, Ronald/C-5132-2008	Derouiche, Amin/0000-0002-7309-2044; Jabs, Ronald/0000-0001-6612-7678; Haseleu, Julia/0000-0002-6827-074X	DFG [SFB/TR3, SPP1172]; EC [FP7-202167]; Land NRW (Graduate School Biotech-Pharma)	DFG(German Research Foundation (DFG)); EC(European CommissionEuropean Commission Joint Research Centre); Land NRW (Graduate School Biotech-Pharma)	This work was supported by DFG (SFB/TR3 to CS, AD and MF; SPP1172 to CS, GS and JT), EC (FP7-202167 NeuroGLIA to CS) and Land NRW (Graduate School Biotech-Pharma to CH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Akopian G, 1996, GLIA, V17, P181; Anlauf E, 2005, GLIA, V49, P96, DOI 10.1002/glia.20094; Anlauf E, 2009, J MICROSC-OXFORD, V233, P225, DOI 10.1111/j.1365-2818.2009.03112.x; Bergersen LH, 2009, NEUROSCIENCE, V158, P260, DOI 10.1016/j.neuroscience.2008.03.074; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bergles DE, 2010, BRAIN RES REV, V63, P130, DOI 10.1016/j.brainresrev.2009.12.003; BERRYMAN M, 1993, J CELL SCI, V105, P1025; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Butt AM, 2005, J ANAT, V207, P695, DOI 10.1111/j.1469-7580.2005.00458.x; Darcy DP, 2009, J NEUROSCI, V29, P2510, DOI 10.1523/JNEUROSCI.5333-08.2009; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; Derouiche A, 2001, GLIA, V36, P330, DOI 10.1002/glia.1120; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Etxeberria A, 2010, NAT NEUROSCI, V13, P287, DOI 10.1038/nn.2500; Ferraguti F, 2008, PHARMACOL REV, V60, P536, DOI 10.1124/pr.108.000166; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; Gautreau A, 2002, CURR OPIN CELL BIOL, V14, P104, DOI 10.1016/S0955-0674(01)00300-3; Ge WP, 2006, SCIENCE, V312, P1533, DOI 10.1126/science.1124669; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Hirrlinger J, 2004, EUR J NEUROSCI, V20, P2235, DOI 10.1111/j.1460-9568.2004.03689.x; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Iwamoto T, 2004, MOL PHARMACOL, V66, P45, DOI 10.1124/mol.66.1.45; Iwamoto T, 1998, AM J PHYSIOL-CELL PH, V275, pC423, DOI 10.1152/ajpcell.1998.275.2.C423; Jabs R, 2005, J CELL SCI, V118, P3791, DOI 10.1242/jcs.02515; JABS R, 1994, PFLUG ARCH EUR J PHY, V426, P310, DOI 10.1007/BF00374787; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Kimelberg HK, 2000, J NEUROSCI RES, V61, P577, DOI 10.1002/1097-4547(20000915)61:6<577::AID-JNR1>3.0.CO;2-T; KIRCHHOFF F, 1992, EUR J NEUROSCI, V4, P1049, DOI 10.1111/j.1460-9568.1992.tb00131.x; Kitajiri S, 2004, J CELL BIOL, V166, P559, DOI 10.1083/jcb.200402007; LAMBERT N, 1985, BIOCHEM J, V228, P635, DOI 10.1042/bj2280635; Laver DR, 2007, CLIN EXP PHARMACOL P, V34, P889, DOI 10.1111/j.1440-1681.2007.04708.x; LERANTH C, 1987, J COMP NEUROL, V261, P33, DOI 10.1002/cne.902610104; Lin SC, 2004, NAT NEUROSCI, V7, P24, DOI 10.1038/nn1162; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Matthias K, 2003, J NEUROSCI, V23, P1750; Nishiyama A, 2007, NEUROSCIENTIST, V13, P62, DOI 10.1177/1073858406295586; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; NOIVA R, 1992, J BIOL CHEM, V267, P3553; Nolte C, 2001, GLIA, V33, P72; Paglini G, 1998, J CELL BIOL, V143, P443, DOI 10.1083/jcb.143.2.443; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Peters A, 2004, J NEUROCYTOL, V33, P345, DOI 10.1023/B:NEUR.0000044195.64009.27; Rodriguez-Moreno A, 2007, TRENDS NEUROSCI, V30, P630, DOI 10.1016/j.tins.2007.10.001; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; SEIFERT G, 1995, EUR J NEUROSCI, V7, P1872, DOI 10.1111/j.1460-9568.1995.tb00708.x; Seifert G, 1997, MOL BRAIN RES, V47, P286, DOI 10.1016/S0169-328X(97)00059-4; Seifert G, 1997, J NEUROPHYSIOL, V78, P2916, DOI 10.1152/jn.1997.78.6.2916; STEINHAUSER C, 1994, PFLUG ARCH EUR J PHY, V428, P610, DOI 10.1007/BF00374585; STEINHAUSER C, 1994, HIPPOCAMPUS, V4, P19, DOI 10.1002/hipo.450040105; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Tong XP, 2009, J CELL BIOL, V186, P113, DOI 10.1083/jcb.200811071; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Verkhratsky A, 2002, CELL CALCIUM, V32, P393, DOI 10.1016/S0143416002001896; Watano T, 1996, BRIT J PHARMACOL, V119, P555, DOI 10.1111/j.1476-5381.1996.tb15708.x; Zamponi GW, 1996, J MEMBRANE BIOL, V151, P77, DOI 10.1007/s002329900059; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	64	73	73	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17575	10.1371/journal.pone.0017575	http://dx.doi.org/10.1371/journal.pone.0017575			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455301	Green Published, Green Submitted, gold			2022-12-27	WOS:000288811500006
J	Dukart, J; Mueller, K; Horstmann, A; Barthel, H; Moller, HE; Villringer, A; Sabri, O; Schroeter, ML				Dukart, Juergen; Mueller, Karsten; Horstmann, Annette; Barthel, Henryk; Moeller, Harald E.; Villringer, Arno; Sabri, Osama; Schroeter, Matthias L.			Combined Evaluation of FDG-PET and MRI Improves Detection and Differentiation of Dementia	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; FRONTOTEMPORAL LOBAR DEGENERATION; MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; GLUCOSE-METABOLISM; FEATURE-SELECTION; F-18-FDG PET; GRAY-MATTER; DIAGNOSIS	Introduction: Various biomarkers have been reported in recent literature regarding imaging abnormalities in different types of dementia. These biomarkers have helped to significantly improve early detection and also differentiation of various dementia syndromes. In this study, we systematically applied whole-brain and region-of-interest (ROI) based support vector machine classification separately and on combined information from different imaging modalities to improve the detection and differentiation of different types of dementia. Methods: Patients with clinically diagnosed Alzheimer's disease (AD: n = 21), with frontotemporal lobar degeneration (FTLD: n = 14) and control subjects (n = 13) underwent both [F18]fluorodeoxyglucose positron emission tomography (FDG-PET) scanning and magnetic resonance imaging (MRI), together with clinical and behavioral assessment. FDG-PET and MRI data were commonly processed to get a precise overlap of all regions in both modalities. Support vector machine classification was applied with varying parameters separately for both modalities and to combined information obtained from MR and FDG-PET images. ROIs were extracted from comprehensive systematic and quantitative meta-analyses investigating both disorders. Results: Using single-modality whole-brain and ROI information FDG-PET provided highest accuracy rates for both, detection and differentiation of AD and FTLD compared to structural information from MRI. The ROI-based multimodal classification, combining FDG-PET and MRI information, was highly superior to the unimodal approach and to the whole-brain pattern classification. With this method, accuracy rate of up to 92% for the differentiation of the three groups and an accuracy of 94% for the differentiation of AD and FTLD patients was obtained. Conclusion: Accuracy rate obtained using combined information from both imaging modalities is the highest reported up to now for differentiation of both types of dementia. Our results indicate a substantial gain in accuracy using combined FDG-PET and MRI information and suggest the incorporation of such approaches to clinical diagnosis and to differential diagnostic procedures of neurodegenerative disorders.	[Dukart, Juergen; Mueller, Karsten; Horstmann, Annette; Moeller, Harald E.; Villringer, Arno; Schroeter, Matthias L.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Villringer, Arno; Schroeter, Matthias L.] Univ Leipzig, Day Clin Cognit Neurol, Leipzig, Germany; [Barthel, Henryk; Sabri, Osama] Univ Leipzig, Dept Nucl Med, Leipzig, Germany	Max Planck Society; Leipzig University; Leipzig University	Dukart, J (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	dukart@cbs.mpg.de	Moller, Harald E/A-1565-2008; Möller, Harald/AAB-4679-2019; Dukart, Juergen/E-5459-2011; Horstmann, Annette/C-9083-2011; Scharre, Douglas W/E-4030-2011	Moller, Harald E/0000-0002-5659-1925; Möller, Harald/0000-0002-5659-1925; Horstmann, Annette/0000-0001-6184-8484; Dukart, Juergen/0000-0003-0492-5644; Villringer, Arno/0000-0003-2604-2404; Sabri, Osama/0000-0002-6425-3504	Max Planck Society; NATIONAL INSTITUTE ON AGING [U19AG010483] Funding Source: NIH RePORTER	Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; CHANG CC, 2001, LIBSVM LIB SUPP VECT; Chaves R, 2009, NEUROSCI LETT, V461, P293, DOI 10.1016/j.neulet.2009.06.052; Davatzikos C, 2008, NEUROIMAGE, V41, P1220, DOI 10.1016/j.neuroimage.2008.03.050; Diehl J, 2004, NEUROBIOL AGING, V25, P1051, DOI 10.1016/j.neurobiolaging.2003.10.007; Diehl-Schmid J, 2007, NEUROBIOL AGING, V28, P42, DOI 10.1016/j.neurobiolaging.2005.11.002; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dukart J, 2010, NEUROIMAGE, V49, P1490, DOI 10.1016/j.neuroimage.2009.09.017; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fung G, 2007, KNOWL INF SYST, V11, P243, DOI 10.1007/s10115-006-0043-5; Hoffman JM, 2000, J NUCL MED, V41, P1920; Horn JF, 2009, ARTIF INTELL MED, V47, P147, DOI 10.1016/j.artmed.2009.05.001; Ishii K, 2005, EUR J NUCL MED MOL I, V32, P959, DOI 10.1007/s00259-004-1740-5; Ishii K, 2001, J NUCL MED, V42, P548; Ishii K, 1997, J NUCL MED, V38, P925; Jeong Y, 2005, J NUCL MED, V46, P233; Kanda T, 2008, EUR J NUCL MED MOL I, V35, P2227, DOI 10.1007/s00259-008-0871-5; Kipps CM, 2009, BRAIN, V132, P2566, DOI 10.1093/brain/awp077; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Knopman DS, 2005, ANN NEUROL, V57, P480, DOI 10.1002/ana.20425; Matsunari I, 2007, J NUCL MED, V48, P1961, DOI 10.2967/jnumed.107.042820; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meguro K, 2004, ALZ DIS ASSOC DIS, V18, P3, DOI 10.1097/00002093-200401000-00002; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MULLERGARTNER HW, 1992, J CEREBR BLOOD F MET, V12, P571, DOI 10.1038/jcbfm.1992.81; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Perneczky R, 2006, AM J GERIAT PSYCHIAT, V14, P139, DOI 10.1097/01.JGP.0000192478.82189.a8; Quarantelli M, 2004, J NUCL MED, V45, P192; Rabinovici G D, 2007, Am J Alzheimers Dis Other Demen, V22, P474, DOI 10.1177/1533317507308779; Ramirez J, 2013, INFORM SCIENCES, V237, P59, DOI 10.1016/j.ins.2009.05.012; Rascovsky K, 2002, NEUROLOGY, V58, P1801, DOI 10.1212/WNL.58.12.1801; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Rousset OG, 1998, J NUCL MED, V39, P904; Sabri O, 2008, EUR J NUCL MED MOL I, V35, pS30, DOI 10.1007/s00259-007-0701-1; Sadeghi N, 2008, I S BIOMED IMAGING, P408, DOI 10.1109/ISBI.2008.4541019; Schroeter ML, 2008, NEUROBIOL AGING, V29, P418, DOI 10.1016/j.neurobiolaging.2006.10.023; Schroeter ML, 2007, NEUROIMAGE, V36, P497, DOI 10.1016/j.neuroimage.2007.03.024; Schroeter ML, 2009, NEUROIMAGE, V47, P1196, DOI 10.1016/j.neuroimage.2009.05.037; van De Pol LA, 2006, J NEUROL NEUROSUR PS, V77, P439, DOI 10.1136/jnnp.2005.075341; Yakushev I, 2009, NEUROIMAGE, V44, P43, DOI 10.1016/j.neuroimage.2008.07.015; Yakushev I, 2008, PSYCHIAT RES-NEUROIM, V164, P143, DOI 10.1016/j.pscychresns.2007.11.004	43	104	107	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18111	10.1371/journal.pone.0018111	http://dx.doi.org/10.1371/journal.pone.0018111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448435	Green Published, gold, Green Submitted			2022-12-27	WOS:000288810500035
J	Litvack, ML; Post, M; Palaniyar, N				Litvack, Michael L.; Post, Martin; Palaniyar, Nades			IgM Promotes the Clearance of Small Particles and Apoptotic Microparticles by Macrophages	PLOS ONE			English	Article							SURFACTANT PROTEIN-A; NATURAL IGM; PATTERN-RECOGNITION; ISCHEMIA/REPERFUSION INJURY; COMPLEMENT ACTIVATION; IN-VIVO; MEDIATED PHAGOCYTOSIS; INFLUENZA-VIRUS; NECROTIC CELLS; SECRETED IGM	Background: Antibodies are often involved in enhancing particle clearance by macrophages. Although the mechanisms of antibody-dependent phagocytosis have been studied for IgG in greater detail, very little is known about IgM-mediated clearance. It has been generally considered that IgM does not support phagocytosis. Recent studies indicate that natural IgM is important to clear microbes and other bioparticles, and that shape is critical to particle uptake by macrophages; however, the relevance of IgM and particle size in their clearance remains unclear. Here we show that IgM has a size-dependent effect on clearance. Methodology/Principal Findings: We used antibody-opsonized sheep red blood cells, different size beads and apoptotic cells to determine the effect of human and mouse IgM on phagocytosis by mouse alveolar macrophages. Our microscopy (light, epifluorescence, confocal) and flow cytometry data show that IgM greatly enhances the clearance of small particles (about 1-2 micron) by these macrophages. There is an inverse relationship between IgM-mediated clearance by macrophages and the particle size; however, macrophages bind and internalize many different size particles coated with IgG. We also show that IgM avidly binds to small size late apoptotic cells or bodies (2-5 micron) and apoptotic microparticles (< 2 mu m) released from dying cells. IgM also promotes the binding and uptake of microparticle-coated beads. Conclusions/Significance: Therefore, while the shape of the particles is important for non-opsonized particle uptake, the particle size matters for antibody-mediated clearance by macrophages. IgM particularly promotes the clearance of small size particles. This finding may have wider implications in IgM-mediated clearing of antigens, microbial pathogens and dying cells by the host.	[Litvack, Michael L.; Palaniyar, Nades] Hosp Sick Children, Lung Innate Immun Res Lab, Toronto, ON M5G 1X8, Canada; [Litvack, Michael L.; Post, Martin; Palaniyar, Nades] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON M5S 1A1, Canada; [Post, Martin; Palaniyar, Nades] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Litvack, ML (corresponding author), Hosp Sick Children, Lung Innate Immun Res Lab, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	nades.palaniyar@sickkids.ca		Palaniyar, Nades/0000-0002-2170-8548	Canadian Institutes of Health [MOP-84312, MOP-134761]; Sickkids Restracomp/Ontario Student Opportunity Trust; Peterborough K.M. Hunter Graduate Studentship	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Sickkids Restracomp/Ontario Student Opportunity Trust; Peterborough K.M. Hunter Graduate Studentship	This study was funded by Canadian Institutes of Health Research grants MOP-84312 and MOP-134761 to NP. MLL is a recipient of Sickkids Restracomp/Ontario Student Opportunity Trust Funds Awards and of the Peterborough K.M. Hunter Graduate Studentships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; Bonifati DM, 2007, MOL IMMUNOL, V44, P999, DOI 10.1016/j.molimm.2006.03.007; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y; Chen YF, 2009, J IMMUNOL, V183, P1346, DOI 10.4049/jimmunol.0900948; Chen YF, 2009, J IMMUNOL, V182, P6031, DOI 10.4049/jimmunol.0804191; Choi YS, 2008, J EXP MED, V205, P3053, DOI 10.1084/jem.20080979; CHOW CW, 2004, CURR PROTOC CELL BIO; Ciurana CLF, 2006, CELL IMMUNOL, V239, P14, DOI 10.1016/j.cellimm.2006.02.006; Ciurana CLF, 2004, EUR J IMMUNOL, V34, P2609, DOI 10.1002/eji.200425045; Clark H, 2002, J IMMUNOL, V169, P2892, DOI 10.4049/jimmunol.169.6.2892; Cline AM, 2004, CLIN IMMUNOL, V112, P175, DOI 10.1016/j.clim.2004.02.017; Connolly SE, 2004, J IMMUNOL, V172, P1191, DOI 10.4049/jimmunol.172.2.1191; Davizon P, 2009, CURR OPIN HEMATOL, V16, P334, DOI 10.1097/MOH.0b013e32832ea49c; Dignat-George F, 2004, THROMB HAEMOSTASIS, V91, P667, DOI 10.1160/TH03-07-0487; Fu M, 2007, APOPTOSIS, V12, P355, DOI 10.1007/s10495-006-0581-z; Gaiha GD, 2008, J IMMUNOL, V181, P601, DOI 10.4049/jimmunol.181.1.601; GEISER M, 2010, J AEROSOL MED PULM D; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Jaffar Z, 2009, J IMMUNOL, V182, P4507, DOI 10.4049/jimmunol.0900237; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Kang YH, 2009, ADV EXP MED BIOL, V653, P117; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Kishore U, 2003, J IMMUNOL, V171, P812, DOI 10.4049/jimmunol.171.2.812; Licht R, 2004, J AUTOIMMUN, V22, P139, DOI 10.1016/j.jaut.2003.11.003; Litvack ML, 2010, MOL IMMUNOL, V48, P37, DOI 10.1016/j.molimm.2010.09.014; Litvack ML, 2010, INNATE IMMUN-LONDON, V16, P191, DOI 10.1177/1753425910369271; Nadesalingam J, 2005, FEBS LETT, V579, P4449, DOI 10.1016/j.febslet.2005.07.012; Nakanishi Y, 2009, ADV EXP MED BIOL, V653, P129; Ogden CA, 2005, AUTOIMMUNITY, V38, P259, DOI 10.1080/08916930500124452; Ojewole E, 2008, EUR J PHARM BIOPHARM, V70, P697, DOI 10.1016/j.ejpb.2008.06.020; Palaniyar N, 2005, J IMMUNOL, V174, P7352, DOI 10.4049/jimmunol.174.11.7352; Palaniyar N, 2004, J BIOL CHEM, V279, P32728, DOI 10.1074/jbc.M403763200; Palaniyar N, 2010, INNATE IMMUN-LONDON, V16, P131, DOI 10.1177/1753425910370498; Peng YF, 2005, MOL IMMUNOL, V42, P781, DOI 10.1016/j.molimm.2004.07.045; Quartier P, 2005, EUR J IMMUNOL, V35, P252, DOI 10.1002/eji.200425497; Rapaka RR, 2010, J EXP MED, V207, P2907, DOI 10.1084/jem.20100034; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; Schulze C, 2008, AUTOIMMUN REV, V8, P5, DOI 10.1016/j.autrev.2008.07.049; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Subramaniam KS, 2010, J IMMUNOL, V184, P5755, DOI 10.4049/jimmunol.0901638; Taborda CP, 2002, IMMUNITY, V16, P791, DOI 10.1016/S1074-7613(02)00328-X; Vaculik C, 2008, CLIN EXP IMMUNOL, V151, P146, DOI 10.1111/j.1365-2249.2007.03534.x; Vollmers HP, 2006, ADV DRUG DELIVER REV, V58, P755, DOI 10.1016/j.addr.2005.08.007; Zhang M, 2004, P NATL ACAD SCI USA, V101, P3886, DOI 10.1073/pnas.0400347101; Zhang M, 2008, MOL IMMUNOL, V45, P4036, DOI 10.1016/j.molimm.2008.06.013; Zhang M, 2007, MOL IMMUNOL, V44, P103, DOI 10.1016/j.molimm.2006.06.022; Zhang M, 2006, J IMMUNOL, V177, P4727, DOI 10.4049/jimmunol.177.7.4727; Zwart B, 2004, AUTOIMMUNITY, V37, P95, DOI 10.1080/0891693042000196183	51	52	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17223	10.1371/journal.pone.0017223	http://dx.doi.org/10.1371/journal.pone.0017223			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448268	gold, Green Published, Green Submitted			2022-12-27	WOS:000288810500004
J	Buechel, HM; Popovic, J; Searcy, JL; Porter, NM; Thibault, O; Blalock, EM				Buechel, Heather M.; Popovic, Jelena; Searcy, James L.; Porter, Nada M.; Thibault, Olivier; Blalock, Eric M.			Deep Sleep and Parietal Cortex Gene Expression Changes Are Related to Cognitive Deficits with Age	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; DAYTIME SLEEPINESS; GLUCOSE-METABOLISM; HIPPOCAMPAL; BRAIN; MEMORY; IMPAIRMENT; CALCIUM; RATS	Background: Age-related cognitive deficits negatively affect quality of life and can presage serious neurodegenerative disorders. Despite sleep disruption's well-recognized negative influence on cognition, and its prevalence with age, surprisingly few studies have tested sleep's relationship to cognitive aging. Methodology: We measured sleep stages in young adult and aged F344 rats during inactive (enhanced sleep) and active (enhanced wake) periods. Animals were behaviorally characterized on the Morris water maze and gene expression profiles of their parietal cortices were taken. Principal Findings: Water maze performance was impaired, and inactive period deep sleep was decreased with age. However, increased deep sleep during the active period was most strongly correlated to maze performance. Transcriptional profiles were strongly associated with behavior and age, and were validated against prior studies. Bioinformatic analysis revealed increased translation and decreased myelin/neuronal pathways. Conclusions: The F344 rat appears to serve as a reasonable model for some common sleep architecture and cognitive changes seen with age in humans, including the cognitively disrupting influence of active period deep sleep. Microarray analysis suggests that the processes engaged by this sleep are consistent with its function. Thus, active period deep sleep appears temporally misaligned but mechanistically intact, leading to the following: first, aged brain tissue appears capable of generating the slow waves necessary for deep sleep, albeit at a weaker intensity than in young. Second, this activity, presented during the active period, seems disruptive rather than beneficial to cognition. Third, this active period deep sleep may be a cognitively pathologic attempt to recover age-related loss of inactive period deep sleep. Finally, therapeutic strategies aimed at reducing active period deep sleep (e.g., by promoting active period wakefulness and/or inactive period deep sleep) may be highly relevant to cognitive function in the aging community.	[Buechel, Heather M.; Popovic, Jelena; Searcy, James L.; Porter, Nada M.; Thibault, Olivier; Blalock, Eric M.] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40526 USA	University of Kentucky	Buechel, HM (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40526 USA.	emblal@uky.edu	Thibault, Olivier/AAY-7614-2020	Thibault, Olivier/0000-0002-3548-3466	University of Kentucky College of Medicine; National Institute on Aging, National Institutes of Health (NIA NIH) [1R01AG037868]; NATIONAL INSTITUTE ON AGING [R01AG037868] Funding Source: NIH RePORTER	University of Kentucky College of Medicine; National Institute on Aging, National Institutes of Health (NIA NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by start-up funding from the University of Kentucky College of Medicine as well as the National Institute on Aging, National Institutes of Health (NIA NIH) 1R01AG037868. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 2005, NEUROLOGY, V65, P1442, DOI 10.1212/01.wnl.0000183056.89590.0d; Ancoli-Israel S, 2006, AM J GERIAT PSYCHIAT, V14, P95, DOI 10.1097/01.JGP.0000196627.12010.d1; Ancoli-Israel S, 2006, J CLIN SLEEP MED, V2, P333; ARMSTRONG DM, 1993, NEUROBIOL AGING, V14, P457, DOI 10.1016/0197-4580(93)90104-J; Avidan Alon Y, 2003, Clin Cornerstone, V5, P51, DOI 10.1016/S1098-3597(03)90035-4; Banks S, 2007, J CLIN SLEEP MED, V3, P519; BARNES CA, 1985, BEHAV NEUROSCI, V99, P1040, DOI 10.1037/0735-7044.99.6.1040; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Blalock EM, 2005, AGEING RES REV, V4, P481, DOI 10.1016/j.arr.2005.06.006; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blalock EM, 2003, J NEUROSCI, V23, P3807; Blalock EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010405; Blalock EM, 2010, J NEUROSCI, V30, P6058, DOI 10.1523/JNEUROSCI.3956-09.2010; BOLSTAD B, 2005, BIOINFORMATICS COMPU; BORBELY AA, 1975, BRAIN RES, V95, P89, DOI 10.1016/0006-8993(75)90209-7; Boric K, 2008, J NEUROSCI, V28, P8034, DOI 10.1523/JNEUROSCI.2036-08.2008; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; Born J, 2010, WORLD J BIOL PSYCHIA, V11, P16, DOI 10.3109/15622971003637637; Burger C, 2008, NEUROBIOL LEARN MEM, V89, P379, DOI 10.1016/j.nlm.2007.11.006; Burger C, 2007, NEUROBIOL LEARN MEM, V87, P21, DOI 10.1016/j.nlm.2006.05.003; Cajochen C, 2006, CHRONOBIOL INT, V23, P461, DOI 10.1080/07420520500545813; Chong MS, 2005, LANCET NEUROL, V4, P576, DOI 10.1016/S1474-4422(05)70168-X; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; d'Hellencourt CL, 2005, J NEUROCHEM, V93, P206, DOI 10.1111/j.1471-4159.2004.03017.x; DETOLEDOMORRELL L, 1988, NEUROBIOL AGING, V9, P581, DOI 10.1016/S0197-4580(88)80117-9; Di Stefano G, 2010, REJUV RES, V13, P224, DOI 10.1089/rej.2009.0965; Diekelmann S, 2011, NAT NEUROSCI; Driscoll I, 2005, REV NEUROSCIENCE, V16, P87, DOI 10.1515/REVNEURO.2005.16.2.87; Espiritu JRD, 2008, CLIN GERIATR MED, V24, P1, DOI 10.1016/j.cger.2007.08.007; Foley D, 2001, J AM GERIATR SOC, V49, P1628, DOI 10.1111/j.1532-5415.2001.49271.x; Foster TC, 1997, HIPPOCAMPUS, V7, P602, DOI 10.1002/(SICI)1098-1063(1997)7:6<602::AID-HIPO3>3.0.CO;2-G; Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x; Foster TC, 2007, NEUROBIOL LEARN MEM, V87, P522, DOI 10.1016/j.nlm.2006.12.009; GAGE FH, 1988, NEUROBIOL AGING, V9, P645, DOI 10.1016/S0197-4580(88)80129-5; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GINSBERG SD, 2010, BIOL PSYCHIAT; Ginsberg Stephen D, 2006, NeuroRx, V3, P302, DOI 10.1016/j.nurx.2006.05.007; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Imeri L, 2004, BRAIN BEHAV IMMUN, V18, P399, DOI 10.1016/j.bbi.2003.12.003; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; Khachaturian Z S, 1989, Aging (Milano), V1, P17; Kirov R, 2002, NEUROSCI LETT, V322, P134, DOI 10.1016/S0304-3940(02)00096-4; Kryger M, 2004, GERIATRICS-US, V59, P24; LANDFIELD PW, 1984, SCIENCE, V226, P1089, DOI 10.1126/science.6494926; LANDFIELD PW, 1987, NEUROBIOL AGING, V8, P346, DOI 10.1016/0197-4580(87)90074-1; Mackiewicz M, 2008, ANN NY ACAD SCI, V1129, P335, DOI 10.1196/annals.1417.030; Mackiewicz M, 2007, PHYSIOL GENOMICS, V31, P441, DOI 10.1152/physiolgenomics.00275.2006; Mackiewicz M, 2009, TRENDS MOL MED, V15, P79, DOI 10.1016/j.molmed.2008.12.002; Mariani E, 2007, J ALZHEIMERS DIS, V12, P23; MARKOWSKA AL, 1989, NEUROBIOL AGING, V10, P31, DOI 10.1016/S0197-4580(89)80008-9; Masliah E, 2006, J ALZHEIMERS DIS, V9, P91; Moore ME, 2005, BIOCHEM SOC T, V33, P573, DOI 10.1042/BST0330573; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Morrison JH, 2007, INT REV NEUROBIOL, V81, P41, DOI 10.1016/S0074-7742(06)81004-4; Naylor E, 1998, SLEEP, V21, P687, DOI 10.1093/sleep/21.7.687; Norris CM, 1999, NEUROBIOL LEARN MEM, V71, P194, DOI 10.1006/nlme.1998.3864; Parachikova A, 2008, NEUROBIOL DIS, V30, P121, DOI 10.1016/j.nbd.2007.12.008; Pawlyk AC, 2008, NEUROSCI BIOBEHAV R, V32, P99, DOI 10.1016/j.neubiorev.2007.06.001; Petersen RC, 2008, CNS SPECTRUMS, V13, P45, DOI 10.1017/S1092852900016151; Prolla TA, 2002, CHEM SENSES, V27, P299, DOI 10.1093/chemse/27.3.299; Reid KJ, 2006, AM J GERIAT PSYCHIAT, V14, P860, DOI 10.1097/01.JGP.0000206164.56404.ba; RONCAGLIOLO M, 1991, BRAIN RES BULL, V27, P573, DOI 10.1016/0361-9230(91)90029-J; ROSENBERG RS, 1979, J GERONTOL, V34, P525, DOI 10.1093/geronj/34.4.525; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sarvari M, 2010, ENDOCRINOLOGY, V151, P3847, DOI 10.1210/en.2010-0375; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Shiromani PJ, 2000, AM J PHYSIOL-REG I, V278, pR125, DOI 10.1152/ajpregu.2000.278.1.R125; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; Stone WS, 1997, EXP AGING RES, V23, P287, DOI 10.1080/03610739708254285; Tasali Esra, 2008, Proc Am Thorac Soc, V5, P207, DOI 10.1513/pats.200708-139MG; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Toescu EC, 2010, CELL CALCIUM, V47, P158, DOI 10.1016/j.ceca.2009.11.013; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G, 2001, NEUROPSYCHOPHARMACOL, V25, pS28, DOI 10.1016/S0893-133X(01)00322-0; Tornatore Jane B, 2003, Am J Alzheimers Dis Other Demen, V18, P240, DOI 10.1177/153331750301800413; Tractenberg RE, 2005, J SLEEP RES, V14, P177, DOI 10.1111/j.1365-2869.2005.00445.x; Van Cauter E, 1998, HORM RES, V49, P147, DOI 10.1159/000023162; VANGOOL WA, 1986, SLEEP, V9, P335, DOI 10.1093/sleep/9.2.335; VANGOOL WA, 1983, BRAIN RES, V279, P394, DOI 10.1016/0006-8993(83)90217-2; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wang XK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-12; Weinert D, 2000, CHRONOBIOL INT, V17, P261, DOI 10.1081/CBI-100101048; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201	91	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18387	10.1371/journal.pone.0018387	http://dx.doi.org/10.1371/journal.pone.0018387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483696	gold, Green Published, Green Submitted			2022-12-27	WOS:000289058700023
J	Chen, JJ; Nag, S; Vidi, PA; Irudayaraj, J				Chen, Jiji; Nag, Suman; Vidi, Pierre-Alexandre; Irudayaraj, Joseph			Single Molecule In Vivo Analysis of Toll-Like Receptor 9 and CpG DNA Interaction	PLOS ONE			English	Article							FLUORESCENCE FLUCTUATION SPECTROSCOPY; CROSS-CORRELATION SPECTROSCOPY; PHOTON-COUNTING HISTOGRAM; NUCLEIC-ACIDS; LIVING CELLS; ACTIVATION; TLR9; TOLL-LIKE-RECEPTOR-9; BACTERIAL; LIFETIME	Toll-like receptor 9 (TLR9) activates the innate immune system in response to oligonucleotides rich in CpG whereas DNA lacking CpG could inhibit its activation. However, the mechanism of how TLR9 interacts with nucleic acid and becomes activated in live cells is not well understood. Here, we report on the successful implementation of single molecule tools, constituting fluorescence correlation/cross-correlation spectroscopy (FCS and FCCS) and photon count histogram (PCH) with fluorescence lifetime imaging (FLIM) to study the interaction of TLR9-GFP with Cy5 labeled oligonucleotide containing CpG or lacking CpG in live HEK 293 cells. Our findings show that i) TLR9 predominantly forms homodimers (80%) before binding to a ligand and further addition of CpG or non CpG DNA does not necessarily increase the proportion of TLR9 dimers, ii) CpG DNA has a lower dissociation constant (62 nM +/- 9 nM) compared to non CpG DNA (153 nM +/- 26 nM) upon binding to TLR9, suggesting that a motif specific binding affinity of TLR9 could be an important factor in instituting a conformational change-dependant activation, and iii) both CpG and non CpG DNA binds to TLR9 with a 1: 2 stoichiometry in vivo. Collectively, through our findings we establish an in vivo model of TLR9 binding and activation by CpG DNA using single molecule fluorescence techniques for single cell studies.	[Chen, Jiji; Irudayaraj, Joseph] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Chen, Jiji; Irudayaraj, Joseph] Purdue Univ, Birck Nanotechnol Ctr, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA; [Nag, Suman] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India; [Vidi, Pierre-Alexandre] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Tata Institute of Fundamental Research (TIFR); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chen, JJ (corresponding author), Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA.	josephi@purdue.edu	Chen, Jiji/K-5551-2012	Irudayaraj, Joseph/0000-0002-0630-1520; Vidi, Pierre-Alexandre/0000-0002-9117-8896	Purdue University; Purdue Center for Cancer Research Innovation; National Science Foundation [NSF 0945771]	Purdue University; Purdue Center for Cancer Research Innovation; National Science Foundation(National Science Foundation (NSF))	Blisland Fellowship from Purdue University is acknowledged. Partial funding from the Purdue Center for Cancer Research Innovation grant, Vice President for Research (Purdue University), and National Science Foundation (NSF 0945771) is appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Banks DS, 2005, BIOPHYS J, V89, P2960, DOI 10.1529/biophysj.104.051078; Beutler B, 2000, CURR OPIN MICROBIOL, V3, P23, DOI 10.1016/S1369-5274(99)00046-6; Caspi A, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.011916; Chen JJ, 2010, ANAL CHEM, V82, P6415, DOI 10.1021/ac101236t; Chen JJ, 2009, ACS NANO, V3, P4071, DOI 10.1021/nn900743v; Chen Y, 2005, BIOPHYS J, V88, P2177, DOI 10.1529/biophysj.104.048413; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Gannot I, 2004, LASER SURG MED, V35, P342, DOI 10.1002/lsm.20101; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Kindrachuk J, 2008, MINI-REV MED CHEM, V8, P590, DOI 10.2174/138955708784534481; Kindrachuk J, 2007, J BIOL CHEM, V282, P13944, DOI 10.1074/jbc.M608089200; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Maiti S, 1997, P NATL ACAD SCI USA, V94, P11753, DOI 10.1073/pnas.94.22.11753; Peter ME, 2009, J IMMUNOL, V182, P7690, DOI 10.4049/jimmunol.0900819; Rigler R., 2001, FLUORESCENCE CORRELA; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Sengupta P, 2003, BIOPHYS J, V84, P1977, DOI 10.1016/S0006-3495(03)75006-1; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Slaughter BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001931; Takeda K, 2002, J ENDOTOXIN RES, V8, P459, DOI 10.1179/096805102125001073; Takeshita F, 2004, SEMIN IMMUNOL, V16, P17, DOI 10.1016/j.smim.2003.10.009; van Manen HJ, 2008, BIOPHYS J, V94, pL67, DOI 10.1529/biophysj.107.127837; Yasuda K, 2006, EUR J IMMUNOL, V36, P431, DOI 10.1002/eji.200535210	39	27	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e17991	10.1371/journal.pone.0017991	http://dx.doi.org/10.1371/journal.pone.0017991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483736	gold, Green Submitted, Green Published			2022-12-27	WOS:000289058700007
J	Swindell, WR; Johnston, A; Carbajal, S; Han, GW; Wohn, C; Lu, J; Xing, XY; Nair, RP; Voorhees, JJ; Elder, JT; Wang, XJ; Sano, S; Prens, EP; DiGiovanni, J; Pittelkow, MR; Ward, NL; Gudjonsson, JE				Swindell, William R.; Johnston, Andrew; Carbajal, Steve; Han, Gangwen; Wohn, Christian; Lu, Jun; Xing, Xianying; Nair, Rajan P.; Voorhees, John J.; Elder, James T.; Wang, Xiao-Jing; Sano, Shigetoshi; Prens, Errol P.; DiGiovanni, John; Pittelkow, Mark R.; Ward, Nicole L.; Gudjonsson, Johann E.			Genome-Wide Expression Profiling of Five Mouse Models Identifies Similarities and Differences with Human Psoriasis	PLOS ONE			English	Article							GENE-EXPRESSION; ANIMAL-MODELS; SUSCEPTIBILITY LOCI; T-CELLS; SKIN; ASSOCIATION; IMIQUIMOD; REVEALS; INSIGHTS; DISEASE	Development of a suitable mouse model would facilitate the investigation of pathomechanisms underlying human psoriasis and would also assist in development of therapeutic treatments. However, while many psoriasis mouse models have been proposed, no single model recapitulates all features of the human disease, and standardized validation criteria for psoriasis mouse models have not been widely applied. In this study, whole-genome transcriptional profiling is used to compare gene expression patterns manifested by human psoriatic skin lesions with those that occur in five psoriasis mouse models (K5-Tie2, imiquimod, K14-AREG, K5-Stat3C and K5-TGFbeta1). While the cutaneous gene expression profiles associated with each mouse phenotype exhibited statistically significant similarity to the expression profile of psoriasis in humans, each model displayed distinctive sets of similarities and differences in comparison to human psoriasis. For all five models, correspondence to the human disease was strong with respect to genes involved in epidermal development and keratinization. Immune and inflammation-associated gene expression, in contrast, was more variable between models as compared to the human disease. These findings support the value of all five models as research tools, each with identifiable areas of convergence to and divergence from the human disease. Additionally, the approach used in this paper provides an objective and quantitative method for evaluation of proposed mouse models of psoriasis, which can be strategically applied in future studies to score strengths of mouse phenotypes relative to specific aspects of human psoriasis.	[Swindell, William R.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Johnston, Andrew; Xing, Xianying; Nair, Rajan P.; Voorhees, John J.; Elder, James T.; Gudjonsson, Johann E.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48104 USA; [Carbajal, Steve] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Han, Gangwen; Wang, Xiao-Jing] Univ Colorado, Dept Pathol, Denver, CO 80202 USA; [Han, Gangwen; Wang, Xiao-Jing] Univ Colorado, Dept Otolaryngol, Denver, CO 80202 USA; [Han, Gangwen; Wang, Xiao-Jing] Univ Colorado, Dept Dermatol, Denver, CO 80202 USA; [Wohn, Christian] Univ Med Ctr, Dept Immunol, Erasmus MC, Rotterdam, Netherlands; [Lu, Jun; Pittelkow, Mark R.] Mayo Clin, Dept Dermatol, Rochester, MN USA; [Elder, James T.] Ann Arbor Vet Affairs Hosp, Ann Arbor, MI USA; [Sano, Shigetoshi] Kochi Univ, Dept Dermatol, Kochi Med Sch, Nankoku, Kochi, Japan; [Prens, Errol P.] Univ Med Ctr, Dept Dermatol, Erasmus MC, Rotterdam, Netherlands; [Prens, Errol P.] Univ Med Ctr, Dept Rheumatol, Erasmus MC, Rotterdam, Netherlands; [DiGiovanni, John] Univ Texas Austin, Dept Nutr Sci, Dell Pediat Res Inst, Austin, TX 78712 USA; [DiGiovanni, John] Univ Texas Austin, Div Pharmacol & Toxicol, Dell Pediat Res Inst, Austin, TX 78712 USA; [Ward, Nicole L.] Case Western Reserve Univ, Dept Dermatol, Cleveland, OH 44106 USA; [Ward, Nicole L.] Case Western Reserve Univ, Murdough Family Ctr Psoriasis, Cleveland, OH 44106 USA; [Ward, Nicole L.] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA	Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; University of Texas System; University of Texas Austin; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; Erasmus University Rotterdam; Erasmus MC; Mayo Clinic; Kochi University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Swindell, WR (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	wswindell@genetics.med.harvard.edu; johanng@med.umich.edu	Voorhees, John/AAM-9966-2020	Voorhees, John/0000-0003-1856-785X; Johnston, Andrew/0000-0002-1313-9402; Prens, Errol/0000-0002-8158-660X; Ward, Nicole L./0000-0003-1907-2621; Wohn, Christian/0000-0002-8276-4658	Taubman Medical Research Institute; Dermatology Foundation; NIH [CA76520, AR052889, AR054966, GM70966, CA79998, CA89849, P30AR39750, P50AR05508]; National Psoriasis Foundation; Murdough Family Center for Psoriasis; NATIONAL CANCER INSTITUTE [R01CA079998, R43CA089849, R01CA076520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052889, P50AR055508, P30AR039750, R01AR054966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070966] Funding Source: NIH RePORTER	Taubman Medical Research Institute; Dermatology Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Psoriasis Foundation; Murdough Family Center for Psoriasis; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Babcock Endowment to Dr. Gudjonsson and Dr. Johnston, the Taubman Medical Research Institute support (Frances and Kenneth Eisenberg Emerging Scholar) and the Dermatology Foundation to Dr. Gudjonsson. The project described was supported by NIH grant number CA76520 to Dr. DiGiovanni, AR052889 and AR054966 to Dr. Elder, GM70966, CA79998 and CA89849 to Dr. Wang and P30AR39750 and P50AR05508, National Psoriasis Foundation and the Murdough Family Center for Psoriasis to Dr. Ward. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen Terri J, 2004, Curr Diab Rep, V4, P435, DOI 10.1007/s11892-004-0053-1; Ardavin C, 2003, NAT REV IMMUNOL, V3, P582, DOI 10.1038/nri1127; Asquith DL, 2009, EUR J IMMUNOL, V39, P2040, DOI 10.1002/eji.200939578; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berking C, 2002, CARCINOGENESIS, V23, P181, DOI 10.1093/carcin/23.1.181; Boehncke WH, 2007, CLIN DERMATOL, V25, P596, DOI 10.1016/j.clindermatol.2007.08.014; Bowcock AM, 2001, HUM MOL GENET, V10, P1793, DOI 10.1093/hmg/10.17.1793; Conrad C, 2007, NAT MED, V13, P836, DOI 10.1038/nm1605; Cook PW, 1997, J CLIN INVEST, V100, P2286, DOI 10.1172/JCI119766; COULOMBE PA, 1989, J CELL BIOL, V109, P2295, DOI 10.1083/jcb.109.5.2295; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; EEDY DJ, 1990, BRIT MED J, V300, P908, DOI 10.1136/bmj.300.6729.908; Elder JT, 2010, J INVEST DERMATOL, V130, P1213, DOI 10.1038/jid.2009.319; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fanti PA, 2006, INT J DERMATOL, V45, P1464, DOI 10.1111/j.1365-4632.2006.02980.x; Gilliet M, 2004, ARCH DERMATOL, V140, P1490, DOI 10.1001/archderm.140.12.1490; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Gudjonsson JE, 2007, J INVEST DERMATOL, V127, P1292, DOI 10.1038/sj.jid.5700807; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; GURD B, 2009, INT J EXP PATHOL, V90, P338; Haider AS, 2008, J INVEST DERMATOL, V128, P606, DOI 10.1038/sj.jid.5701067; Haider AS, 2008, J INVEST DERMATOL, V128, P655, DOI 10.1038/sj.jid.5701064; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Janus C, 2001, PHYSIOL BEHAV, V73, P873, DOI 10.1016/S0031-9384(01)00524-8; Jones N, 2001, EMBO REP, V2, P438, DOI 10.1093/embo-reports/kve093; Khavari PA, 2006, NAT REV CANCER, V6, P270, DOI 10.1038/nrc1838; Kim S, 2009, CLIN EXP OTORHINOLAR, V2, P55, DOI 10.3342/ceo.2009.2.2.55; Kircik LH, 2009, J DRUGS DERMATOL, V8, P546; Kulski JK, 2005, J MOL MED, V83, P964, DOI 10.1007/s00109-005-0721-x; Li AG, 2004, EMBO J, V23, P1770, DOI 10.1038/sj.emboj.7600183; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Lottaz C, 2006, BIOINFORMATICS, V22, P2315, DOI 10.1093/bioinformatics/btl385; LOWE NJ, 1981, J INVEST DERMATOL, V76, P141, DOI 10.1111/1523-1747.ep12525484; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nestle FO, 2006, J EUR ACAD DERMATOL, V20, P24, DOI 10.1111/j.1468-3083.2006.01769.x; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nickoloff BJ, 1999, AM J PATHOL, V155, P145, DOI 10.1016/S0002-9440(10)65109-7; Philippakis AA, 2006, PLOS COMPUT BIOL, V2, P439, DOI 10.1371/journal.pcbi.0020053; Rajan N, 2006, CLIN EXP DERMATOL, V31, P140, DOI 10.1111/j.1365-2230.2005.01938.x; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Romanowska M, 2008, J INVEST DERMATOL, V128, P110, DOI 10.1038/sj.jid.5700943; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Seredkina N, 2009, AM J PATHOL, V175, P97, DOI 10.2353/ajpath.2009.080943; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Swindell WR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011861; Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; VANJOOST T, 1988, BRIT J DERMATOL, V118, P183; WARD NL, 2010, BR J DERMAT IN PRESS; Wolfram JA, 2009, AM J PATHOL, V174, P1443, DOI 10.2353/ajpath.2009.080858; Wu Jason K, 2004, Australas J Dermatol, V45, P47, DOI 10.1111/j.1440-0960.2004.00030.x; Zanolli M D, 1989, Acta Derm Venereol Suppl (Stockh), V146, P58; Zenaro E, 2009, J LEUKOCYTE BIOL, V86, P1393, DOI 10.1189/jlb.0409242; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	60	136	149	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18266	10.1371/journal.pone.0018266	http://dx.doi.org/10.1371/journal.pone.0018266			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483750	Green Published, Green Submitted, gold			2022-12-27	WOS:000289058700016
J	Hirata, K; Kataoka, S; Furutani, S; Hayashi, H; Matsuda, K				Hirata, Koichi; Kataoka, Saori; Furutani, Shogo; Hayashi, Hideo; Matsuda, Kazuhiko			A Fungal Metabolite Asperparaline A Strongly and Selectively Blocks Insect Nicotinic Acetylcholine Receptors: The First Report on the Mode of Action	PLOS ONE			English	Article							ASPERGILLUS-JAPONICUS JV-23; COCKROACH NEURONS; LOOP-D; NEONICOTINOIDS; SENSITIVITY; FIPRONIL; CHANNEL	Asperparalines produced by Aspergillus japonicus JV-23 induce paralysis in silkworm (Bombyx mori) larvae, but the target underlying insect toxicity remains unknown. In the present study, we have investigated the actions of asperparaline A on ligand-gated ion channels expressed in cultured larval brain neurons of the silkworm using patch-clamp electrophysiology. Bath-application of asperparaline A (10 mu M) had no effect on the membrane current, but when delivered for 1 min prior to co-application with 10 mu M acetylcholine (ACh), it blocked completely the ACh-induced current that was sensitive to mecamylamine, a nicotinic acetylcholine receptor (nAChR)-selective antaogonist. In contrast, 10 mu M asperparaline A was ineffective on the c-aminobutyric acid-and L-glutamate-induced responses of the Bombyx larval neurons. The fungal alkaloid showed no-use dependency in blocking the ACh-induced response with distinct affinity for the peak and slowly-desensitizing current amplitudes of the response to 10 mM ACh in terms of IC50 values of 20.2 and 39.6 nM, respectively. Asperparaline A (100 nM) reduced the maximum neuron response to ACh with a minimal shift in EC50, suggesting that the alkaloid is non-competitive with ACh. In contrast to showing marked blocking action on the insect nAChRs, it exhibited only a weak blocking action on chicken alpha 3 beta 4, alpha 4 beta 2 and alpha 7 nAChRs expressed in Xenopus laevis oocytes, suggesting a high selectivity for insect over certain vertebrate nAChRs.	[Hirata, Koichi; Kataoka, Saori; Furutani, Shogo; Matsuda, Kazuhiko] Kinki Univ, Fac Agr, Dept Appl Biol Chem, Nara 631, Japan; [Hayashi, Hideo] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Naka Ku, Osaka, Japan	Kindai University (Kinki University)	Hirata, K (corresponding author), Nippon Soda Co Ltd, Kanagawa, Japan.	kmatsuda@nara.kindai.ac.jp	Matsuda, Kazuhiko/AAX-4926-2020; Hayashi, Hideo/AAI-1910-2020		Ministry of Agriculture, Forestry and Fisheries of Japan [1302]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	KM was supported in part by the Integrated Research Project for Plant, Insect and Animal using Genome Technology from the Ministry of Agriculture, Forestry and Fisheries of Japan (Grant: 1302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hayashi H, 2000, BIOSCI BIOTECH BIOCH, V64, P111, DOI 10.1271/bbb.64.111; Hayashi H, 1997, TETRAHEDRON LETT, V38, P5655, DOI 10.1016/S0040-4039(97)01231-8; Hirata K, 2008, INSECT MOL BIOL, V17, P341, DOI 10.1111/j.1365-2583.2008.00806.x; Ikeda T, 2003, NEUROTOXICOLOGY, V24, P807, DOI 10.1016/S0161-813X(03)00041-X; Matsuda K, 2000, BRIT J PHARMACOL, V130, P981, DOI 10.1038/sj.bjp.0703374; Matsuda K, 1998, BRIT J PHARMACOL, V123, P518, DOI 10.1038/sj.bjp.0701618; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Salgado VL, 2004, J INSECT PHYSIOL, V50, P867, DOI 10.1016/j.jinsphys.2004.07.007; Shao YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-324; Shimomura M, 2006, MOL PHARMACOL, V70, P1255, DOI 10.1124/mol.106.026815; Stromgaard K, 2005, TOXICON, V45, P249, DOI 10.1016/j.toxicon.2004.11.013; Williams RM, 2003, ACCOUNTS CHEM RES, V36, P127, DOI 10.1021/ar020229e; Zhao XL, 2004, J PHARMACOL EXP THER, V310, P192, DOI 10.1124/jpet.104.065516	14	22	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18354	10.1371/journal.pone.0018354	http://dx.doi.org/10.1371/journal.pone.0018354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483774	gold, Green Published, Green Submitted			2022-12-27	WOS:000289058300014
J	Breden, F; Lepik, C; Longo, NS; Montero, M; Lipsky, PE; Scott, JK				Breden, Felix; Lepik, Christa; Longo, Nancy S.; Montero, Marinieve; Lipsky, Peter E.; Scott, Jamie K.			Comparison of Antibody Repertoires Produced by HIV-1 Infection, Other Chronic and Acute Infections, and Systemic Autoimmune Disease	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; MEMORY B-CELLS; VIRUS TYPE-1 GP120; HEAVY-CHAIN; GENE USAGE; NEUTRALIZING ANTIBODIES; EPITOPE-SCAFFOLDS; DEPENDENT ANTIGEN; VACCINE DESIGN; COMBINING SITE	Background: Antibodies (Abs) produced during HIV-1 infection rarely neutralize a broad range of viral isolates; only eight broadly-neutralizing (bNt) monoclonal (M) Abs have been isolated. Yet, to be effective, an HIV-1 vaccine may have to elicit the essential features of these MAbs. The V genes of all of these bNt MAbs are highly somatically mutated, and the V(H) genes of five of them encode a long (>= 20 aa) third complementarity- determining region (CDR-H3). This led us to question whether long CDR-H3s and high levels of somatic mutation (SM) are a preferred feature of anti-HIV bNt MAbs, or if other adaptive immune responses elicit them in general. Methodology and Principal Findings: We assembled a V(H)-gene sequence database from over 700 human MAbs of known antigen specificity isolated from chronic (viral) infections (ChI), acute (bacterial and viral) infections (AcI), and systemic autoimmune diseases (SAD), and compared their CDR-H3 length, number of SMs and germline V(H)-gene usage. We found that anti-HIV Abs, regardless of their neutralization breadth, tended to have long CDR-H3s and high numbers of SMs. However, these features were also common among Abs associated with other chronic viral infections. In contrast, Abs from acute viral infections (but not bacterial infections) tended to have relatively short CDR-H3s and a low number of SMs, whereas SAD Abs were generally intermediate in CDR-H3 length and number of SMs. Analysis of V(H) gene usage showed that ChI Abs also tended to favor distal germline V(H)-genes (particularly V(H)1-69), especially in Abs bearing long CDR-H3s. Conclusions and Significance: The striking difference between the Abs produced during chronic vs. acute viral infection suggests that Abs bearing long CDR-H3s, high levels of SM and V(H)1-69 gene usage may be preferentially selected during persistent infection.	[Breden, Felix] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Lepik, Christa; Montero, Marinieve; Scott, Jamie K.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Longo, Nancy S.; Lipsky, Peter E.] NIAMSD, Repertoire Anal Grp, Autoimmun Branch, NIH, Bethesda, MD 20892 USA; [Scott, Jamie K.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Simon Fraser University	Breden, F (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	breden@sfu.ca; jkscott@sfu.ca		Breden, Felix/0000-0001-9762-6314	National Institutes of Health [AI49111]; Canada Research Chairs; Michael Smith Foundation for Health Research; Natural Sciences and Engineering Research Council of Canada; IRMACS Centre at Simon Fraser University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chairs(Canada Research ChairsCGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); IRMACS Centre at Simon Fraser University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI49111 (J.K.S.; http://www.nih.gov/), Canada Research Chairs (J.K.S.; http://www.chairs-chaires.gc.ca/), the Michael Smith Foundation for Health Research (M.M.;http://www.msfhr.org/), the Natural Sciences and Engineering Research Council of Canada (C.L., M.M., and F.B.; http://www.nserc-crsng.gc.ca/index_eng.asp), and the IRMACS Centre at Simon Fraser University (http://www.irmacs.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Baxendale HE, 2008, CLIN EXP IMMUNOL, V151, P51, DOI 10.1111/j.1365-2249.2007.03535.x; BERBERIAN L, 1993, SCIENCE, V261, P1588, DOI 10.1126/science.7690497; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; DAVID D, 1995, EUR J IMMUNOL, V25, P1524, DOI 10.1002/eji.1830250608; de Wildt RMT, 1999, J MOL BIOL, V294, P701, DOI 10.1006/jmbi.1999.3289; Ditzel HJ, 1997, J MOL BIOL, V267, P684, DOI 10.1006/jmbi.1997.0912; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Gorny MK, 2008, AIDS RES HUM RETROV, V24, P46; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Johnson G, 1998, INT IMMUNOL, V10, P1801, DOI 10.1093/intimm/10.12.1801; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Klonowski KD, 2001, TRENDS IMMUNOL, V22, P400, DOI 10.1016/S1471-4906(01)01953-6; Kunert R, 1998, AIDS RES HUM RETROV, V14, P1115, DOI 10.1089/aid.1998.14.1115; Lefranc Marie-Paule, 2005, Immunome Res, V1, P3, DOI 10.1186/1745-7580-1-3; Mahalanabis M, 2009, J VIROL, V83, P662, DOI 10.1128/JVI.01328-08; Market E, 2003, PLOS BIOL, V1, P24, DOI 10.1371/journal.pbio.0000016; Matsuda F, 1998, J EXP MED, V188, P2151, DOI 10.1084/jem.188.11.2151; Muller S, 1997, Int Rev Immunol, V14, P339, DOI 10.3109/08830189709116524; Nabel GJ, 2005, SCIENCE, V308, P1878, DOI 10.1126/science.1114854; Notkins AL, 2004, TRENDS IMMUNOL, V25, P174, DOI 10.1016/j.it.2004.02.004; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Phan TG, 2005, J IMMUNOL, V174, P4567, DOI 10.4049/jimmunol.174.8.4567; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Scamurra RW, 2000, J IMMUNOL, V164, P5482, DOI 10.4049/jimmunol.164.10.5482; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Song HF, 2003, J EXP MED, V198, P1923, DOI 10.1084/jem.20031498; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tangye SG, 2007, J IMMUNOL, V179, P13, DOI 10.4049/jimmunol.179.1.13; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Viau M, 2007, MOL IMMUNOL, V44, P2124, DOI 10.1016/j.molimm.2006.07.302; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wisnewski A, 1996, J ACQ IMMUN DEF SYND, V11, P31, DOI 10.1097/00042560-199601010-00004; WU TT, 1993, PROTEINS, V16, P1, DOI 10.1002/prot.340160102; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yurasov S, 2006, J EXP MED, V203, P2255, DOI 10.1084/jem.20061446; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zouali M, 2008, TRENDS IMMUNOL, V29, P103, DOI 10.1016/j.it.2007.12.004; Zwick MB, 2004, J VIROL, V78, P3155, DOI 10.1128/JVI.78.6.3155-3161.2004; Zwick MB, 2003, J VIROL, V77, P5863, DOI 10.1128/JVI.77.10.5863-5876.2003	61	71	81	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e16857	10.1371/journal.pone.0016857	http://dx.doi.org/10.1371/journal.pone.0016857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479208	Green Published, Green Submitted, gold			2022-12-27	WOS:000289055700006
J	Chen, Y; Yang, PZ; Li, FZ; Kijlstra, A				Chen, Ying; Yang, Peizeng; Li, Fuzhen; Kijlstra, Aize			The Effects of Th17 Cytokines on the Inflammatory Mediator Production and Barrier Function of ARPE-19 Cells	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; T-CELLS; RHEUMATOID-ARTHRITIS; IL-17 RECEPTOR; EXPRESSION; KERATINOCYTES; DISTINCT; LINEAGE; UVEITIS; IL-23	Th17 cells have emerged as a key factor in the pathogenesis of uveitis as well as other autoimmune disorders. They secrete a number of cytokines including IL-17A, IL-17F and IL-22 and until now the effects of these cytokines on resident cells of the eye were not yet clear. The purpose of this study was to investigate the effects of Interleukin (IL)-17A, IL-17F and IL-22 on the production of inflammatory mediators and barrier function of retinal pigment epithelium cells. We showed that ARPE-19 cells, a spontaneously arisen cell line of retinal pigment epithelium (RPE), constitutively expressed IL-17RC and IL-22R, but not IL-17RA. IL-17A significantly enhanced the production of CXCL8, CCL2, CCL20 and IL-6 by these cells. IL-17F had a similar effect on the production of CXCL8, CCL2 and IL-6 by ARPE-19 cells, but did not influence the expression of CCL20. Both IL-17A and IL-17F significantly decreased the transepithelial electrical resistance (TER) of the ARPE-19 monolayer and increased the diffusion rate of fluorescein isothiocyanate (FITC)-dextran. They also disrupted the distribution of the junction proteins zonula occludens (ZO)-1 and occludin at the interface of adjacent cells. IL-22 did not have a detectable effect on the production of the tested inflammatory mediators by ARPE-19 cells, TER of the ARPE-19 monolayer, the diffusion rate of FITC-dextran or the distribution of ZO-1 and occludin. This study demonstrates that IL-17A and IL-17F, but not IL-22, significantly promoted ARPE-19 cells to secrete inflammatory mediators and compromised the ARPE-19 monolayer barrier function in association with a disrupted distribution of ZO-1 and occludin. These results suggest that both IL-17A and IL-17F may play a role in posterior segment inflammation of the eye.	[Chen, Ying; Yang, Peizeng; Li, Fuzhen] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Eye Inst, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Chen, Ying] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Kijlstra, Aize] Univ Hosp Maastricht, Eye Res Inst Maastricht, Dept Ophthalmol, Maastricht, Netherlands	Chongqing Medical University; Sun Yat Sen University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Eye Inst, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.	peizengycmu@126.com	Yang, Peizeng/C-6336-2013		Natural Science Foundation [30630064, 30910103912]; National Natural Science Foundation [30973242]; National supporting project of P.R. China [2007BAI18B10]; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; Health Bureau of Chongqing [2008115]; Medical Science and Technology of Chongqing [2008-1-15]; Natural Science Foundation of Chongqing (CSTC) [2009BA5037]; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; Fund for Liangjiang Scholar; National Basic Research Program of China (973 program) [2011CB510200]	Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National supporting project of P.R. China; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; Health Bureau of Chongqing; Medical Science and Technology of Chongqing; Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC); Fund for Liangjiang Scholar; National Basic Research Program of China (973 program)(National Basic Research Program of China)	This work was supported by Key Project of Natural Science Foundation (30630064, URL: http://159.226.244.15/portal/proj_search.asp), Natural Science Foundation Major International (Regional) Joint Research Project (30910103912, URL: http://159.226.244.15/portal/proj_search.asp), National Natural Science Foundation Project (30973242, URL: http://159.226.244.15/portal/proj_search.asp), National supporting project of P.R. China (2007BAI18B10, URL: http://www.most.gov.cn/cxfw/index.htm), Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality (URL: http://www.ctin.ac.cn/Class.aspx?clsId=413), Key Project of Health Bureau of Chongqing (2008115, URL: http://www.cqwsj.gov.cn/News.asp), Project of Medical Science and Technology of Chongqing (2008-1-15, URL: http://www.cqwsj.gov.cn/News.asp), Key Project of Natural Science Foundation of Chongqing (CSTC, 2009BA5037, URL: http://www.ctin.ac.cn/Class.aspx?clsId=413), Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003, URL: http://www.ctin.ac.cn/Class.aspx?clsId=413), Fund for Liangjiang Scholar and National Basic Research Program of China (973 program, 2011CB510200, URL: http://www.973.gov.cn/AreaItem.aspx?fid=05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2003, INVEST OPHTH VIS SCI, V44, P4097, DOI 10.1167/iovs.02-0867; Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Caspi R, 2008, IMMUNOL RES, V42, P41, DOI 10.1007/s12026-008-8031-3; Chang SH, 2009, CYTOKINE, V46, P7, DOI 10.1016/j.cyto.2008.12.024; Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390; Chi W, 2007, J ALLERGY CLIN IMMUN, V119, P1218, DOI 10.1016/j.jaci.2007.01.010; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Holtkamp GM, 2001, PROG RETIN EYE RES, V20, P29, DOI 10.1016/S1350-9462(00)00017-3; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Ke Y, 2009, J LEUKOCYTE BIOL, V86, P1377, DOI 10.1189/jlb.0409237; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kerr EC, 2008, PROG RETIN EYE RES, V27, P527, DOI 10.1016/j.preteyeres.2008.07.001; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Leung KW, 2009, MOL IMMUNOL, V46, P1374, DOI 10.1016/j.molimm.2008.12.001; Li ZQ, 2008, J IMMUNOL, V181, P5147, DOI 10.4049/jimmunol.181.7.5147; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; MIURA Y, 2010, INVEST OPHTHALMOL VI; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Tohyama M, 2009, EUR J IMMUNOL, V39, P2779, DOI 10.1002/eji.200939473; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Zech JC, 1998, INVEST OPHTH VIS SCI, V39, P1600; Zrioual S, 2009, J IMMUNOL, V182, P3112, DOI 10.4049/jimmunol.0801967	31	62	69	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18139	10.1371/journal.pone.0018139	http://dx.doi.org/10.1371/journal.pone.0018139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479174	Green Submitted, Green Published, gold			2022-12-27	WOS:000289055700030
J	Hart, JP; Matson, RG; Thompson, RG; Blake, M				Hart, John P.; Matson, R. G.; Thompson, Robert G.; Blake, Michael			Teosinte Inflorescence Phytolith Assemblages Mirror Zea Taxonomy	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC DIVERSITY; NEW-YORK; MAIZE; MAYS; DOMESTICATION; EVOLUTION; POACEAE; ORIGIN	Molecular DNA analyses of the New World grass (Poaceae) genus Zea, comprising five species, has resolved taxonomic issues including the most likely teosinte progenitor (Zea mays ssp. parviglumis) of maize (Zea mays ssp. mays). However, archaeologically, little is known about the use of teosinte by humans both prior to and after the domestication of maize. One potential line of evidence to explore these relationships is opaline phytoliths produced in teosinte fruit cases. Here we use multidimensional scaling and multiple discriminant analyses to determine if rondel phytolith assemblages from teosinte fruitcases reflect teosinte taxonomy. Our results indicate that rondel phytolith assemblages from the various taxa, including subspecies, can be statistically discriminated. This indicates that it will be possible to investigate the archaeological histories of teosinte use pending the recovery of appropriate samples.	[Hart, John P.] New York State Museum & Sci Serv, Albany, NY 12230 USA; [Matson, R. G.; Blake, Michael] Univ British Columbia, Dept Anthropol, Vancouver, BC V5Z 1M9, Canada; [Thompson, Robert G.] Univ Minnesota, Dept Anthropol, Minneapolis, MN USA	University of British Columbia; University of Minnesota System; University of Minnesota Twin Cities	Hart, JP (corresponding author), New York State Museum & Sci Serv, Albany, NY 12230 USA.	tmichaelblake@gmail.com	Hart, John/H-7419-2014	Hart, John/0000-0003-2009-0624				Callen E.O., 1967, PREHISTORY TEHUACAN, VVolume 1, P261; Chavez S. J., 2006, HIST MAIZE MULTIDISC, P415; DOEBLEY JF, 1980, AM J BOT, V67, P982, DOI 10.2307/2442441; Dorweiler JE, 1997, AM J BOT, V84, P1313, DOI 10.2307/2446130; Flannery K., 1986, GUILA NAQUITZ ARCHAI; Fukunaga K, 2005, GENETICS, V169, P2241, DOI 10.1534/genetics.104.031393; Gauch Jr HG, 1982, MULTIVARIATE ANAL CO; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; GOWER JC, 1967, J ROY STAT SOC D-STA, V17, P13; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hart JP, 2009, J ARCHAEOL SCI, V36, P74, DOI 10.1016/j.jas.2008.07.011; Hart JP, 2007, AM ANTIQUITY, V72, P563, DOI 10.2307/40035861; Hart JP, 2003, AM ANTIQUITY, V68, P619, DOI 10.2307/3557065; ILTIS HH, 1980, AM J BOT, V67, P994, DOI 10.2307/2442442; Iltis HH, 2000, ECON BOT, V54, P7, DOI 10.1007/BF02866598; Klecka W. R., 1980, DISCRIMINANT ANAL; MACNEISH RS, 1958, T AM PHIL SOC, V48; Mangelsdorf PC., 1967, PREHISTORY TEHUACAN, P178; MATSON RG, 1974, AM ANTIQUITY, V39, P51, DOI 10.2307/279218; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Mulholland S.C., 1992, PHYTOLITH SYSTEMATIC, P65, DOI DOI 10.1007/978-1-4899-1155-1_4; OVERPECK JT, 1985, QUATERNARY RES, V23, P87, DOI 10.1016/0033-5894(85)90074-2; Pearsall DM, 2003, J ARCHAEOL SCI, V30, P611, DOI 10.1016/S0305-4403(02)00237-6; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Piperno D.R., 1998, ORIGINS AGR LOWLAND; PIPERNO DR, 1993, J ARCHAEOL SCI, V20, P337, DOI 10.1006/jasc.1993.1021; Smalley J, 2003, CURR ANTHROPOL, V44, P675, DOI 10.1086/377664; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Thompson RG, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P82; TORGERSON W, 1958, THEORY METHODS SCALI; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863	32	8	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18349	10.1371/journal.pone.0018349	http://dx.doi.org/10.1371/journal.pone.0018349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479186	gold, Green Published, Green Submitted			2022-12-27	WOS:000289055700051
J	Kiernan, UA; Phillips, DA; Trenchevska, O; Nedelkov, D				Kiernan, Urban A.; Phillips, David A.; Trenchevska, Olgica; Nedelkov, Dobrin			Quantitative Mass Spectrometry Evaluation of Human Retinol Binding Protein 4 and Related Variants	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; PARATHYROID-HORMONE; ALTERED RATIOS; HUMAN PLASMA; IMMUNOASSAY; QUANTIFICATION; DIVERSITY	Background: Retinol Binding Protein 4 (RBP4) is an exciting new biomarker for the determination of insulin resistance and type 2 diabetes. It is known that circulating RBP4 resides in multiple variants which may provide enhanced clinical utility, but conventional immunoassay methods are blind to such differences. A Mass Spectrometric immunoassay (MSIA) technology that can quantitate total RBP4 as well as individual isoforms may provide an enhanced analysis for this biomarker. Methods: RBP4 was isolated and detected from 0.5 uL of human plasma using MSIA technology, for the simultaneous quantification and differentiation of endogenous human RBP4 and its variants. Results: The linear range of the assay was 7.81-500 ug/mL, and the limit of detection and limit of quantification were 3.36 ug/mL and 6.52 ug/mL, respectively. The intra-assay CVs were determined to be 5.1% and the inter-assay CVs were 9.6%. The percent recovery of the RBP4-MSIA ranged from 95 - 105%. Method comparison of the RBP4 MSIA vs the Immun Diagnostik ELISA yielded a Passing & Bablok fit of MSIA = 1.05 x ELISA - 3.09, while the Cusum linearity p-value was > 0.1 and the mean bias determined by the Altman Bland test was 1.2%. Conclusion: The novel RBP4 MSIA provided a fast, accurate and precise quantitative protein measurement as compared to the standard commercially available ELISA. Moreover, this method also allowed for the detection of RBP4 variants that are present in each sample, which may in the future provide a new dimension in the clinical utility of this biomarker.	[Kiernan, Urban A.; Phillips, David A.; Trenchevska, Olgica; Nedelkov, Dobrin] Intrins Bioprobes Inc, Tempe, AZ 85284 USA		Kiernan, UA (corresponding author), Intrins Bioprobes Inc, Tempe, AZ 85284 USA.	ukiernan@intrinsicbio.com	Nedelkov, Dobrin/I-3603-2013		National Institutes of Health (NIH);  [R43RR025701]; NATIONAL CENTER FOR RESEARCH RESOURCES [R43RR025701] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was soley funded under grant no. R43RR025701. Even though the research took place at a commercial institution, it was fully supported by National Institutes of Health (NIH) funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2009, MOL CELL PROTEOMICS, V8, P883, DOI 10.1074/mcp.R800015-MCP200; Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; Bobbert P, 2009, EUR J HEART FAIL, V11, P1163, DOI 10.1093/eurjhf/hfp153; Duncan Mark W., 2008, Briefings in Functional Genomics & Proteomics, V7, P355, DOI 10.1093/bfgp/eln041; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Henze A, 2010, BIOCHEM BIOPH RES CO, V393, P79, DOI 10.1016/j.bbrc.2010.01.082; JACONI S, 1995, J LIPID RES, V36, P1247; Jaconi S, 1996, EUR J ENDOCRINOL, V134, P576, DOI 10.1530/eje.0.1340576; Kierman Urbana, 2002, American Biotechnology Laboratory, V20, P28; Kiernan UA, 2002, BIOCHEM BIOPH RES CO, V297, P401, DOI 10.1016/S0006-291X(02)02212-X; Kiernan UA, 2002, ANAL BIOCHEM, V301, P49, DOI 10.1006/abio.2001.5478; Kiernan UA, 2006, J PROTEOME RES, V5, P1682, DOI 10.1021/pr0601133; Kiernan Urban A, 2008, Expert Opin Med Diagn, V2, P1391, DOI 10.1517/17530050802566488; Klein K, 2010, J WOMENS HEALTH, V19, P517, DOI 10.1089/jwh.2009.1615; Kumar V, 2010, CLIN CHEM, V56, P306, DOI 10.1373/clinchem.2009.134643; Lopez MF, 2010, CLIN CHEM, V56, P281, DOI 10.1373/clinchem.2009.137323; Nedelkov D, 2005, P NATL ACAD SCI USA, V102, P10852, DOI 10.1073/pnas.0500426102; Nedelkov D, 2008, PROTEOMICS, V8, P779, DOI 10.1002/pmic.200700501; NELSON RW, 1995, ANAL CHEM, V67, P1153, DOI 10.1021/ac00103a003; Niederkofler EE, 2003, J LIPID RES, V44, P630, DOI 10.1194/jlr.D200034-JLR200; Niederkofler EE, 2001, ANAL CHEM, V73, P3294, DOI 10.1021/ac010143j; Niederkofler EE, 2008, CIRC-HEART FAIL, V1, P258, DOI 10.1161/CIRCHEARTFAILURE.108.790774; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Stuck BJ, 2009, AM J HYPERTENS, V22, P948, DOI 10.1038/ajh.2009.124; Tubbs KA, 2001, ANAL BIOCHEM, V289, P26, DOI 10.1006/abio.2000.4921; VANWEEME.BK, 1971, FEBS LETT, V15, P232, DOI 10.1016/0014-5793(71)80319-8	27	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17282	10.1371/journal.pone.0017282	http://dx.doi.org/10.1371/journal.pone.0017282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479165	gold, Green Published, Green Submitted			2022-12-27	WOS:000289055700009
J	Liu, J; Yin, DC; Guo, YZ; Wang, XK; Xie, SX; Lu, QQ; Liu, YM				Liu, Jun; Yin, Da-Chuan; Guo, Yun-Zhu; Wang, Xi-Kai; Xie, Si-Xiao; Lu, Qin-Qin; Liu, Yong-Ming			Selecting Temperature for Protein Crystallization Screens Using the Temperature Dependence of the Second Virial Coefficient	PLOS ONE			English	Article							DYNAMIC LIGHT-SCATTERING; CRYSTAL-GROWTH; SOLUBILITY; EQUILIBRIUM; LYSOZYME; PHASE; MODEL	Protein crystals usually grow at a preferable temperature which is however not known for a new protein. This paper reports a new approach for determination of favorable crystallization temperature, which can be adopted to facilitate the crystallization screening process. By taking advantage of the correlation between the temperature dependence of the second virial coefficient (B(22)) and the solubility of protein, we measured the temperature dependence of B(22) to predict the temperature dependence of the solubility. Using information about solubility versus temperature, a preferred crystallization temperature can be proposed. If B(22) is a positive function of the temperature, a lower crystallization temperature is recommended; if B(22) shows opposite behavior with respect to the temperature, a higher crystallization temperature is preferred. Otherwise, any temperature in the tested range can be used.	[Liu, Jun; Yin, Da-Chuan; Guo, Yun-Zhu; Wang, Xi-Kai; Xie, Si-Xiao; Lu, Qin-Qin; Liu, Yong-Ming] NW Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, Xian 710072, Shaanxi, Peoples R China	Northwestern Polytechnical University	Liu, J (corresponding author), NW Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, Xian 710072, Shaanxi, Peoples R China.	yindc@nwpu.edu.cn	Liu, Yong-Ming/AAI-4692-2020; Liu, Jun/AAS-9772-2020; Liu, Yong-Ming/T-5279-2019	Liu, Jun/0000-0003-4094-8974; Liu, Yong-Ming/0000-0001-9606-6570	National Natural Science Foundation of China [10772150]; Ministry of Education of China [200806990011]; National High Technology Research and Development Program of China [2008AA12A220]; National Program on Key Basic Research Project [2011CB710900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Program on Key Basic Research Project(National Basic Research Program of China)	These studies were partly funded by Grant 10772150 from the National Natural Science Foundation of China (www.nsfc.gov.cn), Grant 200806990011 from the Ph.D. Programs Foundation of the Ministry of Education of China (www.cutech.edu.cn), Grant 2008AA12A220 from the National High Technology Research and Development Program of China (www.863.gov.cn) and Grant 2011CB710900 from the National Program on Key Basic Research Project (www.973.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford JR, 2008, ANAL BIOCHEM, V377, P128, DOI 10.1016/j.ab.2008.03.032; Andersson M, 2003, ANAL CHEM, V75, P4279, DOI 10.1021/ac030128+; Annunziata O, 2008, J AM CHEM SOC, V130, P13347, DOI 10.1021/ja804304e; Bajaj H, 2006, PHARM RES-DORDR, V23, P1382, DOI 10.1007/s11095-006-0018-y; BALDWIN ET, 1986, BIOPHYS J, V49, P47, DOI 10.1016/S0006-3495(86)83587-1; BERNE B. J., 1976, DYNAMIC LIGHT SCATTE; BULL HB, 1972, ARCH BIOCHEM BIOPHYS, V149, P164, DOI 10.1016/0003-9861(72)90310-4; Cherezov V, 2002, BIOPHYS J, V83, P3393, DOI 10.1016/S0006-3495(02)75339-3; Christopher GK, 1998, J CRYST GROWTH, V191, P820, DOI 10.1016/S0022-0248(98)00355-8; Deszczynski M, 2006, BIOPHYS CHEM, V120, P106, DOI 10.1016/j.bpc.2005.10.003; Dierks K, 2008, CRYST GROWTH DES, V8, P1628, DOI 10.1021/cg701067r; GEORGE A, 1994, ACTA CRYSTALLOGR D, V50, P361, DOI 10.1107/S0907444994001216; George A, 1997, METHOD ENZYMOL, V276, P100, DOI 10.1016/S0076-6879(97)76052-X; Grabe M, 2003, BIOPHYS J, V84, P854, DOI 10.1016/S0006-3495(03)74904-2; Guo B, 1999, J CRYST GROWTH, V196, P424, DOI 10.1016/S0022-0248(98)00842-2; Haas C, 1999, J PHYS CHEM B, V103, P2808, DOI 10.1021/jp984035l; Hanlon AD, 2010, BIOPHYS J, V98, P297, DOI 10.1016/j.bpj.2009.09.061; Helliwell JR, 2007, NATURE, V448, P658, DOI 10.1038/448658a; Huglin M. B., 1972, LIGHT SCATTERING POL; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kratochvil P., 1987, CLASSICAL LIGHT SCAT; Kuiper MJ, 2002, J PEPT RES, V59, P1, DOI 10.1046/j.1397-002x.2001.00001.x; Leinala EK, 2002, ACTA CRYSTALLOGR D, V58, P1081, DOI 10.1107/S0907444902005334; Lin YB, 2008, CRYST GROWTH DES, V8, P4277, DOI 10.1021/cg800698p; LIU XY, 1995, NATURE, V374, P342, DOI 10.1038/374342a0; McPherson A, 2009, INTRO MACROMOLECULAR; Sasaki T, 2008, J CRYST GROWTH, V310, P1288, DOI 10.1016/j.jcrysgro.2007.11.228; Song XJ, 2007, BIOPHYS J, V92, pL43, DOI 10.1529/biophysj.106.102160; Tanaka S, 2003, BIOPHYS J, V84, P3299, DOI 10.1016/S0006-3495(03)70054-X; Tuncbag N, 2009, BRIEF BIOINFORM, V10, P217, DOI 10.1093/bib/bbp001; Wang XK, 2010, CRYST RES TECHNOL, V45, P479, DOI 10.1002/crat.201000097; Wilson WW, 2003, J STRUCT BIOL, V142, P56, DOI 10.1016/S1047-8477(03)00038-8; Wingren C, 2003, PROTEIN ENG, V16, P255, DOI 10.1093/proeng/gzg038; Yin DC, 2008, CRYST RES TECHNOL, V43, P447, DOI 10.1002/crat.200710998; Zhang CY, 2008, CRYST GROWTH DES, V8, P4227, DOI 10.1021/cg800689j	35	6	7	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17950	10.1371/journal.pone.0017950	http://dx.doi.org/10.1371/journal.pone.0017950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479212	Green Published, gold, Green Submitted			2022-12-27	WOS:000289055700019
J	Stefanovski, D; Richey, JM; Woolcott, O; Lottati, M; Zheng, D; Harrison, LN; Ionut, V; Kim, SP; Hsu, I; Bergman, RN				Stefanovski, Darko; Richey, Joyce M.; Woolcott, Orison; Lottati, Maya; Zheng, Dan; Harrison, Lisa N.; Ionut, Viorica; Kim, Stella P.; Hsu, Isabel; Bergman, Richard N.			Consistency of the Disposition Index in the Face of Diet Induced Insulin Resistance: Potential Role of FFA	PLOS ONE			English	Article							FREE FATTY-ACIDS; IMPAIRED GLUCOSE-TOLERANCE; BETA-CELL; INTRAVENOUS GLUCOSE; PERIPHERAL INSULIN; METABOLIC SYNDROME; FASTING GLUCOSE; SECRETION; SENSITIVITY; LINK	Objective: Insulin resistance induces hyperinsulinemic compensation, which in turn maintains almost a constant disposition index. However, the signal that gives rise to the hyperinsulinemic compensation for insulin resistance remains unknown. Methods: In a dog model of obesity we examined the possibility that potential early-week changes in plasma FFA, glucose, or both could be part of a cascade of signals that lead to compensatory hyperinsulinemia induced by insulin resistance. Results: Hypercaloric high fat feeding in dogs resulted in modest weight gain, and an increase in adipose tissue with no change in the non-adipose tissue size. To compensate for the drop in insulin sensitivity, there was a significant rise in plasma insulin, which can be attributed in part to a decrease in the metabolic clearance rate of insulin and increased insulin secretion. In this study we observed complete compensation for high fat diet induced insulin resistance as measured by the disposition index. The compensatory hyperinsulinemia was coupled with significant changes in plasma FFAs and no change in plasma glucose. Conclusions: We postulate that early in the development of diet induced insulin resistance, a change in plasma FFAs may directly, through signaling at the level of beta-cell, or indirectly, by decreasing hepatic insulin clearance, result in the observed hyperinsulinemic compensation.	[Stefanovski, Darko; Richey, Joyce M.; Woolcott, Orison; Lottati, Maya; Zheng, Dan; Harrison, Lisa N.; Ionut, Viorica; Kim, Stella P.; Hsu, Isabel; Bergman, Richard N.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA	University of Southern California	Stefanovski, D (corresponding author), Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA.	stefanov@usc.edu	Woolcott, Orison O./AAQ-3440-2020	Woolcott, Orison O./0000-0003-2905-972X; Bergman, Richard/0000-0003-1539-4471	National Institutes of Health [DK27619, DK29867]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027619, R37DK027619, R01DK029867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants from the National Institutes of Health (DK27619 and DK29867). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Bergman RN, 2006, OBESITY, V14, p16S, DOI 10.1038/oby.2006.277; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; Boden Guenther, 1998, Frontiers in Bioscience, V3, pD169; Carpentier A, 2000, DIABETES, V49, P399, DOI 10.2337/diabetes.49.3.399; Dai T, 2004, J BIOL CHEM, V279, P45155, DOI 10.1074/jbc.M404764200; FERRANNINI E, 1983, J CLIN INVEST, V72, P1737, DOI 10.1172/JCI111133; Festa A, 2004, DIABETES, V53, P1549, DOI 10.2337/diabetes.53.6.1549; Getty L, 2000, J CLIN INVEST, V106, P421, DOI 10.1172/JCI7815; Hanefeld M, 2003, DIABETES CARE, V26, P868, DOI 10.2337/diacare.26.3.868; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Julius Stevo, 1998, Blood Pressure, V7, P5; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kim SP, 2003, DIABETES, V52, P2453, DOI 10.2337/diabetes.52.10.2453; Kim SP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1590, DOI 10.1152/ajpendo.00669.2006; Kim SP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1581, DOI 10.1152/ajpendo.00351.2006; MAHEUX P, 1994, HYPERTENSION, V24, P695, DOI 10.1161/01.HYP.24.6.695; Miles JM, 2003, DIABETES, V52, P675, DOI 10.2337/diabetes.52.3.675; Mittelman SD, 2000, DIABETES, V49, P2116, DOI 10.2337/diabetes.49.12.2116; Morgan LM, 1999, ANN CLIN BIOCHEM, V36, P447, DOI 10.1177/000456329903600407; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; PACINI G, 1986, COMPUT METH PROG BIO, V23, P113, DOI 10.1016/0169-2607(86)90106-9; POLONSKY KS, 1984, J CLIN INVEST, V74, P1821, DOI 10.1172/JCI111601; REBRIN K, 1995, DIABETES, V44, P1038, DOI 10.2337/diabetes.44.9.1038; Richey JM, 2009, AM J PHYSIOL-ENDOC M, V296, pE1311, DOI 10.1152/ajpendo.90972.2008; Rocchini AP, 1997, AM J PHYSIOL-ENDOC M, V272, pE147, DOI 10.1152/ajpendo.1997.272.1.E147; Steil GM, 2001, AM J PHYSIOL-ENDOC M, V280, pE788, DOI 10.1152/ajpendo.2001.280.5.E788; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; Stumvoll M, 2005, DIABETOLOGIA, V48, P207, DOI 10.1007/s00125-004-1657-3; Tasali E, 2002, AM J RESP CRIT CARE, V165, P562, DOI 10.1164/ajrccm.165.5.2201001b; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Weir GC, 2007, J CLIN INVEST, V117, P81, DOI 10.1172/JCI30862; Wilding JPH, 2007, DIABETIC MED, V24, P934, DOI 10.1111/j.1464-5491.2007.02186.x	34	24	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18134	10.1371/journal.pone.0018134	http://dx.doi.org/10.1371/journal.pone.0018134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479217	Green Published, Green Submitted, gold			2022-12-27	WOS:000289055700029
J	van der Ploeg, R; Mader, U; Homuth, G; Schaffer, M; Denham, EL; Monteferrante, CG; Miethke, M; Marahiel, MA; Harwood, CR; Winter, T; Hecker, M; Antelmann, H; van Dijl, JM				van der Ploeg, Rene; Maeder, Ulrike; Homuth, Georg; Schaffer, Marc; Denham, Emma L.; Monteferrante, Carmine G.; Miethke, Marcus; Marahiel, Mohamed A.; Harwood, Colin R.; Winter, Theresa; Hecker, Michael; Antelmann, Haike; van Dijl, Jan Maarten			Environmental Salinity Determines the Specificity and Need for Tat-Dependent Secretion of the YwbN Protein in Bacillus subtilis	PLOS ONE			English	Article							ARGININE TRANSLOCATION PATHWAY; BACTERIAL CYTOPLASMIC MEMBRANE; FERROUS IRON-UPTAKE; ESCHERICHIA-COLI; SIGNAL PEPTIDE; TRANSPORT-SYSTEM; EXPORT PATHWAY; ADAPTATION; PRECURSOR; COMPLEX	Twin-arginine protein translocation (Tat) pathways are required for transport of folded proteins across bacterial, archaeal and chloroplast membranes. Recent studies indicate that Tat has evolved into a mainstream pathway for protein secretion in certain halophilic archaea, which thrive in highly saline environments. Here, we investigated the effects of environmental salinity on Tat-dependent protein secretion by the Gram-positive soil bacterium Bacillus subtilis, which encounters widely differing salt concentrations in its natural habitats. The results show that environmental salinity determines the specificity and need for Tat-dependent secretion of the Dyp-type peroxidase YwbN in B. subtilis. Under high salinity growth conditions, at least three Tat translocase subunits, namely TatAd, TatAy and TatCy, are involved in the secretion of YwbN. Yet, a significant level of Tat-independent YwbN secretion is also observed under these conditions. When B. subtilis is grown in medium with 1% NaCl or without NaCl, the secretion of YwbN depends strictly on the previously described "minimal Tat translocase" consisting of the TatAy and TatCy subunits. Notably, in medium without NaCl, both tatAyCy and ywbN mutants display significantly reduced exponential growth rates and severe cell lysis. This is due to a critical role of secreted YwbN in the acquisition of iron under these conditions. Taken together, our findings show that environmental conditions, such as salinity, can determine the specificity and need for the secretion of a bacterial Tat substrate.	[van der Ploeg, Rene; Denham, Emma L.; Monteferrante, Carmine G.; van Dijl, Jan Maarten] Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 AV Groningen, Netherlands; [van der Ploeg, Rene; Denham, Emma L.; Monteferrante, Carmine G.; van Dijl, Jan Maarten] Univ Groningen, Groningen, Netherlands; [Maeder, Ulrike; Homuth, Georg; Schaffer, Marc] Ernst Moritz Arndt Univ Greifswald, Dept Funct Genom, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Miethke, Marcus; Marahiel, Mohamed A.] Univ Marburg, Dept Chem Biochem, Marburg, Germany; [Harwood, Colin R.] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Winter, Theresa; Hecker, Michael; Antelmann, Haike] Ernst Moritz Arndt Univ Greifswald, Inst Mikrobiol & Mol Biol, Greifswald, Germany	University of Groningen; University of Groningen; Ernst Moritz Arndt Universitat Greifswald; Philipps University Marburg; Newcastle University - UK; Ernst Moritz Arndt Universitat Greifswald	van der Ploeg, R (corresponding author), Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 AV Groningen, Netherlands.	j.m.van.dijl@med.umcg.nl	Harwood, Colin/AGF-0120-2022; van Dijl, Jan Maarten/G-1205-2013; Antelmann, Haike/I-3129-2019; Denham, Emma/P-3979-2014	Antelmann, Haike/0000-0002-1766-4386; van der Ploeg, Rene/0000-0003-2490-9262; Denham, Emma/0000-0002-5123-4099; Harwood, Colin/0000-0002-3624-0001	Commission of the European Union (CEU) [LSHG-CT-2004-503468, LSHG-CT-2004-005257, LSHM-CT-2006-019064, LSHG-CT-2006-037469, PITN-GA-2008-215524]; transnational Systems Biology of Microorganisms (SysMO) initiative [BACELL SysMO1, BACELL SysMO2]; European Science Foundation; Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research [04-EScope 01-011]; Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie; Bundesministerium fur Bildung und Forschung [03ZIK012]	Commission of the European Union (CEU)(European Commission); transnational Systems Biology of Microorganisms (SysMO) initiative; European Science Foundation(European Science Foundation (ESF)European Commission); Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This research was supported by the Commission of the European Union (CEU) projects LSHG-CT-2004-503468, LSHG-CT-2004-005257, LSHM-CT-2006-019064, LSHG-CT-2006-037469 and PITN-GA-2008-215524, the transnational Systems Biology of Microorganisms (SysMO) initiative through projects BACELL SysMO1 and 2, the European Science Foundation under the EUROCORES Programme EuroSCOPE, and grant 04-EScope 01-011 from the Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research, the "Deutsche Forschungsgemeinschaft", the "Fonds der Chemischen Industrie" and the "Bundesministerium fur Bildung und Forschung" (03ZIK012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Askwith C, 1997, J BIOL CHEM, V272, P401; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Biswas L, 2009, J BACTERIOL, V191, P5921, DOI 10.1128/JB.00642-09; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2002, MICROBIOL-SGM, V148, P3335, DOI 10.1099/00221287-148-11-3335; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Brink S, 1998, FEBS LETT, V434, P425, DOI 10.1016/S0014-5793(98)01028-X; Bursy J, 2007, J BIOL CHEM, V282, P31147, DOI 10.1074/jbc.M704023200; Cao J, 2007, MOL MICROBIOL, V65, P857, DOI 10.1111/j.1365-2958.2007.05802.x; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982; Darmon E, 2006, APPL ENVIRON MICROB, V72, P6876, DOI 10.1128/AEM.01176-06; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Dilks M, 2005, J BACTERIOL, V187, P8104, DOI 10.1128/JB.187.23.8104-8113.2005; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Eijlander RT, 2009, J BACTERIOL, V191, P196, DOI 10.1128/JB.01264-08; Gimenez MI, 2007, MOL MICROBIOL, V66, P1597, DOI 10.1111/j.1365-2958.2007.06034.x; Grosse C, 2006, MOL MICROBIOL, V62, P120, DOI 10.1111/j.1365-2958.2006.05326.x; Hantke K, 1997, J BACTERIOL, V179, P6201, DOI 10.1128/jb.179.19.6201-6204.1997; Hoffmann T, 2002, J BACTERIOL, V184, P718, DOI 10.1128/JB.184.3.718-727.2002; Hoper D, 2006, PROTEOMICS, V6, P1550, DOI 10.1002/pmic.200500197; Hutcheon GW, 2003, BIOCHEM SOC T, V31, P686, DOI 10.1042/bst0310686; Jongbloed JDH, 2006, TRENDS MICROBIOL, V14, P2, DOI 10.1016/j.tim.2005.11.001; Jongbloed JDH, 2002, J BIOL CHEM, V277, P44068, DOI 10.1074/jbc.M203191200; Jongbloed JDH, 2000, J BIOL CHEM, V275, P41350, DOI 10.1074/jbc.M004887200; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kolkman MAB, 2008, APPL ENVIRON MICROB, V74, P7507, DOI 10.1128/AEM.01401-08; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; KOUWEN TR, 2009, PROTEOMICS; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; May JJ, 2001, J BIOL CHEM, V276, P7209, DOI 10.1074/jbc.M009140200; Miethke M, 2006, MOL MICROBIOL, V61, P1413, DOI 10.1111/j.1365-2958.2006.05321.x; Moore CM, 2005, CURR OPIN MICROBIOL, V8, P188, DOI 10.1016/j.mib.2005.02.007; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Steil L, 2003, J BACTERIOL, V185, P6358, DOI 10.1128/JB.185.21.6358-6370.2003; Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200; Thomas JR, 2006, FEMS MICROBIOL LETT, V256, P44, DOI 10.1111/j.1574-6968.2006.00107.x; Tjalsma H, 1998, GENE DEV, V12, P2318, DOI 10.1101/gad.12.15.2318; Wexler M, 1998, FEBS LETT, V431, P339, DOI 10.1016/S0014-5793(98)00790-X; WIDDICK DA, 2007, J MOL BIOL; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4	57	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18140	10.1371/journal.pone.0018140	http://dx.doi.org/10.1371/journal.pone.0018140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479178	Green Published, Green Submitted, gold			2022-12-27	WOS:000289055700031
J	Binder, A; May, D; Baron, R; Maier, C; Tolle, TR; Treede, RD; Berthele, A; Faltraco, F; Flor, H; Gierthmuhlen, J; Haenisch, S; Huge, V; Magerl, W; Maihofner, C; Richter, H; Rolke, R; Scherens, A; Uceyler, N; Ufer, M; Wasner, G; Zhu, JH; Cascorbi, I				Binder, Andreas; May, Denisa; Baron, Ralf; Maier, Christoph; Toelle, Thomas R.; Treede, Rolf-Detlef; Berthele, Achim; Faltraco, Frank; Flor, Herta; Gierthmuehlen, Janne; Haenisch, Sierk; Huge, Volker; Magerl, Walter; Maihoefner, Christian; Richter, Helmut; Rolke, Roman; Scherens, Andrea; Ueceyler, Nurcan; Ufer, Mike; Wasner, Gunnar; Zhu, Jihong; Cascorbi, Ingolf			Transient Receptor Potential Channel Polymorphisms Are Associated with the Somatosensory Function in Neuropathic Pain Patients	PLOS ONE			English	Article							PARADOXICAL HEAT SENSATION; CAPSAICIN RECEPTOR; TRP CHANNEL; COLD; MECHANISMS; HYPERALGESIA; SENSITIVITY; EXPRESSION; NEURONS	Transient receptor potential channels are important mediators of thermal and mechanical stimuli and play an important role in neuropathic pain. The contribution of hereditary variants in the genes of transient receptor potential channels to neuropathic pain is unknown. We investigated the frequency of transient receptor potential ankyrin 1, transient receptor potential melastin 8 and transient receptor potential vanilloid 1 single nucleotide polymorphisms and their impact on somatosensory abnormalities in neuropathic pain patients. Within the German Research Network on Neuropathic Pain (Deutscher Forscbungsverbund Neuropathischer Schmerz) 371 neuropathic pain patients were phenotypically characterized using standardized quantitative sensory testing. Pyrosequencing was employed to determine a total of eleven single nucleotide polymorphisms in transient receptor potential channel genes of the neuropathic pain patients and a cohort of 253 German healthy volunteers. Associations of quantitative sensory testing parameters and single nucleotide polymorphisms between and within groups and subgroups, based on sensory phenotypes, were analyzed. Single nucleotide polymorphisms frequencies did not differ between both the cohorts. However, in neuropathic pain patients transient receptor potential ankyrin 1 710G>A (rs920829, E179K) was associated with the presence of paradoxical heat sensation (p=0.03), and transient receptor potential vanilloid 1 1911A>G (rs8065080, I585V) with cold hypoalgesia (p=0.0035). Two main subgroups characterized by preserved (1) and impaired (2) sensory function were identified. In subgroup 1 transient receptor potential vanilloid 1 1911A>G led to significantly less heat hyperalgesia, pinprick hyperalgesia and mechanical hypaesthesia (p=0.006, p=0.005 and p<0.001) and transient receptor potential vanilloid 1 1103C>G (rs222747, M315I) to cold hypaesthesia (p=0.002), but there was absence of associations in subgroup 2. In this study we found no evidence that genetic variants of transient receptor potential channels are involved in the expression of neuropathic pain, but transient receptor potential channel polymorphisms contributed significantly to the somatosensory abnormalities of neuropathic pain patients.	[Binder, Andreas; Baron, Ralf; Gierthmuehlen, Janne; Wasner, Gunnar] Univ Hosp Schleswig Holstein, Dept Neurol, Div Neurol Pain Res & Therapy, Kiel, Germany; [May, Denisa; Faltraco, Frank; Haenisch, Sierk; Ufer, Mike; Zhu, Jihong; Cascorbi, Ingolf] Univ Hosp Schleswig Holstein, Inst Expt & Clin Pharmacol, Kiel, Germany; [Maier, Christoph; Richter, Helmut; Scherens, Andrea] Ruhr Univ Bochum, Dept Pain Management, BG Kliniken Bergmannsheil, Bochum, Germany; [Toelle, Thomas R.; Berthele, Achim] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-8000 Munich, Germany; [Treede, Rolf-Detlef; Magerl, Walter] Heidelberg Univ, Ctr Biomed & Med Technol Mannheim, Mannheim, Germany; [Flor, Herta] Heidelberg Univ, Cent Inst Mental Hlth, Inst Clin & Cognit Neurosci, D-6800 Mannheim, Germany; [Huge, Volker] Univ Munich, Dept Anaesthesiol, Munich, Germany; [Maihoefner, Christian] Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany; [Rolke, Roman] Univ Bonn, Dept Palliat Care, D-5300 Bonn, Germany; [Rolke, Roman] Johannes Gutenberg Univ Mainz, Dept Neurol, Univ Med Ctr, Mainz, Germany; [Ueceyler, Nurcan] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Ruhr University Bochum; Technical University of Munich; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Munich; University of Erlangen Nuremberg; University of Bonn; Johannes Gutenberg University of Mainz; University of Wurzburg	Binder, A (corresponding author), Univ Hosp Schleswig Holstein, Dept Neurol, Div Neurol Pain Res & Therapy, Campus Kiel, Kiel, Germany.	a.binder@neurologie.uni-kiel.de	Sommer, Claudia/A-9820-2010; Haenisch, Sierk/I-4689-2012; zhu, ji/HDM-1538-2022; Cascorbi, Ingolf/AAT-1927-2021; Rolke, Roman/C-9042-2014; Treede, Rolf-Detlef/I-3632-2014	Sommer, Claudia/0000-0002-7064-5002; Cascorbi, Ingolf/0000-0002-2182-9534; Rolke, Roman/0000-0003-4279-9837; Faltraco, Frank/0000-0002-7943-7971; Flor, Herta/0000-0003-4809-5398; Uceyler, Nurcan/0000-0001-6973-6428; Treede, Rolf-Detlef/0000-0001-8065-1708	German Ministry for Education and Research, BMBF; Pfizer Pharma; National Health and Medical Research Council of Australia (NHMRC); EFIC-Grunenthal-Grant (EGG); Ministry of Science, Commerce and Transportation of Schleswig-Holstein, Germany; Alexander von Humboldt-Stiftung; Pfizer; Grunenthal; Genzyme; Medtronic	German Ministry for Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Pfizer Pharma(Pfizer); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); EFIC-Grunenthal-Grant (EGG); Ministry of Science, Commerce and Transportation of Schleswig-Holstein, Germany; Alexander von Humboldt-Stiftung(Alexander von Humboldt Foundation); Pfizer(Pfizer); Grunenthal(HAL Allergy Group); Genzyme(Sanofi-AventisGenzyme Corporation); Medtronic(Medtronic)	This work was supported by the German Ministry for Education and Research, BMBF, an unrestricted educational grant from Pfizer Pharma, the National Health and Medical Research Council of Australia (NHMRC), the EFIC-Grunenthal-Grant (EGG), the Ministry of Science, Commerce and Transportation of Schleswig-Holstein, Germany and the Alexander von Humboldt-Stiftung. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A. Binder received support for travel from the BMBF, honoraria for lectures from Grunenthal, Allergan and Pfizer, payment for development of educational presentations from Pfizer and travel/accommodation expenses from Pfizer, Allergan and Grunenthal and his institution received financial support from the BMBF. RB received support for travel from the BMBF, has consultancies with and received honoraria and travel/accommodation expenses from Pfizer, Genzyme, Grunenthal, Mundipharma, Allergan, Sanofi Pasteur, Medtronic, Eisai, UCB, Lilly, Astellas, received grants from Pfizer, Grunenthal, Genzyme, received payment for development of educational presentations from Pfizer, Medtronic and his institution received financial support from the BMBF. TT is board member at Pfizer, Lilly, Boehringer Grunenthal, and has consultancies with and received travel/accommodation expenses from Pfizer, Lilly, Boehringer, Grunenthal, Mundipharma, UCB/Schwarz. A. Berthele received honoraria and travel/accommodations expenses from Pfizer and his institution a grant from the BMBF. JG received support for travel from the BMBF and her institution received financial support from the BMBF. VH's institution received financial support from the BMBF. CMh received honoraria from Pfizer and travel/accommodation expenses from Allergan. RR is a board member at Astellas Pharma and received honoraria for lectures from Lilly and Pfizer. GW received honoraria and travel/accommodation expenses from Grunenthal, Medtronic, Pfizer, Mundipharma, his institution received financial support from the BMBF and Pfizer Pharma, and he received financial support for research from the National Health and Medical Research Council of Australia (NHMRC), the EFIC-Grunenthal-Grant (EGG), the Ministry of Science, Commerce and Transportation of Schleswig-Holstein, Germany and the Alexander von Humboldt-Stiftung. IC received honoraria and travel/accommodation expenses from MSD, Bayer-Schering and Sanofi Aventis for lectures. DM, RDT, FF, HF, SH, CM, AS, MU, NU, JZ, WM, HR have disclosed no competing interests. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Backonja M, 2008, LANCET NEUROL, V7, P1106, DOI 10.1016/S1474-4422(08)70228-X; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Baron R, 2009, PAIN, V146, P34, DOI 10.1016/j.pain.2009.06.001; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bevan S, 2009, CURR OPIN INVEST DR, V10, P655; Birklein F, 2008, NEUROSCI LETT, V437, P199, DOI 10.1016/j.neulet.2008.03.081; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cortright DN, 2009, CURR PHARM DESIGN, V15, P1736, DOI 10.2174/138161209788186308; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; Facer P, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-11; Geber C, 2008, PAIN, V139, P73, DOI 10.1016/j.pain.2008.03.006; Hansen C, 1996, BRAIN, V119, P1729, DOI 10.1093/brain/119.5.1729; Hayes P, 2000, PAIN, V88, P205, DOI 10.1016/S0304-3959(00)00353-5; Huge V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002742; Jensen TS, 2003, PAIN, V102, P1, DOI 10.1016/S0304-3959(03)00006-X; Kim H, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036079; Kim HS, 2004, PAIN, V109, P488, DOI 10.1016/j.pain.2004.02.027; Klein T, 2005, PAIN, V115, P227, DOI 10.1016/j.pain.2005.03.021; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Maier C, 2010, PAIN, V150, P439, DOI 10.1016/j.pain.2010.05.002; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; OCHOA JL, 1994, BRAIN, V117, P185, DOI 10.1093/brain/117.1.185; Okazawa M, 2004, NEUROSCI LETT, V359, P33, DOI 10.1016/j.neulet.2004.01.074; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Premkumar LS, 2010, AAPS J, V12, P361, DOI 10.1208/s12248-010-9196-y; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stucky CL, 2009, BRAIN RES REV, V60, P2, DOI 10.1016/j.brainresrev.2008.12.018; Susser E, 1999, BRAIN, V122, P239, DOI 10.1093/brain/122.2.239; Tominaga M., 2007, V179, P489; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Wang H, 2010, BRIT J DERMATOL, V162, P1023, DOI 10.1111/j.1365-2133.2009.09628.x; Woolf CJ, 1998, PAIN, V77, P227, DOI 10.1016/S0304-3959(98)00099-2; Xu H, 2007, AM J PHYSIOL-RENAL, V293, pF1865, DOI 10.1152/ajprenal.00347.2007; YARNITSKY D, 1990, BRAIN, V113, P893, DOI 10.1093/brain/113.4.893	38	94	95	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17387	10.1371/journal.pone.0017387	http://dx.doi.org/10.1371/journal.pone.0017387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21468319	Green Published, Green Submitted, gold			2022-12-27	WOS:000289054600010
J	Erler, S; Popp, M; Lattorff, HMG				Erler, Silvio; Popp, Mario; Lattorff, H. Michael G.			Dynamics of Immune System Gene Expression upon Bacterial Challenge and Wounding in a Social Insect (Bombus terrestris)	PLOS ONE			English	Article							APIS-MELLIFERA; PEPTIDE GENES; DROSOPHILA; DEFENSE; INFECTION; PATHWAY; INJURY; MEMORY; ANTS	The innate immune system which helps individuals to combat pathogens comprises a set of genes representing four immune system pathways (Toll, Imd, JNK and JAK/STAT). There is a lack of immune genes in social insects (e. g. honeybees) when compared to Diptera. Potentially, this might be compensated by an advanced system of social immunity (synergistic action of several individuals). The bumble bee, Bombus terrestris, is a primitively eusocial species with an annual life cycle and colonies headed by a single queen. We used this key pollinator to study the temporal dynamics of immune system gene expression in response to wounding and bacterial challenge. Antimicrobial peptides (AMP) (abaecin, defensin 1, hymenoptaecin) were strongly up-regulated by wounding and bacterial challenge, the latter showing a higher impact on the gene expression level. Sterile wounding down-regulated TEP A, an effector gene of the JAK/STAT pathway, and bacterial infection influenced genes of the Imd (relish) and JNK pathway (basket). Relish was up-regulated within the first hour after bacterial challenge, but decreased strongly afterwards. AMP expression following wounding and bacterial challenge correlates with the expression pattern of relish whereas correlated expression with dorsal was absent. Although expression of AMPs was high, continuous bacterial growth was observed throughout the experiment. Here we demonstrate for the first time the temporal dynamics of immune system gene expression in a social insect. Wounding and bacterial challenge affected the innate immune system significantly. Induction of AMP expression due to wounding might comprise a pre-adaptation to accompanying bacterial infections. Compared with solitary species this social insect exhibits reduced immune system efficiency, as bacterial growth could not be inhibited. A negative feedback loop regulating the Imd-pathway is suggested. AMPs, the end product of the Imd-pathway, inhibited the up-regulation of the transcription factor relish, which is necessary for effector gene expression.	[Erler, Silvio; Popp, Mario; Lattorff, H. Michael G.] Univ Halle Wittenberg, Inst Biol, Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Erler, S (corresponding author), Univ Halle Wittenberg, Inst Biol, Halle, Saale, Germany.	silvio.erler@zoologie.uni-halle.de	Lattorff, Michael/F-6287-2010; Erler, Silvio/B-4162-2012	Lattorff, Michael/0000-0002-8603-6332; Erler, Silvio/0000-0002-9425-8103	BMBF [FKZ: 0315126]	BMBF(Federal Ministry of Education & Research (BMBF))	This project was supported by a grant from the BMBF program FUGATO-Plus (FKZ: 0315126) to HMGL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Bidla G, 2009, J INNATE IMMUN, V1, P301, DOI 10.1159/000168009; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Choi YS, 2008, COMP BIOCHEM PHYS B, V150, P141, DOI 10.1016/j.cbpb.2008.02.007; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Korner P, 2004, J INVERTEBR PATHOL, V87, P59, DOI 10.1016/j.jip.2004.07.004; Kube M, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-110, 10.1186/1471-2164-11-393]; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Markus R, 2005, IMMUNOL LETT, V101, P108, DOI 10.1016/j.imlet.2005.03.021; MERCER AR, 1982, J COMP PHYSIOL, V145, P363, DOI 10.1007/BF00619340; Moret Y, 2001, NATURE, V414, P506, DOI 10.1038/35107138; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rozen S, 2000, Methods Mol Biol, V132, P365; Sadd BM, 2007, CURR BIOL, V17, pR1046, DOI 10.1016/j.cub.2007.11.007; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Viljakainen L, 2008, J MOL EVOL, V67, P643, DOI 10.1007/s00239-008-9173-6; Welchman David P, 2009, Cell Host Microbe, V6, P107, DOI 10.1016/j.chom.2009.07.008; Wilfert L, 2009, INSECT SOC, V56, P44, DOI 10.1007/s00040-008-1034-1; Xu P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004239; Yoon Hyung Joo, 2009, Journal of Asia-Pacific Entomology, V12, P27, DOI 10.1016/j.aspen.2008.11.003	32	74	76	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18126	10.1371/journal.pone.0018126	http://dx.doi.org/10.1371/journal.pone.0018126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479237	Green Submitted, Green Published, gold			2022-12-27	WOS:000289054600029
J	Li, MA; Zhou, YH; Chen, PZ; Yang, HA; Yuan, XY; Tajima, KZ; Cao, J; Wang, H				Li, Mian; Zhou, Yanhong; Chen, Peizhan; Yang, Huan; Yuan, Xiaoyan; Tajima, Kazuo; Cao, Jia; Wang, Hui			Genetic Variants on Chromosome 8q24 and Colorectal Neoplasia Risk: A Case-Control Study in China and a Meta-Analysis of the Published Literature	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CANCER SUSCEPTIBILITY LOCUS; COLON-CANCER; SAMPLE-SIZE; RS6983267; SCAN; ALLELES; RANGE; SHOWS; POWER	Previous studies have found that common genetic variants on chromosome 8q24 are associated with the risk of developing colorectal neoplasia. We conducted a hospital-based case-control study, including 435 cases and 788 unrelated controls to investigate the associations between common variants on 8q24 and the risk of colorectal cancer in a Chinese population. We also evaluated the association of rs6983267 with colorectal neoplasia in the published literature via a meta-analysis study. We found that rs6983267 was significantly associated with the risk of colorectal cancer in the Chinese population, with an adjusted odds-ratio (OR) for the GT heterozygotes and GG homozygotes of 1.30 (95% CI = 0.98-1.71, P = 0.069) and 1.66 (95% CI = 1.18-2.34, P = 0.004), respectively, compared to the TT homozygotes, with a P-trend value of 0.003. No association was found for the other three loci (rs16901979, rs1447295 and rs7837688). In the meta-analysis of the published genetic association studies, the rs6983267 variant was found to be associated with an increased risk of colorectal neoplasia. The heterozygous GT carriers showed a 20% increased risk of colorectal neoplasia (OR = 1.20, 95% CI = 1.16-1.25; random effects model) with a summary OR for homozygous GG carriers of 1.39 (95% CI = 1.32-1.48; random effects model) compared to the TT genotype carriers. We found no significant differences between the association of rs6983267 and colorectal cancer and colorectal adenomas. In summary, our study confirms that the variant rs6983267 is a risk factor for colorectal neoplasia in various populations, including the Chinese population.	[Li, Mian; Chen, Peizhan; Wang, Hui] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Nutr Sci,Key Lab Nutr & Metab, Shanghai, Peoples R China; [Zhou, Yanhong; Yang, Huan; Yuan, Xiaoyan; Cao, Jia] Third Mil Med Univ, Dept Hyg Toxicol, Coll Prevent Med,Minist Educ China, Key Lab Med Protect Electmagnet Radiat, Chongqing, Peoples R China; [Tajima, Kazuo] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Army Medical University; Ministry of Education, China; Aichi Cancer Center	Li, MA (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Nutr Sci,Key Lab Nutr & Metab, Shanghai, Peoples R China.	caojia@mail.tmmu.com.cn; huiwang@sibs.ac.cn			Chinese Academy of Sciences; National Nature Science Foundation [30870513, 30800933, 31070680, 91029715]; Ministry of Science and Technology of China [2007CB947100]; Science and Technology Commission of Shanghai Municipality [08391910800, 10391902100]; National Science and Technology Major Project [2009ZX09102-114, 2009ZX09301-011]; Ministry of Education, Culture, Sports, Science and Technology of Japan [12670383]; Major International (Regional) Joint Research Projects [30320140461]; Science and Technology Commission of Xuhui District of Shanghai Municipality [RCT201001, CRC2010002]; Director Foundation of INS [20090101]; Food Safety Research Center; INS; SIBS; CAS	Chinese Academy of Sciences(Chinese Academy of Sciences); National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Science and Technology Major Project; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Major International (Regional) Joint Research Projects; Science and Technology Commission of Xuhui District of Shanghai Municipality; Director Foundation of INS; Food Safety Research Center; INS; SIBS; CAS(Chinese Academy of Sciences)	This study was supported by grants from One Hundred Talents Program of the Chinese Academy of Sciences, the National Nature Science Foundation (30870513, 30800933, 31070680 and 91029715), the Ministry of Science and Technology of China (2007CB947100), the Science and Technology Commission of Shanghai Municipality (08391910800, 10391902100), National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program'' (2009ZX09102-114, 2009ZX09301-011), the Grant-in Aid for Scientific Research on Special Priority Areas of Cancer from the Ministry of Education, Culture, Sports, Science and Technology of Japan (12670383), and grants from the Major International (Regional) Joint Research Projects (30320140461), the Science and Technology Commission of Xuhui District of Shanghai Municipality (RCT201001, CRC2010002), Director Foundation of INS (20090101), the Food Safety Research Center and Key Laboratory of Nutrition and Metabolism of INS, SIBS, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berndt SI, 2008, HUM MOL GENET, V17, P2665, DOI 10.1093/hmg/ddn166; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Cicek MS, 2009, CANCER EPIDEM BIOMAR, V18, P2492, DOI 10.1158/1055-9965.EPI-09-0362; Cui R, 2011, GUT; Curtin K, 2009, CANCER EPIDEM BIOMAR, V18, P616, DOI 10.1158/1055-9965.EPI-08-0690; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Garcia-Closas M, 1999, AM J EPIDEMIOL, V149, P689; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gruber SB, 2007, CANCER BIOL THER, V6, P1143, DOI 10.4161/cbt.6.7.4704; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; He J, 2011, CANCER EPIDEM BIOMAR, V20, P70, DOI 10.1158/1055-9965.EPI-10-0892; Hutter CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-670; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; KRUPFER SS, 2010, GASTROENTEROLOGY, V139, P1677; Kupfer SS, 2010, GASTROENTEROLOGY, V139, P1677, DOI 10.1053/j.gastro.2010.07.038; Kupfer SS, 2009, CARCINOGENESIS, V30, P1353, DOI 10.1093/carcin/bgp123; Li L, 2008, CANCER EPIDEM BIOMAR, V17, P339, DOI 10.1158/1055-9965.EPI-07-0713; LUBIN JH, 1990, AM J EPIDEMIOL, V131, P552, DOI 10.1093/oxfordjournals.aje.a115530; Matsuo K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-379; Middeldorp A, 2009, CANCER EPIDEM BIOMAR, V18, P3062, DOI 10.1158/1055-9965.EPI-09-0601; Niittymaki I, 2010, CANCER EPIDEM BIOMAR, V19, P1478, DOI 10.1158/1055-9965.EPI-09-1320; Pittman AM, 2008, BRIT J CANCER, V98, P1434, DOI 10.1038/sj.bjc.6604314; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Poynter JN, 2007, CANCER RES, V67, P11128, DOI 10.1158/0008-5472.CAN-07-3239; Schafmayer C, 2009, INT J CANCER, V124, P75, DOI 10.1002/ijc.23872; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tuupanen S, 2008, CANCER RES, V68, P14, DOI 10.1158/0008-5472.CAN-07-5766; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; von Holst S, 2010, BRIT J CANCER, V103, P575, DOI 10.1038/sj.bjc.6605774; White KL, 2010, TWIN RES HUM GENET, V13, P43, DOI 10.1375/twin.13.1.43; Wokolorczyk D, 2008, CANCER RES, V68, P9982, DOI 10.1158/0008-5472.CAN-08-1838; Xiong F, 2010, CANCER EPIDEM BIOMAR, V19, P1855, DOI 10.1158/1055-9965.EPI-10-0210; Xu YF, 2007, HUM MOL GENET, V16, pR14, DOI 10.1093/hmg/ddl486; Yang H, 2009, CANCER EPIDEM BIOMAR, V18, P2522, DOI 10.1158/1055-9965.EPI-09-0398; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	42	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18251	10.1371/journal.pone.0018251	http://dx.doi.org/10.1371/journal.pone.0018251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455501	Green Submitted, Green Published, gold			2022-12-27	WOS:000288811500033
J	Timmusk, S; Paalme, V; Pavlicek, T; Bergquist, J; Vangala, A; Danilas, T; Nevo, E				Timmusk, Salme; Paalme, Viiu; Pavlicek, Tomas; Bergquist, Jonas; Vangala, Ameraswar; Danilas, Triin; Nevo, Eviatar			Bacterial Distribution in the Rhizosphere of Wild Barley under Contrasting Microclimates	PLOS ONE			English	Article							GROWTH-PROMOTING RHIZOBACTERIA; PLANT-GROWTH; PAENIBACILLUS-POLYMYXA; ACC DEAMINASE; GENE-EXPRESSION; CONFER RESISTANCE; EVOLUTION-CANYON; ETHYLENE LEVELS; STRESS; DIVERSITY	Background: All plants in nature harbor a diverse community of rhizosphere bacteria which can affect the plant growth. Our samples are isolated from the rhizosphere of wild barley Hordeum spontaneum at the Evolution Canyon ('EC'), Israel. The bacteria which have been living in close relationship with the plant root under the stressful conditions over millennia are likely to have developed strategies to alleviate plant stress. Methodology/Principal Findings: We studied distribution of culturable bacteria in the rhizosphere of H. spontaneum and characterized the bacterial 1-aminocyclopropane-1-carboxylate deaminase (ACCd) production, biofilm production, phosphorus solubilization and halophilic behavior. We have shown that the H. spontaneum rhizosphere at the stressful South Facing Slope (SFS) harbors significantly higher population of ACCd producing biofilm forming phosphorus solubilizing osmotic stress tolerant bacteria. Conclusions/Significance: The long-lived natural laboratory 'EC' facilitates the generation of theoretical testable and predictable models of biodiversity and genome evolution on the area of plant microbe interactions. It is likely that the bacteria isolated at the stressful SFS offer new opportunities for the biotechnological applications in our agro-ecological systems.	[Timmusk, Salme; Vangala, Ameraswar] Swedish Univ Agr Sci SLU, Uppsala BioCtr, Dept Forest Mycol & Pathol, Uppsala, Sweden; [Paalme, Viiu] Tallinn Univ Technol, Dept Gene Technol, Tallinn, Estonia; [Pavlicek, Tomas; Nevo, Eviatar] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Bergquist, Jonas] Uppsala Univ, Dept Analyt & Phys Chem, Uppsala, Sweden; [Danilas, Triin] Estonian Univ Life Sci, Inst Forestry & Rural Engn, Tartu, Estonia	Swedish University of Agricultural Sciences; Tallinn University of Technology; University of Haifa; Uppsala University; Estonian University of Life Sciences	Timmusk, S (corresponding author), Swedish Univ Agr Sci SLU, Uppsala BioCtr, Dept Forest Mycol & Pathol, Uppsala, Sweden.	salme.timmusk@mykopat.slu.se	Pavlicek, Tomas/C-4768-2008; Bergquist, Jonas/C-5894-2015	timmusk, s/0000-0001-8465-1043; Bergquist, Jonas/0000-0002-4597-041X	FORMAS/Sweden; Ancell-Teicher Research Foundation of Molecular Genetics and Evolution	FORMAS/Sweden(Swedish Research Council Formas); Ancell-Teicher Research Foundation of Molecular Genetics and Evolution	This work was supported by FORMAS/Sweden (to S. Timmusk) and the Ancell-Teicher Research Foundation of Molecular Genetics and Evolution (to E. Nevo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASEA PEA, 1988, SOIL BIOL BIOCHEM, V20, P459, DOI 10.1016/0038-0717(88)90058-2; Baena-Gonzalez E, 2010, MOL PLANT, V3, P300, DOI 10.1093/mp/ssp113; Cheng ZY, 2008, CAN J MICROBIOL, V54, P128, DOI 10.1139/w07-128; Czarny JC, 2006, BIOTECHNOL ADV, V24, P410, DOI 10.1016/j.biotechadv.2006.01.003; DAN J, 1979, SOIL CLASSIFICATION; Duan Jin, 2009, Microb Ecol, V57, P423, DOI 10.1007/s00248-008-9407-6; Echigo Akinobu, 2005, Saline Syst, V1, P8, DOI 10.1186/1746-1448-1-8; EDIPREMOTO M, 1996, JCROP SCI, V11, P13; FIERER N, 2008, ACCESSING UNCULTIVAT, P95; Gamalero E, 2009, MICROBIAL STRATEGIES FOR CROP IMPROVEMENT, P1, DOI 10.1007/978-3-642-01979-1_1; Glick BR, 2005, FEMS MICROBIOL LETT, V251, P1, DOI 10.1016/j.femsle.2005.07.030; GLICK BR, 1995, CAN J MICROBIOL, V41, P109, DOI 10.1139/m95-015; Haggag WM, 2008, J APPL MICROBIOL, V104, P961, DOI 10.1111/j.1365-2672.2007.03611.x; HAO Y, 2009, ENVIRON MICROBIOL, V3, P112; Kis-Papo T, 2003, P NATL ACAD SCI USA, V100, P14970, DOI 10.1073/pnas.2036284100; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Lucy M, 2004, ANTON LEEUW INT J G, V86, P1, DOI 10.1023/B:ANTO.0000024903.10757.6e; Mayak S, 2004, PLANT PHYSIOL BIOCH, V42, P565, DOI 10.1016/j.plaphy.2004.05.009; Mayak S, 2004, PLANT SCI, V166, P525, DOI 10.1016/j.plantsci.2003.10.025; McDonnell L, 2009, PHYSIOL PLANTARUM, V136, P94, DOI 10.1111/j.1399-3054.2009.01208.x; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; NEVO E, 1987, ISOZYMES-CURR T BIOL, V16, P247; NEVO E, 1995, P ROY SOC B-BIOL SCI, V262, P149, DOI 10.1098/rspb.1995.0189; Nevo E, 1997, THEOR POPUL BIOL, V52, P231, DOI 10.1006/tpbi.1997.1330; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nevo E., 2002, EVOLUTION WILD EMMER; PAVLICEK T, 2003, EVOLUTION, V52, P1; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Raz S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005214; Schaeffer A B, 1933, Science, V77, P194, DOI 10.1126/science.77.1990.194; Selezska K, 2007, MYCOLOGIA BALCANICA, V4, P51; Sun YL, 2009, FEMS MICROBIOL LETT, V296, P131, DOI 10.1111/j.1574-6968.2009.01625.x; Timmusk S, 2005, APPL ENVIRON MICROB, V71, P7292, DOI 10.1128/AEM.71.11.7292-7300.2005; Timmusk S, 2009, J APPL MICROBIOL, V107, P736, DOI 10.1111/j.1365-2672.2009.04265.x; Timmusk S, 2009, J APPL MICROBIOL, V106, P1473, DOI 10.1111/j.1365-2672.2009.04123.x; Timmusk S, 1999, SOIL BIOL BIOCHEM, V31, P1847, DOI 10.1016/S0038-0717(99)00113-3; Timmusk S, 1999, MOL PLANT MICROBE IN, V12, P951, DOI 10.1094/MPMI.1999.12.11.951; Timmusk S, 2011, BACTERIA IN AGROBIOLOGY: PLANT NUTRIENT MANAGEMENT, P285, DOI 10.1007/978-3-642-21061-7_12; Walker TS, 2003, PLANT PHYSIOL, V132, P44, DOI 10.1104/pp.102.019661; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004	40	116	126	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17968	10.1371/journal.pone.0017968	http://dx.doi.org/10.1371/journal.pone.0017968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448272	Green Published, Green Submitted, gold			2022-12-27	WOS:000288810500024
J	Saha, P; Bhattacharjee, S; Sarkar, A; Manna, A; Majumder, S; Chatterjee, M				Saha, Piu; Bhattacharjee, Surajit; Sarkar, Avijit; Manna, Alak; Majumder, Subrata; Chatterjee, Mitali			Berberine Chloride Mediates Its Anti-Leishmanial Activity via Differential Regulation of the Mitogen Activated Protein Kinase Pathway in Macrophages	PLOS ONE			English	Article							EXPERIMENTAL VISCERAL LEISHMANIASIS; NITRIC-OXIDE; SIGNAL-TRANSDUCTION; MURINE MACROPHAGES; MOUSE MACROPHAGES; INDUCTION; INTERLEUKIN-10; INFECTION; CYTOKINES; DONOVANI	Background: A complex interplay between Leishmania and macrophages influences parasite survival and necessitates disruption of signaling molecules, eventually resulting in impairment of macrophage function. In this study, we demonstrate the immunomodulatory activity of Berberine chloride in Leishmania infected macrophages. Principal Findings: The IC50 of Berberine chloride, a quaternary isoquinoline alkaloid was tested in an amastigote macrophage model and its safety index measured by a cell viability assay. It eliminated intracellular amastigotes, the IC50 being 2.8 fold lower than its IC50 in promastigotes (7.10 mu M vs. 2.54 mu M) and showed a safety index >16. Levels of intracellular and extracellular nitric oxide (NO) as measured by flow cytometry and Griess assay respectively showed that Berberine chloride in Leishmania infected macrophages increased production of NO. Measurement of the mRNA expression of iNOS, IL-12 and IL-10 by RT-PCR along with levels of IL-12p40 and IL-10 by ELISA showed that in infected macrophages, Berberine chloride enhanced expression of iNOS and IL-12p40, concomitant with a downregulation of IL-10. The phosphorylation status of extracellular signal related kinase (ERK1/2) and p38 mitogen activated protein kinase (p38 MAPK) was studied by western blotting. In infected macrophages, Berberine chloride caused a time dependent activation of p38 MAPK along with deactivation of ERK1/2; addition of a p38 MAPK inhibitor SB203580 inhibited the increased generation of NO and IL-12p40 by Berberine chloride as also prevented its decrease of IL-10. Conclusions: Berberine chloride modulated macrophage effector responses via the mitogen activated protein kinase (MAPK) pathway, highlighting the importance of MAPKs as an antiparasite target.	[Saha, Piu; Sarkar, Avijit; Manna, Alak; Chatterjee, Mitali] Inst Post Grad Med Educ & Res, Dept Pharmacol, Kolkata, India; [Bhattacharjee, Surajit; Majumder, Subrata] Bose Inst, Div Mol Med, Kolkata, India	Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Department of Science & Technology (India); Bose Institute	Saha, P (corresponding author), Inst Post Grad Med Educ & Res, Dept Pharmacol, Kolkata, India.	ilatim@vsnl.net	Chatterjee, Mitali/AAV-2129-2021; Bhattacharjee, Surajit/B-5979-2012; Manna, Alak/AAY-1248-2021; Manna, Alak/AAE-7308-2021	Bhattacharjee, Surajit/0000-0001-9233-4777; Manna, Alak/0000-0003-3894-3277; 	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	The study received no direct funding. However, the corresponding author received funding from the Department of Science and Technology, Government of India for a project entitled "Targetting of thiol mediated anti-oxidant pathways as a potential chemotherapeutic modality in Indian Leishmaniasis." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhardwaj S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/109189; Bhattacharjee S, 2009, J ANTIMICROB CHEMOTH, V63, P317, DOI 10.1093/jac/dkn479; Bhattacharyya S, 2001, INFECT IMMUN, V69, P1499, DOI 10.1128/IAI.69.3.1499-1507.2001; BUCHMULLERROUILLER Y, 1987, INFECT IMMUN, V55, P587; CHATTERJEE A, 1994, TREATISE INDIAN MED, V1, P129; Chatton JY, 2002, METHOD ENZYMOL, V359, P134; da Luz RI, 2009, ANTIMICROB AGENTS CH, V53, P5197, DOI 10.1128/AAC.00866-09; Feng GJ, 1999, J IMMUNOL, V163, P6403; Ganguly S, 2007, J PHARM PHARMACOL, V59, P711, DOI 10.1211/jpp.59.5.0012; Ganguly S, 2006, J MICROBIOL METH, V66, P79, DOI 10.1016/j.mimet.2005.10.011; Gantt KR, 2001, J IMMUNOL, V167, P893, DOI 10.4049/jimmunol.167.2.893; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Ghazanfari T, 2000, SCAND J IMMUNOL, V52, P491, DOI 10.1046/j.1365-3083.2000.00803.x; GHOSH AK, 1985, EXP PARASITOL, V60, P404, DOI 10.1016/0014-4894(85)90047-5; GHOSH AK, 1983, INDIAN J MED RES, V78, P407; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; Kang BY, 2002, BIOCHEM PHARMACOL, V63, P1901, DOI 10.1016/S0006-2952(02)00982-6; KAYE PM, 1991, J IMMUNOL, V146, P2763; Kim TS, 2003, IMMUNOLOGY, V109, P407, DOI 10.1046/j.1365-2567.2003.01673.x; Kropf P, 2004, INFECT IMMUN, V72, P1920, DOI 10.1128/IAI.72.4.1920-1928.2004; Ma XJ, 1997, J BIOL CHEM, V272, P10389; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Murray HW, 2002, INFECT IMMUN, V70, P6284, DOI 10.1128/IAI.70.11.6284-6293.2002; Naderer T, 2008, CELL MICROBIOL, V10, P301, DOI 10.1111/j.1462-5822.2007.01096.x; Roberts MTM, 2005, BRIT MED BULL, V75-76, P115, DOI 10.1093/bmb/ldl003; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Saha P, 2009, FREE RADICAL RES, V43, P1101, DOI 10.1080/10715760903186124; Sarkar A, 2011, CYTOM PART A, V79A, P35, DOI 10.1002/cyto.a.21001; Sarkar D, 2008, INT IMMUNOPHARMACOL, V8, P1264, DOI 10.1016/j.intimp.2008.05.003; Sen R, 2010, INT J ANTIMICROB AG, V36, P43, DOI 10.1016/j.ijantimicag.2010.03.008; Tiscornia A, 2009, J IMMUNOL METHODS, V342, P49, DOI 10.1016/j.jim.2008.11.014; Trinchieri G, 1998, Int Rev Immunol, V16, P365, DOI 10.3109/08830189809043002; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P229, DOI 10.1111/j.1574-695X.2007.00311.x; Ukil A, 2005, J IMMUNOL, V175, P1161, DOI 10.4049/jimmunol.175.2.1161; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769	38	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18467	10.1371/journal.pone.0018467	http://dx.doi.org/10.1371/journal.pone.0018467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483684	Green Published, Green Submitted, gold			2022-12-27	WOS:000289191300024
J	Vijay, S; Rawat, M; Adak, T; Dixit, R; Nanda, N; Srivastava, H; Sharma, JK; Prasad, GBKS; Sharma, A				Vijay, Sonam; Rawat, Manmeet; Adak, Tridibes; Dixit, Rajnikant; Nanda, Nutan; Srivastava, Harish; Sharma, Joginder K.; Prasad, Godavarthi B. K. S.; Sharma, Arun			Parasite Killing in Malaria Non-Vector Mosquito Anopheles culicifacies Species B: Implication of Nitric Oxide Synthase Upregulation	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; TIME BOMB; GAMBIAE; STEPHENSI; IMMUNITY; SUSCEPTIBILITY; MIDGUT; INSECTS; VIVAX; REFRACTORINESS	Background: Anopheles culicifacies, the main vector of human malaria in rural India, is a complex of five sibling species. Despite being phylogenetically related, a naturally selected subgroup species B of this sibling species complex is found to be a poor vector of malaria. We have attempted to understand the differences between vector and non-vector Anopheles culicifacies mosquitoes in terms of transcriptionally activated nitric oxide synthase (AcNOS) physiologies to elucidate the mechanism of refractoriness. Identification of the differences between genes and gene products that may impart refractory phenotype can facilitate development of novel malaria transmission blocking strategies. Methodology/Principal Findings: We conducted a study on phylogenetically related susceptible (species A) and refractory (species B) sibling species of An. culicifacies mosquitoes to characterize biochemical and molecular differences in AcNOS gene and gene elements and their ability to inhibit oocyst growth. We demonstrate that in species B, AcNOS specific activity and nitrite/nitrates in mid-guts and haemolymph were higher as compared to species A after invasion of the mid-gut by P. vivax at the beginning and during the course of blood feeding. Semiquantitative RT-PCR and real time PCR data of AcNOS concluded that this gene is more abundantly expressed in midgut of species B than in species A and is transcriptionally upregulated post blood meals. Dietary feeding of L-NAME along with blood meals significantly inhibited midgut AcNOS activity leading to an increase in oocyst production in An. culicifacies species B. Conclusions/Significance: We hypothesize that upregulation of mosquito innate cytotoxicity due to NOS in refractory strain to Plasmodium vivax infection may contribute to natural refractoriness in An. culicifacies mosquito population. This innate capacity of refractory mosquitoes could represent the ancestral function of the mosquito immune system against the parasite and could be utilized to understand the molecular basis of refractoriness in planning effective vector control strategies.	[Vijay, Sonam; Rawat, Manmeet; Sharma, Arun] Natl Inst Malaria Res ICMR, Prot Biochem & Struct Biol Lab, New Delhi, India; [Adak, Tridibes] Natl Inst Malaria Res ICMR, Vector Biol Lab, New Delhi, India; [Dixit, Rajnikant] Natl Inst Malaria Res ICMR, Host Parasite Interact Grp, New Delhi, India; [Nanda, Nutan] Natl Inst Malaria Res ICMR, Mol Entomol Lab, New Delhi, India; [Srivastava, Harish] Civil Hosp, Entomol Lab, Natl Inst Malaria Res ICMR, Field Unit, Nadiad, Gujarat, India; [Sharma, Joginder K.] Inst Cytol & Prevent Oncol ICMR, Mol Diagnost Lab, Noida, India; [Prasad, Godavarthi B. K. S.] Jiwaji Univ, Dept Biotechnol, Gwalior, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Jiwaji University Gwalior	Vijay, S (corresponding author), Natl Inst Malaria Res ICMR, Prot Biochem & Struct Biol Lab, New Delhi, India.	arushar@gmail.com	Dixit, Rajnikant/D-2566-2009; Adak, Tridibes/C-2501-2011; Manmeet, Rawat/AAE-5057-2021	Dixit, Rajnikant/0000-0002-3536-8329; Rawat, Manmeet/0000-0002-8325-3390	Indian Council of Medical Research	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	Financial support to the work was provided by Indian Council of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak T, 1999, T ROY SOC TROP MED H, V93, P573, DOI 10.1016/S0035-9203(99)90052-4; Adak T, 2006, TROP MED INT HEALTH, V2, P1; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Ali M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012634; Ascenzi P, 2002, IUBMB LIFE, V53, P121, DOI [10.1080/10399710290039016, 10.1080/15216540211472]; Atkinson PW, 2002, GENESIS, V32, P42, DOI 10.1002/gene.10026; Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104; Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin SA, 2008, CELL HOST MICROBE, V3, P364, DOI 10.1016/j.chom.2008.05.007; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Christophides GK, 2004, IMMUNOL REV, V198, P127, DOI 10.1111/j.0105-2896.2004.0127.x; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; COLLINS FH, 1994, SCIENCE, V264, P1874, DOI 10.1126/science.8009215; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; CURTIS CF, 1994, PARASITOL TODAY, V10, P371, DOI 10.1016/0169-4758(94)90222-4; Dimopoulos G, 2003, CELL MICROBIOL, V5, P3, DOI 10.1046/j.1462-5822.2003.00252.x; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Dixit R, 2008, ACTA TROP, V106, P75, DOI 10.1016/j.actatropica.2008.01.001; EYLES DE, 1950, J PARASITOL, V36, P501, DOI 10.2307/3273188; FELDMANN AM, 1989, MED VET ENTOMOL, V3, P41, DOI 10.1111/j.1365-2915.1989.tb00473.x; Ghosh A, 2000, PARASITOL TODAY, V16, P196, DOI 10.1016/S0169-4758(99)01626-9; Ghosh AK, 2001, P NATL ACAD SCI USA, V98, P13278, DOI 10.1073/pnas.241491198; Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003; Habtewold T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000070; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; HENRY JM, 1990, ANAL BIOCHEM, V185, P147, DOI 10.1016/0003-2697(90)90270-J; Hoffmann JA, 1996, CURR OPIN IMMUNOL, V8, P8, DOI 10.1016/S0952-7915(96)80098-7; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Jacobs-Lorena Marcelo, 2003, Journal of Vector Borne Diseases, V40, P73; James AA, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P461; Kaur S, 2000, J PARASITOL, V86, P1345, DOI 10.1645/0022-3395(2000)086[1345:SOSABA]2.0.CO;2; Kim KM, 2002, J BIOCHEM MOL BIOL, V35, P127; Kumar S, 2005, INSECT BIOCHEM MOLEC, V35, P721, DOI 10.1016/j.ibmb.2005.02.014; LACKIE AM, 1988, PARASITOL TODAY, V4, P98, DOI 10.1016/0169-4758(88)90035-X; Lanz-Mendoza H, 2002, J PARASITOL, V88, P702, DOI 10.1645/0022-3395(2002)088[0702:SAIAAH]2.0.CO;2; Lim JH, 2005, INFECT IMMUN, V73, P2778, DOI 10.1128/IAI.73.5.2778-2789.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; MARTINEZ A, 1995, HISTOCHEM J, V27, P770; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; NAOTUNNE TD, 1993, IMMUNOLOGY, V78, P555; NATHAN C, 1995, CELL, V82, P873, DOI 10.1016/0092-8674(95)90019-5; Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037; REGULSKI M, 1995, P NATL ACAD SCI USA, V92, P9072, DOI 10.1073/pnas.92.20.9072; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Rivero A, 2006, TRENDS PARASITOL, V22, P219, DOI 10.1016/j.pt.2006.02.014; ROCKETT KA, 1991, INFECT IMMUN, V59, P3280, DOI 10.1128/IAI.59.9.3280-3283.1991; Rodrigues J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-33; Schwartz A, 2002, J MED ENTOMOL, V39, P84, DOI 10.1603/0022-2585-39.1.84; Sharma A, 2004, J BIOCHEM, V136, P329, DOI 10.1093/jb/mvh128; Sharma A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-71; Sharma VP, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P349; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; SUBBARAO SK, 1988, MED VET ENTOMOL, V2, P219, DOI 10.1111/j.1365-2915.1988.tb00186.x; SUBBARAO SK, 1988, T ROY SOC TROP MED H, V82, P394, DOI 10.1016/0035-9203(88)90132-0; SUBBARAO SK, 1988, J AM MOSQUITO CONTR, V4, P29; SUBBARAO SK, 1998, TECHNICAL PUBLICATIO, V18; VERNICK KD, 1995, EXP PARASITOL, V80, P583, DOI 10.1006/expr.1995.1074; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	62	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18400	10.1371/journal.pone.0018400	http://dx.doi.org/10.1371/journal.pone.0018400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483693	gold, Green Published, Green Submitted			2022-12-27	WOS:000289058700024
J	Wuolikainen, A; Moritz, T; Marklund, SL; Antti, H; Andersen, PM				Wuolikainen, Anna; Moritz, Thomas; Marklund, Stefan L.; Antti, Henrik; Andersen, Peter Munch			Disease-Related Changes in the Cerebrospinal Fluid Metabolome in Amyotrophic Lateral Sclerosis Detected by GC/TOFMS	PLOS ONE			English	Article							MOTOR-NEURON DISEASE; MUTATIONS; ALS; PLS; PHENOTYPES; PLASMA; TDP-43; BLOOD; RISK	Background/Aim: The changes in the cerebrospinal fluid (CSF) metabolome associated with the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS) are poorly understood and earlier smaller studies have shown conflicting results. The metabolomic methodology is suitable for screening large cohorts of samples. Global metabolomics can be used for detecting changes of metabolite concentrations in samples of fluids such as CSF. Methodology: Using gas chromatography coupled to mass spectrometry (GC/TOFMS) and multivariate statistical modeling, we simultaneously studied the metabolome signature of similar to 120 small metabolites in the CSF of patients with ALS, stratified according to hereditary disposition and clinical subtypes of ALS in relation to controls. Principal Findings: The study is the first to report data validated over two sub-sets of ALS vs. control patients for a large set of metabolites analyzed by GC/TOFMS. We find that patients with sporadic amyotrophic lateral sclerosis (SALS) have a heterogeneous metabolite signature in the cerebrospinal fluid, in some patients being almost identical to controls. However, familial amyotrophic lateral sclerosis (FALS) without superoxide dismutase-1 gene (SOD1) mutation is less heterogeneous than SALS. The metabolome of the cerebrospinal fluid of 17 ALS patients with a SOD1 gene mutation was found to form a separate homogeneous group. Analysis of metabolites revealed that glutamate and glutamine were reduced, in particular in patients with a familial predisposition. There are significant differences in the metabolite profile and composition among patients with FALS, SALS and patients carrying a mutation in the SOD1 gene suggesting that the neurodegenerative process in different subtypes of ALS may be partially dissimilar. Conclusions/Significance: Patients with a genetic predisposition to amyotrophic lateral sclerosis have a more distinct and homogeneous signature than patients with a sporadic disease.	[Wuolikainen, Anna; Andersen, Peter Munch] Umea Univ, Inst Pharmacol & Clin Neurosci, Umea, Sweden; [Wuolikainen, Anna; Antti, Henrik] Umea Univ, Dept Chem, Umea, Sweden; [Moritz, Thomas] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Marklund, Stefan L.] Umea Univ, Dept Med Biosci, Umea, Sweden	Umea University; Umea University; Swedish University of Agricultural Sciences; Umea University; Umea University	Wuolikainen, A (corresponding author), Umea Univ, Inst Pharmacol & Clin Neurosci, Umea, Sweden.	Peter.Andersen@neuro.umu.se		Wuolikainen, Anna/0000-0003-0838-5526	Swedish Research Council; Swedish Brain Power Consortium; Hallstens Research Foundation; Swedish Brain Foundation; Swedish Medical Society; Ulla-Carin Lindquist Foundation for ALS Research; Kempe Foundation; Swedish Association for Persons with Neurological Disabilities	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Power Consortium; Hallstens Research Foundation; Swedish Brain Foundation; Swedish Medical Society; Ulla-Carin Lindquist Foundation for ALS Research; Kempe Foundation; Swedish Association for Persons with Neurological Disabilities	This work was supported by the Swedish Research Council; the Swedish Brain Power Consortium; the Hallstens Research Foundation; the Swedish Brain Foundation; the Swedish Medical Society; the Ulla-Carin Lindquist Foundation for ALS Research; the Kempe Foundation and the Swedish Association for Persons with Neurological Disabilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2002, J NEUROL NEUROSUR PS, V73, P199, DOI 10.1136/jnnp.73.2.199; Andersen PM, 2005, EUR J NEUROL, V12, P921, DOI 10.1111/j.1468-1331.2005.01351.x; Blasco H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013223; Brouns R, 2010, NEUROCHEM INT, V56, P865, DOI 10.1016/j.neuint.2009.12.014; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; FELBECKER A, 2001, J NEUROL NEUROSUR PS, V81, P572; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Gros-Louis F, 2009, P NATL ACAD SCI USA, V106, P21777, DOI 10.1073/pnas.0902174106; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Ihara Y, 2005, NEUROL RES, V27, P105, DOI 10.1179/016164105X18430; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; LI TM, 1988, J NEUROL NEUROSUR PS, V51, P778, DOI 10.1136/jnnp.51.6.778; Maekawa S, 2009, NEUROPATHOLOGY, V29, P672, DOI 10.1111/j.1440-1789.2009.01029.x; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Paraskevas GP, 1997, ACTA NEUROL SCAND, V96, P88; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; PERRY TL, 1990, ANN NEUROL, V28, P12, DOI 10.1002/ana.410280105; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; Rozen S, 2005, METABOLOMICS, V1, P101, DOI 10.1007/s11306-005-4810-1; Schymick JC, 2007, J NEUROL NEUROSUR PS, V78, P754, DOI 10.1136/jnnp.2006.109553; Spreux-Varoquaux O, 2002, J NEUROL SCI, V193, P73, DOI 10.1016/S0022-510X(01)00661-X; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Tachikawa M, 2008, J NEUROCHEM, V107, P432, DOI 10.1111/j.1471-4159.2008.05641.x; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Wilson ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015133; Wuolikainen A, 2009, AMYOTROPH LATERAL SC, V10, P229, DOI 10.1080/17482960902871009; Zetterberg H, 2007, EUR J NEUROL, V14, P1329, DOI 10.1111/j.1468-1331.2007.01972.x; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zhou JY, 2010, J PROTEOME RES, V9, P5133, DOI 10.1021/pr100409r; Zoccolella S, 2008, NEUROLOGY, V70, P222, DOI 10.1212/01.wnl.0000297193.53986.6f	34	65	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e17947	10.1371/journal.pone.0017947	http://dx.doi.org/10.1371/journal.pone.0017947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483737	Green Submitted, Green Published, gold			2022-12-27	WOS:000289058700005
J	Ohsugi, T; Kumasaka, T				Ohsugi, Takeo; Kumasaka, Toshio			Low CD4/CD8 T-Cell Ratio Associated with Inflammatory Arthropathy in Human T-Cell Leukemia Virus Type I Tax Transgenic Mice	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; RESEMBLING RHEUMATOID-ARTHRITIS; HTLV-I; MOLECULAR-MECHANISMS; ADOPTIVE TRANSFER; PERIPHERAL-BLOOD; INDUCTION; EXPRESSION; GENE; TRANSFORMATION	Background: Human T-cell leukemia virus type I (HTLV-1) can cause an aggressive malignancy known as adult T-cell leukemia/lymphoma (ATL) as well as inflammatory diseases such as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). A transgenic mouse that expresses HTLV-1 Tax also develops T-cell leukemia/lymphoma and an inflammatory arthropathy that resembles rheumatoid arthritis. The aim of this study was to identify the primary T-cell subsets involved in the development of arthropathy in Tax transgenic mice. Principal Findings: By 24 months of age, Tax transgenic mice developed severe arthropathy with a cumulative incidence of 22.8%. The pathological findings of arthropathy in Tax transgenic mice were similar to those seen in human rheumatoid arthritis or mouse models of rheumatoid arthritis, with synovial proliferation and a positive rheumatoid factor. Before the onset of spontaneous arthropathy, young and old Tax transgenic mice were not sensitive to collagen and did not develop arthritis after immunization with type II collagen. The arthropathic Tax transgenic mice showed a significantly decreased proportion of splenic CD4(+) T cells, whereas the proportion of splenic CD8(+) T cells was increased. Regulatory T cells (CD4(+)CD25(+)Foxp3(+)) were significantly decreased and CD8(+) T cells that expressed the chemokine receptor CCR4 (CD8(+)CCR4(+)) were significantly increased in arthropathic Tax transgenic mice. The expression of tax mRNA was strong in the spleen and joints of arthropathic mice, with a 40-fold increase compared with healthy transgenic mice. Conclusions: Our findings reveal that Tax transgenic mice develop rheumatoid-like arthritis with proliferating synovial cells in the joints; however, the proportion of different splenic T-cell subsets in these mice was completely different from other commonly used animal models of rheumatoid arthritis. The crucial T-cell subsets in arthropathic Tax transgenic mice appear to resemble those in HAM/TSP patients rather than those in rheumatoid arthritis patients.	[Ohsugi, Takeo] Kumamoto Univ, Div Microbiol & Genet, Ctr Anim Resources & Dev, Inst Resource Dev & Anal, Kumamoto, Japan; [Kumasaka, Toshio] Japanese Red Cross Med Ctr, Dept Pathol, Tokyo, Japan	Kumamoto University; Japanese Red Cross Medical Center; University of Tokyo	Ohsugi, T (corresponding author), Kumamoto Univ, Div Microbiol & Genet, Ctr Anim Resources & Dev, Inst Resource Dev & Anal, Kumamoto, Japan.	ohsugi@gpo.kumamoto-u.ac.jp			Japan Society for the Promotion of Science [21500390]; Japan Leukaemia Research Fund; Kumamoto University's Centers of Excellence (COE)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Leukaemia Research Fund; Kumamoto University's Centers of Excellence (COE)	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grant number 21500390), the Japan Leukaemia Research Fund (http://www.flrf.gr.jp), and Kumamoto University's Centers of Excellence (COE) Programs (http://sendou.kuma-u.jp/en/research/research1.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashino T, 2007, EUR J PHARMACOL, V558, P199, DOI 10.1016/j.ejphar.2006.11.072; Benito MJ, 2004, ARTHRITIS RHEUM-US, V50, P1781, DOI 10.1002/art.20260; Cao D, 2006, SCAND J IMMUNOL, V63, P444, DOI 10.1111/j.1365-3083.2006.001755.x; CHIOCCHIA G, 1993, CLIN EXP RHEUMATOL, V11, pS15; de Kleer IM, 2004, J IMMUNOL, V172, P6435, DOI 10.4049/jimmunol.172.10.6435; Doncarli A, 1999, EUR J IMMUNOL, V29, P3636; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fujimoto M, 2008, ARTHRITIS RHEUM-US, V58, P3710, DOI 10.1002/art.24126; Furukawa Y, 2003, JAIDS-J ACQ IMM DEF, V32, P328, DOI 10.1097/00126334-200303010-00013; Gonzalez-Rey E, 2007, ARTHRITIS RHEUM-US, V56, P531, DOI 10.1002/art.22394; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Habu K, 1999, J IMMUNOL, V162, P2956; Han ZN, 1998, AUTOIMMUNITY, V28, P197, DOI 10.3109/08916939808995367; Hasegawa H, 2006, NAT MED, V12, P466, DOI 10.1038/nm1389; Inaoki M, 2003, J CLIN IMMUNOL, V23, P269, DOI 10.1023/A:1024584732614; IWAKURA Y, 1991, SCIENCE, V253, P1026, DOI 10.1126/science.1887217; IWAKURA Y, 1995, J IMMUNOL, V155, P1588; Iwakura Y, 1998, J IMMUNOL, V161, P6592; Kelchtermans H, 2009, ANN RHEUM DIS, V68, P744, DOI 10.1136/ard.2007.086066; Kondo T, 2009, INT IMMUNOL, V21, P523, DOI 10.1093/intimm/dxp019; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kotani M, 1999, EUR J IMMUNOL, V29, P54, DOI 10.1002/(SICI)1521-4141(199901)29:01<54::AID-IMMU54>3.0.CO;2-M; Lairmore MD, 2005, ONCOGENE, V24, P6005, DOI 10.1038/sj.onc.1208974; Lawson CA, 2006, RHEUMATOLOGY, V45, P1210, DOI 10.1093/rheumatology/kel089; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; LESLIE CA, 1985, J EXP MED, V162, P1336, DOI 10.1084/jem.162.4.1336; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Luross JA, 2001, IMMUNOLOGY, V103, P407, DOI 10.1046/j.1365-2567.2001.01267.x; MarinovaMutafchieva L, 1997, CLIN EXP IMMUNOL, V107, P507, DOI 10.1046/j.1365-2249.1997.2901181.x; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Mauri C, 1996, EUR J IMMUNOL, V26, P1511, DOI 10.1002/eji.1830260716; Morgan ME, 2005, ARTHRITIS RHEUM-US, V52, P2212, DOI 10.1002/art.21195; Mottonen M, 2005, CLIN EXP IMMUNOL, V140, P360, DOI 10.1111/j.1365-2249.2005.02754.x; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nguyen LT, 2007, ARTHRITIS RHEUM-US, V56, P509, DOI 10.1002/art.22272; Ohata J, 2007, ARTHRITIS RHEUM, V56, P2947, DOI 10.1002/art.22846; Ohsugi T, 2006, LEUKEMIA RES, V30, P90, DOI 10.1016/j.leukres.2005.06.001; Ohsugi Takeo, 1993, Kurume Medical Journal, V40, P89, DOI 10.2739/kurumemedj.40.89; Ohsugi T, 2007, NAT MED, V13, P527, DOI 10.1038/nm0507-527; Okamoto H, 1997, ARTHRITIS RHEUM, V40, P1096, DOI 10.1002/art.1780400614; OTSUKA A, 2010, J EUR ACAD IN PRESS; Ruprecht CR, 2005, J EXP MED, V201, P1793, DOI 10.1084/jem.20050085; Saggioro D, 1997, J ACQ IMMUN DEF SYND, V14, P272, DOI 10.1097/00042560-199703010-00012; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; SAKURAI M, 1992, INT J CANCER, V52, P323, DOI 10.1002/ijc.2910520228; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; SEKI N, 1988, J IMMUNOL, V140, P1477; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; Tartar DM, 2010, J IMMUNOL, V184, P3377, DOI 10.4049/jimmunol.0903324; TAYLOR PC, 1995, EUR J IMMUNOL, V25, P763, DOI 10.1002/eji.1830250321; TENDLER CL, 1991, J CELL BIOCHEM, V46, P302, DOI 10.1002/jcb.240460405; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; Watanabe T, 1997, INT J HEMATOL, V66, P257; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; WILDIN RS, 1995, J IMMUNOL, V155, P1286; WILLIAMS RO, 1994, P NATL ACAD SCI USA, V91, P2762, DOI 10.1073/pnas.91.7.2762; WOOLEY PH, 1981, J EXP MED, V154, P688, DOI 10.1084/jem.154.3.688; Yamano Y, 2005, J CLIN INVEST, V115, P1361, DOI [10.1172/JCI200523913, 10.1172/JCI23913]; Yamano Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006517; Yang YH, 2004, ARTHRITIS RHEUM-US, V50, P976, DOI 10.1002/art.20201; Yoshino S, 1998, BRIT J PHARMACOL, V123, P237, DOI 10.1038/sj.bjp.0701607; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	64	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18518	10.1371/journal.pone.0018518	http://dx.doi.org/10.1371/journal.pone.0018518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483764	Green Submitted, gold, Green Published			2022-12-27	WOS:000289058300018
J	Yang, XH; Gong, Y; Friesel, R				Yang, Xuehui; Gong, Yan; Friesel, Robert			Spry1 Is Expressed in Hemangioblasts and Negatively Regulates Primitive Hematopoiesis and Endothelial Cell Function	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; AORTIC ENDOTHELIUM; SPROUTY PROTEINS; GENE-EXPRESSION; TRANSGENIC MICE; MOUSE EMBRYO; IN-VIVO; LINEAGE; VEGF; FGF	Background: Development of the hematopoietic and endothelial lineages derives from a common mesodermal precursor, the Flk1(+) hemangioblast. However, the signaling pathways that regulate the development of hematopoietic and endothelial cells from this common progenitor cell remains incompletely understood. Using mouse models with a conditional Spry1 transgene, and a Spry1 knockout mouse, we investigated the role of Spry1 in the development of the endothelial and hematopoietic lineages during development. Methodology/Principal Findings: Quantitative RT-PCR analysis demonstrates that Spry1, Spry2, and Spry4 are expressed in Flk1(+) hemangioblasts in vivo, and decline significantly in c-Kit(+) and CD41(+) hematopoietic progenitors, while expression is maintained in developing endothelial cells. Tie2-Cre-mediated over-expression of Spry1 results in embryonic lethality. At E9.5 Spry1;Tie2-Cre embryos show near normal endothelial cell development and vessel patterning but have reduced hematopoiesis. FACS analysis shows a reduction of primitive hematopoietic progenitors and erythroblastic cells in Spry1; Tie2-Cre embryos compared to controls. Colony forming assays confirm the hematopoietic defects in Spry1; Tie2-Cre transgenic embryos. Immunostaining shows a significant reduction of CD41 or CD71 and dpERK co-stained cells in Spry1; Tie2-Cre embryos compared to controls, whereas the number of VEC(+) and dpERK co-stained cells is comparable. Compared to controls, Spry1; Tie2-Cre embryos also show a decrease in proliferation and an increase in apoptosis. Furthermore, loss of Spry1 results in an increase of CD41(+) and CD71(+) cells at E9.5 compared with controls. Conclusions/Significance: These data indicate that primitive hematopoietic cells derive from Tie2-expressing hemangioblasts and that Spry1 over expression inhibits primitive hematopoietic progenitor and erythroblastic cell development and expansion while having no obvious effect on endothelial cell development.	[Yang, Xuehui; Gong, Yan; Friesel, Robert] Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA	Maine Medical Center	Yang, XH (corresponding author), Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA.	friesr@mmc.org		Gong, Yan/0000-0002-4805-0459	NIH [R01 HL65301, P20 RR15555]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018789, P20RR015555, P30RR030927] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065301] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants R01 HL65301 and P20 RR15555 to RF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Eckfeldt CE, 2005, PLOS BIOL, V3, P1449, DOI 10.1371/journal.pbio.0030254; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; Eichmann A, 1997, P NATL ACAD SCI USA, V94, P5141, DOI 10.1073/pnas.94.10.5141; Ema M, 2006, BLOOD, V108, P4018, DOI 10.1182/blood-2006-03-012872; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fraser ST, 2002, EXP HEMATOL, V30, P1070, DOI 10.1016/S0301-472X(02)00887-1; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hanafusa H, 2009, NAT CELL BIOL, V11, P106, DOI 10.1038/ncb1820; He C, 2008, DEVELOPMENT, V135, P2467, DOI 10.1242/dev.020131; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kramer S, 1999, DEVELOPMENT, V126, P2515; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lee SJ, 2010, MOL CELL BIOCHEM, V338, P255, DOI 10.1007/s11010-009-0359-z; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Lugus JJ, 2009, BLOOD, V113, P563, DOI 10.1182/blood-2008-06-162750; Magnusson PU, 2005, ARTERIOSCL THROM VAS, V25, P944, DOI 10.1161/01.ATV.0000163182.73190.f9; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Nakazawa F, 2006, BLOOD, V108, P3335, DOI 10.1182/blood-2006-05-021386; Okamoto R, 2005, BLOOD, V105, P2757, DOI 10.1182/blood-2004-08-3317; Pearson S, 2008, DEVELOPMENT, V135, P1525, DOI 10.1242/dev.011767; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Schuh AC, 1999, P NATL ACAD SCI USA, V96, P2159, DOI 10.1073/pnas.96.5.2159; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHIGEMATSU A, 2010, STEM CELLS DEV; Tang YF, 2010, GENESIS, V48, P563, DOI 10.1002/dvg.20654; Taniguchi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005467; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yang XH, 2008, DEV BIOL, V321, P64, DOI 10.1016/j.ydbio.2008.05.555; Yokota T, 2009, BLOOD, V113, P2914, DOI 10.1182/blood-2008-07-167106; Zhang Y, 2007, BLOOD, V110, P116, DOI 10.1182/blood-2006-11-060707; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	44	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18374	10.1371/journal.pone.0018374	http://dx.doi.org/10.1371/journal.pone.0018374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483770	Green Published, gold, Green Submitted			2022-12-27	WOS:000289058300015
J	Immecke, SN; Baal, N; Wilhelm, J; Bechtel, J; Knoche, A; Bein, G; Hackstein, H				Immecke, Sabrina N.; Baal, Nelli; Wilhelm, Jochen; Bechtel, Juliane; Knoche, Angela; Bein, Gregor; Hackstein, Holger			The Cyclophilin-Binding Agent Sanglifehrin A Is a Dendritic Cell Chemokine and Migration Inhibitor	PLOS ONE			English	Article							STREPTOMYCES SP A92-308110; IN-VIVO; TOLERANCE; INDUCTION; CD38; TRANSPLANTATION; EXPRESSION; RECEPTORS; MECHANISM; COMPOUND	Sanglifehrin A (SFA) is a cyclophilin-binding immunosuppressant but the immunobiology of action is poorly understood. We and others have reported that SFA inhibits IL-12 production and antigen uptake in dendritic cells (DC) and exhibits lower activity against lymphocytes. Here we show that SFA suppresses DC chemokine production and migration. Gene expression analysis and subsequent protein level confirmation revealed that SFA suppressed CCL5, CCL17, CCL19, CXCL9 and CXCL10 expression in human monocyte-derived DC (moDC). A systems biology analysis, Onto Express, confirmed that SFA interferes with chemokine-chemokine receptor gene expression with the highest impact. Direct comparison with the related agent cyclosporine A (CsA) and dexamethasone indicated that SFA uniquely suppresses moDC chemokine expression. Competitive experiments with a 100-fold molar excess of CsA and with N-Methyl-Val-4-cyclosporin, representing a nonimmunosuppressive derivative of CsA indicated chemokine suppression through a cyclophilin-A independent pathway. Functional assays confirmed reduced migration of CD4+ Tcells and moDCs to supernatant of SFA-exposed moDCs. Vice versa, SFA-exposed moDC exhibited reduced migration against CCL19. Moreover, SFA suppressed expression of the ectoenzyme CD38 that was reported to regulate DC migration and cytokine production. These results identify SFA as a DC chemokine and migration inhibitor and provide novel insight into the immunobiology of SFA.	[Immecke, Sabrina N.; Baal, Nelli; Bechtel, Juliane; Knoche, Angela; Bein, Gregor; Hackstein, Holger] Univ Giessen, Inst Clin Immunol & Transfus Med, D-6300 Giessen, Germany; [Wilhelm, Jochen] Univ Giessen, Dept Pathol, D-6300 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Immecke, SN (corresponding author), Univ Giessen, Inst Clin Immunol & Transfus Med, Langhansstr 7, D-6300 Giessen, Germany.	Holger.Hackstein@immunologie.med.uni-giessen.de	Wilhelm, Jochen/AAX-4302-2021	Wilhelm, Jochen/0000-0001-5544-9647	Excellence Center Cardiopulmonary System (ECCPS, DFG, German Research Foundation); University of Giessen and Marburg Lung Center (UGMLC); Current Collaborative Research Centre, DFG Transregio [84, B3]	Excellence Center Cardiopulmonary System (ECCPS, DFG, German Research Foundation)(German Research Foundation (DFG)); University of Giessen and Marburg Lung Center (UGMLC); Current Collaborative Research Centre, DFG Transregio(German Research Foundation (DFG))	The study was supported by the Excellence Center Cardiopulmonary System (ECCPS, DFG, German Research Foundation), the University of Giessen and Marburg Lung Center (UGMLC) and the Current Collaborative Research Centre, DFG Transregio 84 (Project B3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A, 2004, J IMMUNOL, V172, P4797, DOI 10.4049/jimmunol.172.8.4797; Banchereau J, 2009, ANN NY ACAD SCI, V1174, P24, DOI 10.1111/j.1749-6632.2009.04999.x; Belperio JA, 2008, CIRC RES, V103, P454, DOI 10.1161/CIRCRESAHA.108.182865; Colvin BL, 2002, TRANSPLANTATION, V74, P149, DOI 10.1097/00007890-200207270-00001; Colvin BL, 2008, CLIN LAB MED, V28, P375, DOI 10.1016/j.cll.2008.07.003; Fedele G, 2004, EUR J IMMUNOL, V34, P1342, DOI 10.1002/eji.200324728; Fehr T, 1999, J ANTIBIOT, V52, P474, DOI 10.7164/antibiotics.52.474; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Frasca L, 2006, BLOOD, V107, P2392, DOI 10.1182/blood-2005-07-2913; Hackstein H, 2004, NAT REV IMMUNOL, V4, P24, DOI 10.1038/nri1256; Hackstein H, 2007, AM J TRANSPLANT, V7, P789, DOI 10.1111/j.1600-6143.2006.01729.x; Hackstein H, 2003, BLOOD, V101, P4457, DOI 10.1182/blood-2002-11-3370; Hackstein H, 2002, BLOOD, V100, P1084, DOI 10.1182/blood.V100.3.1084; Hornick P, 2006, METH MOL B, V333, P131; Kallen J, 2005, J BIOL CHEM, V280, P21965, DOI 10.1074/jbc.M501623200; Khatri P, 2005, NUCLEIC ACIDS RES, V33, pW762, DOI 10.1093/nar/gki472; Ko H, 2008, TRANSPL IMMUNOL, V20, P99, DOI 10.1016/j.trim.2008.07.001; Lukacs-Kornek V, 2008, FRONT BIOSCI-LANDMRK, V13, P2238, DOI 10.2741/2838; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Partida-Sanchez S, 2004, IMMUNITY, V20, P279, DOI 10.1016/S1074-7613(04)00048-2; Pemberton TJ, 2003, FEBS LETT, V555, P335, DOI 10.1016/S0014-5793(03)01270-5; Powell JD, 2006, CURR OPIN INVESTIG D, V7, P1002; RAIMONDI G, 2009, J IMMUNOL; Raimondi Giorgio, 2007, Methods Mol Biol, V380, P1; Sanglier JJ, 1999, J ANTIBIOT, V52, P466, DOI 10.7164/antibiotics.52.466; Scandella E, 2004, BLOOD, V103, P1595, DOI 10.1182/blood-2003-05-1643; Sedrani R, 2003, J AM CHEM SOC, V125, P3849, DOI 10.1021/ja021327y; Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinschulte C, 2003, J IMMUNOL, V171, P542, DOI 10.4049/jimmunol.171.2.542; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Turnquist HR, 2010, METHODS MOL BIOL, V595, P135, DOI 10.1007/978-1-60761-421-0_8; Woltman AM, 2004, J IMMUNOL, V172, P6482, DOI 10.4049/jimmunol.172.10.6482; Zenke G, 2001, J IMMUNOL, V166, P7165, DOI 10.4049/jimmunol.166.12.7165	37	8	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18406	10.1371/journal.pone.0018406	http://dx.doi.org/10.1371/journal.pone.0018406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483789	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200071
J	Mansiaux, Y; Joseph, AP; Gelly, JC; de Brevern, AG				Mansiaux, Yohann; Joseph, Agnel Praveen; Gelly, Jean-Christophe; de Brevern, Alexandre G.			Assignment of PolyProline II Conformation and Analysis of Sequence - Structure Relationship	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; BETA-SHEET; HOMOLOGOUS PROTEINS; MOLECULAR-DYNAMICS; GLOBULAR-PROTEINS; AMINO-ACIDS; SH3 DOMAINS; HELIX; ALPHABET; PROLINE	Background: Secondary structures are elements of great importance in structural biology, biochemistry and bioinformatics. They are broadly composed of two repetitive structures namely alpha-helices and beta-sheets, apart from turns, and the rest is associated to coil. These repetitive secondary structures have specific and conserved biophysical and geometric properties. PolyProline II (PPII) helix is yet another interesting repetitive structure which is less frequent and not usually associated with stabilizing interactions. Recent studies have shown that PPII frequency is higher than expected, and they could have an important role in protein - protein interactions. Methodology/Principal Findings: A major factor that limits the study of PPII is that its assignment cannot be carried out with the most commonly used secondary structure assignment methods (SSAMs). The purpose of this work is to propose a PPII assignment methodology that can be defined in the frame of DSSP secondary structure assignment. Considering the ambiguity in PPII assignments by different methods, a consensus assignment strategy was utilized. To define the most consensual rule of PPII assignment, three SSAMs that can assign PPII, were compared and analyzed. The assignment rule was defined to have a maximum coverage of all assignments made by these SSAMs. Not many constraints were added to the assignment and only PPII helices of at least 2 residues length are defined. Conclusions/Significance: The simple rules designed in this study for characterizing PPII conformation, lead to the assignment of 5% of all amino as PPII. Sequence - structure relationships associated with PPII, defined by the different SSAMs, underline few striking differences. A specific study of amino acid preferences in their N and C-cap regions was carried out as their solvent accessibility and contact patterns. Thus the assignment of PPII can be coupled with DSSP and thus opens a simple way for further analysis in this field.	[Mansiaux, Yohann; Joseph, Agnel Praveen; Gelly, Jean-Christophe; de Brevern, Alexandre G.] INSERM, UMR S 665, Paris, France; [Mansiaux, Yohann; Joseph, Agnel Praveen; Gelly, Jean-Christophe; de Brevern, Alexandre G.] Univ Paris 07, Paris, France; [Mansiaux, Yohann; Joseph, Agnel Praveen; Gelly, Jean-Christophe; de Brevern, Alexandre G.] INTS, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mansiaux, Y (corresponding author), INSERM, UMR S 665, Paris, France.	alexandre.debrevern@univ-paris-diderot.fr	de Brevern, Alexandre G./B-4788-2009; Gelly, Jean-Christophe/A-9321-2010	de Brevern, Alexandre G./0000-0001-7112-5626; Gelly, Jean-Christophe/0000-0001-5138-361X	Ministere de la Recherche, Universite Paris Diderot - Paris; National Institute for Blood Transfusion (INTS); Institute for Health and Medical Research (INSERM); CEFIPRA [3903-E]	Ministere de la Recherche, Universite Paris Diderot - Paris(Ministry of Research, France); National Institute for Blood Transfusion (INTS); Institute for Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); CEFIPRA	This work was supported by grants from the Ministere de la Recherche, Universite Paris Diderot - Paris 7, National Institute for Blood Transfusion (INTS) and the Institute for Health and Medical Research (INSERM). APJ has a grant from CEFIPRA number 3903-E. AdB acknowledges CEFIPRA for collaborative grant (number 3903-E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADZHUBEI AA, 1994, PROTEIN SCI, V3, P2395, DOI 10.1002/pro.5560031223; ADZHUBEI AA, 1993, J MOL BIOL, V229, P472, DOI 10.1006/jmbi.1993.1047; ARNOTT S, 1968, ACTA CRYSTALL B-STRU, VB 24, P599, DOI 10.1107/S056774086800289X; Avbelj F, 2009, P NATL ACAD SCI USA, V106, P3137, DOI 10.1073/pnas.0813018106; Banks GB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000958; Bansal M, 2000, J BIOMOL STRUCT DYN, V17, P811, DOI 10.1080/07391102.2000.10506570; Beck DAC, 2008, P NATL ACAD SCI USA, V105, P12259, DOI 10.1073/pnas.0706527105; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berisio R, 2006, PROTEIN PEPTIDE LETT, V13, P847, DOI 10.2174/092986606777841154; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Blanch EW, 2000, J MOL BIOL, V301, P553, DOI 10.1006/jmbi.2000.3981; Bornot A, 2006, BIOINFORMATION, V1, P153, DOI 10.6026/97320630001153; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; Chellgren BW, 2006, J MOL BIOL, V361, P362, DOI 10.1016/j.jmb.2006.06.044; Chellgren BW, 2004, BIOCHEMISTRY-US, V43, P5864, DOI 10.1021/bi049922v; Chen K, 2005, J AM CHEM SOC, V127, P10146, DOI 10.1021/ja052094o; COLLOCH N, 1993, PROTEIN ENG, V6, P377, DOI 10.1093/protein/6.4.377; COWAN PM, 1955, NATURE, V176, P1062, DOI 10.1038/1761062a0; Creamer TP, 2002, ADV PROTEIN CHEM, V62, P263; Creamer TP, 1998, PROTEINS, V33, P218, DOI 10.1002/(SICI)1097-0134(19981101)33:2<218::AID-PROT6>3.0.CO;2-E; Cubellis MV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S8; Cubellis MV, 2005, PROTEINS, V58, P880, DOI 10.1002/prot.20327; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; de Brevern AG, 2003, BIOINFORMATICS, V19, P345, DOI 10.1093/bioinformatics/btf859; de Brevern AG, 2002, PROTEIN SCI, V11, P2871, DOI 10.1110/ps.0220502; de Brevern Alexandre G., 2005, In Silico Biology, V5, P283; de Brevern Alexandre G, 2004, In Silico Biol, V4, P381; DEBREVERN AG, 2011, J THEOR BIO IN PRESS; Dudev M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-106; Eisenberg D, 2003, P NATL ACAD SCI USA, V100, P11207, DOI 10.1073/pnas.2034522100; Eker F, 2004, BIOCHEMISTRY-US, V43, P6893, DOI 10.1021/bi049542+; ESQUE J, 2011, J CHEM INF MODEL; Etchebest C, 2005, PROTEINS, V59, P810, DOI 10.1002/prot.20458; Faure G, 2008, BIOCHIMIE, V90, P626, DOI 10.1016/j.biochi.2007.11.007; Faure G, 2009, BIOCHIMIE, V91, P876, DOI 10.1016/j.biochi.2009.04.008; Fitzkee NC, 2005, TRENDS BIOCHEM SCI, V30, P73, DOI 10.1016/j.tibs.2004.12.005; Fourrier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-58; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hicks JM, 2004, PROTEINS, V55, P330, DOI 10.1002/prot.10630; Hollingsworth SA, 2009, PROTEIN SCI, V18, P1321, DOI 10.1002/pro.133; Horng JC, 2006, PROTEIN SCI, V15, P74, DOI 10.1110/ps.051779806; Jha AK, 2005, BIOCHEMISTRY-US, V44, P9691, DOI 10.1021/bi0474822; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Joseph A.P., 2010, PROTEIN STRUCTURE PR, P75; Joseph Agnel Praveen, 2010, Biophys Rev, V2, P137, DOI 10.1007/s12551-010-0036-1; Jun S, 2006, BIOCHEMISTRY-US, V45, P11666, DOI 10.1021/bi061195b; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kameda T, 2006, P NATL ACAD SCI USA, V103, P17765, DOI 10.1073/pnas.0602632103; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kelly MA, 2001, BIOCHEMISTRY-US, V40, P14376, DOI 10.1021/bi011043a; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Kentsis A, 2004, PROTEINS, V55, P493, DOI 10.1002/prot.20051; King SM, 1999, PROTEINS, V35, P313, DOI 10.1002/(SICI)1097-0134(19990515)35:3<313::AID-PROT5>3.3.CO;2-T; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kuemin M, 2009, J AM CHEM SOC, V131, P15474, DOI 10.1021/ja906466q; Kutter S, 2009, J BIOL CHEM, V284, P12136, DOI 10.1074/jbc.M806228200; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Liu ZG, 2004, J AM CHEM SOC, V126, P15141, DOI 10.1021/ja047594g; Makowska J, 2006, P NATL ACAD SCI USA, V103, P1744, DOI 10.1073/pnas.0510549103; Martin J, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-17; Martin J, 2008, PROTEINS, V71, P92, DOI 10.1002/prot.21659; Mezei M, 2004, PROTEINS, V55, P502, DOI 10.1002/prot.20050; Obuchowski PL, 2008, J BACTERIOL, V190, P1718, DOI 10.1128/JB.01706-07; Offmann B, 2007, CURR BIOINFORM, V2, P165, DOI 10.2174/157489307781662105; Pappu RV, 2002, PROTEIN SCI, V11, P2437, DOI 10.1110/ps.0217402; PAULING L, 1950, J AM CHEM SOC, V72, P5349, DOI 10.1021/ja01167a545; PAULING L, 1951, P NATL ACAD SCI USA, V37, P251, DOI 10.1073/pnas.37.5.251; PAULING L, 1951, P NATL ACAD SCI USA, V37, P272, DOI 10.1073/pnas.37.5.272; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; Perskie LL, 2010, PROTEIN SCI, V19, P1127, DOI 10.1002/pro.399; Peterson FC, 2009, FRONT BIOSCI-LANDMRK, V14, P833, DOI 10.2741/3281; Polverini E, 2008, BIOCHEMISTRY-US, V47, P267, DOI 10.1021/bi701336n; Porter LL, 2011, P NATL ACAD SCI USA, V108, P109, DOI 10.1073/pnas.1014674107; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rath A, 2005, BIOPOLYMERS, V80, P179, DOI 10.1002/bip.20227; RICHARDS FM, 1988, PROTEINS, V3, P71, DOI 10.1002/prot.340030202; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; ROSE GD, 1978, NATURE, V272, P586, DOI 10.1038/272586a0; SASISEKHARAN V, 1959, ACTA CRYSTALLOGR, V12, P897, DOI 10.1107/S0365110X59002535; Shi ZS, 2006, CHEM REV, V106, P1877, DOI 10.1021/cr040433a; Shi ZS, 2011, P NATL ACAD SCI USA, V108, P3, DOI 10.1073/pnas.1017021108; Shi ZS, 2005, P NATL ACAD SCI USA, V102, P17964, DOI 10.1073/pnas.0507124102; Shi ZS, 2002, P NATL ACAD SCI USA, V99, P9190, DOI 10.1073/pnas.112193999; Shi ZS, 2002, ADV PROTEIN CHEM, V62, P163; Sreerama N, 1999, PROTEINS, V36, P400, DOI 10.1002/(SICI)1097-0134(19990901)36:4<400::AID-PROT3>3.0.CO;2-B; Srinivasan R, 1999, P NATL ACAD SCI USA, V96, P14258, DOI 10.1073/pnas.96.25.14258; Stapley BJ, 1999, PROTEIN SCI, V8, P587; SWINDELLS MB, 1995, NAT STRUCT BIOL, V2, P596, DOI 10.1038/nsb0795-596; Thompson EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010056; TIFFANY ML, 1968, BIOPOLYMERS, V6, P1379, DOI 10.1002/bip.1968.360060911; Tyagi M, 2008, PROTEINS, V71, P920, DOI 10.1002/prot.21776; Tyagi M, 2006, NUCLEIC ACIDS RES, V34, pW119, DOI 10.1093/nar/gkl199; Tyagi M, 2006, PROTEINS, V65, P32, DOI 10.1002/prot.21087; Tyagi M, 2009, PROTEIN SCI, V18, P1869, DOI 10.1002/pro.198; Tyagi M, 2009, COMPUT BIOL CHEM, V33, P329, DOI 10.1016/j.compbiolchem.2009.06.002; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VENKATACHALAM CM, 1968, BIOPOLYMERS, V6, P1425, DOI 10.1002/bip.1968.360061006; Vlasov PK, 2001, BIOFIZIKA+, V46, P573; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Watanabe Y, 2006, COMPUT BIOL CHEM, V30, P303, DOI 10.1016/j.compbiolchem.2006.04.004; Whittington SJ, 2003, BIOCHEMISTRY-US, V42, P14690, DOI 10.1021/bi035565x; Wu CY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq478; Zagrovic B, 2005, P NATL ACAD SCI USA, V102, P11698, DOI 10.1073/pnas.0409693102	109	72	71	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18401	10.1371/journal.pone.0018401	http://dx.doi.org/10.1371/journal.pone.0018401			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483785	gold, Green Published, Green Submitted			2022-12-27	WOS:000289057200070
J	Carvalho, G; Poalas, K; Demian, C; Hatchi, E; Vazquez, A; Bidere, N				Carvalho, Gabrielle; Poalas, Konstantinos; Demian, Catherine; Hatchi, Emeline; Vazquez, Aime; Bidere, Nicolas			Participation of the Cell Polarity Protein PALS1 to T-Cell Receptor-Mediated NF-kappa B Activation	PLOS ONE			English	Article							MAMMALIAN EPITHELIAL-CELLS; TIGHT JUNCTION FORMATION; DLGH1; COMPLEXES; LEUKEMIA; MALT1	Background: Beside their established function in shaping cell architecture, some cell polarity proteins were proposed to participate to lymphocyte migration, homing, scanning, as well as activation following antigen receptor stimulation. Although PALS1 is a central component of the cell polarity network, its expression and function in lymphocytes remains unknown. Here we investigated whether PALS1 is present in T cells and whether it contributes to T Cell-Receptor (TCR)-mediated activation. Methodology/Principal Findings: By combining RT-PCR and immunoblot assays, we found that PALS1 is constitutively expressed in human T lymphocytes as well as in Jurkat T cells. siRNA-based knockdown of PALS1 hampered TCR-induced activation and optimal proliferation of lymphocyte. We further provide evidence that PALS1 depletion selectively hindered TCR-driven activation of the transcription factor NF-kappa B. Conclusions: The cell polarity protein PALS1 is expressed in T lymphocytes and participates to the optimal activation of NFkB following TCR stimulation.	[Carvalho, Gabrielle; Poalas, Konstantinos; Demian, Catherine; Hatchi, Emeline; Vazquez, Aime; Bidere, Nicolas] Hop Paul Brousse, INSERM, UMR S 1014, F-94800 Villejuif, France; [Carvalho, Gabrielle; Poalas, Konstantinos; Demian, Catherine; Hatchi, Emeline; Vazquez, Aime; Bidere, Nicolas] Univ Paris 11, F-91400 Orsay, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Carvalho, G (corresponding author), Hop Paul Brousse, INSERM, UMR S 1014, F-94800 Villejuif, France.	nicolas.bidere@inserm.fr	Bidère, Nicolas/K-8887-2015	Bidère, Nicolas/0000-0001-9177-0008	ANR; Fondation de France; Association pour la Recherche contre le Cancer; Universite Paris Sud; Ligue Nationale contre le Cancer (Equipe Labellisee); la Ligue contre le Cancer	ANR(French National Research Agency (ANR)); Fondation de France(Fondation de France); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Universite Paris Sud; Ligue Nationale contre le Cancer (Equipe Labellisee)(Ligue nationale contre le cancer); la Ligue contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from ANR, Fondation de France, Association pour la Recherche contre le Cancer, Universite Paris Sud, and Ligue Nationale contre le Cancer (Equipe Labellisee). GC is supported by a post-doctoral fellowship from la Ligue contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpin-Andre C, 2007, J BIOL CHEM, V282, P33132, DOI 10.1074/jbc.M702279200; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; Carvalho G, 2010, J CELL SCI, V123, P2375, DOI 10.1242/jcs.069476; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Hawkins ED, 2008, ONCOGENE, V27, P7003, DOI 10.1038/onc.2008.350; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Kamberov E, 2000, J BIOL CHEM, V275, P11425, DOI 10.1074/jbc.275.15.11425; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Real E, 2007, J IMMUNOL, V179, P5649, DOI 10.4049/jimmunol.179.9.5649; Roh MH, 2003, J CELL SCI, V116, P2895, DOI 10.1242/jcs.00500; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Round JL, 2005, J EXP MED, V201, P419, DOI 10.1084/jem.20041428; Round JL, 2007, NAT IMMUNOL, V8, P154, DOI 10.1038/ni1422; Shin K, 2005, J CELL BIOL, V168, P705, DOI 10.1083/jcb.200408064; Stephenson LM, 2007, MOL CELL BIOL, V27, P7574, DOI 10.1128/MCB.00439-07; Teoh KT, 2010, MOL BIOL CELL, V21, P3838, DOI 10.1091/mbc.E10-04-0338; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044	23	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18159	10.1371/journal.pone.0018159	http://dx.doi.org/10.1371/journal.pone.0018159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479189	Green Submitted, Green Published, gold			2022-12-27	WOS:000289055700036
J	Kodali, VK; Gannon, SA; Paramasivam, S; Raje, S; Polenova, T; Thorpe, C				Kodali, Vamsi K.; Gannon, Shawn A.; Paramasivam, Sivakumar; Raje, Sonali; Polenova, Tatyana; Thorpe, Colin			A Novel Disulfide-Rich Protein Motif from Avian Eggshell Membranes	PLOS ONE			English	Article							KERATIN-ASSOCIATED PROTEINS; SULFHYDRYL OXIDASE; CHEMICAL-SHIFT; BOND FORMATION; GENE DOMAIN; EGG-WHITE; MATRIX; MINERALIZATION; IDENTIFICATION; DICTYOSTELIUM	Under the shell of a chicken egg are two opposed proteinaceous disulfide-rich membranes. They are fabricated in the avian oviduct using fibers formed from proteins that are extensively coupled by irreversible lysine-derived crosslinks. The intractability of these eggshell membranes (ESM) has slowed their characterization and their protein composition remains uncertain. In this work, reductive alkylation of ESM followed by proteolytic digestion led to the identification of a cysteine rich ESM protein (abbreviated CREMP) that was similar to spore coat protein SP75 from cellular slime molds. Analysis of the cysteine repeats in partial sequences of CREMP reveals runs of remarkably repetitive patterns. Module a contains a C-X(4)-C-X(5)-C-X(8)-C-X(6) pattern (where X represents intervening non-cysteine residues). These inter-cysteine amino acid residues are also strikingly conserved. The evolutionarily-related module b has the same cysteine spacing as a, but has 11 amino acid residues at its C-terminus. Different stretches of CREMP sequences in chicken genomic DNA fragments show diverse repeat patterns: e. g. all a modules; an alternation of a-b modules; or an a-b-b arrangement. Comparable CREMP proteins are found in contigs of the zebra finch (Taeniopygia guttata) and in the oviparous green anole lizard (Anolis carolinensis). In all these cases the long runs of highly conserved modular repeats have evidently led to difficulties in the assembly of full length DNA sequences. Hence the number, and the amino acid lengths, of CREMP proteins are currently unknown. A 118 amino acid fragment (representing an a-b-a-b pattern) from a chicken oviduct EST library expressed in Escherichia coli is a well folded, highly anisotropic, protein with a large chemical shift dispersion in 2D solution NMR spectra. Structure is completely lost on reduction of the 8 disulfide bonds of this protein fragment. Finally, solid state NMR spectra suggest a surprising degree of order in intact ESM fibers.	[Kodali, Vamsi K.; Gannon, Shawn A.; Paramasivam, Sivakumar; Polenova, Tatyana; Thorpe, Colin] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Raje, Sonali] Towson Univ, Dept Chem, Towson, MD USA	University of Delaware; University System of Maryland; Towson University	Kodali, VK (corresponding author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.	cthorpe@udel.edu	Kodali, Vamsi/A-8530-2010	Kodali, Vamsi/0000-0001-8941-9761	National Institutes of Health (NIH) [GM26643]; NCRR, NIH [NIH P20RR017716-08]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026643] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) GM26643 (CT) and NIH P20RR017716-08 from NCRR (TP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias JL, 1997, CONNECT TISSUE RES, V36, P21, DOI 10.3109/03008209709160211; ARIAS JL, 1991, CONNECT TISSUE RES, V26, P37, DOI 10.3109/03008209109152162; BELLAIRS R, 1969, Z ZELLFORSCH MIK ANA, V96, P237, DOI 10.1007/BF00338771; Benitez BAS, 2000, PROTEINS, V40, P168, DOI 10.1002/(SICI)1097-0134(20000701)40:1<168::AID-PROT180>3.0.CO;2-N; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Burley R., 1989, AVIAN EGG CHEM BIOL; CARMON A, PLOS ONE, V5; Case ST, 1997, J MOL EVOL, V44, P452, DOI 10.1007/PL00006165; Cheek S, 2006, J MOL BIOL, V359, P215, DOI 10.1016/j.jmb.2006.03.017; CHOWDHURY SD, 1990, WORLD POULTRY SCI J, V46, P153, DOI 10.1079/WPS19900018; CROMBIE G, 1981, BIOCHIM BIOPHYS ACTA, V640, P365, DOI 10.1016/0005-2736(81)90560-5; Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gregg KY, 2000, DEV BIOL, V224, P81, DOI 10.1006/dbio.2000.9768; GUILLETTE LJ, 1989, J MORPHOL, V201, P145, DOI 10.1002/jmor.1052010205; Hawthorne SK, 2006, GENOMICS, V87, P382, DOI 10.1016/j.ygeno.2005.09.010; Hincke MT, 2000, MATRIX BIOL, V19, P443, DOI 10.1016/S0945-053X(00)00095-0; HOFFER AP, 1971, AM J ANAT, V131, P253, DOI 10.1002/aja.1001310302; Hoober KL, 1999, J BIOL CHEM, V274, P22147, DOI 10.1074/jbc.274.32.22147; Hoober KL, 1996, J BIOL CHEM, V271, P30510, DOI 10.1074/jbc.271.48.30510; IATROU K, 1984, P NATL ACAD SCI-BIOL, V81, P4452, DOI 10.1073/pnas.81.14.4452; KALKHOF S, BIOCHEMISTRY; Kamino K, 2000, J BIOL CHEM, V275, P27360; Kamino K, 2008, MAR BIOTECHNOL, V10, P111, DOI 10.1007/s10126-007-9076-3; KAWASAKI H, 1971, INSECT BIOCHEM, V1, P130, DOI 10.1016/0020-1790(71)90067-9; Kumar Manish, 2008, In Silico Biology, V8, P121; LEACH RM, 1982, POULTRY SCI, V61, P2040, DOI 10.3382/ps.0612040; LEACH RM, 1981, ARCH BIOCHEM BIOPHYS, V207, P353, DOI 10.1016/0003-9861(81)90042-4; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Meier S, 2007, J MOL BIOL, V368, P718, DOI 10.1016/j.jmb.2007.02.026; Morcombe CR, 2003, J MAGN RESON, V162, P479, DOI 10.1016/S1090-7807(03)00082-X; Neue G, 1997, SOLID STATE NUCL MAG, V7, P333, DOI 10.1016/S0926-2040(96)01291-X; Nys Y, 2004, CR PALEVOL, V3, P549, DOI 10.1016/j.crpv.2004.08.002; Rogers MA, 2004, J INVEST DERMATOL, V122, P147, DOI 10.1046/j.0022-202X.2003.22128.x; Rogers MA, 2001, J BIOL CHEM, V276, P19440, DOI 10.1074/jbc.M100657200; Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X; SMITH SV, 1995, PROTEIN SCI, V4, P945; STARCHER BC, 1980, CONNECT TISSUE RES, V8, P53, DOI 10.3109/03008208009152122; Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5; TORRES FG, ACTA BIOMATER, V6, P3687; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Varricchio DJ, 2002, J VERTEBR PALEONTOL, V22, P564, DOI 10.1671/0272-4634(2002)022[0564:EAEFTC]2.0.CO;2; West CM, 1996, MICROBIOL-UK, V142, P2227, DOI 10.1099/13500872-142-8-2227; West CM, 2003, INT REV CYTOL, V222, P237; Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6; Wong JL, 2004, EVOL DEV, V6, P134, DOI 10.1111/j.1525-142X.2004.04019.x; WONG M, 1984, DEV BIOL, V104, P28, DOI 10.1016/0012-1606(84)90033-2	50	49	52	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18187	10.1371/journal.pone.0018187	http://dx.doi.org/10.1371/journal.pone.0018187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479176	Green Published, Green Submitted, gold			2022-12-27	WOS:000289055700037
J	Banerjee, S; Oldridge, D; Poptsova, M; Hussain, WM; Chakravarty, D; Demichelis, F				Banerjee, Samprit; Oldridge, Derek; Poptsova, Maria; Hussain, Wasay M.; Chakravarty, Dimple; Demichelis, Francesca			A Computational Framework Discovers New Copy Number Variants with Functional Importance	PLOS ONE			English	Article							HUMAN BLEOMYCIN HYDROLASE; HIDDEN-MARKOV MODEL; GENE-EXPRESSION; MECHANISMS; CANCER; GENOME; IMPACT	Structural variants which cause changes in copy numbers constitute an important component of genomic variability. They account for 0.7% of genomic differences in two individual genomes, of which copy number variants (CNVs) are the largest component. A recent population-based CNV study revealed the need of better characterization of CNVs, especially the small ones (<500 bp). We propose a three step computational framework (Identification of germline Changes in Copy Number or IgC2N) to discover and genotype germline CNVs. First, we detect candidate CNV loci by combining information across multiple samples without imposing restrictions to the number of coverage markers or to the variant size. Secondly, we fine tune the detection of rare variants and infer the putative copy number classes for each locus. Last, for each variant we combine the relative distance between consecutive copy number classes with genetic information in a novel attempt to estimate the reference model bias. This computational approach is applied to genome-wide data from 1250 HapMap individuals. Novel variants were discovered and characterized in terms of size, minor allele frequency, type of polymorphism (gains, losses or both), and mechanism of formation. Using data generated for a subset of individuals by a 42 million marker platform, we validated the majority of the variants with the highest validation rate (66.7%) was for variants of size larger than 1 kb. Finally, we queried transcriptomic data from 129 individuals determined by RNA-sequencing as further validation and to assess the functional role of the new variants. We investigated the possible enrichment for variant's regulatory effect and found that smaller variants (<1 Kb) are more likely to regulate gene transcript than larger variants (p-value = 2.04e-08). Our results support the validity of the computational framework to detect novel variants relevant to disease susceptibility studies and provide evidence of the importance of genetic variants in regulatory network studies.	[Banerjee, Samprit] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY 10065 USA; [Oldridge, Derek; Poptsova, Maria; Hussain, Wasay M.; Chakravarty, Dimple; Demichelis, Francesca] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Demichelis, Francesca] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY USA	Cornell University; Cornell University; Cornell University	Banerjee, S (corresponding author), Weill Cornell Med Coll, Dept Publ Hlth, New York, NY 10065 USA.	francesca.demichelis@gmail.com	Poptsova, Maria/G-6985-2014; Demichelis, Francesca/J-9829-2016; Chakravarty, Dimple/N-3325-2014	Poptsova, Maria/0000-0002-7198-8234; Demichelis, Francesca/0000-0002-8266-8631; Chakravarty, Dimple/0000-0002-8588-8461	Starr Cancer Consortium; Department of Defense; National Cancer Institute [R01-CA116337]; NATIONAL CANCER INSTITUTE [R01CA116337] Funding Source: NIH RePORTER	Starr Cancer Consortium; Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the Starr Cancer Consortium (S. B., F. D.), the Department of Defense (F. D.), and the National Cancer Institute (R01-CA116337, S. B., F. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Cahan P, 2009, NAT GENET, V41, P430, DOI 10.1038/ng.350; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DIJKSTRA T, OPTIMIZATION ALGORIT, P74; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Ferrando AA, 1996, CANCER RES, V56, P1746; Gokcumen O, 2009, METHODS, V49, P18, DOI 10.1016/j.ymeth.2009.06.001; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Habegger L, 2011, BIOINFORMATICS, V27, P281, DOI 10.1093/bioinformatics/btq643; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hayashi R, 2007, DNA CELL BIOL, V26, P91, DOI 10.1089/dna.2006.0515; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kato M, 2010, HUM MOL GENET, V19, P761, DOI 10.1093/hmg/ddp541; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; LAM HY, NAT BIOTECHNOL, V28, P47; Lee C, 2008, NEW ENGL J MED, V358, P740, DOI 10.1056/NEJMcibr0708452; Lefterov IM, 2000, FASEB J, V14, P1837, DOI 10.1096/fj.99-0938com; Li B, 2009, MOL VIS, V15, P861; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Montoya SE, 1998, NAT GENET, V18, P211, DOI 10.1038/ng0398-211; OLDRIDGE DA, NUCL ACIDS RES, V38, P3275; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; TOMIMARU Y, BR J CANC, V102, P1483; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Waszak SM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000988; YAVAS G, PAC S BIOCOMPUT, P371	41	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17539	10.1371/journal.pone.0017539	http://dx.doi.org/10.1371/journal.pone.0017539			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479260	Green Submitted, Green Published, gold			2022-12-27	WOS:000289054600012
J	Grech, A; Sheppard, J; Marsh, H				Grech, Alana; Sheppard, James; Marsh, Helene			Informing Species Conservation at Multiple Scales Using Data Collected for Marine Mammal Stock Assessments	PLOS ONE			English	Article							GREAT-BARRIER-REEF; TORRES STRAIT; AERIAL SURVEYS; DUGONG; ABUNDANCE; SEAGRASS; QUEENSLAND; CETACEANS; RESERVES; DESIGN	Background: Conservation planning and the design of marine protected areas (MPAs) requires spatially explicit information on the distribution of ecological features. Most species of marine mammals range over large areas and across multiple planning regions. The spatial distributions of marine mammals are difficult to predict using habitat modelling at ecological scales because of insufficient understanding of their habitat needs, however, relevant information may be available from surveys conducted to inform mandatory stock assessments. Methodology and Results: We use a 20-year time series of systematic aerial surveys of dugong (Dugong dugong) abundance to create spatially-explicit models of dugong distribution and relative density at the scale of the coastal waters of northeast Australia (similar to 136,000 km(2)). We interpolated the corrected data at the scale of 2 km * 2 km planning units using geostatistics. Planning units were classified as low, medium, high and very high dugong density on the basis of the relative density of dugongs estimated from the models and a frequency analysis. Torres Strait was identified as the most significant dugong habitat in northeast Australia and the most globally significant habitat known for any member of the Order Sirenia. The models are used by local, State and Federal agencies to inform management decisions related to the Indigenous harvest of dugongs, gill-net fisheries and Australia's National Representative System of Marine Protected Areas. Conclusion/Significance: In this paper we demonstrate that spatially-explicit population models add value to data collected for stock assessments, provide a robust alternative to predictive habitat distribution models, and inform species conservation at multiple scales.	[Grech, Alana] James Cook Univ, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Grech, Alana; Sheppard, James; Marsh, Helene] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Sheppard, James] San Diego Zoo, San Diego Zoo Inst Conservat Res, Escondido, CA USA	James Cook University; James Cook University; Zoological Society of San Diego	Grech, A (corresponding author), James Cook Univ, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	alana.grech@jcu.edu.au	Grech, Alana/U-7776-2019; Grech, Alana/E-9464-2011	Grech, Alana/0000-0003-4117-3779; Grech, Alana/0000-0003-4117-3779; Marsh, Helene/0000-0003-3492-4992	Australian Marine Mammal Centre; Australian Department of Sustainability, Environment, Water, Population and Communities; Queensland Department of Environment and Resource Management; Great Barrier Reef Marine Park Authority; Queensland Government Growing the Smart State PhD Funding Programme; Northern Territory Government; Torres Strait Regional Authority; School of Earth and Environmental Sciences, James Cook University	Australian Marine Mammal Centre; Australian Department of Sustainability, Environment, Water, Population and Communities(Australian Government); Queensland Department of Environment and Resource Management; Great Barrier Reef Marine Park Authority; Queensland Government Growing the Smart State PhD Funding Programme; Northern Territory Government; Torres Strait Regional Authority; School of Earth and Environmental Sciences, James Cook University	Australian Marine Mammal Centre (http://www.marinemammals.gov.au/ammc-grants-scheme); Australian Department of Sustainability, Environment, Water, Population and Communities (http://www.environment.gov.au); Queensland Department of Environment and Resource Management (http://www.derm.qld.gov.au); Great Barrier Reef Marine Park Authority (http://www.gbrmpa.gov.au); Queensland Government Growing the Smart State PhD Funding Programme (http://education.qld.gov.au/corporate/research/smartstate.html); Northern Territory Government (www.nt.gov.au); Torres Strait Regional Authority (www.tsra.gov.au); School of Earth and Environmental Sciences, James Cook University (http://www.jcu.edu.au/ees/index.htm); and an anonymous donor. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre J, 2005, WILDLIFE RES, V32, P53, DOI 10.1071/WR04015; Bicho N., 2015, HUMAN ORIGIN SITES W; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Carr MH, 2003, ECOL APPL, V13, pS90; COLES RG, 2007, DEEDI PUBLICATION; de Stephanis R, 2008, MAR ECOL PROG SER, V353, P275, DOI 10.3354/meps07164; Dobbs K, 2008, OCEAN COAST MANAGE, V51, P368, DOI 10.1016/j.ocecoaman.2007.08.001; Erasmus BFN, 1999, P ROY SOC B-BIOL SCI, V266, P315, DOI 10.1098/rspb.1999.0640; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Foley MM, 2010, MAR POLICY, V34, P955, DOI 10.1016/j.marpol.2010.02.001; *GREAT BARR REEF M, 2009, GREAT BARR REEF OUTL; Grech A, 2008, AQUAT CONSERV, V18, P1127, DOI 10.1002/aqc.943; Grech A, 2008, CONSERV BIOL, V22, P711, DOI 10.1111/j.1523-1739.2008.00923.x; Grech A, 2010, AQUAT CONSERV, V20, P437, DOI 10.1002/aqc.1107; Grech A, 2007, APPL GIS, V3, P1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HINES E, 2011, INT STRATEGIES MANAT; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; JONES S, 1981, DUGONG, P24; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; Laidre KL, 2010, MAR ECOL PROG SER, V402, P269, DOI 10.3354/meps08423; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marsh H, 2005, ECOL APPL, V15, P481, DOI 10.1890/04-0673; Marsh H, 2004, ANIM CONSERV, V7, P435, DOI 10.1017/S1367943004001635; MARSH H, 1989, AUST WILDLIFE RES, V16, P639; MARSH H, 1990, AUST WILDLIFE RES, V17, P511; Marsh H., 2002, EARLY WARNING ASSESS; Marsh H., 2002, DUGONG DISTRIBUTION; Marsh H., 2007, CONDITION STATUS TRE; Marsh H, 2001, DUGONG DISTRIBUTION; MARSH HD, 2008, DISTRIBUTION ABUNDAN; MARSH HD, 2006, IS DUGONG MANAGEMENT; Marsh H, 2008, CONT SHELF RES, V28, P2152, DOI 10.1016/j.csr.2008.03.023; Marsh Helene, 2003, P1; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Pershing AJ, 2009, MAR ECOL PROG SER, V378, P245, DOI 10.3354/meps07829; Pollock KH, 2006, J WILDLIFE MANAGE, V70, P255, DOI 10.2193/0022-541X(2006)70[255:EAAIHE]2.0.CO;2; PREEN A, 1995, WILDLIFE RES, V22, P507, DOI 10.1071/WR9950507; PREEN A, 1995, J MAMMAL, V76, P163, DOI 10.2307/1382325; Preen A., 1992, THESIS J COOK U TOWN; Rasheed MA, 2011, MAR ECOL PROG SER, V422, P93, DOI 10.3354/meps08925; Sheppard JK, 2006, J EXP MAR BIOL ECOL, V334, P64, DOI 10.1016/j.jembe.2006.01.011; Sheppard JK, 2010, MAR MAMMAL SCI, V26, P855, DOI 10.1111/j.1748-7692.2010.00374.x; Sheppard JK, 2009, J WILDLIFE MANAGE, V73, P45, DOI 10.2193/2007-468; Short FT, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P5, DOI 10.1016/B978-044450891-1/50002-5; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Taylor H.A., 2010, DEEDI PUBLICATION; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Vigness-Raposa KJ, 2010, MAR MAMMAL SCI, V26, P161, DOI 10.1111/j.1748-7692.2009.00336.x; Wade PR, 1998, MAR MAMMAL SCI, V14, P1, DOI 10.1111/j.1748-7692.1998.tb00688.x	53	16	16	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17993	10.1371/journal.pone.0017993	http://dx.doi.org/10.1371/journal.pone.0017993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464933	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000289053800010
J	Pratt, CH; Curtain, M; Donahue, LR; Shopland, LS				Pratt, C. Herbert; Curtain, Michelle; Donahue, Leah Rae; Shopland, Lindsay S.			Mitotic Defects Lead to Pervasive Aneuploidy and Accompany Loss of RB1 Activity in Mouse Lmna(Dhe) Dermal Fibroblasts	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; DNA-DAMAGE RESPONSES; A-TYPE LAMINS; NUCLEAR LAMINS; GENOMIC INSTABILITY; PRELAMIN-A; LAMINOPATHIES; ORGANIZATION; MATURATION; CHROMATIN	Background: Lamin A (LMNA) is a component of the nuclear lamina and is mutated in several human diseases, including Emery-Dreifuss muscular dystrophy (EDMD; OMIM ID# 181350) and the premature aging syndrome Hutchinson-Gilford progeria syndrome (HGPS; OMIM ID# 176670). Cells from progeria patients exhibit cell cycle defects in both interphase and mitosis. Mouse models with loss of LMNA function have reduced Retinoblastoma protein (RB1) activity, leading to aberrant cell cycle control in interphase, but how mitosis is affected by LMNA is not well understood. Results: We examined the cell cycle and structural phenotypes of cells from mice with the Lmna allele, Disheveled hair and ears (Lmna(Dhe)). We found that dermal fibroblasts from heterozygous Lmna(Dhe) (Lmna(Dhe/+)) mice exhibit many phenotypes of human laminopathy cells. These include severe perturbations to the nuclear shape and lamina, increased DNA damage, and slow growth rates due to mitotic delay. Interestingly, Lmna(Dhe/+) fibroblasts also had reduced levels of hypophosphorylated RB1 and the non-SMC condensin II-subunit D3 (NCAP-D3), a mitosis specific centromere condensin subunit that depends on RB1 activity. Mitotic check point control by mitotic arrest deficient-like 1 (MAD2L1) also was perturbed in Lmna(Dhe/+) cells. Lmna(Dhe/+) fibroblasts were consistently aneuploid and had higher levels of micronuclei and anaphase bridges than normal fibroblasts, consistent with chromosome segregation defects. Conclusions: These data indicate that RB1 may be a key regulator of cellular phenotype in laminopathy-related cells, and suggest that the effects of LMNA on RB1 include both interphase and mitotic cell cycle control.	[Pratt, C. Herbert; Curtain, Michelle; Donahue, Leah Rae; Shopland, Lindsay S.] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Pratt, CH (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	craig.pratt@jax.org		Pratt, Herb/0000-0002-4964-8292	Eunice Kennedy Shriver National Institute of Child Health and Human Development [T32 HD007065]; Jackson Laboratory; National Science Foundation [MCB 0817787]; National Eye Institute [EY015073]; Jackson Laboratory's Cancer Center, National Cancer Institute [CA034196]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007065] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015073] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Jackson Laboratory; National Science Foundation(National Science Foundation (NSF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Jackson Laboratory's Cancer Center, National Cancer Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was made possible by grants T32 HD007065 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and a Jackson Laboratory Postodoctoral Fellowship from The Jackson Laboratory to CHP; MCB 0817787 from the National Science Foundation to LSS; EY015073 from the National Eye Institute to LRD and The Jackson Laboratory's Cancer Center Support Grant CA034196 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-79; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; BENSON EK, J CELL SCI; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; CHI HI, 1990, J INVEST DERMATOL, V95, P154, DOI 10.1111/1523-1747.ep12477921; COSCHI CH, GENES DEV, V24, P1351; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Gonzalez-Suarez I, 2009, EMBO J, V28, P2414, DOI 10.1038/emboj.2009.196; Gruenbaum Y, 2003, INT REV CYTOL, V226, P1, DOI 10.1016/S0074-7696(03)01001-5; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Liu Y, 2008, FASEB J, V22, P603, DOI 10.1096/fj.07-8598com; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Longworth MS, 2008, GENE DEV, V22, P1011, DOI 10.1101/gad.1631508; Mann MB, 2005, HUM MOL GENET, V14, P813, DOI 10.1093/hmg/ddi075; MANNING AL, GENES DEV, V24, P1364; MARJI J, PLOS ONE, V5; Mattout A, 2006, CURR OPIN CELL BIOL, V18, P335, DOI 10.1016/j.ceb.2006.03.007; Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179; Moir RD, 2000, J STRUCT BIOL, V129, P324, DOI 10.1006/jsbi.2000.4251; Mounkes L, 2003, CURR OPIN GENET DEV, V13, P223, DOI 10.1016/S0959-437X(03)00058-3; Mukherjee AB, 1998, MECH AGEING DEV, V103, P209, DOI 10.1016/S0047-6374(98)00041-4; Musich PR, 2009, AGING-US, V1, P28, DOI 10.18632/aging.100012; Naetar N, 2008, NAT CELL BIOL, V10, P1341, DOI 10.1038/ncb1793; ODGREN PR, PLOS ONE, V5, pE9959; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Stewart CL, 2007, EXP CELL RES, V313, P2144, DOI 10.1016/j.yexcr.2007.03.026; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; TAKASHIMI A, 1998, CURRENT PROTOCOLS CE; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; VANHARN T, GENES DEV, V24, P1377; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wolfram T, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-64; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679; Wright SM, 2009, CANCER RES, V69, P4454, DOI 10.1158/0008-5472.CAN-08-4515	43	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18065	10.1371/journal.pone.0018065	http://dx.doi.org/10.1371/journal.pone.0018065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464947	Green Published, gold, Green Submitted			2022-12-27	WOS:000288813900033
J	Rothman, RB; Cadet, JL; Dersch, CM; McCoy, MT; Lehrmann, E; Becker, KG; Bader, M; Alenina, N; Baumann, MH				Rothman, Richard B.; Cadet, Jean L.; Dersch, Christina M.; McCoy, Michael T.; Lehrmann, Elin; Becker, Kevin G.; Bader, Michael; Alenina, Natalia; Baumann, Michael H.			Altered Gene Expression in Pulmonary Tissue of Tryptophan Hydroxylase-1 Knockout Mice: Implications for Pulmonary Arterial Hypertension	PLOS ONE			English	Article							5-HYDROXYTRYPTAMINE TRANSPORTER GENE; VASCULAR SMOOTH-MUSCLE; SEROTONIN TRANSPORTER; PLASMA SEROTONIN; CARDIAC-FUNCTION; TRANSGENIC MICE; CHRONIC HYPOXIA; DEXFENFLURAMINE; FENFLURAMINE; RECEPTORS	The use of fenfluramines can increase the risk of developing pulmonary arterial hypertension (PAH) in humans, but the mechanisms responsible are unresolved. A recent study reported that female mice lacking the gene for tryptophan hydroxylase-1 (Tph1(-/-) mice) were protected from PAH caused by chronic dexfenfluramine, suggesting a pivotal role for peripheral serotonin (5-HT) in the disease process. Here we tested two alternative hypotheses which might explain the lack of dexfenfluramine-induced PAH in Tph1(-/-) mice. We postulated that: 1) Tph1(-/-) mice express lower levels of pulmonary 5-HT transporter (SERT) when compared to wild-type controls, and 2) Tph1(-/-) mice display adaptive changes in the expression of non-serotonergic pulmonary genes which are implicated in PAH. SERT was measured using radioligand binding methods, whereas gene expression was measured using microarrays followed by quantitative real time PCR (qRT-PCR). Contrary to our first hypothesis, the number of pulmonary SERT sites was modestly up-regulated in female Tph1(-/-) mice. The expression of 51 distinct genes was significantly altered in the lungs of female Tph1(-/-) mice. Consistent with our second hypothesis, qRT-PCR confirmed that at least three genes implicated in the pathogenesis of PAH were markedly up-regulated: Has2, Hapln3 and Retlna. The finding that female Tph1(-/-) mice are protected from dexfenfluramine-induced PAH could be related to compensatory changes in pulmonary gene expression, in addition to reductions in peripheral 5-HT. These observations emphasize the intrinsic limitation of interpreting data from studies conducted in transgenic mice that are not fully characterized.	[Rothman, Richard B.; Dersch, Christina M.; Baumann, Michael H.] NIDA, Translat Pharmacol Sect, Intramural Res Program, NIH, Baltimore, MD USA; [Cadet, Jean L.; McCoy, Michael T.] NIDA, Mol Neuropsychiat Res Branch, Intramural Res Program, NIH, Baltimore, MD USA; [Lehrmann, Elin; Becker, Kevin G.] NIA, Gene Express & Genom Unit, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Bader, Michael; Alenina, Natalia] Max Delbruck Ctr Mol Med, Berlin, Germany	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Rothman, RB (corresponding author), NIDA, Translat Pharmacol Sect, Intramural Res Program, NIH, Baltimore, MD USA.	rrothman@mail.nih.gov	Bader, Michael/K-2124-2013	Lehrmann, Elin/0000-0002-9869-9475; Becker, Kevin/0000-0002-6794-6656; Bader, Michael/0000-0003-4780-4164; Baumann, Michael/0000-0001-7758-1470	National Institute on Drug Abuse; National Institute on Aging, National Institutes of Health, DHHS; NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000522, ZIADA000174, ZIADA000551] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Aging, National Institutes of Health, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Intramural Research Programs, National Institute on Drug Abuse and the National Institute on Aging, National Institutes of Health, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini DJ, 2009, AM J PHYSIOL-LUNG C, V296, pL582, DOI 10.1152/ajplung.90526.2008; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dempsie Y, 2008, CIRCULATION, V117, P2928, DOI 10.1161/CIRCULATIONAHA.108.767558; Eddahibi S, 1998, AM J RESP CRIT CARE, V157, P1111, DOI 10.1164/ajrccm.157.4.9704095; Eddahibi S, 2000, J CLIN INVEST, V105, P1555, DOI 10.1172/JCI8678; Fan CL, 2009, AM J PHYSIOL-LUNG C, V297, pL263, DOI 10.1152/ajplung.90416.2008; Fanburg BL, 2000, J CLIN INVEST, V105, P1521, DOI 10.1172/JCI10230; Fligny C, 2008, FASEB J, V22, P2340, DOI 10.1096/fj.07-100743; Guignabert C, 2006, CIRC RES, V98, P1323, DOI 10.1161/01.RES.0000222546.45372.a0; Guilluy C, 2007, J BIOL CHEM, V282, P2918, DOI 10.1074/jbc.M604195200; Hamidi SA, 2008, EUR RESPIR J, V31, P135, DOI 10.1183/09031936.00105807; Launay JM, 2002, NAT MED, V8, P1129, DOI 10.1038/nm764; Lee SL, 2001, FASEB J, V15, P1324, DOI 10.1096/fj.00-0431fje; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; MacLean MR, 2000, BRIT J PHARMACOL, V131, P161, DOI 10.1038/sj.bjp.0703570; MacLean MR, 2004, CIRCULATION, V109, P2150, DOI 10.1161/01.CIR.0000127375.56172.92; Morecroft I, 2005, J PHARMACOL EXP THER, V313, P539, DOI 10.1124/jpet.104.081182; Papakonstantinou E, 2008, EUR RESPIR J, V32, P1504, DOI 10.1183/09031936.00159507; Rochefort GY, 2006, EUR J PHARMACOL, V550, P149, DOI 10.1016/j.ejphar.2006.08.050; Rothman RB, 1999, CIRCULATION, V100, P869, DOI 10.1161/01.CIR.100.8.869; ROTHMAN RB, 1991, MOL PHARMACOL, V39, P222; Rothman RB, 2009, EXPERT OPIN DRUG SAF, V8, P317, DOI 10.1517/14740330902931524; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Weir EK, 1996, CIRCULATION, V94, P2216, DOI 10.1161/01.CIR.94.9.2216; West J, 2008, AM J PHYSIOL-LUNG C, V295, pL744, DOI 10.1152/ajplung.90255.2008; Zolkowska D, 2008, J PHARMACOL EXP THER, V324, P791, DOI 10.1124/jpet.107.132654; Zolkowska D, 2006, J PHARMACOL EXP THER, V318, P604, DOI 10.1124/jpet.106.101618	29	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17735	10.1371/journal.pone.0017735	http://dx.doi.org/10.1371/journal.pone.0017735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464983	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000288813900009
J	Harvey, A; Zukoff, S				Harvey, Alan; Zukoff, Sarah			Wind-Powered Wheel Locomotion, Initiated by Leaping Somersaults, in Larvae of the Southeastern Beach Tiger Beetle (Cicindela dorsalis media)	PLOS ONE			English	Article							PARASITIC NEMATODE; SOUTH-CAROLINA; BEHAVIOR; COLEOPTERA; KINEMATICS; DISPERSAL; MECHANISM; MOISTURE; DIPTERA	Rapid movement is challenging for elongate, soft-bodied animals with short or no legs. Leaping is known for only a few animals with this "worm-like" morphology. Wheel locomotion, in which the animal's entire body rolls forward along a central axis, has been reported for only a handful of animals worldwide. Here we present the first documented case of wind-powered wheel locomotion, in larvae of the coastal tiger beetle Cicindela dorsalis media. When removed from their shallow burrows, larvae easily can be induced to enter a behavioral sequence that starts with leaping; while airborne, larvae loop their body into a rotating wheel and usually either "hit the ground rolling" or leap again. The direction larvae wheel is closely related to the direction in which winds are blowing; thus, all our larvae wheeled up-slope, as winds at our study site consistently blew from sea to land. Stronger winds increased both the proportion of larvae wheeling, and the distance traveled, exceeding 60 m in some cases. In addition, the proportion of larvae that wheel and the distance traveled by wheeling larvae are significantly greater on smooth sandy beaches than on beach surfaces made rough and irregular by pedestrian, equestrian, and vehicular traffic. Like other coastal species of tiger beetles, C. dorsalis media has suffered major declines in recent years that are clearly correlated with increased human impacts. The present study suggests that the negative effects of beach traffic may be indirect, preventing larvae from escaping from predators using wheel locomotion by disrupting the flat, hard surface necessary for efficient wheeling.	[Harvey, Alan] Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA; [Zukoff, Sarah] Univ Missouri, Div Plant Sci, Columbia, MO USA	University System of Georgia; Georgia Southern University; University of Missouri System; University of Missouri Columbia	Harvey, A (corresponding author), Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA.	aharvey@georgiasouthern.edu		Zukoff, Sarah/0000-0002-4918-3667	University of Missouri	University of Missouri	The only funding support for this research was a $500 travel grant to Sarah Zukoff from the University of Missouri graduate program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Cohen Y, 2005, STRAIN, V41, P19, DOI 10.1111/j.1475-1305.2004.00161.x; BERRIGAN D, 1995, J INSECT PHYSIOL, V41, P329, DOI 10.1016/0022-1910(94)00113-U; Bonduriansky R, 2002, CAN ENTOMOL, V134, P647, DOI 10.4039/Ent134647-5; Brackenbury J, 1999, J INSECT PHYSIOL, V45, P525, DOI 10.1016/S0022-1910(98)00157-7; Brackenbury J, 1997, NATURE, V390, P453, DOI 10.1038/37253; Brust ML, 2006, J INSECT BEHAV, V19, P251, DOI 10.1007/s10905-006-9021-8; CALDWELL RL, 1979, NATURE, V282, P71, DOI 10.1038/282071a0; CAMAZINE S, 1986, ANN ENTOMOL SOC AM, V79, P140, DOI 10.1093/aesa/79.1.140; Campbell JF, 1999, NATURE, V397, P485, DOI 10.1038/17254; Campbell JF, 1999, CAN J ZOOL, V77, P1947, DOI 10.1139/cjz-77-12-1947; CASEY TM, 1991, SCIENCE, V252, P112, DOI 10.1126/science.252.5002.112; Ciegler JC, 1997, COLEOPTS BULL, V51, P177; CIEGLER JC, 2005, WHITE BEACH TIGER BE; GOULD SJ, 1981, NAT HIST, V90, P42; HENSCHEL JR, 1990, S AFR J SCI, V86, P151; Knisley C. B., 1997, BIOL TIGER BEETLES G; LaBarbera M., 1983, AM NAT, V121, P385; MAITLAND DP, 1992, NATURE, V355, P159, DOI 10.1038/355159a0; MAITLAND DP, 1991, S AFR J SCI, V87, P85; Menzel D, 1993, OCEAN PROCESSES US S; *NAT PARKS CONS AS, 2009, CUMB ISL NAT SEASH R; NOTHNAGLE P, 1990, ECOLOGY NE BEACH TIG; Pearson DL, 2006, FIELD GUIDE TIGER BE; PEARSON DL, 2001, TIGER BEETLES EVOLUT; REED EM, 1965, NATURE, V206, P210, DOI 10.1038/206210a0; Schurr FM, 2005, J ECOL, V93, P1017, DOI 10.1111/j.1365-2745.2005.01018.x; US Fish and Wildlife Service, 1994, NE BEACH TIG BEETL C; VOGLER AP, 1993, EVOLUTION, V47, P1192, DOI 10.1111/j.1558-5646.1993.tb02146.x; WILSON EO, 1973, ANIM BEHAV, V21, P292, DOI 10.1016/S0003-3472(73)80069-7; YARBROUGH WW, 1994, ENTOMOL NEWS, V105, P189	30	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17746	10.1371/journal.pone.0017746	http://dx.doi.org/10.1371/journal.pone.0017746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448275	Green Published, gold, Green Submitted			2022-12-27	WOS:000288810500012
J	Shultz, JL; Voziyanova, E; Konieczka, JH; Voziyanov, Y				Shultz, Jeffry L.; Voziyanova, Eugenia; Konieczka, Jay H.; Voziyanov, Yuri			A Genome-Wide Analysis of FRT-Like Sequences in the Human Genome	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINASE; HIDDEN MARKOV MODEL; FLP RECOMBINASE; CRE RECOMBINASE; TARGET SITES; SPECIFICITY; EVOLUTION; CHROMOSOME; MUTATIONS; VARIANTS	Efficient and precise genome manipulations can be achieved by the Flp/FRT system of site-specific DNA recombination. Applications of this system are limited, however, to cases when target sites for Flp recombinase, FRT sites, are pre-introduced into a genome locale of interest. To expand use of the Flp/FRT system in genome engineering, variants of Flp recombinase can be evolved to recognize pre-existing genomic sequences that resemble FRT and thus can serve as recombination sites. To understand the distribution and sequence properties of genomic FRT-like sites, we performed a genome-wide analysis of FRT-like sites in the human genome using the experimentally-derived parameters. Out of 642,151 identified FRT-like sequences, 581,157 sequences were unique and 12,452 sequences had at least one exact duplicate. Duplicated FRT-like sequences are located mostly within LINE1, but also within LTRs of endogenous retroviruses, Alu repeats and other repetitive DNA sequences. The unique FRT-like sequences were classified based on the number of matches to FRT within the first four proximal bases pairs of the Flp binding elements of FRT and the nature of mismatched base pairs in the same region. The data obtained will be useful for the emerging field of genome engineering.	[Shultz, Jeffry L.; Voziyanova, Eugenia; Voziyanov, Yuri] Louisiana Tech Univ, Sch Biol Sci, Ruston, LA 71270 USA; [Konieczka, Jay H.] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA	University of Louisiana System; Louisiana Technical University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Shultz, JL (corresponding author), Louisiana Tech Univ, Sch Biol Sci, Ruston, LA 71270 USA.	voziyan@latech.edu			NIH [NIGMS R01GM085848]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085848] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from NIH (NIGMS R01GM085848) to YV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolusani S, 2006, NUCLEIC ACIDS RES, V34, P5259, DOI 10.1093/nar/gkl548; Buchholz F, 2001, NAT BIOTECHNOL, V19, P1047, DOI 10.1038/nbt1101-1047; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1315, DOI 10.1038/nbt1004-1315; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Kalari Krishna R., 2006, In Silico Biology, V6, P237; KILBY NJ, 1993, TRENDS GENET, V9, P413, DOI 10.1016/0168-9525(93)90104-P; Konieczka JH, 2004, J MOL BIOL, V339, P365, DOI 10.1016/j.jmb.2004.03.060; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mills AA, 2001, TRENDS GENET, V17, P331, DOI 10.1016/S0168-9525(01)02321-6; Nov D, 2007, CURR OPIN BIOTECH, V18, P411, DOI 10.1016/j.copbio.2007.07.013; Qiao JH, 2009, J MOL BIOL, V390, P579, DOI 10.1016/j.jmb.2009.05.012; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rufer AW, 2002, NUCLEIC ACIDS RES, V30, P2764, DOI 10.1093/nar/gkf399; Sambrook J., 2001, MOL CLONING LAB MANU; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; Sellis D, 2007, MOL BIOL EVOL, V24, P2385, DOI 10.1093/molbev/msm181; SENECOFF JF, 1988, J MOL BIOL, V201, P405, DOI 10.1016/0022-2836(88)90147-7; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Tay Y, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1089; UMLAUF SW, 1988, EMBO J, V7, P1845, DOI 10.1002/j.1460-2075.1988.tb03017.x; Voziyanov Y, 2003, J MOL BIOL, V326, P65, DOI 10.1016/S0022-2836(02)01364-5; Voziyanov Y, 2002, NUCLEIC ACIDS RES, V30, P1656, DOI 10.1093/nar/30.7.1656; Yada T, 1998, BIOINFORMATICS, V14, P317, DOI 10.1093/bioinformatics/14.4.317	26	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18077	10.1371/journal.pone.0018077	http://dx.doi.org/10.1371/journal.pone.0018077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448289	gold, Green Published, Green Submitted			2022-12-27	WOS:000288810500033
J	Majumder, R; Nayak, AR; Pandit, R				Majumder, Rupamanjari; Nayak, Alok Ranjan; Pandit, Rahul			Scroll-Wave Dynamics in Human Cardiac Tissue: Lessons from a Mathematical Model with Inhomogeneities and Fiber Architecture	PLOS ONE			English	Article							VENTRICULAR-FIBRILLATION; SPIRAL WAVES; FILAMENT INSTABILITY; ACTION-POTENTIALS; HUMAN HEARTS; OBSTACLE; REENTRY; DEFIBRILLATION; MECHANISMS; ROTATION	Cardiac arrhythmias, such as ventricular tachycardia (VT) and ventricular fibrillation (VF), are among the leading causes of death in the industrialized world. These are associated with the formation of spiral and scroll waves of electrical activation in cardiac tissue; single spiral and scroll waves are believed to be associated with VT whereas their turbulent analogs are associated with VF. Thus, the study of these waves is an important biophysical problem. We present a systematic study of the combined effects of muscle-fiber rotation and inhomogeneities on scroll-wave dynamics in the TNNP (ten Tusscher Noble Noble Panfilov) model for human cardiac tissue. In particular, we use the three-dimensional TNNP model with fiber rotation and consider both conduction and ionic inhomogeneities. We find that, in addition to displaying a sensitive dependence on the positions, sizes, and types of inhomogeneities, scroll-wave dynamics also depends delicately upon the degree of fiber rotation. We find that the tendency of scroll waves to anchor to cylindrical conduction inhomogeneities increases with the radius of the inhomogeneity. Furthermore, the filament of the scroll wave can exhibit drift or meandering, transmural bending, twisting, and break-up. If the scroll-wave filament exhibits weak meandering, then there is a fine balance between the anchoring of this wave at the inhomogeneity and a disruption of wave-pinning by fiber rotation. If this filament displays strong meandering, then again the anchoring is suppressed by fiber rotation; also, the scroll wave can be eliminated from most of the layers only to be regenerated by a seed wave. Ionic inhomogeneities can also lead to an anchoring of the scroll wave; scroll waves can now enter the region inside an ionic inhomogeneity and can display a coexistence of spatiotemporal chaos and quasi-periodic behavior in different parts of the simulation domain. We discuss the experimental implications of our study.	[Majumder, Rupamanjari; Nayak, Alok Ranjan; Pandit, Rahul] Indian Inst Sci, Dept Phys, Ctr Condensed Matter Theory, Bangalore 560012, Karnataka, India; [Pandit, Rahul] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Majumder, R (corresponding author), Indian Inst Sci, Dept Phys, Ctr Condensed Matter Theory, Bangalore 560012, Karnataka, India.	rupamanjari@physics.iisc.ernet.in	Nayak, Alok Ranjan/AAF-1119-2020; Nayak, Alok/E-2979-2016	Nayak, Alok/0000-0003-0102-0778; Breakspear, Michael/0000-0003-4943-3969	Department of Science and Technology (India); University Grants Commission (India); Microsoft Research Corporation (India); Council for Scientific and Industrial Research (India)	Department of Science and Technology (India)(Department of Science & Technology (India)); University Grants Commission (India)(University Grants Commission, India); Microsoft Research Corporation (India); Council for Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India)	The study was supported by research grants from the Department of Science and Technology (India), University Grants Commission (India), and Microsoft Research Corporation (India). ARN was supported by fellowships from the Council for Scientific and Industrial Research (India) and Microsoft Research Corporation (India). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson AP, 2007, LECT NOTES COMPUT SC, V4466, P200; Bernus O, 2002, AM J PHYSIOL-HEART C, V282, pH2296, DOI 10.1152/ajpheart.00731.2001; BRUGADA J, 1991, CIRCULATION, V84, P1296, DOI 10.1161/01.CIR.84.3.1296; Bub G, 1998, P NATL ACAD SCI USA, V95, P10283, DOI 10.1073/pnas.95.17.10283; Bub G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.058101; Bueno-Orovio A, 2008, J THEOR BIOL, V253, P544, DOI 10.1016/j.jtbi.2008.03.029; Bursac N, 2004, P NATL ACAD SCI USA, V101, P15530, DOI 10.1073/pnas.0400984101; Chen JX, 2008, CENT EUR J PHYS, V6, P427, DOI 10.2478/s11534-008-0068-3; Cherry EM, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/125016; Clayton RH, 2008, PROG BIOPHYS MOL BIO, V96, P19, DOI 10.1016/j.pbiomolbio.2007.07.004; Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008; CLUSIN WT, 1982, CIRC RES, V50, P518, DOI 10.1161/01.RES.50.4.518; DAVIDENKO JM, 1990, P NATL ACAD SCI USA, V87, P8785, DOI 10.1073/pnas.87.22.8785; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; DILLON SM, 1988, CIRC RES, V63, P182, DOI 10.1161/01.RES.63.1.182; EFIMOV IR, 2004, CIRC RES        0721; Fenton F, 1998, PHYS REV LETT, V81, P481, DOI 10.1103/PhysRevLett.81.481; Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Ferencik M, 2004, AM J CARDIOLOGY, V93, P1; Gillis AM, 2000, CIRCULATION, V101, P2438, DOI 10.1161/01.CIR.101.20.2438; GRAY RA, 1995, SCIENCE, V270, P1222, DOI 10.1126/science.270.5239.1222; Gullberg GT, 2001, MAGN RESON IMAGING, V19, P233, DOI 10.1016/S0730-725X(01)00232-6; Hwang SM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198103; Hwang SM, 2005, P NATL ACAD SCI USA, V102, P10363, DOI 10.1073/pnas.0501539102; Ikeda T, 1997, CIRC RES, V81, P753; Iravanian S, 2003, AM J PHYSIOL-HEART C, V285, pH449, DOI 10.1152/ajpheart.00896.2002; Jalife J, 1998, CHAOS, V8, P79, DOI 10.1063/1.166289; Kim YH, 1999, CIRCULATION, V100, P1450, DOI 10.1161/01.CIR.100.13.1450; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Kuijpers NHL, 2005, EUROPACE, V7, pS166, DOI 10.1016/j.eupc.2005.03.021; Li GR, 1998, AM J PHYSIOL-HEART C, V275, pH369, DOI 10.1152/ajpheart.1998.275.2.H369; Lim ZY, 2006, CIRCULATION, V114, P2113, DOI 10.1161/CIRCULATIONAHA.105.598631; LUO CH, 1994, CIRC RES, V74, P1097, DOI 10.1161/01.RES.74.6.1097; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Masse S, 2007, AM J PHYSIOL-HEART C, V292, pH2589, DOI 10.1152/ajpheart.01336.2006; Nearing BD, 1996, J CARDIOVASC PHARM, V27, P777, DOI 10.1097/00005344-199606000-00003; Panfilov AV, 1998, CHAOS, V8, P57, DOI 10.1063/1.166287; PANFILOV AV, 2007, PROCS NAT ACD SCI, V104; PERTSOV AM, 1993, CIRCULATION RES, V72; Peters NS, 1996, CLIN SCI, V90, P447, DOI 10.1042/cs0900447; Potse M, 2006, IEEE T BIO-MED ENG, V53, P2425, DOI 10.1109/TBME.2006.880875; Pumir A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.010901; QU Z, 2000, ANN BIOMED ENG, V28; Qu ZL, 2000, BIOPHYS J, V78, P2761, DOI 10.1016/S0006-3495(00)76821-4; Rappel WJ, 2001, CHAOS, V11, P71, DOI 10.1063/1.1338128; Remy-Jardin M, 2009, MED RADIOL DIAGN IMA, P161, DOI 10.1007/978-3-540-72387-5_10; Roth BJ, 2001, PHYSICA D, V150, P127, DOI 10.1016/S0167-2789(01)00145-2; Rusakov A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.022902; Shajahan TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004738; Shajahan TK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011929; Sinha S, 2002, CHAOS, V12, P893, DOI 10.1063/1.1501176; Sinha S, 2001, PHYS REV LETT, V86, P3678, DOI 10.1103/PhysRevLett.86.3678; SINHA S, 2008, EPL, V81, P50002; Starobin JM, 1996, PHYS REV E, V54, P430, DOI 10.1103/PhysRevE.54.430; ten Tusscher KHWJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.062902; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; TENTUSSCHER KHW, 2006, PROGR BIOPHYSICS MOL, V90; Valderrabano M, 2000, J AM COLL CARDIOL, V36, P2000, DOI 10.1016/S0735-1097(00)00941-4; Vigmond EJ, 2008, PROG BIOPHYS MOL BIO, V96, P3, DOI 10.1016/j.pbiomolbio.2007.07.012; Vigmond EJ, 2001, MED BIOL ENG COMPUT, V39, P455, DOI 10.1007/BF02345368; WINSLOW SDF, 2000, ANNU REV BIOMED ENG, V2; Witkowski FX, 1998, NATURE, V392, P78, DOI 10.1038/32170; Wu TJ, 2002, CIRCULATION, V106, P1859, DOI 10.1161/01.CIR.0000031334.49170.FB; Xie F, 1998, PHYS REV E, V58, P6355, DOI 10.1103/PhysRevE.58.6355; Zhang H, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026134; Zhang H, 2008, PROG BIOPHYS MOL BIO, V96, P112, DOI 10.1016/j.pbiomolbio.2007.07.020; Zhang HG, 2004, BIOCHEM BIOPH RES CO, V322, P693, DOI 10.1016/j.bbrc.2004.07.176	69	24	24	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18052	10.1371/journal.pone.0018052	http://dx.doi.org/10.1371/journal.pone.0018052			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483682	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000289191300006
J	Auld, AF; Mbofana, F; Shiraishi, RW; Sanchez, M; Alfredo, C; Nelson, LJ; Ellerbrock, T				Auld, Andrew F.; Mbofana, Francisco; Shiraishi, Ray W.; Sanchez, Mauro; Alfredo, Charity; Nelson, Lisa J.; Ellerbrock, Tedd			Four-Year Treatment Outcomes of Adult Patients Enrolled in Mozambique's Rapidly Expanding Antiretroviral Therapy Program	PLOS ONE			English	Article							HIV-INFECTED ADULTS; SUB-SAHARAN AFRICA; EARLY MORTALITY; FOLLOW-UP; SCALE-UP; PREVENTION INTERVENTIONS; MULTIPLE IMPUTATION; SEXUAL-BEHAVIOR; SOUTH-AFRICA; COTRIMOXAZOLE PROPHYLAXIS	Background: In Mozambique during 2004-2007 numbers of adult patients (>= 15 years old) enrolled on antiretroviral therapy (ART) increased about 16-fold, from <5,000 to 79,500. All ART patients were eligible for co-trimoxazole. ART program outcomes, and determinants of outcomes, have not yet been reported. Methodology/Principal Findings: In a retrospective cohort study, we investigated rates of mortality, attrition (death, loss to follow-up, or treatment cessation), immunologic treatment failure, and regimen-switch, as well as determinants of selected outcomes, among a nationally representative sample of 2,596 adults initiating ART during 2004-2007. At ART initiation, median age of patients was 34 and 62% were female. Malnutrition and advanced disease were common; 18% of patients weighed,45 kilograms, and 15% were WHO stage IV. Median baseline CD4(+) T-cell count was 153/mu L and was lower for males than females (139/mu L vs. 159/mu L, p<0.01). Stavudine, lamivudine, and nevirapine or efavirenz were prescribed to 88% of patients; only 31% were prescribed co-trimoxazole. Mortality and attrition rates were 3.4 deaths and 19.8 attritions per 100 patient-years overall, and 12.9 deaths and 57.2 attritions per 100 patient-years in the first 90 days. Predictors of attrition included male sex [adjusted hazard ratio (AHR) 1.5; 95% confidence interval (CI), 1.3-1.8], weight,45 kg (AHR 2.1; 95% CI, 1.6-2.9, reference group >60 kg), WHO stage IV (AHR 1.7; 95% CI, 1.3-2.4, reference group WHO stage I/II), lack of cotrimoxazole prescription (AHR 1.4; 95% CI, 1.0-1.8), and later calendar year of ART initiation (AHR 1.5; 95% CI, 1.2-1.8). Rates of immunologic treatment failure and regimen-switch were 14.0 and 0.6 events per 100-patient years, respectively. Conclusions: ART initiation at earlier disease stages and scale-up of co-trimoxazole among ART patients could improve outcomes. Research to determine reasons for low regimen-switch rates and increasing rates of attrition during program expansion is needed.	[Auld, Andrew F.; Shiraishi, Ray W.; Ellerbrock, Tedd] Ctr Dis Control & Prevent CDC, Div Global AIDS, Atlanta, GA 30333 USA; [Mbofana, Francisco] Minist Hlth, Natl Inst Hlth, Maputo, Mozambique; [Sanchez, Mauro; Alfredo, Charity; Nelson, Lisa J.] Ctr Dis Control & Prevent CDC, Div Global AIDS, Maputo, Mozambique	Centers for Disease Control & Prevention - USA	Auld, AF (corresponding author), Ctr Dis Control & Prevent CDC, Div Global AIDS, Atlanta, GA 30333 USA.	aauld@cdc.gov	Sanchez, Mauro/AAU-2404-2020	Sanchez, Mauro/0000-0002-0472-1804; Shiraishi, Ray/0000-0001-7640-0666; Auld, Andrew/0000-0001-5089-9163	U.S. Centers for Disease Control and Prevention (CDC)	U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	All parts of this study were funded by the United States President's Emergency Plan for AIDS Relief (PEPFAR, http://www.pepfar.gov/) through the U.S. Centers for Disease Control and Prevention (CDC). Authors employed by the CDC (Drs Auld, Shiraishi, Sanchez, Alfredo, Nelson, and Ellerbrock) contributed substantially to all parts of the study and writing of the manuscript.	Alemu AW, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5398; Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Bennett S, 2006, LANCET, V367, P79, DOI 10.1016/S0140-6736(06)67928-2; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Boerma JT, 2006, B WORLD HEALTH ORGAN, V84, P145, DOI 10.2471/BLT.05.025189; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brentlinger PE, 2010, JAIDS-J ACQ IMM DEF, V55, P351, DOI 10.1097/QAI.0b013e3181e3a4cd; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Coyne-Meyers Kristen, 2004, Nutr Clin Pract, V19, P340, DOI 10.1177/0115426504019004340; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Djomand G, 2003, AIDS, V17, pS5, DOI 10.1097/00002030-200317003-00002; Donovan C, 2007, FOOD NUTR BULL, V28, pS331, DOI 10.1177/15648265070282S212; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Fairley CK, 2005, HIV MED, V6, P366, DOI 10.1111/j.1468-1293.2005.00322.x; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Forgacs P, 2009, ANTIMICROB AGENTS CH, V53, P4789, DOI 10.1128/AAC.01658-08; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; GENG EH, 2009, J ACQ IMMUN DEF SYND, V53, P405; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Gordon CM, 2005, AIDS EDUC PREV, V17, P6, DOI 10.1521/aeap.17.2.6.58697; Gordon CM, 2004, JAIDS-J ACQ IMM DEF, V37, pS53, DOI 10.1097/01.qai.0000142321.27136.8b; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Hoffmann CJ, 2010, AIDS, V24, P1709, DOI 10.1097/QAD.0b013e32833ac6bc; Janssen RS, 2004, JAIDS-J ACQ IMM DEF, V37, pS119, DOI 10.1097/01.qai.0000140610.82134.e3; Jerene D, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-136; KAMENGA M, 1991, AIDS, V5, P61, DOI 10.1097/00002030-199101000-00009; Keiser O, 2010, TROP MED INT HEALTH, V15, P251, DOI 10.1111/j.1365-3156.2009.02445.x; Keiser O, 2009, AIDS, V23, P1867, DOI 10.1097/QAD.0b013e32832e05b2; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lowrance D, 2007, JAIDS-J ACQ IMM DEF, V46, P56; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Makombe SD, 2007, INT J TUBERC LUNG D, V11, P412; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; *MULT TECHN GROUP, IMP DEM HIV SIDA MOZ; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rosen S, 2010, TROP MED INT HEALTH, V15, P98, DOI 10.1111/j.1365-3156.2010.02512.x; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Seyler C, 2003, ANTIVIR THER, V8, P385; Sherr K, 2009, JAIDS-J ACQ IMM DEF, V52, pS20, DOI 10.1097/QAI.0b013e3181bbc9c0; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; *US CDCP, 2003, JAMA-J AM MED ASSOC, V289, P2493; Walker AS, 2010, LANCET, V375, P1278, DOI 10.1016/S0140-6736(10)60057-8; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; Wester CW, 2005, JAIDS-J ACQ IMM DEF, V40, P336, DOI 10.1097/01.qai.0000159668.80207.5b; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; WHO, 2010, ANT THER HIV INF AD; WHO, ANT THER HIV INF AD; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; World Health Organization, 2008, UN ACC SCAL PRIOR HI; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006; Zhou J, 2007, HIV MED, V8, P8, DOI 10.1111/j.1468-1293.2007.00417.x	76	74	75	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18453	10.1371/journal.pone.0018453	http://dx.doi.org/10.1371/journal.pone.0018453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483703	Green Published, gold			2022-12-27	WOS:000289058700029
J	Zanello, G; Berri, M; Dupont, J; Sizaret, PY; D'Inca, R; Salmon, H; Meurens, F				Zanello, Galliano; Berri, Mustapha; Dupont, Joelle; Sizaret, Pierre-Yves; D'Inca, Romain; Salmon, Henri; Meurens, Francois			Saccharomyces cerevisiae Modulates Immune Gene Expressions and Inhibits ETEC-Mediated ERK1/2 and p38 Signaling Pathways in Intestinal Epithelial Cells	PLOS ONE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; INFECTED T84 CELLS; DIFFICILE TOXIN-A; NF-KAPPA-B; IN-VITRO; ANTIMICROBIAL RESISTANCE; TRANSCRIPTION FACTORS; VIRULENCE FACTORS; COLONIC-MUCOSA; BOULARDII	Background: Enterotoxigenic Escherichia coli (ETEC) infections result in large economic losses in the swine industry worldwide. ETEC infections cause pro-inflammatory responses in intestinal epithelial cells and subsequent diarrhea in pigs, leading to reduced growth rate and mortality. Administration of probiotics as feed additives displayed health benefits against intestinal infections. Saccharomyces cerevisiae (Sc) is non-commensal and non-pathogenic yeast used as probiotic in gastrointestinal diseases. However, the immuno-modulatory effects of Sc in differentiated porcine intestinal epithelial cells exposed to ETEC were not investigated. Methodology/Principal Findings: We reported that the yeast Sc (strain CNCM I-3856) modulates transcript and protein expressions involved in inflammation, recruitment and activation of immune cells in differentiated porcine intestinal epithelial IPEC-1 cells. We demonstrated that viable Sc inhibits the ETEC-induced expression of pro-inflammatory transcripts (IL-6, IL-8, CCL20, CXCL2, CXCL10) and proteins (IL-6, IL-8). This inhibition was associated to a decrease of ERK1/2 and p38 MAPK phosphorylation, an agglutination of ETEC by Sc and an increase of the anti-inflammatory PPAR-c nuclear receptor mRNA level. In addition, Sc up-regulates the mRNA levels of both IL-12p35 and CCL25. However, measurement of transepithelial electrical resistance displayed that Sc failed to maintain the barrier integrity in monolayer exposed to ETEC suggesting that Sc does not inhibit ETEC enterotoxin activity. Conclusions: Sc (strain CNCM I-3856) displays multiple immuno-modulatory effects at the molecular level in IPEC-1 cells suggesting that Sc may influence intestinal inflammatory reaction.	[Zanello, Galliano; D'Inca, Romain] Soc Ind Lesaffre, Marcq En Baroeul, France; [Zanello, Galliano; Berri, Mustapha; Salmon, Henri; Meurens, Francois] INRA, UR1282, Tours, France; [Dupont, Joelle] INRA, UMR85, Tours, France; [Sizaret, Pierre-Yves] Univ Tours, Dept Microscopies, Plate Forme RIO Microscopie Elect, Tours, France	INRAE; INRAE; Universite de Tours	Zanello, G (corresponding author), Soc Ind Lesaffre, Marcq En Baroeul, France.	meurens@tours.inra.fr	Meurens, Francois JMA/J-3829-2019; salmon, henri/B-2605-2010	Meurens, Francois JMA/0000-0002-0353-4871; 	Lesaffre company; INRA; French government	Lesaffre company; INRA; French government	The study has been funded mostly by Lesaffre company and partially by INRA (<10%). GZ received a CIFRE PhD grant from Lesaffre company and the French government (50/50). GZ performed all the study at INRA under the supervision of HS and FM (INRA employees). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Adachi M, 2006, GUT, V55, P1104, DOI 10.1136/gut.2005.081745; Bandyopadhaya A, 2009, CAN J MICROBIOL, V55, P1310, DOI [10.1139/W09-093, 10.1139/w09-093]; Berkes J, 2003, GUT, V52, P439, DOI 10.1136/gut.52.3.439; Bridger PS, 2010, VET IMMUNOL IMMUNOP, V137, P54, DOI 10.1016/j.vetimm.2010.04.010; Bruel T, 2010, DEV COMP IMMUNOL, V34, P562, DOI 10.1016/j.dci.2009.12.017; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Castagliuolo I, 1999, INFECT IMMUN, V67, P302, DOI 10.1128/IAI.67.1.302-307.1999; Cekic C, 2009, J BIOL CHEM, V284, P31982, DOI 10.1074/jbc.M109.046383; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; Chen XH, 2009, GASTROENTEROLOGY, V137, P914, DOI 10.1053/j.gastro.2009.05.050; Chow AWM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012091; Czerucka D, 2000, INFECT IMMUN, V68, P5998, DOI 10.1128/IAI.68.10.5998-6004.2000; Dahan S, 2003, INFECT IMMUN, V71, P766, DOI 10.1128/IAI.71.2.766-773.2003; Dahan S, 2002, INFECT IMMUN, V70, P2304, DOI 10.1128/IAI.70.5.2304-2310.2002; Dalmasso G, 2006, RES MICROBIOL, V157, P456, DOI 10.1016/j.resmic.2005.11.007; DESREUMAUX P, 2010, SACCHAROMYCES CEREVI; Devriendt B, 2010, DEV COMP IMMUNOL, V34, P1175, DOI 10.1016/j.dci.2010.06.009; Docic M, 2003, J VET MED B, V50, P27, DOI 10.1046/j.1439-0450.2003.00609.x; Dommisch H, 2010, INNATE IMMUN-LONDON, V16, P226, DOI 10.1177/1753425909339237; Edwards-Ingram L, 2007, APPL ENVIRON MICROB, V73, P2458, DOI 10.1128/AEM.02201-06; Ericsson A, 2006, J IMMUNOL, V176, P3642, DOI 10.4049/jimmunol.176.6.3642; Escher P, 2001, ENDOCRINOLOGY, V142, P4195, DOI 10.1210/en.142.10.4195; ETIENNEMESMIN L, 2010, APPL ENV MICROBIOL; Fahey JV, 2005, HUM REPROD, V20, P1439, DOI 10.1093/humrep/deh806; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Fang L, 2000, INFECT IMMUN, V68, P564, DOI 10.1128/IAI.68.2.564-569.2000; Fietto JLR, 2004, CAN J MICROBIOL, V50, P615, DOI [10.1139/w04-050, 10.1139/W04-050]; Foligne B, 2010, WORLD J GASTROENTERO, V16, P2134, DOI 10.3748/wjg.v16.i17.2134; Frydendahl K, 2002, VET MICROBIOL, V85, P169, DOI 10.1016/S0378-1135(01)00504-1; GonzalezVallina R, 1996, AM J PHYSIOL-GASTR L, V271, pG249, DOI 10.1152/ajpgi.1996.271.2.G249; Hennequin C, 2001, J CLIN MICROBIOL, V39, P551, DOI 10.1128/JCM.39.2.551-559.2001; Huang FC, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/103890; Jin LZ, 2000, APPL MICROBIOL BIOT, V54, P311, DOI 10.1007/s002530000404; JOHNSON AM, 2009, VET MICROBIOL; Jurczyluk J, 2003, CELL BIOL INT, V27, P997, DOI 10.1016/j.cellbi.2003.09.002; Jurgens MH, 1997, J ANIM SCI, V75, P593; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; Kaplan JM, 2010, MOL MED, V16, P491, DOI 10.2119/molmed.2010.00063; Koh SY, 2008, VET MICROBIOL, V130, P191, DOI 10.1016/j.vetmic.2007.12.018; Konstantinov SR, 2008, FEMS MICROBIOL ECOL, V66, P599, DOI 10.1111/j.1574-6941.2008.00517.x; Kuhle AVDA, 2005, INT J FOOD MICROBIOL, V101, P29, DOI 10.1016/j.ijfoodmicro.2004.10.039; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Lanz R, 2003, VET MICROBIOL, V91, P73, DOI 10.1016/S0378-1135(02)00263-8; Lee Sang Kil, 2005, Korean J Gastroenterol, V45, P328; Lessard M, 2009, J ANIM SCI, V87, P922, DOI 10.2527/jas.2008-0919; Levine M M, 1981, Ciba Found Symp, V80, P142; Mansen A, 1996, BIOCHEM BIOPH RES CO, V222, P844, DOI 10.1006/bbrc.1996.0832; Martins FS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008925; Maynard C, 2003, ANTIMICROB AGENTS CH, V47, P3214, DOI 10.1128/AAC.47.10.3214-3221.2003; Meurens F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000677; Meurens F, 2006, VET IMMUNOL IMMUNOP, V113, P313, DOI 10.1016/j.vetimm.2006.05.014; Moeser AJ, 2008, WORLD J GASTROENTERO, V14, P6012, DOI 10.3748/wjg.14.6012; MUMY KL, 2007, AM J PHYSL GASTROINT; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Nighot PK, 2009, EXP CELL RES, V315, P110, DOI 10.1016/j.yexcr.2008.10.001; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Oswald IP, 2006, VET RES, V37, P359, DOI 10.1051/vetres:2006006; Perez-Sotelo Luis Salvador, 2005, Rev Latinoam Microbiol, V47, P70; Qamar A, 2001, INFECT IMMUN, V69, P2762, DOI 10.1128/IAI.69.4.2762-2765.2001; Rizzetto L, 2010, J IMMUNOL, V184, P4258, DOI 10.4049/jimmunol.0902972; Rodrigues ACP, 2000, J APPL MICROBIOL, V89, P404, DOI 10.1046/j.1365-2672.2000.01128.x; Roselli M, 2007, TOXICOL IN VITRO, V21, P224, DOI 10.1016/j.tiv.2006.09.012; Roselli M, 2007, J NUTR, V137, P2709, DOI 10.1093/jn/137.12.2709; Saegusa S, 2009, BIOSCI BIOTECH BIOCH, V73, P2600, DOI 10.1271/bbb.90410; Sanchez J, 2005, CURR OPIN IMMUNOL, V17, P388, DOI 10.1016/j.coi.2005.06.007; Scharl M, 2009, J BIOL CHEM, V284, P27952, DOI 10.1074/jbc.M109.046292; Sougioultzis S, 2006, BIOCHEM BIOPH RES CO, V343, P69, DOI 10.1016/j.bbrc.2006.02.080; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Tallant T, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-33; Valledor AF, 2008, J IMMUNOL, V180, P4523, DOI 10.4049/jimmunol.180.7.4523; Van den Broeck W, 1999, INFECT IMMUN, V67, P520, DOI 10.1128/IAI.67.2.520-526.1999; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WEIGUO Z, 2009, IMMUNOL CELL BIOL, V88, P305; Wu X, 2008, AM J PHYSIOL-GASTR L, V294, pG295, DOI 10.1152/ajpgi.00173.2007; ZANELLO G, VET IMMUNOL IN PRESS; Zanello G, 2009, CURR ISSUES MOL BIOL, V11, P47; Zhou YJ, 2009, MOL CELL BIOCHEM, V325, P131, DOI 10.1007/s11010-009-0027-3	78	98	101	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18573	10.1371/journal.pone.0018573	http://dx.doi.org/10.1371/journal.pone.0018573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483702	Green Published, gold			2022-12-27	WOS:000289058700032
J	Bruno, L; Salierno, M; Wetzler, DE; Desposito, MA; Levi, V				Bruno, Luciana; Salierno, Marcelo; Wetzler, Diana E.; Desposito, Marcelo A.; Levi, Valeria			Mechanical Properties of Organelles Driven by Microtubule-Dependent Molecular Motors in Living Cells	PLOS ONE			English	Article							SINGLE KINESIN MOLECULES; XENOPUS-LAEVIS MELANOPHORES; CYTOPLASMIC DYNEIN; INTRACELLULAR-TRANSPORT; MYOSIN-V; BIDIRECTIONAL MOTILITY; PARTICLE TRACKING; DYNACTIN; PROTEIN; MELANOSOMES	The organization of the cytoplasm is regulated by molecular motors which transport organelles and other cargoes along cytoskeleton tracks. Melanophores have pigment organelles or melanosomes that move along microtubules toward their minus and plus end by the action of cytoplasmic dynein and kinesin-2, respectively. In this work, we used single particle tracking to characterize the mechanical properties of motor-driven organelles during transport along microtubules. We tracked organelles with high temporal and spatial resolutions and characterized their dynamics perpendicular to the cytoskeleton track. The quantitative analysis of these data showed that the dynamics is due to a spring-like interaction between melanosomes and microtubules in a viscoelastic microenvironment. A model based on a generalized Langevin equation explained these observations and predicted that the stiffness measured for the motor complex acting as a linker between organelles and microtubules is, one order smaller than that determined for motor proteins in vitro. This result suggests that other biomolecules involved in the interaction between motors and organelles contribute to the mechanical properties of the motor complex. We hypothesise that the high flexibility observed for the motor linker may be required to improve the efficiency of the transport driven by multiple copies of motor molecules.	[Bruno, Luciana; Desposito, Marcelo A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, RA-1428 Buenos Aires, DF, Argentina; [Salierno, Marcelo; Wetzler, Diana E.; Levi, Valeria] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Bruno, L (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, Pabellon 1,Ciudad Univ, RA-1428 Buenos Aires, DF, Argentina.	vlevi@df.uba.ar	Salierno, Marcelo J/E-5557-2016; Salierno, Marcelo/AAA-7198-2021	Salierno, Marcelo J/0000-0003-3897-3177; Levi, Valeria/0000-0002-1666-4675; Wetzler, Diana Elena/0000-0003-2231-6690	ANPCyT [PICT 2008-1104]; UBACyT [20020090200201]	ANPCyT(ANPCyT); UBACyT	This research was supported by ANPCyT (PICT 2008-1104) and UBACyT (20020090200201). LB, MAD, DW and VL are members of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albet-Torres N, 2007, LANGMUIR, V23, P11147, DOI 10.1021/la7008682; Berezuk MA, 2007, TRAFFIC, V8, P124, DOI 10.1111/j.1600-0854.2006.00517.x; Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; BERLINER E, 1994, J BIOL CHEM, V269, P8610; Bieling P, 2008, EMBO REP, V9, P1121, DOI 10.1038/embor.2008.169; Bruno L, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011912; Bruno L, 2008, CELL BIOCHEM BIOPHYS, V52, P191, DOI 10.1007/s12013-008-9034-3; Brunstein M, 2009, BIOPHYS J, V97, P1548, DOI 10.1016/j.bpj.2009.06.048; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Caspi A, 2000, PHYS REV LETT, V85, P5655, DOI 10.1103/PhysRevLett.85.5655; Coppin CM, 1997, P NATL ACAD SCI USA, V94, P8539, DOI 10.1073/pnas.94.16.8539; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Desposito MA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021111; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Gittes F, 1997, PHYS REV LETT, V79, P3286, DOI 10.1103/PhysRevLett.79.3286; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Guo SL, 2008, PHOTOCHEM PHOTOBIOL, V84, P671, DOI 10.1111/j.1751-1097.2008.00331.x; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Higuchi H, 1997, P NATL ACAD SCI USA, V94, P4395, DOI 10.1073/pnas.94.9.4395; Ishii Y., 2003, MOL MOTORS; Jin S, 2007, BIOPHYS J, V93, P1079, DOI 10.1529/biophysj.106.102244; Kashina AS, 2004, CURR BIOL, V14, P1877, DOI 10.1016/j.cub.2004.10.003; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Kubo R., 1991, STAT PHYS; Levi V, 2006, BIOPHYS J, V90, P318, DOI 10.1529/biophysj.105.067843; Levi V, 2006, BIOPHYS J, V90, pL7, DOI 10.1529/biophysj.105.075556; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Martin DS, 2002, BIOPHYS J, V83, P2109, DOI 10.1016/S0006-3495(02)73971-4; Melkonian KA, 2007, J BIOL CHEM, V282, P19355, DOI 10.1074/jbc.M700003200; Nascimento AA, 2003, ANNU REV CELL DEV BI, V19, P469, DOI 10.1146/annurev.cellbio.19.111401.092937; Nilsson H, 1997, CELL MOTIL CYTOSKEL, V38, P397, DOI 10.1002/(SICI)1097-0169(1997)38:4<397::AID-CM9>3.3.CO;2-5; Olesen OF, 2002, GENE, V283, P299, DOI 10.1016/S0378-1119(01)00869-1; Raupach C, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011918; Rogers SL, 1999, J CELL BIOL, V146, P1265, DOI 10.1083/jcb.146.6.1265; Rogers SL, 1997, P NATL ACAD SCI USA, V94, P3720, DOI 10.1073/pnas.94.8.3720; ROZDZIAL MM, 1986, CELL, V47, P1061, DOI 10.1016/0092-8674(86)90821-4; SAMMAK PJ, 1992, J CELL BIOL, V117, P57, DOI 10.1083/jcb.117.1.57; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Tolic-Norrelykke IM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.078102; Toyabe S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041403; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; Vinales AD, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016111; Wang ZH, 1995, BIOPHYS J, V69, P2011, DOI 10.1016/S0006-3495(95)80071-8; Wilhelm C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.028101; Wong IY, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178101	56	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18332	10.1371/journal.pone.0018332	http://dx.doi.org/10.1371/journal.pone.0018332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483765	Green Published, Green Submitted, gold			2022-12-27	WOS:000289058300011
J	Yang, JR; Lin, YC; Huang, YP; Su, CH; Lo, J; Ho, YL; Yao, CY; Hsu, LC; Wu, HS; Liu, MT				Yang, Ji-Rong; Lin, Yu-Cheng; Huang, Yuan-Pin; Su, Chun-Hui; Lo, Je; Ho, Yu-Lin; Yao, Ching-Yuan; Hsu, Li-Ching; Wu, Ho-Sheng; Liu, Ming-Tsan			Reassortment and Mutations Associated with Emergence and Spread of Oseltamivir-Resistant Seasonal Influenza A/H1N1 Viruses in 2005-2009	PLOS ONE			English	Article							A(H1N1) VIRUSES; A VIRUS; SURVEILLANCE; EVOLUTION; H1N1	A dramatic increase in the frequency of the H275Y mutation in the neuraminidase (NA), conferring resistance to oseltamivir, has been detected in human seasonal influenza A/H1N1 viruses since the influenza season of 2007-2008. The resistant viruses emerged in the ratio of 14.3% and quickly reached 100% in Taiwan from September to December 2008. To explore the mechanisms responsible for emergence and spread of the resistant viruses, we analyzed the complete genome sequences of 25 viruses collected during 2005-2009 in Taiwan, which were chosen from various clade viruses, 1, 2A, 2B-1, 2B-2, 2C-1 and 2C-2 by the classification of hemagglutinin (HA) sequences. Our data revealed that the dominant variant, clade 2B-1, in the 2007-2008 influenza emerged through an intra-subtype 4+ 4 reassortment between clade 1 and 2 viruses. The dominant variant acquired additional substitutions, including A206T in HA, H275Y and D354G in NA, L30R and H41P in PB1-F2, and V411I and P453S in basic polymerase 2 (PB2) proteins and subsequently caused the 2008-2009 influenza epidemic in Taiwan, accompanying the widespread oseltamivir-resistant viruses. We also characterized another 3+ 5 reassortant virus which became double resistant to oseltamivir and amantadine. Comparison of oseltamivir-resistant influenza A/H1N1 viruses belonging to various clades in our study highlighted that both reassortment and mutations were associated with emergence and spread of these viruses and the specific mutation, H275Y, conferring to antiviral resistance, was acquired in a hitch-hiking mechanism during the viral evolutionary processes.	[Yang, Ji-Rong; Lin, Yu-Cheng; Huang, Yuan-Pin; Su, Chun-Hui; Lo, Je; Ho, Yu-Lin; Yao, Ching-Yuan; Hsu, Li-Ching; Wu, Ho-Sheng; Liu, Ming-Tsan] Ctr Dis Control, Res & Diagnost Ctr, Taipei, Taiwan; [Wu, Ho-Sheng] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan	Centers For Disease Control - Taiwan; Taipei Medical University	Yang, JR (corresponding author), Ctr Dis Control, Res & Diagnost Ctr, Taipei, Taiwan.	wuhs@cdc.gov.tw; mtliu@cdc.gov.tw			National Science Council [98-0324-01-F-20, 99-0324-01-F-12]; Centers for Disease Control, Department of Health, Taiwan [DOH98-DC-2011, DOH99-DC-2027]	National Science Council(Ministry of Science and Technology, Taiwan); Centers for Disease Control, Department of Health, Taiwan	This study was supported by grants from the National Science Council (National Research Program for Genome Medicine 98-0324-01-F-20 and 99-0324-01-F-12) and Centers for Disease Control, Department of Health, Taiwan (DOH98-DC-2011 and DOH99-DC-2027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammon A, 2009, EUROSURVEILLANCE, V14; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Baranovich T, 2010, J CLIN VIROL, V47, P23, DOI 10.1016/j.jcv.2009.11.003; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Baz M, 2010, J INFECT DIS, V201, P740, DOI 10.1086/650464; BEAN WJ, 1989, J INFECT DIS, V159, P1050, DOI 10.1093/infdis/159.6.1050; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Casalegno JS, 2010, ANTIVIR RES, V87, P242, DOI 10.1016/j.antiviral.2010.05.010; Cheng PKC, 2010, EMERG INFECT DIS, V16, P155, DOI 10.3201/eid1601.091304; Cheng PKC, 2009, EMERG INFECT DIS, V15, P966, DOI 10.3201/eid1506.081357; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gooskens J, 2009, JAMA-J AM MED ASSOC, V301, P1042, DOI 10.1001/jama.2009.297; HALL CB, 1987, PEDIATRICS, V80, P275; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; HAYDEN FG, 1991, ANTIMICROB AGENTS CH, V35, P1741, DOI 10.1128/AAC.35.9.1741; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Jian JW, 2008, J CLIN MICROBIOL, V46, P1426, DOI 10.1128/JCM.01560-07; Lackenby A., 2008, Eurosurveillance, V13, P8026; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; MUKAIGAWA J, 1991, J VIROL, V65, P245, DOI 10.1128/JVI.65.1.245-253.1991; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; Reece PA, 2007, J MED VIROL, V79, P1577, DOI 10.1002/jmv.20951; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ward Penelope, 2005, J Antimicrob Chemother, V55 Suppl 1, pi5, DOI 10.1093/jac/dki018; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; *WHO, 2009, INFL A H1N1 VIR RES; *WHO, 2009, INFL VIR RES OS OTH; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165	37	29	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18177	10.1371/journal.pone.0018177	http://dx.doi.org/10.1371/journal.pone.0018177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483816	gold, Green Published			2022-12-27	WOS:000289057200039
J	Bansal, V; Tewhey, R; LeProust, EM; Schork, NJ				Bansal, Vikas; Tewhey, Ryan; LeProust, Emily M.; Schork, Nicholas J.			Efficient and Cost Effective Population Resequencing by Pooling and In-Solution Hybridization	PLOS ONE			English	Article							RARE VARIANTS; GENETIC-VARIATION; COMPLEX DISEASES; DNA; ASSOCIATION	High-throughput sequencing of targeted genomic loci in large populations is an effective approach for evaluating the contribution of rare variants to disease risk. We evaluated the feasibility of using in-solution hybridization-based target capture on pooled DNA samples to enable cost-efficient population sequencing studies. For this, we performed pooled ;sequencing of 100 HapMap samples across similar to 600 kb of DNA sequence using the Illumina GAIIx. Using our accurate variant calling method for pooled sequence data, we were able to not only identify single nucleotide variants with a low false discovery rate (<1%) but also accurately detect short insertion/deletion variants. In addition, with sufficient coverage per individual in each pool (30-fold) we detected 97.2% of the total variants and 93.6% of variants below 5% in frequency. Finally, allele frequencies for single nucleotide variants (SNVs) estimated from the pooled data and the HapMap genotype data were tightly correlated (correlation coefficient >= 0.995).	[Bansal, Vikas; Tewhey, Ryan; Schork, Nicholas J.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Tewhey, Ryan] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [LeProust, Emily M.] Agilent Technol LLSU, Genom, Santa Clara, CA USA; [Schork, Nicholas J.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute; University of California System; University of California San Diego; Agilent Technologies; Scripps Research Institute	Bansal, V (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.	vbansal@scripps.edu; rtewhey@ucsd.edu; nschork@scripps.edu		Schork, Nicholas/0000-0003-0920-5013	Price Foundation; Scripps Genomic Medicine;  [U19 AG023122-01];  [R01 MH078151-01A1];  [N01 MH22005];  [U01 DA024417-01];  [P50 MH081755-01];  [UL1 RR025774]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH081755, R01MH078151, N01MH022005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U19AG023122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA024417] Funding Source: NIH RePORTER	Price Foundation; Scripps Genomic Medicine; ; ; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the following research grants: U19 AG023122-01, R01 MH078151-01A1, N01 MH22005, U01 DA024417-01, P50 MH081755-01, UL1 RR025774, the Price Foundation and Scripps Genomic Medicine. This work is the authors' sole responsibility and does not necessarily represent funding agencies' views. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Kim SY, 2010, GENET EPIDEMIOL, V34, P479, DOI 10.1002/gepi.20501; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Out AA, 2009, HUM MUTAT, V30, P1703, DOI 10.1002/humu.21122; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Wang T, 2010, GENET EPIDEMIOL, V34, P492, DOI 10.1002/gepi.20502	18	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18353	10.1371/journal.pone.0018353	http://dx.doi.org/10.1371/journal.pone.0018353			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479135	Green Submitted, Green Published, gold			2022-12-27	WOS:000289055700052
J	Liedtke, HC; Abjornsson, K; Harraca, V; Knudsen, JT; Wallin, EA; Hedenstrom, E; Ryne, C				Liedtke, H. Christoph; Abjornsson, Kajsa; Harraca, Vincent; Knudsen, Jette T.; Wallin, Erika A.; Hedenstrom, Erik; Ryne, Camilla			Alarm Pheromones and Chemical Communication in Nymphs of the Tropical Bed Bug Cimex hemipterus (Hemiptera: Cimicidae)	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; LECTULARIUS; COMPONENTS; BEHAVIOR; BEDBUGS	The recent resurge of bed bug infestations (Cimex spp.; Cimicidae) and their resistance to commonly used pesticides calls for alternative methods of control. Pheromones play an important role in environmentally sustainable methods for the management of many pest insects and may therefore be applicable for the control of bed bugs. The tropical bed bug, Cimex hemipterus, is a temporary ectoparasite on humans and causes severe discomfort. Compared to the common bed bug, Cimex lectularius, little is known about the chemical signalling and pheromone-based behaviour of the tropical species. Here, we show that the antennal morphology and volatile emission of C. hemipterus closely resembles those of C. lectularius and we test their behavioural responses to conspecific odour emissions. Two major volatiles are emitted by male, female and nymph C. hemipterus under stress, (E)-2-hexenal and (E)-2-octenal. Notably, nymph emissions show contrasting ratios of these compounds to adults and are further characterized by the addition of 4-oxo-(E)-2-hexenal and 4-oxo-(E)-2-octenal. The discovery of this nymph pheromone in C. hemipterus is potentially the cause of a repellent effect observed in the biotests, where nymph odours induce a significantly stronger repellent reaction in conspecifics than adult odours. Our results suggest that pheromone-based pest control methods developed for C. lectularius could be applicable to C. hemipterus, with the unique nymph blend showing promising practical properties.	[Liedtke, H. Christoph; Abjornsson, Kajsa; Harraca, Vincent; Knudsen, Jette T.; Wallin, Erika A.; Hedenstrom, Erik; Ryne, Camilla] Lund Univ, Dept Ecol, S-22362 Lund, Sweden; [Wallin, Erika A.; Hedenstrom, Erik] Engn & Math Mid Sweden Univ, Dept Nat Sci, Sundsvall, Sweden	Lund University	Liedtke, HC (corresponding author), Lund Univ, Dept Ecol, S-22362 Lund, Sweden.	jette.knudsen@ekol.lu.se	Liedtke, H. Christoph/K-2253-2015	Liedtke, H. Christoph/0000-0002-6221-8043; Harraca, Vincent/0000-0002-9506-0895	Swedish International Development Agency [SWE 2005-340]; Crafoord Foundation [20080561]; Carl Trygger Foundation [CTS 03:278]; LU; EU Foundation; Lanstyrelsen i Vasternorrlands lan	Swedish International Development Agency; Crafoord Foundation; Carl Trygger Foundation; LU; EU Foundation; Lanstyrelsen i Vasternorrlands lan	Swedish International Development Agency (SWE 2005-340); Crafoord Foundation (20080561); Carl Trygger Foundation (CTS 03:278); LU travel stipend for CR; EU Foundation, and Lanstyrelsen i Vasternorrlands lan for EW and EH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH JR, 1988, ANNU REV ENTOMOL, V33, P211, DOI 10.1146/annurev.en.33.010188.001235; Benoit JB, 2009, J MED ENTOMOL, V46, P572, DOI 10.1603/033.046.0323; Blum M.S., 1985, P193; Blum MS, 1996, ANNU REV ENTOMOL, V41, P353, DOI 10.1146/annurev.en.41.010196.002033; BOASE C, 2007, BED BUGS RES RESURGE, P261; Boase Clive J., 2004, Biologist (London), V51, P9; Burgess I., 2003, PROFESSIONAL PEST CO, V32, P16; CARAYON J, 1971, ANN SOC ENTOMOL FR, V7, P737; Cleary Carmen J, 2004, Nurse Pract, V29, P46, DOI 10.1097/00006205-200406000-00009; DOGGETT SL, 2003, ENV HLTH, P80; DOGGETT SL, 2004, ENV HLTH, P30; Feldlaufer MF, 2010, J MED ENTOMOL, V47, P140, DOI 10.1603/ME09210; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; GEBHARDT H, 1953, ZOOL JB PHYSL, P558; Harraca V, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-121; Harraca V, 2010, CHEM SENSES, V35, P195, DOI 10.1093/chemse/bjp096; Karunaratne SHPP, 2007, PESTIC BIOCHEM PHYS, V88, P102, DOI 10.1016/j.pestbp.2006.09.006; LEVINSON HZ, 1974, NATURWISSENSCHAFTEN, V61, P684, DOI 10.1007/BF00606522; LEVINSON HZ, 1974, J INSECT PHYSIOL, V20, P1231, DOI 10.1016/0022-1910(74)90229-7; LEVINSON HZ, 1971, EXPERIENTIA, V27, P102, DOI 10.1007/BF02137766; MCIVER SB, 1987, INSECT SCI APPL, V8, P627, DOI 10.1017/S1742758400022712; Montes C, 2002, J MED ENTOMOL, V39, P675, DOI 10.1603/0022-2585-39.4.675; Moreira JA, 2005, J CHEM ECOL, V31, P965, DOI 10.1007/s10886-004-1978-1; Myamba J, 2002, MED VET ENTOMOL, V16, P448, DOI 10.1046/j.1365-2915.2002.00389.x; NEWBERRY K, 1989, MED VET ENTOMOL, V3, P407, DOI 10.1111/j.1365-2915.1989.tb00248.x; Olson JF, 2009, J INSECT PHYSIOL, V55, P580, DOI 10.1016/j.jinsphys.2009.03.001; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Ryne C, 2009, ANIM BEHAV, V78, P1471, DOI 10.1016/j.anbehav.2009.09.033; Siljander E, 2008, J CHEM ECOL, V34, P708, DOI 10.1007/s10886-008-9446-y; Singh RN, 1996, INT J INSECT MORPHOL, V25, P183, DOI 10.1016/0020-7322(95)00016-X; Siva-Jothy MT, 2006, PHILOS T ROY SOC B, V361, P269, DOI 10.1098/rstb.2005.1789; Staddon B.W., 1979, Advances in Insect Physiology, V14, P351, DOI 10.1016/S0065-2806(08)60055-7; STEINBRECHT RA, 1976, TISSUE CELL, V8, P615, DOI 10.1016/0040-8166(76)90035-5; Usinger R. L., 1966, MONOGRAPH CIMICIDAE; Valeur PG, 1999, PHYSIOL ENTOMOL, V24, P240, DOI 10.1046/j.1365-3032.1999.00138.x	36	17	18	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18156	10.1371/journal.pone.0018156	http://dx.doi.org/10.1371/journal.pone.0018156			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479180	Green Submitted, Green Published, gold			2022-12-27	WOS:000289055700035
J	Mesoudi, A				Mesoudi, Alex			Variable Cultural Acquisition Costs Constrain Cumulative Cultural Evolution	PLOS ONE			English	Article							GROWTH; DEMOGRAPHY; IMITATION; SCOPE	One of the hallmarks of the human species is our capacity for cumulative culture, in which beneficial knowledge and technology is accumulated over successive generations. Yet previous analyses of cumulative cultural change have failed to consider the possibility that as cultural complexity accumulates, it becomes increasingly costly for each new generation to acquire from the previous generation. In principle this may result in an upper limit on the cultural complexity that can be accumulated, at which point accumulated knowledge is so costly and time-consuming to acquire that further innovation is not possible. In this paper I first review existing empirical analyses of the history of science and technology that support the possibility that cultural acquisition costs may constrain cumulative cultural evolution. I then present macroscopic and individual-based models of cumulative cultural evolution that explore the consequences of this assumption of variable cultural acquisition costs, showing that making acquisition costs vary with cultural complexity causes the latter to reach an upper limit above which no further innovation can occur. These models further explore the consequences of different cultural transmission rules (directly biased, indirectly biased and unbiased transmission), population size, and cultural innovations that themselves reduce innovation or acquisition costs.	Queen Mary Univ London, Sch Biol & Chem Sci, Biol & Expt Psychol Grp, London, England	University of London; Queen Mary University London	Mesoudi, A (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Biol & Expt Psychol Grp, London, England.	a.mesoudi@qmul.ac.uk	Mesoudi, Alex/K-4410-2012	Mesoudi, Alex/0000-0002-7740-1625				Arbesman S, 2011, SCIENTOMETRICS, V86, P245, DOI 10.1007/s11192-010-0232-6; Arthur W. B., 2009, NATURE TECHNOLOGY; Atran S, 2001, HUM NATURE-INT BIOS, V12, P351, DOI 10.1007/s12110-001-1003-0; Basalla G., 1988, EVOLUTION TECHNOLOGY; Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; Bloom P, 2007, SCIENCE, V316, P996, DOI 10.1126/science.1133398; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd R., 1992, HIST EVOLUTION, P178; Boyd Robert, 1996, Proceedings of the British Academy, V88, P77; Catchpole CK, 1995, BIRD SONG BIOL THEME; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; De Solla Price D. J., 1963, LITTLE SCI BIG SCI, DOI 10.7312/pric91844; Enquist M, 2008, THEOR POPUL BIOL, V74, P46, DOI 10.1016/j.tpb.2008.04.007; Enquist M, 2011, PHILOS T R SOC B, V366, P412, DOI 10.1098/rstb.2010.0132; Eriksson K., 2007, J EVOL PSYCHOL, V5, P67, DOI [10.1556/JEP.2007.1009, DOI 10.1556/JEP.2007.1009]; GITTLEMAN A, 1975, HIST MATH; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Hill K, 2009, EVOL ANTHROPOL, V18, P187, DOI 10.1002/evan.20224; Jones BF, 2010, REV ECON STAT, V92, P1, DOI 10.1162/rest.2009.11724; Kelemen D, 1999, COGNITION, V70, P241, DOI 10.1016/S0010-0277(99)00010-4; Lipo CP, 2006, MAPPING OUR ANCESTOR; MAY KO, 1966, SCIENCE, V154, P1672, DOI 10.1126/science.154.3757.1672; Mesoudi A, 2004, EVOLUTION, V58, P1; Mesoudi A., CULTURAL EV IN PRESS; Mesoudi A, 2008, EVOL HUM BEHAV, V29, P350, DOI 10.1016/j.evolhumbehav.2008.04.005; Mesoudi A, 2008, AM ANTIQUITY, V73, P3, DOI 10.2307/25470456; Mesoudi A, 2008, BIOL PHILOS, V23, P243, DOI 10.1007/s10539-007-9097-3; Mesoudi A, 2009, EVOL HUM BEHAV, V30, P41, DOI 10.1016/j.evolhumbehav.2008.07.005; Ogburn W. F., 1950, SOCIAL CHANGE; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Richerson P. J, 2005, NOT GENES ALONE; Sahlins Marshall, 1960, EVOLUTION CULTURE; Schummer J, 1997, SCIENTOMETRICS, V39, P107, DOI 10.1007/BF02457433; Segerstrom PS, 1998, AM ECON REV, V88, P1290; Sperber Dan, 1996, EXPLAINING CULTURE N; Strimling P, 2009, THEOR POPUL BIOL, V76, P77, DOI 10.1016/j.tpb.2009.04.006; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; Vincenti W., 1993, WHAT ENG KNOW THEY K; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069; Wilder R., 1968, EVOLUTION MATH CONCE	44	97	99	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18239	10.1371/journal.pone.0018239	http://dx.doi.org/10.1371/journal.pone.0018239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YK	21479170	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000289055700040
J	Grandes, G; Sanchez, A; Montoya, I; Sanchez-Pinilla, RO; Torcal, J				Grandes, Gonzalo; Sanchez, Alvaro; Montoya, Imanol; Ortega Sanchez-Pinilla, Ricardo; Torcal, Jesus		PEPAF Grp	Two-Year Longitudinal Analysis of a Cluster Randomized Trial of Physical Activity Promotion by General Practitioners	PLOS ONE			English	Article							PRIMARY-CARE; LEISURE-TIME; HEALTH	Background: We evaluate the effectiveness of a physical activity promotion programme carried out by general practitioners with inactive patients in routine care. Methods and Findings: Pragmatic, cluster randomised clinical trial conducted in eleven public primary care centres in Spain. Fifty-six general practitioners (GPs) were randomly assigned to intervention (29) or standard care (27) groups. They assessed the physical activity level of a systematic sample of patients in routine practice and recruited 4317 individuals (2248 intervention and 2069 control) who did not meet minimum physical activity recommendations. Intervention GPs provided advice to all patients and a physical activity prescription to the subgroup attending an additional appointment (30%). A third of these prescriptions were opportunistically repeated. Control GPs provided standard care. Primary outcome measure was the change in self-reported physical activity from baseline to six, 12 and 24 months. Secondary outcomes included cardiorespiratory fitness and health-related quality of life. A total of 3691 patients (85%) were included in the longitudinal analysis and overall trends over the whole 24 month follow-up were significantly better in the intervention group (p < 0.01). The greatest differences with the control group were observed at six months (adjusted difference 1.7 MET*hr/wk [95% CI, 0.8 to 2.6], 25 min/wk [95% CI, 11.3 to 38.4], and a 5.3% higher percentage of patients meeting minimum recommendations [95% CI: 2.1% to 8.8%] NNT = 19). These differences were not statistically significant at 12 and 24 months. No differences were found in secondary outcomes. A significant difference was maintained until 24 months in the proportion of patients achieving minimum recommendation in the subgroup that received a repeat prescription (adjusted difference 10.2%, 95% CI 1.5% to 19.4%). Conclusions: General practitioners are effective at increasing the level of physical activity among their inactive patients during the initial six-months of an intervention but this effect wears off at 12 and 24 months. Only in the subgroup of patients receiving repeat prescriptions of physical activity is the effect maintained in long-term.	[Grandes, Gonzalo; Sanchez, Alvaro; Montoya, Imanol] BHS, Primary Care Res Unit Bizkaia, Bilbao, Spain; [Ortega Sanchez-Pinilla, Ricardo] Castilla La Mancha Healthcare Serv, Santa Barbara Primary Care Ctr, Toledo, Spain; [Torcal, Jesus] Basque Healthcare Serv, Basauri Ariz Primary Care Ctr, Basauri, Spain		Grandes, G (corresponding author), BHS, Primary Care Res Unit Bizkaia, Bilbao, Spain.	gonzalo.grandes@osakidetza.net	torcal, jesus/E-3594-2012; Prevencion, Integracion/E-5463-2012; grandes, gonzalo/E-1753-2012; Grandes, Gonzalo/E-3040-2012	SANCHEZ, ALVARO/0000-0003-1163-9849; Recio-Rodriguez, Jose I/0000-0002-3772-8746; Sanchez, Alvaro/0000-0001-8600-2119	Carlos III Institute of Health of the Spanish Ministry of Health; European Union [FIS PI02/0015, RETICS G03/170, RD06/0018/0018, CAIBERCAI08/01/0065]	Carlos III Institute of Health of the Spanish Ministry of Health(Instituto de Salud Carlos III); European Union(European Commission)	The project was supported by the Carlos III Institute of Health of the Spanish Ministry of Health, and co-financed by ERDF funding of the European Union (FIS PI02/0015; RETICS G03/170 and RD06/0018/0018; CAIBERCAI08/01/0065). The authors are totally independent of the sponsors and have full responsibility for the implementation of the study and the publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Arnaiz AG, 2001, MED CLIN-BARCELONA, V116, P121, DOI 10.1016/S0025-7753(01)71745-9; Balady GJ, 2000, ACSMS GUIDELINES EXE; Bize R, 2007, PREV MED, V45, P401, DOI 10.1016/j.ypmed.2007.07.017; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Department of Health Physical Activity Health Improvement and Prevention, 2004, LEAST 5 WEEK EV IMP; Foster C., 2005, COCHRANE DB SYST REV, V1, P1, DOI 10.1002/14651858.cd003180.pub2; Grandes G, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-213; Grandes G, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-172; Grandes G, 2009, ARCH INTERN MED, V169, P694, DOI 10.1001/archinternmed.2009.23; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Johnson-Kozlow M, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-7; Lawton BA, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2509; Leenders NYJM, 2001, MED SCI SPORT EXER, V33, P1233; Martinez-Gonzalez MA, 2001, MED SCI SPORT EXER, V33, P1142, DOI 10.1097/00005768-200107000-00011; Matthews CE, 2001, AM J EPIDEMIOL, V153, P172, DOI 10.1093/aje/153.2.172; Muller-Riemenschneider F, 2008, PREV MED, V47, P354, DOI 10.1016/j.ypmed.2008.07.006; *NAT I HLTH CLIN E, 2006, NICE PUBL HLTH INT G, V2; Physical Activity Guidelines Advisory Committee, 2008, REP PHYS ACT GUID AD; Pinto BM, 2001, ANN BEHAV MED, V23, P2, DOI 10.1207/S15324796ABM2301_2; Rankinen T, 2007, AM J EPIDEMIOL, V166, P260, DOI 10.1093/aje/kwm130; RAUH MJD, 1992, INT J EPIDEMIOL, V21, P966, DOI 10.1093/ije/21.5.966; Reed GR, 1997, AM J HEALTH PROMOT, V12, P57, DOI 10.4278/0890-1171-12.1.57; SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987; Sanchez A, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-103; Simons-Morton DG, 2001, JAMA-J AM MED ASSOC, V286, P677; Torgerson DJ, 2001, BMJ-BRIT MED J, V322, P355, DOI 10.1136/bmj.322.7282.355; US Preventive Services Task Force, BEH COUNS PRIM CAR P; van Sluijs EMF, 2006, J CLIN EPIDEMIOL, V59, P404, DOI 10.1016/j.jclinepi.2005.08.016; Verbeke G, 2000, LINEAR MIXED MODELS; Wee CC, 2001, JAMA-J AM MED ASSOC, V286, P717, DOI 10.1001/jama.286.6.717; GREEN PRESCRIPTION W; [No title captured]	33	36	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18363	10.1371/journal.pone.0018363	http://dx.doi.org/10.1371/journal.pone.0018363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479243	Green Published, gold, Green Submitted			2022-12-27	WOS:000289054600051
J	Konstantinopoulos, PA; Cannistra, SA; Fountzilas, H; Culhane, A; Pillay, K; Rueda, B; Cramer, D; Seiden, M; Birrer, M; Coukos, G; Zhang, L; Quackenbush, J; Spentzos, D				Konstantinopoulos, Panagiotis A.; Cannistra, Stephen A.; Fountzilas, Helen; Culhane, Aedin; Pillay, Kamana; Rueda, Bo; Cramer, Daniel; Seiden, Michael; Birrer, Michael; Coukos, George; Zhang, Lin; Quackenbush, John; Spentzos, Dimitrios			Integrated Analysis of Multiple Microarray Datasets Identifies a Reproducible Survival Predictor in Ovarian Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; GENOMIC SIGNATURES; STAGE-III; PACLITAXEL; CISPLATIN; PATTERNS; PATHWAY; CELL; CARBOPLATIN; CARCINOMA	Background: Public data integration may help overcome challenges in clinical implementation of microarray profiles. We integrated several ovarian cancer datasets to identify a reproducible predictor of survival. Methodology/Principal Findings: Four microarray datasets from different institutions comprising 265 advanced stage tumors were uniformly reprocessed into a single training dataset, also adjusting for inter-laboratory variation ("batcheffect"). Supervised principal component survival analysis was employed to identify prognostic models. Models were independently validated in a 61-patient cohort using a custom array genechip and a publicly available 229-array dataset. Molecular correspondence of high-and low-risk outcome groups between training and validation datasets was demonstrated using Subclass Mapping. Previously established molecular phenotypes in the 2(nd) validation set were correlated with high and low-risk outcome groups. Functional representational and pathway analysis was used to explore gene networks associated with high and low risk phenotypes. A 19-gene model showed optimal performance in the training set (median OS 31 and 78 months, p < 0.01), 1(st) validation set (median OS 32 months versus not-yet-reached, p=0.026) and 2(nd) validation set (median OS 43 versus 61 months, p=0.013) maintaining independent prognostic power in multivariate analysis. There was strong molecular correspondence of the respective high-and low-risk tumors between training and 1(st) validation set. Low and high-risk tumors were enriched for favorable and unfavorable molecular subtypes and pathways, previously defined in the public 2(nd) validation set. Conclusions/Significance: Integration of previously generated cancer microarray datasets may lead to robust and widely applicable survival predictors. These predictors are not simply a compilation of prognostic genes but appear to track true molecular phenotypes of good-and poor-outcome.	[Konstantinopoulos, Panagiotis A.; Cannistra, Stephen A.; Fountzilas, Helen; Pillay, Kamana; Spentzos, Dimitrios] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med,Sch Med, Boston, MA 02215 USA; [Culhane, Aedin; Quackenbush, John] Harvard Univ, Dept Biostat & Computat Biol, Dana Farber Canc Inst, Dept Biostat,Sch Publ Hlth, Boston, MA 02215 USA; [Rueda, Bo] Harvard Univ, Dept Obstet Gynecol & Reprod Biol, Massachusetts Gen Hosp, Sch Med, Boston, MA 02215 USA; [Cramer, Daniel] Harvard Univ, Dept Obstet Gynecol & Reprod Biol, Brigham & Womens Hosp, Sch Med, Boston, MA 02215 USA; [Seiden, Michael] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Birrer, Michael] Harvard Univ, Div Gynecol Med Oncol, Massachusetts Gen Hosp, Sch Med, Boston, MA 02215 USA; [Coukos, George; Zhang, Lin] Univ Penn, Dept Gynecol Oncol, Philadelphia, PA 19104 USA; [Quackenbush, John] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Fox Chase Cancer Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Pennsylvania; Harvard University; Dana-Farber Cancer Institute	Konstantinopoulos, PA (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med,Sch Med, Boston, MA 02215 USA.	dspentzo@bidmc.harvard.edu	Culhane, Aedin/AAG-8490-2019; Coukos, George/ABG-7389-2020; Zhang, Lin/K-8478-2012	Culhane, Aedin/0000-0002-1395-9734; Coukos, George/0000-0001-8813-7367; Quackenbush, John/0000-0002-2702-5879	NIH/NCI [P50CA105009]; Clinical Investigation Training Program; Beth Israel Deaconess Medical Center; Harvard-MIT Division of Health Sciences and Technology, Boston; Bernice Shopkin Weisman Fund; Ovarian Cancer Research Fund in memory of Amy Sachs Simon; LeAnn's Fund; Sisters Against Ovarian Cancer; NATIONAL CANCER INSTITUTE [P50CA105009] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Clinical Investigation Training Program; Beth Israel Deaconess Medical Center; Harvard-MIT Division of Health Sciences and Technology, Boston; Bernice Shopkin Weisman Fund; Ovarian Cancer Research Fund in memory of Amy Sachs Simon; LeAnn's Fund; Sisters Against Ovarian Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported via the NIH/NCI P50CA105009 Ovarian Cancer SPORE (Career Development Award to Dimitrios Spentzos, and Project 4 to Daniel Cramer/Stephen Cannistra), the Clinical Investigation Training Program, Beth Israel Deaconess Medical Center and Harvard-MIT Division of Health Sciences and Technology, Boston, to Panagiotis Konstantinopoulos, the Bernice Shopkin Weisman Fund, the Ovarian Cancer Research Fund in memory of Amy Sachs Simon, LeAnn's Fund, and the Sisters Against Ovarian Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Baggerly KA, 2008, J CLIN ONCOL, V26, P1186, DOI 10.1200/JCO.2007.15.1951; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Barash Y, 2004, BIOINFORMATICS, V20, P839, DOI 10.1093/bioinformatics/btg487; Berchuck A, 2005, CLIN CANCER RES, V11, P3686, DOI 10.1158/1078-0432.CCR-04-2398; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Culhane AC, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-59; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hoshida Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001195; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Konstantinopoulos PA, 2008, NAT CLIN PRACT ONCOL, V5, P577, DOI 10.1038/ncponc1178; Konstantinopoulos PA, 2009, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-59; Lancaster JM, 2004, J SOC GYNECOL INVEST, V11, P51, DOI 10.1016/j.jsgi.2003.07.004; Marquez RT, 2005, CLIN CANCER RES, V11, P6116, DOI 10.1158/1078-0432.CCR-04-2509; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Meinhold-Heerlein I, 2005, ONCOGENE, V24, P1053, DOI 10.1038/sj.onc.1208298; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Pohl G, 2005, CANCER RES, V65, P1994, DOI 10.1158/0008-5472.CAN-04-3625; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Schwartz DR, 2002, CANCER RES, V62, P4722; Selvakumaran M, 2003, CANCER RES, V63, P1311; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Smith S, 2007, J CLIN ONCOL, V25, P5172, DOI 10.1200/JCO.2007.11.8547; Spentzos D, 2004, J CLIN ONCOL, V22, P4700, DOI 10.1200/JCO.2004.04.070; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; THIGPEN T, 1993, CANCER-AM CANCER SOC, V71, P606; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	34	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18202	10.1371/journal.pone.0018202	http://dx.doi.org/10.1371/journal.pone.0018202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479231	Green Published, gold, Green Submitted			2022-12-27	WOS:000289054600033
J	Axelsson, M; Brink, E; Lundgren, J; Lotvall, J				Axelsson, Malin; Brink, Eva; Lundgren, Jesper; Lotvall, Jan			The Influence of Personality Traits on Reported Adherence to Medication in Individuals with Chronic Disease: An Epidemiological Study in West Sweden	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; QUALITY-OF-LIFE; 5-FACTOR MODEL; INHALED CORTICOSTEROIDS; NONADHERENCE; ASTHMA; HEALTH; PREDICTORS; OUTCOMES; BELIEFS	Background: Limited research exists exploring the influence of personality on adherence behaviour. Since non-adherence is a major obstacle in treating prevalent chronic diseases the aim was to determine whether personality traits are related to reported adherence to medication in individuals with chronic disease. Methodology/Principal Findings: Individuals with chronic disease (n = 749) were identified in a random population sample of 5000 inhabitants aged 30-70 in two municipalities in West Sweden. Data on five personality traits, Neuroticism, Extraversion, Openness to experiences, Agreeableness, and Conscientiousness, and medication adherence behaviour was collected by questionnaires. Statistical analyses resulted in a negative relationship between Neuroticism and medication adherence (P < 0.001), while both Agreeableness (P < 0.001) and Conscientiousness (P < 0.001) were positively related to adherence. At high levels of Conscientiousness, low adherence was related to higher scores in Neuroticism. At high levels of Agreeableness, low adherence was related to low scores in Conscientiousness and high scores in Openness to experiences. Conclusions: This study demonstrated that multiple personality traits are of significant importance for adherence behaviour in individuals with chronic disease. The findings suggest that several personality traits may interact in influencing adherence behaviour. Personality traits could putatively be used to focus efforts to educate and support patients with high risk of low medical adherence.	[Axelsson, Malin; Lotvall, Jan] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Krefting Res Ctr, Gothenburg, Sweden; [Axelsson, Malin; Brink, Eva] Univ West, Dept Nursing Hlth & Culture, Trollhattan, Sweden; [Brink, Eva] Univ Gothenburg, Sahlgrenska Acad, Inst Hlth & Care Sci, S-40020 Gothenburg, Sweden; [Lundgren, Jesper] Univ Gothenburg, Dept Psychol, S-40020 Gothenburg, Sweden	University of Gothenburg; University West - Sweden; University of Gothenburg; University of Gothenburg	Axelsson, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Krefting Res Ctr, Gothenburg, Sweden.	malin.axelsson@gu.se	Lundgren, Jesper/AAD-6298-2019	Lotvall, Jan/0000-0001-9195-9249; Brink, Eva/0000-0001-7804-0342	VBG GROUP CENTRE for Asthma and Allergy Research at the University of Gothenburg; Herman Krefting Foundation against Asthma Allergy	VBG GROUP CENTRE for Asthma and Allergy Research at the University of Gothenburg; Herman Krefting Foundation against Asthma Allergy	Funding was provided by the VBG GROUP CENTRE for Asthma and Allergy Research at the University of Gothenburg and the Herman Krefting Foundation against Asthma Allergy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ADHERENCE LONG TERM; Axelsson M, 2009, RESP MED, V103, P1033, DOI 10.1016/j.rmed.2009.01.013; Brace N., 2006, SPSS PSYCHOLOGISTS G, V3rd; Bruce JM, 2010, J BEHAV MED, V33, P219, DOI 10.1007/s10865-010-9247-y; CHRISTENSEN AJ, 1995, J BEHAV MED, V18, P305, DOI 10.1007/BF01857875; Cohen JL, 2009, ANN ALLERG ASTHMA IM, V103, P325, DOI 10.1016/S1081-1206(10)60532-7; Cohen NL, 2004, CAN J PSYCHIAT, V49, P106, DOI 10.1177/070674370404900205; COSTA PT, 1987, J PERS, V55, P299, DOI 10.1111/j.1467-6494.1987.tb00438.x; Costa PT, 2007, REVISED NEO PERSONAL; Courneya KS, 2002, ANN BEHAV MED, V24, P257, DOI 10.1207/S15324796ABM2404_02; Ediger JP, 2007, AM J GASTROENTEROL, V102, P1417, DOI 10.1111/j.1572-0241.2007.01212.x; George J, 2005, CHEST, V128, P3198, DOI 10.1378/chest.128.5.3198; Good P, 2000, PERMUTATION TESTS PR; Hampson SE, 2007, HEALTH PSYCHOL, V26, P121, DOI 10.1037/0278-6133.26.1.121; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Ho PM, 2008, AM HEART J, V155, P772, DOI 10.1016/j.ahj.2007.12.011; Horne R, 2002, PSYCHOL HEALTH, V17, P17, DOI 10.1080/08870440290001502; Jentzsch NS, 2009, ALLERGY, V64, P1458, DOI 10.1111/j.1398-9995.2009.02037.x; McCrae R. R., 2002, PERSONALITY ADULTHOO; Menckeberg TT, 2008, J PSYCHOSOM RES, V64, P47, DOI 10.1016/j.jpsychores.2007.07.016; O'Cleirigh C, 2007, HEALTH PSYCHOL, V26, P473, DOI 10.1037/0278-6133.26.4.473; O'Connor BP, 2002, ASSESSMENT, V9, P188, DOI 10.1177/10791102009002010; Otsuki MC-B E, 2008, HDB HLTH BEHAV CHANG, P309; Penedo FJ, 2003, J PSYCHOSOM RES, V54, P271, DOI 10.1016/S0022-3999(02)00482-8; Perreault S, 2010, BRIT J CLIN PHARMACO, V69, P74, DOI 10.1111/j.1365-2125.2009.03547.x; Schumaker L., 2007, SPLINE FUNCTIONS BAS, DOI DOI 10.1017/CBO9780511618994; SMITH TW, 1992, J PERS, V60, P395, DOI 10.1111/j.1467-6494.1992.tb00978.x; Stilley CS, 2004, ANN BEHAV MED, V27, P117, DOI 10.1207/s15324796abm2702_6; Telles-Correia D, 2009, TRANSPL P, V41, P1731, DOI 10.1016/j.transproceed.2009.02.067; Terracciano A, 2004, ADDICTION, V99, P472, DOI 10.1111/j.1360-0443.2004.00687.x; Timmreck TC, 1998, INTRO EPIDEMIOLOGY; Williams LK, 2004, J ALLERGY CLIN IMMUN, V114, P1288, DOI 10.1016/j.jaci.2004.09.028	32	83	87	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18241	10.1371/journal.pone.0018241	http://dx.doi.org/10.1371/journal.pone.0018241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743XV	21464898	Green Published, gold, Green Submitted			2022-12-27	WOS:000289053800032
J	Itkin, A; Dupres, V; Dufrene, YF; Bechinger, B; Ruysschaert, JM; Raussens, V				Itkin, Anna; Dupres, Vincent; Dufrene, Yves F.; Bechinger, Burkhard; Ruysschaert, Jean-Marie; Raussens, Vincent			Calcium Ions Promote Formation of Amyloid beta-Peptide (1-40) Oligomers Causally Implicated in Neuronal Toxicity of Alzheimer's Disease	PLOS ONE			English	Article							LONG-TERM POTENTIATION; A-BETA; PHYSIOLOGICAL CONCENTRATIONS; SOLUBLE OLIGOMERS; THIOFLAVIN-T; PROTEIN; CA2+; NEURODEGENERATION; AGGREGATION; CHANNELS	Amyloid beta-peptide (A beta) is directly linked to Alzheimer's disease (AD). In its monomeric form, A beta aggregates to produce fibrils and a range of oligomers, the latter being the most neurotoxic. Dysregulation of Ca2+ homeostasis in aging brains and in neurodegenerative disorders plays a crucial role in numerous processes and contributes to cell dysfunction and death. Here we postulated that calcium may enable or accelerate the aggregation of A beta. We compared the aggregation pattern of A beta(1-40) and that of A beta(1-40)E22G, an amyloid peptide carrying the Arctic mutation that causes early onset of the disease. We found that in the presence of Ca2+, A beta(1-40) preferentially formed oligomers similar to those formed by A beta(1-40) E22G with or without added Ca2+, whereas in the absence of added Ca2+ the A beta(1-40) aggregated to form fibrils. Morphological similarities of the oligomers were confirmed by contact mode atomic force microscopy imaging. The distribution of oligomeric and fibrillar species in different samples was detected by gel electrophoresis and Western blot analysis, the results of which were further supported by thioflavin T fluorescence experiments. In the samples without Ca2+, Fourier transform infrared spectroscopy revealed conversion of oligomers from an anti-parallel beta-sheet to the parallel b-sheet conformation characteristic of fibrils. Overall, these results led us to conclude that calcium ions stimulate the formation of oligomers of A beta(1-40), that have been implicated in the pathogenesis of AD.	[Itkin, Anna; Ruysschaert, Jean-Marie; Raussens, Vincent] Univ Libre Bruxelles, Ctr Struct Biol & Bioinformat, Lab Struct & Funct Biol Membranes, Brussels, Belgium; [Itkin, Anna; Bechinger, Burkhard] Univ Strasbourg, Int Ctr Frontier Res Chem, Inst Chem, Strasbourg, France; [Itkin, Anna; Bechinger, Burkhard] Univ Strasbourg, NMR, Strasbourg, France; [Dupres, Vincent; Dufrene, Yves F.] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium	Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite Catholique Louvain	Itkin, A (corresponding author), Univ Libre Bruxelles, Ctr Struct Biol & Bioinformat, Lab Struct & Funct Biol Membranes, Brussels, Belgium.	vrauss@ulb.ac.be	Dupres, Vincent/GLQ-5321-2022	Dupres, Vincent/0000-0002-1970-3633; Dufrene, Yves/0000-0002-7289-4248	European Community [MRTN-CT-2006-033439]; National Foundation for Scientific Research (FNRS); Foundation for Training in Industrial and Agricultural Research (FRIA); Universite Catholique de Louvain; Federal Office for Scientific, Technical and Cultural Affairs; Research Department of the Communaute Francaise de Belgique	European Community(European Commission); National Foundation for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Foundation for Training in Industrial and Agricultural Research (FRIA)(Fonds de la Recherche Scientifique - FNRS); Universite Catholique de Louvain; Federal Office for Scientific, Technical and Cultural Affairs; Research Department of the Communaute Francaise de Belgique	This work received funding from the European Community's Sixth Framework Programme through a Marie Curie Research Training Network ("Biocontrol" MRTN-CT-2006-033439, http://ibis.tau.ac.il/wiki/biocontrol/index.php/Main_Page). Work in the team of V. D. and Y.F.D. was supported by the National Foundation for Scientific Research (FNRS, www.frs-fnrs.be), the Foundation for Training in Industrial and Agricultural Research (FRIA, http://www1.frs-fnrs.be/fr/financer-les-chercheurs/carriere-chercheur/doctorants/86-bourse-du-fria.html), the Universite Catholique de Louvain (Fonds Speciaux de Recherche), the Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Attraction Poles Programme), and the Research Department of the Communaute Francaise de Belgique (Concerted Research Action). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2009, BBA-PROTEINS PROTEOM, V1794, P1537, DOI 10.1016/j.bbapap.2009.06.022; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Benseny-Cases N, 2007, BIOCHEM BIOPH RES CO, V361, P916, DOI 10.1016/j.bbrc.2007.07.082; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bojarski L, 2008, NEUROCHEM INT, V52, P621, DOI 10.1016/j.neuint.2007.10.002; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Budd SL, 1999, ESSAYS BIOCHEM, V33, P43; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; CHIRGADZE YN, 1976, BIOPOLYMERS, V15, P607, DOI 10.1002/bip.1976.360150402; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; CUMMINGS BJ, 1995, LANCET, V346, P1524, DOI 10.1016/S0140-6736(95)92053-6; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Dewachter I, 2009, NEUROBIOL AGING, V30, P241, DOI 10.1016/j.neurobiolaging.2007.06.011; Etcheberrigaray R, 1998, NEUROBIOL DIS, V5, P37, DOI 10.1006/nbdi.1998.0176; Ferreiro E, 2004, J NEUROSCI RES, V76, P872, DOI 10.1002/jnr.20135; Goormaghtigh E, 1994, Subcell Biochem, V23, P329; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Isaacs AM, 2006, J BIOL CHEM, V281, P27916, DOI 10.1074/jbc.M602061200; ITO E, 1994, P NATL ACAD SCI USA, V91, P534, DOI 10.1073/pnas.91.2.534; Kagan BL, 2004, J MEMBRANE BIOL, V202, P1, DOI 10.1007/s00232-004-0709-4; KAMINO K, 1992, AM J HUM GENET, V51, P998; Kawahara M, 2000, J BIOL CHEM, V275, P14077, DOI 10.1074/jbc.275.19.14077; KHACHATURIAN ZS, 1994, ANN NY ACAD SCI, V747, P1; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; KURODA Y, 1994, TOHOKU J EXP MED, V174, P263, DOI 10.1620/tjem.174.263; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MATTSON MP, 1991, MOL CHEM NEUROPATHOL, V15, P117, DOI 10.1007/BF03159951; MATTSON MP, 1994, ANN NY ACAD SCI, V747, P50; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Molnar Z, 2004, NEUROREPORT, V15, P1649, DOI 10.1097/01.wnr.0000134471.06244.d2; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Paivio A, 2004, J MOL BIOL, V339, P145, DOI 10.1016/j.jmb.2004.03.028; Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287; Pierrot N, 2006, J BIOL CHEM, V281, P39907, DOI 10.1074/jbc.M606015200; QUERFURTH HW, 1994, BIOCHEMISTRY-US, V33, P4550, DOI 10.1021/bi00181a016; Rovira C, 2002, BIOCHEM BIOPH RES CO, V296, P1317, DOI 10.1016/S0006-291X(02)02072-7; Rowan MJ, 2007, BIOCHEM SOC T, V35, P1219, DOI 10.1042/BST0351219; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Smith IF, 2005, CELL CALCIUM, V38, P427, DOI 10.1016/j.ceca.2005.06.021; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Stutzmann GE, 2005, NEUROSCIENTIST, V11, P110, DOI 10.1177/1073858404270899; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; Toescu E.C., 2007, ALTERED CALCIUM HOME; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Whalen BM, 2005, NEUROBIOL DIS, V20, P254, DOI 10.1016/j.nbd.2005.03.007; Xiong J, 2002, J NEUROSCI, V22, P10761	70	87	94	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18250	10.1371/journal.pone.0018250	http://dx.doi.org/10.1371/journal.pone.0018250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464905	Green Submitted, Green Published, gold			2022-12-27	WOS:000289053800033
J	Kim, SM; Kim, H; Kim, JE; Park, KS; Sung, JJ; Kim, SH; Lee, KW				Kim, Sung-Min; Kim, Heejaung; Kim, Jee-Eun; Park, Kyung Seok; Sung, Jung-Joon; Kim, Seung Hyun; Lee, Kwang-Woo			Amyotrophic Lateral Sclerosis Is Associated with Hypolipidemia at the Presymptomatic Stage in Mice	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; DISEASE PROGRESSION; TRANSGENIC MOUSE; ALS; IMPAIRMENT; MODEL; ONSET; DIET	Objective: To demonstrate that hypolipidemia is a typical feature of the mouse model of amyotrophic lateral sclerosis (ALS) and to assess the association between hypolipidemia and disease stage, dietary intake, and sex. Methods: We compared daily dietary intake, body weight, and serumlipid and glucose levels in ALS mice and wild-type controls at different stages of the disease. Findings: Total cholesterol low-density lipoprotein (LDL) and LDL/high-density lipoprotein (HDL) ratio were significantly lower in ALS mice compared with controls. Subgroup analysis revealed that the incidence of hypolipidemia was significantly greater in male, but not female, ALS mice compared with control mice and that hypolipidemia was present at the presymptomatic stage of the disease. This hypolipidemia can be found without a decrease in the serum levels of other energy sources, such as glucose, in the presymptomatic stage. Conclusions: Hypolipidemia is present at the presymptomatic stage of the ALS mouse model in the absence of malnutrition, significant neuromuscular degeneration or regeneration, and respiratory difficulty. Our findings suggest that hypolipidemia might be associated with the pathomechanism of ALS and/or lipid-specific metabolism rather than simply an epiphenomenon of neuromuscular degeneration or energy imbalance.	[Kim, Sung-Min; Kim, Jee-Eun; Park, Kyung Seok; Sung, Jung-Joon; Lee, Kwang-Woo] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Kim, Heejaung; Kim, Seung Hyun] Hanyang Univ, Dept Neurol, Coll Med, Seoul 133791, South Korea	Seoul National University (SNU); Hanyang University	Kim, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea.	jjsaint@snu.ac.kr; kimsh1@hanyang.ac.kr	Kim, Seung Hyun/T-5133-2017; Park, Kyung Seok/J-5472-2012; Lee, Kwang Woo/J-5571-2012	Kim, Seung Hyun/0000-0001-9644-9598; Kim, Heejaung/0000-0002-0755-1740	National Research foundation [2010-0024351]; Seoul National University [04-2007-0930]	National Research foundation; Seoul National University	This work was supported by grant NO. "2010-0024351" from National Research foundation fund and by grant NO. "04-2007-0930" from Seoul National University Hospital fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2005, P NATL ACAD SCI USA, V102, P3857, DOI 10.1073/pnas.0500634102; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; BROOKS BR, 1995, ADV NEUROL, V68, P163; Chio A, 2009, NEUROLOGY, V73, P1681, DOI 10.1212/WNL.0b013e3181c1df1e; Choi CI, 2008, J NEUROL SCI, V268, P40, DOI 10.1016/j.jns.2007.10.024; de Aguilar JLG, 2005, BIOMED PHARMACOTHER, V59, P190, DOI 10.1016/j.biopha.2005.03.003; Desport JC, 2001, AM J CLIN NUTR, V74, P328; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Fergani A, 2007, J LIPID RES, V48, P1571, DOI 10.1194/jlr.M700017-JLR200; Funalot B, 2009, AMYOTROPH LATERAL SC, V10, P113, DOI 10.1080/17482960802295192; Gallou-Kabani C, 2007, OBESITY, V15, P1996, DOI 10.1038/oby.2007.238; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Kieran D, 2007, P NATL ACAD SCI USA, V104, P20606, DOI 10.1073/pnas.0707906105; Kim SM, 2007, J NEUROL NEUROSUR PS, V78, P1387, DOI 10.1136/jnnp.2006.111195; Lacomblez L, 2002, NEUROLOGY, V58, P1112, DOI 10.1212/WNL.58.7.1112; Park JH, 2007, NEUROSCI LETT, V413, P265, DOI 10.1016/j.neulet.2006.11.058; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155	22	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17985	10.1371/journal.pone.0017985	http://dx.doi.org/10.1371/journal.pone.0017985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464953	Green Published, gold, Green Submitted			2022-12-27	WOS:000288813900025
J	Nayak, TK; Garmestani, K; Milenic, DE; Baidoo, KE; Brechbiel, MW				Nayak, Tapan K.; Garmestani, Kayhan; Milenic, Diane E.; Baidoo, Kwamena E.; Brechbiel, Martin W.			HER1-Targeted Y-86-Panitumumab Possesses Superior Targeting Characteristics than Y-86-Cetuximab for PET Imaging of Human Malignant Mesothelioma Tumors Xenografts	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; COPPER-64-LABELED MONOCLONAL-ANTIBODY; DISSEMINATED PERITONEAL DISEASE; PLEURAL MESOTHELIOMA; PHASE-II; CANCER; EXPRESSION; PROTEIN; MODEL; RADIOIMMUNOTHERAPY	Malignant mesothelioma (MM), a rare form of cancer is often associated with previous exposure to fibrous minerals, such as asbestos. Asbestos exposure increases HER1-activity and expression in pre-clinical models. Additionally, HER1 over-expression is observed in the majority of MM cases. In this study, the utility of HER1-targeted chimeric IgG(1), cetuximab, and a human IgG(2), panitumumab, radiolabeled with Y-86, were evaluated for PET imaging to detect MM non-invasively in vivo, and to select an antibody candidate for radioimmunotherapy (RIT). Methods: Radioimmunoconjugates (RICs) of cetuximab and panitumumab were prepared by conjugation with CHX-A"-DTPA followed by radiolabeling with Y-86. The HER1 expression of NCI-H226, NCI-H2052, NCI-H2452 and MSTO-211H human mesothelioma cells was characterized by flow cytometry. In vivo biodistribution, pharmacokinetic analysis, and PET imaging were performed in tumor bearing athymic mice. Results: In vivo studies demonstrated high HER1 tumor uptake of both RICs. Significant reduction in tumor uptake was observed in mice co-injected with excess mAb (0.1 mg), demonstrating that uptake in the tumor was receptor specific. Significant differences were observed in the in vivo characteristics of the RICs. The blood clearance T1/2 alpha of Y-86-cetuximab (0.9-1.1 h) was faster than Y-86-panitumumab (2.6-3.1 h). Also, the tumor area under the curve (AUC) to liver AUC ratios of Y-86-panitumumab were 1.5 to 2.5 times greater than Y-86-cetuximab as observed by the differences in PET tumor to background ratios, which could be critical when imaging orthotopic tumors and concerns regarding radiation doses to normal organs such as the liver. Conclusion: This study demonstrates the more favorable HER1-targeting characteristics of Y-86-panitumumab than Y-86-cetuximab for non-invasive assessment of the HER1 status of MM by PET imaging. Due to lower liver uptake, panitumumab based immunoconjugates may fare better in therapy than corresponding cetuximab based immunoconjugates.	[Nayak, Tapan K.; Garmestani, Kayhan; Milenic, Diane E.; Baidoo, Kwamena E.; Brechbiel, Martin W.] NCI, Radiat Oncol Branch, NIH, Radioimmune & Inorgan Chem Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nayak, TK (corresponding author), NCI, Radiat Oncol Branch, NIH, Radioimmune & Inorgan Chem Sect, Bldg 10, Bethesda, MD 20892 USA.	tapann@gmail.com; martinwb@mail.nih.gov		Nayak, Tapan/0000-0002-3706-6092	NIH; NCI; Center for Cancer Research; United States Department of Health and Human Services; NATIONAL CANCER INSTITUTE [ZIASC006353] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Intramural Research Program of the NIH, NCI, Center for Cancer Research and the United States Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behr TM, 1999, CANCER RES, V59, P2635; Benamore RE, 2005, CLIN RADIOL, V60, P1237, DOI 10.1016/j.crad.2005.05.015; Boswell CA, 2007, NUCL MED BIOL, V34, P757, DOI 10.1016/j.nucmedbio.2007.04.001; CUTLER PD, 1995, J NUCL MED, V36, P2363; Destro A, 2006, LUNG CANCER, V51, P207, DOI 10.1016/j.lungcan.2005.10.016; Edwards JG, 2006, LUNG CANCER, V54, P399, DOI 10.1016/j.lungcan.2006.08.012; Faux SP, 2000, CARCINOGENESIS, V21, P2275, DOI 10.1093/carcin/21.12.2275; Gaafar R, 2010, LUNG CANCER, V70, P43, DOI 10.1016/j.lungcan.2010.01.002; Garland LL, 2007, J CLIN ONCOL, V25, P2406, DOI 10.1200/JCO.2006.09.7634; Garmestani K, 2002, NUCL MED BIOL, V29, P599, DOI 10.1016/S0969-8051(02)00322-0; GIBALDI M, 1982, PHARMACOKINETICS, V8, P494; Govindan R, 2005, CLIN CANCER RES, V11, P2300, DOI 10.1158/1078-0432.CCR-04-1940; Heelan RT, 1999, AM J ROENTGENOL, V172, P1039, DOI 10.2214/ajr.172.4.10587144; Helisch A, 2004, EUR J NUCL MED MOL I, V31, P1386, DOI 10.1007/s00259-004-1561-6; Kamp DW, 2009, TRANSL RES, V153, P143, DOI 10.1016/j.trsl.2009.01.004; KOTHMAIER H, 2007, THORAX; Kramer H, 2004, J NUCL MED, V45, P995; Lee AY, 2007, CANCER-AM CANCER SOC, V109, P1454, DOI 10.1002/cncr.22552; Lee HY, ANN SURG ONCOL; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Lovqvist A, 2001, J NUCL MED, V42, P1281; Milenic DE, 2004, CLIN CANCER RES, V10, P7834, DOI 10.1158/1078-0432.CCR-04-1226; Milenic DE, 2007, CLIN CANCER RES, V13, P1926, DOI 10.1158/1078-0432.CCR-06-2300; Nayak TK, 2011, INT J CANCER, V128, P920, DOI 10.1002/ijc.25409; Nayak TK, 2010, EUR J NUCL MED MOL I, V37, P1368, DOI 10.1007/s00259-009-1370-z; Nayak TK, 2010, J NUCL MED, V51, P942, DOI 10.2967/jnumed.109.071290; Nowak AK, 2010, CLIN CANCER RES, V16, P2409, DOI 10.1158/1078-0432.CCR-09-2313; Okuda K, 2008, J CANCER RES CLIN, V134, P1105, DOI 10.1007/s00432-008-0384-4; Pache JC, 1998, AM J PATHOL, V152, P333; PHILPOTT GW, 1995, J NUCL MED, V36, P1818; Richman CM, 2001, CRIT REV ONCOL HEMAT, V38, P25, DOI 10.1016/S1040-8428(00)00136-0; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Sharkey RM, 2005, J NUCL MED, V46, p115S; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; Verel I, 2003, J NUCL MED, V44, P1663; Vogelzang NJ, 2005, SEMIN ONCOL, V32, P336, DOI 10.1053/j.seminoncol.2005.02.010; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; Wong JYC, 2006, CANCER BIOTHER RADIO, V21, P88, DOI 10.1089/cbr.2006.21.88; Yang HC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-196; Zanella CL, 1996, CANCER RES, V56, P5334; Zinzani PL, 2010, CLIN CANCER RES, V16, P3998, DOI 10.1158/1078-0432.CCR-10-0162	42	46	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18198	10.1371/journal.pone.0018198	http://dx.doi.org/10.1371/journal.pone.0018198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464917	Green Submitted, gold, Green Published			2022-12-27	WOS:000288813900050
J	Ozboyaci, M; Gursoy, A; Erman, B; Keskin, O				Ozboyaci, Musa; Gursoy, Attila; Erman, Burak; Keskin, Ozlem			Molecular Recognition of H3/H4 Histone Tails by the Tudor Domains of JMJD2A: A Comparative Molecular Dynamics Simulations Study	PLOS ONE			English	Article							PROTEIN INTERFACES; FORCE-FIELD; HOT-SPOTS; CHARGE; ENERGIES; INSIGHTS; BINDING; SURFACE	Background: Histone demethylase, JMJD2A, specifically recognizes and binds to methylated lysine residues at histone H3 and H4 tails (especially trimethylated H3K4 (H3K4me3), trimethylated H3K9 (H3K9me3) and di, trimethylated H4K20 (H4K20me2, H4K20me3)) via its tandem tudor domains. Crystal structures of JMJD2A-tudor binding to H3K4me3 and H4K20me3 peptides are available whereas the others are not. Complete picture of the recognition of the four histone peptides by the tandem tudor domains yet remains to be clarified. Methodology/Principal Findings: We report a detailed molecular dynamics simulation and binding energy analysis of the recognition of JMJD2A-tudor with four different histone tails. 25 ns fully unrestrained molecular dynamics simulations are carried out for each of the bound and free structures. We investigate the important hydrogen bonds and electrostatic interactions between the tudor domains and the peptide molecules and identify the critical residues that stabilize the complexes. Our binding free energy calculations show that H4K20me2 and H3K9me3 peptides have the highest and lowest affinity to JMJD2A-tudor, respectively. We also show that H4K20me2 peptide adopts the same binding mode with H4K20me3 peptide, and H3K9me3 peptide adopts the same binding mode with H3K4me3 peptide. Decomposition of the enthalpic and the entropic contributions to the binding free energies indicate that the recognition of the histone peptides is mainly driven by favourable van der Waals interactions. Residue decomposition of the binding free energies with backbone and side chain contributions as well as their energetic constituents identify the hotspots in the binding interface of the structures. Conclusion: Energetic investigations of the four complexes suggest that many of the residues involved in the interactions are common. However, we found two receptor residues that were related to selective binding of the H3 and H4 ligands. Modifications or mutations on one of these residues can selectively alter the recognition of the H3 tails or the H4 tails.	[Ozboyaci, Musa] Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey; Koc Univ, Coll Engn, Istanbul, Turkey	Koc University; Koc University	Ozboyaci, M (corresponding author), Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey.	okeskin@ku.edu.tr	Gursoy, Attila/E-9565-2015; Gursoy, Attila/Z-4394-2019; erman, burak/F-5900-2015	Gursoy, Attila/0000-0002-2297-2113; Gursoy, Attila/0000-0002-2297-2113; erman, burak/0000-0002-2496-6059	Turkish Academy of Sciences (TUBA); Scientific and Technological Research Council of Turkey [109T343, 109E207]	Turkish Academy of Sciences (TUBA)(Turkish Academy of Sciences); Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by Turkish Academy of Sciences (TUBA) Distinguished Young Investigator Award [to O.K.]; the Scientific and Technological Research Council of Turkey Grant Nos: 109T343 and 109E207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DISCOVERY STUDIO 2 0; Babin V., 2008, AMBER; Baris I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000546; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Chen ZZ, 2007, P NATL ACAD SCI USA, V104, P10818, DOI 10.1073/pnas.0704525104; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P98, DOI 10.1038/nsmb0207-98; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; Cukuroglu E, 2010, ANN BIOMED ENG, V38, P2068, DOI 10.1007/s10439-010-0048-9; de la Cruz X, 2005, BIOESSAYS, V27, P164, DOI 10.1002/bies.20176; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frisch M.J., 2016, GAUSSIAN16 REV B01; GASTEIGER J, 1978, TETRAHEDRON LETT, P3181; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kundu TK, 2007, CHROMATIN DIS; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P109, DOI 10.1038/nsmb1326; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Marino-Ramirez L, 2006, PROTEINS, V62, P838, DOI 10.1002/prot.20814; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2007, NAT STRUCT MOL BIOL, V14, P252, DOI 10.1038/nsmb0407-252; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pigache A, 2004, AUTOMATIC HIGHLY REP; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Tan HD, 2008, MOL BIOL REP, V35, P551, DOI 10.1007/s11033-007-9121-3; Torok MS, 2006, RES PRO CEL, V41, P25, DOI 10.1007/016; Tuncbag N, 2008, J MOL BIOL, V381, P785, DOI 10.1016/j.jmb.2008.04.071; Tuncbag N, 2010, NUCLEIC ACIDS RES, V38, pW402, DOI 10.1093/nar/gkq323; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; Tuncel A, 2008, BIOPHYS J, V95, P3628, DOI 10.1529/biophysj.107.123042; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; Wiencke JK, 2008, ONCOGENE, V27, P2412, DOI 10.1038/sj.onc.1210895; Wilson JR, 2007, NAT STRUCT MOL BIOL, V14, P682, DOI 10.1038/nsmb0807-682; Yogurtcu ON, 2008, BIOPHYS J, V94, P3475, DOI 10.1529/biophysj.107.114835	48	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e14765	10.1371/journal.pone.0014765	http://dx.doi.org/10.1371/journal.pone.0014765			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464980	gold, Green Submitted, Green Published			2022-12-27	WOS:000288813900001
J	Simmons, LW; Beveridge, M				Simmons, Leigh W.; Beveridge, Maxine			Seminal Fluid Affects Sperm Viability in a Cricket	PLOS ONE			English	Article							COMPETITION; EVOLUTION; QUALITY; DISPLACEMENT; ASSOCIATION; PROTEINS; ADJUST; MALES	Recent studies have suggested that males may vary the quality of their ejaculates in response to sperm competition, although the mechanisms by which they do so remain unclear. The viability of sperm is an important aspect of ejaculate quality that determines competitive fertilization success in the field cricket Teleogryllus oceanicus. Using in vitro mixtures of sperm and seminal fluid from pairs of male crickets, we show that seminal fluid can affect the viability of sperm in this species. We found that males who invest greatly in the viability of their own sperm can enhance the viability of rival sperm, providing the opportunity for males to exploit the investments in sperm competition made by their rivals. Transitive effects of seminal fluids across the ejaculates of different males are expected to have important implications for the dynamics of male investments in sperm competition.	[Simmons, Leigh W.; Beveridge, Maxine] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, Australia	University of Western Australia	Simmons, LW (corresponding author), Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, Australia.	leigh.simmons@uwa.edu.au	Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474	Australian Research Council [DP35600500]	Australian Research Council(Australian Research Council)	This research was funded by the Australian Research Council (DP35600500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2006, MOL CELL ENDOCRINOL, V250, P66, DOI 10.1016/j.mce.2005.12.026; Andres JA, 2006, MOL BIOL EVOL, V23, P1574, DOI 10.1093/molbev/msl020; Aziz N, 2004, FERTIL STERIL, V81, P349, DOI 10.1016/j.fertnstert.2003.06.026; Birkhead TR, 1998, SPERM COMPETITION SE; Bjork A, 2007, P ROY SOC B-BIOL SCI, V274, P1779, DOI 10.1098/rspb.2007.0293; Braswell WE, 2006, GENOME, V49, P1069, DOI 10.1139/G06-061; Cameron E, 2007, AM NAT, V169, pE158, DOI 10.1086/516718; Chapman T, 2008, PLOS BIOL, V6, P1379, DOI 10.1371/journal.pbio.0060179; CLARK AG, 1995, GENETICS, V139, P189; Cornwallis CK, 2007, AM NAT, V170, P758, DOI 10.1086/521955; Cornwallis CK, 2009, P ROY SOC B-BIOL SCI, V276, P3467, DOI 10.1098/rspb.2009.0807; den Boer SPA, 2010, SCIENCE, V327, P1506, DOI 10.1126/science.1184709; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Fiumera AC, 2005, GENETICS, V169, P243, DOI 10.1534/genetics.104.032870; Fiumera AC, 2007, GENETICS, V176, P1245, DOI 10.1534/genetics.106.064915; Garcia-Gonzalez F, 2005, J EVOLUTION BIOL, V18, P1097, DOI 10.1111/j.1420-9101.2005.00889.x; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Garcia-Gonzalez F, 2007, CURR BIOL, V17, P32, DOI 10.1016/j.cub.2006.10.054; Garcia-Gonzalez F, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-140; Gasparini C, 2009, BIOL LETTERS, V5, P792, DOI 10.1098/rsbl.2009.0413; Hodgson DJ, 2006, J THEOR BIOL, V243, P230, DOI 10.1016/j.jtbi.2006.06.024; Holman L, 2009, FUNCT ECOL, V23, P180, DOI 10.1111/j.1365-2435.2008.01509.x; Kilgallon SJ, 2005, BIOL LETTERS, V1, P253, DOI 10.1098/rsbl.2005.0324; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Poiani A, 2006, BEHAV ECOL SOCIOBIOL, V60, P289, DOI 10.1007/s00265-006-0178-0; Price CSC, 1999, NATURE, V400, P449, DOI 10.1038/22755; Rudolfsen G, 2006, P ROY SOC B-BIOL SCI, V273, P325, DOI 10.1098/rspb.2005.3305; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2007, BIOL LETTERS, V3, P520, DOI 10.1098/rsbl.2007.0328; Simmons LW, 2005, SCIENCE, V309, P2031, DOI 10.1126/science.1114500; Snook RR, 2004, NATURE, V428, P939, DOI 10.1038/nature02455; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Thomas ML, 2007, AM NAT, V170, P190, DOI 10.1086/519404; Thomas ML, 2009, P R SOC B, V276, P383, DOI 10.1098/rspb.2008.1206; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Wigby S, 2009, CURR BIOL, V19, P751, DOI 10.1016/j.cub.2009.03.036; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7; 1988, J REPROD FERTILITY, V84, P341; 2006, MOL CELLULAR ENDOCRI, V250, P80	39	39	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17975	10.1371/journal.pone.0017975	http://dx.doi.org/10.1371/journal.pone.0017975			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455309	Green Published, gold, Green Submitted			2022-12-27	WOS:000288811500016
J	Yu, H; Zhu, GY; Xu, RZ; Niu, HZ; Lu, Q; Li, GZ; Wang, ZY; Zhang, DS; Gu, N; Teng, GJ				Yu, Hui; Zhu, Guang-Yu; Xu, Rui-Zhi; Niu, Huan-Zhang; Lu, Qin; Li, Guo-Zhao; Wang, Zi-Yu; Zhang, Dong-Sheng; Gu, Ning; Teng, Gao-Jun			Arterial Embolization Hyperthermia Using As2O3 Nanoparticles in VX2 Carcinoma-Induced Liver Tumors	PLOS ONE			English	Article							UNRESECTABLE HEPATOCELLULAR-CARCINOMA; MAGNETIC FLUID HYPERTHERMIA; ENDOTHELIAL GROWTH-FACTOR; ARSENIC TRIOXIDE; TRANSARTERIAL CHEMOEMBOLIZATION; FERROMAGNETIC EMBOLIZATION; ANGIOGENESIS; METASTASIS; APOPTOSIS; MODEL	Background: Combination therapy for arterial embolization hyperthermia (AEH) with arsenic trioxide (As2O3) nanoparticles (ATONs) is a novel treatment for solid malignancies. This study was performed to evaluate the feasibility and therapeutic effect of AEH with As2O3 nanoparticles in a rabbit liver cancer model. The protocol was approved by our institutional animal use committee. Methodology/Principal Findings: In total, 60 VX2 liver-tumor-bearing rabbits were randomly assigned to five groups (n = 12/group) and received AEH with ATONs (Group 1), hepatic arterial embolization with ATONs (Group 2), lipiodol (Group 3), or saline (Group 4), on day 14 after tumor implantation. Twelve rabbits that received AEH with ATONs were prepared for temperature measurements, and were defined as Group 5. Computed tomography was used to measure the tumors' longest dimension, and evaluation was performed according to the Response Evaluation Criteria in Solid Tumors. Hepatic toxicity, tumor necrosis rate, vascular endothelial growth factor level, and microvessel density were determined. Survival rates were measured using the Kaplan-Meier method. The therapeutic temperature (42.5 degrees C) was obtained in Group 5. Hepatotoxicity reactions occurred but were transient in all groups. Tumor growth was delayed and survival was prolonged in Group 1 (treated with AEH and ATONs). Plasma and tumor vascular endothelial growth factor and microvessel density were significantly inhibited in Group 1, while tumor necrosis rates were markedly enhanced compared with those in the control groups. Conclusions: ATON-based AEH is a safe and effective treatment that can be targeted at liver tumors using the dual effects of hyperthermia and chemotherapy. This therapy can delay tumor growth and noticeably inhibit tumor angiogenesis.	[Yu, Hui; Zhu, Guang-Yu; Niu, Huan-Zhang; Lu, Qin; Li, Guo-Zhao; Teng, Gao-Jun] Southeast Univ, Jiangsu Key Lab Mol Imaging & Funct Imaging, Dept Radiol, Zhong Da Hosp,Med Sch, Nanjing, Peoples R China; [Xu, Rui-Zhi; Gu, Ning] Southeast Univ, Jiangsu Lab Biomat & Devices, State Key Lab BioElect, Sch Biol Sci & Med Engn, Nanjing, Peoples R China; [Wang, Zi-Yu; Zhang, Dong-Sheng] Southeast Univ, Sch Med, Dept Pathol & Pathophysiol, Nanjing, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China	Teng, GJ (corresponding author), Southeast Univ, Jiangsu Key Lab Mol Imaging & Funct Imaging, Dept Radiol, Zhong Da Hosp,Med Sch, Nanjing, Peoples R China.	gjteng@vip.sina.com			National Natural Science Foundation of China [30470507, 30870703]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by National Natural Science Foundation of China (NSFC No. 30470507 and NSFC No. 30870703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biolato M, 2010, EUR REV MED PHARMACO, V14, P356; Gallagher RE, 1998, NEW ENGL J MED, V339, P1389, DOI 10.1056/NEJM199811053391909; Griffin RJ, 2000, NEOPLASIA, V2, P555, DOI 10.1038/sj.neo.7900123; Griffin RJ, 2003, INT J HYPERTHER, V19, P575, DOI 10.1080/0265673031000124316; Hajitou A, 2008, P NATL ACAD SCI USA, V105, P4471, DOI 10.1073/pnas.0712184105; Hamaguchi S, 2003, CANCER SCI, V94, P834, DOI 10.1111/j.1349-7006.2003.tb01527.x; Hassouneh B, 2007, MOL CANCER THER, V6, P1039, DOI 10.1158/1535-7163.MCT-06-0524; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hines-Peralta A, 2006, RADIOLOGY, V240, P82, DOI 10.1148/radiol.2401050788; Johannsen M, 2005, INT J HYPERTHER, V21, P637, DOI 10.1080/02656730500158360; Jones SK, 2002, INT J HYPERTHER, V18, P117, DOI 10.1080/02656730110103519; Kinjo K, 2000, LEUKEMIA, V14, P431, DOI 10.1038/sj.leu.2401646; Kito M, 2003, CANCER SCI, V94, P1010, DOI 10.1111/j.1349-7006.2003.tb01393.x; Kito M, 2002, BIOCHEM BIOPH RES CO, V291, P861, DOI 10.1006/bbrc.2002.6525; Lew YS, 1999, CANCER RES, V59, P6033; Lew YS, 2002, CANCER RES, V62, P4202; Lin CC, 2007, INVEST NEW DRUG, V25, P77, DOI 10.1007/s10637-006-9004-9; Liu B, 2006, CANCER SCI, V97, P675, DOI 10.1111/j.1349-7006.2006.00230.x; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Lu Q, 2008, CANCER BIOL THER, V7, P218, DOI 10.4161/cbt.7.2.5258; Maeda H, 2001, CANCER RES, V61, P5432; Marelli L, 2007, CARDIOVASC INTER RAD, V30, P6, DOI 10.1007/s00270-006-0062-3; Monzen Hajime, 2004, Radiat Med, V22, P205; Moroz P, 2002, INT J HYPERTHER, V18, P267, DOI 10.1080/02656730110108785; Moroz P, 2002, PHYS MED BIOL, V47, P1591, DOI 10.1088/0031-9155/47/9/312; Moroz P, 2002, INT J HYPERTHER, V18, P129, DOI 10.1080/02656730110095609; Moroz P, 2001, J SURG ONCOL, V78, P22, DOI 10.1002/jso.1118; Pacella CM, 2001, RADIOLOGY, V219, P669, DOI 10.1148/radiology.219.3.r01ma02669; Paoloni MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004972; Park MJ, 2003, INT J ONCOL, V22, P1271; Park WH, 2003, BIOCHEM BIOPH RES CO, V300, P230, DOI 10.1016/S0006-291X(02)02831-0; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PATTERSON J, 1979, INT J RADIAT ONCOL, V5, P235, DOI 10.1016/0360-3016(79)90725-9; Roboz GJ, 2000, BLOOD, V96, P1525, DOI 10.1182/blood.V96.4.1525.h8001525_1525_1530; RUIZHI X, 2009, MAGNETICS IEEE T, V45, P3085; RUIZHI X, 2007, MAGNETICS IEEE T, V43, P1078; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Vogl TJ, 2004, RADIOLOGY, V230, P450, DOI 10.1148/radiol.2302020646; Vogl TJ, 2003, RADIOLOGY, V229, P457, DOI 10.1148/radiol.2292021329; Wang ZY, 2009, WORLD J GASTROENTERO, V15, P2995, DOI 10.3748/wjg.15.2995; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Xu HY, 2004, WORLD J GASTROENTERO, V10, P3677, DOI 10.3748/wjg.v10.i24.3677; Xu HY, 2000, WORLD J GASTROENTERO, V6, P681; Yamaguchi R, 1998, HEPATOLOGY, V28, P68, DOI 10.1002/hep.510280111; Yan SY, 2005, J NANOSCI NANOTECHNO, V5, P1185, DOI 10.1166/jnn.2005.219; Yoon CJ, 2003, RADIOLOGY, V229, P126, DOI 10.1148/radiol.2291021029; Yoshiji H, 2002, HEPATOLOGY, V35, P834, DOI 10.1053/jhep.2002.32541; Zhu AL, 2004, WORLD J GASTROENTERO, V10, P1659, DOI 10.3748/wjg.v10.i11.1659	50	23	24	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17926	10.1371/journal.pone.0017926	http://dx.doi.org/10.1371/journal.pone.0017926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448278	Green Submitted, gold, Green Published			2022-12-27	WOS:000288810500023
J	Cellerai, C; Harari, A; Stauss, H; Yerly, S; Geretti, AM; Carroll, A; Yee, T; Ainsworth, J; Williams, I; Sweeney, J; Freedman, A; Johnson, M; Pantaleo, G; Kinloch-de Loes, S				Cellerai, Cristina; Harari, Alexandre; Stauss, Hans; Yerly, Sabine; Geretti, Anna-Maria; Carroll, Anne; Yee, Thynn; Ainsworth, Jonathan; Williams, Ian; Sweeney, John; Freedman, Andrew; Johnson, Margaret; Pantaleo, Giuseppe; Kinloch-de Loes, Sabine			Early and Prolonged Antiretroviral Therapy Is Associated with an HIV-1-Specific T-Cell Profile Comparable to That of Long-Term Non-Progressors	PLOS ONE			English	Article							ACUTE HIV-1 INFECTION; IMMUNE CONTROL; VIRAL CONTROL; TREATMENT INTERRUPTIONS; FUNCTIONAL SIGNATURES; PERFORIN EXPRESSION; VIRUS-REPLICATION; HLA-B; CD8(+); PROLIFERATION	Background: Intervention with antiretroviral treatment (ART) and control of viral replication at the time of HIV-1 seroconversion may curtail cumulative immunological damage. We have therefore hypothesized that ART maintenance over a very prolonged period in HIV-1 seroconverters could induce an immuno-virological status similar to that of HIV-1 long-term non-progressors (LTNPs). Methodology/Principal Findings: We have investigated a cohort of 20 HIV-1 seroconverters on long-term ART (LTTS) and compared it to one of 15 LTNPs. Residual viral replication and reservoirs in peripheral blood, as measured by cell-associated HIV-1 RNA and DNA, respectively, were demonstrated to be similarly low in both cohorts. These two virologically matched cohorts were then comprehensively analysed by polychromatic flow cytometry for HIV-1-specific CD4(+) and CD8(+) T-cell functional profile in terms of cytokine production and cytotoxic capacity using IFN-gamma, IL-2, TNF-alpha production and perforin expression, respectively. Comparable levels of highly polyfunctional HIV-1-specific CD4(+) and CD8(+) T-cells were found in LTTS and LTNPs, with low perforin expression on HIV-1-specific CD8+ T-cells, consistent with a polyfunctional/non-cytotoxic profile in a context of low viral burden. Conclusions: Our results indicate that prolonged ART initiated at the time of HIV-1 seroconversion is associated with immuno-virological features which resemble those of LTNPs, strengthening the recent emphasis on the positive impact of early treatment initiation and paving the way for further interventions to promote virological control after treatment interruption.	[Cellerai, Cristina; Harari, Alexandre; Pantaleo, Giuseppe] CHU Vaudois, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland; [Harari, Alexandre; Pantaleo, Giuseppe] Univ Lausanne, Swiss Vaccine Res Inst, Lausanne, Switzerland; [Stauss, Hans; Kinloch-de Loes, Sabine] UCL, Dept Immunol, London, England; [Yerly, Sabine] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; [Yerly, Sabine] Univ Hosp Geneva, Virol Lab, Geneva, Switzerland; [Geretti, Anna-Maria] UCL, Dept Virol, London, England; [Carroll, Anne; Johnson, Margaret; Kinloch-de Loes, Sabine] Royal Free Hosp, Royal Free Ctr, HIV Med Ian Charleson Day Ctr, London NW3 2QG, England; [Yee, Thynn] Royal Free Hosp, Haemostasis & Haemophilia Dept, London NW3 2QG, England; [Ainsworth, Jonathan] N Middlesex Hosp, Dept Infect Dis, London N18 1QX, England; [Williams, Ian] UCL, Ctr Sexual Hlth & HIV Res, London, England; [Sweeney, John] Victoria Hosp, Dept GU Med, Blackpool, England; [Freedman, Andrew] Cardiff Univ, Sch Med, Dept Med, Cardiff, S Glam, Wales	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of London; University College London; University of Geneva; University of Geneva; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Cardiff University	Cellerai, C (corresponding author), CHU Vaudois, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland.	sabine@kinloch.u-net.com	Pantaleo, Giuseppe/K-6163-2016; Yee, Thynn Thynn/H-5862-2012	Harari, Alexandre/0000-0002-1055-2090; Geretti, Anna Maria/0000-0002-3670-6588	Bill and Melinda Gates Foundation; Royal Free Special Trustee [07450]; Royal Free Hospital, London	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Royal Free Special Trustee; Royal Free Hospital, London	This research was conducted as part of the Vaccine Immune Monitoring Consortium under the Collaboration for AIDS Vaccine Discovery with support from the Bill and Melinda Gates Foundation. Funding was also provided from The Royal Free Special Trustee account 07450, Royal Free Hospital, London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Andersson J, 2002, J INFECT DIS, V185, P1355, DOI 10.1086/340124; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; BERKE G, 1995, CELL, V81, P9, DOI 10.1016/0092-8674(95)90365-8; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Casazza JP, 2001, J VIROL, V75, P6508, DOI 10.1128/JVI.75.14.6508-6516.2001; Cellerai C, 2010, J VIROL, V84, P3868, DOI 10.1128/JVI.02565-09; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Chun TW, 2010, AIDS, V24, P2803, DOI 10.1097/QAD.0b013e328340a239; Chun TW, 2003, P NATL ACAD SCI USA, V100, P1908, DOI 10.1073/pnas.0437640100; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Daucher M, 2008, J VIROL, V82, P4102, DOI 10.1128/JVI.02212-07; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; DESCOURS B, 2010, IAS 2010 M; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Gray CM, 1999, J IMMUNOL, V162, P1780; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Guihot A, 2010, AIDS, V24, P614, DOI 10.1097/QAD.0b013e32833556f3; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Harari A, 2007, P NATL ACAD SCI USA, V104, P16233, DOI 10.1073/pnas.0707570104; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Harari A, 2009, J VIROL, V83, P2862, DOI 10.1128/JVI.02528-08; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Hocqueloux L, 2010, AIDS, V24, P1598, DOI 10.1097/QAD.0b013e32833b61ba; Hoen B, 2007, CLIN INFECT DIS, V45, P381, DOI 10.1086/519428; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Iyasere C, 2003, J VIROL, V77, P10900, DOI 10.1128/JVI.77.20.10900-10909.2003; Jansen CA, 2005, AIDS, V19, P1145, DOI 10.1097/01.aids.0000176214.17990.94; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kaufmann GR, 2000, AIDS, V14, P2643, DOI 10.1097/00002030-200012010-00003; Kern F, 1998, NAT MED, V4, P975, DOI 10.1038/nm0898-975; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kinloch-de Loes S, 2005, J INFECT DIS, V192, P607, DOI 10.1086/432002; Koegl C, 2009, EUR J MED RES, V14, P277; Kovacs A, 2004, LANCET, V363, P833, DOI 10.1016/S0140-6736(04)15770-X; Lafeuillade A, 2003, J INFECT DIS, V188, P1426, DOI 10.1086/379251; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Makedonas G, 2011, IMMUNOL REV, V239, P109, DOI 10.1111/j.1600-065X.2010.00968.x; Makedonas G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000798; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2009, J VIROL, V83, P11876, DOI 10.1128/JVI.01153-09; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Nesbit L, 2010, INFECT IMMUN, V78, P309, DOI 10.1128/IAI.00953-09; Ortiz GM, 2001, P NATL ACAD SCI USA, V98, P13288, DOI 10.1073/pnas.221452198; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; Oxenius A, 2002, P NATL ACAD SCI USA, V99, P13747, DOI 10.1073/pnas.202372199; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; PEREYRA F, 2008, AIDS VACCINE 2008 M; Rehr M, 2008, J VIROL, V82, P3391, DOI 10.1128/JVI.02383-07; RIVIERE Y, 1995, AIDS RES HUM RETROV, V11, P903, DOI 10.1089/aid.1995.11.903; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tilling R, 2002, AIDS, V16, P589, DOI 10.1097/00002030-200203080-00010; Tilton JC, 2007, J VIROL, V81, P2713, DOI 10.1128/JVI.01830-06; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; Yerly S, 2004, AIDS, V18, P1951, DOI 10.1097/00002030-200409240-00011; Yerly S, 1999, J INFECT DIS, V180, P850, DOI 10.1086/314932; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102; LANLW; LAH SRAW	84	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18164	10.1371/journal.pone.0018164	http://dx.doi.org/10.1371/journal.pone.0018164			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483676	Green Published, gold, Green Submitted			2022-12-27	WOS:000289191300007
J	Hill, SE; Miti, T; Richmond, T; Muschol, M				Hill, Shannon E.; Miti, Tatiana; Richmond, Tyson; Muschol, Martin			Spatial Extent of Charge Repulsion Regulates Assembly Pathways for Lysozyme Amyloid Fibrils	PLOS ONE			English	Article							PROTEIN AGGREGATION; COMMON MECHANISM; SCATTERING; LIGHT; FIBRILLATION; OLIGOMERS; IMPLIES	Formation of large protein fibrils with a characteristic cross beta-sheet architecture is the key indicator for a wide variety of systemic and neurodegenerative amyloid diseases. Recent experiments have strongly implicated oligomeric intermediates, transiently formed during fibril assembly, as critical contributors to cellular toxicity in amyloid diseases. At the same time, amyloid fibril assembly can proceed along different assembly pathways that might or might not involve such oligomeric intermediates. Elucidating the mechanisms that determine whether fibril formation proceeds along non-oligomeric or oligomeric pathways, therefore, is important not just for understanding amyloid fibril assembly at the molecular level but also for developing new targets for intervening with fibril formation. We have investigated fibril formation by hen egg white lysozyme, an enzyme for which human variants underlie non-neuropathic amyloidosis. Using a combination of static and dynamic light scattering, atomic force microscopy and circular dichroism, we find that amyloidogenic lysozyme monomers switch between three different assembly pathways: from monomeric to oligomeric fibril assembly and, eventually, disordered precipitation as the ionic strength of the solution increases. Fibril assembly only occurred under conditions of net repulsion among the amyloidogenic monomers while net attraction caused precipitation. The transition from monomeric to oligomeric fibril assembly, in turn, occurred as salt-mediated charge screening reduced repulsion among individual charged residues on the same monomer. We suggest a model of amyloid fibril formation in which repulsive charge interactions are a prerequisite for ordered fibril assembly. Furthermore, the spatial extent of non-specific charge screening selects between monomeric and oligomeric assembly pathways by affecting which subset of denatured states can form suitable intermolecular bonds and by altering the energetic and entropic requirements for the initial intermediates emerging along the monomeric vs. oligomeric assembly path.	[Hill, Shannon E.; Miti, Tatiana; Richmond, Tyson; Muschol, Martin] Univ S Florida, Dept Phys, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Hill, SE (corresponding author), Univ S Florida, Dept Phys, Tampa, FL 33620 USA.	mmuschol@usf.edu		Muschol, Martin/0000-0002-6488-0049	National Science Foundation; Office of Undergraduate Research at USF; Byrd Alzheimer's Institute [ARG-2007-22]; USF BITT Florida Center of Excellence; USF	National Science Foundation(National Science Foundation (NSF)); Office of Undergraduate Research at USF; Byrd Alzheimer's Institute; USF BITT Florida Center of Excellence; USF	This work was supported, in part, by a National Science Foundation IGERT fellowship (S.H.), the Office of Undergraduate Research at USF (T.M.) and funding from the Byrd Alzheimer's Institute (ARG-2007-22), the USF BITT Florida Center of Excellence and the USF Neuroscience Collaborative (M.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaudov LN, 2005, BIOPHYS J, V88, P515, DOI 10.1529/biophysj.104.048819; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Canet D, 1999, BIOCHEMISTRY-US, V38, P6419, DOI 10.1021/bi983037t; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; DELATORRE JG, 1981, Q REV BIOPHYS, V14, P81, DOI 10.1017/S0033583500002080; Dobson CM, 2004, SCIENCE, V304, P1259, DOI 10.1126/science.1093078; FINK AL, 1994, BIOCHEMISTRY-US, V33, P12504, DOI 10.1021/bi00207a018; Frare E, 2004, J MOL BIOL, V340, P1153, DOI 10.1016/j.jmb.2004.05.056; GEORGE A, 1994, ACTA CRYSTALLOGR D, V50, P361, DOI 10.1107/S0907444994001216; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Guo B, 1999, J CRYST GROWTH, V196, P424, DOI 10.1016/S0022-0248(98)00842-2; HAGEN MHJ, 1994, J CHEM PHYS, V101, P4093, DOI 10.1063/1.467526; Hess S, 2007, EMBO REP, V8, P1196, DOI 10.1038/sj.embor.7401096; Hill SE, 2009, BIOPHYS J, V96, P3781, DOI 10.1016/j.bpj.2009.01.044; Hunter R. J., 1987, FDN COLLOIDAL SCI; Juarez J, 2009, BIOPHYS J, V96, P2353, DOI 10.1016/j.bpj.2008.12.3901; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862; Kuehner DE, 1997, BIOPHYS J, V73, P3211, DOI 10.1016/S0006-3495(97)78346-2; Kuehner DE, 1999, J PHYS CHEM B, V103, P1368, DOI 10.1021/jp983852i; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264; Muschol M, 1995, J CHEM PHYS, V103, P10424, DOI 10.1063/1.469891; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Parmar AS, 2009, BIOPHYS J, V97, P590, DOI 10.1016/j.bpj.2009.04.045; Pellarin R, 2006, J MOL BIOL, V360, P882, DOI 10.1016/j.jmb.2006.05.033; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Perrin F, 1936, J PHYS-PARIS, V7, P1, DOI 10.1051/jphysrad:01936007010100; PTITSYN OB, 1994, FEBS LETT, V341, P15, DOI 10.1016/0014-5793(94)80231-9; Rosenbaum DF, 1996, J CRYST GROWTH, V169, P752, DOI 10.1016/S0022-0248(96)00455-1; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SOPHIANOPOULOS AJ, 1962, J BIOL CHEM, V237, P1107; tenWolde PR, 1996, J CHEM PHYS, V104, P9932, DOI 10.1063/1.471721; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Velev OD, 1998, BIOPHYS J, V75, P2682, DOI 10.1016/S0006-3495(98)77713-6	42	68	68	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18171	10.1371/journal.pone.0018171	http://dx.doi.org/10.1371/journal.pone.0018171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483680	Green Published, Green Submitted, gold			2022-12-27	WOS:000289191300008
J	Costantini, M; Committeri, G; Sinigaglia, C				Costantini, Marcello; Committeri, Giorgia; Sinigaglia, Corrado			Ready Both to Your and to My Hands: Mapping the Action Space of Others	PLOS ONE			English	Article							AREA F5; OBJECTS; REPRESENTATION; CORTEX; BODY; RECOGNITION; PERSPECTIVE; MECHANISMS; GAZE	To date, mutual interaction between action and perception has been investigated mainly by focusing on single individuals. However, we perceive affording objects and acts upon them in a surrounding world inhabited by other perceiving and acting bodies. Thus, the issue arises as to whether our action-oriented object perception might be modulated by the presence of another potential actor. To tackle this issue we used the spatial alignment effect paradigm and systematically examined this effect when a visually presented handled object was located close either to the perceiver or to another individual (a virtual avatar). We found that the spatial alignment effect occurred whenever the object was presented within the reaching space of a potential actor, regardless of whether it was the participant's own or the other's reaching space. These findings show that objects may afford a suitable motor act when they are ready not only to our own hand but also, and most importantly, to the other's hand. Our proposal is that this effect is likely to be due to a mapping of our own and the other's reaching space and we posit that such mapping could play a critical role in joining our own and the other's action.	[Costantini, Marcello; Committeri, Giorgia] Univ G DAnnunzio, Lab Neuropsychol & Cognit Neurosci, Dept Neurosci & Imaging, Chieti, Italy; [Costantini, Marcello; Committeri, Giorgia] Fdn Univ G dAnnunzio, Inst Adv Biomed Technol, Chieti, Italy; [Sinigaglia, Corrado] Univ Milan, Dept Philosophy, Milan, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Milan	Costantini, M (corresponding author), Univ G DAnnunzio, Lab Neuropsychol & Cognit Neurosci, Dept Neurosci & Imaging, Chieti, Italy.	marcello.costantini@unich.it	Committeri, Giorgia/AAC-1035-2022; Costantini, Marcello/F-7083-2011; sinigaglia, corrado/AAI-2220-2021; SINIGAGLIA, CORRADO/AGY-7196-2022	SINIGAGLIA, CORRADO/0000-0002-3365-7522; Costantini, Marcello/0000-0002-0504-1296	MIUR [2008PBT985]	MIUR(Ministry of Education, Universities and Research (MIUR))	GC was supported by a grant from MIUR, no. 2008PBT985 (www.miur.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MA, 2003, VIS COGN, V10, P157, DOI 10.1080/13506280244000078; Becchio C, 2008, TRENDS COGN SCI, V12, P254, DOI 10.1016/j.tics.2008.04.005; Bub DN, 2010, J EXP PSYCHOL HUMAN, V36, P341, DOI 10.1037/a0017606; Buccino G, 2009, NEUROPSYCHOLOGIA, V47, P3074, DOI 10.1016/j.neuropsychologia.2009.07.003; CARDINI F, 2010, J COGN NEUROSCI; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; COSTANTINI M, 2011, JOINT ATTEN IN PRESS; Costantini M, 2010, EXP BRAIN RES, V207, P95, DOI 10.1007/s00221-010-2435-8; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; Grezes J, 2003, EUR J NEUROSCI, V17, P2735, DOI 10.1046/j.1460-9568.2003.02695.x; Ishida H, 2010, J COGNITIVE NEUROSCI, V22, P83, DOI 10.1162/jocn.2009.21185; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Lambrey S, 2008, BRAIN, V131, P523, DOI 10.1093/brain/awm317; Maravita A, 2002, COGNITION, V83, pB25, DOI 10.1016/S0010-0277(02)00003-3; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Pierno AC, 2006, J COGNITIVE NEUROSCI, V18, P2130, DOI 10.1162/jocn.2006.18.12.2130; Raos V, 2006, J NEUROPHYSIOL, V95, P709, DOI 10.1152/jn.00463.2005; REED CL, 1995, J EXP PSYCHOL HUMAN, V21, P334, DOI 10.1037/0096-1523.21.2.334; Richardson MJ, 2007, J EXP PSYCHOL HUMAN, V33, P845, DOI 10.1037/0096-1523.33.4.845; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; SIRIGU A, 1991, BRAIN, V114, P2555, DOI 10.1093/brain/114.6.2555; Thomas R, 2006, ACTA PSYCHOL, V121, P317, DOI 10.1016/j.actpsy.2005.08.002; Tucker M, 2001, VIS COGN, V8, P769, DOI 10.1080/13506280042000144; Tucker M, 2004, ACTA PSYCHOL, V116, P185, DOI 10.1016/j.actpsy.2004.01.004; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; Umilta MA, 2008, P NATL ACAD SCI USA, V105, P2209, DOI 10.1073/pnas.0705985105; Vainio L, 2007, BRAIN COGNITION, V65, P195, DOI 10.1016/j.bandc.2007.07.004; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799	29	74	75	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e17923	10.1371/journal.pone.0017923	http://dx.doi.org/10.1371/journal.pone.0017923			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743ZC	21483734	Green Published, Green Submitted, gold			2022-12-27	WOS:000289058700004
J	Pham, M; Helluy, X; Kleinschnitz, C; Kraft, P; Bartsch, AJ; Jakob, P; Nieswandt, B; Bendszus, M; Stoll, G				Pham, Mirko; Helluy, Xavier; Kleinschnitz, Christoph; Kraft, Peter; Bartsch, Andreas J.; Jakob, Peter; Nieswandt, Bernhard; Bendszus, Martin; Stoll, Guido			Sustained Reperfusion after Blockade of Glycoprotein-Receptor-Ib in Focal Cerebral Ischemia: An MRI Study at 17.6 Tesla	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; EXPERIMENTAL STROKE; MAGNETIC-RESONANCE; ARTERIAL WATER; BRAIN; PERFUSION; MICE; INFLAMMATION; COEFFICIENT; MECHANISMS	Background: Inhibition of early platelet adhesion by blockade of glycoprotein-IB (GPIb) protects mice from ischemic stroke. To elucidate underlying mechanisms in-vivo, infarct development was followed by ultra-high field MRI at 17.6 Tesla. Methods: Cerebral infarction was induced by transient-middle-cerebral-artery-occlusion (tMCAO) for 1 hour in C57/BL6 control mice (N = 10) and mice treated with 100 mg Fab-fragments of the GPIb blocking antibody p0p/B 1 h after tMCAO (N = 10). To control for the effect of reperfusion, additional mice underwent permanent occlusion and received anti-GPIb treatment (N = 6; pMCAO) or remained without treatment (N = 3; pMCAO). MRI 2 h and 24 h after MCAO measured cerebral-blood-flow (CBF) by continuous arterial-spin labelling, the apparent-diffusion-coefficient (ADC), quantitative-T2 and T2-weighted imaging. All images were registered to a standard mouse brain MRI atlas and statistically analysed voxel-wise, and by cortico-subcortical ROI analysis. Results: Anti-GPIb treatment led to a relative increase of postischemic CBF vs. controls in the cortical territory of the MCA (2 h: 44.2 +/- 6.9 ml/100g/min versus 24 h: 60.5 +/- 8.4; p = 0.0012, F-(1,F-18) = 14.63) after tMCAO. Subcortical CBF 2 h after tMCAO was higher in anti-GPIb treated animals (45.3 +/- 5.9 vs. controls: 33.6 +/- 4.3; p = 0.04). In both regions, CBF findings were clearly related to a lower probability of infarction (Cortex/Subcortex of treated group: 35%/65% vs. controls: 95%/100%) and improved quantitative-T2 and ADC. After pMCAO, anti-GPIb treated mice developed similar infarcts preceded by severe irreversible hypoperfusion as controls after tMCAO indicating dependency of stroke protection on reperfusion. Conclusion: Blockade of platelet adhesion by anti-GPIb-Fab-fragments results in substantially improved CBF early during reperfusion. This finding was in exact spatial correspondence with the prevention of cerebral infarction and indicates in-vivo an increased patency of the microcirculation. Thus, progression of infarction during early ischemia and reperfusion can be mitigated by anti-platelet treatment.	[Pham, Mirko; Bartsch, Andreas J.; Bendszus, Martin] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany; [Helluy, Xavier; Jakob, Peter] Univ Wurzburg, Dept Expt Phys, Sect 5, Wurzburg, Germany; [Kleinschnitz, Christoph; Kraft, Peter; Stoll, Guido] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, Wurzburg, Germany; [Nieswandt, Bernhard] Univ Wurzburg, Chair Expt Med, Wurzburg, Germany	Ruprecht Karls University Heidelberg; University of Wurzburg; University of Wurzburg; German Research Foundation (DFG); University of Wurzburg; University of Wurzburg	Pham, M (corresponding author), Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany.	mirko.pham@med.uni-heidelberg.de	Pham, Mirko/AAI-8713-2020	Jakob, Peter/0000-0002-3481-5545	Medical Faculty of the University of Heidelberg, Germany; Deutsche Forschungsgemeinschaft [SFB 688]	Medical Faculty of the University of Heidelberg, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a Postdoctoral Fellowship granted to MP from the Medical Faculty of the University of Heidelberg, Germany (www.medizinische-fakultaet-hd.uni-heidelberg.de) and by the Deutsche Forschungsgemeinschaft (www.dfg.de), SFB 688 (TP B1 granted to BN and GS, TP A13 granted to CK and Z2 to PJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PA, 2005, NEUROSCI LETT, V388, P54, DOI 10.1016/j.neulet.2005.06.067; Coutts SB, 2009, STROKE, V40, P2661, DOI 10.1161/STROKEAHA.109.557447; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; De Meyer SF, 2010, ARTERIOSCL THROM VAS, V30, P1949, DOI 10.1161/ATVBAHA.110.208918; DEMEYER SF, 2010, ARTERIOSCLER THROMB; Denes A, 2010, BRAIN BEHAV IMMUN, V24, P708, DOI 10.1016/j.bbi.2009.09.010; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dirnagl U, 2006, J CEREBR BLOOD F MET, V26, P1465, DOI 10.1038/sj.jcbfm.9600298; Elvers M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000551; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kaur J, 2009, INT J STROKE, V4, P159, DOI 10.1111/j.1747-4949.2009.00288.x; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Kleinschnitz C, 2009, BLOOD, V113, P3600, DOI 10.1182/blood-2008-09-180695; Leithner C, 2010, J CEREBR BLOOD F MET, V30, P1821, DOI 10.1038/jcbfm.2010.160; Maccotta L, 1997, NMR BIOMED, V10, P216, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<216::AID-NBM468>3.0.CO;2-U; MacKenzie-Graham A, 2004, J ANAT, V204, P93, DOI 10.1111/j.1469-7580.2004.00264.x; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Petri B, 2010, BLOOD, V116, P4712, DOI 10.1182/blood-2010-03-276311; Pham M, 2010, NEUROIMAGE, V49, P2907, DOI 10.1016/j.neuroimage.2009.11.061; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; STOLL G, ANN NY ACAD IN PRESS; Stoll G, 2008, BLOOD, V112, P3555, DOI 10.1182/blood-2008-04-144758; Stoll G, 2010, ANN NY ACAD SCI, V1207, P149, DOI 10.1111/j.1749-6632.2010.05730.x; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wong EC, 1998, MAGNET RESON MED, V40, P348, DOI 10.1002/mrm.1910400303; ZHANG WG, 1993, MAGNET RESON MED, V29, P416, DOI 10.1002/mrm.1910290323	34	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18386	10.1371/journal.pone.0018386	http://dx.doi.org/10.1371/journal.pone.0018386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483769	Green Published, gold, Green Submitted			2022-12-27	WOS:000289058300016
J	Adekambi, T; Butler, RW; Hanrahan, F; Delcher, AL; Drancourt, M; Shinnick, TM				Adekambi, Toidi; Butler, Ray W.; Hanrahan, Finnian; Delcher, Arthur L.; Drancourt, Michel; Shinnick, Thomas M.			Core Gene Set As the Basis of Multilocus Sequence Analysis of the Subclass Actinobacteridae	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; ET-AL. 2000; SP NOV.; EMENDED DESCRIPTION; PHYLOGENETIC ANALYSIS; MOLECULAR PHYLOGENY; GENOME; MYCOBACTERIUM; EVOLUTION; RPOB	Comparative genomic sequencing is shedding new light on bacterial identification, taxonomy and phylogeny. An in silico assessment of a core gene set necessary for cellular functioning was made to determine a consensus set of genes that would be useful for the identification, taxonomy and phylogeny of the species belonging to the subclass Actinobacteridae which contained two orders Actinomycetales and Bifidobacteriales. The subclass Actinobacteridae comprised about 85% of the actinobacteria families. The following recommended criteria were used to establish a comprehensive gene set; the gene should (i) be long enough to contain phylogenetically useful information, (ii) not be subject to horizontal gene transfer, (iii) be a single copy (iv) have at least two regions sufficiently conserved that allow the design of amplification and sequencing primers and (v) predict whole-genome relationships. We applied these constraints to 50 different Actinobacteridae genomes and made 1,224 pairwise comparisons of the genome conserved regions and gene fragments obtained by using Sequence VARiability Analysis Program (SVARAP), which allow designing the primers. Following a comparative statistical modeling phase, 3 gene fragments were selected, ychF, rpoB, and secY with R-2 > 0.85. Selected sets of broad range primers were tested from the 3 gene fragments and were demonstrated to be useful for amplification and sequencing of 25 species belonging to 9 genera of Actinobacteridae. The intraspecies similarities were 96.3-100% for ychF, 97.8-100% for rpoB and 96.9-100% for secY among 73 strains belonging to 15 species of the subclass Actinobacteridae compare to 99.4-100% for 16S rRNA. The phylogenetic topology obtained from the combined datasets ychF+rpoB+secY was globally similar to that inferred from the 16S rRNA but with higher confidence. It was concluded that multi-locus sequence analysis using core gene set might represent the first consensus and valid approach for investigating the bacterial identification, phylogeny and taxonomy.	[Adekambi, Toidi; Butler, Ray W.; Shinnick, Thomas M.] Ctr Dis Control & Prevent, Mycobacteriol Lab Branch, Div TB Eliminat, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Hanrahan, Finnian; Delcher, Arthur L.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Drancourt, Michel] Univ Mediterranee, Unite Rech Malad Infect & Trop Emergentes, CNRS, UMR 6236,IRD 198,IFR 48,Fac Med, Marseille, France	Centers for Disease Control & Prevention - USA; University System of Maryland; University of Maryland College Park; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Adekambi, T (corresponding author), Ctr Dis Control & Prevent, Mycobacteriol Lab Branch, Div TB Eliminat, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	tadekambi@gmail.com			ASM/CCID	ASM/CCID	Toidi Adekambi was supported by ASM/CCID postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Adekambi T, 2003, J CLIN MICROBIOL, V41, P5699, DOI 10.1128/JCM.41.12.5699-5708.2003; Adekambi T, 2004, INT J SYST EVOL MICR, V54, P2095, DOI 10.1099/ijs.0.63094-0; Adekambi T, 2006, J CLIN MICROBIOL, V44, P3493, DOI 10.1128/JCM.00724-06; Adekambi T, 2009, TRENDS MICROBIOL, V17, P37, DOI 10.1016/j.tim.2008.09.008; Adekambi T, 2008, INT J SYST EVOL MICR, V58, P1807, DOI 10.1099/ijs.0.65440-0; Ara I, 2008, INT J SYST EVOL MICR, V58, P1950, DOI 10.1099/ijs.0.65548-0; Atlas R., 1997, PRINCIPLES MICROBIOL; Bininda-Emonds ORP, 2004, TRENDS ECOL EVOL, V19, P315, DOI 10.1016/j.tree.2004.03.015; Boucher Y, 2004, J BACTERIOL, V186, P3980, DOI 10.1128/JB.186.12.3980-3990.2004; Butler WR, 2005, INT J SYST EVOL MICR, V55, P1615, DOI 10.1099/ijs.0.63465-0; Chun J, 1997, INT J SYST BACTERIOL, V47, P127, DOI 10.1099/00207713-47-1-127; Coenye T, 2005, FEMS MICROBIOL REV, V29, P147, DOI 10.1016/j.femsre.2004.11.004; Colson P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-21; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Devulder G, 2005, INT J SYST EVOL MICR, V55, P293, DOI 10.1099/ijs.0.63222-0; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; EMBLEY TM, 1994, ANNU REV MICROBIOL, V48, P257, DOI 10.1146/annurev.mi.48.100194.001353; Gao B, 2006, ANTON LEEUW INT J G, V90, P69, DOI 10.1007/s10482-006-9061-2; Gao BL, 2005, INT J SYST EVOL MICR, V55, P2401, DOI 10.1099/ijs.0.63785-0; GARRITY GM, 2004, BERGERYS MANUAL SYST; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Guo YP, 2008, INT J SYST EVOL MICR, V58, P149, DOI 10.1099/ijs.0.65224-0; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kampfer P, 1999, INT J SYST BACTERIOL, V49, P681, DOI 10.1099/00207713-49-2-681; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Koonin EV, 2000, ANNU REV GENOM HUM G, V1, P99, DOI 10.1146/annurev.genom.1.1.99; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Lee SD, 2006, INT J SYST EVOL MICR, V56, P2391, DOI 10.1099/ijs.0.64268-0; Lehnen A, 2006, INT J SYST EVOL MICR, V56, P861, DOI 10.1099/ijs.0.63923-0; McKenzie CM, 2006, INT J SYST EVOL MICR, V56, P2279, DOI 10.1099/ijs.0.63978-0; Mignard S, 2008, INT J SYST EVOL MICR, V58, P1432, DOI 10.1099/ijs.0.65658-0; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Ninet B, 1996, J CLIN MICROBIOL, V34, P2531, DOI 10.1128/JCM.34.10.2531-2536.1996; Novichkov PS, 2004, J BACTERIOL, V186, P6575, DOI 10.1128/JB.186.19.6575-6585.2004; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; RAINEY FA, 1995, INT J SYST BACTERIOL, V45, P32, DOI 10.1099/00207713-45-1-32; Richert K, 2007, SYST APPL MICROBIOL, V30, P102, DOI 10.1016/j.syapm.2006.04.001; ROGALL T, 1990, INT J SYST BACTERIOL, V40, P323, DOI 10.1099/00207713-40-4-323; ROLLER C, 1992, J GEN MICROBIOL, V138, P1167, DOI 10.1099/00221287-138-6-1167; Santos SR, 2004, ENVIRON MICROBIOL, V6, P754, DOI 10.1111/j.1462-2920.2004.00617.x; Soddell JA, 2006, INT J SYST EVOL MICR, V56, P739, DOI 10.1099/ijs.0.63855-0; Stach JEM, 2003, ENVIRON MICROBIOL, V5, P828, DOI 10.1046/j.1462-2920.2003.00483.x; Stackebrandt E, 1997, INT J SYST BACTERIOL, V47, P479, DOI 10.1099/00207713-47-2-479; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Stackebrandt E, 2007, CURR MICROBIOL, V55, P42, DOI 10.1007/s00284-006-0569-5; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ueda K, 1999, J BACTERIOL, V181, P78, DOI 10.1128/JB.181.1.78-82.1999; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Ventura M, 2006, INT J SYST EVOL MICR, V56, P2783, DOI 10.1099/ijs.0.64233-0; Wang Y, 2000, MICROBIOL-UK, V146, P2845, DOI 10.1099/00221287-146-11-2845; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wertz JE, 2003, J EVOLUTION BIOL, V16, P1236, DOI 10.1046/j.1420-9101.2003.00612.x; Yamamoto S, 1996, INT J SYST BACTERIOL, V46, P506, DOI 10.1099/00207713-46-2-506; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999; Zeigler DR, 2003, INT J SYST EVOL MICR, V53, P1893, DOI 10.1099/ijs.0.02713-0; Zhi XY, 2009, INT J SYST EVOL MICR, V59, P589, DOI 10.1099/ijs.0.65780-0	65	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e14792	10.1371/journal.pone.0014792	http://dx.doi.org/10.1371/journal.pone.0014792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483493	Green Published, gold, Green Submitted			2022-12-27	WOS:000289057200003
J	Goergen, EM; Leger, EA; Espeland, EK				Goergen, Erin M.; Leger, Elizabeth A.; Espeland, Erin K.			Native Perennial Grasses Show Evolutionary Response to Bromus tectorum (Cheatgrass) Invasion	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; NATURAL-SELECTION; PLANT; COMPETITION; PLASTICITY; RESISTANCE; TRAITS; WATER; RESTORATION; COMMUNITIES	Invasive species can change selective pressures on native plants by altering biotic and abiotic conditions in invaded habitats. Although invasions can lead to native species extirpation, they may also induce rapid evolutionary changes in remnant native plants. We investigated whether adult plants of five native perennial grasses exhibited trait shifts consistent with evolution in response to invasion by the introduced annual grass Bromus tectorum L. (cheatgrass), and asked how much variation there was among species and populations in the ability to grow successfully with the invader. Three hundred and twenty adult plants were collected from invaded and uninvaded communities from four locations near Reno, Nevada, USA. Each plant was divided in two and transplanted into the greenhouse. One clone was grown with B. tectorum while the other was grown alone, and we measured tolerance (ability to maintain size) and the ability to reduce size of B. tectorum for each plant. Plants from invaded populations consistently had earlier phenology than those from uninvaded populations, and in two out of four sites, invaded populations were more tolerant of B. tectorum competition than uninvaded populations. Poa secunda and one population of E. multisetus had the strongest suppressive effect on B. tectorum, and these two species were the only ones that flowered in competition with B. tectorum. Our study indicates that response to B. tectorum is a function of both location and species identity, with some, but not all, populations of native grasses showing trait shifts consistent with evolution in response to B. tectorum invasion within the Great Basin.	[Goergen, Erin M.; Leger, Elizabeth A.] Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA; [Espeland, Erin K.] Agr Res Serv ARS Sidney, NPARL, USDA, Sidney, MT USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; United States Department of Agriculture (USDA)	Goergen, EM (corresponding author), Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA.	erin.goergen@gmail.com		Leger, Elizabeth/0000-0003-0308-9496; Espeland, Erin/0000-0001-8541-3610	USDA CSREES; Great Basin Native Plant Selection and Increase Project	USDA CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Great Basin Native Plant Selection and Increase Project	This research was funded by a USDA CSREES Seed Grant to E. Leger and E. Espeland and The Great Basin Native Plant Selection and Increase Project. The funders had no role in study design, data collection, analysis, or manuscript preparation.	Arredondo JT, 1998, J RANGE MANAGE, V51, P584, DOI 10.2307/4003380; Beckstead J, 2004, BIOL INVASIONS, V6, P417, DOI 10.1023/B:BINV.0000041557.92285.43; Blank RR, 2008, INVAS PLANT SCI MANA, V1, P226, DOI 10.1614/IPSM-07-026.1; Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; Booth MS, 2003, J ECOL, V91, P36, DOI 10.1046/j.1365-2745.2003.00739.x; Bradley BA, 2006, ECOL APPL, V16, P1132, DOI 10.1890/1051-0761(2006)016[1132:CTLDOA]2.0.CO;2; Callaway RM, 2005, J ECOL, V93, P576, DOI 10.1111/j.1365-2745.2005.00994.x; Carroll SP, 2007, ECOL RES, V22, P892, DOI 10.1007/s11284-007-0352-5; CHEPLICK GP, 1995, INT J PLANT SCI, V156, P522, DOI 10.1086/297275; Cipollini KA, 2008, OHIO J SCI, V108, P47; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; D'Antonio C, 2002, RESTOR ECOL, V10, P703, DOI 10.1046/j.1526-100X.2002.01051.x; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Dyer AR, 2000, ECOL LETT, V3, P523, DOI 10.1046/j.1461-0248.2000.00187.x; Ferrero-Serrano A, 2011, RESTOR ECOL, V19, P545, DOI 10.1111/j.1526-100X.2009.00611.x; GOLDBERG DE, 1991, J ECOL, V79, P1013, DOI 10.2307/2261095; Gonzalez A, 2008, OIKOS, V117, P1247, DOI 10.1111/j.0030-1299.2008.16419.x; Hangelbroek HH, 2004, EVOL ECOL RES, V6, P147; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; HuberSannwald E, 1996, AM J BOT, V83, P919, DOI 10.2307/2446270; Humphrey LD, 2004, J ARID ENVIRON, V58, P405, DOI 10.1016/j.jaridenv.2003.11.008; Jones T.A., 2010, RANGELANDS, V32, P38, DOI DOI 10.2111/RANGELANDS-D-09-00011.1; Jones TA, 2009, FRONT ECOL ENVIRON, V7, P541, DOI 10.1890/080028; Keddy P, 1998, J VEG SCI, V9, P777, DOI 10.2307/3237043; KEDDY PA, 1994, J ECOL, V82, P635, DOI 10.2307/2261270; Kulmatiski A, 2006, PLANT SOIL, V288, P271, DOI 10.1007/s11104-006-9115-2; Lau JA, 2008, ECOLOGY, V89, P1023, DOI 10.1890/06-1999.1; Leger EA, 2008, ECOL APPL, V18, P1226, DOI 10.1890/07-1598.1; Leger EA, 2010, EVOL APPL, V3, P169, DOI 10.1111/j.1752-4571.2009.00105.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Mealor BA, 2007, OIKOS, V116, P1493, DOI 10.1111/j.0030-1299.2007.15781.x; MELGOZA G, 1990, OECOLOGIA, V83, P7, DOI 10.1007/BF00324626; Murren CJ, 2006, ECOLOGY, V87, P2591, DOI 10.1890/0012-9658(2006)87[2591:IACEOM]2.0.CO;2; Nord EA, 2009, J EXP BOT, V60, P1927, DOI 10.1093/jxb/erp018; Rice KJ, 2003, FRONT ECOL ENVIRON, V1, P469, DOI 10.1890/1540-9295(2003)001[0469:MMRITF]2.0.CO;2; Strauss SY, 2006, ECOL LETT, V9, P354, DOI 10.1111/j.1461-0248.2005.00874.x; Van Kleunen M, 2003, J EVOLUTION BIOL, V16, P474, DOI 10.1046/j.1420-9101.2003.00532.x; WALKER LR, 1991, ECOLOGY, V72, P1449, DOI 10.2307/1941117; Willis CG, 2010, J EVOLUTION BIOL, V23, P1412, DOI 10.1111/j.1420-9101.2010.02003.x	41	57	60	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18145	10.1371/journal.pone.0018145	http://dx.doi.org/10.1371/journal.pone.0018145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479185	Green Submitted, Green Published, gold			2022-12-27	WOS:000289055700033
J	Lin, CY; Chen, JY; Lin, TN; Jeng, WJ; Huang, CH; Huang, CW; Chang, SW; Sheen, IS				Lin, Chun-Yen; Chen, Ji-Yih; Lin, Tsung-Nan; Jeng, Wen-Juei; Huang, Chien-Hao; Huang, Chang-Wen; Chang, Su-Wei; Sheen, I-Shyan			IL28B SNP rs12979860 Is a Critical Predictor for On-Treatment and Sustained Virologic Response in Patients with Hepatitis C Virus Genotype-1 Infection	PLOS ONE			English	Article							ALPHA-2B PLUS RIBAVIRIN; PEGINTERFERON ALPHA-2A; GENETIC-VARIATION; SPONTANEOUS CLEARANCE; TREATMENT DURATION; POLYMORPHISM; INTERFERON; GENOMICS; EFFICACY	Background: Single nucleotide polymorphisms (SNPs) of interleukin-28B (IL28B) have received considerable interest for their association with sustained virological response (SVR) when treating patients of genotype-1 hepatitis C virus (GT1-HCV) chronic infection with pegylated interferon and ribavirin (PegIFN/RBV). This study was to investigate the predictive power of IL28B SNPs for on-treatment responses and SVR in treatment-naive patients with GT1-HCV chronic infection. Methodology/Principal Findings: We analyzed ten SNPs of IL28B in 191 treatment-naive patients with GT1-HCV chronic infection who received PegIFN/RBV. In these patients, rapid virological response (RVR), early virological response (EVR) and SVR were achieved in 69.6%, 95.8% and 68.6% of the patients, respectively. Multivariate analysis (odds ratio; 95% confidence interval; P value) indicated age (0.96; 0.93-0.99; 0.012), low baseline viral load (4.65; 2.23-9.66; < 0.001) and CC genotype of rs12979860 (7.74; 2.55-23.53; < 0.001) but no other SNPs were independent predictors for SVR. In addition, none of the ten SNPs examined were associated with baseline viral load and stages of liver fibrosis. Regarding RVR, low baseline viral load (2.83; 1.40-5.73; 0.004) and CC genotype of rs12979860 (10.52; 3.45-32.04; < 0.001) were two critical predictors. As for EVR, only CC genotype of rs12979860 (36.21; 6.68-196.38; < 0.001) was the predictor. Similarly, for end of treatment response (ETR), CC genotype of rs12979860 (15.42; 4.62-51.18; < 0.001) was the only predictor. For patients with RVR, only low baseline viral load (3.90; 1.57-9.68; 0.003) could predict the SVR. For patients without RVR, only rs12979860 (4.60; 1.13-18.65; 0.033) was the predictor for SVR. Conclusions/ Significance: rs12979860 is the critical predictor for RVR, EVR, ETR and SVR in treatment-naive patients of GT1-HCV chronic infection. Furthermore, this SNP is the only predictor for SVR in patients without RVR. These results have provided evidence that rs12979860 is the ideal IL28B SNP for genetic testing in treating patients of GT1-HCV chronic infection.	[Lin, Chun-Yen; Lin, Tsung-Nan; Jeng, Wen-Juei; Huang, Chien-Hao; Huang, Chang-Wen; Sheen, I-Shyan] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Gastroenterol & Hepatol, Tao Yuan, Taiwan; [Chen, Ji-Yih] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Rheumatol Allergy & Immunol, Tao Yuan, Taiwan; [Lin, Chun-Yen; Chen, Ji-Yih; Sheen, I-Shyan] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chang, Su-Wei] Acad Sinica, Inst Biomed Sci, Div Biostat, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Academia Sinica - Taiwan	Lin, CY (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept Gastroenterol & Hepatol, Tao Yuan, Taiwan.	issheen.jks@gmail.com		Huang, Chien-Hao/0000-0003-1689-3221; LIN, TSUNGNAN/0000-0001-5659-1194; Lin, Chun-Yen/0000-0003-3007-3190	National Science Council, Taiwan; Chang Gung Memorial Hospital [CMRPG 390682, 37542, 360463]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by National Science Council, Taiwan, and CMRPG 390682, 37542, 360463 from Chang Gung Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 2010, J HEPATOLOG IN PRESS; Abe H, 2010, J HEPATOL, V53, P439, DOI 10.1016/j.jhep.2010.03.022; Afdhal NH, 2011, HEPATOLOGY, V53, P336, DOI 10.1002/hep.24052; Montes-Cano MA, 2010, HEPATOLOGY, V52, P33, DOI 10.1002/hep.23624; Aparicio E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013771; BALAGOPAL A, 2010, GASTROENTEROLOGY, DOI DOI 10.1053/J.GASTRO.2010.1010.1004; Chen JY, 2006, ARTHRITIS RHEUM-US, V54, P3908, DOI 10.1002/art.22220; Dalgard O, 2004, HEPATOLOGY, V40, P1260, DOI 10.1002/hep.20467; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Ferenci P, 2008, GASTROENTEROLOGY, V135, P451, DOI 10.1053/j.gastro.2008.04.015; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gheorghe L, 2007, J GASTROINTEST LIVER, V16, P23; Grebely J, 2010, HEPATOLOGY, V52, P1216, DOI 10.1002/hep.23850; Iadonato SP, 2009, NATURE, V461, P357, DOI 10.1038/461357a; Jensen DM, 2006, HEPATOLOGY, V43, P954, DOI 10.1002/hep.21159; Kamal SM, 2007, HEPATOLOGY, V46, P1732, DOI 10.1002/hep.21917; Kuboki M, 2007, J GASTROEN HEPATOL, V22, P645, DOI 10.1111/j.1440-1746.2007.04834.x; LANGHANS B, 2010, J HEPATOLOG IN PRESS; Lee Hyuk, 2006, Korean J Hepatol, V12, P31; Liu CH, 2008, CLIN INFECT DIS, V47, P1260, DOI 10.1086/592579; Liu CJ, 2009, GASTROENTEROLOGY, V136, P496, DOI 10.1053/j.gastro.2008.10.049; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Mangia A, 2008, HEPATOLOGY, V47, P43, DOI 10.1002/hep.22061; Mangia A, 2010, GASTROENTEROLOGY, V139, P821, DOI 10.1053/j.gastro.2010.05.079; Martin MP, 2010, J INFECT DIS, V202, P1749, DOI 10.1086/657146; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; Rauch A, 2010, EUR J CLIN INVEST, V40, P950, DOI 10.1111/j.1365-2362.2010.02337.x; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; STATTERMAYER AF, 2010, CLIN GASTRO IN PRESS; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; von Wagner M, 2005, GASTROENTEROLOGY, V129, P522, DOI 10.1053/j.gastro.2005.05.008; Yu ML, 2008, HEPATOLOGY, V47, P1884, DOI 10.1002/hep.22319; Yu ML, 2007, GUT, V56, P553, DOI 10.1136/gut.2006.102558; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976; Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x; Yu ML, 2006, LIVER INT, V26, P73, DOI 10.1111/j.1478-3231.2005.01196.x; Zeuzem S, 2006, J HEPATOL, V44, P97, DOI 10.1016/j.jhep.2005.10.003; ZHANG L, 2010, J HEPATOL IN PRESS	43	48	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18322	10.1371/journal.pone.0018322	http://dx.doi.org/10.1371/journal.pone.0018322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479134	Green Published, gold, Green Submitted			2022-12-27	WOS:000289055700046
J	Dias-Santagata, D; Lam, Q; Vernovsky, K; Vena, N; Lennerz, JK; Borger, DR; Batchelor, TT; Ligon, KL; Iafrate, AJ; Ligon, AH; Louis, DN; Santagata, S				Dias-Santagata, Dora; Lam, Quynh; Vernovsky, Kathy; Vena, Natalie; Lennerz, Jochen K.; Borger, Darrell R.; Batchelor, Tracy T.; Ligon, Keith L.; Iafrate, A. John; Ligon, Azra H.; Louis, David N.; Santagata, Sandro			BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications	PLOS ONE			English	Article							ANAPLASTIC FEATURES; GENETIC ALTERATIONS; MAPK PATHWAY; EXPRESSION; DUPLICATION; FUSION; IDH1; CLASSIFICATION; GANGLIOGLIOMA; ACTIVATION	Pleomorphic xanthoastrocytoma (PXA) is low-grade glial neoplasm principally affecting children and young adults. Approximately 40% of PXA are reported to recur within 10 years of primary resection. Upon recurrence, patients receive radiation therapy and conventional chemotherapeutics designed for high-grade gliomas. Genetic changes that can be targeted by selective therapeutics have not been extensively evaluated in PXA and ancillary diagnostic tests to help discriminate PXA from other pleomorphic and often more aggressive astrocytic malignancies are limited. In this study, we apply the SNaPshot multiplexed targeted sequencing platform in the analysis of brain tumors to interrogate 60 genetic loci that are frequently mutated in 15 cancer genes. In our analysis we detect BRAF V600E mutations in 12 of 20 (60%) WHO grade II PXA, in 1 of 6 (17%) PXA with anaplasia and in 1 glioblastoma arising in a PXA. Phospho-ERK was detected in all tumors independent of the BRAF mutation status. BRAF duplication was not detected in any of the PXA cases. BRAF V600E mutations were identified in only 2 of 71 (2.8%) glioblastoma (GBM) analyzed, including 1 of 9 (11.1%) giant cell GBM (gcGBM). The finding that BRAF V600E mutations are common in the majority of PXA has important therapeutic implications and may help in differentiating less aggressive PXAs from lethal gcGBMs and GBMs.	[Dias-Santagata, Dora; Lam, Quynh; Lennerz, Jochen K.; Iafrate, A. John; Louis, David N.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Dias-Santagata, Dora; Lam, Quynh; Lennerz, Jochen K.; Iafrate, A. John; Louis, David N.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Vernovsky, Kathy; Borger, Darrell R.; Batchelor, Tracy T.] Massachusetts Gen Hosp, Ctr Canc, Div Hematol Oncol, Boston, MA USA; [Dias-Santagata, Dora; Lam, Quynh; Vernovsky, Kathy; Lennerz, Jochen K.; Borger, Darrell R.; Batchelor, Tracy T.; Ligon, Keith L.; Iafrate, A. John; Ligon, Azra H.; Louis, David N.; Santagata, Sandro] Harvard Univ, Sch Med, Boston, MA USA; [Vena, Natalie; Ligon, Keith L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Vena, Natalie; Ligon, Keith L.; Ligon, Azra H.] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Batchelor, Tracy T.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Batchelor, Tracy T.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Ligon, Keith L.; Santagata, Sandro] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ligon, Keith L.; Ligon, Azra H.; Santagata, Sandro] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital	Dias-Santagata, D (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.	ssantagata@partners.org		Santagata, Sandro/0000-0002-7528-9668; Ligon, Keith/0000-0002-7733-600X	Aid for Cancer Research Foundation; PLGA Foundation; National Institutes of Health (NIH) [CA095616, CA57683, K08NS064168]; Sontag Foundation; Goldhirsh Foundation; V Foundation for Cancer Research; Brain Science Foundation; NATIONAL CANCER INSTITUTE [R01CA057683, P01CA095616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS064168] Funding Source: NIH RePORTER	Aid for Cancer Research Foundation; PLGA Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sontag Foundation; Goldhirsh Foundation; V Foundation for Cancer Research; Brain Science Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Aid for Cancer Research Foundation and from an anonymous donor (to MGH) and the PLGA Foundation. KLL is supported by National Institutes of Health (NIH) grant CA095616, the Sontag Foundation, and the Goldhirsh Foundation. DNL is supported by NIH grant CA57683. SS is supported by NIH grant K08NS064168, the V Foundation for Cancer Research and the Brain Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Basto D, 2005, ACTA NEUROPATHOL, V109, P207, DOI 10.1007/s00401-004-0936-x; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Bruger P., 2002, SURG PATHOLOGY NERVO, P405; Camelo-Piragua S, 2010, ACTA NEUROPATHOL, V119, P509, DOI 10.1007/s00401-009-0632-y; Cartmill M, 2001, CHILD NERV SYST, V17, P563; Chang HT, 2006, CHILD NERV SYST, V22, P609, DOI 10.1007/s00381-005-0005-3; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; DOUGHERTY MJ, 2010, NEURO ONCOL, V12; Flaherty KT, 2010, ANN INTERN MED, V153, P587, DOI 10.7326/0003-4819-153-9-201011020-00008; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fletcher CD, 2007, DIAGNOSTIC HISTOPATH; Forshew T, 2009, J PATHOL, V218, P172, DOI 10.1002/path.2558; Giannini C, 1997, BRAIN PATHOL, V7, P785, DOI 10.1111/j.1750-3639.1997.tb01064.x; Giannini C, 2001, NEUROGENETICS, V3, P159, DOI 10.1007/s100480100116; Giannini C, 1999, CANCER, V85, P2033, DOI 10.1002/(SICI)1097-0142(19990501)85:9<2033::AID-CNCR22>3.3.CO;2-Q; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Hagemann C, 2009, INT J MOL MED, V23, P17, DOI 10.3892/ijmm_00000097; Horbinski C, 2011, BRAIN PATHOL, V21, P57, DOI 10.1111/j.1750-3639.2010.00453.x; Ironside JW, 2002, DIAGNOSTIC PATHOLOGY; Jones DTW, 2009, ONCOGENE, V28, P2119, DOI 10.1038/onc.2009.73; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kaulich K, 2002, J NEUROPATH EXP NEUR, V61, P1092, DOI 10.1093/jnen/61.12.1092; KEPES JJ, 1993, BRAIN PATHOL, V3, P269, DOI 10.1111/j.1750-3639.1993.tb00753.x; KEPES JJ, 1979, CANCER, V44, P1839, DOI 10.1002/1097-0142(197911)44:5<1839::AID-CNCR2820440543>3.0.CO;2-0; KEPES JJ, 1973, ACTA NEUROPATHOL, V23, P187, DOI 10.1007/BF00687875; Kim YH, 2010, AM J PATHOL, V177, P2708, DOI 10.2353/ajpath.2010.100680; Knobbe CB, 2004, ACTA NEUROPATHOL, V108, P467, DOI 10.1007/s00401-004-0929-9; Koga T, 2009, NEURO-ONCOLOGY, V11, P446, DOI 10.1215/15228517-2008-112; KROS JM, 1991, HUM PATHOL, V22, P1128, DOI 10.1016/0046-8177(91)90265-Q; Louis DN, 2007, WHO HISTOLOGICAL CLA; Lurkin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008802; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; MeyerPuttlitz B, 1997, AM J PATHOL, V151, P853; Munoz EL, 1996, J NEUROPATHOL EXP NE, V55, P606; MURRAY JC, 2010, J NEUROONCOL; Pahapill PA, 1996, NEUROSURGERY, V38, P822, DOI 10.1227/00006123-199604000-00038; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paulus W, 1996, ACTA NEUROPATHOL, V91, P293, DOI 10.1007/s004010050428; Peraud A, 1997, J NEUROPATH EXP NEUR, V56, P1236, DOI 10.1097/00005072-199711000-00008; Peraud A, 1999, LAB INVEST, V79, P123; Perry A, 1997, AM J SURG PATHOL, V21, P763, DOI 10.1097/00000478-199707000-00004; Perry A., 2010, PRACTICAL SURG NEURO; Pfister S, 2008, J CLIN INVEST, V118, P1739, DOI 10.1172/JCI33656; Rao AAN, 2010, PEDIATR BLOOD CANCER, V55, P290, DOI 10.1002/pbc.22490; Schiffman JD, 2010, CANCER RES, V70, P512, DOI 10.1158/0008-5472.CAN-09-1851; Schindler G, 2011, ACTA NEUROPATHOL, V121, P397, DOI 10.1007/s00401-011-0802-6; Sievert AJ, 2009, BRAIN PATHOL, V19, P449, DOI 10.1111/j.1750-3639.2008.00225.x; Sugita Y, 2009, BRAIN TUMOR PATHOL, V26, P31, DOI 10.1007/s10014-009-0244-1; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Weber RG, 2007, ONCOGENE, V26, P1088, DOI 10.1038/sj.onc.1209851; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	56	209	225	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17948	10.1371/journal.pone.0017948	http://dx.doi.org/10.1371/journal.pone.0017948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479234	Green Published, gold, Green Submitted			2022-12-27	WOS:000289054600021
J	Toivari, E; Manninen, T; Nahata, AK; Jalonen, TO; Linne, ML				Toivari, Eeva; Manninen, Tiina; Nahata, Amit K.; Jalonen, Tuula O.; Linne, Marja-Leena			Effects of Transmitters and Amyloid-Beta Peptide on Calcium Signals in Rat Cortical Astrocytes: Fura-2AM Measurements and Stochastic Model Simulations	PLOS ONE			English	Article							COUPLED CHEMICAL-REACTIONS; ALZHEIMERS-DISEASE; A-BETA; IN-VITRO; DEPRESSION; NEURONS; EQUATION; PATHWAYS; WAVES; DYSREGULATION	Background: To better understand the complex molecular level interactions seen in the pathogenesis of Alzheimer's disease, the results of the wet-lab and clinical studies can be complemented by mathematical models. Astrocytes are known to become reactive in Alzheimer's disease and their ionic equilibrium can be disturbed by interaction of the released and accumulated transmitters, such as serotonin, and peptides, including amyloid-beta peptides (A beta). We have here studied the effects of small amounts of A beta 25-35 fragments on the transmitter-induced calcium signals in astrocytes by Fura-2AM fluorescence measurements and running simulations of the detected calcium signals. Methodology/Principal Findings: Intracellular calcium signals were measured in cultured rat cortical astrocytes following additions of serotonin and glutamate, or either of these transmitters together with A beta 25-35. A beta 25-35 increased the number of astrocytes responding to glutamate and exceedingly increased the magnitude of the serotonin-induced calcium signals. In addition to A beta 25-35-induced effects, the contribution of intracellular calcium stores to calcium signaling was tested. When using higher stimulus frequency, the subsequent calcium peaks after the initial peak were of lower amplitude. This may indicate inadequate filling of the intracellular calcium stores between the stimuli. In order to reproduce the experimental findings, a stochastic computational model was introduced. The model takes into account the major mechanisms known to be involved in calcium signaling in astrocytes. Model simulations confirm the principal experimental findings and show the variability typical for experimental measurements. Conclusions/Significance: Nanomolar A beta 25-35 alone does not cause persistent change in the basal level of calcium in astrocytes. However, even small amounts of A beta 25-35, together with transmitters, can have substantial synergistic effects on intracellular calcium signals. Computational modeling further helps in understanding the mechanisms associated with intracellular calcium oscillations. Modeling the mechanisms is important, as astrocytes have an essential role in regulating the neuronal microenvironment of the central nervous system.	[Toivari, Eeva; Manninen, Tiina; Linne, Marja-Leena] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Nahata, Amit K.] DCI, Kidney Care Ctr, Steubenville, OH USA; [Jalonen, Tuula O.] St Georges Univ, Sch Med, Dept Physiol & Neurosci, St Georges, Grenada	Tampere University	Toivari, E (corresponding author), Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland.	eeva.toivari@tut.fi; marja-leena.linne@tut.fi		Linne, Marja-Leena/0000-0003-2577-7329; Manninen, Tiina/0000-0002-0456-1185	Tampere University of Technology Doctoral Programme; Tampere Doctoral Programme in Information Science and Engineering (TISE); Academy of Finland [213462, 129657, 106030, 107694, 124615, 126556]; Emil Aaltonen Foundation; Finnish Concordia Fund	Tampere University of Technology Doctoral Programme; Tampere Doctoral Programme in Information Science and Engineering (TISE); Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Finnish Concordia Fund	This work was supported in part by Tampere University of Technology Doctoral Programme (www.tut.fi), Tampere Doctoral Programme in Information Science and Engineering (TISE) (www.cs.tut.fi/tise/), the Academy of Finland, No. 213462, and 129657 (Finnish 320 Programme for Centres of Excellence in Research 2006-2011), 106030, 107694, 124615, and 126556 (www.aka.fi), Emil Aaltonen Foundation (www.emilaaltonen.fi), and Finnish Concordia Fund (www.konkordia-liitto.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2004, BBA-MOL CELL RES, V1742, P81, DOI 10.1016/j.bbamcr.2004.09.006; Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Alberts B, 2002, MOL BIOL CELL; [Anonymous], [No title captured]; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Blankenfeld G.v, 1995, NEUROGLIA, P335; Bojarski L, 2008, NEUROCHEM INT, V52, P621, DOI 10.1016/j.neuint.2007.10.002; Branden C., 1999, INTRO PROTEIN STRUCT; Charles A, 1998, GLIA, V24, P39, DOI 10.1002/(SICI)1098-1136(199809)24:1<39::AID-GLIA5>3.0.CO;2-W; Cheng L, 2009, SYNAPSE, V63, P206, DOI 10.1002/syn.20599; D'Ursi AM, 2004, J MED CHEM, V47, P4231, DOI 10.1021/jm040773o; Di Garbo A, 2007, BIOSYSTEMS, V89, P74, DOI 10.1016/j.biosystems.2006.05.013; Di Garbo A, 2009, J BIOL PHYS, V35, P361, DOI 10.1007/s10867-009-9143-2; Falcke M, 2004, ADV PHYS, V53, P255, DOI 10.1080/00018730410001703159; Findeis MA, 2007, PHARMACOL THERAPEUT, V116, P266, DOI 10.1016/j.pharmthera.2007.06.006; FRANGAKIS MV, 1984, NEUROCHEM RES, V9, P1689, DOI 10.1007/BF00968079; Freir DB, 2003, J NEUROPHYSIOL, V89, P3061, DOI 10.1152/jn.00992.2002; Galoyan AA, 2008, ALZHEIMERS DEMENT, V4, P332, DOI 10.1016/j.jalz.2007.10.019; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Hofer T, 2002, J NEUROSCI, V22, P4850, DOI 10.1523/JNEUROSCI.22-12-04850.2002; Jalonen TO, 1997, BRAIN RES, V746, P85, DOI 10.1016/S0006-8993(96)01189-4; Jalonen TO, 1997, BRAIN RES, V758, P69, DOI 10.1016/S0006-8993(97)00163-7; JALONEN TO, 1997, THESIS U TAMPERE CIT; Khachaturian ZS, 2006, J ALZHEIMERS DIS, V9, P409; Kimelberg H. K., 1992, V94, P57; Kimelberg HK, 1997, J NEUROCHEM, V68, P1088; KIMELBERG HK, 1997, GLIAL CELLS THEIR RO, P107; Kita Y, 2009, PSYCHOGERIATRICS, V9, P180, DOI 10.1111/j.1479-8301.2009.00293.x; Klementiev B, 2007, NEUROSCIENCE, V145, P209, DOI 10.1016/j.neuroscience.2006.11.060; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; Lavrentovich M, 2008, J THEOR BIOL, V251, P553, DOI 10.1016/j.jtbi.2007.12.011; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; MAKIRAATIKKA E, 2007, P 5 IEEE INT WORKSH; Manninen T, 2006, COMPUT BIOL CHEM, V30, P280, DOI 10.1016/j.compbiolchem.2006.04.002; Marhl M, 2010, BIOPHYS CHEM, V148, P42, DOI 10.1016/j.bpc.2010.02.006; Matrisciano F, 2007, MOL PSYCHIATR, V12, P704, DOI 10.1038/sj.mp.4002005; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Miao JT, 2008, NEUROPEPTIDES, V42, P557, DOI 10.1016/j.npep.2008.08.004; Nicoletti F, 1996, TRENDS NEUROSCI, V19, P267, DOI 10.1016/S0166-2236(96)20019-0; Nie BM, 2008, NEUROPHARMACOLOGY, V54, P845, DOI 10.1016/j.neuropharm.2008.01.003; Paradisi S, 2004, GLIA, V46, P252, DOI 10.1002/glia.20005; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; Perc M, 2008, BIOPHYS CHEM, V132, P33, DOI 10.1016/j.bpc.2007.10.002; Perc M, 2009, CHAOS, V19, DOI 10.1063/1.3160017; Perea G, 2005, J NEURAL TRANSM, V112, P127, DOI 10.1007/s00702-004-0170-7; Perea G, 2005, CELL CALCIUM, V38, P375, DOI 10.1016/j.ceca.2005.06.015; Resende R, 2007, BRAIN RES, V1143, P11, DOI 10.1016/j.brainres.2007.01.071; Saarinen A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000004; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Schupf N, 2008, P NATL ACAD SCI USA, V105, P14052, DOI 10.1073/pnas.0805902105; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Smith IF, 2005, CELL CALCIUM, V38, P427, DOI 10.1016/j.ceca.2005.06.021; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; Verkhratsky A, 1996, TRENDS NEUROSCI, V19, P346, DOI 10.1016/0166-2236(96)10048-5; Vesce S, 1999, CELL MOL LIFE SCI, V56, P991, DOI 10.1007/s000180050488; Wilkinso D.J., 2006, STOCHASTIC MODELLING	62	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17914	10.1371/journal.pone.0017914	http://dx.doi.org/10.1371/journal.pone.0017914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21483471	Green Submitted, Green Published, gold			2022-12-27	WOS:000289054600020
J	Lempiainen, H; Muller, A; Brasa, S; Teo, SS; Roloff, TC; Morawiec, L; Zamurovic, N; Vicart, A; Funhoff, E; Couttet, P; Schubeler, D; Grenet, O; Marlowe, J; Moggs, J; Terranova, R				Lempiaeinen, Harri; Mueller, Arne; Brasa, Sarah; Teo, Soon-Siong; Roloff, Tim-Christoph; Morawiec, Laurent; Zamurovic, Natasa; Vicart, Axel; Funhoff, Enrico; Couttet, Philippe; Schuebeler, Dirk; Grenet, Olivier; Marlowe, Jennifer; Moggs, Jonathan; Terranova, Remi			Phenobarbital Mediates an Epigenetic Switch at the Constitutive Androstane Receptor (CAR) Target Gene Cyp2b10 in the Liver of B6C3F1 Mice	PLOS ONE			English	Article							COVALENT HISTONE MODIFICATIONS; RESPONSIVE ENHANCER MODULE; DNA METHYLATION; HUMAN CANCERS; EXPRESSION; CELLS; HYPOMETHYLATION; TUMORIGENESIS; TRANSCRIPTION; POLYCOMB	Evidence suggests that epigenetic perturbations are involved in the adverse effects associated with some drugs and toxicants, including certain classes of non-genotoxic carcinogens. Such epigenetic changes (altered DNA methylation and covalent histone modifications) may take place at the earliest stages of carcinogenesis and their identification holds great promise for biomedical research. Here, we evaluate the sensitivity and specificity of genome-wide epigenomic and transcriptomic profiling in phenobarbital (PB)-treated B6C3F1 mice, a well-characterized rodent model of non-genotoxic liver carcinogenesis. Methylated DNA Immunoprecipitation (MeDIP)-coupled microarray profiling of 17,967 promoter regions and 4,566 intergenic CpG islands was combined with genome-wide mRNA expression profiling to identify liver tissue-specific PB-mediated DNA methylation and transcriptional alterations. Only a limited number of significant anti-correlations were observed between PB-induced transcriptional and promoter-based DNA methylation perturbations. However, the constitutive androstane receptor (CAR) target gene Cyp2b10 was found to be concomitantly hypomethylated and transcriptionally activated in a liver tissue-specific manner following PB treatment. Furthermore, analysis of active and repressive histone modifications using chromatin immunoprecipitation revealed a strong PB-mediated epigenetic switch at the Cyp2b10 promoter. Our data reveal that PB-induced transcriptional perturbations are not generally associated with broad changes in the DNA methylation status at proximal promoters and suggest that the drug-inducible CAR pathway regulates an epigenetic switch from repressive to active chromatin at the target gene Cyp2b10. This study demonstrates the utility of integrated epigenomic and transcriptomic profiling for elucidating early mechanisms and biomarkers of nongenotoxic carcinogenesis.	[Lempiaeinen, Harri; Mueller, Arne; Brasa, Sarah; Teo, Soon-Siong; Morawiec, Laurent; Zamurovic, Natasa; Vicart, Axel; Funhoff, Enrico; Couttet, Philippe; Grenet, Olivier; Marlowe, Jennifer; Moggs, Jonathan; Terranova, Remi] Novartis Inst Biomed Res, Basel, Switzerland; [Roloff, Tim-Christoph; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Novartis; Friedrich Miescher Institute for Biomedical Research	Lempiainen, H (corresponding author), Novartis Inst Biomed Res, Basel, Switzerland.	remi.terranova@novartis.com	Couttet, Philippe/AAH-5489-2019	Couttet, Philippe/0000-0002-5255-6647; Lempiainen, Harri/0000-0002-8945-6295; Vicart, Axel/0000-0002-2841-8471	Innovative Medicine Initiative Joint Undertaking (IMI JU) [115001]	Innovative Medicine Initiative Joint Undertaking (IMI JU)	The research leading to these results is funded by the Innovative Medicine Initiative Joint Undertaking (IMI JU) under grant agreement number 115001 (MARCAR project). URL: http://www.imi-marcar.eu/.Novartis is a full participant in the IMI consortium and provides in kind financial contribution to the scientific program. All IMI-MARCAR consortium partners had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman AN, 2006, TOXICOL SCI, V91, P393, DOI 10.1093/toxsci/kfj155; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; BECKER FF, 1982, CANCER RES, V42, P3918; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bombail V, 2004, TOXICOL LETT, V149, P51, DOI 10.1016/j.toxlet.2004.01.003; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Csoka AB, 2009, MED HYPOTHESES, V73, P770, DOI 10.1016/j.mehy.2008.10.039; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Goodman JI, 2010, TOXICOL SCI, V116, P375, DOI 10.1093/toxsci/kfq133; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Handel AE, 2010, TRENDS MOL MED, V16, P7, DOI 10.1016/j.molmed.2009.11.003; HIROSE M, 1981, CARCINOGENESIS, V2, P1299, DOI 10.1093/carcin/2.12.1299; HONKAKOSKI P, 1992, BIOCHEM J, V285, P979, DOI 10.1042/bj2850979; Honkakoski P, 1997, J BIOL CHEM, V272, P14943, DOI 10.1074/jbc.272.23.14943; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PL, 1999, SEMIN CANCER BIOL, V9, P339, DOI 10.1006/scbi.1999.0134; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Klug M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r63; LeBaron MJ, 2010, MUTAT RES-REV MUTAT, V705, P83, DOI 10.1016/j.mrrev.2010.04.003; Lee GH, 2000, TOXICOL PATHOL, V28, P215, DOI 10.1177/019262330002800201; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Mohn Fabio, 2009, V507, P55, DOI 10.1007/978-1-59745-522-0_5; MONCMAN CL, 1995, CELL MOTIL CYTOSKEL, V32, P205, DOI 10.1002/cm.970320305; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; PERAINO C, 1973, JNCI-J NATL CANCER I, V51, P1349, DOI 10.1093/jnci/51.4.1349; PERAINO C, 1971, CANCER RES, V31, P1506; Phillips JM, 2007, TOXICOL SCI, V96, P72, DOI 10.1093/toxsci/kfl188; Phillips JM, 2009, TOXICOL SCI, V110, P319, DOI 10.1093/toxsci/kfp108; Phillips JM, 2009, TOXICOL SCI, V109, P193, DOI 10.1093/toxsci/kfp050; Phillips JM, 2009, TOXICOL SCI, V108, P273, DOI 10.1093/toxsci/kfp031; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Ross J, 2010, TOXICOL SCI, V116, P452, DOI 10.1093/toxsci/kfq118; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; UCHIDA E, 1981, J CANCER RES CLIN, V100, P231, DOI 10.1007/BF00410683; Umlauf David, 2004, Methods Mol Biol, V287, P99; Watson RE, 2002, TOXICOL SCI, V67, P11, DOI 10.1093/toxsci/67.1.11; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; WOLFFE AP, 1994, DEV GENET, V15, P463, DOI 10.1002/dvg.1020150604; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Yamamoto Y, 2003, ARCH BIOCHEM BIOPHYS, V409, P207, DOI 10.1016/S0003-9861(02)00456-3	61	61	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18216	10.1371/journal.pone.0018216	http://dx.doi.org/10.1371/journal.pone.0018216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455306	Green Published, gold, Green Submitted			2022-12-27	WOS:000288811500029
J	Friederici, AD; Mueller, JL; Oberecker, R				Friederici, Angela D.; Mueller, Jutta L.; Oberecker, Regine			Precursors to Natural Grammar Learning: Preliminary Evidence from 4-Month-Old Infants	PLOS ONE			English	Article							BRAIN POTENTIALS; 8-MONTH-OLD INFANTS; LANGUAGE; NEWBORNS; SENTENCE; ERP	When learning a new language, grammar-although difficult-is very important, as grammatical rules determine the relations between the words in a sentence. There is evidence that very young infants can detect rules determining the relation between neighbouring syllables in short syllable sequences. A critical feature of all natural languages, however, is that many grammatical rules concern the dependency relation between non-neighbouring words or elements in a sentence i.e. between an auxiliary and verb inflection as in is singing. Thus, the issue of when and how children begin to recognize such non-adjacent dependencies is fundamental to our understanding of language acquisition. Here, we use brain potential measures to demonstrate that the ability to recognize dependencies between non-adjacent elements in a novel natural language is observable by the age of 4 months. Brain responses indicate that 4-month-old German infants discriminate between grammatical and ungrammatical dependencies in auditorily presented Italian sentences after only brief exposure to correct sentences of the same type. As the grammatical dependencies are realized by phonologically distinct syllables the present data most likely reflect phonologically based implicit learning mechanisms which can serve as a precursor to later grammar learning.	[Friederici, Angela D.; Mueller, Jutta L.; Oberecker, Regine] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany	Max Planck Society	Friederici, AD (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	angelafr@cbs.mpg.de	Mueller, Jutta L./ABC-1954-2020	Mueller, Jutta L./0000-0002-5463-9585	EU [EC12778/NEST-CALACEI]	EU(European Commission)	This project was supported by the EU (EC12778/NEST-CALACEI Project). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEOURLUHTANEN M, 1995, HEARING RES, V82, P53, DOI 10.1016/0378-5955(94)00164-L; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dehaene-Lambertz G, 2001, NEUROREPORT, V12, P3155, DOI 10.1097/00001756-200110080-00034; Dehaene-Lambertz G, 2006, P NATL ACAD SCI USA, V103, P14240, DOI 10.1073/pnas.0606302103; Endress AD, 2005, J EXP PSYCHOL GEN, V134, P406, DOI 10.1037/0096-3445.134.3.406; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; Friederici AD, 2007, CURR BIOL, V17, P1208, DOI 10.1016/j.cub.2007.06.011; Gomez R, 2005, INFANCY, V7, P183, DOI 10.1207/s15327078in0702_4; Gomez RL, 2002, PSYCHOL SCI, V13, P431, DOI 10.1111/1467-9280.00476; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hauser MD, 2008, SCIENCE, V322, P1057, DOI 10.1126/science.1167437; Hohle B, 2006, LANG LEARN DEV, V2, P277, DOI 10.1207/s15473341lld0204_3; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Leppanen PHT, 1997, DEV NEUROPSYCHOL, V13, P175, DOI 10.1080/87565649709540677; Mannel C, 2009, J COGNITIVE NEUROSCI, V21, P1988, DOI 10.1162/jocn.2009.21221; Mandel DR, 1996, COGNITIVE DEV, V11, P181, DOI 10.1016/S0885-2014(96)90002-7; Marcus GF, 1999, SCIENCE, V283, P77, DOI 10.1126/science.283.5398.77; Mueller JL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-89; Oberecker R, 2006, NEUROREPORT, V17, P1017, DOI 10.1097/01.wnr.0000223397.12694.9a; Pelucchi B, 2009, CHILD DEV, V80, P674, DOI 10.1111/j.1467-8624.2009.01290.x; Ramscar M, 2007, COGNITIVE SCI, V31, P927, DOI 10.1080/03640210701703576; Saffran J, 2008, COGNITION, V107, P479, DOI 10.1016/j.cognition.2007.10.010; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Santelmann LM, 1998, COGNITION, V69, P105, DOI 10.1016/S0010-0277(98)00060-2; Slobin Dan I., 1985, CROSSLINGUISTIC STUD, V2, P1175; Teinonen T, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-21; Thompson-Schill SL, 2009, CURR DIR PSYCHOL SCI, V18, P259, DOI 10.1111/j.1467-8721.2009.01648.x; van Heugten M, 2010, J MEM LANG, V63, P197, DOI 10.1016/j.jml.2010.04.001	29	42	43	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17920	10.1371/journal.pone.0017920	http://dx.doi.org/10.1371/journal.pone.0017920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	740QI	21445341	Green Submitted, Green Published, gold			2022-12-27	WOS:000288809100016
J	Lin, FPY; Lan, RT; Sintchenko, V; Gilbert, GL; Kong, FR; Coiera, E				Lin, Frank Po-Yen; Lan, Ruiting; Sintchenko, Vitali; Gilbert, Gwendolyn L.; Kong, Fanrong; Coiera, Enrico			Computational Bacterial Genome-Wide Analysis of Phylogenetic Profiles Reveals Potential Virulence Genes of Streptococcus agalactiae	PLOS ONE			English	Article							HOST-PATHOGEN INTERACTIONS; NEISSERIA-MENINGITIDIS; STAPHYLOCOCCUS-AUREUS; PROTEIN; SEQUENCE; IDENTIFICATION; INFECTION; AFFINITY; ADHESIN; ISLANDS	The phylogenetic profile of a gene is a reflection of its evolutionary history and can be defined as the differential presence or absence of a gene in a set of reference genomes. It has been employed to facilitate the prediction of gene functions. However, the hypothesis that the application of this concept can also facilitate the discovery of bacterial virulence factors has not been fully examined. In this paper, we test this hypothesis and report a computational pipeline designed to identify previously unknown bacterial virulence genes using group B streptococcus (GBS) as an example. Phylogenetic profiles of all GBS genes across 467 bacterial reference genomes were determined by candidate-against-all BLAST searches, which were then used to identify candidate virulence genes by machine learning models. Evaluation experiments with known GBS virulence genes suggested good functional and model consistency in cross-validation analyses (areas under ROC curve, 0.80 and 0.98 respectively). Inspection of the top-10 genes in each of the 15 virulence functional groups revealed at least 15 (of 119) homologous genes implicated in virulence in other human pathogens but previously unrecognized as potential virulence genes in GBS. Among these highly-ranked genes, many encode hypothetical proteins with possible roles in GBS virulence. Thus, our approach has led to the identification of a set of genes potentially affecting the virulence potential of GBS, which are potential candidates for further in vitro and in vivo investigations. This computational pipeline can also be extended to in silico analysis of virulence determinants of other bacterial pathogens.	[Lin, Frank Po-Yen; Sintchenko, Vitali; Coiera, Enrico] Univ New S Wales, Ctr Hlth Informat, Sydney, NSW, Australia; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Sintchenko, Vitali; Gilbert, Gwendolyn L.; Kong, Fanrong] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol Publ Hlth, Sydney, NSW 2006, Australia; [Sintchenko, Vitali; Gilbert, Gwendolyn L.; Kong, Fanrong] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney	Lin, FPY (corresponding author), Univ New S Wales, Ctr Hlth Informat, Sydney, NSW, Australia.	f.lin@unsw.edu.au	Gilbert, Gwendolyn/B-7733-2013; Lin, Frank/R-1275-2019	Gilbert, Gwendolyn/0000-0001-7490-6727; Lin, Frank/0000-0001-9250-6874; Coiera, Enrico/0000-0002-6444-6584; Lan, Ruiting/0000-0001-9834-5258; Sintchenko, Vitali/0000-0002-9261-3650	Australian National Health & Medical Research Council (NHMRC)	Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This research is supported by Australian National Health & Medical Research Council (NH&MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokarewa MI, 2006, INT J BIOCHEM CELL B, V38, P504, DOI 10.1016/j.biocel.2005.07.005; Bowers PM, 2004, SCIENCE, V306, P2246, DOI 10.1126/science.1103330; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Casadevall A, 2001, J INFECT DIS, V184, P337, DOI 10.1086/322044; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Clarke SR, 2002, INFECT IMMUN, V70, P6680, DOI 10.1128/IAI.70.12.6680-6687.2002; Claverys JP, 2001, RES MICROBIOL, V152, P231, DOI 10.1016/S0923-2508(01)01195-0; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Falkow S, 2004, NAT REV MICROBIOL, V2, P67, DOI 10.1038/nrmicro799; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Franken C, 2001, MOL MICROBIOL, V41, P925, DOI 10.1046/j.1365-2958.2001.02563.x; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Gibbs RS, 2004, OBSTET GYNECOL, V104, P1062, DOI 10.1097/01.AOG.0000144128.03913.c2; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Haas W, 2005, J BACTERIOL, V187, P8205, DOI 10.1128/JB.187.23.8205-8210.2005; Haas W, 2004, J BACTERIOL, V186, P8463, DOI 10.1128/JB.186.24.8463-8471.2004; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hotopp JCD, 2006, MICROBIOL-SGM, V152, P3733, DOI 10.1099/mic.0.29261-0; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Johri AK, 2006, NAT REV MICROBIOL, V4, P932, DOI 10.1038/nrmicro1552; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KATO T, 1992, J BACTERIOL, V174, P3889, DOI 10.1128/jb.174.12.3889-3895.1992; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lin FPY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-86; Marcotte EM, 2000, P NATL ACAD SCI USA, V97, P12115, DOI 10.1073/pnas.220399497; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perrin A, 2002, INFECT IMMUN, V70, P7063, DOI 10.1128/IAI.70.12.7063-7072.2002; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; Rhem MN, 2000, INFECT IMMUN, V68, P3776, DOI 10.1128/IAI.68.6.3776-3779.2000; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; Schrag SJ, 2002, NEW ENGL J MED, V347, P233, DOI 10.1056/NEJMoa020205; Soong G, 2006, J CLIN INVEST, V116, P2297, DOI 10.1172/JCI27920; Sutcliffe IC, 2008, MICROBIOL-SGM, V154, P1354, DOI 10.1099/mic.0.2007/014522-0; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Van Dyke MK, 2009, NEW ENGL J MED, V360, P2626, DOI 10.1056/NEJMoa0806820; Wassenaar TM, 2001, FEMS MICROBIOL LETT, V201, P1; Witten I. H., 2005, DATA MINING PRACTICA; Wu J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-80; Xu Y, 2004, J INFECT DIS, V189, P2323, DOI 10.1086/420851; Yamanishi Y, 2004, BIOINFORMATICS, V20, P363, DOI 10.1093/bioinformatics/bth910; Yoon SH, 2007, NUCLEIC ACIDS RES, V35, pD395, DOI 10.1093/nar/gkl790; Zheng Y, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-243	48	14	17	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e17964	10.1371/journal.pone.0017964	http://dx.doi.org/10.1371/journal.pone.0017964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483735	Green Published, gold, Green Submitted			2022-12-27	WOS:000289058700006
J	Real, C; Remedio, L; Caiado, F; Igreja, C; Borges, C; Trindade, A; Pinto-do-O, P; Yagita, H; Duarte, A; Dias, S				Real, Carla; Remedio, Leonor; Caiado, Francisco; Igreja, Catia; Borges, Cristina; Trindade, Alexandre; Pinto-do-O, Perpetua; Yagita, Hideo; Duarte, Antonio; Dias, Sergio			Bone Marrow-Derived Endothelial Progenitors Expressing Delta-Like 4 (Dll4) Regulate Tumor Angiogenesis	PLOS ONE			English	Article							HEMATOPOIETIC STEM; UP-REGULATION; CELLS; GROWTH; VEGF; RECRUITMENT; INHIBITION; LETHALITY; DEFECTS; THERAPY	Neo-blood vessel growth (angiogenesis), which may involve the activation of pre-existing endothelial cells (EC) and/or the recruitment of bone marrow-derived vascular precursor cells (BM-VPC), is essential for tumor growth. Molecularly, besides the well established roles for Vascular endothelial growth factor (VEGF), recent findings show the Notch signalling pathway, in particular the ligand Delta-like 4 (Dll4), is also essential for adequate tumor angiogenesis; Dll4 inhibition results in impaired, non-functional, angiogenesis and reduced tumor growth. However, the role of BM-VPC in the setting of Notch pathway modulation was not addressed and is the subject of the present report. Here we show that SDF-1 and VEGF, which are produced by tumors, increase Dll4 expression on recruited BM-VPC. Mechanistically, BM-VPC activated, in a Dll4-dependent manner, a transcriptional program on mature EC suggestive of EC activation and stabilization. BM-VPC induced ICAM-2 and Fibronectin expression on EC, an effect that was blocked by a Dll4-specific neutralizing antibody. In vivo, transplantation of BM-VPC with decreased Dll4 into tumor-bearing mice resulted in the formation of microvessels with decreased pericyte coverage and reduced fibronectin expression. Consequently, transplantation of BM-VPC with decreased Dll4 resulted in impaired tumor angiogenesis, increased tumor hypoxia and apoptosis, and decreased tumor growth. Taken together, our data suggests that Dll4 expression by BM-VPC affects their communication with tumor vessel endothelial cells, thereby modulating tumor angiogenesis by affecting vascular stability.	[Real, Carla; Remedio, Leonor; Caiado, Francisco; Igreja, Catia; Dias, Sergio] CIPM Portuguese Inst Oncol, Angiogenesis Lab, Lisbon, Portugal; [Real, Carla; Remedio, Leonor; Caiado, Francisco; Igreja, Catia; Dias, Sergio] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Real, Carla] Univ Univ Lisboa, Ctr Quim & Bioquim, Fac Ciencias, Lisbon, Portugal; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Dias, Sergio] Univ Nova Lisboa, CEDOC, Fac Ciencias Med, P-1200 Lisbon, Portugal; [Borges, Cristina; Trindade, Alexandre; Duarte, Antonio] Univ Tecn Lisboa, CIISA, Fac Med Vet, Lisbon, Portugal; [Pinto-do-O, Perpetua] Univ Porto, Div Biomat, INEB Inst Engn Biomed, P-4100 Oporto, Portugal	Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Juntendo University; Universidade Nova de Lisboa; Universidade de Lisboa; Universidade do Porto	Real, C (corresponding author), CIPM Portuguese Inst Oncol, Angiogenesis Lab, Lisbon, Portugal.	sergidias@ipolisboa.min-saude.pt	Dias, Sergio/L-1250-2014; Trindade, Alexandre/AAC-9726-2019; Trindade, Alexandre/J-3606-2013; Pinto-do-Ó, Perpetua/ABD-7205-2020; Real, Carla/D-5444-2009; Pinto-do-Ó, Perpetua/K-3742-2012; Igreja, Catia/I-8902-2018; Igreja, Catia/J-3674-2017; Duarte, Antonio/V-1178-2018	Dias, Sergio/0000-0002-7603-4616; Trindade, Alexandre/0000-0002-3104-9259; Pinto-do-Ó, Perpetua/0000-0002-6477-6030; Real, Carla/0000-0001-8067-2023; Pinto-do-Ó, Perpetua/0000-0002-6477-6030; Duarte, Antonio/0000-0002-9255-3635; Caiado, Francisco/0000-0003-4096-4448; Igreja, Catia/0000-0003-3563-1788; Borges, Ana/0000-0002-2572-6823	Fundacao para a Ciencia e Tecnologia (FCT)	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by Fundacao para a Ciencia e Tecnologia (FCT) grants (AD and PPdoO) and by individual FCT fellowships (CR, LR, FC, CI, CB, AT). The funders had no role in the design or orientation of the project, or in the preparation of the manuscript.	Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Caiado F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003752; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Deutsch U, 2008, EXP CELL RES, V314, P1202, DOI 10.1016/j.yexcr.2007.12.026; Dias S, 1998, INT J CANCER, V75, P151, DOI 10.1002/(SICI)1097-0215(19980105)75:1<151::AID-IJC23>3.0.CO;2-I; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Dudley AC, 2010, BLOOD, V116, P3367, DOI 10.1182/blood-2010-02-271122; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Huang MT, 2005, BLOOD, V106, P1636, DOI 10.1182/blood-2004-12-4716; Krebs LT, 2000, GENE DEV, V14, P1343; Larrivee B, 2005, J IMMUNOL, V175, P2890, DOI 10.4049/jimmunol.175.5.2890; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Moore MAS, 2001, ANN NY ACAD SCI, V938, P36; Motzer RJ, 2006, J CLIN ONCOL, V24, P5601, DOI 10.1200/JCO.2006.08.5415; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Oliner J, 2004, CANCER CELL, V6, P507, DOI 10.1016/j.ccr.2004.09.030; Pasquier E, 2010, CURR CANCER DRUG TAR, V10, P914, DOI 10.2174/156800910793358041; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Scott KA, 2000, BRIT J CANCER, V83, P1538, DOI 10.1054/bjoc.2000.1487; Trindade A, 2008, BLOOD, V112, P1720, DOI 10.1182/blood-2007-09-112748; Uyttendaele H, 2001, P NATL ACAD SCI USA, V98, P5643, DOI 10.1073/pnas.091584598; Verheul HMW, 2007, NAT REV CANCER, V7, P475, DOI 10.1038/nrc2152; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22	32	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18323	10.1371/journal.pone.0018323	http://dx.doi.org/10.1371/journal.pone.0018323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483741	gold, Green Submitted, Green Published			2022-12-27	WOS:000289058700019
J	Tiemersma, EW; van der Werf, MJ; Borgdorff, MW; Williams, BG; Nagelkerke, NJD				Tiemersma, Edine W.; van der Werf, Marieke J.; Borgdorff, Martien W.; Williams, Brian G.; Nagelkerke, Nico J. D.			Natural History of Tuberculosis: Duration and Fatality of Untreated Pulmonary Tuberculosis in HIV Negative Patients: A Systematic Review	PLOS ONE			English	Review							MULTIDRUG-RESISTANT TUBERCULOSIS; HUMAN-IMMUNODEFICIENCY-VIRUS; FRAMINGHAM COMMUNITY-HEALTH; FOLLOW-UP; HARVEIAN-LECTURES; MYCOBACTERIUM-TUBERCULOSIS; RESPIRATORY TUBERCULOSIS; TREATMENT OUTCOMES; INFECTED PATIENTS; SMEAR MICROSCOPY	Background: The prognosis, specifically the case fatality and duration, of untreated tuberculosis is important as many patients are not correctly diagnosed and therefore receive inadequate or no treatment. Furthermore, duration and case fatality of tuberculosis are key parameters in interpreting epidemiological data. Methodology and Principal Findings: To estimate the duration and case fatality of untreated pulmonary tuberculosis in HIV negative patients we reviewed studies from the pre-chemotherapy era. Untreated smear-positive tuberculosis among HIV negative individuals has a 10-year case fatality variously reported between 53% and 86%, with a weighted mean of 70%. Ten-year case fatality of culture-positive smear-negative tuberculosis was nowhere reported directly but can be indirectly estimated to be approximately 20%. The duration of tuberculosis from onset to cure or death is approximately 3 years and appears to be similar for smear-positive and smear-negative tuberculosis. Conclusions: Current models of untreated tuberculosis that assume a total duration of 2 years until self-cure or death underestimate the duration of disease by about one year, but their case fatality estimates of 70% for smear-positive and 20% for culture-positive smear-negative tuberculosis appear to be satisfactory.	[Tiemersma, Edine W.; van der Werf, Marieke J.] KNCV TB Fdn, The Hague, Netherlands; [Tiemersma, Edine W.; van der Werf, Marieke J.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Borgdorff, Martien W.] Municipal Hlth Serv GGD Amsterdam, Amsterdam, Netherlands; [Williams, Brian G.] S African Ctr Epidemiol Modelling & Anal, Stellenbosch, South Africa; [Nagelkerke, Nico J. D.] UAE Univ, Dept Community Med, Fac Med & Hlth Sci, Al Ain, U Arab Emirates	KNCV Tuberculosis Foundation; University of Amsterdam; Academic Medical Center Amsterdam; National Research Foundation - South Africa; United Arab Emirates University	Tiemersma, EW (corresponding author), KNCV TB Fdn, The Hague, Netherlands.	tiemersmae@kncvtbc.nl	Trajman, Anete/C-7679-2016	Trajman, Anete/0000-0002-4000-4984; Williams, Brian/0000-0002-3174-4876; van der Werf, Marieke J./0000-0001-8021-1358	KNCV Tuberculosis Foundation; World Health Organization	KNCV Tuberculosis Foundation; World Health Organization(World Health Organization)	The study was financed by KNCV Tuberculosis Foundation and the World Health Organization. Funding involved time allocation of the authors and attendance to two workshops discussing the estimates used to assess the burden of tuberculosis in the scope of the Global Burden of Disease project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akksilp S, 2007, EMERG INFECT DIS, V13, P1001, DOI 10.3201/eid1307.061506; AMES WR, 1953, AM REV TUBERC PULM, V68, P9; Armstrong DB, 2005, INT J EPIDEMIOL, V34, P1183, DOI 10.1093/ije/dyi176; ARMSTRONG DB, 1921, AM REV TUBERC, V4, P908; Backer J., 1937, DODELIGHETEN BLANDT; BARDSWELL ND, 1919, PULMONARY TUBERCULOS, P5; BENJAMIN B, 1963, PROC R SOC SER B-BIO, V159, P38, DOI 10.1098/rspb.1963.0066; BENTLEY FJ, 1948, BRIT MED J, V1, P1254, DOI 10.1136/bmj.1.4564.1254-b; BERG G, 1951, Beitr Klin Tuberk Spezif Tuberkuloseforsch, V106, P1, DOI 10.1007/BF02152328; Berg G., 1939, ACTA TUBERC SCAND S, V4, P1; Bonnet M, 2007, INT J TUBERC LUNG D, V11, P953; BRAEUNING H., 1936, Zeitschrift fur Tuberkulose und Heilstattenwesen, V75, P305; BRAEUNING H, 1930, Z TUBERK, V59, P109; BRAEUNING H, 1933, TUBERKULOSE BIBLIOTH, V52; BRAEUNING H, 1924, BEITR KLIN TUBERK, V58, P429; BRAEUNING HB, 1920, Z TUBERK, V33, P129; BREWSTER AW, 1949, PUBLIC HEALTH REP, V64, P687, DOI 10.2307/4586975; BUHL K, 1967, B WORLD HEALTH ORGAN, V37, P907; Chan ED, 2008, CURR OPIN INFECT DIS, V21, P587, DOI 10.1097/QCO.0b013e328319bce6; Clark W R, 1914, Cal State J Med, V12, P319; COCHRANE E., 1935, Tubercle, V16, P529, DOI 10.1016/S0041-3879(34)80211-5; COHEN D, 1954, J CONSULT PSYCHOL, V18, P405; Comstock GW, 2005, INT J EPIDEMIOL, V34, P1188, DOI 10.1093/ije/dyi178; COMSTOCK GW, 1951, PUBLIC HEALTH REP, V66, P695, DOI 10.2307/4587739; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; COX GL, 1923, BRIT J TUBERC, V1, P27; Cox H, 2006, PLOS MED, V3, P1836, DOI 10.1371/journal.pmed.0030384; CUMMINS SL, 1935, BRIT J TUBERC, V29, P4; DAW RH, 1950, LANCET, V258, P830; DEBESCHE AD, 1925, NORSK MAGAZIN LAEGEV, V86, P1229; DELAFAILLE RLB, 1939, THESIS U UTRECHT UTR; den Boon S, 2006, INT J TUBERC LUNG D, V10, P876; DOEGE TC, 1965, J AMER MED ASSOC, V192, P1045, DOI 10.1001/jama.1965.03080250023005; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; DROLET G. J., 1938, American Review of Tuberculosis and Pulmonary Diseases, V37, P125; Dubos Rene, 1987, WHITE PLAGUE TUBERCU; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Dye C, 2008, LANCET INFECT DIS, V8, P233, DOI 10.1016/S1473-3099(07)70291-8; ELDERTON WP, 1913, STUDIES NATURAL DETE, V8; ELDERTON WP, 2010, STUDIES NATURAL DETE, V6; ELLIOT W, 1949, BRIT MED J, V2, P297, DOI 10.1136/bmj.2.4622.297; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; FRASER R, 1948, BRIT MED J, V2, P106, DOI 10.1136/bmj.2.4566.106-d; Frieden TR, 2002, INT J EPIDEMIOL, V31, P894, DOI 10.1093/ije/31.5.894; FRIMODT-MOLLER J, 1960, Bull World Health Organ, V22, P61; Furth E, 1931, BEITRAGE KLIN TUBERK, V76, P573; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Gauld RL, 1941, AM J PUBLIC HEALTH N, V31, P568, DOI 10.2105/AJPH.31.6.568; GEISSLER D, 1923, BEITR KLIN TUBERK, V55, P155; Gillespie JR, 1928, BRIT MED J, V1928, P436, DOI 10.1136/bmj.1.3506.436; GOTTSTEIN A., 1931, Klinische Wochenschrift, V10, P796, DOI 10.1007/BF01744924; GOTTSTEIN A, 1931, ALLGEMEINE EPIDEMIOL; GRIEP WA, 1939, THESIS U AMSTERDAM A; HAMEL GH, 1912, GESCHICHTLICHE STAT, V13; HAMEL GH, 1928, Z TUBERK, V51, P497; HARTLEY PHS, 1935, BROMPTON HOSP REPORT, V4; Heise FH, 1921, CAN MED ASSOC J, V11, P314; Hilleboe HE, 1941, PUBLIC HEALTH REP, V56, P895, DOI 10.2307/4583713; HILLEBOE H. E., 1936, American Review of Tuberculosis and Pulmonary Diseases, V34, P713; HILLEBOE HE, 1940, CHEST, V6, P104; HILLERDAL O, 1963, Sven Lakartidn, V60, P1059; HILLERDAL O, 1963, ACTA TUBERC PNEUM SC, V42, P251; HOLST PF, 2006, DTSCH ARCH KLIN MED, V88, P325; HORWITZ O, 1960, Bull World Health Organ, V23, P669; HORWITZ OLE, 1964, BULL WORLD HEALTH ORGAN, V30, P609; JENSEN KA, 1932, ZENTRALB BAKTERIOL P, V1, P222; Johnston William, 1995, HARVARD E ASIAN MONO, V162; Jones DS, 2002, B HIST MED, V76, P749, DOI 10.1353/bhm.2002.0186; Kang'ombe C, 2000, T ROY SOC TROP MED H, V94, P305, DOI 10.1016/S0035-9203(00)90335-3; Kannel WB, 2005, INT J EPIDEMIOL, V34, P1187, DOI 10.1093/ije/dyi177; KASIUS RV, 1947, PUBLIC HEALTH REP, V62, P1296, DOI 10.2307/4586266; KATZ J, 1954, AM REV TUBERC PULM, V70, P32; KATZ J, 1952, AM REV TUBERC PULM, V66, P651; KAYSERPETERSEN JE, 1926, BEITR KLIN TUBERK, V63, P503; KAYSERPETERSEN JE, 1934, BEITR KLIN TUBERK, V84, P492; Kerntke G, 1965, Beitr Klin Erforsch Tuberk Lungenkr, V131, P382, DOI 10.1007/BF02091499; KLARE K, 1922, BEITR KLIN TUBERK, V50, P318; KLARE K, 1936, BEITR KLIN TUBERK, V88, P268; Korenromp EL, 2009, INT J TUBERC LUNG D, V13, P283; KRAUSE K, 1927, BEITR KLIN TUBERK, V67, P386; Krebs W., 1930, BEITR KLIN TUBERK, V74, P345; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; Lewis-Faning E, 1943, Br Med J, V2, P684; Lindhardt, 1939, STAT PULMONARY TUBER; LOEWENSTEIN E, 1931, ZENTRALBL BAKTERIOL, V1, P127; Lowe CR, 1954, BRIT J PREV SOC MED, V8, P91; MAGNUSSON SIG, 1938, ACTA TUBERC SCAND, V12, P201; Maguire R, 1900, BRIT MED J, V1900, P1695; Maguire R, 1900, BRIT MED J, V1900, P1637; Maguire R, 1900, BRIT MED J, V1900, P1566; MAY W, 1928, Z TUBERK, V51, P177; McDonald JC, 1952, BR J SOC MED, V6, P259; MCDONALD JC, 1954, BRIT MED BULL, V10, P77, DOI 10.1093/oxfordjournals.bmb.a069409; Meidell B, 1931, SKAND AKTUARIETIDSKR, V14, P217; Moro ML, 1998, AIDS, V12, P1095, DOI 10.1097/00002030-199809000-00017; MUNCHBACH W, 1933, TUBERKULOSE BIBLIOTH, V49; MUNTENDAM P, 1959, Acta Tuberc Scand, V37, P63; NARAIN R, 1963, INDIAN J TUBERC, V10, P85; *NAT TUB I, 1974, B WORLD HEALTH ORGAN, V51, P473; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; OLDENBURG F, 1931, Z TUBERK, V61, P334; PAINE AL, 1964, AM REV RESPIR DIS, V90, P760; PALMER CE, 1957, AM REV TUBERC PULM, V76, P517; PAMRA SP, 1973, IND J TUBERC, V20, P57; PAYNE B, 2007, BMJ CLIN EVID, V12, P920; PHILLIPS S, 1964, AM REV RESPIR DIS, V90, P61; PHILLIPS S, 1964, AM REV RESPIR DIS, V90, P120; Puffer RR, 1939, AM J PUBLIC HEALTH N, V29, P894, DOI 10.2105/AJPH.29.8.894; Quy HT, 2006, INT J TUBERC LUNG D, V10, P45; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Radhakrishna S, 2007, INT J TUBERC LUNG D, V11, P282; RAVIGLIONE MC, 2006, REICHMAN HERSHFIEL A; RAY D, 1995, TUBERCLE LUNG DIS, V76, P190, DOI 10.1016/S0962-8479(05)80003-6; Rieder HL, 1999, EPIDEMIOLOGICAL BASI; Ritacco V, 1997, J INFECT DIS, V176, P637, DOI 10.1086/514084; ROLOFF W, 1931, BEITR KLIN TUBERK, V78, P495; RUGE H, 1909, Z TUBERK, V15, P146; Rullan JV, 1996, EMERG INFECT DIS, V2, P125, DOI 10.3201/eid0202.960208; Rutledge J. A., 1919, AM REV TUBERC, V2, P755; Ryan F., 1992, TUBERCULOSIS GREATES; SAEGLER E, 1934, Z TBK, V71, P285; SIMPSON DG, 1964, AM REV RESPIR DIS, V89, P165; SINDINGLARSEN CMF, 1937, ACTA MED SCAND, V91, P39; SMALL PM, 1991, NEW ENGL J MED, V324, P289, DOI 10.1056/NEJM199101313240503; STADLER E, 1903, DTSCH ARCH KLIN MED, V95, P412; STEPHANI J, 1951, BRIT J TUBERC DIS CH, V45, P1, DOI 10.1016/S0366-0869(51)80047-9; STEPHENS MG, 1941, AM REV TUBERC, V44, P451; Stobie W, 1933, BRIT MED J, V1933, P507, DOI 10.1136/bmj.1.3768.507; TATTERSALL W H, 1947, Tubercle, V28, ppassim, DOI 10.1016/S0041-3879(47)80007-8; TATTERSALL W H, 1947, Tubercle, V28, P107, DOI 10.1016/S0041-3879(47)80088-1; Thompson BC, 1943, BRIT MED J, V1943, P721, DOI 10.1136/bmj.2.4326.721; TRAIL RR, 1931, REPORT EXPERIENCE PA; TRAUGER DA, 1963, AM REV RESPIR DIS, V87, P582, DOI 10.1164/arrd.1963.87.4.582; van Cleeff MRA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-111; van der Werf MJ, 2007, TROP MED INT HEALTH, V12, P475, DOI 10.1111/j.1365-3156.2006.01799.x; VANJOOST CRN, 1935, GENEESKUND TIJDSCHR, V75, P1223; VANVLIET B, 1963, NED TIJDSCHR GENEES, V107, P2180; VONDURING K, 1927, BEITR KLIN TUBERK, V65, P694; VONFRISCH AV, 1925, BEITR KLIN TUBERK, V62, P629; WEGELIUS C, 1957, Beitr Klin Tuberk Spezif Tuberkuloseforsch, V117, P101, DOI 10.1007/BF02148468; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WESTERGAARD H, 2001, LEHRE MORTALITA MORB; WHO, 2008, GLOBAL TUBERCULOSIS; WILLIAMS CT, 1971, ROY MED CHIR T, V54, P95; WITTKOWER ED, 1955, AM REV TUBERC PULM, V71, P201; 1936, TUBERCLE, V17, P171; 1953, LANCET, V1, P178; 2005, NATL TB PREVALENCE S	149	280	285	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e17601	10.1371/journal.pone.0017601	http://dx.doi.org/10.1371/journal.pone.0017601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483732	gold, Green Published, Green Submitted			2022-12-27	WOS:000289058700002
J	To, A; Bai, Y; Shen, A; Gong, H; Umamoto, S; Lu, SW; Liu, FY				To, Aaron; Bai, Yong; Shen, Ao; Gong, Hao; Umamoto, Sean; Lu, Sangwei; Liu, Fenyong			Yeast Two Hybrid Analyses Reveal Novel Binary Interactions between Human Cytomegalovirus-Encoded Virion Proteins	PLOS ONE			English	Article							SMALLEST CAPSID PROTEIN; SIMPLEX-VIRUS TYPE-1; TEGUMENT PROTEINS; INTERACTION MAP; RNASE P; HERPESVIRUS; GENOME; REPLICATION; RECRUITMENT; INHIBITION	Human cytomegalovirus (HCMV) is the largest human herpesvirus and its virion contains many viral encoded proteins found in the capsid, tegument, and envelope. In this study, we carried out a yeast two-hybrid (YTH) analysis to study potential binary interactions among 56 HCMV-encoded virion proteins. We have tested more than 3,500 pairwise combinations for binary interactions in the YTH analysis, and identified 79 potential interactions that involve 37 proteins. Forty five of the 79 interactions were also identified in human cells expressing the viral proteins by co-immunoprecipitation (co-IP) experiments. To our knowledge, 58 of the 79 interactions revealed by YTH analysis, including those 24 that were also identified in co-IP experiments, have not been reported before. Novel potential interactions were found between viral capsid proteins and tegument proteins, between tegument proteins, between tegument proteins and envelope proteins, and between envelope proteins. Furthermore, both the YTH and co-IP experiments have identified 9, 7, and 5 interactions that were involved with UL25, UL24, and UL89, respectively, suggesting that these "hub" proteins may function as the organizing centers for connecting multiple virion proteins in the mature virion and for recruiting other virion proteins during virion maturation and assembly. Our study provides a framework to study potential interactions between HCMV proteins and investigate the roles of protein-protein interactions in HCMV virion formation or maturation process.	[To, Aaron; Shen, Ao; Gong, Hao; Lu, Sangwei; Liu, Fenyong] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Bai, Yong; Umamoto, Sean; Lu, Sangwei; Liu, Fenyong] Univ Calif Berkeley, Program Comparat Biochem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	To, A (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.	liu_fy@uclink4.berkeley.edu		SHEN, AO/0000-0002-1559-3895	NIH [T32AI007620, AI050468, DE014145, DE014842, DE016813]; University of California-Berkeley; State of California AIDS research program [D07-B-414]; Chinese Ministry of Education; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050468, T32AI007620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014145, R01DE016813, R01DE014842] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California-Berkeley(University of California System); State of California AIDS research program; Chinese Ministry of Education(Ministry of Education, China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	A.T. acknowledges support from NIH (T32AI007620) and Y.B. was partially supported by a Block Grant Graduate Fellowship (University of California-Berkeley). S.U. was a recipient of the predoctoral dissertation fellowship of the State of California AIDS research program (D07-B-414). A. S. was a visiting graduate student from State Key Laboratory of Virology, Wuhan University (P.R. China) and a recipient of a China Graduate Student Scholarship from the Chinese Ministry of Education. This research was, in part, supported by NIH (AI050468, DE014145, DE014842, and DE016813). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adair R, 2002, J GEN VIROL, V83, P1315, DOI 10.1099/0022-1317-83-6-1315; Baldick CJ, 1996, J VIROL, V70, P6097, DOI 10.1128/JVI.70.9.6097-6105.1996; BRITT WJ, 1999, SEXUALLY TRANSMITTED, P269; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125; Chen DH, 1999, VIROLOGY, V260, P10, DOI 10.1006/viro.1999.9791; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; Davison AJ, 2003, J GEN VIROL, V84, P17, DOI 10.1099/vir.0.18606-0; Desai P, 1996, VIROLOGY, V220, P516, DOI 10.1006/viro.1996.0341; Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0; Dunn W, 2005, CELL MICROBIOL, V7, P1684, DOI 10.1111/j.1462-5822.2005.00598.x; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Dunn W, 2001, P NATL ACAD SCI USA, V98, P14831, DOI 10.1073/pnas.261560598; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fossum E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000570; Gibson W, 1996, INTERVIROLOGY, V39, P389, DOI 10.1159/000150509; Gibson W, 1996, J VIROL, V70, P7454, DOI 10.1128/JVI.70.11.7454-7461.1996; Gibson W, 1996, J VIROL, V70, P5680, DOI 10.1128/JVI.70.8.5680-5683.1996; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; GREIS KD, 1994, J VIROL, V68, P8339, DOI 10.1128/JVI.68.12.8339-8349.1994; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; JABS DA, 1989, ARCH OPHTHALMOL-CHIC, V107, P75, DOI 10.1001/archopht.1989.01070010077031; Klupp BG, 2002, J VIROL, V76, P3065, DOI 10.1128/JVI.76.6.3065-3071.2002; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Lai LL, 2003, J VIROL, V77, P2730, DOI 10.1128/JVI.77.4.2730-2735.2003; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lischka P, 2007, J GEN VIROL, V88, P405, DOI 10.1099/vir.0.82480-0; LIU F, 2007, COMP VIRION STRUCTUR, P27; Loveland AN, 2007, J VIROL, V81, P620, DOI 10.1128/JVI.01903-06; Mackay JP, 2007, TRENDS BIOCHEM SCI, V32, P530, DOI 10.1016/j.tibs.2007.09.006; Marchini A, 2001, J VIROL, V75, P1870, DOI 10.1128/JVI.75.4.1870-1878.2001; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Moorman AC, 1999, ANN EPIDEMIOL, V9, P349, DOI 10.1016/S1047-2797(99)00005-8; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Murphy E, 2003, P NATL ACAD SCI USA, V100, P14976, DOI 10.1073/pnas.2136652100; Okoye ME, 2006, J VIROL, V80, P929, DOI 10.1128/JVI.80.2.929-940.2006; Park MY, 2006, J VIROL, V80, P2718, DOI 10.1128/JVI.80.6.2718-2727.2006; PHILLIPS SL, 2010, J VIROL IN PRESS; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Rozen R, 2008, J VIROL, V82, P4742, DOI 10.1128/JVI.02745-07; Schierling K, 2004, J VIROL, V78, P9512, DOI 10.1128/JVI.78.17.9512-9523.2004; Schnee M, 2006, J VIROL, V80, P11658, DOI 10.1128/JVI.01662-06; Spaderna S, 2005, J VIROL, V79, P11837, DOI 10.1128/JVI.79.18.11837-11847.2005; Trang P, 2000, P NATL ACAD SCI USA, V97, P5812, DOI 10.1073/pnas.100101797; Trus BL, 1999, J VIROL, V73, P2181, DOI 10.1128/JVI.73.3.2181-2192.1999; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Vittone V, 2005, J VIROL, V79, P9566, DOI 10.1128/JVI.79.15.9566-9571.2005; Wang D, 2004, P NATL ACAD SCI USA, V101, P16642, DOI 10.1073/pnas.0407233101; Wood LJ, 1997, J VIROL, V71, P179, DOI 10.1128/JVI.71.1.179-190.1997; Yu D, 2003, P NATL ACAD SCI USA, V100, P12396, DOI 10.1073/pnas.1635160100; Yu XK, 2005, P NATL ACAD SCI USA, V102, P7103, DOI 10.1073/pnas.0408826102	53	59	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e17796	10.1371/journal.pone.0017796	http://dx.doi.org/10.1371/journal.pone.0017796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483780	gold, Green Published, Green Submitted			2022-12-27	WOS:000289058300004
J	Ghosh, S; Tan, F; Yu, TW; Li, YH; Adisa, O; Mosunjac, M; Ofori-Acquah, SF				Ghosh, Samit; Tan, Fang; Yu, Tianwei; Li, Yuhua; Adisa, Olufolake; Mosunjac, Mario; Ofori-Acquah, Solomon F.			Global Gene Expression Profiling of Endothelium Exposed to Heme Reveals an Organ-Specific Induction of Cytoprotective Enzymes in Sickle Cell Disease	PLOS ONE			English	Article							NAD(P)H-QUINONE OXIDOREDUCTASE-1; OXYGENASE-1 DEFICIENCY; SUPEROXIDE SCAVENGER; SKIN CARCINOGENESIS; MICROVASCULAR FLOW; OXIDATIVE STRESS; BREAST-CANCER; LUNG INJURY; MICE; VASOOCCLUSION	Background: Sickle cell disease (SCD) is characterized by hemolysis, vaso-occlusion and ischemia reperfusion injury. These events cause endothelial dysfunction and vasculopathies in multiple systems. However, the lack of atherosclerotic lesions has led to the idea that there are adaptive mechanisms that protect the endothelium from major vascular insults in SCD patients. The molecular bases for this phenomenon are poorly defined. This study was designed to identify the global profile of genes induced by heme in the endothelium, and assess expression of the heme-inducible cytoprotective enzymes in major organs impacted by SCD. Methods and Findings: Total RNA isolated from heme-treated endothelial monolayers was screened with the Affymetrix U133 Plus 2.0 chip, and the microarray data analyzed using multiple bioinformatics software. Hierarchical cluster analysis of significantly differentially expressed genes successfully segregated heme and vehicle-treated endothelium. Validation studies showed that the induction of cytoprotective enzymes by heme was influenced by the origin of endothelial cells, the duration of treatment, as well as the magnitude of induction of individual enzymes. In agreement with these heterogeneities, we found that induction of two major Nrf2-regulated cytoprotective enzymes, heme oxygenase-1 and NAD(P)H:quinone oxidoreductase-1 is organ-specific in two transgenic mouse models of SCD. This data was confirmed in the endothelium of post-mortem lung tissues of SCD patients. Conclusions: Individual organ systems induce unique profiles of cytoprotective enzymes to neutralize heme in SCD. Understanding this heterogeneity may help to develop effective therapies to manage vasculopathies of individual systems.	[Ghosh, Samit; Tan, Fang; Adisa, Olufolake; Ofori-Acquah, Solomon F.] Emory Univ Sch Med, Dept Pediat, Aflac Canc Ctr, Atlanta, GA 30322 USA; [Ghosh, Samit; Tan, Fang; Adisa, Olufolake; Ofori-Acquah, Solomon F.] Emory Univ Sch Med, Dept Pediat, Blood Disorders Serv, Atlanta, GA USA; [Yu, Tianwei] Emory Univ Sch Med, Dept Biostat & Bioinformat, Atlanta, GA USA; [Li, Yuhua] Emory Univ Sch Med, Winship Canc Ctr, Atlanta, GA USA; [Mosunjac, Mario] Emory Univ Sch Med, Dept Pathol & Lab Med, Atlanta, GA USA; [Ofori-Acquah, Solomon F.] Childrens Healthcare Atlanta, Ctr Endothelial Biol, Atlanta, GA USA	Emory University; Emory University; Emory University; Emory University; Emory University; Children's Healthcare of Atlanta (CHOA)	Ghosh, S (corresponding author), Emory Univ Sch Med, Dept Pediat, Aflac Canc Ctr, Atlanta, GA 30322 USA.	soforia@emory.edu	Mosunjac, Marina/A-4150-2012; Ghosh, Samit/F-1772-2015	Ghosh, Samit/0000-0002-3536-3077; Yu, Tianwei/0000-0003-2502-1628; Ofori-Acquah, Solomon/0000-0001-5000-3048	National Institutes of Health (NIH) [K02HL088026]; Emory Center for AIDS Research, NIH [P30-AI-50409]; Emory's Clinical Research (CTSI) [1 UL1RR025008-03]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL088026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Center for AIDS Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory's Clinical Research (CTSI); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant # K02HL088026 awarded to SFOA. The gene expression studies were carried out in part with resources from the Emory Center for AIDS Research, NIH grant # P30-AI-50409. The microarray study was supported by Emory's Clinical Research grant (CTSI grant # 1 UL1RR025008-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLA G, 1991, ARTERIOSCLER THROMB, V11, P1700, DOI 10.1161/01.ATV.11.6.1700; BALLA J, 1993, T ASSOC AM PHYSICIAN, V106, P128; Beckman JD, 2009, AM J PHYSIOL-HEART C, V297, pH1243, DOI 10.1152/ajpheart.00327.2009; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Belcher JD, 2005, AM J PHYSIOL-HEART C, V288, pH2715, DOI 10.1152/ajpheart.00986.2004; Belcher JD, 2003, BLOOD, V101, P3953, DOI 10.1182/blood-2002-10-3313; Belcher JD, 2010, J MOL MED, V88, P665, DOI 10.1007/s00109-010-0613-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENSINGER TA, 1974, ARCH INTERN MED, V133, P624, DOI 10.1001/archinte.133.4.624; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Embury S, 1995, SICKLE CELL DIS BASI; Embury SH, 2004, BLOOD, V104, P3378, DOI 10.1182/blood-2004-02-0713; Fagerholm R, 2008, NAT GENET, V40, P844, DOI 10.1038/ng.155; FOIDART M, 1983, J LAB CLIN MED, V102, P838; Fujita T, 2001, NAT MED, V7, P598, DOI 10.1038/87929; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graham JK, 2007, AM J FOREN MED PATH, V28, P168, DOI 10.1097/01.paf.0000257397.92466.50; Han SJ, 2009, MOL GENET METAB, V97, P85, DOI 10.1016/j.ymgme.2009.01.012; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iskander K, 2005, CANCER RES, V65, P2054, DOI 10.1158/0008-5472.CAN-04-3157; Jison ML, 2004, BLOOD, V104, P270, DOI 10.1182/blood-2003-08-2760; Kaul DK, 2004, AM J PHYSIOL-HEART C, V287, pH293, DOI 10.1152/ajpheart.01150.2003; Kawashima A, 2002, HUM PATHOL, V33, P125, DOI 10.1053/hupa.2002.30217; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Long DJ, 2000, CANCER RES, V60, P5913; Mahaseth H, 2005, J LAB CLIN MED, V145, P204, DOI 10.1016/j.lab.2005.02.008; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Maines MD, 2001, ADV EXP MED BIOL, V502, P249; Manci EA, 2006, BLOOD, V107, P1651, DOI 10.1182/blood-2005-07-2839; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Menzel HJ, 2004, BRIT J CANCER, V90, P1989, DOI 10.1038/sj.bjc.6601779; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Nakamichi I, 2005, J CLIN INVEST, V115, P3007, DOI 10.1172/JCI24912; Nath KA, 2001, AM J PATHOL, V158, P893, DOI 10.1016/S0002-9440(10)64037-0; Ohta K, 2000, AM J KIDNEY DIS, V35, P863, DOI 10.1016/S0272-6386(00)70256-3; Park SJ, 2003, MUTAT RES-GEN TOX EN, V536, P131, DOI 10.1016/S1383-5718(03)00041-X; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Setty BNY, 1996, BLOOD, V88, P2311, DOI 10.1182/blood.V88.6.2311.bloodjournal8862311; Shen J, 2010, CANCER RES, V70, P1006, DOI 10.1158/0008-5472.CAN-09-2938; Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238; Stocker R, 2006, CIRCULATION, V114, P2178, DOI 10.1161/CIRCULATIONAHA.105.598698; Umbreit J, 2007, AM J HEMATOL, V82, P134, DOI 10.1002/ajh.20738; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Zhang JH, 2003, CARCINOGENESIS, V24, P905, DOI 10.1093/carcin/bgg019; Zhu H, 2007, CARDIOVASC TOXICOL, V7, P202, DOI 10.1007/s12012-007-9001-z	50	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18399	10.1371/journal.pone.0018399	http://dx.doi.org/10.1371/journal.pone.0018399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483798	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200069
J	Vodstrcil, LA; Hocking, JS; Cummings, R; Chen, MY; Bradshaw, CS; Read, TRH; Sze, JK; Fairley, CK				Vodstrcil, Lenka A.; Hocking, Jane S.; Cummings, Rosey; Chen, Marcus Y.; Bradshaw, Catriona S.; Read, Tim R. H.; Sze, Jun K.; Fairley, Christopher K.			Computer Assisted Self Interviewing in a Sexual Health Clinic as Part of Routine Clinical Care; Impact on Service and Patient and Clinician Views	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; TRANSMITTED-DISEASES; HISTORY	Background: Computer assisted self interviewing (CASI) has been used at the Melbourne Sexual Health Centre (MSHC) since 2008 for obtaining sexual history and identifying patients' risk factors for sexually transmitted infections (STIs). We aimed to evaluate the impact of CASI operating at MSHC. Methodology/Principal Findings: The proportion of patients who decline to answer questions using CASI was determined. We then compared consultation times and STI-testing rates during comparable CASI and non-CASI operating periods. Patients and staff completed anonymous questionnaires about their experience with CASI. 14,190 patients completed CASI during the audit period. Men were more likely than women to decline questions about the number of partners they had of the opposite sex (4.4% v 3.6%, p = 0.05) and same sex (8.9% v 0%, p < 0.001). One third (34%) of HIV-positive men declined the number of partners they had and 11-17% declined questions about condom use. Women were more likely than men to decline to answer questions about condom use (2.9% v 2.3%, p = 0.05). There was no difference in the mean consultation times during CASI and non-CASI operating periods (p >= 0.17). Only the proportion of women tested for chlamydia differed between the CASI and non-CASI period (84% v 88% respectively, p < 0.01). 267 patients completed the survey about CASI. Most (72% men and 69% women) were comfortable using the computer and reported that all their answers were accurate (76% men and 71% women). Half preferred CASI but 18% would have preferred a clinician to have asked the questions. 39 clinicians completed the staff survey. Clinicians felt that for some STI risk factors (range 11%-44%), face-to-face questioning was more accurate than CASI. Only 5% were unsatisfied with CASI. Conclusions: We have demonstrated that CASI is acceptable to both patients and clinicians in a sexual health setting and does not adversely affect various measures of clinical output.	[Vodstrcil, Lenka A.; Cummings, Rosey; Chen, Marcus Y.; Bradshaw, Catriona S.; Read, Tim R. H.; Sze, Jun K.; Fairley, Christopher K.] Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Vodstrcil, Lenka A.; Hocking, Jane S.; Chen, Marcus Y.; Read, Tim R. H.; Fairley, Christopher K.] Univ Melbourne, Sexual Hlth Unit, Melbourne Sch Populat Hlth, Melbourne, Vic 3010, Australia; [Hocking, Jane S.] Univ Melbourne, Key Ctr Womens Hlth, Melbourne Sch Populat Hlth, Melbourne, Vic 3010, Australia; [Bradshaw, Catriona S.] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic 3800, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Monash University	Vodstrcil, LA (corresponding author), Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.	cfairley@unimelb.edu.au	Vodstrcil, Lenka/AAC-1896-2019; Hocking, Jane/AAD-5203-2021; Vodstrcil, Lenka/AAF-8722-2020	Hocking, Jane/0000-0001-9329-8501; Vodstrcil, Lenka/0000-0003-3679-9195; bradshaw, catriona/0000-0002-6643-5678; Christopher, Fairley/0000-0001-9081-1664	National Health and Medical Research Council [568971]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was in part supported by funds from the National Health and Medical Research Council (grant number 568971) and there was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraitser P, 2011, SEX HEALTH, V8, P23, DOI 10.1071/SH10029; Fairley CK, 2010, SEX TRANSM DIS, V37, P665, DOI 10.1097/OLQ.0b013e3181f7d505; Fairley CK, 1997, JAMA-J AM MED ASSOC, V278, P117, DOI 10.1001/jama.278.2.117; Ghanem KG, 2005, SEX TRANSM INFECT, V81, P421, DOI 10.1136/sti.2004.013193; *HC HLTH COMM, 3 HOUS COMM HLTH COM; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Keehan S, 2008, HEALTH AFFAIR, V27, pW145, DOI 10.1377/hlthaff.27.2.w145; Kissinger P, 1999, AM J EPIDEMIOL, V149, P950, DOI 10.1093/oxfordjournals.aje.a009739; Kurth AE, 2004, SEX TRANSM DIS, V31, P719, DOI 10.1097/01.olq.0000145855.36181.13; Kurth AE, 2010, SEX TRANSM DIS, V37, P669, DOI 10.1097/OLQ.0b013e3181f90503; Richens J, 2010, SEX TRANSM INFECT, V86, P310, DOI 10.1136/sti.2010.043422; Tideman R, 2006, INT J STD AIDS, V17, P170, DOI 10.1258/095646206775809114; Tideman RL, 2007, SEX TRANSM INFECT, V83, P52, DOI 10.1136/sti.2006.020776; Tideman RL, 2004, SEX TRANSM INFECT, V80, P389, DOI 10.1136/sti.2003.007559; Weinhardt LS, 2007, AIDS BEHAV, V11, P549, DOI 10.1007/s10461-006-9163-x; White PJ, 2005, J INFECT DIS, V192, P824, DOI 10.1086/432004; Yeung A, 2010, INT J STD AIDS, V21, P755, DOI 10.1258/ijsa.2010.010220	17	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18456	10.1371/journal.pone.0018456	http://dx.doi.org/10.1371/journal.pone.0018456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483799	Green Published, gold, Green Submitted			2022-12-27	WOS:000289057200083
J	Schaber, J; Flottmann, M; Li, J; Tiger, CF; Hohmann, S; Klipp, E				Schaber, Joerg; Floettmann, Max; Li, Jian; Tiger, Carl-Fredrik; Hohmann, Stefan; Klipp, Edda			Automated Ensemble Modeling with modelMaGe: Analyzing Feedback Mechanisms in the Sho1 Branch of the HOG Pathway	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BIOLOGY MARKUP LANGUAGE; SACCHAROMYCES-CEREVISIAE; YEAST OSMOREGULATION; PERFECT ADAPTATION; BIOCHEMICAL-MODELS; NEGATIVE FEEDBACK; SYSTEMS; ACCUMULATION; INHIBITION	In systems biology uncertainty about biological processes translates into alternative mathematical model candidates. Here, the goal is to generate, fit and discriminate several candidate models that represent different hypotheses for feedback mechanisms responsible for downregulating the response of the Sho1 branch of the yeast high osmolarity glycerol (HOG) signaling pathway after initial stimulation. Implementing and testing these candidate models by hand is a tedious and error-prone task. Therefore, we automatically generated a set of candidate models of the Sho1 branch with the tool modelMaGe. These candidate models are automatically documented, can readily be simulated and fitted automatically to data. A ranking of the models with respect to parsimonious data representation is provided, enabling discrimination between candidate models and the biological hypotheses underlying them. We conclude that a previously published model fitted spurious effects in the data. Moreover, the discrimination analysis suggests that the reported data does not support the conclusion that a desensitization mechanism leads to the rapid attenuation of Hog1 signaling in the Sho1 branch of the HOG pathway. The data rather supports a model where an integrator feedback shuts down the pathway. This conclusion is also supported by dedicated experiments that can exclusively be predicted by those models including an integrator feedback. modelMaGe is an open source project and is distributed under the Gnu General Public License (GPL) and is available from http://modelmage.org.	[Schaber, Joerg] Otto Von Guericke Univ, Fac Med, Inst Expt Internal Med, Magdeburg, Germany; [Schaber, Joerg; Floettmann, Max; Li, Jian; Klipp, Edda] Humboldt Univ, Dept Biol, D-1040 Berlin, Germany; [Tiger, Carl-Fredrik; Hohmann, Stefan] Univ Gothenburg, Dept Cell & Mol Biol, Gothenburg, Sweden	Otto von Guericke University; Humboldt University of Berlin; University of Gothenburg	Schaber, J (corresponding author), Otto Von Guericke Univ, Fac Med, Inst Expt Internal Med, Magdeburg, Germany.	schaber@med.ovgu.de	Hohmann, Stefan/K-9895-2013	Hohmann, Stefan/0000-0002-0809-1985; Schaber, Jorg/0000-0001-6971-2530	Max Planck Society; German Academic Exchange Service (DAAD); European Commission [043310]; Vinnova, Sweden; DAAD [PPP D/05/50405]	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); European Commission(European CommissionEuropean Commission Joint Research Centre); Vinnova, Sweden(Vinnova); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	MF was supported by the Max Planck Society and the German Academic Exchange Service (DAAD). This work was supported by the European Commission via the CELLCOMPUT project (Contract No. 043310 to EK and SK), Vinnova, Sweden (Multidisciplinary BIO to SH), and the DAAD (PPP D/05/50405 to JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Behar M, 2007, BIOPHYS J, V93, P806, DOI 10.1529/biophysj.107.107516; Bhalla US, 2003, PROG BIOPHYS MOL BIO, V81, P45, DOI 10.1016/S0079-6107(02)00046-9; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; DIBROV BF, 1982, J MATH BIOL, V15, P51, DOI 10.1007/BF00275788; Finney A, 2003, BIOCHEM SOC T, V31, P1472; Flottmann Max, 2008, Genome Inform, V20, P52; Funahashi Akira, 2007, In Silico Biology, V7, pS81; Hao N, 2007, CURR BIOL, V17, P659, DOI 10.1016/j.cub.2007.02.044; Hohmann S, 2002, INT REV CYTOL, V215, P149; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Klipp E, 2007, NAT BIOTECHNOL, V25, P390, DOI 10.1038/nbt0407-390; Kuepfer L, 2007, NAT BIOTECHNOL, V25, P1001, DOI 10.1038/nbt1330; Le Novere N, 2005, NAT BIOTECHNOL, V23, P1509, DOI 10.1038/nbt1156; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Schaber J, 2009, IET SYST BIOL, V3, P1, DOI 10.1049/iet-syb:20070042; Schaber J, 2010, EUR BIOPHYS J BIOPHY, V39, P1547, DOI 10.1007/s00249-010-0612-0; Schulz Marvin, 2006, Genome Inform, V17, P62; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Tatebayashi K, 2007, EMBO J, V26, P3521, DOI 10.1038/sj.emboj.7601796; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513	32	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e14791	10.1371/journal.pone.0014791	http://dx.doi.org/10.1371/journal.pone.0014791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21483474	Green Published, gold, Green Submitted			2022-12-27	WOS:000289055700003
J	Obata, H; Manabe, A; Nakamura, N; Onishi, T; Senba, Y				Obata, Hiroki; Manabe, Aya; Nakamura, Naoko; Onishi, Tomokazu; Senba, Yasuko			A New Light on the Evolution and Propagation of Prehistoric Grain Pests: The World's Oldest Maize Weevils Found in Jomon Potteries, Japan	PLOS ONE			English	Article							RICE WEEVIL; CURCULIONIDAE; COLEOPTERA; REPLACEMENT	Three Sitophilus species (S. granarius L., S. oryzae L., and S. zeamais Mots.) are closely related based on DNA analysis of their endosymbionts. All are seed parasites of cereal crops and important economic pest species in stored grain. The Sitophilus species that currently exist, including these three species, are generally believed to be endemic to Asia's forested areas, suggesting that the first infestations of stored grain must have taken place near the forested mountains of southwestern Asia. Previous archaeological data and historical records suggest that the three species may have been diffused by the spread of Neolithic agriculture, but this hypothesis has only been established for granary weevils in European and southwestern Asian archaeological records. There was little archeological evidence for grain pests in East Asia before the discovery of maize weevil impressions in Jomon pottery in 2004 using the "impression replica" method. Our research on Jomon agriculture based on seed and insect impressions in pottery continued to seek additional evidence. In 2010, we discovered older weevil impressions in Jomon pottery dating to ca. 10 500 BP. These specimens are the oldest harmful insects in the world discovered at archaeological sites. Our results provide evidence of harmful insects living in the villages from the Earliest Jomon, when no cereals were cultivated. This suggests we must reconsider previous scenarios for the evolution and propagation of grain pest weevils, especially in eastern Asia. Although details of their biology or the foods they infested remain unclear, we hope future interdisciplinary collaborations among geneticists, entomologists, and archaeologists will provide the missing details.	[Obata, Hiroki; Manabe, Aya] Kumamoto Univ, Fac Letters, Kumamoto, Japan; [Nakamura, Naoko] Kagoshima Univ, Fac Law & Letters, Kagoshima 890, Japan; [Onishi, Tomokazu] Int Univ Kagoshima, Fac Intercultural Studies, Kagoshima, Japan; [Senba, Yasuko] Kumamoto Univ, Project Seed Impress Studies, Kumamoto, Japan	Kumamoto University; Kagoshima University; International University Kagoshima; Kumamoto University	Obata, H (corresponding author), Kumamoto Univ, Fac Letters, Kumamoto, Japan.	totori@kumamoto-u.ac.jp			Japan Society for Promotion of Science	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by Grant-in-Aid for Scientific Research on Areas A ( subject number: 20242022) by Japan Society for Promotion of Science (http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKAKI N, 1982, JPN J APPL ENTOMOL Z, V26, P166, DOI 10.1303/jjaez.26.166; Campbell JF, 2002, J INSECT BEHAV, V15, P429, DOI 10.1023/A:1016225427886; Conord C, 2008, MOL BIOL EVOL, V25, P859, DOI 10.1093/molbev/msn027; DELOBEL B, 1993, J STORED PROD RES, V29, P7, DOI 10.1016/0022-474X(93)90014-U; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Hara T., 1971, ECOLOGY CONTROL FOOD; HAYASHI N, 1999, ENV ENT BEHAV PHYSL, P321; Lefevre C, 2004, MOL BIOL EVOL, V21, P965, DOI 10.1093/molbev/msh063; Longstaff B.C., 1981, PROT ECOL, V2, P83; MIYAMOTO K, 2003, CULTURA ANTIQUE, V55, P1; MORI Y, 2001, HOUSE HOUSEHOLD INSE, V23, P23; MORIMOTO K, 1980, HOUSE HOUSEHOLD INSE, V7, P65; Nakayama S., 2008, B YAMANASHI MUSEUM, V2, P1; NAKAYAMA S, 2009, ANCIENT CULTURE, V61, P40; Obata H., 2008, CEREALS PREHISTORIC, V3, P43; OBATA H, 2006, UTILIZATION ACORNS P, P31; OBATA H, 2010, PREHISTORY ARCHAEOL, V5, P239; OMEARA B, 2001, THESIS HARVARD U; ONBE S, 2009, NEWSLETTER JOMON STU, V20, P114; *PALC RES I, 2006, SANKAKUYAMA SITES, V3, P252; Plarre R, 2010, EUR J ENTOMOL, V107, P1, DOI 10.14411/eje.2010.001; SATO Y, 2002, HIST RICE CULTIVATIO; SHINTO K, 2008, HDB JOMON POTTERY, P186; SUGIYAMA S, 2001, MONTHLY J EARTH, V23, P645; TAKAMIYA H, 1999, JPN J ETHNOL, V63, P283; UDATSU T, 2004, SUBSTANTIAL STUDY DI; YAMADA G, 2009, B HIST MUSEUM HOKKAI, V37, P13; Yamasaki S, 2005, ISSUES AGR NEOLITHIC, P33; Yasue Y., 1976, INSECTA, V13, P182; Yasue Y., 1959, NEW INSECTS, V12, P25; YASUTOMI K, 2000, ILLUSTRATED ENCY HOU; YOSHIDA T, 2001, ILLUSTRATIONS PESTS; YOSHIDA T, 1956, B FAC FINE ARTS LIT, V1, P137	33	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e14785	10.1371/journal.pone.0014785	http://dx.doi.org/10.1371/journal.pone.0014785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479261	gold, Green Published, Green Submitted			2022-12-27	WOS:000289054600004
J	Yung, LM; Wong, WT; Tian, XY; Leung, FP; Yung, LH; Chen, ZY; Yao, XQ; Lau, CW; Huang, Y				Yung, Lai Ming; Wong, Wing Tak; Tian, Xiao Yu; Leung, Fung Ping; Yung, Lai Hang; Chen, Zhen Yu; Yao, Xiaoqiang; Lau, Chi Wai; Huang, Yu			Inhibition of Renin-Angiotensin System Reverses Endothelial Dysfunction and Oxidative Stress in Estrogen Deficient Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HORMONE REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; ESSENTIAL-HYPERTENSION; SMOOTH-MUSCLE; RECEPTOR; CANDESARTAN; EXPRESSION; BRADYKININ; CELLS	Background: Estrogen deficiency increases the cardiovascular risks in postmenopausal women. Inhibition of the renin-angiotensin system (RAS) and associated oxidative stress confers a cardiovascular protection, but the role of RAS in estrogen deficiency-related vascular dysfunction is unclear. The present study investigates whether the up-regulation of RAS and associated oxidative stress contributes to the development of endothelial dysfunction during estrogen deficiency in ovariectomized (OVX) rats. Methodology/Principal Findings: Adult female rats were ovariectomized with and without chronic treatment with valsartan and enalapril. Isometric force measurement was performed in isolated aortae. The expression of RAS components was determined by immunohistochemistry and Western blotting method while ROS accumulation in the vascular wall was evaluated by dihydroethidium fluorescence. Ovariectomy increased the expression of angiotensin-converting enzyme (ACE), angiotensin II type 1 receptor (AT(1)R), NAD(P)H oxidase, and nitrotyrosine in the rat aorta. An over-production of angiotensin II and ROS was accompanied by decreased phosphorylation of eNOS at Ser(1177) in OVX rat aortae. These pathophysiological changes were closely coupled with increased oxidative stress and decreased nitric oxide bioavailability, culminating in markedly impaired endothelium-dependent relaxations. Furthermore, endothelial dysfunction and increased oxidative stress in aortae of OVX rats were inhibited or reversed by chronic RAS inhibition with enalapril or valsartan. Conclusions/Significance: The novel findings highlight a significant therapeutic benefit of RAS blockade in the treatment of endothelial dysfunction-related vascular complications in postmenopausal states.	[Yung, Lai Ming; Wong, Wing Tak; Tian, Xiao Yu; Leung, Fung Ping; Yung, Lai Hang; Yao, Xiaoqiang; Lau, Chi Wai; Huang, Yu] Chinese Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Inst Hlth Sci, Inst Vasc Med, Hong Kong, Hong Kong, Peoples R China; [Chen, Zhen Yu] Chinese Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Yung, LM (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Inst Hlth Sci, Inst Vasc Med, Hong Kong, Hong Kong, Peoples R China.	yu-huang@cuhk.edu.hk	Huang, Yu/K-2866-2017; Yao, Xiaoqiang/I-5413-2016; Tian, Xiao Yu/P-1092-2016; Wong, Wing Tak Jack/Q-4512-2018	Huang, Yu/0000-0002-1277-6784; Yao, Xiaoqiang/0000-0002-0687-8186; Tian, Xiao Yu/0000-0003-3472-9898; Wong, Wing Tak Jack/0000-0002-4514-3780	Hong Kong GRF [465308]; CUHK; Li Ka Shing Institute of Health Sciences	Hong Kong GRF(Hong Kong Research Grants Council); CUHK(Chinese University of Hong Kong); Li Ka Shing Institute of Health Sciences	This study was supported by Hong Kong GRF (465308), CUHK Focused Investment Scheme and Li Ka Shing Institute of Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaba Y, 2009, J BONE MINER RES, V24, P241, DOI [10.1359/jbmr.081006, 10.1359/JBMR.081006]; Elesber AA, 2007, AM HEART J, V153, P1081, DOI 10.1016/j.ahj.2007.03.007; Ginnan R, 2008, FREE RADICAL BIO MED, V44, P1232, DOI 10.1016/j.freeradbiomed.2007.12.025; Gragasin FS, 2003, ARTERIOSCL THROM VAS, V23, P38, DOI 10.1161/01.ATV.0000047868.93732.B7; Halligan SC, 2004, MAYO CLIN PROC, V79, P1514, DOI 10.4065/79.12.1514; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Hinojosa-Laborde C, 2004, HYPERTENSION, V44, P405, DOI 10.1161/01.HYP.0000142893.08655.96; Hodgin JB, 2002, J CLIN INVEST, V109, P541, DOI 10.1172/JCI200214066; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Imanishi T, 2006, HYPERTENSION, V48, P1058, DOI 10.1161/01.HYP.0000248920.16956.d8; Lavi S, 2007, CIRCULATION, V115, P2715, DOI 10.1161/CIRCULATIONAHA.106.671420; Li YQ, 2009, CAN J PHYSIOL PHARM, V87, P51, DOI 10.1139/Y08-097; Malmqvist K, 2000, AM J HYPERTENS, V13, P504, DOI 10.1016/S0895-7061(99)00264-2; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Nickenig G, 1998, CIRCULATION, V97, P2197, DOI 10.1161/01.CIR.97.22.2197; Nogawa N, 2001, MENOPAUSE, V8, P210, DOI 10.1097/00042192-200105000-00011; Ono H, 2008, HYPERTENS RES, V31, P271, DOI 10.1291/hypres.31.271; Phoon S, 2002, J RENIN-ANGIO-ALDO S, V3, P36, DOI 10.3317/jraas.2002.006; Schunkert H, 1997, CIRCULATION, V95, P39, DOI 10.1161/01.CIR.95.1.39; Shimizu H, 2008, FASEB J, V22, P2465, DOI 10.1096/fj.07-098954; Sumino H, 1999, AM J HYPERTENS, V12, P1044, DOI 10.1016/S0895-7061(99)00094-1; Tran D, 2001, J RENIN-ANGIO-ALDO S, V2, P199, DOI 10.3317/jraas.2001.028; Ungvari Z, 2006, ANTIOXID REDOX SIGN, V8, P1121, DOI 10.1089/ars.2006.8.1121; Vitale C, 2008, ARTERIOSCL THROM VAS, V28, P348, DOI 10.1161/ATVBAHA.107.158634; Wassmann K, 2006, MATURITAS, V53, P176, DOI 10.1016/j.maturitas.2005.04.002; Wassmann S, 2001, CIRCULATION, V103, P435; Wassmann S, 2004, HYPERTENSION, V44, P381, DOI 10.1161/01.HYP.0000142232.29764.a7; WENGER NK, 1993, NEW ENGL J MED, V329, P247, DOI 10.1056/NEJM199307223290406; Wong CM, 2006, VASC PHARMACOL, V44, P290, DOI 10.1016/j.vph.2005.12.005; Yoshida K, 2007, J HYPERTENS, V25, P1633, DOI 10.1097/HJH.0b013e32814db89f; Yung Lai Ming, 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P1	31	58	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17437	10.1371/journal.pone.0017437	http://dx.doi.org/10.1371/journal.pone.0017437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479266	Green Submitted, Green Published, gold			2022-12-27	WOS:000289054600011
J	Shrestha, B; Reed, JM; Starks, PT; Kaufman, GE; Goldstone, JV; Roelke, ME; O'Brien, SJ; Koepfli, KP; Frank, LG; Court, MH				Shrestha, Binu; Reed, J. Michael; Starks, Philip T.; Kaufman, Gretchen E.; Goldstone, Jared V.; Roelke, Melody E.; O'Brien, Stephen J.; Koepfli, Klaus-Peter; Frank, Laurence G.; Court, Michael H.			Evolution of a Major Drug Metabolizing Enzyme Defect in the Domestic Cat and Other Felidae: Phylogenetic Timing and the Role of Hypercarnivory	PLOS ONE			English	Article							DEFICIENT ACETAMINOPHEN GLUCURONIDATION; SPECIES-DIFFERENCES; CONJUGATION; BIOTRANSFORMATION; SUPERFAMILY; PSEUDOGENES; CARNIVORA; ELEPHANT; GENOME; UGT1A6	The domestic cat (Felis catus) shows remarkable sensitivity to the adverse effects of phenolic drugs, including acetaminophen and aspirin, as well as structurally-related toxicants found in the diet and environment. This idiosyncrasy results from pseudogenization of the gene encoding UDP-glucuronosyltransferase (UGT) 1A6, the major species-conserved phenol detoxification enzyme. Here, we established the phylogenetic timing of disruptive UGT1A6 mutations and explored the hypothesis that gene inactivation in cats was enabled by minimal exposure to plant-derived toxicants. Fixation of the UGT1A6 pseudogene was estimated to have occurred between 35 and 11 million years ago with all extant Felidae having dysfunctional UGT1A6. Out of 22 additional taxa sampled, representative of most Carnivora families, only brown hyena (Parahyaena brunnea) and northern elephant seal (Mirounga angustirostris) showed inactivating UGT1A6 mutations. A comprehensive literature review of the natural diet of the sampled taxa indicated that all species with defective UGT1A6 were hypercarnivores (>70% dietary animal matter). Furthermore those species with UGT1A6 defects showed evidence for reduced amino acid constraint (increased dN/dS ratios approaching the neutral selection value of 1.0) as compared with species with intact UGT1A6. In contrast, there was no evidence for reduced amino acid constraint for these same species within UGT1A1, the gene encoding the enzyme responsible for detoxification of endogenously generated bilirubin. Our results provide the first evidence suggesting that diet may have played a permissive role in the devolution of a mammalian drug metabolizing enzyme. Further work is needed to establish whether these preliminary findings can be generalized to all Carnivora.	[Shrestha, Binu; Court, Michael H.] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Comparat & Mol Pharmacogen Lab, Boston, MA 02111 USA; [Shrestha, Binu; Reed, J. Michael; Starks, Philip T.] Tufts Univ, Dept Biol, Medford, MA 02155 USA; [Kaufman, Gretchen E.] Tufts Cummings Sch Vet Med, Dept Environm & Populat Hlth, North Grafton, MA USA; [Goldstone, Jared V.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Roelke, Melody E.] NCI, Lab Genom Divers, SAIC Frederick Inc, Frederick, MD 21701 USA; [Frank, Laurence G.] Univ Calif Berkeley, Living Lions Project Kenya, Museum Vertebrate Zool, Berkeley, CA 94720 USA	Tufts University; Tufts University; Woods Hole Oceanographic Institution; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of California System; University of California Berkeley	Shrestha, B (corresponding author), Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Comparat & Mol Pharmacogen Lab, Boston, MA 02111 USA.	michael.court@tufts.edu	Koepfli, Klaus-Peter/AAT-9320-2020; OBRIEN, STEPHEN/ABD-1346-2020; Johnson, Warren/D-4149-2016	Johnson, Warren/0000-0002-5954-186X; OBRIEN, STEPHEN/0000-0001-7857-0757; Goldstone, Jared/0000-0002-9618-4961	United States Department of State; National Institute of General Medical Sciences [R01GM061834]; National Cancer Institute (NCI) [N01-CO-12400]; NCI Center for Cancer Research, National Institutes of Health (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061834] Funding Source: NIH RePORTER	United States Department of State; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Center for Cancer Research, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Binu Shrestha was supported by a Fulbright scholarship from the United States Department of State. This project was funded by grant R01GM061834 from the National Institute of General Medical Sciences, contract N01-CO-12400 from the National Cancer Institute (NCI), and by the Intramural Research Program, NCI Center for Cancer Research, National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock KW, 2003, BIOCHEM PHARMACOL, V66, P691, DOI 10.1016/S0006-2952(03)00296-X; BOSMA PJ, 1994, J BIOL CHEM, V269, P17960; Bustamante CD, 2002, MOL BIOL EVOL, V19, P110, DOI 10.1093/oxfordjournals.molbev.a003975; CALDWELL J, 1981, DRUG METAB REV, V12, P221, DOI 10.3109/03602538108994030; CALDWELL J, 1975, FEBS LETT, V60, P391, DOI 10.1016/0014-5793(75)80756-3; CAPEL ID, 1972, XENOBIOTICA, V2, P25, DOI 10.3109/00498257209036231; CAPEL ID, 1974, XENOBIOTICA, V4, P601, DOI 10.1080/00498257409169763; Court MH, 1997, BIOCHEM PHARMACOL, V53, P1041, DOI 10.1016/S0006-2952(97)00072-5; Court MH, 2001, J VET PHARMACOL THER, V24, P415, DOI 10.1046/j.1365-2885.2001.00366.x; Court MH, 1997, J PHARM PHARMACOL, V49, P446, DOI 10.1111/j.2042-7158.1997.tb06822.x; Court MH, 2000, PHARMACOGENETICS, V10, P355, DOI 10.1097/00008571-200006000-00009; DAVIS LE, 1972, AM J VET RES, V33, P1253; FRENCH MR, 1974, FEBS LETT, V46, P134, DOI 10.1016/0014-5793(74)80352-2; Gaubert P, 2003, P ROY SOC B-BIOL SCI, V270, P2523, DOI 10.1098/rspb.2003.2521; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; Higdon JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-216; HOELZEL AR, 1993, J HERED, V84, P443, DOI 10.1093/oxfordjournals.jhered.a111370; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Khachane AN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-435; Koepfli KP, 2006, MOL PHYLOGENET EVOL, V38, P603, DOI 10.1016/j.ympev.2005.10.017; Li X, 2005, PLOS GENET, V1, P27, DOI 10.1371/journal.pgen.0010003; Li X, 2009, J HERED, V100, pS90, DOI 10.1093/jhered/esp015; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; MCGEACHIN RL, 1979, COMP BIOCHEM PHYS B, V63, P437, DOI 10.1016/0305-0491(79)90274-8; Morris JG, 2002, NUTR RES REV, V15, P153, DOI 10.1079/NRR200238; Nowak R. M., 2005, WALKERS CARNIVORES W; Pfeifer GP, 2006, CURR TOP MICROBIOL, V301, P259; ROBINSON D, 1958, BIOCHEM J, V68, pP23; SAVIDES MC, 1984, TOXICOL APPL PHARM, V74, P26, DOI 10.1016/0041-008X(84)90266-7; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Trepanier LA, 1997, BIOCHEM PHARMACOL, V54, P73, DOI 10.1016/S0006-2952(97)00140-8; Van Valkenburgh B, 1999, ANNU REV EARTH PL SC, V27, P463, DOI 10.1146/annurev.earth.27.1.463; van Valkenburgh B., 1989, P410; Van Valkenburgh B, 2007, INTEGR COMP BIOL, V47, P147, DOI 10.1093/icb/icm016; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003	35	58	59	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18046	10.1371/journal.pone.0018046	http://dx.doi.org/10.1371/journal.pone.0018046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464924	gold, Green Submitted, Green Published			2022-12-27	WOS:000289053800014
J	Wang, YJ; Wang, RL; Jiang, SJ; Zhou, WJ; Liu, Y; Wang, YJ; Gu, Q; Gu, Y; Dong, YY; Liu, M; Gu, XX; Ding, F; Gu, XS				Wang, Yongjun; Wang, Ruili; Jiang, Shengjuan; Zhou, Weijuan; Liu, Yan; Wang, Yingjie; Gu, Qing; Gu, Yun; Dong, Yingying; Liu, Mei; Gu, Xingxing; Ding, Fei; Gu, Xiaosong			Gecko CD59 Is Implicated in Proximodistal Identity during Tail Regeneration	PLOS ONE			English	Article							AMPHIBIAN LIMB REGENERATION; FUNCTIONAL-CHARACTERIZATION; POSITIONAL IDENTITY; SEQUENCE-ANALYSIS; AXOLOTL LIMBS; CELLS; EXPRESSION; NEWT; COMPLEMENT; DATABASE	Several adult reptiles, such as Gekko japonicus, have the ability to precisely re-create a missing tail after amputation. To ascertain the associated acquisition of positional information from blastemal cells and the underlying molecular mechanism of tail regeneration, a candidate molecule CD59 was isolated from gecko. CD59 transcripts displayed a graded expression in the adult gecko spinal cord with the highest level in the anterior segment, with a stable expression along the normal tail. After tail amputation, CD59 transcripts in the spinal cord proximal to the injury sites increased markedly at 1 day and 2 weeks; whereas in the regenerating blastema, strong CD59 positive signals were detected in the blastemal cells anterior to the blastema, with a gradual decrease along the proximodistal (PD) axis. When treated with RA following amputation, CD59 transcripts in the blastema were up-regulated. PD confrontation assays revealed that the proximal blastema engulfed the distal one after in vitro culture, and rabbit-anti human CD59 antibody was able to block this PD engulfment. Overexpression of the CD59 during tail regeneration causes distal blastemal cells to translocate to a more proximal location. Our results suggest that position identity is not restricted to amphibian limb regeneration, but has already been established in tail blastema of reptiles. The CD59, a cell surface molecule, acted as a determinant of proximal-distal cell identity.	[Wang, Yongjun; Wang, Ruili; Zhou, Weijuan; Liu, Yan; Wang, Yingjie; Gu, Qing; Gu, Yun; Dong, Yingying; Liu, Mei; Gu, Xingxing; Ding, Fei; Gu, Xiaosong] Nantong Univ, Key Lab Neuroregenerat, Nantong, Peoples R China; [Jiang, Shengjuan] Anhui Sci & Technol Univ, Coll Life Sci, Fengyang, Peoples R China	Nantong University; Anhui Science & Technology University	Wang, YJ (corresponding author), Nantong Univ, Key Lab Neuroregenerat, Nantong, Peoples R China.	neurongu@public.nt.js.cn		Wang, Yongjun/0000-0001-5040-8926	Ministry of Science and Technology of China [2003CB515306]; National Natural Science Foundation of China [30670283]; Jiangsu Education Department [10KJA180041, 09KJA180005]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Education Department	The work was financially supported by the National Basic Research Program (973 Program) of the Ministry of Science and Technology of China (2003CB515306), the National Natural Science Foundation of China (30670283), and the Basic Research Program of Jiangsu Education Department (10KJA180041; 09KJA180005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdek-Karim Ahmed E., 1993, Qatar University Science Journal, V13, P293; ABDELKARIM, 1994, QATAR U SCI J, V14, P82; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], BIOL REPTILIA; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6; Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; Burland T G, 2000, Methods Mol Biol, V132, P71; CRAWFORD K, 1988, DEVELOPMENT, V102, P687; da Silva SM, 2002, DEV CELL, V3, P547, DOI 10.1016/S1534-5807(02)00288-5; DAVIES A, 1989, J EXP MED, V170, P637, DOI 10.1084/jem.170.3.637; Del Rio-Tsonis K, 1998, J IMMUNOL, V161, P6819; Echeverri K, 2005, DEV BIOL, V279, P391, DOI 10.1016/j.ydbio.2004.12.029; Echeverri K, 2002, SCIENCE, V298, P1993, DOI 10.1126/science.1077804; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Gargioli C, 2004, DEVELOPMENT, V131, P2669, DOI 10.1242/dev.01155; Garza-Garcia A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007123; GHOSH S, 1994, INT J DEV BIOL, V38, P479; Hinchliffe SJ, 1998, J IMMUNOL, V160, P3924; Jiang MR, 2009, MOL BIOL REP, V36, P215, DOI 10.1007/s11033-007-9169-0; Kimberley FC, 2007, MOL IMMUNOL, V44, P73, DOI 10.1016/j.molimm.2006.06.019; Kimura Y, 2003, J IMMUNOL, V170, P2331, DOI 10.4049/jimmunol.170.5.2331; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Kumar A, 2007, CR BIOL, V330, P485, DOI 10.1016/j.crvi.2007.01.006; Liu GZ, 2007, MOL IMMUNOL, V44, P3661, DOI 10.1016/j.molimm.2007.04.006; Liu Y, 2006, J MOL NEUROSCI, V29, P21, DOI 10.1385/JMN:29:1:21; Maden M, 2002, CURR BIOL, V12, pR773, DOI 10.1016/S0960-9822(02)01290-3; MADEN M, 1982, NATURE, V295, P672, DOI 10.1038/295672a0; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mercader N, 2005, DEVELOPMENT, V132, P4131, DOI 10.1242/dev.01976; MITASHOV IV, 1996, INT J DEV BIOL, V40, P833; Mochii M, 2007, DEV GROWTH DIFFER, V49, P155, DOI 10.1111/j.1440-169X.2007.00912.x; MONKEMEYER J, 1992, DEV DYNAM, V193, P286, DOI 10.1002/aja.1001930309; NARDI JB, 1983, DIFFERENTIATION, V25, P27; Nye HLD, 2003, DEV DYNAM, V226, P280, DOI 10.1002/dvdy.10236; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Papanastasiou AD, 2007, MOL IMMUNOL, V44, P1300, DOI 10.1016/j.molimm.2006.05.014; PHILBRICK WM, 1990, EUR J IMMUNOL, V20, P87, DOI 10.1002/eji.1830200113; Rehm BHA, 2001, APPL MICROBIOL BIOT, V57, P579, DOI 10.1007/s00253-001-0844-0; REYER RW, 1954, Q REV BIOL, V29, P1, DOI 10.1086/399936; SAWADA R, 1990, DNA CELL BIOL, V9, P213, DOI 10.1089/dna.1990.9.213; TONE M, 1992, J MOL BIOL, V227, P971, DOI 10.1016/0022-2836(92)90239-G; Wang SH, 2009, MOL CELL ENDOCRINOL, V313, P57, DOI 10.1016/j.mce.2009.08.024; Wang YJ, 2009, BRAIN RES BULL, V80, P414, DOI 10.1016/j.brainresbull.2009.08.010; Zhenkun C, 1990, J YUNNAN AGR, V7, P51	44	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17878	10.1371/journal.pone.0017878	http://dx.doi.org/10.1371/journal.pone.0017878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464923	Green Published, Green Submitted, gold			2022-12-27	WOS:000289053800004
J	Chung, MC; Tonry, JH; Narayanan, A; Manes, NP; Mackie, RS; Gutting, B; Mukherjee, DV; Popova, TG; Kashanchi, F; Bailey, CL; Popov, SG				Chung, Myung-Chul; Tonry, Jessica H.; Narayanan, Aarthi; Manes, Nathan P.; Mackie, Ryan S.; Gutting, Bradford; Mukherjee, Dhritiman V.; Popova, Taissia G.; Kashanchi, Fatah; Bailey, Charles L.; Popov, Serguei G.			Bacillus anthracis Interacts with Plasmin(ogen) to Evade C3b-Dependent Innate Immunity	PLOS ONE			English	Article							PLASMINOGEN-BINDING-PROTEIN; COMPLEMENT COMPONENT C3; STREPTOCOCCUS-PNEUMONIAE; ALPHA-ENOLASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MYCOBACTERIUM-TUBERCULOSIS; FACTOR-H; SURFACE; ACTIVATION; IDENTIFICATION	The causative agent of anthrax, Bacillus anthracis, is capable of circumventing the humoral and innate immune defense of the host and modulating the blood chemistry in circulation to initiate a productive infection. It has been shown that the pathogen employs a number of strategies against immune cells using secreted pathogenic factors such as toxins. However, interference of B. anthracis with the innate immune system through specific interaction of the spore surface with host proteins such as the complement system has heretofore attracted little attention. In order to assess the mechanisms by which B. anthracis evades the defense system, we employed a proteomic analysis to identify human serum proteins interacting with B. anthracis spores, and found that plasminogen (PLG) is a major surface-bound protein. PLG efficiently bound to spores in a lysine- and exosporium-dependent manner. We identified alpha-enolase and elongation factor tu as PLG receptors. PLG-bound spores were capable of exhibiting anti-opsonic properties by cleaving C3b molecules in vitro and in rabbit bronchoalveolar lavage fluid, resulting in a decrease in macrophage phagocytosis. Our findings represent a step forward in understanding the mechanisms involved in the evasion of innate immunity by B. anthracis through recruitment of PLG resulting in the enhancement of anti-complement and anti-opsonization properties of the pathogen.	[Chung, Myung-Chul; Tonry, Jessica H.; Narayanan, Aarthi; Manes, Nathan P.; Mukherjee, Dhritiman V.; Popova, Taissia G.; Kashanchi, Fatah; Bailey, Charles L.; Popov, Serguei G.] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA; [Mackie, Ryan S.; Gutting, Bradford] Naval Surface Warfare Ctr, Dahlgren Div, Chem Biol & Radiol Def Div, Dahlgren, VA USA	George Mason University	Chung, MC (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA.	mchung3@gmu.edu	Manes, Nathan P/E-2817-2012	Manes, Nathan P/0000-0001-6701-3314	U.S. Department of Energy [DE-FC52-FC04NA25455]	U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by U.S. Department of Energy grant DE-FC52-FC04NA25455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, BBA-PROTEINS PROTEOM, V1784, P986, DOI 10.1016/j.bbapap.2008.03.017; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Beaufort N, 2008, BIOCHEM J, V410, P157, DOI 10.1042/BJ20070650; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Boxx GM, 2009, MOL IMMUNOL, V46, P473, DOI 10.1016/j.molimm.2008.10.008; Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; Brittingham KC, 2005, J IMMUNOL, V174, P5545, DOI 10.4049/jimmunol.174.9.5545; Chitlaru T, 2007, INFECT IMMUN, V75, P2841, DOI 10.1128/IAI.02029-06; Chung MC, 2006, J BIOL CHEM, V281, P31408, DOI 10.1074/jbc.M605526200; Comer JE, 2005, INFECT IMMUN, V73, P8275, DOI 10.1128/IAI.73.12.8275-8281.2005; Cowan GJM, 2007, VACCINE, V25, P7197, DOI 10.1016/j.vaccine.2007.07.040; DelVecchio VG, 2006, APPL ENVIRON MICROB, V72, P6355, DOI 10.1128/AEM.00455-06; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Feng YJ, 2009, J INFECT DIS, V200, P1583, DOI 10.1086/644602; Ferguson JS, 2004, INFECT IMMUN, V72, P2564, DOI 10.1128/IAI.72.5.2564-2573.2004; FREDENBURGH JC, 1992, J BIOL CHEM, V267, P26150; Gadjeva M, 1998, J IMMUNOL, V161, P985; Gatfield J, 2003, ADV IMMUNOL, V81, P45, DOI 10.1016/S0065-2776(03)81002-7; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; Goto H, 1998, P NATL ACAD SCI USA, V95, P10224, DOI 10.1073/pnas.95.17.10224; GROSS GN, 1978, J CLIN INVEST, V62, P373, DOI 10.1172/JCI109138; Grosskinsky S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004858; Guidi-Rontani C, 1999, MOL MICROBIOL, V31, P9, DOI 10.1046/j.1365-2958.1999.01137.x; Guidi-Rontani C, 2002, TRENDS MICROBIOL, V10, P405, DOI 10.1016/S0966-842X(02)02422-8; Harvill ET, 2005, INFECT IMMUN, V73, P4420, DOI 10.1128/IAI.73.7.4420-4422.2005; Khan AS, 2006, J CHEM INF MODEL, V46, P111, DOI 10.1021/ci0501138; Kraiczy P, 2006, MOL IMMUNOL, V43, P31, DOI 10.1016/j.molimm.2005.06.016; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; LIOTTA LA, 1981, CANCER RES, V41, P4629; Loving CL, 2007, INFECT IMMUN, V75, P2689, DOI 10.1128/IAI.01875-06; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500; Matta SK, 2010, BBA-PROTEINS PROTEOM, V1804, P2111, DOI 10.1016/j.bbapap.2010.08.004; MCCOY HE, 1991, J INFECT DIS, V164, P515, DOI 10.1093/infdis/164.3.515; Monroy V, 2000, INFECT IMMUN, V68, P4327, DOI 10.1128/IAI.68.7.4327-4330.2000; Mueller-Ortiz SL, 2001, INFECT IMMUN, V69, P7501, DOI 10.1128/IAI.69.12.7501-7511.2001; Mukhopadhyay S, 2009, MOL CELL PROTEOMICS, V8, P1174, DOI 10.1074/mcp.M800403-MCP200; Narasaki R, 2005, J BIOL CHEM, V280, P14278, DOI 10.1074/jbc.M500241200; Okumura Y, 1999, FEBS LETT, V442, P39, DOI 10.1016/S0014-5793(98)01612-3; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2003, MICROB PATHOGENESIS, V35, P293, DOI 10.1016/j.micpath.2003.08.004; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Premanandan C, 2009, MICROB PATHOGENESIS, V46, P306, DOI 10.1016/j.micpath.2009.03.004; Redmond C, 2004, MICROBIOL-SGM, V150, P355, DOI 10.1099/mic.0.26681-0; Rojas M, 2008, ACTA TROP, V107, P54, DOI 10.1016/j.actatropica.2008.04.013; Russell BH, 2007, CELL MICROBIOL, V9, P1262, DOI 10.1111/j.1462-5822.2006.00869.x; Schlott B, 1997, J BIOL CHEM, V272, P6067, DOI 10.1074/jbc.272.9.6067; Shaw CA, 2008, INFECT IMMUN, V76, P2603, DOI 10.1128/IAI.01718-07; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Stie J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005780; Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x; Vieira ML, 2009, INFECT IMMUN, V77, P4092, DOI 10.1128/IAI.00353-09; Walz Alexander, 2007, Proteome Sci, V5, P11, DOI 10.1186/1477-5956-5-11; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986	59	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18119	10.1371/journal.pone.0018119	http://dx.doi.org/10.1371/journal.pone.0018119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464960	Green Published, Green Submitted, gold			2022-12-27	WOS:000288813900040
J	Visell, Y; Giordano, BL; Millet, G; Cooperstock, JR				Visell, Yon; Giordano, Bruno L.; Millet, Guillaume; Cooperstock, Jeremy R.			Vibration Influences Haptic Perception of Surface Compliance During Walking	PLOS ONE			English	Article							HUMAN BALANCE CONTROL; CUTANEOUS MECHANORECEPTIVE AFFERENTS; PLANTAR SOLE; DISCRIMINATION; ADAPTATION; LOCOMOTION; SOFTNESS; TEXTURE; NEUROPATHY; FOOTSTEPS	Background: The haptic perception of ground compliance is used for stable regulation of dynamic posture and the control of locomotion in diverse natural environments. Although rarely investigated in relation to walking, vibrotactile sensory channels are known to be active in the discrimination of material properties of objects and surfaces through touch. This study investigated how the perception of ground surface compliance is altered by plantar vibration feedback. Methodology/Principal Findings: Subjects walked in shoes over a rigid floor plate that provided plantar vibration feedback, and responded indicating how compliant it felt, either in subjective magnitude or via pairwise comparisons. In one experiment, the compliance of the floor plate was also varied. Results showed that perceived compliance of the plate increased monotonically with vibration feedback intensity, and depended to a lesser extent on the temporal or frequency distribution of the feedback. When both plate stiffness ( inverse compliance) and vibration amplitude were manipulated, the effect persisted, with both factors contributing to compliance perception. A significant influence of vibration was observed even for amplitudes close to psychophysical detection thresholds. Conclusions/Significance: These findings reveal that vibrotactile sensory channels are highly salient to the perception of surface compliance, and suggest that correlations between vibrotactile sensory information and motor activity may be of broader significance for the control of human locomotion than has been previously acknowledged.	[Visell, Yon; Millet, Guillaume; Cooperstock, Jeremy R.] McGill Univ, Ctr Intelligent Machines, Montreal, PQ, Canada; [Visell, Yon; Giordano, Bruno L.; Millet, Guillaume; Cooperstock, Jeremy R.] McGill Univ, CIRMMT, Montreal, PQ, Canada; [Giordano, Bruno L.] McGill Univ, Dept Mus Res, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Visell, Y (corresponding author), McGill Univ, Ctr Intelligent Machines, Montreal, PQ, Canada.	yon@cim.mcgill.ca	Cooperstock, Jeremy/AAU-1549-2020; Giordano, Bruno L./A-4398-2008	Giordano, Bruno L./0000-0001-7002-0486	Ministere du Developpement economique, innovation et exportation of Quebec [222107]	Ministere du Developpement economique, innovation et exportation of Quebec	This research was supported by a grant from the Ministere du Developpement economique, innovation et exportation of Quebec (http://www.mdeie.gouv.qc.ca/) for the European 7th Framework Programme project Natural Interactive Walking (NIW, no. 222107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alava MJ, 2006, ADV PHYS, V55, P349, DOI 10.1080/00018730300741518; Bensmaia S, 2005, PERCEPT PSYCHOPHYS, V67, P842, DOI 10.3758/BF03193537; Bensmaia SJ, 2005, J NEUROPHYSIOL, V94, P3023, DOI 10.1152/jn.00002.2005; Bensmaia SJ, 2003, SOMATOSENS MOT RES, V20, P33, DOI 10.1080/0899022031000083825; Courtine G, 2007, J NEUROPHYSIOL, V97, P772, DOI 10.1152/jn.00764.2006; Dixon SJ, 2000, MED SCI SPORT EXER, V32, P1919, DOI 10.1097/00005768-200011000-00016; Donelan JM, 2002, J EXP BIOL, V205, P3717; Ekimov A, 2006, J ACOUST SOC AM, V120, P762, DOI 10.1121/1.2217371; Ferris DP, 1998, P ROY SOC B-BIOL SCI, V265, P989, DOI 10.1098/rspb.1998.0388; FREYBERGER FKB, 2006, P EUROHAPTICS 06, P271; Friedman RM, 2008, EXP BRAIN RES, V191, P133, DOI 10.1007/s00221-008-1507-5; GALBRAITH FW, 1970, J ACOUST SOC AM, V48, P1288, DOI 10.1121/1.1912271; GIORDANO B, 2010, AUDIOHAPTIC ID UNPUB; Giordano B. L., 2008, J ACOUST SOC AM, V123, P3412, DOI [DOI 10.1121/1.2934136, 10.1121/1.2934136]; Hardin EC, 2004, MED SCI SPORT EXER, V36, P838, DOI 10.1249/01.MSS.0000126605.65966.40; HARPER R, 1964, Q J EXP PSYCHOL, V16, P204, DOI 10.1080/17470216408416370; Herrmann HJ., 1990, STAT MODELS FRACTURE; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P695, DOI 10.3758/BF03206916; Hollins M, 2000, PERCEPTION, V29, P1455, DOI 10.1068/p3044; Howe R. D., 1989, P IEEE INT C ROB AUT, V1, P145; Ivanenko YP, 2000, J NEUROPHYSIOL, V84, P1737, DOI 10.1152/jn.2000.84.4.1737; JONES LA, 1990, EXP BRAIN RES, V79, P150; Kavounoudias A, 1998, NEUROREPORT, V9, P3247, DOI 10.1097/00001756-199810050-00021; KENNEDY PM, 2002, J PHYSL, V583; Kinsella-Shaw Jeffrey M., 1992, Ecological Psychology, V4, P223, DOI 10.1207/s15326969eco0404_2; Klatzky RL, 1999, PERCEPT PSYCHOPHYS, V61, P591, DOI 10.3758/BF03205532; Klatzky RL, 2003, PERCEPT PSYCHOPHYS, V65, P613, DOI 10.3758/BF03194587; Kobayashi Y, 2008, IEEE T NEUR SYS REH, V16, P99, DOI 10.1109/TNSRE.2007.910283; LaMotte RH, 2000, J NEUROPHYSIOL, V83, P1777, DOI 10.1152/jn.2000.83.4.1777; Lecluyse W, 2009, J ACOUST SOC AM, V126, P2570, DOI 10.1121/1.3238248; Leung YY, 2005, J NEUROPHYSIOL, V94, P3037, DOI 10.1152/jn.00001.2005; Lockhart TE, 2002, SAFETY SCI, V40, P689, DOI 10.1016/S0925-7535(01)00067-4; MacLellan MJ, 2006, EXP BRAIN RES, V173, P521, DOI 10.1007/s00221-006-0399-5; Marigold DS, 2005, J NEUROPHYSIOL, V94, P1733, DOI 10.1152/jn.00019.2005; Maurer C, 2001, NEUROSCI LETT, V302, P45, DOI 10.1016/S0304-3940(01)01655-X; Meyer PF, 2004, EXP BRAIN RES, V156, P505, DOI 10.1007/s00221-003-1804-y; Moritz CT, 2004, J APPL PHYSIOL, V97, P1313, DOI 10.1152/japplphysiol.00393.2004; Moritz CT, 2004, J APPL PHYSIOL, V96, P1996, DOI 10.1152/japplphysiol.00983.2003; MUELLER MJ, 1994, PHYS THER, V74, P299, DOI 10.1093/ptj/74.4.299; Novak P, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-9; OKAMURA A, 1998, 1998 IEEE INT C ROB, V1; Roll R, 2002, NEUROREPORT, V13, P1957, DOI 10.1097/00001756-200210280-00025; SCOTTBLAIR G, 1940, BRIT J PSYCHOL, V31, P61; Simmons RW, 1997, DIABETES RES CLIN PR, V36, P153, DOI 10.1016/S0168-8227(97)00044-2; SIMONEAU GG, 1994, DIABETES CARE, V17, P1411, DOI 10.2337/diacare.17.12.1411; Smith J.O., 2010, PHYS AUDIO SIGNAL PR; SRINIVASAN MA, 1995, J NEUROPHYSIOL, V73, P88, DOI 10.1152/jn.1995.73.1.88; Stal F, 2003, J VESTIBUL RES-EQUIL, V13, P39; TAN HZ, 1995, PERCEPT PSYCHOPHYS, V57, P495, DOI 10.3758/BF03213075; THOMPSON C, 2010, HUMAN MOVEM IN PRESS; Tiest WMB, 2009, IEEE T HAPTICS, V2, P189, DOI [10.1109/TOH.2009.16, 10.1109/ToH.2009.16]; Trulsson M, 2001, EXP BRAIN RES, V137, P111, DOI 10.1007/s002210000649; Verschueren SMP, 2002, EXP BRAIN RES, V143, P231, DOI 10.1007/s00221-001-0987-3; VISELL Y, 2010, P IEEE HAPT S; VISELL Y, 2009, INT J HUMAN COMPUTER; Visell Y, 2009, IEEE T HAPTICS, V2, P148, DOI [10.1109/TOH.2009.31, 10.1109/ToH.2009.31]; [No title captured]	58	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17697	10.1371/journal.pone.0017697	http://dx.doi.org/10.1371/journal.pone.0017697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464979	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000288813900006
J	Pang, YP; Park, JG; Wang, SH; Vummenthala, A; Mishra, RK; McLaughlin, JE; Di, R; Kahn, JN; Tumer, NE; Janosi, L; Davis, J; Millard, CB				Pang, Yuan-Ping; Park, Jewn Giew; Wang, Shaohua; Vummenthala, Anuradha; Mishra, Rajesh K.; McLaughlin, John E.; Di, Rong; Kahn, Jennifer Nielsen; Tumer, Nilgun E.; Janosi, Laszlo; Davis, Jon; Millard, Charles B.			Small-Molecule Inhibitor Leads of Ribosome-Inactivating Proteins Developed Using the Doorstop Approach	PLOS ONE			English	Article							RICIN-A-CHAIN; ESCHERICHIA-COLI O157-H7; SHIGA-LIKE TOXINS; X-RAY-STRUCTURE; TRANSITION-STATE; FIREFLY LUCIFERASE; ACTIVE-SITE; AMINO-ACIDS; LOOP RNA; IDENTIFICATION	Ribosome-inactivating proteins (RIPs) are toxic because they bind to 28S rRNA and depurinate a specific adenine residue from the alpha-sarcin/ricin loop (SRL), thereby inhibiting protein synthesis. Shiga-like toxins (Stx1 and Stx2), produced by Escherichia coli, are RIPs that cause outbreaks of foodborne diseases with significant morbidity and mortality. Ricin, produced by the castor bean plant, is another RIP lethal to mammals. Currently, no US Food and Drug Administration-approved vaccines nor therapeutics exist to protect against ricin, Shiga-like toxins, or other RIPs. Development of effective small-molecule RIP inhibitors as therapeutics is challenging because strong electrostatic interactions at the RIP center dot SRL interface make drug-like molecules ineffective in competing with the rRNA for binding to RIPs. Herein, we report small molecules that show up to 20% cell protection against ricin or Stx2 at a drug concentration of 300 nM. These molecules were discovered using the doorstop approach, a new approach to protein center dot polynucleotide inhibitors that identifies small molecules as doorstops to prevent an active-site residue of an RIP (e.g., Tyr80 of ricin or Tyr77 of Stx2) from adopting an active conformation thereby blocking the function of the protein rather than contenders in the competition for binding to the RIP. This work offers promising leads for developing RIP therapeutics. The results suggest that the doorstop approach might also be applicable in the development of other protein center dot polynucleotide inhibitors as antiviral agents such as inhibitors of the Z-DNA binding proteins in poxviruses. This work also calls for careful chemical and biological characterization of drug leads obtained from chemical screens to avoid the identification of irrelevant chemical structures and to avoid the interference caused by direct interactions between the chemicals being screened and the luciferase reporter used in screening assays.	[Pang, Yuan-Ping; Park, Jewn Giew; Wang, Shaohua; Vummenthala, Anuradha; Mishra, Rajesh K.] Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN 55905 USA; [McLaughlin, John E.; Di, Rong; Kahn, Jennifer Nielsen; Tumer, Nilgun E.] Rutgers State Univ, Sch Environm & Biol Sci, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA; [Janosi, Laszlo; Davis, Jon; Millard, Charles B.] Walter Reed Army Inst Res, Div Biochem, Silver Spring, MD USA	Mayo Clinic; Rutgers State University New Brunswick; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Pang, YP (corresponding author), Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN 55905 USA.	pang@mayo.edu; tumer@aesop.rutgers.edu; charles.b.millard@us.army.mil	McLaughlin, John/AAE-5024-2019; McLaughlin, John/D-6966-2011	McLaughlin, John/0000-0003-4511-6202; Pang, Yuan-Ping/0000-0003-0838-2560	United States Army Medical Research and Materiel Command [W81XWH-04-2-0001]; Mayo Foundation for Medical Education and Research; United States National Institute of Allergy and Infectious Diseases [1U01AI082120-01, R01AI072425]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072425, U01AI082120] Funding Source: NIH RePORTER	United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Mayo Foundation for Medical Education and Research; United States National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the United States Army Medical Research and Materiel Command (W81XWH-04-2-0001 to YPP), the Mayo Foundation for Medical Education and Research (to YPP), and the United States National Institute of Allergy and Infectious Diseases (1U01AI082120-01 to YPP, NET and CBM; R01AI072425 to NET). The computational studies were supported in part by the University of Minnesota Supercomputing Institute. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions or assertions contained herein belong to the authors and are not necessarily the official views of the funders.	Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Auld DS, 2008, ACS CHEM BIOL, V3, P463, DOI 10.1021/cb8000793; Auld DS, 2010, P NATL ACAD SCI USA, V107, P4878, DOI 10.1073/pnas.0909141107; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Bai Y, 2009, ARCH BIOCHEM BIOPHYS, V483, P23, DOI 10.1016/j.abb.2008.12.013; Benary E, 1913, BER DTSCH CHEM GES, V46, P1363, DOI 10.1002/cber.19130460215; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BOYCE TG, 1995, NEW ENGL J MED, V333, P364, DOI 10.1056/NEJM199508103330608; Braibante MEF, 2002, TETRAHEDRON LETT, V43, P8079, DOI 10.1016/S0040-4039(02)01961-5; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen XY, 2000, J AM CHEM SOC, V122, P1609, DOI 10.1021/ja992750i; Chen XY, 2000, J AM CHEM SOC, V122, P6527, DOI 10.1021/ja992751a; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CORWIN AH, 1955, J AM CHEM SOC, V77, P464, DOI 10.1021/ja01607a073; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAVOLL J, 1953, J CHEM SOC, P3802, DOI 10.1039/jr9530003802; Dooley AJ, 2006, BIOORG MED CHEM LETT, V16, P830, DOI 10.1016/j.bmcl.2005.11.018; Ekstrom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005957; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; FRISCH MJ, 1999, GAUSSIAN, V98; GALDINO SL, 1985, EUR J MED CHIM THER, V5, P439; Heitman LH, 2008, J MED CHEM, V51, P4724, DOI 10.1021/jm8004509; Ho MC, 2009, P NATL ACAD SCI USA, V106, P20276, DOI 10.1073/pnas.0911606106; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Iizuka N, 1997, METHODS, V11, P353, DOI 10.1006/meth.1996.0433; JANOSI L, 2006, ASM BIOD RES M; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kahmann JD, 2004, P NATL ACAD SCI USA, V101, P2712, DOI 10.1073/pnas.0308612100; KIM Y, 1992, PROTEIN ENG, V5, P775, DOI 10.1093/protein/5.8.775; Kim YG, 2003, P NATL ACAD SCI USA, V100, P6974, DOI 10.1073/pnas.0431131100; KIM YS, 1992, BIOCHEMISTRY-US, V31, P3294, DOI 10.1021/bi00127a035; KORA FA, 1986, J SERB CHEM SOC, V51, P529; Korennykh AV, 2007, BIOCHEMISTRY-US, V46, P12744, DOI 10.1021/bi700931y; Korennykh AV, 2006, NAT STRUCT MOL BIOL, V13, P436, DOI 10.1038/nsmb1082; Li XP, 2009, BIOCHEMISTRY-US, V48, P3853, DOI 10.1021/bi802371h; Melton-Celsa AR, 2002, MOL MICROBIOL, V43, P207, DOI 10.1046/j.1365-2958.2002.02733.x; MeltonCelsa AR, 1996, INFECT IMMUN, V64, P1569, DOI 10.1128/IAI.64.5.1569-1576.1996; Miller DJ, 2002, J MED CHEM, V45, P90, DOI 10.1021/jm010186s; MLSNA D, 1993, PROTEIN SCI, V2, P429; MONZINGO AF, 1992, J MOL BIOL, V227, P1136, DOI 10.1016/0022-2836(92)90526-P; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; OBRIEN AD, 1987, MICROBIOL REV, V51, P206, DOI 10.1128/MMBR.51.2.206-220.1987; OBRIG TG, 1987, BIOCHEM J, V244, P287, DOI 10.1042/bj2440287; Olsnes S, 2004, TOXICON, V44, P361, DOI 10.1016/j.toxicon.2004.05.003; Pang YP, 2008, IBM J RES DEV, V52, P69, DOI 10.1147/rd.521.0069; Pang YP, 2001, J COMPUT CHEM, V22, P1750, DOI 10.1002/jcc.1129; Pang YP, 2001, FEBS LETT, V502, P93, DOI 10.1016/S0014-5793(01)02672-2; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Perola E, 2000, J MED CHEM, V43, P401, DOI 10.1021/jm990408a; Reyes A, 2000, TETRAHEDRON-ASYMMETR, V11, P1411, DOI 10.1016/S0957-4166(00)00066-5; Roday S, 2004, BIOCHEMISTRY-US, V43, P4923, DOI 10.1021/bi0498499; Roday S, 2007, BIOCHEMISTRY-US, V46, P6169, DOI 10.1021/bi0621821; RUTENBER E, 1991, PROTEINS, V10, P240, DOI 10.1002/prot.340100308; Saenz JB, 2007, INFECT IMMUN, V75, P4552, DOI 10.1128/IAI.00442-07; Shimizu T, 2007, MICROB PATHOGENESIS, V43, P88, DOI 10.1016/j.micpath.2007.04.003; Snedeker KG, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-144; Stechmann B, 2010, CELL, V141, P231, DOI 10.1016/j.cell.2010.01.043; Sturm MB, 2007, J AM CHEM SOC, V129, P5544, DOI 10.1021/ja068054h; Sturm MB, 2009, BIOCHEMISTRY-US, V48, P9941, DOI 10.1021/bi901425h; Tan C, 2004, BIOORG MED CHEM LETT, V14, P1407, DOI 10.1016/j.bmcl.2004.01.064; Too PHM, 2009, NUCLEIC ACIDS RES, V37, P602, DOI 10.1093/nar/gkn922; WAHOME PG, 2010, TOXICON, P1; Wang Q, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000531; WESTON SA, 1994, J MOL BIOL, V244, P410, DOI 10.1006/jmbi.1994.1739; Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063; Yan XJ, 1997, J MOL BIOL, V266, P1043, DOI 10.1006/jmbi.1996.0865	70	28	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17883	10.1371/journal.pone.0017883	http://dx.doi.org/10.1371/journal.pone.0017883			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455295	Green Submitted, gold, Green Published			2022-12-27	WOS:000288811500012
J	Richters, O; Peixoto, TP				Richters, Oliver; Peixoto, Tiago P.			Trust Transitivity in Social Networks	PLOS ONE			English	Article								Non-centralized recommendation-based decision making is a central feature of several social and technological processes, such as market dynamics, peer-to-peer file-sharing and the web of trust of digital certification. We investigate the properties of trust propagation on networks, based on a simple metric of trust transitivity. We investigate analytically the percolation properties of trust transitivity in random networks with arbitrary in/out-degree distributions, and compare with numerical realizations. We find that the existence of a non-zero fraction of absolute trust (i.e. entirely confident trust) is a requirement for the viability of global trust propagation in large systems: The average pair-wise trust is marked by a discontinuous transition at a specific fraction of absolute trust, below which it vanishes. Furthermore, we perform an extensive analysis of the Pretty Good Privacy (PGP) web of trust, in view of the concepts introduced. We compare different scenarios of trust distribution: community-and authority-centered. We find that these scenarios lead to sharply different patterns of trust propagation, due to the segregation of authority hubs and densely-connected communities. While the authority-centered scenario is more efficient, and leads to higher average trust values, it favours weakly-connected "fringe'' nodes, which are directly trusted by authorities. The community-centered scheme, on the other hand, favours nodes with intermediate in/out-degrees, in detriment of the authorities and its "fringe'' peers.	[Richters, Oliver; Peixoto, Tiago P.] Tech Univ Darmstadt, Inst Festkorperphys, Darmstadt, Germany	Technical University of Darmstadt	Richters, O (corresponding author), Tech Univ Darmstadt, Inst Festkorperphys, Darmstadt, Germany.	tiago@fkp.tu-darmstadt.de	Peixoto, Tiago P./E-8756-2011; Richters, Oliver/AFU-0818-2022	Peixoto, Tiago P./0000-0002-4505-0517; Richters, Oliver/0000-0001-8253-4716	Deutsche Forschungsgemeinschaft (DFG) [Dr300/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work has been supported by the Deutsche Forschungsgemeinschaft (DFG) under Contract No. Dr300/5-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAND K, 2009, 1507196 SOC SCI RES; Boguna M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056122; Brandes U, 2005, NETWWORK ANAL METHOL; BRENNEN VA, 2008, KEYSIGNING PARTY HOW; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Guardiola X., 2002, CONDMAT0206240 ARXIV; Josang A., 2006, P 29 AUSTR COMP SCI, V48; Kamvar S.D., 2003, P 12 INT C WORLD WID, P640, DOI DOI 10.1145/775152.775242; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Page L, 1999, PAGERANK CITATION RA, DOI DOI 10.1109/IISWC.2012.6402911; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Serrano MA, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056114; Serrano MA, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056115; THAYER R, 2007, OPENPGP MESSAGE FORM; Vanstone S., 1996, HDB APPL CRYPTOGRAPH; VRIEND NJ, 1994, 9403013 SANT FE I; WALTER FE, 2009, P 3 ACM C REC SYST R; Zamora-Lopez G, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016106; ZLATIC V, 2011, 11012435 ARXIV	25	37	37	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18384	10.1371/journal.pone.0018384	http://dx.doi.org/10.1371/journal.pone.0018384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483683	Green Published, gold, Green Submitted			2022-12-27	WOS:000289191300020
J	Zaravinos, A; Lambrou, GI; Boulalas, I; Delakas, D; Spandidos, DA				Zaravinos, Apostolos; Lambrou, George I.; Boulalas, Ioannis; Delakas, Dimitris; Spandidos, Demetrios A.			Identification of Common Differentially Expressed Genes in Urinary Bladder Cancer	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; NF-KAPPA-B; YIN YANG 1; CDNA MICROARRAYS; HEPATOCELLULAR-CARCINOMA; COMPUTATIONAL ANALYSIS; CHROMOSOMAL DOMAINS; EXPERIMENTAL-DESIGN; PITUITARY-ADENOMAS; HYDROGEN-PEROXIDE	Background: Current diagnosis and treatment of urinary bladder cancer (BC) has shown great progress with the utilization of microarrays. Purpose: Our goal was to identify common differentially expressed (DE) genes among clinically relevant subclasses of BC using microarrays. Methodology/Principal Findings: BC samples and controls, both experimental and publicly available datasets, were analyzed by whole genome microarrays. We grouped the samples according to their histology and defined the DE genes in each sample individually, as well as in each tumor group. A dual analysis strategy was followed. First, experimental samples were analyzed and conclusions were formulated; and second, experimental sets were combined with publicly available microarray datasets and were further analyzed in search of common DE genes. The experimental dataset identified 831 genes that were DE in all tumor samples, simultaneously. Moreover, 33 genes were up-regulated and 85 genes were down-regulated in all 10 BC samples compared to the 5 normal tissues, simultaneously. Hierarchical clustering partitioned tumor groups in accordance to their histology. K-means clustering of all genes and all samples, as well as clustering of tumor groups, presented 49 clusters. K-means clustering of common DE genes in all samples revealed 24 clusters. Genes manifested various differential patterns of expression, based on PCA. YY1 and NF kappa B were among the most common transcription factors that regulated the expression of the identified DE genes. Chromosome 1 contained 32 DE genes, followed by chromosomes 2 and 11, which contained 25 and 23 DE genes, respectively. Chromosome 21 had the least number of DE genes. GO analysis revealed the prevalence of transport and binding genes in the common down-regulated DE genes; the prevalence of RNA metabolism and processing genes in the up-regulated DE genes; as well as the prevalence of genes responsible for cell communication and signal transduction in the DE genes that were down-regulated in T1-Grade III tumors and up-regulated in T2/T3-Grade III tumors. Combination of samples from all microarray platforms revealed 17 common DE genes, (BMP4, CRYGD, DBH, GJB1, KRT83, MPZ, NHLH1, TACR3, ACTC1, MFAP4, SPARCL1, TAGLN, TPM2, CDC20, LHCGR, TM9SF1 and HCCS) 4 of which participate in numerous pathways. Conclusions/Significance: The identification of the common DE genes among BC samples of different histology can provide further insight into the discovery of new putative markers.	[Zaravinos, Apostolos; Boulalas, Ioannis; Spandidos, Demetrios A.] Univ Crete, Virol Lab, Sch Med, Iraklion, Greece; [Lambrou, George I.] Univ Athens, Choremeio Res Lab, Dept Pediat 1, Athens, Greece; [Boulalas, Ioannis; Delakas, Dimitris] Asklipieio Gen Hosp, Dept Urol, Athens, Greece	University of Crete; National & Kapodistrian University of Athens	Zaravinos, A (corresponding author), Univ Crete, Virol Lab, Sch Med, Iraklion, Greece.	spandidos@spandidos.gr	Zaravinos, Apostolos/B-2528-2019; Lambrou, George/F-9674-2011	Zaravinos, Apostolos/0000-0003-4625-5562; Lambrou, George/0000-0001-8389-1360; Spandidos, Demetrios/0000-0002-1146-931X	Department of Urology, Asklipieio General Hospital, Athens, Greece	Department of Urology, Asklipieio General Hospital, Athens, Greece	The Department of Urology, Asklipieio General Hospital, 16673 Voula, Athens, Greece funded the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin SA, 2009, CARCINOGENESIS, V30, P449, DOI 10.1093/carcin/bgp005; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Altman NS, 2006, GENET RES, V88, P153, DOI 10.1017/S0016672307008476; Beisvag V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-470; Bohgaki M, 2008, BBA-MOL CELL RES, V1783, P826, DOI 10.1016/j.bbamcr.2007.09.006; Brolinson A, 2008, ENDOCRINOLOGY, V149, P3158, DOI 10.1210/en.2007-1402; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; Castillo-Martin M, 2010, UROL ONCOL-SEMIN ORI, V28, P401, DOI 10.1016/j.urolonc.2009.04.019; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chang TS, 2004, FREE RADICAL BIO MED, V37, P521, DOI 10.1016/j.freeradbiomed.2004.05.006; Chen B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-99; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Cole SW, 2005, BIOINFORMATICS, V21, P803, DOI 10.1093/bioinformatics/bti038; Czerniak B, 1999, ONCOGENE, V18, P1185, DOI 10.1038/sj.onc.1202385; Diez D, 2007, BIOINFORMATICS, V23, P1168, DOI 10.1093/bioinformatics/btm072; Do Kim J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-85; Duggan BJ, 2003, CLIN CANCER RES, V9, P1240; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Dyrskjot L, 2003, EXPERT REV MOL DIAGN, V3, P635, DOI 10.1586/14737159.3.5.635; Enesa K, 2008, J BIOL CHEM, V283, P18582, DOI 10.1074/jbc.M801312200; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Greene FL, 2008, CA-CANCER J CLIN, V58, P180, DOI 10.3322/CA.2008.0001; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; Halleck M, 2009, TOXICOLOGY, V258, P116, DOI 10.1016/j.tox.2009.01.017; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Jiang C, 2004, J BIOL CHEM, V279, P27781, DOI 10.1074/jbc.M401809200; Juric D, 2007, J CLIN ONCOL, V25, P1341, DOI 10.1200/JCO.2006.09.3534; Kakar S, 2003, AM J CLIN PATHOL, V119, P361, DOI 10.1309/8L872RPHEJRKF5JJ; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Kim IY, 2004, CANCER RES, V64, P7355, DOI 10.1158/0008-5472.CAN-04-0154; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Klonisch T, 2007, ADV EXP MED BIOL, V612, P104; KOLLEGAL M, 2005, COMP SYST BIOINF C W, P101; Kraemer K, 2006, INT J CANCER, V119, P1276, DOI 10.1002/ijc.21975; Langat DL, 2008, AM J PATHOL, V172, P1303, DOI 10.2353/ajpath.2008.071139; Li YH, 2001, CANCER RES, V61, P6428; Li Z, 2009, ANN NY ACAD SCI, V1160, P374, DOI 10.1111/j.1749-6632.2008.03803.x; Liu JP, 2006, FEBS LETT, V580, P245, DOI 10.1016/j.febslet.2005.12.005; Lopez-Beltran A, 2004, EUR UROL, V46, P170, DOI 10.1016/j.eururo.2004.03.017; Mansure J. J., 2009, CANCER BIOL THER, V8, P6, DOI DOI 10.4161/CBT.8.7.7853; Marks Friedrich, 2007, V174, P37; Matsumoto M, 2010, INT J MOL MED, V26, P241, DOI 10.3892/ijmm_00000458; Mengual L, 2009, J UROLOGY, V182, P741, DOI 10.1016/j.juro.2009.03.084; Modlich O, 2004, CLIN CANCER RES, V10, P3410, DOI 10.1158/1078-0432.CCR-03-0134; Monzon FA, 2009, J CLIN ONCOL, V27, P2503, DOI 10.1200/JCO.2008.17.9762; Mor O, 2003, ONCOGENE, V22, P7702, DOI 10.1038/sj.onc.1207039; Nishioka H, 2005, ACTA NEUROPATHOL, V109, P598, DOI 10.1007/s00401-005-1008-6; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; REESE DH, 1979, MED HYPOTHESES, V5, P1007, DOI 10.1016/0306-9877(79)90049-5; Reyal F, 2005, CANCER RES, V65, P1376, DOI 10.1158/0008-5472.CAN-04-2706; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Rotondo F, 2009, APPL IMMUNOHISTO M M, V17, P185, DOI 10.1097/PAI.0b013e31818fa0ed; Sanchez-Carbayo M, 2003, AM J PATHOL, V163, P505, DOI 10.1016/S0002-9440(10)63679-6; Sanchez-Carbayo M, 2002, CANCER RES, V62, P6973; Seligson D, 2005, INT J ONCOL, V27, P131; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Sirbu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013822; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storey John D, 2003, Methods Mol Biol, V224, P149; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Sun YH, 2002, UROL ONCOL, V7, P207, DOI 10.1016/S1078-1439(02)00192-8; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; Thykjaer T, 2001, CANCER RES, V61, P2492; Townsend JP, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-41; Wasch R, 2010, ONCOGENE, V29, P1, DOI 10.1038/onc.2009.325; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wu W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-309; Yang XM, 2009, CHRONOBIOL INT, V26, P1323, DOI 10.3109/07420520903431301; Yauk CL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh123; Zaravinos A, 2010, CELL CYCLE, V9, P512, DOI 10.4161/cc.9.3.10588; Zaravinos A, 2009, CELL CYCLE, V8, P1402, DOI 10.4161/cc.8.9.8308; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zhou Y, 2007, CELL, V129, P163, DOI 10.1016/j.cell.2007.02.037; Zhu Y, 2009, CANCER RES, V69, P9315, DOI 10.1158/0008-5472.CAN-09-0648	88	72	78	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18135	10.1371/journal.pone.0018135	http://dx.doi.org/10.1371/journal.pone.0018135			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483740	Green Published, gold			2022-12-27	WOS:000289058700010
J	Canonici, A; Siret, C; Pellegrino, E; Pontier-Bres, R; Pouyet, L; Montero, MP; Colin, C; Czerucka, D; Rigot, V; Andre, F				Canonici, Alexandra; Siret, Carole; Pellegrino, Emilie; Pontier-Bres, Rodolphe; Pouyet, Laurent; Montero, Marie Pierre; Colin, Carole; Czerucka, Dorota; Rigot, Veronique; Andre, Frederic			Saccharomyces boulardii Improves Intestinal Cell Restitution through Activation of the alpha 2 beta 1 Integrin Collagen Receptor	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PROTEIN-KINASE ACTIVATION; GROWTH-FACTOR; EPITHELIAL-CELLS; ALPHA-CATENIN; CANCER CELLS; CROHNS-DISEASE; E-CADHERIN; RAT COLON; IN-VITRO	Intestinal epithelial cell damage is frequently seen in the mucosal lesions of inflammatory bowel diseases such as ulcerative colitis or Crohn's disease. Complete remission of these diseases requires both the cessation of inflammation and the migration of enterocytes to repair the damaged epithelium. Lyophilized Saccharomyces boulardii (Sb, Biocodex) is a nonpathogenic yeast widely used as a therapeutic agent for the treatment and prevention of diarrhea and other gastrointestinal disorders. In this study, we determined whether Sb could accelerate enterocyte migration. Cell migration was determined in Sb force-fed C57BL6J mice and in an in vitro wound model. The impact on alpha 2 beta 1 integrin activity was assessed using adhesion assays and the analysis of alpha 2 beta 1 mediated signaling pathways both in vitro and in vivo. We demonstrated that Sb secretes compounds that enhance the migration of enterocytes independently of cell proliferation. This enhanced migration was associated with the ability of Sb to favor cell-extracellular matrix interaction. Indeed, the yeast activates alpha 2 beta 1 integrin collagen receptors. This leads to an increase in tyrosine phosphorylation of cytoplasmic molecules, including focal adhesion kinase and paxillin, involved in the integrin signaling pathway. These changes are associated with the reorganization of focal adhesion structures. In conclusion Sb secretes motogenic factors that enhance cell restitution through the dynamic regulation of alpha 2 beta 1 integrin activity. This could be of major importance in the development of novel therapies targeting diseases characterized by severe mucosal injury, such as inflammatory and infectious bowel diseases.	[Canonici, Alexandra; Siret, Carole; Pellegrino, Emilie; Montero, Marie Pierre; Colin, Carole; Rigot, Veronique; Andre, Frederic] Ctr Rech Oncol & Oncopharmacol, INSERM, UMR 911, Marseille, France; [Canonici, Alexandra; Siret, Carole; Pellegrino, Emilie; Montero, Marie Pierre; Colin, Carole; Rigot, Veronique; Andre, Frederic] Aix Marseille Univ, UMR 911, Marseille, France; [Pontier-Bres, Rodolphe; Czerucka, Dorota] Ctr Mediterraneen Med Mol C3M, INSERM, U895, Team Inflammat 4, Nice, France; [Pouyet, Laurent] INSERM, U624, F-13258 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm)	Canonici, A (corresponding author), Ctr Rech Oncol & Oncopharmacol, INSERM, UMR 911, Marseille, France.	frederic.andre@univmed.fr		PONTIER-BRES, Rodolphe/0000-0002-4139-5913; Montero, Marie-Pierre/0000-0003-4280-0674	Institut National du Cancer (InCa, Canceropole PACA); Fondation pour la Recherche Medicale	Institut National du Cancer (InCa, Canceropole PACA)(Institut National du Cancer (INCA) France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was financed in part by an institutional grant from Institut National du Cancer (InCa, Canceropole PACA). L. Pouyet is recipient of a postdoctoral fellowship award from Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 1999, INT J CANCER, V83, P497, DOI 10.1002/(SICI)1097-0215(19991112)83:4<497::AID-IJC11>3.3.CO;2-4; Andre F, 2004, ONCOGENE, V23, P1177, DOI 10.1038/sj.onc.1207238; Andre F, 1999, GASTROENTEROLOGY, V116, P64, DOI 10.1016/S0016-5085(99)70230-1; ARROYO AG, 1993, J BIOL CHEM, V268, P9863; Basson MD, 2001, LIFE SCI, V69, P3005, DOI 10.1016/S0024-3205(01)01408-4; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; BRASKEN P, 1990, ANN CHIR GYNAECOL FE, V79, P65; Buts JP, 2010, SCAND J GASTROENTERO, V45, P175, DOI 10.3109/00365520903453141; Buts JP, 2009, DIGEST DIS SCI, V54, P15, DOI 10.1007/s10620-008-0322-y; Canonici A, 2008, INT J CANCER, V122, P572, DOI 10.1002/ijc.23164; CHANTRET I, 1994, J CELL SCI, V107, P213; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; Czerucka D, 2007, ALIMENT PHARM THER, V26, P767, DOI 10.1111/j.1365-2036.2007.03442.x; Dalmasso G, 2006, GASTROENTEROLOGY, V131, P1812, DOI 10.1053/j.gastro.2006.10.001; Dalmasso G, 2006, RES MICROBIOL, V157, P456, DOI 10.1016/j.resmic.2005.11.007; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; FANTINI J, 1986, J CELL SCI, V83, P235; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Girard P, 2005, DIGEST DIS SCI, V50, P2183, DOI 10.1007/s10620-005-3029-3; Goke M, 1998, GASTROENTEROLOGY, V114, P697, DOI 10.1016/S0016-5085(98)70583-9; Grzesiak JJ, 2008, INT J CANCER, V122, P2199, DOI 10.1002/ijc.23368; Guslandi M, 2000, DIGEST DIS SCI, V45, P1462, DOI 10.1023/A:1005588911207; Humphries MJ, 1996, CURR OPIN CELL BIOL, V8, P632, DOI 10.1016/S0955-0674(96)80104-9; Ido A, 2005, J GASTROENTEROL, V40, P925, DOI 10.1007/s00535-005-1705-x; Lee Sang Kil, 2005, Korean J Gastroenterol, V45, P328; MANSKE M, 1994, INT REV CYTOL, V155, P49, DOI 10.1016/S0074-7696(08)62096-3; Martins FS, 2009, LETT APPL MICROBIOL, V49, P738, DOI 10.1111/j.1472-765X.2009.02732.x; Mumy KL, 2008, AM J PHYSIOL-GASTR L, V294, pG599, DOI 10.1152/ajpgi.00391.2007; PLEIN K, 1993, Z GASTROENTEROL, V31, P129; Pothoulakis C, 2009, ALIMENT PHARM THER, V30, P826, DOI 10.1111/j.1365-2036.2009.04102.x; Qureshi FG, 2005, GASTROENTEROLOGY, V128, P1012, DOI 10.1053/j.gastro.2005.01.052; Rigot V, 1998, J CELL SCI, V111, P3119; Sinha A, 2003, NEW ENGL J MED, V349, P350, DOI 10.1056/NEJMoa013136; Sougioultzis S, 2006, BIOCHEM BIOPH RES CO, V343, P69, DOI 10.1016/j.bbrc.2006.02.080; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; VERMEULEN SJ, 1995, CANCER RES, V55, P4722; Wilson AJ, 1997, CLIN SCI, V93, P97, DOI 10.1042/cs0930097; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zanello G, 2009, CURR ISSUES MOL BIOL, V11, P47; Zeeh JM, 1996, GASTROENTEROLOGY, V110, P1077, DOI 10.1053/gast.1996.v110.pm8612996; Zhang JH, 2006, GASTROENTEROLOGY, V131, P1179, DOI 10.1053/j.gastro.2006.08.007	41	29	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18427	10.1371/journal.pone.0018427	http://dx.doi.org/10.1371/journal.pone.0018427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483797	Green Submitted, gold, Green Published			2022-12-27	WOS:000289057200076
J	Um, JH; Pendergast, JS; Springer, DA; Foretz, M; Viollet, B; Brown, A; Kim, MK; Yamazaki, S; Chung, JH				Um, Jee-Hyun; Pendergast, Julie S.; Springer, Danielle A.; Foretz, Marc; Viollet, Benoit; Brown, Alexandra; Kim, Myung K.; Yamazaki, Shin; Chung, Jay H.			AMPK Regulates Circadian Rhythms in a Tissue- and Isoform-Specific Manner	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; PPAR-GAMMA; SUPRACHIASMATIC NUCLEUS; MITOCHONDRIAL BIOGENESIS; CALORIE RESTRICTION; PERIPHERAL-TISSUES; CLOCK GENES; FOOD-INTAKE; SIRT1	Background: AMP protein kinase (AMPK) plays an important role in food intake and energy metabolism, which are synchronized to the light-dark cycle. In vitro, AMPK affects the circadian rhythm by regulating at least two clock components, CKI alpha and CRY1, via direct phosphorylation. However, it is not known whether the catalytic activity of AMPK actually regulates circadian rhythm in vivo. Methodology/Principal Finding: The catalytic subunit of AMPK has two isoforms: alpha 1 and alpha 2. We investigate the circadian rhythm of behavior, physiology and gene expression in AMPK alpha 1-/- and AMPK alpha 2-/- mice. We found that both alpha 1-/- and alpha 2-/- mice are able to maintain a circadian rhythm of activity in dark-dark (DD) cycle, but alpha 1-/- mice have a shorter circadian period whereas alpha 2-/- mice showed a tendency toward a slightly longer circadian period. Furthermore, the circadian rhythm of body temperature was dampened in alpha 1-/- mice, but not in alpha 2-/- mice. The circadian pattern of core clock gene expression was severely disrupted in fat in alpha 1-/- mice, but it was severely disrupted in the heart and skeletal muscle of alpha 2-/- mice. Interestingly, other genes that showed circadian pattern of expression were dysreguated in both alpha 1-/- and alpha 2-/- mice. The circadian rhythm of nicotinamide phosphoryl-transferase (NAMPT) activity, which converts nicotinamide (NAM) to NAD(+), is an important regulator of the circadian clock. We found that the NAMPT rhythm was absent in AMPK-deficient tissues and cells. Conclusion/Significance: This study demonstrates that the catalytic activity of AMPK regulates circadian rhythm of behavior, energy metabolism and gene expression in isoform-and tissue-specific manners.	[Um, Jee-Hyun; Brown, Alexandra; Kim, Myung K.; Chung, Jay H.] NHLBI, Lab Obes & Aging Res, Genet & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA; [Pendergast, Julie S.; Yamazaki, Shin] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA; [Springer, Danielle A.] NHLBI, Mouse Phenotyping Core Facil, NIH, Bethesda, MD 20892 USA; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Foretz, Marc; Viollet, Benoit] INSERM, U567, Paris, France	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Um, JH (corresponding author), NHLBI, Lab Obes & Aging Res, Genet & Dev Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	chungj@nhlbi.nih.gov	Viollet, Benoit/O-6927-2017; Viollet, Benoit/N-2397-2019; FORETZ, Marc/O-7334-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032; Yamazaki, Shin/0000-0002-6691-1531	National Heart Lung and Blood Institute, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002243, ZIGHL006020, ZIAHL006118] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program, National Heart Lung and Blood Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Ando H, 2005, ENDOCRINOLOGY, V146, P5631, DOI 10.1210/en.2005-0771; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Goh BC, 2007, BIOCHEM BIOPH RES CO, V360, P828, DOI 10.1016/j.bbrc.2007.06.136; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Ibuka N, 1980, Waking Sleeping, V4, P167; IBUKA N, 1977, BRAIN RES, V122, P33, DOI 10.1016/0006-8993(77)90660-6; Jensen TE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002102; Jorgensen SB, 2005, FASEB J, V19, P1146, DOI 10.1096/fj.04-3144fje; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Lihn A, 2004, BIOCHEM BIOPH RES CO, V316, P853, DOI 10.1016/j.bbrc.2004.02.139; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; OKAMURA H, 2007, COLD SPRING HARB SYM, V72, P551; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Refinetti R., 2006, CIRCADIAN PHYSL, V2nd; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Um JH, 2007, J BIOL CHEM, V282, P20794, DOI 10.1074/jbc.C700070200; Vieira E, 2008, AM J PHYSIOL-ENDOC M, V295, pE1032, DOI 10.1152/ajpendo.90510.2008; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Weaver DR, 1998, J BIOL RHYTHM, V13, P100, DOI 10.1177/074873098128999952; WELSH DK, 1988, PHYSIOL BEHAV, V43, P771, DOI 10.1016/0031-9384(88)90375-7; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18; Yang ST, 2009, ENDOCRINOLOGY, V150, P2153, DOI 10.1210/en.2008-0705; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	61	80	85	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18450	10.1371/journal.pone.0018450	http://dx.doi.org/10.1371/journal.pone.0018450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483791	Green Submitted, Green Published, gold			2022-12-27	WOS:000289057200081
J	Crockett, DK; Piccolo, SR; Ridge, PG; Margraf, RL; Lyon, E; Williams, MS; Mitchell, JA				Crockett, David K.; Piccolo, Stephen R.; Ridge, Perry G.; Margraf, Rebecca L.; Lyon, Elaine; Williams, Marc S.; Mitchell, Joyce A.			Predicting Phenotypic Severity of Uncertain Gene Variants in the RET Proto-Oncogene	PLOS ONE			English	Article							ENDOCRINE NEOPLASIA TYPE-2; MEDULLARY-THYROID CANCER; AMINO-ACID SUBSTITUTIONS; AFFECT PROTEIN FUNCTION; CLINICAL GENETICS; MUTATIONS; DISEASE; DATABASE; SIFT	Although reported gene variants in the RET oncogene have been directly associated with multiple endocrine neoplasia type 2 and hereditary medullary thyroid carcinoma, other mutations are classified as variants of uncertain significance (VUS) until the associated clinical phenotype is made clear. Currently, some 46 non-synonymous VUS entries exist in curated archives. In the absence of a gold standard method for predicting phenotype outcomes, this follow up study applies feature selected amino acid physical and chemical properties feeding a Bayes classifier to predict disease association of uncertain gene variants into categories of benign and pathogenic. Algorithm performance and VUS predictions were compared to established phylogenetic based mutation prediction algorithms. Curated outcomes and unpublished RET gene variants with known disease association were used to benchmark predictor performance. Reliable classification of RET uncertain gene variants will augment current clinical information of RET mutations and assist in improving prediction algorithms as knowledge increases.	[Crockett, David K.; Piccolo, Stephen R.; Williams, Marc S.; Mitchell, Joyce A.] Univ Utah Sch Med, Salt Lake City, UT 84132 USA; [Crockett, David K.; Ridge, Perry G.; Margraf, Rebecca L.; Lyon, Elaine] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Williams, Marc S.] Intermt Healthcare Clin Genet Inst, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Intermountain Healthcare	Crockett, DK (corresponding author), Univ Utah Sch Med, Salt Lake City, UT 84132 USA.	david.crockett@aruplab.com		Williams, Marc/0000-0001-6165-8701	University of Utah School of Medicine; Department of Pathology and ARUP Institute for Clinical and Experimental Pathology; NLM [LM007124]; NCRR [1KL2RR025763 01]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025763] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007124] Funding Source: NIH RePORTER	University of Utah School of Medicine; Department of Pathology and ARUP Institute for Clinical and Experimental Pathology; NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the University of Utah School of Medicine, Department of Pathology and ARUP Institute for Clinical and Experimental Pathology, NLM training grant LM007124 and NCRR translational science award 1KL2RR025763 01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; ATTIE T, 1995, HUM MOL GENET, V4, P1381, DOI 10.1093/hmg/4.8.1381; Crockett DK, 2010, J DATA MINING GENOM, V1, P1; Dorfman R, 2010, CLIN GENET, V77, P464, DOI 10.1111/j.1399-0004.2009.01351.x; Eng C, 1996, JAMA-J AM MED ASSOC, V276, P1575, DOI 10.1001/jama.276.19.1575; Engelhardt BE, 2005, PLOS COMPUT BIOL, V1, P432, DOI 10.1371/journal.pcbi.0010045; Ensenauer RE, 2005, MAYO CLIN PROC, V80, P63; Ferreira-Gonzalez A, 2008, PERS MED, V5, P521, DOI 10.2217/17410541.5.5.521; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Kang HH, 2006, BRIT J CANCER, V95, P914, DOI 10.1038/sj.bjc.6603358; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kloos RT, 2009, THYROID, V19, P565, DOI 10.1089/thy.2008.0403; Kouvaraki MA, 2005, THYROID, V15, P531, DOI 10.1089/thy.2005.15.531; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Machens A, 2001, J CLIN ENDOCR METAB, V86, P1104, DOI 10.1210/jc.86.3.1104; Margraf RL, 2009, HUM MUTAT, V30, P548, DOI 10.1002/humu.20928; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; NOWAK R, 1994, SCIENCE, V265, P464, DOI 10.1126/science.8036486; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Spencer DS, 1996, J MOL BIOL, V257, P497, DOI 10.1006/jmbi.1996.0180; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tchernitchko D, 2004, CLIN CHEM, V50, P1974, DOI 10.1373/clinchem.2004.036053; Wei QO, 2010, PROTEINS, V78, P2058, DOI 10.1002/prot.22722; Weinstein Neil D., 1999, Journal of the National Cancer Institute Monographs, P15; Williams MS, 2009, AM J MED GENET C, V151C, P175, DOI 10.1002/ajmg.c.30216	28	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18380	10.1371/journal.pone.0018380	http://dx.doi.org/10.1371/journal.pone.0018380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479187	Green Submitted, gold, Green Published			2022-12-27	WOS:000289055700053
J	Girard-Buttoz, C; Higham, JP; Heistermann, M; Wedegartner, S; Maestripieri, D; Engelhardt, A				Girard-Buttoz, Cedric; Higham, James P.; Heistermann, Michael; Wedegaertner, Stefan; Maestripieri, Dario; Engelhardt, Antje			Urinary C-Peptide Measurement as a Marker of Nutritional Status in Macaques	PLOS ONE			English	Article							RHESUS-MONKEYS; ENERGY-BALANCE; BODY-MASS; TESTOSTERONE; INSULIN; PRIMATE; WEIGHT; GROWTH; SIZE; AVAILABILITY	Studies of the nutritional status of wild animals are important in a wide range of research areas such as ecology, behavioural ecology and reproductive biology. However, they have so far been strongly limited by the indirect nature of the available non-invasive tools for the measurement of individual energetic status. The measurement of urinary C-peptide (UCP), which in humans and great apes shows a close link to individual nutritional status, may be a more direct, non-invasive tool for such studies in other primates as well and possibly even in non-primate mammals. Here, we test the suitability of UCPs as markers of nutritional status in non-hominid primates, investigating relationships between UCPs and body-mass-index (BMI), skinfold fatness, and plasma C-peptide levels in captive and free-ranging macaques. We also conducted a food reduction experiment, with daily monitoring of body weight and UCP levels. UCP levels showed significant positive correlations with BMI and skinfold fatness in both captive and free-ranging animals and with plasma C-peptide levels in captive ones. In the feeding experiment, UCP levels were positively correlated with changes in body mass and were significantly lower during food reduction than during re-feeding and the pre-experimental control condition. We conclude that UCPs may be used as reliable biomarkers of body condition and nutritional status in studies of free-ranging catarrhines. Our results open exciting opportunities for energetic studies on free-ranging primates and possibly also other mammals.	[Girard-Buttoz, Cedric; Wedegaertner, Stefan; Engelhardt, Antje] German Primate Ctr, Reprod Biol Unit, Jr Res Grp Primate Sexual Select, Gottingen, Germany; [Girard-Buttoz, Cedric; Engelhardt, Antje] Univ Gottingen, Gottingen, Germany; [Higham, James P.; Maestripieri, Dario] Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA	Deutsches Primatenzentrum (DPZ); University of Gottingen; University of Chicago	Girard-Buttoz, C (corresponding author), German Primate Ctr, Reprod Biol Unit, Jr Res Grp Primate Sexual Select, Gottingen, Germany.	cgirard-buttoz@dpz.eu	Engelhardt, Antje/A-2660-2013; Girard-Buttoz, Cedric/J-6285-2019	Engelhardt, Antje/0000-0003-2704-7493	German Research Council (DFG) [DFG EN 719/2]; Volkswagen Foundation, on Cayo Santiago; National Institutes of Health [R21-AG029862]; NIH National Center for Research Resources (NCRR) [CM-5-P40RR003640]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067175] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR003640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG029862] Funding Source: NIH RePORTER	German Research Council (DFG)(German Research Foundation (DFG)); Volkswagen Foundation, on Cayo Santiago(Volkswagen); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research at DPZ was supported by the German Research Council (DFG EN 719/2) and the Volkswagen Foundation, on Cayo Santiago, This research was supported by the National Institutes of Health (grant number R21-AG029862 to DM). This publication was made possible by grant number CM-5-P40RR003640 from the NIH National Center for Research Resources (NCRR) to the Caribbean Primate Research Center of the University of Puerto Rico. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1987, OECOLOGIA, V72, P15, DOI 10.1007/BF00385038; ALTMANN J, 1993, AM J PRIMATOL, V30, P149, DOI 10.1002/ajp.1350300207; ALTMANN J, 1992, BEHAV ECOL SOCIOBIOL, V29, P391; Altmann S.A., 1998, FORAGING SURVIVAL, DOI University of Chicago Press; Bahr NI, 2000, GEN COMP ENDOCR, V117, P427, DOI 10.1006/gcen.1999.7431; BARTON RA, 1993, FOLIA PRIMATOL, V61, P1, DOI 10.1159/000156722; BERMAN CM, 1988, AM J PRIMATOL, V14, P53, DOI 10.1002/ajp.1350140105; BERNSTEIN IS, 1989, AM J PRIMATOL, V18, P251, DOI 10.1002/ajp.1350180309; Blanc S, 2005, J MED PRIMATOL, V34, P130, DOI 10.1111/j.1600-0684.2005.00106.x; Bronson FH, 1989, MAMMALIAN REPROD BIO; Campbell BC, 2004, J MED PRIMATOL, V33, P70, DOI 10.1111/j.1600-0684.2004.00055.x; Chivers DJ, 1998, P NUTR SOC, V57, P321, DOI 10.1079/PNS19980047; Cooper MA, 2004, INT J PRIMATOL, V25, P165, DOI 10.1023/B:IJOP.0000014648.12402.b6; Cuthill Innes C., 1997, P97; Deschner T, 2008, HORM BEHAV, V54, P620, DOI 10.1016/j.yhbeh.2008.06.005; GLICK BB, 1979, FOLIA PRIMATOL, V32, P268; GOLDIZEN AW, 1988, J ANIM ECOL, V57, P893, DOI 10.2307/5099; Hamada Y, 1999, PRIMATES, V40, P439, DOI 10.1007/BF02557580; Harris TR, 2010, BEHAV ECOL, V21, P46, DOI 10.1093/beheco/arp150; Harrison T, 2007, AM J PHYS ANTHROPOL, P126; Hoffman CL, 2008, BEHAV ECOL SOCIOBIOL, V62, P1711, DOI 10.1007/s00265-008-0599-z; HOOGWERF BJ, 1986, AM J CLIN NUTR, V43, P350, DOI 10.1093/ajcn/43.3.350; JURGENS KD, 1991, COMP BIOCHEM PHYS A, V100, P703, DOI 10.1016/0300-9629(91)90393-Q; KARASOV WH, 1986, TRENDS ECOL EVOL, V1, P101, DOI 10.1016/0169-5347(86)90034-0; Kelly TR, 2004, VET REC, V154, P729, DOI 10.1136/vr.154.23.729; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Knott CD, 2005, CAM S BIO EVOL ANTHR, V44, P351, DOI 10.1017/CBO9780511542343.013; Koenig A, 1997, J ZOOL, V243, P215, DOI 10.1111/j.1469-7998.1997.tb02778.x; Krebs JR, 1993, INTRO BEHAV ECOLOGY; KRUSZYNSKA YT, 1987, DIABETOLOGIA, V30, P16, DOI 10.1007/BF01788901; LIFSON N, 1966, J THEOR BIOL, V12, P46, DOI 10.1016/0022-5193(66)90185-8; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Marriott B.M., 1989, Puerto Rico Health Sciences Journal, V8, P87; MEISTAS MT, 1982, METABOLISM, V31, P1224, DOI 10.1016/0026-0495(82)90008-7; MORI A, 1979, Primates, V20, P371, DOI 10.1007/BF02373390; Muehlenbein MP, 2005, AM J PHYS ANTHROPOL, V127, P335, DOI 10.1002/ajpa.20071; Muller MN, 2004, ANIM BEHAV, V67, P113, DOI 10.1016/j.anbehav.2003.03.013; PURI CP, 1981, ACTA ENDOCRINOL-COP, V97, P118, DOI 10.1530/acta.0.0970118; Rawlins RG., 1986, CAYO SANTIAGO MACAQU; RUBENSTEIN AH, 1969, NATURE, V224, P697, DOI 10.1038/224697a0; SAPOLSKY RM, 1982, HORM BEHAV, V16, P279, DOI 10.1016/0018-506X(82)90027-7; SAPOLSKY RM, 1986, ENDOCRINOLOGY, V118, P1630, DOI 10.1210/endo-118-4-1630; SAPOLSKY RM, 1985, ENDOCRINOLOGY, V116, P2273, DOI 10.1210/endo-116-6-2273; Schlulke O, 2006, AM J PRIMATOL, V68, P951, DOI 10.1002/ajp.20300; Sherry DS, 2007, AM J PHYS ANTHROPOL, V133, P771, DOI 10.1002/ajpa.20562; Thompson ME, 2008, HORM BEHAV, V53, P526, DOI 10.1016/j.yhbeh.2007.12.005; Thompson ME, 2009, HORM BEHAV, V55, P299, DOI 10.1016/j.yhbeh.2008.11.005; Wich SA, 2006, INT J PRIMATOL, V27, P1535, DOI 10.1007/s10764-006-9093-5; Wolden-Hanson T, 1993, Obes Res, V1, P5; Yoshida N, 2006, J PSYCHOSOM RES, V61, P571, DOI 10.1016/j.jpsychores.2006.02.009	50	44	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18042	10.1371/journal.pone.0018042	http://dx.doi.org/10.1371/journal.pone.0018042			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479215	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000289055700023
J	Koshimizu, E; Imamura, S; Qi, J; Toure, J; Valdez, DM; Carr, CE; Hanai, J; Kishi, S				Koshimizu, Eriko; Imamura, Shintaro; Qi, Jie; Toure, Jamal; Valdez, Delgado M., Jr.; Carr, Christopher E.; Hanai, Jun-ichi; Kishi, Shuji			Embryonic Senescence and Laminopathies in a Progeroid Zebrafish Model	PLOS ONE			English	Article							HUTCHINSON-GILFORD-PROGERIA; A-TYPE LAMINS; NUCLEAR-ENVELOPE; PRELAMIN-A; CELL-DIFFERENTIATION; GRADUAL SENESCENCE; STEM-CELLS; INHIBITING FARNESYLATION; RETINOBLASTOMA PROTEIN; RESTRICTIVE DERMOPATHY	Background: Mutations that disrupt the conversion of prelamin A to mature lamin A cause the rare genetic disorder Hutchinson-Gilford progeria syndrome and a group of laminopathies. Our understanding of how A-type lamins function in vivo during early vertebrate development through aging remains limited, and would benefit from a suitable experimental model. The zebrafish has proven to be a tractable model organism for studying both development and aging at the molecular genetic level. Zebrafish show an array of senescence symptoms resembling those in humans, which can be targeted to specific aging pathways conserved in vertebrates. However, no zebrafish models bearing human premature senescence currently exist. Principal Findings: We describe the induction of embryonic senescence and laminopathies in zebrafish harboring disturbed expressions of the lamin A gene (LMNA). Impairments in these fish arise in the skin, muscle and adipose tissue, and sometimes in the cartilage. Reduced function of lamin A/C by translational blocking of the LMNA gene induced apoptosis, cell-cycle arrest, and craniofacial abnormalities/cartilage defects. By contrast, induced cryptic splicing of LMNA, which generates the deletion of 8 amino acid residues lamin A (zlamin A-Delta 8), showed embryonic senescence and S-phase accumulation/arrest. Interestingly, the abnormal muscle and lipodystrophic phenotypes were common in both cases. Hence, both decrease-of-function of lamin A/C and gain-of-function of aberrant lamin A protein induced laminopathies that are associated with mesenchymal cell lineages during zebrafish early development. Visualization of individual cells expressing zebrafish progerin (zProgerin/zlamin A-Delta 37) fused to green fluorescent protein further revealed misshapen nuclear membrane. A farnesyltransferase inhibitor reduced these nuclear abnormalities and significantly prevented embryonic senescence and muscle fiber damage induced by zProgerin. Importantly, the adult Progerin fish survived and remained fertile with relatively mild phenotypes only, but had shortened lifespan with obvious distortion of body shape. Conclusion: We generated new zebrafish models for a human premature aging disorder, and further demonstrated the utility for studying laminopathies. Premature aging could also be modeled in zebrafish embryos. This genetic model may thus provide a new platform for future drug screening as well as genetic analyses aimed at identifying modifier genes that influence not only progeria and laminopathies but also other age-associated human diseases common in vertebrates.	[Koshimizu, Eriko; Imamura, Shintaro; Qi, Jie; Toure, Jamal; Kishi, Shuji] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02163 USA; [Koshimizu, Eriko] Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Tokyo, Japan; [Carr, Christopher E.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA USA; [Hanai, Jun-ichi] Harvard Univ, Sch Med, Div Nephrol Interdisciplinary Med & Biotechnol, Dept Med,Beth Israel Deaconess Med Ctr, Boston, MA USA; [Qi, Jie; Valdez, Delgado M., Jr.; Kishi, Shuji] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL USA	Harvard University; Harvard Medical School; Tokyo University of Marine Science & Technology; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Scripps Research Institute	Koshimizu, E (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02163 USA.	kishi@scripps.edu		Carr, Christopher/0000-0002-7946-5622	Ellison Medical Foundation; Glenn Foundation for Medical Research	Ellison Medical Foundation(Lawrence Ellison Foundation); Glenn Foundation for Medical Research	This study was supported by The Ellison Medical Foundation and The Glenn Foundation for Medical Research (S.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati F, 2004, GENE EXPRESSION, V12, P39, DOI 10.3727/000000004783992189; Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Candelario J, 2008, AGING CELL, V7, P355, DOI 10.1111/j.1474-9726.2008.00393.x; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; Csoka AB, 2004, AGING CELL, V3, P235, DOI 10.1111/j.1474-9728.2004.00105.x; Davies BSJ, 2010, HUM MOL GENET, V19, P2682, DOI 10.1093/hmg/ddq158; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Sandre-Giovannoli A, 2006, PROG MOLEC, V44, P199; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dialynas G, 2010, DEVELOPMENT, V137, P3067, DOI 10.1242/dev.048231; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Domingo DL, 2009, ORAL DIS, V15, P187, DOI 10.1111/j.1601-0825.2009.01521.x; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Espada J, 2008, J CELL BIOL, V181, P27, DOI 10.1083/jcb.200801096; FAWCETT DW, 1966, AM J ANAT, V119, P129, DOI 10.1002/aja.1001190108; Foster HA, 2007, CHROMOSOME RES, V15, P163, DOI 10.1007/s10577-006-1088-8; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; Gerhard GS, 2002, EXP GERONTOL, V37, P1055, DOI 10.1016/S0531-5565(02)00088-8; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Gotic I, 2010, STEM CELLS, V28, P480, DOI 10.1002/stem.292; Grabher C, 2004, METHOD CELL BIOL, V77, P381; Halaschek-Wiener J, 2007, J GERONTOL A-BIOL, V62, P3, DOI 10.1093/gerona/62.1.3; Hernandez L, 2010, DEV CELL, V19, P413, DOI 10.1016/j.devcel.2010.08.013; Hofemeister H, 2002, EUR J CELL BIOL, V81, P51, DOI 10.1078/0171-9335-00229; Hukriede NA, 1999, P NATL ACAD SCI USA, V96, P9745, DOI 10.1073/pnas.96.17.9745; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kaufman CK, 2009, NAT PROTOC, V4, P1422, DOI 10.1038/nprot.2009.144; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishi S, 2004, ANN NY ACAD SCI, V1019, P521, DOI 10.1196/annals.1297.097; Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6; Kishi S, 2009, GERONTOLOGY, V55, P430, DOI 10.1159/000228892; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; LEHNER CF, 1987, J CELL BIOL, V105, P577, DOI 10.1083/jcb.105.1.577; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Liu TX, 2003, DEV CELL, V5, P903, DOI 10.1016/S1534-5807(03)00339-3; Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Mariappan I, 2005, MOL BIOL CELL, V16, P1948, DOI 10.1091/mbc.E04-02-0154; Mariappan I, 2007, BIOCHEM BIOPH RES CO, V355, P981, DOI 10.1016/j.bbrc.2007.02.060; McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269; Meng A, 1999, METHOD CELL BIOL, V60, P133; Meshorer E, 2008, J CELL BIOL, V181, P9, DOI 10.1083/jcb.200802155; Moulson CL, 2005, J INVEST DERMATOL, V125, P913, DOI 10.1111/j.0022-202X.2005.23846.x; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Naetar N, 2008, NAT CELL BIOL, V10, P1341, DOI 10.1038/ncb1793; Navarro CL, 2004, HUM MOL GENET, V13, P2493, DOI 10.1093/hmg/ddh265; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Nitta RT, 2006, MOL CELL BIOL, V26, P5360, DOI 10.1128/MCB.02464-05; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Passeri MJ, 2009, HEPATOLOGY, V49, P443, DOI 10.1002/hep.22667; Peter A, 2008, EUR J CELL BIOL, V87, P879, DOI 10.1016/j.ejcb.2008.06.001; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; PRATHER RS, 1989, BIOL REPROD, V41, P123, DOI 10.1095/biolreprod41.1.123; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Raharjo WH, 2001, J CELL SCI, V114, P4447; ROBER RA, 1989, DEVELOPMENT, V105, P365; Rodriguez JI, 1999, AM J MED GENET, V82, P242, DOI 10.1002/(SICI)1096-8628(19990129)82:3<242::AID-AJMG9>3.3.CO;2-5; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Schlegel A, 2006, BIOCHEMISTRY-US, V45, P15179, DOI 10.1021/bi0619268; Schlombs K, 2003, P NATL ACAD SCI USA, V100, P14024, DOI 10.1073/pnas.2331794100; Schulze SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007564; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; SINENSKY M, 1994, J CELL SCI, V107, P61; Soroldoni Daniele, 2009, V546, P117, DOI 10.1007/978-1-60327-977-2_8; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Tsai SB, 2007, AGING CELL, V6, P209, DOI 10.1111/j.1474-9726.2007.00278.x; van Engelen BGM, 2005, NEUROLOGY, V64, P374, DOI 10.1212/01.WNL.0000149763.15180.00; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Wilson KL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000554; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Yang SH, 2008, J CLIN INVEST, V118, P3291, DOI 10.1172/JCI35876; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968; Young SG, 2005, J LIPID RES, V46, P2531, DOI 10.1194/jlr.R500011-JLR200; Young SG, 2006, J BIOL CHEM, V281, P39741, DOI 10.1074/jbc.R600033200; Yu LL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000014; Zeller J, 2002, DEV BIOL, V252, P241, DOI 10.1006/dbio.2002.0852; Zhdanova IV, 2008, BRAIN RES BULL, V75, P433, DOI 10.1016/j.brainresbull.2007.10.053	90	38	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17688	10.1371/journal.pone.0017688	http://dx.doi.org/10.1371/journal.pone.0017688			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479207	gold, Green Published, Green Submitted			2022-12-27	WOS:000289055700015
J	Pfeiffer, T; Bertram, L; Ioannidis, JPA				Pfeiffer, Thomas; Bertram, Lars; Ioannidis, John P. A.			Quantifying Selective Reporting and the Proteus Phenomenon for Multiple Datasets with Similar Bias	PLOS ONE			English	Article							MISLEADING FUNNEL PLOT; PUBLICATION BIAS; GENETIC ASSOCIATION; CLINICAL-RESEARCH; METAANALYSIS; TRIALS; PROBABILITY; DISEASE; EXCESS	Meta-analyses play an important role in synthesizing evidence from diverse studies and datasets that address similar questions. A major obstacle for meta-analyses arises from biases in reporting. In particular, it is speculated that findings which do not achieve formal statistical significance are less likely reported than statistically significant findings. Moreover, the patterns of bias can be complex and may also depend on the timing of the research results and their relationship with previously published work. In this paper, we present an approach that is specifically designed to analyze large-scale datasets on published results. Such datasets are currently emerging in diverse research fields, particularly in molecular medicine. We use our approach to investigate a dataset on Alzheimer's disease (AD) that covers 1167 results from case-control studies on 102 genetic markers. We observe that initial studies on a genetic marker tend to be substantially more biased than subsequent replications. The chances for initial, statistically non-significant results to be published are estimated to be about 44% (95% CI, 32% to 63%) relative to statistically significant results, while statistically non-significant replications have almost the same chance to be published as statistically significant replications (84%; 95% CI, 66% to 107%). Early replications tend to be biased against initial findings, an observation previously termed Proteus phenomenon: The chances for nonsignificant studies going in the same direction as the initial result are estimated to be lower than the chances for nonsignificant studies opposing the initial result (73%; 95% CI, 55% to 96%). Such dynamic patters in bias are difficult to capture by conventional methods, where typically simple publication bias is assumed to operate. Our approach captures and corrects for complex dynamic patterns of bias, and thereby helps generating conclusions from published results that are more robust against the presence of different coexisting types of selective reporting.	[Pfeiffer, Thomas] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Bertram, Lars] Max Planck Inst Mol Genet, Neuropsychiat Genet Grp, Dept Vertebrate Genom, Berlin, Germany; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Biomed Res Inst,Fdn Res & Technol Hellas, GR-45110 Ioannina, Greece; [Pfeiffer, Thomas; Ioannidis, John P. A.] Tufts Univ, Sch Med, Ctr Genet Epidemiol & Modeling, ICRHPS,Tufts Med Ctr, Boston, MA 02111 USA; [Pfeiffer, Thomas; Ioannidis, John P. A.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Ioannidis, John P. A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Stanford, CA 94305 USA	Harvard University; Max Planck Society; Foundation for Research & Technology - Hellas (FORTH); University of Ioannina; Tufts Medical Center; Tufts University; Tufts University; Harvard University; Harvard T.H. Chan School of Public Health; Stanford University	Pfeiffer, T (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	pfeiffer@fas.harvard.edu	Ioannidis, John P. A./G-9836-2011; Bertram, Lars/K-3889-2015; Pfeiffer, Thomas/R-1339-2019	Bertram, Lars/0000-0002-0108-124X; Pfeiffer, Thomas/0000-0002-0592-577X	National Institutes of Health [UL1 RR025752]; Society in Science/The Branco Weiss Fellowship; Cure Alzheimer's Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society in Science/The Branco Weiss Fellowship; Cure Alzheimer's Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for the Tufts Clinical and Translational Science Institute and the Center for Genetic Epidemiology and Modeling is offered by grant UL1 RR025752 from the National Institutes of Health. Thomas Pfeiffer gratefully acknowledges funding from Society in Science/The Branco Weiss Fellowship. AlzGene is funded by the Cure Alzheimer's Fund. The Alzheimer Research Forum is hosting AlzGene on their site. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; COURSOL A, 1986, PROF PSYCHOL-RES PR, V17, P136, DOI 10.1037/0735-7028.17.2.136; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010271; Hedges LV, 1996, J EDUC BEHAV STAT, V21, P299, DOI 10.2307/1165338; Hedges LV, 1992, STAT SCI, V7, P246, DOI DOI 10.1214/SS/1177011364; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; Iyengar S., 1988, STAT SCI, V3, P109, DOI DOI 10.1214/SS/1177013012; Kavvoura FK, 2008, AM J EPIDEMIOL, V168, P855, DOI 10.1093/aje/kwn206; Kullback S., 1997, INFORM THEORY STAT; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; LINDLEY DV, 1956, ANN MATH STAT, V27, P986, DOI 10.1214/aoms/1177728069; Little J, 2009, HUM GENET, V125, P131, DOI 10.1007/s00439-008-0592-7; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; Nelson JD, 2005, PSYCHOL REV, V112, P979, DOI 10.1037/0033-295X.112.4.979; Pfeiffer T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004607; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Sutton AJ, 2000, STAT METHODS MED RES, V9, P421, DOI 10.1191/096228000701555244; Tang JL, 2000, J CLIN EPIDEMIOL, V53, P477, DOI 10.1016/S0895-4356(99)00204-8; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Yesupriya A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-31	31	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18362	10.1371/journal.pone.0018362	http://dx.doi.org/10.1371/journal.pone.0018362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479240	Green Submitted, gold, Green Published			2022-12-27	WOS:000289054600050
J	Rother, F; Shmidt, T; Popova, E; Krivokharchenko, A; Hugel, S; Vilianovich, L; Ridders, M; Tenner, K; Alenina, N; Kohler, M; Hartmann, E; Bader, M				Rother, Franziska; Shmidt, Tatiana; Popova, Elena; Krivokharchenko, Alexander; Huegel, Stefanie; Vilianovich, Larissa; Ridders, Michael; Tenner, Katja; Alenina, Natalia; Koehler, Matthias; Hartmann, Enno; Bader, Michael			Importin alpha 7 Is Essential for Zygotic Genome Activation and Early Mouse Development	PLOS ONE			English	Article							EARLY EMBRYONIC-DEVELOPMENT; PORE-TARGETING COMPLEX; GENE ACTIVATION; NUCLEAR; TRANSPORT; FAMILY; MICE; TRANSITION; EXPRESSION; SUBUNIT	Importin alpha is involved in the nuclear import of proteins. It also contributes to spindle assembly and nuclear membrane formation, however, the underlying mechanisms are poorly understood. Here, we studied the function of importin alpha 7 by gene targeting in mice and show that it is essential for early embryonic development. Embryos lacking importin alpha 7 display a reduced ability for the first cleavage and arrest completely at the two-cell stage. We show that the zygotic genome activation is severely disturbed in these embryos. Our findings indicate that importin alpha 7 is a new member of the small group of maternal effect genes.	[Rother, Franziska; Shmidt, Tatiana; Popova, Elena; Krivokharchenko, Alexander; Huegel, Stefanie; Vilianovich, Larissa; Ridders, Michael; Tenner, Katja; Alenina, Natalia; Bader, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany; [Koehler, Matthias] Univ Kiel, Dept Hypertens & Nephrol, Kiel, Germany; [Koehler, Matthias] Ctr Nephrol & Hypertens, Ostsee Clin, Damp, Germany; [Koehler, Matthias] Reha Clin Damp, Damp, Germany; [Rother, Franziska; Hartmann, Enno] Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biol, Lubeck, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Kiel; University of Lubeck	Rother, F (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	mbader@mdc-berlin.de	Bader, Michael/K-2124-2013; Hartmann, Enno/C-5687-2013	Bader, Michael/0000-0003-4780-4164; Popova, Elena/0000-0002-3043-9650	Deutsche Forschungsgemeinschaft [KO 1950/3-1]; European Union [NEST 12702]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by grants of the Deutsche Forschungsgemeinschaft (KO 1950/3-1; www.dfg.de) and the European Union (NEST 12702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUNIOL C, 1995, EXP CELL RES, V218, P57, DOI 10.1006/excr.1995.1130; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorjanacz M, 2006, J STRUCT BIOL, V154, P27, DOI 10.1016/j.jsb.2005.12.007; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hachet V, 2004, EMBO J, V23, P1526, DOI 10.1038/sj.emboj.7600154; HU J, 2010, J BIOL CHEM; Kamei Y, 1999, J HISTOCHEM CYTOCHEM, V47, P363, DOI 10.1177/002215549904700310; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Kigami D, 2003, BIOL REPROD, V68, P651, DOI 10.1095/biolreprod.102.007906; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; Krivokharchenko A, 2003, BIOL REPROD, V68, P829, DOI 10.1095/biolreprod.102.006494; Lykke-Andersen K, 2008, MOL BIOL CELL, V19, P4383, DOI 10.1091/mbc.E08-02-0219; Mason DA, 2003, GENETICS, V165, P1943; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Popova E, 2005, METH MOLEC MED, V108, P33; Ratan R, 2008, GENETICS, V178, P839, DOI 10.1534/genetics.107.081778; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Shmidt T, 2007, NAT CELL BIOL, V9, P1337, DOI 10.1038/ncb1207-1337; Tejomurtula J, 2009, BIOL REPROD, V81, P333, DOI 10.1095/biolreprod.109.077396; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tsuji L, 1997, FEBS LETT, V416, P30, DOI 10.1016/S0014-5793(97)01092-2; Walther T, 1998, J BIOL CHEM, V273, P11867, DOI 10.1074/jbc.273.19.11867; Wan LB, 2008, DEVELOPMENT, V135, P2729, DOI 10.1242/dev.024539; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038	28	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18310	10.1371/journal.pone.0018310	http://dx.doi.org/10.1371/journal.pone.0018310			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479251	Green Published, Green Accepted, gold			2022-12-27	WOS:000289054600042
J	Hedman, E; Andersson, G; Ljotsson, B; Andersson, E; Ruck, C; Mortberg, E; Lindefors, N				Hedman, Erik; Andersson, Gerhard; Ljotsson, Brjann; Andersson, Erik; Ruck, Christian; Mortberg, Ewa; Lindefors, Nils			Internet-Based Cognitive Behavior Therapy vs. Cognitive Behavioral Group Therapy for Social Anxiety Disorder: A Randomized Controlled Non-inferiority Trial	PLOS ONE			English	Article							COMORBIDITY SURVEY REPLICATION; PLACEBO-CONTROLLED TRIAL; PSYCHOMETRIC PROPERTIES; SELF-REPORT; FOLLOW-UP; DSM-IV; GROUP EXPOSURE; PHOBIA; SCALE; POPULATION	Background and Aims: Cognitive behavioral group therapy (CBGT) is an effective, well-established, but not widely available treatment for social anxiety disorder (SAD). Internet-based cognitive behavior therapy (ICBT) has the potential to increase availability and facilitate dissemination of therapeutic services for SAD. However, ICBT for SAD has not been directly compared with in-person treatments such as CBGT and few studies investigating ICBT have been conducted in clinical settings. Our aim was to investigate if ICBT is at least as effective as CBGT for SAD when treatments are delivered in a psychiatric setting. Methods: We conducted a randomized controlled non-inferiority trial with allocation to ICBT (n = 64) or CBGT (n = 62) with blinded assessment immediately following treatment and six months post-treatment. Participants were 126 individuals with SAD who received CBGT or ICBT for a duration of 15 weeks. The Liebowitz Social Anxiety Scale (LSAS) was the main outcome measure. The following non-inferiority margin was set: following treatment, the lower bound of the 95 % confidence interval (CI) of the mean difference between groups should be less than 10 LSAS-points. Results: Both groups made large improvements. At follow-up, 41 (64%) participants in the ICBT group were classified as responders (95% CI, 52%-76%). In the CBGT group, 28 participants (45%) responded to the treatment (95% CI, 33%-58%). At post-treatment and follow-up respectively, the 95 % CI of the LSAS mean difference was 0.68-17.66 (Cohen's d between group = 0.41) and -22.51-15.69 (Cohen's d between group = 0.36) favoring ICBT, which was well within the non-inferiority margin. Mixed effects models analyses showed no significant interaction effect for LSAS, indicating similar improvement across treatments (F = 1.58; df = 2, 219; p = .21). Conclusions: ICBT delivered in a psychiatric setting can be as effective as CBGT in the treatment of SAD and could be used to increase availability to CBT.	[Hedman, Erik; Andersson, Gerhard; Ljotsson, Brjann; Andersson, Erik; Ruck, Christian; Lindefors, Nils] Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden; [Andersson, Gerhard] Linkoping Univ, Swedish Inst Disabil Res, Dept Behav Sci & Learning, Linkoping, Sweden; [Mortberg, Ewa] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden	Karolinska Institutet; Linkoping University; Stockholm University	Hedman, E (corresponding author), Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden.	erik.hedman.2@ki.se	Andersson, Gerhard/J-8529-2012; Rück, Christian/J-4396-2012; Hedman-Lagerlöf, Erik/I-9031-2012; Andersson, Erik/C-6934-2012	Andersson, Gerhard/0000-0003-4753-6745; Rück, Christian/0000-0002-8742-0168; Ljotsson, Brjann/0000-0001-8086-1668; Andersson, Erik/0000-0003-0088-8719; Hedman-Lagerlof, Erik/0000-0002-7939-9848; Mortberg, Ewa/0000-0001-9760-8298	Stockholm County Council; Bror Gadelius Fund	Stockholm County Council(Stockholm County Council); Bror Gadelius Fund	This study was supported by research grants from Stockholm County Council (Nils Lindefors) and the Bror Gadelius Fund (Erik Hedman). The main funding organization (Stockholm County Council) is a public institution and neither of the funding organizations had any role in the design and conduct of the study; in the collection, management, and analysis of the data; or in the preparation, review and approval of the manuscript.	American PsychiatricAssociation, 2000, DIAGN STAT MAN MENT, V4th; Andersson G, 2006, J CONSULT CLIN PSYCH, V74, P677, DOI 10.1037/0022-006X.74.4.677; Andersson G, 2009, BEHAV RES THER, V47, P175, DOI 10.1016/j.brat.2009.01.010; Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Baker SL, 2002, BEHAV RES THER, V40, P701, DOI 10.1016/S0005-7967(01)00060-2; Barak A, 2009, ANN BEHAV MED, V38, P4, DOI 10.1007/s12160-009-9130-7; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Berger T, 2009, J CLIN PSYCHOL, V65, P1021, DOI 10.1002/jclp.20603; Berman AH, 2005, EUR ADDICT RES, V11, P22, DOI 10.1159/000081413; Blanco C, 2010, ARCH GEN PSYCHIAT, V67, P286, DOI 10.1001/archgenpsychiatry.2010.11; BORKOVEC TD, 1972, J BEHAV THER EXP PSY, V3, P257, DOI 10.1016/0005-7916(72)90045-6; Carlbring P, 2007, BRIT J PSYCHIAT, V190, P123, DOI 10.1192/bjp.bp.105.020107; Carlbring P, 2009, BEHAV RES THER, V47, P848, DOI 10.1016/j.brat.2009.06.012; Clark DM, 2003, J CONSULT CLIN PSYCH, V71, P1058, DOI 10.1037/0022-006X.71.6.1058; Clark DM., 1995, SOCIAL PHOBIA DIAGNO, P63; Clark-Carter D., 1997, DOING QUANTITATIVE P; Erwin BA, 2004, J ANXIETY DISORD, V18, P629, DOI 10.1016/j.janxdis.2003.08.002; First M. B., 1997, STRUCTURED CLIN INTE; First MB, 2002, STRUCTURED CLIN INTE; Fresco DM, 2001, PSYCHOL MED, V31, P1025, DOI 10.1017/S0033291701004056; Frisch M.B., 1992, PSYCHOL ASSESS, V4, P92, DOI [10.1037/1040-3590.4.1.92, DOI 10.1037/1040-3590.4.1.92]; Furmark T, 1999, SOC PSYCH PSYCH EPID, V34, P416, DOI 10.1007/s001270050163; Furmark T, 2009, BRIT J PSYCHIAT, V195, P440, DOI 10.1192/bjp.bp.108.060996; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Guy W, 1976, ECDEU ASSESSMENT MAN; Hedman E, 2010, COMPUT HUM BEHAV, V26, P736, DOI 10.1016/j.chb.2010.01.010; Heimberg R.G., 2002, COGNITIVE BEHAV GROU; Heimberg RG, 1999, PSYCHOL MED, V29, P199, DOI 10.1017/S0033291798007879; HEIMBERG RG, 1993, COGNITIVE THER RES, V17, P325, DOI 10.1007/BF01177658; Heimberg RG, 1998, ARCH GEN PSYCHIAT, V55, P1133, DOI 10.1001/archpsyc.55.12.1133; HEIMBERG RG, 1990, COGNITIVE THER RES, V14, P1, DOI 10.1007/BF01173521; Heimberg RG, 2002, BIOL PSYCHIAT, V51, P101, DOI 10.1016/S0006-3223(01)01183-0; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; Hunsley J, 2007, PROF PSYCHOL-RES PR, V38, P21, DOI 10.1037/0735-7028.38.1.21; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jorstad-Stein EC, 2009, PSYCHIAT CLIN N AM, V32, P641, DOI 10.1016/j.psc.2009.05.003; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Ledley DR, 2009, BEHAV THER, V40, P414, DOI 10.1016/j.beth.2008.12.001; Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141; Maffei C, 1997, J PERS DISORD, V11, P279, DOI 10.1521/pedi.1997.11.3.279; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; McAlister FA, 2001, AM J MED, V111, P553, DOI 10.1016/S0002-9343(01)00900-7; Mortberg E, 2007, ACTA PSYCHIAT SCAND, V115, P142, DOI 10.1111/j.1600-0447.2006.00839.x; Ponniah K, 2008, PSYCHOL MED, V38, P3, DOI 10.1017/S0033291707000918; REICH J, 1994, PSYCHIAT RES, V54, P249, DOI 10.1016/0165-1781(94)90019-1; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Ruscio AM, 2008, PSYCHOL MED, V38, P15, DOI 10.1017/S0033291707001699; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SCHNEIER FR, 1994, J CLIN PSYCHIAT, V55, P322; Shapiro DA, 2003, BEHAV COGN PSYCHOTH, V31, P185, DOI 10.1017/S1352465803002066; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Soykan C, 2003, PSYCHOL REP, V93, P1059, DOI 10.2466/PR0.93.7.1059-1069; Stangier U, 2003, BEHAV RES THER, V41, P991, DOI 10.1016/S0005-7967(02)00176-6; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Tillfors M, 2008, DEPRESS ANXIETY, V25, P708, DOI 10.1002/da.20416; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P585, DOI 10.1080/00048670802119762; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010885; Yonkers KA, 2003, DEPRESS ANXIETY, V17, P173, DOI 10.1002/da.10106; Zanarini MC, 2001, COMPR PSYCHIAT, V42, P369, DOI 10.1053/comp.2001.24556	59	159	165	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18001	10.1371/journal.pone.0018001	http://dx.doi.org/10.1371/journal.pone.0018001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	740SE	21483704	Green Published, Green Submitted, gold			2022-12-27	WOS:000288813900027
J	Bochner, BR; Siri, M; Huang, RH; Noble, S; Lei, XH; Clemons, PA; Wagner, BK				Bochner, Barry R.; Siri, Mark; Huang, Richard H.; Noble, Shawn; Lei, Xiang-He; Clemons, Paul A.; Wagner, Bridget K.			Assay of the Multiple Energy-Producing Pathways of Mammalian Cells	PLOS ONE			English	Article							GLUTAMINE-METABOLISM; GLUCOSE-HOMEOSTASIS; CARBOHYDRATE; BROWN; MITOCHONDRIAL; GLYCOLYSIS; OXIDATION; COMPLEX; MUSCLE; SUGAR	Background: To elucidate metabolic changes that occur in diabetes, obesity, and cancer, it is important to understand cellular energy metabolism pathways and their alterations in various cells. Methodology and Principal Findings: Here we describe a technology for simultaneous assessment of cellular energy metabolism pathways. The technology employs a redox dye chemistry specifically coupled to catabolic energy-producing pathways. Using this colorimetric assay, we show that human cancer cell lines from different organ tissues produce distinct profiles of metabolic activity. Further, we show that murine white and brown adipocyte cell lines produce profiles that are distinct from each other as well as from precursor cells undergoing differentiation. Conclusions: This technology can be employed as a fundamental tool in genotype-phenotype studies to determine changes in cells from shared lineages due to differentiation or mutation.	[Bochner, Barry R.; Siri, Mark; Huang, Richard H.; Noble, Shawn; Lei, Xiang-He] Biolog Inc, Hayward, CA 94545 USA; [Clemons, Paul A.; Wagner, Bridget K.] Harvard & MIT, Broad Inst, Chem Biol Program, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bochner, BR (corresponding author), Biolog Inc, Hayward, CA 94545 USA.	bbochner@biolog.com			National Institutes of Health-National Cancer Institute (NIH-NCI) [R43-CA101605]; National Institutes of Health-National Institute of Mental Health (NIH-NIMH) [R44-MH074145]; Biolog, Inc.; NCI's Initiative for Chemical Genetics [N01-CO-12400]; NIH [RL1-HG004671]; NIH Molecular Libraries Network [U54-HG005032]; Juvenile Diabetes Research Foundation; NIH-NIDDK [DP2-DK-083048]; NATIONAL CANCER INSTITUTE [R43CA101605] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RL1HG004671, U54HG005032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK083048, R24DK080261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R44MH074145] Funding Source: NIH RePORTER	National Institutes of Health-National Cancer Institute (NIH-NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health-National Institute of Mental Health (NIH-NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Biolog, Inc.; NCI's Initiative for Chemical Genetics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Molecular Libraries Network; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Principal funding for the research at Biolog was provided by National Institutes of Health (NIH) Grants R43-CA101605 from National Institutes of Health-National Cancer Institute (NIH-NCI) and grant R44-MH074145 (Small Business Innovation Research) from National Institutes of Health-National Institute of Mental Health (NIH-NIMH). Additional funding and support was from Biolog, Inc., which employed the authors who designed the studies, collected the data, analyzed the data, and prepared the manuscript. P.A.C. is supported in part by NCI's Initiative for Chemical Genetics (N01-CO-12400), NIH Genomics-Based Drug Discovery/Target ID Project (RL1-HG004671), and NIH Molecular Libraries Network (U54-HG005032). B.K.W. is supported by the Juvenile Diabetes Research Foundation and a Type 1 Diabetes Pathfinder Award (DP2-DK-083048, NIH-NIDDK). Barry Bochner, CEO and CSO at Biolog, made the decision to publish the manuscript.	Aft RL, 2002, BRIT J CANCER, V87, P805, DOI 10.1038/sj.bjc.6600547; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bernas T, 2000, ARCH BIOCHEM BIOPHYS, V380, P108, DOI 10.1006/abbi.2000.1907; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bochner B.R., 2006, ENCY RAPID MICROBIOL, V2, P55; Bochner BR, 2008, MOL MICROBIOL, V70, P274, DOI 10.1111/j.1365-2958.2008.06383.x; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bochner BR, 2003, NAT REV GENET, V4, P309, DOI 10.1038/nrg1046; BOCHNER BR, 1989, NATURE, V339, P157, DOI 10.1038/339157a0; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BURNS RL, 1976, J CELL PHYSIOL, V88, P307, DOI 10.1002/jcp.1040880306; Butler M, 1987, Adv Biochem Eng Biotechnol, V34, P57; Caraccio N, 2005, J CLIN ENDOCR METAB, V90, P4057, DOI 10.1210/jc.2004-2344; COONEY G, 1986, BIOCHEM BIOPH RES CO, V138, P687, DOI 10.1016/S0006-291X(86)80551-4; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Dhaliwal R, 2005, CURR OPIN CRIT CARE, V11, P461; EAGLE H, 1958, J BIOL CHEM, V233, P551; FITZPATRICK L, 1993, APPL BIOCHEM BIOTECH, V43, P93, DOI 10.1007/BF02916435; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GOLDBERG AL, 1978, FED PROC, V37, P2301; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Haqq AM, 2005, CONTEMP CLIN TRIALS, V26, P616, DOI 10.1016/j.cct.2005.09.003; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Joachimiak Romana, 2007, Acta Pol Pharm, V64, P561; JOHANNES K, 2002, BIOESSAYS, V24, P382; JUNGAS RL, 1992, PHYSIOL REV, V72, P419, DOI 10.1152/physrev.1992.72.2.419; KELLY JH, 1994, Patent No. 5290684; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Li L, 2005, AM J PHYSIOL-ENDOC M, V288, pE208, DOI 10.1152/ajpendo.00346.2004; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; MORGAN MJ, 1981, BIOSCIENCE REP, V1, P669, DOI 10.1007/BF01116465; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Ramshur EB, 2002, J CELL PHYSIOL, V192, P339, DOI 10.1002/jcp.10139; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; SCRIVER CR, 1985, METABOLISM, V34, P868, DOI 10.1016/0026-0495(85)90112-X; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Simpson NH, 1998, BIOTECHNOL BIOENG, V59, P90, DOI 10.1002/(SICI)1097-0290(19980705)59:1<90::AID-BIT12>3.0.CO;2-6; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Ukropcova B, 2005, J CLIN INVEST, V115, P1934, DOI 10.1172/JCI24332; VanItallie TB, 2003, NUTR REV, V61, P327, DOI 10.1301/nr.2003.oct.327-341; Vega RB, 1997, J BIOL CHEM, V272, P31693, DOI 10.1074/jbc.272.50.31693; VISTICA DT, 1991, CANCER RES, V51, P2515; WICE BM, 1983, J BIOL CHEM, V258, P3134; WICE BM, 1981, J BIOL CHEM, V256, P7812; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923	51	40	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18147	10.1371/journal.pone.0018147	http://dx.doi.org/10.1371/journal.pone.0018147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455318	Green Submitted, Green Published, gold			2022-12-27	WOS:000288811500025
J	Nishiura, H; Chowell, G; Castillo-Chavez, C				Nishiura, Hiroshi; Chowell, Gerardo; Castillo-Chavez, Carlos			Did Modeling Overestimate the Transmission Potential of Pandemic (H1N1-2009)? Sample Size Estimation for Post-Epidemic Seroepidemiological Studies	PLOS ONE			English	Article							H1N1 2009 VIRUS; FINAL-SIZE; INTERVAL ESTIMATION; INFECTIOUS-DISEASE; REAL-TIME; INFLUENZA; INFERENCE; PREVALENCE; ANTIBODIES; SEVERITY	Background: Seroepidemiological studies before and after the epidemic wave of H1N1-2009 are useful for estimating population attack rates with a potential to validate early estimates of the reproduction number, R, in modeling studies. Methodology/Principal Findings: Since the final epidemic size, the proportion of individuals in a population who become infected during an epidemic, is not the result of a binomial sampling process because infection events are not independent of each other, we propose the use of an asymptotic distribution of the final size to compute approximate 95% confidence intervals of the observed final size. This allows the comparison of the observed final sizes against predictions based on the modeling study (R = 1.15, 1.40 and 1.90), which also yields simple formulae for determining sample sizes for future seroepidemiological studies. We examine a total of eleven published seroepidemiological studies of H1N1-2009 that took place after observing the peak incidence in a number of countries. Observed seropositive proportions in six studies appear to be smaller than that predicted from R = 1.40; four of the six studies sampled serum less than one month after the reported peak incidence. The comparison of the observed final sizes against R = 1.15 and 1.90 reveals that all eleven studies appear not to be significantly deviating from the prediction with R = 1.15, but final sizes in nine studies indicate overestimation if the value R = 1.90 is used. Conclusions: Sample sizes of published seroepidemiological studies were too small to assess the validity of model predictions except when R = 1.90 was used. We recommend the use of the proposed approach in determining the sample size of post-epidemic seroepidemiological studies, calculating the 95% confidence interval of observed final size, and conducting relevant hypothesis testing instead of the use of methods that rely on a binomial proportion.	[Nishiura, Hiroshi] PRESTO, Japan Sci & Technol Agcy, Saitama, Japan; [Nishiura, Hiroshi] Univ Utrecht, Utrecht, Netherlands; [Nishiura, Hiroshi] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Chowell, Gerardo; Castillo-Chavez, Carlos] Arizona State Univ, Math & Computat Modeling Sci Ctr, Sch Human Evolut & Social Change, Tempe, AZ USA; [Chowell, Gerardo] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Castillo-Chavez, Carlos] Santa Fe Inst, Santa Fe, NM 87501 USA	Japan Science & Technology Agency (JST); Utrecht University; University of Hong Kong; Arizona State University; Arizona State University-Tempe; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); The Santa Fe Institute	Nishiura, H (corresponding author), PRESTO, Japan Sci & Technol Agcy, Saitama, Japan.	nishiura@hku.hk	Castillo-Chavez, Carlos/E-1412-2014; Nishiura, Hiroshi/D-1426-2011; Chowell, Gerardo/F-5038-2012	Castillo-Chavez, Carlos/0000-0002-1046-3901; Chowell, Gerardo/0000-0003-2194-2251; Nishiura, Hiroshi/0000-0003-0941-8537	Japan Science and Technology Agency PRESTO; College of the Liberal Arts and Sciences of Arizona State University; National Science Foundation (NSF) [DMS - 0502349]; U.S. Department of Defense (NSA) [H98230-06-1-0097]; Alfred T. Sloan Foundation; Office of the Provost of Arizona State University	Japan Science and Technology Agency PRESTO(Japan Science & Technology Agency (JST)); College of the Liberal Arts and Sciences of Arizona State University; National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); U.S. Department of Defense (NSA)(National Security AgencyUnited States Department of Defense); Alfred T. Sloan Foundation(Alfred P. Sloan Foundation); Office of the Provost of Arizona State University	HN was supported by the Japan Science and Technology Agency PRESTO program. GC received financial support from the College of the Liberal Arts and Sciences of Arizona State University. National Science Foundation (NSF - Grant DMS - 0502349), U.S. Department of Defense (NSA - Grant H98230-06-1-0097), the Alfred T. Sloan Foundation and the Office of the Provost of Arizona State University support CCC's research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; AHO M, 2010, EURO SURVEILL, V15; Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; Andersson H, 2000, LECT NOTES STAT, V151, DOI 10.1007/978-1-4612-1158-7; Andreasen V, 2011, B MATH BIOL, V73, P2305, DOI 10.1007/s11538-010-9623-3; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P229; Bacaer N, 2011, J MATH BIOL, V62, P741, DOI 10.1007/s00285-010-0354-8; Bacaer N, 2009, B MATH BIOL, V71, P1954, DOI 10.1007/s11538-009-9433-7; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Ball F, 1999, J APPL PROBAB, V36, P473, DOI 10.1017/S0021900200017265; BALL F, 1995, J APPL PROBAB, V32, P579, DOI 10.2307/3215114; BALL F, 1993, ADV APPL PROBAB, V25, P721, DOI 10.2307/1427788; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Boelle PY, 2009, EUROSURVEILLANCE, V14, P10; Brauer F, 2010, MATH BIOSCI ENG, V7, P1, DOI 10.3934/mbe.2010.7.1; Brauer Fred, 2009, Journal of Biological Dynamics, V3, P324, DOI 10.1080/17513750802415822; Brauer F, 2008, MATH BIOSCI ENG, V5, P681, DOI 10.3934/mbe.2008.5.681; Britton T, 2010, MATH BIOSCI, V225, P24, DOI 10.1016/j.mbs.2010.01.006; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chan YJ, 2010, J CHIN MED ASSOC, V73, P62, DOI 10.1016/S1726-4901(10)70003-4; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; CHEN M, 2010, JAMA-J AM MED ASSOC, V303, P1381; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Deng Y, 2011, EPIDEMIOL INFECT, V139, P52, DOI 10.1017/S0950268810002189; DESILVA UC, 2009, EURO SURVEILL, V14; DESU MM, 1988, SAMPLE SIZE METHODOL; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; Graubard BI, 2002, STAT SCI, V17, P73, DOI 10.1214/ss/1023798999; Hahne S, 2009, EUROSURVEILLANCE, V14, P2; HALLORAN ME, 1995, EPIDEMIOLOGY, V6, P142, DOI 10.1097/00001648-199503000-00010; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hens N, 2011, VACCINE, V29, P896, DOI 10.1016/j.vaccine.2010.05.010; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; LACHIN JM, 1981, CONTROL CLIN TRIALS, V2, P93, DOI 10.1016/0197-2456(81)90001-5; Lee VJ, 2010, J INFECT DIS, V202, P1319, DOI 10.1086/656480; Ma JL, 2006, B MATH BIOL, V68, P679, DOI 10.1007/s11538-005-9047-7; McBryde ES, 2009, EUROSURVEILLANCE, V14, P45; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Munayco CV, 2009, EUROSURVEILLANCE, V14, P6; *NAT I INF DIS, 2010, SURV SER STAT INFL 2; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nishiura H, 2009, EUROSURVEILLANCE, V14; NISHIURA H, 2009, MATH STAT ESTIMATION, P53, DOI DOI 10.1007/978-90-481-2313-1_3; Nishiura H, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-15; Nishiura H, 2010, MATH BIOSCI ENG, V7, P851, DOI 10.3934/mbe.2010.7.851; Nishiura H, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-1; Omori R, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-2; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Scalia-Tomba G., 1990, STOCHASTIC PROCESSES, P189, DOI [10.1007/978-3-662-10067-7_18, DOI 10.1007/978-3-662-10067-7_18]; SCALIATOMBA G, 1985, ADV APPL PROBAB, V17, P477, DOI 10.2307/1427116; SELLKE T, 1983, J APPL PROBAB, V20, P390, DOI 10.2307/3213811; Skowronski DM, 2010, CAN MED ASSOC J, V182, P1851, DOI 10.1503/cmaj.100910; Tandale BV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-255; TUITE AR, 2009, CMAJ, V182, P131, DOI DOI 10.1503/CMAJ.091807; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601	65	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17908	10.1371/journal.pone.0017908	http://dx.doi.org/10.1371/journal.pone.0017908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455307	Green Submitted, gold, Green Published			2022-12-27	WOS:000288811500015
J	Vareed, SK; Bhat, VB; Thompson, C; Vasu, VT; Fermin, D; Choi, H; Creighton, CJ; Gayatri, S; Lan, L; Putluri, N; Thangjam, GS; Kaur, P; Shabahang, M; Giri, JG; Nesvizhskii, AI; Asea, AAA; Cashikar, AG; Rao, A; McLoughlin, J; Sreekumar, A				Vareed, Shaiju K.; Bhat, Vadiraja B.; Thompson, Christopher; Vasu, Vihas T.; Fermin, Damian; Choi, Hyungwon; Creighton, Chad J.; Gayatri, Sitaram; Lan, Ling; Putluri, Nagireddy; Thangjam, Gagan Singh; Kaur, Punit; Shabahang, Mohsen; Giri, Judith G.; Nesvizhskii, Alexey I.; Asea, Alexander A. A.; Cashikar, Anil G.; Rao, Arundhati; McLoughlin, James; Sreekumar, Arun			Metabolites of Purine Nucleoside Phosphorylase (NP) in Serum Have the Potential to Delineate Pancreatic Adenocarcinoma	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; LIQUID-CHROMATOGRAPHY; GEL-ELECTROPHORESIS; GAMMA-SYNUCLEIN; CANCER; PROTEIN; BIOMARKER; GENE	Pancreatic Adenocarcinoma (PDAC), the fourth highest cause of cancer related deaths in the United States, has the most aggressive presentation resulting in a very short median survival time for the affected patients. Early detection of PDAC is confounded by lack of specific markers that has motivated the use of high throughput molecular approaches to delineate potential biomarkers. To pursue identification of a distinct marker, this study profiled the secretory proteome in 16 PDAC, 2 carcinoma in situ (CIS) and 7 benign patients using label-free mass spectrometry coupled to 1D-SDS-PAGE and Strong Cation-Exchange Chromatography (SCX). A total of 431 proteins were detected of which 56 were found to be significantly elevated in PDAC. Included in this differential set were Parkinson disease autosomal recessive, early onset 7 (PARK 7) and Alpha Synuclein (aSyn), both of which are known to be pathognomonic to Parkinson's disease as well as metabolic enzymes like Purine Nucleoside Phosphorylase (NP) which has been exploited as therapeutic target in cancers. Tissue Microarray analysis confirmed higher expression of aSyn and NP in ductal epithelia of pancreatic tumors compared to benign ducts. Furthermore, extent of both aSyn and NP staining positively correlated with tumor stage and perineural invasion while their intensity of staining correlated with the existence of metastatic lesions in the PDAC tissues. From the biomarker perspective, NP protein levels were higher in PDAC sera and furthermore serum levels of its downstream metabolites guanosine and adenosine were able to distinguish PDAC from benign in an unsupervised hierarchical classification model. Overall, this study for the first time describes elevated levels of aSyn in PDAC as well as highlights the potential of evaluating NP protein expression and levels of its downstream metabolites to develop a multiplex panel for non-invasive detection of PDAC.	[Vareed, Shaiju K.; Vasu, Vihas T.; Gayatri, Sitaram; Putluri, Nagireddy; Thangjam, Gagan Singh; Cashikar, Anil G.; Sreekumar, Arun] Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Cashikar, Anil G.] Med Coll Georgia, Ctr Mol Chaperones & Radiobiol, Augusta, GA 30912 USA; [Bhat, Vadiraja B.; Thompson, Christopher; Choi, Hyungwon; Kaur, Punit; Shabahang, Mohsen; Asea, Alexander A. A.; Rao, Arundhati] Scott & White Hosp, Dept Pathol, Temple, TX USA; [Fermin, Damian; Nesvizhskii, Alexey I.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Lan, Ling] Med Coll Georgia, Dept Biostat, Augusta, GA 30912 USA; [McLoughlin, James; Sreekumar, Arun] Med Coll Georgia, Dept Surg Oncol, Augusta, GA 30912 USA; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Gayatri, Sitaram] IIT, Chicago, IL 60616 USA; [Giri, Judith G.] Med Coll Georgia, Tumor Bank Dept Pathol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Michigan System; University of Michigan; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Baylor College of Medicine; Illinois Institute of Technology; University System of Georgia; Augusta University	Vareed, SK (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	sreekuma@bcm.edu	Cashikar, Anil G/F-5968-2011; Choi, Hyungwon/S-8824-2019; Vasu, Vihas T/D-6673-2014; Gayatri, Sitaram/GLT-7340-2022; Vasu, Vihas T/G-7303-2012; Nesvizhskii, Alexey/A-5410-2012	Choi, Hyungwon/0000-0002-6687-3088; Vasu, Vihas T/0000-0003-2275-2476; Vasu, Vihas T/0000-0003-2275-2476; Nesvizhskii, Alexey/0000-0002-2806-7819; Gayatri, Sitaram/0000-0002-0773-6278; Putluri, Nagireddy/0000-0003-4488-7400; Cashikar, Anil/0000-0002-3671-684X	National Cancer Institute [RO1CA13345, 1 R03 CA139489-01, RCA145444A, PSRP00030CS, P30 CA125123, R01 CA-126239]; Georgia Cancer Research Distinguished Scientist award; NATIONAL CANCER INSTITUTE [P30CA125123, R01CA126239, R03CA139489, R01CA133458] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Research Distinguished Scientist award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by the National Cancer Institute grants RO1CA13345 (AS), 1 R03 CA139489-01 (AS), RCA145444A (AS), PSRP00030CS (AS, JM), P30 CA125123 (CJC), and R01 CA-126239 (AIN). A.S. is supported by Georgia Cancer Research Distinguished Scientist award. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Ahmad M, 2007, FASEB J, V21, P3419, DOI 10.1096/fj.07-8379rev; Bantia S, 2010, INT IMMUNOPHARMACOL, V10, P784, DOI 10.1016/j.intimp.2010.04.009; Berger AC, 2004, ANN SURG ONCOL, V11, P644, DOI 10.1245/ASO.2004.11.025; Bhat VB, 2005, J PROTEOME RES, V4, P1814, DOI 10.1021/pr0501463; Boeck S, 2006, ONCOLOGY-BASEL, V70, P255, DOI 10.1159/000094888; Boeck S, 2010, CLIN CANCER RES, V16, P986, DOI 10.1158/1078-0432.CCR-09-2205; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Breci L, 2005, PROTEOMICS, V5, P2018, DOI 10.1002/pmic.200401103; Chen R, 2005, MOL CELL PROTEOMICS, V4, P523, DOI 10.1074/mcp.R500004-MCP200; Chen R, 2002, MOL CANCER, V9, P149; Chen R, 2007, PANCREAS, V34, P70, DOI 10.1097/01.mpa.0000240615.20474.fd; Chen R, 2006, PROTEOMICS, V6, P3871, DOI 10.1002/pmic.200500702; Chesselet MF, 2008, EXP NEUROL, V209, P22, DOI 10.1016/j.expneurol.2007.08.006; Chintanaboina J, 2008, SOUTH MED J, V101, P661, DOI 10.1097/SMJ.0b013e318170584b; Chung JC, 2008, ANZ J SURG, V78, P245, DOI 10.1111/j.1445-2197.2008.04429.x; Conry RM, 1998, IMMUNOPHARMACOLOGY, V40, P1, DOI 10.1016/S0162-3109(98)00012-5; Crnogorac-Jurcevic T, 2005, GASTROENTEROLOGY, V129, P1454, DOI 10.1053/j.gastro.2005.08.012; Cui YZ, 2009, PANCREATOLOGY, V9, P89, DOI 10.1159/000178879; Cui YZ, 2009, CANCER INVEST, V27, P747, DOI 10.1080/07357900802672746; Dalal I, 2001, CLIN GENET, V59, P430, DOI 10.1034/j.1399-0004.2001.590608.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farrell James J., 2005, Cancer Biomarkers, V1, P157; GIBLETT ER, 1975, LANCET, V1, P1010, DOI 10.1016/S0140-6736(75)91950-9; Goggins M, 2000, J SURG ONCOL, V74, P243, DOI 10.1002/1096-9098(200008)74:4<243::AID-JSO1>3.0.CO;2-C; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Gronborg M, 2004, J PROTEOME RES, V3, P1042, DOI 10.1021/pr0499085; Gupta A, 2003, ONCOGENE, V22, P7593, DOI 10.1038/sj.onc.1206880; Hibi T, 2009, CLIN CANCER RES, V15, P2864, DOI 10.1158/1078-0432.CCR-08-2946; Hidalgo M, N ENGL J MED, V362, P1605; Horth P, 2006, MOL CELL PROTEOMICS, V5, P1968, DOI 10.1074/mcp.T600037-MCP200; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jia TL, 1999, CANCER RES, V59, P742; Kakisaka T, 2007, J CHROMATOGR B, V852, P257, DOI 10.1016/j.jchromb.2007.01.029; Kang TH, 2007, PROTEOMICS, V7, P2624, DOI 10.1002/pmic.200601028; Khan AP, 2010, MOL CELL PROTEOMICS, V9, P298, DOI 10.1074/mcp.M900159-MCP200; Kim YC, 2010, FEBS LETT, V584, P3891, DOI 10.1016/j.febslet.2010.08.010; Kristiansson MH, 2007, J PROTEOME RES, V6, P1735, DOI 10.1021/pr060497x; Li YG, 2009, DIGEST LIVER DIS, V41, P605, DOI 10.1016/j.dld.2008.11.010; Li ZK, 2004, CANCER-AM CANCER SOC, V101, P58, DOI 10.1002/cncr.20321; Markert ML, 1997, HUM MUTAT, V9, P118, DOI 10.1002/(SICI)1098-1004(1997)9:2<118::AID-HUMU3>3.0.CO;2-5; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Matsuo Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010481; Melle C, 2007, CLIN CHEM, V53, P629, DOI 10.1373/clinchem.2006.079194; MESAROSOVA A, 1993, NEOPLASMA, V40, P341; Mo JS, J CELL BIOCH, V110, P229; Morgan J, 2009, GYNECOL ONCOL, V114, P293, DOI 10.1016/j.ygyno.2009.04.036; Morris PE, 2000, CURR PHARM DESIGN, V6, P943, DOI 10.2174/1381612003400083; Mougenot AL, J NEUROSCI METHODS; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Nikov G, 2003, ANAL BIOCHEM, V320, P214, DOI 10.1016/S0003-2697(03)00359-2; Ortsater H, 2007, PROTEOMICS, V7, P3105, DOI 10.1002/pmic.200601019; Park IJ, 2009, ANTICANCER RES, V29, P4303; Polymeropoulos MH, 1996, SCIENCE, V274, P1197, DOI 10.1126/science.274.5290.1197; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; *R DEV COR, 2008, R LANG ENV STAT COMP; Rebours V, 2010, CLIN GASTROENTEROL H, V8, P206, DOI 10.1016/j.cgh.2009.09.009; Ringel J, 2006, CANCER RES, V66, P9045, DOI 10.1158/0008-5472.CAN-05-3287; Ritts R E, 1998, Surg Oncol Clin N Am, V7, P93; Roberts ELL, 2004, CLIN CHIM ACTA, V344, P109, DOI 10.1016/j.cccn.2004.02.008; Rosty C, 2002, HEMATOL ONCOL CLIN N, V16, P37, DOI 10.1016/S0889-8588(01)00007-7; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schirle M, 2003, MOL CELL PROTEOMICS, V2, P1297, DOI 10.1074/mcp.M300087-MCP200; SCHNEIDER MU, 1984, SCAND J GASTROENTERO, V19, P139, DOI 10.1080/00365521.1984.12005699; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sitek B, 2009, J PROTEOME RES, V8, P1647, DOI 10.1021/pr800890j; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sun ZL, 2007, BBA-PROTEINS PROTEOM, V1774, P764, DOI 10.1016/j.bbapap.2007.04.001; Tian M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-241; Tonack S, 2009, PANCREATOLOGY, V9, P567, DOI 10.1159/000212083; van Duijn C. M., 2001, American Journal of Human Genetics, V69, P629, DOI 10.1086/322996; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Xu X, 2007, BLOOD CELL MOL DIS, V45, P227; Ye Q, 2010, ONCOL REP, V23, P429, DOI 10.3892/or_00000652; Ye Q, 2009, WORLD J GASTROENTERO, V15, P5035, DOI 10.3748/wjg.15.5035; Yoshioka Masato, 2002, J Hepatobiliary Pancreat Surg, V9, P376, DOI 10.1007/s005340200043; Zhao J, 2007, J PROTEOME RES, V6, P1126, DOI 10.1021/pr0604458; Zhou L, 2007, PROTEOMICS, V7, P1345, DOI 10.1002/pmic.200600086	81	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17177	10.1371/journal.pone.0017177	http://dx.doi.org/10.1371/journal.pone.0017177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448452	Green Published, gold, Green Submitted			2022-12-27	WOS:000288810500003
J	Barbagallo, APM; Wang, ZL; Zheng, H; D'Adamio, L				Barbagallo, Alessia P. M.; Wang, Zilai; Zheng, Hui; D'Adamio, Luciano			The Intracellular Threonine of Amyloid Precursor Protein That Is Essential for Docking of Pin1 Is Dispensable for Developmental Function	PLOS ONE			English	Article							JNK-INTERACTING PROTEIN-1; LONG-TERM POTENTIATION; PROLYL ISOMERASE PIN1; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; A-BETA; DEFICIENT MICE; DOMAIN; FE65; PHOSPHORYLATION	Background: Processing of Ab-precursor protein (APP) plays an important role in Alzheimer's Disease (AD) pathogenesis. Thr residue at amino acid 668 of the APP intracellular domain (AID) is highly conserved. When phosphorylated, this residue generates a binding site for Pin1. The interaction of APP with Pin1 has been involved in AD pathogenesis. Methodology/Principal Findings: To dissect the functions of this sequence in vivo, we created an APP knock-in allele, in which Thr(668) is replaced by an Ala (T-668 A). Doubly deficient APP/APP-like protein 2 (APLP2) mice present postnatal lethality and neuromuscular synapse defects. Previous work has shown that the APP intracellular domain is necessary for preventing early lethality and neuromuscular junctions (NMJ) defects. Crossing the T-668 A allele into the APLP2 knockout background showed that mutation of Thr(668) does not cause a defective phenotype. Notably, the T 668 A mutant APP is able to bind Mint1. Conclusions/Significance: Our results argue against an important role of the Thr 668 residue in the essential function of APP in developmental regulation. Furthermore, they indicate that phosphorylation at this residue is not functionally involved in those APP-mediated functions that prevent (NMJ) defects and early lethality in APLP2 null mice.	[Barbagallo, Alessia P. M.; D'Adamio, Luciano] Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY USA; [Wang, Zilai; Zheng, Hui] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [D'Adamio, Luciano] CNR, Inst Neurobiol & Mol Med, Rome, Italy	Yeshiva University; Albert Einstein College of Medicine; Baylor College of Medicine; Consiglio Nazionale delle Ricerche (CNR)	Barbagallo, APM (corresponding author), Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY USA.	luciano.dadamio@einstein.yu.edu		D'Adamio, Luciano/0000-0002-2204-9441; D'Adamio, Luciano/0000-0002-9820-4882	Alzheimer Disease Research Grants [A2003-076, NIRG-10-173876]; NIH [AG033007, AG020670, AG032051]; NATIONAL INSTITUTE ON AGING [R01AG033007, R01AG032051, R01AG020670] Funding Source: NIH RePORTER	Alzheimer Disease Research Grants; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Alzheimer Disease Research Grants (A2003-076 to L. D. and NIRG-10-173876 to APB), and grants from NIH (AG033007 to L. D, AG020670 and AG032051 to H. Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Balastik M, 2007, BBA-MOL BASIS DIS, V1772, P422, DOI 10.1016/j.bbadis.2007.01.006; Barbagallo APM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015503; BARBAGALLO AP, 2011, J BIOL CHEM; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Fitzjohn SM, 2000, NEUROSCI LETT, V288, P9, DOI 10.1016/S0304-3940(00)01204-0; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy John, 2006, Current Alzheimer Research, V3, P71, DOI 10.2174/156720506775697098; Hata Y, 1996, J NEUROSCI, V16, P2488; Heber S, 2000, J NEUROSCI, V20, P7951; Inomata H, 2003, J BIOL CHEM, V278, P22946, DOI 10.1074/jbc.M212160200; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Li HL, 1997, J NEUROBIOL, V32, P469, DOI 10.1002/(SICI)1097-4695(199705)32:5<469::AID-NEU3>3.3.CO;2-5; Li HM, 2010, J BIOL CHEM, V285, P30598, DOI 10.1074/jbc.M110.137729; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Li ZW, 1996, P NATL ACAD SCI USA, V93, P6158, DOI 10.1073/pnas.93.12.6158; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Magara F, 1999, P NATL ACAD SCI USA, V96, P4656, DOI 10.1073/pnas.96.8.4656; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; Muresan Z, 2005, J CELL BIOL, V171, P615, DOI 10.1083/jcb.200502043; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Phinney AL, 1999, NEUROSCIENCE, V90, P1207, DOI 10.1016/S0306-4522(98)00645-9; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Price DL, 2000, ANN NY ACAD SCI, V920, P179; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; Scheinfeld MH, 2003, J BIOL CHEM, V278, P42058, DOI 10.1074/jbc.M304853200; Scheinfeld MH, 2002, J BIOL CHEM, V277, P44195, DOI 10.1074/jbc.M208110200; Scheinfeld MH, 2003, P NATL ACAD SCI USA, V100, P1729, DOI 10.1073/pnas.0437908100; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Selkoe DJ, 2000, NEUROL CLIN, V18, P903, DOI 10.1016/S0733-8619(05)70232-2; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Sisodia SS, 2001, TRENDS NEUROSCI, V24, pS2, DOI 10.1016/S0166-2236(00)01987-1; Steinbach JP, 1998, CELL DEATH DIFFER, V5, P858, DOI 10.1038/sj.cdd.4400391; Sultana R, 2006, NEUROBIOL AGING, V27, P918, DOI 10.1016/j.neurobiolaging.2005.05.005; Swistowski A, 2009, J NEUROSCI, V29, P15703, DOI 10.1523/JNEUROSCI.4351-09.2009; Tamayev R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-28; Tarr PE, 2002, J BIOL CHEM, V277, P16798, DOI 10.1074/jbc.M110286200; Tremml P, 1998, BEHAV BRAIN RES, V95, P65, DOI 10.1016/S0166-4328(97)00211-8; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; White AR, 1999, BRAIN RES, V842, P439, DOI 10.1016/S0006-8993(99)01861-2; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zhou DW, 2009, J ALZHEIMERS DIS, V16, P301, DOI 10.3233/JAD-2009-0970; Zhou DW, 2004, J BIOL CHEM, V279, P25374, DOI 10.1074/jbc.M400488200	59	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18006	10.1371/journal.pone.0018006	http://dx.doi.org/10.1371/journal.pone.0018006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445342	Green Published, gold, Green Submitted			2022-12-27	WOS:000288809100023
J	Wong, CCY; Caspi, A; Williams, B; Houts, R; Craig, IW; Mill, J				Wong, Chloe Chung Yi; Caspi, Avshalom; Williams, Benjamin; Houts, Renate; Craig, Ian W.; Mill, Jonathan			A Longitudinal Twin Study of Skewed X Chromosome-Inactivation	PLOS ONE			English	Article							MONOZYGOTIC TWINS; HUMAN FEMALES; NORMAL WOMEN; METHYLATION; PATTERNS; AGE; GENE; DNA; DISCORDANCE; DISORDERS	X-chromosome inactivation (XCI) is a pivotal epigenetic mechanism involved in the dosage compensation of X-linked genes between males and females. In any given cell, the process of XCI in early female development is thought to be random across alleles and clonally maintained once established. Recent studies, however, suggest that XCI might not always be random and that skewed inactivation may become more prevalent with age. The factors influencing such XCI skewing and its changes over time are largely unknown. To elucidate the influence of stochastic, heritable and environmental factors in longitudinal changes in XCI, we examined X inactivation profiles in a sample of monozygotic (MZ) (n = 23) and dizygotic (DZ) (n = 22) female twin-pairs at ages 5 and 10 years. Compared to MZ twins who were highly concordant for allelic XCI ratios, DZ twins showed much lower levels of concordance. Whilst XCI patterns were moderately stable between ages 5 and 10 years, there was some drift over time with an increased prevalence of more extreme XCI skewing at age 10. To our knowledge, this study represents the earliest longitudinal assessment of skewed XCI patterns, and suggests that skewed XCI may already be established in early childhood. Our data also suggest a link between MZ twinning and the establishment of allelic XCI ratios, and demonstrate that acquired skewing in XCI after establishment is primarily mediated by stochastic mechanisms. These data have implications for our understanding about sex differences in complex disease, and the potential causes of phenotypic discordance between MZ female twins.	[Wong, Chloe Chung Yi; Caspi, Avshalom; Williams, Benjamin; Craig, Ian W.; Mill, Jonathan] Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Caspi, Avshalom; Williams, Benjamin; Houts, Renate] Duke Univ, Inst Genome Sci & Policy, Dept Psychol & Neurosci, Durham, NC USA; [Caspi, Avshalom; Williams, Benjamin; Houts, Renate] Duke Univ, Dept Psychiat, Inst Genome Sci & Policy, Durham, NC 27706 USA; [Caspi, Avshalom; Williams, Benjamin; Houts, Renate] Duke Univ, Dept Behav Sci, Inst Genome Sci & Policy, Durham, NC USA	University of London; King's College London; Duke University; Duke University; Duke University	Wong, CCY (corresponding author), Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England.	jonathan.mill@kcl.ac.uk	Wong, Chloe/B-3679-2012; Houts, Renate/AAC-5304-2019; Wong, Chloe/AAN-9416-2021; caspi, avshalom/AAJ-5874-2020; Mill, Jonathan S/B-3276-2010; caspi, avshalom/D-5294-2011; Mill, Jonathan/B-5678-2014; Craig, Ian/AAF-9167-2019	Wong, Chloe/0000-0003-4886-8506; Houts, Renate/0000-0002-1518-2631; Wong, Chloe/0000-0003-4886-8506; caspi, avshalom/0000-0003-0082-4600; Mill, Jonathan S/0000-0003-1115-3224; caspi, avshalom/0000-0003-0082-4600; Mill, Jonathan/0000-0003-1115-3224; Craig, Ian/0000-0002-4063-1005	UK Medical Research Council [G9806489, G0100527, G0601483]; US-National Institutes of Health [MH077874, HD061298]; London University; Royal Society; UK Medical Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077874] Funding Source: NIH RePORTER; MRC [G9806489, G0601483, G1002190, G0100527] Funding Source: UKRI; Medical Research Council [G9806489, G0100527, G9817803B, G1002190, G0601483] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US-National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); London University; Royal Society(Royal Society of London); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research received support from UK Medical Research Council grants G9806489, G0100527 and G0601483, US-National Institutes of Health grants MH077874 and HD061298, and the London University Central Research Fund. Avshalom Caspi is a Royal Society-Wolfson Merit Award holder. Chloe Wong is a PhD student funded by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Amos-Landgraf JM, 2006, AM J HUM GENET, V79, P493, DOI 10.1086/507565; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bittel DC, 2008, J MED GENET, V45, P309, DOI 10.1136/jmg.2007.055244; Busque L, 1996, BLOOD, V88, P59; Champion KM, 1997, BRIT J HAEMATOL, V97, P920, DOI 10.1046/j.1365-2141.1997.1933010.x; Chitnis S, 1999, AM J HUM GENET, V65, P570, DOI 10.1086/302502; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738; Gale RE, 1997, BRIT J HAEMATOL, V98, P512, DOI 10.1046/j.1365-2141.1997.2573078.x; Hall JG, 2003, LANCET, V362, P735, DOI 10.1016/S0140-6736(03)14237-7; Hatakeyama C, 2004, CLIN GENET, V66, P327, DOI 10.1111/j.1399-0004.2004.00310.x; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Knudsen PS, 2007, CYTOGENET GENOME RES, V116, P24, DOI 10.1159/000097414; Kristiansen M, 2005, EUR J HUM GENET, V13, P599, DOI 10.1038/sj.ejhg.5201398; Kuratomi G, 2008, MOL PSYCHIATR, V13, P429, DOI 10.1038/sj.mp.4002001; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Migeon BR, 2006, JAMA-J AM MED ASSOC, V295, P1428, DOI 10.1001/jama.295.12.1428; Mill J, 2006, AM J MED GENET B, V141B, P421, DOI 10.1002/ajmg.b.30316; Moffitt TE, 2002, J CHILD PSYCHOL PSYC, V43, P727, DOI 10.1111/1469-7610.00082; Monteiro J, 1998, AM J HUM GENET, V63, P339, DOI 10.1086/301978; Ohlsson R, 2001, TRENDS GENET, V17, P136, DOI 10.1016/S0168-9525(00)02211-3; Plenge RM, 2002, AM J HUM GENET, V71, P168, DOI 10.1086/341123; RICHARDS CS, 1990, AM J HUM GENET, V46, P672; Rosa A, 2008, AM J MED GENET B, V147B, P459, DOI 10.1002/ajmg.b.30616; Sandovici I, 2004, HUM GENET, V115, P387, DOI 10.1007/s00439-004-1177-8; Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382; Tonon L, 1998, BRIT J HAEMATOL, V102, P996, DOI 10.1046/j.1365-2141.1998.00867.x; van Dijk JP, 2002, LEUKEMIA, V16, P362, DOI 10.1038/sj.leu.2402379; VANDEKAMP JM, 2010, CLIN GENET, DOI DOI 10.1111/J.1399-0004.2010.01460.X; Vickers MA, 2001, BLOOD, V97, P1274, DOI 10.1182/blood.V97.5.1274; Wong CCY, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12226	32	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17873	10.1371/journal.pone.0017873	http://dx.doi.org/10.1371/journal.pone.0017873			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445353	gold, Green Submitted, Green Published			2022-12-27	WOS:000288809100012
J	Zhang, ZP; Wang, YL; Wang, SH; Liu, JT; Warren, W; Mitreva, M; Walter, RB				Zhang, Ziping; Wang, Yilei; Wang, Shuhong; Liu, Jingtao; Warren, Wesley; Mitreva, Makedonka; Walter, Ronald B.			Transcriptome Analysis of Female and Male Xiphophorus maculatus Jp 163 A	PLOS ONE			English	Article							SEX DETERMINATION; DIFFERENTIAL DISPLAY; GENE-EXPRESSION; VITELLOGENIN GENE; RAINBOW-TROUT; EVOLUTION; PROTEIN; GENOME; FISH; SRY	Background: Xiphophorus models are important for melanoma, sex determination and differentiation, ovoviviparity and evolution. To gain a global view of the molecular mechanism(s) whereby gene expression may influence sexual dimorphism in Xiphophorus and to develop a database for future studies, we performed a large-scale transcriptome study. Methodology/Principal Findings: The 454-FLX massively parallel DNA sequencing platform was employed to obtain 742,771 and 721,543 reads from 2 normalized cDNA libraries generated from whole adult female and male X. maculatus Jp 163 A, respectively. The reads assembled into 45,538 contigs (here, a "contig" is a set of contiguous sequences), of which, 11,918 shared homology to existing protein sequences. These numbers estimate that the contigs may cover 53% of the total number of Xiphophorus transcriptome. Putative translations were obtained for 11,918 cDNA contigs, of which, 3,049 amino acid sequences contain Pfam domains and 11,064 contigs encode secretory proteins. A total of 3,898 contigs were associated with 2,781 InterPro (IPR) entries and 5,411 contigs with 132 KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways. There were 10,446 contigs annotated with 69,778 gene ontology (GO) terms and the three corresponding organizing principles. Fifty-four potential sex differentially expressed genes have been identified from these contigs. Eight and nine of these contigs were confirmed by real-time PCR as female and male predominantly expressed genes respectively. Based on annotation results, 34 contigs were predicted to be differentially expressed in male and female and 17 of them were also confirmed by real-time PCR. Conclusions/Significance: This is the first report of an annotated overview of the transcriptome of X. maculatus and identification of sex differentially expressed genes. These data will be of interest to researchers using the Xiphophorus model. This work also provides an archive for future studies in molecular mechanisms of sexual dimorphism and evolution, and can be used in comparative studies of other fish.	[Zhang, Ziping; Liu, Jingtao; Walter, Ronald B.] Texas State Univ, Dept Chem & Biochem, Mol Biosci Res Grp, San Marcos, TX 78666 USA; [Wang, Yilei; Wang, Shuhong] Jimei Univ, Fujian Prov Univ, Key Lab Sci & Technol Aquaculture & Food Safety, Fisheries Biotechnol Inst,Fisheries Coll, Xiamen, Peoples R China; [Warren, Wesley; Mitreva, Makedonka] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO USA	Texas State University System; Texas State University San Marcos; Fuzhou University; Jimei University; Washington University (WUSTL)	Zhang, ZP (corresponding author), Texas State Univ, Dept Chem & Biochem, Mol Biosci Res Grp, San Marcos, TX 78666 USA.	RWalter@txstate.edu	Zhang, Ziping/AAH-2392-2021; Walter, Ronald/AAI-5522-2020	Zhang, Ziping/0000-0003-2802-1586; Mitreva, Makedonka/0000-0001-9572-3436	NIH, National Center for Research Resources [R24-RR024790]; National Cancer Institute [R15CA147871]; NATIONAL CANCER INSTITUTE [R15CA147871] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR024790] Funding Source: NIH RePORTER	NIH, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH, National Center for Research Resources (R24-RR024790), National Cancer Institute (R15CA147871). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2005, NATURE, V435, P134, DOI 10.1038/435134a; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BIDWELL CA, 1995, J MOL EVOL, V41, P104, DOI 10.1007/BF00174046; Boswell MG, 2009, COMP BIOCHEM PHYS C, V149, P258, DOI 10.1016/j.cbpc.2008.11.005; Brawand D, 2008, PLOS BIOL, V6, P507, DOI 10.1371/journal.pbio.0060063; Breyne P, 2003, MOL GENET GENOMICS, V269, P173, DOI 10.1007/s00438-003-0830-6; CHEN TT, 1983, CAN J BIOCHEM CELL B, V61, P802, DOI 10.1139/o83-102; CHENCHIK A, 1998, GENE CLONING ANAL RT, P305; Chiriva-Internati M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-61; DEBOUCK C, 1995, CURR OPIN BIOTECH, V6, P597, DOI 10.1016/0958-1669(95)80098-0; Deng XN, 2000, J ANDROL, V21, P822; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; FOSTER JW, 1994, P NATL ACAD SCI USA, V91, P1927, DOI 10.1073/pnas.91.5.1927; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; KALLMAN KD, 1983, COPEIA, P755; KALLMAN KD, 1984, NEW LOOK SEX DETERMI, P95; KAZIANIS S, 2005, SEX DETERMINATION PL, P381; King V, 2007, GENETICS, V175, P1855, DOI 10.1534/genetics.106.066779; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Macgregor PF, 2002, CLIN CHEM, V48, P1170; MCCLELLAND M, 1995, TRENDS GENET, V11, P242, DOI 10.1016/S0168-9525(00)89058-7; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; MEYER A, 1993, P ROY SOC B-BIOL SCI, V254, P153, DOI 10.1098/rspb.1993.0140; Miracle A, 2006, ECOTOX ENVIRON SAFE, V63, P337, DOI 10.1016/j.ecoenv.2005.12.002; Mouchel N, 1997, GENE, V197, P147, DOI 10.1016/S0378-1119(97)00253-9; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Richardson RT, 2001, GENE, V274, P67, DOI 10.1016/S0378-1119(01)00605-9; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Sawaguchi S, 2006, MOL REPROD DEV, V73, P719, DOI 10.1002/mrd.20446; Schartl M, 2004, MECH DEVELOP, V121, P639, DOI 10.1016/j.mod.2004.03.001; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shetty J, 2003, J BIOL CHEM, V278, P30506, DOI 10.1074/jbc.M301713200; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; STEVANOVIC M, 1993, HUM MOL GENET, V2, P2013, DOI 10.1093/hmg/2.12.2013; Trichet V, 2000, MOL GEN GENET, V263, P828, DOI 10.1007/s004380000247; Volff JN, 2007, SEX DEV, V1, P85, DOI 10.1159/000100030; Volff JN, 2001, GENETICA, V111, P101, DOI 10.1023/A:1013795415808; Walter R B, 2001, ILAR J, V42, P299; WALTER RB, 2006, XIPHOPHORUS GENETIC, P1; Wang H, 2000, GENE, V256, P303, DOI 10.1016/S0378-1119(00)00376-0; Zarkower D, 2001, NAT REV GENET, V2, P175, DOI 10.1038/35056032; Zhang ZP, 2007, COMP BIOCHEM PHYS B, V147, P466, DOI 10.1016/j.cbpb.2007.02.013; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	46	27	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18379	10.1371/journal.pone.0018379	http://dx.doi.org/10.1371/journal.pone.0018379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483681	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000289191300019
J	de Boer, MGJ; Jolink, H; Halkes, CJM; van der Heiden, PLJ; Kremer, D; Falkenburg, JHF; van de Vosse, E; van Dissel, JT				de Boer, Mark G. J.; Jolink, Hetty; Halkes, Constantijn J. M.; van der Heiden, Pim L. J.; Kremer, Dennis; Falkenburg, J. H. Frederik; van de Vosse, Esther; van Dissel, Jaap T.			Influence of Polymorphisms in Innate Immunity Genes on Susceptibility to Invasive Aspergillosis after Stem Cell Transplantation	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PULMONARY ASPERGILLOSIS; RISK-FACTORS; FUNGAL-INFECTIONS; MYELOID-LEUKEMIA; GAMMA GENE; FUMIGATUS; INTERLEUKIN-10; TUBERCULOSIS; RECIPIENTS	The innate immune system plays a pivotal role in the primary defence against invasive fungal infection. Genetic variation in genes that regulate this response, initiated by pulmonary macrophages, may influence susceptibility to invasive aspergillosis in patients at risk. We investigated in a clinical setting whether common polymorphisms in Toll-like receptor (TLR) and cytokine genes involved in macrophage regulation are associated with susceptibility to invasive aspergillosis. Forty-four allogeneic stem cell transplantation recipients diagnosed with probable or proven IA according to the criteria of the European Organization for Research and Treatment of Cancer/Mycoses Study Group, were enrolled. The control group consisted of 64 allogeneic stem cell transplantation recipients without invasive aspergillosis. The TLR4 1063A>G single nucleotide polymorphism was associated with invasive aspergillosis when present in donors of allogeneic stem cell transplantation recipients (unadjusted OR 3.77 95% CI 1.08-13.2, p=0.03). In a multivariate analysis, adjusted for occurrence of graft-versus-host-disease, Cytomegalovirus serostatus and duration of neutropenia, paired presence of the TLR4 1063A>G and IFNG 874T>A single nucleotide polymorphisms showed a trend towards increased susceptibility to invasive aspergillosis (p=0.04). These findings point to the relevant immunological pathway involved in resistance to invasive aspergillosis and warrant further study of the effects of TLR and cytokine polymorphisms and their interaction, which may occur on different levels of the complex biological interplay between the immunocompromised host and Aspergillus sp.	[de Boer, Mark G. J.; Jolink, Hetty; van de Vosse, Esther; van Dissel, Jaap T.] Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands; [Jolink, Hetty; Halkes, Constantijn J. M.; van der Heiden, Pim L. J.; Falkenburg, J. H. Frederik] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands; [Kremer, Dennis] Leiden Univ, Dept Mol Epidemiol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Boer, MGJ (corresponding author), Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands.	M.G.J.de_Boer@lumc.nl	van de Vosse, Esther/HDO-0723-2022; de Boer, mark/AGE-5167-2022; van de Vosse, Esther/B-7285-2009	de Boer, mark/0000-0002-5009-6499; van de Vosse, Esther/0000-0001-5199-3426				ABDI J, 2011, CRIT REV ONCOL HEMAT; Avery Robin K, 2009, Curr Infect Dis Rep, V11, P223, DOI 10.1007/s11908-009-0033-3; Bjorklund A, 2007, BONE MARROW TRANSPL, V40, P1055, DOI 10.1038/sj.bmt.1705856; Bochud PY, 2008, NEW ENGL J MED, V359, P1766, DOI 10.1056/NEJMoa0802629; Brieland JK, 2001, INFECT IMMUN, V69, P1554, DOI 10.1128/IAI.69.3.1554-1560.2001; Carvalho A, 2008, J INFECT DIS, V197, P618, DOI 10.1086/526500; Cenci E, 1998, J INFECT DIS, V178, P1750, DOI 10.1086/314493; Chai LYA, 2009, MED MYCOL, V47, P227, DOI 10.1080/13693780802209082; Chai LYA, 2009, INFECT IMMUN, V77, P2184, DOI 10.1128/IAI.01455-08; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dickinson AM, 2010, HAEMATOL-HEMATOL J, V95, P922, DOI 10.3324/haematol.2009.016220; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Kesh S, 2005, ANN NY ACAD SCI, V1062, P95, DOI 10.1196/annals.1358.012; Lasker MV, 2006, J IMMUNOL, V177, P11, DOI 10.4049/jimmunol.177.1.11; Liang XY, 2009, BRIT J HAEMATOL, V146, P418, DOI 10.1111/j.1365-2141.2009.07790.x; Luther K, 2008, MICROBES INFECT, V10, P175, DOI 10.1016/j.micinf.2007.11.001; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Meier A, 2003, CELL MICROBIOL, V5, P561, DOI 10.1046/j.1462-5822.2003.00301.x; Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846; Netea MG, 2004, EUR J CLIN MICROBIOL, V23, P672, DOI 10.1007/s10096-004-1192-7; Netea MG, 2003, J INFECT DIS, V188, P320, DOI 10.1086/376456; Nieters A, 2006, GENES IMMUN, V7, P615, DOI 10.1038/sj.gene.6364337; Pagano L, 2010, HAEMATOL-HEMATOL J, V95, P644, DOI 10.3324/haematol.2009.012054; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; Rossouw M, 2003, LANCET, V361, P1871, DOI 10.1016/S0140-6736(03)13491-5; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sahiratmadja E, 2007, TUBERCULOSIS, V87, P303, DOI 10.1016/j.tube.2007.02.001; Sainz J, 2008, J CLIN IMMUNOL, V28, P473, DOI 10.1007/s10875-008-9197-0; Sainz J, 2007, IMMUNOL LETT, V109, P76, DOI 10.1016/j.imlet.2007.01.005; Seo KW, 2005, BONE MARROW TRANSPL, V36, P1089, DOI 10.1038/sj.bmt.1705181; Shoham S, 2005, BRIT J HAEMATOL, V129, P569, DOI 10.1111/j.1365-2141.2005.05397.x; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; Wilkinson RJ, 1999, J EXP MED, V189, P1863, DOI 10.1084/jem.189.12.1863	36	47	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18403	10.1371/journal.pone.0018403	http://dx.doi.org/10.1371/journal.pone.0018403			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483748	Green Published, gold, Green Submitted			2022-12-27	WOS:000289058700025
J	Yun, K; Chung, D; Jang, B; Kim, JH; Jeong, J				Yun, Kyongsik; Chung, Dongil; Jang, Bosun; Kim, Jin Ho; Jeong, Jaeseung			Mathematically Gifted Adolescents Have Deficiencies in Social Valuation and Mentalization	PLOS ONE			English	Article							ECONOMIC DECISION-MAKING; ULTIMATUM GAME; MENTAL ROTATION; EEG; INTELLIGENCE; FAIRNESS; STUDENTS; CHILDREN; CORTEX	Many mathematically gifted adolescents are characterized as being indolent, underachieving and unsuccessful despite their high cognitive ability. This is often due to difficulties with social and emotional development. However, research on social and emotional interactions in gifted adolescents has been limited. The purpose of this study was to observe differences in complex social strategic behaviors between gifted and average adolescents of the same age using the repeated Ultimatum Game. Twenty-two gifted adolescents and 24 average adolescents participated in the Ultimatum Game. Two adolescents participate in the game, one as a proposer and the other as a responder. Because of its simplicity, the Ultimatum Game is an apt tool for investigating complex human emotional and cognitive decision-making in an empirical setting. We observed strategic but socially impaired offers from gifted proposers and lower acceptance rates from gifted responders, resulting in lower total earnings in the Ultimatum Game. Thus, our results indicate that mathematically gifted adolescents have deficiencies in social valuation and mentalization.	[Yun, Kyongsik] CALTECH, Div Biol Computat & Neural Syst, Pasadena, CA 91125 USA; [Yun, Kyongsik; Chung, Dongil; Jeong, Jaeseung] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Jang, Bosun] Korea Adv Inst Sci & Technol, Dept Phys, Taejon 305701, South Korea; [Kim, Jin Ho] Korea Adv Inst Sci & Technol, Div Elect Engn, Taejon 305701, South Korea	California Institute of Technology; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Yun, K (corresponding author), CALTECH, Div Biol Computat & Neural Syst, Pasadena, CA 91125 USA.	jsjeong@kaist.ac.kr	Yun, Kyongsik/U-8476-2019; Chung, Dongil/B-4284-2018; Jeong, Jaeseung/C-1620-2011	Yun, Kyongsik/0000-0002-6103-7187; Chung, Dongil/0000-0003-1999-0326; 	Korea Advanced Institute of Technology	Korea Advanced Institute of Technology	This work was supported by the Undergraduate Research Program, Korea Advanced Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JE, 1996, INT J PSYCHOPHYSIOL, V23, P25, DOI 10.1016/0167-8760(96)00031-1; BRODY LE, 1986, J YOUTH ADOLESCENCE, V15, P1, DOI 10.1007/BF02140780; DAUBER SL, 1990, GIFTED CHILD QUART, V34, P10, DOI 10.1177/001698629003400103; Gaultney JF, 1996, J EXP CHILD PSYCHOL, V61, P43, DOI 10.1006/jecp.1996.0002; GEARY DC, 1991, DEV PSYCHOL, V27, P398, DOI 10.1037/0012-1649.27.3.398; Gill HS, 1998, CORTEX, V34, P707, DOI 10.1016/S0010-9452(08)70774-3; Gross M. U. M., 2004, EXCEPTIONALLY GIFTED; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Janos PaulM., 1985, GIFTED TALENTED DEV, P149, DOI 10.1037/10054-006; Jausovec N, 2003, COGNITIVE BRAIN RES, V16, P267, DOI 10.1016/S0926-6410(02)00282-3; Jausovec N, 2000, BIOL PSYCHOL, V55, P137, DOI 10.1016/S0301-0511(00)00076-4; Jausovec N, 1996, INTELLIGENCE, V23, P159, DOI 10.1016/S0160-2896(96)90001-X; Jin SH, 2007, INT J NEUROSCI, V117, P1167, DOI 10.1080/00207450600934655; KHATENA J, 1976, KHATENATORRANCE CREA; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Lee KH, 2006, NEUROIMAGE, V29, P578, DOI 10.1016/j.neuroimage.2005.07.036; Lovecky D. V., 1992, ROEPER REV, V15, P18, DOI [DOI 10.1080/02783199209553451, 10.1080/02783199209553451]; Murnighan JK, 1998, J ECON PSYCHOL, V19, P415, DOI 10.1016/S0167-4870(98)00017-8; Neihart, 2002, SOCIAL EMOTIONAL DEV; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; O'Boyle MW, 2005, COGNITIVE BRAIN RES, V25, P583, DOI 10.1016/j.cogbrainres.2005.08.004; Oosterbeek H, 2004, EXP ECON, V7, P171, DOI 10.1023/B:EXEC.0000026978.14316.74; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Robinson A, 1998, ANNU REV PSYCHOL, V49, P117, DOI 10.1146/annurev.psych.49.1.117; Rogers K. B., 1986, J EDUC GIFTED, V10, P17, DOI DOI 10.1177/016235328601000103; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Singh H, 2004, NEUROPSYCHOLOGY, V18, P371, DOI 10.1037/0894-4105.18.2.371; Slembeck T., 1999, REPUTATIONS FAIRNESS; SWIATEK MA, 1995, GIFTED CHILD QUART, V39, P154, DOI 10.1177/001698629503900305; van't Wout M, 2006, EXP BRAIN RES, V169, P564, DOI 10.1007/s00221-006-0346-5; Wechsler D., 1992, WECHSLER INTELLIGENC; Xiao E, 2005, P NATL ACAD SCI USA, V102, P7398, DOI 10.1073/pnas.0502399102	33	6	6	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18224	10.1371/journal.pone.0018224	http://dx.doi.org/10.1371/journal.pone.0018224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743ZC	21483742	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000289058700014
J	Lv, L; Pan, K; Li, XD; She, KL; Zhao, JJ; Wang, W; Chen, JG; Chen, YB; Yun, JP; Xia, JC				Lv, Lin; Pan, Ke; Li, Xiao-dong; She, Ke-lin; Zhao, Jing-jing; Wang, Wei; Chen, Ju-gao; Chen, Yi-bin; Yun, Jing-ping; Xia, Jian-chuan			The Accumulation and Prognosis Value of Tumor Infiltrating IL-17 Producing Cells in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							DELTA T-CELLS; TH17 CELLS; IL-17-PRODUCING CELLS; OVARIAN-CANCER; IMMUNITY; GROWTH; METASTASIS; EXPRESSION; SURVIVAL; PROTUMOR	Background: The role of IL-17 producing cells in tumors is controversial. In the present study, we investigated the prognostic value of measuring tumor-infiltrating IL-17 producing cell levels in human esophageal squamous cell carcinoma (ESCC). Methodology/Principal Findings: Immunohistochemical staining was performed to investigate the levels of IL-17+ tumor infiltrating lymphocytes (TILs), as well as CD8+ cytotoxic T lymphocytes (CTLs) and CD57+ natural killer (NK) cells from 181 ESCC patients. The prognostic value of measuring the densities of IL-17+ TILs and the correlation with CTLs and NK was evaluated. IL-17 producing cells were detected in esophageal squamous cell carcinoma tissues. The IL-17 producing cells were major CD4 positive, but Foxp3 negative. The median level of IL-17+ TILs was 3.90 cells/high power microscopic field (HPF). The density of IL-17 producing cells correlated negatively with T stage (P = 0.042). The higher densities of tumor infiltrating IL-17+ lymphocytes were associated with better overall survival (P = 0.031). Furthermore, we found that there were positive correlations between levels of IL-17 producing cells and the densities of CD8+ cells, as well as CD57+ cells (r = 0.198, P = 0.008 for CD8+ cells and r = 0.261, P, 0.001 for CD57+ cells, respectively). The prognosis analysis also showed that the higher levels of CD8+ CTLs and CD57+ NK cells correlated with better overall survival of ESCC patients. Conclusions: Our study suggests that tumor infiltrating IL-17 producing cells in ESCC patients may have protective roles in the tumor microenvironment and may be treated as a prognostic marker for ESCC patients.	[Lv, Lin; Pan, Ke; Li, Xiao-dong; She, Ke-lin; Zhao, Jing-jing; Wang, Wei; Chen, Ju-gao; Chen, Yi-bin; Yun, Jing-ping; Xia, Jian-chuan] Sun Yat Sen Univ, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Lv, Lin; Pan, Ke; Li, Xiao-dong; She, Ke-lin; Zhao, Jing-jing; Wang, Wei; Chen, Ju-gao; Chen, Yi-bin; Yun, Jing-ping; Xia, Jian-chuan] Sun Yat Sen Univ, Dept Expt Res, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Li, Xiao-dong; She, Ke-lin] Sun Yat Sen Univ, Dept Thorac Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Yun, Jing-ping] Sun Yat Sen Univ, Dept Pathol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Wei] Sun Yat Sen Univ, Dept Gastr & Pancreat Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Lv, L (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China.	yunjp@mail.sysu.edu.cn; xiajch@mail.sysu.edu.cn			National Natural Science Foundation of China [u0772002, 30700985, 30973398]; Guangdong Natural Science Foundation [925100890]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (u0772002, 30700985, 30973398) and Guangdong Natural Science Foundation (925100890). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x; Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Cho Y, 2003, CANCER RES, V63, P1555; Couzin J, 2006, SCIENCE, V313, P1868; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Dong GF, 2003, CHINESE MED J-PEKING, V116, P543; Dunn Gavin P, 2007, Cancer Immun, V7, P12; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Hsia Jiun-Yi, 2005, Chang Gung Med J, V28, P335; Islami F, 2004, BRIT J CANCER, V90, P1402, DOI 10.1038/sj.bjc.6601737; Kato T, 2001, BIOCHEM BIOPH RES CO, V282, P735, DOI 10.1006/bbrc.2001.4618; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; LEE JJ, 2010, HEAD NECK; Leffers N, 2009, CANCER IMMUNOL IMMUN, V58, P449, DOI 10.1007/s00262-008-0583-5; LIU J, 2010, PATHOL RES PRACT; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; O'Brien RL, 2009, INVEST OPHTH VIS SCI, V50, P3266, DOI 10.1167/iovs.08-2982; O'Brien RL, 2009, EUR J IMMUNOL, V39, P662, DOI 10.1002/eji.200839120; Oukka M, 2008, ANN RHEUM DIS, V67, P26, DOI 10.1136/ard.2008.098004; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Simonian PL, 2009, TRANSL RES, V154, P222, DOI 10.1016/j.trsl.2009.08.006; Taghavi N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-138; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Traves SL, 2008, CURR MOL MED, V8, P416, DOI 10.2174/156652408785160998; Xue L, 2010, DIS ESOPHAGUS, V23, P340, DOI 10.1111/j.1442-2050.2009.01013.x; Yamada Hisakata, 2009, Nihon Rinsho Meneki Gakkai Kaishi, V32, P249; Yoshioka T, 2008, BRIT J CANCER, V98, P1258, DOI 10.1038/sj.bjc.6604294; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhang YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-4; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	40	89	95	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18219	10.1371/journal.pone.0018219	http://dx.doi.org/10.1371/journal.pone.0018219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483813	Green Submitted, gold, Green Published			2022-12-27	WOS:000289057200044
J	Rahmah, NN; Murata, T; Yako, T; Horiuchi, T; Hongo, K				Rahmah, Nunung Nur; Murata, Takahiro; Yako, Takehiro; Horiuchi, Tetsuyoshi; Hongo, Kazuhiro			Correlation between Squamous Suture and Sylvian Fissure: Osirix DICOM Viewer Study	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; SUPERFICIAL TEMPORAL ARTERY; MICROVASCULAR BYPASS SURGERY; SURGICAL ANATOMY; IDENTIFICATION; OCCLUSION; CISTERNS; VEINS	Background: Sylvian fissure (SF) is an important corridor in neurosurgery, and the end of sylvian fissure (eSF) represents the optimal target area to expose suitable recipient artery in STA-MCA bypass. Unfortunately little have been addressed concerning its relationship with external cranial surface. Objective: Correlation between Squamous Suture (SS) and SF was investigated. Methods: 50-adult 3D-CTA images were studied using OSIRIX DICOM viewer. The measurement points were determined from external auditory meatus 0, 1, 1.5, 2, 2.5, 3, 3.5 and 4-cm anteriorly, perpendicular from orbitomeatal (OM) line. The distance of SF was compared with the one of SS. Results: SSs were all located below SF at 0 cm. At a distance of 0 to 1.5 cm, SSs were located above SF, then started to merge and went side by side from 2 cm anteriorly. Anterior sylvian point, the most anterior part of SF, was found at 4 cm from OM line. Inferior Rolandic point, which corresponds to the central sulcus inferior extent, was found to be at 2 cm from OM line. The eSF was identified at 0 cm anteriorly from OM, and perpendicularly 1.5 cm above SS. 50% patients had Chater's point (CP) above eSF. Average value for CP was 0.01 below eSF, giving a significantly closer value compared to the one of SS (p, 0.01). However, SS showed consistent value of 1.5 below SF. Furthermore, SS is a bony landmark, which has no shifting effect during surgery, therefore drawing a 1.5-cm line upward from SS could lead to exact location of eSF. Conclusion: The course of SF and its correlation to SS have been identified, and this is also the first study to investigate the relationship of SS and eSF using OSIRIX DICOM viewer. SS is also comparable to CP, therefore it is usable for a simple	[Rahmah, Nunung Nur; Murata, Takahiro; Horiuchi, Tetsuyoshi; Hongo, Kazuhiro] Shinshu Univ, Dept Neurosurg, Matsumoto, Nagano 390, Japan; [Yako, Takehiro] Aizawa Hosp, Dept Neurosurg, Matsumoto, Nagano, Japan	Shinshu University	Rahmah, NN (corresponding author), Shinshu Univ, Dept Neurosurg, Matsumoto, Nagano 390, Japan.	tetuyosi@shinshu-u.ac.jp						Aydin IH, 1996, ACTA NEUROCHIR, V138, P1380, DOI 10.1007/BF01411115; Charbel FT, 2006, ATLAS NEUROSURGICAL, P370; CHATER N, 1976, J NEUROSURG, V44, P712, DOI 10.3171/jns.1976.44.6.0712; EBELING U, 1989, AM J ROENTGENOL, V153, P1051, DOI 10.2214/ajr.153.5.1051; GIBO H, 1981, J NEUROSURG, V54, P151, DOI 10.3171/jns.1981.54.2.0151; GRATZL O, 1976, J NEUROSURG, V44, P313, DOI 10.3171/jns.1976.44.3.0313; HARKEY HL, 1989, NEUROSURGERY, V24, P651, DOI 10.1227/00006123-198905000-00001; Kadri PAS, 2007, NEUROSURGERY, V61, P74, DOI 10.1227/01.NEU.0000279979.63673.9E; Kazumata K, 2003, NEUROL MED-CHIR, V43, P427, DOI 10.2176/nmc.43.427; Kikuta KI, 2006, NEUROSURGERY, V59, P320, DOI 10.1227/01.NEU.0000232775.06672.F4; Mendelowitsch A, 2004, ACTA NEUROCHIR, V146, P95, DOI 10.1007/s00701-003-0154-7; Newell DW, 2005, SKULL BASE-INTERD AP, V15, P133, DOI 10.1055/s-2005-870599; Pena-Tapia PG, 2008, J NEUROSURG, V108, P655, DOI 10.3171/JNS/2008/108/4/0655; Ribas GC, 2006, NEUROSURGERY, V59, P177, DOI 10.1227/01.NEU.0000240682.28616.b2; Ribas Guilherme Carvalhal, 2005, Neurosurg Focus, V18, pE2; SCHMIEDEK P, 1994, J NEUROSURG, V81, P236, DOI 10.3171/jns.1994.81.2.0236; SPETZLER R, 1976, J NEUROSURG, V45, P508, DOI 10.3171/jns.1976.45.5.0508; SUNDT TM, 1987, NEW ENGL J MED, V316, P814, DOI 10.1056/NEJM198703263161318; Wanebo JE, 2004, NEUROSURGERY, V55, P395, DOI 10.1227/01.NEU.0000129549.99061.94; WU RQ, 1982, CHINESE MED J-PEKING, V95, P583; Yasargil M G, 1976, Surg Neurol, V6, P83; YASARGIL MG, 1976, J NEUROSURG, V44, P298; Yasargil MG., 1984, MICRONEUROSURGERY, V1, P5; Yasargil MG, 1969, MICROSURGERY APPL NE, P119	24	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18199	10.1371/journal.pone.0018199	http://dx.doi.org/10.1371/journal.pone.0018199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483821	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200041
J	Frampton, D; Kerr, J; Harrison, TJ; Kellam, P				Frampton, Daniel; Kerr, Jonathan; Harrison, Tim J.; Kellam, Paul			Assessment of a 44 Gene Classifier for the Evaluation of Chronic Fatigue Syndrome from Peripheral Blood Mononuclear Cell Gene Expression	PLOS ONE			English	Article							EXPLORATION	Chronic fatigue syndrome (CFS) is a clinically defined illness estimated to affect millions of people worldwide causing significant morbidity and an annual cost of billions of dollars. Currently there are no laboratory-based diagnostic methods for CFS. However, differences in gene expression profiles between CFS patients and healthy persons have been reported in the literature. Using mRNA relative quantities for 44 previously identified reporter genes taken from a large dataset comprising both CFS patients and healthy volunteers, we derived a gene profile scoring metric to accurately classify CFS and healthy samples. This metric out-performed any of the reporter genes used individually as a classifier of CFS. To determine whether the reporter genes were robust across populations, we applied this metric to classify a separate blind dataset of mRNA relative quantities from a new population of CFS patients and healthy persons with limited success. Although the metric was able to successfully classify roughly two-thirds of both CFS and healthy samples correctly, the level of misclassification was high. We conclude many of the previously identified reporter genes are study-specific and thus cannot be used as a broad CFS diagnostic.	[Frampton, Daniel; Kellam, Paul] UCL, Div Infect & Immun, Dept Infect, London, England; [Kerr, Jonathan] Univ London St Georges Hosp, Div Clin Sci, London, England; [Harrison, Tim J.] UCL, Sch Med, Dept Internal Med, London W1N 8AA, England; [Kellam, Paul] Wellcome Trust Sanger Inst, Cambridge, England	University of London; University College London; St Georges University London; University of London; University College London; UCL Medical School; Wellcome Trust Sanger Institute	Frampton, D (corresponding author), UCL, Div Infect & Immun, Dept Infect, London, England.	pk5@sanger.ac.uk		Kellam, Paul/0000-0003-3166-4734; Universidad del Rosario, Biblioteca/0000-0003-3491-9392	Chronic Fatigue Syndrome Research Foundation	Chronic Fatigue Syndrome Research Foundation	This study was funded by a research grant from the Chronic Fatigue Syndrome Research Foundation (http://www.cfsrf.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspler AL, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-44; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Fang H, 2006, PHARMACOGENOMICS, V7, P429, DOI 10.2217/14622416.7.3.429; Fostel J, 2006, PHARMACOGENOMICS, V7, P441, DOI 10.2217/14622416.7.3.441; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gow JW, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-38; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Jenner RG, 2003, P NATL ACAD SCI USA, V100, P10399, DOI 10.1073/pnas.1630810100; Kaushik N, 2005, J CLIN PATHOL, V58, P826, DOI 10.1136/jcp.2005.025718; Kerr JR, 2008, J INFECT DIS, V197, P1171, DOI 10.1086/533453; Presson AP, 2009, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-95; Reynolds Kenneth J, 2004, Cost Eff Resour Alloc, V2, P4, DOI 10.1186/1478-7547-2-4; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saiki T, 2008, MOL MED, V14, P599, DOI 10.2119/2007-00059.Saiki; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vinciotti Veronica, 2006, Appl Bioinformatics, V5, P1, DOI 10.2165/00822942-200605010-00001; Xu Y, 2002, CANCER RES, V62, P3493	18	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e16872	10.1371/journal.pone.0016872	http://dx.doi.org/10.1371/journal.pone.0016872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479222	Green Published, gold, Green Submitted			2022-12-27	WOS:000289055700007
J	Giorgio, C; Mohamed, IH; Flammini, L; Barocelli, E; Incerti, M; Lodola, A; Tognolini, M				Giorgio, Carmine; Mohamed, Iftiin Hassan; Flammini, Lisa; Barocelli, Elisabetta; Incerti, Matteo; Lodola, Alessio; Tognolini, Massimiliano			Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation	PLOS ONE			English	Article							RECEPTOR-TYROSINE KINASE; BILE-ACIDS; COLON-CANCER; MELANOMA-CELLS; EXPRESSION; ANGIOGENESIS; ANTAGONISTS; CARCINOMA; SURVIVAL; BEHAVIOR	Eph-ephrin system plays a central role in a large variety of human cancers. In fact, alterated expression and/or de-regulated function of Eph-ephrin system promotes tumorigenesis and development of a more aggressive and metastatic tumour phenotype. In particular EphA2 upregulation is correlated with tumour stage and progression and the expression of EphA2 in non-trasformed cells induces malignant transformation and confers tumorigenic potential. Based on these evidences our aim was to identify small molecules able to modulate EphA2-ephrinA1 activity through an ELISA-based binding screening. We identified lithocholic acid (LCA) as a competitive and reversible ligand inhibiting EphA2-ephrinA1 interaction (Ki = 49 mu M). Since each ephrin binds many Eph receptors, also LCA does not discriminate between different Eph-ephrin binding suggesting an interaction with a highly conserved region of Eph receptor family. Structurally related bile acids neither inhibited Eph-ephrin binding nor affected Eph phosphorylation. Conversely, LCA inhibited EphA2 phosphorylation induced by ephrinA1-Fc in PC3 and HT29 human prostate and colon adenocarcinoma cell lines (IC50 = 48 and 66 mM, respectively) without affecting cell viability or other receptor tyrosine-kinase (EGFR, VEGFR, IGFR1 beta, IRK beta) activity. LCA did not inhibit the enzymatic kinase activity of EphA2 at 100 mu M (LANCE method) confirming to target the Eph-ephrin protein-protein interaction. Finally, LCA inhibited cell rounding and retraction induced by EphA2 activation in PC3 cells. In conclusion, our findings identified a hit compound useful for the development of molecules targeting ephrin system. Moreover, as ephrin signalling is a key player in the intestinal cell renewal, our work could provide an interesting starting point for further investigations about the role of LCA in the intestinal homeostasis.	[Giorgio, Carmine; Mohamed, Iftiin Hassan; Flammini, Lisa; Barocelli, Elisabetta; Tognolini, Massimiliano] Univ Parma, Dipartimento Sci Farmacol Biol & Chim Applicate, I-43100 Parma, Italy; [Incerti, Matteo; Lodola, Alessio] Univ Parma, Dipartimento Farmaceut, I-43100 Parma, Italy	University of Parma; University of Parma	Giorgio, C (corresponding author), Univ Parma, Dipartimento Sci Farmacol Biol & Chim Applicate, I-43100 Parma, Italy.	massimiliano.tognolini@unipr.it	Lodola, Alessio/H-9078-2013; giorgio, carmine/A-6840-2018; tognolini, massimiliano/B-5768-2012; Incerti, Matteo/M-3896-2017	Lodola, Alessio/0000-0002-8675-1002; giorgio, carmine/0000-0001-6414-8221; Tognolini, Massimiliano/0000-0002-4715-0407	"Associazione Italiana Ricerca sul Cancro" (AIRC) [6181]	"Associazione Italiana Ricerca sul Cancro" (AIRC)(Fondazione AIRC per la ricerca sul cancro)	"My First AIRC Grant" number 6181 of the "Associazione Italiana Ricerca sul Cancro" (AIRC) supported this work (www.airc.it). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford SC, 2007, EXP CELL RES, V313, P4170, DOI 10.1016/j.yexcr.2007.07.019; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; BARTLEY TD, 1994, NATURE, V368, P558, DOI 10.1038/368558a0; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bin Fang W, 2005, ONCOGENE, V24, P7859, DOI 10.1038/sj.onc.1208937; Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Brantley-Sieders DM, 2006, CANCER RES, V66, P10315, DOI 10.1158/0008-5472.CAN-06-1560; Carles-Kinch K, 2002, CANCER RES, V62, P2840; Chang Q, 2008, BRIT J CANCER, V99, P1074, DOI 10.1038/sj.bjc.6604676; CHEAH PY, 1990, NUTR CANCER, V14, P5, DOI 10.1080/01635589009514073; Dobrzanski P, 2004, CANCER RES, V64, P910, DOI 10.1158/0008-5472.CAN-3430-2; Gale NW, 1997, CELL TISSUE RES, V290, P227, DOI 10.1007/s004410050927; Herrem CJ, 2005, CLIN CANCER RES, V11, P226; Hess AR, 2006, CANCER BIOL THER, V5, P228, DOI 10.4161/cbt.5.2.2510; HILL MJ, 1990, MUTAT RES, V238, P313, DOI 10.1016/0165-1110(90)90023-5; HILL MJ, 1971, LANCET, V1, P95; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Katona BW, 2007, J MED CHEM, V50, P6048, DOI 10.1021/jm0707931; Katona BW, 2009, J BIOL CHEM, V284, P3354, DOI 10.1074/jbc.M805804200; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kinch MS, 2003, CLIN CANCER RES, V9, P613; Koolpe M, 2002, J BIOL CHEM, V277, P46974, DOI 10.1074/jbc.M208495200; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miyazaki T, 2003, INT J CANCER, V103, P657, DOI 10.1002/ijc.10860; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Olive DM, 2004, EXPERT REV PROTEOMIC, V1, P327, DOI 10.1586/14789450.1.3.327; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; REDDY BS, 1977, CANCER RES, V37, P1697; Tanaka M, 2005, J BIOL CHEM, V280, P42375, DOI 10.1074/jbc.M503786200; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Wykosky J, 2008, ONCOGENE, V27, P7260, DOI 10.1038/onc.2008.328; Yang NY, 2006, J BIOL CHEM, V281, P32574, DOI 10.1074/jbc.M604338200; Zelinski DP, 2001, CANCER RES, V61, P2301	40	58	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18128	10.1371/journal.pone.0018128	http://dx.doi.org/10.1371/journal.pone.0018128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479221	Green Submitted, Green Published, gold			2022-12-27	WOS:000289055700028
J	Hashimoto, T; Kikkawa, U; Kamada, S				Hashimoto, Toshiaki; Kikkawa, Ushio; Kamada, Shinji			Contribution of Caspase(s) to the Cell Cycle Regulation at Mitotic Phase	PLOS ONE			English	Article							X-LINKED INHIBITOR; UBIQUITIN-PROTEIN LIGASE; SPINDLE CHECKPOINT; APOPTOSIS; ACTIVATION; CANCER; XIAP; MITOSIS; DEGRADATION; PROGRESSION	Caspases have been suggested to contribute to not only apoptosis regulation but also non-apoptotic cellular phenomena. Recently, we have reported the involvement of caspase-7 to the cell cycle progression at mitotic phase by knockdown of caspase-7 using small interfering RNAs and short hairpin RNA. Here we showed that chemically synthesized broad-spectrum caspase inhibitors, which have been used to suppress apoptosis, prevented the cell proliferation in a dose-dependent manner, and that the subtype-specific peptide-based caspase inhibitor for caspase-3 and -7, but not for caspase-9, inhibited cell proliferation. It was also indicated that the BIR2 domain of X-linked inhibitor of apoptosis protein, functioning as an inhibitor for caspase-3 and -7, but not the BIR3 domain which plays as a caspase-9 inhibitor, induced cell cycle arrest. Furthermore, flow cytometry revealed that the cells treated with caspase inhibitors arrested at G(2)/M phase. By using HeLa. S-Fucci (fluorescent ubiquitination-based cell cycle indicator) cells, the prevention of the cell proliferation by caspase inhibitors induced cell cycle arrest at mitotic phase accompanying the accumulation of the substrates for APC/C, suggesting the impairment of the APC/C activity at the transition from M to G(1) phases. These results indicate that caspase(s) contribute to the cell cycle regulation at mitotic phase.	[Hashimoto, Toshiaki; Kikkawa, Ushio; Kamada, Shinji] Kobe Univ, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo 657, Japan	Kobe University	Hashimoto, T (corresponding author), Kobe Univ, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo 657, Japan.	skamada@kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Scientific Research on Priority Areas of the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by Grant-in-Aid for Scientific Research (B) of Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Broemer M, 2010, MOL CELL, V40, P810, DOI 10.1016/j.molcel.2010.11.011; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Faragher AJ, 2007, MOL BIOL CELL, V18, P1337, DOI 10.1091/mbc.E06-05-0409; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Galvan V, 2004, FEBS LETT, V558, P57, DOI 10.1016/S0014-5793(03)01488-1; Hashimoto T, 2008, GENES CELLS, V13, P609, DOI 10.1111/j.1365-2443.2008.01192.x; Hofer-Warbinek R, 2000, J BIOL CHEM, V275, P22064, DOI 10.1074/jbc.M910346199; Hsu SL, 2006, APOPTOSIS, V11, P765, DOI 10.1007/s10495-006-5880-x; Huang HK, 2000, J BIOL CHEM, V275, P26661; Huh JR, 2004, PLOS BIOL, V2, P43, DOI 10.1371/journal.pbio.0020015; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim M, 2005, MOL CELL BIOL, V25, P9232, DOI 10.1128/MCB.25.21.9232-9248.2005; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kuranaga E, 2006, CELL, V126, P583, DOI 10.1016/j.cell.2006.05.048; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lewis J, 2004, J BIOL CHEM, V279, P9023, DOI 10.1074/jbc.M312891200; Misaghi S, 2006, CELL DEATH DIFFER, V13, P163, DOI 10.1038/sj.cdd.4401716; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nakopoulou L, 2001, PATHOBIOLOGY, V69, P266, DOI 10.1159/000064337; Newton K, 2003, GENE DEV, V17, P819, DOI 10.1101/gad.1077403; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Samuel T, 2005, CANCER RES, V65, P210; Sanna MG, 2002, MOL CELL BIOL, V22, P1754, DOI 10.1128/MCB.22.6.1754-1766.2002; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Swe M, 2000, APOPTOSIS, V5, P29, DOI 10.1023/A:1009681408367; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vakkala M, 1999, BRIT J CANCER, V81, P592, DOI 10.1038/sj.bjc.6690735; van Leuken R, 2008, BBA-REV CANCER, V1786, P49, DOI 10.1016/j.bbcan.2008.05.002; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Yan XX, 2001, J COMP NEUROL, V433, P4, DOI 10.1002/cne.1121; Yang L, 2003, CANCER RES, V63, P6815; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343	50	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18449	10.1371/journal.pone.0018449	http://dx.doi.org/10.1371/journal.pone.0018449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479177	Green Published, Green Submitted, gold			2022-12-27	WOS:000289055700059
J	Tracy, JL; Hart, J; Martens, JP				Tracy, Jessica L.; Hart, Joshua; Martens, Jason P.			Death and Science: The Existential Underpinnings of Belief in Intelligent Design and Discomfort with Evolution	PLOS ONE			English	Article							TERROR MANAGEMENT THEORY; MORTALITY SALIENCE; WORLDVIEW DEFENSE; BIOLOGY TEACHERS; ACCESSIBILITY; THOUGHTS; CREATURELINESS; CONSERVATISM; UNCERTAINTY; DISGUST	The present research examined the psychological motives underlying widespread support for intelligent design theory (IDT), a purportedly scientific theory that lacks any scientific evidence; and antagonism toward evolutionary theory (ET), a theory supported by a large body of scientific evidence. We tested whether these attitudes are influenced by IDT's provision of an explanation of life's origins that better addresses existential concerns than ET. In four studies, existential threat (induced via reminders of participants' own mortality) increased acceptance of IDT and/or rejection of ET, regardless of participants' religion, religiosity, educational background, or preexisting attitude toward evolution. Effects were reversed by teaching participants that naturalism can be a source of existential meaning (Study 4), and among natural-science students for whom ET may already provide existential meaning (Study 5). These reversals suggest that the effect of heightened mortality awareness on attitudes toward ET and IDT is due to a desire to find greater meaning and purpose in science when existential threats are activated.	[Tracy, Jessica L.; Martens, Jason P.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Hart, Joshua] Union Coll, Dept Psychol, Schenectady, NY 12308 USA	University of British Columbia; Union College	Tracy, JL (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	jltracy@psych.ubc.ca			Social Sciences and Humanities Research Council of Canada [410-2009-2458]; Michael Smith Foundation [CI-SCH-01862(07-1)]; Union College; Social Science and Humanities Research Council of Canada	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Michael Smith Foundation(Michael Smith Foundation for Health Research); Union College; Social Science and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This project was supported by the Social Sciences and Humanities Research Council of Canada, Standard Research Grant #410-2009-2458, a Michael Smith Foundation for Health Research Scholar Award [CI-SCH-01862(07-1)] to the first author, a Faculty Research Fund Grant from Union College, and a Social Science and Humanities Research Council of Canada Graduate Scholarship to the third author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAAS, 2006, STAT TEACH EV; Altemeyer B., 2004, INT J PSYCHOL RELIG, V14, P47, DOI DOI 10.1207/S15327582IJPR1401_4; [Anonymous], 2009, ENCY BRITANNICA; BEHE MJ, 2000, SCI EVIDENCE DESIGN; BEHE MJ, 1996, NY TIMES        1029; Behe MJ., 1996, DARWINS BLACK BOX BI; Berkman MB, 2008, PLOS BIOL, V6, P920, DOI 10.1371/journal.pbio.0060124; Brem SK, 2003, SCI EDUC, V87, P181, DOI 10.1002/sce.10105; Bumiller Elisabeth, 2005, NY TIMES; Cohen F, 2004, PSYCHOL SCI, V15, P846, DOI 10.1111/j.0956-7976.2004.00765.x; Cox CR, 2007, EUR J SOC PSYCHOL, V37, P494, DOI 10.1002/ejsp.370; DAWKINS R, 1998, UNWEAVING RAINBOW; Dawkins R., 2006, SELFISH GENE, P360; DeWall CN, 2007, PSYCHOL SCI, V18, P984, DOI 10.1111/j.1467-9280.2007.02013.x; Druyan Ann, 2006, VARIETIES SCI EXPERI, pix; Evans EM, 2001, COGNITIVE PSYCHOL, V42, P217, DOI 10.1006/cogp.2001.0749; Fritsche I, 2008, J PERS SOC PSYCHOL, V95, P524, DOI 10.1037/a0012666; Gewin V, 2005, NATURE, V436, P761, DOI 10.1038/436761a; Goldenberg JL, 2001, J EXP PSYCHOL GEN, V130, P427, DOI 10.1037//0096-3445.130.3.427; GORSUCH RL, 1989, J SCI STUD RELIG, V28, P348, DOI 10.2307/1386745; Greenberg J, 2003, PSYCHOL SCI, V14, P516, DOI 10.1111/1467-9280.03454; GREENBERG J, 1994, J PERS SOC PSYCHOL, V67, P627, DOI 10.1037/0022-3514.67.4.627; GREENBERG J, 1990, J PERS SOC PSYCHOL, V58, P308, DOI 10.1037/0022-3514.58.2.308; Hart J, 2005, J PERS SOC PSYCHOL, V88, P999, DOI 10.1037/0022-3514.88.6.999; Heine SJ, 2006, PERS SOC PSYCHOL REV, V10, P88, DOI 10.1207/s15327957pspr1002_1; Hoag H, 2006, NATURE, V440, P720, DOI 10.1038/440720b; Jonas E, 2006, J PERS SOC PSYCHOL, V91, P553, DOI 10.1037/0022-3514.91.3.553; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Landau MJ, 2006, J PERS SOC PSYCHOL, V90, P879, DOI 10.1037/0022-3514.90.6.879; Landau MJ, 2004, PERS SOC PSYCHOL B, V30, P1136, DOI 10.1177/0146167204267988; Lifton R.J., 1983, BROKEN CONNECTION DE; Lombrozo T., 2008, EVOL EDUC OUTREACH, V1, P290, DOI [10.1007/s12052-008-0061-8, DOI 10.1007/S12052-008-0061-8]; Lombrozo T, 2007, PSYCHOL SCI, V18, P999, DOI 10.1111/j.1467-9280.2007.02015.x; Martin JD, 2006, J MEDIA RELIG, V5, P49, DOI 10.1207/s15328415jmr0501_3; Martin LL, 1999, PSYCHOL INQ, V10, P195, DOI 10.1207/S15327965PLI1003_1; McCann SJH, 2008, J PERS SOC PSYCHOL, V94, P913, DOI 10.1037/0022-3514.94.5.913; McGregor I, 2001, J PERS SOC PSYCHOL, V80, P472, DOI 10.1037//0022-3514.80.3.472; Meyer S. C., 2005, TEACH CONTROVERSY; Nehm RH, 2009, SCI EDUC, V93, P1122, DOI 10.1002/sce.20340; Norenzayan A, 2006, PERS SOC PSYCHOL B, V32, P174, DOI 10.1177/0146167205280251; OSARCHUK M, 1973, J PERS SOC PSYCHOL, V27, P256, DOI 10.1037/h0034769; Pyszczynski T, 1999, PSYCHOL REV, V106, P835, DOI 10.1037/0033-295X.106.4.835; Pyszczynski T, 2006, PERS SOC PSYCHOL B, V32, P525, DOI 10.1177/0146167205282157; Pyszczynski T., 2003, WAKE 9 11 PSYCHOL TE; ROSENBLATT A, 1989, J PERS SOC PSYCHOL, V57, P681, DOI 10.1037/0022-3514.57.4.681; Rutjens BT, 2009, PERS SOC PSYCHOL B, V35, P535, DOI 10.1177/0146167208331252; Rutledge ML, 2000, AM BIOL TEACH, V62, P23, DOI 10.1662/0002-7685(2000)062[0023:ETTNOS]2.0.CO;2; Schimel J, 2007, J PERS SOC PSYCHOL, V92, P789, DOI 10.1037/0022-3514.92.5.789; Shtulman A, 2008, COGNITIVE SCI, V32, P1049, DOI 10.1080/03640210801897864; Sinatra GM, 2003, J RES SCI TEACH, V40, P510, DOI 10.1002/tea.10087; van den Bos K, 2005, J EXP SOC PSYCHOL, V41, P91, DOI 10.1016/j.jesp.2004.06.001; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	52	31	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17349	10.1371/journal.pone.0017349	http://dx.doi.org/10.1371/journal.pone.0017349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YK	21479169	Green Published, Green Submitted, gold			2022-12-27	WOS:000289055700010
J	de Andrade, ACV; Luz, PM; Velasque, L; Veloso, VG; Moreira, RI; Russomano, F; Chicarino-Coelho, J; Pires, E; Levi, JE; Grinsztejn, B; Friedman, RK				Vasconcelos de Andrade, Angela Cristina; Luz, Paula Mendes; Velasque, Luciane; Veloso, Valdilea Goncalves; Moreira, Ronaldo I.; Russomano, Fabio; Chicarino-Coelho, Janice; Pires, Elaine; Levi, Jose Eduardo; Grinsztejn, Beatriz; Friedman, Ruth Khalili			Factors Associated with Colposcopy-Histopathology Confirmed Cervical Intraepithelial Neoplasia among HIV-Infected Women from Rio De Janeiro, Brazil	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-PAPILLOMAVIRUS; CANCER-RISK; AIDS; PREVALENCE; TERMINOLOGY; PREDICTORS; MANAGEMENT; PEOPLE	Introduction: Despite the availability of preventive strategies (screening tests and vaccines), cervical cancer continues to impose a significant health burden in low- and medium-resourced countries. HIV-infected women are at increased risk for infection with human papillomavirus (HPV) and thus development of cervical squamous intraepithelial neoplasia (CIN). Methods: Study participants included HIV-infected women enrolling the prospective open cohort of Evandro Chagas Clinical Research Institute, Oswaldo Cruz Foundation (IPEC/FIOCRUZ). At cohort entry, women were subjected to conventional Papanicolaou test, HPV-DNA test and colposcopy; lesions suspicious for CIN were biopsied. Histopathology report was based on directed biopsy or on specimens obtained by excision of the transformation zone or cervical conization. Poisson regression modeling was used to assess factors associated with CIN2+ diagnosis. Results: The median age of the 366 HIV-infected women included in the study was 34 years (interquartile range: 28-41 years). The prevalence of CIN1, CIN2 and CIN3 were 20.0%, 3.5%, and 2.2%, respectively. One woman was found to have cervical cancer. The prevalence of CIN2+ was 6.0%. Factors associated with CIN2+ diagnosis in the multivariate model were age < years compared to >= 35 years (aPR = 3.22 95% CI 1.23-8.39), current tobacco use (aPR = 3.69 95% CI 1.54-8.78), nadir CD4 T-cell count < 350 cells/mm3 when compared to >= 350 cells/mm3 (aPR = 6.03 95% CI 1.50-24.3) and concomitant diagnosis of vulvar and/or vaginal intraepithelial lesion (aPR = 2.68 95% CI 0.99-7.24). Discussion: Increased survival through wide-spread use of highly active antiretroviral therapy might allow for the development of cervical cancer. In Brazil, limited cytology screening and gynecological care adds further complexity to the HIV-HPV co-infection problem. Integrated HIV care and cervical cancer prevention programs are needed for the prevention of cervical cancer mortality in this group of women.	[Vasconcelos de Andrade, Angela Cristina; Luz, Paula Mendes; Velasque, Luciane; Veloso, Valdilea Goncalves; Moreira, Ronaldo I.; Chicarino-Coelho, Janice; Pires, Elaine; Grinsztejn, Beatriz; Friedman, Ruth Khalili] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Velasque, Luciane] Univ Fed Estado Rio de Janeiro, Dept Matemat & Estat, Rio De Janeiro, Brazil; [Russomano, Fabio] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, Brazil; [Levi, Jose Eduardo] Univ Sao Paulo, Inst Trop Med, Virol Lab, Sao Paulo, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade de Sao Paulo	de Andrade, ACV (corresponding author), Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil.	gbeatriz@ipec.fiocruz.br	Veloso, Valdilea Gonçalves/J-6189-2012	Luz, Paula/0000-0001-9746-719X				Anastos K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013525; Arrossi S, 2003, SALUD PUBLICA MEXICO, V45, pS306; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Behrens T, 2004, METHOD INFORM MED, V43, P505; Bollen LJM, 2006, SEX TRANSM DIS, V33, P259; Brasil. Ministerio da Saude (MS). Secretaria de Vigilancia em Saude. Programa Nacional de DST/Aids, 2006, MAN CONTR DOENC SEX; Campos DP, 2005, AIDS, V19, pS22, DOI 10.1097/01.aids.0000191486.92285.1c; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Conley LJ, 2002, LANCET, V359, P108, DOI 10.1016/S0140-6736(02)07368-3; Dexeus S, 2002, EUR J GYNAECOL ONCOL, V23, P269; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Franceschi S, 2003, JAIDS-J ACQ IMM DEF, V34, P84, DOI 10.1097/00126334-200309010-00013; Franceschi S, 2007, CLIN INFECT DIS, V45, P510, DOI 10.1086/520022; Heard I, 2002, AIDS, V16, P1799, DOI 10.1097/00002030-200209060-00013; *INCA, 2009, EST 2010 INC CANC BR; INCA, 2006, NOM BRAS LAUD CERV C; Jamieson DJ, 2006, OBSTET GYNECOL, V107, P1023, DOI 10.1097/01.AOG.0000210237.80211.ff; Massad LS, 1999, J ACQ IMMUN DEF SYND, V21, P33, DOI 10.1097/00126334-199905010-00005; Massad LS, 2004, AM J OBSTET GYNECOL, V190, P1241, DOI 10.1016/j.ajog.2003.12.037; Orem J, 2004, CURR OPIN ONCOL, V16, P468, DOI 10.1097/00001622-200409000-00010; Palefsky JM, 2003, CURR OPIN ONCOL, V15, P382, DOI 10.1097/00001622-200309000-00007; Parham GP, 2006, GYNECOL ONCOL, V103, P1017, DOI 10.1016/j.ygyno.2006.06.015; Petersen MR, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-9; PRENDIVILLE W, 1989, BRIT J OBSTET GYNAEC, V96, P1054, DOI 10.1111/j.1471-0528.1989.tb03380.x; RICHART RM, 1990, OBSTET GYNECOL, V75, P131; Sahasrabuddhe VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008634; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; UNAIDS, 2010, AIDS EP UPD 2009; Walker P, 2003, OBSTET GYNECOL, V101, P175, DOI 10.1016/S0029-7844(02)02581-4; Yang BH, 2004, INT J CANCER, V109, P418, DOI 10.1002/ijc.11719; Zimmermmann JB, 2006, REV BRAS GINECOL OBS, V28, P345, DOI 10.1590/S0100-72032006000600005	33	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18297	10.1371/journal.pone.0018297	http://dx.doi.org/10.1371/journal.pone.0018297			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479179	Green Published, Green Submitted, gold			2022-12-27	WOS:000289055700045
J	Congiu, L; Pujolar, JM; Forlani, A; Cenadelli, S; Dupanloup, I; Barbisan, F; Galli, A; Fontana, F				Congiu, Leonardo; Pujolar, Jose Martin; Forlani, Anna; Cenadelli, Silvia; Dupanloup, Isabelle; Barbisan, Federica; Galli, Andrea; Fontana, Francesco			Managing Polyploidy in Ex Situ Conservation Genetics: The Case of the Critically Endangered Adriatic Sturgeon (Acipenser naccarii)	PLOS ONE			English	Article							POPULATION; IDENTIFICATION; MANAGEMENT; DIVERSITY	While the current expansion of conservation genetics enables to address more efficiently the management of threatened species, alternative methods for genetic relatedness data analysis in polyploid species are necessary. Within this framework, we present a standardized and simple protocol specifically designed for polyploid species that can facilitate management of genetic diversity, as exemplified by the ex situ conservation program for the tetraploid Adriatic sturgeon Acipenser naccarii. A critically endangered endemic species of the Adriatic Sea tributaries, its persistence is strictly linked to the ex situ conservation of a single captive broodstock currently decimated to about 25 individuals, which represents the last remaining population of Adriatic sturgeon of certain wild origin. The genetic variability of three F1 broodstocks available as future breeders was estimated based on mitochondrial and microsatellite information and compared with the variability of the parental generation. Genetic data showed that the F1 stocks have only retained part of the genetic variation present in the original stock due to the few parent pairs used as founders. This prompts for the urgent improvement of the current F1 stocks by incorporating new founders that better represent the genetic diversity available. Following parental allocation based on band sharing values, we set up a user-friendly tool for selection of candidate breeders according to relatedness between all possible parent-pairs that secures the use of non-related individuals. The approach developed here could also be applied to other endangered tetraploid sturgeon species overexploited for caviar production, particularly in regions lacking proper infrastructure and/or expertise.	[Congiu, Leonardo; Pujolar, Jose Martin; Forlani, Anna; Barbisan, Federica] Univ Padua, Dipartimento Biol, Padua, Italy; [Cenadelli, Silvia; Galli, Andrea] Ist Sperimentale Lazzaro Spallanzani, Rivolta Dadda, Italy; [Dupanloup, Isabelle] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Fontana, Francesco] Univ Ferrara, Dipartimento Biol, I-44100 Ferrara, Italy	University of Padua; University of Bern; University of Ferrara	Congiu, L (corresponding author), Univ Padua, Dipartimento Biol, Padua, Italy.	leonardo.congiu@unipd.it	Dupanloup, Isabelle/AAD-5372-2020; Congiu, Leonardo/G-7967-2011; Galli, Andrea/AAC-1623-2019; Dupanloup, Isabelle/O-8609-2017	Dupanloup, Isabelle/0000-0002-9258-6963; pujolar, marti/0000-0002-5037-8840; CONGIU, LEONARDO/0000-0002-9293-9837	EU [04NAT/IT/00126]; University of Padova [CPDA087543/08]	EU(European Commission); University of Padova	This work was supported by the EU Life project "Cobice" 04NAT/IT/00126 and by the University of Padova grant CPDA087543/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; Arlati G., 1988, RIV ITAL ACQUACOL, V23, P94; BRONZI P, 1994, INT C STURG BIOD CON; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Fontana F, 2001, GENETICA, V111, P359, DOI 10.1023/A:1013711919443; Forlani A, 2008, CONSERV GENET, V9, P461, DOI 10.1007/s10592-007-9335-x; GIOVANNINI G, 1991, ACIPENSER, P401; Goossens B, 2005, MOL ECOL, V14, P441, DOI 10.1111/j.1365-294X.02421.x; GULYAS T, 2000, PUBLICATIONES ESTACI, V1999, P61; Henderson-Arzapalo A, 2002, MOL ECOL NOTES, V2, P437, DOI 10.1046/j.1471-8286.2002.00262.x; Jenneckens I, 2001, J APPL ICHTHYOL, V17, P39, DOI 10.1046/j.1439-0426.2001.00234.x; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lippe C, 2006, MOL ECOL, V15, P1769, DOI 10.1111/j.1365-294X.2006.02902.x; Ludwig A, 2000, GENETICS, V156, P1933; Ludwig A, 2008, J APPL ICHTHYOL, V24, P2, DOI 10.1111/j.1439-0426.2008.01085.x; Ludwig A, 2003, MOL ECOL, V12, P3253, DOI 10.1046/j.1365-294X.2003.01999.x; Ludwig A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-221; May B, 1997, CAN J FISH AQUAT SCI, V54, P1542, DOI 10.1139/cjfas-54-7-1542; McQuown EC, 2000, T AM FISH SOC, V129, P1380, DOI 10.1577/1548-8659(2000)129&lt;1380:MAOGVI&gt;2.0.CO;2; Pikitch EK, 2005, FISH FISH, V6, P233, DOI 10.1111/j.1467-2979.2005.00190.x; Pourkazemi M, 2006, J APPL ICHTHYOL, V22, P12, DOI 10.1111/j.1439-0426.2007.00923.x; *RAMS DECL GLOB SU, 2005, J APPL ICHTHYOL, V22, P5; Russello MA, 2004, MOL ECOL, V13, P2829, DOI 10.1111/j.1365-294X.2004.02266.x; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tortonese E., 1989, FRESHWATER FISHES EU, V1, P285; Welsh AB, 2003, MOL ECOL NOTES, V3, P47, DOI 10.1046/j.1471-8286.2003.00346.x; Zane L, 2002, MOL ECOL NOTES, V2, P586, DOI 10.1046/j.1471-8286.2002.00328.x	30	35	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18249	10.1371/journal.pone.0018249	http://dx.doi.org/10.1371/journal.pone.0018249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21483472	Green Published, gold, Green Submitted			2022-12-27	WOS:000289054600038
J	Becker, NG; Wang, DC				Becker, Niels G.; Wang, Dingcheng			Can Antiviral Drugs Contain Pandemic Influenza Transmission?	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; NEURAMINIDASE INHIBITOR OSELTAMIVIR; VARIANCE HETEROGENEITY; EFFICACY; SAFETY; APPROXIMATION; PROPHYLAXIS; MANAGEMENT; HOUSEHOLDS; STOCKPILE	Antiviral drugs dispensed during the 2009 influenza pandemic generally failed to contain transmission. This poses the question of whether preparedness for a future pandemic should include plans to use antiviral drugs to mitigate transmission. Simulations using a standard transmission model that allows for infected arrivals and delayed vaccination show that attempts to contain transmission require relatively few antiviral doses. In contrast, persistent use of antiviral drugs when the reproduction number remains above 1 use very many doses and are unlikely to reduce the eventual attack rate appreciably unless the stockpile is very large. A second model, in which the community has a household structure, shows that the effectiveness of a strategy of dispensing antiviral drugs to infected households decreases rapidly with time delays in dispensing the antivirals. Using characteristics of past pandemics it is estimated that at least 80% of primary household cases must present upon show of symptoms to have a chance of containing transmission by dispensing antiviral drugs to households. To determine data needs, household outbreaks were simulated with 50% receiving antiviral drugs early and 50% receiving antiviral drugs late. A test to compare the size of household outbreaks indicates that at least 100-200 household outbreaks need to be monitored to find evidence that antiviral drugs can mitigate transmission of the newly emerged virus. Use of antiviral drugs in an early attempt to contain transmission should be part of preparedness plans for a future influenza pandemic. Data on the incidence of the first 350 cases and the eventual attack rates of the first 200 hundred household outbreaks should be used to estimate the initial reproduction number R and the effectiveness of antiviral drugs to mitigate transmission. Use of antiviral drugs to mitigate general transmission should cease if these estimates indicate that containment of transmission is unlikely.	[Becker, Niels G.; Wang, Dingcheng] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia	Australian National University	Becker, NG (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	Niels.Becker@anu.edu.au			National Health and Medical Research Council [471436]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by National Health and Medical Research Council grant 471436. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RA, 1994, J EDUC STAT, V19, P91, DOI 10.3102/10769986019002091; Bailey NTJ, 1975, MATH THEORY INFECT D; Ball F, 2006, STAT METHODS MED RES, V15, P481, DOI 10.1177/0962280206071643; Barnes B, 2007, MATH BIOSCI, V209, P403, DOI 10.1016/j.mbs.2007.02.008; BARTOSZYNSKI R, 1972, APPL MATH, V13, P139; Becker N G, 2010, Euro Surveill, V15; BECKER NG, 1995, MATH BIOSCI, V127, P207, DOI 10.1016/0025-5564(94)00055-5; BECKER NG, 1989, ANAL INFECT DIS DATA; Caley P, 2008, J R SOC INTERFACE, V5, P631, DOI 10.1098/rsif.2007.1197; Cheng MH, 2005, LANCET INFECT DIS, V5, P746, DOI 10.1016/S1473-3099(05)70290-5; Cowling BJ, 2010, EPIDEMIOLOGY, V21, P842, DOI 10.1097/EDE.0b013e3181f20977; Esveld M, 2006, VACCINE, V24, P6793, DOI 10.1016/j.vaccine.2006.06.068; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Glass K, 2009, J R SOC INTERFACE, V6, P695, DOI 10.1098/rsif.2008.0404; Harrod ME, 2006, MED J AUSTRALIA, V185, pS58; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hayden FG, 1996, JAMA-J AM MED ASSOC, V275, P295, DOI 10.1001/jama.275.4.295; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Hayden FG, 1997, NEW ENGL J MED, V337, P874, DOI 10.1056/NEJM199709253371302; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Lett D, 2005, CAN MED ASSOC J, V172, P1167, DOI 10.1503/cmaj.050332; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mccaw JM, 2007, MATH BIOSCI, V209, P336, DOI 10.1016/j.mbs.2007.02.003; Mercer GN, 2011, STAT MED, V30, P984, DOI 10.1002/sim.4174; MERCER GN, 2010, STAT MED IN PRESS; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Schneider PJ, 1997, J EXP EDUC, V65, P271, DOI 10.1080/00220973.1997.9943459; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748	31	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17764	10.1371/journal.pone.0017764	http://dx.doi.org/10.1371/journal.pone.0017764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464934	Green Submitted, Green Published, gold			2022-12-27	WOS:000289053800003
J	Blackburn, MB; Martin, PAW; Kuhar, D; Farrar, RR; Gundersen-Rindal, DE				Blackburn, Michael B.; Martin, Phyllis A. W.; Kuhar, Daniel; Farrar, Robert R., Jr.; Gundersen-Rindal, Dawn E.			The Occurrence of Photorhabdus-Like Toxin Complexes in Bacillus thuringiensis	PLOS ONE			English	Article							INSECTICIDAL TOXINS; SEQUENCE; GENES; AGENT; SOIL	Recently, genomic sequencing of a Bacillus thuringiensis (Bt) isolate from our collection revealed the presence of an apparent operon encoding an insecticidal toxin complex (Tca) similar to that first described from the entomopathogen Photorhabdus luminescens. To determine whether these genes are widespread among Bt strains, we screened isolates from the collection for the presence of tccC, one of the genes needed for the expression of fully functional toxin complexes. Among 81 isolates chosen to represent commonly encountered biochemical phenotypes, 17 were found to possess a tccC. Phylogenetic analysis of the 81 isolates by multilocus sequence typing revealed that all the isolates possessing a tccC gene were restricted to two sequence types related to Bt varieties morrisoni, tenebrionis, israelensis and toumanoffi. Sequencing of the similar to 17 kb tca operon from two isolates representing each of the two sequence types revealed >99% sequence identity. Optical mapping of DNA from Bt isolates representing each of the sequence types revealed nearly identical plasmids of ca. 333 and 338 kbp, respectively. Selected isolates were found to be toxic to gypsy moth larvae, but were not as effective as a commercial strain of Bt kurstaki. Some isolates were found to inhibit growth of Colorado potato beetle. Custom Taqman (R) relative quantitative real-time PCR assays for Tc-encoding Bt revealed both tcaA and tcaB genes were expressed within infected gypsy moth larvae.	[Blackburn, Michael B.; Martin, Phyllis A. W.; Kuhar, Daniel; Farrar, Robert R., Jr.; Gundersen-Rindal, Dawn E.] Henry A Wallace Beltsville Agr Res Ctr, USDA, ARS, Invas Insect Biocontrol & Behav Lab, Beltsville, MD USA	United States Department of Agriculture (USDA)	Blackburn, MB (corresponding author), Henry A Wallace Beltsville Agr Res Ctr, USDA, ARS, Invas Insect Biocontrol & Behav Lab, Beltsville, MD USA.	mike.blackburn@ars.usda.gov	huang, tiffany/F-9764-2012	Blackburn, Michael/0000-0001-5541-4831	Agricultural Research Service of the USDA	Agricultural Research Service of the USDA(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The research was fully funded by the Agricultural Research Service of the USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atlas RM., 2004, HDB MICROBIOLOGICAL; BAUM JA, 2010, Patent No. 7662940; Bell RA., 1981, USDA TECH B, P599; Bizzarri MF, 2008, MICROB ECOL, V56, P133, DOI 10.1007/s00248-007-9331-1; Blackburn MB, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.32; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Gelman D B, 2001, J Insect Sci, V1, P7; HEY TD, 2009, Patent No. 7491698; Hurst MRH, 2000, J BACTERIOL, V182, P5127, DOI 10.1128/JB.182.18.5127-5138.2000; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Martin PAW, 2004, BIOL CONTROL, V29, P109, DOI 10.1016/S1049-9644(03)00125-7; Martin PAW, 2010, SYST APPL MICROBIOL, V33, P204, DOI 10.1016/j.syapm.2010.04.002; Morgan JAW, 2001, APPL ENVIRON MICROB, V67, P2062, DOI 10.1128/AEM.67.5.2062-2069.2001; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Reslewic S, 2005, APPL ENVIRON MICROB, V71, P5511, DOI 10.1128/AEM.71.9.5511-5522.2005; TRAVERS RS, 1987, APPL ENVIRON MICROB, V53, P1263, DOI 10.1128/AEM.53.6.1263-1266.1987; Waterfield N, 2005, CELL MICROBIOL, V7, P373, DOI 10.1111/j.1462-5822.2004.00467.x; Waterfield NR, 2001, TRENDS MICROBIOL, V9, P185, DOI 10.1016/S0966-842X(01)01978-3	21	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18122	10.1371/journal.pone.0018122	http://dx.doi.org/10.1371/journal.pone.0018122			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464948	Green Published, gold, Green Submitted			2022-12-27	WOS:000288813900041
J	Pinto, VV; Ditlev, SB; Jensen, KE; Resende, M; Dahlback, M; Andersen, G; Andersen, P; Theander, TG; Salanti, A; Nielsen, MA				Pinto, Vera V.; Ditlev, Sisse B.; Jensen, Kamilla E.; Resende, Mafalda; Dahlback, Madeleine; Andersen, Gorm; Andersen, Pernille; Theander, Thor G.; Salanti, Ali; Nielsen, Morten A.			Differential Induction of Functional IgG Using the Plasmodium falciparum Placental Malaria Vaccine Candidate VAR2CSA	PLOS ONE			English	Article							PREGNANCY-ASSOCIATED MALARIA; CROSS-REACTIVE ANTIBODIES; CHONDROITIN-SULFATE-A; IMMUNOGLOBULIN-G; STRUCTURAL BASIS; CELL-SURFACE; B-CELLS; BINDING; PARASITES; EPITOPES	Background: In Plasmodium falciparum malaria endemic areas placental malaria (PM) is an important complication of malaria. The recurrence of malaria in primigravidae women irrespective of acquired protection during childhood is caused by the interaction between the parasite-expressed VAR2CSA antigen and chondroitin sulfate A (CSA) in the placental intervillous space and lack of protective antibodies. PM impairs fetal development mainly by excessive inflammation processes. After infections during pregnancy women acquire immunity to PM conferred by antibodies against VAR2CSA. Ideally, a vaccine against PM will induce antibody-mediated immune responses that block the adhesion of infected erythrocytes (IE) in the placenta. Principal Findings: We have previously shown that antibodies raised in rat against individual domains of VAR2CSA can block IE binding to CSA. In this study we have immunized mice, rats and rabbits with each individual domain and the full-length protein corresponding to the FCR3 VAR2CSA variant. We found there is an inherently higher immunogenicity of C-terminal domains compared to N-terminally located domains. This was irrespective of whether antibodies were induced against single domains or the full-length protein. Species-specific antibody responses were also found, these were mainly directed against single domains and not the full-length VAR2CSA protein. Conclusions/Significance: Binding inhibitory antibodies appeared to be against conformational B-cell epitopes. Nonbinding inhibitory antibodies reacted highly against the C-terminal end of the VAR2CSA molecule especially the highly polymorphic DBL6 epsilon domain. Differential species-specific induction of antibody responses may allow for more direct analysis of functional versus non-functional B-cell epitopes.	[Pinto, Vera V.; Ditlev, Sisse B.; Jensen, Kamilla E.; Resende, Mafalda; Dahlback, Madeleine; Andersen, Gorm; Andersen, Pernille; Theander, Thor G.; Salanti, Ali; Nielsen, Morten A.] Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Pinto, Vera V.; Ditlev, Sisse B.; Jensen, Kamilla E.; Resende, Mafalda; Dahlback, Madeleine; Andersen, Gorm; Andersen, Pernille; Theander, Thor G.; Salanti, Ali; Nielsen, Morten A.] Rigshosp, Copenhagen Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen	Pinto, VV (corresponding author), Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	mortenn@sund.ku.dk	Theander, Thor/F-6714-2015	Theander, Thor/0000-0002-3509-7514; Salanti, Ali/0000-0003-2207-5575; Nielsen, Morten Agertoug/0000-0003-2668-4992; Ditlev, Sisse Bolm/0000-0003-4417-9711	Bill and Melinda Gates Foundation [47029]; Danish Research Council (SSVF) [22-03-0333]; Novo Nordisk Foundation [10335]; Danish Research Council for Development Research (RUF) [104.Dan.8.L.306, 8.L.306]; PreMalStruct [FP7-HEALTH-2007-A ID 201222]; University of Copenhagen	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Danish Research Council (SSVF)(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Research Council for Development Research (RUF); PreMalStruct; University of Copenhagen	This study received funding primarily from the PMI2 (#47029) Gates Malaria Programme grant from the Bill and Melinda Gates Foundation. The work was also supported by the Danish Research Council (SSVF) (grant 22-03-0333), The Novo Nordisk Foundation (grant 10335), the Danish Research Council for Development Research (RUF) (grant 104.Dan.8.L.306 and 8.L.306), The PreMalStruct FP7-HEALTH-2007-A ID 201222 and The University of Copenhagen Program of Excellence (Membrane topology and quaternary structure of key parasite proteins involved in Plasmodium falciparum malaria pathogenesis and immunity). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, IMMUNOL CELL BIOL, V87, P279, DOI 10.1038/icb.2009.14; Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; Avril M, 2008, INFECT IMMUN, V76, P1791, DOI 10.1128/IAI.01470-07; Avril M, 2010, INFECT IMMUN, V78, P2248, DOI 10.1128/IAI.00410-09; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Barfod L, 2006, INFECT IMMUN, V74, P4357, DOI 10.1128/IAI.01617-05; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Duffy MF, 2006, MOL BIOCHEM PARASIT, V148, P117, DOI 10.1016/j.molbiopara.2006.03.006; Fernandez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012558; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Fried Michal, 2002, Methods Mol Med, V72, P555, DOI 10.1385/1-59259-271-6:555; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Guinovart C, 2007, AM J TROP MED HYG, V77, P276, DOI 10.4269/ajtmh.2007.77.276; Haase RN, 2006, INFECT IMMUN, V74, P3035, DOI 10.1128/IAI.74.5.3035-3038.2006; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Hviid L, 2005, ACTA TROP, V95, P270, DOI 10.1016/j.actatropica.2005.06.012; Jimenez-Diaz MB, 2009, ANTIMICROB AGENTS CH; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Kriek N, 2003, MOL MICROBIOL, V50, P1215, DOI 10.1046/j.1365-2958.2003.03784.x; Magistrado P, 2008, J INFECT DIS, V198, P1071, DOI 10.1086/591502; Magistrado PA, 2011, VACCINE, V29, P437, DOI 10.1016/j.vaccine.2010.10.080; Ndam NGT, 2006, J INFECT DIS, V193, P713, DOI 10.1086/500146; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Nielsen MA, 2007, EXP PARASITOL, V117, P1, DOI 10.1016/j.exppara.2007.03.002; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Oleinikov AV, 2008, J INFECT DIS, V197, P1119, DOI 10.1086/529526; Paus D, 2006, P NATL ACAD SCI USA, V103, P9172, DOI 10.1073/pnas.0600263103; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; SURH CD, 1990, J IMMUNOL, V144, P2647; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622	42	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17942	10.1371/journal.pone.0017942	http://dx.doi.org/10.1371/journal.pone.0017942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464946	Green Published, Green Submitted, gold			2022-12-27	WOS:000288813900022
J	El-Kereamy, A; El-Sharkawy, I; Ramamoorthy, R; Taheri, A; Errampalli, D; Kumar, P; Jayasankar, S				El-Kereamy, Ashraf; El-Sharkawy, Islam; Ramamoorthy, Rengasamy; Taheri, Ali; Errampalli, Deena; Kumar, Prakash; Jayasankar, Subramanian			Prunus domestica Pathogenesis-Related Protein-5 Activates the Defense Response Pathway and Enhances the Resistance to Fungal Infection	PLOS ONE			English	Article							THAUMATIN-LIKE PROTEIN; PHYTOALEXIN-DEFICIENT MUTANTS; TRANSGENIC WHEAT PLANTS; ARABIDOPSIS-THALIANA; CAMALEXIN BIOSYNTHESIS; DISEASE RESISTANCE; ACCUMULATION; ANTIFUNGAL; EXPRESSION; GENES	Pathogenesis-related protein-5 (PR-5) has been implicated in plant disease resistance and its antifungal activity has been demonstrated in some fruit species. However, their roles, especially their interactions with the other defense responses in plant cells, are still not fully understood. In this study, we have cloned and characterized a new PR-5 cDNA named PdPR5-1 from the European plum (Prunus domestica). Expression of PdPR5-1 was studied in different cultivars varying in resistance to the brown rot disease caused by the necrotrophic fungus Monilinia fructicola. In addition transgenic Arabidopsis, ectopically expressing PdPR5-1 was used to study its role in other plant defense responses after fungal infection. We show that the resistant cultivars exhibited much higher levels of transcripts than the susceptible cultivars during fruit ripening. However, significant rise in the transcript levels after infection with M. fructicola was observed in the susceptible cultivars too. Transgenic Arabidopsis plants exhibited more resistance to Alternaria brassicicola. Further, there was a significant increase in the transcripts of genes involved in the phenylpropanoid biosynthesis pathway such as phenylalanine ammonia-lyase (PAL) and phytoalexin (camalexin) pathway leading to an increase in camalexin content after fungal infection. Our results show that PdPR5-1 gene, in addition to its anti-fungal properties, has a possible role in activating other defense pathways, including phytoalexin production.	[El-Kereamy, Ashraf; El-Sharkawy, Islam; Jayasankar, Subramanian] Univ Guelph, Dept Plant Agr, Vineland Stn, ON, Canada; [Ramamoorthy, Rengasamy; Kumar, Prakash] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Taheri, Ali] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada; [Errampalli, Deena] Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, Vineland Stn, ON, Canada	University of Guelph; National University of Singapore; University of Guelph; Agriculture & Agri Food Canada	El-Kereamy, A (corresponding author), Univ Guelph, Dept Plant Agr, Vineland Stn, ON, Canada.	jsubrama@uoguelph.ca	Ramamoorthy, Rengasamy/C-2656-2011; Ramamoorthy, Rengasamy/AAW-8518-2020; Ramamoorthy, Rengasamy/L-3982-2015; EL-KEREAMY, ASHRAF/GON-9302-2022; Kumar, Prakash P/A-6236-2009	Ramamoorthy, Rengasamy/0000-0003-1045-9109; Ramamoorthy, Rengasamy/0000-0003-1045-9109; Kumar, Prakash P/0000-0002-0963-1664; Taheri, Ali/0000-0002-4019-7982	Ministry of Research and Innovation; OMAFRA	Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); OMAFRA	These studies were funded by an ERA grant by Ministry of Research and Innovation and OMAFRA SP2 grant to SJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2003, J EXP BOT, V54, P1101, DOI 10.1093/jxb/erg110; Barre A, 2000, PLANTA, V211, P791, DOI 10.1007/s004250000354; Boss PK, 1996, PLANT PHYSIOL, V111, P1059, DOI 10.1104/pp.111.4.1059; BROWNE LM, 1991, TETRAHEDRON, V47, P3909, DOI 10.1016/S0040-4020(01)86431-0; Chen WP, 1999, THEOR APPL GENET, V99, P755, DOI 10.1007/s001220051294; Christensen AB, 2002, MOL PLANT PATHOL, V3, P135, DOI 10.1046/j.1364-3703.2002.00105.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Datta K, 1999, THEOR APPL GENET, V98, P1138, DOI 10.1007/s001220051178; Denby KJ, 2005, PLANT J, V41, P673, DOI 10.1111/j.1365-313X.2005.02327.x; Dhekney SA, 2010, 12 WORLD C INT ASS P; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; El Oirdi M, 2010, ENVIRON MICROBIOL, V12, P239, DOI 10.1111/j.1462-2920.2009.02063.x; FilsLycaon BR, 1996, PLANT PHYSIOL, V111, P269, DOI 10.1104/pp.111.1.269; Fu DL, 2005, PLANT SCI, V168, P671, DOI 10.1016/j.plantsci.2004.09.032; Glawischnig E, 2006, BIOCHEM SOC T, V34, P1206, DOI 10.1042/BST0341206; Glawischnig E, 2004, P NATL ACAD SCI USA, V101, P8245, DOI 10.1073/pnas.0305876101; Glawischnig E, 2007, PHYTOCHEMISTRY, V68, P401, DOI 10.1016/j.phytochem.2006.12.005; GLAZEBROOK J, 1994, P NATL ACAD SCI USA, V91, P8955, DOI 10.1073/pnas.91.19.8955; Glazebrook J, 1997, GENETICS, V146, P381; GUSTINE DL, 1978, PLANT PHYSIOL, V61, P226, DOI 10.1104/pp.61.2.226; HAIN R, 1993, NATURE, V361, P153, DOI 10.1038/361153a0; He XZ, 2000, PLANT CELL, V12, P1689, DOI 10.1105/tpc.12.9.1689; Hoffmann-Sommergruber K, 2002, BIOCHEM SOC T, V30, P930, DOI 10.1042/BST0300930; Hu X, 1997, PLANT MOL BIOL, V34, P949, DOI 10.1023/A:1005893119263; HU X, 1995, PLANT PHYSIOL, V107, P305, DOI 10.1104/pp.107.1.305; Hull AK, 2000, P NATL ACAD SCI USA, V97, P2379, DOI 10.1073/pnas.040569997; Jayasankar S, 2003, FUNCT PLANT BIOL, V30, P1105, DOI 10.1071/FP03066; Kiefer E, 2000, PLANT MOL BIOL REP, V18, P33, DOI 10.1007/BF02825291; Koga J, 2006, PLANT PHYSIOL, V140, P1475, DOI 10.1104/pp.105.070334; Koiwa H, 1997, PLANT CELL PHYSIOL, V38, P783, DOI 10.1093/oxfordjournals.pcp.a029236; Koiwa H, 1999, J MOL BIOL, V286, P1137, DOI 10.1006/jmbi.1998.2540; Krebitz M, 2003, J MOL BIOL, V329, P721, DOI 10.1016/S0022-2836(03)00403-0; Ladyzhenskaia E P, 2006, Prikl Biokhim Mikrobiol, V42, P462; LAWTON MA, 1987, MOL CELL BIOL, V7, P335, DOI 10.1128/MCB.7.1.335; LIU D, 1994, P NATL ACAD SCI USA, V91, P1888, DOI 10.1073/pnas.91.5.1888; Mackintosh CA, 2007, PLANT CELL REP, V26, P479, DOI 10.1007/s00299-006-0265-8; Malitsky S, 2008, PLANT PHYSIOL, V148, P2021, DOI 10.1104/pp.108.124784; Narasimhan ML, 2005, MOL CELL, V17, P171, DOI 10.1016/j.molcel.2004.11.050; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Pedras MSC, 2006, PHYTOCHEMISTRY, V67, P1503, DOI 10.1016/j.phytochem.2006.05.020; Rowe HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000861; Sakamoto Y, 2006, PLANT PHYSIOL, V141, P793, DOI 10.1104/pp.106.076679; Salzman RA, 1998, PLANT PHYSIOL, V117, P465, DOI 10.1104/pp.117.2.465; Saunders JA, 2004, BIOCONTROL, V49, P715, DOI 10.1007/s10526-004-5281-4; Schuhegger R, 2007, J PLANT PHYSIOL, V164, P636, DOI 10.1016/j.jplph.2006.04.012; Schuhegger R, 2006, PLANT PHYSIOL, V141, P1248, DOI 10.1104/pp.106.082024; Seo PJ, 2008, PLANT CELL PHYSIOL, V49, P334, DOI 10.1093/pcp/pcn011; SHOWALTER AM, 1985, P NATL ACAD SCI USA, V82, P6551, DOI 10.1073/pnas.82.19.6551; Tattersall DB, 1997, PLANT PHYSIOL, V114, P759, DOI 10.1104/pp.114.3.759; TSUJI J, 1992, PLANT PHYSIOL, V98, P1304, DOI 10.1104/pp.98.4.1304; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; VANDERWEL H, 1972, EUR J BIOCHEM, V31, P221; Velazhahan R., 2001, Acta Phytopathologica et Entomologica Hungarica, V36, P311, DOI 10.1556/APhyt.36.2001.3-4.12; VIGERS AJ, 1992, PLANT SCI, V83, P155, DOI 10.1016/0168-9452(92)90074-V; Wang HX, 2002, PHYTOCHEMISTRY, V61, P1, DOI 10.1016/S0031-9422(02)00144-9; WHITEHEAD IM, 1982, PLANTA, V154, P156, DOI 10.1007/BF00387910; Yun DJ, 1998, MOL CELL, V1, P807, DOI 10.1016/S1097-2765(00)80080-5; Zhao JM, 1998, PLANT CELL, V10, P359, DOI 10.1105/tpc.10.3.359; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419	60	62	73	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17973	10.1371/journal.pone.0017973	http://dx.doi.org/10.1371/journal.pone.0017973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448276	Green Published, gold, Green Submitted			2022-12-27	WOS:000288810500025
J	Espeseth, AS; Fishel, R; Hazuda, D; Huang, QA; Xu, M; Yoder, K; Zhou, HL				Espeseth, Amy S.; Fishel, Rick; Hazuda, Daria; Huang, Qian; Xu, Min; Yoder, Kristine; Zhou, Honglin			siRNA Screening of a Targeted Library of DNA Repair Factors in HIV Infection Reveals a Role for Base Excision Repair in HIV Integration	PLOS ONE			English	Article							RETROVIRAL DNA; T-CELLS; VIRUS; REPLICATION; PROTEINS; IDENTIFICATION; ACCUMULATION; TRANSDUCTION; POLYMERASE; MECHANISMS	Host DNA repair enzymes have long been assumed to play a role in HIV replication, and many different DNA repair factors have been associated with HIV. In order to identify DNA repair pathways required for HIV infection, we conducted a targeted siRNA screen using 232 siRNA pools for genes associated with DNA repair. Mapping the genes targeted by effective siRNA pools to well-defined DNA repair pathways revealed that many of the siRNAs targeting enzymes associated with the short patch base excision repair (BER) pathway reduced HIV infection. For six siRNA pools targeting BER enzymes, the negative effect of mRNA knockdown was rescued by expression of the corresponding cDNA, validating the importance of the gene in HIV replication. Additionally, mouse embryo fibroblasts (MEFs) lacking expression of specific BER enzymes had decreased transduction by HIV-based retroviral vectors. Examining the role BER enzymes play in HIV infection suggests a role for the BER pathway in HIV integration.	[Espeseth, Amy S.; Hazuda, Daria; Huang, Qian; Xu, Min; Zhou, Honglin] Merck Res Labs, Dept Antiviral Res, West Point, PA 19486 USA; [Fishel, Rick; Yoder, Kristine] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	Merck & Company; University System of Ohio; Ohio State University	Espeseth, AS (corresponding author), Merck Res Labs, Dept Antiviral Res, West Point, PA 19486 USA.	Amy.Espeseth@merck.com; Daria.Hazuda@merck.com	Yoder, Kristine/E-4353-2011	Yoder, Kristine/0000-0002-5598-9018	National Institutes of Health [AI82422]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	KY and RF are supported by National Institutes of Health grant AI82422. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amouroux R, 2010, NUCLEIC ACIDS RES, V38, P2878, DOI 10.1093/nar/gkp1247; Aukrust P, 2005, BLOOD, V105, P4730, DOI 10.1182/blood-2004-11-4272; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; Daniel R, 2005, J VIROL, V79, P2058, DOI 10.1128/JVI.79.4.2058-2065.2005; Daniel R, 2004, J VIROL, V78, P8573, DOI 10.1128/JVI.78.16.8573-8581.2004; Daniel R, 1999, SCIENCE, V284, P644, DOI 10.1126/science.284.5414.644; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Gotte M, 1999, ARCH BIOCHEM BIOPHYS, V365, P199, DOI 10.1006/abbi.1999.1209; Hazuda DJ, 2004, P NATL ACAD SCI USA, V101, P11233, DOI 10.1073/pnas.0402357101; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Imai K, 2005, J BIOL CHEM, V280, P26701, DOI 10.1074/jbc.M503313200; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kameoka M, 2004, J VIROL, V78, P8931, DOI 10.1128/JVI.78.16.8931-8934.2004; Kilzer JM, 2003, VIROLOGY, V314, P460, DOI 10.1016/S0042-6822(03)00455-0; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Smith JA, 2006, ACS CHEM BIOL, V1, P217, DOI 10.1021/cb600131q; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Srivastava DK, 2001, AIDS, V15, P433, DOI 10.1097/00002030-200103090-00001; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; Waninger S, 2004, J VIROL, V78, P12829, DOI 10.1128/JVI.78.23.12829-12837.2004; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834; Yan N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000327; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; YODER K, 2010, PLOS ONE IN PRESS; Yoder KE, 2000, J VIROL, V74, P11191, DOI 10.1128/JVI.74.23.11191-11200.2000; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	38	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17612	10.1371/journal.pone.0017612	http://dx.doi.org/10.1371/journal.pone.0017612			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448273	gold, Green Published, Green Submitted			2022-12-27	WOS:000288810500009
J	Gray, ER; Garson, JA; Breuer, J; Edwards, S; Kellam, P; Pillay, D; Towers, GJ				Gray, Eleanor R.; Garson, Jeremy A.; Breuer, Judith; Edwards, Simon; Kellam, Paul; Pillay, Deenan; Towers, Greg J.			No Evidence of XMRV or Related Retroviruses in a London HIV-1-Positive Patient Cohort	PLOS ONE			English	Article							VIRUS-RELATED VIRUS; CHRONIC-FATIGUE-SYNDROME; PROSTATE-CANCER; INFECTIOUS RETROVIRUS; BLOOD-CELLS; MOUSE DNA; CONTAMINATION; PREVALENCE; SEQUENCES; TISSUE	Background: Several studies have implicated a recently discovered gammaretrovirus, XMRV (Xenotropic murine leukaemia virus-related virus), in chronic fatigue syndrome and prostate cancer, though whether as causative agent or opportunistic infection is unclear. It has also been suggested that the virus can be found circulating amongst the general population. The discovery has been controversial, with conflicting results from attempts to reproduce the original studies. Methodology/Principal Findings: We extracted peripheral blood DNA from a cohort of 540 HIV-1-positive patients (approximately 20% of whom have never been on anti-retroviral treatment) and determined the presence of XMRV and related viruses using TaqMan PCR. While we were able to amplify as few as 5 copies of positive control DNA, we did not find any positive samples in the patient cohort. Conclusions/Significance: In view of these negative findings in this highly susceptible group, we conclude that it is unlikely that XMRV or related viruses are circulating at a significant level, if at all, in HIV-1-positive patients in London or in the general population.	[Gray, Eleanor R.; Garson, Jeremy A.; Breuer, Judith; Kellam, Paul; Pillay, Deenan; Towers, Greg J.] UCL, Dept Infect & Immun, London, England; [Edwards, Simon] Camden Primary Care Trust, Mortimer Market Ctr, London, England; [Kellam, Paul] Wellcome Trust Sanger Inst, Cambridge, England	University of London; University College London; Wellcome Trust Sanger Institute	Gray, ER (corresponding author), UCL, Dept Infect & Immun, London, England.	e.gray@ucl.ac.uk	Towers, Greg J/H-8892-2012; Garson, Jeremy A/C-5357-2008	Garson, Jeremy/0000-0003-0553-0126; Towers, Gregory/0000-0002-7707-0264; Kellam, Paul/0000-0003-3166-4734; Gray, Eleanor/0000-0002-6515-839X; Breuer, Judith/0000-0001-8246-0534	Department of Health's NIHR Biomedical Research Centres; Wellcome Trust [WT090940]; Medical Research Council; Medical Research Council [G0801172, G9721629] Funding Source: researchfish; MRC [G0801172, G9721629] Funding Source: UKRI	Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was undertaken at UCLH/UCL, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. Additional funding was provided by a Wellcome Trust Senior Fellowship WT090940 to GJT and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi SM, 2007, PAK J MED SCI, V23, P510; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Barnes E, 2010, J INFECT DIS, V202, P1482, DOI 10.1086/657167; Cornelissen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012040; Danielson BP, 2010, J INFECT DIS, V202, P1470, DOI 10.1086/656146; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Henrich TJ, 2010, J INFECT DIS, V202, P1478, DOI 10.1086/657168; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Jeziorski E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-63; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Kunstman KJ, 2010, AIDS, V24, P1784, DOI 10.1097/QAD.0b013e32833b76fb; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Luczkowiak J, 2011, EMERG INFECT DIS, V17, P314, DOI 10.3201/eid1702.100978; McCormick AL, 2008, NEUROLOGY, V70, P278, DOI 10.1212/01.wnl.0000297552.13219.b4; Ngo-Giang-Huong N, 2010, INT J INFECT DIS, V14, pE602, DOI 10.1016/j.ijid.2009.09.002; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; Quiros-Roldan E, 2003, INFECTION, V31, P172, DOI 10.1007/s15010-003-3122-5; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Singh IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009948; Sulkowski MS, 2008, J HEPATOL, V48, P353, DOI 10.1016/j.jhep.2007.11.009; Tsang J, 2009, AIDS, V23, P2255, DOI 10.1097/QAD.0b013e328331a4ce; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; Weiss RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-124	32	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18096	10.1371/journal.pone.0018096	http://dx.doi.org/10.1371/journal.pone.0018096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448291	Green Published, gold, Green Submitted			2022-12-27	WOS:000288810500034
J	Meijer, K; de Vries, M; Al-Lahham, S; Bruinenberg, M; Weening, D; Dijkstra, M; Kloosterhuis, N; van der Leij, RJ; van der Want, H; Kroesen, BJ; Vonk, R; Rezaee, F				Meijer, Kees; de Vries, Marcel; Al-Lahham, Saad; Bruinenberg, Marcel; Weening, Desiree; Dijkstra, Martijn; Kloosterhuis, Niels; van der Leij, Roelof Jan; van der Want, Han; Kroesen, Bart-Jan; Vonk, Roel; Rezaee, Farhad			Human Primary Adipocytes Exhibit Immune Cell Function: Adipocytes Prime Inflammation Independent of Macrophages	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ADIPOSE-TISSUE; INSULIN-RESISTANCE; DENSITY-LIPOPROTEIN; OBESITY; EXPRESSION; LEPTIN; GENES	Background: Obesity promotes inflammation in adipose tissue (AT) and this is implicated in pathophysiological complications such as insulin resistance, type 2 diabetes and cardiovascular disease. Although based on the classical hypothesis, necrotic AT adipocytes (ATA) in obese state activate AT macrophages (ATM) that then lead to a sustained chronic inflammation in AT, the link between human adipocytes and the source of inflammation in AT has not been in-depth and systematically studied. So we decided as a new hypothesis to investigate human primary adipocytes alone to see whether they are able to prime inflammation in AT. Methods and Results: Using mRNA expression, human preadipocytes and adipocytes express the cytokines/chemokines and their receptors, MHC II molecule genes and 14 acute phase reactants including C-reactive protein. Using multiplex ELISA revealed the expression of 50 cytokine/chemokine proteins by human adipocytes. Upon lipopolysaccharide stimulation, most of these adipocyte-associated cytokines/chemokines and immune cell modulating receptors were up-regulated and a few down-regulated such as (ICAM-1, VCAM-1, MCP-1, IP-10, IL-6, IL-8, TNF-alpha and TNF-beta highly up-regulated and IL-2, IL-7, IL-10, IL-13 and VEGF down-regulated. In migration assay, human adipocyte-derived chemokines attracted significantly more CD4+ T cells than controls and the number of migrated CD4+ cells was doubled after treating the adipocytes with LPS. Neutralizing MCP-1 effect produced by adipocytes reduced CD4+ migration by approximately 30%. Conclusion: Human adipocytes express many cytokines/chemokines that are biologically functional. They are able to induce inflammation and activate CD4+ cells independent of macrophages. This suggests that the primary event in the sequence leading to chronic inflammation in AT is metabolic dysfunction in adipocytes, followed by production of immunological mediators by these adipocytes, which is then exacerbated by activated ATM, activation and recruitment of immune cells. This study provides novel knowledge about the prime of inflammation in human obese adipose tissue, opening a new avenue of investigations towards obesity-associated type 2 diabetes.	[Meijer, Kees; de Vries, Marcel; Al-Lahham, Saad; Weening, Desiree; Dijkstra, Martijn; Kloosterhuis, Niels; Vonk, Roel; Rezaee, Farhad] Univ Groningen, Ctr Med Biom, Univ Med Ctr Groningen, Groningen, Netherlands; [Bruinenberg, Marcel] Univ Groningen, Dept Med Genet, Univ Med Ctr Groningen, Groningen, Netherlands; [van der Leij, Roelof Jan; Kroesen, Bart-Jan] Univ Groningen, Dept Pathol & Med Biol, Univ Med Ctr Groningen, Groningen, Netherlands; [van der Want, Han] Univ Groningen, Ctr Imaging, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Meijer, K (corresponding author), Univ Groningen, Ctr Med Biom, Univ Med Ctr Groningen, Groningen, Netherlands.	f.rezaee@med.umcg.nl		Meijer, Kees/0000-0002-6430-0155	Netherlands Proteomic Centre [6.3]; TI Pharma [T2-105]	Netherlands Proteomic Centre; TI Pharma	This work was supported by the Netherlands Proteomic Centre (project 6.3.) and TI Pharma (T2-105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2007, MOL CELL PROTEOMICS, V6, P1257, DOI 10.1074/mcp.M600476-MCP200; Alfonso C, 2000, ANNU REV IMMUNOL, V18, P113, DOI 10.1146/annurev.immunol.18.1.113; BOYDEN SV, 1962, IMMUNOLOGY, V5, P370; Christensen P, 2005, THERIOGENOLOGY, V63, P992, DOI 10.1016/j.theriogenology.2004.05.026; Considine RV, 1996, CLIN CHEM, V42, P843; ECKEL RH, 1992, DIABETES, V41, P641, DOI 10.2337/diabetes.41.5.641; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Rezaee F, 2006, PROTEOMICS, V6, P721, DOI 10.1002/pmic.200500191; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Sartipy P, 2003, J BIOL CHEM, V278, P52298, DOI 10.1074/jbc.M306922200; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Schwarz BA, 2006, IMMUNOL REV, V209, P47, DOI 10.1111/j.0105-2896.2006.00350.x; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Skurk T, 2005, ENDOCRINOLOGY, V146, P1006, DOI 10.1210/en.2004-0924; Skurk T, 2005, EUR J ENDOCRINOL, V152, P863, DOI 10.1530/eje.1.01897; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Trayhurn P, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2007.00316.x; Tzanavari T, 2007, MOL CELL ENDOCRINOL, V279, P26, DOI 10.1016/j.mce.2007.08.015; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yeh ETH, 2001, CIRCULATION, V104, P974, DOI 10.1161/01.CIR.104.9.974	28	155	159	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17154	10.1371/journal.pone.0017154	http://dx.doi.org/10.1371/journal.pone.0017154			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448265	Green Published, gold, Green Submitted			2022-12-27	WOS:000288810500002
J	Satoh, K; Shimizu, T; Kondoh, H; Hiraguri, A; Sasaya, T; Choi, IR; Omura, T; Kikuchi, S				Satoh, Kouji; Shimizu, Takumi; Kondoh, Hiroaki; Hiraguri, Akihiro; Sasaya, Takahide; Choi, Il-Ryong; Omura, Toshihiro; Kikuchi, Shoshi			Relationship between Symptoms and Gene Expression Induced by the Infection of Three Strains of Rice dwarf virus	PLOS ONE			English	Article							DEFENSE-RELATED GENES; NAC-DOMAIN PROTEIN; TRANSCRIPTION FACTOR; EVOLUTIONARY EXPANSION; SIGNALING PATHWAYS; SALICYLIC-ACID; MOSAIC-VIRUS; BIOSYNTHESIS; RESISTANCE; OVEREXPRESSION	Background: Rice dwarf virus (RDV) is the causal agent of rice dwarf disease, which often results in severe yield losses of rice in East Asian countries. The disease symptoms are stunted growth, chlorotic specks on leaves, and delayed and incomplete panicle exsertion. Three RDV strains, O, D84, and S, were reported. RDV-S causes the most severe symptoms, whereas RDV-O causes the mildest. Twenty amino acid substitutions were found in 10 of 12 virus proteins among three RDV strains. Methodology/Principal Findings: We analyzed the gene expression of rice in response to infection with the three RDV strains using a 60-mer oligonucleotide microarray to examine the relationship between symptom severity and gene responses. The number of differentially expressed genes (DEGs) upon the infection of RDV-O, -D84, and -S was 1985, 3782, and 6726, respectively, showing a correlation between the number of DEGs and symptom severity. Many DEGs were related to defense, stress response, and development and morphogenesis processes. For defense and stress response processes, gene silencing-related genes were activated by RDV infection and the degree of activation was similar among plants infected with the three RDV strains. Genes for hormone-regulated defense systems were also activated by RDV infection, and the degree of activation seemed to be correlated with the concentration of RDV in plants. Some development and morphogenesis processes were suppressed by RDV infection, but the degree of suppression was not correlated well with the RDV concentration. Conclusions/Significance: Gene responses to RDV infection were regulated differently depending on the gene groups regulated and the strains infecting. It seems that symptom severity is associated with the degree of gene response in defense-related and development- and morphogenesis-related processes. The titer levels of RDV in plants and the amino acid substitutions in RDV proteins could be involved in regulating such gene responses.	[Satoh, Kouji; Shimizu, Takumi; Hiraguri, Akihiro; Sasaya, Takahide; Omura, Toshihiro] Natl Agr Res Ctr, Res Team Vector Borne Plant Pathogens, Tsukuba, Ibaraki 305, Japan; [Satoh, Kouji; Kondoh, Hiroaki; Kikuchi, Shoshi] Natl Inst Agrobiol Sci, Div Genome & Biodivers Res, Tsukuba, Ibaraki, Japan; [Choi, Il-Ryong] Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Manila, Philippines	National Agriculture & Food Research Organization - Japan; National Institute of Agrobiological Sciences - Japan; CGIAR; International Rice Research Institute (IRRI)	Satoh, K (corresponding author), Natl Agr Res Ctr, Res Team Vector Borne Plant Pathogens, Tsukuba, Ibaraki 305, Japan.	skikuchi@nias.affrc.go.jp	Hiraguri, Akihiro/O-4584-2014		Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	This work was supported by the project grants from the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN). The subject of each study is not selected by the funder but only reported to the funder annually. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko M, 2008, GENES GENET SYST, V83, P237, DOI 10.1266/ggs.83.237; Agudelo-Romero P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002397; Anand A, 2003, MOL PLANT MICROBE IN, V16, P916, DOI 10.1094/MPMI.2003.16.10.916; Attia KA, 2009, CURR ISSUES MOL BIOL, V11, pI29, DOI 10.21775/cimb.011.i29; Babu M, 2008, J GEN VIROL, V89, P1069, DOI 10.1099/vir.0.83531-0; Babu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-325; Banerjee J, 2010, BIOCHEM BIOPH RES CO, V394, P178, DOI 10.1016/j.bbrc.2010.02.142; Cao XS, 2005, J VIROL, V79, P13018, DOI 10.1128/JVI.79.20.13018-13027.2005; Catoni M, 2009, MOL PLANT MICROBE IN, V22, P1504, DOI 10.1094/MPMI-22-12-1504; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Diaz-Pendon JA, 2008, ANNU REV PHYTOPATHOL, V46, P303, DOI 10.1146/annurev.phyto.46.081407.104746; Dill A, 2001, GENETICS, V159, P777; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elhiti M, 2009, PLANT SIGNAL BEHAV, V4, P86, DOI 10.4161/psb.4.2.7692; Fischer U, 2004, MOL PLANT MICROBE IN, V17, P1162, DOI 10.1094/MPMI.2004.17.10.1162; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Havelda Z, 2008, PLANT J, V55, P278, DOI 10.1111/j.1365-313X.2008.03501.x; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Hirsch S, 2009, PLANT SIGNAL BEHAV, V4, P698, DOI 10.4161/psb.4.8.9176; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Jain M, 2006, GENOMICS, V88, P360, DOI 10.1016/j.ygeno.2006.04.008; Kapoor M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-451; KIMURA I, 1987, J GEN VIROL, V68, P3211, DOI 10.1099/0022-1317-68-12-3211; KIMURA I, 1968, ANN PHYTOPATHOL SOC, V28, P205; Lee MW, 2001, MOL PLANT MICROBE IN, V14, P527, DOI 10.1094/MPMI.2001.14.4.527; Li Y, 2004, J VIROL, V78, P5382, DOI 10.1128/JVI.78.10.5382-5389.2004; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; LIU D, 1994, P NATL ACAD SCI USA, V91, P1888, DOI 10.1073/pnas.91.5.1888; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Love AJ, 2007, MOL PLANT MICROBE IN, V20, P659, DOI 10.1094/MPMI-20-6-0659; Mao CZ, 2007, NEW PHYTOL, V176, P288, DOI 10.1111/j.1469-8137.2007.02177.x; Margis-Pinheiro M, 2005, PLANT CELL REP, V23, P819, DOI 10.1007/s00299-004-0896-6; Nagasaki H, 2007, P NATL ACAD SCI USA, V104, P14867, DOI 10.1073/pnas.0704339104; OMURA T, 2005, VIRUS TAXONOMY, P543; Park SH, 2007, PLANTA, V227, P1, DOI 10.1007/s00425-007-0576-1; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Rieu I, 2008, PLANT J, V53, P488, DOI 10.1111/j.1365-313X.2007.03356.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Sanchez G, 2010, MOL PLANT MICROBE IN, V23, P394, DOI 10.1094/MPMI-23-4-0394; Satoh K, 2010, J GEN VIROL, V91, P294, DOI 10.1099/vir.0.015990-0; Selth LA, 2004, MOL PLANT MICROBE IN, V17, P27, DOI 10.1094/MPMI.2004.17.1.27; Senthil G, 2005, J GEN VIROL, V86, P2615, DOI 10.1099/vir.0.81043-0; Shigyo M, 2007, PLANT CELL PHYSIOL, V48, P179, DOI 10.1093/pcp/pcl044; Shikata M, 2009, PLANT CELL PHYSIOL, V50, P2133, DOI 10.1093/pcp/pcp148; Shimizu T, 2007, MOL PLANT MICROBE IN, V20, P247, DOI 10.1094/MPMI-20-3-0247; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Stotz HU, 2009, PLANT MOL BIOL, V71, P131, DOI 10.1007/s11103-009-9512-z; Szilassy D, 1999, MOL PLANT MICROBE IN, V12, P1105, DOI 10.1094/MPMI.1999.12.12.1105; Takahashi H, 2004, PLANT CELL PHYSIOL, V45, P803, DOI 10.1093/pcp/pch085; TAKAHASHI Y, 1991, PLANT DIS, V75, P458, DOI 10.1094/PD-75-0458; Takasaki H, 2010, MOL GENET GENOMICS, V284, P173, DOI 10.1007/s00438-010-0557-0; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; van der Graaff E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-248; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Wang LP, 2009, CELL RES, V19, P598, DOI 10.1038/cr.2009.36; Wang S, 2007, PLANT J, V50, P858, DOI 10.1111/j.1365-313X.2007.03096.x; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Yoshii M, 2010, PLANT J, V61, P804, DOI 10.1111/j.1365-313X.2009.04107.x; Yoshii M, 2009, PLANT J, V57, P615, DOI 10.1111/j.1365-313X.2008.03712.x; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206; Zhang SB, 2005, PLANT PHYSIOL, V139, P1107, DOI 10.1104/pp.105.069005; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308; Zhu SF, 2005, PLANT PHYSIOL, V139, P1935, DOI 10.1104/pp.105.072306	69	41	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18094	10.1371/journal.pone.0018094	http://dx.doi.org/10.1371/journal.pone.0018094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445363	Green Published, Green Submitted, gold			2022-12-27	WOS:000288809100031
J	Yue, Y; Gui, J; Ai, WQ; Xu, W; Xiong, SD				Yue, Yan; Gui, Jun; Ai, Wenqing; Xu, Wei; Xiong, Sidong			Direct Gene Transfer with IP-10 Mutant Ameliorates Mouse CVB3-Induced Myocarditis by Blunting Th1 Immune Responses	PLOS ONE			English	Article							COXSACKIEVIRUS B3-INDUCED MYOCARDITIS; VIRAL MYOCARDITIS; IN-VIVO; DILATED CARDIOMYOPATHY; DENDRITIC CELLS; HEART-DISEASE; CHEMOKINE; MICE; EXPRESSION; B3	Background: Myocarditis is an inflammation of the myocardium that often follows the enterovirus infections, with coxsackievirus B3 (CVB3) being the most dominant etiologic agent. We and other groups previously reported that chemokine IP-10 was significantly induced in the heart tissue of CVB3-infected mice and contributed to the migration of massive inflammatory cells into the myocardium, which represents one of the most important mechanisms of viral myocarditis. To evaluate the direct effect of IP-10 on the inflammatory responses in CVB3 myocarditis, herein an IP-10 mutant deprived of chemo-attractant function was introduced into mice to antagonize the endogenous IP-10 activity, and its therapeutic effect on CVB3-induced myocarditis was evaluated. Methodology/Principal Findings: The depletion mutant pIP-10-AT, with an additional methionine after removal of the 5 N-terminal amino acids, was genetically constructed and intramuscularly injected into BALB/c mice after CVB3 infection. Compared with vector or no treatment, pIP-10-AT treatment had significantly reduced heart/body weight ratio and serum CK-MB level, increased survival rate and improved heart histopathology, suggesting an ameliorated myocarditis. This therapeutic effect was not attributable to an enhanced viral clearance, but to a blunted Th1 immune response, as evidenced by significantly decreased splenic CD4(+)/CD8(+)IFN-gamma(+) T cell percentages and reduced myocardial Th1 cytokine levels. Conclusion/Significance: Our findings constitute the first preclinical data indicating that interfering in vivo IP-10 activity could ameliorate CVB3 induced myocarditis. This strategy may represent as a new therapeutic approach in treating viral myocarditis.	[Yue, Yan; Xiong, Sidong] Soochow Univ, Inst Biol Sci, Lab Infect & Immun, Suzhou, Peoples R China; [Yue, Yan; Xiong, Sidong] Soochow Univ, Inst Med Sci, Lab Infect & Immun, Suzhou, Peoples R China; [Gui, Jun; Ai, Wenqing; Xu, Wei; Xiong, Sidong] Fudan Univ, Inst Immunobiol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Soochow University - China; Soochow University - China; Fudan University	Yue, Y (corresponding author), Soochow Univ, Inst Biol Sci, Lab Infect & Immun, Suzhou, Peoples R China.	wx2362@hotmail.com; sdxiongfd@126.com			China NSFC [81072413]; Jiangsu "Pan-Deng" Project [BK2010004]; National Science & Technology Key Projects during the Eleventh Five-Year Plan Period of China [2009ZX10004-104]; Jiangsu High Level "Shuang-Chuang" Project, Major State Basic Research Development Program of China [2007CB512401]; Program for Outstanding Medical Academic Leader [LJ06011]	China NSFC(National Natural Science Foundation of China (NSFC)); Jiangsu "Pan-Deng" Project; National Science & Technology Key Projects during the Eleventh Five-Year Plan Period of China; Jiangsu High Level "Shuang-Chuang" Project, Major State Basic Research Development Program of China(National Basic Research Program of China); Program for Outstanding Medical Academic Leader	This work was funded by China NSFC grant (81072413), Jiangsu "Pan-Deng" Project (BK2010004), the National Science & Technology Key Projects during the Eleventh Five-Year Plan Period of China (2009ZX10004-104), Jiangsu High Level "Shuang-Chuang" Project, Major State Basic Research Development Program of China (2007CB512401), Program for Outstanding Medical Academic Leader (LJ06011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini C, 1998, J IMMUNOL, V161, P6413; Athanassopoulos P, 2006, CELL BIOCHEM BIOPHYS, V44, P83, DOI 10.1385/CBB:44:1:083; Bujak M, 2009, CIRC RES, V105, P973, DOI 10.1161/CIRCRESAHA.109.199471; Calabrese F, 2003, CARDIOVASC RES, V60, P11, DOI 10.1016/S0008-6363(03)00475-9; Chen P, 2009, INT IMMUNOPHARMACOL, V9, P1304, DOI 10.1016/j.intimp.2009.07.014; Cihakova D, 2008, AM J PATHOL, V172, P1195, DOI 10.2353/ajpath.2008.070207; Dixon AE, 2000, AM J PHYSIOL-LUNG C, V279, pL592, DOI 10.1152/ajplung.2000.279.3.L592; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Esfandiarei M, 2008, ANNU REV PATHOL-MECH, V3, P127, DOI 10.1146/annurev.pathmechdis.3.121806.151534; Filippatos G, 2003, CURR MOL MED, V3, P139, DOI 10.2174/1566524033361546; Frangogiannis NG, 2004, CURR VASC PHARMACOL, V2, P163, DOI 10.2174/1570161043476375; Frisancho-Kiss S, 2009, BRAIN BEHAV IMMUN, V23, P649, DOI 10.1016/j.bbi.2008.12.002; Grabie N, 2003, J CLIN INVEST, V111, P671, DOI 10.1172/JCI200316867; Gupta G, 2009, J INFECT DIS, V200, P1300, DOI 10.1086/605895; Hasegawa H, 2006, ARTHRITIS RHEUM-US, V54, P1174, DOI 10.1002/art.21745; Huber SA, 2002, J VIROL, V76, P10785, DOI 10.1128/JVI.76.21.10785-10790.2002; Huber SA, 2006, CIRC RES, V99, P1109, DOI 10.1161/01.RES.0000249405.13536.49; Ikejima H, 2010, CIRC J, V74, P337, DOI 10.1253/circj.CJ-09-0484; Jiang Z, 2008, J GENE MED, V10, P918, DOI 10.1002/jgm.1215; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; LODGE PA, 1987, AM J PATHOL, V128, P455; Luo HH, 2010, CARDIOVASC RES, V85, P347, DOI 10.1093/cvr/cvp225; Maekawa Y, 2007, CIRCULATION, V115, P5, DOI 10.1161/CIRCULATIONAHA.106.670554; Maier Reinhard, 2004, Clin Dev Immunol, V11, P1, DOI 10.1080/10446670410001670427; Maisch BD, 2002, CARDIOVASC PATHOL, V11, P112, DOI 10.1016/S1054-8807(01)00113-2; Pinkert S, 2009, CIRCULATION, V120, P2358, DOI 10.1161/CIRCULATIONAHA.108.845339; Rothenbacher D, 2006, ARTERIOSCL THROM VAS, V26, P194, DOI 10.1161/01.ATV.0000191633.52585.14; Seko Y, 1998, CIRC RES, V82, P613, DOI 10.1161/01.RES.82.5.613; Shen Y, 2004, J VIROL, V78, P12548, DOI 10.1128/JVI.78.22.12548-12556.2004; Shen Yan, 2003, Zhonghua Yi Xue Za Zhi, V83, P981; Shi Y, 2009, J AM COLL CARDIOL, V53, P1219, DOI 10.1016/j.jacc.2008.10.064; Singh Udai P, 2008, BMC Immunol, V9, P25, DOI 10.1186/1471-2172-9-25; Tam PE, 2006, VIRAL IMMUNOL, V19, P133, DOI 10.1089/vim.2006.19.133; Vasquez RE, 2006, INFECT IMMUN, V74, P6769, DOI 10.1128/IAI.01073-06; Wan T, 2004, BLOOD, V103, P1747, DOI 10.1182/blood-2003-08-2828; Wang P, 2010, CANCER IMMUNOL IMMUN, V59, P1715, DOI 10.1007/s00262-010-0901-6; Weinzierl AO, 2008, J VIROL, V82, P8149, DOI 10.1128/JVI.00047-08; Yang XL, 2006, J LEUKOCYTE BIOL, V80, P1434, DOI 10.1189/jlb.0306212; Yuan J, 2009, CIRC RES, V104, P628, DOI 10.1161/CIRCRESAHA.108.192179; Zhang HFM, 2005, MOL CELL BIOL, V25, P6247, DOI 10.1128/MCB.25.14.6247-6258.2005	40	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18186	10.1371/journal.pone.0018186	http://dx.doi.org/10.1371/journal.pone.0018186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445362	Green Published, Green Submitted, gold			2022-12-27	WOS:000288809100034
J	Tsai, PW; Yang, CY; Chang, HT; Lan, CY				Tsai, Pei-Wen; Yang, Cheng-Yao; Chang, Hao-Teng; Lan, Chung-Yu			Human Antimicrobial Peptide LL-37 Inhibits Adhesion of Candida albicans by Interacting with Yeast Cell-Wall Carbohydrates	PLOS ONE			English	Article							HUMAN CATHELICIDIN; BIOFILM FORMATION; MULTIPLE ROLES; BETA-DEFENSINS; ADHERENCE; ANALOGS; BINDING; IDENTIFICATION; COLONIZATION; MECHANISM	Candida albicans is the major fungal pathogen of humans. Fungal adhesion to host cells is the first step of mucosal infiltration. Antimicrobial peptides play important roles in the initial mucosal defense against C. albicans infection. LL-37 is the only member of the human cathelicidin family of antimicrobial peptides and is commonly expressed in various tissues and cells, including epithelial cells of both the oral cavity and urogenital tract. We found that, at sufficiently low concentrations that do not kill the fungus, LL-37 was still able to reduce C. albicans infectivity by inhibiting C. albicans adhesion to plastic surfaces, oral epidermoid OECM-1 cells, and urinary bladders of female BALB/c mice. Moreover, LL-37-treated C. albicans floating cells that did not adhere to the underlying substratum aggregated as a consequence of LL-37 bound to the cell surfaces. According to the results of a competition assay, the inhibitory effects of LL-37 on cell adhesion and aggregation were mediated by its preferential binding to mannan, the main component of the C. albicans cell wall, and partially by its ability to bind chitin or glucan, which underlie the mannan layer. Therefore, targeting of cell-wall carbohydrates by LL-37 provides a new strategy to prevent C. albicans infection, and LL-37 is a useful, new tool to screen for other C. albicans components involved in adhesion.	[Tsai, Pei-Wen; Lan, Chung-Yu] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Yang, Cheng-Yao] Anim Technol Inst Taiwan, Div Anim Med, Miaoli, Taiwan; [Chang, Hao-Teng] China Med Univ, Grad Inst Mol Syst Biomed, Taichung, Taiwan; [Chang, Hao-Teng] China Med Univ, Ctr Inflammat Res, Taichung, Taiwan; [Lan, Chung-Yu] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan	National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan; National Tsing Hua University	Tsai, PW (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	htchang@mail.cmu.edu.tw; cylan@life.nthu.edu.tw	Chang, Hao-Teng/O-2875-2015	Chang, Hao-Teng/0000-0001-8756-5220; Lan, Chung-Yu/0000-0002-1533-3049; Yang, Cheng-Yao/0000-0002-8694-9561	National Science Council (Taiwan) [NSC98-2627-B-007-015, NSC99-2627-B-007-007]; China Medical University (Taiwan) [CMU97-289, CMU98-N2-13]	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); China Medical University (Taiwan)(China Medical University)	This work was supported by grants NSC98-2627-B-007-015 and NSC99-2627-B-007-007 (to CYL) from the National Science Council (Taiwan) and in part by CMU97-289 and CMU98-N2-13 (to HTC) from China Medical University (Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Bergsson G, 2009, J IMMUNOL, V183, P543, DOI 10.4049/jimmunol.0803959; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Calderone RA., 2002, CANDIDA CANDIDIASIS; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; Chaffin WL, 1998, MICROBIOL MOL BIOL R, V62, P130, DOI 10.1128/MMBR.62.1.130-180.1998; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005; Dale BA, 2005, CURR ISSUES MOL BIOL, V7, P119; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; den Hertog AL, 2005, BIOCHEM J, V388, P689, DOI 10.1042/BJ20042099; Dietrich DE, 2008, INFECT IMMUN, V76, P5714, DOI 10.1128/IAI.00997-08; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Dromer F, 2002, ANTIMICROB AGENTS CH, V46, P3869, DOI 10.1128/AAC.46.12.3869-3876.2002; Feng Z, 2005, J DENT RES, V84, P445, DOI 10.1177/154405910508400509; Filler SG, 2006, PLOS PATHOG, V2, P1099, DOI 10.1371/journal.ppat.0020129; Filler SG, 2006, CURR OPIN MICROBIOL, V9, P333, DOI 10.1016/j.mib.2006.06.005; Foschiatti M, 2009, MOL MICROBIOL, V72, P1137, DOI 10.1111/j.1365-2958.2009.06707.x; Frick IM, 2008, MOL MICROBIOL, V70, P695, DOI 10.1111/j.1365-2958.2008.06439.x; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Harris M, 2009, MICROBIOL-SGM, V155, P1058, DOI 10.1099/mic.0.026120-0; Hell E, 2010, LETT APPL MICROBIOL, V50, P211, DOI 10.1111/j.1472-765X.2009.02778.x; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kai-Larsen Y, 2008, FRONT BIOSCI, V13, P3760, DOI 10.2741/2964; Kauffman CA, 2005, CLIN INFECT DIS, V41, pS371, DOI 10.1086/430918; Kauffman Carol A, 2006, Proc Am Thorac Soc, V3, P35, DOI 10.1513/pats.200510-110JH; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; LI RK, 1993, J BIOL CHEM, V268, P18293; Li YF, 2007, PROTEIN EXPRES PURIF, V54, P157, DOI 10.1016/j.pep.2007.02.003; Loit E, 2010, INT J ANTIMICROB AG, V35, P410, DOI 10.1016/j.ijantimicag.2009.12.003; MAISCH PA, 1981, INFECT IMMUN, V32, P92, DOI 10.1128/IAI.32.1.92-97.1981; Masuoka J, 2004, CLIN MICROBIOL REV, V17, P281, DOI 10.1128/CMR.17.2.281-310.2004; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P3402, DOI 10.1128/JCM.39.9.3402-3408.2001; MIYAKAWA Y, 1992, INFECT IMMUN, V60, P2493, DOI 10.1128/IAI.60.6.2493-2499.1992; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nett J, 2007, ANTIMICROB AGENTS CH, V51, P510, DOI 10.1128/AAC.01056-06; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Odds FC, 1979, CANDIDA CANDIDOSIS; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Pingel LC, 2008, IMMUNOL CELL BIOL, V86, P643, DOI 10.1038/icb.2008.56; Sahl HG, 2005, J LEUKOCYTE BIOL, V77, P466, DOI 10.1189/jlb.0804452; Samaranayake LP, 2009, PERIODONTOL 2000, V49, P39, DOI 10.1111/j.1600-0757.2008.00291.x; Sandini S, 2007, CELL MICROBIOL, V9, P1223, DOI 10.1111/j.1462-5822.2006.00862.x; SHIBATA N, 1985, ARCH BIOCHEM BIOPHYS, V243, P338, DOI 10.1016/0003-9861(85)90511-9; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Steele C, 2002, INFECT IMMUN, V70, P577, DOI 10.1128/IAI.70.2.577-583.2002; Takeshima K, 2003, J BIOL CHEM, V278, P1310, DOI 10.1074/jbc.M208762200; Tecle T, 2007, J IMMUNOL, V178, P8046, DOI 10.4049/jimmunol.178.12.8046; Tronchin G, 2008, MED MYCOL, V46, P749, DOI 10.1080/13693780802206435; Tseng MC, 2007, ANAL BIOCHEM, V371, P1, DOI 10.1016/j.ab.2007.08.035; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Wenzel RP, 2005, CLIN INFECT DIS, V41, pS369, DOI 10.1086/430917; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; Wilson D, 2009, FEMS YEAST RES, V9, P688, DOI 10.1111/j.1567-1364.2009.00524.x; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zaparozhets T. S., 2010, Biomeditsinskaya Khimiya, V56, P350; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhu WD, 2010, CELL MICROBIOL, V12, P273, DOI 10.1111/j.1462-5822.2009.01412.x	69	109	121	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17755	10.1371/journal.pone.0017755	http://dx.doi.org/10.1371/journal.pone.0017755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21448240	Green Submitted, Green Published, gold			2022-12-27	WOS:000288512400025
J	Kovochich, M; Marsden, MD; Zack, JA				Kovochich, Michael; Marsden, Matthew D.; Zack, Jerome A.			Activation of Latent HIV Using Drug-Loaded Nanoparticles	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; IMMUNODEFICIENCY-VIRUS TYPE-1; NON-HODGKINS-LYMPHOMA; CELLS-IN-VITRO; BRYOSTATIN 1; PHASE-II; T-CELLS; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; LIPOSOMES	Antiretroviral therapy is currently only capable of controlling HIV replication rather than completely eradicating virus from patients. This is due in part to the establishment of a latent virus reservoir in resting CD4(+) T cells, which persists even in the presence of HAART. It is thought that forced activation of latently infected cells could induce virus production, allowing targeting of the cell by the immune response. A variety of molecules are able to stimulate HIV from latency. However no tested purging strategy has proven capable of eliminating the infection completely or preventing viral rebound if therapy is stopped. Hence novel latency activation approaches are required. Nanoparticles can offer several advantages over more traditional drug delivery methods, including improved drug solubility, stability, and the ability to simultaneously target multiple different molecules to particular cell or tissue types. Here we describe the development of a novel lipid nanoparticle with the protein kinase C activator bryostatin-2 incorporated (LNP-Bry). These particles can target and activate primary human CD4(+) T-cells and stimulate latent virus production from human T-cell lines in vitro and from latently infected cells in a humanized mouse model ex vivo. This activation was synergistically enhanced by the HDAC inhibitor sodium butyrate. Furthermore, LNP-Bry can also be loaded with the protease inhibitor nelfinavir (LNP-Bry-Nel), producing a particle capable of both activating latent virus and inhibiting viral spread. Taken together these data demonstrate the ability of nanotechnological approaches to provide improved methods for activating latent HIV and provide key proof-of-principle experiments showing how novel delivery systems may enhance future HIV therapy.	[Kovochich, Michael; Zack, Jerome A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Marsden, Matthew D.; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kovochich, M (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	jzack@ucla.edu			NIH [AI070010]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070010] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI070010 and by the UCLA CFAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlen PA, 2006, J VIROL, V80, P1599, DOI 10.1128/JVI.80.3.1599-1603.2006; Baert L, 2009, EUR J PHARM BIOPHARM, V72, P502, DOI 10.1016/j.ejpb.2009.03.006; Brooks DG, 2002, J VIROL, V76, P1673, DOI 10.1128/JVI.76.4.1673-1681.2002; Brooks DG, 2001, NAT MED, V7, P459, DOI 10.1038/86531; Brooks DG, 2003, P NATL ACAD SCI USA, V100, P12955, DOI 10.1073/pnas.2233345100; Brooks DG, 2003, IMMUNITY, V19, P413, DOI 10.1016/S1074-7613(03)00236-X; CAGDAS FM, PHARM DEV TECHNOL; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Desormeaux A, 2005, METHOD ENZYMOL, V391, P330, DOI 10.1016/S0076-6879(05)91019-7; Dou HY, 2009, J IMMUNOL, V183, P661, DOI 10.4049/jimmunol.0900274; Dutta T, 2008, EUR J PHARM SCI, V34, P181, DOI 10.1016/j.ejps.2008.04.002; Dutta T, 2007, J DRUG TARGET, V15, P89, DOI 10.1080/10611860600965914; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; GABIZON A, 1994, CANCER RES, V54, P987; GABIZON A, 1994, ACTA ONCOL, V33, P779, DOI 10.3109/02841869409083948; Gagne JF, 2002, BBA-BIOMEMBRANES, V1558, P198, DOI 10.1016/S0005-2736(01)00432-1; Garg M, 2006, J PHARM PHARMACOL, V58, P605, DOI 10.1211/jpp.58.5.0005; HANSEN CB, 1995, BBA-BIOMEMBRANES, V1239, P133, DOI 10.1016/0005-2736(95)00138-S; JONES HW, 1971, OBSTET GYNECOL, V38, P945; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Kaur CD, 2008, J DRUG TARGET, V16, P798, DOI 10.1080/10611860802475688 ; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; LAUGHLIN MA, 1993, VIROLOGY, V196, P496, DOI 10.1006/viro.1993.1505; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Levchenko TS, 2002, INT J PHARMACEUT, V240, P95, DOI 10.1016/S0378-5173(02)00129-1; Lindkvist Annica, 2009, AIDS Res Ther, V6, P15, DOI 10.1186/1742-6405-6-15; MEHLA R, PLOS ONE, V5; Mohammad RM, 1998, CLIN CANCER RES, V4, P445; Mutter R, 2000, BIOORGAN MED CHEM, V8, P1841, DOI 10.1016/S0968-0896(00)00150-4; Oussoren C, 2001, ADV DRUG DELIVER REV, V50, P143, DOI 10.1016/S0169-409X(01)00154-5; PEREZ M, CURR HIV RES; PETROS RA, NAT REV DRUG DISCOV, V9, P615; Pollock S, 2008, AIDS, V22, P1961, DOI 10.1097/QAD.0b013e32830efd96; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; Propper DJ, 1998, BRIT J CANCER, V78, P1337, DOI 10.1038/bjc.1998.680; QATSHA KA, 1993, P NATL ACAD SCI USA, V90, P4674, DOI 10.1073/pnas.90.10.4674; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Scripture-Adams DD, 2002, J VIROL, V76, P13077, DOI 10.1128/JVI.76.24.13077-13082.2002; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Van Praag RME, 2001, J CLIN IMMUNOL, V21, P218, DOI 10.1023/A:1011091300321; Varterasian ML, 2000, CLIN CANCER RES, V6, P825; Varterasian ML, 2001, INVEST NEW DRUG, V19, P245, DOI 10.1023/A:1010676719178; Varterasian ML, 1998, J CLIN ONCOL, V16, P56, DOI 10.1200/JCO.1998.16.1.56; VLACH J, 1992, VIROLOGY, V187, P63, DOI 10.1016/0042-6822(92)90295-Z; Wagner V, 2006, NAT BIOTECHNOL, V24, P1211, DOI 10.1038/nbt1006-1211; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400	49	69	74	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18270	10.1371/journal.pone.0018270	http://dx.doi.org/10.1371/journal.pone.0018270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483687	Green Submitted, gold, Green Published			2022-12-27	WOS:000289191300015
J	Melby, ES; Soldat, DJ; Barak, P				Melby, Eric S.; Soldat, Douglas J.; Barak, Phillip			Synthesis and Detection of Oxygen-18 Labeled Phosphate	PLOS ONE			English	Article							OXYGEN ISOTOPIC COMPOSITION; PHOSPHORUS; WATER	Phosphorus (P) has only one stable isotope and therefore tracking P dynamics in ecosystems and inferring sources of P loading to water bodies have been difficult. Researchers have recently employed the natural abundance of the ratio of O-18/O-16 of phosphate to elucidate P dynamics. In addition, phosphate highly enriched in oxygen-18 also has potential to be an effective tool for tracking specific sources of P in the environment, but has so far been used sparingly, possibly due to unavailability of oxygen-18 labeled phosphate (OLP) and uncertainty in synthesis and detection. One objective of this research was to develop a simple procedure to synthesize highly enriched OLP. Synthesized OLP is made up of a collection of species that contain between zero and four oxygen-18 atoms and, as a result, the second objective of this research was to develop a method to detect and quantify each OLP species. OLP was synthesized by reacting either PCl5 or POCl3 with water enriched with 97 atom % oxygen-18 in ambient atmosphere under a fume hood. Unlike previous reports, we observed no loss of oxygen-18 enrichment during synthesis. Electrospray ionization mass spectrometertry (ESI-MS) was used to detect and quantify each species present in OLP. OLP synthesized from POCl3 contained 1.2% (PO16O3)-O-18, 18.2% (PO2O2)-O-18-O-16, 67.7% (PO3O)-O-18-O-16, and 12.9% (PO4)-O-18, and OLP synthesized from PCl5 contained 0.7% (PO4)-O-16, 9.3% (PO3O)-O-18-O-16, and 90.0% (PO4)-O-18. We found that OLP can be synthesized using a simple procedure in ambient atmosphere without the loss of oxygen-18 enrichment and ESI-MS is an effective tool to detect and quantify OLP that sheds light on the dynamics of synthesis in ways that standard detection methods cannot.	[Melby, Eric S.; Soldat, Douglas J.; Barak, Phillip] Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Melby, ES (corresponding author), Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA.	djsoldat@wisc.edu	Melby, Eric/Z-2879-2019	Barak, Phillip/0000-0002-1033-3795; Soldat, Douglas/0000-0002-2323-7786	University of Wisconsin-Madison Graduate School	University of Wisconsin-Madison Graduate School	This research was funded by the University of Wisconsin-Madison Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez R, 2000, INT J MASS SPECTROM, V203, P177, DOI 10.1016/S1387-3806(00)00297-9; Blake RE, 2005, AM J SCI, V305, P596, DOI 10.2475/ajs.305.6-8.596; Blumenthal E, 1937, T FARADAY SOC, V33, P0849, DOI 10.1039/tf9373300849; Colman AS, 2005, P NATL ACAD SCI USA, V102, P13023, DOI 10.1073/pnas.0506455102; Elsbury KE, 2009, ENVIRON SCI TECHNOL, V43, P3108, DOI 10.1021/es8034126; Gruau G, 2005, WATER RES, V39, P232, DOI 10.1016/j.watres.2004.08.035; JOHANSEN HS, 1989, APPL RADIAT ISOTOPES, V40, P641; JOHANSEN HS, 1988, APPL RADIAT ISOTOPES, V39, P1059, DOI 10.1016/0883-2889(88)90141-4; LARSEN S, 1989, PLANT SOIL, V117, P143, DOI 10.1007/BF02206267; Markel Doron, 1994, Israel Journal of Earth Sciences, V43, P165; McLaughlin K, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000079; McLaughlin K, 2006, ESTUAR COAST SHELF S, V70, P499, DOI 10.1016/j.ecss.2006.06.030; MIDDELBOE V, 1992, APPL RADIAT ISOTOPES, V43, P1167; Paytan A, 2007, CHEM REV, V107, P563, DOI 10.1021/cr0503613; RAY WJ, 1992, J LABELLED COMPD RAD, V31, P637, DOI 10.1002/jlcr.2580310810; RISLEY JM, 1978, J LABELLED COMPD RAD, V15, P533, DOI 10.1002/jlcr.2580150162; Young MB, 2009, ENVIRON SCI TECHNOL, V43, P5190, DOI 10.1021/es900337q	17	20	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18420	10.1371/journal.pone.0018420	http://dx.doi.org/10.1371/journal.pone.0018420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483747	Green Published, Green Submitted, gold			2022-12-27	WOS:000289058700026
J	Daus, ML; Breyer, J; Wagenfuehr, K; Wemheuer, WM; Thomzig, A; Schulz-Schaeffer, WJ; Beekes, M				Daus, Martin L.; Breyer, Johanna; Wagenfuehr, Katja; Wemheuer, Wiebke M.; Thomzig, Achim; Schulz-Schaeffer, Walter J.; Beekes, Michael			Presence and Seeding Activity of Pathological Prion Protein (PrPTSE) in Skeletal Muscles of White-Tailed Deer Infected with Chronic Wasting Disease	PLOS ONE			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; CREUTZFELDT-JAKOB-DISEASE; CERVUS-ELAPHUS-NELSONI; ODOCOILEUS-VIRGINIANUS; PRPSC ACCUMULATION; TRANSGENIC MICE; MULE DEER; SCRAPIE; HAMSTERS; AGGREGATION	Chronic wasting disease (CWD) is a contagious, rapidly spreading transmissible spongiform encephalopathy (TSE), or prion disease, occurring in cervids such as white tailed-deer (WTD), mule deer or elk in North America. Despite efficient horizontal transmission of CWD among cervids natural transmission of the disease to other species has not yet been observed. Here, we report for the first time a direct biochemical demonstration of pathological prion protein PrPTSE and of PrPTSE-associated seeding activity, the static and dynamic biochemical markers for biological prion infectivity, respectively, in skeletal muscles of CWD-infected cervids, i.e. WTD for which no clinical signs of CWD had been recognized. The presence of PrPTSE was detected by Western-and postfixed frozen tissue blotting, while the seeding activity of PrPTSE was revealed by protein misfolding cyclic amplification (PMCA). Semi-quantitative Western blotting indicated that the concentration of PrPTSE in skeletal muscles of CWD-infected WTD was approximately 2000-10000 - fold lower than in brain tissue. Tissue-blot-analyses revealed that PrPTSE was located in muscle-associated nerve fascicles but not, in detectable amounts, in myocytes. The presence and seeding activity of PrPTSE in skeletal muscle from CWD-infected cervids suggests prevention of such tissue in the human diet as a precautionary measure for food safety, pending on further clarification of whether CWD may be transmissible to humans.	[Daus, Martin L.; Wagenfuehr, Katja; Thomzig, Achim; Beekes, Michael] Robert Koch Inst, D-1000 Berlin, Germany; [Breyer, Johanna; Wemheuer, Wiebke M.; Schulz-Schaeffer, Walter J.] Univ Med Ctr Gottingen, Dept Neuropathol, Prion & Dementia Res Unit, Gottingen, Germany	Robert Koch Institute; University of Gottingen	Daus, ML (corresponding author), Robert Koch Inst, D-1000 Berlin, Germany.	BeekesM@rki.de	Beekes, Michael/S-1975-2018	Beekes, Michael/0000-0002-6454-6657; Jurgens-Wemheuer, Wiebke/0000-0002-1234-3321	Alberta Prion Research Institute (APRI)	Alberta Prion Research Institute (APRI)	The study was sponsored by the Alberta Prion Research Institute (APRI, www.prioninstitute.ca), and the study was carried out within the APRI-sponsored research project "Comprehensive risk assessment of Chronic Wasting Disease (CWD) transmission to humans using non-human primates". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Andreoletti O, 2004, NAT MED, V10, P591, DOI 10.1038/nm1055; Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Balachandran A, 2010, CAN VET J, V51, P169; BEEKES M, 1995, J GEN VIROL, V76, P2567, DOI 10.1099/0022-1317-76-10-2567; Beekes M, 2007, FEBS J, V274, P588, DOI 10.1111/j.1742-4658.2007.05631.x; Bosque PJ, 2002, P NATL ACAD SCI USA, V99, P3812, DOI 10.1073/pnas.052707499; Brown P, 2005, LANCET, V365, P122, DOI 10.1016/S0140-6736(05)17700-9; Caughey B, 1997, J VIROL, V71, P4107, DOI 10.1128/JVI.71.5.4107-4110.1997; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Hamir AN, 2008, VET PATHOL, V45, P297, DOI 10.1354/vp.45-3-297; Hamir AN, 2004, VET PATHOL, V41, P78, DOI 10.1354/vp.41-1-78; Herzog C, 2005, J VIROL, V79, P14339, DOI 10.1128/JVI.79.22.14339-14345.2005; Jewell JE, 2006, J GEN VIROL, V87, P3443, DOI 10.1099/vir.0.81777-0; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; Peden AH, 2006, AM J PATHOL, V168, P927, DOI 10.2353/ajpath.2006.050788; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Race B, 2009, EMERG INFECT DIS, V15, P1366, DOI 10.3201/eid1509.090253; Raymond GJ, 2007, J VIROL, V81, P4305, DOI 10.1128/JVI.02474-06; Sandberg MK, 2010, J GEN VIROL, V91, P2651, DOI 10.1099/vir.0.024380-0; Schulz-Schaeffer WJ, 2000, AM J PATHOL, V156, P51, DOI 10.1016/S0002-9440(10)64705-0; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; Sigurdson CJ, 2007, BBA-MOL BASIS DIS, V1772, P610, DOI 10.1016/j.bbadis.2006.10.010; Soto C, 2002, TRENDS NEUROSCI, V25, P390, DOI 10.1016/S0166-2236(02)02195-1; Spraker TR, 2002, VET PATHOL, V39, P110, DOI 10.1354/vp.39-1-110; Thomzig A, 2006, J GEN VIROL, V87, P251, DOI 10.1099/vir.0.81277-0; Thomzig A, 2004, J CLIN INVEST, V113, P1465, DOI 10.1172/JCI200421083; Thomzig A, 2003, EMBO REP, V4, P530, DOI 10.1038/sj.embor.embor827; Weber P, 2006, P NATL ACAD SCI USA, V103, P15818, DOI 10.1073/pnas.0605608103; Wemheuer WM, 2009, VET REC, V164, P677, DOI 10.1136/vr.164.22.677; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530	34	20	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18345	10.1371/journal.pone.0018345	http://dx.doi.org/10.1371/journal.pone.0018345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483771	gold, Green Submitted, Green Published			2022-12-27	WOS:000289058300012
J	Sjowall, J; Fryland, L; Nordberg, M; Sjogren, F; Garpmo, U; Jansson, C; Carlsson, SA; Bergstrom, S; Ernerudh, J; Nyman, D; Forsberg, P; Ekerfelt, C				Sjowall, Johanna; Fryland, Linda; Nordberg, Marika; Sjogren, Florence; Garpmo, Ulf; Jansson, Christian; Carlsson, Sten-Anders; Bergstrom, Sven; Ernerudh, Jan; Nyman, Dag; Forsberg, Pia; Ekerfelt, Christina			Decreased Th1-Type Inflammatory Cytokine Expression in the Skin Is Associated with Persisting Symptoms after Treatment of Erythema Migrans	PLOS ONE			English	Article							EARLY LYME-DISEASE; BORRELIA-BURGDORFERI; CEREBROSPINAL-FLUID; ANTIBIOTIC-TREATMENT; PERIPHERAL-BLOOD; INTERFERON-GAMMA; MESSENGER-RNA; UP-REGULATION; FOLLOW-UP; NEUROBORRELIOSIS	Background: Despite the good prognosis of erythema migrans (EM), some patients have persisting symptoms of various character and duration post-treatment. Several factors may affect the clinical outcome of EM, e. g. the early interaction between Borrelia (B.) burgdorferi and the host immune response, the B. burgdorferi genotype, antibiotic treatment as well as other clinical circumstances. Our study was designed to determine whether early cytokine expression in the skin and in peripheral blood in patients with EM is associated with the clinical outcome. Methods: A prospective follow-up study of 109 patients with EM was conducted at the A land Islands, Finland. Symptoms were evaluated at 3, 6, 12 and 24 months post-treatment. Skin biopsies from the EM and healthy skin were immunohistochemically analysed for expression of interleukin (IL)-4, IL-10, IL-12p70 and interferon (IFN)-gamma, as well as for B. burgdorferi DNA. Blood samples were analysed for B. burgdorferi antibodies, allergic predisposition and levels of systemic cytokines. Findings: None of the patients developed late manifestations of Lyme borreliosis. However, at the 6-month follow-up, 7 of 88 patients reported persisting symptoms of diverse character. Compared to asymptomatic patients, these 7 patients showed decreased expression of the Th1-associated cytokine IFN-gamma in the EM biopsies (p = 0.003). B. afzelii DNA was found in 48%, B. garinii in 15% and B. burgdorferi sensu stricto in 1% of the EM biopsies, and species distribution was the same in patients with and without post-treatment symptoms. The two groups did not differ regarding baseline patient characteristics, B. burgdorferi antibodies, allergic predisposition or systemic cytokine levels. Conclusion: Patients with persisting symptoms following an EM show a decreased Th1-type inflammatory response in infected skin early during the infection, which might reflect a dysregulation of the early immune response. This finding supports the importance of an early, local Th1-type response for optimal resolution of LB.	[Sjowall, Johanna; Nordberg, Marika; Forsberg, Pia] Linkoping Univ, Fac Hlth Sci, Div Infect Dis, Dept Clin & Expt Med, Linkoping, Sweden; [Sjowall, Johanna; Fryland, Linda; Ernerudh, Jan; Ekerfelt, Christina] Linkoping Univ, Fac Hlth Sci, Div Clin Immunol, Dept Clin & Expt Med, Linkoping, Sweden; [Sjogren, Florence] Linkoping Univ, Fac Hlth Sci, Div Dermatol, Dept Clin & Expt Med, Linkoping, Sweden; [Garpmo, Ulf] Kalmar Hosp, Dept Clin Microbiol, Kalmar, Sweden; [Bergstrom, Sven] Umea Univ, Dept Microbiol, S-90187 Umea, Sweden; [Nordberg, Marika; Jansson, Christian; Carlsson, Sten-Anders; Nyman, Dag] Aland Borrelia Grp, The Aland Isl, Finland	Linkoping University; Linkoping University; Linkoping University; Umea University	Sjowall, J (corresponding author), Linkoping Univ, Fac Hlth Sci, Div Infect Dis, Dept Clin & Expt Med, Linkoping, Sweden.	linda.fryland@liu.se	Nordberg, Markus/L-4255-2017	Sjowall, Johanna/0000-0001-5622-866X	Swedish Research Council (Medicine); Health Research Council in South-East Sweden (FORSS); Ostergotland County Council; A land Foundation for Medical Research; Wilhelm and Else Stockmann Foundation	Swedish Research Council (Medicine)(Swedish Research Council); Health Research Council in South-East Sweden (FORSS); Ostergotland County Council; A land Foundation for Medical Research; Wilhelm and Else Stockmann Foundation	This work was supported by grants from The Swedish Research Council (Medicine), the Health Research Council in South-East Sweden (FORSS), ALF grants from the Ostergotland County Council, grants from the A land Foundation for Medical Research, and the Wilhelm and Else Stockmann Foundation. The funding sources had no involvement in the study design, the data analysis or in the writing of the report.	ANDERSSON J, 1994, IMMUNOLOGY, V83, P16; Auvinen JP, 2009, SPINE, V34, P1192, DOI 10.1097/BRS.0b013e3181a401df; Auwaerter PG, 2007, CLIN INFECT DIS, V45, P143, DOI 10.1086/518854; Bennet L, 2003, SCAND J INFECT DIS, V35, P129, DOI 10.1080/0036554021000027009; BERGLUND J, 1995, NEW ENGL J MED, V333, P1319, DOI 10.1056/NEJM199511163332004; Bleharski JR, 2003, SCIENCE, V301, P1527, DOI 10.1126/science.1087785; Borish L, 1998, J ALLERGY CLIN IMMUN, V101, P293, DOI 10.1016/S0091-6749(98)70238-6; Cerar T, 2008, CLIN MICROBIOL INFEC, V14, P653, DOI 10.1111/j.1469-0691.2008.02013.x; Comstedt P, 2006, EMERG INFECT DIS, V12, P1087; Ekerfelt C, 2007, CLIN EXP IMMUNOL, V150, P189, DOI 10.1111/j.1365-2249.2007.03474.x; Ekerfelt C, 1997, J NEUROIMMUNOL, V79, P155, DOI 10.1016/S0165-5728(97)00118-5; Ekerfelt C, 1999, CLIN EXP IMMUNOL, V115, P498; Gross DM, 1998, J IMMUNOL, V160, P1022; Grusell M, 2002, J NEUROIMMUNOL, V131, P173, DOI 10.1016/S0165-5728(02)00255-2; Henningsson AJ, 2010, CLIN MICROBIOL INFEC, V16, P1245, DOI 10.1111/j.1469-0691.2009.03059.x; Hickie I, 2006, BRIT MED J, V333, P575, DOI 10.1136/bmj.38933.585764.AE; Jones KL, 2008, CLIN INFECT DIS, V46, P85, DOI 10.1086/524022; Kang IS, 1997, INFECT IMMUN, V65, P3107, DOI 10.1128/IAI.65.8.3107-3111.1997; Kowalski TJ, 2010, CLIN INFECT DIS, V50, P512, DOI 10.1086/649920; Lipsker D, 2002, BRIT J DERMATOL, V146, P872, DOI 10.1046/j.1365-2133.2002.04628.x; LJOSTAD U, 2009, EUR J NEUROL; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; LUGER SW, 1995, ANTIMICROB AGENTS CH, V39, P661, DOI 10.1128/AAC.39.3.661; MASSAROTTI EM, 1992, AM J MED, V92, P396, DOI 10.1016/0002-9343(92)90270-L; Mullegger RR, 2000, J INVEST DERMATOL, V115, P1115, DOI 10.1046/j.1523-1747.2000.00198.x; Nowakowski J, 2003, AM J MED, V115, P91, DOI 10.1016/S0002-9343(03)00308-5; Oksi J, 1996, INFECT IMMUN, V64, P3620, DOI 10.1128/IAI.64.9.3620-3623.1996; Ornstein K, 2001, J CLIN MICROBIOL, V39, P1294, DOI 10.1128/JCM.39.4.1294-1298.2001; Picha D, 2006, SCAND J INFECT DIS, V38, P747, DOI 10.1080/00365540600810000; Salazar JC, 2003, J IMMUNOL, V171, P2660, DOI 10.4049/jimmunol.171.5.2660; Sjowall J, 2005, CLIN EXP IMMUNOL, V141, P89, DOI 10.1111/j.1365-2249.2005.02820.x; Smith RP, 2002, ANN INTERN MED, V136, P421, DOI 10.7326/0003-4819-136-6-200203190-00005; Stanek G, 2009, CURR OPIN INFECT DIS, V22, P450, DOI 10.1097/QCO.0b013e32832ee880; STEERE AC, 1983, ANN INTERN MED, V99, P22, DOI 10.7326/0003-4819-99-1-22; Strle F, 1999, ANN INTERN MED, V130, P32, DOI 10.7326/0003-4819-130-1-199901050-00006; Vrethem M, 2002, ACTA NEUROL SCAND, V106, P205, DOI 10.1034/j.1600-0404.2002.01358.x; Wang WZ, 1995, SCAND J IMMUNOL, V42, P694, DOI 10.1111/j.1365-3083.1995.tb03713.x; Widhe M, 2005, INT IMMUNOL, V17, P1283, DOI 10.1093/intimm/dxh304; Widhe M, 2004, J INFECT DIS, V189, P1881, DOI 10.1086/382893; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2009, CLIN MICROBIOL REV, V22, P387, DOI 10.1128/CMR.00004-09; Wormser GP, 2003, ANN INTERN MED, V138, P697, DOI 10.7326/0003-4819-138-9-200305060-00005; Yin ZN, 1997, ARTHRITIS RHEUM, V40, P69, DOI 10.1002/art.1780400111	43	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18220	10.1371/journal.pone.0018220	http://dx.doi.org/10.1371/journal.pone.0018220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483819	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200045
J	Eaker, S; Wigertz, A; Lambert, PC; Bergkvist, L; Ahlgren, J; Lambe, M				Eaker, Sonja; Wigertz, Annette; Lambert, Paul C.; Bergkvist, Leif; Ahlgren, Johan; Lambe, Mats		Uppsala Oerebro Breast Canc Grp	Breast Cancer, Sickness Absence, Income and Marital Status. A Study on Life Situation 1 Year Prior Diagnosis Compared to 3 and 5 Years after Diagnosis	PLOS ONE			English	Article							LYMPH-NODE DISSECTION; QUALITY-OF-LIFE; POSTMENOPAUSAL WOMEN; CONSERVING THERAPY; WORK; RETURN; SURVIVORS; RISK; MAMMOGRAPHY; PAIN	Background: Improved cancer survival poses important questions about future life conditions of the survivor. We examined the possible influence of a breast cancer diagnosis on subsequent working and marital status, sickness absence and income. Materials: We conducted a matched cohort study including 4,761 women 40-59 years of age and registered with primary breast cancer in a Swedish population-based clinical register during 1993-2003, and 2,3805 women without breast cancer. Information on socioeconomic standing was obtained from a social database 1 year prior and 3 and 5 years following the diagnosis. In Conditional Poisson Regression models, risk ratios (RRs) and 95% confidence intervals (CIs) were estimated to assess the impact of a breast cancer diagnosis. Findings: Three years after diagnosis, women who had had breast cancer more often had received sickness benefits (RR = 1.49, 95% CI 1.40-1.58) or disability pension (RR = 1.47, 95% CI 1.37-1.58) than had women without breast cancer. We found no effect on income (RR = 0.99), welfare payments (RR = 0.98), or marital status (RR = 1.02). A higher use of sickness benefits and disability pension was evident in all stages of the disease, although the difference in use of sickness benefits decreased after 5 years, whereas the difference in disability pension increased. For woman with early stage breast cancer, the sickness absence was higher following diagnosis among those with low education, who had undergone mastectomy, and had received chemo-or hormonal therapy. Neither tumour size nor presence of lymph nodes metastasis was associated with sickness absence after adjustment for treatment. Interpretation: Even in early stage breast cancer, a diagnosis negatively influences working capacity both 3 and 5 years after diagnosis, and it seems that the type of treatment received had the largest impact. A greater focus needs to be put on rehabilitation of breast cancer patients, work-place adaptations and research on long-term sequelae of treatment.	[Eaker, Sonja] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Eaker, Sonja; Wigertz, Annette; Lambe, Mats] Univ Uppsala Hosp, Reg Oncol Ctr, Uppsala, Sweden; [Lambert, Paul C.] Univ Leicester, Dept Hlth Sci, Ctr Biostat & Genet Epidemiol, Leicester, Leics, England; [Lambert, Paul C.; Lambe, Mats] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Bergkvist, Leif] Uppsala Univ, Cent Hosp, Dept Surg, Vasteras, Sweden; [Bergkvist, Leif] Uppsala Univ, Cent Hosp, Clin Res Ctr, Vasteras, Sweden; [Ahlgren, Johan] Gavle Cent Hosp, Dept Oncol, S-80187 Gavle, Sweden; [Ahlgren, Johan] Uppsala Univ Cty Gavleborg, Clin Res Ctr, Gavle, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital; University of Leicester; Karolinska Institutet; Uppsala University; Vasteras Central Hospital; Uppsala University; Vasteras Central Hospital; Uppsala University	Eaker, S (corresponding author), Uppsala Univ, Dept Surg Sci, Uppsala, Sweden.	sonja.eaker@surgsci.uu.se		Lambert, Paul/0000-0002-5337-663X; Lambe, Mats/0000-0002-4624-3767	Swedish Council for Working Life and Social Research [2005-1032, 2007-2148]; Swedish Cancer Society [003-0441]	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by grants from the Swedish Council for Working Life and Social Research (2005-1032, 2007-2148) and the Swedish Cancer Society (003-0441). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 2005, LANCET, V366, P2087; Arndt V, 2008, J CANCER RES CLIN, V134, P1311, DOI 10.1007/s00432-008-0418-y; Balak F, 2008, J OCCUP REHABIL, V18, P267, DOI 10.1007/s10926-008-9146-z; Bergh J, 2001, ACTA ONCOL, V40, P253, DOI 10.1080/02841860151116349; Bouknight RR, 2006, J CLIN ONCOL, V24, P345, DOI 10.1200/JCO.2004.00.4929; Carlsen K, 2008, EUR J CANCER, V44, P1866, DOI 10.1016/j.ejca.2008.05.020; Carlsen K, 2008, SCAND J PUBLIC HEALT, V36, P117, DOI 10.1177/1403494807085192; Carlsen K, 2007, EUR J CANCER, V43, P2093, DOI 10.1016/j.ejca.2007.05.024; de Boer AGEM, 2009, JAMA-J AM MED ASSOC, V301, P753, DOI 10.1001/jama.2009.187; Dorval M, 1999, J NATL CANCER I, V91, P54, DOI 10.1093/jnci/91.1.54; Drolet M, 2005, J CLIN ONCOL, V23, P8305, DOI 10.1200/JCO.2005.09.500; Duffy SW, 2002, CANCER-AM CANCER SOC, V95, P458, DOI 10.1002/cncr.10765; Engel Jutta, 2004, Breast J, V10, P223, DOI 10.1111/j.1075-122X.2004.21323.x; Fredholm H, 2009, PLOS ONE, V4, pA38, DOI 10.1371/journal.pone.0007695; Gartner R, 2009, JAMA-J AM MED ASSOC, V302, P1985, DOI 10.1001/jama.2009.1568; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; HESSELIUS P, 2007, J SOCIO-ECON, V36, P288, DOI DOI 10.1016/J.S0CEC.2005.11.037; Johnsson A, 2007, ACTA ONCOL, V46, P90, DOI 10.1080/02841860600857318; Johnsson A, 2009, ACTA ONCOL, V48, P93, DOI 10.1080/02841860802477899; Koopmans PC, 2008, OCCUP ENVIRON MED, V65, P494, DOI 10.1136/oem.2007.034322; Mansel RE, 2006, J NATL CANCER I, V98, P599, DOI 10.1093/jnci/djj158; Nesvold IL, 2008, ACTA ONCOL, V47, P835, DOI 10.1080/02841860801961257; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Olsson S, 2000, J MED SCREEN, V7, P14, DOI 10.1136/jms.7.1.14; Peintinger F, 2003, BRIT J CANCER, V89, P648, DOI 10.1038/sj.bjc.6601150; Peuckmann V, 2009, EUR J CANCER, V45, P625, DOI 10.1016/j.ejca.2008.09.027; *REG ONC CTR UPPS, BREAST CANC QUAL REG; ROELEN CA, 2010, PSYCHOONCOLOGY  0728; Roelen CAM, 2009, INT ARCH OCC ENV HEA, V82, P543, DOI 10.1007/s00420-008-0359-4; Statistics Sweden, LONG INT DAT HLTH IN; Steegers MA, 2008, J PAIN, V9, P813, DOI 10.1016/j.jpain.2008.04.001; Syse A, 2009, J CANCER SURVIV, V3, P66, DOI 10.1007/s11764-008-0078-6; Syse Astri, 2008, J Cancer Surviv, V2, P149, DOI 10.1007/s11764-008-0053-2; Syse Astri, 2008, J Cancer Surviv, V2, P205, DOI 10.1007/s11764-008-0062-1; Talback M, 2003, ACTA ONCOL, V42, P637, DOI 10.1080/02841860310013391; Thorsen L, 2011, ACTA ONCOL, V50, P212, DOI 10.3109/0284186X.2010.531050; Verdecchia A, 2009, EUR J CANCER, V45, P1042, DOI 10.1016/j.ejca.2008.11.029; Wallace MS, 1996, PAIN, V66, P195, DOI 10.1016/0304-3959(96)03064-3; Ziller V, 2009, ANN ONCOL, V20, P431, DOI 10.1093/annonc/mdn646	40	60	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18040	10.1371/journal.pone.0018040	http://dx.doi.org/10.1371/journal.pone.0018040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479209	Green Published, Green Submitted, gold			2022-12-27	WOS:000289055700022
J	Almeida, C; Azevedo, NF; Santos, S; Keevil, CW; Vieira, MJ				Almeida, Carina; Azevedo, Nuno F.; Santos, Silvio; Keevil, Charles W.; Vieira, Maria J.			Discriminating Multi-Species Populations in Biofilms with Peptide Nucleic Acid Fluorescence In Situ Hybridization (PNA FISH)	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; HELICOBACTER-PYLORI; BACTERIAL BIOFILMS; LISTERIA-MONOCYTOGENES; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; INFECTIOUS-DISEASES; MICROBIAL BIOFILMS; CYSTIC-FIBROSIS; WATER BIOFILMS	Background: Our current understanding of biofilms indicates that these structures are typically composed of many different microbial species. However, the lack of reliable techniques for the discrimination of each population has meant that studies focusing on multi-species biofilms are scarce and typically generate qualitative rather than quantitative data. Methodology/Principal Findings: We employ peptide nucleic acid fluorescence in situ hybridization (PNA FISH) methods to quantify and visualize mixed biofilm populations. As a case study, we present the characterization of Salmonella enterica/Listeria monocytogenes/Escherichia coli single, dual and tri-species biofilms in seven different support materials. Ex-situ, we were able to monitor quantitatively the populations of,56 mixed species biofilms up to 48 h, regardless of the support material. In situ, a correct quantification remained more elusive, but a qualitative understanding of biofilm structure and composition is clearly possible by confocal laser scanning microscopy (CLSM) at least up to 192 h. Combining the data obtained from PNA FISH/CLSM with data from other established techniques and from calculated microbial parameters, we were able to develop a model for this tri-species biofilm. The higher growth rate and exopolymer production ability of E. coli probably led this microorganism to outcompete the other two [average cell numbers (cells/cm(2)) for 48 h biofilm: E. coli 2,1x10(8) (+/-2,4x10(7)); L. monocytogenes 6,8x10(7) (+/-9,4x10(6)); and S. enterica 1,4x10(6) (+/-4,1x10(5))]. This overgrowth was confirmed by CSLM, with two well-defined layers being easily identified: the top one with E. coli, and the bottom one with mixed regions of L. monocytogenes and S. enterica. Significance: While PNA FISH has been described previously for the qualitative study of biofilm populations, the present investigation demonstrates that it can also be used for the accurate quantification and spatial distribution of species in polymicrobial communities. Thus, it facilitates the understanding of interspecies interactions and how these are affected by changes in the surrounding environment.	[Almeida, Carina; Santos, Silvio; Vieira, Maria J.] Univ Minho, Ctr Biol Engn, IBB, Braga, Portugal; [Almeida, Carina; Keevil, Charles W.] Univ Southampton, Sch Biol Sci, Environm Healthcare Unit, Southampton, Hants, England; [Azevedo, Nuno F.] Univ Porto, Dept Chem Engn, Fac Engn, P-4100 Oporto, Portugal	Universidade do Minho; University of Southampton; Universidade do Porto	Almeida, C (corresponding author), Univ Minho, Ctr Biol Engn, IBB, Campus Gualta, Braga, Portugal.	mjv@deb.uminho.pt	Azevedo, Nuno/I-4915-2013; Santos, Silvio/O-5491-2015; Guimarães, Nuno/J-6879-2013	Santos, Silvio/0000-0003-0801-8080; Guimarães, Nuno/0000-0002-7623-3877; Keevil, Charles/0000-0003-1917-7706; Vieira, Maria Joao/0000-0002-1379-890X; Almeida, Carina/0000-0002-0175-1119; Almeida, Carina/0000-0003-0613-8855; Azevedo, Nuno/0000-0001-5864-3250	Portuguese Institute Fundacao para a Ciencia e Tecnologia [SFRH/BD/29297/2006]	Portuguese Institute Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology)	This work was supported by the Portuguese Institute Fundacao para a Ciencia e Tecnologia, PhD Fellowship SFRH/BD/29297/2006 (http://alfa.fct.mctes.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ahmad A, 2007, J MED MICROBIOL, V56, P681, DOI 10.1099/jmm.0.47094-0; Almeida C, 2010, APPL ENVIRON MICROB, V76, P4476, DOI 10.1128/AEM.01678-09; Almeida C, 2009, APPL ENVIRON MICROB, V75, P2925, DOI 10.1128/AEM.02470-08; Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Azevedo NF, 2008, APPL ENVIRON MICROB, V74, P1805, DOI 10.1128/AEM.02241-07; Azevedo NF, 2007, APPL ENVIRON MICROB, V73, P3423, DOI 10.1128/AEM.00047-07; Azevedo NF, 2006, J APPL MICROBIOL, V101, P718, DOI 10.1111/j.1365-2672.2006.03029.x; Azevedo NF, 2003, WATER SCI TECHNOL, V47, P155, DOI 10.2166/wst.2003.0307; Beech WB, 2004, CURR OPIN BIOTECH, V15, P181, DOI 10.1016/j.copbio.2004.05.001; Braganca SM, 2007, WATER SCI TECHNOL, V55, P387, DOI 10.2166/wst.2007.282; Bremer PJ, 2001, J FOOD PROTECT, V64, P1369, DOI 10.4315/0362-028X-64.9.1369; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838; Carlson G, 1998, WATER RES, V32, P1580, DOI 10.1016/S0043-1354(97)00354-0; Carpentier B, 2004, INT J FOOD MICROBIOL, V97, P111, DOI 10.1016/j.ijfoodmicro.2004.03.031; Cerqueira L, 2008, INT J MOL SCI, V9, P1944, DOI 10.3390/ijms9101944; Chmielewski R A N, 2003, Compr Rev Food Sci Food Saf, V2, P22, DOI 10.1111/j.1541-4337.2003.tb00012.x; Coetser SE, 2005, CRIT REV MICROBIOL, V31, P213, DOI 10.1080/10408410500304074; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Daims H, 2007, APPL MICROBIOL BIOT, V75, P237, DOI 10.1007/s00253-007-0886-z; Delatolla R, 2009, WATER RES, V43, P1775, DOI 10.1016/j.watres.2009.01.009; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Dige I, 2009, ORAL MICROBIOL IMMUN, V24, P69, DOI 10.1111/j.1399-302X.2008.00482.x; Flemming HC, 2002, APPL MICROBIOL BIOT, V59, P629, DOI 10.1007/s00253-002-1066-9; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Garner MR, 2006, APPL ENVIRON MICROB, V72, P5384, DOI 10.1128/AEM.00764-06; GILBERT P, 1991, J APPL BACTERIOL, V71, P72; Gu F, 2005, J MICROBIOL METH, V62, P145, DOI 10.1016/j.mimet.2005.02.013; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hannig C, 2007, ARCH ORAL BIOL, V52, P1048, DOI 10.1016/j.archoralbio.2007.05.006; Hansen MC, 2001, MICROBIOL-SGM, V147, P1383, DOI 10.1099/00221287-147-5-1383; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Harrison JJ, 2008, ANTIMICROB AGENTS CH, V52, P2870, DOI 10.1128/AAC.00203-08; Hood SK, 1997, J FOOD PROTECT, V60, P1135, DOI 10.4315/0362-028X-60.9.1135; Hoshino T, 2008, APPL ENVIRON MICROB, V74, P5068, DOI 10.1128/AEM.00208-08; KRAMER JG, 1992, APPL ENVIRON MICROB, V58, P201, DOI 10.1128/AEM.58.1.201-207.1992; Kumar CG, 1998, INT J FOOD MICROBIOL, V42, P9, DOI 10.1016/S0168-1605(98)00060-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LERICHE V, 1995, J FOOD PROTECT, V58, P1186, DOI 10.4315/0362-028X-58.11.1186; MacDonald R, 2000, WATER RES, V34, P2439, DOI 10.1016/S0043-1354(99)00409-1; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Malic S, 2009, MICROBIOL-SGM, V155, P2603, DOI 10.1099/mic.0.028712-0; Molteni C, 2010, APPL ENVIRON MICROB, V76, P4099, DOI 10.1128/AEM.00424-10; Murray TS, 2007, CURR OPIN PEDIATR, V19, P83, DOI 10.1097/MOP.0b013e3280123a5d; Naves P, 2008, MICROB PATHOGENESIS, V45, P86, DOI 10.1016/j.micpath.2008.03.003; Neu TR, 2010, FEMS MICROBIOL ECOL, V72, P1, DOI 10.1111/j.1574-6941.2010.00837.x; Norhana MNW, 2010, FOOD CONTROL, V21, P343, DOI 10.1016/j.foodcont.2009.06.020; Oulahal N, 2007, INNOV FOOD SCI EMERG, V8, P192, DOI 10.1016/j.ifset.2006.10.001; Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400-3409.2003; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Pavlekovic M, 2009, J MICROBIOL METH, V78, P119, DOI 10.1016/j.mimet.2009.04.003; Perry-O'Keefe H, 2001, J MICROBIOL METH, V47, P281, DOI 10.1016/S0167-7012(01)00303-7; Ramaswamy Vidhya, 2007, Journal of Microbiology Immunology and Infection, V40, P4; Rodrigues AC, 2003, WATER SCI TECHNOL, V47, P139, DOI 10.2166/wst.2003.0302; Rosche B, 2009, TRENDS BIOTECHNOL, V27, P636, DOI 10.1016/j.tibtech.2009.08.001; Schaudinn C, 2009, J MICROSC-OXFORD, V235, P124, DOI 10.1111/j.1365-2818.2009.03201.x; Stender H, 2003, EXPERT REV MOL DIAGN, V3, P649, DOI 10.1586/14737159.3.5.649; Stender H, 2002, J MICROBIOL METH, V48, P1, DOI 10.1016/S0167-7012(01)00340-2; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Stewart PS, 1997, MICROBIAL ECOL, V33, P2, DOI 10.1007/s002489900002; Thimm T, 2003, APPL ENVIRON MICROB, V69, P2875, DOI 10.1128/AEM.69.5.2875-2878.2003; Thurnheer T, 2004, J MICROBIOL METH, V56, P37, DOI 10.1016/j.mimet.2003.09.003; Turner K, 2000, J APPL MICROBIOL, V89, P90, DOI 10.1046/j.1365-2672.2000.01086.x; Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005; VANDERVLIET GME, 1994, ANTIMICROB AGENTS CH, V38, P1959, DOI 10.1128/AAC.38.9.1959; Wang ZW, 2009, APPL MICROBIOL BIOT, V83, P1, DOI 10.1007/s00253-009-1940-9; Warnes SL, 2010, APPL ENVIRON MICROB, V76, P5390, DOI 10.1128/AEM.03050-09; WEAVER L, 2010, J APPL MICR IN PRESS; Wellinghausen N, 2005, J CLIN MICROBIOL, V43, P4070, DOI 10.1128/JCM.43.8.4070-4075.2005; Zhu L, 2004, APPL ENVIRON MICROB, V70, P597, DOI 10.1128/AEM.70.1.597-598.2004	72	107	114	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e14786	10.1371/journal.pone.0014786	http://dx.doi.org/10.1371/journal.pone.0014786			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479268	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000289054600005
J	Jeanes, AI; Maya-Mendoza, A; Streuli, CH				Jeanes, Alexa I.; Maya-Mendoza, Apolinar; Streuli, Charles H.			Cellular Microenvironment Influences the Ability of Mammary Epithelia to Undergo Cell Cycle	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; IN-VITRO; BASEMENT-MEMBRANE; BREAST-CANCER; GROWTH-FACTOR; PROLIFERATION; DIFFERENTIATION; MORPHOGENESIS; GLAND; CULTURE	The use of cell culture models is a principal and fundamental technology used in understanding how mammalian cells work. However, for some cell types such as mammary epithelia, the lines selected for extended culture are often transformed or have chromosomal abnormalities, while primary cultures have such a curtailed lifespan that their use is restricted. For example, mammary luminal epithelial cells (MECs) are used to study mechanisms of breast cancer, but the proliferation of primary cell cultures is highly limited. Here we describe the establishment of a new culture system to allow extended analysis of cultures of primary mouse MECs. In 2D monolayer culture, primary MECs showed a burst of proliferation 2-3 days post isolation, after which cell cycle decreased substantially. Addition of mammary epithelial growth factors, such as Epidermal Growth Factor, Fibroblast Growth Factor-2, Hepatocyte Growth Factor, and Receptor Activator for Nuclear Factor kappa B Ligand, or extracellular matrix proteins did not maintain their proliferation potential, neither did replating the cells to increase the mitogenic response. However, culturing MECs directly after tissue extraction in a 3D microenvironment consisting of basement membrane proteins, extended the time in culture in which the cells could proliferate. Our data reveal that the cellular microenvironment has profound effects on the proliferative properties of the mammary epithelia and is dominant over growth factors. Moreover, manipulating the cellular environment using this novel method can maintain the proliferative potential of primary MECs, thus enabling cell cycle to be studied as an endpoint after gene transfer or gene deletion experiments.	[Jeanes, Alexa I.; Maya-Mendoza, Apolinar; Streuli, Charles H.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Jeanes, AI (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester, Lancs, England.	cstreuli@manchester.ac.uk		Maya-Mendoza, Apolinar/0000-0001-7452-9896	Wellcome Trust [081203/Z/06/Z]; Breast Cancer campaign [2006NovPHD12]	Wellcome Trust(Wellcome TrustEuropean Commission); Breast Cancer campaign	This work was funded by the Wellcome Trust (081203/Z/06/Z), wellcome.ac.uk, and Breast Cancer campaign (2006NovPHD12), breastcancercampaign.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGELER J, 1991, J CELL SCI, V99, P407; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Buck SB, 2008, BIOTECHNIQUES, V44, P927, DOI 10.2144/000112812; Cardiff RD, 1999, J MAMMARY GLAND BIOL, V4, P105, DOI 10.1023/A:1018712905244; CHAMMAS R, 1994, J CELL SCI, V107, P1031; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Ehmann UK, 2003, CELL PROLIFERAT, V36, P177, DOI 10.1046/j.1365-2184.2003.00265.x; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Gache C, 1998, IN VITRO CELL DEV-AN, V34, P347; Gonzalez-Suarez E, 2007, MOL CELL BIOL, V27, P1442, DOI 10.1128/MCB.01298-06; Gordon KE, 2000, BREAST CANCER RES, V2, P222, DOI 10.1186/bcr57; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Gudjonsson T, 2003, METHODS, V30, P247, DOI 10.1016/S1046-2023(03)00031-8; Hopfer U, 1996, AM J PHYSIOL-CELL PH, V270, pC1, DOI 10.1152/ajpcell.1996.270.1.C1; Hovey RC, 1998, IN VITRO CELL DEV-AN, V34, P385; Huck L, 2010, P NATL ACAD SCI USA, V107, P15559, DOI 10.1073/pnas.1003034107; IMAGAWA W, 1990, ENDOCR REV, V11, P494, DOI 10.1210/edrv-11-4-494; IMAGAWA W, 1982, P NATL ACAD SCI-BIOL, V79, P4074, DOI 10.1073/pnas.79.13.4074; JEANES A, 2010, BETA INTEGRIN UNPUB; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Kim NS, 2006, MOL CELL BIOL, V26, P1002, DOI 10.1128/MCB.26.3.1002-1013.2006; KITTRELL FS, 1992, CANCER RES, V52, P1924; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li N, 2005, EMBO J, V24, P1942, DOI 10.1038/sj.emboj.7600674; Li YZ, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-7; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Naylor MJ, 2005, J CELL BIOL, V171, P717, DOI 10.1083/jcb.200503144; OLSON DJ, 1994, CELL GROWTH DIFFER, V5, P197; Pullan S, 1996, J CELL SCI, V109, P631; Pullan Shirley E., 1996, P97; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Runswick SK, 2001, NAT CELL BIOL, V3, P823, DOI 10.1038/ncb0901-823; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Smalley MJ, 1998, IN VITRO CELL DEV-AN, V34, P711; SMALLEY MJ, 2010, ISOLATION CULTURE AN, P139; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Stoker AW, 1990, CURR OPIN CELL BIOL, V2, P864, DOI 10.1016/0955-0674(90)90085-S; Streuli CH, 1998, J MAMMARY GLAND BIOL, V3, P107, DOI 10.1023/A:1018734620748; STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Sunil N, 2002, ENDOCRINOLOGY, V143, P2953, DOI 10.1210/en.143.8.2953; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; WHITE MT, 1978, IN VITRO CELL DEV B, V14, P271; Woodward TL, 2000, ENDOCRINOLOGY, V141, P3578, DOI 10.1210/en.141.10.3578; YANG J, 1981, CANCER RES, V41, P1021	50	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18144	10.1371/journal.pone.0018144	http://dx.doi.org/10.1371/journal.pone.0018144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479230	Green Published, Green Submitted, gold			2022-12-27	WOS:000289054600031
J	Zhang, L; Yokoi, F; Jin, YH; DeAndrade, MP; Hashimoto, K; Standaert, DG; Li, YQ				Zhang, Lin; Yokoi, Fumiaki; Jin, Yuan-Hu; DeAndrade, Mark P.; Hashimoto, Kenji; Standaert, David G.; Li, Yuqing			Altered Dendritic Morphology of Purkinje cells in Dyt1 Delta GAG Knock-In and Purkinje Cell-Specific Dyt1 Conditional Knockout Mice	PLOS ONE			English	Article							ONSET TORSION DYSTONIA; SYNAPTIC PLASTICITY; MUTANT TORSINA; GENE DYT1; EXPRESSION; PROTEIN; MODEL; SUPPRESSION; IMPAIRMENT; CEREBELLUM	Background: DYT1 early-onset generalized dystonia is a neurological movement disorder characterized by involuntary muscle contractions. It is caused by a trinucleotide deletion of a GAG (Delta GAG) in the DYT1 (TOR1A) gene encoding torsinA; the mouse homolog of this gene is Dyt1 (Tor1a). Although structural and functional alterations in the cerebellum have been reported in DYT1 dystonia, neuronal morphology has not been examined in vivo. Methodology/Principal Findings: In this study, we examined the morphology of the cerebellum in Dyt1 Delta GAG knock-in (KI) mice. Golgi staining of the cerebellum revealed a reduction in the length of primary dendrites and a decrease in the number of spines on the distal dendrites of Purkinje cells. To determine if this phenomenon was cell autonomous and mediated by a loss of torsinA function in Purkinje cells, we created a knockout of the Dyt1 gene only in Purkinje cells of mice. We found the Purkinje-cell specific Dyt1 conditional knockout (Dyt1 pKO) mice have similar alterations in Purkinje cell morphology, with shortened primary dendrites and decreased spines on the distal dendrites. Conclusion/Significance: These results suggest that the torsinA is important for the proper development of the cerebellum and a loss of this function in the Purkinje cells results in an alteration in dendritic structure.	[Zhang, Lin; Yokoi, Fumiaki; Jin, Yuan-Hu; DeAndrade, Mark P.; Standaert, David G.; Li, Yuqing] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Sch Med, Birmingham, AL 35294 USA; [Hashimoto, Kenji] Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan	University of Alabama System; University of Alabama Birmingham; Chiba University	Li, YQ (corresponding author), Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Sch Med, Birmingham, AL 35294 USA.	yuqing.li@neurology.ufl.edu	ZHANG, LIN/F-9873-2011; Li, Yuqing/AAR-9383-2021; Li, Yuqing/G-1596-2011; DeAndrade, Mark/G-4930-2011; Hashimoto, Kenji/I-5800-2015	Li, Yuqing/0000-0003-1211-5529; Li, Yuqing/0000-0003-1211-5529; DeAndrade, Mark/0000-0003-3610-6459; Standaert, David/0000-0003-2921-8348; Hashimoto, Kenji/0000-0002-8892-0439	National Institutes of Health [NS37409, NS47466, NS47692, NS54246, NS57098, NS65273, NS72872, NS74423]; Department of Neurology (UAB); Tyler's Hope for a Dystonia Cure, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047466, P50NS037409, R21NS047692, P30NS057098, R21NS072872, P01NS037409, R21NS065273, R03NS074423, R01NS054246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Neurology (UAB); Tyler's Hope for a Dystonia Cure, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants (NS37409, NS47466, NS47692, NS54246, NS57098, NS65273, NS72872, and NS74423), the Department of Neurology (UAB), and Tyler's Hope for a Dystonia Cure, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; Argyelan M, 2009, J NEUROSCI, V29, P9740, DOI 10.1523/JNEUROSCI.2300-09.2009; Augood SJ, 1999, ANN NEUROL, V46, P761, DOI 10.1002/1531-8249(199911)46:5<761::AID-ANA12>3.3.CO;2-Q; Augood SJ, 2003, BRAIN RES, V986, P12, DOI 10.1016/S0006-8993(03)03164-0; Augood SJ, 1998, ANN NEUROL, V43, P669, DOI 10.1002/ana.410430518; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Blazquez PM, 2004, CEREBELLUM, V3, P188, DOI 10.1080/14734220410018120; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Burdette AJ, 2010, CELL STRESS CHAPERON, V15, P605, DOI 10.1007/s12192-010-0173-2; Caldwell GA, 2003, HUM MOL GENET, V12, P307, DOI 10.1093/hmg/ddg027; Campbell DB, 1999, EXP NEUROL, V160, P268, DOI 10.1006/exnr.1999.7171; Campos VE, 2004, BIOCHEM BIOPH RES CO, V320, P606, DOI 10.1016/j.bbrc.2004.05.204; CAO S, DIS MODEL MECH, V3, P386; Carbon M, 2009, NEUROSCIENCE, V164, P220, DOI 10.1016/j.neuroscience.2008.12.041; Carbon M, 2008, BRAIN, V131, P146, DOI 10.1093/brain/awm243; Dang MT, 2006, NEUROSCI RES, V56, P470, DOI 10.1016/j.neures.2006.09.005; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; Delmaire C, 2007, NEUROLOGY, V69, P376, DOI 10.1212/01.wnl.0000266591.49624.1a; Draganski B, 2003, NEUROLOGY, V61, P1228, DOI 10.1212/01.WNL.0000094240.93745.83; Fahn S, 1988, Adv Neurol, V50, P1; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; Hewett JW, 2006, NEUROBIOL DIS, V22, P98, DOI 10.1016/j.nbd.2005.10.012; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Ichikawa R, 2002, J NEUROSCI, V22, P8487; Kamm C, 2004, J BIOL CHEM, V279, P19882, DOI 10.1074/jbc.M401332200; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Koh YH, 2004, HUM MOL GENET, V13, P2019, DOI 10.1093/hmg/ddh208; Kuner R, 2003, NEUROSCI LETT, V350, P153, DOI 10.1016/S0304-3940(03)00904-2; Le Ber I, 2006, NEUROLOGY, V67, P1769, DOI 10.1212/01.wnl.0000244484.60489.50; LEDOUX MS, 1995, BRAIN RES, V697, P91, DOI 10.1016/0006-8993(95)00792-O; LEDOUX MS, 1993, EXP NEUROL, V120, P302, DOI 10.1006/exnr.1993.1064; Martella G, 2009, BRAIN, V132, P2336, DOI 10.1093/brain/awp194; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Neychev VK, 2008, BRAIN, V131, P2499, DOI 10.1093/brain/awn168; Obermann M, 2007, MOVEMENT DISORD, V22, P1117, DOI 10.1002/mds.21495; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Pizoli CE, 2002, J NEUROSCI, V22, P7825; Rossi S, 2008, RESTOR NEUROL NEUROS, V26, P475; RUMBACH L, 1995, MOVEMENT DISORD, V10, P522, DOI 10.1002/mds.870100424; Shashidharan P, 2004, J NEUROCHEM, V88, P1019, DOI 10.1046/j.1471-4159.2003.02233.x; Xiao JF, 2005, MOL BRAIN RES, V141, P181, DOI 10.1016/j.molbrainres.2005.09.009; Yokoi F, 2008, J BIOCHEM, V143, P39, DOI 10.1093/jb/mvm191; Yokoi F, 2010, J BIOCHEM, V148, P459, DOI 10.1093/jb/mvq078; Yokoi F, 2009, NEUROSCI RES, V65, P228, DOI 10.1016/j.neures.2009.07.004	47	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18357	10.1371/journal.pone.0018357	http://dx.doi.org/10.1371/journal.pone.0018357			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479250	gold, Green Submitted, Green Published			2022-12-27	WOS:000289054600049
J	Hoa, NT; Tran, TBC; Tran, TTN; Dung, NV; Campbell, J; Anh, PH; Tho, HH; Nguyen, VVC; Bryant, JE; Hien, TT; Farrar, J; Schultsz, C				Ngo Thi Hoa; Tran Thi Bich Chieu; Tran Thi Thu Nga; Nguyen Van Dung; Campbell, James; Pham Hong Anh; Huynh Huu Tho; Nguyen Van Vinh Chau; Bryant, Juliet E.; Tran Tinh Hien; Farrar, Jeremy; Schultsz, Constance			Slaughterhouse Pigs Are a Major Reservoir of Streptococcus suis Serotype 2 Capable of Causing Human Infection in Southern Vietnam	PLOS ONE			English	Article							MURAMIDASE-RELEASED PROTEIN; NORTH-AMERICA; DISEASED PIGS; TYPE-2; VIRULENCE; SEQUENCE; CHINA; GENE; IDENTIFICATION; GENOTYPES	Streptococcus suis is a pathogen of major economic significance to the swine industry and is increasingly recognized as an emerging zoonotic agent in Asia. In Vietnam, S. suis is the leading cause of bacterial meningitis in adult humans. Zoonotic transmission is most frequently associated with serotype 2 strains and occupational exposure to pigs or consumption of infected pork. To gain insight into the role of pigs for human consumption as a reservoir for zoonotic infection in southern Vietnam, we determined the prevalence and diversity of S. suis carriage in healthy slaughterhouse pigs. Nasopharyngeal tonsils were sampled from pigs at slaughterhouses serving six provinces in southern Vietnam and Ho Chi Minh City area from September 2006 to November 2007. Samples were screened by bacterial culture. Isolates of S. suis were serotyped and characterized by multi locus sequence typing (MLST) and pulse field gel electrophoresis (PFGE). Antibiotic susceptibility profiles and associated genetic resistance determinants, and the presence of putative virulence factors were determined. 41% (222/542) of pigs carried S. suis of one or multiple serotypes. 8% (45/542) carried S. suis serotype 2 which was the most common serotype found (45/317 strains, 14%). 80% of serotype 2 strains belonged to the MLST clonal complex 1, which was previously associated with meningitis cases in Vietnam and outbreaks of severe disease in China in 1998 and 2005. These strains clustered with representative strains isolated from patients with meningitis in PFGE analysis, and showed similar antimicrobial resistance and virulence factor profiles. Slaughterhouse pigs are a major reservoir of S. suis serotype 2 capable of causing human infection in southern Vietnam. Strict hygiene at processing facilities, and health education programs addressing food safety and proper handling of pork should be encouraged.	[Ngo Thi Hoa; Tran Thi Bich Chieu; Tran Thi Thu Nga; Campbell, James; Pham Hong Anh; Bryant, Juliet E.; Farrar, Jeremy; Schultsz, Constance] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Nguyen Van Dung; Huynh Huu Tho] Subdept Anim Hlth, Ho Chi Minh City, Vietnam; [Ngo Thi Hoa; Bryant, Juliet E.; Farrar, Jeremy] Univ Oxford, Ctr Trop Med, Oxford, England; [Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Ctr Poverty Related Communicable Dis, NL-1105 AZ Amsterdam, Netherlands	University of Oxford; University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam	Hoa, NT (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam.	hoant@oucru.org	Farrar, Jeremy J./HGA-7610-2022	Ngo, Hoa/0000-0001-9320-4050; Farrar, Jeremy/0000-0002-2700-623X; Bryant, Juliet/0000-0001-9535-4925; Van Nguyen, Dung/0000-0002-0590-0679	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by the Wellcome Trust Major Overseas Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amass SF, 1997, J CLIN MICROBIOL, V35, P1595, DOI 10.1128/JCM.35.6.1595-1596.1997; Chang B, 2006, JPN J INFECT DIS, V59, P397; CLIFTONHADLEY FA, 1980, VET REC, V107, P40, DOI 10.1136/vr.107.2.40; CLIFTONHADLEY FA, 1983, BRIT VET J, V139, P1; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fittipaldi N, 2009, VET MICROBIOL, V139, P310, DOI 10.1016/j.vetmic.2009.06.024; Gottschalk M, 1998, CAN J VET RES, V62, P75; Gottschalk M., 2010, Clinical Microbiology Newsletter, V32, P97, DOI 10.1016/j.clinmicnews.2010.06.001; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Haleis A, 2009, EMERG INFECT DIS, V15, P350, DOI 10.3201/eid1502.080842; Han DU, 2001, CAN J VET RES, V65, P151; HOA NT, BMC INFECT DIS, V11, P6; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Kerdsin A, 2009, J MED MICROBIOL, V58, P1508, DOI 10.1099/jmm.0.013656-0; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Malhotra-Kumar S, 2005, ANTIMICROB AGENTS CH, V49, P4798, DOI 10.1128/AAC.49.11.4798-4800.2005; Marois C, 2007, CAN J VET RES, V71, P14; Montanari MP, 2003, J CLIN MICROBIOL, V41, P428, DOI 10.1128/JCM.41.1.428-431.2003; Nghia HDT, 2008, EMERG INFECT DIS, V14, P155, DOI 10.3201/eid1401.070534; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Princivalli MS, 2009, EURO SURVEILL, V14; Silva LMG, 2006, VET MICROBIOL, V115, P117, DOI 10.1016/j.vetmic.2005.12.013; SMITH HE, 1992, INFECT IMMUN, V60, P2361, DOI 10.1128/IAI.60.6.2361-2367.1992; Staats JJ, 1999, VET MICROBIOL, V70, P201, DOI 10.1016/S0378-1135(99)00147-9; Takamatsu D, 2008, EMERG INFECT DIS, V14, P181, DOI 10.3201/eid1401.070568; VECHT U, 1991, INFECT IMMUN, V59, P3156, DOI 10.1128/IAI.59.9.3156-3162.1991; Wangsomboonsiri W, 2008, J INFECTION, V57, P392, DOI 10.1016/j.jinf.2008.08.006; Wei ZG, 2009, VET MICROBIOL, V137, P196, DOI 10.1016/j.vetmic.2008.12.015; Wertheim HFL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005973; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; WILKLER MA, 2008, 28 CLIN LAB STAND S; Wisselink HJ, 2000, VET MICROBIOL, V74, P237, DOI 10.1016/S0378-1135(00)00188-7; Ye CY, 2006, EMERG INFECT DIS, V12, P1203, DOI 10.3201/eid1708.060232; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang Chun-Ping, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P235	35	50	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17943	10.1371/journal.pone.0017943	http://dx.doi.org/10.1371/journal.pone.0017943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464930	Green Published, Green Submitted, gold			2022-12-27	WOS:000289053800007
J	Cordes, CM; Bennett, RG; Siford, GL; Hamel, FG				Cordes, Crystal M.; Bennett, Robert G.; Siford, Gerri L.; Hamel, Frederick G.			Redox Regulation of Insulin Degradation by Insulin-Degrading Enzyme	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHIC ANALYSIS; PROTEIN S-NITROSYLATION; NITRIC-OXIDE; ALZHEIMERS-DISEASE; CHROMOSOME 10Q; NITROSOGLUTATHIONE; GLUTATHIONE; SUSCEPTIBILITY; POLYMORPHISMS; PRODUCTS	Insulin-degrading enzyme (IDE) is a thiol sensitive peptidase that degrades insulin and amyloid beta, and has been linked to type 2 diabetes mellitus and Alzheimer's disease. We examined the thiol sensitivity of IDE using S-nitrosoglutathione, reduced glutathione, and oxidized glutathione to distinguish the effects of nitric oxide from that of the redox state. The in vitro activity of IDE was studied using either partially purified cytosolic enzyme from male Sprague-Dawley rats, or purified rat recombinant enzyme. We confirm that nitric oxide inhibits the degrading activity of IDE, and that it affects proteasome activity through this interaction with IDE, but does not affect the proteasome directly. Oxidized glutathione inhibits IDE through glutathionylation, which was reversible by dithiothreitol but not by ascorbic acid. Reduced glutathione had no effect on IDE, but reacted with partially degraded insulin to disrupt its disulfide bonds and accelerate its breakdown to trichloroacetic acid soluble fragments. Our results demonstrate the sensitivity of insulin degradation by IDE to the redox environment and suggest another mechanism by which the cell's oxidation state may contribute to the development of, and the link between, type 2 diabetes and Alzheimer's disease.	[Cordes, Crystal M.; Bennett, Robert G.; Siford, Gerri L.; Hamel, Frederick G.] Omaha Vet Affairs Med Ctr, Res Serv, Omaha, NE USA; [Bennett, Robert G.; Siford, Gerri L.; Hamel, Frederick G.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE USA; [Cordes, Crystal M.; Hamel, Frederick G.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Bennett, Robert G.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Cordes, CM (corresponding author), Omaha Vet Affairs Med Ctr, Res Serv, Omaha, NE USA.	fghamel@unmc.edu		Krause, Crystal/0000-0001-9523-4798	Department of Veterans Affairs, Office of Research and Development (Biomedical Laboratory Research and Development); Bly Memorial Research Fund; Merit Review grant	Department of Veterans Affairs, Office of Research and Development (Biomedical Laboratory Research and Development)(US Department of Veterans Affairs); Bly Memorial Research Fund; Merit Review grant	This work was supported by a Department of Veterans Affairs, Office of Research and Development (Biomedical Laboratory Research and Development), Merit Review grant (to Frederick G. Hamel, Ph.D.), and by the Bly Memorial Research Fund. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bennett RG, 1997, DIABETES, V46, P197, DOI 10.2337/diabetes.46.2.197; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Bjork BF, 2007, NEUROBIOL AGING, V28, P1374, DOI 10.1016/j.neurobiolaging.2006.06.017; Blomqvist MEL, 2005, NEUROBIOL AGING, V26, P795, DOI 10.1016/j.neurobiolaging.2004.07.011; CLANCY RM, 1994, P NATL ACAD SCI USA, V91, P3680, DOI 10.1073/pnas.91.9.3680; Cordes CM, 2009, BIOCHEM PHARMACOL, V77, P1064, DOI 10.1016/j.bcp.2008.12.006; Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137; DUCKWORT.WC, 1972, P NATL ACAD SCI USA, V69, P3698, DOI 10.1073/pnas.69.12.3698; DUCKWORTH WC, 1994, J BIOL CHEM, V269, P24575; DUCKWORTH WC, 1988, ENDOCRINOLOGY, V123, P2701, DOI 10.1210/endo-123-6-2701; DUCKWORTH WC, 1988, ENDOCR REV, V9, P319, DOI 10.1210/edrv-9-3-319; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Finch CE, 2007, CURR ALZHEIMER RES, V4, P185, DOI 10.2174/156720507780362254; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; Furukawa Y, 2008, J CLIN ENDOCR METAB, V93, P310, DOI 10.1210/jc.2007-1029; Haan MN, 2006, NAT CLIN PRACT NEURO, V2, P159, DOI 10.1038/ncpneuro0124; HAMEL FG, 1986, ENDOCRINOLOGY, V118, P328, DOI 10.1210/endo-118-1-328; Hamel FG, 1998, ENDOCRINOLOGY, V139, P4061, DOI 10.1210/en.139.10.4061; HAMEL FG, 1987, DIABETES, V36, P702, DOI 10.2337/diabetes.36.6.702; Hamel FG, 2003, ENDOCRINOLOGY, V144, P2404, DOI 10.1210/en.2002-0007; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; Huang KP, 2002, BIOCHEM PHARMACOL, V64, P1049, DOI 10.1016/S0006-2952(02)01175-9; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; JAFFREY SR, 2001, SCI STKE; Ji YB, 1999, ARCH BIOCHEM BIOPHYS, V362, P67, DOI 10.1006/abbi.1998.1013; Karamohamed S, 2003, DIABETES, V52, P1562, DOI 10.2337/diabetes.52.6.1562; KHARITONOV VG, 1995, J BIOL CHEM, V270, P28158; Li JF, 2001, J BIOL CHEM, V276, P3098, DOI 10.1074/jbc.M008260200; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; MATHEWS WR, 1993, J PHARMACOL EXP THER, V267, P1529; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Neant-Fery M, 2008, P NATL ACAD SCI USA, V105, P9582, DOI 10.1073/pnas.0801261105; Noble DR, 1999, CHEM COMMUN, P2317, DOI 10.1039/a907891f; Nordman S, 2009, EXP CLIN ENDOCR DIAB, V117, P186, DOI 10.1055/s-0028-1100419; Ralat LA, 2009, J BIOL CHEM, V284, P34005, DOI 10.1074/jbc.M109.030627; Shinall H, 2005, BIOCHEMISTRY-US, V44, P15345, DOI 10.1021/bi050650l; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Tao LM, 2004, BIOCHEMISTRY-US, V43, P4028, DOI 10.1021/bi035924o	41	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18138	10.1371/journal.pone.0018138	http://dx.doi.org/10.1371/journal.pone.0018138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448434	Green Submitted, Green Published, gold			2022-12-27	WOS:000288810500044
J	Lin, M; Luo, ZY; Bai, BF; Xu, F; Lu, TJ				Lin, Min; Luo, Zheng Yuan; Bai, Bo Feng; Xu, Feng; Lu, Tian Jian			Fluid Mechanics in Dentinal Microtubules Provides Mechanistic Insights into the Difference between Hot and Cold Dental Pain	PLOS ONE			English	Article							THERMAL-STIMULATION; INTRADENTAL NERVES; SENSORY TRANSDUCTION; ION CHANNELS; A-DELTA; TEETH; FLOW; TUBULES; DISPLACEMENT; ODONTOBLASTS	Dental thermal pain is a significant health problem in daily life and dentistry. There is a long-standing question regarding the phenomenon that cold stimulation evokes sharper and more shooting pain sensations than hot stimulation. This phenomenon, however, outlives the well-known hydrodynamic theory used to explain dental thermal pain mechanism. Here, we present a mathematical model based on the hypothesis that hot or cold stimulation-induced different directions of dentinal fluid flow and the corresponding odontoblast movements in dentinal microtubules contribute to different dental pain responses. We coupled a computational fluid dynamics model, describing the fluid mechanics in dentinal microtubules, with a modified Hodgkin-Huxley model, describing the discharge behavior of intradental neuron. The simulated results agreed well with existing experimental measurements. We thence demonstrated theoretically that intradental mechano-sensitive nociceptors are not "equally sensitive" to inward (into the pulp) and outward (away from the pulp) fluid flows, providing mechanistic insights into the difference between hot and cold dental pain. The model developed here could enable better diagnosis in endodontics which requires an understanding of pulpal histology, neurology and physiology, as well as their dynamic response to the thermal stimulation used in dental practices.	[Lin, Min; Xu, Feng; Lu, Tian Jian] Xi An Jiao Tong Univ, Sch Aerosp, Biomed Engn & Biomech Ctr, Xian 710049, Peoples R China; [Luo, Zheng Yuan; Bai, Bo Feng] Xi An Jiao Tong Univ, State Key Lab Multiphase Flow Power Engn, Xian 710049, Peoples R China; [Xu, Feng] Harvard Univ, Brigham & Womens Hosp, HST Ctr Biomed Engn, Dept Med,Med Sch, Boston, MA 02115 USA	Xi'an Jiaotong University; Xi'an Jiaotong University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lin, M (corresponding author), Xi An Jiao Tong Univ, Sch Aerosp, Biomed Engn & Biomech Ctr, Xian 710049, Peoples R China.	fxu2@rics.bwh.harvard.edu; tjlu@mail.xjtu.edu.cn	Xu, Feng/C-7430-2011; liu, fusheng/J-4815-2014; Luo, Zhengyuan/AAU-6325-2020; Xu, Feng/H-4468-2011; Lin, Min/F-1348-2018; bai, bofeng/C-7663-2011; Lu, Tian Jian/E-6063-2016; Xu, Feng/E-8549-2018	Xu, Feng/0000-0003-4351-0222; Lin, Min/0000-0002-6198-9022; Lin, Min/0000-0002-3259-1955	National Natural Science Foundation of China [10825210, 31050110125, 81000453]; National 111 Project of China [B06024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 111 Project of China(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China (10825210, 31050110125, 81000453) and the National 111 Project of China (B06024). The funders had no role in study design, data collection and ananlysis, decision to publish, or preparation of the manuscript.	Alberts B., 1994, MOL BIOL CELL; Andrew D, 2000, J PHYSIOL-LONDON, V529, P791, DOI 10.1111/j.1469-7793.2000.00791.x; BERGGREN G, 1965, J DENT RES, V44, P408, DOI 10.1177/00220345650440021701; BRANNSTROM M, 1970, ACTA ODONTOL SCAND, V28, P59, DOI 10.3109/00016357009033132; BRANNSTROM M, 1986, J ENDODONT, V12, P453, DOI 10.1016/S0099-2399(86)80198-4; BRANNSTROM M, 1964, J DENT RES, V43, P619, DOI 10.1177/00220345640430041601; BRANNSTROM M, 1962, ORAL SURG ORAL MED O, V15, P203; Byers MR, 1999, CRIT REV ORAL BIOL M, V10, P4, DOI 10.1177/10454411990100010101; BYERS MR, 1984, INT REV NEUROBIOL, V25, P39, DOI 10.1016/S0074-7742(08)60677-7; Carda C, 2006, TISSUE CELL, V38, P141, DOI 10.1016/j.tice.2006.01.002; Cesare P, 1999, P NATL ACAD SCI USA, V96, P7658, DOI 10.1073/pnas.96.14.7658; Charoenlarp P, 2007, ARCH ORAL BIOL, V52, P625, DOI 10.1016/j.archoralbio.2006.12.014; Chidchuangchai W, 2007, ARCH ORAL BIOL, V52, P154, DOI 10.1016/j.archoralbio.2006.09.009; Choi CH, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.066001; Choi CH, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2337669; FEARNHEAD RW, 1957, J ANAT, V91, P267; Hermanstyne TO, 2008, J DENT RES, V87, P834, DOI 10.1177/154405910808700910; HILDEBRAND C, 1995, PROG NEUROBIOL, V45, P165, DOI 10.1016/0301-0082(94)00045-J; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOLLAND GR, 1987, J PHYSIOL-LONDON, V386, P31, DOI 10.1113/jphysiol.1987.sp016520; Ibuki T, 1996, J DENT RES, V75, P1963, DOI 10.1177/00220345960750120801; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; JYVASJARVI E, 1987, J PHYSIOL-LONDON, V391, P193, DOI 10.1113/jphysiol.1987.sp016733; Kim SY, 2010, J DENT, V38, P343, DOI 10.1016/j.jdent.2009.12.008; LIN M, 2011, ARCH ORAL BIOL, DOI DOI 10.1016/J.ARCHOALBIO.2011.02.011; Lin M, 2010, DENT MATER, V26, P501, DOI 10.1016/j.dental.2010.02.009; Linsulwanont P, 2007, ARCH ORAL BIOL, V52, P218, DOI 10.1016/j.archoralbio.2006.10.009; Linsuwanont P, 2008, ARCH ORAL BIOL, V53, P261, DOI 10.1016/j.archoralbio.2007.10.006; Marshall G W Jr, 1993, Quintessence Int, V24, P606; MATTHEWS B, 1994, ARCH ORAL BIOL, V39, pS87, DOI 10.1016/0003-9969(94)90193-7; MATTHEWS B, 1977, J PHYSIOL-LONDON, V264, P641, DOI 10.1113/jphysiol.1977.sp011687; McCleskey EW, 1999, ANNU REV PHYSIOL, V61, P835, DOI 10.1146/annurev.physiol.61.1.835; MENGEL MKC, 1993, PAIN, V55, P159, DOI 10.1016/0304-3959(93)90145-F; Nixdorf DR, 2010, J ENDODONT, V36, P224, DOI 10.1016/j.joen.2009.11.007; Paphangkorakit J, 2000, ARCH ORAL BIOL, V45, P1033, DOI 10.1016/S0003-9969(00)00090-X; Park CK, 2006, J BIOL CHEM, V281, P17304, DOI 10.1074/jbc.M511072200; Pashley DH, 1996, CRIT REV ORAL BIOL M, V7, P104, DOI 10.1177/10454411960070020101; Ratih DN, 2007, DENT MATER, V23, P1405, DOI 10.1016/j.dental.2006.11.029; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; Rugiero F, 2010, J PHYSIOL-LONDON, V588, P301, DOI 10.1113/jphysiol.2009.182360; SESSLE BJ, 1987, J DENT RES, V66, P962, DOI 10.1177/00220345870660052201; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Sherrington C.S., 1906, INTEGRATIVE ACTION N; Trowbridge H O, 1980, J Endod, V6, P405, DOI 10.1016/S0099-2399(80)80216-0; Vongsavan N, 2007, ARCH ORAL BIOL, V52, P640, DOI 10.1016/j.archoralbio.2006.12.019; Xu F, 2008, J THERM BIOL, V33, P223, DOI 10.1016/j.jtherbio.2008.01.004; Xu F, 2010, COMPUT BIOL MED, V40, P478, DOI 10.1016/j.compbiomed.2010.03.002; Xu F, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2939370	48	70	70	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18068	10.1371/journal.pone.0018068	http://dx.doi.org/10.1371/journal.pone.0018068			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448459	Green Published, Green Submitted, gold			2022-12-27	WOS:000288810500032
J	Re, DE; Whitehead, RD; Xiao, DK; Perrett, DI				Re, Daniel E.; Whitehead, Ross D.; Xiao, Dengke; Perrett, David I.			Oxygenated-Blood Colour Change Thresholds for Perceived Facial Redness, Health, and Attractiveness	PLOS ONE			English	Article							SECONDARY SEXUAL COLOR; BIOLOGICAL COMPONENTS; RHESUS MACAQUES; SKIN; RED; SYMMETRY; TESTOSTERONE; AVERAGENESS; PREFERENCE; EVOLUTION	Blood oxygenation level is associated with cardiovascular fitness, and raising oxygenated blood colouration in human faces increases perceived health. The current study used a two-alternative forced choice (2AFC) psychophysics design to quantify the oxygenated blood colour (redness) change threshold required to affect perception of facial colour, health and attractiveness. Detection thresholds for colour judgments were lower than those for health and attractiveness, which did not differ. The results suggest redness preferences do not reflect a sensory bias, rather preferences may be based on accurate indications of health status. Furthermore, results suggest perceived health and attractiveness may be perceptually equivalent when they are assessed based on facial redness. Appearance-based motivation for lifestyle change can be effective; thus future studies could assess the degree to which cardiovascular fitness increases face redness and could quantify changes in aerobic exercise needed to increase facial attractiveness.	[Re, Daniel E.; Whitehead, Ross D.; Xiao, Dengke; Perrett, David I.] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland	University of St Andrews	Re, DE (corresponding author), Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland.	dr296@st-andrews.ac.uk	Whitehead, Ross D/G-8569-2014	Perrett, David/0000-0002-6025-0939	British Academy; Wolfson Foundation [WRP/2008/87]	British Academy; Wolfson Foundation	This research was supported by funding from the British Academy (http://www.britac.ac.uk) and the Wolfson Foundation (http://www.wolfson.org.uk) joint research fellowship, Reference: WRP/2008/87. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Armstrong N, 2001, EUR J APPL PHYSIOL, V85, P546, DOI 10.1007/s004210100485; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; BIELERT C, 1989, J ZOOL, V219, P569, DOI 10.1111/j.1469-7998.1989.tb02601.x; Brincat MP, 2000, MATURITAS, V35, P107, DOI 10.1016/S0378-5122(00)00097-9; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Charkoudian N, 1999, J APPL PHYSIOL, V87, P1719, DOI 10.1152/jappl.1999.87.5.1719; Claeys KG, 2004, CEREB CORTEX, V14, P803, DOI 10.1093/cercor/bhh040; Cloutier J, 2008, J COGNITIVE NEUROSCI, V20, P941, DOI 10.1162/jocn.2008.20062; COETZEE V, BODY IMAGE IN PRESS; Drummond PD, 1999, PSYCHOPHYSIOLOGY, V36, P325, DOI 10.1017/S0048577299980344; Drummond PD, 1997, PSYCHOPHYSIOLOGY, V34, P163, DOI 10.1111/j.1469-8986.1997.tb02127.x; Drummond PD, 1997, PERS INDIV DIFFER, V23, P575, DOI 10.1016/S0191-8869(97)00077-9; Drummond PD, 2001, PSYCHOPHYSIOLOGY, V38, P190, DOI 10.1111/1469-8986.3820190; Elliot AJ, 2008, J PERS SOC PSYCHOL, V95, P1150, DOI 10.1037/0022-3514.95.5.1150; Elliot AJ, 2010, J EXP PSYCHOL GEN, V139, P399, DOI 10.1037/a0019689; Franklin A, 2010, DEVELOPMENTAL SCI, V13, P346, DOI 10.1111/j.1467-7687.2009.00884.x; Gerald MS, 2007, INT J PRIMATOL, V28, P1, DOI 10.1007/s10764-006-9110-8; Greenlees I, 2008, J SPORT SCI, V26, P569, DOI 10.1080/02640410701744446; Hagemann N, 2008, PSYCHOL SCI, V19, P769, DOI 10.1111/j.1467-9280.2008.02155.x; Hill RA, 2005, NATURE, V435, P293, DOI 10.1038/435293a; Hong GW, 2001, COLOR RES APPL, V26, P76, DOI 10.1002/1520-6378(200102)26:1<76::AID-COL8>3.0.CO;2-3; Hurlbert AC, 2007, CURR BIOL, V17, pR623, DOI 10.1016/j.cub.2007.06.022; Ishai A, 2007, INT J PSYCHOPHYSIOL, V63, P181, DOI 10.1016/j.ijpsycho.2006.03.010; JACOBS L, 1990, INT MARKET REV, V8, P21; Jones BC, 2004, EVOL HUM BEHAV, V25, P24, DOI 10.1016/S1090-5138(03)00080-1; JONES JL, 1994, HEALTH PSYCHOL, V13, P86, DOI 10.1037/0278-6133.13.1.86; Katchadourian H. A., 1984, FUNDAMENTALS HUMAN S; Knight C, 1995, CAMB ARCHAEOL J, V5, P75, DOI [10.1017/S0959774300001190, DOI 10.1017/S0959774300001190]; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Little A.C., 2007, J EVOLUTIONARY PSYCH, V5, P161, DOI [10. 1556/JEP. 2007. 1008, DOI 10.1556/JEP.2007.1008, https://doi.org/10.1556/JEP.2007.1008]; LIU D, 1992, DIABETOLOGIA, V35, P287, DOI 10.1007/BF00400932; Madden JR, 2003, ANIM BEHAV, V65, P1077, DOI 10.1006/anbe.2003.2126; Mehlman PT, 1997, PSYCHIAT RES, V72, P89, DOI 10.1016/S0165-1781(97)00084-X; Muhe L, 2000, TROP MED INT HEALTH, V5, P805, DOI 10.1046/j.1365-3156.2000.00637.x; Naz K., 2004, COLL STUDENT J, V38, P396; PAUERSTEIN CJ, 1978, AM J OBSTET GYNECOL, V130, P876, DOI 10.1016/0002-9378(78)90264-8; Perrett, 2010, YOUR FACE NEW SCI HU; Pierard GE, 1998, J EUR ACAD DERMATOL, V10, P1; REGAS JC, 1998, READ MY LIPS CULTU; Rhodes G, 2007, PERCEPTION, V36, P1244, DOI 10.1068/p5712; Rhodes L, 1997, J REPROD FERTIL, V111, P51; Rodd FH, 2002, P ROY SOC B-BIOL SCI, V269, P475, DOI 10.1098/rspb.2001.1891; Ryan M.J., 1990, Oxford Surveys in Evolutionary Biology, V7, P157; Setchell JM, 2005, ETHOLOGY, V111, P25, DOI 10.1111/j.1439-0310.2004.01054.x; Setchell JM, 2006, P ROY SOC B-BIOL SCI, V273, P2395, DOI 10.1098/rspb.2006.3573; Smith C, 2004, P ROY SOC B-BIOL SCI, V271, P949, DOI 10.1098/rspb.2004.2690; Sotchell JM, 2001, HORM BEHAV, V39, P177, DOI 10.1006/hbeh.2000.1628; Stadie WC, 1919, J EXP MED, V30, P215, DOI 10.1084/jem.30.3.215; Stephen ID, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005083; THORNHILL R, 1993, HUM NATURE-INT BIOS, V4, P237, DOI 10.1007/BF02692201; Waitt C, 2003, P ROY SOC B-BIOL SCI, V270, pS144, DOI 10.1098/rsbl.2003.0065; Waitt C, 2006, AM J PRIMATOL, V68, P738, DOI 10.1002/ajp.20264; Winston JS, 2007, NEUROPSYCHOLOGIA, V45, P195, DOI 10.1016/j.neuropsychologia.2006.05.009	54	68	69	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17859	10.1371/journal.pone.0017859	http://dx.doi.org/10.1371/journal.pone.0017859			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	740QW	21448270	Green Published, gold			2022-12-27	WOS:000288810500018
J	Planer, D; Metzger, S; Zcharia, E; Wexler, ID; Vlodavsky, I; Chajek-Shaul, T				Planer, David; Metzger, Shulamit; Zcharia, Eyal; Wexler, Isaiah D.; Vlodavsky, Israel; Chajek-Shaul, Tova			Role of Heparanase on Hepatic Uptake of Intestinal Derived Lipoprotein and Fatty Streak Formation in Mice	PLOS ONE			English	Article							TRIGLYCERIDE-RICH LIPOPROTEINS; CORONARY-ARTERY-DISEASE; SULFATE PROTEOGLYCANS; LDL RECEPTOR; MAMMALIAN HEPARANASE; CHYLOMICRON REMNANTS; LIGAND CATABOLISM; DEFICIENT MICE; METABOLISM; CLEARANCE	Background: Heparanase modulates the level of heparan sulfate proteoglycans (HSPGs) which have an important role in multiple cellular processes. Recent studies indicate that HSPGs have an important function in hepatic lipoprotein handling and processes involving removal of lipoprotein particles. Principal Findings: To determine the effects of decreased HSPGs chain length on lipoprotein metabolism and atherosclerosis, transgenic mice over-expressing the human heparanase gene were studied. Hepatic lipid uptake in hpa-Tg mice were evaluated by giving transgenic mice oral fat loads and labeled retinol. Sections of aorta from mice over-expressing heparanase (hpa-Tg) and controls (C57/BL6) fed an atherogenic diet were examined for evidence of atherosclerosis. Heparanase over-expression results in reduced hepatic clearance of postprandial lipoproteins and higher levels of fasting and postprandial serum triglycerides. Heparanase over-expression also induces formation of fatty streaks in the aorta. The mean lesion cross-sectional area in heparanase over-expressing mice was almost 6 times higher when compared to control mice (23,984 mu m(2)+/-5,922 vs. 4,189 mu m(2)+/-1,130, p<0.001). Conclusions: Over-expression of heparanase demonstrates the importance of HSPGs for the uptake of intestinal derived lipoproteins and its role in the formation of fatty streaks.	[Planer, David; Metzger, Shulamit; Chajek-Shaul, Tova] Hadassah Hebrew Univ, Dept Med, Med Ctr, Jerusalem, Israel; [Zcharia, Eyal; Vlodavsky, Israel] Hadassah Hebrew Univ, Sharett Inst Oncol, Med Ctr, Jerusalem, Israel; [Wexler, Isaiah D.] Hadassah Hebrew Univ, Dept Pediat, Med Ctr, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Planer, D (corresponding author), Hadassah Hebrew Univ, Dept Med, Med Ctr, Jerusalem, Israel.	chajek@hadassah.org.il						Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Boquist S, 1999, CIRCULATION, V100, P723, DOI 10.1161/01.CIR.100.7.723; CHANG SY, 1994, BBA-LIPID LIPID MET, V1215, P205, DOI 10.1016/0005-2760(94)90112-0; CHUNG BH, 1994, ARTERIOSCLER THROMB, V14, P622, DOI 10.1161/01.ATV.14.4.622; Ebara T, 2000, J CLIN INVEST, V105, P1807, DOI 10.1172/JCI8283; Franssen R, 2010, CIRC-CARDIOVASC GENE, V3, P169, DOI 10.1161/CIRCGENETICS.109.908905; Fuki IV, 2000, J BIOL CHEM, V275, P25742, DOI 10.1074/jbc.M909173199; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; George J, 2001, CIRCULATION, V104, P1646, DOI 10.1161/hc3901.095772; GOLDBERG DM, 1990, BIOCHIM BIOPHYS ACTA, V1047, P103, DOI 10.1016/0005-2760(90)90035-V; Ishibashi S, 1996, J BIOL CHEM, V271, P22422, DOI 10.1074/jbc.271.37.22422; JI ZS, 1995, J LIPID RES, V36, P583; Kudchadkar R, 2008, EXPERT OPIN INV DRUG, V17, P1769, DOI 10.1517/13543784.17.11.1769 ; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Mahley RW, 2007, J CLIN INVEST, V117, P94, DOI 10.1172/JCI30889; Mero N, 2000, ATHEROSCLEROSIS, V150, P167, DOI 10.1016/S0021-9150(99)00364-0; Metzger S, 2001, AM J PHYSIOL-ENDOC M, V281, pE957, DOI 10.1152/ajpendo.2001.281.5.E957; Noto ATW, 2008, LIPIDS, V43, P353, DOI 10.1007/s11745-008-3159-4; PATSCH JR, 1992, ARTERIOSCLER THROMB, V12, P1336, DOI 10.1161/01.ATV.12.11.1336; RAPP JH, 1994, ARTERIOSCLER THROMB, V14, P1767, DOI 10.1161/01.ATV.14.11.1767; STANFORD KI, 2009, J CLIN INVEST; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Toyoshima M, 1999, J BIOL CHEM, V274, P24153, DOI 10.1074/jbc.274.34.24153; VLODAVSKY I, 1990, CANCER METAST REV, V9, P203, DOI 10.1007/BF00046361; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; WEINSTEIN MM, ARTERIOSCLER THROMB, V30, P20; Williams KJ, 2008, J CLIN INVEST, V118, P3247, DOI 10.1172/JCI35206; Williams KJ, 2005, DIABETES, V54, P1116, DOI 10.2337/diabetes.54.4.1116; Williams KJ, 1997, CURR OPIN LIPIDOL, V8, P253; WILLIAMS KJ, CURR OPIN LIPIDOL, V21, P218; Zhang XH, 2008, CIRC RES, V102, P250, DOI 10.1161/CIRCRESAHA.107.156554; Zheng CY, 2006, ARTERIOSCL THROM VAS, V26, P891, DOI 10.1161/01.ATV.0000203512.01007.3d; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473	36	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18370	10.1371/journal.pone.0018370	http://dx.doi.org/10.1371/journal.pone.0018370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483695	Green Submitted, Green Published, gold			2022-12-27	WOS:000289058700020
J	Siu, KY; Yu, MKE; Wu, XG; Zong, M; Roth, MG; Chan, HC; Yu, S				Siu, Ka Yu; Yu, Mei Kuen; Wu, Xinggang; Zong, Min; Roth, Michael G.; Chan, Hsiao Chang; Yu, Sidney			The Non-Catalytic Carboxyl-Terminal Domain of ARFGAP1 Regulates Actin Cytoskeleton Reorganization by Antagonizing the Activation of Rac1	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; BINDING PROTEIN; PHOSPHOLIPASE-D; SACCHAROMYCES-CEREVISIAE; DOWNSTREAM EFFECTOR; EXCHANGE FACTOR; GOLGI-COMPLEX; STRESS FIBERS; KDEL RECEPTOR; ARF	Background: The regulation of the actin cytoskeleton and membrane trafficking is coordinated in mammalian cells. One of the regulators of membrane traffic, the small GTP-binding protein ARF1, also activates phosphatidylinositol kinases that in turn affect actin polymerization. ARFGAP1 is a GTPase activating protein (GAP) for ARF1 that is found on Golgi membranes. We present evidence that ARFGAP1 not only serves as a GAP for ARF1, but also can affect the actin cytoskeleton. Principal Findings: As cells attach to a culture dish foci of actin appear prior to the cells flattening and spreading. We have observed that overexpression of a truncated ARFGAP1 that lacks catalytic activity for ARF, called GAP273, caused these foci to persist for much longer periods than non-transfected cells. This phenomenon was dependent on the level of GAP273 expression. Furthermore, cell spreading after re-plating or cell migration into a previously scraped area was inhibited in cells transfected with GAP273. Live cell imaging of such cells revealed that actin-rich membrane blebs formed that seldom made protrusions of actin spikes or membrane ruffles, suggesting that GAP273 interfered with the regulation of actin dynamics during cell spreading. The over-expression of constitutively active alleles of ARF6 and Rac1 suppressed the effect of GAP273 on actin. In addition, the activation of Rac1 by serum, but not that of RhoA or ARF6, was inhibited in cells over-expressing GAP273, suggesting that Rac1 is a likely downstream effector of ARFGAP1. The carboxyl terminal 65 residues of ARFGAP1 were sufficient to produce the effects on actin and cell spreading in transfected cells and co-localized with cortical actin foci. Conclusions: ARFGAP1 functions as an inhibitor upstream of Rac1 in regulating actin cytoskeleton. In addition to its GAP catalytic domain and Golgi binding domain, it also has an actin regulation domain in the carboxyl-terminal portion of the protein.	[Siu, Ka Yu; Yu, Mei Kuen; Wu, Xinggang; Zong, Min; Chan, Hsiao Chang; Yu, Sidney] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Yu, Mei Kuen; Chan, Hsiao Chang; Yu, Sidney] Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Shatin, Hong Kong, Peoples R China; [Roth, Michael G.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Chinese University of Hong Kong; Chinese University of Hong Kong; University of Texas System; University of Texas Southwestern Medical Center Dallas	Siu, KY (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	Sidney.yu@cuhk.edu.hk	Zong, Min/B-6706-2016; Chan, Hsiao Chang/E-1507-2016; Bin Sidney Yu, Siu/R-4936-2018	Zong, Min/0000-0001-9381-5791; Bin Sidney Yu, Siu/0000-0001-9643-2729; Roth, Michael/0000-0002-9056-332X	NIH [GM37547]; School of Biomedical Sciences, CUHK; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037547] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); School of Biomedical Sciences, CUHK(Chinese University of Hong Kong); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM37547 from the NIH to MGR, and the One-line budget of the School of Biomedical Sciences, CUHK, to SY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoe T, 1999, J BIOL CHEM, V274, P20545, DOI 10.1074/jbc.274.29.20545; Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Blader IJ, 1999, MOL BIOL CELL, V10, P581, DOI 10.1091/mbc.10.3.581; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chen JL, 2005, J CELL BIOL, V169, P383, DOI 10.1083/jcb.200501157; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Fucini RV, 2002, MOL BIOL CELL, V13, P621, DOI 10.1091/mbc.01-11-0547; Fucini RV, 2000, J BIOL CHEM, V275, P18824, DOI 10.1074/jbc.M000024200; Godbey WT, 1999, GENE THER, V6, P1380, DOI 10.1038/sj.gt.3300976; HammondsOdie LP, 1996, J BIOL CHEM, V271, P18859, DOI 10.1074/jbc.271.31.18859; Heimann K, 1999, J BIOL CHEM, V274, P10743, DOI 10.1074/jbc.274.16.10743; HIROKI I, 2007, TRAFFIC, V8, P1465; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Jones DH, 2000, J BIOL CHEM, V275, P13962, DOI 10.1074/jbc.C901019199; Jou TS, 2000, MOL BIOL CELL, V11, P287, DOI 10.1091/mbc.11.1.287; KAHN RA, 1986, J BIOL CHEM, V261, P7906; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Liu YH, 2005, J BIOL CHEM, V280, P8884, DOI 10.1074/jbc.M412200200; Lorra C, 1999, NAT CELL BIOL, V1, pE113, DOI 10.1038/12939; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Oda A, 2003, J BIOL CHEM, V278, P6456, DOI 10.1074/jbc.M210817200; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Oshiro T, 2002, J BIOL CHEM, V277, P38618, DOI 10.1074/jbc.M203453200; Poon PP, 2001, J CELL BIOL, V155, P1239, DOI 10.1083/jcb.200108075; Poon PP, 1996, P NATL ACAD SCI USA, V93, P10074, DOI 10.1073/pnas.93.19.10074; Pruyne D, 2000, J CELL SCI, V113, P571; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Radhakrishna H, 1999, J CELL SCI, V112, P855; Rein U, 2002, J CELL BIOL, V157, P395, DOI 10.1083/jcb.200112092; Ren XD, 2000, METHOD ENZYMOL, V325, P264; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Robinson M, 2006, MOL BIOL CELL, V17, P1845, DOI 10.1091/mbc.E05-09-0832; Roth MG, 2000, FR MOLEC B, V24, P176; Roth MG, 1999, CHEM PHYS LIPIDS, V98, P141, DOI 10.1016/S0009-3084(99)00026-2; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Shin OH, 2005, METHOD ENZYMOL, V404, P359, DOI 10.1016/S0076-6879(05)04031-0; Shome K, 1998, J BIOL CHEM, V273, P30836, DOI 10.1074/jbc.273.46.30836; Song J, 1998, J CELL SCI, V111, P2257; Stow JL, 1998, TRENDS CELL BIOL, V8, P138, DOI 10.1016/S0962-8924(98)01238-0; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Valderrama F, 2001, TRAFFIC, V2, P717, DOI 10.1034/j.1600-0854.2001.21006.x; Valderrama F, 2000, P NATL ACAD SCI USA, V97, P1560, DOI 10.1073/pnas.97.4.1560; Yang S, 1999, MOL BIOL CELL, V10, P2265, DOI 10.1091/mbc.10.7.2265; Yoshimori T, 1996, J CELL BIOL, V133, P247, DOI 10.1083/jcb.133.2.247; Yu S, 2002, MOL BIOL CELL, V13, P2559, DOI 10.1091/mbc.E02-04-0189; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	63	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18458	10.1371/journal.pone.0018458	http://dx.doi.org/10.1371/journal.pone.0018458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483700	Green Published, Green Submitted, gold			2022-12-27	WOS:000289058700030
J	Zolkipli, Z; Pedersen, CB; Lamhonwah, AM; Gregersen, N; Tein, I				Zolkipli, Zarazuela; Pedersen, Christina B.; Lamhonwah, Anne-Marie; Gregersen, Niels; Tein, Ingrid			Vulnerability to Oxidative Stress In Vitro in Pathophysiology of Mitochondrial Short-Chain Acyl-CoA Dehydrogenase Deficiency: Response to Antioxidants	PLOS ONE			English	Article							CREATINE-KINASE ACTIVITY; NEWBORN BLOOD SPOTS; ETHYLMALONIC ACID; SUPEROXIDE-DISMUTASE; RAT-BRAIN; HYDROGEN-PEROXIDE; SCAD DEFICIENCY; CEREBRAL-CORTEX; YOUNG-RATS; CELL-DEATH	Objective: To elucidate the pathophysiology of SCAD deficient patients who have a unique neurological phenotype, among fatty acid oxidation disorders, with early developmental delay, CNS malformations, intractable seizures, myopathy and clinical signs suggesting oxidative stress. Methods: We studied skin fibroblast cultures from patients homozygous for ACADS common variant c.625G > A (n = 10), compound heterozygous for c.625G > A/c.319C > T (n = 3) or homozygous for pathogenic c.319C > T (n = 2) and c.1138C > T (n = 2) mutations compared to fibroblasts from patients with carnitine palmitoyltransferase 2 (CPT2) (n = 5), mitochondrial trifunctional protein (MTP)/long-chain L-3-hydroxyacyl-CoA dehydrogenase (LCHAD) (n = 7), and medium-chain acyl-CoA dehydrogenase (MCAD) deficiencies (n = 4) and normal controls (n = 9). All were exposed to 50 mu M menadione at 37 degrees C. Additonal conditions included exposure to 39 degrees C and/or hypoglycemia. Time to 100% cell death was confirmed with trypan blue dye exclusion. Experiments were repeated with antioxidants (Vitamins C and E or N-acetylcysteine), Bezafibrate or glucose and temperature rescue. Results: The most significant risk factor for vulnerability to menadione-induced oxidative stress was the presence of a FAO defect. SCADD fibroblasts were the most vulnerable compared to other FAO disorders and controls, and were similarly affected, independent of genotype. Cell death was exacerbated by hyperthermia and/or hypoglycemia. Hyperthermia was a more significant independent risk factor than hypoglycemia. Rescue significantly prolonged survival. Incubation with antioxidants and Bezafibrate significantly increased viability of SCADD fibroblasts. Interpretation: Vulnerability to oxidative stress likely contributes to neurotoxicity of SCADD regardless of ACADS genotype and is significantly exacerbated by hyperthermia. We recommend rigorous temperature control in SCADD patients during acute illness. Antioxidants and Bezafibrate may also prove instrumental in their management.	[Zolkipli, Zarazuela; Lamhonwah, Anne-Marie; Tein, Ingrid] Univ Toronto, Hosp Sick Children, Dept Pediat, Neurometab Res Lab,Div Neurol, Toronto, ON M5G 1X8, Canada; [Zolkipli, Zarazuela; Lamhonwah, Anne-Marie; Tein, Ingrid] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Pedersen, Christina B.; Gregersen, Niels] Aarhus Univ Hosp, Res Unit Mol Med, DK-8000 Aarhus N, Denmark	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Aarhus University	Zolkipli, Z (corresponding author), Univ Toronto, Hosp Sick Children, Dept Pediat, Neurometab Res Lab,Div Neurol, Toronto, ON M5G 1X8, Canada.	Ingrid.tein@sickkids.ca			Physicians' Services Incorporated Foundation of Ontario; Danish Medical Research Council; Department of Pediatrics, Hospital for Sick Children, Toronto	Physicians' Services Incorporated Foundation of Ontario; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Pediatrics, Hospital for Sick Children, Toronto	This work was supported in part by an operating grant from the Physicians' Services Incorporated Foundation of Ontario as well as grants from the Danish Medical Research Council (no relevant grant numbers). ZZ was funded by the Department of Pediatrics, Hospital for Sick Children, Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2009, PLOS ONE, V4, pA57, DOI 10.1371/journal.pone.0007719; Barschak AG, 2006, METAB BRAIN DIS, V21, P11, DOI 10.1007/s11011-006-9000-y; Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Corydon MJ, 1996, PEDIATR RES, V39, P1059, DOI 10.1203/00006450-199606000-00021; Djouadi F, 2005, HUM MOL GENET, V14, P2695, DOI 10.1093/hmg/ddi303; DUEE ED, 1969, J BIOL CHEM, V244, P3932; DUTHIE SJ, 1989, BRIT J CANCER, V60, P566, DOI 10.1038/bjc.1989.314; FAZZONE H, 1993, J CLIN INVEST, V92, P1278, DOI 10.1172/JCI116700; FLINT DH, 1993, J BIOL CHEM, V268, P22369; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fridovich I, 1998, PROTEIN SCI, V7, P2688, DOI 10.1002/pro.5560071225; Gregersen N, 1998, HUM MOL GENET, V7, P619, DOI 10.1093/hmg/7.4.619; GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Kelly G S, 1998, Altern Med Rev, V3, P114; Leipnitz G, 2003, NEUROCHEM RES, V28, P771, DOI 10.1023/A:1022874103630; Loor G, 2010, FREE RADICAL BIO MED, V49, P1925, DOI 10.1016/j.freeradbiomed.2010.09.021; MAK IT, 1986, J BIOL CHEM, V261, P1153; Nagan N, 2003, MOL GENET METAB, V78, P239, DOI 10.1016/S1096-7192(03)00034-9; PANDE SV, 1971, J BIOL CHEM, V246, P402; Pedersen CB, 2003, J BIOL CHEM, V278, P47449, DOI 10.1074/jbc.M309514200; Pedersen CB, 2008, HUM GENET, V124, P43, DOI 10.1007/s00439-008-0521-9; Pedersen CB, 2010, J INHERIT METAB DIS, V33, P211, DOI 10.1007/s10545-010-9086-6; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Schuck PF, 2009, NEUROCHEM INT, V54, P519, DOI 10.1016/j.neuint.2009.02.009; Schuck PF, 2010, NEUROCHEM RES, V35, P298, DOI 10.1007/s11064-009-0055-0; Schuck PF, 2009, BRAIN RES, V1296, P117, DOI 10.1016/j.brainres.2009.08.053; Schuck PF, 2002, NEUROCHEM RES, V27, P1633, DOI 10.1023/A:1021682910373; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; SIES H, 1985, PHILOS T ROY SOC B, V311, P617, DOI 10.1098/rstb.1985.0168; TAKESHIGE K, 1979, BIOCHEM J, V180, P129, DOI 10.1042/bj1800129; Tein I, 1999, NEUROLOGY, V52, P366, DOI 10.1212/WNL.52.2.366; Tein I, 2008, MOL GENET METAB, V93, P179, DOI 10.1016/j.ymgme.2007.09.021; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; van Maldegem B T, 2008, Ned Tijdschr Geneeskd, V152, P1678; van Maldegem BT, 2006, JAMA-J AM MED ASSOC, V296, P943, DOI 10.1001/jama.296.8.943; van Maldegem BT, 2005, J INHERIT METAB DIS, V28, P557, DOI 10.1007/s10545-005-0557-0; VIGNAIS PV, 1976, BIOCHIM BIOPHYS ACTA, V456, P1, DOI 10.1016/0304-4173(76)90007-0; Zolkipli Z, 2008, J INHERIT METAB DIS, V31, P31	42	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e17534	10.1371/journal.pone.0017534	http://dx.doi.org/10.1371/journal.pone.0017534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483766	Green Published, Green Submitted, gold			2022-12-27	WOS:000289058300002
J	Chu, HY; Wang, ML; Shi, DN; Ma, L; Zhang, ZZ; Tong, N; Huo, XY; Wang, W; Luo, DW; Gao, Y; Zhang, ZD				Chu, Haiyan; Wang, Meilin; Shi, Danni; Ma, Lan; Zhang, Zhizhong; Tong, Na; Huo, Xinying; Wang, Wei; Luo, Dewei; Gao, Yan; Zhang, Zhengdong			Hsa-miR-196a2 Rs11614913 Polymorphism Contributes to Cancer Susceptibility: Evidence from 15 Case-Control Studies	PLOS ONE			English	Article							NORTH INDIAN POPULATION; COMMON GENETIC-VARIANTS; SQUAMOUS-CELL CARCINOMA; LUNG-CANCER; MICRORNA TARGETS; CLINICAL-TRIALS; PRE-MICRORNAS; RISK; METAANALYSIS; ASSOCIATION	Background: MicroRNAs (miRNAs) are a family of endogenous, small and noncoding RNAs that negatively regulate gene expression by suppressing translation or degrading mRNAs. Recently, many studies investigated the association between hsa-miR-196a2 rs11614913 polymorphism and cancer risk, which showed inconclusive results. Methodology/Principal Findings: We conducted a meta-analysis of 15 studies that included 9,341 cancer cases and 10,569 case-free controls. We assessed the strength of the association, using odds ratios (ORs) with 95% confidence intervals (CIs). Overall, individuals with the TC/CC genotypes were associated with higher cancer risk than those with the TT genotype (OR = 1.18, 95% CI = 1.03-1.34, P<0.001 for heterogeneity test). In the stratified analyses, we observed that the CC genotype might modulate breast cancer risk (OR = 1.11, 95% CI = 1.01-1.23, P-heterogeneity = 0.210) and lung cancer risk (OR = 1.25, 95% CI = 1.06-1.46, P-heterogeneity = 0.958), comparing with the TC/TT genotype. Moreover, a significantly increased risk was found among Asian populations in a dominant model (TC/CC versus TT, OR = 1.24, 95% CI = 1.07-1.43, P-heterogeneity = 0.006). Conclusions: These findings supported that hsa-miR-196a2 rs11614913 polymorphism may contribute to the susceptibility of cancers.	[Chu, Haiyan; Wang, Meilin; Shi, Danni; Ma, Lan; Zhang, Zhizhong; Tong, Na; Huo, Xinying; Wang, Wei; Luo, Dewei; Gao, Yan; Zhang, Zhengdong] Nanjing Med Univ, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Peoples R China; [Chu, Haiyan; Wang, Meilin; Tong, Na; Zhang, Zhengdong] Nanjing Med Univ, Key Lab Modern Toxicol, Minist Educ, Nanjing, Peoples R China; [Chu, Haiyan; Wang, Meilin; Tong, Na; Zhang, Zhengdong] Nanjing Med Univ, Dept Mol & Genet Toxicol, Sch Publ Hlth, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Chu, HY (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Peoples R China.	drzdzhang@gmail.com	zhang, zheng/HCH-9684-2022		National Natural Science Foundation of China [30872084, 30972444]; Jiangsu Provincial Department of Education [08KJA330001]; National Science Foundation of Jiangsu Province [BK2010080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Department of Education; National Science Foundation of Jiangsu Province	This study was partly supported by National Natural Science Foundation of China (30872084, 30972444), the Key Program for Basic Research of Jiangsu Provincial Department of Education (08KJA330001) and National Science Foundation of Jiangsu Province (BK2010080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Catucci I, 2010, HUM MUTAT, V31, pE1052, DOI 10.1002/humu.21141; Chen KX, 2008, CARCINOGENESIS, V29, P1306, DOI 10.1093/carcin/bgn116; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dou TH, 2010, J CANCER RES CLIN, V136, P1853, DOI 10.1007/s00432-010-0844-5; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gao LB, 2011, BREAST CANCER RES TR, V125, P571, DOI 10.1007/s10549-010-0993-x; George GP, 2011, MOL BIOL REP, V38, P1609, DOI 10.1007/s11033-010-0270-4; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Kim MJ, 2010, LUNG CANCER, V69, P127, DOI 10.1016/j.lungcan.2010.04.015; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li XD, 2010, PATHOLOGY, V42, P669, DOI 10.3109/00313025.2010.522175; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; MANTEL N, 1959, J NATL CANCER I, V22, P719; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Peng S, 2010, DIGEST DIS SCI, V55, P2288, DOI 10.1007/s10620-009-1007-x; PINEAU P, P NATL ACAD SCI US, V107, P264; Qi P, 2010, HUM IMMUNOL, V71, P621, DOI 10.1016/j.humimm.2010.02.017; RYAN BM, NAT REV CANC, V10, P389; Srivastava K, 2010, J HUM GENET, V55, P495, DOI 10.1038/jhg.2010.54; Tian T, 2009, CANCER EPIDEM BIOMAR, V18, P1183, DOI 10.1158/1055-9965.EPI-08-0814; Wang K, 2010, BIOMARKERS, V15, P614, DOI 10.3109/1354750X.2010.505299; WHITEHEAD A, 1991, STAT MED, V10, P1665, DOI 10.1002/sim.4780101105; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135	36	40	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18108	10.1371/journal.pone.0018108	http://dx.doi.org/10.1371/journal.pone.0018108			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483822	gold, Green Submitted, Green Published			2022-12-27	WOS:000289057200029
J	Gays, F; Koh, ASC; Mickiewicz, KM; Aust, JG; Brooks, CG				Gays, Frances; Koh, Alan S. C.; Mickiewicz, Katarzyna M.; Aust, Jonathan G.; Brooks, Colin G.			Comprehensive Analysis of Transcript Start Sites in Ly49 Genes Reveals an Unexpected Relationship with Gene Function and a Lack Of Upstream Promoters	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; MHC CLASS-I; GENOME-WIDE ANALYSIS; NK CELLS; RECEPTOR REPERTOIRE; REGULATORY ELEMENT; CORE PROMOTER; RMA-S; EXPRESSION; IDENTIFICATION	Comprehensive analysis of the transcription start sites of the Ly49 genes of C57BL/6 mice using the oligo-capping 5'-RACE technique revealed that the genes encoding the "missing self" inhibitory receptors, Ly49A, C, G, and I, were transcribed from multiple broad regions in exon 1, in the intron1/exon2 region, and upstream of exon - 1b. Ly49E was also transcribed in this manner, and uniquely showed a transcriptional shift from exon1 to exon 2 when NK cells were activated in vitro with IL2. Remarkably, a large proportion of Ly49E transcripts was then initiated from downstream of the translational start codon. By contrast, the genes encoding Ly49B and Q in myeloid cells, the activating Ly49D and H receptors in NK cells, and Ly49F in activated T cells, were predominantly transcribed from a conserved site in a pyrimidine-rich region upstream of exon 1. An similar to 200 bp fragment from upstream of the Ly49B start site displayed tissue-specific promoter activity in dendritic cell lines, but the corresponding upstream fragments from all other Ly49 genes lacked detectable tissue-specific promoter activity. In particular, none displayed any significant activity in a newly developed adult NK cell line that expressed multiple Ly49 receptors. Similarly, no promoter activity could be found in fragments upstream of intron1/exon2. Collectively, these findings reveal a previously unrecognized relationship between the pattern of transcription and the expression/function of Ly49 receptors, and indicate that transcription of the Ly49 genes expressed in lymphoid cells is achieved in a manner that does not require classical upstream promoters.	[Gays, Frances; Koh, Alan S. C.; Mickiewicz, Katarzyna M.; Aust, Jonathan G.; Brooks, Colin G.] Med Sch Newcastle Upon Tyne, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Gays, F (corresponding author), Med Sch Newcastle Upon Tyne, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	colin.brooks@ncl.ac.uk	Koh, Alan/ABA-9226-2021	Koh, Alan/0000-0002-9267-455X; Mickiewicz, Katarzyna/0000-0001-9109-2120	Biotechnology and Biological Sciences Research Council, United Kingdom; Medical Research Council, United Kingdom; MRC [G0601166] Funding Source: UKRI; Medical Research Council [G0601166] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was generously supported by grants from the Biotechnology and Biological Sciences Research Council, United Kingdom, and Medical Research Council, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; Aust JG, 2011, J IMMUNOL, V186, P2013, DOI 10.4049/jimmunol.1003698; Aust JG, 2009, J IMMUNOL, V183, P106, DOI 10.4049/jimmunol.0804281; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BROOKS CG, 1993, J IMMUNOL, V151, P6645; Brooks CG, 2000, METH MOL B, V121, P13; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carninci P, 2007, CURR OPIN GENET DEV, V17, P139, DOI 10.1016/j.gde.2007.02.008; Coles MC, 2000, EUR J IMMUNOL, V30, P236, DOI 10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.3.CO;2-O; Dimasi N, 2005, IMMUNOL CELL BIOL, V83, P1, DOI 10.1111/j.1440-1711.2005.01301.x; Fraser KP, 2002, EUR J IMMUNOL, V32, P868, DOI 10.1002/1521-4141(200203)32:3<868::AID-IMMU868>3.0.CO;2-A; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Gays F, 2005, J IMMUNOL, V175, P2938, DOI 10.4049/jimmunol.175.5.2938; Gays F, 2000, J IMMUNOL, V164, P5094, DOI 10.4049/jimmunol.164.10.5094; Gays F, 2006, J IMMUNOL, V177, P5840, DOI 10.4049/jimmunol.177.9.5840; Gosselin P, 2000, IMMUNOGENETICS, V51, P326, DOI 10.1007/s002510050626; Held W, 1998, EUR J IMMUNOL, V28, P2407, DOI 10.1002/(SICI)1521-4141(199808)28:08&lt;2407::AID-IMMU2407&gt;3.0.CO;2-D; Jin VX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-114; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; KUBO S, 1993, GENE, V136, P329; Kubo S, 1999, BBA-GENE STRUCT EXPR, V1444, P191, DOI 10.1016/S0167-4781(98)00284-X; Kunz B, 2001, J IMMUNOL, V166, P6181, DOI 10.4049/jimmunol.166.10.6181; LUTZ MB, 1994, J IMMUNOL METHODS, V174, P269, DOI 10.1016/0022-1759(94)90031-0; MARUYAMA K, 1994, GENE, V138, P171; Mazda O, 1997, J IMMUNOL METHODS, V204, P143, DOI 10.1016/S0022-1759(97)00036-7; McQueen KL, 2001, IMMUNOGENETICS, V52, P212; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; Raulet DH, 1997, IMMUNOL REV, V155, P41, DOI 10.1111/j.1600-065X.1997.tb00938.x; Rouhi A, 2007, MOL IMMUNOL, V44, P821, DOI 10.1016/j.molimm.2006.04.006; Rouhi A, 2009, NUCLEIC ACIDS RES, V37, P5331, DOI 10.1093/nar/gkp592; Saleh A, 2004, IMMUNITY, V21, P55, DOI 10.1016/j.immuni.2004.06.005; Saleh A, 2002, J IMMUNOL, V168, P5163, DOI 10.4049/jimmunol.168.10.5163; Shen ZH, 1997, J IMMUNOL, V158, P2723; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smith HRC, 2000, J EXP MED, V191, P1341, DOI 10.1084/jem.191.8.1341; Suzuki Y, 2001, EMBO REP, V2, P388, DOI 10.1093/embo-reports/kve085; Takei F, 2001, IMMUNOL REV, V181, P90, DOI 10.1034/j.1600-065X.2001.1810107.x; Tanamachi DM, 2004, J IMMUNOL, V172, P1074, DOI 10.4049/jimmunol.172.2.1074; Toomey JA, 1998, EUR J IMMUNOL, V28, P47, DOI 10.1002/(SICI)1521-4141(199801)28:01<47::AID-IMMU47>3.0.CO;2-A; Toomey JA, 2003, J LEUKOCYTE BIOL, V74, P233, DOI 10.1189/jlb.0303097; Toyama-Sorimachi N, 2004, P NATL ACAD SCI USA, V101, P1016, DOI 10.1073/pnas.0305400101; Tsutsui H, 1996, J IMMUNOL, V157, P3967; Van Beneden K, 2002, J IMMUNOL, V168, P3295, DOI 10.4049/jimmunol.168.7.3295; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wilhelm BT, 2001, IMMUNOGENETICS, V53, P215, DOI 10.1007/s002510100313; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055	47	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18475	10.1371/journal.pone.0018475	http://dx.doi.org/10.1371/journal.pone.0018475			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483805	Green Published, gold, Green Submitted			2022-12-27	WOS:000289057200085
J	Washburn, LR; Zekzer, D; Eitan, S; Lu, YX; Dang, H; Middleton, B; Evans, CJ; Tian, JD; Kaufman, DL				Washburn, Lorraine R.; Zekzer, Dan; Eitan, Shoshana; Lu, Yuxin; Dang, Hoa; Middleton, Blake; Evans, Christopher J.; Tian, Jide; Kaufman, Daniel L.			A Potential Role for Shed Soluble Major Histocompatibility Class I Molecules as Modulators of Neurite Outgrowth	PLOS ONE			English	Article							MHC CLASS-I; CENTRAL-NERVOUS-SYSTEM; HUMAN-SERUM; COMPLEMENT COMPONENT-C1S; AXONAL REGENERATION; IMMUNE-RESPONSE; GENE-EXPRESSION; PROTEIN-KINASE; HEAVY-CHAIN; SPINAL-CORD	The neurobiological activities of classical major histocompatibility class I (MHCI) molecules are just beginning to be explored. To further examine MHCI's actions during the formation of neuronal connections, we cultured embryonic mouse retina explants a short distance from wildtype thalamic explants, or thalami from transgenic mice (termed "NSE-D-b") whose neurons express higher levels of MHCI. While retina neurites extended to form connections with wildtype thalami, we were surprised to find that retina neurite outgrowth was very stunted in regions proximal to NSE-D-b thalamic explants, suggesting that a diffusible factor from these thalami inhibited retina neurite outgrowth. It has been long known that MHCI-expressing cells release soluble forms of MHCI (sMHCI) due to the shedding of intact MHCI molecules, as well as the alternative exon splicing of its heavy chain or the action proteases which cleave off it's transmembrane anchor. We show that the diffusible inhibitory factor from the NSE-D-b thalami is sMHCI. We also show that COS cells programmed to express murine MHCI release sMHCI that inhibits neurite outgrowth from nearby neurons in vitro. The neuroinhibitory effect of sMHCI could be blocked by lowering cAMP levels, suggesting that the neuronal MHCI receptor's signaling mechanism involves a cyclic nucleotide-dependent pathway. Our results suggest that MHCI may not only have neurobiological activity in its membrane-bound form, it may also influence local neurons as a soluble molecule. We discuss the involvement of complement proteins in generating sMHCI and new theoretical models of MHCI's biological activities in the nervous system.	[Washburn, Lorraine R.; Zekzer, Dan; Lu, Yuxin; Dang, Hoa; Middleton, Blake; Tian, Jide; Kaufman, Daniel L.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Eitan, Shoshana; Evans, Christopher J.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Washburn, LR (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	dkaufman@mednet.ucla.edu	Kaufman, Daniel/AAU-1228-2021	Kaufman, Daniel/0000-0002-9844-5918	National Institute of Health [R21NS053847, R21NS047383]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053847, R21NS047383] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health grants R21NS053847 and R21NS047383 to DLK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamashvili I, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-13; ALLISON JP, 1977, J IMMUNOL, V118, P1004; Arosa FA, 2007, TRENDS IMMUNOL, V28, P115, DOI 10.1016/j.it.2007.01.002; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; AULITZKY WE, 1991, CLIN EXP IMMUNOL, V86, P236; BJORCK L, 1984, ACTA PATH MICRO IM C, V92, P19; Carbone E, 1996, EUR J IMMUNOL, V26, P683, DOI 10.1002/eji.1830260326; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Chapman TL, 2000, IMMUNITY, V13, P727, DOI 10.1016/S1074-7613(00)00071-6; CHARLTON RK, 1970, SCIENCE, V170, P636, DOI 10.1126/science.170.3958.636; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; DOBBE LME, 1988, IMMUNOGENETICS, V27, P203, DOI 10.1007/BF00346587; Eriksson H, 1996, IMMUNOTECHNOLOGY, V2, P163, DOI 10.1016/S1380-2933(96)00050-4; ERIKSSON H, 1992, BIOCHEM BIOPH RES CO, V187, P832, DOI 10.1016/0006-291X(92)91272-R; ERIKSSON H, 1990, BIOCHIM BIOPHYS ACTA, V1037, P209, DOI 10.1016/0167-4838(90)90169-G; Escande-Beillard N, 2010, J IMMUNOL, V184, P816, DOI 10.4049/jimmunol.0902159; Greenfield EA, 1998, CRIT REV IMMUNOL, V18, P389, DOI 10.1615/CritRevImmunol.v18.i5.10; Guido W, 1997, J NEUROPHYSIOL, V77, P511, DOI 10.1152/jn.1997.77.1.511; HAGA JA, 1991, J BIOL CHEM, V266, P3695; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; JOLY E, 1991, SCIENCE, V253, P1283, DOI 10.1126/science.1891717; Kambayashi T, 2001, J LEUKOCYTE BIOL, V70, P903; KAMMER GM, 1988, IMMUNOL TODAY, V9, P222, DOI 10.1016/0167-5699(88)91220-0; Kimura T, 2000, J VIROL, V74, P6117, DOI 10.1128/JVI.74.13.6117-6125.2000; KRANGEL MS, 1986, J EXP MED, V163, P1173, DOI 10.1084/jem.163.5.1173; LAMPSON LA, 1995, MICROSC RES TECHNIQ, V32, P267, DOI 10.1002/jemt.1070320402; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LENSCHOW DJ, 1993, CURR OPIN IMMUNOL, V5, P747, DOI 10.1016/0952-7915(93)90132-C; MAIO M, 1989, CANCER RES, V49, P2980; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Natarajan K, 1999, Rev Immunogenet, V1, P32; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779; NISSEN MH, 1990, EUR J BIOCHEM, V189, P423, DOI 10.1111/j.1432-1033.1990.tb15505.x; PEDERSEN LO, 1995, EUR J IMMUNOL, V25, P1609, DOI 10.1002/eji.1830250621; PUPPO F, 1995, J CLIN IMMUNOL, V15, P179, DOI 10.1007/BF01541087; PUPPO F, 1995, IMMUNOL TODAY, V16, P124, DOI 10.1016/0167-5699(95)80127-8; RALL GF, 1995, J EXP MED, V182, P1201, DOI 10.1084/jem.182.5.1201; SARIRIAN K, 1993, TISSUE ANTIGENS, V42, P9, DOI 10.1111/j.1399-0039.1993.tb02159.x; Shiroishi M, 2003, P NATL ACAD SCI USA, V100, P8856, DOI 10.1073/pnas.1431057100; SMALHEISER NR, 1981, BRAIN RES, V204, P159, DOI 10.1016/0006-8993(81)90659-4; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Spaggiari GM, 2002, BLOOD, V100, P4098, DOI 10.1182/blood-2002-04-1284; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; TAKAYAMA H, 1989, J PHARM SCI, V78, P8, DOI 10.1002/jps.2600780104; Thams S, 2009, J NEUROSCI, V29, P13503, DOI 10.1523/JNEUROSCI.0981-09.2009; Torres AR, 2006, HUM IMMUNOL, V67, P346, DOI 10.1016/j.humimm.2006.01.001; VANROOD JJ, 1970, NATURE, V226, P366, DOI 10.1038/226366a0; Viret C, 1999, Rev Immunogenet, V1, P91; WONG GHW, 1984, NATURE, V310, P688, DOI 10.1038/310688a0; Wu ZP, 2011, J NEUROIMMUNOL, V232, P8, DOI 10.1016/j.jneuroim.2010.09.009; Wu ZP, 2011, IMMUNOL LETT, V135, P118, DOI 10.1016/j.imlet.2010.10.011; Zanon RG, 2006, EXP NEUROL, V200, P521, DOI 10.1016/j.expneurol.2006.03.004; Zavazava N, 1996, NAT MED, V2, P1005, DOI 10.1038/nm0996-1005; Zavazava N, 1998, MOL MED TODAY, V4, P116, DOI 10.1016/S1357-4310(97)01185-4	62	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18439	10.1371/journal.pone.0018439	http://dx.doi.org/10.1371/journal.pone.0018439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483793	Green Published, gold			2022-12-27	WOS:000289057200079
J	Michaelsson, K; Byberg, L; Ahlbom, A; Melhus, H; Farahmand, BY				Michaelsson, Karl; Byberg, Liisa; Ahlbom, Anders; Melhus, Hakan; Farahmand, Bahman Y.			Risk of Severe Knee and Hip Osteoarthritis in Relation to Level of Physical Exercise: A Prospective Cohort Study of Long-Distance Skiers in Sweden	PLOS ONE			English	Article							MIDDLE-AGED WOMEN; CARTILAGE THICKNESS; ARTICULAR-CARTILAGE; JOINT; MORTALITY; INJURIES; ADULTS	Background: To complete long-distance ski races, regular physical exercise is required. This includes not only cross-country skiing but also endurance exercise during the snow-free seasons. The aim of this study was to determine whether the level of physical exercise is associated with future risk of severe osteoarthritis independent of previous diseases and injuries. Methodology/Principal Findings: We used a cohort that consisted of 48 574 men and 5 409 women who participated in the 90 km ski race Vasaloppet at least once between 1989 and 1998. Number of performed races and finishing time were used as estimates of exercise level. By matching to the National Patient Register we identified participants with severe osteoarthritis, defined as arthroplasty of knee or hip due to osteoarthritis. With an average follow-up of 10 years, we identified 528 men and 42 women with incident osteoarthritis. The crude rate was 1.1/1000 person-years for men and 0.8/1000 person-years for women. Compared with racing once, participation in >= 5 races was associated with a 70% higher rate of osteoarthritis (multivariable-adjusted hazard ratio (HR) 1.72, 95% confidence interval (CI) 1.33 to 2.22). The association was dose-dependent with an adjusted HR of 1.09, 95% CI 1.05 to 1.13 for each completed race. A faster finishing time, in comparison with a slow finishing time, was also associated with an increased rate (adjusted HR 1.51, 95% CI 1.14 to 2.01). Contrasting those with 5 or more ski races and a fast finish time to those who only participated once with a slow finish time, the adjusted HR of osteoarthritis was 2.73, 95% CI 1.78 to 4.18. Conclusions/Significance: Participants with multiple and fast races have an increased risk of subsequent arthroplasty of knee and hip due to osteoarthritis, suggesting that intensive exercise may increase the risk.	[Michaelsson, Karl; Byberg, Liisa] Uppsala Univ, Sect Orthopaed, Dept Surg Sci, Uppsala, Sweden; [Michaelsson, Karl; Byberg, Liisa; Melhus, Hakan] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Ahlbom, Anders; Farahmand, Bahman Y.] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Melhus, Hakan] Uppsala Univ, Clin Pharmacol Sect, Dept Med Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Karolinska Institutet; Uppsala University	Michaelsson, K (corresponding author), Uppsala Univ, Sect Orthopaed, Dept Surg Sci, Uppsala, Sweden.	karl.michaelsson@surgsci.uu.se	Michaelsson, Karl/AAM-9094-2021	Michaelsson, Karl/0000-0003-2815-1217	Swedish Research Council [K2006-73P-20267-01-4, K2009-52x-13511-10-3]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Swedish Research Council (K2006-73P-20267-01-4 and K2009-52x-13511-10-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AROKOSKI J, 1994, INT J SPORTS MED, V15, P254, DOI 10.1055/s-2007-1021056; Astrand PO., 1986, TXB WORK PHYSL, P391; Buckwalter JA, 2004, CURR OPIN RHEUMATOL, V16, P634, DOI 10.1097/01.bor.0000132647.55056.a9; Byberg L, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b688; Carlsson S, 2006, MED SCI SPORT EXER, V38, P1396, DOI 10.1249/01.mss.0000228941.17034.c1; Cheng YL, 2000, J CLIN EPIDEMIOL, V53, P315, DOI 10.1016/S0895-4356(99)00168-7; Cooper C, 2000, ARTHRITIS RHEUM, V43, P995, DOI 10.1002/1529-0131(200005)43:5<995::AID-ANR6>3.0.CO;2-1; Creamer P, 1997, LANCET, V350, P503, DOI 10.1016/S0140-6736(97)07226-7; De Moor MHM, 2007, TWIN RES HUM GENET, V10, P812, DOI 10.1375/twin.10.6.812; Engstrom L, 1993, LIFESTYLE FUNCTION H; Farahmand BY, 2003, J INTERN MED, V253, P276, DOI 10.1046/j.1365-2796.2003.01122.x; Felson DT, 2007, ARTHRIT RHEUM-ARTHR, V57, P6, DOI 10.1002/art.22464; Felson DT, 1997, ARTHRITIS RHEUM, V40, P728, DOI 10.1002/art.1780400420; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Forsberg A, 2002, IMPROVE YOUR FITNESS; Fransen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004376.pub2; Garstang SV, 2006, AM J PHYS MED REHAB, V85, pS2, DOI 10.1097/01.phm.0000245568.69434.1a; Gelber AC, 2000, ANN INTERN MED, V133, P321, DOI 10.7326/0003-4819-133-5-200009050-00007; Hart DJ, 1999, ARTHRITIS RHEUM, V42, P17, DOI 10.1002/1529-0131(199901)42:1<17::AID-ANR2>3.0.CO;2-E; Hart LE, 2008, CLIN J SPORT MED, V18, P508, DOI 10.1097/JSM.0b013e3181865ed4; Hootman JM, 2003, PREV MED, V36, P636, DOI 10.1016/S0091-7435(03)00018-5; Hunter DJ, 2009, J ANAT, V214, P197, DOI 10.1111/j.1469-7580.2008.01013.x; KIVIRANTA I, 1992, CLIN ORTHOP RELAT R, P302; Lane NE, 1998, J RHEUMATOL, V25, P334; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Leitzmann MF, 2007, ARCH INTERN MED, V167, P2453, DOI 10.1001/archinte.167.22.2453; Lievense AM, 2003, ARTHRIT RHEUM-ARTHR, V49, P228, DOI 10.1002/art.11012; Lohmander LS, 2009, ANN RHEUM DIS, V68, P490, DOI 10.1136/ard.2008.089748; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; McAlindon TE, 1999, AM J MED, V106, P151, DOI 10.1016/S0002-9343(98)00413-6; Muhlbauer R, 2000, AM J SPORT MED, V28, P541; Newton PM, 1997, AM J SPORT MED, V25, P282, DOI 10.1177/036354659702500302; Pollock M L, 1977, Ann N Y Acad Sci, V301, P310, DOI 10.1111/j.1749-6632.1977.tb38209.x; RENSTROM P, 1989, SPORTS MED, V8, P346, DOI 10.2165/00007256-198908060-00004; RUSKO HK, 1992, MED SCI SPORT EXER, V24, P1040; Soderman P, 2000, J ARTHROPLASTY, V15, P884, DOI 10.1054/arth.2000.8591; Spector Tim D, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS39; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Szoeke CEI, 2006, BONE, V39, P1149, DOI 10.1016/j.bone.2006.05.016; VENN G, 1995, ARTHRITIS RHEUM, V38, P525, DOI 10.1002/art.1780380410; Vignon E, 2006, JOINT BONE SPINE, V73, P442, DOI 10.1016/j.jbspin.2006.03.001	43	33	33	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18339	10.1371/journal.pone.0018339	http://dx.doi.org/10.1371/journal.pone.0018339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479136	gold, Green Submitted, Green Published			2022-12-27	WOS:000289055700050
J	Chai, YP; Zhang, DM; Lin, YF				Chai, Yongping; Zhang, Dai-Min; Lin, Yu-Fung			Activation of cGMP-Dependent Protein Kinase Stimulates Cardiac ATP-Sensitive Potassium Channels via a ROS/Calmodulin/CaMKII Signaling Cascade	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; RABBIT VENTRICULAR MYOCYTES; OXYGEN-FREE RADICALS; K+ CHANNELS; MEDIATED PHOSPHORYLATION; SKELETAL-MUSCLE; SULFONYLUREA RECEPTOR; INSULIN-SECRETION; DOPAMINE RELEASE; MEMBRANE PATCHES	Background: Cyclic GMP (cGMP)-dependent protein kinase (PKG) is recognized as an important signaling component in diverse cell types. PKG may influence the function of cardiac ATP-sensitive potassium (K(ATP)) channels, an ion channel critical for stress adaptation in the heart; however, the underlying mechanism remains largely unknown. The present study was designed to address this issue. Methods and Findings: Single-channel recordings of cardiac K(ATP) channels were performed in both cell-attached and inside-out patch configurations using transfected human embryonic kidney (HEK) 293 cells and rabbit ventricular cardiomyocytes. We found that Kir6.2/SUR2A (the cardiac-type K(ATP)) channels were activated by cGMP-selective phosphodiesterase inhibitor zaprinast in a concentration-dependent manner in cell-attached patches obtained from HEK293 cells, an effect mimicked by the membrane-permeable cGMP analog 8-bromo-cGMP whereas abolished by selective PKG inhibitors. Intriguingly, direct application of PKG moderately reduced rather than augmented Kir6.2/SUR2A single-channel currents in excised, inside-out patches. Moreover, PKG stimulation of Kir6.2/SUR2A channels in intact cells was abrogated by ROS/H(2)O(2) scavenging, antagonism of calmodulin, and blockade of calcium/calmodulin-dependent protein kinase II (CaMKII), respectively. Exogenous H(2)O(2) also concentration-dependently stimulated Kir6.2/SUR2A channels in intact cells, and its effect was prevented by inhibition of calmodulin or CaMKII. PKG stimulation of K(ATP) channels was confirmed in intact ventricular cardiomyocytes, which was ROS- and CaMKII-dependent. Kinetically, PKG appeared to stimulate these channels by destabilizing the longest closed state while stabilizing the long open state and facilitating opening transitions. Conclusion: The present study provides novel evidence that PKG exerts dual regulation of cardiac K(ATP) channels, including marked stimulation resulting from intracellular signaling mediated by ROS (H(2)O(2) in particular), calmodulin and CaMKII, alongside of moderate channel suppression likely mediated by direct PKG phosphorylation of the channel or some closely associated proteins. The novel cGMP/PKG/ROS/calmodulin/CaMKII signaling pathway may regulate cardiomyocyte excitability by opening K(ATP) channels and contribute to cardiac protection against ischemia-reperfusion injury.	[Chai, Yongping; Zhang, Dai-Min; Lin, Yu-Fung] Univ Calif Davis, Dept Physiol, Davis, CA 95616 USA; [Chai, Yongping; Zhang, Dai-Min; Lin, Yu-Fung] Univ Calif Davis, Dept Membrane Biol, Davis, CA 95616 USA; [Lin, Yu-Fung] Univ Calif Davis, Dept Anesthesiol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Chai, YP (corresponding author), Univ Calif Davis, Dept Physiol, Davis, CA 95616 USA.	yu-fung.lin@ucdmc.ucdavis.edu	Zhang, Dai-Min/J-2765-2019	Zhang, Dai-Min/0000-0001-5251-3113; Lin, Yu-Fung/0000-0003-1471-949X	American Heart Association National Center [0730320N]; National Center for Research Resources, National Institutes of Health [C06 RR-12088-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER	American Heart Association National Center(American Heart Association); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by a grant (0730320N) from American Heart Association National Center (Y.F.L.), and was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 RR-12088-01 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Bryan L, 1998, PHYSIOL REV, V78, P227, DOI 10.1152/physrev.1998.78.1.227; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; Avshalumov MV, 2003, P NATL ACAD SCI USA, V100, P11729, DOI 10.1073/pnas.1834314100; Avshalumov MV, 2003, J NEUROSCI, V23, P2744; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Baines CP, 1997, J MOL CELL CARDIOL, V29, P207, DOI 10.1006/jmcc.1996.0265; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Chai Y, 2008, PFLUG ARCH EUR J PHY, V456, P897, DOI 10.1007/s00424-008-0447-z; Chai YP, 2010, AM J PHYSIOL-CELL PH, V298, pC875, DOI 10.1152/ajpcell.00196.2009; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COETZEE WA, 1995, AM J PHYSIOL-HEART C, V269, pH1625, DOI 10.1152/ajpheart.1995.269.5.H1625; DUGAN LL, 1995, J NEUROSCI, V15, P6377; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; GOLDHABER JI, 1989, J CLIN INVEST, V83, P1800, DOI 10.1172/JCI114085; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han J, 2002, AM J PHYSIOL-HEART C, V283, pH1545, DOI 10.1152/ajpheart.01052.2001; Han J, 2001, J BIOL CHEM, V276, P22140, DOI 10.1074/jbc.M010103200; Hayabuchi Y, 2001, J PHYSIOL-LONDON, V530, P193, DOI 10.1111/j.1469-7793.2001.0193l.x; HORN R, 1987, BIOPHYS J, V51, P255, DOI 10.1016/S0006-3495(87)83331-3; Hu K, 1999, AM J PHYSIOL-HEART C, V276, pH488, DOI 10.1152/ajpheart.1999.276.2.H488; Ichinari K, 1996, J MOL CELL CARDIOL, V28, P1867, DOI 10.1006/jmcc.1996.0179; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; ISLAM MS, 1993, FEBS LETT, V319, P128, DOI 10.1016/0014-5793(93)80051-U; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kane GC, 2006, HUM MOL GENET, V15, P2285, DOI 10.1093/hmg/ddl154; Krippeit-Drews P, 1999, J PHYSIOL-LONDON, V514, P471, DOI 10.1111/j.1469-7793.1999.471ae.x; KUBO M, 1994, CIRC RES, V74, P471, DOI 10.1161/01.RES.74.3.471; Light PE, 2000, P NATL ACAD SCI USA, V97, P9058, DOI 10.1073/pnas.160068997; Lin YF, 2008, NEUROSCIENCE, V152, P371, DOI 10.1016/j.neuroscience.2008.01.003; Lin YF, 2004, P NATL ACAD SCI USA, V101, P7799, DOI 10.1073/pnas.0402496101; Lin YF, 2000, EMBO J, V19, P942, DOI 10.1093/emboj/19.5.942; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Maier LS, 2009, FRONT BIOSCI-LANDMRK, V14, P486, DOI 10.2741/3257; Mao X, 2007, AM J PHYSIOL-CELL PH, V292, pC2239, DOI 10.1152/ajpcell.00326.2006; MCMANUS OB, 1988, J PHYSIOL-LONDON, V402, P79, DOI 10.1113/jphysiol.1988.sp017195; Miki T, 2005, J MOL CELL CARDIOL, V38, P917, DOI 10.1016/j.yjmcc.2004.11.019; NAKAZAKI M, 1995, DIABETES, V44, P878, DOI 10.2337/diabetes.44.8.878; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Okuyama Y, 1998, PFLUG ARCH EUR J PHY, V435, P595, DOI 10.1007/s004240050559; Oldenburg O, 2004, AM J PHYSIOL-HEART C, V286, pH468, DOI 10.1152/ajpheart.00360.2003; Olson TM, 2010, PFLUG ARCH EUR J PHY, V460, P295, DOI 10.1007/s00424-009-0771-y; Pitt GS, 2007, CARDIOVASC RES, V73, P641, DOI 10.1016/j.cardiores.2006.10.019; Ropero AB, 1999, J PHYSIOL-LONDON, V521, P397, DOI 10.1111/j.1469-7793.1999.00397.x; Sakura H, 1995, FEBS LETT, V377, P338, DOI 10.1016/0014-5793(95)01369-5; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Shi Y, 2008, J BIOL CHEM, V283, P2488, DOI 10.1074/jbc.M708769200; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Thorneloe KS, 2002, J PHYSIOL-LONDON, V541, P65, DOI 10.1113/jphysiol.2002.018101; Tokube K, 1996, AM J PHYSIOL-HEART C, V271, pH478, DOI 10.1152/ajpheart.1996.271.2.H478; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; Wagner S, 2009, CIRC-ARRHYTHMIA ELEC, V2, P285, DOI 10.1161/CIRCEP.108.842799; Wang X, 1997, J NEUROCHEM, V68, P443; WEIK R, 1989, J MEMBRANE BIOL, V110, P217, DOI 10.1007/BF01869152; Wellman GC, 1998, J PHYSIOL-LONDON, V507, P117, DOI 10.1111/j.1469-7793.1998.117bu.x; Xu ZL, 2004, AM J PHYSIOL-HEART C, V286, pH1433, DOI 10.1152/ajpheart.00882.2003; Zhang T, 2004, RECENT PROG HORM RES, V59, P141, DOI 10.1210/rp.59.1.141; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	62	34	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18191	10.1371/journal.pone.0018191	http://dx.doi.org/10.1371/journal.pone.0018191			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479273	gold, Green Published			2022-12-27	WOS:000289054600032
J	Cremer, S; Schrempf, A; Heinze, J				Cremer, Sylvia; Schrempf, Alexandra; Heinze, Juergen			Competition and Opportunity Shape the Reproductive Tactics of Males in the Ant Cardiocondyla obscurior	PLOS ONE			English	Article							DIMORPHIC MALES; DISPERSAL; EVOLUTION; MIMICRY; QUEENS	Context-dependent adjustment of mating tactics can drastically increase the mating success of behaviourally flexible animals. We used the ant Cardiocondyla obscurior as a model system to study adaptive adjustment of male mating tactics. This species shows a male diphenism of wingless fighter males and peaceful winged males. Whereas the wingless males stay and exclusively mate in the maternal colony, the mating behaviour of winged males is plastic. They copulate with female sexuals in their natal nests early in life but later disperse in search for sexuals outside. In this study, we observed the nest-leaving behaviour of winged males under different conditions and found that they adaptively adjust the timing of their dispersal to the availability of mating partners, as well as the presence, and even the type of competitors in their natal nests. In colonies with virgin female queens winged males stayed longest when they were the only male in the nest. They left earlier when mating partners were not available or when other males were present. In the presence of wingless, locally mating fighter males, winged males dispersed earlier than in the presence of docile, winged competitors. This suggests that C. obscurior males are capable of estimating their local breeding chances and adaptively adjust their dispersal behaviour in both an opportunistic and a risk-sensitive way, thus showing hitherto unknown behavioural plasticity in social insect males.	[Cremer, Sylvia; Schrempf, Alexandra; Heinze, Juergen] Univ Regensburg, Regensburg, Germany	University of Regensburg	Cremer, S (corresponding author), IST Austria, Klosterneuburg, Austria.	sylvia.cremer@ist.ac.at	Cremer, Sylvia/B-2199-2013	Cremer, Sylvia/0000-0002-2193-3868	German Science Foundation [He 1623/23]	German Science Foundation(German Research Foundation (DFG))	This work was supported by the German Science Foundation (www.dfg.de, He 1623/23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2003, BEHAV ECOL, V14, P54, DOI 10.1093/beheco/14.1.54; Boomsma JJ, 2005, ANNU REV ENTOMOL, V50, P395, DOI 10.1146/annurev.ento.50.071803.130416; Cremer S, 2003, CURR BIOL, V13, P219, DOI 10.1016/S0960-9822(03)00012-5; Cremer S, 2002, NATURE, V419, P897, DOI 10.1038/419897a; Cremer S, 2008, NATURWISSENSCHAFTEN, V95, P1101, DOI 10.1007/s00114-008-0430-8; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Heinze J, 1998, BEHAV ECOL SOCIOBIOL, V42, P239, DOI 10.1007/s002650050435; HEINZE J, 1993, P NATL ACAD SCI USA, V90, P8412, DOI 10.1073/pnas.90.18.8412; Heinze J, 2005, MOL PHYLOGENET EVOL, V37, P278, DOI 10.1016/j.ympev.2005.04.005; KINOMURA K, 1987, J ETHOL, V5, P75, DOI 10.1007/BF02347897; KODRICBROWN A, 1986, BEHAV ECOL SOCIOBIOL, V19, P425, DOI 10.1007/BF00300545; LAWRENCE WS, 1987, BEHAV ECOL SOCIOBIOL, V21, P367, DOI 10.1007/BF00299931; OLIVEIRA RF, ALTERNATIVE REPROD T; STEPHENS DW, FORAGING BEHAV ECOLO; STUART RJ, 1987, NATURWISSENSCHAFTEN, V74, P548, DOI 10.1007/BF00367076; Thornhill R., 1983, pi	16	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17323	10.1371/journal.pone.0017323	http://dx.doi.org/10.1371/journal.pone.0017323			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21468323	gold, Green Published			2022-12-27	WOS:000289054600009
J	Bott-Flugel, L; Bernshausen, A; Schneider, H; Luppa, P; Zimmermann, K; Albrecht-Kupper, B; Kast, R; Laugwitz, KL; Ehmke, H; Knorr, A; Seyfarth, M				Bott-Fluegel, Lorenz; Bernshausen, Alexandra; Schneider, Heike; Luppa, Peter; Zimmermann, Katja; Albrecht-Kuepper, Barbara; Kast, Raimund; Laugwitz, Karl-Ludwig; Ehmke, Heimo; Knorr, Andreas; Seyfarth, Melchior			Selective Attenuation of Norepinephrine Release and Stress-Induced Heart Rate Increase by Partial Adenosine A(1) Agonism	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; RECEPTOR AGONISTS; ACTIVATION; STIMULATION; MECHANISM; NORADRENALINE; HYPERTROPHY; SUBTYPES; FAILURE; DRUGS	The release of the neurotransmitter norepinephrine (NE) is modulated by presynaptic adenosine receptors. In the present study we investigated the effect of a partial activation of this feedback mechanism. We hypothesized that partial agonism would have differential effects on NE release in isolated hearts as well as on heart rate in vivo depending on the genetic background and baseline sympathetic activity. In isolated perfused hearts of Wistar and Spontaneously Hypertensive Rats (SHR), NE release was induced by electrical stimulation under control conditions (S1), and with capadenoson 6 . 10(-8) M (30 mu g/l), 6 . 10(-7) M (300 mu g/l) or 2-chloro-N-6-cyclopentyladenosine (CCPA) 10(-6) M (S2). Under control conditions (S1), NE release was significantly higher in SHR hearts compared to Wistar (766+/-87 pmol/g vs. 173+/-18 pmol/g, p<0.01). Capadenoson led to a concentration-dependent decrease of the stimulation-induced NE release in SHR (S2/S1 = 0.90+/-0.08 with capadenoson 6 . 10(-8) M, 0.54+/-0.02 with 6 . 10(-7) M), but not in Wistar hearts (S2/S1 = 1.05+/-0.12 with 6 . 10(-8) M, 1.03+/-0.09 with 6 . 10(-7) M). CCPA reduced NE release to a similar degree in hearts from both strains. In vivo capadenoson did not alter resting heart rate in Wistar rats or SHR. Restraint stress induced a significantly greater increase of heart rate in SHR than in Wistar rats. Capadenoson blunted this stress-induced tachycardia by 45% in SHR, but not in Wistar rats. Using a [S-35]GTP gamma S assay we demonstrated that capadenoson is a partial agonist compared to the full agonist CCPA (74+/22% A(1)-receptor stimulation). These results suggest that partial adenosine A(1)-agonism dampens stress-induced tachycardia selectively in rats susceptible to strong increases in sympathetic activity, most likely due to a presynaptic attenuation of NE release.	[Bott-Fluegel, Lorenz; Bernshausen, Alexandra; Laugwitz, Karl-Ludwig] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 1, D-8000 Munich, Germany; [Bott-Fluegel, Lorenz; Bernshausen, Alexandra; Laugwitz, Karl-Ludwig] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany; [Schneider, Heike; Luppa, Peter] Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-8000 Munich, Germany; [Zimmermann, Katja; Albrecht-Kuepper, Barbara; Kast, Raimund; Knorr, Andreas] Bayer Schering Pharma AG, Global Drug Discovery, Wuppertal, Germany; [Ehmke, Heimo] Univ Klinikum Hamburg Eppendorf, Inst Vegetat Physiol & Pathophysiol, Hamburg, Germany; [Seyfarth, Melchior] Univ Witten Herdecke, Med Klin 3, HELIOS Klinikum Wuppertal, Witten, Germany; [Seyfarth, Melchior] Univ Witten Herdecke, Lehrstuhl Kardiol, Witten, Germany	Technical University of Munich; German Heart Centre Munich; Technical University of Munich; Technical University of Munich; Bayer AG; Bayer Healthcare Pharmaceuticals; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helios Kliniken; Witten Herdecke University; Witten Herdecke University	Bott-Flugel, L (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Med Klin 1, D-8000 Munich, Germany.	bottfluegel@online.de		Bott-Flugel, Lorenz/0000-0003-0932-1241	Medizinische Klinik and Institut fur Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, TU Munchen; Bayer Schering Pharma; Bayer Schering Pharma GmbH	Medizinische Klinik and Institut fur Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, TU Munchen; Bayer Schering Pharma(Bayer AG); Bayer Schering Pharma GmbH	The in vitro experiments were funded by 1. Medizinische Klinik and Institut fur Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, TU Munchen. Bayer Schering Pharma provided funding for the in vivo studies and took part in the design and data aquisition/analysis of the in vivo experiments. Bayer Schering had no role in data interpretation and decision to publish.; L. Bott-Flugel received travel fees from Bayer Schering Pharma GmbH. H. Ehmke serves as consultant to Bayer Schering Pharma GmbH. K. Zimmermann, A. Knorr, B. Albrecht-Kupper, and R. Kast are employees of Bayer Schering Pharma GmbH. Bayer Schering Pharma provided funding for the in vivo studies and took part in the design, data aquisition and analysis of the in vivo experiments. The principal investigators (L. Bott-Flugel, H. Ehmke, and Melchior Seyfarth) had access to the raw data, and Bayer Schering had no role in the interpretation of the data and decision to publish. The authors declare that funding by Bayer Schering Pharma does not influence their adherence to the PLoS ONE policies on sharing data and materials.	ARMAH BI, 1988, ARZNEIMITTEL-FORSCH, V38-2, P1426; Brodde OE, 1999, PHARMACOL REV, V51, P651; Burgdorf C, 2001, CARDIOVASC RES, V49, P713, DOI 10.1016/S0008-6363(00)00309-6; CONRAD CH, 1995, CIRCULATION, V91, P161, DOI 10.1161/01.CIR.91.1.161; Dart AM, 2002, CARDIOVASC RES, V53, P678, DOI 10.1016/S0008-6363(01)00508-9; ELWORTHY PM, 1986, J CHROMATOGR, V380, P33, DOI 10.1016/S0378-4347(00)83622-1; Elzein E, 2008, EXPERT OPIN INV DRUG, V17, P1901, DOI [10.1517/13543780802497284, 10.1517/13543780802497284 ]; Ernsberger P, 1997, AM J PHYSIOL-REG I, V273, pR1572, DOI 10.1152/ajpregu.1997.273.5.R1572; Gan XHT, 2005, J PHARMACOL EXP THER, V312, P27, DOI 10.1124/jpet.104.073122; Grundemann D, 2002, BRIT J PHARMACOL, V137, P910, DOI 10.1038/sj.bjp.0704926; Guyenet PG, 1997, AM J PHYSIOL-REG I, V273, pR1580, DOI 10.1152/ajpregu.1997.273.5.R1580; Hattori Y, 1998, LIFE SCI, V62, P1449, DOI 10.1016/S0024-3205(98)00088-5; Head GA, 1997, CLIN EXP HYPERTENS, V19, P591, DOI 10.3109/10641969709083172; Kobayashi S, 1996, AM J PHYSIOL-REG I, V271, pR704, DOI 10.1152/ajpregu.1996.271.3.R704; LOHSE MJ, 1984, N-S ARCH PHARMACOL, V326, P69, DOI 10.1007/BF00518781; LOHSE MJ, 1987, N-S ARCH PHARMACOL, V336, P204, DOI 10.1007/BF00165806; Lorbar M, 2004, CAN J PHYSIOL PHARM, V82, P1026, DOI 10.1139/Y04-108; Lorenzen A, 1996, MOL PHARMACOL, V49, P915; LORENZEN A, 1993, MOL PHARMACOL, V44, P115; McDougall SJ, 2000, HYPERTENSION, V35, P126, DOI 10.1161/01.HYP.35.1.126; Nell PG, 2009, PROGR MED CHEM, V47, P163, DOI 10.1016/S0079-6468(08)00204-X; PACKER M, 1987, CIRCULATION, V75, P80; Persson H, 2002, EUR J HEART FAIL, V4, P73, DOI 10.1016/S1388-9842(01)00196-9; PRICHARD B N C, 1987, European Heart Journal, V8, P121; RICHARDT G, 1989, J MOL CELL CARDIOL, V21, P269, DOI 10.1016/0022-2828(89)90742-6; SEYFARTH M, 1993, CIRC RES, V73, P496, DOI 10.1161/01.RES.73.3.496; Song Y, 2002, CIRCULATION, V105, P118, DOI 10.1161/hc0102.101392; Szabo B, 2002, PHARMACOL THERAPEUT, V93, P1, DOI 10.1016/S0163-7258(01)00170-X; Tendera M, 2007, J AM COLL CARDIOL, V49, p232A; TSUBOI H, 1987, J HYPERTENS, V5, P323, DOI 10.1097/00004872-198706000-00010; VANDERWENDEN EM, 1995, EUR J PHARM-MOLEC PH, V290, P189, DOI 10.1016/0922-4106(95)00064-X; YAMADA K, 1992, CLIN EXP PHARMACOL P, V19, P563, DOI 10.1111/j.1440-1681.1992.tb00505.x; ZSOTER TT, 1982, CLIN EXP HYPERTENS, V4, P431, DOI 10.3109/10641968209060753; Zugck C, 2003, J HYPERTENS, V21, P1363, DOI 10.1097/00004872-200307000-00026	34	23	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18048	10.1371/journal.pone.0018048	http://dx.doi.org/10.1371/journal.pone.0018048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464936	Green Submitted, Green Published, gold			2022-12-27	WOS:000289053800016
J	der Rieden, PMJI; Jansen, HJ; Durston, AJ				der Rieden, Paul M. J. In; Jansen, Hans J.; Durston, Antony J.			XMeis3 Is Necessary for Mesodermal Hox Gene Expression and Function	PLOS ONE			English	Article							COOPERATIVE DNA-BINDING; NUCLEAR-LOCALIZATION; HOMEODOMAIN PROTEIN; HOMEOBOX GENES; SEGMENTAL EXPRESSION; PBX PROTEINS; XENOPUS; EXTRADENTICLE; ACTIVATION; HINDBRAIN	Hox transcription factors provide positional information during patterning of the anteroposterior axis. Hox transcription factors can co-operatively bind with PBC-class co-factors, enhancing specificity and affinity for their appropriate binding sites. The nuclear localisation of these co-factors is regulated by the Meis-class of homeodomain proteins. During development of the zebrafish hindbrain, Meis3 has previously been shown to synergise with Hoxb1 in the autoregulation of Hoxb1. In Xenopus XMeis3 posteriorises the embryo upon ectopic expression. Recently, an early temporally collinear expression sequence of Hox genes was detected in Xenopus gastrula mesoderm (see intro. P3). There is evidence that this sequence sets up the embryo's later axial Hox expression pattern by time-space translation. We investigated whether XMeis3 is involved in regulation of this early mesodermal Hox gene expression. Here, we present evidence that XMeis3 is necessary for expression of Hoxd1, Hoxb4 and Hoxc6 in mesoderm during gastrulation. In addition, we show that XMeis3 function is necessary for the progression of gastrulation. Finally, we present evidence for synergy between XMeis3 and Hoxd1 in Hoxd1 autoregulation in mesoderm during gastrulation.	[der Rieden, Paul M. J. In] Studiekring, Utrecht, Netherlands; [Jansen, Hans J.; Durston, Antony J.] Sylvius Lab, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	der Rieden, PMJI (corresponding author), Studiekring, Utrecht, Netherlands.	A.J.Durston@biology.leidenuniv.nl		Jansen, Hans/0000-0002-8563-4146	EU [LSHM-CT-2003-504468]	EU(European Commission)	This work was supported by EU grant FP6 No. LSHM-CT-2003-504468. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Shaar M, 1999, GENE DEV, V13, P935, DOI 10.1101/gad.13.8.935; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; BURGLIN TR, 1991, NATURE, V351, P703, DOI 10.1038/351703a0; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; BURGLIN TR, 1993, CURR OPIN GENET DEV, V3, P615, DOI 10.1016/0959-437X(93)90097-9; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; DEROBERTIS EM, 1989, CELL, V57, P189, DOI 10.1016/0092-8674(89)90954-9; Deschamps J, 1999, INT J DEV BIOL, V43, P635; Dibner C, 2001, DEVELOPMENT, V128, P3415; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; DURSTON AJ, 2010, GENOMICS IN PRESS; Elkouby YM, 2010, DEVELOPMENT, V137, P1531, DOI 10.1242/dev.044750; Ferretti E, 2000, DEVELOPMENT, V127, P155; Gaunt SJ, 1996, DEV DYNAM, V207, P270, DOI 10.1002/(SICI)1097-0177(199611)207:3<270::AID-AJA4>3.0.CO;2-E; Godsave SF, 1998, DEV DYNAM, V213, P39, DOI 10.1002/(SICI)1097-0177(199809)213:1<39::AID-AJA4>3.0.CO;2-Z; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402; HARVEY RP, 1988, CELL, V53, P687, DOI 10.1016/0092-8674(88)90087-6; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838; INDERRIEDEN PMJ, 2010, DEV DYNAM, V29, P226; Jabet C, 1999, J MOL BIOL, V291, P521, DOI 10.1006/jmbi.1999.2983; Jaw TJ, 2000, MECH DEVELOP, V91, P279, DOI 10.1016/S0925-4773(99)00316-0; KNOEPFLER PS, 1995, MOL CELL BIOL, V15, P5811; KOLM PJ, 1995, DEV BIOL, V167, P34, DOI 10.1006/dbio.1995.1005; LAWRENCE PA, 1994, CELL, V78, P181, DOI 10.1016/0092-8674(94)90289-5; MANAK JR, 1994, DEVELOPMENT, P61; Marty T, 2001, DEVELOPMENT, V128, P2833; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; McNulty CL, 2005, DEVELOPMENT, V132, P2861, DOI 10.1242/dev.01872; Morrison AD, 1998, BIOESSAYS, V20, P794, DOI 10.1002/(SICI)1521-1878(199810)20:10<794::AID-BIES4>3.0.CO;2-E; Neuteboom STC, 1997, MOL CELL BIOL, V17, P4696, DOI 10.1128/MCB.17.8.4696; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; OLIVER G, 1988, EMBO J, V7, P3199, DOI 10.1002/j.1460-2075.1988.tb03187.x; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Peltenburg LTC, 1996, EMBO J, V15, P3385, DOI 10.1002/j.1460-2075.1996.tb00704.x; Pinsonneault J, 1997, EMBO J, V16, P2032, DOI 10.1093/emboj/16.8.2032; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; Pownall ME, 1996, DEVELOPMENT, V122, P3881; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; Salzberg A, 1999, MECH DEVELOP, V80, P3, DOI 10.1016/S0925-4773(98)00187-7; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SIVE HL, 1991, GENE DEV, V5, P1321, DOI 10.1101/gad.5.8.1321; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Streit A, 2002, DEV BIOL, V242, P96, DOI 10.1006/dbio.2001.0544; VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6; Vlachakis N, 2001, DEVELOPMENT, V128, P1299; Wacker SA, 2004, DEV BIOL, V268, P207, DOI 10.1016/j.ydbio.2003.12.022; Waskiewicz AJ, 2001, DEVELOPMENT, V128, P4139	53	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18010	10.1371/journal.pone.0018010	http://dx.doi.org/10.1371/journal.pone.0018010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464931	gold, Green Submitted, Green Published			2022-12-27	WOS:000289053800012
J	Nyangoga, H; Mercier, P; Libouban, H; Basle, MF; Chappard, D				Nyangoga, Herve; Mercier, Philippe; Libouban, Helene; Basle, Michel Felix; Chappard, Daniel			Three-Dimensional Characterization of the Vascular Bed in Bone Metastasis of the Rat by Microcomputed Tomography (MicroCT)	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ANGIOGENESIS; CANCER; CELLS; MODEL; TUMORS; NEOVASCULARIZATION; MICROENVIRONMENT; SKELETON; MARROW	Background: Angiogenesis contributes to proliferation and metastatic dissemination of cancer cells. Anatomy of blood vessels in tumors has been characterized with 2D techniques (histology or angiography). They are not fully representative of the trajectories of vessels throughout the tissues and are not adapted to analyze changes occurring inside the bone marrow cavities. Methodology/Principal Findings: We have characterized the vasculature of bone metastases in 3D at different times of evolution of the disease. Metastases were induced in the femur of Wistar rats by a local injection of Walker 256/B cells. Microfil(R), (a silicone-based polymer) was injected at euthanasia in the aorta 12, 19 and 26 days after injection of tumor cells. Undecalcified bones (containing the radio opaque vascular casts) were analyzed by microCT, and a first 3D model was reconstructed. Bones were then decalcified and reanalyzed by microCT; a second model (comprising only the vessels) was obtained and overimposed on the former, thus providing a clear visualization of vessel trajectories in the invaded metaphysic allowing quantitative evaluation of the vascular volume and vessel diameter. Histological analysis of the marrow was possible on the decalcified specimens. Walker 256/B cells induced a marked osteolysis with cortical perforations. The metaphysis of invaded bones became progressively hypervascular. New vessels replaced the major central medullar artery coming from the diaphyseal shaft. They sprouted from the periosteum and extended into the metastatic area. The newly formed vessels were irregular in diameter, tortuous with a disorganized architecture. A quantitative analysis of vascular volume indicated that neoangiogenesis increased with the development of the tumor with the appearance of vessels with a larger diameter. Conclusion: This new method evidenced the tumor angiogenesis in 3D at different development times of the metastasis growth. Bone and the vascular bed can be identified by a double reconstruction and allowed a quantitative evaluation of angiogenesis upon time.	[Nyangoga, Herve; Mercier, Philippe; Libouban, Helene; Basle, Michel Felix; Chappard, Daniel] CHU Angers, INSERM, LHEA U922, IRIS IBS Inst Biol Sante, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Nyangoga, H (corresponding author), CHU Angers, INSERM, LHEA U922, IRIS IBS Inst Biol Sante, Angers, France.	daniel.chappard@univ-angers.fr	Libouban, Hélène/ABA-6927-2021; Daniel, chappard/AAG-3528-2022; Daniel, chappard/AFK-4857-2022	LIBOUBAN, Helene/0000-0002-8293-4143	INSERM; Contrat de Plan Etat - Region "Pays de la Loire''; BIOREGOS2 project	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Contrat de Plan Etat - Region "Pays de la Loire''(Region Pays de la Loire); BIOREGOS2 project	This work was made possible by grants from INSERM, Contrat de Plan Etat - Region "Pays de la Loire'' and BIOREGOS2 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1993, CANCER, V72, P32, DOI 10.1002/1097-0142(19930701)72:1<32::AID-CNCR2820720108>3.0.CO;2-6; Andersen TL, 2009, AM J PATHOL, V174, P239, DOI 10.2353/ajpath.2009.080627; Badraoui R, 2009, CHEM-BIOL INTERACT, V182, P98, DOI 10.1016/j.cbi.2009.09.010; Baron-Menguy C, 2007, FASEB J, V21, P3511, DOI 10.1096/fj.06-7782com; Blouin S, 2006, CELLS TISSUES ORGANS, V182, P182, DOI 10.1159/000093967; Blouin S, 2005, CLIN EXP METASTAS, V22, P605, DOI 10.1007/s10585-006-9002-5; Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917; Bussard KM, 2008, CANCER METAST REV, V27, P41, DOI 10.1007/s10555-007-9109-4; Chantrain CF, 2008, CANCER MICROENVIRON, V1, P23, DOI 10.1007/s12307-008-0010-7; Chappard D, 2005, J BONE MINER RES, V20, P1177, DOI 10.1359/JBMR.050205; Chen Q, 2003, CANCER IMMUNOL IMMUN, V52, P670, DOI 10.1007/s00262-003-0425-4; Duvall CL, 2004, AM J PHYSIOL-HEART C, V287, pH302, DOI 10.1152/ajpheart.00928.2003; Eichhorn ME, 2008, CANCER BIOL THER, V7, P1006, DOI 10.4161/cbt.7.7.5997; Eriksen EF, 2007, J BONE MINER RES, V22, P1, DOI 10.1359/JBMR.060910; FILMON R, 2009, IMAGE ANAL STEREOL, V28, P1; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Ganter P., 1969, HISTOCHIMIE NORMALE, VVolume 1; Guise TA, 2003, CLIN ORTHOP RELAT R, pS32, DOI 10.1097/01.blo.0000093055.96273.69; Guise TA, 1998, ENDOCR REV, V19, P18, DOI 10.1210/er.19.1.18; Guzman R, 2005, EUR SPINE J, V14, P263, DOI 10.1007/s00586-004-0757-6; Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Iyer AK, 2006, DRUG DISCOV TODAY, V11, P812, DOI 10.1016/j.drudis.2006.07.005; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Maehara N, 2003, EUR RADIOL, V13, P1559, DOI 10.1007/s00330-002-1729-z; Marxen M, 2004, MED PHYS, V31, P305, DOI 10.1118/1.1637971; Mastro AM, 2003, CLIN EXP METASTAS, V20, P275, DOI 10.1023/A:1022995403081; Mazo IB, 1999, J LEUKOCYTE BIOL, V66, P25, DOI 10.1002/jlb.66.1.25; MILLER SC, 1980, METAB BONE DIS RELAT, V2, P239, DOI 10.1016/0221-8747(80)90013-2; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nieman K, 2001, LANCET, V357, P599, DOI 10.1016/S0140-6736(00)04058-7; Pugsley MK, 2000, J PHARMACOL TOX MET, V44, P333, DOI 10.1016/S1056-8719(00)00125-8; Savai R, 2009, NEOPLASIA, V11, P48, DOI 10.1593/neo.81036; Schirmer Clemens M, 2006, Neurosurgery, V59, pE431, DOI 10.1227/01.NEU.0000223503.92392.CE; Schneider P, 2009, MICROSC RES TECHNIQ, V72, P690, DOI 10.1002/jemt.20720; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Silvestre JS, 2003, CIRC RES, V93, P114, DOI 10.1161/01.RES.0000081594.21764.44; Sugimoto K, 2007, HEPATOL RES, V37, P464, DOI 10.1111/j.1872-034X.2007.00060.x; WIETHOLT C, 2008, IEEE NUCL SCI S, P4848; Yamashita T, 2001, INVEST RADIOL, V36, P713, DOI 10.1097/00004424-200112000-00006; Zhang FJ, 2009, J BONE MINER RES, V24, P1224, DOI [10.1359/JBMR.090204, 10.1359/jbmr.090204]	46	43	45	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17336	10.1371/journal.pone.0017336	http://dx.doi.org/10.1371/journal.pone.0017336			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464932	Green Published, Green Submitted, gold			2022-12-27	WOS:000289053800001
J	de Goede, J; Verschuren, WMM; Boer, JMA; Kromhout, D; Geleijnse, JM				de Goede, Janette; Verschuren, W. M. Monique; Boer, Jolanda M. A.; Kromhout, Daan; Geleijnse, Johanna M.			Alpha-Linolenic Acid Intake and 10-Year Incidence of Coronary Heart Disease and Stroke in 20,000 Middle-Aged Men and Women in The Netherlands	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; CARDIOVASCULAR RISK; RELATIVE VALIDITY; DIETARY-INTAKE; COHORT; FISH; REPRODUCIBILITY; OUTCOMES; HEALTH; CHAIN	Background: Whether intake of alpha-linolenic acid (ALA), the plant-derived n-3 polyunsaturated fatty acid (PUFA), could prevent cardiovascular diseases is not yet clear. We examined the associations of ALA intake with 10-year incidence of coronary heart disease (CHD) and stroke in the Netherlands. Methods: Data were collected from a general population of 20,069 generally healthy men and women, aged 20 to 65 years. Habitual diet was assessed at baseline (1993-1997) with a validated 178-item food frequency questionnaire. Incidences of CHD and stroke were assessed through linkage with mortality and morbidity registers. Hazard ratios (HR) were calculated with multivariable Cox proportional hazards models, adjusted for age, gender, lifestyle, and dietary factors. Results: During 8-13 years of follow-up, we observed 280 incident CHD events (19% fatal) and 221 strokes (4% fatal). Intakes of energy-adjusted ALA in quintiles ranged from less than 1.0 g/d in the bottom quintile (Q1) to more than 1.9 g/d in the top quintile (Q5). ALA intake was not associated with incident CHD, with HRs varying between 0.89 and 1.01 (all p > 0.05) in Q2-Q5 compared with the bottom quintile of ALA intake. For incident stroke, however, participants in Q2-Q5 had a 35-50% lower risk compared with the reference group. HRs were 0.65 (0.43-0.97), 0.49 (0.31-0.76), 0.53 (0.34-0.83), and 0.65 (0.41-1.04) for Q2-Q5 respectively. Conclusion: In this general Dutch population, ALA intake was not associated with incident CHD. The data suggested that a low intake of ALA may be a risk factor for incident stroke. These results warrant confirmation in other population-based studies and in trials.	[de Goede, Janette; Kromhout, Daan; Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Verschuren, W. M. Monique; Boer, Jolanda M. A.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment	de Goede, J (corresponding author), Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.	Marianne.geleijnse@wur.nl	Kromhout, Daan/A-8566-2014; Geleijnse, Johanna Marianna M/B-5749-2012	Geleijnse, Johanna Marianna M/0000-0001-7638-0589	Alpro Foundation, Belgium; Ministry of Health, Welfare and Sport of The Netherlands; National Institute for Public Health and the Environment, Bilthoven, The Netherlands; European Union	Alpro Foundation, Belgium; Ministry of Health, Welfare and Sport of The Netherlands; National Institute for Public Health and the Environment, Bilthoven, The Netherlands(Netherlands Government); European Union(European Commission)	Dr. Geleijnse obtained an unrestricted grant from the Alpro Foundation, Belgium, to cover the costs of data analysis for the present study. The other authors report no financial disclosures. The Monitoring Project on Risk Factors for Chronic Diseases (MORGEN) study was financially supported by the Ministry of Health, Welfare and Sport of The Netherlands and the National Institute for Public Health and the Environment, Bilthoven, The Netherlands, and the Europe Against Cancer Program of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2005, CIRCULATION, V112, P3232, DOI 10.1161/CIRCULATIONAHA.105.572008; Ascherio A, 1996, BMJ-BRIT MED J, V313, P84, DOI 10.1136/bmj.313.7049.84; Brenna JT, 2009, PROSTAG LEUKOTR ESS, V80, P85, DOI 10.1016/j.plefa.2009.01.004; Brouwer IA, 2004, J NUTR, V134, P919, DOI 10.1093/jn/134.4.919; Burdge GC, 2006, PROSTAG LEUKOTR ESS, V75, P161, DOI 10.1016/j.plefa.2006.05.013; Burdge GC, 2006, NUTR RES REV, V19, P26, DOI 10.1079/NRR2005113; Campos H, 2008, CIRCULATION, V118, P339, DOI 10.1161/CIRCULATIONAHA.107.762419; De Bruin A, LINKING DATA NATL AM; DOLECEK TA, 1991, WORLD REV NUTR DIET, V66, P205; Elmadfa I, 2009, ANN NUTR METAB, V55, P56, DOI 10.1159/000228996; Harris WS, 2008, CIRCULATION, V118, P323, DOI 10.1161/CIRCULATIONAHA.108.791467; Harris WS, 2005, CIRCULATION, V111, P2872, DOI 10.1161/CIRCULATIONAHA.105.545640; He K, 2004, CIRCULATION, V109, pE107; He K, 2004, STROKE, V35, P1538, DOI 10.1161/01.STR.0000130856.31468.47; HOEVENAARBLOM MP, 2010, EUR J CARDIOVASC PRE; Hu FB, 1999, AM J CLIN NUTR, V69, P890; Iso H, 2002, STROKE, V33, P2086, DOI 10.1161/01.STR.0000023890.25066.50; Kris-Etherton PM, 2000, AM J CLIN NUTR, V71, p179S, DOI 10.1093/ajcn/71.1.179S; Laaksonen DE, 2005, ARCH INTERN MED, V165, P193, DOI 10.1001/archinte.165.2.193; Merry AH, 2009, EUR J EPIDEMIOL; Mozaffarian D, 2005, CIRCULATION, V111, P157, DOI 10.1161/01.CIR.0000152099.87287.83; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Nguemeni C, PHARM RES, V61, P226; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49; Oomen CM, 2001, AM J CLIN NUTR, V74, P457; Pietinen P, 1997, AM J EPIDEMIOL, V145, P876, DOI 10.1093/oxfordjournals.aje.a009047; Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181; Reimer WJMSO, 2006, STROKE, V37, P1844, DOI 10.1161/01.STR.0000226463.17988.a3; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Sanderson P, 2002, BRIT J NUTR, V88, P573, DOI 10.1079/BJN2002691; SIMON JA, 1995, STROKE, V26, P778, DOI 10.1161/01.STR.26.5.778; Stark AH, 2008, NUTR REV, V66, P326, DOI 10.1111/j.1753-4887.2008.00040.x; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; Voskuil DW, 1996, EUR J CLIN NUTR, V50, P784; Wang CC, 2006, AM J CLIN NUTR, V84, P5, DOI 10.1093/ajcn/84.1.5; Wendland E, 2006, HEART, V92, P166, DOI 10.1136/hrt.2004.053538; Willett W.C., 1998, SAUPTIKAPARVAN MAHAB, DOI [10.1093/acprof:oso/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.003.11]; Zhao GX, 2004, J NUTR, V134, P2991, DOI 10.1093/jn/134.11.2991	39	54	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17967	10.1371/journal.pone.0017967	http://dx.doi.org/10.1371/journal.pone.0017967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464993	Green Published, gold, Green Submitted			2022-12-27	WOS:000288813900024
J	Li, J; Kushima, A; Eapen, J; Lin, X; Qian, XF; Mauro, JC; Diep, P; Yip, S				Li, Ju; Kushima, Akihiro; Eapen, Jacob; Lin, Xi; Qian, Xiaofeng; Mauro, John C.; Diep, Phong; Yip, Sidney			Computing the Viscosity of Supercooled Liquids: Markov Network Model	PLOS ONE			English	Article							LONG-TIME DYNAMICS; GLASS-TRANSITION; BROKEN ERGODICITY; ENERGY LANDSCAPE; TEMPERATURE	The microscopic origin of glass transition, when liquid viscosity changes continuously by more than ten orders of magnitude, is challenging to explain from first principles. Here we describe the detailed derivation and implementation of a Markovian Network model to calculate the shear viscosity of deeply supercooled liquids based on numerical sampling of an atomistic energy landscape, which sheds some light on this transition. Shear stress relaxation is calculated from a master-equation description in which the system follows a transition-state pathway trajectory of hopping among local energy minima separated by activation barriers, which is in turn sampled by a metadynamics-based algorithm. Quantitative connection is established between the temperature variation of the calculated viscosity and the underlying potential energy and inherent stress landscape, showing a different landscape topography or "terrain" is needed for low-temperature viscosity (of order 10(7) Pa.s) from that associated with high-temperature viscosity (10(-5) Pa.s). Within this range our results clearly indicate the crossover from an essentially Arrhenius scaling behavior at high temperatures to a low-temperature behavior that is clearly super-Arrhenius (fragile) for a Kob-Andersen model of binary liquid. Experimentally the manifestation of this crossover in atomic dynamics continues to raise questions concerning its fundamental origin. In this context this work explicitly demonstrates that a temperature-dependent "terrain" characterizing different parts of the same potential energy surface is sufficient to explain the signature behavior of vitrification, at the same time the notion of a temperature-dependent effective activation barrier is quantified.	[Li, Ju; Kushima, Akihiro] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Kushima, Akihiro; Qian, Xiaofeng; Yip, Sidney] MIT, Dept Nucl Sci & Engn, Cambridge, MA 02139 USA; [Kushima, Akihiro; Qian, Xiaofeng; Yip, Sidney] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Eapen, Jacob] N Carolina State Univ, Dept Nucl Engn, Raleigh, NC 27695 USA; [Lin, Xi] Boston Univ, Div Engn & Mat Sci, Dept Mech Engn, Boston, MA 02215 USA; [Mauro, John C.; Diep, Phong] Corning Inc, Div Sci & Technol, Corning, NY 14831 USA	University of Pennsylvania; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of North Carolina; North Carolina State University; Boston University; Corning Inc; State University of New York (SUNY) System; SUNY Community College	Li, J (corresponding author), Univ Penn, Dept Mat Sci & Engn, 3231 Walnut St, Philadelphia, PA 19104 USA.	liju@seas.upenn.edu	Lin, Xi/D-5321-2011; Qian, Xiaofeng/E-7727-2012; Li, Ju/A-2993-2008; lin, xi/GZL-4959-2022; Kushima, Akihiro/H-2347-2011; Qian, Xiaofeng/P-4715-2016; Qian, Xiaofeng/AAE-9530-2019; Eapen, Jacob/A-2777-2011	Qian, Xiaofeng/0000-0003-1627-288X; Li, Ju/0000-0002-7841-8058; Kushima, Akihiro/0000-0001-5166-4198; Qian, Xiaofeng/0000-0003-1627-288X; Qian, Xiaofeng/0000-0003-1627-288X; Eapen, Jacob/0000-0001-6796-4013; Mauro, John/0000-0002-4319-3530	Corning Inc.; Boston University Center for Scientific Computing and Visualization; NSF [DMR-1008104, DMR-0520020]; AFOSR [FA9550-08-1-0325]	Corning Inc.; Boston University Center for Scientific Computing and Visualization; NSF(National Science Foundation (NSF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by Corning Inc. and Boston University Center for Scientific Computing and Visualization. JL and AK acknowledge the support by NSF DMR-1008104, DMR-0520020 and AFOSR FA9550-08-1-0325. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Even though Corning Inc. is the employer of John C. Mauro and Phong Diep and provided partial funding for this work, the purpose of this paper is entirely on the fundamental science of viscosity, and therefore the company played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelani L, 2000, PHYS REV E, V61, P1681, DOI 10.1103/PhysRevE.61.1681; Angelani L, 1998, PHYS REV LETT, V81, P4648, DOI 10.1103/PhysRevLett.81.4648; ANGELL CA, 1988, J PHYS CHEM SOLIDS, V49, P863, DOI 10.1016/0022-3697(88)90002-9; Chong SH, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041501; Gotze W., 1991, LIQUIDS FREEZING GLA; Gupta PK, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2738471; Heuer A, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/37/373101; Horbach J, 1999, PHYS REV B, V60, P3169, DOI 10.1103/PhysRevB.60.3169; Kivelson D, 1996, PHYS REV E, V53, P751, DOI 10.1103/PhysRevE.53.751; KOB W, 1995, PHYS REV E, V51, P4626, DOI 10.1103/PhysRevE.51.4626; Kushima A, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3243854; Kushima A, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3139006; Laio A, 2005, J PHYS CHEM B, V109, P6714, DOI 10.1021/jp045424k; Mallamace F, 2010, P NATL ACAD SCI USA, V107, P22457, DOI 10.1073/pnas.1015340107; Mauro JC, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2731774; Mauro JC, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2733674; Mauro JC, 2007, J PHYS CHEM A, V111, P7957, DOI 10.1021/jp0731194; Mauro JC, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.094204; Mauro JC, 2008, SCI MODEL SIMUL, V15, P241, DOI 10.1007/s10820-008-9092-2; Mauro JC, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.174202; McQuarrie D. A., 1973, STAT MECH; PALMER RG, 1982, ADV PHYS, V31, P669, DOI 10.1080/00018738200101438; Sastry S, 1998, NATURE, V393, P554, DOI 10.1038/31146; Sciortino F, 1999, PHYS REV LETT, V83, P3214, DOI 10.1103/PhysRevLett.83.3214; STILLINGER FH, 1982, PHYS REV A, V25, P978, DOI 10.1103/PhysRevA.25.978	25	23	23	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17909	10.1371/journal.pone.0017909	http://dx.doi.org/10.1371/journal.pone.0017909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464988	Green Published, Green Submitted, gold			2022-12-27	WOS:000288813900017
J	Spencer, KL; Olson, LM; Schnetz-Boutaud, N; Gallins, P; Agarwal, A; Iannaccone, A; Kritchevsky, SB; Garcia, M; Nalls, MA; Newman, AB; Scott, WK; Pericak-Vance, MA; Haines, JL				Spencer, Kylee L.; Olson, Lana M.; Schnetz-Boutaud, Nathalie; Gallins, Paul; Agarwal, Anita; Iannaccone, Alessandro; Kritchevsky, Stephen B.; Garcia, Melissa; Nalls, Michael A.; Newman, Anne B.; Scott, William K.; Pericak-Vance, Margaret A.; Haines, Jonathan L.			Using Genetic Variation and Environmental Risk Factor Data to Identify Individuals at High Risk for Age-Related Macular Degeneration	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; PIGMENT OPTICAL-DENSITY; BREAST-CANCER; UNITED-STATES; FACTOR-B; ASSOCIATION; POLYMORPHISM; DISEASE; VARIANT; SUSCEPTIBILITY	A major goal of personalized medicine is to pre-symptomatically identify individuals at high risk for disease using knowledge of each individual's particular genetic profile and constellation of environmental risk factors. With the identification of several well-replicated risk factors for age-related macular degeneration (AMD), the leading cause of legal blindness in older adults, this previously unreachable goal is beginning to seem less elusive. However, recently developed algorithms have either been much less accurate than expected, given the strong effects of the identified risk factors, or have not been applied to independent datasets, leaving unknown how well they would perform in the population at large. We sought to increase accuracy by using novel modeling strategies, including multifactor dimensionality reduction (MDR) and grammatical evolution of neural networks (GENN), in addition to the traditional logistic regression approach. Furthermore, we rigorously designed and tested our models in three distinct datasets: a Vanderbilt-Miami (VM) clinic-based case-control dataset, a VM family dataset, and the population-based Age-related Maculopathy Ancillary (ARMA) Study cohort. Using a consensus approach to combine the results from logistic regression and GENN models, our algorithm was successful in differentiating between high- and low-risk groups (sensitivity 77.0%, specificity 74.1%). In the ARMA cohort, the positive and negative predictive values were 63.3% and 70.7%, respectively. We expect that future efforts to refine this algorithm by increasing the sample size available for model building, including novel susceptibility factors as they are discovered, and by calibrating the model for diverse populations will improve accuracy.	[Spencer, Kylee L.; Olson, Lana M.; Schnetz-Boutaud, Nathalie; Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Gallins, Paul; Scott, William K.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Agarwal, Anita] Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, Nashville, TN USA; [Iannaccone, Alessandro] Univ Tennessee, Hlth Sci Ctr, Hamilton Eye Inst, Memphis, TN USA; [Kritchevsky, Stephen B.] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA; [Kritchevsky, Stephen B.] Wake Forest Univ, Sticht Ctr Aging, Winston Salem, NC 27109 USA; [Garcia, Melissa] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Nalls, Michael A.] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Newman, Anne B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA	Vanderbilt University; University of Miami; Vanderbilt University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Spencer, KL (corresponding author), Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA.	Kylee.Spencer@vanderbilt.edu	Haines, Jonathan/C-3374-2012; Newman, Anne B./C-6408-2013	Haines, Jonathan/0000-0002-4351-4728; Newman, Anne B./0000-0002-0106-1150; Kritchevsky, Stephen/0000-0003-3336-6781; Scott, William/0000-0001-9336-6404; Iannaccone, Alessandro/0000-0001-5737-8424	National Institutes of Health (NIH)/National Eye Institute [EY12118, EY000409]; NIH/National Institute on Aging (NIA) [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106]; International Retinal Research Foundation, Inc., Birmingham, AL; Research to Prevent Blindness, New York, NY; NIH/NIA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012118, K23EY000409, U10EY012118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062103, N01AG062101, N01AG062106] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH/National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); International Retinal Research Foundation, Inc., Birmingham, AL; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants EY12118 (to M.A.P.-V. and J.L.H.) and EY000409 (K23 Award to A.I.) from the National Institutes of Health (NIH)/National Eye Institute, contracts N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106 (to S.B.K.) from the NIH/National Institute on Aging (NIA), grants from the International Retinal Research Foundation, Inc., Birmingham, AL (to A.I.), by Research to Prevent Blindness, New York, NY (Career Development Award to A.I. and an unrestricted grant to the UTHSC Hamilton Eye Institute), and in part by the Intramural Research Program of the NIH/NIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Gallaher KT, 2007, VISION RES, V47, P1253, DOI 10.1016/j.visres.2007.01.013; Gibson J, 2010, BRIT J OPHTHALMOL, V94, P1382, DOI 10.1136/bjo.2010.182568; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hughes AE, 2007, PLOS MED, V4, P1993, DOI 10.1371/journal.pmed.0040355; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Iannaccone A, 2007, INVEST OPHTH VIS SCI, V48, P1458, DOI 10.1167/iovs.06-0438; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Jakobsdottir J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002199; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; Kassoff A, 1999, CONTROL CLIN TRIALS, V20, P573; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Mistry K, 2003, J AM BOARD FAM PRACT, V16, P95, DOI 10.3122/jabfm.16.2.95; Motsinger-Reif AA, 2008, GENET EPIDEMIOL, V32, P325, DOI 10.1002/gepi.20307; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Pepe MS, 2004, STAT EVALUATION MED; Postel EA, 2005, AM J OPHTHALMOL, V139, P820, DOI 10.1016/j.ajo.2004.12.029; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Schmidt S, 2000, MOL VIS, V6, P287; Seddon Johanna M., 2004, International Ophthalmology Clinics, V44, P17, DOI 10.1097/00004397-200404440-00004; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P2044, DOI 10.1167/iovs.08-3064; Smith RA, 2009, CA-CANCER J CLIN, V59, P27, DOI 10.3322/caac.20008; Spencer KL, 2008, HUM MOL GENET, V17, P1821, DOI 10.1093/hmg/ddn075; Spencer KL, 2007, HUM MOL GENET, V16, P1986, DOI 10.1093/hmg/ddm146; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; VELEZ DR, 2007, GENET EPIDEMIOL; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618	38	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17784	10.1371/journal.pone.0017784	http://dx.doi.org/10.1371/journal.pone.0017784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455292	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000288811500009
J	Durand, C; Roeth, R; Dweep, H; Vlatkovic, I; Decker, E; Schneider, KU; Rappold, G				Durand, Claudia; Roeth, Ralph; Dweep, Harsh; Vlatkovic, Irena; Decker, Eva; Schneider, Katja Ute; Rappold, Gudrun			Alternative Splicing and Nonsense-Mediated RNA Decay Contribute to the Regulation of SHOX Expression	PLOS ONE			English	Article							HOMEOBOX GENE SHOX; LERI-WEILL DYSCHONDROSTEOSIS; SHORT STATURE; TURNER-SYNDROME; HUMAN TRANSCRIPTOME; LIMB; EVOLUTION; DOWNSTREAM; PHENOTYPES; MICRORNAS	The human SHOX gene is composed of seven exons and encodes a paired-related homeodomain transcription factor. SHOX mutations or deletions have been associated with different short stature syndromes implying a role in growth and bone formation. During development, SHOX is expressed in a highly specific spatiotemporal expression pattern, the underlying regulatory mechanisms of which remain largely unknown. We have analysed SHOX expression in diverse embryonic, fetal and adult human tissues and detected expression in many tissues that were not known to express SHOX before, e. g. distinct brain regions. By using RT-PCR and comparing the results with RNA-Seq data, we have identified four novel exons (exon 2a, 7-1, 7-2 and 7-3) contributing to different SHOX isoforms, and also established an expression profile for the emerging new SHOX isoforms. Interestingly, we found the exon 7 variants to be exclusively expressed in fetal neural tissues, which could argue for a specific role of these variants during brain development. A bioinformatical analysis of the three novel 3'UTR exons yielded insights into the putative role of the different 3'UTRs as targets for miRNA binding. Functional analysis revealed that inclusion of exon 2a leads to nonsense-mediated RNA decay altering SHOX expression in a tissue and time specific manner. In conclusion, SHOX expression is regulated by different mechanisms and alternative splicing coupled with nonsense-mediated RNA decay constitutes a further component that can be used to fine tune the SHOX expression level.	[Durand, Claudia; Roeth, Ralph; Decker, Eva; Schneider, Katja Ute; Rappold, Gudrun] Univ Heidelberg, Dept Human Mol Genet, Heidelberg, Germany; [Dweep, Harsh] Univ Heidelberg, Med Res Ctr, Fac Med Mannheim, D-6800 Mannheim, Germany; [Vlatkovic, Irena] Austrian Acad Sci, Res Ctr Mol Med, A-1010 Vienna, Austria	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Austrian Academy of Sciences	Durand, C (corresponding author), Univ Heidelberg, Dept Human Mol Genet, Heidelberg, Germany.	gudrun_rappold@med.uni-heidelberg.de		Vlatkovic, Irena/0000-0001-8745-4299	Deutsche Forschungsgemeinschaft; Landesgraduiertenforderung Baden-Wurttemberg; MRC [G9900837, G0700089] Funding Source: UKRI; Medical Research Council [G9900837, G0700089] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Landesgraduiertenforderung Baden-Wurttemberg; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft. C. Durand was funded by a fellowship from Landesgraduiertenforderung Baden-Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; Benito-Sanz S, 2005, AM J HUM GENET, V77, P533, DOI 10.1086/449313; Blaschke RJ, 2003, J BIOL CHEM, V278, P47820, DOI 10.1074/jbc.M306685200; Blaschke RJ, 1998, P NATL ACAD SCI USA, V95, P2406, DOI 10.1073/pnas.95.5.2406; Boncinelli E, 1997, CURR OPIN GENET DEV, V7, P331, DOI 10.1016/S0959-437X(97)80146-3; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cuccurese M, 2005, NUCLEIC ACIDS RES, V33, P5965, DOI 10.1093/nar/gki905; Danckwardt S, 2002, BLOOD, V99, P1811, DOI 10.1182/blood.V99.5.1811; Durand C, 2010, EUR J HUM GENET, V18, P527, DOI 10.1038/ejhg.2009.216; Eberle AB, 2008, PLOS BIOL, V6, P849, DOI 10.1371/journal.pbio.0060092; Fukami M, 2006, AM J HUM GENET, V78, P167, DOI 10.1086/499254; Gonzalez CI, 2001, GENE, V274, P15, DOI 10.1016/S0378-1119(01)00552-2; Goodman FR, 2002, AM J MED GENET, V112, P256, DOI 10.1002/ajmg.10776; Grandemange S, 2009, HUM MOL GENET, V18, P4746, DOI 10.1093/hmg/ddp437; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Lareau LF, 2007, ADV EXP MED BIOL, V623, P190, DOI 10.1007/978-0-387-77374-2_12; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Rao E, 2001, HUM MOL GENET, V10, P3083, DOI 10.1093/hmg/10.26.3083; Rappold G, 2007, J MED GENET, V44, P306, DOI 10.1136/jmg.2006.046581; Sabherwal N, 2007, HUM MOL GENET, V16, P210, DOI 10.1093/hmg/ddl470; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; Skandalis A, 2004, NUCLEIC ACIDS RES, V32, P6557, DOI 10.1093/nar/gkh967; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; THALMEIER K, 1994, BLOOD, V83, P1799; Tiecke E, 2006, DEV BIOL, V298, P585, DOI 10.1016/j.ydbio.2006.07.008; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Zhang X, 2007, GENE, V400, P131, DOI 10.1016/j.gene.2007.06.008	39	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18115	10.1371/journal.pone.0018115	http://dx.doi.org/10.1371/journal.pone.0018115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448463	Green Submitted, Green Published, gold			2022-12-27	WOS:000288810500039
J	Cheever, TR; Olson, EA; Ervasti, JM				Cheever, Thomas R.; Olson, Emily A.; Ervasti, James M.			Axonal Regeneration and Neuronal Function Are Preserved in Motor Neurons Lacking beta-Actin In Vivo	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; AMYOTROPHIC-LATERAL-SCLEROSIS; DIAPHRAGM MUSCLE DEVELOPMENT; DETERMINING GENE-PRODUCT; MESSENGER-RNA; NEUROMUSCULAR-JUNCTIONS; MOUSE MODEL; GROWTH CONES; PHRENIC-NERVE; SCHWANN-CELLS	In The proper localization of beta-actin mRNA and protein is essential for growth cone guidance and axon elongation in cultured neurons. In addition, decreased levels of beta-actin mRNA and protein have been identified in the growth cones of motor neurons cultured from a mouse model of Spinal Muscular Atrophy (SMA), suggesting that beta-actin loss-of-function at growth cones or pre-synaptic nerve terminals could contribute to the pathogenesis of this disease. However, the role of beta-actin in motor neurons in vivo and its potential relevance to disease has yet to be examined. We therefore generated motor neuron specific beta-actin knock-out mice (Actb-MNsKO) to investigate the function of beta-actin in motor neurons in vivo. Surprisingly, beta-actin was not required for motor neuron viability or neuromuscular junction maintenance. Skeletal muscle from Actb-MNsKO mice showed no histological indication of denervation and did not significantly differ from controls in several measurements of physiologic function. Finally, motor axon regeneration was unimpaired in Actb-MNsKO mice, suggesting that beta-actin is not required for motor neuron function or regeneration in vivo.	[Cheever, Thomas R.; Olson, Emily A.; Ervasti, James M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Cheever, TR (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	jervasti@umn.edu	Ervasti, James/AAZ-4786-2020		National Institutes of Health [AR007612, AR049899]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612, R01AR049899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health Training Program in Muscle Research (AR007612) and a grant from the National Institutes of Health (AR049899). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan DW, 1997, J COMP NEUROL, V382, P459, DOI 10.1002/(SICI)1096-9861(19970616)382:4<459::AID-CNE3>3.0.CO;2-1; Baloh RH, 2007, MUSCLE NERVE, V36, P107, DOI 10.1002/mus.20755; Bassell GJ, 1998, J NEUROSCI, V18, P251; BENHAMIDA C, 1994, MUSCLE NERVE, V17, P400; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Bolis A, 2005, J NEUROSCI, V25, P8567, DOI 10.1523/JNEUROSCI.2493-05.2005; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Chipman PH, 2010, EUR J NEUROSCI, V31, P238, DOI 10.1111/j.1460-9568.2009.07049.x; CHOO QL, 1978, J NEUROCHEM, V31, P217, DOI 10.1111/j.1471-4159.1978.tb12451.x; Chow LML, 2006, DEV DYNAM, V235, P2991, DOI 10.1002/dvdy.20948; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Cole JC, 2000, J PHYSIOL-LONDON, V525, P579, DOI 10.1111/j.1469-7793.2000.t01-2-00579.x; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dugina V, 2009, J CELL SCI, V122, P2980, DOI 10.1242/jcs.041970; Franz CK, 2008, BRAIN, V131, P1492, DOI 10.1093/brain/awn039; Fu AKY, 2005, P NATL ACAD SCI USA, V102, P15224, DOI 10.1073/pnas.0507678102; George LT, 2003, J RECONSTR MICROSURG, V19, P41, DOI 10.1055/s-2003-37190; GLINKA M, 2010, HUM MOL GENET; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Greer JJ, 1999, J APPL PHYSIOL, V86, P779, DOI 10.1152/jappl.1999.86.3.779; Hess DM, 2007, J COMP NEUROL, V501, P465, DOI 10.1002/cne.21163; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Inserra MM, 1998, MICROSURG, V18, P119, DOI 10.1002/(SICI)1098-2752(1998)18:2<119::AID-MICR10>3.3.CO;2-Z; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Jaeger MA, 2009, FASEB J, V23, P2205, DOI 10.1096/fj.09-129783; Jevsek M, 2006, P NATL ACAD SCI USA, V103, P6374, DOI 10.1073/pnas.0601468103; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Li XM, 2008, NAT NEUROSCI, V11, P262, DOI 10.1038/nn2053; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; Lund LM, 1996, J NEUROBIOL, V31, P476; Luria V, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-13; Mantilla CB, 2008, J APPL PHYSIOL, V104, P1818, DOI 10.1152/japplphysiol.01192.2007; McGovern VL, 2008, HUM MOL GENET, V17, P2900, DOI 10.1093/hmg/ddn189; Mejat A, 2009, J CELL BIOL, V184, P31, DOI 10.1083/jcb.200811035; MENDE Y, 2010, HUM MOL GENET; Micheva KD, 1998, EUR J NEUROSCI, V10, P3785, DOI 10.1046/j.1460-9568.1998.00391.x; Monani UR, 2003, J CELL BIOL, V160, P41, DOI 10.1083/jcb.200208079; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Murray LM, 2010, HUM MOL GENET, V19, P420, DOI 10.1093/hmg/ddp506; Palazzolo I, 2009, NEURON, V63, P316, DOI 10.1016/j.neuron.2009.07.019; Perrin BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001158; Prins KW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002419; PRINS KW, 2011, J CELL SCI IN PRESS; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schwander M, 2004, J NEUROSCI, V24, P8181, DOI 10.1523/JNEUROSCI.1345-04.2004; Shawlot W, 1998, TRANSGENIC RES, V7, P95, DOI 10.1023/A:1008816308171; Shmerling D, 2005, GENESIS, V42, P229, DOI 10.1002/gene.20135; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; Sonnemann KJ, 2006, DEV CELL, V11, P387, DOI 10.1016/j.devcel.2006.07.001; Tadesse H, 2008, HUM MOL GENET, V17, P506, DOI 10.1093/hmg/ddm327; TELERMANTOPPET N, 1978, MUSCLE NERVE, V1, P133, DOI 10.1002/mus.880010205; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Van Damme P, 2003, NEUROSCI LETT, V343, P81, DOI 10.1016/S0304-3940(03)00314-8; Varejao ASP, 2004, NEUROL RES, V26, P186, DOI 10.1179/016164104225013833; Vogelaar CF, 2009, MOL CELL NEUROSCI, V42, P102, DOI 10.1016/j.mcn.2009.06.002; Wang XH, 1996, J PHYSIOL-LONDON, V491, P187, DOI 10.1113/jphysiol.1996.sp021206; Weinberger R, 1996, J NEUROSCI, V16, P238; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yisraeli JK, 2005, BIOL CELL, V97, P87	71	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17768	10.1371/journal.pone.0017768	http://dx.doi.org/10.1371/journal.pone.0017768			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445349	gold, Green Published, Green Submitted			2022-12-27	WOS:000288809100007
J	Santosuosso, M; Righi, E; Hill, ED; Leblanc, PR; Kodish, B; Mylvaganam, HN; Siddappa, NB; Stevceva, L; Hu, SL; Ghebremichael, M; Chenine, AL; Hovav, AH; Ruprecht, RM; Poznansky, MC				Santosuosso, Michael; Righi, Elda; Hill, E. David; Leblanc, Pierre R.; Kodish, Brett; Mylvaganam, Hari N.; Siddappa, Nagadenahalli B.; Stevceva, Liljana; Hu, Shiu-Lok; Ghebremichael, Musie; Chenine, Agnes-L.; Hovav, Avi-Hai; Ruprecht, Ruth M.; Poznansky, Mark C.			R5-SHIV Induces Multiple Defects in T Cell Function during Early Infection of Rhesus Macaques Including Accumulation of T Reg Cells in Lymph Nodes	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE PROTEIN; INDUCED APOPTOSIS; IMMUNE-RESPONSES; DENDRITIC CELLS; HIV-INFECTION; GP120; ACTIVATION; CD4(+); TYPE-1	Background: HIV-1 is a pathogen that T cell responses fail to control. HIV-1gp120 is the surface viral envelope glycoprotein that interacts with CD4 T cells and mediates entry. HIV-1gp120 has been implicated in immune dysregulatory functions that may limit anti-HIV antigen-specific T cell responses. We hypothesized that in the context of early SHIV infection, immune dysregulation of antigen-specific T-effector cell and regulatory functions would be detectable and that these would be associated or correlated with measurable concentrations of HIV-1gp120 in lymphoid tissues. Methods: Rhesus macaques were intravaginally inoculated with a Clade C CCR5-tropic simian-human immunodeficiency virus, SHIV-1157ipd3N4. HIV-1gp120 levels, antigen-specificity, levels of apoptosis/anergy and frequency and function of Tregs were examined in lymph node and blood derived T cells at 5 and 12 weeks post inoculation. Results/Conclusions: We observed reduced responses to Gag in CD4 and gp120 in CD8 lymph node-derived T cells compared to the peripheral blood at 5 weeks post-inoculation. Reduced antigen-specific responses were associated with higher levels of PD-1 on lymph node-derived CD4 T cells as compared to peripheral blood and uninfected lymph node-derived CD4 T cells. Lymph nodes contained increased numbers of Tregs as compared to peripheral blood, which positively correlated with gp120 levels; T regulatory cell depletion restored CD8 T cell responses to Gag but not to gp120. HIV gp120 was also able to induce T regulatory cell chemotaxis in a dose-dependent, CCR5-mediated manner. These studies contribute to our broader understanding of the ways in which HIV-1 dysregulates T cell function and localization during early infection.	[Santosuosso, Michael; Righi, Elda; Hill, E. David; Leblanc, Pierre R.; Kodish, Brett; Mylvaganam, Hari N.; Stevceva, Liljana; Poznansky, Mark C.] Massachusetts Gen Hosp, Vaccine & Immunotherapy Ctr, Infect Dis Med Div, Charlestown, MA USA; [Siddappa, Nagadenahalli B.; Chenine, Agnes-L.; Ruprecht, Ruth M.] Dana Farber Canc Inst, Dept Canc Immunol, Boston, MA 02115 USA; [Siddappa, Nagadenahalli B.; Chenine, Agnes-L.; Ruprecht, Ruth M.] Dana Farber Canc Inst, AIDS, Boston, MA 02115 USA; [Hu, Shiu-Lok] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; [Ghebremichael, Musie] Harvard Univ, Sch Publ Hlth, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Hovav, Avi-Hai] Hebrew Univ Jerusalem, Fac Med Dent, Inst Dent Sci, Jerusalem, Israel	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; Hebrew University of Jerusalem	Santosuosso, M (corresponding author), Massachusetts Gen Hosp, Vaccine & Immunotherapy Ctr, Infect Dis Med Div, Charlestown, MA USA.	mpoznansky@partners.org	Leblanc, Pierre/AAB-3554-2020; Poznansky, Mark C/M-4996-2015; Righi, Elda/Y-3558-2019	Leblanc, Pierre/0000-0001-8756-2396; Poznansky, Mark C/0000-0003-1344-7103; Righi, Elda/0000-0001-8718-1200; Byrareddy, Siddappa/0000-0002-7423-1763	National Institutes of Health (NIH) [RO1 AI49757, PO1 AI048240, RO1 DE016013]; Yerkes National Primate Research center [RR00165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI048240, R01AI049757, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016013] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yerkes National Primate Research center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was completed via support of MCP (National Institutes of Health (NIH) RO1 AI49757), RMR (NIH grants PO1 AI048240 and RO1 DE016013) and Yerkes National Primate Research center (Grant #RR00165). MS is a research fellow of the Canadian Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accornero P, 1998, FEBS LETT, V436, P461, DOI 10.1016/S0014-5793(98)01127-2; Algeciras A, 1998, J EXP MED, V187, P711, DOI 10.1084/jem.187.5.711; Antons AK, 2008, J IMMUNOL, V180, P764, DOI 10.4049/jimmunol.180.2.764; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Bachis A, 2004, J NEUROSCI RES, V75, P75, DOI 10.1002/jnr.10826; Balabanian K, 2004, J IMMUNOL, V173, P7150, DOI 10.4049/jimmunol.173.12.7150; BANDA NK, 1992, J EXP MED, V176, P1099, DOI 10.1084/jem.176.4.1099; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Becker C, 2009, BLOOD, V114, P1263, DOI 10.1182/blood-2009-02-206730; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Biancotto A, 2007, BLOOD, V109, P4272, DOI 10.1182/blood-2006-11-055764; Bonsignori M, 2009, J IMMUNOL, V183, P2708, DOI 10.4049/jimmunol.0901068; Brainard DM, 2004, J VIROL, V78, P5184, DOI 10.1128/JVI.78.10.5184-5193.2004; Chenine AL, 2010, J INFECT DIS, V201, P1155, DOI 10.1086/651274; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Chougnet C, 2006, J LEUKOCYTE BIOL, V80, P994, DOI 10.1189/jlb.0306135; COOPER DA, 1988, J INFECT DIS, V157, P889, DOI 10.1093/infdis/157.5.889; CORBEIL J, 1995, J GEN VIROL, V76, P681, DOI 10.1099/0022-1317-76-3-681; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dunham RM, 2008, J IMMUNOL, V180, P5582, DOI 10.4049/jimmunol.180.8.5582; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Fantuzzi L, 2004, J VIROL, V78, P9763, DOI 10.1128/JVI.78.18.9763-9772.2004; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Fauci AS, 2008, NATURE, V453, P289, DOI 10.1038/453289a; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Haeryfar SMM, 2005, J IMMUNOL, V174, P3344, DOI 10.4049/jimmunol.174.6.3344; Hovav AH, 2009, J VIROL, V83, P10941, DOI 10.1128/JVI.00394-09; Hu HT, 2008, J IMMUNOL, V180, P5593, DOI 10.4049/jimmunol.180.8.5593; Humbert M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-94; Ji JX, 2009, INT IMMUNOL, V21, P283, DOI 10.1093/intimm/dxn146; Kaufmann GR, 1998, J INFECT DIS, V178, P1812, DOI 10.1086/314480; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Klasse PJ, 2004, VIROLOGY, V323, P1, DOI 10.1016/j.virol.2004.03.003; Krathwohl MD, 2006, J INFECT DIS, V193, P494, DOI 10.1086/499597; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Moore AC, 2005, J IMMUNOL, V175, P7264, DOI 10.4049/jimmunol.175.11.7264; Munier ML, 2007, IMMUNOL CELL BIOL, V85, P6, DOI 10.1038/sj.icb.7100015; Musey LK, 1999, J INFECT DIS, V180, P278, DOI 10.1086/314868; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Ronaldson PT, 2006, MOL PHARMACOL, V70, P1087, DOI 10.1124/mol.106.025973; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Santosuosso M, 2009, J INFECT DIS, V200, P1050, DOI 10.1086/605695; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; Song RJ, 2006, J VIROL, V80, P8729, DOI 10.1128/JVI.00558-06; Stevceva L, 2008, J IMMUNOL, V181, P5510, DOI 10.4049/jimmunol.181.8.5510; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wang XTZ, 2003, IMMUNITY, V18, P631, DOI 10.1016/S1074-7613(03)00116-X; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0	58	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18465	10.1371/journal.pone.0018465	http://dx.doi.org/10.1371/journal.pone.0018465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483689	gold, Green Submitted, Green Published			2022-12-27	WOS:000289191300023
J	Slattery, M; Ma, LJ; Negre, N; White, KP; Mann, RS				Slattery, Matthew; Ma, Lijia; Negre, Nicolas; White, Kevin P.; Mann, Richard S.			Genome-Wide Tissue-Specific Occupancy of the Hox Protein Ultrabithorax and Hox Cofactor Homothorax in Drosophila	PLOS ONE			English	Article							BITHORAX COMPLEX; GENE-FUNCTION; TARGET GENE; ORGAN SIZE; BODY; TRANSCRIPTION; WINGLESS; DNA; RECOGNITION; IDENTITY	The Hox genes are responsible for generating morphological diversity along the anterior-posterior axis during animal development. The Drosophila Hox gene Ultrabithorax (Ubx), for example, is required for specifying the identity of the third thoracic (T3) segment of the adult, which includes the dorsal haltere, an appendage required for flight, and the ventral T3 leg. Ubx mutants show homeotic transformations of the T3 leg towards the identity of the T2 leg and the haltere towards the wing. All Hox genes, including Ubx, encode homeodomain containing transcription factors, raising the question of what target genes Ubx regulates to generate these adult structures. To address this question, we carried out whole genome ChIP-chip studies to identify all of the Ubx bound regions in the haltere and T3 leg imaginal discs, which are the precursors to these adult structures. In addition, we used ChIP-chip to identify the sites bound by the Hox cofactor, Homothorax (Hth). In contrast to previous ChIP-chip studies carried out in Drosophila embryos, these binding studies reveal that there is a remarkable amount of tissue-and transcription factor-specific binding. Analyses of the putative target genes bound and regulated by these factors suggest that Ubx regulates many downstream transcription factors and developmental pathways in the haltere and T3 leg. Finally, we discovered additional DNA sequence motifs that in some cases are specific for individual data sets, arguing that Ubx and/or Hth work together with many regionally expressed transcription factors to execute their functions. Together, these data provide the first whole-genome analysis of the binding sites and target genes regulated by Ubx to specify the morphologies of the adult T3 segment of the fly.	[Slattery, Matthew; Mann, Richard S.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Ma, Lijia; Negre, Nicolas; White, Kevin P.] Univ Chicago, Dept Ecol & Evolut, Dept Human Genet, Inst Genom & Syst Biol, Chicago, IL 60637 USA	Columbia University; University of Chicago	Slattery, M (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA.	rsm10@columbia.edu		Negre, Nicolas/0000-0001-9727-3416	NIH-NHGRI; NIH [5R01GM054510]; NIH NRSA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054510] Funding Source: NIH RePORTER	NIH-NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research is funded by an NIH-NHGRI, modENCODE grant awarded to KPW, by NIH grant 5R01GM054510 awarded to RSM, and by an NIH NRSA grant awarded to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2001, SCIENCE, V292, P1080, DOI 10.1126/science.1060856; Ayers KL, 2010, DEV CELL, V18, P605, DOI 10.1016/j.devcel.2010.02.015; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; BOEDIGHEIMER M, 1993, DEVELOPMENT, V118, P1291; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Calleja M, 2000, DEVELOPMENT, V127, P3971; Crickmore MA, 2008, BIOESSAYS, V30, P843, DOI 10.1002/bies.20806; Crickmore MA, 2006, SCIENCE, V313, P63, DOI 10.1126/science.1128650; Crickmore MA, 2007, DEVELOPMENT, V134, P327, DOI 10.1242/dev.02737; Crickmore MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000633; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; de Navas LF, 2006, DEVELOPMENT, V133, P4495, DOI 10.1242/dev.02609; Diez del Corral R, 1999, GENE DEV, V13, P1754, DOI 10.1101/gad.13.13.1754; Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290; Eklund EA, 2007, CURR OPIN HEMATOL, V14, P85, DOI 10.1097/MOH.0b013e32801684b6; Estella C, 2008, DEV CELL, V14, P86, DOI 10.1016/j.devcel.2007.11.002; Estella C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001001; Galant R, 2002, DEVELOPMENT, V129, P3115; Garaulet DL, 2008, DEVELOPMENT, V135, P3219, DOI 10.1242/dev.025809; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; GONZALEZREYES A, 1990, CELL, V61, P515, DOI 10.1016/0092-8674(90)90533-K; Hersh BM, 2005, DEVELOPMENT, V132, P1567, DOI 10.1242/dev.01737; Hersh BM, 2007, DEV BIOL, V302, P717, DOI 10.1016/j.ydbio.2006.11.011; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Hueber SD, 2007, DEVELOPMENT, V134, P381, DOI 10.1242/dev.02746; Iimura T, 2007, DEV GROWTH DIFFER, V49, P265, DOI 10.1111/j.1440-169x.2007.00928.x; IRVINE KD, 1993, DEVELOPMENT, V117, P387; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; KASSIS JA, 1992, P NATL ACAD SCI USA, V89, P1919, DOI 10.1073/pnas.89.5.1919; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kirkpatrick CA, 2004, DEV CELL, V7, P513, DOI 10.1016/j.devcel.2004.08.004; Korenjak M, 2005, CURR OPIN GENET DEV, V15, P520, DOI 10.1016/j.gde.2005.07.001; Kozu S, 2006, DEV BIOL, V294, P497, DOI 10.1016/j.ydbio.2006.03.015; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Maeda RK, 2009, CURR TOP DEV BIOL, V88, P1, DOI 10.1016/S0070-2153(09)88001-0; Makhijani K, 2007, DEV BIOL, V302, P243, DOI 10.1016/j.ydbio.2006.09.029; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; MANN RS, 1995, BIOESSAYS, V17, P855, DOI 10.1002/bies.950171007; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1; MANN RS, 1990, CELL, V60, P597, DOI 10.1016/0092-8674(90)90663-Y; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Maurange C, 2005, TRENDS NEUROSCI, V28, P30, DOI 10.1016/j.tins.2004.10.009; Miller DFB, 2001, MECH DEVELOP, V102, P3, DOI 10.1016/S0925-4773(01)00301-X; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Mohit P, 2006, DEV BIOL, V291, P356, DOI 10.1016/j.ydbio.2005.12.022; Morata G, 2001, NAT REV MOL CELL BIO, V2, P89, DOI 10.1038/35052047; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Noyes MB, 2008, NUCLEIC ACIDS RES, V36, P2547, DOI 10.1093/nar/gkn048; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Oh H, 2010, TRENDS CELL BIOL, V20, P410, DOI 10.1016/j.tcb.2010.04.005; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pradel J, 1998, INT J DEV BIOL, V42, P417; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Spradling AC, 1999, GENETICS, V153, P135; STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380; STRUHL G, 1985, CELL, V43, P507, DOI 10.1016/0092-8674(85)90180-1; Tsuji T, 2008, DEVELOPMENT, V135, P3859, DOI 10.1242/dev.025189; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VILLANO JL, 1995, DEVELOPMENT, V121, P2767; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Walsh CM, 2007, DEVELOPMENT, V134, P3585, DOI 10.1242/dev.009522; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Zhang L, 2009, FLY, V3, P68, DOI 10.4161/fly.3.1.7788	81	62	63	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e14686	10.1371/journal.pone.0014686	http://dx.doi.org/10.1371/journal.pone.0014686			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483663	Green Submitted, gold, Green Published			2022-12-27	WOS:000289191300001
J	Hubben, G; Bootsma, M; Luteijn, M; Glynn, D; Bishai, D; Bonten, M; Postma, M				Hubben, Gijs; Bootsma, Martin; Luteijn, Michiel; Glynn, Diarmuid; Bishai, David; Bonten, Marc; Postma, Maarten			Modelling the Costs and Effects of Selective and Universal Hospital Admission Screening for Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; INFECTION-CONTROL; RISK-FACTORS; MRSA; IMPACT; STATES; TRANSMISSION; SPREAD; SURVEILLANCE; PREVALENCE	Background: Screening at hospital admission for carriage of methicillin-resistant Staphylococcus aureus (MRSA) has been proposed as a strategy to reduce nosocomial infections. The objective of this study was to determine the long-term costs and health benefits of selective and universal screening for MRSA at hospital admission, using both PCR-based and chromogenic media-based tests in various settings. Methodology/Principal Findings: A simulation model of MRSA transmission was used to determine costs and effects over 15 years from a US healthcare perspective. We compared admission screening together with isolation of identified carriers against a baseline policy without screening or isolation. Strategies included selective screening of high risk patients or universal admission screening, with PCR-based or chromogenic media-based tests, in medium (5%) or high nosocomial prevalence (15%) settings. The costs of screening and isolation per averted MRSA infection were lowest using selective chromogenic-based screening in high and medium prevalence settings, at $4,100 and $10,300, respectively. Replacing the chromogenic-based test with a PCR-based test costs $13,000 and $36,200 per additional infection averted, and subsequent extension to universal screening with PCR would cost $131,000 and $232,700 per additional infection averted, in high and medium prevalence settings respectively. Assuming $17,645 benefit per infection averted, the most cost-saving strategies in high and medium prevalence settings were selective screening with PCR and selective screening with chromogenic, respectively. Conclusions/ Significance: Admission screening costs $4,100-$21,200 per infection averted, depending on strategy and setting. Including financial benefits from averted infections, screening could well be cost saving.	[Hubben, Gijs; Postma, Maarten] Univ Groningen, Dept Pharm, Groningen, Netherlands; [Bootsma, Martin] Univ Utrecht, Fac Sci, Dept Math, Utrecht, Netherlands; [Bootsma, Martin; Bonten, Marc] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Med Microbiol, Utrecht, Netherlands; [Hubben, Gijs; Glynn, Diarmuid] BaseCase Software, Berlin, Germany; [Luteijn, Michiel] Univ Ulster, Sch Nursing, Belfast, Antrim, North Ireland; [Bishai, David] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of Groningen; Utrecht University; Utrecht University; Utrecht University Medical Center; Ulster University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hubben, G (corresponding author), Univ Groningen, Dept Pharm, Groningen, Netherlands.	g.hubben@basecase.com	, David Bishai/GRO-4211-2022	Postma, Maarten/0000-0002-6306-3653; Bishai, David/0000-0003-0714-9062; Luteijn, Michiel/0000-0002-9526-9015	Becton Dickinson (San Diego, CA); 3M (Minneapolis, MI); Netherlands Organization for Scientific Research [916-05-041, 918.76.611]; BaseCase (Berlin, Germany); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	Becton Dickinson (San Diego, CA); 3M (Minneapolis, MI)(3M); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); BaseCase (Berlin, Germany); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was financially supported by Becton Dickinson (San Diego, CA; www.bd.com) and 3M (Minneapolis, MI; www.3m.com) through research grants without publication restrictions. The funders had no role in study design, data collection and analysis, data interpretation, decision to publish, or preparation of the manuscript. MCJB and MJMB are supported by the Netherlands Organization for Scientific Research (VENI NWO GRANT 916-05-041 and VICI NWO Grant 918.76.611 www.nwo.nl). GAAH, DMG, DB, MJP, and JML have no financial disclosures.; This study was financially supported by Becton Dickinson (San Diego, CA) and 3M (Minneapolis, MI), through research grants without publication restrictions. This did not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. GAAH and DMG are financially supported by BaseCase (Berlin, Germany). In their capacities as consultants for BaseCase software, GAAH and DMG have performed consulting work for Becton Dickinson. This did not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. DB, MJP, and JML declare no competing interests.	Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; Bootsma MCJ, 2006, P NATL ACAD SCI USA, V103, P5620, DOI 10.1073/pnas.0510077103; Cepeda JA, 2005, LANCET, V365, P295, DOI 10.1016/S0140-6736(05)17783-6; Chaix C, 1999, JAMA-J AM MED ASSOC, V282, P1745, DOI 10.1001/jama.282.18.1745; Chaudhury H, 2005, ENVIRON BEHAV, V37, P760, DOI 10.1177/0013916504272658; Clements A, 2008, LANCET INFECT DIS, V8, P427, DOI 10.1016/S1473-3099(08)70151-8; Coello R, 1997, J HOSP INFECT, V37, P39, DOI 10.1016/S0195-6701(97)90071-2; Conterno LO, 2007, J HOSP INFECT, V65, P354, DOI 10.1016/j.jhin.2006.12.014; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Gold MR, 1996, COST EFFECTIVENESS H; Gould IM, 2006, INT J ANTIMICROB AG, V28, P379, DOI 10.1016/j.ijantimicag.2006.09.001; Grundmann H, 2002, J INFECT DIS, V185, P481, DOI 10.1086/338568; Harbarth S, 1998, ARCH INTERN MED, V158, P182, DOI 10.1001/archinte.158.2.182; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Herr CEW, 2003, INFECT CONT HOSP EP, V24, P673, DOI 10.1086/502274; *HLTH COUNC NETH, 2006, 2006 PUBL HLTH COUNC; Hori S, 2002, J HOSP INFECT, V50, P25, DOI 10.1053/jhin.2001.1130; Jarvis WR, 2007, AM J INFECT CONTROL, V35, P631, DOI 10.1016/j.ajic.2007.10.009; Keshtgar MRS, 2008, BRIT J SURG, V95, P381, DOI 10.1002/bjs.6013; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lagace-Wiens PRS, 2008, J CLIN MICROBIOL, V46, P1174, DOI 10.1128/JCM.01253-07; Luteijn JM, 2011, CLIN MICROBIOL INFEC, V17, P146, DOI 10.1111/j.1469-0691.2010.03202.x; Nijssen S, 2005, CLIN INFECT DIS, V40, P405, DOI 10.1086/427281; PANLILIO AL, 1992, INFECT CONT HOSP EP, V13, P582; Paule SM, 2007, J CLIN MICROBIOL, V45, P2993, DOI 10.1128/JCM.00670-07; Ritchie K, 2007, CLIN COST EFFECTIVEN; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Rubin RJ, 1999, EMERG INFECT DIS, V5, P9, DOI 10.3201/eid0501.990102; Smith DL, 2005, P NATL ACAD SCI USA, V102, P3153, DOI 10.1073/pnas.0409523102; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; Wernitz MH, 2005, CLIN MICROBIOL INFEC, V11, P466, DOI 10.1111/j.1469-0691.2005.01153.x; Wigglesworth N, 2006, J HOSP INFECT, V63, P156, DOI 10.1016/j.jhin.2006.02.008; Woolhandler S, 2003, NEW ENGL J MED, V349, P768, DOI 10.1056/NEJMsa022033	36	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e14783	10.1371/journal.pone.0014783	http://dx.doi.org/10.1371/journal.pone.0014783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483492	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200002
J	Matsumoto, Y; Sumiya, E; Sugita, T; Sekimizu, K				Matsumoto, Yasuhiko; Sumiya, Eriko; Sugita, Takuya; Sekimizu, Kazuhisa			An Invertebrate Hyperglycemic Model for the Identification of Anti-Diabetic Drugs	PLOS ONE			English	Article							ADVANCED GLYCATION; SILKWORM LARVAE; INFECTION MODEL; DIABETIC-RATS; BOMBYX-MORI; GLUCOSE; AMINOGUANIDINE; METABOLISM; VIRULENCE; FRUCTOSE	The number of individuals diagnosed with type 2 diabetes mellitus, which is caused by insulin resistance and/or abnormal insulin secretion, is increasing worldwide, creating a strong demand for the development of more effective anti-diabetic drugs. However, animal-based screening for anti-diabetic compounds requires sacrifice of a large number of diabetic animals, which presents issues in terms of animal welfare. Here, we established a method for evaluating the anti-diabetic effects of compounds using an invertebrate animal, the silkworm, Bombyx mori. Sugar levels in silkworm hemolymph increased immediately after feeding silkworms a high glucose-containing diet, resulting in impaired growth. Human insulin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR), an AMP-activated protein kinase (AMPK) activator, decreased the hemolymph sugar levels of the hyperglycemic silkworms and restored growth. Treatment of the isolated fat body with human insulin in an in vitro culture system increased total sugar in the fat body and stimulated Akt phosphorylation. These responses were inhibited by wortmannin, an inhibitor of phosphoinositide 3 kinase. Moreover, AICAR stimulated AMPK phosphorylation in the silkworm fat body. Administration of aminoguanidine, a Maillard reaction inhibitor, repressed the accumulation of Maillard reaction products (advanced glycation end-products; AGEs) in the hyperglycemic silkworms and restored growth, suggesting that the growth defect of hyperglycemic silkworms is caused by AGE accumulation in the hemolymph. Furthermore, we identified galactose as a hypoglycemic compound in jiou, an herbal medicine for diabetes, by monitoring its hypoglycemic activity in hyperglycemic silkworms. These results suggest that the hyperglycemic silkworm model is useful for identifying anti-diabetic drugs that show therapeutic effects in mammals.	[Matsumoto, Yasuhiko; Sumiya, Eriko; Sugita, Takuya; Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo, Japan	University of Tokyo	Matsumoto, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo, Japan.	sekimizu@mol.f.u-tokyo.ac.jp	Matsumoto, Yasuhiko/H-5767-2019	Matsumoto, Yasuhiko/0000-0002-0796-2304	National Institute of Biomedical Innovation (NIBIO) [21790062]; Ministry of Health, Labour and Welfare; Suzuken Memorial Foundation; Genome Pharmaceuticals Institute Co., Ltd (Tokyo, Japan)	National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Suzuken Memorial Foundation; Genome Pharmaceuticals Institute Co., Ltd (Tokyo, Japan)	The project was supported by a Grant-in-Aid for Scientific Research (21790062) and also in part by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), the grant from the Ministry of Health, Labour and Welfare (Research on Biological Resources and Animal Models for Drug Development), the research grant of Suzuken Memorial Foundation, and Genome Pharmaceuticals Institute Co., Ltd (Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asami Yukihiro, 2010, BMC Pharmacology, V10, P7, DOI 10.1186/1471-2210-10-7; Cha SH, 2008, P NATL ACAD SCI USA, V105, P16871, DOI 10.1073/pnas.0809255105; Coughlan MT, 2008, ANN NY ACAD SCI, V1126, P190, DOI 10.1196/annals.1433.018; Drel VR, 2007, EUR J PHARMACOL, V569, P48, DOI 10.1016/j.ejphar.2007.05.055; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Hamamoto A, 2005, INT J ANTIMICROB AG, V26, P38, DOI 10.1016/j.ijantimicag.2005.03.008; Hamamoto H, 2004, ANTIMICROB AGENTS CH, V48, P774, DOI 10.1128/AAC.48.3.774-779.2004; Hamamoto H, 2009, COMP BIOCHEM PHYS C, V149, P334, DOI 10.1016/j.cbpc.2008.08.008; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hedge J.E., 1962, CARBOHYDRATE CHEM, Vseventeenth; Iwami M, 2000, ZOOL SCI, V17, P1035, DOI 10.2108/zsj.17.1035; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kanamori Y, 2010, INSECT BIOCHEM MOLEC, V40, P30, DOI 10.1016/j.ibmb.2009.12.006; KIHO T, 1992, YAKUGAKU ZASSHI, V112, P393, DOI 10.1248/yakushi1947.112.6_393; Kurokawa K, 2007, METHOD ENZYMOL, V422, P233, DOI 10.1016/S0076-6879(06)22011-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Masumura M, 2000, GEN COMP ENDOCR, V118, P393, DOI 10.1006/gcen.1999.7438; Miura J, 2003, J DIABETES COMPLICAT, V17, P16, DOI 10.1016/S1056-8727(02)00183-6; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Nagata S, 2008, COMP BIOCHEM PHYS B, V151, P355, DOI 10.1016/j.cbpb.2008.08.002; Orihara Y, 2008, J GEN VIROL, V89, P188, DOI 10.1099/vir.0.83208-0; Russell WMS., 1959, MED J AUSTRALIA; Soulis T, 1997, DIABETOLOGIA, V40, P1141, DOI 10.1007/s001250050799; Stadler K, 2005, DIABETES-METAB RES, V21, P189, DOI 10.1002/dmrr.501; Summers SA, 1999, ANN NY ACAD SCI, V892, P169, DOI 10.1111/j.1749-6632.1999.tb07795.x; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	27	67	72	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18292	10.1371/journal.pone.0018292	http://dx.doi.org/10.1371/journal.pone.0018292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479175	gold, Green Published, Green Submitted			2022-12-27	WOS:000289055700044
J	Fry, AM; Lu, XY; Olsen, SJ; Chittaganpitch, M; Sawatwong, P; Chantra, S; Baggett, HC; Erdman, D				Fry, Alicia M.; Lu, Xiaoyan; Olsen, Sonja J.; Chittaganpitch, Malinee; Sawatwong, Pongpun; Chantra, Somrak; Baggett, Henry C.; Erdman, Dean			Human Rhinovirus Infections in Rural Thailand: Epidemiological Evidence for Rhinovirus as Both Pathogen and Bystander	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ACUTE RESPIRATORY ILLNESS; CLINICAL SYMPTOMS; PNEUMONIA; VIRUSES; SURVEILLANCE; CHILDREN; TRACT; HOSPITALIZATIONS; INFLUENZA	Background: We describe human rhinovirus (HRV) detections in SaKaeo province, Thailand. Methods: From September 1, 2003-August 31, 2005, we tested hospitalized patients with acute lower respiratory illness and outpatient controls without fever or respiratory symptoms for HRVs with polymerase chain reaction and molecularly-typed select HRVs. We compared HRV detection among hospitalized patients and controls and estimated enrollment adjusted incidence. Results: HRVs were detected in 315 (16%) of 1919 hospitalized patients and 27 (9.6%) of 280 controls. Children had the highest frequency of HRV detections (hospitalized: <1 year: 29%, 1-4 year: 29%, >= 65 years: 9%; controls: <1 year: 24%, 1-4 year: 14%, >= 65 years: 2.8%). Enrollment adjusted hospitalized HRV detection rates were highest among persons aged <1 year (1038/100,000 persons/year), 1-4 years (457), and >= 65 years (71). All three HRV species were identified, HRV-A was the most common species in most age groups including children aged <1 year (61%) and all adult age groups. HRV-C was the most common species in the 1-4 year (51%) and 5-19 year age groups (54%). Compared to controls, hospitalized adults (>= 19 years) and children were more likely to have HRV detections (odds ratio [OR]: 4.8, 95% confidence interval [CI]: 1.5, 15.8; OR: 2.0, CI: 1.2, 3.3, respectively) and hospitalized children were more likely to have HRV-A (OR 1.7, CI: 0.8, 3.5) or HVR-C (OR 2.7, CI: 1.2, 5.9) detection. Conclusions: HRV rates were high among hospitalized children and the elderly but asymptomatic children also had substantial HRV detection. HRV (all species), and HRV-A and HRV-C detections were epidemiologically-associated with hospitalized illness. Treatment or prevention modalities effective against HRV could reduce hospitalizations due to HRV in Thailand.	[Fry, Alicia M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; [Lu, Xiaoyan; Erdman, Dean] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA; [Olsen, Sonja J.] Ctr Dis Control & Prevent, Div Emerging Infect & Surveillance Serv, Atlanta, GA USA; [Chittaganpitch, Malinee] Thailand Minist Publ Hlth, Natl Inst Hlth, Nonthaburi, Thailand; [Sawatwong, Pongpun; Chantra, Somrak; Baggett, Henry C.] Thai MOPH US CDC Collaborat, Int Emerging Infect Program, Nonthaburi, Thailand	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand	Fry, AM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	afry@cdc.gov						[Anonymous], POP PROJ THAIL 2000; Cheuk DKL, 2007, PEDIATR INFECT DIS J, V26, P995, DOI 10.1097/INF.0b013e3181586b63; Dare RK, 2007, J INFECT DIS, V196, P1321, DOI 10.1086/521308; Falsey AR, 2002, J INFECT DIS, V185, P1338, DOI 10.1086/339881; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Garbino J, 2004, CHEST, V125, P1033, DOI 10.1378/chest.125.3.1033; Garbino J, 2009, THORAX, V64, P399, DOI 10.1136/thx.2008.105155; Gerna G, 2009, J MED VIROL, V81, P1498, DOI 10.1002/jmv.21548; Ghosh S, 1999, CLIN INFECT DIS, V29, P528, DOI 10.1086/598627; Hayden FG, 2004, REV MED VIROL, V14, P17, DOI 10.1002/rmv.406; Jartti T, 2004, EMERG INFECT DIS, V10, P1095, DOI 10.3201/eid1006.030629; Jartti T, 2004, J MED VIROL, V72, P695, DOI 10.1002/jmv.20027; Javadi M, 2006, INT J INFECT DIS, V10, P129, DOI 10.1016/j.ijid.2005.01.007; Jennings LC, 2008, THORAX, V63, P42, DOI 10.1136/thx.2006.075077; Khetsuriani N, 2007, J ALLERGY CLIN IMMUN, V119, P314, DOI 10.1016/j.jaci.2006.08.041; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; Linsuwanon P, 2009, J INFECTION, V59, P115, DOI 10.1016/j.jinf.2009.05.009; LU X, 2009, 25 ANN CLIN VIR S AN; Mackay IM, 2008, J CLIN VIROL, V42, P297, DOI 10.1016/j.jcv.2008.04.002; Miller EK, 2007, J INFECT DIS, V195, P773, DOI 10.1086/511821; Miller EK, 2009, J ALLERGY CLIN IMMUN, V123, P98, DOI 10.1016/j.jaci.2008.10.007; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Olsen SJ, 2010, EPIDEMIOL INFECT, V138, P1811, DOI 10.1017/S0950268810000646; Phares CR, 2007, CLIN INFECT DIS, V45, pE147, DOI 10.1086/523003; Roghmann M, 2003, BONE MARROW TRANSPL, V32, P1085, DOI 10.1038/sj.bmt.1704257; Simmerman JM, 2006, VACCINE, V24, P4417, DOI 10.1016/j.vaccine.2005.12.060; van Kraaij MGJ, 2005, CLIN INFECT DIS, V40, P662, DOI 10.1086/427801; Winther B, 2006, J MED VIROL, V78, P644, DOI 10.1002/jmv.20588; Wisdom A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008518; Wright PF, 2007, J CLIN MICROBIOL, V45, P2126, DOI 10.1128/JCM.02553-06	32	87	91	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17780	10.1371/journal.pone.0017780	http://dx.doi.org/10.1371/journal.pone.0017780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479259	Green Published, Green Submitted, gold			2022-12-27	WOS:000289054600016
J	Han, YH; Chen, JH; Zhao, XK; Liang, CZ; Wang, Y; Sun, LA; Jiang, ZM; Zhang, ZF; Yang, RL; Chen, J; Li, ZS; Tang, AF; Li, XX; Ye, JX; Guan, ZC; Gui, YT; Cai, ZM				Han, Yonghua; Chen, Jiahao; Zhao, Xiaokun; Liang, Chaozhao; Wang, Yong; Sun, Liang; Jiang, Zhimao; Zhang, Zhongfu; Yang, Ruilin; Chen, Jing; Li, Zesong; Tang, Aifa; Li, Xianxin; Ye, Jiongxian; Guan, Zhichen; Gui, Yaoting; Cai, Zhiming			MicroRNA Expression Signatures of Bladder Cancer Revealed by Deep Sequencing	PLOS ONE			English	Article							IDENTIFICATION; GENES	Background: MicroRNAs (miRNAs) are a class of small noncoding RNAs that regulate gene expression. They are aberrantly expressed in many types of cancers. In this study, we determined the genome-wide miRNA profiles in bladder urothelial carcinoma by deep sequencing. Methodology/Principal Findings: We detected 656 differentially expressed known human miRNAs and miRNA antisense sequences (miRNA*s) in nine bladder urothelial carcinoma patients by deep sequencing. Many miRNAs and miRNA*s were significantly upregulated or downregulated in bladder urothelial carcinoma compared to matched histologically normal urothelium. hsa-miR-96 was the most significantly upregulated miRNA and hsa-miR-490-5p was the most significantly downregulated one. Upregulated miRNAs were more common than downregulated ones. The hsa-miR-183, hsa-miR-200b similar to 429, hsa-miR-200c similar to 141 and hsa-miR-17 similar to 92 clusters were significantly upregulated. The hsa-miR-143 similar to 145 cluster was significantly downregulated. hsa-miR-182, hsa-miR-183, hsa-miR-200a, hsa-miR-143 and hsa-miR-195 were evaluated by Real-Time qPCR in a total of fifty-one bladder urothelial carcinoma patients. They were aberrantly expressed in bladder urothelial carcinoma compared to matched histologically normal urothelium (p < 0.001 for each miRNA). Conclusions/Significance: To date, this is the first study to determine genome-wide miRNA expression patterns in human bladder urothelial carcinoma by deep sequencing. We found that a collection of miRNAs were aberrantly expressed in bladder urothelial carcinoma compared to matched histologically normal urothelium, suggesting that they might play roles as oncogenes or tumor suppressors in the development and/or progression of this cancer. Our data provide novel insights into cancer biology.	[Han, Yonghua; Li, Xianxin; Guan, Zhichen; Cai, Zhiming] Peking Univ, Shenzhen Hosp, Dept Urol, Shenzhen, Peoples R China; [Han, Yonghua; Wang, Yong; Sun, Liang; Jiang, Zhimao; Zhang, Zhongfu; Yang, Ruilin; Chen, Jing; Li, Zesong; Tang, Aifa; Ye, Jiongxian; Gui, Yaoting; Cai, Zhiming] Peking Univ, Shenzhen Hosp, Guangdong Key Lab Male Reprod Med & Genet, Shenzhen, Peoples R China; [Chen, Jiahao] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Zhao, Xiaokun] Cent S Univ, Xiangya Hosp 2, Dept Urol, Changsha, Hunan, Peoples R China; [Liang, Chaozhao] Anhui Med Univ, Affiliated Hosp 1, Dept Urol, Hefei, Peoples R China; [Wang, Yong; Sun, Liang; Jiang, Zhimao; Zhang, Zhongfu; Chen, Jing; Li, Zesong; Tang, Aifa; Li, Xianxin; Ye, Jiongxian; Guan, Zhichen; Gui, Yaoting] Shenzhen PKU HKUST Med Ctr, Inst Urol, Shenzhen, Peoples R China; [Yang, Ruilin] Shantou Univ, Coll Med, Shantou, Peoples R China; [Cai, Zhiming] Second Peoples Hosp Shenzhen, Dept Urol, Shenzhen, Peoples R China	Peking University; Peking University; Beijing Genomics Institute (BGI); Central South University; Anhui Medical University; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Shantou University; Second People's Hospital of Shenzhen	Han, YH (corresponding author), Peking Univ, Shenzhen Hosp, Dept Urol, Shenzhen, Peoples R China.	caizhiming2000@yahoo.com.cn	gui, yaoting/GLT-3684-2022	Chen, Jiahao/0000-0001-7719-3216	National High Technology Research and Development Program of China [2006AA02A302, 2009AA022707]; Promotion Program for Shenzhen Key Laboratory, Shenzhen, China [CXB200903090055A]; Bank of Clinical Data of Major Diseases and Biological Specimens of Shenzhen [CXC201005260001A]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Promotion Program for Shenzhen Key Laboratory, Shenzhen, China; Bank of Clinical Data of Major Diseases and Biological Specimens of Shenzhen	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program, 2006AA02A302 and 2009AA022707) and the Promotion Program for Shenzhen Key Laboratory, Shenzhen, China (CXB200903090055A), Bank of Clinical Data of Major Diseases and Biological Specimens of Shenzhen (CXC201005260001A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Hartmann A, 1999, AM J PATHOL, V154, P721, DOI 10.1016/S0002-9440(10)65318-7; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Kim WJ, 2008, CANCER SCI, V99, P646, DOI 10.1111/j.1349-7006.2008.00735.x; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin TX, 2009, J UROLOGY, V181, P1372, DOI 10.1016/j.juro.2008.10.149; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Neely LA, 2010, UROL ONCOL-SEMIN ORI, V28, P39, DOI 10.1016/j.urolonc.2008.06.006; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Rathjen T, 2009, FEBS LETT, V583, P1422, DOI 10.1016/j.febslet.2009.03.048; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Stenvang J, 2008, SEMIN CANCER BIOL, V18, P89, DOI 10.1016/j.semcancer.2008.01.004; Wang G, 2010, INT UROL NEPHROL, V42, P95, DOI 10.1007/s11255-009-9584-3; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311	31	204	216	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18286	10.1371/journal.pone.0018286	http://dx.doi.org/10.1371/journal.pone.0018286			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464941	gold, Green Submitted, Green Published			2022-12-27	WOS:000289053800037
J	Evans, JT; Wani, RLS; Anderson, L; Gibson, AL; Smith, EG; Wood, A; Olowokure, B; Abubakar, I; Mann, JS; Gardiner, S; Jones, H; Sonnenberg, P; Hawkey, PM				Evans, Jason T.; Wani, Robert L. Serafino; Anderson, Laura; Gibson, Andrea L.; Smith, E. Grace; Wood, Annette; Olowokure, Babatunde; Abubakar, Ibrahim; Mann, Jonathan S.; Gardiner, Sarah; Jones, Helen; Sonnenberg, Pam; Hawkey, Peter M.			A Geographically-Restricted but Prevalent Mycobacterium tuberculosis Strain Identified in the West Midlands Region of the UK between 1995 and 2008	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; NEW-YORK; TRANSMISSION; OUTBREAK; CLUSTER; USERS; CITY	Background: We describe the identification of, and risk factors for, the single most prevalent Mycobacterium tuberculosis strain in the West Midlands region of the UK. Methodology/Principal Findings: Prospective 15-locus MIRU-VNTR genotyping of all M. tuberculosis isolates in the West Midlands between 2004 and 2008 was undertaken. Two retrospective epidemiological investigations were also undertaken using univariable and multivariable logistic regression analysis. The first study of all TB patients in the West Midlands between 2004 and 2008 identified a single prevalent strain in each of the study years (total 155/3,056 (5%) isolates). This prevalent MIRU-VNTR profile (32333 2432515314 434443183) remained clustered after typing with an additional 9-loci MIRU-VNTR and spoligotyping. The majority of these patients (122/155, 79%) resided in three major cities located within a 40 km radius. From the apparent geographical restriction, we have named this the "Mercian" strain. A multivariate analysis of all TB patients in the West Midlands identified that infection with a Mercian strain was significantly associated with being UK-born (OR = 9.03, 95% CI = 4.56-17.87, p < 0.01), Black Caribbean (OR = 5.68, 95% CI = 2.96-10.91, p < 0.01) resident in Wolverhampton (OR = 9.29, 95% CI = 5.69-15.19, p < 0.01) and negatively associated with age > 65 years old (OR = 0.25, 95% CI = 0.09-0.67, p < 0.01). A second more detailed investigation analyzed a cohort of 82 patients resident in Wolverhampton between 2003 and 2006. A significant association with being born in the UK remained after a multivariate analysis (OR = 9.68, 95% CI = 2.00-46.78, p < 0.01) and excess alcohol intake and cannabis use (OR = 6.26, 95% CI = 1.45-27.02, p = .01) were observed as social risk factors for infection. Conclusions/Significance: The continued consistent presence of the Mercian strain suggests ongoing community transmission. Whilst significant associations have been found, there may be other common risk factors yet to be identified. Future investigations should focus on targeting the relevant risk groups and elucidating the biological factors that mediate continued transmission of this strain.	[Evans, Jason T.; Gibson, Andrea L.; Smith, E. Grace; Gardiner, Sarah; Hawkey, Peter M.] Heart England NHS Fdn Trust, Hlth Protect Agcy, W Midlands Lab, Birmingham, W Midlands, England; [Wani, Robert L. Serafino] Guys & St Thomas NHS Fdn Trust, Dept Infect, London, England; [Anderson, Laura; Abubakar, Ibrahim] Hlth Protect Agcy, Dept Resp Dis, TB Sect, Ctr Infect, London, England; [Wood, Annette] Hlth Protect Agcy, W Midlands E Hlth Protect Unit, Birmingham, W Midlands, England; [Olowokure, Babatunde] Hlth Protect Agcy, W Midlands Reg Epidemiol Unit, Birmingham, W Midlands, England; [Mann, Jonathan S.] New Cross Hosp, Dept Resp Med, Wolverhampton, W Midlands, England; [Jones, Helen] New Cross Hosp, Dept Microbiol, Wolverhampton, W Midlands, England; [Sonnenberg, Pam] UCL, Dept Infect & Populat Hlth, Ctr Sexual Hlth & HIV Res, London, England; [Hawkey, Peter M.] Univ Birmingham, Sch Immun & Infect, Coll Med & Dent Sci, Birmingham, W Midlands, England	Health Protection Agency; Heart of England NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Health Protection Agency; Health Protection Agency; Health Protection Agency; New Cross Hospital; New Cross Hospital; University of London; University College London; University of Birmingham	Evans, JT (corresponding author), Heart England NHS Fdn Trust, Hlth Protect Agcy, W Midlands Lab, Birmingham, W Midlands, England.	jason.evans@heartofengland.nhs.uk		Abubakar, Ibrahim/0000-0002-0370-1430; Sonnenberg, Pam/0000-0002-1067-1583	UK Department of Health	UK Department of Health	The implementation of prospective DNA fingerprinting was enabled by a grant from the UK Department of Health. The Department of Health had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; Borgdorff MW, 2001, AM J EPIDEMIOL, V154, P934, DOI 10.1093/aje/154.10.934; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cowan LS, 2004, J CLIN MICROBIOL, V42, P474, DOI 10.1128/JCM.42.1.474-477.2004; de Vries G, 2007, AM J RESP CRIT CARE, V176, P201, DOI 10.1164/rccm.200612-1877OC; Evans JT, 2007, LANCET, V369, P1270, DOI 10.1016/S0140-6736(07)60598-4; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Ghebremichael S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010893; Gibson AL, 2008, J CLIN MICROBIOL, V46, P1259, DOI 10.1128/JCM.02231-07; Hawkey PM, 2003, J CLIN MICROBIOL, V41, P3514, DOI 10.1128/JCM.41.8.3514-3520.2003; *HLTH PROT AG, 2009, TUBERCULOSIS UK ANN; *HPA, 2010, HPA UK MYC TUB STRAI; Jackson AD, 2009, INT J TUBERC LUNG D, V13, P486; Kik SV, 2008, AM J RESP CRIT CARE, V178, P96, DOI 10.1164/rccm.200708-1256OC; Love J, 2009, INT J TUBERC LUNG D, V13, P201; McNabb SJN, 2004, AM J EPIDEMIOL, V160, P589, DOI 10.1093/aje/kwh253; Moss AR, 1997, INT J TUBERC LUNG D, V1, P115; Oeltmann JE, 2006, EMERG INFECT DIS, V12, P1156, DOI 10.3201/eid1207.051436; *OFF NAT STAT, 2010, W MIDL POP MIGR; Lazzarini LCO, 2008, J CLIN MICROBIOL, V46, P2175, DOI 10.1128/JCM.00065-08; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Perlman DC, 1997, J SUBST ABUSE TREAT, V14, P3, DOI 10.1016/S0740-5472(96)00182-1; Ruddy MC, 2004, THORAX, V59, P279, DOI 10.1136/thx.2003.010405; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Stavrum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004540; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; van Soolingen D, 1999, J INFECT DIS, V180, P726, DOI 10.1086/314930; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANWEEZENBEEK CSL, 2003, INT J TUBERC LUNG D, V7, pS463; ZALUCKYJ S, 2001, MERCIAN ANGLO SAXON	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17930	10.1371/journal.pone.0017930	http://dx.doi.org/10.1371/journal.pone.0017930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464965	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000288813900020
J	Ferri, F; Frassinetti, F; Costantini, M; Gallese, V				Ferri, Francesca; Frassinetti, Francesca; Costantini, Marcello; Gallese, Vittorio			Motor Simulation and the Bodily Self	PLOS ONE			English	Article							MENTAL ROTATION; BODY-OWNERSHIP; NEURAL BASIS; CORTEX; REPRESENTATIONS; ASYMMETRY; HANDS; RECOGNITION; PERCEPTION; MOVEMENT	Previous studies demonstrated the human ability to implicitly recognize their own body. When submitted to a visual matching task, participants showed the so-called self-advantage, that is, a better performance with self rather than others' body or body parts. Here, we investigated whether the body self-advantage relies upon a motor representation of one's body. Participants were submitted to a laterality judgment of self and others' hands (Experiment 1 and 3), which involves a sensory-motor mental simulation. Moreover, to investigate whether the self-advantage emerges also when an explicit self processing is required, the same participants were submitted to an explicit self-body recognition task (Experiment 2). Participants showed the self-advantage when performing the laterality judgment, but not when self-recognition was explicitly required. Thus, implicit and explicit recognition of the bodily self dissociate and only an implicit recognition of the bodily self, mapped in motor terms, allows the self-advantage to emerge.	[Ferri, Francesca; Gallese, Vittorio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Frassinetti, Francesca] Univ Bologna, Dept Psychol, Bologna, Italy; [Costantini, Marcello] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Costantini, Marcello] Fdn Univ G dAnnunzio, ITAB, Chieti, Italy; [Gallese, Vittorio] Italian Inst Technol, Brain Ctr Social & Motor Cognit, Parma, Italy	University of Parma; University of Bologna; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Istituto Italiano di Tecnologia - IIT	Ferri, F (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	francesca.ferri@nemo.unipr.it	Gallese, Vittorio/ABD-5097-2021; FRASSINETTI, FRANCESCA/ABI-1533-2020; Costantini, Marcello/F-7083-2011; Frassinetti, Francesca/K-1474-2016; Ferri, Francesca/AAC-2527-2022	Gallese, Vittorio/0000-0003-4815-3607; FRASSINETTI, FRANCESCA/0000-0001-6810-2861; Frassinetti, Francesca/0000-0001-6810-2861; Ferri, Francesca/0000-0003-1821-5870; Costantini, Marcello/0000-0002-0504-1296	Ministry of University and Research; Vittorio Gallese; EU	Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Vittorio Gallese; EU(European Commission)	This work was supported by grants from the Ministry of University and Research to Francesca Frassinetti and Vittorio Gallese, and from the EU grant DISCOS (http://www.schattauer-discos.de) to Vittorio Gallese. Francesca Ferri was supported by the EU grant ROSSI (http://win.rossiproject.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 1996, NEUROIMAGE, V4, P216, DOI 10.1006/nimg.1996.0073; Aranda C, 2010, ATTEN PERCEPT PSYCHO, V72, P1756, DOI 10.3758/APP.72.7.1756; BERTI A, 1992, J COGNITIVE NEUROSCI, V4, P345, DOI 10.1162/jocn.1992.4.4.345; BERTI A, 1994, CORTEX, V30, P181, DOI 10.1016/S0010-9452(13)80192-X; Bracci S, 2010, J NEUROPHYSIOL, V103, P3389, DOI 10.1152/jn.00215.2010; Buchner H, 1995, Electromyogr Clin Neurophysiol, V35, P207; Casile A, 2006, CURR BIOL, V16, P69, DOI 10.1016/j.cub.2005.10.071; Conson M, 2010, EXP BRAIN RES, V206, P449, DOI 10.1007/s00221-010-2418-9; COOPER LA, 1975, J EXP PSYCHOL HUMAN, V104, P48, DOI 10.1037/0096-1523.1.1.48; DECETY J, 1991, BEHAV BRAIN RES, V42, P1, DOI 10.1016/S0166-4328(05)80033-6; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Devue C, 2007, BRAIN RES, V1143, P169, DOI 10.1016/j.brainres.2007.01.055; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Frassinetti F, 2008, J COGNITIVE NEUROSCI, V20, P1507, DOI 10.1162/jocn.2008.20067; Frassinetti F, 2010, CORTEX, V46, P322, DOI 10.1016/j.cortex.2009.03.015; Frassinetti F, 2009, NEUROPSYCHOLOGIA, V47, P1988, DOI 10.1016/j.neuropsychologia.2009.03.012; Gallese V, 2010, NEUROPSYCHOLOGIA, V48, P746, DOI 10.1016/j.neuropsychologia.2009.09.038; Gentilucci M, 1998, COGNITIVE BRAIN RES, V6, P185, DOI 10.1016/S0926-6410(97)00034-7; Ionta S, 2007, EXP BRAIN RES, V183, P1, DOI 10.1007/s00221-007-1020-2; Jeannerod M, 2004, NAT NEUROSCI, V7, P422, DOI 10.1038/nn0504-422; Jung P, 2003, NEUROIMAGE, V19, P913, DOI 10.1016/S1053-8119(03)00164-2; Kawashima R, 1997, NEUROREPORT, V8, P1729, DOI 10.1097/00001756-199705060-00032; Linkenauger SA, 2009, PSYCHOL SCI, V20, P1373, DOI 10.1111/j.1467-9280.2009.02447.x; Loula F, 2005, J EXP PSYCHOL HUMAN, V31, P210, DOI 10.1037/0096-1523.31.1.210; Moro V, 2008, NEURON, V60, P235, DOI 10.1016/j.neuron.2008.09.022; Orlov T, 2010, NEURON, V68, P586, DOI 10.1016/j.neuron.2010.09.032; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1987, J EXP PSYCHOL GEN, V116, P172, DOI 10.1037/0096-3445.116.2.172; Parsons LM, 1998, J NEUROSCI, V18, P6539; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Peelen MV, 2005, NAT NEUROSCI, V8, P125, DOI 10.1038/nn0205-125a; Petit LS, 2003, BRAIN COGNITION, V51, P95, DOI 10.1016/S0278-2626(02)00526-2; Porro CA, 1996, J NEUROSCI, V16, P7688; Rochat P, 2003, CONSCIOUS COGN, V12, P717, DOI 10.1016/S1053-8100(03)00081-3; Rochat P, 2010, NEUROPSYCHOLOGIA, V48, P738, DOI 10.1016/j.neuropsychologia.2009.11.021; Schneider W., 2002, E PRIME VERSION 20 C; Schneider W., 2002, E PRIME USERS GUIDE; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Sugiura M, 2006, NEUROIMAGE, V32, P1905, DOI 10.1016/j.neuroimage.2006.05.026; Thayer ZC, 2001, NEUROREPORT, V12, P3433, DOI 10.1097/00001756-200111160-00011; Tsakiris M, 2007, CONSCIOUS COGN, V16, P645, DOI 10.1016/j.concog.2007.05.012; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Zilles K, 1997, HUM BRAIN MAPP, V5, P218, DOI 10.1002/(SICI)1097-0193(1997)5:4<218::AID-HBM2>3.0.CO;2-6	45	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17927	10.1371/journal.pone.0017927	http://dx.doi.org/10.1371/journal.pone.0017927			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464959	Green Published, Green Submitted, gold			2022-12-27	WOS:000288813900019
J	Gibbons, HS; Broomall, SM; McNew, LA; Daligault, H; Chapman, C; Bruce, D; Karavis, M; Krepps, M; McGregor, PA; Hong, C; Park, KH; Akmal, A; Feldman, A; Lin, JS; Chang, WLE; Higgs, BW; Demirev, P; Lindquist, J; Liem, A; Fochler, E; Read, TD; Tapia, R; Johnson, S; Bishop-Lilly, KA; Detter, C; Han, C; Sozhamannan, S; Rosenzweig, CN; Skowronski, EW				Gibbons, Henry S.; Broomall, Stacey M.; McNew, Lauren A.; Daligault, Hajnalka; Chapman, Carol; Bruce, David; Karavis, Mark; Krepps, Michael; McGregor, Paul A.; Hong, Charles; Park, Kyong H.; Akmal, Arya; Feldman, Andrew; Lin, Jeffrey S.; Chang, Wenling E.; Higgs, Brandon W.; Demirev, Plamen; Lindquist, John; Liem, Alvin; Fochler, Ed; Read, Timothy D.; Tapia, Roxanne; Johnson, Shannon; Bishop-Lilly, Kimberly A.; Detter, Chris; Han, Cliff; Sozhamannan, Shanmuga; Rosenzweig, C. Nicole; Skowronski, Evan W.			Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant	PLOS ONE			English	Article							EXPERIMENTAL POPULATIONS; BACTERIAL-POPULATIONS; SURFACTIN PRODUCTION; RESPONSE REGULATOR; NITRIC-OXIDE; SUBTILIS; SPORULATION; GENE; ANTHRACIS; SEQUENCE	Background: Despite the decades-long use of Bacillus atrophaeus var. globigii (BG) as a simulant for biological warfare (BW) agents, knowledge of its genome composition is limited. Furthermore, the ability to differentiate signatures of deliberate adaptation and selection from natural variation is lacking for most bacterial agents. We characterized a lineage of BGwith a long history of use as a simulant for BW operations, focusing on classical bacteriological markers, metabolic profiling and whole-genome shotgun sequencing (WGS). Results: Archival strains and two "present day" type strains were compared to simulant strains on different laboratory media. Several of the samples produced multiple colony morphotypes that differed from that of an archival isolate. To trace the microevolutionary history of these isolates, we obtained WGS data for several archival and present-day strains and morphotypes. Bacillus-wide phylogenetic analysis identified B. subtilis as the nearest neighbor to B. atrophaeus. The genome of B. atrophaeus is, on average, 86% identical to B. subtilis on the nucleotide level. WGS of variants revealed that several strains were mixed but highly related populations and uncovered a progressive accumulation of mutations among the "military" isolates. Metabolic profiling and microscopic examination of bacterial cultures revealed enhanced growth of "military" isolates on lactate-containing media, and showed that the "military" strains exhibited a hypersporulating phenotype. Conclusions: Our analysis revealed the genomic and phenotypic signatures of strain adaptation and deliberate selection for traits that were desirable in a simulant organism. Together, these results demonstrate the power of whole-genome and modern systems-level approaches to characterize microbial lineages to develop and validate forensic markers for strain discrimination and reveal signatures of deliberate adaptation.	[Gibbons, Henry S.; Broomall, Stacey M.; McNew, Lauren A.; Karavis, Mark; Krepps, Michael; McGregor, Paul A.; Hong, Charles; Park, Kyong H.; Liem, Alvin; Fochler, Ed; Rosenzweig, C. Nicole; Skowronski, Evan W.] Edgewood Chem Biol Ctr, BioSci Div, Aberdeen Proving Ground, MD USA; [McNew, Lauren A.] Battelle Mem Inst, Aberdeen Proving Ground, MD USA; [McGregor, Paul A.] Sci Applicat Int Corp, Aberdeen Proving Ground, MD USA; [Feldman, Andrew; Lin, Jeffrey S.; Demirev, Plamen] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Lindquist, John] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Liem, Alvin; Fochler, Ed] OptiMetrics Inc, Abingdon, Oxon, England; [Chapman, Carol; Akmal, Arya; Read, Timothy D.; Bishop-Lilly, Kimberly A.; Sozhamannan, Shanmuga] USN, Med Res Ctr, Biol Def Res Directorate, Silver Spring, MD USA; [Hong, Charles] Def Threat Reduct Agcy, Ft Belvoir, VA USA; [Chang, Wenling E.; Higgs, Brandon W.] Mitre Corp, Mclean, VA USA; [Daligault, Hajnalka; Bruce, David; Tapia, Roxanne; Johnson, Shannon; Detter, Chris; Han, Cliff] Los Alamos Natl Lab, Dept Energy, Joint Genome Inst, Los Alamos, NM USA; [Krepps, Michael] Excet Inc, Aberdeen Proving Ground, MD USA	United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); Science Applications International Corporation (SAIC); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Wisconsin System; University of Wisconsin Madison; United States Department of Defense; United States Navy; United States Department of Defense; Defense Threat Reduction Agency; MITRE Corporation; United States Department of Energy (DOE); Los Alamos National Laboratory	Gibbons, HS (corresponding author), Edgewood Chem Biol Ctr, BioSci Div, Aberdeen Proving Ground, MD USA.	henry.gibbons@us.army.mil	Sozhamannan, Shanmuga/AGF-2410-2022; Johnson, Shannon Lyn/H-2799-2019; Read, Timothy/E-6240-2011; Sozhamannan, Shanmuga/AAN-7809-2020	Johnson, Shannon Lyn/0000-0002-3972-9208; Sozhamannan, Shanmuga/0000-0002-6762-7874; Higgs, Brandon/0000-0002-2951-0245; Bishop-Lilly, Kimberly/0000-0002-5744-8493; Read, Timothy/0000-0001-8966-9680; Gibbons, Henry/0000-0002-5603-8679	Department of Homeland [NBCHC070040]	Department of Homeland(United States Department of Homeland Security (DHS))	This work was made possible by the Defense Threat Reduction Agency Transformational Medical Technologies Initiative CB2847 to HSG and ES; by TMTI0068_07_NM_T (to KBL and SS), and by Department of Homeland Security award number NBCHC070040 to AF, PD, and JL. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The opinions therein are those of the authors and are not necessarily those of the U. S. Government or any of its agencies. Information in this report is unclassified and cleared for public release.	Asai K, 2007, BIOSCI BIOTECH BIOCH, V71, P397, DOI 10.1271/bbb.60445; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bagyan I, 1998, J BACTERIOL, V180, P2057, DOI 10.1128/JB.180.8.2057-2062.1998; BAI U, 1990, J BACTERIOL, V172, P5432, DOI 10.1128/jb.172.9.5432-5439.1990; BARRICK JE, 2009, COLD SPRING HARB S Q; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Brunstetter BC, 1932, J BACTERIOL, V24, P85, DOI 10.1128/JB.24.2.85-122.1932; Bryan EM, 1996, J BACTERIOL, V178, P4778, DOI 10.1128/jb.178.16.4778-4786.1996; Burke SA, 2004, APPL ENVIRON MICROB, V70, P2786, DOI 10.1128/AEM.70.5.2786-2790.2004; Buttner MP, 2004, APPL ENVIRON MICROB, V70, P7040, DOI 10.1128/AEM.70.12.7040-7045.2004; Carrera M, 2007, J APPL MICROBIOL, V102, P303, DOI 10.1111/j.1365-2672.2006.03111.x; Casadevall A, 2010, BIOSECUR BIOTERROR, V8, P151, DOI 10.1089/bsp.2010.0012; CasillasMartinez L, 1997, J BACTERIOL, V179, P7420, DOI 10.1128/jb.179.23.7420-7425.1997; Chemerilova VI, 2007, MICROBIOLOGY+, V76, P446, DOI 10.1134/S0026261707040108; Cooper TF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-11; Cummings CA, 2009, FORENS SCI INT-GEN S, V2, P300, DOI 10.1016/j.fsigss.2009.08.097; Daegelen P, 2009, J MOL BIOL, V394, P634, DOI 10.1016/j.jmb.2009.09.022; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ferenci T, 2008, HEREDITY, V100, P446, DOI 10.1038/sj.hdy.6801077; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; Fritze D, 2001, INT J SYST EVOL MICR, V51, P35, DOI 10.1099/00207713-51-1-35; Gerike U, 1998, MICROBIOL-UK, V144, P929, DOI 10.1099/00221287-144-4-929; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Greenberg David L, 2010, Investig Genet, V1, P4, DOI 10.1186/2041-2223-1-4; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; HARRISWARRICK RM, 1978, J BACTERIOL, V133, P1237, DOI 10.1128/JB.133.3.1237-1245.1978; HAYWARD AE, 1946, J BACTERIOL, V52, P51, DOI 10.1128/JB.52.1.51-54.1946; Holt KE, 2009, BIOINFORMATICS, V25, P2074, DOI 10.1093/bioinformatics/btp344; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; IOERGER TR, 2010, J BACTERIOL; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Kinsinger RF, 2003, J BACTERIOL, V185, P5627, DOI 10.1128/JB.185.18.5627-5631.2003; KLOCKGETHER J, 2009, J BACTERIOL; Kojetin DJ, 2005, BIOMETALS, V18, P449, DOI 10.1007/s10534-005-4303-8; Kotewicz ML, 2007, MICROBIOL-SGM, V153, P1720, DOI 10.1099/mic.0.2006/004507-0; Kotewicz ML, 2008, MICROBIOL-SGM, V154, P3518, DOI 10.1099/mic.0.2008/019026-0; Kournikakis B, 2010, J OCCUP ENVIRON HYG, V7, P71, DOI 10.1080/15459620903389558; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Latreille P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-321; LIGGETT RW, 1948, BACTERIOL REV, V12, P297, DOI 10.1128/MMBR.12.4.297-311.1948; Liu CM, 2010, J VIROL METHODS, V163, P109, DOI 10.1016/j.jviromet.2009.09.007; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; Maharjan R, 2006, SCIENCE, V313, P514, DOI 10.1126/science.1129865; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maughan H, 2004, J BACTERIOL, V186, P2212, DOI 10.1128/JB.186.7.2212-2214.2004; Maughan H, 2007, GENETICS, V177, P937, DOI 10.1534/genetics.107.075663; Maughan H, 2006, EVOLUTION, V60, P686; McNeil LK, 2007, NUCLEIC ACIDS RES, V35, pD347, DOI 10.1093/nar/gkl947; NAKAMURA LK, 1989, INT J SYST BACTERIOL, V39, P295, DOI 10.1099/00207713-39-3-295; NAKANO MM, 1989, J BACTERIOL, V171, P5347, DOI 10.1128/jb.171.10.5347-5353.1989; NAKANO MM, 1991, J BACTERIOL, V173, P1770, DOI 10.1128/jb.173.5.1770-1778.1991; NAKANO MM, 1988, J BACTERIOL, V170, P5662, DOI 10.1128/jb.170.12.5662-5668.1988; Nakano MM, 2002, J BACTERIOL, V184, P1783, DOI 10.1128/JB.184.6.1783-1787.2002; PAGE WF, 2007, LONG TERM HLTH EFFEC, V18; PEREGO M, 1988, J BACTERIOL, V170, P2560, DOI 10.1128/jb.170.6.2560-2567.1988; PHILLIPS CR, 1949, AM J HYG, V50, P280, DOI 10.1093/oxfordjournals.aje.a119360; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; PREDICH M, 1992, J BACTERIOL, V174, P2771, DOI 10.1128/JB.174.9.2771-2778.1992; REGIS E, 1999, BIOL DOOM HIST AM SE; ROTH NG, 1955, DEV PROCESSES PRODUC; Sagripanti JL, 2007, J APPL MICROBIOL, V102, P11, DOI 10.1111/j.1365-2672.2006.03235.x; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Silva J M F, 2007, PDA J Pharm Sci Technol, V61, P204; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; STEIN DC, 1984, APPL ENVIRON MICROB, V48, P280, DOI 10.1128/AEM.48.2.280-284.1984; Stratis-Cullum DN, 2003, ANAL CHEM, V75, P275, DOI 10.1021/ac026068+; TAKAHASHI I, 1965, J BACTERIOL, V89, P294, DOI 10.1128/JB.89.2.294-298.1965; Team RDC, 2009, R LANG ENV STAT COMP; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Turnbough CL, 2003, J MICROBIOL METH, V53, P263, DOI 10.1016/S0167-7012(03)00030-7; Tzeng YL, 1997, J MOL BIOL, V272, P200, DOI 10.1006/jmbi.1997.1226; *US PHARM, 2000, BIOL IND ETH OX STER, P231; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06; Worsham PL, 1999, CAN J MICROBIOL, V45, P1, DOI 10.1139/cjm-45-1-1; Yang ACC, 2005, J COMPUT BIOL, V12, P1103, DOI 10.1089/cmb.2005.12.1103; YOUNG FE, 1964, J BIOL CHEM, V239, P3600; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	81	32	33	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17836	10.1371/journal.pone.0017836	http://dx.doi.org/10.1371/journal.pone.0017836			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464989	Green Published, Green Submitted, gold			2022-12-27	WOS:000288813900013
J	Guo, FK; Zhang, SM; Tripathi, P; Mattner, J; Phelan, J; Sproles, A; Mo, J; Wills-Karp, M; Grimes, HL; Hildeman, D; Zheng, Y				Guo, Fukun; Zhang, Shuangmin; Tripathi, Pulak; Mattner, Jochen; Phelan, James; Sproles, Alyssa; Mo, Jun; Wills-Karp, Marsha; Grimes, H. Leighton; Hildeman, David; Zheng, Yi			Distinct Roles of Cdc42 in Thymopoiesis and Effector and Memory T Cell Differentiation	PLOS ONE			English	Article							IMMUNOLOGICAL SYNAPSE; GTPASE CDC42; RECEPTOR MICROCLUSTERS; SIGNAL-TRANSDUCTION; DIRECTED MIGRATION; RHO-GTPASES; ACTIVATION; POLARIZATION; BALANCE; NAIVE	Cdc42 of the Rho GTPase family has been implicated in cell actin organization, proliferation, survival, and migration but its physiological role is likely cell-type specific. By a T cell-specific deletion of Cdc42 in mouse, we have recently shown that Cdc42 maintains naive T cell homeostasis through promoting cell survival and suppressing T cell activation. Here we have further investigated the involvement of Cdc42 in multiple stages of T cell differentiation. We found that in Cdc42(-/-) thymus, positive selection of CD4(+)CD8(+) double-positive thymocytes was defective, CD4(+) and CD8(+) single-positive thymocytes were impaired in migration and showed an increase in cell apoptosis triggered by anti-CD3/-CD28 antibodies, and thymocytes were hyporesponsive to anti-CD3/-CD28-induced cell proliferation and hyperresponsive to anti-CD3/-CD28-stimulated MAP kinase activation. At the periphery, Cdc42-deficient naive T cells displayed an impaired actin polymerization and TCR clustering during the formation of mature immunological synapse, and showed an enhanced differentiation to Th1 and CD8(+) effector and memory cells in vitro and in vivo. Finally, Cdc42(-/-) mice exhibited exacerbated liver damage in an induced autoimmune disease model. Collectively, these data establish that Cdc42 is critically involved in thymopoiesis and plays a restrictive role in effector and memory T cell differentiation and autoimmunity.	[Guo, Fukun; Zhang, Shuangmin; Zheng, Yi] Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Tripathi, Pulak; Mattner, Jochen; Phelan, James; Sproles, Alyssa; Wills-Karp, Marsha; Grimes, H. Leighton; Hildeman, David] Childrens Hosp Res Fdn, Div Immunobiol, Cincinnati, OH 45229 USA; [Mattner, Jochen] Univ Klinikum Erlangen, Microbiol Inst Clin Microbiol Immunol & Hyg, Erlangen, Germany; [Mattner, Jochen] Univ Erlangen Nurnberg, Erlangen, Germany; [Mo, Jun] Childrens Hosp, Div Pathol, Res Fdn, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Guo, FK (corresponding author), Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.	fukun.guo@cchmc.org	Hildeman, David/AAA-1757-2020; Hildeman, David/I-4884-2015; Zheng, Yi/J-7235-2015; Mattner, Jochen/AAT-7866-2021	Hildeman, David/0000-0002-0421-8483; Hildeman, David/0000-0002-0421-8483; Zheng, Yi/0000-0001-7089-6074; Tripp, Ralph/0000-0002-2924-9956; Grimes, H. Leighton/0000-0001-8162-6758	National Institutes of Health [R01 HL085362]; Cincinnati Children's Hospital; NATIONAL CANCER INSTITUTE [T32CA117846] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cincinnati Children's Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant R01 HL085362 (to Yi Zheng)(www.nih.gov) and Cincinnati Children's Hospital Trustee Grant (to Fukun Guo)(www.cchmc.org). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Becart S, 2007, J CLIN INVEST, V117, P2164, DOI 10.1172/JCI31640; Bowen H, 2008, CLIN EXP ALLERGY, V38, P1422, DOI 10.1111/j.1365-2222.2008.03067.x; Cannon JL, 2002, IMMUNOL REV, V186, P90, DOI 10.1034/j.1600-065X.2002.18609.x; Czuchra A, 2005, MOL BIOL CELL, V16, P4473, DOI 10.1091/mbc.E05-01-0061; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Dorn T, 2007, BLOOD, V109, P2346, DOI 10.1182/BLOOD-2006-04-019034; Dumont C, 2009, BLOOD, V113, P3990, DOI 10.1182/blood-2008-09-181180; Gu Y, 2006, NAT IMMUNOL, V7, P1182, DOI 10.1038/ni1396; Guo F, 2008, BLOOD, V112, P1767, DOI 10.1182/blood-2008-01-132068; Guo FK, 2010, P NATL ACAD SCI USA, V107, P18505, DOI 10.1073/pnas.1010249107; Guo FK, 2009, BLOOD, V114, P2909, DOI 10.1182/blood-2009-04-214676; Haddad E, 2001, BLOOD, V97, P33, DOI 10.1182/blood.V97.1.33; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kaiko GE, 2008, IMMUNOLOGY, V123, P326, DOI 10.1111/j.1365-2567.2007.02719.x; Kato Y, 2003, CELL IMMUNOL, V224, P29, DOI 10.1016/j.cellimm.2003.07.001; Koh CG, 2006, NEUROSIGNALS, V15, P228, DOI 10.1159/000101527; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Leitenberg D, 1999, SEMIN IMMUNOL, V11, P283, DOI 10.1006/smim.1999.0184; Mattner J, 2008, CELL HOST MICROBE, V3, P304, DOI 10.1016/j.chom.2008.03.009; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; Mohammed JP, 2009, EXPERT REV CLIN IMMU, V5, P369, DOI 10.1586/ECI.09.23; Morales-Tirado V, 2010, BLOOD, V115, P3498, DOI 10.1182/blood-2009-07-235754; Na SQ, 1999, ONCOGENE, V18, P7966, DOI 10.1038/sj.onc.1203122; Nakayama T, 2010, SEMIN IMMUNOL, V22, P303, DOI 10.1016/j.smim.2010.04.010; Nembrini C, 2006, J IMMUNOL, V176, P7180, DOI 10.4049/jimmunol.176.12.7180; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; Rosloniec EF, 2002, ARTHRITIS RES, V4, P333, DOI 10.1186/ar432; Rutishauser RL, 2010, IMMUNOL REV, V235, P219, DOI 10.1111/j.0105-2896.2010.00901.x; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Herruzo JAS, 2009, REV ESP ENFERM DIG, V101, P413; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Szczur K, 2006, BLOOD, V108, P4205, DOI 10.1182/blood-2006-03-013789; Tskvitaria-Fuller I, 2006, J IMMUNOL, V177, P1708, DOI 10.4049/jimmunol.177.3.1708; van Leeuwen EMM, 2009, CURR OPIN IMMUNOL, V21, P167, DOI 10.1016/j.coi.2009.02.005; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang L, 2007, TRENDS CELL BIOL, V17, P58, DOI 10.1016/j.tcb.2006.11.009; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Wojciechowski S, 2007, J EXP MED, V204, P1665, DOI 10.1084/jem.20070618; Yang L, 2007, BLOOD, V110, P3853, DOI 10.1182/blood-2007-03-079582; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	48	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18002	10.1371/journal.pone.0018002	http://dx.doi.org/10.1371/journal.pone.0018002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455314	gold, Green Published, Green Submitted			2022-12-27	WOS:000288811500018
J	Grabrucker, AM; Garner, CC; Boeckers, TM; Bondioli, L; Ruozi, B; Forni, F; Vandelli, MA; Tosi, G				Grabrucker, Andreas M.; Garner, Craig C.; Boeckers, Tobias M.; Bondioli, Lucia; Ruozi, Barbara; Forni, Flavio; Vandelli, Maria Angela; Tosi, Giovanni			Development of Novel Zn2+ Loaded Nanoparticles Designed for Cell-Type Targeted Drug Release in CNS Neurons: In Vitro Evidences	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FORCED SWIMMING TEST; BLOOD-BRAIN-BARRIER; POSTSYNAPTIC DENSITY; ZINC; ANTIDEPRESSANT; DEPRESSION; MICE; ACTIVATION; VIVO	Intact synaptic function and plasticity are fundamental prerequisites to a healthy brain. Therefore, synaptic proteins are one of the major targets for drugs used as neuro-chemical therapeutics. Unfortunately, the majority of drugs is not able to cross the blood-brain barrier (BBB) and is therefore distributed within the CNS parenchyma. Here, we report the development of novel biodegradable Nanoparticles (NPs), made of poly-lactide-co-glycolide (PLGA) conjugated with glycopeptides that are able to cross the BBB and deliver for example Zn2+ ions. We also provide a thorough characterization of loaded and unloaded NPs for their stability, cellular uptake, release properties, toxicity, and impact on cell trafficking. Our data reveal that these NPs are biocompatible, and can be used to elevate intracellular levels of Zn2+. Importantly, by engineering the surface of NPs with antibodies against NCAM1 and CD44, we were able to selectively target neurons or glial cells, respectively. Our results indicate that these biodegradable NPs provide a potential new venue for the delivery Zn2+ to the CNS and thus a means to explore the influence of altered zinc levels linked to neuropsychological disorders such as depression.	[Grabrucker, Andreas M.; Garner, Craig C.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford Sch Med, Stanford, CA 94305 USA; [Grabrucker, Andreas M.; Boeckers, Tobias M.] Univ Ulm, Inst Anat & Cell Biol, Ulm, Germany; [Bondioli, Lucia; Ruozi, Barbara; Forni, Flavio; Vandelli, Maria Angela; Tosi, Giovanni] Univ Modena & Reggio Emilia, Dept Pharmaceut Sci, TeFarTI Grp, Modena, Italy; [Bondioli, Lucia; Ruozi, Barbara; Forni, Flavio; Vandelli, Maria Angela; Tosi, Giovanni] Univ Modena & Reggio Emilia, Dept Pharmaceut Sci, TeFarTI Grp, Reggio Emilia, Italy	Stanford University; Ulm University; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Grabrucker, AM (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford Sch Med, Stanford, CA 94305 USA.	andreas.grabrucker@stanford.edu; giovanni.tosi@unimore.it	Forni, Flavio/D-5492-2015; Ruozi, Barbara/D-5500-2015; Vandelli, Maria Angela/D-5497-2015; Tosi, Giovanni/D-4547-2011	Forni, Flavio/0000-0001-5974-6286; Ruozi, Barbara/0000-0002-2400-9910; Vandelli, Maria Angela/0000-0003-1462-8133; Tosi, Giovanni/0000-0001-8318-667X; Garner, Craig/0000-0003-1970-5417; Grabrucker, Andreas/0000-0003-0005-4810	Deutsche Forschungsgemeinschaft (DFG); National Institutes of Health [PO1 NS053862, R21MH091471]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH091471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS053862] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	AMG has been supported by a fellowship from the Deutsche Forschungsgemeinschaft (DFG) and the National Institutes of Health (PO1 NS053862; R21MH091471) to CCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amani R, 2010, BIOL TRACE ELEM RES, V137, P150, DOI 10.1007/s12011-009-8572-x; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Blanco MD, 1997, EUR J PHARM BIOPHARM, V43, P287, DOI 10.1016/S0939-6411(97)00056-8; BURKE M, 1999, CENTRAL NERVOUS SYST, P184; Canzoniero LMT, 1999, J NEUROSCI, V19; Cope EC, 2010, CURR OPIN CLIN NUTR, V13, P685, DOI 10.1097/MCO.0b013e32833df61a; Costantino L, 2005, J CONTROL RELEASE, V108, P84, DOI 10.1016/j.jconrel.2005.07.013; Cunha MP, 2008, PROG NEURO-PSYCHOPH, V32, P1913, DOI 10.1016/j.pnpbp.2008.09.006; Depino AM, 2003, EUR J NEUROSCI, V18, P2731, DOI 10.1111/j.1460-9568.2003.03014.x; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Garcia-Garcia E, 2005, INT J PHARMACEUT, V298, P274, DOI 10.1016/j.ijpharm.2005.03.031; Goslin K., 1991, CULTURING NERVE CELL, P251; GRABRUCKER AM, 2011, EMBO J; Gundelfinger ED, 2006, TRENDS BIOCHEM SCI, V31, P366, DOI 10.1016/j.tibs.2006.05.007; Hansen GH, 2009, AM J PHYSIOL-GASTR L, V297, pG708, DOI 10.1152/ajpgi.00192.2009; Huttner W B, 1991, Curr Opin Neurobiol, V1, P388, DOI 10.1016/0959-4388(91)90058-F; Kreuter J, 2007, INT J PHARMACEUT, V331, P1, DOI 10.1016/j.ijpharm.2006.10.021; Kroczka B, 2001, BRAIN RES BULL, V55, P297, DOI 10.1016/S0361-9230(01)00473-7; Kroczka B, 2000, POL J PHARMACOL, V52, P403; Levenson CW, 2006, NUTR REV, V64, P39, DOI 10.1301/nr.2006.jan.39-42; Liu YT, 2010, BIOMATERIALS, V31, P9145, DOI 10.1016/j.biomaterials.2010.08.053; Lom B, 1999, J NEUROSCI, V19, P9928; MAES M, 1994, J AFFECT DISORDERS, V31, P135, DOI 10.1016/0165-0327(94)90117-1; Manser W W, 1989, J Pak Med Assoc, V39, P269; Marchetti B, 2005, ANN NY ACAD SCI, V1057, P296, DOI 10.1196/annals.1356.023; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; MCLOUGHLIN IJ, 1990, ACTA PSYCHIAT SCAND, V82, P451, DOI 10.1111/j.1600-0447.1990.tb03077.x; Nowak G, 2005, PHARMACOL REP, V57, P713; Nowak G, 2003, BRAIN RES BULL, V61, P159, DOI 10.1016/S0361-9230(03)00104-7; Nowak G, 2002, POL J PHARMACOL, V54, P587; Pardridge William M, 2003, Mol Interv, V3, P90, DOI 10.1124/mi.3.2.90; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Rosa AO, 2003, BEHAV BRAIN RES, V144, P87, DOI 10.1016/S0166-4328(03)00069-X; Sawada T, 2010, EUR J CLIN NUTR, V64, P331, DOI 10.1038/ejcn.2009.158; SCHUBERT P, 2005, ALZHEIMERS DIS, P209; Seidenbecher CI, 1998, J BIOL CHEM, V273, P21324, DOI 10.1074/jbc.273.33.21324; Shi NY, 2000, P NATL ACAD SCI USA, V97, P7567, DOI 10.1073/pnas.130187497; Szewczyk B, 2002, POL J PHARMACOL, V54, P681; Tassabehji NM, 2008, PHYSIOL BEHAV, V95, P365, DOI 10.1016/j.physbeh.2008.06.017; Tosi G, 2007, J CONTROL RELEASE, V122, P1, DOI 10.1016/j.jconrel.2007.05.022; Tosi G, 2010, J CONTROL RELEASE, V145, P49, DOI 10.1016/j.jconrel.2010.03.008; TOSI G, 2010, INVESTIGATI IN PRESS; Tosi G, 2008, EXPERT OPIN DRUG DEL, V5, P155, DOI 10.1517/17425247.5.2.155; Vergoni AV, 2009, NANOMED-NANOTECHNOL, V5, P369, DOI 10.1016/j.nano.2009.02.005; WEISS JH, 1993, NEURON, V10, P43, DOI 10.1016/0896-6273(93)90240-R; Whittle N, 2009, AMINO ACIDS, V36, P147, DOI 10.1007/s00726-008-0195-6; Wojcik J, 2006, PHARMACOL REP, V58, P571; YOKOYAMA M, 1986, NEUROSCI LETT, V71, P351, DOI 10.1016/0304-3940(86)90646-4	48	38	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17851	10.1371/journal.pone.0017851	http://dx.doi.org/10.1371/journal.pone.0017851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448455	gold, Green Submitted, Green Published			2022-12-27	WOS:000288810500017
J	Kim, EJ; Ables, JL; Dickel, LK; Eisch, AJ; Johnson, JE				Kim, Euiseok J.; Ables, Jessica L.; Dickel, Lauren K.; Eisch, Amelia J.; Johnson, Jane E.			Ascl1 (Mash1) Defines Cells with Long-Term Neurogenic Potential in Subgranular and Subventricular Zones in Adult Mouse Brain	PLOS ONE			English	Article							NEURAL STEM-CELLS; IN-VIVO ANALYSIS; DENTATE GYRUS; MAINTENANCE; INHIBITION; QUIESCENT; NEURONS; LINEAGE; MICE	Ascl1 (Mash1) is a bHLH transcription factor essential for neural differentiation during embryogenesis but its role in adult neurogenesis is less clear. Here we show that in the adult brain Ascl1 is dynamically expressed during neurogenesis in the dentate gyrus subgranular zone (SGZ) and more rostral subventricular zone (SVZ). Specifically, we find Ascl1 levels low in SGZ Type-1 cells and SVZ B cells but increasing as the cells transition to intermediate progenitor stages. In vivo genetic lineage tracing with a tamoxifen (TAM) inducible Ascl1(CreERT2) knock-in mouse strain shows that Ascl1 lineage cells continuously generate new neurons over extended periods of time. There is a regionally-specific difference in neuron generation, with mice given TAM at postnatal day 50 showing new dentate gyrus neurons through 30 days post-TAM, but showing new olfactory bulb neurons even 180 days post-TAM. These results show that Ascl1 is not restricted to transit amplifying populations but is also found in a subset of neural stem cells with long-term neurogenic potential in the adult brain.	[Kim, Euiseok J.; Dickel, Lauren K.; Johnson, Jane E.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Ables, Jessica L.; Eisch, Amelia J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kim, EJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	Jane.Johnson@utsouthwestern.edu		/0000-0002-8605-2746; Eisch, Amelia/0000-0001-6476-5385; Ables, Jessica L./0000-0003-1818-3506	National Institutes of Health [R01 NS32817, R21 DA023701, K02 DA023555, T32 MH076690]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH076690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA023555, R21DA023701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by National Institutes of Health (http://www.nih.gov/) R01 NS32817 to JEJ, R21 DA023701 and K02 DA023555 to AJE, and T32 MH076690 to JLA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Gage FH, 2008, ADULT NEUROGENESIS; Garcia-Bellido A, 2009, GENETICS, V182, P631, DOI 10.1534/genetics.109.104083; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kim EJ, 2007, J NEUROSCI, V27, P12764, DOI 10.1523/JNEUROSCI.3178-07.2007; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rousseau A, 2006, J NEUROPATH EXP NEUR, V65, P1149, DOI 10.1097/01.jnen.0000248543.90304.2b; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Somasundaram K, 2005, ONCOGENE, V24, P7073, DOI 10.1038/sj.onc.1208865; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037	26	188	191	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18472	10.1371/journal.pone.0018472	http://dx.doi.org/10.1371/journal.pone.0018472			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483754	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200084
J	Balaban, PM; Malyshev, AY; Ierusalimsky, VN; Aseyev, N; Korshunova, TA; Bravarenko, NI; Lemak, MS; Roshchin, M; Zakharov, IS; Popova, Y; Boyle, R				Balaban, Pavel M.; Malyshev, Aleksey Y.; Ierusalimsky, Victor N.; Aseyev, Nikolay; Korshunova, Tania A.; Bravarenko, Natasha I.; Lemak, M. S.; Roshchin, Matvey; Zakharov, Igor S.; Popova, Yekaterina; Boyle, Richard			Functional Changes in the Snail Statocyst System Elicited by Microgravity	PLOS ONE			English	Article							STATIC VESTIBULOOCULAR REFLEX; HAIR-CELL; EXPRESSION; NEURONS; EXCITABILITY; FMRFAMIDE; TADPOLES; ENHANCEMENT; EXPERIENCE; DURATION	Background: The mollusk statocyst is a mechanosensing organ detecting the animal's orientation with respect to gravity. This system has clear similarities to its vertebrate counterparts: a weight-lending mass, an epithelial layer containing small supporting cells and the large sensory hair cells, and an output eliciting compensatory body reflexes to perturbations. Methodology/Principal Findings: In terrestrial gastropod snail we studied the impact of 16-(Foton M-2) and 12-day (Foton M-3) exposure to microgravity in unmanned orbital missions on: (i) the whole animal behavior (Helix lucorum L.), (ii) the statoreceptor responses to tilt in an isolated neural preparation (Helix lucorum L.), and (iii) the differential expression of the Helix pedal peptide (HPep) and the tetrapeptide FMRFamide genes in neural structures (Helix aspersa L.). Experiments were performed 13-42 hours after return to Earth. Latency of body re-orientation to sudden 90 degrees head-down pitch was significantly reduced in postflight snails indicating an enhanced negative gravitaxis response. Statoreceptor responses to tilt in postflight snails were independent of motion direction, in contrast to a directional preference observed in control animals. Positive relation between tilt velocity and firing rate was observed in both control and postflight snails, but the response magnitude was significantly larger in postflight snails indicating an enhanced sensitivity to acceleration. A significant increase in mRNA expression of the gene encoding HPep, a peptide linked to ciliary beating, in statoreceptors was observed in postflight snails; no differential expression of the gene encoding FMRFamide, a possible neurotransmission modulator, was observed. Conclusions/Significance: Upregulation of statocyst function in snails following microgravity exposure parallels that observed in vertebrates suggesting fundamental principles underlie gravi-sensing and the organism's ability to adapt to gravity changes. This simple animal model offers the possibility to describe general subcellular mechanisms of nervous system's response to conditions on Earth and in space.	[Balaban, Pavel M.; Malyshev, Aleksey Y.; Ierusalimsky, Victor N.; Aseyev, Nikolay; Korshunova, Tania A.; Bravarenko, Natasha I.; Lemak, M. S.; Roshchin, Matvey] Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia; [Zakharov, Igor S.] Russian Acad Sci, Koltzov Inst Dev Biol, Moscow, Russia; [Popova, Yekaterina; Boyle, Richard] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Institute of Higher Nervous Activity & Neurophysiology of RAS; Russian Academy of Sciences; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Balaban, PM (corresponding author), Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia.	balaban@ihna.msk.ru; richard.boyle@nasa.gov	Aseyev, Nikolay/O-1030-2017; Malyshev, Alexey/P-2775-2015; Korshunova, Tatiana/T-7821-2017; Roshchin, Matvey/AAO-3021-2020; Balaban, Pavel M/I-5811-2014; Zakharov, Igor S/K-5488-2013; Malyshev, Aleksey/R-8471-2018	Aseyev, Nikolay/0000-0002-7165-3514; Roshchin, Matvey/0000-0002-9707-7746; Balaban, Pavel M/0000-0001-9248-8207; Ierusalimsky, Victor/0000-0002-9254-6099; Malyshev, Aleksey/0000-0002-4633-7691	RF President Council; Russian Foundation for Basic Research; Russian Academy of Science; NASA [03-OBPR-04]; Fundamental Space Biology Program	RF President Council; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Science(Russian Academy of Sciences); NASA(National Aeronautics & Space Administration (NASA)); Fundamental Space Biology Program	This research was supported by grants from the RF President Council for grants to P. Balaban, Russian Foundation for Basic Research, Russian Academy of Science, NASA 03-OBPR-04 and a Fundamental Space Biology Program grant to R. Boyle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKON DL, 1989, SCI AM, V261, P42, DOI 10.1038/scientificamerican0789-42; ALKON DL, 1973, J GEN PHYSIOL, V61, P619, DOI 10.1085/jgp.61.5.619; Balaban PM, 2002, NEUROSCI BIOBEHAV R, V26, P597, DOI 10.1016/S0149-7634(02)00022-2; BALABAN PM, 2008, J GRAV PHYSL, V15, pP273; BALABAN PM, 2006, J GRAV PHYSIO, V13, pP201; BALLARINO J, 1984, AM J PHYSIOL, V246, pR305, DOI 10.1152/ajpregu.1984.246.3.R305; BELL CC, 1981, J COMP NEUROL, V195, P391, DOI 10.1002/cne.901950303; BLUMENFELD H, 1990, NEURON, V5, P487, DOI 10.1016/0896-6273(90)90088-W; Boser S, 2008, ARCH ITAL BIOL, V146, P1; Boyle R, 2001, J NEUROPHYSIOL, V86, P2118, DOI 10.1152/jn.2001.86.4.2118; Boyle R, 2009, J NEUROPHYSIOL, V102, P1513, DOI 10.1152/jn.91367.2008; Brugeaud A, 2006, NEUROREPORT, V17, P1697, DOI 10.1097/01.wnr.0000239961.98813.19; Brusca RC, 2003, INVERTEBRATES; Chabbert C, 2003, EUR J NEUROSCI, V17, P2497, DOI 10.1046/j.1460-9568.2003.02682.x; Chrachri A, 1998, J NEUROPHYSIOL, V80, P656, DOI 10.1152/jn.1998.80.2.656; Cohen B, 2005, ADV SPACE B, V10, P105, DOI 10.1016/S1569-2574(05)10005-7; COLMERS WF, 1982, NEUROSCIENCE, V7, P461, DOI 10.1016/0306-4522(82)90280-9; CROW T, 1988, TRENDS NEUROSCI, V11, P136, DOI 10.1016/0166-2236(88)90138-5; Crow T, 1997, J NEUROPHYSIOL, V78, P3460, DOI 10.1152/jn.1997.78.6.3460; DETWILER PB, 1973, J GEN PHYSIOL, V62, P618, DOI 10.1085/jgp.62.5.618; DRENCKHAHN D, 1991, J CELL BIOL, V112, P641, DOI 10.1083/jcb.112.4.641; Eatock RA, 2000, ANNU REV NEUROSCI, V23, P285, DOI 10.1146/annurev.neuro.23.1.285; EATOCK RA, 1987, J NEUROSCI, V7, P2821; ELEKES K, 1990, CELL TISSUE RES, V262, P177, DOI 10.1007/BF00327760; FARLEY J, 1990, BEHAV NEUROSCI, V104, P135, DOI 10.1037/0735-7044.104.1.135; Farley J, 1997, J NEUROPHYSIOL, V77, P1861, DOI 10.1152/jn.1997.77.4.1861; FENCHEL T, 1984, J EXP BIOL, V110, P17; FERANDEZ C, 1963, ARCHIV OTOLARYNGOL, V77, P449; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; FLOCK A, 1977, J CELL BIOL, V75, P339, DOI 10.1083/jcb.75.2.339; FLOCK A, 1973, J PHYSIOL-LONDON, V235, P591, DOI 10.1113/jphysiol.1973.sp010406; Frysztak RJ, 1997, J NEUROSCI, V17, P4426; FRYSZTAK RJ, 1993, J NEUROSCI, V13, P2889; FRYSZTAK RJ, 1994, J NEUROSCI, V14, P1245, DOI 10.1523/JNEUROSCI.14-03-01245.1994; GOLDBERG JM, 1990, J NEUROPHYSIOL, V63, P781, DOI 10.1152/jn.1990.63.4.781; Gorgiladze G I, 2002, Aviakosm Ekolog Med, V36, P41; Gorgiladze GI, 2002, B EXP BIOL MED+, V133, P114, DOI 10.1023/A:1015570032353; Horn ER, 2006, J EXP BIOL, V209, P2847, DOI 10.1242/jeb.02298; HOWLAND HC, 1981, VESTIBULAR SYSTEM FU, P77; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; LIM DJ, 1974, AEROSPACE MED, V45, P705; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; LLOYD PE, 1989, J NEUROSCI, V9, P312; Lychakov D V, 1991, Physiologist, V34, pS204; LYCHAKOV DV, 1985, KOSM BIOL AVIAK MED+, V19, P48; Moorman SJ, 2002, DEV DYNAM, V223, P285, DOI 10.1002/dvdy.10052; O'Brien EK, 2003, EVOL DEV, V5, P572, DOI 10.1046/j.1525-142X.2003.03062.x; Ohsuga K, 2000, CELL TISSUE RES, V300, P165, DOI 10.1007/s004410000186; Poteryaev DA, 1997, NEUROREPORT, V8, P3631, DOI 10.1097/00001756-199711100-00041; Reason JT., 1975, MOTION SICKNESS; Ross M D, 1993, J Vestib Res, V3, P241; Ross MD, 2000, ACTA OTO-LARYNGOL, V120, P490, DOI 10.1080/000164800750045983; Sahley CL, 1998, LEARN MEMORY, P197; Sakakibara M, 2005, J NEUROPHYSIOL, V94, P3884, DOI 10.1152/jn.01163.2004; Sebastian C, 2001, J NEUROBIOL, V46, P59, DOI 10.1002/1097-4695(200101)46:1<59::AID-NEU6>3.0.CO;2-X; Sebastian C, 1998, NEUROSCI LETT, V253, P171, DOI 10.1016/S0304-3940(98)00633-8; Sebastian C, 1996, EXP BRAIN RES, V112, P213; SHEPHERD GMG, 1990, P NATL ACAD SCI USA, V87, P8627, DOI 10.1073/pnas.87.21.8627; Smith CA, 1967, 3 S ROL VEST ORG SPA, P183; SMITH CUM, 2000, BIOL SENSORY SYSTEMS; Sondag HNPM, 1996, BRAIN RES BULL, V40, P353, DOI 10.1016/0361-9230(96)00127-X; SONDAG HNPM, 1995, ACTA OTO-LARYNGOL, V115, P227, DOI 10.3109/00016489509139297; SPOENDLIN H, 1969, ACTA OTO-LARYNGOL, V67, P239, DOI 10.3109/00016486909125448; Stensio E. A., 1927, SKR SVALBARD ISHAVET, V12, P1; Suzuki M, 1993, J Vestib Res, V3, P253; Tsubata N, 2003, NEUROSCI LETT, V337, P46, DOI 10.1016/S0304-3940(02)01289-2; VINNIKOV YA, 1983, ZH OBSHCH BIOL, V44, P147; VINNIKOV YA, 1976, ARKHIV ANATOMII GIST, V1, P11; WELTMAN JK, 1973, P NATL ACAD SCI USA, V70, P3230, DOI 10.1073/pnas.70.11.3230; Wiederhold M L, 2000, J Gravit Physiol, V7, pP39; Wiederhold M L, 1997, J Gravit Physiol, V4, pP51; Willows AOD, 1997, J EXP BIOL, V200, P1433; WOLFF HG, 1969, Z ZELLFORSCH MIK ANA, V100, P251, DOI 10.1007/BF00343882; WOLFF HG, 1970, Z VERGL PHYSIOL, V70, P401, DOI 10.1007/BF00298194; Zaitseva O V, 1994, Neurosci Behav Physiol, V24, P47, DOI 10.1007/BF02355652	75	12	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17710	10.1371/journal.pone.0017710	http://dx.doi.org/10.1371/journal.pone.0017710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479267	gold, Green Published, Green Submitted			2022-12-27	WOS:000289054600015
J	Balfry, S; Welch, DW; Atkinson, J; Lill, A; Vincent, S				Balfry, Shannon; Welch, David W.; Atkinson, Jody; Lill, Al; Vincent, Stephen			The Effect of Hatchery Release Strategy on Marine Migratory Behaviour and Apparent Survival of Seymour River Steelhead Smolts (Oncorhynchus mykiss)	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; JUVENILE CHINOOK SALMON; RENIBACTERIUM-SALMONINARUM; DETECTION PROBABILITIES; STRESS RESPONSES; BRITISH-COLUMBIA; RAINBOW-TROUT; FISH; MORTALITY; CORTISOL	Early marine migratory behaviour and apparent survival of hatchery-reared Seymour River steelhead (Oncorhynchus mykiss) smolts was examined over a four year period (2006-2009) to assess the impact of various management strategies on improving early marine survival. Acoustically tagged smolts were released to measure their survival using estuary and coastal marine receivers forming components of the Pacific Ocean Shelf Tracking (POST) array. Early marine survival was statistically indistinguishable between releases of summer run and winter run steelhead races, night and day releases, and groups released 10 days apart. In 2009, the survival of summer run steelhead released into the river was again trialed against groups released directly into the ocean at a distance from the river mouth. Apparent survival was improved significantly for the ocean released groups. The health and physiological status of the various release groups were monitored in years 20072009, and results indicate that the fish were in good health, with no clinical signs of disease at the time of release. The possibility of a disease event contributing to early marine mortality was further examined in 2009 by vaccinating half of the released fish against common fish diseases (vibriosis, furunculosis). The results suggest that marine survival may be enhanced using this approach, although not to the extent observed when the smolts were transported away from the river mouth before release. In summary, direct experimental testing of different release strategies using the POST array to measure ocean survival accelerated the scientific process by allowing rapid collection of data which enabled the rejection of several existing theories and allowed tentative identification of several new alternative approaches that might improve early marine survival of Seymour River steelhead.	[Balfry, Shannon] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC V5Z 1M9, Canada; [Welch, David W.] Kintama Res Serv Ltd, Nanaimo, BC, Canada; [Atkinson, Jody] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Lill, Al] Living Rivers Georgia Basin Vancouver Isl, N Vancouver, BC, Canada; [Vincent, Stephen] Seymour Salmonid Soc, N Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Balfry, S (corresponding author), DFO UBC Ctr Aquaculture & Environm Res, W Vancouver, BC, Canada.	balfry@mail.ubc.ca			Pacific Salmon Foundation (PSF); Pacific Ocean Shelf Tracking (POST)(Census of Marine Life)	Pacific Salmon Foundation (PSF); Pacific Ocean Shelf Tracking (POST)(Census of Marine Life)	Pacific Salmon Foundation (PSF) (www.psf.ca); Pacific Ocean Shelf Tracking (POST)(Census of Marine Life)(www.vanaqua.org/post). The POST and PSF funding was used to purchase materials and supplies for this research. Neither the POST nor PSF had any role in the design of the study, data collection and analyses, decision to publish, or preparation of the manuscript. Additional in-kind support: Seymour Salmonid Society (www.seymoursalmon.com) provided staff time, equipment, and supplies in-kind for this project; Freshwater Fisheries Society of BC (www.gofishbc.ca) provided staff time, use of transport truck (all in-kind contributions) for this project. The FFSBC had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Kintama Research Corporation (www.kintamaresearch.org) provided salary in-kind contributions for tagging staff and salary for author D. Welch to participate in this project; BC Living Rivers Trust Fund (www.livingrivers.ca) provided funding for this project and in-kind support for the salary of co-author A. Lill to participate in this project. The PSF and POST had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DP, 1992, VET IMMUNOL IMMUNOP, V30, P419, DOI 10.1016/0165-2427(92)90110-C; Arkoosh MR, 2001, J AQUAT ANIM HEALTH, V13, P257, DOI 10.1577/1548-8667(2001)013&lt;0257:ISOJCS&gt;2.0.CO;2; BANNER CR, 1986, J FISH DIS, V9, P273, DOI 10.1111/j.1365-2761.1986.tb01013.x; BARRY TP, 1993, AQUACULTURE, V117, P351, DOI 10.1016/0044-8486(93)90331-R; BARTON BA, 1985, GEN COMP ENDOCR, V59, P468, DOI 10.1016/0016-6480(85)90406-X; CHITTENDEN CM, PLOS ONE, V5; CHITTENDEN CM, 2008, ENVIRON BIOL FISH, V84, P129; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; ENGLISH KK, 2008, UPSTREAM BATTLE DECL; *FISH HLTH SEC AM, 2003, AFS FHS SUGG PROC DE; GOEDE RW, 1990, AM FISHERIES SOC S, V8, P93; Handeland SO, 1996, CAN J FISH AQUAT SCI, V53, P2673, DOI 10.1139/f96-227; HILLE S, 1982, J FISH BIOL, V20, P535, DOI 10.1111/j.1095-8649.1982.tb03954.x; Kent ML, 1998, J AQUAT ANIM HEALTH, V10, P211, DOI 10.1577/1548-8667(1998)010&lt;0211:SOSPIO&gt;2.0.CO;2; Klontz G.W., 1994, TECHNIQUES FISH IMMU, P121; Lacroix GL, 2004, T AM FISH SOC, V133, P211, DOI 10.1577/T03-071; LUDWIG B, 1995, AM FISH S S, V15, P139; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; McCormick S.D., 1987, AM FISH SOC S, V1, P211; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; Melnychuk MC, 2009, J FISH BIOL, V75, P1773, DOI 10.1111/j.1095-8649.2009.02428.x; Melnychuk MC, 2010, CAN J FISH AQUAT SCI, V67, P641, DOI 10.1139/F09-199; Melnychuk MC, 2009, MAR FRESHWATER RES, V60, P1231, DOI 10.1071/MF08361; MELYNCHUK MC, 2009, 2 CAN NAT RAILW CO; Mesa MG, 1998, CAN J FISH AQUAT SCI, V55, P1599, DOI 10.1139/cjfas-55-7-1599; Moore A, 2003, AQUACULTURE, V222, P253, DOI 10.1016/S0044-8486(03)00126-1; Moore ME, 2010, T AM FISH SOC, V139, P49, DOI 10.1577/T09-012.1; PASCHO RJ, 1987, CAN J FISH AQUAT SCI, V44, P183, DOI 10.1139/f87-024; Pascho RJ, 1998, J VET DIAGN INVEST, V10, P60, DOI 10.1177/104063879801000111; PAYAN P, 1984, FISH PHYSIOL, V10, P39; RECHISKY EL, 2010, PACIFIC NW AQUATIC M, P71; Rechisky EL, 2009, CAN J FISH AQUAT SCI, V66, P1019, DOI 10.1139/F09-078; ROBERSON BS, 1990, TECHNIQUES FISH IMMU, P81; SCHROCK RM, 1994, T AM FISH SOC, V123, P223, DOI 10.1577/1548-8659(1994)123&lt;0223:AMFGSP&gt;2.3.CO;2; SORUM U, 2004, AQUAC, V232, P33; Ward BR, 2000, CAN J FISH AQUAT SCI, V57, P298, DOI 10.1139/cjfas-57-2-298; Welch DW, 2007, HYDROBIOLOGIA, V582, P289, DOI 10.1007/s10750-006-0553-x; Welch DW, 2008, PLOS BIOL, V6, P2101, DOI 10.1371/journal.pbio.0060265; Welch DW, 2009, CAN J FISH AQUAT SCI, V66, P736, DOI 10.1139/F09-032; Welch DW, 2000, FISH OCEANOGR, V9, P17; Welch DW, 2004, DEEP-SEA RES PT II, V51, P897, DOI 10.1016/j.dsr2.2004.05.010; Welch DW, 2002, OCEANOL ACTA, V25, P243, DOI 10.1016/S0399-1784(02)01206-9; WELCH DW, 2011, P NAT ACAD IN PRESS; WOOD CC, 2011, T AM FISH S IN PRESS	44	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e14779	10.1371/journal.pone.0014779	http://dx.doi.org/10.1371/journal.pone.0014779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21468320	Green Submitted, Green Published, gold			2022-12-27	WOS:000289054600001
J	Leonardi, E; Andreazza, S; Vanin, S; Busolin, G; Nobile, C; Tosatto, SCE				Leonardi, Emanuela; Andreazza, Simonetta; Vanin, Stefano; Busolin, Giorgia; Nobile, Carlo; Tosatto, Silvio C. E.			A Computational Model of the LGI1 Protein Suggests a Common Binding Site for ADAM Proteins	PLOS ONE			English	Article							LEUCINE-RICH-REPEAT; LATERAL TEMPORAL EPILEPSY; AUTOSOMAL-DOMINANT; STABILITY CHANGES; STRUCTURAL INFORMATION; SYNAPTIC-TRANSMISSION; STRUCTURE PREDICTION; SECONDARY STRUCTURE; MAXIMUM-LIKELIHOOD; QUALITY ESTIMATION	Mutations of human leucine-rich glioma inactivated (LGI1) gene encoding the epitempin protein cause autosomal dominant temporal lateral epilepsy (ADTLE), a rare familial partial epileptic syndrome. The LGI1 gene seems to have a role on the transmission of neuronal messages but the exact molecular mechanism remains unclear. In contrast to other genes involved in epileptic disorders, epitempin shows no homology with known ion channel genes but contains two domains, composed of repeated structural units, known to mediate protein-protein interactions. A three dimensional in silico model of the two epitempin domains was built to predict the structure-function relationship and propose a functional model integrating previous experimental findings. Conserved and electrostatic charged regions of the model surface suggest a possible arrangement between the two domains and identifies a possible ADAM protein binding site in the b-propeller domain and another protein binding site in the leucine-rich repeat domain. The functional model indicates that epitempin could mediate the interaction between proteins localized to different synaptic sides in a static way, by forming a dimer, or in a dynamic way, by binding proteins at different times. The model was also used to predict effects of known disease-causing missense mutations. Most of the variants are predicted to alter protein folding while several other map to functional surface regions. In agreement with experimental evidence, this suggests that non-secreted LGI1 mutants could be retained within the cell by quality control mechanisms or by altering interactions required for the secretion process.	[Leonardi, Emanuela; Andreazza, Simonetta; Vanin, Stefano; Tosatto, Silvio C. E.] Univ Padua, Dept Biol, Padua, Italy; [Vanin, Stefano] Univ Huddersfield, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Busolin, Giorgia; Nobile, Carlo] CNR, Inst Neurosci, Padua, Italy	University of Padua; University of Huddersfield; Consiglio Nazionale delle Ricerche (CNR)	Leonardi, E (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	silvio@cribi.unipd.it	Tosatto, Silvio/B-2840-2009; Busolin, Giorgia/K-7623-2014	Tosatto, Silvio/0000-0003-4525-7793; Nobile, Carlo/0000-0002-0634-2218; Vanin, Stefano/0000-0003-1676-5916; Andreazza, Simonetta/0000-0001-8816-4955; Leonardi, Emanuela/0000-0001-8486-8461	Genetics Commission of Italian League Against Epilepsy; University of Padua [CPDA098382]	Genetics Commission of Italian League Against Epilepsy; University of Padua	This study was supported by the Genetics Commission of Italian League Against Epilepsy (grant to CN) and by a "Progetto di Ateneo" (No. CPDA098382/09) from the University of Padua to ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2003, PROTEIN ENG, V16, P459, DOI 10.1093/protein/gzg063; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2009, PROTEINS, V77, P173, DOI 10.1002/prot.22532; Bindewald E, 2003, PROTEIN ENG, V16, P785, DOI 10.1093/protein/gzg106; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Buchanan SGS, 1996, PROG BIOPHYS MOL BIO, V65, P1, DOI 10.1016/S0079-6107(96)00003-X; Bujnicki JM, 2001, BIOINFORMATICS, V17, P750, DOI 10.1093/bioinformatics/17.8.750; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Chernova OB, 1998, ONCOGENE, V17, P2873, DOI 10.1038/sj.onc.1202481; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fukata Y, 2006, SCIENCE, V313, P1792, DOI 10.1126/science.1129947; Fukata Y, 2010, P NATL ACAD SCI USA, V107, P3799, DOI 10.1073/pnas.0914537107; Gilis D, 2000, PROTEIN ENG, V13, P849, DOI 10.1093/protein/13.12.849; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gu WL, 2005, MOL BIOL EVOL, V22, P2209, DOI 10.1093/molbev/msi214; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Herranz-Perez V, 2010, BRAIN RES, V1307, P177, DOI 10.1016/j.brainres.2009.10.013; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kajava AV, 2002, PROTEIN SCI, V11, P1082, DOI 10.1110/ps.4010102; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Kiel C, 2008, ANNU REV BIOCHEM, V77, P415, DOI 10.1146/annurev.biochem.77.062706.133317; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kunapuli P, 2004, J BIOL CHEM, V279, P23151, DOI 10.1074/jbc.M314192200; Kunapuli P, 2003, ONCOGENE, V22, P3985, DOI 10.1038/sj.onc.1206584; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Marsella L, 2009, BIOINFORMATICS, V25, pI289, DOI 10.1093/bioinformatics/btp232; Matsushima N, 2005, CELL MOL LIFE SCI, V62, P2771, DOI 10.1007/s00018-005-5187-z; Michelucci R, 2003, EPILEPSIA, V44, P1289, DOI 10.1046/j.1528-1157.2003.20003.x; Morante-Redolat JM, 2002, HUM MOL GENET, V11, P1119, DOI 10.1093/hmg/11.9.1119; Nobile C, 2009, HUM MUTAT, V30, P530, DOI 10.1002/humu.20925; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; Owuor K, 2009, MOL CELL NEUROSCI, V42, P448, DOI 10.1016/j.mcn.2009.09.008; Ozkaynak E, 2010, J NEUROSCI, V30, P3857, DOI 10.1523/JNEUROSCI.6287-09.2010; Paoli M, 2001, NAT STRUCT BIOL, V8, P744, DOI 10.1038/nsb0901-744; Perry J, 2005, P NATL ACAD SCI USA, V102, P17594, DOI 10.1073/pnas.0508581102; Sagane K, 2008, INT J BIOL SCI, V4, P387; Scheel H, 2002, HUM MOL GENET, V11, P1757, DOI 10.1093/hmg/11.15.1757; Senechal KR, 2005, HUM MOL GENET, V14, P1613, DOI 10.1093/hmg/ddi169; Sirerol-Piquer MS, 2006, HUM MOL GENET, V15, P3436, DOI 10.1093/hmg/ddl421; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sommer I, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-364; Staub E, 2002, TRENDS BIOCHEM SCI, V27, P441, DOI 10.1016/S0968-0004(02)02163-1; Stirnimann C. U., 2010, TRENDS BIOCH SCI; Strimmer K, 1997, MOL BIOL EVOL, V14, P210, DOI 10.1093/oxfordjournals.molbev.a025756; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tosatto SCE, 2005, J COMPUT BIOL, V12, P1316, DOI 10.1089/cmb.2005.12.1316; Tosatto SCE, 2002, PROTEIN ENG, V15, P279, DOI 10.1093/protein/15.4.279; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vullo A, 2006, NUCLEIC ACIDS RES, V34, pW164, DOI 10.1093/nar/gkl166; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Zhou YD, 2009, NAT MED, V15, P1208, DOI 10.1038/nm.2019	64	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18142	10.1371/journal.pone.0018142	http://dx.doi.org/10.1371/journal.pone.0018142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479274	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000289054600030
J	Li, YZ; Li, GB; Wen, ZN; Yin, H; Hu, M; Xiao, JM; Li, ML				Li, Yizhou; Li, Gongbing; Wen, Zhining; Yin, Hui; Hu, Mei; Xiao, Jiamin; Li, Menglong			Novel Feature for Catalytic Protein Residues Reflecting Interactions with Other Residues	PLOS ONE			English	Article							FUNCTIONALLY IMPORTANT RESIDUES; ACTIVE-SITES; PREDICTION; NETWORK; ENZYME; SEQUENCE; EVOLUTION	Owing to their potential for systematic analysis, complex networks have been widely used in proteomics. Representing a protein structure as a topology network provides novel insight into understanding protein folding mechanisms, stability and function. Here, we develop a new feature to reveal correlations between residues using a protein structure network. In an original attempt to quantify the effects of several key residues on catalytic residues, a power function was used to model interactions between residues. The results indicate that focusing on a few residues is a feasible approach to identifying catalytic residues. The spatial environment surrounding a catalytic residue was analyzed in a layered manner. We present evidence that correlation between residues is related to their distance apart: most environmental parameters of the outer layer make a smaller contribution to prediction; and (ii) catalytic residues tend to be located near key positions in enzyme folds. Feature analysis revealed satisfactory performance for our features, which were combined with several conventional features in a prediction model for catalytic residues using a comprehensive data set from the Catalytic Site Atlas. Values of 88.6% for sensitivity and 88.4% for specificity were obtained by 10-fold cross-validation. These results suggest that these features reveal the mutual dependence of residues and are promising for further study of structure-function relationship.	[Li, Yizhou] Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China; Sichuan Univ, State Key Lab Biotherapy, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Li, YZ (corresponding author), Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China.	liml@scu.edu.cn	meng, li/GVT-2063-2022		National Nature Science Foundation of China [20972103]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (No. 20972103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Bagler G, 2005, PHYSICA A, V346, P27, DOI 10.1016/j.physa.2004.08.046; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Ben-Shimon A, 2005, J MOL BIOL, V351, P309, DOI 10.1016/j.jmb.2005.06.047; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Burt RS, 2004, AM J SOCIOL, V110, P349, DOI 10.1086/421787; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Chea E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-153; Cheng G, 2005, NUCLEIC ACIDS RES, V33, P5861, DOI 10.1093/nar/gki894; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P8637, DOI 10.1073/pnas.122076099; Fischer JD, 2008, BIOINFORMATICS, V24, P613, DOI 10.1093/bioinformatics/btm626; Goyal K, 2007, NUCLEIC ACIDS RES, V35, pW503, DOI 10.1093/nar/gkm252; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; Gutteridge A, 2003, J MOL BIOL, V330, P719, DOI 10.1016/S0022-2836(03)00515-1; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Ikura T, 2008, PROTEIN ENG DES SEL, V21, P83, DOI 10.1093/protein/gzm087; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Ko J, 2005, BIOINFORMATICS, V21, pI258, DOI 10.1093/bioinformatics/bti1039; La D, 2005, PROTEINS, V58, P309, DOI 10.1002/prot.20321; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ondrechen MJ, 2001, P NATL ACAD SCI USA, V98, P12473, DOI 10.1073/pnas.211436698; Pazos F, 2004, P NATL ACAD SCI USA, V101, P14754, DOI 10.1073/pnas.0404569101; Petrova NV, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-312; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Pugalenthi G, 2008, BIOCHEM BIOPH RES CO, V367, P630, DOI 10.1016/j.bbrc.2008.01.038; Sacquin-Mora S, 2007, PROTEINS, V67, P350, DOI 10.1002/prot.21353; Sankararaman S, 2010, BIOINFORMATICS, V26, P617, DOI 10.1093/bioinformatics/btq008; SHOICHET BK, 1995, P NATL ACAD SCI USA, V92, P452, DOI 10.1073/pnas.92.2.452; Stark A, 2004, STRUCTURE, V12, P1405, DOI 10.1016/j.str.2004.05.012; Sterner B, 2007, J COMPUT BIOL, V14, P1058, DOI 10.1089/cmb.2007.0042; Tang YR, 2008, PROTEIN ENG DES SEL, V21, P295, DOI 10.1093/protein/gzn003; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tong WX, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000266; Torrance JW, 2005, J MOL BIOL, V347, P565, DOI 10.1016/j.jmb.2005.01.044; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Wangikar PP, 2003, J MOL BIOL, V326, P955, DOI 10.1016/S0022-2836(02)01384-0; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Youn E, 2007, PROTEIN SCI, V16, P216, DOI 10.1110/ps.062523907; Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433	45	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e16932	10.1371/journal.pone.0016932	http://dx.doi.org/10.1371/journal.pone.0016932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21468322	Green Submitted, Green Published, gold			2022-12-27	WOS:000289054600007
J	Yin, HE; Vosters, JL; Roescher, N; D'Souza, A; Kurien, BT; Tak, PP; Chiorini, JA				Yin, Hongen; Vosters, Jelle L.; Roescher, Nienke; D'Souza, Anil; Kurien, Biji T.; Tak, Paul P.; Chiorini, John A.			Location of Immunization and Interferon-gamma Are Central to Induction of Salivary Gland Dysfunction in Ro60 Peptide Immunized Model of Sjogren's Syndrome	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CELL-LINE; ANTI-RO; AUTOANTIGEN; MICE; MOUSE	Introduction: Anti-Ro antibodies can be found in the serum of the majority of patients with Sjogren's syndrome (SS). Immunization with a 60-kDa Ro peptide has been shown to induce SS-like symptoms in mice. The aim of this study was to investigate factors involved in salivary gland (SG) dysfunction after immunization and to test whether the induction of SS could be improved. Methods: Ro60 peptide immunization was tested in Balb/c mice, multiple antigenic peptide (MAP)-Ro60 and Pertussis toxin (PTX) were tested in SJL/J mice. In addition, two injection sites were compared in these two strains: the abdominal area and the tailbase. Each group of mice was tested for a loss of SG function, SG lymphocytic infiltration, anti-Ro and anti-La antibody formation, and cytokine production in cultured cells or homogenized SG extracts. Results: Ro60 peptide immunization in the abdominal area of female Balb/c mice led to impaired SG function, which corresponded with increased Th1 cytokines (IFN-gamma and IL-12) systemically and locally in the SG. Moreover, changing the immunization conditions to MAP-Ro60 in the abdominal area, and to lesser extend in the tailbase, also led to impaired SG function in SJL/J mice. As was seen in the Balb/c mice, increased IFN-gamma in the SG draining lymph nodes accompanied the SG dysfunction. However, no correlation was observed with anti-MAP-Ro60 antibody titers, and there was no additional effect on disease onset or severity. Conclusions: Effective induction of salivary gland dysfunction after Ro60 peptide immunization depended on the site of injection. Disease induction was not affected by changing the immunization conditions. However, of interest is that the mechanism of action of Ro60 peptide immunization appears to involve an increase in Th1 cytokines, resulting in the induction of SG dysfunction.	[Yin, Hongen; Vosters, Jelle L.; Roescher, Nienke; Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Vosters, Jelle L.; Roescher, Nienke; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [D'Souza, Anil; Kurien, Biji T.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Amsterdam; Academic Medical Center Amsterdam; University of Oklahoma System; University of Oklahoma Health Sciences Center	Yin, HE (corresponding author), Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA.	jchiorini@dir.nidcr.nih.gov	Kurien, Biji T/C-2392-2008	Kurien, Biji T/0000-0002-7877-6859	Dutch Arthritis Association [NR 07-1-406]; NIH, NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000695] Funding Source: NIH RePORTER	Dutch Arthritis Association; NIH, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is supported by a Dutch Arthritis Association grant [NR 07-1-406] to JLV and an NIH, NIDCR intramural research grant to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson AK, 2009, ANN RHEUM DIS, V68, P1746, DOI 10.1136/ard.2008.097642; Bombardieri M, 2004, ARTHRITIS RES THER, V6, pR447, DOI 10.1186/ar1209; Cruz LJ, 2004, BIOCONJUGATE CHEM, V15, P112, DOI 10.1021/bc034119j; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Hansen A, 2003, CURR OPIN RHEUMATOL, V15, P563, DOI 10.1097/00002281-200309000-00007; HARLEY JB, 1992, RHEUM DIS CLIN N AM, V18, P337; JAMES JA, 1995, J EXP MED, V181, P453, DOI 10.1084/jem.181.2.453; Lodde BM, 2006, ORAL DIS, V12, P566, DOI 10.1111/j.1601-0825.2006.01241.x; Meehan S, 1997, AM J PHYSIOL-CELL PH, V273, pC2030, DOI 10.1152/ajpcell.1997.273.6.C2030; Oscherwitz J, 2009, INFECT IMMUN, V77, P5509, DOI 10.1128/IAI.00899-09; Papenfuss TL, 2004, J NEUROIMMUNOL, V150, P59, DOI 10.1016/j.jneuroim.2004.01.018; Pastor S, 2009, J IMMUNOL, V182, P5268, DOI 10.4049/jimmunol.0800681; Praprotnik S, 1999, CLIN EXP RHEUMATOL, V17, P63; Rhodes DA, 2002, IMMUNOLOGY, V106, P246, DOI 10.1046/j.1365-2567.2002.01417.x; Sasaki Motoko, 2002, Dev Immunol, V9, P103, DOI 10.1080/1044667021000096455; Scofield RH, 2005, J IMMUNOL, V175, P8409, DOI 10.4049/jimmunol.175.12.8409; Scofield RH, 1996, J IMMUNOL, V156, P4059; Scofield RH, 1999, ARTHRITIS RHEUM, V42, P1017, DOI 10.1002/1529-0131(199905)42:5<1017::AID-ANR22>3.0.CO;2-7; Silver PB, 1999, INVEST OPHTH VIS SCI, V40, P2898; Vivino FB, 2002, J RHEUMATOL, V29, P938; Vosters JL, 2009, ARTHRITIS RHEUM-US, V60, P3633, DOI 10.1002/art.24980; Wu AJ, 1997, J CELL PHYSIOL, V173, P110, DOI 10.1002/(SICI)1097-4652(199710)173:1<110::AID-JCP13>3.0.CO;2-M	22	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18003	10.1371/journal.pone.0018003	http://dx.doi.org/10.1371/journal.pone.0018003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464925	Green Published, Green Submitted, gold			2022-12-27	WOS:000289053800011
J	Barbet-Massin, M; Jiguet, F				Barbet-Massin, Morgane; Jiguet, Frederic			Back from a Predicted Climatic Extinction of an Island Endemic: A Future for the Corsican Nuthatch	PLOS ONE			English	Article							SPECIES RANGE SHIFTS; BIOTIC INTERACTIONS; DISTRIBUTIONS; MODELS; BIODIVERSITY; DIVERSITY; IMPACTS; THREATS	The Corsican Nuthatch (Sitta whiteheadi) is red-listed as vulnerable to extinction by the IUCN because of its endemism, reduced population size, and recent decline. A further cause is the fragmentation and loss of its spatially-restricted favourite habitat, the Corsican pine (Pinus nigra laricio) forest. In this study, we aimed at estimating the potential impact of climate change on the distribution of the Corsican Nuthatch using species distribution models. Because this species has a strong trophic association with the Corsican and Maritime pines (P. nigra laricio and P. pinaster), we first modelled the current and future potential distribution of both pine species in order to use them as habitat variables when modelling the nuthatch distribution. However, the Corsican pine has suffered large distribution losses in the past centuries due to the development of anthropogenic activities, and is now restricted to mountainous woodland. As a consequence, its realized niche is likely significantly smaller than its fundamental niche, so that a projection of the current distribution under future climatic conditions would produce misleading results. To obtain a predicted pine distribution at closest to the geographic projection of the fundamental niche, we used available information on the current pine distribution associated to information on the persistence of isolated natural pine coppices. While common thresholds (maximizing the sum of sensitivity and specificity) predicted a potential large loss of the Corsican Nuthatch distribution by 2100, the use of more appropriate thresholds aiming at getting closer to the fundamental distribution of the Corsican pine predicted that 98% of the current presence points should remain potentially suitable for the nuthatch and its range could be 10% larger in the future. The habitat of the endemic Corsican Nuthatch is therefore more likely threatened by an increasing frequency and intensity of wildfires or anthropogenic activities than by climate change.	[Barbet-Massin, Morgane; Jiguet, Frederic] Museum Natl Hist Nat, Ctr Rech Biol Populat Oiseaux, UMR MNHN CNRS UPMC 7204, F-75231 Paris, France	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Barbet-Massin, M (corresponding author), Museum Natl Hist Nat, Ctr Rech Biol Populat Oiseaux, UMR MNHN CNRS UPMC 7204, F-75231 Paris, France.	barbet@mnhn.fr			Centre National de la Recherche Scientifique; University Pierre et Marie Curie; Museum National d'Histoire Naturelle	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Pierre et Marie Curie; Museum National d'Histoire Naturelle	The study has been funded by the Centre National de la Recherche Scientifique, the University Pierre et Marie Curie and the Museum National d'Histoire Naturelle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], GLOB CLIM DAT; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2009, P NATL ACAD SCI USA, V106, pE45, DOI 10.1073/pnas.0813294106; Barbet-Massin M, 2009, BIOL LETTERS, V5, P248, DOI 10.1098/rsbl.2008.0715; BARTLEIN PJ, 1986, J BIOGEOGR, V13, P35, DOI 10.2307/2844848; Benichou P, 1987, AGROMETEOROLOGIE REG, P51; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Brooker RW, 2007, J THEOR BIOL, V245, P59, DOI 10.1016/j.jtbi.2006.09.033; Brotons L, 2010, EFFECTS CLIMATE CHAN; Caujape-Castells J, 2010, PERSPECT PLANT ECOL, V12, P107, DOI 10.1016/j.ppees.2009.10.001; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; Cronk QCB, 1997, BIODIVERS CONSERV, V6, P477, DOI 10.1023/A:1018372910025; Diamond J., 1989, P37; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; IUCN, 2010, RED LIST THREATENED; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; JOHNSON TH, 1990, IBIS, V132, P167, DOI 10.1111/j.1474-919X.1990.tb01036.x; Kreft H, 2008, ECOL LETT, V11, P116, DOI 10.1111/j.1461-0248.2007.01129.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Moneglia P, 2009, J ORNITHOL, V150, P577, DOI 10.1007/s10336-009-0379-1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; Preston K, 2008, GLOBAL CHANGE BIOL, V14, P2501, DOI 10.1111/j.1365-2486.2008.01671.x; ROOT T, 1988, J BIOGEOGR, V15, P489, DOI 10.2307/2845278; Sadler JP, 1999, J BIOGEOGR, V26, P75, DOI 10.1046/j.1365-2699.1999.00285.x; Sodhi NS, 2004, ANNU REV ECOL EVOL S, V35, P323, DOI 10.1146/annurev.ecolsys.35.112202.130209; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Syphard AD, 2009, CONSERV BIOL, V23, P758, DOI 10.1111/j.1523-1739.2009.01223.x; Thibault JC, BIRD CONSER IN PRESS; Thibault JC, 2006, J AVIAN BIOL, V37, P477, DOI 10.1111/j.0908-8857.2006.03645.x; Thibault Jean-Claude, 2004, Ecologia Mediterranea, V30, P195; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037	44	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18228	10.1371/journal.pone.0018228	http://dx.doi.org/10.1371/journal.pone.0018228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464916	Green Published, Green Submitted, gold			2022-12-27	WOS:000288813900054
J	Cai, J; Wu, L; Qi, XP; Shaw, L; Calzi, SL; Caballero, S; Jiang, WG; Vinores, SA; Antonetti, D; Ahmed, A; Grant, MB; Boulton, ME				Cai, Jun; Wu, Lin; Qi, Xiaoping; Shaw, Lynn; Calzi, Sergio Li; Caballero, Sergio; Jiang, Wen G.; Vinores, Stanley A.; Antonetti, David; Ahmed, Asif; Grant, Maria B.; Boulton, Michael E.			Placenta Growth Factor-1 Exerts Time-Dependent Stabilization of Adherens Junctions Following VEGF-Induced Vascular Permeability	PLOS ONE			English	Article							BLOOD-RETINAL BARRIER; FACTOR RECEPTOR-1; ENDOTHELIAL-CELLS; TIGHT JUNCTIONS; TUMOR-GROWTH; PATHOLOGICAL CONDITIONS; INDUCED ANGIOGENESIS; CADHERIN GENE; CANCER-CELLS; MICE	Increased vascular permeability is an early event characteristic of tissue ischemia and angiogenesis. Although VEGF family members are potent promoters of endothelial permeability the role of placental growth factor (PlGF) is hotly debated. Here we investigated PlGF isoforms 1 and 2 and present in vitro and in vivo evidence that PlGF-1, but not PlGF-2, can inhibit VEGF-induced permeability but only during a critical window post-VEGF exposure. PlGF-1 promotes VE-cadherin expression via the trans-activating Sp1 and Sp3 interaction with the VE-cadherin promoter and subsequently stabilizes transendothelial junctions, but only after activation of endothelial cells by VEGF. PlGF-1 regulates vascular permeability associated with the rapid localization of VE-cadherin to the plasma membrane and dephosphorylation of tyrosine residues that precedes changes observed in claudin 5 tyrosine phosphorylation and membrane localization. The critical window during which PlGF-1 exerts its effect on VEGF-induced permeability highlights the importance of the translational significance of this work in that PLGF-1 likely serves as an endogenous anti-permeability factor whose effectiveness is limited to a precise time point following vascular injury. Clinical approaches that would pattern nature's approach would thus limit treatments to precise intervals following injury and bring attention to use of agents only during therapeutic windows.	[Cai, Jun; Wu, Lin; Qi, Xiaoping; Boulton, Michael E.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32611 USA; [Shaw, Lynn; Calzi, Sergio Li; Caballero, Sergio; Grant, Maria B.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA; [Jiang, Wen G.] Cardiff Univ, Sch Med, Dept Surg, Cardiff, S Glam, Wales; [Vinores, Stanley A.] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA; [Antonetti, David] Penn State Coll Med, Hershey, PA USA; [Ahmed, Asif] Univ Edinburgh, Coll Med & Vet Med, Queens Med Res Inst, BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Cardiff University; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Edinburgh	Cai, J (corresponding author), Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32611 USA.	meboulton@ufl.edu	Jiang, Wen G/B-1293-2010; Ahmed, Asif/ABE-9544-2020; Ahmed, Asif/A-7268-2010; jiang, wen/GYI-9662-2022; Jiang, Wen G./AAF-1876-2020	Jiang, Wen G/0000-0002-3283-1111; Ahmed, Asif/0000-0002-8755-8546; Jiang, Wen G./0000-0002-3283-1111; antonetti, david/0000-0003-1130-6577; Goswami, Kaushal/0000-0002-7052-4358	National Institutes of Health (NIH) [EY018358, EY007739, EY012601, U01 HL087366, EY017164, EY012021]; Wellcome Trust, UK; Research to Prevent Blindness; Medical Research Council [G0601295, G0700288]; British Heart Foundation [RG/09/001/25940]; Juvenile Diabetes Research Foundation; NATIONAL EYE INSTITUTE [R01EY007739, R01EY018358, R29EY007739, R01EY012601, R01EY017164, P30EY021721, R01EY012021] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090730] Funding Source: NIH RePORTER; MRC [G0601295, G0700288] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust, UK(Wellcome Trust); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by National Institutes of Health (NIH) grants: EY018358 to MEB; EY007739, EY012601 and U01 HL087366 to MBG; EY017164 to SAV; EY012021 to DAA. Other funding included the Wellcome Trust, UK (MEB, AA), Research to Prevent Blindness (SAV), Medical Research Council (G0601295 and G0700288) and British Heart Foundation (RG/09/001/25940) to AA and the Juvenile Diabetes Research Foundation (DAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autiero M, 2003, J THROMB HAEMOST, V1, P1356, DOI 10.1046/j.1538-7836.2003.00263.x; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bais C, 2010, CELL, V141, P166, DOI 10.1016/j.cell.2010.01.033; Balda MS, 2008, J CELL SCI, V121, P3677, DOI 10.1242/jcs.023887; Bjorndahl M, 2004, CIRC RES, V94, P1443, DOI 10.1161/01.RES.0000129194.61747.bf; Cai J, 2006, MICROVASC RES, V71, P20, DOI 10.1016/j.mvr.2005.10.004; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Cai J, 2003, DIABETES, V52, P2959, DOI 10.2337/diabetes.52.12.2959; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Derevjanik NL, 2002, INVEST OPHTH VIS SCI, V43, P2462; DiPalma T, 1996, MAMM GENOME, V7, P6, DOI 10.1007/s003359900003; Erickson Kathryn K., 2007, Angiogenesis, V10, P103, DOI 10.1007/s10456-007-9067-z; Eriksson A, 2002, CANCER CELL, V1, P99, DOI 10.1016/S1535-6108(02)00028-4; Esteve PO, 2007, J BIOL CHEM, V282, P2615, DOI 10.1074/jbc.M606203200; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gavard J, 2009, FEBS LETT, V583, P1, DOI 10.1016/j.febslet.2008.11.032; Gory S, 1998, J BIOL CHEM, V273, P6750, DOI 10.1074/jbc.273.12.6750; Gulino D, 1998, J BIOL CHEM, V273, P29786, DOI 10.1074/jbc.273.45.29786; Higgins KJ, 2006, BIOCHEM BIOPH RES CO, V345, P292, DOI 10.1016/j.bbrc.2006.04.111; Khaliq A, 1998, LAB INVEST, V78, P109; Kowanetz M, 2006, CLIN CANCER RES, V12, P5018, DOI 10.1158/1078-0432.CCR-06-1520; Luna JD, 1997, J NEUROSCI RES, V49, P268, DOI 10.1002/(SICI)1097-4547(19970801)49:3<268::AID-JNR2>3.0.CO;2-A; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Luttun A, 2002, BIOCHEM BIOPH RES CO, V295, P428, DOI 10.1016/S0006-291X(02)00677-0; Mac Gabhann F, 2004, AM J PHYSIOL-HEART C, V286, pH153, DOI 10.1152/ajpheart.00254.2003; MAGLIONE D, 1993, ONCOGENE, V8, P925; Martin TA, 2005, HISTOPATHOLOGY, V46, P422, DOI 10.1111/j.1365-2559.2005.02104.x; May C, 2005, BLOOD, V105, P4337, DOI 10.1182/blood-2005-01-0010; Migdal M, 1998, J BIOL CHEM, V273, P22272, DOI 10.1074/jbc.273.35.22272; Monsky WL, 1999, CANCER RES, V59, P4129; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Odorisio T, 2002, J CELL SCI, V115, P2559; Oura H, 2003, BLOOD, V101, P560, DOI 10.1182/blood-2002-05-1516; PARK JE, 1994, J BIOL CHEM, V269, P25646; Prandini MH, 2005, ONCOGENE, V24, P2992, DOI 10.1038/sj.onc.1208483; Ribatti D, 2008, ANGIOGENESIS, V11, P215, DOI 10.1007/s10456-008-9114-4; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Shih SC, 2003, J CLIN INVEST, V112, P50, DOI 10.1172/JCI200317808; Soma T, 2004, EXP CELL RES, V300, P202, DOI 10.1016/j.yexcr.2004.07.012; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Weis SM, 2008, CURR OPIN HEMATOL, V15, P243, DOI 10.1097/MOH.0b013e3282f97d86; Xu L, 2006, CANCER RES, V66, P3971, DOI 10.1158/0008-5472.CAN-04-3085; Yamamoto M, 2008, AM J PATHOL, V172, P521, DOI 10.2353/ajpath.2008.070076; Yamazaki Y, 2006, MOL DIVERS, V10, P515, DOI 10.1007/s11030-006-9027-3; Ziche M, 1997, LAB INVEST, V76, P517	54	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18076	10.1371/journal.pone.0018076	http://dx.doi.org/10.1371/journal.pone.0018076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464949	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000288813900036
J	Caro, LN; Moreau, CJ; Revilloud, J; Vivaudou, M				Caro, Lydia N.; Moreau, Christophe J.; Revilloud, Jean; Vivaudou, Michel			beta(2)-Adrenergic Ion-Channel Coupled Receptors as Conformational Motion Detectors	PLOS ONE			English	Article							K-ATP CHANNEL; SULFONYLUREA RECEPTOR; INTERFACE; SUBUNIT; BETA(2); KIR6.2; TRAFFICKING; MUTATIONS; COMPLEXES; RESIDUES	Ion Channel-Coupled Receptors (ICCRs) are artificial proteins comprised of a G protein-coupled receptor and a fused ion channel, engineered to couple channel gating to ligand binding. These novel biological objects have potential use in drug screening and functional characterization, in addition to providing new tools in the synthetic biology repertoire as synthetic K+-selective ligand-gated channels. The ICCR concept was previously validated with fusion proteins between the K+ channel Kir6.2 and muscarinic M-2 or dopaminergic D-2 receptors. Here, we extend the concept to the distinct, longer beta(2)-adrenergic receptor which, unlike M-2 and D-2 receptors, displayed barely detectable surface expression in our Xenopus oocyte expression system and did not couple to Kir6.2 when unmodified. Here, we show that a Kir6.2-binding protein, the N-terminal transmembrane domain of the sulfonylurea receptor, can greatly increase plasma membrane expression of beta(2) constructs. We then demonstrate how engineering of both receptor and channel can produce beta(2)-Kir6.2 ICCRs. Specifically, removal of 62-72 residues from the cytoplasmic C-terminus of the receptor was required to enable coupling, suggesting that ligand-dependent conformational changes do not efficiently propagate to the distal C-terminus. Characterization of the beta(2) ICCRs demonstrated that full and partial agonists had the same coupling efficacy, that an inverse agonist had no effect and that the stabilizing mutation E122 W reduced agonist-induced coupling efficacy without affecting affinity. Because the ICCRs are expected to report motions of the receptor C-terminus, these results provide novel insights into the conformational dynamics of the beta(2) receptor.	[Caro, Lydia N.; Moreau, Christophe J.; Revilloud, Jean; Vivaudou, Michel] CNRS, Inst Biol Struct, Grenoble, France; [Caro, Lydia N.; Moreau, Christophe J.; Revilloud, Jean; Vivaudou, Michel] CEA, Inst Biol Struct, Grenoble, France; [Caro, Lydia N.; Moreau, Christophe J.; Revilloud, Jean; Vivaudou, Michel] Univ Grenoble 1, Inst Biol Struct, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Caro, LN (corresponding author), CNRS, Inst Biol Struct, Grenoble, France.	vivaudou@ibs.fr	MOREAU, Christophe/AAC-7912-2020; MOREAU, Christophe J/D-3736-2009; Vivaudou, Michel/C-5338-2008	MOREAU, Christophe/0000-0002-5463-9593; MOREAU, Christophe J/0000-0002-5463-9593; Vivaudou, Michel/0000-0002-9777-3127	European Union [STREP NMP4-CT-2005-017114]; Agence Nationale de la Recherche [ANR-09-PIRI-0010]	European Union(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by the Sixth Framework Program of the European Union (Receptronics project, STREP NMP4-CT-2005-017114) and the Agence Nationale de la Recherche (ICCR project, grant ANR-09-PIRI-0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson H, 2003, MOL PHARMACOL, V64, P570, DOI 10.1124/mol.64.3.570; Antcliff JF, 2005, EMBO J, V24, P229, DOI 10.1038/sj.emboj.7600487; Baker JG, 2010, BRIT J PHARMACOL, V160, P1048, DOI 10.1111/j.1476-5381.2010.00754.x; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Caro LN, 2010, BIOPHYS J, V98, p193A, DOI 10.1016/j.bpj.2009.12.1025; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; Chelikani P, 2007, P NATL ACAD SCI USA, V104, P7027, DOI 10.1073/pnas.0702024104; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Corringer PJ, 2010, J PHYSIOL-LONDON, V588, P565, DOI 10.1113/jphysiol.2009.183160; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Doupnik CA, 2008, J RECEPT SIG TRANSD, V28, P83, DOI [10.1080/10799890801941970, 10.1080/10799890801941970 ]; Dupuis JP, 2008, J PHYSIOL-LONDON, V586, P3075, DOI 10.1113/jphysiol.2008.152744; Frishman WH, 2008, AM J THER, V15, P565, DOI 10.1097/MJT.0b013e318188bdca; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Hague C, 2004, J PHARMACOL EXP THER, V309, P388, DOI 10.1124/jpet.103.060509; Hosy E, 2007, J PHYSIOL-LONDON, V582, P27, DOI 10.1113/jphysiol.2007.134288; Hosy E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.043307; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Kisilevsky AE, 2008, NEURON, V58, P557, DOI 10.1016/j.neuron.2008.03.002; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Lavine N, 2002, J BIOL CHEM, V277, P46010, DOI 10.1074/jbc.M205035200; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; MINNEMAN KP, 1981, ANNU REV NEUROSCI, V4, P419, DOI 10.1146/annurev.ne.04.030181.002223; Moreau C, 2005, J MOL CELL CARDIOL, V38, P951, DOI 10.1016/j.yjmcc.2004.11.030; Moreau C, 2000, EMBO J, V19, P6644, DOI 10.1093/emboj/19.24.6644; Moreau CJ, 2008, NAT NANOTECHNOL, V3, P620, DOI 10.1038/nnano.2008.242; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Roth CB, 2008, J MOL BIOL, V376, P1305, DOI 10.1016/j.jmb.2007.12.028; Taira CA, 2010, METHOD ENZYMOL, V485, P37, DOI [10.1016/S0076-6879(10)85003-7, 10.1016/B978-0-12-381296-4.00003-8]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	38	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18226	10.1371/journal.pone.0018226	http://dx.doi.org/10.1371/journal.pone.0018226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464970	Green Published, Green Submitted, gold			2022-12-27	WOS:000288813900053
J	Wang, Z; Zhang, XC; Le, MH; Xu, D; Stacey, G; Cheng, JL				Wang, Zheng; Zhang, Xue-Cheng; Le, Mi Ha; Xu, Dong; Stacey, Gary; Cheng, Jianlin			A Protein Domain Co-Occurrence Network Approach for Predicting Protein Function and Inferring Species Phylogeny	PLOS ONE			English	Article							LARGE-SCALE ORGANIZATION; GLOBAL ALIGNMENT; GENE ONTOLOGY; BIOLOGY; CLASSIFICATION; EVOLUTION; DATABASE; YEAST; LIFE; TOOL	Protein Domain Co-occurrence Network (DCN) is a biological network that has not been fully-studied. We analyzed the properties of the DCNs of H. sapiens, S. cerevisiae, C. elegans, D. melanogaster, and 15 plant genomes. These DCNs have the hallmark features of scale-free networks. We investigated the possibility of using DCNs to predict protein and domain functions. Based on our experiment conducted on 66 randomly selected proteins, the best of top 3 predictions made by our DCN-based aggregated neighbor-counting method achieved a semantic similarity score of 0.81 to the actual Gene Ontology terms of the proteins. Moreover, the top 3 predictions using neighbor-counting, chi(2), and a SVM-based method achieved an accuracy of 66%, 59%, and 61%, respectively, when used to predict specific Gene Ontology terms of human target domains. These predictions on average had a semantic similarity score of 0.82, 0.80, and 0.79 to the actual Gene Ontology terms, respectively. We also used DCNs to predict whether a domain is an enzyme domain, and our SVM-based and neighbor-inference method correctly classified 79% and 77% of the target domains, respectively. When using DCNs to classify a target domain into one of the six enzyme classes, we found that, as long as there is one EC number available in the neighboring domains, our SVM-based and neighboring-counting method correctly classified 92.4% and 91.9% of the target domains, respectively. Furthermore, we benchmarked the performance of using DCNs to infer species phylogenies on six different combinations of 398 single-chromosome prokaryotic genomes. The phylogenetic tree of 54 prokaryotic taxa generated by our DCNs-alignment-based method achieved a 93.45% similarity score compared to the Bergey's taxonomy. In summary, our studies show that genome-wide DCNs contain rich information that can be effectively used to decipher protein function and reveal the evolutionary relationship among species.	[Wang, Zheng; Xu, Dong; Cheng, Jianlin] Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA; [Zhang, Xue-Cheng; Xu, Dong; Stacey, Gary; Cheng, Jianlin] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO USA; [Zhang, Xue-Cheng; Le, Mi Ha; Stacey, Gary] Univ Missouri, Div Plant Sci, Columbia, MO USA; [Xu, Dong; Cheng, Jianlin] Univ Missouri, Inst Informat, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Wang, Z (corresponding author), Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA.	chengji@missouri.edu	Cheng, Jianlin/N-8209-2013	Cheng, Jianlin/0000-0003-0305-2853	National Institute of General Medical Science [1R01GM093123, R21/R33 GM078601]; Department of Energy [DE-SC0004898]; National Science Foundation [IOS-1025752]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM078601, R01GM093123] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1025752] Funding Source: National Science Foundation	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is partially supported by a National Institutes of Health (NIH) grant 1R01GM093123 from National Institute of General Medical Science (http://www.nigms.nih.gov/), an NIH grant R21/R33 GM078601 from National Institute of General Medical Science (http://www.nigms.nih.gov/), a DOE grant DE-SC0004898 from Department of Energy (http://www.energy.gov/), and an NSF grant IOS-1025752 from National Science Foundation (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Agarwal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000817; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Basu MK, 2008, GENOME RES, V18, P449, DOI 10.1101/gr.6943508; BATEMAN A, 2004, NUCLEIC ACIDS RES, V32, P276; Bergey D.H., BERGEYS MANUAL DETER; Bonneau R, 2008, NAT CHEM BIOL, V4, P658, DOI 10.1038/nchembio.122; Borgwardt K, 2005, KERNEL METHODS PROTE; Borgwardt KM, 2005, BIOINFORMATICS, V21, pI47, DOI 10.1093/bioinformatics/bti1007; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; Cai CZ, 2004, PROTEINS, V55, P66, DOI 10.1002/prot.20045; Chen XW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001562; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; CHENG J, 2005, IEEE INTELL SYST APP, V20, P1; Deeds EJ, 2005, GENOME RES, V15, P393, DOI 10.1101/gr.3033805; Du ZD, 2009, NUCLEIC ACIDS RES, V37, pW345, DOI 10.1093/nar/gkp463; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fong JH, 2007, J MOL BIOL, V366, P307, DOI 10.1016/j.jmb.2006.11.017; Gao L, 2007, SCI CHINA SER C, V50, P587, DOI 10.1007/s11427-007-0084-3; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HIROTO S, 2010, BMC BIOINFORMATICS, V11, pS31; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Issel-Tarver L, 2002, METHOD ENZYMOL, V350, P329, DOI 10.1016/S0076-6879(02)50972-1; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jensen LJ, 2003, BIOINFORMATICS, V19, P635, DOI 10.1093/bioinformatics/btg036; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Joachims T., 1999, ADV KERNEL METHODS S; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Komurov K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000889; Lanckriet GRG, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P300; Lewis ACF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-100; Li D, 2006, PROTEOMICS, V6, P456, DOI 10.1002/pmic.200500228; Li F, 2010, BIOINFORMATICS, V26, P275, DOI 10.1093/bioinformatics/btp634; Liao CS, 2009, BIOINFORMATICS, V25, pI253, DOI 10.1093/bioinformatics/btp203; Lin GN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S5; Luo YQ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-266; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nguyen TP, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-103; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Ramirez F, 2007, PROTEOMICS, V7, P2541, DOI 10.1002/pmic.200600924; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; RHEE S, 2003, NUCLEIC ACIDS RES, P224; Rinner O, 2007, NAT BIOTECHNOL, V25, P345, DOI 10.1038/nbt1289; Saigo H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S31; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SARAH K, 2009, BMC BIOINFORMATICS, V10, P39; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Scott J, 2006, J COMPUT BIOL, V13, P133, DOI 10.1089/cmb.2006.13.133; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Servant Florence, 2002, Brief Bioinform, V3, P246, DOI 10.1093/bib/3.3.246; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Wu XM, 2007, BIOINFORMATICS, V23, P1744, DOI 10.1093/bioinformatics/btm248; Wuchty S, 2001, MOL BIOL EVOL, V18, P1694, DOI 10.1093/oxfordjournals.molbev.a003957; Wuchty S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-24; ZHANG A, PROTEIN INTERACTION; ZHANG C, 2009, INT J COMPU IN PRESS	70	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17906	10.1371/journal.pone.0017906	http://dx.doi.org/10.1371/journal.pone.0017906			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455299	Green Published, gold, Green Submitted			2022-12-27	WOS:000288811500014
J	Antrobus, R; Borner, GHH				Antrobus, Robin; Borner, Georg H. H.			Improved Elution Conditions for Native Co-Immunoprecipitation	PLOS ONE			English	Article							PROTEIN; LOCALIZATION; CLATHRIN; ADAPTIN; AP-1	Background: Native immunoprecipitation followed by protein A-mediated recovery of the immuno-complex is a powerful tool to study protein-protein interactions. A limitation of this technique is the concomitant recovery of large amounts of immunoglobulin, which interferes with down-stream applications such as mass spectrometric analysis and Western blotting. Here we report a detergent-based "soft" elution protocol that allows effective recovery of immunoprecipitated antigen and binding partners, yet avoids elution of the bulk of the immunoglobulin. Methodology/Principal Findings: We assessed the performance of the soft elution protocol using immunoprecipitation of Adaptor protein complex 1 (AP-1) and associated proteins as a test case. Relative to conventional elution conditions, the novel protocol substantially improved the sensitivity of mass spectrometric identification of immunoprecipitated proteins from unfractionated solution digests. Averaging over three independent experiments, Mascot scores of identified AP-1 binding partners were increased by 39%. Conversely, the estimated amount of recovered immunoglobulin was reduced by 44%. We tested the protocol with five further antibodies derived from rabbit, mouse and goat. In each case we observed a significant reduction of co-eluting immunoglobulin. Conclusions/Significance: The soft elution protocol presented here shows superior performance compared to standard elution conditions for subsequent protein identification by mass spectrometry from solution digests. The method was developed for rabbit polyclonal antibodies, but also performed well with the tested goat and mouse antibodies. Hence we expect the soft elution protocol to be widely applicable.	[Antrobus, Robin; Borner, Georg H. H.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Wellcome Trust, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute	Antrobus, R (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Wellcome Trust, Cambridge CB2 2QQ, England.	ghhb2@cam.ac.uk		Borner, Georg H H/0000-0002-3166-3435	Wellcome Trust at the Cambridge Institute for Medical Research, Cambridge, UK [RG52996, RG53217]	Wellcome Trust at the Cambridge Institute for Medical Research, Cambridge, UK(Wellcome Trust)	This work was performed as a collaboration between Dr Georg H.H. Borner and Dr Robin Antrobus. Georg H. H. Borner is a Senior Research Associate in the laboratory of Professor Margaret Robinson, who is a Wellcome Trust Principal Research Fellow (award number RG52996; http://www.wellcome.ac.uk) at the Cambridge Institute for Medical Research, Cambridge, UK. Robin Antrobus is a Research Associate funded by the "Quantitative mass spectrometry analysis of subcellular organelles and protein dynamics" Wellcome Trust equipment grant (award number RG53217; http://www.wellcome.ac.uk), at the Cambridge Institute for Medical Research, Cambridge, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL CL, 1995, J CELL SCI, V108, P2865; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Bonifacino JS, 2006, CURR PROTOC NEUROSCI; Borner GHH, 2007, TRAFFIC, V8, P893, DOI 10.1111/j.1600-0854.2007.00576.x; Delevoye C, 2009, J CELL BIOL, V187, P247, DOI 10.1083/jcb.200907122; HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Hirst J, 2005, MOL BIOL CELL, V16, P2554, DOI 10.1091/mbc.E04-12-1077; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Page LJ, 1999, J CELL BIOL, V146, P993, DOI 10.1083/jcb.146.5.993; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Sambrook J., 2001, MOL CLONING LAB MANU; Seaman MNJ, 1996, J BIOL CHEM, V271, P25446, DOI 10.1074/jbc.271.41.25446; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; TIWARI RK, 1987, EMBO J, V6, P3373, DOI 10.1002/j.1460-2075.1987.tb02659.x	15	42	44	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18218	10.1371/journal.pone.0018218	http://dx.doi.org/10.1371/journal.pone.0018218			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448433	gold, Green Published, Green Submitted			2022-12-27	WOS:000288810500048
J	Kobayashi, K; Umeda-Yano, S; Yamamori, H; Takeda, M; Suzuki, H; Hashimoto, R				Kobayashi, Katsunori; Umeda-Yano, Satomi; Yamamori, Hidenaga; Takeda, Masatoshi; Suzuki, Hidenori; Hashimoto, Ryota			Correlated Alterations in Serotonergic and Dopaminergic Modulations at the Hippocampal Mossy Fiber Synapse in Mice Lacking Dysbindin	PLOS ONE			English	Article							SUSCEPTIBILITY GENE; SANDY MICE; SCHIZOPHRENIA; DTNBP1; TRANSMISSION; PROTEIN; BLOC-1	Dysbindin-1 (dystrobrevin-binding protein 1, DTNBP1) is one of the promising schizophrenia susceptibility genes. Dysbindin protein is abundantly expressed in synaptic regions of the hippocampus, including the terminal field of the mossy fibers, and this hippocampal expression of dysbindin is strongly reduced in patients with schizophrenia. In the present study, we examined the functional role of dysbindin in hippocampal mossy fiber-CA3 synaptic transmission and its modulation using the sandy mouse, a spontaneous mutant with deletion in the dysbindin gene. Electrophysiological recordings were made in hippocampal slices prepared from adult male sandy mice and their wild-type littermates. Basic properties of the mossy fiber synaptic transmission in the mutant mice were generally normal except for slightly reduced frequency facilitation. Serotonin and dopamine, two major neuromodulators implicated in the pathophysiology of schizophrenia, can potentiate mossy fiber synaptic transmission probably via an increase in cAMP levels. Synaptic potentiation induced by serotonin and dopamine was very variable in magnitude in the mutant mice, with some mice showing prominent enhancement as compared with the wild-type mice. In addition, the magnitude of potentiation induced by these monoamines significantly correlated with each other in the mutant mice, indicating that a subpopulation of sandy mice has marked hypersensitivity to both serotonin and dopamine. While direct activation of the cAMP cascade by forskolin induced robust synaptic potentiation in both wildtype and mutant mice, this forskolin-induced potentaition correlated in magnitude with the serotonin-induced potentiation only in the mutant mice, suggesting a possible change in coupling of receptor activation to downstream signaling. These results suggest that the dysbindin deficiency could be an essential genetic factor that causes synaptic hypersensitivity to dopamine and serotonin. The altered monoaminergic modulation at the mossy fiber synapse could be a candidate pathophysiological basis for impairment of hippocampus-dependent brain functions in schizophrenia.	[Kobayashi, Katsunori; Suzuki, Hidenori] Nippon Med Sch, Dept Pharmacol, Tokyo 113, Japan; [Kobayashi, Katsunori; Suzuki, Hidenori; Hashimoto, Ryota] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan; [Umeda-Yano, Satomi; Yamamori, Hidenaga] Osaka Univ, Dept Mol Neuropsychiat, Grad Sch Med, Osaka, Japan; [Yamamori, Hidenaga; Takeda, Masatoshi; Hashimoto, Ryota] Osaka Univ, Dept Psychiat, Grad Sch Med, Osaka, Japan; [Hashimoto, Ryota] Kanazawa Univ, Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Osaka, Japan; [Hashimoto, Ryota] Hamamatsu Univ Sch Med, Osaka, Japan	Nippon Medical School; Japan Science & Technology Agency (JST); Osaka University; Osaka University; Kanazawa University; Osaka University; Hamamatsu University School of Medicine	Kobayashi, K (corresponding author), Nippon Med Sch, Dept Pharmacol, 1-1-5 Sendagi, Tokyo 113, Japan.	kkatsu-tky@umin.ac.jp	Hashimoto, Ryota/P-8572-2014; Hashimoto, Ryota/AAE-3200-2019; Kobayashi, Katsunori/V-5326-2018	Hashimoto, Ryota/0000-0002-5941-4238; Hashimoto, Ryota/0000-0002-5941-4238; Kobayashi, Katsunori/0000-0001-8537-8448	Japan Science and Technology Agency, Core Research for Evolutional Science and Technology	Japan Science and Technology Agency, Core Research for Evolutional Science and Technology(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by the Japan Science and Technology Agency, Core Research for Evolutional Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Bhardwaj SK, 2009, BEHAV BRAIN RES, V197, P435, DOI 10.1016/j.bbr.2008.10.011; Chen XW, 2008, J CELL BIOL, V181, P791, DOI 10.1083/jcb.200711021; Feng YQ, 2008, SCHIZOPHR RES, V106, P218, DOI 10.1016/j.schres.2008.07.018; Hashimoto R, 2010, WORLD J BIOL PSYCHIA, V11, P431, DOI [10.3109/15622970902736503, 10.1080/15622970902736503]; Hashimoto R, 2009, PSYCHIAT CLIN NEUROS, V63, P550, DOI 10.1111/j.1440-1819.2009.01985.x; Hattori S, 2008, BIOCHEM BIOPH RES CO, V373, P298, DOI 10.1016/j.bbrc.2008.06.016; Hernandez-Rabaza V, 2007, BRAIN RES BULL, V72, P315, DOI 10.1016/j.brainresbull.2007.01.013; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Jentsch JD, 2009, NEUROPSYCHOPHARMACOL, V34, P2601, DOI 10.1038/npp.2009.90; Ji YY, 2009, P NATL ACAD SCI USA, V106, P19593, DOI 10.1073/pnas.0904289106; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Kobayashi K, 2008, J NEUROSCI, V28, P6272, DOI 10.1523/JNEUROSCI.1656-08.2008; Kobayashi K, 2007, NEUROPHARMACOLOGY, V52, P552, DOI 10.1016/j.neuropharm.2006.08.026; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P8434, DOI 10.1073/pnas.0912690107; Kobayashi K, 2009, MOL NEUROBIOL, V39, P24, DOI 10.1007/s12035-008-8049-5; Lee JH, 2005, J ABNORM PSYCHOL, V114, P599, DOI 10.1037/0021-843X.114.4.599; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; O'Tuathaigh CMP, 2007, NEUROSCI BIOBEHAV R, V31, P60, DOI 10.1016/j.neubiorev.2006.04.002; Reif A, 2007, EUR ARCH PSY CLIN N, V257, P290, DOI 10.1007/s00406-007-0733-3; Remington G, 2008, PROG BRAIN RES, V172, P117, DOI 10.1016/S0079-6123(08)00906-0; Sachidhanandam S, 2009, J NEUROSCI, V29, P5000, DOI 10.1523/JNEUROSCI.5807-08.2009; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Weickert CS, 2008, SCHIZOPHR RES, V98, P105, DOI 10.1016/j.schres.2007.05.041; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	29	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18113	10.1371/journal.pone.0018113	http://dx.doi.org/10.1371/journal.pone.0018113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448290	Green Submitted, Green Published, gold			2022-12-27	WOS:000288810500037
J	Hatin, WI; Nur-Shafawati, A; Zahri, MK; Xu, SH; Jin, L; Tan, SG; Rizman-Idid, M; Zilfalil, B				Hatin, Wan Isa; Nur-Shafawati, Ab Rajab; Zahri, Mohd-Khairi; Xu, Shuhua; Jin, Li; Tan, Soon-Guan; Rizman-Idid, Mohammed; Zilfalil, Bin Alwi		HUGO Pan-Asian SNP Consortium	Population Genetic Structure of Peninsular Malaysia Malay Sub-Ethnic Groups	PLOS ONE			English	Article							SINGLE; INFERENCES; ORIGIN	Patterns of modern human population structure are helpful in understanding the history of human migration and admixture. We conducted a study on genetic structure of the Malay population in Malaysia, using 54,794 genome-wide single nucleotide polymorphism genotype data generated in four Malay sub-ethnic groups in peninsular Malaysia (Melayu Kelantan, Melayu Minang, Melayu Jawa and Melayu Bugis). To the best of our knowledge this is the first study conducted on these four Malay sub-ethnic groups and the analysis of genotype data of these four groups were compiled together with 11 other populations' genotype data from Indonesia, China, India, Africa and indigenous populations in Peninsular Malaysia obtained from the Pan-Asian SNP database. The phylogeny of populations showed that all of the four Malay sub-ethnic groups are separated into at least three different clusters. The Melayu Jawa, Melayu Bugis and Melayu Minang have a very close genetic relationship with Indonesian populations indicating a common ancestral history, while the Melayu Kelantan formed a distinct group on the tree indicating that they are genetically different from the other Malay sub-ethnic groups. We have detected genetic structuring among the Malay populations and this could possibly be accounted for by their different historical origins. Our results provide information of the genetic differentiation between these populations and a valuable insight into the origins of the Malay sub-ethnic groups in Peninsular Malaysia.	[Hatin, Wan Isa; Nur-Shafawati, Ab Rajab; Zahri, Mohd-Khairi; Zilfalil, Bin Alwi] Univ Sains Malaysia, Sch Med Sci, Ctr Human Genome, Kelantan, Malaysia; [Zilfalil, Bin Alwi] Univ Sains Malaysia, Sch Med Sci, Dept Pediat, Kelantan, Malaysia; [Xu, Shuhua; Jin, Li] Chinese Acad Sci, Max Planck Soc, Partner Inst Computat Biol, Shanghai Inst Biol Sci,CAS MPG, Shanghai, Peoples R China; [Rizman-Idid, Mohammed] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Tan, Soon-Guan] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang, Malaysia; [Rizman-Idid, Mohammed] Univ Malaya, Ctr Res Computat Sci & Informat Biol Bioind Envir, CRYSTAL, Fac Sci, Kuala Lumpur, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Universiti Malaya; Universiti Putra Malaysia; Universiti Malaya	Hatin, WI (corresponding author), Univ Sains Malaysia, Sch Med Sci, Ctr Human Genome, Kelantan, Malaysia.	zilfalil@kb.usm.my	Tan, Soon Guan/V-1782-2019; Wu, Jer-Yuarn/S-7010-2018; Xu, Shuhua/AAH-7620-2020; Scaria, Vinod/B-2819-2008; Jin, Li/C-1468-2009; Tongsima, Sissades/F-4891-2011; De Ungria, Maria Corazon Abogado/T-9736-2019; XU, SHUHUA/D-5345-2009; Jin, Li/M-5063-2019; Hoh, Boon-Peng/H-8682-2016; Ahmed, Ikhlak/Q-2494-2019; IDID, MOHAMMED RIZMAN/B-9058-2010; Mitchell, Wayne P/C-5219-2008; Tan, S G/B-2448-2010; Zilfalil, Bin Alwi/A-7069-2019	Tan, Soon Guan/0000-0001-9960-4493; Xu, Shuhua/0000-0002-1975-1002; Jin, Li/0000-0002-4546-2415; Tongsima, Sissades/0000-0002-1491-1839; De Ungria, Maria Corazon Abogado/0000-0001-7722-5193; XU, SHUHUA/0000-0002-1975-1002; Hoh, Boon-Peng/0000-0001-9249-4965; Tan, S G/0000-0001-9960-4493; Phipps, Maude/0000-0001-8314-068X; Zilfalil, Bin Alwi/0000-0001-5055-7892; YAO, YIN/0000-0003-3053-8429; Ahmed, Ikhlak/0000-0002-5753-9627	Fundamental Research Grants Scheme (FRGS) [203/PPSP/6170025]; Universiti Sains Malaysia (USM); Grants-in-Aid for Scientific Research [19101008] Funding Source: KAKEN	Fundamental Research Grants Scheme (FRGS); Universiti Sains Malaysia (USM)(Universiti Sains Malaysia); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Fundamental Research Grants Scheme (FRGS) project (Grant Number: 203/PPSP/6170025) and Universiti Sains Malaysia (USM) Fellowship Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; ALLEN FA, 1879, J ANTHR I GREAT BRIT, V8, P38; ALLEN SJ, 1998, INT J HIST ARCHAEOL, V2, P261; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Bellwood Peter, 1997, PREHISTORY INDOMALAY; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; Carey I., 1976, ORANG ASLI ABORIGINA; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; CRANDALL K, 2008, RAPID NEIGHBOUR JOIN, P113; FIX AG, 1995, AM ANTHROPOL, V97, P313, DOI 10.1525/aa.1995.97.2.02a00090; Gao XY, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-34; Hill C, 2006, MOL BIOL EVOL, V23, P2480, DOI 10.1093/molbev/msl124; *I RAC REL, AR S IND MAL SING; JACQHERGOUALCH M, MALAY PENINSULA CROS; Kashyap V. K., 2003, International Journal of Human Genetics, V3, P5; Kuhner MK, 2000, GENETICS, V156, P439; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Majumder PP, 2008, CURR OPIN GENET DEV, V18, P280, DOI 10.1016/j.gde.2008.07.003; Mihaescu R, 2009, ALGORITHMICA, V54, P1, DOI 10.1007/s00453-007-9116-4; Nielsen R, 2000, GENETICS, V154, P931; OMAR AH, 2004, LANGUAGES LIT ENCY M; Petkovski E, 2003, INT CONGR SER, V1239, P33, DOI 10.1016/S0531-5131(02)00517-4; RAHMAN NHS, 1998, EARLY HIST ENCY MALA; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SYUKRI I, 2002, SEJARAH KERAJAAN MEL, P131; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR JG, 2003, INDONESIA PEOPLES HI, pR21; TENG YS, 1979, JPN J HUM GENET, V24, P1, DOI 10.1007/BF01890105; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; *THE HUGO PAN AS S, 2009, SCIENCE, V326, P1541; Tishkoff SA, 2004, NAT GENET, V36, pS21, DOI 10.1038/ng1438; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Wheatly Paul, 1961, GOLDEN KHERSONESE, P216; Wolters O. W., 2008, EARLY SE ASIA SELECT	35	62	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18312	10.1371/journal.pone.0018312	http://dx.doi.org/10.1371/journal.pone.0018312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483678	gold, Green Published, Green Submitted			2022-12-27	WOS:000289191300018
J	Peng, JP; Yang, JA; Jin, Q				Peng, Junping; Yang, Jian; Jin, Qi			An Integrated Approach for Finding Overlooked Genes in Shigella	PLOS ONE			English	Article							RNA-ENCODING GENES; MOLECULAR EVOLUTIONARY HISTORY; COMPLETE GENOME SEQUENCE; SMALL NONCODING RNAS; ESCHERICHIA-COLI; COMPUTATIONAL APPROACH; INTERGENIC REGIONS; SOLUBLE-RNAS; IDENTIFICATION; PREDICTION	Background: The completion of numerous genome sequences introduced an era of whole-genome study. However, many genes are missed during genome annotation, including small RNAs (sRNAs) and small open reading frames (sORFs). In order to improve genome annotation, we aimed to identify novel sRNAs and sORFs in Shigella, the principal etiologic agents of bacillary dysentery. Methodology/Principal Findings: We identified 64 sRNAs in Shigella, which were experimentally validated in other bacteria based on sequence conservation. We employed computer-based and tiling array-based methods to search for sRNAs, followed by RT-PCR and northern blots, to identify nine sRNAs in Shigella flexneri strain 301 (Sf301) and 256 regions containing possible sRNA genes. We found 29 candidate sORFs using bioinformatic prediction, array hybridization and RTPCR verification. We experimentally validated 557 (57.9%) DOOR operon predictions in the chromosomes of Sf301 and 46 (76.7%) in virulence plasmid. We found 40 additional co-expressed gene pairs that were not predicted by DOOR. Conclusions/Significance: We provide an updated and comprehensive annotation of the Shigella genome. Our study increased the expected numbers of sORFs and sRNAs, which will impact on future functional genomics and proteomics studies. Our method can be used for large scale reannotation of sRNAs and sORFs in any microbe with a known genome sequence.	[Peng, Junping; Yang, Jian; Jin, Qi] Chinese Acad Med Sci, Peking Union Med Coll, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Peking Union Medical College	Peng, JP (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100037, Peoples R China.	zdsys@vip.sina.com	Jin, Qi/B-5379-2009		National Natural Science Foundation of China [30700033]; Institute of Pathogen Biology [2008IPB112]; National Major Science and Technology Project for Prevention and Treatment of AIDS and Viral Hepatitis and Other Major Infectious Diseases [2009ZX10004-303]; National Basic Research Program of China [2009CB522603, 2005CB522904, 2011CB504901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Institute of Pathogen Biology; National Major Science and Technology Project for Prevention and Treatment of AIDS and Viral Hepatitis and Other Major Infectious Diseases; National Basic Research Program of China(National Basic Research Program of China)	JP is supported by the National Natural Science Fund (Grant No. 30700033) from the National Natural Science Foundation of China and an intramural grant from Institute of Pathogen Biology (Grant No. 2008IPB112). JY is supported by the National Major Science and Technology Project for Prevention and Treatment of AIDS and Viral Hepatitis and Other Major Infectious Diseases (2009ZX10004-303) and the National Basic Research Program (2009CB522603) of China. QJ is supported by the National Basic Research Program (Grants No. 2005CB522904 and 2011CB504901) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama T, 2009, J BACTERIOL, V191, P3321, DOI 10.1128/JB.00120-09; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Carter RJ, 2001, NUCLEIC ACIDS RES, V29, P3928, DOI 10.1093/nar/29.19.3928; Chen S, 2002, BIOSYSTEMS, V65, P157, DOI 10.1016/S0303-2647(02)00013-8; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; GIANGROSSI M, 2010, NUCL ACIDS RES; Grieshaber NA, 2006, MOL MICROBIOL, V59, P541, DOI 10.1111/j.1365-2958.2005.04949.x; Gruber AR, 2007, NUCLEIC ACIDS RES, V35, pW335, DOI 10.1093/nar/gkm222; He HS, 2007, GENOME RES, V17, P1471, DOI 10.1101/gr.6611807; Hemm MR, 2010, J BACTERIOL, V192, P46, DOI 10.1128/JB.00872-09; Hobbs EC, 2010, J BACTERIOL, V192, P59, DOI 10.1128/JB.00873-09; Huang HY, 2009, NUCLEIC ACIDS RES, V37, pD150, DOI 10.1093/nar/gkn852; Huttenhofer A, 2005, TRENDS GENET, V21, P289, DOI 10.1016/j.tig.2005.03.007; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Kumar A, 2002, NAT BIOTECHNOL, V20, P58, DOI 10.1038/nbt0102-58; Kumar R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-350; Liu JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp080; Livny J, 2005, NUCLEIC ACIDS RES, V33, P4096, DOI 10.1093/nar/gki715; Livny J, 2007, CURR OPIN MICROBIOL, V10, P96, DOI 10.1016/j.mib.2007.03.005; Livny J, 2006, NUCLEIC ACIDS RES, V34, P3484, DOI 10.1093/nar/gkl453; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Majdalani N, 2005, CRIT REV BIOCHEM MOL, V40, P93, DOI 10.1080/10409230590918702; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; Mathe C, 2002, NUCLEIC ACIDS RES, V30, P4103, DOI 10.1093/nar/gkf543; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Murphy ER, 2007, INFECT IMMUN, V75, P3470, DOI 10.1128/IAI.00112-07; Nie H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-173; Oglesby AG, 2005, MOL MICROBIOL, V58, P1354, DOI 10.1111/j.1365-2958.2005.04920.x; Ohtani K, 2002, FEMS MICROBIOL LETT, V209, P113, DOI 10.1111/j.1574-6968.2002.tb11118.x; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Peng JP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-218; Peng JP, 2009, INFECT GENET EVOL, V9, P147, DOI 10.1016/j.meegid.2008.10.003; Perez N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007668; Pfeiffer V, 2007, MOL MICROBIOL, V66, P1174, DOI 10.1111/j.1365-2958.2007.05991.x; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Pupo GM, 1997, INFECT IMMUN, V65, P2685, DOI 10.1128/IAI.65.7.2685-2692.1997; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Saito S, 2009, GENE, V428, P2, DOI 10.1016/j.gene.2008.09.024; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; Shimizu T, 2002, MOL MICROBIOL, V43, P257, DOI 10.1046/j.1365-2958.2002.02743.x; Silvaggi JM, 2006, J BACTERIOL, V188, P532, DOI 10.1128/JB.188.2.532-541.2006; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Suzek BE, 2001, BIOINFORMATICS, V17, P1123, DOI 10.1093/bioinformatics/17.12.1123; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Tsui HCT, 2010, J BACTERIOL, V192, P264, DOI 10.1128/JB.01204-09; Wang LL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-255; Wang XF, 2006, BIOINFORMATICS, V22, P2955, DOI 10.1093/bioinformatics/btl525; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wei CD, 2008, PROTEOMICS, V8, P4209, DOI 10.1002/pmic.200800226; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954; Yang J, 2007, J MOL EVOL, V64, P71, DOI 10.1007/s00239-006-0052-8; Ye CY, 2010, J CLIN MICROBIOL, V48, P419, DOI 10.1128/JCM.00614-09	71	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18509	10.1371/journal.pone.0018509	http://dx.doi.org/10.1371/journal.pone.0018509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483688	Green Published, Green Submitted, gold			2022-12-27	WOS:000289191300026
J	Sohn, CS; Cheng, TT; Drummond, ML; Peng, ED; Vermont, SJ; Xia, D; Cheng, SJ; Wastling, JM; Bradley, PJ				Sohn, Catherine S.; Cheng, Tim T.; Drummond, Michael L.; Peng, Eric D.; Vermont, Sarah J.; Xia, Dong; Cheng, Stephen J.; Wastling, Jonathan M.; Bradley, Peter J.			Identification of Novel Proteins in Neospora caninum Using an Organelle Purification and Monoclonal Antibody Approach	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; TACHYZOITE SURFACE PROTEIN; DENSE GRANULE PROTEIN; TOXOPLASMA-GONDII; PARASITOPHOROUS VACUOLE; APICOMPLEXAN PARASITES; HOST-CELLS; INVASION; FAMILY; ROP2	Neospora caninum is an important veterinary pathogen that causes abortion in cattle and neuromuscular disease in dogs. Neospora has also generated substantial interest because it is an extremely close relative of the human pathogen Toxoplasma gondii, yet does not appear to infect humans. While for Toxoplasma there are a wide array of molecular tools and reagents available for experimental investigation, relatively few reagents exist for Neospora. To investigate the unique biological features of this parasite and exploit the recent sequencing of its genome, we have used an organelle isolation and monoclonal antibody approach to identify novel organellar proteins and develop a wide array of probes for subcellular localization. We raised a panel of forty-six monoclonal antibodies that detect proteins from the rhoptries, micronemes, dense granules, inner membrane complex, apicoplast, mitochondrion and parasite surface. A subset of the proteins was identified by immunoprecipitation and mass spectrometry and reveal that we have identified and localized many of the key proteins involved in invasion and host interaction in Neospora. In addition, we identified novel secretory proteins not previously studied in any apicomplexan parasite. Thus, this organellar monoclonal antibody approach not only greatly enhances the tools available for Neospora cell biology, but also identifies novel components of the unique biological characteristics of this important veterinary pathogen.	[Sohn, Catherine S.; Cheng, Tim T.; Drummond, Michael L.; Peng, Eric D.; Cheng, Stephen J.; Bradley, Peter J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA; [Sohn, Catherine S.] Univ Calif Los Angeles, Div Lab Anim Med, Los Angeles, CA USA; [Vermont, Sarah J.; Xia, Dong; Wastling, Jonathan M.] Univ Liverpool, Dept Infect Biol, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Liverpool	Sohn, CS (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA.	pbradley@ucla.edu		Xia, Dong/0000-0003-4571-2776	National Institutes of Health (NIH) [R01 (AI064616)]; BBSRC [BBS/B/03807]; Biotechnology and Biological Sciences Research Council [BBS/B/03807] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064616] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was funded by a National Institutes of Health (NIH) Grant R01 (AI064616) to P.J.B. and BBSRC (BBS/B/03807) funding to J.M.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Anderson-White BR, 2011, CELL MICROBIOL, V13, P18, DOI 10.1111/j.1462-5822.2010.01514.x; Beck HP, 2009, INT J PARASITOL, V39, P175, DOI 10.1016/j.ijpara.2008.10.001; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Bradley PJ, 2007, CURR OPIN MICROBIOL, V10, P582, DOI 10.1016/j.mib.2007.09.013; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Bradley PJ, 2002, MOL BIOCHEM PARASIT, V125, P189, DOI 10.1016/S0166-6851(02)00162-7; Bradley PJ, 2001, INT J PARASITOL, V31, P1177, DOI 10.1016/S0020-7519(01)00242-9; Bradley PJ, 1999, MOL BIOCHEM PARASIT, V100, P103, DOI 10.1016/S0166-6851(99)00035-3; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Carruthers Vern B., 2008, V47, P33; Chen ZQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003611; DeRocher AE, 2008, EUKARYOT CELL, V7, P1518, DOI 10.1128/EC.00081-08; Dubey JP, 2006, J COMP PATHOL, V134, P267, DOI 10.1016/j.jcpa.2005.11.004; Dubey John P., 2003, Korean Journal of Parasitology, V41, P1, DOI 10.3347/kjp.2003.41.1.1; El Hajj H, 2007, PLOS PATHOG, V3, P200, DOI 10.1371/journal.ppat.0030014; El Hajj H, 2006, PROTEOMICS, V6, P5773, DOI 10.1002/pmic.200600187; Fuchs N, 1999, INT J PARASITOL, V29, P1597, DOI 10.1016/S0020-7519(99)00118-6; Gilbert LA, 2007, EUKARYOT CELL, V6, P73, DOI 10.1128/EC.00309-06; Gondim LFP, 2006, TRENDS PARASITOL, V22, P247, DOI 10.1016/j.pt.2006.03.008; Gubbels MJ, 2004, MOL BIOCHEM PARASIT, V137, P99, DOI 10.1016/j.molbiopara.2004.05.007; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Hemphill A, 1997, PARASITOLOGY, V115, P371, DOI 10.1017/S0031182097001455; Hemphill A, 1997, PARASITOLOGY, V115, P581, DOI 10.1017/S0031182097001650; Hemphill A, 2006, PARASITOLOGY, V133, P261, DOI 10.1017/S0031182006000485; Hemphill A, 1998, INT J PARASITOL, V28, P429, DOI 10.1016/S0020-7519(97)00193-8; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Johnson TM, 2007, MOL BIOL CELL, V18, P3039, DOI 10.1091/mbc.E07-01-0040; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Labesse G, 2009, STRUCTURE, V17, P139, DOI 10.1016/j.str.2008.11.005; Lally N, 1997, MOL BIOCHEM PARASIT, V87, P239, DOI 10.1016/S0166-6851(97)00070-4; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; Lovett JL, 2000, MOL BIOCHEM PARASIT, V107, P33, DOI 10.1016/S0166-6851(99)00228-5; Mather MW, 2007, CURR DRUG TARGETS, V8, P49, DOI 10.2174/138945007779315632; Mather MW, 2008, J BIOENERG BIOMEMBR, V40, P425, DOI 10.1007/s10863-008-9176-4; Mercier C, 2005, INT J PARASITOL, V35, P829, DOI 10.1016/j.ijpara.2005.03.011; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; Naguleswaran A, 2003, EXP PARASITOL, V104, P149, DOI 10.1016/S0014-4894(03)00137-1; Naguleswaran A, 2002, INT J PARASITOL, V32, P695, DOI 10.1016/S0020-7519(02)00014-0; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Pino P, 2007, PLOS PATHOG, V3, P1092, DOI 10.1371/journal.ppat.0030115; Reese ML, 2009, TRAFFIC, V10, P1458, DOI 10.1111/j.1600-0854.2009.00958.x; Reiss M, 2001, J CELL BIOL, V152, P563, DOI 10.1083/jcb.152.3.563; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Rome ME, 2008, INFECT IMMUN, V76, P4865, DOI 10.1128/IAI.00782-08; Scapigliati G, 1999, BIOL REPROD, V60, P783, DOI 10.1095/biolreprod60.4.783; Sibley LD, 2009, PHILOS T R SOC B, V364, P2749, DOI 10.1098/rstb.2009.0087; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Sinai AP, 2001, J CELL BIOL, V154, P95, DOI 10.1083/jcb.200101073; Sonda S, 1998, MOL BIOCHEM PARASIT, V97, P97, DOI 10.1016/S0166-6851(98)00133-9; SPEER CA, 1989, J PROTOZOOL, V36, P458, DOI 10.1111/j.1550-7408.1989.tb01081.x; Straub KW, 2009, CELL MICROBIOL, V11, P590, DOI 10.1111/j.1462-5822.2008.01276.x; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Wastling JM, 2009, INT J PARASITOL, V39, P135, DOI 10.1016/j.ijpara.2008.10.003; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wiesner J, 2008, CURR PHARM DESIGN, V14, P855, DOI 10.2174/138161208784041105; Xia D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r116; Zhang HS, 2007, MOL BIOCHEM PARASIT, V151, P205, DOI 10.1016/j.molbiopara.2006.11.005; Zhou XW, 2005, J BIOL CHEM, V280, P34233, DOI 10.1074/jbc.M504160200	63	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18383	10.1371/journal.pone.0018383	http://dx.doi.org/10.1371/journal.pone.0018383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483743	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000289058700022
J	Holmberg, J; He, XB; Peredo, I; Orrego, A; Hesselager, G; Ericsson, C; Hovatta, O; Oba-Shinjo, SM; Marie, SKN; Nister, M; Muhr, J				Holmberg, Johan; He, Xiaobing; Peredo, Inti; Orrego, Abiel; Hesselager, Goran; Ericsson, Christer; Hovatta, Outi; Oba-Shinjo, Sueli Mieko; Nagahashi Marie, Suely Kazue; Nister, Monica; Muhr, Jonas			Activation of Neural and Pluripotent Stem Cell Signatures Correlates with Increased Malignancy in Human Glioma	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTIONAL NETWORK; PROGENITOR IDENTITY; ENDODERM FORMATION; BRAIN-TUMORS; ES CELLS; GLIOBLASTOMA; EXPRESSION; CANCER	The presence of stem cell characteristics in glioma cells raises the possibility that mechanisms promoting the maintenance and self-renewal of tissue specific stem cells have a similar function in tumor cells. Here we characterized human gliomas of various malignancy grades for the expression of stem cell regulatory proteins. We show that cells in high grade glioma co-express an array of markers defining neural stem cells (NSCs) and that these proteins can fulfill similar functions in tumor cells as in NSCs. However, in contrast to NSCs glioma cells co-express neural proteins together with pluripotent stem cell markers, including the transcription factors Oct4, Sox2, Nanog and Klf4. In line with this finding, in high grade gliomas mesodermal-and endodermal-specific transcription factors were detected together with neural proteins, a combination of lineage markers not normally present in the central nervous system. Persistent presence of pluripotent stem cell traits could only be detected in solid tumors, and observations based on in vitro studies and xenograft transplantations in mice imply that this presence is dependent on the combined activity of intrinsic and extrinsic regulatory cues. Together these results demonstrate a general deregulated expression of neural and pluripotent stem cell traits in malignant human gliomas, and indicate that stem cell regulatory factors may provide significant targets for therapeutic strategies.	[Holmberg, Johan; Muhr, Jonas] Karolinska Inst, Ludwig Inst Canc Res, Stockholm, Sweden; [Holmberg, Johan; Muhr, Jonas] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [He, Xiaobing; Orrego, Abiel; Ericsson, Christer; Nister, Monica] Karolinska Univ Hosp Solna, Dept Oncol Pathol, Karolinska Inst, CCK R8 05, Stockholm, Sweden; [Peredo, Inti] Karolinska Univ Hosp Solna, Dept Clin Neurosci, Karolinska Inst, Stockholm, Sweden; [Hesselager, Goran] Uppsala Univ, Univ Hosp, Dept Neurosci, Uppsala, Sweden; [Hovatta, Outi] Karolinska Univ Hosp Huddinge, Dept Clin Sci Intervent & Technol, Karolinska Inst, Stockholm, Sweden; [Oba-Shinjo, Sueli Mieko; Nagahashi Marie, Suely Kazue] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, Brazil	Karolinska Institutet; Ludwig Institute for Cancer Research; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Uppsala University Hospital; Karolinska Institutet; Karolinska University Hospital; Universidade de Sao Paulo	Holmberg, J (corresponding author), Karolinska Inst, Ludwig Inst Canc Res, Stockholm, Sweden.	johan.holmberg@licr.ki.se; jonas.muhr@licr.ki.se	Oba-Shinjo, Sueli M./C-4017-2012; Marie, Suely Kazue Nagahashi/D-1870-2012; Ericsson, Christer/I-5887-2014	Oba-Shinjo, Sueli M./0000-0002-1650-5973; Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Ericsson, Christer/0000-0002-8709-2264	Swedish Cancer Society; Swedish Childhood Cancer Foundation; Swedish Research Council; Karolinska Institutet; Karolinska University Hospital; Cancer Society in Stockholm; King Gustaf V Jubilee Fund	Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Karolinska University Hospital(Karolinska Institutet); Cancer Society in Stockholm; King Gustaf V Jubilee Fund	This project was supported by the Swedish Cancer Society and The Swedish Childhood Cancer Foundation. J.H., M.N. and J.M. are also supported by the Swedish Research Council and J.H., M.N., J.M. and C.E. have received support from Karolinska Institutet or the Karolinska University Hospital. M.N. was supported by the Cancer Society in Stockholm and the King Gustaf V Jubilee Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Clark AT, 2007, STEM CELL REV, V3, P49, DOI 10.1007/s12015-007-0002-x; Das S, 2008, NAT CLIN PRACT NEURO, V4, P427, DOI 10.1038/ncpneuro0862; Du ZH, 2009, GLIA, V57, P724, DOI 10.1002/glia.20800; Engert S, 2009, GENESIS, V47, P603, DOI 10.1002/dvg.20540; Fang XF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-11; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Ge YQ, 2010, BIOCHEM BIOPH RES CO, V397, P711, DOI 10.1016/j.bbrc.2010.06.015; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Holmberg J, 2008, DEVELOPMENT, V135, P1843, DOI 10.1242/dev.020180; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Kim R, 2003, J VIROL, V77, P2056, DOI 10.1128/JVI.77.3.2056-2062.2003; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Liu TM, 2009, STEM CELLS DEV, V18, P1013, DOI 10.1089/scd.2008.0335; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; McCord AM, 2009, MOL CANCER RES, V7, P489, DOI 10.1158/1541-7786.MCR-08-0360; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyama K, 1999, DEV BIOL, V208, P123, DOI 10.1006/dbio.1998.9197; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Pevny L, 2005, CURR OPIN NEUROBIOL, V15, P7, DOI 10.1016/j.conb.2005.01.016; Sattler HP, 2000, PROSTATE, V45, P207, DOI 10.1002/1097-0045(20001101)45:3<207::AID-PROS2>3.0.CO;2-H; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sinner D, 2006, DEVELOPMENT, V133, P1955, DOI 10.1242/dev.02358; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Technau U, 2003, INT J DEV BIOL, V47, P531; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wardle FC, 2008, CURR OPIN GENET DEV, V18, P418, DOI 10.1016/j.gde.2008.07.017; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Xia Y, 2000, CANCER RES, V60, P6303; Yuan P, 2009, GENE DEV, V23, P2507, DOI 10.1101/gad.1831909; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137	58	65	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18454	10.1371/journal.pone.0018454	http://dx.doi.org/10.1371/journal.pone.0018454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483788	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200082
J	Hou, J; Xu, J; Liu, M; Zhao, RZ; Luo, HB; Ke, HM				Hou, Jing; Xu, Jie; Liu, Ming; Zhao, Ruizhi; Luo, Hai-Bin; Ke, Hengming			Structural Asymmetry of Phosphodiesterase-9, Potential Protonation of a Glutamic Acid, and Role of the Invariant Glutamine	PLOS ONE			English	Article							CRYSTAL-STRUCTURES; MECHANICAL CALCULATIONS; INHIBITOR SELECTIVITY; SUBSTRATE-SPECIFICITY; BINDING; INSIGHT; MEMORY; CGMP	PDE9 inhibitors show potential for treatment of diseases such as diabetes. To help with discovery of PDE9 inhibitors, we performed mutagenesis, kinetic, crystallographic, and molecular dynamics analyses on the active site residues of Gln453 and its stabilizing partner Glu406. The crystal structures of the PDE9 Q453E mutant (PDE9Q453E) in complex with inhibitors IBMX and (S)-BAY73-6691 showed asymmetric binding of the inhibitors in two subunits of the PDE9Q453E dimer and also the significant positional change of the M-loop at the active site. The kinetic analysis of the Q453E and E406A mutants suggested that the invariant glutamine is critical for binding of substrates and inhibitors, but is unlikely to play a key role in the differentiation between substrates of cGMP and cAMP. The molecular dynamics simulations suggest that residue Glu406 may be protonated and may thus explain the hydrogen bond distance between two side chain oxygens of Glu453 and Glu406 in the crystal structure of the PDE9Q453E mutant. The information from these studies may be useful for design of PDE9 inhibitors.	[Hou, Jing; Xu, Jie; Liu, Ming; Zhao, Ruizhi; Luo, Hai-Bin; Ke, Hengming] Sun Yat Sen Univ, Struct Biol Lab, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Ke, Hengming] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA; [Ke, Hengming] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Sun Yat Sen University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hou, J (corresponding author), Sun Yat Sen Univ, Struct Biol Lab, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China.	luohb77@mail.sysu.edu.cn; hke@med.unc.edu	, PEP-MX Core/AGV-4051-2022		US NIH [GM59791]; Important National Science and Technology Specific Projects of China [2009ZX09304-003]; Natural Science Foundation of China [30870481]; Natural Science Foundation of Guangdong Province [9451008901001994]; Research Fund for the Doctoral Program of Higher Education of China [20090171120057]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059791] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Important National Science and Technology Specific Projects of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research is financially supported by US NIH grant GM59791 (HK), Important National Science and Technology Specific Projects of China (2009ZX09304-003), Natural Science Foundation of China (30870481), Natural Science Foundation of Guangdong Province (9451008901001994), and the Research Fund for the Doctoral Program of Higher Education of China (20090171120057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell AS, 2004, Patent No. [WO 2004096811, 2004096811]; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; BLACK SC, 2005, Patent No. 2005041972; Blokland A, 2006, CURR PHARM DESIGN, V12, P2511, DOI 10.2174/138161206777698855; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deninno M. P., 2003, Patent No. [WO 03/037899, 03037899]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRYBURG DA, 2003, Patent No. 03037432; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Huai Q, 2004, P NATL ACAD SCI USA, V101, P9624, DOI 10.1073/pnas.0401120101; Huai Q, 2004, J BIOL CHEM, V279, P13095, DOI 10.1074/jbc.M311556200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Ke HM, 2007, CURR TOP MED CHEM, V7, P391, DOI 10.2174/156802607779941242; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; Liu SP, 2008, P NATL ACAD SCI USA, V105, P13309, DOI 10.1073/pnas.0708850105; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Miyamoto S, 1992, J COMPUT CHEM, V13, P8952; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rotella DP, 2002, NAT REV DRUG DISCOV, V1, P674, DOI 10.1038/nrd893; Sharma RK, 2006, INT J MOL MED, V18, P95; STOTE RH, 1995, PROTEINS, V23, P12, DOI 10.1002/prot.340230104; van der Staay FJ, 2008, NEUROPHARMACOLOGY, V55, P908, DOI 10.1016/j.neuropharm.2008.07.005; Wang HC, 2007, J MOL BIOL, V371, P302, DOI 10.1016/j.jmb.2007.05.060; Wang HC, 2007, P NATL ACAD SCI USA, V104, P5782, DOI 10.1073/pnas.0700279104; Wang HC, 2010, J MED CHEM, V53, P1726, DOI 10.1021/jm901519f; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wunder F, 2005, MOL PHARMACOL, V68, P1775, DOI 10.1124/mol.105.017608; Xiong Y, 2006, BIOPHYS J, V91, P1858, DOI 10.1529/biophysj.106.086835; Zhang KYJ, 2004, MOL CELL, V15, P279, DOI 10.1016/j.molcel.2004.07.005; Zoraghi R, 2006, J BIOL CHEM, V281, P5553, DOI 10.1074/jbc.M510372200	37	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18092	10.1371/journal.pone.0018092	http://dx.doi.org/10.1371/journal.pone.0018092			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483814	Green Submitted, Green Published, gold			2022-12-27	WOS:000289057200026
J	Iwasa, Y; Michor, F				Iwasa, Yoh; Michor, Franziska			Evolutionary Dynamics of Intratumor Heterogeneity	PLOS ONE			English	Article							TUMOR HETEROGENEITY; CANCER; MODEL; POLYMORPHISM; PROGRESSION; DIVERSITY; HYPOXIA; CELLS	Intraneoplastic diversity in human tumors is a widespread phenomenon of critical importance for tumor progression and the response to therapeutic intervention. Insights into the evolutionary events that control tumor heterogeneity would be a major breakthrough in our comprehension of cancer development and could lead to more effective prevention methods and therapies. In this paper, we design an evolutionary mathematical framework to study the dynamics of heterogeneity over time. We consider specific situations arising during tumorigenesis, such as the emergence of positively selected mutations ("drivers") and the accumulation of neutral variation ("passengers"). We perform exact computer simulations of the emergence of diverse tumor cell clones over time, and derive analytical estimates for the extent of heterogeneity within a population of cancer cells. Our methods contribute to a quantitative understanding of tumor heterogeneity and the impact of heritable alterations on this tumor trait.	[Iwasa, Yoh] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Kyushu University; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Iwasa, Y (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan.	michor@jimmy.harvard.edu	Iwasa, Yoh/G-5368-2010	Iwasa, Yoh/0000-0003-0691-1852	National Cancer Institute (NCI) initiative [U54CA143798]; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER	National Cancer Institute (NCI) initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (NCI) initiative to fund Physical Science-Oncology Centers (grant U54CA143798) (F.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUADE M, 1989, GENETICS, V122, P607; Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Barton NH, 1998, GENET RES, V72, P123, DOI 10.1017/S0016672398003462; Campbell I, 2009, CANCER RES, V69, P6765, DOI 10.1158/0008-5472.CAN-08-4253; Chevin LM, 2008, GENETICS, V180, P1645, DOI 10.1534/genetics.108.093351; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DEXTER DL, 1986, J CLIN ONCOL, V4, P244, DOI 10.1200/JCO.1986.4.2.244; Durrett R, 2004, THEOR POPUL BIOL, V66, P129, DOI 10.1016/j.tpb.2004.04.002; Durrett R., 2002, PROB APPL S; DURRETT R, 2011, GENETICS IN PRESS; Durrett R, 2010, THEOR POPUL BIOL, V78, P54, DOI 10.1016/j.tpb.2010.05.001; FIDLER IJ, 1978, CANCER RES, V38, P2651; Frank SA, 2003, GENETICS, V163, P1527; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Gonzalez-Garcia I, 2002, P NATL ACAD SCI USA, V99, P13085, DOI 10.1073/pnas.202139299; Grimmett G., 1992, PROBABILITY RANDOM P; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; HEPPNER GH, 1984, CANCER RES, V44, P2259; Ichim CV, 2006, LEUKEMIA LYMPHOMA, V47, P2017, DOI 10.1080/10428190600733325; KAPLAN NL, 1989, GENETICS, V123, P887; KIMURA M, 1964, GENETICS, V49, P725; LEITH JT, 1987, CANCER RES, V47, P1045; Magurran A.E, 2003, MEASURING BIOL DIVER; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Michor F, 2003, P ROY SOC B-BIOL SCI, V270, P2017, DOI 10.1098/rspb.2003.2483; Moran P., 1962, STAT PROCESSES EVOLU; Muggerud AA, 2010, MOL ONCOL, V4, P357, DOI 10.1016/j.molonc.2010.06.007; Park SY, 2010, CLIN CANCER RES, V16, P876, DOI 10.1158/1078-0432.CCR-09-1532; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Pepper JW, 2007, PLOS COMPUT BIOL, V3, P2532, DOI 10.1371/journal.pcbi.0030250; Przeworski M, 2002, GENETICS, V160, P1179; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; SIMONSEN KL, 1995, GENETICS, V141, P413; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; STEPHAN W, 1989, GENETICS, V121, P89, DOI 10.1093/genetics/121.1.89; STEPHAN W, 1992, THEOR POPUL BIOL, V41, P237, DOI 10.1016/0040-5809(92)90045-U; Vincent TL, 2008, INT J ONCOL, V32, P729; WIEHE THE, 1993, MOL BIOL EVOL, V10, P842, DOI 10.1093/oxfordjournals.molbev.a040046; Zhang L, 2009, MATH COMPUT MODEL, V49, P307, DOI 10.1016/j.mcm.2008.05.011	39	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17866	10.1371/journal.pone.0017866	http://dx.doi.org/10.1371/journal.pone.0017866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479218	gold, Green Published			2022-12-27	WOS:000289055700016
J	Kim, SM; Park, KS; Nam, H; Ahn, SW; Kim, S; Sung, JJ; Lee, KW				Kim, Sung-Min; Park, Kyung Seok; Nam, Hyunwoo; Ahn, Suk-Won; Kim, Suhyun; Sung, Jung-Joon; Lee, Kwang-Woo			Capnography for Assessing Nocturnal Hypoventilation and Predicting Compliance with Subsequent Noninvasive Ventilation in Patients with ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; POSITIVE-PRESSURE VENTILATION; QUALITY-OF-LIFE; SLEEP-APNEA; MANAGEMENT; ANESTHESIA; DIAGNOSIS; SURVIVAL; ACCURACY; DISEASE	Background: Patients with amyotrophic lateral sclerosis (ALS) suffer from hypoventilation, which can easily worsen during sleep. This study evaluated the efficacy of capnography monitoring in patients with ALS for assessing nocturnal hypoventilation and predicting good compliance with subsequent noninvasive ventilation (NIV) treatment. Methods: Nocturnal monitoring and brief wake screening by capnography/pulse oximetry, functional scores, and other respiratory signs were assessed in 26 patients with ALS. Twenty-one of these patients were treated with NIV and had their treatment compliance evaluated. Results: Nocturnal capnography values were reliable and strongly correlated with the patients' respiratory symptoms (R(2) = 0.211-0.305, p = 0.004-0.021). The duration of nocturnal hypercapnea obtained by capnography exhibited a significant predictive power for good compliance with subsequent NIV treatment, with an area-under-the-curve value of 0.846 (p=0.018). In contrast, no significant predictive values for nocturnal pulse oximetry or functional scores for nocturnal hypoventilation were found. Brief waking supine capnography was also useful as a screening tool before routine nocturnal capnography monitoring. Conclusion: Capnography is an efficient tool for assessing nocturnal hypoventilation and predicting good compliance with subsequent NIV treatment of ALS patients, and may prove useful as an adjunctive tool for assessing the need for NIV treatment in these patients.	[Kim, Sung-Min; Park, Kyung Seok; Sung, Jung-Joon; Lee, Kwang-Woo] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Kim, Sung-Min; Park, Kyung Seok] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Gyeonggi, South Korea; [Nam, Hyunwoo] Boramae Hosp, Dept Neurol, Seoul, South Korea; [Ahn, Suk-Won] Chung Ang Univ Hosp, Dept Neurol, Seoul, South Korea; [Kim, Suhyun] Natl Canc Ctr, Dept Neurol, Gyeonggi, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Chung Ang University; Chung Ang University Hospital; National Cancer Center - Korea (NCC)	Kim, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea.	jjsaint@snu.ac.kr; sueh916@gmail.com	Lee, Kwang Woo/J-5571-2012; Park, Kyung Seok/J-5472-2012; Nam, Hyunwoo/J-5457-2012		Korea Health Industry Development Institute [A-102044]; Seoul National University [21-2004-0240]	Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); Seoul National University	This work was supported by Grant No. A-102044 from Korea Health Industry Development Institute funds and by Grant No. 21-2004-0240 from the Seoul National University Hospital Research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PM, 2007, AMYOTROPH LATERAL SC, V8, P195, DOI 10.1080/17482960701262376; Atalaia A, 2007, AMYOTROPH LATERAL SC, V8, P101, DOI 10.1080/17482960601029883; Bach JR, 2006, CHEST, V130, P1949, DOI 10.1378/chest.130.6.1949; Bach JR, 2004, CHEST, V126, P1502, DOI 10.1378/chest.126.5.1502; BACH JR, 2004, MANAGEMENT PATIENTS, pR16; Bourke SC, 2006, LANCET NEUROL, V5, P140, DOI 10.1016/S1474-4422(05)70326-4; Bourke SC, 2003, NEUROLOGY, V61, P171, DOI 10.1212/01.WNL.0000076182.13137.38; Braunwald E., 2001, HARRISONS PRINCIPLES; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Buhre W, 2003, LANCET, V362, P1839, DOI 10.1016/S0140-6736(03)14905-7; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Kim SM, 2007, J NEUROL NEUROSUR PS, V78, P1387, DOI 10.1136/jnnp.2006.111195; Kirk VG, 2006, SLEEP, V29, P1601, DOI 10.1093/sleep/29.12.1601; Kotterba S, 2001, CLIN NEUROL NEUROSUR, V103, P87, DOI 10.1016/S0303-8467(01)00120-2; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; Lechtzin N, 2002, CHEST, V121, P436, DOI 10.1378/chest.121.2.436; LEGER P, 1994, CHEST, V105, P100, DOI 10.1378/chest.105.1.100; Leigh PN, 2003, J NEUROL NEUROSUR PS, V74, P32; LIU SY, 1992, CHEST, V102, P1512, DOI 10.1378/chest.102.5.1512; Lo Coco D, 2006, NEUROLOGY, V67, P761, DOI 10.1212/01.wnl.0000227785.73714.64; MAGNAN A, 1993, CHEST, V103, P129, DOI 10.1378/chest.103.1.129; Miller RG, 1999, MUSCLE NERVE, V22, P1104, DOI 10.1002/(SICI)1097-4598(199908)22:8<1104::AID-MUS15>3.0.CO;2-2; Mitsumoto H., 1998, AMYOTROPHIC LATERAL; Newsom-Davis IC, 2001, J NEUROL NEUROSUR PS, V71, P482, DOI 10.1136/jnnp.71.4.482; Radunovic A, 2007, LANCET NEUROL, V6, P913, DOI 10.1016/S1474-4422(07)70244-2; SANDERS MH, 1994, CHEST, V106, P472, DOI 10.1378/chest.106.2.472; SCHIFFMAN PL, 1993, CHEST, V103, P508, DOI 10.1378/chest.103.2.508; Tuggey JM, 2005, THORAX, V60, P859, DOI 10.1136/thx.2005.041327; WHITESELL R, 1981, ANESTH ANALG, V60, P508	29	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17893	10.1371/journal.pone.0017893	http://dx.doi.org/10.1371/journal.pone.0017893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479202	Green Published, gold, Green Submitted			2022-12-27	WOS:000289055700018
J	Bhogal, RH; Hodson, J; Bartlett, DC; Weston, CJ; Curbishley, SM; Haughton, E; Williams, KT; Reynolds, GM; Newsome, PN; Adams, DH; Afford, SC				Bhogal, Ricky H.; Hodson, James; Bartlett, David C.; Weston, Christopher J.; Curbishley, Stuart M.; Haughton, Emma; Williams, Kevin T.; Reynolds, Gary M.; Newsome, Phillip N.; Adams, David H.; Afford, Simon C.			Isolation of Primary Human Hepatocytes from Normal and Diseased Liver Tissue: A One Hundred Liver Experience	PLOS ONE			English	Article								Successful and consistent isolation of primary human hepatocytes remains a challenge for both cell-based therapeutics/transplantation and laboratory research. Several centres around the world have extensive experience in the isolation of human hepatocytes from non-diseased livers obtained from donor liver surplus to surgical requirement or at hepatic resection for tumours. These livers are an important but limited source of cells for therapy or research. The capacity to isolate cells from diseased liver tissue removed at transplantation would substantially increase availability of cells for research. However no studies comparing the outcome of human hepatocytes isolation from diseased and non-diseased livers presently exist. Here we report our experience isolating human hepatocytes from organ donors, non-diseased resected liver and cirrhotic tissue. We report the cell yields and functional qualities of cells isolated from the different types of liver and demonstrate that a single rigorous protocol allows the routine harvest of good quality primary hepatocytes from the most commonly accessible human liver tissue samples.	[Bhogal, Ricky H.; Bartlett, David C.; Weston, Christopher J.; Curbishley, Stuart M.; Haughton, Emma; Williams, Kevin T.; Reynolds, Gary M.; Newsome, Phillip N.; Adams, David H.; Afford, Simon C.] Univ Birmingham, Liver Res Ctr, Inst Biomed Res, Birmingham, W Midlands, England; [Hodson, James] Queen Elizabeth Hosp, Univ Hosp Birmingham NHS Fdn Trust, Birmingham B15 2TH, W Midlands, England	University of Birmingham; University of Birmingham	Bhogal, RH (corresponding author), Univ Birmingham, Liver Res Ctr, Inst Biomed Res, Birmingham, W Midlands, England.	balsin@hotmail.com	Newsome, Philip N/D-4495-2018; Reynolds, Gary/F-8641-2014; Shepherd, Emma/ADY-7280-2022; Adams, David H/C-9092-2009	Newsome, Philip N/0000-0001-6085-3652; Reynolds, Gary/0000-0002-3250-0582; Shepherd, Emma/0000-0002-1345-1746; Adams, David H/0000-0001-6776-0336; Bartlett, David/0000-0001-8564-9420; Hodson, James/0000-0003-3487-0090; Weston, Chris/0000-0002-9651-1264	Wellcome Trust [DDDP. RCHX14183]; MRC [G0901952] Funding Source: UKRI; Medical Research Council [G0901952] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been funded by the Wellcome Trust (grant number DDDP. RCHX14183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova K, 2005, CELL TRANSPLANT, V14, P845, DOI 10.3727/000000005783982530; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bhogal RH, 2010, LIVER TRANSPLANT, V16, P1303, DOI 10.1002/lt.22157; Dhawan A, 2005, ACTA GASTRO-ENT BELG, V68, P457; Gonzalez R, 2007, FREE RADICAL BIO MED, V43, P1439, DOI 10.1016/j.freeradbiomed.2007.07.023; Guicciardi ME, 1998, HEPATOLOGY, V28, P1721, DOI 10.1002/hep.510280639; Hewes JC, 2006, J HEPATOL, V45, P263, DOI 10.1016/j.jhep.2006.02.015; Hughes RD, 2006, LIVER TRANSPLANT, V12, P713, DOI 10.1002/lt.20732; Kawahara T, 2010, LIVER TRANSPLANT, V16, P974, DOI 10.1002/lt.22099; Laba A, 2005, ARCH IMMUNOL THER EX, V53, P442; LeCluyse EL, 2010, METHODS MOL BIOL, V640, P57, DOI 10.1007/978-1-60761-688-7_3; Li AP, 2007, CHEM-BIOL INTERACT, V168, P16, DOI 10.1016/j.cbi.2007.01.001; LI AP, 1992, J TISSUE CULT METHOD, V14, P139; Mitry RR, 2003, CELL TRANSPLANT, V12, P69, DOI 10.3727/000000003783985197; Pichard Lydiane, 2006, Methods Mol Biol, V320, P283; Rodrigues CMP, 1998, MOL MED, V4, P165, DOI 10.1007/BF03401914; Sagias FG, 2010, CELL TRANSPLANT, V19, P1487, DOI 10.3727/096368910X514620; Schaffert CS, 2009, WORLD J GASTROENTERO, V15, P1209, DOI 10.3748/wjg.15.1209; VORDNAN FW, 2008, ARTIF ORGANS, V32, P205	19	98	102	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18222	10.1371/journal.pone.0018222	http://dx.doi.org/10.1371/journal.pone.0018222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479238	Green Published, gold, Green Submitted			2022-12-27	WOS:000289054600034
J	Figueroa, KP; Waters, MF; Garibyan, V; Bird, TD; Gomez, CM; Ranum, LPW; Minassian, NA; Papazian, DM; Pulst, SM				Figueroa, Karla P.; Waters, Michael F.; Garibyan, Vartan; Bird, Thomas D.; Gomez, Christopher M.; Ranum, Laura P. W.; Minassian, Natali A.; Papazian, Diane M.; Pulst, Stefan M.			Frequency of KCNC3 DNA Variants as Causes of Spinocerebellar Ataxia 13 (SCA13)	PLOS ONE			English	Article							DOMINANT CEREBELLAR-ATAXIA; POTASSIUM CHANNEL; MUTATIONS	Background: Gain-of function or dominant-negative mutations in the voltage-gated potassium channel KCNC3 (Kv3.3) were recently identified as a cause of autosomal dominant spinocerebellar ataxia. Our objective was to describe the frequency of mutations associated with KCNC3 in a large cohort of index patients with sporadic or familial ataxia presenting to three US ataxia clinics at academic medical centers. Methodology: DNA sequence analysis of the coding region of the KCNC3 gene was performed in 327 index cases with ataxia. Analysis of channel function was performed by expression of DNA variants in Xenopus oocytes. Principal Findings: Sequence analysis revealed two non-synonymous substitutions in exon 2 and five intronic changes, which were not predicted to alter splicing. We identified another pedigree with the p.Arg423His mutation in the highly conserved S4 domain of this channel. This family had an early-onset of disease and associated seizures in one individual. The second coding change, p.Gly263Asp, subtly altered biophysical properties of the channel, but was unlikely to be disease-associated as it occurred in an individual with an expansion of the CAG repeat in the CACNA1A calcium channel. Conclusions: Mutations in KCNC3 are a rare cause of spinocerebellar ataxia with a frequency of less than 1%. The p.Arg423His mutation is recurrent in different populations and associated with early onset. In contrast to previous p.Arg423His mutation carriers, we now observed seizures and mild mental retardation in one individual. This study confirms the wide phenotypic spectrum in SCA13.	[Figueroa, Karla P.; Garibyan, Vartan; Pulst, Stefan M.] Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA; [Waters, Michael F.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Waters, Michael F.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Bird, Thomas D.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Bird, Thomas D.] Vet Affairs Med Ctr, Seattle, WA 98108 USA; [Gomez, Christopher M.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Ranum, Laura P. W.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Ranum, Laura P. W.] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN USA; [Minassian, Natali A.; Papazian, Diane M.] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90024 USA; [Pulst, Stefan M.] Univ Utah, Inst Brain, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Chicago; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Los Angeles; Utah System of Higher Education; University of Utah	Figueroa, KP (corresponding author), Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA.	stefan.pulst@hsc.utah.edu			Veterans Affairs Research Funds; National Institutes of Health [R01 NS058500, 5R01NS033123-10]; American Academy of Neurology Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033123, R01NS040389, R01NS058500, R01NS056158] Funding Source: NIH RePORTER	Veterans Affairs Research Funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Academy of Neurology Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	funding sources for this work are: Thomas D. Bird, MD - Veterans Affairs Research Funds, Role: Salary and supplies, Diane M. Papazian PhD National Institutes of Health R01 NS058500, Role: Salary and supplies, Stefan M. Pulst MD, Dr Med - National Institutes of Health 5R01NS033123-10, Role: Salary and supplies, Michael F. Waters - Raymond D. Adams Clinical Research Training Fellowship from the American Academy of Neurology Foundation, Role: Salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	den Dunnen JT, 2000, HUM MUTAT, V15, P7; Figueroa KP, 2010, HUM MUTAT, V31, P191, DOI 10.1002/humu.21165; Herman-Bert A, 2000, AM J HUM GENET, V67, P229, DOI 10.1086/302958; HOFFMAN EP, 1995, CELL, V80, P681, DOI 10.1016/0092-8674(95)90345-3; Houlden H, 2007, NAT GENET, V39, P1434, DOI 10.1038/ng.2007.43; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Kuzmenkin A, 2003, PFLUG ARCH EUR J PHY, V447, P71, DOI 10.1007/s00424-003-1137-5; Mariotti C, 2008, CEREBELLUM, V7, P184, DOI 10.1007/s12311-008-0053-9; Matsumura R, 1997, NEUROLOGY, V49, P1238, DOI 10.1212/WNL.49.5.1238; Moseley ML, 1998, NEUROLOGY, V51, P1666, DOI 10.1212/WNL.51.6.1666; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Pujana MA, 1999, HUM GENET, V104, P516, DOI 10.1007/s004390050997; Rae JL, 2000, EXP EYE RES, V70, P339, DOI 10.1006/exer.1999.0796; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Schols L, 2000, HUM GENET, V107, P132, DOI 10.1007/s004390000346; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; van de Leemput J, 2007, PLOS GENET, V3, P1076, DOI 10.1371/journal.pgen.0030108; Waters MF, 2006, NAT GENET, V38, P447, DOI 10.1038/ng1758; Waters MF, 2005, NEUROLOGY, V65, P1111, DOI 10.1212/01.wnl.0000177490.05162.41; Yabe I, 2003, ARCH NEUROL-CHICAGO, V60, P1749, DOI 10.1001/archneur.60.12.1749	21	40	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17811	10.1371/journal.pone.0017811	http://dx.doi.org/10.1371/journal.pone.0017811			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479265	Green Published, gold, Green Submitted			2022-12-27	WOS:000289054600017
J	Fukuma, A; Abe, M; Morikawa, Y; Miyazawa, T; Yasuda, J				Fukuma, Aiko; Abe, Masumi; Morikawa, Yuko; Miyazawa, Takayuki; Yasuda, Jiro			Cloning and Characterization of the Antiviral Activity of Feline Tetherin/BST-2	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; MOLECULAR-CLONING; VIRUS; PROTEIN; RESTRICTION; DETERMINES; RELEASE; MARKER; CELLS; GENE	Human Tetherin/BST-2 has recently been identified as a cellular antiviral factor that blocks the release of various enveloped viruses. In this study, we cloned a cDNA fragment encoding a feline homolog of Tetherin/BST-2 and characterized the protein product. The degree of amino acid sequence identity between human Tetherin/BST-2 and the feline homolog was 44.4%. Similar to human Tetherin/BST-2, the expression of feline Tetherin/BST-2 mRNA was inducible by type I interferon (IFN). Exogenous expression of feline Tetherin/BST-2 efficiently inhibited the release of feline endogenous retrovirus RD-114. The extracellular domain of feline Tetherin/BST-2 has two putative N-linked glycosylation sites, N79 and N119. Complete loss of N-linked glycosylation by introduction of mutations into both sites resulted in almost complete abolition of its antiviral activity. In addition, feline Tetherin/BST-2 was insensitive to antagonism by HIV-1 Vpu, although the antiviral activity of human Tetherin/BST-2 was antagonized by HIV-1 Vpu. Our data suggest that feline Tetherin/BST-2 functions as a part of IFN-induced innate immunity against virus infection and that the induction of feline Tetherin/BST-2 in vivo may be effective as a novel antiviral strategy for viral infection.	[Fukuma, Aiko; Yasuda, Jiro] Nagasaki Univ, Dept Emerging Infect Dis, Inst Trop Med, Nagasaki 852, Japan; [Fukuma, Aiko; Abe, Masumi; Yasuda, Jiro] Natl Res Inst Police Sci, Dept Forens Sci 1, Biol Sect Microbiol 5, Kashiwa, Chiba 2270882, Japan; [Fukuma, Aiko; Morikawa, Yuko] Kitasato Univ, Kitasato Inst Life Sci, Tokyo, Japan; [Fukuma, Aiko; Morikawa, Yuko] Kitasato Univ, Grad Sch Infect Control, Tokyo, Japan; [Miyazawa, Takayuki] Kyoto Univ, Inst Virus Res, Lab Signal Transduct, Kyoto 606, Japan	Nagasaki University; Kitasato University; Kitasato University; Kyoto University	Fukuma, A (corresponding author), Nagasaki Univ, Dept Emerging Infect Dis, Inst Trop Med, Nagasaki 852, Japan.	j-yasuda@nagasaki-u.ac.jp		Miyazawa, Takayuki/0000-0003-1938-9661; Yasuda, Jiro/0000-0001-9928-5621	Bio-Oriented Technology Research Advancement Institution; Japan Society for the Promotion of Science	Bio-Oriented Technology Research Advancement Institution; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Bio-Oriented Technology Research Advancement Institution and the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; Baumann JG, 1998, J VIROL, V72, P7685, DOI 10.1128/JVI.72.9.7685-7687.1998; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Douglas JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000913; DUNN KJ, 1993, J VIROL, V67, P4704, DOI 10.1128/JVI.67.8.4704-4711.1993; GOTTLINGER HG, 1993, P NATL ACAD SCI USA, V90, P7381, DOI 10.1073/pnas.90.15.7381; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; Mattiuzzo G, 2010, J VIROL, V84, P2618, DOI 10.1128/JVI.01928-09; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Miyazawa T, 2010, J VIROL, V84, P3690, DOI 10.1128/JVI.02715-09; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; REEVES RH, 1985, J VIROL, V56, P303, DOI 10.1128/JVI.56.1.303-306.1985; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Rong LW, 2009, J VIROL, V83, P7536, DOI 10.1128/JVI.00620-09; Sakaguchi S, 2008, J VET MED SCI, V70, P785, DOI 10.1292/jvms.70.785; Sakuma T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006934; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Urata S, 2006, J VIROL, V80, P4191, DOI 10.1128/JVI.80.8.4191-4195.2006; Yasuda J, 1998, J VIROL, V72, P4095, DOI 10.1128/JVI.72.5.4095-4103.1998; Yoshikawa R, 2010, J CLIN MICROBIOL, V48, P3366, DOI 10.1128/JCM.00992-10; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	32	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18247	10.1371/journal.pone.0018247	http://dx.doi.org/10.1371/journal.pone.0018247			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479233	Green Submitted, Green Published, gold			2022-12-27	WOS:000289054600037
J	Hoeke, RK; Jokiel, PL; Buddemeier, RW; Brainard, RE				Hoeke, Ron K.; Jokiel, Paul L.; Buddemeier, Robert W.; Brainard, Russell E.			Projected Changes to Growth and Mortality of Hawaiian Corals over the Next 100 Years	PLOS ONE			English	Article							ZONE CHLOROPHYLL FRONT; CLIMATE-CHANGE; OCEAN ACIDIFICATION; CALCIFICATION RATE; TEMPERATURE; REEFS; ADAPTATION; RESILIENCE; PACIFIC; IMPACTS	Background: Recent reviews suggest that the warming and acidification of ocean surface waters predicated by most accepted climate projections will lead to mass mortality and declining calcification rates of reef-building corals. This study investigates the use of modeling techniques to quantitatively examine rates of coral cover change due to these effects. Methodology/Principal Findings: Broad-scale probabilities of change in shallow-water scleractinian coral cover in the Hawaiian Archipelago for years 2000-2099 A. D. were calculated assuming a single middle-of-the-road greenhouse gas emissions scenario. These projections were based on ensemble calculations of a growth and mortality model that used sea surface temperature (SST), atmospheric carbon dioxide (CO2), observed coral growth (calcification) rates, and observed mortality linked to mass coral bleaching episodes as inputs. SST and CO2 predictions were derived from the World Climate Research Programme (WCRP) multi-model dataset, statistically downscaled with historical data. Conclusions/Significance: The model calculations illustrate a practical approach to systematic evaluation of climate change effects on corals, and also show the effect of uncertainties in current climate predictions and in coral adaptation capabilities on estimated changes in coral cover. Despite these large uncertainties, this analysis quantitatively illustrates that a large decline in coral cover is highly likely in the 21(st) Century, but that there are significant spatial and temporal variances in outcomes, even under a single climate change scenario.	[Hoeke, Ron K.] Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Hoeke, Ron K.; Brainard, Russell E.] NOAA, CRED, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA; [Jokiel, Paul L.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Buddemeier, Robert W.] Kansas Geol Survey, Lawrence, KS 66044 USA	University of Hawaii System; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System	Hoeke, RK (corresponding author), Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.	hoeke@hawaii.edu	Hoeke, Ron K/F-4085-2014	Hoeke, Ron K/0000-0003-0576-9436	EPA [R832224-010]; NOAA-NOS MOA; U.S. Environmental Protection Agency's (EPA's) Office of Atmospheric Programs [68-W-02-027]; Office of Research and Development [R832224]	EPA(United States Environmental Protection Agency); NOAA-NOS MOA; U.S. Environmental Protection Agency's (EPA's) Office of Atmospheric Programs(United States Environmental Protection Agency); Office of Research and Development	This work was partially supported by EPA Star Grant R832224-010 and NOAA-NOS MOA "Research in Support of the NWHI Coral Reef Ecosystem Reserve, HIMB, SOEST, UH Manoa". Additional support was provided by the NOAA Coral Reef Conservation Program. The COMBO model was developed and tested with the financial support of the U.S. Environmental Protection Agency's (EPA's) Office of Atmospheric Programs (Contract #68-W-02-027) and Office of Research and Development (STAR Grant #R832224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2005, SCI MAR, V69, P347, DOI 10.3989/scimar.2005.69n3347; Atkinson MJ, 2008, MAR ECOL PROG SER, V373, P249, DOI 10.3354/meps07867; Baird A, 2008, SCIENCE, V320, P315, DOI 10.1126/science.320.5874.315; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Bograd SJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020637; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Buddemeier RW, 2008, LIMNOL OCEANOGR-METH, V6, P395, DOI 10.4319/lom.2008.6.395; BUDDEMEIER RW, MODELING RE IN PRESS; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; CLAUSEN CD, 1975, MAR BIOL, V33, P93, DOI 10.1007/BF00390713; COLES SL, 1978, MAR BIOL, V49, P187, DOI 10.1007/BF00391130; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; DONNER SD, 2007, P NATL ACAD SCI USA, V104, P5259; Grigg R.W., 1982, Coral Reefs, V1, P29, DOI 10.1007/BF00286537; Grigg Richard W., 2008, V1, P573, DOI 10.1007/978-1-4020-6847-8_14; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoeke RK, 2009, J OPER OCEANOGR, V2, P3, DOI 10.1080/1755876X.2009.12027737; Hoeke Ronald, 2006, Atoll Research Bulletin, P489; Houck J. E, 1977, Proceedings int Coral Reef Symp, V3, P425; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jokiel Paul L., 2004, Pacific Science, V58, P159, DOI 10.1353/psc.2004.0018; Jokiel PL, 2004, GLOBAL CHANGE BIOL, V10, P1627, DOI 10.1111/j.1365-2486.2004.00836.x; JOKIEL PL, 1974, PAC SCI, V28, P1; JOKIEL PL, 1977, MAR BIOL, V43, P201, DOI 10.1007/BF00402312; Joos F, 2001, GLOBAL BIOGEOCHEM CY, V15, P891, DOI 10.1029/2000GB001375; Kenyon J. C., 2006, P 10 INT COR REEF S, P631; Kenyon JC, 2006, COAST MANAGE, V34, P339, DOI 10.1080/08920750600686711; Kleypas J. A., 2006, CORAL REEFS CLIMATE, V61, P73, DOI DOI 10.1029/61CE06; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Knutti R, 2006, J CLIMATE, V19, P4224, DOI 10.1175/JCLI3865.1; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Maina J, 2008, ECOL MODEL, V212, P180, DOI 10.1016/j.ecolmodel.2007.10.033; Manzello DP, 2010, CORAL REEFS, V29, P749, DOI 10.1007/s00338-010-0623-4; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Murphy J, 1999, J CLIMATE, V12, P2256, DOI 10.1175/1520-0442(1999)012<2256:AEOSAD>2.0.CO;2; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Riegl BM, 2009, ECOL MODEL, V220, P192, DOI 10.1016/j.ecolmodel.2008.09.022; Sheppard C, 2005, MAR ENVIRON RES, V60, P389, DOI 10.1016/j.marenvres.2004.12.006; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Solomon S., 2007, PHYS SCI BASIS WORKI; Takahashi T, 1997, P NATL ACAD SCI USA, V94, P8292, DOI 10.1073/pnas.94.16.8292; VAZGUEZ J, 1998, NOAA NASA AVHRR OCEA; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x	56	43	44	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18038	10.1371/journal.pone.0018038	http://dx.doi.org/10.1371/journal.pone.0018038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479235	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000289054600025
J	Wiley, M; Teygong, C; Phelps, E; Radke, J; Blader, IJ				Wiley, Mandi; Teygong, Crystal; Phelps, Eric; Radke, Jay; Blader, Ira J.			Serum Response Factor Regulates Immediate Early Host Gene Expression in Toxoplasma gondii-Infected Host Cells	PLOS ONE			English	Article							ANTHRAX LETHAL FACTOR; TRANSCRIPTION; ACTIVATION; SRF; PHOSPHORYLATION; DOMAIN; FIBROBLASTS; INHIBITION; APOPTOSIS; KINASES	Toxoplasma gondii is a wide spread pathogen that can cause severe and even fatal disease in fetuses and immune-compromised hosts. As an obligate intracellular parasite, Toxoplasma must alter the environment of its host cell in order to establish its replicative niche. This is accomplished, in part, by secretion of factors into the host cell that act to modulate processes such as transcription. Previous studies demonstrated that genes encoding transcription factors such as c-jun, junB, EGR1, and EGR2 were amongst the host genes that were the most rapidly upregulated following infection. In cells stimulated with growth factors, these genes are regulated by a transcription factor named Serum Response Factor. Serum Response Factor is a ubiquitously expressed DNA binding protein that regulates growth and actin cytoskeleton genes via MAP kinase or actin cytoskeletal signaling, respectively. Here, we report that Toxoplasma infection leads to the rapid activation of Serum Response Factor. Serum Response Factor activation is a Toxoplasma-specific event since the transcription factor is not activated by the closely related protozoan parasite, Neospora caninum. We further demonstrate that Serum Response Factor activation requires a parasite-derived secreted factor that signals via host MAP kinases but independently of the host actin cytoskeleton. Together, these data define Serum Response Factor as a host cell transcription factor that regulates immediate early gene expression in Toxoplasma-infected cells.	[Wiley, Mandi; Teygong, Crystal; Phelps, Eric; Blader, Ira J.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Radke, Jay] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA; [Radke, Jay] Montana State Univ, Ctr Immunotherapies Zoonot Dis, Bozeman, MT 59717 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Wiley, M (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.	iblader@ouhsc.edu			NIH [AI069986, AIO74355-01, P20 RR020185]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069986] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI069986 to I.J.B. and AIO74355-01 and P20 RR020185 to J.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Blader IJ, 2009, APMIS, V117, P458, DOI 10.1111/j.1600-0463.2009.02453.x; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Busche S, 2008, J CELL SCI, V121, P1025, DOI 10.1242/jcs.014456; Chang SH, 2004, J NEUROSCI, V24, P2277, DOI 10.1523/JNEUROSCI.4868-03.2004; Collier RJ, 2009, MOL ASPECTS MED, V30, P413, DOI 10.1016/j.mam.2009.06.003; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; COPPENS I, 2001, EXPERT REV MOL MED, P1; Gail M, 2001, MOL GENET GENOMICS, V265, P905, DOI 10.1007/s004380100487; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Gilbert LA, 2007, EUKARYOT CELL, V6, P73, DOI 10.1128/EC.00309-06; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Goebel S, 2001, J CELL SCI, V114, P3495; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; JOHANSEN FE, 1994, MOL CELL BIOL, V14, P5920, DOI 10.1128/MCB.14.9.5920; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; KHAN A, 2009, PHENOTYPIC GENE EXPR, P1828; Kim Ji-Young, 2006, Korean Journal of Parasitology, V44, P197, DOI 10.3347/kjp.2006.44.3.197; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Kim L, 2005, J IMMUNOL, V174, P4178, DOI 10.4049/jimmunol.174.7.4178; Leaner VD, 2003, ONCOGENE, V22, P5619, DOI 10.1038/sj.onc.1206644; Masek KS, 2006, J CELL SCI, V119, P4565, DOI 10.1242/jcs.03206; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Ong YC, 2010, J BIOL CHEM, V285, P28731, DOI 10.1074/jbc.M110.112359; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Payne TM, 2003, J CELL SCI, V116, P4345, DOI 10.1242/jcs.00756; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Phelps ED, 2008, INFECT IMMUN, V76, P4703, DOI 10.1128/IAI.01447-07; Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955; Radke JR, 2006, PLOS PATHOG, V2, P964, DOI 10.1371/journal.ppat.0020105; Ravindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008143; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Salles II, 2003, P NATL ACAD SCI USA, V100, P12426, DOI 10.1073/pnas.2134042100; Sharrocks AD, 2002, BIOCHEM SOC T, V30, P1; Sinai AP, 1997, J CELL SCI, V110, P2117; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Spyres LM, 2001, INFECT IMMUN, V69, P599, DOI 10.1128/IAI.69.1.599-601.2001; SWEENEY KR, 2010, EUKARYOTIC CELL; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Walker' ME, 2008, MICROBES INFECT, V10, P1440, DOI 10.1016/j.micinf.2008.08.014; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Wiley M, 2010, J BIOL CHEM, V285, P26852, DOI 10.1074/jbc.M110.147041; Witteck A, 2003, EXP CELL RES, V287, P106, DOI 10.1016/S0014-4827(03)00129-0; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703	49	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18335	10.1371/journal.pone.0018335	http://dx.doi.org/10.1371/journal.pone.0018335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479245	Green Published, Green Submitted, gold			2022-12-27	WOS:000289054600045
J	Wen, ZN; Wang, ZJ; Wang, S; Ravula, R; Yang, L; Xu, J; Wang, C; Zuo, Z; Chow, MSS; Shi, LM; Huang, Y				Wen, Zhining; Wang, Zhijun; Wang, Steven; Ravula, Ranadheer; Yang, Lun; Xu, Jun; Wang, Charles; Zuo, Zhong; Chow, Moses S. S.; Shi, Leming; Huang, Ying			Discovery of Molecular Mechanisms of Traditional Chinese Medicinal Formula Si-Wu-Tang Using Gene Expression Microarray and Connectivity Map	PLOS ONE			English	Article							HEME OXYGENASE-1; UP-REGULATION; CONSTITUENTS; DETOXIFICATION; CONSISTENCY; PROFILES; THERAPY; EXTRACT; INDUCE; KEGG	To pursue a systematic approach to discovery of mechanisms of action of traditional Chinese medicine (TCM), we used microarrays, bioinformatics and the "Connectivity Map" (CMAP) to examine TCM-induced changes in gene expression. We demonstrated that this approach can be used to elucidate new molecular targets using a model TCM herbal formula Si-Wu-Tang (SWT) which is widely used for women's health. The human breast cancer MCF-7 cells treated with 0.1 mu M estradiol or 2.56 mg/ml of SWT showed dramatic gene expression changes, while no significant change was detected for ferulic acid, a known bioactive compound of SWT. Pathway analysis using differentially expressed genes related to the treatment effect identified that expression of genes in the nuclear factor erythroid 2-related factor 2 (Nrf2) cytoprotective pathway was most significantly affected by SWT, but not by estradiol or ferulic acid. The Nrf2-regulated genes HMOX1, GCLC, GCLM, SLC7A11 and NQO1 were upreguated by SWT in a dose-dependent manner, which was validated by real-time RT-PCR. Consistently, treatment with SWT and its four herbal ingredients resulted in an increased antioxidant response element (ARE)-luciferase reporter activity in MCF-7 and HEK293 cells. Furthermore, the gene expression profile of differentially expressed genes related to SWT treatment was used to compare with those of 1,309 compounds in the CMAP database. The CMAP profiles of estradiol-treated MCF-7 cells showed an excellent match with SWT treatment, consistent with SWT's widely claimed use for women's diseases and indicating a phytoestrogenic effect. The CMAP profiles of chemopreventive agents withaferin A and resveratrol also showed high similarity to the profiles of SWT. This study identified SWT as an Nrf2 activator and phytoestrogen, suggesting its use as a nontoxic chemopreventive agent, and demonstrated the feasibility of combining microarray gene expression profiling with CMAP mining to discover mechanisms of actions and to identify new health benefits of TCMs.	[Wen, Zhining; Yang, Lun; Shi, Leming] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Wen, Zhining] Sichuan Univ, Coll Chem, Chengdu 610064, Sichuan, Peoples R China; [Wang, Zhijun; Wang, Steven; Ravula, Ranadheer; Chow, Moses S. S.; Huang, Ying] Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA USA; [Wang, Zhijun; Wang, Steven; Ravula, Ranadheer; Chow, Moses S. S.; Huang, Ying] Western Univ Hlth Sci, Coll Pharm, Ctr Adv Drug Res & Evaluat, Pomona, CA USA; [Yang, Lun; Shi, Leming] Fudan Univ, Sch Pharm, Dept Clin Pharm, Shanghai 200433, Peoples R China; [Yang, Lun; Shi, Leming] Fudan Univ, Sch Pharm, Ctr Pharmacogenom, Shanghai 200433, Peoples R China; [Xu, Jun] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Inst Med Genet, David Geffen Sch Med, Los Angeles, CA 90048 USA; [Wang, Charles] City Hope Comprehens Canc Ctr, Beckman Res Inst, Duarte, CA USA; [Zuo, Zhong] Chinese Univ Hong Kong, Fac Med, Sch Pharm, Hong Kong, Hong Kong, Peoples R China	US Food & Drug Administration (FDA); Sichuan University; Western University of Health Sciences; Western University of Health Sciences; Fudan University; Fudan University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; City of Hope; Beckman Research Institute of City of Hope; Chinese University of Hong Kong	Wen, ZN (corresponding author), US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	leming.shi@gmail.com; yhuang@westernu.edu	Zuo, Zhong/B-6884-2008; Yang, Lun/B-4859-2012; Shi, Leming/B-3150-2010; Wang, zhijun/G-8543-2015	Shi, Leming/0000-0002-7143-2033; Wang, zhijun/0000-0001-8783-8946; Zuo, Zhong/0000-0002-6976-6157	U.S. Food and Drug Administration; Innovation and Technology Commission of the Hong Kong Special Administrative Region of the People's Republic of China [ITS/112/07, ITS/446/09]	U.S. Food and Drug Administration; Innovation and Technology Commission of the Hong Kong Special Administrative Region of the People's Republic of China	This work was supported by the U.S. Food and Drug Administration. The preparation of Si-Wu-Tang product was supported by the Innovation and Technology Fund (ITS/112/07) from the Innovation and Technology Commission of the Hong Kong Special Administrative Region of the People's Republic of China. This study was partially supported by the Innovation and Technology Grant (ITS/446/09) from the Innovation and Technology Commission of the Hong Kong Special Administrative Region of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views presented in this article do not necessarily reflect those of the U.S. Food and Drug Administration.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Bancos S, 2010, CELL IMMUNOL, V262, P18, DOI 10.1016/j.cellimm.2009.12.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Chang CJ, 2006, EUR J CLIN INVEST, V36, P588, DOI 10.1111/j.1365-2362.2006.01676.x; Chang CJ, 2006, MENOPAUSE, V13, P967, DOI 10.1097/01.gme.0000227025.96686.8b; Chavan P, 2006, EVID-BASED COMPL ALT, V3, P447, DOI 10.1093/ecam/nel075; Cheng WY, 2008, AM J CHINESE MED, V36, P783, DOI 10.1142/S0192415X08006235; Chow Moses Sing Sum, 2010, Curr Drug Discov Technol, V7, P1; De Preter K, 2009, CLIN CANCER RES, V15, P3690, DOI 10.1158/1078-0432.CCR-08-2699; Dietz BM, 2008, CHEM RES TOXICOL, V21, P1939, DOI 10.1021/tx8001274; Efferth T, 2007, TRENDS MOL MED, V13, P353, DOI 10.1016/j.molmed.2007.07.001; Gheeya J, 2010, CANCER LETT, V293, P124, DOI 10.1016/j.canlet.2010.01.004; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hsu HY, 1996, J ETHNOPHARMACOL, V52, P113, DOI 10.1016/0378-8741(96)01400-6; Huang Y, 2005, CANCER RES, V65, P7446, DOI 10.1158/0008-5472.CAN-04-4267; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Jarmi T, 2009, CURR HYPERTENS REP, V11, P56, DOI 10.1007/s11906-009-0011-z; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kang JX, 2005, CARCINOGENESIS, V26, P1934, DOI 10.1093/carcin/bgi154; Kronke G, 2003, J BIOL CHEM, V278, P51006, DOI 10.1074/jbc.M304103200; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee SE, 1999, AM J CHINESE MED, V27, P387, DOI 10.1142/S0192415X99000446; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Liang QD, 2006, BIOL PHARM BULL, V29, P1378, DOI 10.1248/bpb.29.1378; Lv Guanghua, 2010, Zhongguo Zhong Yao Za Zhi, V35, P194; Masoudi-Nejad Ali, 2007, V406, P437; McMahon M, 2001, CANCER RES, V61, P3299; Moiseeva EP, 2009, CANCER PREV RES, V2, P611, DOI 10.1158/1940-6207.CAPR-08-0102; OHTA H, 1993, PHARMACOL BIOCHEM BE, V45, P719, DOI 10.1016/0091-3057(93)90530-7; Pon D, 2010, THER DELIV, V1, P335, DOI 10.4155/TDE.10.29; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2009, INTEGR ANAL SYST, P3, DOI 10.1007/978-0-387-72719-6_1; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Shi LM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S12; Simon R, 2009, BEST PRACT RES CL HA, V22, P271, DOI 10.1016/j.beha.2009.07.001; *STAT PHARM COMM P, 2005, PHARM PEOPL REPUBLIC; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; Vanaja DK, 2000, CANCER RES, V60, P4714; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang CC, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-108; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang L, 2011, INT J PHARMACEUT, V406, P99, DOI 10.1016/j.ijpharm.2011.01.001; Wang Steven, 2010, Curr Drug Discov Technol, V7, P67; Wang ZJ, 2009, J PHARMACEUT BIOMED, V50, P232, DOI 10.1016/j.jpba.2009.04.001; Watanabe Hiroshi, 1998, Journal of Toxicological Sciences, V23, P234; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Yang NS, 2004, J BIOMED SCI, V11, P418, DOI [10.1159/000077111, 10.1007/BF02254447]; Yeh LLL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000719; Zhang HJ, 2004, J PHARMACEUT BIOMED, V34, P705, DOI 10.1016/S0731-7085(03)00650-2; Zhang JL, 2009, PLANTA MED, V75, P396, DOI 10.1055/s-0028-1088381	56	108	120	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18278	10.1371/journal.pone.0018278	http://dx.doi.org/10.1371/journal.pone.0018278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464939	Green Published, gold, Green Submitted			2022-12-27	WOS:000289053800036
J	Censolo, R; Craighero, L; Ponti, G; Rizzo, L; Canto, R; Fadiga, L				Censolo, Roberto; Craighero, Laila; Ponti, Giovanni; Rizzo, Leonzio; Canto, Rosario; Fadiga, Luciano			Electromyographic Activity of Hand Muscles in a Motor Coordination Game: Effect of Incentive Scheme and Its Relation with Social Capital	PLOS ONE			English	Article							CONSEQUENCES	Background: A vast body of social and cognitive psychology studies in humans reports evidence that external rewards, typically monetary ones, undermine intrinsic motivation. These findings challenge the standard selfish-rationality assumption at the core of economic reasoning. In the present work we aimed at investigating whether the different modulation of a given monetary reward automatically and unconsciously affects effort and performance of participants involved in a game devoid of visual and verbal interaction and without any perspective-taking activity. Methodology/Principal Findings: Twelve pairs of participants were submitted to a simple motor coordination game while recording the electromyographic activity of First Dorsal Interosseus (FDI), the muscle mainly involved in the task. EMG data show a clear effect of alternative rewards strategies on subjects' motor behavior. Moreover, participants' stock of relevant past social experiences, measured by a specifically designed questionnaire, was significantly correlated with EMG activity, showing that only low social capital subjects responded to monetary incentives consistently with a standard rationality prediction. Conclusions/Significance: Our findings show that the effect of extrinsic motivations on performance may arise outside social contexts involving complex cognitive processes due to conscious perspective-taking activity. More importantly, the peculiar performance of low social capital individuals, in agreement with standard economic reasoning, adds to the knowledge of the circumstances that makes the crowding out/in of intrinsic motivation likely to occur. This may help in improving the prediction and accuracy of economic models and reconcile this puzzling effect of external incentives with economic theory.	[Censolo, Roberto; Craighero, Laila; Ponti, Giovanni; Rizzo, Leonzio; Canto, Rosario; Fadiga, Luciano] Univ Ferrara, I-44100 Ferrara, Italy; [Fadiga, Luciano] Italian Inst Technol, Genoa, Italy	University of Ferrara; Istituto Italiano di Tecnologia - IIT	Censolo, R (corresponding author), Univ Ferrara, I-44100 Ferrara, Italy.	fdl@unife.it	Fadiga, Luciano/AAC-7404-2022; Craighero, Laila/F-3408-2015	Craighero, Laila/0000-0002-5400-8732; Rizzo, Leonzio/0000-0001-8099-8699; fadiga, luciano/0000-0001-5691-5080; Ponti, Giovanni/0000-0003-1680-3580	European Community	European Community(European Commission)	This work has been accomplished with the contribution of the European Community Grants Robot-Cub and Poeticon and of the Fondazione Cassa di Risparmio di Ferrara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2001, SOC CAP COMM BENCHM; Bargh E, 1985, J EXP PSYCHOL LEARN, V11, P59; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; Bargh JA, 2008, PERSPECT PSYCHOL SCI, V3, P73, DOI 10.1111/j.1745-6916.2008.00064.x; Benabou R, 2003, REV ECON STUD, V70, P489, DOI 10.1111/1467-937X.00253; Benabou R, 2006, AM ECON REV, V96, P1652, DOI 10.1257/aer.96.5.1652; Bohnet I, 2001, AM POLIT SCI REV, V95, P131, DOI 10.1017/S0003055401000211; Cardenas JC, 2000, WORLD DEV, V28, P1719, DOI 10.1016/S0305-750X(00)00055-3; Chen M, 1999, PERS SOC PSYCHOL B, V25, P215, DOI 10.1177/0146167299025002007; Deci E., 1975, INTRINSIC MOTIVATION; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Dijksterhuis A, 2001, ADV EXPT SOCIAL PSYC; EDIN BB, 1995, J NEUROSCI, V15, P830; ELIASSON AC, 1995, EXP BRAIN RES, V106, P425; EPSTEIN S, 1994, AM PSYCHOL, V49, P709, DOI 10.1037/0003-066X.49.8.709; Fehr E, 2002, 34 I EMP RES EC; Frey B., 1997, NOT JUST MONEY EC TH; Frey BS, 1997, AM ECON REV, V87, P746; Frey BS, 2001, J ECON SURV, V15, P589, DOI 10.1111/1467-6419.00150; Gneezy U, 2000, J LEGAL STUD, V29, P1, DOI 10.1086/468061; Gneezy U, 2000, Q J ECON, V115, P791, DOI 10.1162/003355300554917; Gollwitzer P, 1996, SOCIAL PSYCHOL HDB B; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; KIHLSTROM JF, 1987, SCIENCE, V237, P1445, DOI 10.1126/science.3629249; Lepper M., 1978, HIDDEN COST REWARD N; Neely J. H., 1991, BASIC PROCESSES READ, P264, DOI DOI 10.1016/J.BRAINRES.2007.05.058; Neumann R, 2003, PSYCHOL EVALUATION A; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Shah J, 2002, MOTIVATED SOCIAL PER; Spencer S, 2005, SOCIAL MOTIVATION CO; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491; Westen D, 1998, PSYCHOL BULL, V124, P333, DOI 10.1037/0033-2909.124.3.333	34	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17372	10.1371/journal.pone.0017372	http://dx.doi.org/10.1371/journal.pone.0017372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	740SE	21464986	Green Submitted, Green Published, gold			2022-12-27	WOS:000288813900003
J	Choi, SS; Chivers, PT; Berg, DE				Choi, Sung Sook; Chivers, Peter T.; Berg, Douglas E.			Point Mutations in Helicobacter pylori's fur Regulatory Gene that Alter Resistance to Metronidazole, a Prodrug Activated by Chemical Reduction	PLOS ONE			English	Article							FERRIC UPTAKE REGULATOR; DNA-BINDING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DOMAIN INTERACTIONS; AMINO-ACIDS; REPRESSOR; PROTEIN; RDXA; PERR	Background: Helicobacter pylori's Fur regulatory protein controls transcription of dozens of genes in response to iron availability, acidity and oxidative stress, and affects the vigor of infection and severity of disease. It is unusual among Fur family proteins in being active both when iron-loaded and iron-free. Metholodolgy/Principal Findings: We tested if H. pylori fur mutations could affect resistance to metronidazole (Mtz), an anti-H. pylori prodrug rendered bactericidal by chemical reduction. Point mutations were made by PCR in DNA containing fur and a downstream chloramphenicol resistance gene, and were placed in the H. pylori chromosome by transformation of a fur-deletion (Dfur) strain. Several substitutions affecting H. pylori Fur's,10 residue N terminal arm, which has no counterpart in prototype (E. coli-type) Fur proteins, increased Mtz resistance, as did mutations affecting the region between DNA binding and dimerization domains. Three types of mutations decreased resistance more than did Dfur: substitutions affecting the N-terminal arm; substitutions affecting the metal binding pocket; and nonsense mutations that resulted in a truncated Fur protein with no C-terminal dimerization domain. Most metal binding pocket mutations were obtained only in fur genes with additional inactivating mutations, and thus seemed deleterious or lethal because they. Conclusions/Significance: These results establish that H. pylori Fur's distinctive N terminal arm is functional, and more generally illustrate that point mutations can confer informative phenotypes, distinct from those conferred by null mutations. We propose that fur mutations can affect Mtz susceptibility by altering the balance among Fur's several competing activities, and thereby the expression of genes that control cellular redox potential or elimination of bactericidal Mtz activation products. Further analyses of selected mutants should provide insights into Fur interactions with other cellular components, metabolic circuitry, and how H. pylori thrives in its special gastric niche.	[Choi, Sung Sook; Berg, Douglas E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Chivers, Peter T.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Choi, SS (corresponding author), Sahmyook Univ, Coll Pharm, Seoul, South Korea.	berg@borcim.wustl.edu		Chivers, Peter/0000-0002-8779-1452	U.S. National Institutes of Health (NIH) [RO1 DK63041, R21 AI078237, R21 AI088337]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088337, R21AI078237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063041] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the U.S. National Institutes of Health (NIH) RO1 DK63041, R21 AI078237 and R21 AI088337. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada JK, 2003, MICROBIOL-SGM, V149, P1901, DOI 10.1099/mic.0.26129-0; Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Benanti EL, 2007, J BIOL CHEM, V282, P20365, DOI 10.1074/jbc.M702982200; Benanti EL, 2010, J BACTERIOL, V192, P4327, DOI 10.1128/JB.00152-10; Boneca IG, 2008, APPL ENVIRON MICROB, V74, P2095, DOI 10.1128/AEM.01348-07; Carpenter BM, 2010, J BACTERIOL, V192, P5037, DOI 10.1128/JB.00198-10; Carpenter BM, 2009, INFECT IMMUN, V77, P2590, DOI 10.1128/IAI.00116-09; Chalker AF, 2001, J BACTERIOL, V183, P1259, DOI 10.1128/JB.183.4.1259-1268.2001; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Croxen MA, 2006, J BACTERIOL, V188, P2656, DOI 10.1128/JB.188.7.2656-2665.2006; Danielli A, 2010, FEMS MICROBIOL REV, V34, P738, DOI 10.1111/j.1574-6976.2010.00233.x; Dian C, 2011, MOL MICROBIOL, V79, P1260, DOI 10.1111/j.1365-2958.2010.07517.x; Ernst FD, 2005, MICROBIOL-SGM, V151, P533, DOI 10.1099/mic.0.27404-0; Goodwin A, 1998, MOL MICROBIOL, V28, P383, DOI 10.1046/j.1365-2958.1998.00806.x; Hall HK, 1996, J BACTERIOL, V178, P5683, DOI 10.1128/jb.178.19.5683-5691.1996; HOCHSCHILD A, 1983, CELL, V32, P319, DOI 10.1016/0092-8674(83)90451-8; Jacquamet L, 2009, MOL MICROBIOL, V73, P20, DOI 10.1111/j.1365-2958.2009.06753.x; Jeong JY, 2000, ANTIMICROB AGENTS CH, V44, P3127, DOI 10.1128/AAC.44.11.3127-3132.2000; Jeong JY, 2001, J BACTERIOL, V183, P5155, DOI 10.1128/JB.183.17.5155-5162.2001; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; PABO CO, 1982, NATURE, V298, P441, DOI 10.1038/298441a0; Pecqueur L, 2006, J BIOL CHEM, V281, P21286, DOI 10.1074/jbc.M601278200; Peek RM, 2010, PHYSIOL REV, V90, P831, DOI 10.1152/physrev.00039.2009; Pennella MA, 2006, J MOL BIOL, V356, P1124, DOI 10.1016/j.jmb.2005.12.019; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Saviola B, 1998, J MOL BIOL, V278, P539, DOI 10.1006/jmbi.1998.1712; Schreiber S, 2004, P NATL ACAD SCI USA, V101, P5024, DOI 10.1073/pnas.0308386101; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sheikh MA, 2009, MOL MICROBIOL, V72, P1208, DOI 10.1111/j.1365-2958.2009.06718.x; Sisson G, 2000, J BACTERIOL, V182, P5091, DOI 10.1128/JB.182.18.5091-5096.2000; Tan SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000407; Tan SM, 2004, J BACTERIOL, V186, P885, DOI 10.1128/JB.186.3.885-888.2004; Tiss A, 2005, FEBS LETT, V579, P5454, DOI 10.1016/j.febslet.2005.08.067; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Traore DAK, 2006, MOL MICROBIOL, V61, P1211, DOI 10.1111/j.1365-2958.2006.05313.x; Tsugawa H, 2011, ANTIOXID REDOX SIGN, V14, P15, DOI 10.1089/ars.2010.3146; White A, 1998, NATURE, V394, P502, DOI 10.1038/28893; Whitmire JM, 2007, CURR MED CHEM, V14, P469, DOI 10.2174/092986707779941069; Wu M, 2001, J MOL BIOL, V307, P1001, DOI 10.1006/jmbi.2001.4531	43	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18236	10.1371/journal.pone.0018236	http://dx.doi.org/10.1371/journal.pone.0018236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464913	Green Published, gold			2022-12-27	WOS:000288813900055
J	Xu, HB; Wang, XL; Morici, LA; Pahar, B; Veazey, RS				Xu, Huanbin; Wang, Xiaolei; Morici, Lisa A.; Pahar, Bapi; Veazey, Ronald S.			Early Divergent Host Responses in SHIVsf162P3 and SIVmac251 Infected Macaques Correlate with Control of Viremia	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; MEMORY T-CELLS; SIV INFECTION; GASTROINTESTINAL-TRACT; NONHUMAN-PRIMATES; AIDS; MAINTENANCE; APOPTOSIS; DEPLETION; MONKEYS	We previously showed intravaginal inoculation with SHIVsf162p3 results in transient viremia followed by undetectable viremia in most macaques, and some displayed subsequent immunity to superinfection with pathogenic SIVmac251. Here we compare early T cell activation, proliferation, and plasma cytokine/chemokine responses in macaques intravaginally infected with either SHIVsf162p3 or SIVmac251 to determine whether distinct differences in host responses may be associated with early viral containment. The data show SIVmac251 infection results in significantly higher levels of T cell activation, proliferation, and a mixed cytokine/chemokine "storm" in plasma in primary infection, whereas infection with SHIVsf162p3 resulted in significantly lower levels of T cell activation, proliferation, and better preservation of memory CD4+ T cells in early infection which immediately preceded control of viremia. These results support the hypothesis that early systemic immune activation, T cell proliferation, and a more prominent and broader array of cytokine/chemokine responses facilitate SIV replication, and may play a key role in persistence of infection, and the progression to AIDS. In contrast, immune unresponsiveness may be associated with eventual clearance of virus, a concept that may have key significance for therapy and vaccine design.	[Xu, Huanbin; Wang, Xiaolei; Pahar, Bapi; Veazey, Ronald S.] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA; [Morici, Lisa A.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	Tulane University; Tulane University	Xu, HB (corresponding author), Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA.	rveazey@tulane.edu	Xu, Huanbin/S-4870-2019; Pahar, Bapi/AFM-3129-2022	Pahar, Bapi/0000-0003-1949-973X	United States National Institutes of Health [AI49080, AI084793, RR000164]; Tulane University; James B. Pendleton Charitable Trust Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049080, R01AI084793] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University; James B. Pendleton Charitable Trust Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by United States National Institutes of Health grants AI49080, AI084793, and RR000164, a Tulane University Enhancement Grant, and a grant from the James B. Pendleton Charitable Trust Foundation. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangs SC, 2009, J IMMUNOL, V182, P1962, DOI 10.4049/jimmunol.0802596; Bessis AS, 2003, AMINO ACIDS, V24, P303, DOI 10.1007/s00726-002-0405-6; Cumont MC, 2008, J VIROL, V82, P1175, DOI 10.1128/JVI.00450-07; Gea-Banacloche JC, 2000, J IMMUNOL, V165, P1082, DOI 10.4049/jimmunol.165.2.1082; Harouse JM, 1999, SCIENCE, V284, P816, DOI 10.1126/science.284.5415.816; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; Kaur A, 2008, J VIROL, V82, P1084, DOI 10.1128/JVI.02197-07; Kornfeld C, 2005, J CLIN INVEST, V115, P1082, DOI 10.1172/JCI200523006; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Manches O, 2009, J CLIN INVEST, V119, P3512, DOI 10.1172/JCI41509; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Meythaler M, 2009, J VIROL, V83, P572, DOI 10.1128/JVI.01715-08; PAHAR B, 2009, VIROLOGY; Pahar B, 2009, VIROLOGY, V387, P273, DOI 10.1016/j.virol.2009.02.014; Paiardini M, 2009, BLOOD, V113, P612, DOI 10.1182/blood-2008-06-159442; Pandrea I, 2007, BLOOD, V109, P1069, DOI 10.1182/blood-2006-05-024364; Silvestri G, 2007, J CLIN INVEST, V117, P3148, DOI 10.1172/JCI33034; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Veazey Ronald, 2003, AIDS Rev, V5, P245; Veazey RS, 2003, J EXP MED, V198, P1551, DOI 10.1084/jem.20031266; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Zou W, 1997, AIDS, V11, P533	23	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17965	10.1371/journal.pone.0017965	http://dx.doi.org/10.1371/journal.pone.0017965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464951	Green Published, Green Submitted, gold			2022-12-27	WOS:000288813900023
J	Hertlein, T; Sturm, V; Kircher, S; Basse-Lusebrink, T; Haddad, D; Ohlsen, K; Jakob, P				Hertlein, Tobias; Sturm, Volker; Kircher, Stefan; Basse-Luesebrink, Thomas; Haddad, Daniel; Ohlsen, Knut; Jakob, Peter			Visualization of Abscess Formation in a Murine Thigh Infection Model of Staphylococcus aureus by F-19-Magnetic Resonance Imaging (MRI)	PLOS ONE			English	Article							SOFT-TISSUE INFECTION; IN-VIVO; IRON-OXIDE; F-19 MRI; INFLAMMATION; PARTICLES; LESIONS	Background: During the last years, F-19-MRI and perfluorocarbon nanoemulsion (PFC) emerged as a powerful contrast agent methodology to track cells and to visualize inflammation. We applied this new modality to visualize deep tissue abscesses during acute and chronic phase of inflammation caused by Staphylococcus aureus infection. Methodology and Principal Findings: In this study, a murine thigh infection model was used to induce abscess formation and PFC or CLIO (cross linked ironoxides) was administered during acute or chronic phase of inflammation. 24 h after inoculation, the contrast agent accumulation was imaged at the site of infection by MRI. Measurements revealed a strong accumulation of PFC at the abscess rim at acute and chronic phase of infection. The pattern was similar to CLIO accumulation at chronic phase and formed a hollow sphere around the edema area. Histology revealed strong influx of neutrophils at the site of infection and to a smaller extend macrophages during acute phase and strong influx of macrophages at chronic phase of inflammation. Conclusion and Significance: We introduce F-19-MRI in combination with PFC nanoemulsions as a new platform to visualize abscess formation in a murine thigh infection model of S. aureus. The possibility to track immune cells in vivo by this modality offers new opportunities to investigate host immune response, the efficacy of antibacterial therapies and the influence of virulence factors for pathogenesis.	[Hertlein, Tobias; Ohlsen, Knut] Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany; [Sturm, Volker; Basse-Luesebrink, Thomas; Jakob, Peter] Univ Wurzburg, Dept Expt Phys 5, Wurzburg, Germany; [Kircher, Stefan] Uniklin Wurzburg, Inst Pathol, Wurzburg, Germany; [Haddad, Daniel] Magnet Resonance Bavaria, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Hertlein, T (corresponding author), Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany.	knut.ohlsen@mail.uni-wuerzburg.de; peja@physik.uni-wuerzburg.de		Jakob, Peter/0000-0002-3481-5545	German Science Foundation (DFG) [SFB 630]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Science Foundation (DFG) SFB 630. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Bettegowda C, 2005, P NATL ACAD SCI USA, V102, P1145, DOI 10.1073/pnas.0408861102; Bleeker-Rovers CP, 2005, J NUCL MED, V46, P2014; CRAIG WA, 1991, J ANTIMICROB CHEM SC, V27; Ebner B, 2010, CIRC-CARDIOVASC IMAG, V3, P202, DOI 10.1161/CIRCIMAGING.109.902312; Engelsman AF, 2009, J BIOMED MATER RES B, V88B, P123, DOI 10.1002/jbm.b.31158; Flogel U, 2008, CIRCULATION, V118, P140, DOI 10.1161/CIRCULATIONAHA.107.737890; Janjic JM, 2009, WIRES NANOMED NANOBI, V1, P492, DOI 10.1002/wnan.35; Kaim AH, 2003, RADIOLOGY, V227, P169, DOI 10.1148/radiol.2272020490; Kaim AH, 2002, RADIOLOGY, V225, P808, DOI 10.1148/radiol.2253011485; Krafft MP, 2001, ADV DRUG DELIVER REV, V47, P209, DOI 10.1016/S0169-409X(01)00107-7; Kraft SL, 2004, INFECT IMMUN, V72, P5963, DOI 10.1128/IAI.72.10.5963-5971.2004; Kuklin NA, 2003, ANTIMICROB AGENTS CH, V47, P2740, DOI 10.1128/AAC.47.9.2740-2748.2003; Ledermann HP, 2000, EUR RADIOL, V10, P1815, DOI 10.1007/s003300000480; Lee JS, 2006, RADIOLOGY, V241, P142, DOI 10.1148/radiol.2403051156; Pohmann R, 2001, MAGN RESON MED, V45, P817, DOI 10.1002/mrm.1110; Ruiz-Cabello J, 1999, MAGN RESON IMAGING, V17, P1327, DOI 10.1016/S0730-725X(99)00061-2; Sijbers J, 1999, INT J IMAG SYST TECH, V10, P109, DOI 10.1002/(SICI)1098-1098(1999)10:2<109::AID-IMA2>3.0.CO;2-R; Speck O, 2002, MAGNET RESON MED, V48, P633, DOI 10.1002/mrm.10279; Srinivas M, 2007, MAGN RESON MED, V58, P725, DOI 10.1002/mrm.21352; Tournebize R, 2006, CELL MICROBIOL, V8, P33, DOI 10.1111/j.1462-5822.2005.00597.x	21	50	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18246	10.1371/journal.pone.0018246	http://dx.doi.org/10.1371/journal.pone.0018246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455319	Green Submitted, gold, Green Published			2022-12-27	WOS:000288811500032
J	Sagona, AP; Nezis, IP; Bache, KG; Haglund, K; Bakken, AC; Skotheim, RI; Stenmark, H				Sagona, Antonia P.; Nezis, Ioannis P.; Bache, Kristi G.; Haglund, Kaisa; Bakken, Anne Cathrine; Skotheim, Rolf I.; Stenmark, Harald			A Tumor-Associated Mutation of FYVE-CENT Prevents Its Interaction with Beclin 1 and Interferes with Cytokinesis	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; BREAST-CANCER; AUTOPHAGY; TUMORIGENESIS; UVRAG; PROTEIN; GENE	The tumor suppressor activity of Beclin 1 (BECN1), a subunit of class III phosphatidylinositol 3-kinase complex, has been attributed to its regulation of apoptosis and autophagy. Here, we identify FYVE-CENT (ZFYVE26), a phosphatidylinositol 3-phosphate binding protein important for cytokinesis, as a novel interacting protein of Beclin 1. A mutation in FYVE-CENT (R1945Q) associated with breast cancer abolished the interaction between FYVE-CENT and Beclin 1, and reduced the localization of these proteins at the intercellular bridge during cytokinesis. Breast cancer cells containing the FYVE-CENT R1945Q mutation displayed a significant increase in cytokinetic profiles and bi - multinuclear phenotype. Both Beclin 1 and FYVE-CENT were found to be downregulated in advanced breast cancers. These findings suggest a positive feedback loop for recruitment of FYVE-CENT and Beclin 1 to the intercellular bridge during cytokinesis, and reveal a novel potential tumor suppressor mechanism for Beclin 1.	[Sagona, Antonia P.; Nezis, Ioannis P.; Bache, Kristi G.; Haglund, Kaisa; Bakken, Anne Cathrine; Skotheim, Rolf I.; Stenmark, Harald] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Sagona, Antonia P.; Nezis, Ioannis P.; Bache, Kristi G.; Haglund, Kaisa; Stenmark, Harald] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, Oslo, Norway; [Bakken, Anne Cathrine; Skotheim, Rolf I.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Canc Prevent, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Sagona, AP (corresponding author), Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway.	stenmark@ulrik.uio.no	Nezis, Ioannis/AAE-8625-2020; Bache, Kristi G./AAD-9335-2020; Stenmark, Harald/B-8868-2008; Nezis, Ioannis P/I-4910-2014; Nezis, Ioannis/Q-6124-2019; Skotheim, Rolf I./H-6192-2017; Haglund, Kaisa/B-3927-2017	Nezis, Ioannis P/0000-0003-0233-7574; Nezis, Ioannis/0000-0003-0233-7574; Skotheim, Rolf I./0000-0002-5609-4048; Haglund, Kaisa/0000-0002-7946-3299	ENDOCYTE Research training network of the European Union; Research Council of Norway; Norwegian Cancer Society; European Research Council	ENDOCYTE Research training network of the European Union; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); European Research Council(European Research Council (ERC)European Commission)	A.P.S. is a Ph.D. student supported by ENDOCYTE Research training network of the European Union Marie Curie Program and by the FUGE Program of the Research Council of Norway. I.P.N. is a postdoctoral fellow of European Research Council. K.G.B. is a postdoctoral fellow and K.H. a senior research fellow of the Research Council of Norway. R.I.S. is a group leader supported by the Norwegian Cancer Society, and A.C.B. is a research associate supported by the Research Council of Norway. This work was supported by an Advanced Grant from the European Research Council (to H.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Nezis IP, 2010, TRENDS CELL BIOL, V20, P642, DOI 10.1016/j.tcb.2010.08.010; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Sagona AP, 2010, FEBS LETT, V584, P2652, DOI 10.1016/j.febslet.2010.03.044; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; THORESEN SB, 2010, EXP CELL RES	20	24	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17086	10.1371/journal.pone.0017086	http://dx.doi.org/10.1371/journal.pone.0017086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455500	Green Published, Green Submitted, gold			2022-12-27	WOS:000288811500002
J	Tabunoki, H; Ode, H; Banno, Y; Katsuma, S; Shimada, T; Mita, K; Yamamoto, K; Sato, R; Ishii-Nozawa, R; Satoh, J				Tabunoki, Hiroko; Ode, Hiroaki; Banno, Yutaka; Katsuma, Susumu; Shimada, Toru; Mita, Kazuei; Yamamoto, Kimiko; Sato, Ryoichi; Ishii-Nozawa, Reiko; Satoh, Jun-ichi			BmDJ-1 Is a Key Regulator of Oxidative Modification in the Development of the Silkworm, Bombyx mori	PLOS ONE			English	Article							PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; DROSOPHILA DJ-1; PROTEIN; SEQUENCE; GENOME; MODEL	We cloned cDNA for the Bombyx mori DJ-1 protein (BmDJ-1) from the brains of larvae. BmDJ-1 is composed of 190 amino acids and encoded by 672 nucleotides. Northern blot analysis showed that BmDJ-1 is transcribed as a 756-bp mRNA and has one isoform. Reverse transcriptase (RT)-PCR experiments revealed that the BmDJ-1 was present in the brain, fatbody, Malpighian tubule, ovary and testis but present in only low amounts in the silkgland and hemocyte of day 4 fifth instar larvae. Immunological analysis demonstrated the presence of BmDJ-1 in the brain, midgut, fatbody, Malpighian tubule, testis and ovary from the larvae to the adult. We found that BmDJ-1 has a unique expression pattern through the fifth instar larval to adult developmental stage. We assessed the anti-oxidative function of BmDJ-1 using rotenone (ROT) in day 3 fifth instar larvae. Administration of ROT to day 3 fifth instar larvae, together with exogenous (BmNPV-BmDJ-1 infection for 4 days in advance) BmDJ-1, produced significantly lower 24-h mortality in BmDJ-1 groups than in the control. 2D-PAGE revealed an isoelectric point (pI) shift to an acidic form for BmDJ-1 in BmN4 cells upon ROT stimulus. Among the factors examined for their effects on expression level of BmDJ-1 in the hemolymph, nitric oxide (NO) concentration was identified based on dramatic developmental stage-dependent changes. Administration of isosorbide dinitrate (ISDN), which is an NO donor, to BmN4 cells produced increased expression of BmDJ-1 compared to the control. These results suggest that BmDJ-1 might control oxidative stress in the cell due to NO and serves as a development modulation factor in B. mori.	[Tabunoki, Hiroko; Ode, Hiroaki; Satoh, Jun-ichi] Meiji Pharmaceut Univ, Dept Bioinformat & Mol Neuropathol, Tokyo, Japan; [Banno, Yutaka] Kyushu Univ, Ctr Genet Resources, Fukuoka 812, Japan; [Katsuma, Susumu; Shimada, Toru] Univ Tokyo, Dept Agr & Environm Biol, Grad Sch Agr & Life Sci, Tokyo, Japan; [Mita, Kazuei; Yamamoto, Kimiko] Natl Inst Agrobiol Sci, Insect Genome Lab, Tsukuba, Ibaraki, Japan; [Sato, Ryoichi] Tokyo Univ Agr & Technol, Bioapplicat & Syst Engn, Tokyo, Japan; [Ishii-Nozawa, Reiko] Meiji Pharmaceut Univ, Dept Clin Pharmacol, Tokyo, Japan	Meiji Pharmaceutical University; Kyushu University; University of Tokyo; National Institute of Agrobiological Sciences - Japan; Tokyo University of Agriculture & Technology; Meiji Pharmaceutical University	Tabunoki, H (corresponding author), Meiji Pharmaceut Univ, Dept Bioinformat & Mol Neuropathol, Tokyo, Japan.	tabunoki@my-pharm.ac.jp	Shimada, Toru/AAZ-2703-2021; Sato, Ryoichi/G-1074-2013; TABUNOKI, Hiroko/H-6593-2013; Shimada, Toru/A-2033-2011	Shimada, Toru/0000-0002-5791-0000; TABUNOKI, Hiroko/0000-0003-1823-9952; Shimada, Toru/0000-0002-5791-0000	Ministry of Education, Science, Sports and Culture [22710195]; High-Tech Research Center; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [S0801043]; Ministry of Health, Labour and Welfare of Japan [H22-Nanchi-Ippan-136]	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); High-Tech Research Center(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	H.T. was supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid (http://www.jsps.go.jp/english/e-grants/grants.html) for Young Scientists (B), 2010, 22710195. This work was in part supported by grants from the High-Tech Research Center Project (http://www.mext.go.jp/english/), the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (S0801043), and the Research on Intractable Diseases (http://www.nanbyou.or.jp/english/index.htm), the Ministry of Health, Labour and Welfare of Japan (H22-Nanchi-Ippan-136) to J.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Anderson PC, 2008, BIOCHEMISTRY-US, V47, P9380, DOI 10.1021/bi800677k; Bandyopadhyay S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-6; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; CHOI SK, 1995, BIOCHEM BIOPH RES CO, V207, P452, DOI 10.1006/bbrc.1995.1209; da Costa CA, 2007, CURR MOL MED, V7, P650, DOI 10.2174/156652407782564426; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Finny D., 1947, PROBIT ANAL STAT TRE; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Inoue M, 2004, REDOX REP, V9, P237, DOI 10.1179/135100004225006010; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; MAEDA S, 1985, NATURE, V315, P592, DOI 10.1038/315592a0; Menzies FM, 2005, CURR BIOL, V15, P1578, DOI 10.1016/j.cub.2005.07.036; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Ohnishi A, 2006, P NATL ACAD SCI USA, V103, P4398, DOI 10.1073/pnas.0511270103; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Tabunoki H, 2002, J BIOL CHEM, V277, P32133, DOI 10.1074/jbc.M204507200; Tabunoki H, 2008, NEUROSCI RES, V61, P271, DOI 10.1016/j.neures.2008.03.007; Tao X, 2003, J BIOL CHEM, V278, P31372, DOI 10.1074/jbc.M304221200; Terzioglu M, 2008, FEBS J, V275, P1384, DOI 10.1111/j.1742-4658.2008.06302.x; Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yamamoto K, 2006, GENETICS, V173, P151, DOI 10.1534/genetics.105.053801	30	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17683	10.1371/journal.pone.0017683	http://dx.doi.org/10.1371/journal.pone.0017683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455296	Green Published, gold, Green Submitted			2022-12-27	WOS:000288811500007
J	Barnes, DC; Chapuis, J; Chaudhury, D; Wilson, DA				Barnes, Dylan C.; Chapuis, Julie; Chaudhury, Dipesh; Wilson, Donald A.			Odor Fear Conditioning Modifies Piriform Cortex Local Field Potentials Both during Conditioning and during Post-Conditioning Sleep	PLOS ONE			English	Article							SLOW-WAVE SLEEP; REM-SLEEP; LOW ACETYLCHOLINE; OLFACTORY CORTEX; DEPENDENT MEMORY; STATE; RAT; HIPPOCAMPUS; REPLAY; CONSOLIDATION	Background: Sleep plays an active role in memory consolidation. Sleep structure (REM/Slow wave activity [SWS]) can be modified after learning, and in some cortical circuits, sleep is associated with replay of the learned experience. While the majority of this work has focused on neocortical and hippocampal circuits, the olfactory system may offer unique advantages as a model system for exploring sleep and memory, given the short, non-thalamic pathway from nose to primary olfactory (piriform cortex), and rapid cortex-dependent odor learning. Methodology/Principal Findings: We examined piriform cortical odor responses using local field potentials (LFPs) from freely behaving Long-Evans hooded rats over the sleep-wake cycle, and the neuronal modifications that occurred within the piriform cortex both during and after odor-fear conditioning. We also recorded LFPs from naive animals to characterize sleep activity in the piriform cortex and to analyze transient odor-evoked cortical responses during different sleep stages. Naive rats in their home cages spent 40% of their time in SWS, during which the piriform cortex was significantly hypo-responsive to odor stimulation compared to awake and REM sleep states. Rats trained in the paired odor-shock conditioning paradigm developed enhanced conditioned odor evoked gamma frequency activity in the piriform cortex over the course of training compared to pseudo-conditioned rats. Furthermore, conditioned rats spent significantly more time in SWS immediately post-training both compared to pre-training days and compared to pseudo-conditioned rats. The increase in SWS immediately after training significantly correlated with the duration of odor-evoked freezing the following day. Conclusions/Significance: The rat piriform cortex is hypo-responsive to odors during SWS which accounts for nearly 40% of each 24 hour period. The duration of slow-wave activity in the piriform cortex is enhanced immediately post-conditioning, and this increase is significantly correlated with subsequent memory performance. Together, these results suggest the piriform cortex may go offline during SWS to facilitate consolidation of learned odors with reduced external interference.	[Barnes, Dylan C.; Chapuis, Julie; Chaudhury, Dipesh; Wilson, Donald A.] Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY USA; [Barnes, Dylan C.; Wilson, Donald A.] CUNY, Cognit Neurosci Program, New York, NY 10021 USA; [Wilson, Donald A.] NYU, Sch Med, New York, NY USA	Nathan Kline Institute for Psychiatric Research; City University of New York (CUNY) System; New York University	Barnes, DC (corresponding author), Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY USA.	dbarnes@nki.rfmh.org		Wilson, Donald/0000-0001-8918-2151	NIDCD [DC003906]; Fyssen Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003906, R01DC009910] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Fyssen Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by grant DC003906 from the NIDCD (www.nih.gov) to DAW. JC was supported by a fellowship from the Fyssen Foundation (http://www.fondation-fyssen.org/subventionsUS.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G., 2006, RHYTHMS BRAIN; Cai DJ, 2009, LEARN MEMORY, V16, P595, DOI 10.1101/lm.1515609; Cai DJ, 2009, BEHAV NEUROSCI, V123, P713, DOI 10.1037/a0016415; Carskadon MA, 2004, SLEEP, V27, P402; Chapuis J, 2009, J NEUROSCI, V29, P10287, DOI 10.1523/JNEUROSCI.0505-09.2009; CHEN CF, 2009, ACHEMS ANN M ABSTR; Cohen JD, 2010, J NEUROPHYSIOL, V104, P1661, DOI 10.1152/jn.00340.2010; Costa-Miserachs D, 2003, J NEUROSCI METH, V130, P93, DOI 10.1016/S0165-0270(03)00229-2; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Edeline JM, 2000, J NEUROPHYSIOL, V84, P934, DOI 10.1152/jn.2000.84.2.934; Eschenko O, 2008, LEARN MEMORY, V15, P222, DOI 10.1101/lm.726008; Fletcher ML, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0005.2002; Gais S, 2004, P NATL ACAD SCI USA, V101, P2140, DOI 10.1073/pnas.0305404101; Hanlon EC, 2009, SLEEP, V32, P719, DOI 10.1093/sleep/32.6.719; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; Hegoburu C, 2009, LEARN MEMORY, V16, P687, DOI 10.1101/lm.1584209; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kadohisa M, 2006, P NATL ACAD SCI USA, V103, P15206, DOI 10.1073/pnas.0604313103; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Landsness EC, 2009, SLEEP, V32, P1273; LECONTE P, 1974, PHYSIOL BEHAV, V13, P675, DOI 10.1016/0031-9384(74)90239-X; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Li AA, 2010, NEUROSCI LETT, V480, P44, DOI 10.1016/j.neulet.2010.05.093; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Magloire V, 2009, BEHAV BRAIN RES, V205, P568, DOI 10.1016/j.bbr.2009.08.039; McCarley RW, 2007, SLEEP MED, V8, P302, DOI 10.1016/j.sleep.2007.03.005; McCormick David A., 1994, Current Opinion in Neurobiology, V4, P550, DOI 10.1016/0959-4388(94)90056-6; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; Neville K.R., 2004, SYNAPTIC ORG BRAIN, P415, DOI DOI 10.1093/ACPR0F:0S0/9780195159561.003.0010; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Paxinos G, 2009, RAT BRAIN STEREOTAXI; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rasch B, 2009, NEUROPSYCHOPHARMACOL, V34, P1843, DOI 10.1038/npp.2009.6; Rauchs G, 2005, J SLEEP RES, V14, P123, DOI 10.1111/j.1365-2869.2005.00450.x; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Rosanova M, 2005, J PHYSIOL-LONDON, V562, P569, DOI 10.1113/jphysiol.2004.071381; Rowland NC, 2010, NEUROSCIENCE, V166, P698, DOI 10.1016/j.neuroscience.2009.12.048; Sevelinges Y, 2004, LEARN MEMORY, V11, P761, DOI 10.1101/lm.83604; Sevelinges Y, 2008, LEARN MEMORY, V15, P649, DOI 10.1101/lm.998508; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Stickgold R, 2007, SLEEP MED, V8, P331, DOI 10.1016/j.sleep.2007.03.011; Stuck BA, 2007, SLEEP, V30, P506, DOI 10.1093/sleep/30.4.506; Tononi Giulio, 2009, J Clin Sleep Med, V5, pS16; Tucker MA, 2006, NEUROBIOL LEARN MEM, V86, P241, DOI 10.1016/j.nlm.2006.03.005; Walker MP, 2009, J CLIN SLEEP MED, V5, pS20; Wilson DA, 2003, NEUROSCI BIOBEHAV R, V27, P307, DOI 10.1016/S0149-7634(03)00050-2; Wilson DA, 2001, LEARN MEMORY, V8, P279, DOI 10.1101/lm.42601; WILSON DA, 2010, J NEUROPHYS IN PRESS; Wilson DA, 2006, SEMIN CELL DEV BIOL, V17, P462, DOI 10.1016/j.semcdb.2006.04.008; Wilson DA, 2010, J NEUROSCI, V30, P1760, DOI 10.1523/JNEUROSCI.5636-09.2010	58	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18130	10.1371/journal.pone.0018130	http://dx.doi.org/10.1371/journal.pone.0018130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448432	Green Published, gold			2022-12-27	WOS:000288810500043
J	Wolkowitz, OM; Mellon, SH; Epel, ES; Lin, J; Dhabhar, FS; Su, YL; Reus, VI; Rosser, R; Burke, HM; Kupferman, E; Compagnone, M; Nelson, JC; Blackburn, EH				Wolkowitz, Owen M.; Mellon, Synthia H.; Epel, Elissa S.; Lin, Jue; Dhabhar, Firdaus S.; Su, Yali; Reus, Victor I.; Rosser, Rebecca; Burke, Heather M.; Kupferman, Eve; Compagnone, Mariana; Nelson, J. Craig; Blackburn, Elizabeth H.			Leukocyte Telomere Length in Major Depression: Correlations with Chronicity, Inflammation and Oxidative Stress - Preliminary Findings	PLOS ONE			English	Article							MASS-SPECTROMETRIC QUANTIFICATION; CENTRAL-NERVOUS-SYSTEM; CARDIOVASCULAR-DISEASE; RISK-FACTOR; DNA-DAMAGE; PREDICTS MORTALITY; LIPID-PEROXIDATION; BIOLOGICAL-FLUIDS; MONONUCLEAR-CELLS; PERIPHERAL-BLOOD	Background: Depression is associated with an unusually high rate of aging-related illnesses and early mortality. One aspect of "accelerated aging" in depression may be shortened leukocyte telomeres. When telomeres critically shorten, as often occurs with repeated mitoses or in response to oxidation and inflammation, cells may die. Indeed, leukocyte telomere shortening predicts early mortality and medical illnesses in non-depressed populations. We sought to determine if leukocyte telomeres are shortened in Major Depressive Disorder (MDD), whether this is a function of lifetime depression exposure and whether this is related to putative mediators, oxidation and inflammation. Methodology: Leukocyte telomere length was compared between 18 unmedicated MDD subjects and 17 controls and was correlated with lifetime depression chronicity and peripheral markers of oxidation (F2-isoprostane/Vitamin C ratio) and inflammation (IL-6). Analyses were controlled for age and sex. Principal Findings: The depressed group, as a whole, did not differ from the controls in telomere length. However, telomere length was significantly inversely correlated with lifetime depression exposure, even after controlling for age (p < 0.05). Average telomere length in the depressed subjects who were above the median of lifetime depression exposure (>= 9.2 years' cumulative duration) was 281 base pairs shorter than that in controls (p < 0.05), corresponding to approximately seven years of "accelerated cell aging." Telomere length was inversely correlated with oxidative stress in the depressed subjects (p < 0.01) and in the controls (p < 0.05) and with inflammation in the depressed subjects (p < 0.05). Conclusions: These preliminary data indicate that accelerated aging at the level of leukocyte telomeres is proportional to lifetime exposure to MDD. This might be related to cumulative exposure to oxidative stress and inflammation in MDD. This suggest that telomere shortening does not antedate depression and is not an intrinsic feature. Rather, telomere shortening may progress in proportion to lifetime depression exposure.	[Wolkowitz, Owen M.; Epel, Elissa S.; Reus, Victor I.; Rosser, Rebecca; Burke, Heather M.; Kupferman, Eve; Compagnone, Mariana; Nelson, J. Craig] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA; [Mellon, Synthia H.] Univ Calif San Francisco, Sch Med, Dept OB GYN & Reprod Sci, San Francisco, CA USA; [Epel, Elissa S.; Burke, Heather M.] Univ Calif San Francisco, Sch Med, Hlth Psychol Program, San Francisco, CA USA; [Lin, Jue; Blackburn, Elizabeth H.] Univ Calif San Francisco, Sch Med, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Dhabhar, Firdaus S.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Su, Yali] Kronos Sci Lab, Phoenix, AZ USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Wolkowitz, OM (corresponding author), Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA.	owen.wolkowitz@ucsf.edu	reus, victor i/I-7923-2015; Wolkowitz, Owen M/J-6649-2013	reus, victor i/0000-0002-8193-5697; Wolkowitz, Owen M/0000-0003-0655-5042	National Institute of Mental Health (NIMH) [R01-MH083784]; O'Shaughnessy Foundation; UCSF Academic Senate; UCSF Research Evaluation and Allocation Committee (REAC); Bernard and Barbro Foundation; National Institutes of Health/National Center for Research Resources (NIH/NCRR) UCSF-CTSI [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083784] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); O'Shaughnessy Foundation; UCSF Academic Senate; UCSF Research Evaluation and Allocation Committee (REAC); Bernard and Barbro Foundation; National Institutes of Health/National Center for Research Resources (NIH/NCRR) UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by a grant from the National Institute of Mental Health (NIMH) (Grant Number R01-MH083784), the O'Shaughnessy Foundation and grants from the UCSF Academic Senate, the UCSF Research Evaluation and Allocation Committee (REAC) and the Bernard and Barbro Foundation. This project was also supported by National Institutes of Health/National Center for Research Resources (NIH/NCRR) UCSF-CTSI Grant Number UL1 RR024131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaikalakoteswari A, 2005, DIABETIC MED, V22, P1151, DOI 10.1111/j.1464-5491.2005.01574.x; Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Andersen K, 2005, EPIDEMIOLOGY, V16, P233, DOI 10.1097/01.ede.0000152116.32580.24; Arfken CL, 1999, J GERONTOL A-BIOL, V54, pM152, DOI 10.1093/gerona/54.3.M152; Aviv A, 2002, J MOL MED, V80, P689, DOI 10.1007/s00109-002-0377-8; Aviv A., 2004, SCI AGING KNOWLEDGE, V2004, pp, DOI [10.1126/sageke.2004.51.pe43, DOI 10.1126/SAGEKE.2004.51.PE43]; Aviv A, 2006, J GERONTOL A-BIOL, V61, P871, DOI 10.1093/gerona/61.8.871; Bauer ME, 2009, ANN NY ACAD SCI, V1153, P139, DOI 10.1111/j.1749-6632.2008.03966.x; Beyne-Rauzy O, 2005, BLOOD, V106, P3200, DOI 10.1182/blood-2005-04-1386; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Block G, 2002, AM J EPIDEMIOL, V156, P274, DOI 10.1093/aje/kwf029; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Brown ES, 2004, BIOL PSYCHIAT, V55, P1, DOI 10.1016/S0006-3223(03)00473-6; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherubini A, 2005, FREE RADICAL BIO MED, V39, P841, DOI 10.1016/j.freeradbiomed.2005.06.025; CHODOSH J, 2007, AM J GERIATR PSYCHIA; Cumurcu BE, 2009, PSYCHIAT CLIN NEUROS, V63, P639, DOI 10.1111/j.1440-1819.2009.02004.x; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; De Meyer T, 2008, FRONT BIOSCI-LANDMRK, V13, P2960, DOI 10.2741/2901; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Dhabhar FS, 2009, J PSYCHIATR RES, V43, P962, DOI 10.1016/j.jpsychires.2009.05.010; Dietrich M, 2003, NUTR CANCER, V45, P176, DOI 10.1207/S15327914NC4502_06; Dinan TG, 2009, CURR OPIN PSYCHIATR, V22, P32, DOI 10.1097/YCO.0b013e328315a561; Ding T, 2005, NEUROCHEM INT, V46, P435, DOI 10.1016/j.neuint.2004.12.009; DIPIETRO L, 1993, MED SCI SPORT EXER, V25, P628; Dodd S, 2008, INT J NEUROPSYCHOPH, V11, P179; Effros RB, 1997, DEV COMP IMMUNOL, V21, P471, DOI 10.1016/S0145-305X(97)00027-X; Effros RB, 2009, J GERONTOL A-BIOL, V64, P511, DOI 10.1093/gerona/glp001; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Epel ES, 2009, AGING-US, V1, P81; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; First MB, 2002, STRUCTURED CLIN INTE; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Flanary BE, 2003, J ANTI-AGING MED, V6, P299, DOI 10.1089/109454503323028894; Forlenza MJ, 2006, PSYCHOSOM MED, V68, P1, DOI 10.1097/01.psy.0000195780.37277.2a; Franco Sonia, 2006, Alzheimers Dement, V2, P164, DOI 10.1016/j.jalz.2006.03.001; Fuster JJ, 2006, CIRC RES, V99, P1167, DOI 10.1161/01.RES.0000251281.00845.18; Godbout JP, 2006, NEUROL CLIN, V24, P521, DOI 10.1016/j.ncl.2006.03.010; Grodstein F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001590; Gump BB, 2005, STROKE, V36, P98, DOI 10.1161/01.STR.0000149626.50127.d0; Haendeler J, 2004, CIRC RES, V94, P768, DOI 10.1161/01.RES.0000121104.05977.F3; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Harding AH, 2008, ARCH INTERN MED, V168, P1493, DOI 10.1001/archinte.168.14.1493; HARTMANN N, 2010, DEPRESS ANXIETY; Helmersson J, 2009, BRIT J NUTR, V101, P1775, DOI 10.1017/S0007114508147377; Heuser I, 2002, MATURITAS, V41, pS19; Hezel AF, 2005, CURR MOL MED, V5, P145, DOI 10.2174/1566524053586563; Honig LS, 2006, ANN NEUROL, V60, P181, DOI 10.1002/ana.20894; Hornsby PJ, 2006, AGING CELL, V5, P577, DOI 10.1111/j.1474-9726.2006.00249.x; Horrobin DF, 1999, PROSTAG LEUKOTR ESS, V60, P217, DOI 10.1054/plef.1999.0037; Hosoi Toru, 2002, Current Drug Targets - Inflammation and Allergy, V1, P257, DOI 10.2174/1568010023344599; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; HUZEN J, FRONT BIOSCI, V15, P35; Huzen J, 2010, AGE AGEING, V39, P223, DOI 10.1093/ageing/afp256; Ilmonen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002143; Irie M, 2005, J PSYCHIATR RES, V39, P553, DOI 10.1016/j.jpsychires.2005.01.009; Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kessing LV, 2004, J NEUROL NEUROSUR PS, V75, P1662, DOI 10.1136/jnnp.2003.031773; Khanzode SD, 2003, REDOX REP, V8, P365, DOI 10.1179/135100003225003393; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; KIECOLTGLASER JK, 2010, PSYCHOSOMAT IN PRESS; Leonard B, 2000, World J Biol Psychiatry, V1, P17, DOI 10.3109/15622970009150562; Licinio J, 1999, MOL PSYCHIATR, V4, P317, DOI 10.1038/sj.mp.4000586; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Liu H, 2004, BRAIN RES, V1025, P43, DOI 10.1016/j.brainres.2004.07.071; Lukens JN, 2009, ALZHEIMERS DEMENT, V5, P463, DOI 10.1016/j.jalz.2009.05.666; Lung FW, 2007, PSYCHIAT GENET, V17, P195, DOI 10.1097/YPG.0b013e32808374f6; Lupien SJ, 1999, REV NEUROSCIENCE, V10, P117; Maes M, 2000, J AFFECT DISORDERS, V58, P241, DOI 10.1016/S0165-0327(99)00121-4; Maes M, 2009, NEUROENDOCRINOL LETT, V30, P462; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; Margolis SA, 1997, J CHROMATOGR B, V690, P25, DOI 10.1016/S0378-4347(96)00401-X; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Martin-Ruiz C, 2006, ANN NEUROL, V60, P174, DOI 10.1002/ana.20869; Mattson MP, 2001, J NEUROSCI RES, V63, P1; McCusker J, 2007, GEN HOSP PSYCHIAT, V29, P340, DOI 10.1016/j.genhosppsych.2007.03.007; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; McEwen BS, 2002, NEUROBIOL AGING, V23, P921, DOI 10.1016/S0197-4580(02)00027-1; McEwen BS, 2001, HUM PSYCHOPHARM CLIN, V16, pS7, DOI 10.1002/hup.266; McIntyre Roger S, 2007, Ann Clin Psychiatry, V19, P257, DOI 10.1080/10401230701653377; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Milne GL, 2007, METHOD ENZYMOL, V433, P113, DOI 10.1016/S0076-6879(07)33006-1; Morrow Jason D, 2002, Methods Mol Biol, V186, P57; Morrow JD, 1999, DRUG METAB REV, V31, P117, DOI 10.1081/DMR-100101910; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Myint PK, 2008, AM J CLIN NUTR, V87, P64, DOI 10.1093/ajcn/87.1.64; Ozcan ME, 2004, INT CLIN PSYCHOPHARM, V19, P89, DOI 10.1097/01.yic.0000110796.97676.89; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Pollmacher T, 2002, BRAIN BEHAV IMMUN, V16, P525, DOI 10.1016/S0889-1591(02)00004-1; POST RM, 1988, AM J PSYCHIAT, V145, P844; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Ramirez R, 2005, AM J KIDNEY DIS, V45, P353, DOI 10.1053/j.ajkd.2004.10.022; Rapp MA, 2008, AM J GERIAT PSYCHIAT, V16, P844, DOI 10.1097/JGP.0b013e31818254eb; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Sackeim Harold A., 2001, Journal of Clinical Psychiatry, V62, P10; Sahin E, 2007, COMP BIOCHEM PHYS C, V144, P342, DOI 10.1016/j.cbpc.2006.10.009; Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715; Sanders JL, 2009, J BONE MINER RES, V24, P1531, DOI [10.1359/JBMR.090318, 10.1359/jbmr.090318]; Sapolsky, 1996, Stress, V1, P1, DOI 10.3109/10253899609001092; Sapolsky RM, 2000, BIOL PSYCHIAT, V48, P755, DOI 10.1016/S0006-3223(00)00971-9; Sarandol A, 2007, HUM PSYCHOPHARM CLIN, V22, P67, DOI 10.1002/hup.829; Schulz R, 2000, ARCH INTERN MED, V160, P1761, DOI 10.1001/archinte.160.12.1761; Sebastian C, 2009, J IMMUNOL, V183, P2356, DOI 10.4049/jimmunol.0901131; Serrano AL, 2004, CIRC RES, V94, P575, DOI 10.1161/01.RES.0000122141.18795.9C; Sheline YI, 1999, J NEUROSCI, V19, P5034; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; Song C, 2009, PHARMACOPSYCHIATRY, V42, P182, DOI 10.1055/s-0029-1202263; SPECK CE, 1995, EPIDEMIOLOGY, V6, P366, DOI 10.1097/00001648-199507000-00006; Szuster-Ciesielska A, 2008, PROG NEURO-PSYCHOPH, V32, P686, DOI 10.1016/j.pnpbp.2007.11.012; Tsirpanlis G, 2006, NEPHROLOGY, V11, P506, DOI 10.1111/j.1440-1797.2006.00697.x; Tsuboi H, 2004, J PSYCHOSOM RES, V56, P53, DOI 10.1016/S0022-3999(03)00567-1; TYRKA AR, 2009, BIOL PSYCHIAT; Valdes AM, 2007, OSTEOPOROSIS INT, V18, P1203, DOI 10.1007/s00198-007-0357-5; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; van der Harst P, 2010, ANN MED, V42, P36, DOI 10.3109/07853890903321567; von Zglinicki T, 2000, LAB INVEST, V80, P1739, DOI 10.1038/labinvest.3780184; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Voss P, 2006, FREE RADICAL RES, V40, P1339, DOI 10.1080/10715760600953859; WEINSTEIN AA, BIOL PSYCHOL; Wolkowitz OM, 2008, WORLD J BIOL PSYCHIA, V9, P2, DOI 10.1080/15622970701875601; Wolkowitz OM, 2010, DEPRESS ANXIETY, V27, P327, DOI 10.1002/da.20686; Yehuda R, 2006, ANN NY ACAD SCI, V1071, P137, DOI 10.1196/annals.1364.012; Zhang P, 2007, NEUROSCIENCE, V145, P1439, DOI 10.1016/j.neuroscience.2006.11.052; Zhu HY, 2000, J NEUROCHEM, V75, P117, DOI 10.1046/j.1471-4159.2000.0750117.x	133	300	311	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17837	10.1371/journal.pone.0017837	http://dx.doi.org/10.1371/journal.pone.0017837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448457	Green Published, gold			2022-12-27	WOS:000288810500016
J	Hughes, LAE; Simons, CCJM; van den Brandt, PA; Goldbohm, RA; de Goeij, AF; de Bruine, AP; van Engeland, M; Weijenberg, MP				Hughes, Laura A. E.; Simons, Colinda C. J. M.; van den Brandt, Piet A.; Goldbohm, R. Alexandra; de Goeij, Anton F.; de Bruine, Adriaan P.; van Engeland, Manon; Weijenberg, Matty P.			Body Size, Physical Activity and Risk of Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP)	PLOS ONE			English	Article							SELF-REPORTED HEIGHT; SCALE PROSPECTIVE COHORT; POPULATION-BASED SAMPLE; LIFE-STYLE FACTORS; COLON-CANCER; MICROSATELLITE INSTABILITY; NETHERLANDS COHORT; PROMOTER METHYLATION; ENERGY RESTRICTION; TUMOR-SUPPRESSOR	Background: We investigated how body size and physical activity influence the risk of the CpG island methylator phenotype (CIMP) in colorectal cancer (CRC). Methods: In the Netherlands Cohort Study (n = 120,852), risk factors were self-reported at baseline in 1986. After 7.3 years of follow-up, 603 cases and 4,631 sub-cohort members were available. CIMP status according to the Weisenberger markers was determined using methylation specific PCR on DNA from paraffin embedded tumor tissue. Hazard rate ratios (HR) and 95% confidence intervals for CIMP (27.7%) and non-CIMP (72.3%) tumors were calculated according to BMI, BMI at age 20, BMI change, trouser/skirt size, height, and physical activity. Results: BMI modeled per 5 kg/m(2) increase was associated with both CIMP and non-CIMP tumors, however, HRs were attenuated when additionally adjusted for trouser/skirt size. Trouser/skirt size, per 2 size increase, was associated with both tumor subtypes, even after adjustment for BMI (CIMP HR: 1.20, 95% CI: 1.01-1.43; non-CIMP HR: 1.14, 95% CI: 1.04-1.28). Height per 5 cm was associated with both tumor sub-types, but HRs were attenuated when adjusted for body weight. BMI at age 20 was positively associated with increased risk of CIMP tumors and the association was significantly less pronounced for non-CIMP tumors (P-heterogeneity = 0.01). Physical activity was inversely associated with both subtypes, but a dose-response association was observed only for non-CIMP tumors (P-trend = 0.02). Conclusions: Body size, especially central adiposity, may increase the risk of both CIMP and non-CIMP tumors. Body fat at young age may differentially influence risk. Physical activity appears to decrease the risk of CRC regardless of these molecular subtypes.	[Hughes, Laura A. E.; Simons, Colinda C. J. M.; van den Brandt, Piet A.; Weijenberg, Matty P.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Epidemiol, Maastricht, Netherlands; [Goldbohm, R. Alexandra] TNO Qual Life, Dept Prevent & Hlth, Leiden, Netherlands; [de Goeij, Anton F.; de Bruine, Adriaan P.; van Engeland, Manon] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Pathol, Maastricht, Netherlands	Maastricht University; Netherlands Organization Applied Science Research; Maastricht University	Hughes, LAE (corresponding author), Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Epidemiol, Maastricht, Netherlands.	laura.hughes@maastrichtuniversity.nl	van Engeland, Manon/A-7479-2009; Toon, Christopher W/G-3610-2012	van Engeland, Manon/0000-0002-7952-6843; van den Brandt, Piet/0000-0001-8781-8099	World Cancer Research Fund (WCRF) [2007/54]	World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF))	This project was funded by the World Cancer Research Fund (WCRF), grant # 2007/54 to Matty P. Weijenberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barault L, 2008, CANCER RES, V68, P8541, DOI 10.1158/0008-5472.CAN-08-1171; Bolton-Smith C, 2000, J EPIDEMIOL COMMUN H, V54, P143, DOI 10.1136/jech.54.2.143; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; Campbell PT, 2010, JNCI-J NATL CANCER I, V102, P391, DOI 10.1093/jnci/djq011; de Vogel S, 2008, CARCINOGENESIS, V29, P1765, DOI 10.1093/carcin/bgn074; Derks S, 2004, CELL ONCOL, V26, P291; Derks S, 2008, CARCINOGENESIS, V29, P434, DOI 10.1093/carcin/bgm270; Dirx MJM, 2003, CANCER-AM CANCER SOC, V97, P46, DOI 10.1002/cncr.11052; Ferguson LR, 2004, ENVIRON MOL MUTAGEN, V44, P36, DOI 10.1002/em.20029; Frankel S, 1998, BMJ-BRIT MED J, V316, P499, DOI 10.1136/bmj.316.7130.499; Frazier ML, 2003, CANCER RES, V63, P4805; Gebhard H, 1989, ERMITTLUNG ARBEITSEN; GOLDBOHM RA, 1995, EUR J CLIN NUTR, V49, P420; GOLDBOHM RA, 1994, EUR J CLIN NUTR, V48, P253; Goldbohm RA, 1994, TIJDSCHR SOC GEZONDH, V72, P80; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hodge DR, 2005, CANCER RES, V65, P4673, DOI 10.1158/0008-5472.CAN-04-3589; Hughes LAE, 2010, INT J EPIDEMIOL, V39, P1333, DOI 10.1093/ije/dyq062; Hughes LAE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007951; Hughes LAE, 2009, EPIDEMIOLOGY, V20, P673, DOI 10.1097/EDE.0b013e3181a66eb5; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Kang GH, 2003, AM J PATHOL, V163, P1551, DOI 10.1016/S0002-9440(10)63511-0; Noffsinger AE, 2009, ANNU REV PATHOL-MECH, V4, P343, DOI 10.1146/annurev.pathol.4.110807.092317; Nyholm M, 2007, OBESITY, V15, P197, DOI 10.1038/oby.2007.536; Ogino S, 2006, GUT, V55, P1000, DOI 10.1136/gut.2005.082933; Ogino S, 2007, J MOL DIAGN, V9, P305, DOI 10.2353/jmoldx.2007.060170; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Ogino S, 2010, J NATL CANCER I, V102, P365, DOI 10.1093/jnci/djq031; Okasha M, 2002, BEST PRACT RES CL EN, V16, P225, DOI 10.1053/beem.2002.0204; Park SJ, 2003, AM J PATHOL, V162, P815, DOI 10.1016/S0002-9440(10)63878-3; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Pylypchuk RD, 2009, AM J EPIDEMIOL, V170, P297, DOI 10.1093/aje/kwp123; Samowitz WS, 2007, J MOL DIAGN, V9, P281, DOI 10.2353/jmoldx.2007.070031; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Sieber OM, 2003, NAT REV CANCER, V3, P701, DOI 10.1038/nrc1170; Slattery ML, 2007, INT J CANCER, V120, P656, DOI 10.1002/ijc.22342; Slattery ML, 2010, CANCER CAUSE CONTROL, V21, P1237, DOI 10.1007/s10552-010-9551-4; Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Svensson E, 2005, CANCER CAUSE CONTROL, V16, P215, DOI 10.1007/s10552-004-3073-x; Svensson E, 2002, EUR J CANCER PREV, V11, P489, DOI 10.1097/00008469-200210000-00012; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; VANDENBRANDT PA, 1990, INT J EPIDEMIOL, V19, P553; VANDENBRANDT PA, 1990, J CLIN EPIDEMIOL, V43, P285, DOI 10.1016/0895-4356(90)90009-E; Wada K, 2005, INT J OBESITY, V29, P1093, DOI 10.1038/sj.ijo.0803012; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wong JJL, 2007, GUT, V56, P140, DOI 10.1136/gut.2005.088799; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	52	57	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18571	10.1371/journal.pone.0018571	http://dx.doi.org/10.1371/journal.pone.0018571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483668	Green Published, Green Submitted, gold			2022-12-27	WOS:000289191300029
J	Zhu, DM; Shi, JA; Liu, SL; Liu, YX; Zheng, DX				Zhu, Dan-Ming; Shi, Juan; Liu, Shilian; Liu, Yanxin; Zheng, Dexian			HIV Infection Enhances TRAIL-Induced Cell Death in Macrophage by Down-Regulating Decoy Receptor Expression and Generation of Reactive Oxygen Species	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; MEDIATED APOPTOSIS; TUMORICIDAL ACTIVITY; MONOCLONAL-ANTIBODY; ACTIVATION; INHIBITION; PATHWAY; FAMILY; BCL-2	Background: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) could induce apoptosis of HIV-1-infected monocyte-derived macrophage (MDM), but the molecular mechanisms are not well understood. Methodology/Principal Findings: By using an HIV-1 Env-pseudotyped virus (HIV-1 PV)-infected MDM cell model we demonstrate that HIV-1 PV infection down-regulates the expression of TRAIL decoy receptor 1 (DcR1) and 2 (DcR2), and cellular FLICE-inhibitory protein (c-FLIP), but dose not affect the expression of death receptor 4 and 5 (DR4, DR5), and Bcl-2 family members in MDM cells. Furthermore, recombinant soluble TRAIL and an agonistic anti-DR5 antibody, AD5-10, treatment stimulates reactive oxygen species (ROS) generation and JNK phosphorylation. Conclusions/Significance: HIV infection facilitates TRIAL-induced cell death in MDM by down-regulating the expression of TRAIL decoy receptors and intracellular c-FLIP. Meanwhile, the agonistic anti-DR5 antibody, AD5-10, induces apoptosis synergistically with TRAIL in HIV-1-infected cells. ROS generation and JNK phosphorylation are involved in this process. These findings potentiate clinical usage of the combination of TRAIL and AD5-10 in eradication of HIV-infected macrophage and AIDS.	[Zhu, Dan-Ming] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhu, DM (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China.	liuyx2000@tom.com; zhengdx@pumc.edu.cn	Serei, Virian D/B-4616-2015		Natural Science Foundation of China [30721063, 30623009, 30972684]; State Key Basic Research Program of China [2007CB507404, 2006CB504200]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research Program of China(National Basic Research Program of China)	This work was partially supported by the Natural Science Foundation of China (Grant No. 30721063, 30623009 and 30972684) and the State Key Basic Research Program of China (Grant No. 2007CB507404 and 2006CB504200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Aillet F, 1998, J VIROL, V72, P9698, DOI 10.1128/JVI.72.12.9698-9705.1998; Andrews JI, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.031; Babu CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004623; Biancotto A, 2007, BLOOD, V109, P4272, DOI 10.1182/blood-2006-11-055764; Carter CA, 2008, ANNU REV MICROBIOL, V62, P425, DOI 10.1146/annurev.micro.62.081307.162758; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; Chen CF, 2009, CELL RES, V19, P984, DOI 10.1038/cr.2009.60; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Crowe SM, 1995, AUST NZ J MED, V25, P777, DOI 10.1111/j.1445-5994.1995.tb02881.x; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dharmapatni AASSK, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2603; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Erdmann N, 2009, J NEUROCHEM, V109, P551, DOI 10.1111/j.1471-4159.2009.05989.x; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Guo YB, 2005, J BIOL CHEM, V280, P41940, DOI 10.1074/jbc.M503621200; Gura T, 1997, SCIENCE, V277, P768, DOI 10.1126/science.277.5327.768; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; Huang YL, 2006, J IMMUNOL, V177, P2304, DOI 10.4049/jimmunol.177.4.2304; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; KARACOSTAS V, 1989, P NATL ACAD SCI USA, V86, P8964, DOI 10.1073/pnas.86.22.8964; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Lum JJ, 2001, J VIROL, V75, P11128, DOI 10.1128/JVI.75.22.11128-11136.2001; Ma H, 2005, INT J CANCER, V116, P314, DOI 10.1002/ijc.20982; Mahalingam D, 2009, CANCER TREAT REV, V35, P280, DOI 10.1016/j.ctrv.2008.11.006; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Saeki K, 2002, BIOCHEM J, V368, P705, DOI 10.1042/BJ20020101; Schnell G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000395; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Shih CM, 2004, J CELL BIOCHEM, V91, P384, DOI 10.1002/jcb.10761; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Toro-Nieves DM, 2009, J NEUROVIROL, V15, P36, DOI 10.1080/13550280802385505; Tsang J, 2009, AIDS, V23, P2255, DOI 10.1097/QAD.0b013e328331a4ce; van Noesel MM, 2002, CANCER RES, V62, P2157; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002	44	65	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18291	10.1371/journal.pone.0018291	http://dx.doi.org/10.1371/journal.pone.0018291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483669	gold, Green Published, Green Submitted			2022-12-27	WOS:000289191300016
J	Buschard, K; Hansen, AK; Jensen, K; Lindenbergh-Kortleve, DJ; de Ruiter, LF; Krohn, TC; Hufeldt, MR; Vogensen, FK; Aasted, B; Osterbye, T; Roep, BO; de Haar, C; Nieuwenhuis, EE				Buschard, Karsten; Hansen, Axel Kornerup; Jensen, Karen; Lindenbergh-Kortleve, Dicky J.; de Ruiter, Lilian F.; Krohn, Thomas C.; Hufeldt, Majbritt R.; Vogensen, Finn K.; Aasted, Bent; Osterbye, Thomas; Roep, Bart O.; de Haar, Colin; Nieuwenhuis, Edward E.			Alcohol Facilitates CD1d Loading, Subsequent Activation of NKT Cells, and Reduces the Incidence of Diabetes in NOD Mice	PLOS ONE			English	Article							T-CELLS; INFLAMMATORY MARKERS; INSULIN SENSITIVITY; BODY-COMPOSITION; CONSUMPTION; EXPRESSION; PREVENTS; MOUSE; GALACTOSYLCERAMIDE; RISK	Background: Ethanol ('alcohol') is a partly hydrophobic detergent that may affect the accessibility of glycolipids thereby influencing immunological effects of these molecules. Methods: The study included cellular in vitro tests using alpha-galactosylceramide (alpha GalCer), and in vivo NOD mice experiments detecting diabetes incidence and performing behavioural and bacterial analyses. Results: Alcohol in concentrations from 0.6% to 2.5% increased IL-2 production from NKT cells stimulated with alpha GalCer by 60% (p < 0.05). CD1d expressed on HeLa cells contained significantly increasing amounts of alpha GalCer with increasing concentrations of alcohol, suggesting that alcohol facilitated the passive loading of alpha GalCer to CD1d. NOD mice were found to tolerate 5% ethanol in their drinking water without signs of impairment in liver function. Giving this treatment, the diabetes incidence declined significantly. Higher numbers of CD3+CD49b+ NKT cells were found in spleen and liver of the alcohol treated compared to the control mice (p < 0.05), whereas the amount of CD4+Foxp3+ regulator T cells did not differ. Increased concentrations of IFN-gamma were detected in 24-hour blood samples of alcohol treated mice. Behavioural studies showed no change in attitude of the ethanol-consuming mice, and bacterial composition of caecum samples was not affected by alcohol, disqualifying these as protective mechanisms. Conclusion: Alcohol facilitates the uptake of glycolipids and the stimulation of NKT cells, which are known to counteract Type 1 diabetes development. We propose that this is the acting mechanism by which treatment with alcohol reduces the incidence of diabetes in NOD mice. This is corroborated by epidemiology showing beneficial effect of alcohol to reduce the severity of atherosclerosis and related diseases.	[Buschard, Karsten; Osterbye, Thomas] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark; [Hansen, Axel Kornerup; Jensen, Karen; Krohn, Thomas C.; Hufeldt, Majbritt R.; Aasted, Bent] Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Lindenbergh-Kortleve, Dicky J.; de Ruiter, Lilian F.] Erasmus MC, Pediat Lab, Rotterdam, Netherlands; [Lindenbergh-Kortleve, Dicky J.; de Ruiter, Lilian F.] Erasmus MC, Dept Pediat Gastroenterol, Rotterdam, Netherlands; [Vogensen, Finn K.] Univ Copenhagen, Fac Life Sci, Dept Food Sci, Frederiksberg, Denmark; [Roep, Bart O.] Leiden Univ, Dept Immunohaematol & Blood Transfus, Med Ctr, Leiden, Netherlands; [de Haar, Colin] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Nieuwenhuis, Edward E.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Gastroenterol, Utrecht, Netherlands	Rigshospitalet; University of Copenhagen; University of Copenhagen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Copenhagen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Buschard, K (corresponding author), Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark.	buschard@dadlnet.dk	Roep, Bart/AAD-7609-2021; Vogensen, Finn/E-1245-2015	Vogensen, Finn/0000-0003-2151-7802; Buschard, Karsten/0000-0002-0126-7423; de Haar, Colin/0000-0003-4358-2410	Tuborgfondet	Tuborgfondet	Tuborgfondet is thanked for financial support. None of the authors have or have had any employment or any consultancy, patents, products in development or marketed products related to Tuborgfondet or associated companies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Beaudoin L, 2002, IMMUNITY, V17, P725, DOI 10.1016/S1074-7613(02)00473-9; Blomqvist M, 2003, J CELL BIOCHEM, V89, P301, DOI 10.1002/jcb.10513; Buschard K, 2001, AUTOIMMUNITY, V34, P9, DOI 10.3109/08916930108994121; Chen L, 2004, J APPL PHYSIOL, V96, P167, DOI 10.1152/japplphysiol.00751.2003; Colgan SP, 2003, J CLIN INVEST, V112, P745, DOI 10.1172/JC1200317241; Falcone M, 2004, J IMMUNOL, V172, P5908, DOI 10.4049/jimmunol.172.10.5908; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; Hansen AK, 2006, DIABETES-METAB RES, V22, P220, DOI 10.1002/dmrr.609; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; HUFELDT A, 2010, COMPARATIVE MED, V60, P336; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Kallberg H, 2009, ANN RHEUM DIS, V68, P222, DOI 10.1136/ard.2007.086314; Kang L, 2007, ALCOHOL CLIN EXP RES, V31, P1581, DOI 10.1111/j.1530-0277.2007.00452.x; KLATSKY AL, 1995, AM J PUBLIC HEALTH, V85, P16, DOI 10.2105/AJPH.85.1.16; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Lau AH, 2006, J LEUKOCYTE BIOL, V79, P941, DOI 10.1189/jlb.0905517; Liu RL, 2005, J IMMUNOL, V175, P7898, DOI 10.4049/jimmunol.175.12.7898; Maraldi C, 2006, ARCH INTERN MED, V166, P1490, DOI 10.1001/archinte.166.14.1490; MARMOT MG, 1981, LANCET, V1, P580; Novak J, 2005, J IMMUNOL, V174, P1954, DOI 10.4049/jimmunol.174.4.1954; Pai JK, 2006, ATHEROSCLEROSIS, V186, P113, DOI 10.1016/j.atherosclerosis.2005.06.037; Popova S, 2007, ALCOHOL ALCOHOLISM, V42, P465, DOI 10.1093/alcalc/agl124; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Razay G, 1997, BRIT MED J, V314, P443, DOI 10.1136/bmj.314.7078.443a; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Shi FD, 2001, P NATL ACAD SCI USA, V98, P6777, DOI 10.1073/pnas.121169698; Ting JW, 2006, PHARMACOL THERAPEUT, V111, P346, DOI 10.1016/j.pharmthera.2005.10.004; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; van der Vliet HJJ, 2001, CLIN IMMUNOL, V100, P144, DOI 10.1006/clim.2001.5060; Volpato S, 2004, CIRCULATION, V109, P607, DOI 10.1161/01.CIR.0000109503.13955.00; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	34	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e17931	10.1371/journal.pone.0017931	http://dx.doi.org/10.1371/journal.pone.0017931			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483778	gold, Green Published, Green Submitted			2022-12-27	WOS:000289058300005
J	Bagrow, JP; Wang, DS; Barabasi, AL				Bagrow, James P.; Wang, Dashun; Barabasi, Albert-Laszlo			Collective Response of Human Populations to Large-Scale Emergencies	PLOS ONE			English	Article							MOBILE COMMUNICATION-NETWORKS; PREDICTABILITY; EPIDEMICS; BEHAVIOR; LAWS	Despite recent advances in uncovering the quantitative features of stationary human activity patterns, many applications, from pandemic prediction to emergency response, require an understanding of how these patterns change when the population encounters unfamiliar conditions. To explore societal response to external perturbations we identified real-time changes in communication and mobility patterns in the vicinity of eight emergencies, such as bomb attacks and earthquakes, comparing these with eight non-emergencies, like concerts and sporting events. We find that communication spikes accompanying emergencies are both spatially and temporally localized, but information about emergencies spreads globally, resulting in communication avalanches that engage in a significant manner the social network of eyewitnesses. These results offer a quantitative view of behavioral changes in human activity under extreme conditions, with potential long-term impact on emergency detection and response.	[Bagrow, James P.; Wang, Dashun; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Ctr Complex Network Res, Boston, MA 02115 USA; [Bagrow, James P.; Wang, Dashun; Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Northeastern University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Bagrow, JP (corresponding author), Northeastern Univ, Dept Phys, Ctr Complex Network Res, Boston, MA 02115 USA.	bagrowjp@gmail.com	Barabasi, Albert-Laszlo/S-6474-2017; Bagrow, James/E-1701-2016	Barabasi, Albert/0000-0002-4028-3522; Bagrow, James/0000-0002-4614-0792	James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems; National Science Foundation within the Information Technology Research [DMR-0426737]; Defense Threat Reduction Agency [HDTRA1-08-1-0027]; United States Army Research Laboratory [W911NF-09-2-0053]; United States Office of Naval Research [N000141010968];  [IIS-0513650]	James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems; National Science Foundation within the Information Technology Research; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); United States Army Research Laboratory; United States Office of Naval Research(Office of Naval Research); 	The authors were funded by the James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems, National Science Foundation within the Information Technology Research (DMR-0426737) and IIS-0513650 programs, the Defense Threat Reduction Agency award HDTRA1-08-1-0027, the Network Science Collaborative Technology Alliance sponsored by the United States Army Research Laboratory under agreement number W911NF-09-2-0053, and the United States Office of Naval Research Award (N000141010968). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Butts Carter T., 2008, INT J MASS EMERGENCI, V28, P133; Caldarelli G., 2007, SCALE FREE NETWORKS; Bohorquez JC, 2009, NATURE, V462, P911, DOI 10.1038/nature08631; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Gabrielli A, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/02/P02046; Goncalves B, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026123; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168001; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Kaplan EH, 2002, P NATL ACAD SCI USA, V99, P10935, DOI 10.1073/pnas.162282799; Kapoor A., 2010, P AAAI ART INT DEV A, P51; Lambiotte R, 2008, PHYSICA A, V387, P5317, DOI 10.1016/j.physa.2008.05.014; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lind BE, 2008, INT J EMERG MANAG, V5, P75, DOI 10.1504/IJEM.2008.019908; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Onnela J.-P., 2010, P NATL ACAD SCI; Ratkiewicz J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158701; Rodriguez H, 2006, HDB DISASTER RES; Rybski D, 2009, P NATL ACAD SCI USA, V106, P12640, DOI 10.1073/pnas.0902667106; SHEETZ S, 2010, J EMERGENCY MANAGEME; Singer HM, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026113; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104	30	194	195	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17680	10.1371/journal.pone.0017680	http://dx.doi.org/10.1371/journal.pone.0017680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479206	Green Submitted, gold, Green Published			2022-12-27	WOS:000289055700014
J	Strelnikov, K; Rosito, M; Barone, P				Strelnikov, Kuzma; Rosito, Maxime; Barone, Pascal			Effect of Audiovisual Training on Monaural Spatial Hearing in Horizontal Plane	PLOS ONE			English	Article							SOUND-LOCALIZATION; AUDITORY-CORTEX; MULTISENSORY CONVERGENCE; ACOUSTICAL VISION; VISUAL AREAS; INTEGRATION; CONNECTIONS; PLASTICITY; IDENTIFICATION; PROJECTION	The article aims to test the hypothesis that audiovisual integration can improve spatial hearing in monaural conditions when interaural difference cues are not available. We trained one group of subjects with an audiovisual task, where a flash was presented in parallel with the sound and another group in an auditory task, where only sound from different spatial locations was presented. To check whether the observed audiovisual effect was similar to feedback, the third group was trained using the visual feedback paradigm. Training sessions were administered once per day, for 5 days. The performance level in each group was compared for auditory only stimulation on the first and the last day of practice. Improvement after audiovisual training was several times higher than after auditory practice. The group trained with visual feedback demonstrated a different effect of training with the improvement smaller than the group with audiovisual training. We conclude that cross-modal facilitation is highly important to improve spatial hearing in monaural conditions and may be applied to the rehabilitation of patients with unilateral deafness and after unilateral cochlear implantation.	[Strelnikov, Kuzma; Rosito, Maxime; Barone, Pascal] Univ Toulouse 3, Univ Toulouse, CerCo, Toulouse, France; [Strelnikov, Kuzma; Rosito, Maxime; Barone, Pascal] Fac Med Rangueil, CNRS, UMR 5549, Toulouse, France; [Strelnikov, Kuzma] Ctr Hosp Univ, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Strelnikov, K (corresponding author), Univ Toulouse 3, Univ Toulouse, CerCo, Toulouse, France.	pascal.barone@cerco.ups-tlse.fr	BARONE, Pascal/AHE-2323-2022; Barone, Pascal/A-4008-2009	BARONE, Pascal/0000-0003-0125-7468; Strelnikov, Kuzma/0000-0002-6613-2300	Federation pour la Recherche sur le Cerveau; ANR Hearing Loss [ANR-06-Neuro-021-04]; CNRS	Federation pour la Recherche sur le Cerveau; ANR Hearing Loss(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	Federation pour la Recherche sur le Cerveau (to PB), ANR Hearing Loss (ANR-06-Neuro-021-04 to PB), CNRS Atip+ program (to KS, BP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011283; Barone P, 2010, PHYS LIFE REV, V7, P291, DOI 10.1016/j.plrev.2010.07.002; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Beer AL, 2009, EXP BRAIN RES, V198, P353, DOI 10.1007/s00221-009-1769-6; Bolognini N, 2005, EXP BRAIN RES, V160, P273, DOI 10.1007/s00221-004-2005-z; BUTLER RA, 1987, PERCEPT PSYCHOPHYS, V41, P1, DOI 10.3758/BF03208206; Cappe C, 2005, EUR J NEUROSCI, V22, P2886, DOI 10.1111/j.1460-9568.2005.04462.x; Cappe C, 2009, CEREB CORTEX, V19, P2025, DOI 10.1093/cercor/bhn228; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Clarey JC, 1992, MAMMALIAN AUDITORY P, P232, DOI [10.1007/978-1-4612-2838-7_5, DOI 10.1007/978-1-4612-2838-7_5]; COLLETTI V, 1988, British Journal of Audiology, V22, P113, DOI 10.3109/03005368809077805; Darwin CJ, 2004, J ACOUST SOC AM, V116, P502, DOI 10.1121/1.1760794; Falchier A, 2002, J NEUROSCI, V22, P5749; Falchier A, 2010, CEREB CORTEX, V20, P1529, DOI 10.1093/cercor/bhp213; Foxe JJ, 2000, COGNITIVE BRAIN RES, V10, P77, DOI 10.1016/S0926-6410(00)00024-0; Frassinetti F, 2005, J COGNITIVE NEUROSCI, V17, P1442, DOI 10.1162/0898929054985446; Frassinetti F, 2002, J COGNITIVE NEUROSCI, V14, P62, DOI 10.1162/089892902317205320; Fu SM, 2003, PSYCHOPHYSIOLOGY, V40, P770, DOI 10.1111/1469-8986.00077; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Giraud AL, 2001, NEURON, V30, P657, DOI 10.1016/S0896-6273(01)00318-X; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Grantham DW, 2008, LARYNGOSCOPE, V118, P145, DOI 10.1097/MLG.0b013e31815661f9; Hackett TA, 1999, BRAIN RES, V817, P45, DOI 10.1016/S0006-8993(98)01182-2; HEFFNER HE, 1990, J NEUROPHYSIOL, V64, P915, DOI 10.1152/jn.1990.64.3.915; Hervais-Adelman A, 2008, J EXP PSYCHOL HUMAN, V34, P460, DOI 10.1037/0096-1523.34.2.460; Hofman PM, 1998, J ACOUST SOC AM, V103, P2634, DOI 10.1121/1.422784; Hua TM, 2010, CURR BIOL, V20, P887, DOI 10.1016/j.cub.2010.03.066; Ison JR, 1998, J ACOUST SOC AM, V104, P1689, DOI 10.1121/1.424381; JENKINS WM, 1982, J NEUROPHYSIOL, V47, P987, DOI 10.1152/jn.1982.47.6.987; Kaas JH, 2000, J COMP NEUROL, V421, P143, DOI 10.1002/(SICI)1096-9861(20000529)421:2<143::AID-CNE1>3.0.CO;2-H; KAVANAGH GL, 1987, J NEUROPHYSIOL, V57, P1746, DOI 10.1152/jn.1987.57.6.1746; Kawase T, 2009, NEUROREPORT, V20, P1231, DOI 10.1097/WNR.0b013e32832fbef8; Kayser J, 2007, PSYCHOPHYSIOLOGY, V44, P949, DOI 10.1111/j.1469-8986.2007.00562.x; Kim RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001532; King AJ, 1996, PROG BRAIN RES, V112, P335; King AJ, 2001, TRENDS COGN SCI, V5, P261, DOI 10.1016/S1364-6613(00)01660-0; King AJ, 2009, PHILOS T R SOC B, V364, P331, DOI 10.1098/rstb.2008.0230; KNUDSEN EI, 1995, ANNU REV NEUROSCI, V18, P19, DOI 10.1146/annurev.ne.18.030195.000315; Kumpik DP, 2010, J NEUROSCI, V30, P4883, DOI 10.1523/JNEUROSCI.5488-09.2010; Ladavas E, 2008, ANN NY ACAD SCI, V1124, P98, DOI 10.1196/annals.1440.008; Lehmann S, 2005, COGNITIVE BRAIN RES, V24, P326, DOI 10.1016/j.cogbrainres.2005.02.005; Leo F, 2008, BRAIN, V131, P855, DOI 10.1093/brain/awn003; Lewald J, 1998, J ACOUST SOC AM, V104, P1586, DOI 10.1121/1.424371; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Lippert M, 2007, BRAIN RES, V1173, P102, DOI 10.1016/j.brainres.2007.07.050; Lovelace CT, 2003, COGNITIVE BRAIN RES, V17, P447, DOI 10.1016/S0926-6410(03)00160-5; Luntz Michal, 2005, Cochlear Implants Int, V6, P1, DOI 10.1179/cim.2005.6.Supplement-1.1; Malhotra S, 2004, J NEUROPHYSIOL, V92, P1625, DOI 10.1152/jn.01205.2003; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; Merabet LB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003046; Middlebrooks JC, 2002, NEUROSCIENTIST, V8, P73, DOI 10.1177/107385840200800112; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; MUSICANT AD, 1984, HEARING RES, V14, P185, DOI 10.1016/0378-5955(84)90017-0; Nava E, 2009, HEARING RES, V255, P91, DOI 10.1016/j.heares.2009.06.007; NEFF WD, 1977, J NEUROPHYSIOL, V40, P44, DOI 10.1152/jn.1977.40.1.44; Nodal FR, 2010, J NEUROPHYSIOL, V103, P1209, DOI 10.1152/jn.00991.2009; PANDYA DN, 1969, BRAIN RES, V14, P49, DOI 10.1016/0006-8993(69)90030-4; RAUSCHECKER JP, 1991, PHYSIOL REV, V71, P587, DOI 10.1152/physrev.1991.71.2.587; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Rouger J, 2007, P NATL ACAD SCI USA, V104, P7295, DOI 10.1073/pnas.0609419104; SAMSON FK, 1993, J NEUROPHYSIOL, V70, P492, DOI 10.1152/jn.1993.70.2.492; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Seitz AR, 2006, CURR BIOL, V16, P1422, DOI 10.1016/j.cub.2006.05.048; SHAMS L, 2010, PHYS LIFE REV; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; Shub DE, 2008, J ACOUST SOC AM, V124, P3132, DOI 10.1121/1.2981634; SLATTERY WH, 1994, HEARING RES, V75, P38, DOI 10.1016/0378-5955(94)90053-1; Smiley JF, 2007, J COMP NEUROL, V502, P894, DOI 10.1002/cne.21325; Sperdin HF, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.002.2009; Stein BE, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.021.2009; Stein BE., 1993, MERGING SENSES; Strelnikov K, 2009, NEUROPSYCHOLOGIA, V47, P972, DOI 10.1016/j.neuropsychologia.2008.10.017; SWETS JA, 1978, PERCEPT PSYCHOPHYS, V23, P275, DOI 10.3758/BF03199711; Van Wanrooij MM, 2007, J NEUROPHYSIOL, V97, P715, DOI 10.1152/jn.00260.2006; Van Wanrooij MM, 2005, J NEUROSCI, V25, P5413, DOI 10.1523/JNEUROSCI.0850-05.2005; Van Wanrooij MM, 2004, J NEUROSCI, V24, P4163, DOI 10.1523/JNEUROSCI.0048-04.2004; Wang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-79; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; WELCH RB, 1986, HDB PERCEPTION HUMAN, P1; WITHINGTONWRAY DJ, 1990, DEV BRAIN RES, V51, P225, DOI 10.1016/0165-3806(90)90279-8; Wright BA, 2006, INT J AUDIOL, V45, pS92, DOI 10.1080/14992020600783004; Zwiers MP, 2003, NAT NEUROSCI, V6, P175, DOI 10.1038/nn999	88	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18344	10.1371/journal.pone.0018344	http://dx.doi.org/10.1371/journal.pone.0018344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479241	Green Published, gold, Green Submitted			2022-12-27	WOS:000289054600046
J	Wolfs, TGAM; Kallapur, SG; Polglase, GR; Pillow, JJ; Nitsos, I; Newnham, JP; Chougnet, CA; Kroon, E; Spierings, J; Willems, CHMP; Jobe, AH; Kramer, BW				Wolfs, Tim G. A. M.; Kallapur, Suhas G.; Polglase, Graeme R.; Pillow, J. Jane; Nitsos, Ilias; Newnham, John P.; Chougnet, Claire A.; Kroon, Elke; Spierings, Julia; Willems, Coen H. M. P.; Jobe, Alan H.; Kramer, Boris W.			IL-1 alpha Mediated Chorioamnionitis Induces Depletion of FoxP3+Cells and Ileal Inflammation in the Ovine Fetal Gut	PLOS ONE			English	Article							REGULATORY T-CELLS; INTESTINAL LAMINA PROPRIA; NECROTIZING ENTEROCOLITIS; TNF-ALPHA; TGF-BETA; PRETERM; DISEASE; LUNG; INDUCTION; FOXP3	Background: Endotoxin induced chorioamnionitis increases IL-1 and provokes an inflammatory response in the fetal ileum that interferes with intestinal maturation. In the present study, we tested in an ovine chorioamnionitis model whether IL-1 is a major cytokine driving the inflammatory response in the fetal ileum. Method: Sheep bearing singleton fetuses received a single intraamniotic injection of recombinant ovine IL-1 alpha at 7, 3 or 1 d before caesarian delivery at 125 days gestational age (term = 150 days). Results: 3 and 7 d after IL-1 alpha administration, intestinal mRNA levels for IL-4, IL-10, IFN-gamma and TNF-alpha were strongly elevated. Numbers of CD3+ and CD4+ T-lymphocytes and myeloidperoxidase+ cells were increased whereas FoxP3+ T-cells were detected at low frequency. This increased proinflammatory state was associated with ileal mucosal barrier loss as demonstrated by decreased levels of the intestinal fatty acid binding protein and disruption of the tight junctional protein ZO-1. Conclusion: Intraamniotic IL-1 alpha causes an acute detrimental inflammatory response in the ileum, suggesting that induction of IL-1 is a critical element in the pathophysiological effects of endotoxin induced chorioamnionitis. A disturbed balance between T-effector and FoxP3+ cells may contribute to this process.	[Wolfs, Tim G. A. M.; Kroon, Elke; Spierings, Julia; Willems, Coen H. M. P.; Kramer, Boris W.] Maastricht Univ Med Ctr MUMC, Dept Pediat, Sch Oncol & Dev Biol GROW, Maastricht, Netherlands; [Wolfs, Tim G. A. M.; Kallapur, Suhas G.; Jobe, Alan H.] Univ Cincinnati, Sch Med, Dept Neonatol, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Polglase, Graeme R.; Pillow, J. Jane; Nitsos, Ilias; Newnham, John P.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Chougnet, Claire A.] Univ Cincinnati, Dept Pediat, Div Mol Immunol, Cincinnati Childrens Hosp Med Ctr,Sch Med, Cincinnati, OH 45221 USA	Maastricht University; Maastricht University Medical Centre (MUMC); Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Western Australia; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Wolfs, TGAM (corresponding author), Maastricht Univ Med Ctr MUMC, Dept Pediat, Sch Oncol & Dev Biol GROW, Maastricht, Netherlands.	b.kramer@mumc.nl	Willems, Coen/G-6347-2013; Spierings, Julia/ABI-1737-2020; Pillow, Jane/A-3335-2009; Kramer, Boris/AAO-3183-2021	Pillow, Jane/0000-0002-6500-0138; Wolfs, Tim/0000-0003-4417-4144; Newnham, John/0000-0001-9983-7457; Polglase, Graeme/0000-0002-8906-614X; Spierings, Julia/0000-0002-2546-312X	National Institutes of Health [HD-57869]; Dutch Scientific Research Organization [016.096.141]; Royal Netherlands Academy of Arts and Sciences; Research School for Oncology and Developmental Biology (GROW), Maastricht University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Scientific Research Organization; Royal Netherlands Academy of Arts and Sciences; Research School for Oncology and Developmental Biology (GROW), Maastricht University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the National Institutes of Health Grant HD-57869 (to S. Kallapur), the Dutch Scientific Research Organization Veni Grant 016.096.141 (to B.W. Kramer), the Ter Meulen Fund of the Royal Netherlands Academy of Arts and Sciences (to T. G. A. M. Wolfs) and the Research School for Oncology and Developmental Biology (GROW), Maastricht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand RJ, 2007, SHOCK, V27, P124, DOI 10.1097/01.shk.0000239774.02904.65; Andrews WW, 2006, AM J OBSTET GYNECOL, V195, P803, DOI 10.1016/j.ajog.2006.06.083; Arntzen KJ, 1998, J PERINAT MED, V26, P17, DOI 10.1515/jpme.1998.26.1.17; BAERGEN R, 1994, ARCH PATHOL LAB MED, V118, P52; Baud O, 1999, BRIT J OBSTET GYNAEC, V106, P72, DOI 10.1111/j.1471-0528.1999.tb08088.x; BERRY CA, 2011, REPROD SCI IN PRESS; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Caplan Michael S, 2005, Semin Pediatr Surg, V14, P145, DOI 10.1053/j.sempedsurg.2005.05.002; Challis JRG, 2001, ANN NY ACAD SCI, V943, P225, DOI 10.1111/j.1749-6632.2001.tb03804.x; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Derikx JPM, 2009, J CLIN GASTROENTEROL, V43, P727, DOI 10.1097/MCG.0b013e31819194b0; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Gantert M, 2010, J PERINATOL, V30, pS21, DOI 10.1038/jp.2010.96; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Graham PL, 2006, PEDIATR INFECT DIS J, V25, P113, DOI 10.1097/01.inf.0000199310.52875.10; Ikegami M, 2003, AM J PHYSIOL-LUNG C, V285, pL121, DOI 10.1152/ajplung.00393.2002; Kallapur SG, 2009, AM J RESP CRIT CARE, V179, P955, DOI 10.1164/rccm.200811-1728OC; Kramer BW, 2008, J PERINATOL, V28, pS21, DOI 10.1038/jp.2008.46; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Makita S, 2007, J IMMUNOL, V178, P4937, DOI 10.4049/jimmunol.178.8.4937; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Pelsers MMAL, 2005, CLIN CHIM ACTA, V352, P15, DOI 10.1016/j.cccn.2004.09.001; Presicce P, 2010, CYTOM PART A, V77A, P571, DOI 10.1002/cyto.a.20875; ROMERO R, 1992, AM J REPROD IMMUNOL, V27, P117, DOI 10.1111/j.1600-0897.1992.tb00737.x; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sangild PT, 2006, GASTROENTEROLOGY, V130, P1776, DOI 10.1053/j.gastro.2006.02.026; Sosenko IRS, 2006, PEDIATR RES, V60, P294, DOI 10.1203/01.pdr.0000233115.51309.d3; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wang J, 2010, MOL IMMUNOL, V48, P137, DOI 10.1016/j.molimm.2010.08.017; Weitkamp JH, 2009, PEDIATR DEVEL PATHOL, V12, P443, DOI 10.2350/08-09-0533.1; Westendorf AM, 2005, GUT, V54, P60, DOI 10.1136/gut.2003.037663; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Willet KE, 2002, AM J PHYSIOL-LUNG C, V282, pL411, DOI 10.1152/ajplung.00097.2001; Wolfs TGAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005837	38	37	38	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18355	10.1371/journal.pone.0018355	http://dx.doi.org/10.1371/journal.pone.0018355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479249	Green Published, Green Submitted, gold			2022-12-27	WOS:000289054600047
J	Koralewski, TE; Krutovsky, KV				Koralewski, Tomasz E.; Krutovsky, Konstantin V.			Evolution of Exon-Intron Structure and Alternative Splicing	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; TRANSCRIPTIONAL INITIATION; GENE DUPLICATION; DIVERSITY; HISTORY; ORIGIN	Despite significant advances in high-throughput DNA sequencing, many important species remain understudied at the genome level. In this study we addressed a question of what can be predicted about the genome-wide characteristics of less studied species, based on the genomic data from completely sequenced species. Using NCBI databases we performed a comparative genome-wide analysis of such characteristics as alternative splicing, number of genes, gene products and exons in 36 completely sequenced model species. We created statistical regression models to fit these data and applied them to loblolly pine (Pinus taeda L.), an example of an important species whose genome has not been completely sequenced yet. Using these models, the genome-wide characteristics, such as total number of genes and exons, can be roughly predicted based on parameters estimated from available limited genomic data, e. g. exon length and exon/gene ratio.	[Koralewski, Tomasz E.; Krutovsky, Konstantin V.] Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Koralewski, TE (corresponding author), Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX 77843 USA.	k-krutovsky@tamu.edu	Krutovsky, Konstantin V./A-5419-2012	Krutovsky, Konstantin V./0000-0002-8819-7084	United States Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service (CSREES); Texas Agricultural Experiment Station (TAES)	United States Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service (CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Texas Agricultural Experiment Station (TAES)	This study was funded by the United States Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service (CSREES) and the Texas Agricultural Experiment Station (TAES) McIntire-Stennis Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2000, P NATL ACAD SCI USA, V97, P4463, DOI 10.1073/pnas.97.9.4463; Ahuja MR, 2005, SILVAE GENET, V54, P59, DOI 10.1515/sg-2005-0010; Babenko VN, 2004, NUCLEIC ACIDS RES, V32, P3724, DOI 10.1093/nar/gkh686; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Chi KR, 2008, NAT METHODS, V5, P11, DOI 10.1038/NMETH1154; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Gray MW, 2009, IUBMB LIFE, V61, P1101, DOI 10.1002/iub.272; Gray MW, 2003, IUBMB LIFE, V55, P227, DOI 10.1080/1521654031000119425; Grotkopp E, 2004, EVOLUTION, V58, P1705, DOI 10.1111/j.0014-3820.2004.tb00456.x; Hughes AL, 2008, GENETICA, V134, P181, DOI 10.1007/s10709-007-9223-9; Iida K, 2004, NUCLEIC ACIDS RES, V32, P5096, DOI 10.1093/nar/gkh845; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kondrashov FA, 2003, TRENDS GENET, V19, P115, DOI 10.1016/S0168-9525(02)00029-X; Kondrashov FA, 2001, HUM MOL GENET, V10, P2661, DOI 10.1093/hmg/10.23.2661; Kopelman NM, 2005, NAT GENET, V37, P588, DOI 10.1038/ng1575; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Long MY, 1995, P NATL ACAD SCI USA, V92, P12495, DOI 10.1073/pnas.92.26.12495; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Mano S, 1999, PLANT J, V17, P309, DOI 10.1046/j.1365-313X.1999.00378.x; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; McGuire AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r50; MCKEOWN M, 1992, ANNU REV CELL BIOL, V8, P133, DOI 10.1146/annurev.cb.08.110192.001025; Morse AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004332; Nagasaki H, 2005, GENE, V364, P53, DOI 10.1016/j.gene.2005.07.027; Nagasaki H, 2006, BIOINFORMATICS, V22, P1211, DOI 10.1093/bioinformatics/btl067; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Sammeth M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000147; Severing EI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-154; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Su ZX, 2006, GENOME RES, V16, P182, DOI 10.1101/gr.4197006; *USDA, 2010, COMP GRANTS PROGR SB, V5, P10; Valentine JW, 2000, PALEOBIOLOGY, V26, P513, DOI 10.1666/0094-8373(2000)026<0513:TGPTTE>2.0.CO;2; von Bubnoff A, 2008, CELL, V132, P721, DOI 10.1016/j.cell.2008.02.028; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	43	56	59	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18055	10.1371/journal.pone.0018055	http://dx.doi.org/10.1371/journal.pone.0018055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464961	Green Published, gold			2022-12-27	WOS:000288813900031
J	Nijman, V; Shepherd, CR				Nijman, Vincent; Shepherd, Chris R.			The Role of Thailand in the International Trade in CITES-Listed Live Reptiles and Amphibians	PLOS ONE			English	Article							WILDLIFE; ASIA	Background: International wildlife trade is one of the leading threats to biodiversity conservation. The Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) is the most important initiative to monitor and regulate the international trade of wildlife but its credibility is dependent on the quality of the trade data. We report on the performance of CITES reporting by focussing on the commercial trade in non-native reptiles and amphibians into Thailand as to illustrate trends, species composition and numbers of wild-caught vs. captive-bred specimens. Methodology/Principal Findings: Based on data in the WCMC-CITES trade database, we establish that a total of 75,594 individuals of 169 species of reptiles and amphibians (including 27 globally threatened species) were imported into Thailand in 1990-2007. The majority of individuals (59,895, 79%) were listed as captive-bred and a smaller number (15,699, 21%) as wild-caught. In the 1990s small numbers of individuals of a few species were imported into Thailand, but in 2003 both volumes and species diversity increased rapidly. The proportion of captive-bred animals differed greatly between years (from 0 to > 80%). Wild-caught individuals were mainly sourced from African countries, and captive-bred individuals from Asian countries (including from non-CITES Parties). There were significant discrepancies between exports and imports. Thailand reports the import of > 10,000 individuals (51 species) originating from Kazakhstan, but Kazakhstan reports no exports of these species. Similar discrepancies, involving smaller numbers (> 100 individuals of 9 species), can be seen in the import of reptiles into Thailand via Macao. Conclusion/Significance: While there has been an increase in imports of amphibian and reptiles into Thailand, erratic patterns in proportions of captive-bred specimens and volumes suggests either capricious markets or errors in reporting. Large discrepancies with respect to origin point to misreporting or possible violations of the rules and intentions of CITES.	[Nijman, Vincent; Shepherd, Chris R.] Oxford Brookes Univ, Oxford Wildlife Trade Res Grp, Sch Social Sci & Law, Oxford OX3 0BP, England; [Shepherd, Chris R.] TRAFFIC SE Asia, Petaling Jaya, Selangor, Malaysia	Oxford Brookes University	Nijman, V (corresponding author), Oxford Brookes Univ, Oxford Wildlife Trade Res Grp, Sch Social Sci & Law, Oxford OX3 0BP, England.	vnijman@brookes.ac.uk	Nijman, Vincent/AHD-8685-2022	Nijman, Vincent/0000-0002-5600-4276				[Anonymous], 2008, CITES SECR 23 M AN C; Auliya M., 2003, HOT TRADE COOL CREAT; Bell D, 2004, PHILOS T R SOC B, V359, P1107, DOI 10.1098/rstb.2004.1492; Bickford D, 2011, SCIENCE, V331, P857, DOI 10.1126/science.331.6019.857-c; Blundell AG, 2005, CONSERV BIOL, V19, P2020, DOI 10.1111/j.1523-1739.2005.00253.x; Bridges V. E., 2001, REPTILE AMPHIBIAN CO; Carpenter AI, 2004, BIOL CONSERV, V120, P291, DOI 10.1016/j.biocon.2004.03.002; Chen TH, 2009, CHELONIAN CONSERV BI, V8, P11, DOI 10.2744/CCB-0747.1; DODD C K JR, 1986, Herpetological Review, V17, P76; Franke J., 2001, REPTILES PETS EXAMIN; Gehring T, 2008, GLOBAL ENVIRON POLIT, V8, P123, DOI 10.1162/glep.2008.8.2.123; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gorzula Stefan, 1996, Herpetological Review, V27, P116; Highfield AC, 2009, CAPTIVE BRED ILLEGAL; Hoover C, 1998, US ROLE INT LIVE REP; Nijman V, 2009, ASIA BIODIV CONSERV, V19, P1101; Nijman V., 2009, WILDLIFE TRADE ASEAN; Nijman V, 2011, WILDLIFE TR IN PRESS; Nijman V, 2007, CONTRIB ZOOL, V76, P207, DOI 10.1163/18759866-07603007; Nijman V, 2010, BIODIVERS CONSERV, V19, P1963, DOI 10.1007/s10531-010-9814-0; Nooren H., 2001, WILDLIFE TRADE LAOS; Phelps J, 2010, SCIENCE, V330, P1752, DOI 10.1126/science.1195558; Schlaepfer MA, 2005, BIOSCIENCE, V55, P256, DOI 10.1641/0006-3568(2005)055[0256:CIETIO]2.0.CO;2; Shepherd C.R., 2008, ASSESSMENT TRADE FRE; Shepherd CR, 2008, BIODIVERS CONSERV, V17, P35, DOI 10.1007/s10531-007-9228-9; Smith KF, 2009, SCIENCE, V324, P594, DOI 10.1126/science.1174460; Smith MJ, 2011, BIOL CONSERV, V144, P82, DOI 10.1016/j.biocon.2010.10.018; Stuart BL, 2006, SCIENCE, V312, P1137, DOI 10.1126/science.312.5777.1137b; Styles D, 2009, ELEPHANT IVORY TRADE; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; Todd M., 2011, TRADE MADAGASCARS RE; Van Borm S, 2005, EMERG INFECT DIS, V11, P702, DOI 10.3201/eid1105.050211; van Dijk P. P., 2000, CHELONIAN RES MONOGR, V2; van Dijk PP, 2000, CHELON RES MONOGR, P137; Vinke T., 2010, SCHILDKROTEN IM FOKU, V7, P1; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Zhang L, 2008, BIODIVERS CONSERV, V17, P1493, DOI 10.1007/s10531-008-9358-8; Zhou ZH, 2004, CONSERV BIOL, V18, P1386, DOI 10.1111/j.1523-1739.2004.00251.x	38	24	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17825	10.1371/journal.pone.0017825	http://dx.doi.org/10.1371/journal.pone.0017825			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464976	Green Published, gold, Green Submitted			2022-12-27	WOS:000288813900012
J	Riscili, BP; Anderson, TB; Prescott, HC; Exline, MC; Sopirala, MM; Phillips, GS; Ali, NA				Riscili, Brent P.; Anderson, Tyler B.; Prescott, Hallie C.; Exline, Matthew C.; Sopirala, Madhuri M.; Phillips, Gary S.; Ali, Naeem A.			An Assessment of H1N1 Influenza-Associated Acute Respiratory Distress Syndrome Severity after Adjustment for Treatment Characteristics	PLOS ONE			English	Article							ACUTE LUNG INJURY; CRITICALLY-ILL PATIENTS; A(H1N1) INFECTION; UNITED-STATES; VIRUS; VENTILATION; STRATEGIES	Pandemic influenza caused significant increases in healthcare utilization across several continents including the use of high-intensity rescue therapies like extracorporeal membrane oxygenation (ECMO) or high-frequency oscillatory ventilation (HFOV). The severity of illness observed with pandemic influenza in 2009 strained healthcare resources. Because lung injury in ARDS can be influenced by daily management and multiple organ failure, we performed a retrospective cohort study to understand the severity of H1N1 associated ARDS after adjustment for treatment. Sixty subjects were identified in our hospital with ARDS from "direct injury" within 24 hours of ICU admission over a three month period. Twenty-three subjects (38.3%) were positive for H1N1 within 72 hours of hospitalization. These cases of H1N1-associated ARDS were compared to non-H1N1 associated ARDS patients. Subjects with H1N1-associated ARDS were younger and more likely to have a higher body mass index (BMI), present more rapidly and have worse oxygenation. Severity of illness (SOFA score) was directly related to worse oxygenation. Management was similar between the two groups on the day of admission and subsequent five days with respect to tidal volumes used, fluid balance and transfusion practices. There was, however, more frequent use of "rescue" therapy like prone ventilation, HFOV or ECMO in H1N1 patients. First morning set tidal volumes and BMI were significantly associated with increased severity of lung injury (Lung injury score, LIS) at presentation and over time while prior prescription of statins was protective. After assessment of the effect of these co-interventions LIS was significantly higher in H1N1 patients. Patients with pandemic influenza-associated ARDS had higher LIS both at presentation and over the course of the first six days of treatment when compared to non-H1N1 associated ARDS controls. The difference in LIS persisted over the duration of observation in patients with H1N1 possibly explaining the increased duration of mechanical ventilation.	[Riscili, Brent P.; Exline, Matthew C.; Ali, Naeem A.] Ohio State Univ, Med Ctr, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Sopirala, Madhuri M.] Ohio State Univ, Med Ctr, Div Infect Dis, Columbus, OH 43210 USA; [Riscili, Brent P.; Anderson, Tyler B.; Prescott, Hallie C.; Exline, Matthew C.; Sopirala, Madhuri M.; Ali, Naeem A.] Ohio State Univ, Med Ctr, Dept Internal Med, Columbus, OH 43210 USA; [Phillips, Gary S.] Ohio State Univ, Med Ctr, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Riscili, BP (corresponding author), Ohio State Univ, Med Ctr, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA.	naeem.ali@osumc.edu	Exline, Matthew/E-3047-2011	ALI, NORA'AINI/0000-0003-1391-2757; Prescott, Hallie/0000-0002-8442-6724	NIH [K23 RR019544, K23 HL095772]; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR019544, UL1RR025755] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL095772] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	K23 RR019544, NIH to NAA; K23 HL095772, NIH to MCE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral ACKB, 2005, INTENS CARE MED, V31, P243, DOI 10.1007/s00134-004-2528-6; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Estenssoro E, 2010, AM J RESP CRIT CARE, V182, P41, DOI [10.1164/rccm.201001-0037OC, 10.1164/201001-0037OC]; Gajic O, 2007, AM J RESP CRIT CARE, V176, P886, DOI 10.1164/rccm.200702-271OC; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Ginocchio CC, 2009, J CLIN MICROBIOL, V47, P2347, DOI 10.1128/JCM.01027-09; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lee N, 2007, CLIN INFECT DIS, V45, P723, DOI 10.1086/520981; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; McCallister J, 2009, CLIN CHEST MED, V30, P495, DOI 10.1016/j.ccm.2009.05.008; Miller RR, 2010, CHEST, V137, P752, DOI 10.1378/chest.09-2517; Mitchell MD, 2010, CRIT CARE MED, V38, P1398, DOI 10.1097/CCM.0b013e3181de45db; O'Brien JM, 2004, ANN INTERN MED, V140, P338, DOI 10.7326/0003-4819-140-5-200403020-00009; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Vincent Jean-Louis, 2006, Surg Infect (Larchmt), V7 Suppl 2, pS69; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785	24	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18166	10.1371/journal.pone.0018166	http://dx.doi.org/10.1371/journal.pone.0018166			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464952	gold, Green Published, Green Submitted			2022-12-27	WOS:000288813900044
J	Smallwood, J; Brown, KS; Tipper, C; Giesbrecht, B; Franklin, MS; Mrazek, MD; Carlson, JM; Schooler, JW				Smallwood, Jonathan; Brown, Kevin S.; Tipper, Christine; Giesbrecht, Barry; Franklin, Michael S.; Mrazek, Michael D.; Carlson, Jean M.; Schooler, Jonathan W.			Pupillometric Evidence for the Decoupling of Attention from Perceptual Input during Offline Thought	PLOS ONE			English	Article							STIMULUS-INDEPENDENT THOUGHT; SUSTAINED ATTENTION; LOCUS-COERULEUS; DEFAULT NETWORK; EXECUTIVE-CONTROL; WANDERING MINDS; WORKING-MEMORY; BRAIN-FUNCTION; ADAPTIVE GAIN; TASK	Accumulating evidence suggests that the brain can efficiently process both external and internal information. The processing of internal information is a distinct "offline" cognitive mode that requires not only spontaneously generated mental activity; it has also been hypothesized to require a decoupling of attention from perception in order to separate competing streams of internal and external information. This process of decoupling is potentially adaptive because it could prevent unimportant external events from disrupting an internal train of thought. Here, we use measurements of pupil diameter (PD) to provide concrete evidence for the role of decoupling during spontaneous cognitive activity. First, during periods conducive to offline thought but not during periods of task focus, PD exhibited spontaneous activity decoupled from task events. Second, periods requiring external task focus were characterized by large task evoked changes in PD; in contrast, encoding failures were preceded by episodes of high spontaneous baseline PD activity. Finally, high spontaneous PD activity also occurred prior to only the slowest 20% of correct responses, suggesting high baseline PD indexes a distinct mode of cognitive functioning. Together, these data are consistent with the decoupling hypothesis, which suggests that the capacity for spontaneous cognitive activity depends upon minimizing disruptions from the external world.	[Smallwood, Jonathan] Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany; [Brown, Kevin S.; Carlson, Jean M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Tipper, Christine; Giesbrecht, Barry; Franklin, Michael S.; Mrazek, Michael D.; Schooler, Jonathan W.] Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA	Max Planck Society; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Smallwood, J (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany.	smallwood@cbs.mpg.de	Schooler, Jonathan/AAZ-3977-2020; Schooler, Jonathan/ABE-6434-2020; Tipper, Christine/F-9409-2013; Smallwood, Jonathan/ABE-8365-2020	Tipper, Christine/0000-0003-1666-9203; Brown, Kevin/0000-0003-2959-2401; Smallwood, Jonathan/0000-0002-7298-2459	David and Lucile Packard Foundation; U. S. Army Research Office [W911NF-09-D-0001]; Bower Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); U. S. Army Research Office; Bower Foundation	KSB and JMC thank the David and Lucile Packard Foundation and the Institute for Collaborative Biotechnologies through contract no. W911NF-09-D-0001 from the U. S. Army Research Office. JWS and MSF were supported by a grant from the Bower Foundation.	Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Beatty J., 2000, HDB PSYCHOPHYSIOL, V2, P142; Carriere JSA, 2008, CONSCIOUS COGN, V17, P835, DOI 10.1016/j.concog.2007.04.008; Carriere JSA, 2010, PSYCHOL AGING, V25, P569, DOI 10.1037/a0019363; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dehaene S, 2005, PLOS BIOL, V3, P910, DOI 10.1371/journal.pbio.0030141; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Einhauser W, 2008, P NATL ACAD SCI USA, V105, P1704, DOI 10.1073/pnas.0707727105; FernandezDuque D, 1997, NEUROPSYCHOLOGIA, V35, P477, DOI 10.1016/S0028-3932(96)00103-0; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Harrison NA, 2007, EMOTION, V7, P724, DOI 10.1037/1528-3542.7.4.724; Hupe JM, 2009, J VISION, V9, DOI 10.1167/9.7.10; Kam JWY, 2011, J COGNITIVE NEUROSCI, V23, P460, DOI 10.1162/jocn.2010.21443; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mcvay JC, 2010, PSYCHOL BULL, V136, P188, DOI 10.1037/a0018298; McVay JC, 2009, J EXP PSYCHOL LEARN, V35, P196, DOI 10.1037/a0014104; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Raichle ME, 2009, J NEUROSCI, V29, P12729, DOI 10.1523/JNEUROSCI.4366-09.2009; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Siegle GJ, 2003, NEUROIMAGE, V20, P114, DOI 10.1016/S1053-8119(03)00298-2; Singer J.L., 1966, DAYDREAMING INTRO EX; Smallwood J, 2006, CONSCIOUS COGN, V15, P218, DOI 10.1016/j.concog.2005.03.003; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood J., 2006, IMAGINATION COGNITIO, V24, P355; Smallwood J, SELFREFLECT IN PRESS; Smallwood JM, 2003, CONSCIOUS COGN, V12, P452, DOI 10.1016/S1053-8100(03)00018-7; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2007, COGNITION EMOTION, V21, P816, DOI 10.1080/02699930600911531; Smallwood J, 2007, PSYCHON B REV, V14, P527, DOI 10.3758/BF03194102; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2010, PSYCHOL BULL, V136, P202, DOI 10.1037/a0018673; Smallwood J, 2009, CONSCIOUS COGN, V18, P118, DOI 10.1016/j.concog.2008.11.004; Smallwood J, 2009, EMOTION, V9, P271, DOI 10.1037/a0014855; Smilek D, 2010, NEUROPSYCHOLOGIA, V48, P2564, DOI 10.1016/j.neuropsychologia.2010.05.002; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; TEASDALE JD, 1995, MEM COGNITION, V23, P551, DOI 10.3758/BF03197257; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	49	175	175	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18298	10.1371/journal.pone.0018298	http://dx.doi.org/10.1371/journal.pone.0018298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	740SE	21464969	Green Published, gold			2022-12-27	WOS:000288813900057
J	Wheatley, AK; Kramski, M; Alexander, MR; Toe, JG; Center, RJ; Purcell, DFJ				Wheatley, Adam K.; Kramski, Marit; Alexander, Marina R.; Toe, Jesse G.; Center, Rob J.; Purcell, Damian F. J.			Co-Expression of miRNA Targeting the Expression of PERK, but Not PKR, Enhances Cellular Immunity from an HIV-1 Env DNA Vaccine	PLOS ONE			English	Article							PROTEIN-KINASE PKR; ENDOPLASMIC-RETICULUM-STRESS; DOUBLE-STRANDED-RNA; INITIATION-FACTOR 2; CD4 T-CELLS; IMMUNODEFICIENCY-VIRUS; MAMMALIAN-CELLS; BINDING-PROTEIN; MEDIATED-IMMUNITY; ENVELOPE PROTEIN	Small non-coding micro-RNAs (miRNA) are important post-transcriptional regulators of mammalian gene expression that can be used to direct the knockdown of expression from targeted genes. We examined whether DNA vaccine vectors co-expressing miRNA with HIV-1 envelope (Env) antigens could influence the magnitude or quality of the immune responses to Env in mice. Human miR-155 and flanking regions from the non-protein encoding gene mirhg155 were introduced into an artificial intron within an expression vector for HIV-1 Env gp140. Using the miR-155-expressing intron as a scaffold, we developed novel vectors for miRNA-mediated targeting of the cellular antiviral proteins PKR and PERK, which significantly down-modulated target gene expression and led to increased Env expression in vitro. Finally, vaccinating BALB/c mice with a DNA vaccine vector delivering miRNA targeting PERK, but not PKR, was able to augment the generation of Env-specific T-cell immunity. This study provides proof-of-concept evidence that miRNA effectors incorporated into vaccine constructs can positively influence vaccine immunogenicity. Further testing of vaccine-encoded miRNA will determine if such strategies can enhance protective efficacy from vaccines against HIV-1 for eventual human use.	[Wheatley, Adam K.; Kramski, Marit; Alexander, Marina R.; Toe, Jesse G.; Center, Rob J.; Purcell, Damian F. J.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Toe, Jesse G.] Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Melbourne, Vic 3050, Australia	University of Melbourne; Walter & Eliza Hall Institute	Wheatley, AK (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	dfjp@unimelb.edu.au	Alexander, Marina/AAK-9995-2021; Purcell, Damian F/G-5068-2011	Alexander, Marina/0000-0003-0745-7903; Wheatley, Adam/0000-0002-5593-9387	National Health and Medical Research Council of Australia [510488, 359233]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia grants 510488 and Career Development Award 359233 to RJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MR, 2010, NUCLEIC ACIDS RES, V38, P3041, DOI 10.1093/nar/gkp1224; Alexander M, 2010, J VIROL, V84, P4100, DOI 10.1128/JVI.02068-09; BEATTIE E, 1995, VIROLOGY, V210, P254, DOI 10.1006/viro.1995.1342; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Cai RR, 2000, ARCH BIOCHEM BIOPHYS, V373, P361, DOI 10.1006/abbi.1999.1583; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Center RJ, 2000, J VIROL, V74, P4448, DOI 10.1128/JVI.74.10.4448-4455.2000; Center RJ, 2009, VACCINE, V27, P6605, DOI 10.1016/j.vaccine.2009.08.016; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; Child SJ, 2004, J VIROL, V78, P197, DOI 10.1128/JVI.78.1.197-205.2004; CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x; Christensen HS, 2007, J VIROL, V81, P5121, DOI 10.1128/JVI.01511-06; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Corr M, 1996, J EXP MED, V184, P1555, DOI 10.1084/jem.184.4.1555; Dale CJ, 2004, J VIROL, V78, P13819, DOI 10.1128/JVI.78.24.13819-13828.2004; de Vries W, 2008, GENE THER, V15, P545, DOI 10.1038/gt.2008.12; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-1; Du GW, 2006, FEBS J, V273, P5421, DOI 10.1111/j.1742-4658.2006.05534.x; EARL PL, 1991, J VIROL, V65, P2047, DOI 10.1128/JVI.65.4.2047-2055.1991; Fang ZY, 2001, VIROLOGY, V291, P272, DOI 10.1006/viro.2001.1209; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; GALABRU J, 1987, J BIOL CHEM, V262, P15538; Gil J, 2000, ONCOGENE, V19, P3665, DOI 10.1038/sj.onc.1203710; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Hansmann L, 2008, CLIN IMMUNOL, V127, P252, DOI 10.1016/j.clim.2008.01.014; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Hu T, 2009, INT J MOL SCI, V10, P2158, DOI 10.3390/ijms10052158; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Kataoka N, 2009, MOL CELL BIOL, V29, P3243, DOI 10.1128/MCB.00360-09; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; KIT S, 1963, EXP CELL RES, V31, P297, DOI 10.1016/0014-4827(63)90007-7; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; KRUST B, 1984, J BIOL CHEM, V259, P8494; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee ES, 2007, FEBS LETT, V581, P4325, DOI 10.1016/j.febslet.2007.08.001; Lemaire PA, 2008, J MOL BIOL, V381, P351, DOI 10.1016/j.jmb.2008.05.056; Li SY, 2000, EUR J BIOCHEM, V267, P1598, DOI 10.1046/j.1432-1327.2000.01134.x; Lu W, 2009, J BIOL CHEM, V284, P24281, DOI 10.1074/jbc.M109.008821; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Meurs EF, 1995, VIROLOGY, V214, P653, DOI 10.1006/viro.1995.0080; MONACO JJ, 1992, IMMUNOL RES, V11, P125, DOI 10.1007/BF02918617; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Muto NF, 1999, J VIROL, V73, P9021, DOI 10.1128/JVI.73.11.9021-9028.1999; Ong CL, 2005, J VIROL, V79, P12763, DOI 10.1128/JVI.79.20.12763-12772.2005; Otteken A, 1996, J VIROL, V70, P3407, DOI 10.1128/JVI.70.6.3407-3415.1996; PARK HS, 1994, P NATL ACAD SCI USA, V91, P4713, DOI 10.1073/pnas.91.11.4713; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Pavio N, 2003, J VIROL, V77, P3578, DOI 10.1128/JVI.77.6.3578-3585.2003; Su J, 2008, VIROLOGY, V375, P48, DOI 10.1016/j.virol.2008.01.011; Sudhakar A, 2000, BIOCHEMISTRY-US, V39, P12929, DOI 10.1021/bi0008682; TAKAHASHI H, 1988, P NATL ACAD SCI USA, V85, P3105, DOI 10.1073/pnas.85.9.3105; Urano F, 2000, J CELL SCI, V113, P3697; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wu SY, 1996, J BIOL CHEM, V271, P1756, DOI 10.1074/jbc.271.3.1756; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	66	10	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18225	10.1371/journal.pone.0018225	http://dx.doi.org/10.1371/journal.pone.0018225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464971	Green Published, gold			2022-12-27	WOS:000288813900052
J	Walker, TL; Turnbull, GW; Mackay, EW; Hannan, AJ; Bartlett, PF				Walker, Tara L.; Turnbull, Geoff W.; Mackay, Eirinn W.; Hannan, Anthony J.; Bartlett, Perry F.			The Latent Stem Cell Population Is Retained in the Hippocampus of Transgenic Huntington's Disease Mice but Not Wild-Type Mice	PLOS ONE			English	Article							MOUSE MODEL; ENVIRONMENTAL ENRICHMENT; PROGENITOR CELLS; DENTATE GYRUS; R6/2 MOUSE; NEUROGENESIS; DEFICITS; BRAIN; PROLIFERATION; PRECURSORS	The demonstration of the brain's ability to initiate repair in response to disease or injury has sparked considerable interest in therapeutic strategies to stimulate adult neurogenesis. In this study we examined the effect of a progressive neurodegenerative condition on neural precursor activity in the subventricular zone (SVZ) and hippocampus of the R6/1 transgenic mouse model of Huntington's disease (HD). Our results revealed an age-related decline in SVZ precursor numbers in both wild-type (WT) and HD mice. Interestingly, hippocampal precursor numbers declined with age in WT mice, although we observed maintenance in hippocampal precursor number in the HD animals in response to advancement of the disease. This maintenance was consistent with activation of a recently identified latent hippocampal precursor population. We found that the small latent stem cell population was also maintained in the HD hippocampus at 33 weeks, whereas it was not present in the WT. Our findings demonstrate that, despite a loss of neurogenesis in the HD hippocampus in vivo, there is a unique maintenance of the precursor and stem cells, which may potentially be activated to ameliorate disease symptoms.	[Walker, Tara L.; Turnbull, Geoff W.; Mackay, Eirinn W.; Bartlett, Perry F.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Hannan, Anthony J.] Univ Melbourne, Howard Florey Inst, Melbourne, Vic 3010, Australia	University of Queensland; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Walker, TL (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	p.bartlett@uq.edu.au	Bartlett, Perry/F-3813-2012; Walker, Tara/C-6242-2017	Walker, Tara/0000-0002-8472-0245; Hannan, Anthony/0000-0001-7532-8922; Mackay, Eirinn/0000-0003-1436-2259	National Health and Medical Research Council; Australian Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This study was funded by a National Health and Medical Research Council program grant (PFB). PFB is supported by an Australian Research Council Federation Fellowship. The authors would like to thank Frank and Patsy Youngleson for a private donation, which helped to fund this work. No commercial funding was received to fund this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista CMC, 2006, J NEUROSCI, V26, P10452, DOI 10.1523/JNEUROSCI.2850-06.2006; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Curtis MA, 2005, NEUROSCIENCE, V132, P777, DOI 10.1016/j.neuroscience.2004.12.051; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Felling RJ, 2003, J NEUROSCI RES, V73, P277, DOI 10.1002/jnr.10670; Grote HE, 2005, EUR J NEUROSCI, V22, P2081, DOI 10.1111/j.1460-9568.2005.04365.x; Jhaveri DJ, 2010, J NEUROSCI, V30, P2795, DOI 10.1523/JNEUROSCI.3780-09.2010; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lazic SE, 2006, EUR J NEUROSCI, V23, P1829, DOI 10.1111/j.1460-9568.2006.04715.x; Lazic SE, 2004, NEUROREPORT, V15, P811, DOI 10.1097/00001756-200404090-00014; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mazarakis NK, 2005, J NEUROSCI, V25, P3059, DOI 10.1523/JNEUROSCI.4320-04.2005; Pang TYC, 2006, NEUROSCIENCE, V141, P569, DOI 10.1016/j.neuroscience.2006.04.013; Phillips W, 2005, J NEUROSCI, V25, P11564, DOI 10.1523/JNEUROSCI.3796-05.2005; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Tattersfield AS, 2004, NEUROSCIENCE, V127, P319, DOI 10.1016/j.neuroscience.2004.04.061; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; Walker TL, 2008, J NEUROSCI, V28, P5240, DOI 10.1523/JNEUROSCI.0344-08.2008; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007	21	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18153	10.1371/journal.pone.0018153	http://dx.doi.org/10.1371/journal.pone.0018153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455316	Green Published, gold			2022-12-27	WOS:000288811500026
J	Yu, HY; Peng, ZX; Zhan, YH; Wang, J; Yan, YL; Chen, M; Lu, W; Ping, SZ; Zhang, W; Zhao, ZL; Li, SY; Takeo, M; Lin, M				Yu, Haiying; Peng, Zixin; Zhan, Yuhua; Wang, Jin; Yan, Yongliang; Chen, Ming; Lu, Wei; Ping, Shuzhen; Zhang, Wei; Zhao, Zhonglin; Li, Shuying; Takeo, Masahiro; Lin, Min			Novel Regulator MphX Represses Activation of Phenol Hydroxylase Genes Caused by a XylR/DmpR-Type Regulator MphR in Acinetobacter calcoaceticus	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; COMAMONAS-TESTOSTERONI R5; CARBON CATABOLITE REPRESSION; INTEGRATION HOST FACTOR; PSEUDOMONAS-PUTIDA; ALCOHOL-DEHYDROGENASE; METABOLIZING ENZYMES; DEGRADING BACTERIA; AROMATIC-COMPOUNDS; ESCHERICHIA-COLI	Acinetobacter calcoaceticus PHEA-2 utilizes phenol as its sole carbon and energy source and has a multi-component phenol hydroxylase-encoding gene operon (mphKLMNOP) for phenol degradation. Two additional genes, mphR and mphX, were found upstream and downstream of mphKLMNOP, respectively. The mphR gene encodes a XylR/DmpR-type regulator-like protein and is transcribed in the opposite direction to mphKLMNOP. The mphX gene is transcribed in the same direction as mphKLMNOP and encodes a protein with 293 amino acid residues showing weak identity with some unknown proteins encoded in the meta-cleavage pathway gene clusters for aromatic compound degradation. Disruption of mphR by homologous recombination resulted in the loss of phenol degradation while disruption of mphX caused significantly faster phenol degradation than in the wild type strain. Transcriptional assays for mphK, mphR, and mphX revealed that mphR activated mphKLMNOP transcription in the presence of phenol, but mphX partially repressed this activation. Gel mobility-shift assay demonstrated a direct interaction of MphR with the mphK promoter region. These results indicate the involvement of a novel repressor protein MphX in transcriptional regulation of phenol hydroxylase genes caused by a XylR/DmpR-type regulator MphR.	[Peng, Zixin; Takeo, Masahiro] Univ Hyogo, Grad Sch Engn, Dept Mat Sci & Chem, Himeji, Hyogo, Japan; [Yu, Haiying; Lin, Min] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Yu, Haiying; Peng, Zixin; Zhan, Yuhua; Wang, Jin; Yan, Yongliang; Chen, Ming; Lu, Wei; Ping, Shuzhen; Zhang, Wei; Zhao, Zhonglin; Li, Shuying; Lin, Min] Chinese Acad Agr Sci, Minist Agr, Biotechnol Res Inst, Key Lab Crop Biotechnol, Beijing, Peoples R China; [Yan, Yongliang; Zhang, Wei] Natl Ctr Plant Gene Res, Beijing, Peoples R China	University of Hyogo; China Agricultural University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences	Yu, HY (corresponding author), China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China.	takeo@eng.u-hyogo.ac.jp; linmin57@vip.163.com	Takeo, Masahiro/GYA-3639-2022; min, lin/AAJ-7325-2020; li, shuying/GLR-8636-2022	yan, yongliang/0000-0002-4297-6648	National Natural Science Foundation of China [30925002, 30800022]; National Basic Research (973) Program of China [2007CB707805, 2010CB126504]; National High-Tech (863) Program of China [2007AA021304, 2010AA10A203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research (973) Program of China(National Basic Research Program of China); National High-Tech (863) Program of China(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (No. 30925002 and 30800022), the National Basic Research (973) Program of China (No. 2007CB707805 and 2010CB126504) and the National High-Tech (863) Program of China (No. 2007AA021304 and 2010AA10A203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 1999, MOL MICROBIOL, V33, P1132, DOI 10.1046/j.1365-2958.1999.01554.x; Arai H, 2000, MICROBIOL-UK, V146, P1707, DOI 10.1099/00221287-146-7-1707; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butler JE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-180; Cases I, 2005, NAT REV MICROBIOL, V3, P105, DOI 10.1038/nrmicro1084; Cheng Q, 2000, J BACTERIOL, V182, P4744, DOI 10.1128/JB.182.17.4744-4751.2000; Dago AE, 2007, J BIOL CHEM, V282, P1087, DOI 10.1074/jbc.M608715200; Diaz E, 2000, CURR OPIN BIOTECH, V11, P467, DOI 10.1016/S0958-1669(00)00126-9; DITTA G, 1985, PLASMID, V13, P149, DOI 10.1016/0147-619X(85)90068-X; Duffner FM, 2000, GENE, V256, P215, DOI 10.1016/S0378-1119(00)00352-8; EHRT S, 1995, MOL MICROBIOL, V18, P13, DOI 10.1111/j.1365-2958.1995.mmi_18010013.x; FOLSOM BR, 1990, APPL ENVIRON MICROB, V56, P1279, DOI 10.1128/AEM.56.5.1279-1285.1990; Fukumori F, 2001, J GEN APPL MICROBIOL, V47, P329, DOI 10.2323/jgam.47.329; Garmendia J, 2000, MOL MICROBIOL, V38, P401, DOI 10.1046/j.1365-2958.2000.02139.x; HALES LM, 1994, J BACTERIOL, V176, P2999, DOI 10.1128/JB.176.10.2999-3006.1994; Heinaru E, 2000, FEMS MICROBIOL ECOL, V31, P195, DOI 10.1111/j.1574-6941.2000.tb00684.x; James KD, 2000, J BACTERIOL, V182, P3136, DOI 10.1128/JB.182.11.3136-3141.2000; KALIN M, 1992, J BACTERIOL, V174, P7112; KUKOR JJ, 1992, J BACTERIOL, V174, P6518, DOI 10.1128/JB.174.20.6518-6526.1992; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Laurie AD, 2003, J BIOL CHEM, V278, P1494, DOI 10.1074/jbc.M209268200; Li DH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-36; Liang O, 2005, MICROBIOL-SGM, V151, P3435, DOI 10.1099/mic.0.28137-0; MORETT E, 1993, J BACTERIOL, V175, P6067, DOI 10.1128/JB.175.19.6067-6074.1993; Muller C, 1996, J BACTERIOL, V178, P2030; Ng LC, 1996, J BIOL CHEM, V271, P17281, DOI 10.1074/jbc.271.29.17281; NG LC, 1995, J BACTERIOL, V177, P1485, DOI 10.1128/jb.177.6.1485-1490.1995; NORDLUND I, 1990, J BACTERIOL, V172, P6826, DOI 10.1128/jb.172.12.6826-6833.1990; O'Neill E, 2001, EMBO J, V20, P819, DOI 10.1093/emboj/20.4.819; Omokoko B, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-197; Park SM, 2003, J BIOTECHNOL, V103, P227, DOI 10.1016/S0168-1656(03)00122-6; Peng ZX, 2010, BIOTECHNOL LETT, V32, P1265, DOI 10.1007/s10529-010-0317-6; Petruschka L, 2001, MOL GENET GENOMICS, V266, P199, DOI 10.1007/s004380100539; Powlowski Justin, 1994, Biodegradation, V5, P219, DOI 10.1007/BF00696461; Ramos JL, 1997, ANNU REV MICROBIOL, V51, P341, DOI 10.1146/annurev.micro.51.1.341; Rappas M, 2007, CURR OPIN STRUC BIOL, V17, P110, DOI 10.1016/j.sbi.2006.11.002; Sandhu A, 2009, MICROB ECOL, V57, P276, DOI 10.1007/s00248-008-9473-9; Sarand I, 2001, APPL ENVIRON MICROB, V67, P162, DOI 10.1128/AEM.67.1.162-171.2001; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schirmer F, 1998, MOL GEN GENET, V257, P330, DOI 10.1007/s004380050654; Schirmer F, 1997, J BACTERIOL, V179, P1329, DOI 10.1128/jb.179.4.1329-1336.1997; Shingler V, 2003, ENVIRON MICROBIOL, V5, P1226, DOI 10.1111/j.1462-2920.2003.00472.x; SHINGLER V, 1993, J BACTERIOL, V175, P1596, DOI 10.1128/JB.175.6.1596-1604.1993; Sze CC, 2001, J BACTERIOL, V183, P2842, DOI 10.1128/JB.183.9.2842-2851.2001; Takahashi Y, 2009, APPL ENVIRON MICROB, V75, P3920, DOI 10.1128/AEM.02373-08; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Teramoto M, 1999, MOL GEN GENET, V262, P552, DOI 10.1007/s004380051117; Teramoto M, 2002, J BACTERIOL, V184, P3941, DOI 10.1128/JB.184.14.3941-3946.2002; Teramoto M, 2001, J BACTERIOL, V183, P4227, DOI 10.1128/JB.183.14.4227-4234.2001; Toyama H, 2003, BIOSCI BIOTECH BIOCH, V67, P1397, DOI 10.1271/bbb.67.1397; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004; Wigneshweplaraj SR, 2005, PROG NUCLEIC ACID RE, V79, P339, DOI 10.1016/S0079-6603(04)79007-8; Xu YQ, 2003, CURR MICROBIOL, V46, P235, DOI 10.1007/s00284-002-3840-4; Zhan YH, 2009, CURR MICROBIOL, V59, P368, DOI 10.1007/s00284-009-9446-3; Zhan YH, 2008, CURR MICROBIOL, V57, P609, DOI 10.1007/s00284-008-9251-4	55	17	19	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17350	10.1371/journal.pone.0017350	http://dx.doi.org/10.1371/journal.pone.0017350			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455294	Green Submitted, gold, Green Published			2022-12-27	WOS:000288811500003
J	Striem-Amit, E; Hertz, U; Amedi, A				Striem-Amit, Ella; Hertz, Uri; Amedi, Amir			Extensive Cochleotopic Mapping of Human Auditory Cortical Fields Obtained with Phase-Encoding fMRI	PLOS ONE			English	Article							SUPERIOR TEMPORAL REGION; RESONANCE-IMAGING FMRI; TONOTOPIC ORGANIZATION; FUNCTIONAL-ORGANIZATION; PLANUM TEMPORALE; VISUAL-CORTEX; HUMAN-BRAIN; SUBDIVISIONS; CONNECTIONS; AREAS	The primary sensory cortices are characterized by a topographical mapping of basic sensory features which is considered to deteriorate in higher-order areas in favor of complex sensory features. Recently, however, retinotopic maps were also discovered in the higher-order visual, parietal and prefrontal cortices. The discovery of these maps enabled the distinction between visual regions, clarified their function and hierarchical processing. Could such extension of topographical mapping to high-order processing regions apply to the auditory modality as well? This question has been studied previously in animal models but only sporadically in humans, whose anatomical and functional organization may differ from that of animals (e.g. unique verbal functions and Heschl's gyrus curvature). Here we applied fMRI spectral analysis to investigate the cochleotopic organization of the human cerebral cortex. We found multiple mirror-symmetric novel cochleotopic maps covering most of the core and high-order human auditory cortex, including regions considered non-cochleotopic, stretching all the way to the superior temporal sulcus. These maps suggest that topographical mapping persists well beyond the auditory core and belt, and that the mirror-symmetry of topographical preferences may be a fundamental principle across sensory modalities.	[Striem-Amit, Ella; Hertz, Uri; Amedi, Amir] Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Med Neurobiol, Jerusalem, Israel; [Hertz, Uri; Amedi, Amir] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci ELSC, Jerusalem, Israel; [Amedi, Amir] Hebrew Univ Jerusalem, Cognit Sci Program, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Striem-Amit, E (corresponding author), Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Med Neurobiol, Jerusalem, Israel.	amir.amedi@ekmd.huji.ac.il	Hertz, Uri/AAA-4799-2020; Striem-Amit, Ella/K-3715-2014	Hertz, Uri/0000-0003-4852-3516; Striem-Amit, Ella/0000-0002-5900-3455; Amedi, Amir/0000-0001-5042-2533	International Human Frontier Science Program Organization (HFSPO); Israel Science Foundation [1530/08]; European Union [MIRG-CT-2007-205357]; Edmond and Lily Safra Center for Brain Sciences; Alon fund; Sieratzki fund; Moscona fund; Hebrew University	International Human Frontier Science Program Organization (HFSPO)(Human Frontier Science Program); Israel Science Foundation(Israel Science Foundation); European Union(European Commission); Edmond and Lily Safra Center for Brain Sciences; Alon fund; Sieratzki fund; Moscona fund; Hebrew University	AA is supported by the International Human Frontier Science Program Organization (HFSPO); Israel Science Foundation (grant number 1530/08); a European Union Marie Curie International Reintegration Grant (MIRG-CT-2007-205357); the Edmond and Lily Safra Center for Brain Sciences; and the Alon, Sieratzki, and Moscona funds. ESA is supported by the Hebrew University Hoffman Leadership and Responsibility Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Amedi A, 2005, EXP BRAIN RES, V166, P559, DOI 10.1007/s00221-005-2396-5; Bach-y-Rita P, 2003, TRENDS COGN SCI, V7, P541, DOI 10.1016/j.tics.2003.10.013; Bandyopadhyay S, 2010, NAT NEUROSCI, V13, P361, DOI 10.1038/nn.2490; Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Binder JR, 1996, BRAIN, V119, P1239, DOI 10.1093/brain/119.4.1239; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brodmann K, 1909, VERGLEICHENDE LOKALI; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; COLLIGNON O, 2008, EXP BRAIN RES; Counter SA, 1997, JMRI-J MAGN RESON IM, V7, P606, DOI 10.1002/jmri.1880070327; DEYOE EA, 1994, J NEUROSCI METH, V54, P171, DOI 10.1016/0165-0270(94)90191-0; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Fullerton BC, 2007, J COMP NEUROL, V504, P470, DOI 10.1002/cne.21432; GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312; GALABURDA AM, 1983, J COMP NEUROL, V221, P169, DOI 10.1002/cne.902210206; GALABURDA AM, 1978, ARCH NEUROL-CHICAGO, V35, P812, DOI 10.1001/archneur.1978.00500360036007; Goebel R, 2001, VISION RES, V41, P1459, DOI 10.1016/S0042-6989(01)00069-4; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Guiraud J, 2007, J NEUROSCI, V27, P7838, DOI 10.1523/JNEUROSCI.0154-07.2007; Hackett TA, 1998, J COMP NEUROL, V394, P475, DOI 10.1002/(SICI)1096-9861(19980518)394:4<475::AID-CNE6>3.0.CO;2-Z; Hackett TA, 1999, BRAIN RES, V817, P45, DOI 10.1016/S0006-8993(98)01182-2; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Hackett TA, 1998, J COMP NEUROL, V400, P271, DOI 10.1002/(SICI)1096-9861(19981019)400:2<271::AID-CNE8>3.0.CO;2-6; Hackett TA, 2008, J AM ACAD AUDIOL, V19, P774, DOI 10.3766/jaaa.19.10.5; Hall DA, 2003, AUDIOL NEURO-OTOL, V8, P1, DOI 10.1159/000067894; HERDENER M, 2010, TOPOGRAPHICALLY ORDE; Humphries C, 2010, NEUROIMAGE, V50, P1202, DOI 10.1016/j.neuroimage.2010.01.046; IMIG TJ, 1977, J COMP NEUROL, V171, P111, DOI 10.1002/cne.901710108; JONES EG, 1995, J COMP NEUROL, V362, P153, DOI 10.1002/cne.903620202; JONES EG, 1976, J COMP NEUROL, V168, P197, DOI 10.1002/cne.901680203; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kaas JH, 1998, AUDIOL NEURO-OTOL, V3, P73, DOI 10.1159/000013783; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; Kalatsky VA, 2005, P NATL ACAD SCI USA, V102, P13325, DOI 10.1073/pnas.0505592102; Kayser C, 2007, BRAIN STRUCT FUNCT, V212, P121, DOI 10.1007/s00429-007-0154-0; King AJ, 2009, NAT NEUROSCI, V12, P698, DOI 10.1038/nn.2308; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; LAUTER JL, 1985, HEARING RES, V20, P199, DOI 10.1016/0378-5955(85)90024-3; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Linden DEJ, 1999, PERCEPTION, V28, P469, DOI 10.1068/p2820; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; MERZENICH MM, 1973, BRAIN RES, V50, P275, DOI 10.1016/0006-8993(73)90731-2; MERZENICH MM, 1975, J NEUROPHYSIOL, V38, P231, DOI 10.1152/jn.1975.38.2.231; MOREL A, 1993, J COMP NEUROL, V335, P437, DOI 10.1002/cne.903350312; MOREL A, 1992, J COMP NEUROL, V318, P27, DOI 10.1002/cne.903180104; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Nelken I, 2004, J NEUROPHYSIOL, V92, P2574, DOI 10.1152/jn.00276.2004; NELKEN I, 2008, CURR OPIN NEUROBIOL; PANDYA DN, 1973, Z ANAT ENTWICKLUNGS, V139, P127, DOI 10.1007/BF00523634; Pantev C, 2003, ANN NY ACAD SCI, V999, P438, DOI 10.1196/annals.1284.054; Petkov CI, 2006, PLOS BIOL, V4, P1213, DOI 10.1371/journal.pbio.0040215; Poremba A, 2003, SCIENCE, V299, P568, DOI 10.1126/science.1078900; Price C, 2005, TRENDS COGN SCI, V9, P271, DOI 10.1016/j.tics.2005.03.009; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, AUDIOL NEURO-OTOL, V3, P86, DOI 10.1159/000013784; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; Rivier F, 1997, NEUROIMAGE, V6, P288, DOI 10.1006/nimg.1997.0304; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Romanski LM, 1999, J COMP NEUROL, V403, P141, DOI 10.1002/(SICI)1096-9861(19990111)403:2<141::AID-CNE1>3.0.CO;2-V; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Saygin AP, 2008, CEREB CORTEX, V18, P2158, DOI 10.1093/cercor/bhm242; Schonwiesner M, 2002, NEUROIMAGE, V17, P1144, DOI 10.1006/nimg.2002.1250; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Seifritz E, 2002, CURR BIOL, V12, P2147, DOI 10.1016/S0960-9822(02)01356-8; Sereno MI, 2006, NAT NEUROSCI, V9, P1337, DOI 10.1038/nn1777; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shapleske J, 1999, BRAIN RES REV, V29, P26, DOI 10.1016/S0165-0173(98)00047-2; Stevens AA, 2009, BEHAV BRAIN RES, V196, P134, DOI 10.1016/j.bbr.2008.07.041; Sweet RA, 2005, J COMP NEUROL, V491, P270, DOI 10.1002/cne.20702; Talairach J., 1988, COPLANAR STEREOTAXIC; Talavage TM, 2004, J NEUROPHYSIOL, V91, P1282, DOI 10.1152/jn.01125.2002; TANJI K, 2009, NEUROIMAGE; Upadhyay J, 2007, CEREB CORTEX, V17, P2420, DOI 10.1093/cercor/bhl150; Vouloumanos A, 2001, J COGNITIVE NEUROSCI, V13, P994, DOI 10.1162/089892901753165890; Wallace MN, 2002, EXP BRAIN RES, V143, P499, DOI 10.1007/s00221-002-1014-z; Walters NB, 2003, P NATL ACAD SCI USA, V100, P2981, DOI 10.1073/pnas.0437896100; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Weeks RA, 1999, NEUROSCI LETT, V262, P155, DOI 10.1016/S0304-3940(99)00062-2; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Wessinger CM, 1997, HUM BRAIN MAPP, V5, P18, DOI 10.1002/(SICI)1097-0193(1997)5:1<18::AID-HBM3>3.0.CO;2-Q; Woods DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005183; ZATORRE RJ, 2005, PLASTICITY CENTRAL A, P241; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0	99	80	81	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17832	10.1371/journal.pone.0017832	http://dx.doi.org/10.1371/journal.pone.0017832			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448274	gold, Green Published, Green Submitted			2022-12-27	WOS:000288810500015
J	Donia, MS; Fricke, WF; Ravel, J; Schmidt, EW				Donia, Mohamed S.; Fricke, W. Florian; Ravel, Jacques; Schmidt, Eric W.			Variation in Tropical Reef Symbiont Metagenomes Defined by Secondary Metabolism	PLOS ONE			English	Article							CYANOBACTERIAL SYMBIONT; NATURAL-PRODUCTS; GENE-CLUSTER; BIOSYNTHESIS; PROCHLORON; IDENTIFICATION; ASCIDIANS; DIVERSITY; PATHWAY; CLONING	The complex evolution of secondary metabolism is important in biology, drug development, and synthetic biology. To examine this problem at a fine scale, we compared the genomes and chemistry of 24 strains of uncultivated cyanobacteria, Prochloron didemni, that live symbiotically with tropical ascidians and that produce natural products isolated from the animals. Although several animal species were obtained along a>5500 km transect of the Pacific Ocean, P. didemni strains are >97% identical across much of their genomes, with only a few exceptions concentrated in secondary metabolism. Secondary metabolic gene clusters were sporadically present or absent in identical genomic locations with no consistent pattern of co-occurrence. Discrete mutations were observed, leading to new chemicals that we isolated from animals. Functional cassettes encoding diverse chemicals are exchanged among a single population of symbiotic P. didemni that spans the tropical Pacific, providing the host animals with a varying arsenal of secondary metabolites.	[Donia, Mohamed S.; Schmidt, Eric W.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Fricke, W. Florian; Ravel, Jacques] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Inst Genome Sci, Baltimore, MD 21201 USA	Utah System of Higher Education; University of Utah; University System of Maryland; University of Maryland Baltimore	Donia, MS (corresponding author), Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA.	ews1@utah.edu	Ravel, Jacques/D-2530-2009	Ravel, Jacques/0000-0002-0851-2233; Fricke, W. Florian/0000-0003-1586-0962	National Institutes of Health (NIH) [GM071425, EF-0412226]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071425] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health (NIH GM071425 and EF-0412226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banik JJ, 2010, CURR OPIN MICROBIOL, V13, P603, DOI 10.1016/j.mib.2010.08.012; Bode HB, 2003, MOL MICROBIOL, V47, P471, DOI 10.1046/j.1365-2958.2003.03309.x; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Bruntner C, 1999, MOL GEN GENET, V262, P102; Carroll AR, 1996, J ORG CHEM, V61, P4059, DOI 10.1021/jo951379o; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261; COWAN ME, 1981, MAR ECOL PROG SER, V6, P335, DOI 10.3354/meps006335; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Donia MS, 2008, NAT CHEM BIOL, V4, P341, DOI 10.1038/nchembio.84; Donia MS, 2006, NAT CHEM BIOL, V2, P729, DOI 10.1038/nchembio829; Fisch KM, 2009, NAT CHEM BIOL, V5, P494, DOI 10.1038/nchembio.176; Gerth K, 2003, J BIOTECHNOL, V106, P233, DOI 10.1016/j.jbiotec.2003.07.015; Gu LC, 2009, J AM CHEM SOC, V131, P16033, DOI 10.1021/ja9071578; Haft DH, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-70; Haft DH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-15; KOIKE I, 1993, AUST J MAR FRESH RES, V44, P173; Kroiss J, 2010, NAT CHEM BIOL, V6, P261, DOI [10.1038/NCHEMBIO.331, 10.1038/nchembio.331]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Ladygina N, 2006, PROCESS BIOCHEM, V41, P1001, DOI 10.1016/j.procbio.2005.12.007; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; Li B, 2010, P NATL ACAD SCI USA, V107, P10430, DOI 10.1073/pnas.0913677107; Lim-Fong GE, 2008, APPL ENVIRON MICROB, V74, P3605, DOI 10.1128/AEM.02798-07; Mayer AMS, 2010, TRENDS PHARMACOL SCI, V31, P255, DOI 10.1016/j.tips.2010.02.005; McIntosh JA, 2009, NAT PROD REP, V26, P537, DOI 10.1039/b714132g; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; Munchhoff J, 2007, ENVIRON MICROBIOL, V9, P890, DOI 10.1111/j.1462-2920.2006.01209.x; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Paul VJ, 2008, NAT PROD REP, V25, P662, DOI 10.1039/b702742g; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Schmidt EW, 2008, NAT CHEM BIOL, V4, P466, DOI 10.1038/nchembio.101; Schmidt EW, 2010, CURR OPIN BIOTECH, V21, P827, DOI 10.1016/j.copbio.2010.10.006; Schmidt EW, 2000, MAR BIOL, V136, P969, DOI 10.1007/s002270000273; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Schmidt EW, 2004, J NAT PROD, V67, P1341, DOI 10.1021/np049948n; Sudek S, 2007, J NAT PROD, V70, P67, DOI 10.1021/np060361d; Tomitani A, 1999, NATURE, V400, P159, DOI 10.1038/22101; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Walsh CT, 2010, J AM CHEM SOC, V132, P2469, DOI 10.1021/ja909118a; Yokobori S, 2006, MOL PHYLOGENET EVOL, V40, P8, DOI 10.1016/j.ympev.2005.11.025; Zhang XJ, 2007, ANTIMICROB AGENTS CH, V51, P946, DOI 10.1128/AAC.01214-06	45	53	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17897	10.1371/journal.pone.0017897	http://dx.doi.org/10.1371/journal.pone.0017897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445351	Green Submitted, Green Published, gold			2022-12-27	WOS:000288809100015
J	Mccue, HV; Burgoyne, RD; Haynes, LP				McCue, Hannah V.; Burgoyne, Robert D.; Haynes, Lee P.			Determination of the Membrane Topology of the Small EF-Hand Ca2+-Sensing Proteins CaBP7 and CaBP8	PLOS ONE			English	Article							TAIL-ANCHORED PROTEINS; FLUORESCENCE PROTEASE PROTECTION; CALCIUM SENSOR PROTEINS; CALDENDRIN; INSERTION; TRANSLOCATION; BINDING	The CaBPs represent a subfamily of small EF-hand containing calcium (Ca2+)-sensing proteins related to calmodulin that regulate key ion channels in the mammalian nervous system. In a recent bioinformatic analyses we determined that CaBP7 and CaBP8 form an evolutionarily distinct branch within the CaBPs ( also known as the calneurons) a finding that is consistent with earlier observations characterising a putative C-terminal transmembrane (TM) spanning helix in each of these proteins which is essential for their sub-cellular targeting to the Golgi apparatus and constitutive secretory vesicles. The C-terminal position of the predicted TM-helix suggests that CaBP7 and CaBP8 could be processed in a manner analogous to tail-anchored integral membrane proteins which exhibit the ability to insert across membranes post-translationally. In this study we have investigated the topology of CaBP7 and CaBP8 within cellular membranes through a combination of trypsin protection and epitope accessibility analyses. Our results indicate that the TM-helices of CaBP7 and CaBP8 insert fully across membranes such that their extreme C-termini are luminal. The observed type-II membrane topology is consistent with processing of CaBP7 and CaBP8 as true tail-anchored proteins. This targeting mechanism is distinct from any other calmodulin related Ca2+-sensor and conceivably underpins unique physiological functions of these proteins.	[McCue, Hannah V.; Burgoyne, Robert D.; Haynes, Lee P.] Univ Liverpool, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Mccue, HV (corresponding author), Univ Liverpool, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England.	leeh@liv.ac.uk	Burgoyne, Robert/C-6706-2008; Burgoyne, Robert D/P-6641-2019	Burgoyne, Robert/0000-0002-9219-0387; Burgoyne, Robert D/0000-0002-9219-0387; McCue, Hannah/0000-0001-5237-3261	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust prize PhD studentship awarded to HVM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 2004, EMBO J, V23, P2755, DOI 10.1038/sj.emboj.7600281; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Borgese N, 2010, TRAFFIC, V11, P877, DOI 10.1111/j.1600-0854.2010.01068.x; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Fries R, 2010, J NEUROCHEM, V113, P1150, DOI 10.1111/j.1471-4159.2010.06676.x; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haynes LP, 2008, NAT CHEM BIOL, V4, P90, DOI 10.1038/nchembio0208-90; Haynes LP, 2004, J BIOL CHEM, V279, P547, DOI 10.1074/jbc.M309617200; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Kasri NN, 2004, EMBO J, V23, P312, DOI 10.1038/sj.emboj.7600037; Kim PK, 1997, BIOCHEMISTRY-US, V36, P8873, DOI 10.1021/bi970090t; Kuroda R, 1996, J BIOCHEM-TOKYO, V120, P828; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laube G, 2002, MOL CELL NEUROSCI, V19, P459, DOI 10.1006/mcne.2001.1078; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; McCue HV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004085; McCue Hannah V, 2010, BMC Res Notes, V3, P118, DOI 10.1186/1756-0500-3-118; Mccue HV, 2009, BIOCHEM BIOPH RES CO, V380, P825, DOI 10.1016/j.bbrc.2009.01.177; Mikhaylova M, 2006, BBA-MOL CELL RES, V1763, P1229, DOI 10.1016/j.bbamcr.2006.08.047; Mikhaylova M, 2009, P NATL ACAD SCI USA, V106, P9093, DOI 10.1073/pnas.0903001106; O'Callaghan DW, 2002, J BIOL CHEM, V277, P14227, DOI 10.1074/jbc.M111750200; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Rieke F, 2008, INVEST OPHTH VIS SCI, V49, P5126, DOI 10.1167/iovs.08-2236; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; WATT R, 1983, P NATL ACAD SCI-BIOL, V80, P6307, DOI 10.1073/pnas.80.20.6307	35	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17853	10.1371/journal.pone.0017853	http://dx.doi.org/10.1371/journal.pone.0017853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445352	Green Published, gold, Green Submitted			2022-12-27	WOS:000288809100010
J	Atashili, J; Smith, JS; Adimora, AA; Eron, J; Miller, WC; Myers, E				Atashili, Julius; Smith, Jennifer S.; Adimora, Adaora A.; Eron, Joseph; Miller, William C.; Myers, Evan			Potential Impact of Antiretroviral Therapy and Screening on Cervical Cancer Mortality in HIV-Positive Women in Sub-Saharan Africa: A Simulation	PLOS ONE			English	Article							SQUAMOUS INTRAEPITHELIAL LESIONS; HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS; COST-EFFECTIVENESS; ERA; INFECTION; NEOPLASIA	Background: Despite having high cervical cancer incidence and mortality rates, screening for cervical precancerous lesions remains infrequent in sub-Saharan Africa. The need to screen HIV-positive women because of the higher prevalence and faster progression of cervical precancerous lesions may be heightened by the increased access to highly-active antiretroviral therapy (HAART). Policymakers need quantitative data on the effect of HAART and screening to better allocate limited resources. Our aim was to quantify the potential effect of these interventions on cervical cancer mortality. Methods and Findings: We constructed a Markov state-transition model of a cohort of HIV-positive women in Cameroon. Published data on the prevalence, progression and regression of lesions as well as mortality rates from HIV, cervical cancer and other causes were incorporated into the model. We examined the potential impact, on cumulative cervical cancer mortality, of four possible scenarios: no HAART and no screening (NHNS), HAART and no screening (HNS), HAART and screening once on HAART initiation (HSHI), and HAART and screening once at age 35 (HS35). Our model projected that, compared to NHNS, lifetime cumulative cervical cancer mortality approximately doubled with HNS. It will require 262 women being screened at HAART initiation to prevent one cervical cancer death amongst women on HAART. The magnitudes of these effects were most sensitive to the rate of progression of precancerous lesions. Conclusions: Screening, even when done once, has the potential of reducing cervical cancer mortality among HIV-positive women in Africa. The most feasible and cost-effective screening strategy needs to be determined in each setting.	[Atashili, Julius] Univ Buea, Fac Hlth Sci, Buea, Cameroon; [Smith, Jennifer S.; Adimora, Adaora A.; Eron, Joseph; Miller, William C.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Myers, Evan] Duke Univ, Duke Med Sch, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University	Atashili, J (corresponding author), Univ Buea, Fac Hlth Sci, Buea, Cameroon.	atashili@yahoo.ie	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827	GSK; Digene; GenProbe; Merck Co.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD059358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	GSK(GlaxoSmithKline); Digene; GenProbe; Merck Co.(Merck & Company); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JA has previously received honoraria from GSK and research supplies from Digene. JSS has received research grants, honoraria, or consulting fees during the last three years from GSK, Digene and GenProbe. ERM has received research funding and done consulting for Merck & Co.	[Anonymous], REP GLOB AIDS EP 200; [Anonymous], 2008, WORLD HLTH STAT 2008; De Vuyst H, 2008, EUR J CANCER PREV, V17, P545, DOI 10.1097/CEJ.0b013e3282f75ea1; FERLAY J, 2004, IARC CANC BASE, V5; Franceschi S, 2007, CLIN INFECT DIS, V45, P510, DOI 10.1086/520022; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Goldie SJ, 1999, ANN INTERN MED, V130, P97, DOI 10.7326/0003-4819-130-2-199901190-00003; Hawes SE, 2006, J NATL CANCER I, V98, P100, DOI 10.1093/jnci/djj010; Massad LS, 2001, J ACQ IMMUN DEF SYND, V27, P432, DOI 10.1097/00126334-200108150-00003; Mbu Enow R, 2008, Reprod Health, V5, P3, DOI 10.1186/1742-4755-5-3; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Naimark D, 1997, MED DECIS MAKING, V17, P152, DOI 10.1177/0272989X9701700205; Palefsky JM, 2003, CURR OPIN ONCOL, V15, P382, DOI 10.1097/00001622-200309000-00007; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Schuman P, 2003, J INFECT DIS, V188, P128, DOI 10.1086/375783; Six C, 1998, AIDS, V12, P1047, DOI 10.1097/00002030-199809000-00012; *UN STAT DIV, 2009, WORLD STAT POCK; *UNAIDS, 2007, REP GLOB AIDS EP 200; WHO, 2006, COMPR CERV CONTR GUI; World Health Organization, 2001, MACR HLTH INV HLTH E	22	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18527	10.1371/journal.pone.0018527	http://dx.doi.org/10.1371/journal.pone.0018527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483701	Green Published, gold, Green Submitted			2022-12-27	WOS:000289058700031
J	Miranda, A; Pericuesta, E; Ramirez, MA; Gutierrez-Adan, A				Miranda, Alberto; Pericuesta, Eva; Angel Ramirez, Miguel; Gutierrez-Adan, Alfonso			Prion Protein Expression Regulates Embryonic Stem Cell Pluripotency and Differentiation	PLOS ONE			English	Article							MESSENGER-RNA; MICE LACKING; NANOG; PRP; BEHAVIOR; NETWORKS; SUPPORTS; INTEGRIN	Cellular prion protein (PRNP) is a glycoprotein involved in the pathogenesis of transmissible spongiform encephalopathies (TSEs). Although the physiological function of PRNP is largely unknown, its key role in prion infection has been extensively documented. This study examines the functionality of PRNP during the course of embryoid body (EB) differentiation in mouse Prnp-null (KO) and WT embryonic stem cell (ESC) lines. The first feature observed was a new population of EBs that only appeared in the KO line after 5 days of differentiation. These EBs were characterized by their expression of several primordial germ cell (PGC) markers until Day 13. In a comparative mRNA expression analysis of genes playing an important developmental role during ESC differentiation to EBs, Prnp was found to participate in the transcription of a key pluripotency marker such as Nanog. A clear switching off of this gene on Day 5 was observed in the KO line as opposed to the WT line, in which maximum Prnp and Nanog mRNA levels appeared at this time. Using a specific antibody against PRNP to block PRNP pathways, reduced Nanog expression was confirmed in the WT line. In addition, antibody-mediated inhibition of ITGB5 (integrin alpha v beta 5) in the KO line rescued the low expression of Nanog on Day 5, suggesting the regulation of Nanog transcription by Prnp via this Itgb5. mRNA expression analysis of the PRNP-related proteins PRND (Doppel) and SPRN (Shadoo), whose PRNP function is known to be redundant, revealed their incapacity to compensate for the absence of PRNP during early ESC differentiation. Our findings provide strong evidence for a relationship between Prnp and several key pluripotency genes and attribute Prnp a crucial role in regulating self-renewal/differentiation status of ESC, confirming the participation of PRNP during early embryogenesis.	[Miranda, Alberto; Pericuesta, Eva; Angel Ramirez, Miguel; Gutierrez-Adan, Alfonso] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Reprod Anim & Conservac Recursos Zoogenet, Madrid, Spain; [Miranda, Alberto] Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Invest Sanidad Anim, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Miranda, A (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Reprod Anim & Conservac Recursos Zoogenet, Madrid, Spain.	miranda.alberto@inia.es	Gutierrez-Adan, Alfonso/A-1485-2014; de Paz, Miguel Ángel Ramírez/H-3171-2015	Gutierrez-Adan, Alfonso/0000-0001-9893-9179; de Paz, Miguel Ángel Ramírez/0000-0002-5868-2134; Miranda-Bedate, Alberto/0000-0003-2623-2857	Spanish Ministry of Science and Innovation [AGL2009-11358]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by Grant AGL2009-11358 from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ramirez MA, 2009, BIOL REPROD, V80, P1216, DOI 10.1095/biolreprod.108.075044; Behrens A, 2002, EMBO J, V21, P3652, DOI 10.1093/emboj/cdf386; Bermejo-Alvarez P, 2008, PHYSIOL GENOMICS, V32, P264, DOI 10.1152/physiolgenomics.00234.2007; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Brown DR, 1998, BIOCHEM J, V334, P423, DOI 10.1042/bj3340423; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Castilla J, 2004, J NEUROSCI, V24, P2156, DOI 10.1523/JNEUROSCI.3811-03.2004; Castilla J, 2003, ARCH VIROL, V148, P677, DOI 10.1007/s00705-002-0958-4; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Coitinho AS, 2003, NEUROREPORT, V14, P1375, DOI 10.1097/01.wnr.0000078541.07662.90; Colling SB, 1997, BRAIN RES, V755, P28, DOI 10.1016/S0006-8993(97)00087-5; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Criado JR, 2005, NEUROBIOL DIS, V19, P255, DOI 10.1016/j.nbd.2005.01.001; Faustino RS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r6; Fuhrmann M, 2006, J NEUROCHEM, V98, P1876, DOI 10.1111/j.1471-4159.2006.04011.x; Fujisawa M, 2004, J REPROD DEVELOP, V50, P565, DOI 10.1262/jrd.50.565; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Grskovic M, 2007, PLOS GENET, V3, P1524, DOI 10.1371/journal.pgen.0030145; Hajj GNM, 2007, J CELL SCI, V120, P1915, DOI 10.1242/jcs.03459; Hajj GNM, 2009, J COMP NEUROL, V517, P371, DOI 10.1002/cne.22157; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Hiyama K, 2005, INT J ONCOL, V27, P87; HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583; Ishii M, 2006, J REPROD DEVELOP, V52, P461, DOI 10.1262/jrd.17111; Klamt F, 2001, FREE RADICAL BIO MED, V30, P1137; Kondoh H, 2008, EXP CELL RES, V314, P1923, DOI 10.1016/j.yexcr.2008.03.007; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Lee ST, 2010, BIOMATERIALS, V31, P1219, DOI 10.1016/j.biomaterials.2009.10.054; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; MEHRPOUR M, 2009, CANC LETT; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Monnet C, 2004, FEBS LETT, V576, P114, DOI 10.1016/j.febslet.2004.08.076; MORITAFUJIMURA Y, 2009, DEV GROWTH DIFFER, P6; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Muras AG, 2009, INT J CANCER, V125, P1523, DOI 10.1002/ijc.24425; O'Shea KS, 2004, BIOL REPROD, V71, P1755, DOI 10.1095/biolreprod.104.028100; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pan YL, 2006, FASEB J, V20, P1886, DOI 10.1096/fj.06-6138fje; Qin J, 2009, BIOLOGICALS, V37, P235, DOI 10.1016/j.biologicals.2009.03.001; Ramirez MA, 2007, INT J DEV BIOL, V51, P397, DOI 10.1387/ijdb.062255mr; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Stella R, 2010, MOL CELL BIOL, V30, P4864, DOI 10.1128/MCB.01040-09; Tanaka TS, 2009, REPROD FERT DEVELOP, V21, P67, DOI 10.1071/RD08219; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; Walker JL, 2002, DEV DYNAM, V223, P273, DOI 10.1002/dvdy.10050; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Young R, 2009, FEBS LETT, V583, P3296, DOI 10.1016/j.febslet.2009.09.027; Yu GH, 2009, MOL REPROD DEV, V76, P3, DOI 10.1002/mrd.20960; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103	60	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18422	10.1371/journal.pone.0018422	http://dx.doi.org/10.1371/journal.pone.0018422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483752	gold, Green Submitted, Green Published			2022-12-27	WOS:000289058700027
J	Nikooyan, AA; van der Helm, FCT; Westerhoff, P; Graichen, F; Bergmann, G; Veeger, HEJ				Nikooyan, Ali Asadi; van der Helm, Frans C. T.; Westerhoff, Peter; Graichen, Friedmar; Bergmann, Georg; Veeger, H. E. J. (Dirkjan)			Comparison of Two Methods for In Vivo Estimation of the Glenohumeral Joint Rotation Center (GH-JRC) of the Patients with Shoulder Hemiarthroplasty	PLOS ONE			English	Article							HELICAL AXIS ESTIMATION; KINEMATICS; VALIDATION; POSITION; ELBOW	Determination of an accurate glenohumeral-joint rotation center (GH-JRC) from marker data is essential for kinematic and dynamic analysis of shoulder motions. Previous studies have focused on the evaluation of the different functional methods for the estimation of the GH-JRC for healthy subjects. The goal of this paper is to compare two widely used functional methods, namely the instantaneous helical axis (IHA) and symmetrical center of rotation (SCoRE) methods, for estimating the GH-JRC in vivo for patients with implanted shoulder hemiarthroplasty. The motion data of five patients were recorded while performing three different dynamic motions (circumduction, abduction, and forward flexion). The GH-JRC was determined using the CT-images of the subjects (geometric GH-JRC) and was also estimated using the two IHA and SCoRE methods. The rotation centers determined using the IHA and SCoRE methods were on average 1.47 +/- 0.62 cm and 2.07 +/- 0.55 cm away from geometric GH-JRC, respectively. The two methods differed significantly (two-tailed p-value from paired t-Test similar to 0.02, post-hoc power similar to 0.30). The SCoRE method showed a significant lower (two-tailed p-value from paired t-Test similar to 0.03, post-hoc power similar to 0.68) repeatability error calculated between the different trials of each motion and each subject and averaged across all measured subjects (0.62 +/- 0.10 cm for IHA vs. 0.43 +/- 0.12 cm for SCoRE). It is concluded that the SCoRE appeared to be a more repeatable method whereas the IHA method resulted in a more accurate estimation of the GH-JRC for patients with endoprostheses.	[Nikooyan, Ali Asadi; van der Helm, Frans C. T.; Veeger, H. E. J. (Dirkjan)] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands; [Westerhoff, Peter; Graichen, Friedmar; Bergmann, Georg] Univ Med, Charite, Julius Wolff Inst, Berlin, Germany; [Veeger, H. E. J. (Dirkjan)] Vrije Univ Amsterdam, Res Inst MOVE, Amsterdam, Netherlands	Delft University of Technology; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Vrije Universiteit Amsterdam	Nikooyan, AA (corresponding author), Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands.	a.asadinikooyan@tudelft.nl	veeger, dirkjan/E-6183-2013	veeger, dirkjan/0000-0003-0292-6520	Dutch Technology Foundation STW [07354]	Dutch Technology Foundation STW(Technologiestichting STW)	This project was partially financed by the Dutch Technology Foundation STW. Project number: 07354. URL: www.stw.nl. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	[Anonymous], P C SIM VIS SIMVIS; Barnett ND, 1999, CLIN BIOMECH, V14, P287, DOI 10.1016/S0268-0033(98)00106-5; Begon M, 2007, GAIT POSTURE, V25, P353, DOI 10.1016/j.gaitpost.2006.04.010; Campbell AC, 2009, J BIOMECH, V42, P1527, DOI 10.1016/j.jbiomech.2009.03.039; Cereatti A, 2009, J BIOMECH, V42, P818, DOI 10.1016/j.jbiomech.2009.01.031; Chang LY, 2007, J BIOMECH, V40, P1392, DOI 10.1016/j.jbiomech.2006.05.010; Ehrig RM, 2006, J BIOMECH, V39, P2798, DOI 10.1016/j.jbiomech.2005.10.002; Gamage SSHU, 2002, J BIOMECH, V35, P87, DOI 10.1016/S0021-9290(01)00160-9; Graichen H, 2000, J BIOMECH, V33, P609, DOI 10.1016/S0021-9290(99)00209-2; Halvorsen K, 2003, J BIOMECH, V36, P999, DOI 10.1016/S0021-9290(03)00070-8; Halvorsen K, 1999, J BIOMECH, V32, P1221, DOI 10.1016/S0021-9290(99)00120-7; Karduna AR, 2001, J BIOMECH ENG-T ASME, V123, P184, DOI 10.1115/1.1351892; Lempereur M, 2010, J BIOMECH, V43, P370, DOI 10.1016/j.jbiomech.2009.09.029; Meskers CGM, 1998, J BIOMECH, V31, P93, DOI 10.1016/S0021-9290(97)00101-2; Meskers CGM, 1998, CLIN BIOMECH, V13, P280, DOI 10.1016/S0268-0033(98)00095-3; Monnet T, 2007, J BIOMECH, V40, P3487, DOI 10.1016/j.jbiomech.2007.05.030; Nikooyan AA, 2010, J BIOMECH, V43, P3007, DOI 10.1016/j.jbiomech.2010.06.015; Stokdijk M, 2000, J BIOMECH, V33, P1629, DOI 10.1016/S0021-9290(00)00121-4; van Andel CJ, 2008, GAIT POSTURE, V27, P120, DOI 10.1016/j.gaitpost.2007.03.002; VANDERHELM FCT, 1992, J BIOMECH, V25, P129, DOI 10.1016/0021-9290(92)90270-B; VANDERHELM FCT, 1989, J BIOMECH, V22, P1092; Veeger HEJ, 2000, J BIOMECH, V33, P1711, DOI 10.1016/S0021-9290(00)00141-X; VELDPAUS FE, 1988, J BIOMECH, V21, P45, DOI 10.1016/0021-9290(88)90190-X; Woltring H. J., 1990, BIOMECHANICS HUMAN M; WOLTRING HJ, 1994, J BIOMECH, V27, P1415, DOI 10.1016/0021-9290(94)90192-9; WOLTRING HJ, 1985, J BIOMECH, V18, P379, DOI 10.1016/0021-9290(85)90293-3; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042	27	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18488	10.1371/journal.pone.0018488	http://dx.doi.org/10.1371/journal.pone.0018488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483808	Green Published, gold			2022-12-27	WOS:000289057200086
J	Hut, RA; Pilorz, V; Boerema, AS; Strijkstra, AM; Daan, S				Hut, Roelof A.; Pilorz, Violetta; Boerema, Ate S.; Strijkstra, Arjen M.; Daan, Serge			Working for Food Shifts Nocturnal Mouse Activity into the Day	PLOS ONE			English	Article							DORSOMEDIAL HYPOTHALAMIC NUCLEUS; ANTICIPATORY CIRCADIAN-RHYTHMS; CLOCK; RATS; TEMPERATURE; EXPRESSION; LESIONS; ENTRAINMENT; BEHAVIOR	Nocturnal rodents show diurnal food anticipatory activity when food access is restricted to a few hours in daytime. Timed food access also results in reduced food intake, but the role of food intake in circadian organization per se has not been described. By simulating natural food shortage in mice that work for food we show that reduced food intake alone shifts the activity phase from the night into the day and eventually causes nocturnal torpor (natural hypothermia). Release into continuous darkness with ad libitum food, elicits immediate reversal of activity to the previous nocturnal phase, indicating that the classical circadian pacemaker maintained its phase to the light-dark cycle. This flexibility in behavioral timing would allow mice to exploit the diurnal temporal niche while minimizing energy expenditure under poor feeding conditions in nature. This study reveals an intimate link between metabolism and mammalian circadian organization.	[Hut, Roelof A.; Pilorz, Violetta; Boerema, Ate S.; Strijkstra, Arjen M.; Daan, Serge] Univ Groningen, Ctr Behav & Neurosci, Chronobiol Unit, Groningen, Netherlands	University of Groningen	Hut, RA (corresponding author), Univ Groningen, Ctr Behav & Neurosci, Chronobiol Unit, Groningen, Netherlands.	r.a.hut@rug.nl	Boerema, A.S./W-9810-2018; Hut, Roelof A./I-3483-2012	Boerema, A.S./0000-0002-4771-5156; 	EC [018741, 221095]; EMBO [666828]	EC(European CommissionEuropean Commission Joint Research Centre); EMBO(European Molecular Biology Organization (EMBO))	The study was supported by EC-FP6 Integrated Project 018741 "EUCLOCK", EMBO fellowship 666828 to RAH, and EC-FP6 Marie-Curie fellowship 221095 "ClockWork" to VP (project supervisor RAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Challet E, 1996, BEHAV BRAIN RES, V77, P155, DOI 10.1016/0166-4328(95)00224-3; Challet E, 1998, BRAIN RES, V801, P244, DOI 10.1016/S0006-8993(98)00590-3; Challet E, 1997, BRAIN RES BULL, V43, P209, DOI 10.1016/S0361-9230(96)00439-X; Challet E, 1996, NEUROSCI LETT, V216, P214, DOI 10.1016/S0304-3940(96)13012-3; DAAN S, 2011, J BIOL RHYT IN PRESS, V26; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Froy O, 2008, NEUROSCIENCE, V155, P1152, DOI 10.1016/j.neuroscience.2008.06.060; Gattermann R, 2008, BIOL LETTERS, V4, P253, DOI 10.1098/rsbl.2008.0066; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; HONMA KI, 1986, PHYSIOL BEHAV, V38, P687, DOI 10.1016/0031-9384(86)90265-9; HOOGENBOOM I, 1984, OECOLOGIA, V61, P18, DOI 10.1007/BF00379084; KAWAMURA H, 1979, BIOL RHYTHMS THEIR C, P335; KRIEGER DT, 1977, SCIENCE, V197, P398, DOI 10.1126/science.877566; Landry GJ, 2006, AM J PHYSIOL-REG I, V290, pR1527, DOI 10.1152/ajpregu.00874.2005; Landry GJ, 2007, J BIOL RHYTHM, V22, P467, DOI 10.1177/0748730407307804; Landry GJ, 2007, J BIOL RHYTHM, V22, P484, DOI 10.1177/0748730407307811; Levy O, 2007, CHRONOBIOL INT, V24, P599, DOI 10.1080/07420520701534640; Mendoza J, 2008, J NEUROENDOCRINOL, V20, P251, DOI 10.1111/j.1365-2826.2007.01636.x; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; Mistlberger Ralph E, 2009, J Circadian Rhythms, V7, P3, DOI 10.1186/1740-3391-7-3; MISTLBERGER RE, 1984, PHYSIOL BEHAV, V33, P227, DOI 10.1016/0031-9384(84)90104-5; Mohawk JA, 2009, P NATL ACAD SCI USA, V106, P3519, DOI 10.1073/pnas.0813366106; Moriya T, 2009, EUR J NEUROSCI, V29, P1447, DOI 10.1111/j.1460-9568.2009.06697.x; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Pezuk P, 2010, J BIOL RHYTHM, V25, P432, DOI 10.1177/0748730410385204; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Schubert KA, 2010, BIOL LETTERS, V6, P132, DOI 10.1098/rsbl.2009.0569; Spoelstra K, 2004, J BIOL RHYTHM, V19, P518, DOI 10.1177/0748730404268122; STEPHAN FK, 1983, BEHAV BRAIN RES, V7, P81, DOI 10.1016/0166-4328(83)90006-2; Stephan Friedrich K., 2001, Handbook of Behavioral Neurobiology, V12, P223; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Wiersma P, 2005, J EXP BIOL, V208, P4091, DOI 10.1242/jeb.01854	35	74	74	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17527	10.1371/journal.pone.0017527	http://dx.doi.org/10.1371/journal.pone.0017527			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479166	Green Submitted, Green Published, gold			2022-12-27	WOS:000289055700013
J	Zheng, X; Zheng, H; Lan, R; Ye, C; Wang, Y; Zhang, J; Jing, H; Chen, C; Segura, M; Gottschalk, M; Xu, J				Zheng, Xiao; Zheng, Han; Lan, Ruiting; Ye, Changyun; Wang, Yiting; Zhang, Ji; Jing, Huaiqi; Chen, Chen; Segura, Mariela; Gottschalk, Marcelo; Xu, Jianguo			Identification of Genes and Genomic Islands Correlated with High Pathogenicity in Streptococcus suis Using Whole Genome Tilling Microarrays	PLOS ONE			English	Article							CAPSULAR TYPES; SEQUENCE TYPE-7; SEROTYPE 14; MENINGITIS; VIRULENCE; RESTRICTION; EXPRESSION; PHAGOCYTOSIS; PATHOGENESIS; INFECTIONS	Streptococcus suis is an important zoonotic pathogen that can cause meningitis and sepsis in both pigs and humans. Infections in humans have been sporadic worldwide but two severe outbreaks occurred in China in recent years, while infections in pigs are a major problem in the swine industry. Some S. suis strains are more pathogenic than others with 2 sequence types (ST), ST1 and ST7, being well recognized as highly pathogenic. We analyzed 31 isolates from 23 serotypes and 25 STs by NimbleGen tiling microarray using the genome of a high pathogenicity (HP) ST1 strain, GZ1, as reference and a new algorithm to detect gene content difference. The number of genes absent in a strain ranged from 49 to 225 with a total of 632 genes absent in at least one strain, while 1346 genes were found to be invariably present in all strains as the core genome of S. suis, accounting for 68% of the GZ1 genome. The majority of genes are located in chromosomal blocks with two or more contiguous genes. Sixty two blocks are absent in two or more strains and defined as regions of difference (RDs), among which 26 are putative genomic islands (GIs). Clustering and statistical analyses revealed that 8 RDs including 6 putative GIs and 21 genes within these RDs are significantly associated with HP. Three RDs encode known virulence related factors including the extracellular factor, the capsular polysaccharide and a SrtF pilus. The strains were divided into 5 groups based on population genetic analysis of multilocus sequence typing data and the distribution of the RDs among the groups revealed gain and loss of RDs in different groups. Our study elucidated the gene content diversity of S. suis and identified genes that potentially promote HP.	[Zheng, Xiao; Zheng, Han; Ye, Changyun; Wang, Yiting; Zhang, Ji; Jing, Huaiqi; Chen, Chen; Xu, Jianguo] State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zheng, Xiao; Zheng, Han; Ye, Changyun; Wang, Yiting; Zhang, Ji; Jing, Huaiqi; Chen, Chen; Xu, Jianguo] Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Segura, Mariela; Gottschalk, Marcelo] Univ Montreal, Fac Med Vet, St Hyacinthe, PQ J2S 7C6, Canada	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of New South Wales Sydney; Universite de Montreal	Zheng, X (corresponding author), State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	xujianguo@icdc.cn	CHEN, CHEN/HDM-6657-2022; Gottschalk, Marcelo/I-8116-2012; Segura, Mariela/AAG-5708-2020; chen, chen/AAQ-1805-2021; Zheng, Han/AAH-6977-2019	chen, chen/0000-0003-1765-8899; Lan, Ruiting/0000-0001-9834-5258	China-Canada Collaboration grant [2008DFA31830]; Ministry of Science and Technology, People's Republic of China [2008ZX10004-001, 2009ZX10004-101]; Wellcome Trust	China-Canada Collaboration grant; Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China); Wellcome Trust(Wellcome Trust)	This work was supported by China-Canada Collaboration grant to JX (no. 2008DFA31830) and by funds from the Ministry of Science and Technology, People's Republic of China (no. 2008ZX10004-001 and 2009ZX10004-101).; This work made use of the Multi Locus Sequence Typing website (http://www.mlst.net) at Imperial College London developed by David Aanensen and funded by the Wellcome Trust. We thank Drs Pengcheng Du and Luxi Wang from ICDC for their technical assistance with microarray data processing.	Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Ando T, 2002, CANCER RES, V62, P2385; ARENDS JP, 1988, REV INFECT DIS, V10, P131; Bart A, 2001, INFECT IMMUN, V69, P1816, DOI 10.1128/IAI.69.3.1816-1820.2001; Baums Christoph Georg, 2009, Animal Health Research Reviews, V10, P65, DOI 10.1017/S146625230999003X; Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chabot-Roy G, 2006, MICROB PATHOGENESIS, V41, P21, DOI 10.1016/j.micpath.2006.04.001; CHANTER N, 1993, VET MICROBIOL, V36, P39, DOI 10.1016/0378-1135(93)90127-S; Charland N, 1996, FEMS IMMUNOL MED MIC, V14, P195, DOI 10.1111/j.1574-695X.1996.tb00287.x; Charland N, 1998, MICROBIOL-SGM, V144, P325, DOI 10.1099/00221287-144-2-325; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Derre I, 1999, MOL MICROBIOL, V31, P117, DOI 10.1046/j.1365-2958.1999.01152.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Falush D, 2003, GENETICS, V164, P1567; Feil EJ, 2000, GENETICS, V154, P1439; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Frees D, 2007, MOL MICROBIOL, V63, P1285, DOI 10.1111/j.1365-2958.2007.05598.x; GOTTSCHALK M, 1989, J CLIN MICROBIOL, V27, P2633, DOI 10.1128/JCM.27.12.2633-2636.1989; GOTTSCHALK M, 1991, J CLIN MICROBIOL, V29, P2590, DOI 10.1128/JCM.29.11.2590-2594.1991; Gottschalk M, 1999, J CLIN MICROBIOL, V37, P4202, DOI 10.1128/JCM.37.12.4202-4203.1999; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Haleis A, 2009, EMERG INFECT DIS, V15, P350, DOI 10.3201/eid1502.080842; HIGGINS R, 1995, J VET DIAGN INVEST, V7, P405, DOI 10.1177/104063879500700322; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Ibrahim YM, 2005, INFECT IMMUN, V73, P730, DOI 10.1128/IAI.73.2.730-740.2005; Jackson SA, 2007, FORENSIC SCI INT, V168, P183, DOI 10.1016/j.forsciint.2006.06.079; Jiang H, 2009, VET MICROBIOL, V133, P309, DOI 10.1016/j.vetmic.2008.07.014; Kerdsin A, 2009, J MED MICROBIOL, V58, P1508, DOI 10.1099/jmm.0.013656-0; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Kopic J, 2002, SCAND J INFECT DIS, V34, P683, DOI 10.1080/00365540210147769; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lalonde M, 2000, MICROBIOL-SGM, V146, P1913, DOI 10.1099/00221287-146-8-1913; Langille MGI, 2010, NAT REV MICROBIOL, V8, P372, DOI 10.1038/nrmicro2350; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Leung AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-413; Maharjan RP, 2008, RES MICROBIOL, V159, P602, DOI 10.1016/j.resmic.2008.08.004; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; MURRAY NE, 1993, MOL MICROBIOL, V9, P133, DOI 10.1111/j.1365-2958.1993.tb01675.x; Nair S, 2000, MOL MICROBIOL, V35, P800, DOI 10.1046/j.1365-2958.2000.01752.x; Nair S, 2000, INFECT IMMUN, V68, P7061, DOI 10.1128/IAI.68.12.7061-7068.2000; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; PERCH B, 1983, J CLIN MICROBIOL, V17, P993, DOI 10.1128/JCM.17.6.993-996.1983; Poggenborg R, 2008, SCAND J INFECT DIS, V40, P346, DOI 10.1080/00365540701716825; Pouillot F, 2007, MICROBIOL-SGM, V153, P2426, DOI 10.1099/mic.0.2007/005736-0; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; REAMS RY, 1994, J VET DIAGN INVEST, V6, P326, DOI 10.1177/104063879400600308; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Segura M, 2002, INFECT IMMUN, V70, P4312, DOI 10.1128/IAI.70.8.4312-4322.2002; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Smith HE, 1999, INFECT IMMUN, V67, P1750; Takamatsu D, 2008, EMERG INFECT DIS, V14, P181, DOI 10.3201/eid1401.070568; Takamatsu D, 2009, VET MICROBIOL, V138, P132, DOI 10.1016/j.vetmic.2009.02.013; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tay CY, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-126; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Urban AE, 2006, P NATL ACAD SCI USA, V103, P4534, DOI 10.1073/pnas.0511340103; VECHT U, 1991, INFECT IMMUN, V59, P3156, DOI 10.1128/IAI.59.9.3156-3162.1991; Vickerman MM, 2007, J BACTERIOL, V189, P7799, DOI 10.1128/JB.01023-07; Ye CY, 2008, EMERG INFECT DIS, V14, P787, DOI 10.3201/eid1405.070437; Ye CY, 2006, EMERG INFECT DIS, V12, P1203, DOI 10.3201/eid1708.060232; Ye CY, 2009, J INFECT DIS, V199, P97, DOI 10.1086/594370; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang W, 2006, GENOME RES, V16, P757, DOI 10.1101/gr.4759706	68	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17987	10.1371/journal.pone.0017987	http://dx.doi.org/10.1371/journal.pone.0017987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479213	Green Published, Green Submitted, gold			2022-12-27	WOS:000289055700020
J	Armstrong, AW; Lin, SW; Chambers, CJ; Sockolov, ME; Chin, DL				Armstrong, April W.; Lin, Steven W.; Chambers, Cynthia J.; Sockolov, Mary E.; Chin, David L.			Psoriasis and Hypertension Severity: Results from a Case-Control Study	PLOS ONE			English	Article							RISK-FACTORS; ANGIOTENSIN-II; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; VASCULAR-DISEASES; POPULATION; MORTALITY; ASSOCIATION; PREVALENCE	Background: Epidemiologic studies have provided new insights into the association between psoriasis and cardiovascular diseases. Previous population studies have examined hypertension frequency in psoriasis patients. However, the relationship between severity of hypertension and psoriasis has not been characterized. Objective: We sought to investigate whether patients with psoriasis have more difficult-to-manage hypertension compared to non-psoriatic hypertensive patients. Approach: We performed a case-control study using the University of California Davis electronic medical records. The cases were defined as patients diagnosed with both psoriasis and hypertension, and controls were defined as patients with hypertension and without psoriasis. In this identified population, 835 cases were matched on age, sex, and body mass index (BMI) to 2418 control patients. Key Results: Treatment with multiple anti-hypertensives was significantly associated with the presence of psoriasis using univariate (p < 0.0001) and multivariable analysis, after adjusting for diabetes, hyperlipidemia, and race (p < 0.0001). Compared to hypertensive patients without psoriasis, psoriasis patients with hypertension were 5 times more likely to be on a monotherapy antihypertensive regimen (95% CI 3.607.05), 9.5 times more likely to be on dual antihypertensive therapy (95% CI 6.68-13.65), 16.5 times more likely to be on triple antihypertensive regimen (95% CI 11.01-24.84), and 19.9 times more likely to be on quadruple therapy or centrally-acting agent (95% CI 10.58-37.33) in multivariable analysis after adjusting for traditional cardiac risk factors. Conclusions: Psoriasis patients appear to have more difficult-to-control hypertension compared to non-psoriatic, hypertensive patients.	[Armstrong, April W.; Lin, Steven W.; Chambers, Cynthia J.; Sockolov, Mary E.] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA; [Chin, David L.] Univ Calif Davis, Ctr Healthcare Policy & Res, Grad Grp Epidemiol, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Armstrong, AW (corresponding author), Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA.	aprilarmstrong@post.harvard.edu	Chin, David L/M-3956-2015	Chin, David L/0000-0002-2341-6207				Altobelli E, 2009, EUR J DERMATOL, V19, P252, DOI 10.1684/ejd.2009.0644; BETTMAN S, 1926, DERMAT WCHNSCHR, V83; Boehncke WH, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5666; Bonifati C, 1998, ACTA DERM-VENEREOL, V78, P22; BRAVERMA.IM, 1972, J INVEST DERMATOL, V59, P91, DOI 10.1111/1523-1747.ep12625852; Cohen AD, 2010, ACTA DERM-VENEREOL, V90, P23, DOI 10.2340/00015555-0741; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; Dreiher J, 2008, ACTA DERM-VENEREOL, V88, P561, DOI 10.2340/00015555-0510; Engeli S, 2005, HYPERTENSION, V45, P356, DOI 10.1161/01.HYP.0000154361.47683.d3; Gelfand JM, 2007, ARCH DERMATOL, V143, P1493, DOI 10.1001/archderm.143.12.1493; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gisondi P, 2007, BRIT J DERMATOL, V157, P68, DOI 10.1111/j.1365-2133.2007.07986.x; Gisondi P, 2009, SEMIN THROMB HEMOST, V35, P313, DOI 10.1055/s-0029-1222610; Huerta C, 2007, ARCH DERMATOL, V143, P1559, DOI 10.1001/archderm.143.12.1559; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; JEA S, 2006, J AM ACAD DERMATOL, V56, P629; Kaye JA, 2008, BRIT J DERMATOL, V159, P895, DOI 10.1111/j.1365-2133.2008.08707.x; Kim S, 2000, PHARMACOL REV, V52, P11; Kimball AB, 2008, DERMATOLOGY, V217, P27, DOI 10.1159/000121333; KULKA JP, 1964, ANN NY ACAD SCI, V116, P1018, DOI 10.1111/j.1749-6632.1964.tb52565.x; LAWLER JC, 1960, ARCH DERMATOL, V82, P190, DOI 10.1001/archderm.1960.01580020032004; Ludwig RJ, 2007, BRIT J DERMATOL, V156, P271, DOI 10.1111/j.1365-2133.2006.07562.x; Mallbris L, 2004, EUR J EPIDEMIOL, V19, P225, DOI 10.1023/B:EJEP.0000020447.59150.f9; MCDONALD CJ, 1978, BRIT J DERMATOL, V99, P469, DOI 10.1111/j.1365-2133.1978.tb02012.x; MEHTA N, 2009, EUR HEART J; Nataraj C, 1999, J CLIN INVEST, V104, P1693, DOI 10.1172/JCI7451; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Prodanovich S, 2009, ARCH DERMATOL, V145, P700, DOI 10.1001/archdermatol.2009.94; Qureshi AA, 2009, ARCH DERMATOL, V145, P379, DOI 10.1001/archdermatol.2009.48; Shapiro J, 2007, J AM ACAD DERMATOL, V56, P629, DOI 10.1016/j.jaad.2006.09.017; Sommer DM, 2006, ARCH DERMATOL RES, V298, P321, DOI 10.1007/s00403-006-0703-z; Sowers JR, 2002, NEW ENGL J MED, V346, P1999, DOI 10.1056/NEJMe020054; The Seventh Report of the Joint National Committee on Prevention, 2004, 7 JOINT NAT COMM PRE	33	58	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18227	10.1371/journal.pone.0018227	http://dx.doi.org/10.1371/journal.pone.0018227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479272	gold, Green Published, Green Submitted			2022-12-27	WOS:000289054600035
J	Garlapati, S; Saraiya, AA; Wang, CC				Garlapati, Srinivas; Saraiya, Ashesh A.; Wang, Ching C.			A La Autoantigen Homologue Is Required for the Internal Ribosome Entry Site Mediated Translation of Giardiavirus	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; POLIOVIRUS RNA; 5'-NONCODING REGION; CELLULAR-PROTEINS; MESSENGER-RNA; INITIATION; BINDS; IDENTIFICATION; PICORNAVIRUS; TRANSCRIPT	Translation of Giardiavirus (GLV) mRNA is initiated at an internal ribosome entry site (IRES) in the viral transcript. The IRES localizes to a downstream portion of 59 untranslated region (UTR) and a part of the early downstream coding region of the transcript. Recent studies indicated that the IRES does not require a pre-initiation complex to initiate translation but may directly recruit the small ribosome subunit with the help of a number of trans-activating protein factors. A La autoantigen homologue in the viral host Giardia lamblia, GlLa, was proposed as one of the potential trans-activating factors based on its specific binding to GLV-IRES in vitro. In this study, we further elucidated the functional role of GlLa in GLV-IRES mediated translation in Giardia by knocking down GlLa with antisense morpholino oligo, which resulted in a reduction of GLV-IRES activity by 40%. An over-expression of GlLa in Giardia moderately stimulated GLV-IRES activity by 20%. A yeast inhibitory RNA (IRNA), known to bind mammalian and yeast La autoantigen and inhibit Poliovirus and Hepatitis C virus IRES activities in vitro and in vivo, was also found to bind to GlLa protein in vitro and inhibited GLV-IRES function in vivo. The C-terminal domain of La autoantigen interferes with the dimerization of La and inhibits its function. An over-expression of the C-terminal domain (200-348aa) of GlLa in Giardia showed a dominant-negative effect on GLV-IRES activity, suggesting a potential inhibition of GlLa dimerization. HA tagged GlLa protein was detected mainly in the cytoplasm of Giardia, thus supporting a primary role of GlLa in translation initiation in Giardiavirus.	[Garlapati, Srinivas; Saraiya, Ashesh A.; Wang, Ching C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Garlapati, S (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ccwang@cgl.ucsf.edu			National Institutes of Health [R01 AI-30475]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021786, R01AI030475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a National Institutes of Health grant R01 AI-30475. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali N, 1997, P NATL ACAD SCI USA, V94, P2249, DOI 10.1073/pnas.94.6.2249; BACHMANN M, 1989, MOL CELL BIOCHEM, V85, P103, DOI 10.1007/BF00577106; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Bayfield MA, 2010, BBA-GENE REGUL MECH, V1799, P365, DOI 10.1016/j.bbagrm.2010.01.011; Belsham GJ, 2000, TRENDS MICROBIOL, V8, P330, DOI 10.1016/S0966-842X(00)01788-1; Bousquet-Antonelli C, 2009, RNA, V15, P750, DOI 10.1261/rna.1478709; Carpenter ML, 2009, EUKARYOT CELL, V8, P916, DOI 10.1128/EC.00041-09; Costa-Mattioli M, 2004, MOL CELL BIOL, V24, P6861, DOI 10.1128/mcb.24.15.6861-6870.2004; Craig AWB, 1997, MOL CELL BIOL, V17, P163, DOI 10.1128/MCB.17.1.163; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; Das S, 1996, J VIROL, V70, P1624, DOI 10.1128/JVI.70.3.1624-1632.1996; DAS S, 1994, J VIROL, V68, P7200, DOI 10.1128/JVI.68.11.7200-7211.1994; Dasgupta A, 2004, FEMS MICROBIOL LETT, V234, P189, DOI 10.1016/j.femsle.2004.03.045; EHRENFELD E, 1996, TRANSLATIONAL CONTRO, P549; Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; Gamarnik AV, 1997, RNA, V3, P882; Garlapati S, 2005, EUKARYOT CELL, V4, P742, DOI 10.1128/EC.4.4.742-754.2005; Garlapati S, 2004, J BIOL CHEM, V279, P3389, DOI 10.1074/jbc.M307565200; Garlapati S, 2002, RNA, V8, P601, DOI 10.1017/S135583820202071X; Garlapati S, 2001, J MOL BIOL, V308, P623, DOI 10.1006/jmbi.2001.4568; Garlapati S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007435; Gourguechon S, 2011, EUKARYOT CELL, V10, P142, DOI 10.1128/EC.00190-10; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Holcik M, 2000, MOL CELL BIOL, V20, P4648, DOI 10.1128/MCB.20.13.4648-4657.2000; Intine RV, 2003, MOL CELL, V12, P1301, DOI 10.1016/S1097-2765(03)00429-5; Izumi RE, 2004, J VIROL, V78, P3763, DOI 10.1128/JVI.78.7.3763-3776.2004; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kim YK, 1999, J GEN VIROL, V80, P3159, DOI 10.1099/0022-1317-80-12-3159; Kim YK, 2001, NUCLEIC ACIDS RES, V29, P5009, DOI 10.1093/nar/29.24.5009; Le SY, 1996, VIRUS GENES, V12, P135, DOI 10.1007/BF00572952; Li L, 2004, J BIOL CHEM, V279, P14656, DOI 10.1074/jbc.M309879200; Maraia RJ, 2002, GENE EXPRESSION, V10, P41; Martinez-Salas E, 2008, J GEN VIROL, V89, P611, DOI 10.1099/vir.0.83426-0; MEEROVITCH K, 1989, GENE DEV, V3, P1026, DOI 10.1101/gad.3.7.1026; Merrick WC., 1996, TRANSLATION CONTROL, P31; Niepmann M, 1997, J VIROL, V71, P8330, DOI 10.1128/JVI.71.11.8330-8339.1997; Pudi R, 2005, J VIROL, V79, P9842, DOI 10.1128/JVI.79.15.9842-9853.2005; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Sun CH, 2000, MOL BIOCHEM PARASIT, V105, P51, DOI 10.1016/S0166-6851(99)00163-2; SVITKIN YV, 1994, J VIROL, V68, P1544, DOI 10.1128/JVI.68.3.1544-1550.1994; Venkatesan A, 1999, NUCLEIC ACIDS RES, V27, P562, DOI 10.1093/nar/27.2.562; WANG AL, 1986, MOL BIOCHEM PARASIT, V21, P269, DOI 10.1016/0166-6851(86)90132-5; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; YU DC, 1995, MOL CELL BIOL, V15, P4867	46	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18263	10.1371/journal.pone.0018263	http://dx.doi.org/10.1371/journal.pone.0018263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479239	gold, Green Submitted, Green Published			2022-12-27	WOS:000289054600040
J	Mahomed, H; Hawkridge, T; Verver, S; Abrahams, D; Geiter, L; Hatherill, M; Ehrlich, R; Hanekom, WA; Hussey, GD				Mahomed, Hassan; Hawkridge, Tony; Verver, Suzanne; Abrahams, Deborah; Geiter, Lawrence; Hatherill, Mark; Ehrlich, Rodney; Hanekom, Willem A.; Hussey, Gregory D.			The Tuberculin Skin Test versus QuantiFERON TB Gold (R) in Predicting Tuberculosis Disease in an Adolescent Cohort Study in South Africa	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; MYCOBACTERIUM-TUBERCULOSIS; INFECTION; CONTACTS; IMMUNODIAGNOSIS; DIAGNOSIS; UPDATE	Setting: This study was conducted in a high tuberculosis (TB) burden area in Worcester, South Africa, with a notified all TB incidence rate of 1,400/100,000. Main Objective: To compare the predictive value of a baseline tuberculin skin test (TST) with that of the QuantiFERON TB Gold (In-tube) assay (QFT) for subsequent microbiologically confirmed TB disease among adolescents. Methods: Adolescents aged 12-18 years were recruited from high schools in the study area. At baseline, blood was drawn for QFT and a TST administered. Participants were followed up for up to 3.8 years for incident TB disease (median 2.4 years). Results: After exclusions, 5244 (82.4%) of 6,363 adolescents enrolled, were analysed. The TB incidence rate was 0.60 cases per 100 person years (pyrs) (95% CI 0.43-0.82) for baseline TST positive (>= 5 mm) participants and 0.64 cases per 100 pyrs (95% CI 0.45-0.87) for baseline QFT positive participants. TB incidence rates were 0.22 per 100 pyrs (0.11-0.39) and 0.22 per 100 pyrs (0.12-0.38) among those with a negative baseline TST and QFT respectively. Sensitivity for incident TB disease was 76.9% for TST and 75.0% for QFT (p = 0.81). Positive predictive value was 1.4% for TST and 1.5% for QFT. Conclusion: Positive TST and QFT tests were moderately sensitive predictors of progression to microbiologically confirmed TB disease. There was no significant difference in the predictive ability of these tests for TB disease amongst adolescents in this high burden setting. Therefore, these findings do not support use of QFT in preference to TST to predict the risk of TB disease in this study population.	[Mahomed, Hassan; Abrahams, Deborah; Hatherill, Mark; Hanekom, Willem A.; Hussey, Gregory D.] Univ Cape Town, S African TB Vaccine Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Mahomed, Hassan; Abrahams, Deborah; Hatherill, Mark; Hanekom, Willem A.; Hussey, Gregory D.] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7925 Cape Town, South Africa; [Ehrlich, Rodney] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Hawkridge, Tony] Univ Cape Town, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Verver, Suzanne] Univ Amsterdam, Acad Med Ctr, CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Verver, Suzanne] KNCV TB Fdn, The Hague, Netherlands; [Geiter, Lawrence] Aeras Global TB Vaccine Fdn, Rockville, MD USA	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Amsterdam; Academic Medical Center Amsterdam; KNCV Tuberculosis Foundation	Mahomed, H (corresponding author), Univ Cape Town, S African TB Vaccine Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	hassan.mahomed@uct.ac.za	; Ehrlich, Rodney/M-5654-2014	Hanekom, Willem/0000-0003-3070-6154; Ehrlich, Rodney/0000-0001-5736-9237	Aeras Global TB Vaccine Foundation; Gates Grand Challenge 6; Gates Grand Challenge 12	Aeras Global TB Vaccine Foundation; Gates Grand Challenge 6; Gates Grand Challenge 12	This study was funded by the Aeras Global TB Vaccine Foundation with some support from the Gates Grand Challenge 6 and Gates Grand Challenge 12 grants for the QuantiFERON testing. T. Hawkridge and L. Geiter both previously worked for the Aeras Global Tuberculosis Vaccine Foundation and both had input into the design, analysis and review of this manuscript.	Adetifa IMO, 2007, INT J TUBERC LUNG D, V11, P350; Bakir M, 2008, ANN INTERN MED, V149, P777, DOI 10.7326/0003-4819-149-11-200812020-00248; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; del Corral H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008257; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Groenewald P, 2007, ANN HLTH STATUS REPO; Harstad I, 2010, INT J TUBERC LUNG D, V14, P1209; JASON E, 2008, AM J RESP CRIT CARE, V177, P1055; Kik SV, 2010, EUR RESPIR J, V35, P1346, DOI 10.1183/09031936.00098509; Kik SV, 2009, INT J TUBERC LUNG D, V13, P820; Leung CC, 2010, AM J RESP CRIT CARE, V182, P834, DOI 10.1164/rccm.200912-1875OC; Lienhardt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010508; Mahomed H, 2011, INT J TUBERC LUNG D, V15, P331; Moran-Mendoza O, 2007, INT J TUBERC LUNG D, V11, P1014; Nsutebu E, 2008, PUBLIC HEALTH, V122, P1284, DOI 10.1016/j.puhe.2007.12.007; Ohno Hitoshi, 2008, Journal of Infection and Chemotherapy, V14, P66, DOI 10.1007/s10156-007-0565-0; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; van Helden PD, 2002, IUBMB LIFE, V53, P219, DOI 10.1080/15216540212653	24	94	97	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17984	10.1371/journal.pone.0017984	http://dx.doi.org/10.1371/journal.pone.0017984			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479236	Green Published, gold, Green Submitted			2022-12-27	WOS:000289054600024
J	Piek, E; van der Meer, K; Hoogendijk, WJG; Penninx, BWJH; Nolen, WA				Piek, Ellen; van der Meer, Klaas; Hoogendijk, Witte J. G.; Penninx, Brenda W. J. H.; Nolen, Willem A.			Most Antidepressant Use in Primary Care Is Justified; Results of the Netherlands Study of Depression and Anxiety	PLOS ONE			English	Article							DIAGNOSTIC INTERVIEW CIDI; GENERAL-PRACTICE; FOLLOW-UP; RELIABILITY; DISORDER; RECOGNITION; APPROPRIATENESS; FEASIBILITY; POPULATION; GUIDELINES	Background: Depression is a common illness, often treated in primary care. Many studies have reported undertreatment with antidepressants in primary care. Recently, some studies also reported overtreatment with antidepressants. The present study was designed to assess whether treatment with antidepressants in primary care is in accordance with current guidelines, with a special focus on overtreatment. Methodology: We used baseline data of primary care respondents from the Netherlands Study of Depression and Anxiety (NESDA) (n = 1610). Seventy-nine patients with treatment in secondary care were excluded. We assessed justification for treatment with antidepressant according to the Dutch primary care guidelines for depression and for anxiety disorders. Use of antidepressants was based on drug-container inspection or, if unavailable, on self-report. Results were recalculated to the original population of primary care patients from which the participants in NESDA were selected (n = 10,677). Principal Findings: Of 1531 included primary care patients, 199 (13%) used an antidepressant, of whom 188 (94.5%) (possibly) justified. After recalculating these numbers to the original population (n = 10,677), we found 908 (95% CI 823 to 994) antidepressant users. Forty-nine (95% CI 20 to 78) of them (5.4%) had no current justification for an antidepressant, but 27 of them (54.5%) had a justified reason for an antidepressant at some earlier point in their life. Conclusions: We found that overtreatment with antidepressants in primary care is not a frequent problem. Too long continuation of treatment seems to explain the largest proportion of overtreatment as opposed to inappropriate initiation of treatment.	[Piek, Ellen; van der Meer, Klaas] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [Penninx, Brenda W. J. H.; Nolen, Willem A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Hoogendijk, Witte J. G.; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Penninx, Brenda W. J. H.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands	University of Groningen; University of Groningen; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Piek, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands.	e.piek@med.umcg.nl	Nolen, Willem A/E-9006-2014; Penninx, Brenda WJH/S-7627-2017	Penninx, Brenda WJH/0000-0001-7779-9672	Netherlands Organisation for Health Research and Development (Zon-Mw) [10-000-1002]; VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute); Ely Lilly; Lundbeck; Servier; Bristol-Myers Squibb; Organon; European Union; Stanley Medical Research Institute; Astra Zeneca; GlaxoSmithKline; Wyeth	Netherlands Organisation for Health Research and Development (Zon-Mw)(Netherlands Organization for Health Research and Development); VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute); Ely Lilly; Lundbeck(Lundbeck Corporation); Servier(Servier); Bristol-Myers Squibb(Bristol-Myers Squibb); Organon; European Union(European Commission); Stanley Medical Research Institute; Astra Zeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Wyeth(Wyeth)	The infrastructure for De Nederlandse Studie naar Depressie en Angst (NESDA) study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw, grant number 10-000-1002) and is supported by participating universities and mental health care organizations (VU University Medical Center, GGZ inGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Scientific Institute for Quality of Healthcare (IQ healthcare), Netherlands Institute for Health Services Research (NIVEL) and Netherlands Institute of Mental Health and Addiction (Trimbos Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; E Piek: None. K van der Meer: None. WJG Hoogendijk: Lectured and advised for, and received unrestricted research grants from Ely Lilly, Lundbeck, Servier, Bristol-Myers Squibb and Organon for which payments were made to the independent research foundation of GGZ inGeest. Hoogendijk holds a patent for gene-expression profiling in peripheral blood as a biomarker for depression. All these activities are not directly related to the present study and, therefore, do not form a conflict of interest. BWJH Penninx: None. WA Nolen: received grants from the Netherlands Organisation for Health Research and Development, the European Union, the Stanley Medical Research Institute, Astra Zeneca, Eli Lilly, GlaxoSmithKline and Wyeth, received honoraria and speaker's fees from Astra Zeneca, Eli Lilly, Pfizer, Servier and Wyeth, and participated in advisory boards of Astra Zeneca, Cyberonics, Pfizer and Servier.	Ackermann RT, 2002, J GEN INTERN MED, V17, P293, DOI 10.1046/j.1525-1497.2002.10350.x; Anderson IM, 2008, J PSYCHOPHARMACOL, V22, P343, DOI 10.1177/0269881107088441; Andrews G, 1999, PSYCHOL MED, V29, P787, DOI 10.1017/S0033291799008648; [Anonymous], 2004, GUARDIAN; [Anonymous], 2009, ENCY BRITANNICA; Balestrieri M, 2004, SOC PSYCH PSYCH EPID, V39, P171, DOI 10.1007/s00127-004-0722-z; Beck CA, 2005, SOC PSYCH PSYCH EPID, V40, P799, DOI 10.1007/s00127-005-0968-0; Berardi D, 2005, PSYCHOTHER PSYCHOSOM, V74, P225, DOI 10.1159/000085146; Bosmans JE, 2008, J AFFECT DISORDERS, V111, P106, DOI 10.1016/j.jad.2008.02.002; *CAMD ISL MENT HLT, 2003, DEPR GUID; Cameron IM, 2009, BRIT J GEN PRACT, V59, P644, DOI 10.3399/bjgp09X454061; Denicoff KD, 1997, J PSYCHIAT RES, V31, P593, DOI 10.1016/S0022-3956(96)00027-1; Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700; Gardarsdottir H, 2007, J AFFECT DISORDERS, V98, P109, DOI 10.1016/j.jad.2006.07.003; Hermens MLM, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-36; Honig A, 2001, PATIENT EDUC COUNS, V43, P43, DOI 10.1016/S0738-3991(00)00144-0; Institute for Clinical Systems Improvement, 2009, ICSI HLTH CAR GUID M; Kennedy SH, 2001, CAN J PSYCHIAT, V46, p38S; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Lecrubier Y, 2007, J CLIN PSYCHIAT, V68, P36; MEEUWISSEN JC, 2009, RICHTLIJNHERZIENING; Mueller TI, 1999, AM J PSYCHIAT, V156, P1000; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; *NAT ADV COMM HLTH, 1996, GUID TREATM MAN DEPR; National Collaborating Centre for Mental Health, 2009, DEPR TREATM MAN DEPR; Ormel O, 2003, NED TIJDSCHR GENEES, V147, P1005; Patten S B, 2000, Chronic Dis Can, V21, P68; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Pinto-Meza A, 2008, PSYCHIAT SERV, V59, P78, DOI 10.1176/ps.2008.59.1.78; ROSHOLM JU, 1995, SCAND J PRIM HEALTH, V13, P281, DOI 10.3109/02813439508996776; Sihvo S, 2008, J AFFECT DISORDERS, V110, P94, DOI 10.1016/j.jad.2008.01.012; Solomon DA, 2000, AM J PSYCHIAT, V157, P229, DOI 10.1176/appi.ajp.157.2.229; Stafford Randall S., 2000, Prim Care Companion J Clin Psychiatry, V2, P211; SUNDERLAND M, 2010, SOC PSYCHIA IN PRESS; Susser E, 2000, SCHIZOPHR RES, V42, P67, DOI 10.1016/S0920-9964(99)00088-2; ten Doesschate MC, 2009, J AFFECT DISORDERS, V115, P167, DOI 10.1016/j.jad.2008.07.011; TERLUIN B, 2004, HUISARTS WET, V47, P26; Van der Veen WJ, 2009, INT J METH PSYCH RES, V18, P229, DOI 10.1002/mpr.297; van Geffen ECG, 2009, BRIT J GEN PRACT, V59, P81, DOI 10.3399/bjgp09X395067; Van Os TWDP, 2006, EUR PSYCHIAT, V21, P87, DOI 10.1016/j.eurpsy.2005.05.002; VANMARWIJK HWJ, 2003, HUISARTS WET, V46, P614; Wells JE, 2004, PSYCHOL MED, V34, P1001, DOI 10.1017/S0033291703001843; Wilson I, 2003, FAM PRACT, V20, P685, DOI 10.1093/fampra/cmg611; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; Wittchen HU, 2002, HUM PSYCHOPHARM CLIN, V17, pS1, DOI 10.1002/hup.398	47	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e14784	10.1371/journal.pone.0014784	http://dx.doi.org/10.1371/journal.pone.0014784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YC	21479264	gold, Green Published, Green Submitted			2022-12-27	WOS:000289054600003
J	Wagner, V; Antunes, PM; Ristow, M; Lechner, U; Hensen, I				Wagner, Viktoria; Antunes, Pedro M.; Ristow, Michael; Lechner, Ute; Hensen, Isabell			Prevailing Negative Soil Biota Effect and No Evidence for Local Adaptation in a Widespread Eurasian Grass	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; AMMOPHILA-ARENARIA; SEEDLING MORTALITY; AUSTRALIAN ACACIA; TEMPERATE TREE; PLANT; PATHOGENS; FEEDBACK; GROWTH; RESISTANCE	Background: Soil biota effects are increasingly accepted as an important driver of the abundance and distribution of plants. While biogeographical studies on alien invasive plant species have indicated coevolution with soil biota in their native distribution range, it is unknown whether adaptation to soil biota varies among populations within the native distribution range. The question of local adaptation between plants and their soil biota has important implications for conservation of biodiversity and may justify the use of seed material from local provenances in restoration campaigns. Methodology/Principal Findings: We studied soil biota effects in ten populations of the steppe grass Stipa capillata from two distinct regions, Europe and Asia. We tested for local adaptation at two different scales, both within (ca. 10-80 km) and between (ca. 3300 km) regions, using a reciprocal inoculation experiment in the greenhouse for nine months. Generally, negative soil biota effects were consistent. However, we did not find evidence for local adaptation: both within and between regions, growth of plants in their 'home soil' was not significantly larger relative to that in soil from other, more distant, populations. Conclusions/Significance: Our study suggests that negative soil biota effects can prevail in different parts of a plant species' range. Absence of local adaptation points to the possibility of similar rhizosphere biota composition across populations and regions, sufficient gene flow to prevent coevolution, selection in favor of plasticity, or functional redundancy among different soil biota. From the point of view of plant - soil biota interactions, our findings indicate that the current practice of using seeds exclusively from local provenances in ecosystem restoration campaigns may not be justified.	[Wagner, Viktoria; Hensen, Isabell] Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, Halle, Germany; [Antunes, Pedro M.] Algoma Univ, Dept Biol, Sault Ste Marie, ON, Canada; [Ristow, Michael] Univ Potsdam, Inst Biol Plant Ecol & Nat Conservat, Potsdam, Germany; [Lechner, Ute] Univ Halle Wittenberg, Inst Biol Microbiol, Halle, Germany	Martin Luther University Halle Wittenberg; Algoma University; University of Potsdam; Martin Luther University Halle Wittenberg	Wagner, V (corresponding author), Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, Halle, Germany.	viktoria.wagner@botanik.uni-halle.de	Wagner, Viktoria/D-9897-2011; Madeira Antunes, Pedro/C-2949-2008	Madeira Antunes, Pedro/0000-0003-3596-6983; Wagner, Viktoria/0000-0002-2665-9888	German Academic Exchange Service, DAAD	German Academic Exchange Service, DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This study was made possible through a grant from the German Academic Exchange Service, DAAD, to V. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Antunes PM, 2011, NEW PHYTOL, V189, P507, DOI 10.1111/j.1469-8137.2010.03480.x; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Becker U, 2006, OECOLOGIA, V150, P506, DOI 10.1007/s00442-006-0534-9; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Bischoff A, 2006, J ECOL, V94, P1130, DOI 10.1111/j.1365-2745.2006.01174.x; Brinkman EP, 2010, J ECOL, V98, P1063, DOI 10.1111/j.1365-2745.2010.01695.x; Burdon JJ, 1999, J APPL ECOL, V36, P398, DOI 10.1046/j.1365-2664.1999.00409.x; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Canty A., 2010, BOOT BOOTSTRAP R S P; Carvalho LM, 2010, OIKOS, V119, P1172, DOI 10.1111/j.1600-0706.2009.18148.x; de la Pena E, 2009, PLANT SOIL, V324, P307, DOI 10.1007/s11104-009-9958-4; Dyer AR, 1997, ECOL APPL, V7, P484, DOI 10.1890/1051-0761(1997)007[0484:IADCTR]2.0.CO;2; Ehrenfeld JG, 2005, ANNU REV ENV RESOUR, V30, P75, DOI 10.1146/annurev.energy.30.050504.144212; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; FOX LR, 1981, AM ZOOL, V21, P853; GarciaRamos G, 1997, EVOLUTION, V51, P21, DOI 10.2307/2410956; Gray AJ, 2002, HANDBOOK OF ECOLOGICAL RESTORATION, VOL 1, P66; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoeksema JD, 2007, J EVOLUTION BIOL, V20, P1148, DOI 10.1111/j.1420-9101.2006.01287.x; Katan J., 2002, Plant roots: the hidden half, P949; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Knevel IC, 2004, OECOLOGIA, V141, P502, DOI 10.1007/s00442-004-1662-8; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Lavrenko E. M., 1970, BOT ZH, V55, P1734; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; LINHART YB, 1991, TRENDS ECOL EVOL, V6, P392, DOI 10.1016/0169-5347(91)90160-Y; Macel M, 2007, ECOLOGY, V88, P424, DOI 10.1890/0012-9658(2007)88[424:CVSFIL]2.0.CO;2; McCarthy-Neumann S, 2010, J ECOL, V98, P396, DOI 10.1111/j.1365-2745.2009.01619.x; McCarthy-Neumann S, 2010, J ECOL, V98, P408, DOI 10.1111/j.1365-2745.2009.01620.x; Mukhin VA, 2006, RUSS J ECOL+, V37, P1, DOI 10.1134/S1067413606010012; Nunez MA, 2009, ECOLOGY, V90, P2352, DOI 10.1890/08-2139.1; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; PARKER MA, 1995, ECOLOGY, V76, P1525, DOI 10.2307/1938154; Parker MA, 1999, AM NAT, V153, pS48, DOI 10.1086/303211; Parker MA, 2006, DIVERS DISTRIB, V12, P563, DOI 10.1111/j.1366-9516.2006.00255.x; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Pinheiro J., 2010, NLME LINEAR NONLINEA, P1; Pinheiro J, 2001, MIXED EFFECTS MODELS; PONOMAREV A. N., 1961, Botanicheskii Zhurnal, V46, P1229; R Development Core, 2010, R LANG ENV STAT COMP; Reinhart KO, 2005, J ECOL, V93, P890, DOI 10.1111/j.1365-2745.2005.01028.x; Reinhart KO, 2009, ECOLOGY, V90, P2984, DOI 10.1890/08-1380.1; Reynolds HL, 2003, ECOLOGY, V84, P2281, DOI 10.1890/02-0298; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Ronsheim ML, 2001, OECOLOGIA, V128, P77, DOI 10.1007/s004420000625; Shi ZY, 2007, SCI CHINA SER D, V50, P135, DOI 10.1007/s11430-007-5014-5; Stinchcombe JR, 2001, AM NAT, V158, P376, DOI 10.1086/321990; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; SVENNING MM, 1991, PHYSIOL PLANTARUM, V83, P381, DOI 10.1111/j.1399-3054.1991.tb00109.x; Sylvia DM, 2003, MYCORRHIZA, V13, P177, DOI 10.1007/s00572-003-0232-y; Thompson J. N., 2005, INTERSPEC INTERACT; Thrall PH, 2007, J ECOL, V95, P1110, DOI 10.1111/j.1365-2745.2007.01278.x; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; van der Heijden MGA, 2004, ECOL LETT, V7, P293, DOI 10.1111/j.1461-0248.2004.00577.x; van der Heijden MGA, 1998, ECOLOGY, V79, P2082, DOI 10.1890/0012-9658(1998)079[2082:DAMFSA]2.0.CO;2; Van Grunsven RHA, 2009, S AFR J BOT, V75, P172, DOI 10.1016/j.sajb.2008.09.003; van Grunsven RHA, 2010, GLOBAL CHANGE BIOL, V16, P380, DOI 10.1111/j.1365-2486.2009.01996.x; VANDERPUTTEN WH, 1993, NATURE, V362, P53; WAGNER V, ECOGRAPHY IN PRESS; Zuur Alain F., 2009, P1	65	11	11	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17580	10.1371/journal.pone.0017580	http://dx.doi.org/10.1371/journal.pone.0017580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479262	Green Published, Green Submitted, gold			2022-12-27	WOS:000289054600013
J	Babigumira, JB; Castelnuovo, B; Stergachis, A; Kiragga, A; Shaefer, P; Lamorde, M; Kambugu, A; Muwanga, A; Garrison, LP				Babigumira, Joseph B.; Castelnuovo, Barbara; Stergachis, Andy; Kiragga, Agnes; Shaefer, Petra; Lamorde, Mohammed; Kambugu, Andrew; Muwanga, Alice; Garrison, Louis P.			Cost Effectiveness of a Pharmacy-Only Refill Program in a Large Urban HIV/AIDS Clinic in Uganda	PLOS ONE			English	Article							HUMAN-RESOURCES; HEALTH; CARE	Background: HIV/AIDS clinics in Uganda and other low-income countries face increasing numbers of patients and workforce shortages. We performed a cost-effectiveness analysis comparing a Pharmacy-only Refill Program (PRP), a form of task-shifting, to the Standard of Care (SOC) at a large HIV/AIDS clinic in Uganda, the Infectious Diseases Institute (IDI). The PRP was started to reduce workforce shortages and optimize patient care by substituting pharmacy visits for SOC involving monthly physician visits for accessing antiretroviral medicines. Methodology/Principal Findings: We used a retrospective cohort analysis to compare the effectiveness of the PRP compared to SOC. Effectiveness was defined as Favorable Immune Response (FIR), measured as having a CD4 lymphocyte count of over 500 cells/mu l at follow-up. We used multivariate logistic regression to assess the difference in FIR between patients in the PRP and SOC. We incorporated estimates of effectiveness into an incremental cost-effectiveness analysis performed from a limited societal perspective. We estimated costs from previous studies at IDI and conducted univariate and probabilistic sensitivity analyses. We identified 829 patients, 578 in the PRP and 251 in SOC. After 12.8 months (PRP) and 15.1 months (SOC) of follow-up, 18.9% of patients had a FIR, 18.6% in the PRP and 19.6% in SOC. There was a non-significant 9% decrease in the odds of having a FIR for PRP compared to SOC after adjusting for other variables (OR 0.93, 95% CI 0.55-1.58). The PRP was less costly than the SOC (US$ 520 vs. 655 annually, respectively). The incremental cost-effectiveness ratio comparing PRP to SOC was US$ 13,500 per FIR. PRP remained cost-effective at univariate and probabilistic sensitivity analysis. Conclusion/Significance: The PRP is more cost-effective than the standard of care. Similar task-shifting programs might help large HIV/AIDS clinics in Uganda and other low-income countries to cope with increasing numbers of patients seeking care.	[Babigumira, Joseph B.; Stergachis, Andy; Garrison, Louis P.] Univ Washington, Sch Pharm, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA; [Castelnuovo, Barbara; Kiragga, Agnes; Shaefer, Petra; Lamorde, Mohammed; Kambugu, Andrew; Muwanga, Alice] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Stergachis, Andy] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Stergachis, Andy] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Makerere University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Babigumira, JB (corresponding author), Univ Washington, Sch Pharm, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA.	babijo@uw.edu	Babigumira, Joseph/T-4208-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI027757] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anyangwe Stella C E, 2007, Int J Environ Res Public Health, V4, P93, DOI 10.3390/ijerph2007040002; Babigumira JB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-192; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Brentlinger PE, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-23; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Castelnuovo B, 2009, INT J STD AIDS, V20, P123, DOI 10.1258/ijsa.2008.008174; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Garrison LP, 2010, VALUE HEALTH, V13, P8, DOI 10.1111/j.1524-4733.2009.00660.x; Gold MR, 1996, COST EFFECTIVENESS H; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; *JOINT UN PROGR HI, 2009, AIDS EP UPD; McCollum ED, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009626; Morris MB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-5; Price J, 2010, DEV WORLD BIOETH, V10, P99, DOI 10.1111/j.1471-8847.2010.00281.x; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; SCHRANTZ S, 2007, 45 ANN C INF DIS SOC; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; TUGUME SB, 1995, CLIN DIAGN LAB IMMUN, V2, P233, DOI 10.1128/CDLI.2.2.233-235.1995; *WHOCHOICE, 2010, EST UN COSTS PAT SER; World Health Organization (WHO), 2009, WORLD HLTH STAT; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	23	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18193	10.1371/journal.pone.0018193	http://dx.doi.org/10.1371/journal.pone.0018193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464895	Green Submitted, Green Published, gold			2022-12-27	WOS:000289053800027
J	Timpka, T; Eriksson, H; Gursky, EA; Stromgren, M; Holm, E; Ekberg, J; Eriksson, O; Grimvall, A; Valter, L; Nyce, JM				Timpka, Toomas; Eriksson, Henrik; Gursky, Elin A.; Stromgren, Magnus; Holm, Einar; Ekberg, Joakim; Eriksson, Olle; Grimvall, Anders; Valter, Lars; Nyce, James M.			Requirements and Design of the PROSPER Protocol for Implementation of Information Infrastructures Supporting Pandemic Response: A Nominal Group Study	PLOS ONE			English	Article							PUBLIC-HEALTH; INFECTIOUS-DISEASE; INFLUENZA; SURVEILLANCE; SYSTEMS; EVOLUTION; QUALITY; CARE; EPIDEMIOLOGY; UNCERTAINTY	Background: Advanced technical systems and analytic methods promise to provide policy makers with information to help them recognize the consequences of alternative courses of action during pandemics. Evaluations still show that response programs are insufficiently supported by information systems. This paper sets out to derive a protocol for implementation of integrated information infrastructures supporting regional and local pandemic response programs at the stage(s) when the outbreak no longer can be contained at its source. Methods: Nominal group methods for reaching consensus on complex problems were used to transform requirements data obtained from international experts into an implementation protocol. The analysis was performed in a cyclical process in which the experts first individually provided input to working documents and then discussed them in conferences calls. Argument-based representation in design patterns was used to define the protocol at technical, system, and pandemic evidence levels. Results: The Protocol for a Standardized information infrastructure for Pandemic and Emerging infectious disease Response (PROSPER) outlines the implementation of information infrastructure aligned with pandemic response programs. The protocol covers analyses of the community at risk, the response processes, and response impacts. For each of these, the protocol outlines the implementation of a supporting information infrastructure in hierarchical patterns ranging from technical components and system functions to pandemic evidence production. Conclusions: The PROSPER protocol provides guidelines for implementation of an information infrastructure for pandemic response programs both in settings where sophisticated health information systems already are used and in developing communities where there is limited access to financial and technical resources. The protocol is based on a generic health service model and its functions are adjusted for community-level analyses of outbreak detection and progress, and response program effectiveness. Scientifically grounded reporting principles need to be established for interpretation of information derived from outbreak detection algorithms and predictive modeling.	[Timpka, Toomas; Ekberg, Joakim; Valter, Lars; Nyce, James M.] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Timpka, Toomas; Eriksson, Henrik; Ekberg, Joakim; Eriksson, Olle; Grimvall, Anders] Linkoping Univ, Dept Comp Sci, Linkoping, Sweden; [Gursky, Elin A.] ANSER Analyt Serv Inc, Natl Strategies Support Directorate, Arlington, VA USA; [Stromgren, Magnus; Holm, Einar] Umea Univ, Dept Social & Econ Geog, Umea, Sweden; [Nyce, James M.] Ball State Univ, Dept Anthropol, Muncie, IN 47306 USA	Linkoping University; Linkoping University; Umea University; Ball State University	Timpka, T (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden.	toomas.timpka@liu.se	Timpka, Toomas/E-8065-2018		Swedish Research Council [2006-4433, 2008-5252]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This research was supported by the Swedish Research Council (www.vr.se) under contracts 2006-4433 and 2008-5252. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKOFF RL, 1979, J OPER RES SOC, V30, P189, DOI 10.1057/jors.1979.41; Alexander C., 1979, TIMELESS WAY BUILDIN; Armstrong R, 2006, J PUBLIC HEALTH-UK, V28, P384, DOI 10.1093/pubmed/fdl072; Buckeridge DL, 2008, J AM MED INFORM ASSN, V15, P760, DOI 10.1197/jamia.M2799; BUSCHMANN F, 1996, SYSTEM PATTERNS PATT; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Dato V, 2004, PUBLIC HEALTH REP, V119, P464, DOI 10.1016/j.phr.2004.07.003; Davidoff F, 2008, QUAL SAF HEALTH CARE, V17, P3, DOI 10.1136/qshc.2008.029066; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Eccles MP, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-18; EKBERG J, 2009, ELECT HEALTHCARE, P28; Eriksson Henrik, 2009, AMIA Annu Symp Proc, V2009, P173; Eriksson H, 2007, STUD HEALTH TECHNOL, V129, P755; ERIKSSON O, 2007, THESIS LINKOPING U L; Ernesater A, 2009, J ADV NURS, V65, P1074, DOI 10.1111/j.1365-2648.2009.04966.x; Gennari JH, 2003, INT J HUM-COMPUT ST, V58, P89, DOI 10.1016/S1071-5819(02)00127-1; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; HOLM E, 2002, GERUM, V4; Holm E, 2007, STUD HEALTH TECHNOL, V129, P464; Hutwagner L, 2003, J URBAN HEALTH, V80, pI89; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; KNORR E, 2008, INFOWORLD       0407; Krumkamp R, 2009, HEALTH POLICY, V92, P21, DOI 10.1016/j.healthpol.2009.01.006; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Levy PP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-179; Liechti R, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq004; Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380; MONLONEY A, 2009, LANCET, V373, P1591; Morse SS, 2007, HEALTH AFFAIR, V26, P1069, DOI 10.1377/hlthaff.26.4.1069; Mounier-Jack S, 2007, B WORLD HEALTH ORGAN, V85, P923, DOI 10.2471/BLT.06.039834; Naditz A, 2009, TELEMED J E-HEALTH, V15, P825, DOI 10.1089/tmj.2009.9938; Pappaioanou M, 2003, SOC SCI MED, V57, P1925, DOI 10.1016/S0277-9536(03)00058-3; Perry HN, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-24; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; RAINE R, 2005, BMJ-BRIT MED J, V331, P6313; Ringel JS, 2009, DISASTER MED PUBLIC, V3, pS160, DOI 10.1097/DMP.0b013e3181ad1833; RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730; SANDIFORD P, 1992, SOC SCI MED, V34, P1077, DOI 10.1016/0277-9536(92)90281-T; Sintchenko V, 2009, ARCH PATHOL LAB MED, V133, P916, DOI 10.1043/1543-2165-133.6.916; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Suk JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001253; Ten Eyck RP, 2008, PREHOSPITAL DISASTER, V23, P103, DOI 10.1017/S1049023X00005707; Timpka T, 2009, B WORLD HEALTH ORGAN, V87, P305, DOI 10.2471/BLT.07.050203; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wahlin K, 2008, ENVIRON SCI POLICY, V11, P115, DOI 10.1016/j.envsci.2007.12.001; Wilson JW, 1998, B AM METEOROL SOC, V79, P2079, DOI 10.1175/1520-0477(1998)079<2079:NTASR>2.0.CO;2; Wilson Nick, 2005, Hum Resour Health, V3, P7, DOI 10.1186/1478-4491-3-7; Wirehn ABE, 2007, SCAND J PUBLIC HEALT, V35, P424, DOI 10.1080/14034940701195230; 2009, LANCET INFECT DIS, V9, P331	49	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17941	10.1371/journal.pone.0017941	http://dx.doi.org/10.1371/journal.pone.0017941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743XV	21464918	Green Published, Green Submitted, gold			2022-12-27	WOS:000289053800006
J	Hannemann, A; Flatman, PW				Hannemann, Anke; Flatman, Peter W.			Phosphorylation and Transport in the Na-K-2Cl Cotransporters, NKCC1 and NKCC2A, Compared in HEK-293 Cells	PLOS ONE			English	Article							K-CL COTRANSPORTER; CATION-CHLORIDE COTRANSPORTERS; REGULATORY PHOSPHORYLATION; NA+-K+-2CL(-) COTRANSPORT; BLOOD-PRESSURE; PROTEIN; SPAK; KINASES; OUABAIN; ION	Na-K-2Cl cotransporters help determine cell composition and volume. NKCC1 is widely distributed whilst NKCC2 is only found in the kidney where it plays a vital role reabsorbing 20% of filtered NaCl. NKCC2 regulation is poorly understood because of its restricted distribution and difficulties with its expression in mammalian cell cultures. Here we compare phosphorylation of the N-termini of the cotransporters, measured with phospho-specific antibodies, with bumetanide-sensitive transport of K+ (Rb-86(+)) (activity) in HEK-293 cells stably expressing fNKCC1 or fNKCC2A which were cloned from ferret kidney. Activities of transfected transporters were distinguished from those of endogenous ones by working at 37 degrees C. fNKCC1 and fNKCC2A activities were highest after pre-incubation of cells in hypotonic low-[Cl-] media to reduce cell [Cl-] and volume during flux measurement. Phosphorylation of both transporters more than doubled. Pre-incubation with ouabain also strongly stimulated fNKCC1 and fNKCC2A and substantially increased phosphorylation, whereas preincubation in Na+-free media maximally stimulated fNKCC1 and doubled its phosphorylation, but inhibited fNKCC2A, with a small increase in its phosphorylation. Kinase inhibitors halved phosphorylation and activity of both transporters whereas inhibition of phosphatases with calyculin A strongly increased phosphorylation of both transporters but only slightly stimulated fNKCC1 and inhibited fNCCC2A. Thus kinase inhibition reduced phosphorylation and transport, and transport stimulation was only seen when phosphorylation increased, but transport did not always increase with phosphorylation. This suggests phosphorylation of the N-termini determines the transporters' potential capacity to move ions, but final activity also depends on other factors. Transport cannot be reliably inferred solely using phospho-specific antibodies on whole-cell lysates.	[Hannemann, Anke; Flatman, Peter W.] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Hannemann, A (corresponding author), Univ Cambridge, Sch Vet, Dept Vet Med, Cambridge, England.	peter.flatman@ed.ac.uk	Hannemann, Anke/AAE-2445-2019	Hannemann, Anke/0000-0002-2925-1124	Wellcome Trust [077711]	Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported by the Wellcome Trust (077711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITON JF, 1983, BIOCHIM BIOPHYS ACTA, V734, P279, DOI 10.1016/0005-2736(83)90126-8; Aoki Y, 1996, AM J PHYSIOL-REG I, V271, pR1561, DOI 10.1152/ajpregu.1996.271.6.R1561; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BAKKERGRUNWALD T, 1982, BIOCHIM BIOPHYS ACTA, V687, P333, DOI 10.1016/0005-2736(82)90564-8; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Darman RB, 2001, J BIOL CHEM, V276, P34359, DOI 10.1074/jbc.C100368200; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; ELLIS D, 1977, J PHYSIOL-LONDON, V273, P211, DOI 10.1113/jphysiol.1977.sp012090; Flatman PW, 1999, J PHYSIOL-LONDON, V517, P699, DOI 10.1111/j.1469-7793.1999.0699s.x; Flatman PW, 2005, J PHYSIOL-LONDON, V563, P421, DOI 10.1113/jphysiol.2004.080507; Flatman PW, 2002, BBA-BIOMEMBRANES, V1566, P140, DOI 10.1016/S0005-2736(02)00586-2; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Gagnon E, 2002, AM J PHYSIOL-RENAL, V283, pF1046, DOI 10.1152/ajprenal.00107.2002; Gagnon KB, 2010, J PHYSIOL-LONDON, V588, P3385, DOI 10.1113/jphysiol.2010.191932; Gagnon KB, 2010, J BIOL CHEM, V285, P14115, DOI 10.1074/jbc.M110.112672; Gagnon KBE, 2007, AM J PHYSIOL-CELL PH, V292, pC1809, DOI 10.1152/ajpcell.00580.2006; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gimenez I, 2005, AM J PHYSIOL-RENAL, V289, pF1341, DOI 10.1152/ajprenal.00214.2005; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Hannemann A, 2009, J BIOL CHEM, V284, P35348, DOI 10.1074/jbc.M109.060004; Isenring P, 1998, J BIOL CHEM, V273, P11295, DOI 10.1074/jbc.273.18.11295; Isenring P, 1997, J BIOL CHEM, V272, P24556, DOI 10.1074/jbc.272.39.24556; Klein JD, 1995, AM J PHYSIOL-CELL PH, V269, pC1524, DOI 10.1152/ajpcell.1995.269.6.C1524; Kurihara K, 2002, AM J PHYSIOL-CELL PH, V282, pC817, DOI 10.1152/ajpcell.00352.2001; Lytle C, 1998, AM J PHYSIOL-CELL PH, V274, pC299, DOI 10.1152/ajpcell.1998.274.2.C299; Lytle C, 1996, AM J PHYSIOL-CELL PH, V270, pC437, DOI 10.1152/ajpcell.1996.270.2.C437; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; MATSKEVICH I, 2003, J PHYSL, V547, pC20; Matskevich L, 2005, BBA-BIOMEMBRANES, V1714, P25, DOI 10.1016/j.bbamem.2005.06.001; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Nesher M, 2009, AM J PHYSIOL-HEART C, V297, pH2026, DOI 10.1152/ajpheart.00734.2009; PAYNE JA, 1994, P NATL ACAD SCI USA, V91, P4544, DOI 10.1073/pnas.91.10.4544; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220	40	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17992	10.1371/journal.pone.0017992	http://dx.doi.org/10.1371/journal.pone.0017992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464992	Green Submitted, gold, Green Published			2022-12-27	WOS:000288813900026
J	Pedersen, KS; Bamlet, WR; Oberg, AL; de Andrade, M; Matsumoto, ME; Tang, H; Thibodeau, SN; Petersen, GM; Wang, LA				Pedersen, Katrina S.; Bamlet, William R.; Oberg, Ann L.; de Andrade, Mariza; Matsumoto, Martha E.; Tang, Hui; Thibodeau, Stephen N.; Petersen, Gloria M.; Wang, Liang			Leukocyte DNA Methylation Signature Differentiates Pancreatic Cancer Patients from Healthy Controls	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ABERRANT METHYLATION; SUSCEPTIBILITY; EPIGENETICS; CARCINOMA; BIOMARKER; INVASION; COMMON; BLOOD	Pancreatic adenocarcinoma (PaC) is one of most difficult tumors to treat. Much of this is attributed to the late diagnosis. To identify biomarkers for early detection, we examined DNA methylation differences in leukocyte DNA between PaC cases and controls in a two-phase study. In phase I, we measured methylation levels at 1,505 CpG sites in treatment-naive leukocyte DNA from 132 never-smoker PaC patients and 60 never-smoker healthy controls. We found significant differences in 110 CpG sites (false discovery rate < 0.05). In phase II, we tested and validated 88 of 96 phase I selected CpG sites in 240 PaC cases and 240 matched controls (p <= 0.05). Using penalized logistic regression, we built a prediction model consisting of five CpG sites (IL10_P348, LCN2_P86, ZAP70_P220, AIM2_P624, TAL1_P817) that discriminated PaC patients from controls (C-statistic = 0.85 in phase I; 0.76 in phase II). Interestingly, one CpG site (LCN2_P86) alone could discriminate resectable patients from controls (C-statistic = 0.78 in phase I; 0.74 in phase II). We also performed methylation quantitative trait loci (methQTL) analysis and identified three CpG sites (AGXT_P180_F, ALOX12_E85_R, JAK3_P1075_R) where the methylation levels were significantly associated with single nucleotide polymorphisms (SNPs) (false discovery rate,0.05). Our results demonstrate that epigenetic variation in easily obtainable leukocyte DNA, manifested by reproducible methylation differences, may be used to detect PaC patients. The methylation differences at certain CpG sites are partially attributable to genetic variation. This study strongly supports future epigenome-wide association study using leukocyte DNA for biomarker discovery in human diseases.	[Pedersen, Katrina S.] Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA; [Bamlet, William R.; Oberg, Ann L.; de Andrade, Mariza; Matsumoto, Martha E.; Tang, Hui; Petersen, Gloria M.] Mayo Clin, Coll Med, Dept Hlth Sci, Rochester, MN USA; [Thibodeau, Stephen N.; Wang, Liang] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Pedersen, KS (corresponding author), Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA.	wang.liang@mayo.edu		Pedersen, Katrina/0000-0003-2793-6901; de Andrade, Mariza/0000-0003-2329-2686; Bamlet, William/0000-0003-2903-1284	Mayo Clinic SPORE in Pancreatic Cancer [P50 CA102701]; Department of Laboratory Medicine and Pathology, Mayo Clinic; NATIONAL CANCER INSTITUTE [R25CA092049, P50CA102701] Funding Source: NIH RePORTER	Mayo Clinic SPORE in Pancreatic Cancer; Department of Laboratory Medicine and Pathology, Mayo Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Mayo Clinic SPORE in Pancreatic Cancer (P50 CA102701) and the Department of Laboratory Medicine and Pathology, Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Duffy MJ, 2009, EUR J CANCER, V45, P335, DOI 10.1016/j.ejca.2008.12.008; Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; Feinberg Andrew P, 2008, JAMA, V299, P1345, DOI 10.1001/jama.299.11.1345; Fukushima N, 2003, CANCER BIOL THER, V2, P78; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Jansen M, 2002, CANCER BIOL THER, V1, P293, DOI 10.4161/cbt.84; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Lopez J, 2009, BRIT J CANCER, V100, P571, DOI 10.1038/sj.bjc.6604930; Matsubayashi H, 2006, CANCER RES, V66, P1208, DOI 10.1158/0008-5472.CAN-05-2664; Matsubayashi H, 2003, CLIN CANCER RES, V9, P1446; Moniaux N, 2008, BRIT J CANCER, V98, P1540, DOI 10.1038/sj.bjc.6604329; Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X; *NCI, 2010, SEER STAT FACT SHEET; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Poch B, 2007, LANGENBECK ARCH SURG, V392, P353, DOI 10.1007/s00423-006-0140-7; Sato N, 2005, ONCOGENE, V24, P850, DOI 10.1038/sj.onc.1208050; Sato N, 2003, CANCER RES, V63, P3735; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tan AC, 2009, MOL ONCOL, V3, P425, DOI 10.1016/j.molonc.2009.03.004; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; Ueki T, 2000, CANCER RES, V60, P1835; *USPSTF, 2004, US PREV SERV TASK FO; Wang L, 2010, J THORAC ONCOL, V5, P778, DOI 10.1097/JTO.0b013e3181d6e0b3; Widschwendter M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002656; Zhang Yingying, 2009, PLoS Genet, V5, pe1000438, DOI 10.1371/journal.pgen.1000438	33	65	67	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18223	10.1371/journal.pone.0018223	http://dx.doi.org/10.1371/journal.pone.0018223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455317	gold, Green Submitted, Green Published			2022-12-27	WOS:000288811500030
J	Qiao, JJ; Li, SY; Wei, LX; Jiang, J; Long, R; Mao, H; Wei, L; Wang, LY; Yang, H; Grossniklaus, HE; Liu, ZR; Yang, JJ				Qiao, Jingjuan; Li, Shunyi; Wei, Lixia; Jiang, Jie; Long, Robert; Mao, Hui; Wei, Ling; Wang, Liya; Yang, Hua; Grossniklaus, Hans E.; Liu, Zhi-Ren; Yang, Jenny J.			HER2 Targeted Molecular MR Imaging Using a De Novo Designed Protein Contrast Agent	PLOS ONE			English	Article							BREAST-CANCER; IN-VIVO; RECEPTORS; CELLS	The application of magnetic resonance imaging (MRI) to non-invasively assess disease biomarkers has been hampered by the lack of desired contrast agents with high relaxivity, targeting capability, and optimized pharmacokinetics. We have developed a novel MR imaging probe targeting to HER2, a biomarker for various cancer types and a drug target for anticancer therapies. This multimodal HER20targeted MR imaging probe integrates a de novo designed protein contrast agent with a high affinity HER2 affibody and a near IR fluorescent dye. Our probe can differentially monitor tumors with different expression levels of HER2 in both human cell lines and xenograft mice models. In addition to its 100-fold higher dose efficiency compared to clinically approved non-targeting contrast agent DTPA, our developed agent also exhibits advantages in crossing the endothelial boundary, tissue distribution, and tumor tissue retention over reported contrast agents as demonstrated by even distribution of the imaging probe across the entire tumor mass. This contrast agent will provide a powerful tool for quantitative assessment of molecular markers, and improved resolution for diagnosis, prognosis and drug discovery.	[Qiao, Jingjuan; Li, Shunyi; Jiang, Jie; Wei, Ling; Yang, Jenny J.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Wei, Lixia; Liu, Zhi-Ren] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Long, Robert; Mao, Hui; Wang, Liya] Emory Univ, Dept Radiol, Atlanta, GA 30322 USA; [Yang, Hua; Grossniklaus, Hans E.] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Emory University; Emory University	Qiao, JJ (corresponding author), Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.	biozrl@langate.gsu.edu; chejjy@langate.gsu.edu			NIH [CA118113, GM62999, EB007268]; Georgia State University; NATIONAL CANCER INSTITUTE [R01CA118113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062999] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by research grants from NIH CA118113 to Zhi-Ren Liu, NIH GM62999 and EB007268 to Jenny J Yang, and Georgia State University Brain and Behavior fellowship to Jingjuan Qiao. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime S, 2005, ANGEW CHEM INT EDIT, V44, P1813, DOI 10.1002/anie.200462566; Allison M, 2010, NAT BIOTECHNOL, V28, P117, DOI 10.1038/nbt0210-117; Artemov D, 2004, CURR PHARM BIOTECHNO, V5, P485, DOI 10.2174/1389201043376553; Chen T.-J., 2008, J BIOL INORG CHEM; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Crich SG, 2005, J BIOL INORG CHEM, V10, P78, DOI 10.1007/s00775-004-0616-2; Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550; Frullano L, 2004, CHEM-EUR J, V10, P5205, DOI 10.1002/chem.200400369; Funovics MA, 2004, MAGN RESON IMAGING, V22, P843, DOI 10.1016/j.mri.2004.01.050; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; Gown AM, 2008, MODERN PATHOL, V21, pS8, DOI 10.1038/modpathol.2008.34; Kobayashi H, 2003, CANCER RES, V63, P271; Menard S, 2001, ANN ONCOL, V12, P15, DOI 10.1023/A:1011151505425; Morawski AM, 2004, MAGN RESON MED, V51, P480, DOI 10.1002/mrm.20010; Nunn A D, 1997, Q J Nucl Med, V41, P155; PARK JG, 1990, CANCER RES, V50, P2773; Phillips KA, 2009, CANCER-AM CANCER SOC, V115, P5166, DOI 10.1002/cncr.24574; Sherry AD, 2008, ANNU REV BIOMED ENG, V10, P391, DOI 10.1146/annurev.bioeng.9.060906.151929; Sipkins DA, 1998, NAT MED, V4, P623, DOI 10.1038/nm0598-623; Tagliabue E, 2001, BREAST CANCER RES TR, V70, P155, DOI 10.1023/A:1012955229031; Tweedle MF, 2009, ACCOUNTS CHEM RES, V42, P958, DOI 10.1021/ar800215p; Waters EA, 2008, BASIC RES CARDIOL, V103, P114, DOI 10.1007/s00395-008-0711-6; Weinmann HJ, 2003, EUR J RADIOL, V46, P33, DOI 10.1016/S0720-048X(02)00332-7; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Wikman M, 2004, PROTEIN ENG DES SEL, V17, P455, DOI 10.1093/protein/gzh053; Yang DJ, 1998, CLIN CANCER RES, V4, P993; Yang JJ, 2008, J AM CHEM SOC, V130, P9260, DOI 10.1021/ja800736h; Yang W, 2005, J AM CHEM SOC, V127, P2085, DOI 10.1021/ja0431307; Zhu WL, 2008, MAGN RESON MED, V59, P679, DOI 10.1002/mrm.21508	29	32	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18103	10.1371/journal.pone.0018103	http://dx.doi.org/10.1371/journal.pone.0018103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455310	Green Published, Green Submitted, gold			2022-12-27	WOS:000288811500022
J	Djegbe, I; Cornelie, S; Rossignol, M; Demettre, E; Seveno, M; Remoue, F; Corbel, V				Djegbe, Innocent; Cornelie, Sylvie; Rossignol, Marie; Demettre, Edith; Seveno, Martial; Remoue, Franck; Corbel, Vincent			Differential Expression of Salivary Proteins between Susceptible and Insecticide-Resistant Mosquitoes of Culex quinquefasciatus	PLOS ONE			English	Article							ADULT FEMALE MOSQUITO; ANOPHELES-GAMBIAE; PIPIENS DIPTERA; PROBING TIME; ACETYLCHOLINESTERASE; COST; ENHANCEMENT; INFECTION; CONFER; AEDES	Background: The Culex quinquefasciatus mosquito, a major pest and vector of filariasis and arboviruses in the tropics, has developed multiple resistance mechanisms to the main insecticide classes currently available in public health. Among them, the insensitive acetylcholinesterase (ace-1(R) allele) is widespread worldwide and confers cross-resistance to organophosphates and carbamates. Fortunately, in an insecticide-free environment, this mutation is associated with a severe genetic cost that can affect various life history traits. Salivary proteins are directly involved in human-vector contact during biting and therefore play a key role in pathogen transmission. Methods and Results: An original proteomic approach combining 2D-electrophoresis and mass spectrometry was adopted to compare the salivary expression profiles of two strains of C. quinquefasciatus with the same genetic background but carrying either the ace-1(R) resistance allele or not (wild type). Four salivary proteins were differentially expressed (> 2 fold, P < 0.05) in susceptible (SLAB) and resistant (SR) mosquito strains. Protein identification indicated that the D7 long form, a major salivary protein involved in blood feeding success, presented lower expression in the resistant strain than the susceptible strain. In contrast, three other proteins, including metabolic enzymes (endoplasmin, triosephosphate isomerase) were significantly over-expressed in the salivary gland of ace-1(R) resistant mosquitoes. A catalogue of 67 salivary proteins of C. quinquefasciatus sialotranscriptome was also identified and described. Conclusion: The "resistance"-dependent expression of salivary proteins in mosquitoes may have considerable impact on biting behaviour and hence on the capacity to transmit parasites/viruses to humans. The behaviour of susceptible and insecticide-resistant mosquitoes in the presence of vertebrate hosts and its impact on pathogen transmission urgently requires further investigation.	[Djegbe, Innocent; Remoue, Franck; Corbel, Vincent] CREC, IRD, CNRS IRD UM1 5290 224, Cotonou, Benin; [Cornelie, Sylvie; Rossignol, Marie; Remoue, Franck; Corbel, Vincent] Ctr IRD, Lab Lutte Insectes Nuisibles LIN, IRD, CNRS IRD UM1 5290 224, Montpellier, France; [Demettre, Edith; Seveno, Martial] Univ Montpellier I & II, IGF, CNRS UMR 5203, INSERM U661, Montpellier, France	Entomological Research Center of Cotonou (CREC); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Djegbe, I (corresponding author), CREC, IRD, CNRS IRD UM1 5290 224, Cotonou, Benin.	djegbe1@yahoo.fr	Corbel, VIncent/G-9576-2016	cornelie, sylvie/0000-0003-3662-1450; corbel, vincent/0000-0003-0995-3257; SEVENO, Martial/0000-0002-5000-8735	IRD (Departement Soutien et Formation); French Institut de Recherche pour le Developpement (IRD); Anopheles Biology & Control (ABC) network	IRD (Departement Soutien et Formation); French Institut de Recherche pour le Developpement (IRD); Anopheles Biology & Control (ABC) network	Innocent Djegbe was supported by a fellowship provided by the IRD (Departement Soutien et Formation). This research was supported by the French Institut de Recherche pour le Developpement (IRD) and the Anopheles Biology & Control (ABC) network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2004, EVOLUTION, V58, P579, DOI 10.1111/j.0014-3820.2004.tb01680.x; Alout H, 2009, INSECT BIOCH MOL BIO; Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Berticat C, 2004, GENET RES, V83, P189, DOI 10.1017/S0016672304006792; Berticat C, 2002, GENET RES, V79, P41, DOI 10.1017/S001667230100547X; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; Bourguet D, 2004, EVOLUTION, V58, P128, DOI 10.1111/j.0014-3820.2004.tb01579.x; Bourguet D, 1997, GENETICS, V147, P1225; Calvo E, 2006, INSECT BIOCHEM MOLEC, V36, P570, DOI 10.1016/j.ibmb.2006.04.005; Champagne Donald E., 1996, P85; Choumet V, 2007, PROTEOMICS, V7, P3384, DOI 10.1002/pmic.200700334; Cui F, 2006, J MED ENTOMOL, V43, P878, DOI 10.1603/0022-2585(2006)43[878:REOIAI]2.0.CO;2; Djogbenou L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-12; Djogbenou L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002172; Dohm DJ, 2002, J MED ENTOMOL, V39, P221, DOI 10.1603/0022-2585-39.1.221; Donovan MJ, 2007, INFECT IMMUN, V75, P2523, DOI 10.1128/IAI.01928-06; Edwards JF, 1998, J MED ENTOMOL, V35, P261, DOI 10.1093/jmedent/35.3.261; GEORGHIOU GP, 1966, B WORLD HEALTH ORGAN, V35, P691; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Labbe P, 2007, MOL BIOL EVOL, V24, P1056, DOI 10.1093/molbev/msm025; Lenormand T, 1999, NATURE, V400, P861, DOI 10.1038/23685; Maxwell CA, 1999, B WORLD HEALTH ORGAN, V77; McCarroll L, 2000, NATURE, V407, P961, DOI 10.1038/35039671; Nascimento EP, 2000, ARCH INSECT BIOCHEM, V43, P9, DOI 10.1002/(SICI)1520-6327(200001)43:1&lt;9::AID-ARCH2&gt;3.0.CO;2-2; Petrak J, 2008, PROTEOMICS, V8, P1744, DOI 10.1002/pmic.200700919; Raymond M, 2001, GENETICA, V112, P287, DOI 10.1023/A:1013300108134; Ribeiro JMC, 2000, MED VET ENTOMOL, V14, P142, DOI 10.1046/j.1365-2915.2000.00227.x; Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P543, DOI 10.1016/j.ibmb.2004.02.008; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6; ROSSIGNOL PA, 1984, AM J TROP MED HYG, V33, P17, DOI 10.4269/ajtmh.1984.33.17; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi MA, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-5; Tantely ML, 2010, INSECT BIOCHEM MOLEC, V40, P317, DOI 10.1016/j.ibmb.2010.02.005; Wasinpiyamongkol L, 2010, PROTEOMICS, V10, P1906, DOI 10.1002/pmic.200900626; Weill M, 2003, M S-MED SCI, V19, P1190, DOI 10.1051/medsci/200319121190; Weill M, 2005, INSECTICIDE RESISTAN; World Health Organization, 2006, GUIDELINES FOOD FORT	39	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17496	10.1371/journal.pone.0017496	http://dx.doi.org/10.1371/journal.pone.0017496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448269	Green Published, Green Submitted, gold			2022-12-27	WOS:000288810500006
J	Foldi, CJ; Eyles, DW; McGrath, JJ; Burne, THJ				Foldi, Claire J.; Eyles, Darryl W.; McGrath, John J.; Burne, Thomas H. J.			The Effects of Breeding Protocol in C57BL/6J Mice on Adult Offspring Behaviour	PLOS ONE			English	Article							ADVANCING PATERNAL AGE; MALE GERM-CELLS; REPRODUCTIVE SUCCESS; EARLY EXPERIENCE; PRENATAL STRESS; PLUS-MAZE; ANXIETY; RISK; SCHIZOPHRENIA; EMOTIONALITY	Animal experiments have demonstrated that a wide range of prenatal exposures can impact on the behaviour of the offspring. However, there is a lack of evidence as to whether the duration of sire exposure could affect such outcomes. We compared two widely used methods for breeding offspring for behavioural studies. The first involved housing male and female C57Bl/6J mice together for a period of time (usually 10-12 days) and checking for pregnancy by the presence of a distended abdomen (Pair-housed; PH). The second involved daily introduction of female breeders to the male homecage followed by daily checks for pregnancy by the presence of vaginal plugs (Time-mated; TM). Male and female offspring were tested at 10 weeks of age on a behavioural test battery including the elevated plus-maze, hole board, light/dark emergence, forced swim test, novelty-suppressed feeding, active avoidance and extinction, tests for nociception and for prepulse inhibition (PPI) of the acoustic startle response. We found that length of sire exposure (LSE) had no significant effects on offspring behaviour, suggesting that the two breeding protocols do not differentially affect the behavioural outcomes of interest. The absence of LSE effects on the selected variables examined does not detract from the relevance of this study. Information regarding the potential influences of breeding protocol is not only absent from the literature, but also likely to be of particular interest to researchers studying the influence of prenatal manipulations on adult behaviour.	[Foldi, Claire J.; Eyles, Darryl W.; McGrath, John J.; Burne, Thomas H. J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Eyles, Darryl W.; McGrath, John J.; Burne, Thomas H. J.] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Richlands, Qld, Australia; [McGrath, John J.] Univ Queensland, Dept Psychiat, St Lucia, Qld, Australia	University of Queensland; Queensland Centre for Mental Health Research; University of Queensland	Foldi, CJ (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	t.burne@uq.edu.au	Burne, Thomas H/C-5656-2009; Foldi, Claire J/I-9400-2019; Eyles, Darryl W/X-3386-2018; McGrath, John Joseph/G-5493-2010	Burne, Thomas H/0000-0003-3502-9789; Foldi, Claire J/0000-0002-3293-8242; Eyles, Darryl W/0000-0002-5023-7095; McGrath, John Joseph/0000-0002-4792-6068	National Health and Medical Research Council of Australia [569528]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Project Grant no. 569528 from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADER R, 1963, SCIENCE, V142, P411, DOI 10.1126/science.142.3590.411; Alter MD, 2009, BIOL PSYCHIAT, V66, P1061, DOI 10.1016/j.biopsych.2009.05.026; Bredy TW, 2004, HORM BEHAV, V46, P30, DOI 10.1016/j.yhbeh.2003.09.017; Brinkworth MH, 2000, INT J ANDROL, V23, P123, DOI 10.1046/j.1365-2605.2000.00222.x; Brown AS, 2002, AM J PSYCHIAT, V159, P1528, DOI 10.1176/appi.ajp.159.9.1528; Burne THJ, 2005, BEHAV BRAIN RES, V157, P299, DOI 10.1016/j.bbr.2004.07.008; Chang T, 2007, PSYCHOPHARMACOLOGY, V191, P211, DOI 10.1007/s00213-006-0649-z; Chung S, 2005, ENDOCRINOLOGY, V146, P3202, DOI 10.1210/en.2004-1458; Crow JF, 2006, J RADIAT RES, V47, pB75, DOI 10.1269/jrr.47.B75; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; Dalman C, 2002, AM J PSYCHIAT, V159, P1591, DOI 10.1176/appi.ajp.159.9.1591; Darnaudery M, 2008, BRAIN RES REV, V57, P571, DOI 10.1016/j.brainresrev.2007.11.004; Drickamer LC, 2000, ANIM BEHAV, V59, P371, DOI 10.1006/anbe.1999.1316; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Durkin MS, 2008, AM J EPIDEMIOL, V168, P1268, DOI 10.1093/aje/kwn250; Egan CM, 2007, NAT GENET, V39, P1384, DOI 10.1038/ng.2007.19; Estanislau C, 2006, INT J DEV NEUROSCI, V24, P255, DOI 10.1016/j.ijdevneu.2006.03.001; Foldi CJ, 2010, EUR J NEUROSCI, V31, P556, DOI 10.1111/j.1460-9568.2010.07074.x; Frick KM, 2000, NEUROSCIENCE, V95, P293; GARCIAPALOMARES S, 2008, BIOL REPROD; Gilmer WS, 2003, J AFFECT DISORDERS, V75, P97, DOI 10.1016/S0165-0327(03)00046-6; Gowaty PA, 2003, ANIM BEHAV, V65, P95, DOI 10.1006/anbe.2002.2026; Hava G, 2006, DEV PSYCHOBIOL, V48, P162, DOI 10.1002/dev.20116; Holmes A, 2005, NEUROSCI BIOBEHAV R, V29, P1335, DOI 10.1016/j.neubiorev.2005.04.012; Lightfoot JT, 2004, PHYSIOL GENOMICS, V19, P270, DOI 10.1152/physiolgenomics.00125.2004; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Lundstrom S, 2010, J CHILD PSYCHOL PSYC, V51, P850, DOI 10.1111/j.1469-7610.2010.02223.x; LUPODIPRISCO C, 1978, PHYSIOL BEHAV, V20, P345, DOI 10.1016/0031-9384(78)90230-5; Malaspina D, 2005, PSYCHIAT GENET, V15, P117, DOI 10.1097/00041444-200506000-00008; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; Margulis SW, 2005, ANIM BEHAV, V69, P627, DOI 10.1016/j.anbehav.2004.04.021; Maruoka T, 2009, NEUROSCI LETT, V454, P28, DOI 10.1016/j.neulet.2009.02.052; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Oakes CC, 2007, DEV BIOL, V307, P368, DOI 10.1016/j.ydbio.2007.05.002; Pallares ME, 2007, PHYSIOL BEHAV, V92, P951, DOI 10.1016/j.physbeh.2007.06.021; PARKENING TA, 1988, J GERONTOL, V43, pB79, DOI 10.1093/geronj/43.3.B79; PORSOLT RD, 1979, BIOMEDICINE, V30, P139; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Saha S, 2009, SCHIZOPHR RES, V115, P130, DOI 10.1016/j.schres.2009.09.012; Saha S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000040; Scott J, 2010, ARCH GEN PSYCHIAT, V67, P111, DOI 10.1001/archgenpsychiatry.2009.188; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Skeer M, 2009, DRUG ALCOHOL DEPEN, V104, P65, DOI 10.1016/j.drugalcdep.2009.03.017; Smith RG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008456; Sternberg WF, 2003, PHYSIOL BEHAV, V78, P375, DOI 10.1016/S0031-9384(03)00015-5; STRONG R, 1980, NEUROBIOL AGING, V1, P59, DOI 10.1016/0197-4580(80)90025-1; Swerdlow NR, 2000, BEHAV PHARMACOL, V11, P185, DOI 10.1097/00008877-200006000-00002; WERBOFF J, 1968, PHYSIOL BEHAV, V3, P35, DOI 10.1016/0031-9384(68)90028-0; Wright SL, 2000, J COMP PSYCHOL, V114, P183, DOI 10.1037/0735-7036.114.2.183	51	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18152	10.1371/journal.pone.0018152	http://dx.doi.org/10.1371/journal.pone.0018152			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448436	Green Submitted, Green Published, gold			2022-12-27	WOS:000288810500046
J	Mhawech-Fauceglia, P; Wang, D; Kesterson, J; Syriac, S; Clark, K; Frederick, PJ; Lele, S; Liu, S				Mhawech-Fauceglia, Paulette; Wang, Dan; Kesterson, Joshua; Syriac, Susanna; Clark, Kimberly; Frederick, Peter J.; Lele, Shashikant; Liu, Song			Gene Expression Profiles in Stage I Uterine Serous Carcinoma in Comparison to Grade 3 and Grade 1 Stage I Endometrioid Adenocarcinoma	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; CYTOSKELETAL LINKING PROTEIN; CLEAR-CELL; CANCER; SYNUCLEIN; INVASION; ARCHITECTURE; METASTASIS; TUMORS; EZRIN	Background: Endometrial cancer is the most common gynecologic malignancy in the developed countries. Clinical studies have shown that early stage uterine serous carcinoma (USC) has outcomes similar to early stage high grade endometrioid adenocarcinoma (EAC-G3) than to early stage low grade endometrioid adenocarcinoma (EAC-G1). However, little is known about the origin of these different clinical outcomes. This study applied the whole genome expression profiling to explore the expression difference of stage I USC (n = 11) relative to stage I EAC-G3 (n = 11) and stage I EAC-G1 (n = 11), respectively. Methodology/Principal Finding: We found that the expression difference between USC and EAC-G3, as measured by the number of differentially expressed genes (DEGs), is consistently less than that found between USC and EAC-G1. Pathway enrichment analyses suggested that DEGs specific to USC vs. EAC-G3 are enriched for genes involved in signaling transduction, while DEGs specific to USC vs. EAC-G1 are enriched for genes involved in cell cycle. Gene expression differences for selected DEGs are confirmed by quantitative RT-PCR with a high validation rate. Conclusion: This data, although preliminary, indicates that stage I USC is genetically similar to stage I EAC-G3 compared to stage I EAC-G1. DEGs identified from this study might provide an insight in to the potential mechanisms that influence the clinical outcome differences between endometrial cancer subtypes. They might also have potential prognostic and therapeutic impacts on patients diagnosed with uterine cancer.	[Mhawech-Fauceglia, Paulette; Syriac, Susanna] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Wang, Dan; Liu, Song] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA; [Kesterson, Joshua; Frederick, Peter J.; Lele, Shashikant] Roswell Pk Canc Inst, Dept Gynecol Oncol Surg, Buffalo, NY 14263 USA; [Clark, Kimberly] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Mhawech-Fauceglia, P (corresponding author), Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA.	pmhawech1@yahoo.com; song.liu@roswellpark.org			Roswell Park Cancer Institute; NATIONAL CANCER INSTITUTE [T32CA108456] Funding Source: NIH RePORTER	Roswell Park Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by Roswell Park Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiatari I, 2010, J CELL MOL MED, V14, P1166, DOI 10.1111/j.1582-4934.2009.00772.x; Alektiar KM, 2002, INT J RADIAT ONCOL, V54, P79, DOI 10.1016/S0360-3016(02)02913-9; Benito V, 2009, INT J GYNECOL CANCER, V19, P1364, DOI 10.1111/IGC.0b013e3181b7a1d5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Chapman EJ, 2008, MOL CANCER RES, V6, P1154, DOI 10.1158/1541-7786.MCR-07-2168; Cirisano FD, 2000, GYNECOL ONCOL, V77, P55, DOI 10.1006/gyno.2000.5737; Creasman W T, 2001, J Epidemiol Biostat, V6, P47; Creasman WT, 2004, GYNECOL ONCOL, V95, P593, DOI 10.1016/j.ygyno.2004.08.019; Davies S, 2010, ANTICANCER RES, V30, P1163; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hong X, 2010, J SURG ONCOL, V101, P564, DOI 10.1002/jso.21538; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Idaghdour Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000052; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji HJ, 1997, CANCER RES, V57, P759; Jia TL, 1999, CANCER RES, V59, P742; Kitchener HC, 2009, INT J GYNECOL CANCER, V19, P134, DOI 10.1111/IGC.0b013e3181995f90; Lallemand D, 2010, PIGM CELL MELANOMA R, V23, P6, DOI 10.1111/j.1755-148X.2009.00650.x; Liu HY, 2005, CANCER RES, V65, P7635, DOI 10.1158/0008-5472.CAN-05-1089; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Mezzanzanica D, 2008, CLIN CANCER RES, V14, P1726, DOI 10.1158/1078-0432.CCR-07-0428; Moh MC, 2009, CELL ADHES MIGR, V3, P334, DOI 10.4161/cam.3.4.9246; Morgan J, 2009, GYNECOL ONCOL, V114, P293, DOI 10.1016/j.ygyno.2009.04.036; National Comprehensive Cancer Network (NCCN), 2010, CLIN PRACT GUID ONC; Naumann RW, 2008, CURR ONCOL REP, V10, P505, DOI 10.1007/s11912-008-0076-x; Ofori-Acquah SF, 2008, TRANSL RES, V151, P122, DOI 10.1016/j.trsl.2007.09.006; Ohtani K, 1999, CANCER LETT, V147, P31, DOI 10.1016/S0304-3835(99)00272-4; Ohtani K, 2002, CANCER LETT, V179, P79, DOI 10.1016/S0304-3835(01)00857-6; Oliveira-Ferrer L, 2004, CANCER RES, V64, P8932, DOI 10.1158/0008-5472.CAN-04-0505; Parris TZ, 2010, CLIN CANCER RES, V16, P3860, DOI 10.1158/1078-0432.CCR-10-0889; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soslow RA, 2007, AM J SURG PATHOL, V31, P979, DOI 10.1097/PAS.0b013e31802ee494; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Willis ND, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002988; Willis ND, 2008, BIOCHEM SOC T, V36, P1350, DOI 10.1042/BST0361350; Ye Q, 2009, WORLD J GASTROENTERO, V15, P5035, DOI 10.3748/wjg.15.5035	39	23	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18066	10.1371/journal.pone.0018066	http://dx.doi.org/10.1371/journal.pone.0018066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448288	Green Published, gold, Green Submitted			2022-12-27	WOS:000288810500031
J	Neuwald, JL; Valenzuela, N				Neuwald, Jennifer L.; Valenzuela, Nicole			The Lesser Known Challenge of Climate Change: Thermal Variance and Sex-Reversal in Vertebrates with Temperature-Dependent Sex Determination	PLOS ONE			English	Article							TURTLES CHRYSEMYS-PICTA; FLUCTUATING INCUBATION TEMPERATURES; EMBRYONIC PAINTED TURTLES; HATCHLING PHENOTYPES; NATURAL NESTS; OFFSPRING SEX; CONSTANT; RATIO; DIFFERENTIATION; ENVIRONMENTS	Climate change is expected to disrupt biological systems. Particularly susceptible are species with temperature-dependent sex determination (TSD), as in many reptiles. While the potentially devastating effect of rising mean temperatures on sex ratios in TSD species is appreciated, the consequences of increased thermal variance predicted to accompany climate change remain obscure. Surprisingly, no study has tested if the effect of thermal variance around high-temperatures (which are particularly relevant given climate change predictions) has the same or opposite effects as around lower temperatures. Here we show that sex ratios of the painted turtle (Chrysemys picta) were reversed as fluctuations increased around low and high unisexual mean-temperatures. Unexpectedly, the developmental and sexual responses around female-producing temperatures were decoupled in a more complex manner than around male-producing values. Our novel observations are not fully explained by existing ecological models of development and sex determination, and provide strong evidence that thermal fluctuations are critical for shaping the biological outcomes of climate change.	[Neuwald, Jennifer L.; Valenzuela, Nicole] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Iowa City, IA USA	Iowa State University	Neuwald, JL (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Iowa City, IA USA.	nvalenzu@iastate.edu	Neuwald, Jennifer/AAH-3468-2021	Neuwald, Jennifer/0000-0002-8850-5534; Valenzuela, Nicole/0000-0003-1148-631X	United States National Science Foundation [IOS0743284];  [IOS-0826664];  [IOS-0824550];  [IOS-0924290];  [IOS-0925486]	United States National Science Foundation(National Science Foundation (NSF)); ; ; ; 	This study was supported in part by the research grant IOS0743284 from the United States National Science Foundation and associated supplements IOS-0826664, IOS-0824550, IOS-0924290, and IOS-0925486 to Nicole Valenzuela. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrewartha SJ, 2010, PHYSIOL BIOCHEM ZOOL, V83, P597, DOI 10.1086/652245; Boer GJ, 2009, J CLIMATE, V22, P3098, DOI 10.1175/2008JCLI2835.1; BULL JJ, 1985, ECOLOGY, V66, P1115, DOI 10.2307/1939163; CAGLE KD, 1993, FUNCT ECOL, V7, P653, DOI 10.2307/2390185; CHARNOV EL, 1977, NATURE, V266, P828, DOI 10.1038/266828a0; DALLWITZ MJ, 1992, 2 CSIRO DIV ENT, P1; DEEMING DC, 1989, AM ZOOL, V29, P973; Doody JS, 2006, EVOL ECOL, V20, P307, DOI 10.1007/s10682-006-0003-2; Du WG, 2009, J THERM BIOL, V34, P250, DOI 10.1016/j.jtherbio.2009.03.002; ETCHBERGER CR, 1992, CAN J ZOOL, V70, P391, DOI 10.1139/z92-058; EWERT MA, 1991, COPEIA, P50, DOI 10.2307/1446248; EWERT MA, 1985, BIOL REPTILIA DEV A; Georges A, 2005, PHYSIOL BIOCHEM ZOOL, V78, P18, DOI 10.1086/425200; GEORGES A, 1994, J EXP ZOOL, V270, P432, DOI 10.1002/jez.1402700504; Georges Arthur, 2004, P79; GUTZKE WHN, 1987, HERPETOLOGICA, V43, P393; GUTZKE WHN, 1984, COPEIA, P546, DOI 10.2307/1445216; Hays GC, 2003, GLOBAL CHANGE BIOL, V9, P642, DOI 10.1046/j.1365-2486.2003.00606.x; Janzen FJ, 2002, J HERPETOL, V36, P308, DOI 10.1670/0022-1511(2002)036[0308:ESITAP]2.0.CO;2; JANZEN FJ, 1994, P NATL ACAD SCI USA, V91, P7487, DOI 10.1073/pnas.91.16.7487; JANZEN FJ, 1994, ECOLOGY, V75, P1593, DOI 10.2307/1939620; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Les HL, 2007, J EXP ZOOL PART A, V307A, P274, DOI 10.1002/jez.374; Les HL, 2009, PHYSIOL BIOCHEM ZOOL, V82, P105, DOI 10.1086/590263; MAHMOUD IY, 1973, J MORPHOL, V141, P269, DOI 10.1002/jmor.1051410303; Morjan CL, 2003, BEHAV ECOL SOCIOBIOL, V53, P254, DOI 10.1007/s00265-002-0570-3; MROSOVSKY N, 1992, CAN J ZOOL, V70, P530, DOI 10.1139/z92-080; Mullins MA, 2006, HERPETOLOGICA, V62, P27, DOI 10.1655/04-02.1; PACKARD GC, 1991, HERPETOLOGICA, V47, P125; Paitz RT, 2010, CAN J ZOOL, V88, P479, DOI 10.1139/Z10-020; Parrott A, 2010, ECOL MODEL, V221, P1378, DOI 10.1016/j.ecolmodel.2010.02.004; Patterson LD, 2008, CAN J ZOOL, V86, P882, DOI 10.1139/Z08-067; PIEAU C, 1982, J EXP ZOOL, V220, P353, DOI 10.1002/jez.1402200310; Sarma SSS, 2005, HYDROBIOLOGIA, V542, P315, DOI 10.1007/s10750-004-3247-2; SCHWARZKOPF L, 1985, CAN J ZOOL, V63, P2543, DOI 10.1139/z85-378; SCHWARZKOPF L, 1987, COPEIA, P53, DOI 10.2307/1446037; Souza Roselis Remor De, 1994, Journal of Herpetology, V28, P453; Sternadel LL, 2006, PHYSIOL BIOCHEM ZOOL, V79, P1069, DOI 10.1086/507662; Stouffer RJ, 2007, J CLIMATE, V20, P5455, DOI 10.1175/2007JCLI1384.1; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; Valenzuela N, 2001, EVOL ECOL RES, V3, P779; Valenzuela N, 2010, SEX DEV, V4, P39, DOI 10.1159/000277935; Valenzuela N, 2001, ECOLOGY, V82, P3010, DOI 10.2307/2679831; VALENZUELA N, 2009, PAINTED TURTLE CHRYS, DOI DOI 10.1101/PDB.EMO124; VALENZUELA N, 2009, EGG INCUBATION COLLE, DOI DOI 10.1101/PDB.PROT5238; VALENZUELA N, 2011, CHROMOSOME IN PRESS; VALENZUELA N, UNPUB; Valenzuela N., 2004, TEMPERATURE DEPENDEN; Valenzuela Nicole, 2004, P131; Warner DA, 2008, NATURE, V451, P566, DOI 10.1038/nature06519; Weisrock DW, 1999, FUNCT ECOL, V13, P94, DOI 10.1046/j.1365-2435.1999.00288.x; WILHOFT DC, 1983, J HERPETOL, V17, P38, DOI 10.2307/1563778	52	75	76	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18117	10.1371/journal.pone.0018117	http://dx.doi.org/10.1371/journal.pone.0018117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448294	gold, Green Published			2022-12-27	WOS:000288810500040
J	Heuer, A; Muller, C; Rubner, O; Hagemann, N; Strauss, B				Heuer, Andreas; Mueller, Christian; Rubner, Oliver; Hagemann, Norbert; Strauss, Bernd			Usefulness of Dismissing and Changing the Coach in Professional Soccer	PLOS ONE			English	Article								Whether a coach dismissal during the mid-season has an impact on the subsequent team performance has long been a subject of controversial scientific discussion. Here we find a clear-cut answer to this question by using a recently developed statistical framework for the team fitness and by analyzing the first two moments of the effect of a coach dismissal. We can show with an unprecedented small statistical error for the German soccer league that dismissing the coach within the season has basically no effect on the subsequent performance of a team. Changing the coach between two seasons has no effect either. Furthermore, an upper bound for the actual influence of the coach on the team fitness can be estimated. Beyond the immediate relevance of this result, this study may lead the way to analogous studies for exploring the effect of managerial changes, e. g., in economic terms.	[Heuer, Andreas; Rubner, Oliver] Univ Munster, Inst Phys Chem, D-4400 Munster, Germany; [Mueller, Christian] Univ Munster, Inst Organ Chem, D-4400 Munster, Germany; [Hagemann, Norbert] Univ Kassel, Inst Sports Sci, Kassel, Germany; [Strauss, Bernd] Univ Munster, Inst Sports Sci, D-4400 Munster, Germany	University of Munster; University of Munster; Universitat Kassel; University of Munster	Heuer, A (corresponding author), Univ Munster, Inst Phys Chem, Schlosspl 4, D-4400 Munster, Germany.	andheuer@uni-muenster.de		Hagemann, Norbert/0000-0002-7721-7916; Strauss, Bernd/0000-0003-1438-6322				[Anonymous], 2000, EUROPEAN J SPORT MAN; Audas R., 1997, Economic Affairs (London), V17, P30, DOI 10.1111/1468-0270.00039; Audas R., 2002, J ECON BUS, V54, P633, DOI [https://doi.org/10.1016/S0148-6195(02)00120-0, DOI 10.1016/S0148-6195(02)00120-0]; Barros CP, 2009, APPL ECON, V41, P3303, DOI 10.1080/00036840701721455; Breuer C., 1996, LEISTUNGSSPORT, V4, P41; Bruinshoofd A, 2003, EUR J OPER RES, V148, P233, DOI 10.1016/S0377-2217(02)00680-X; Carron A.V., 2005, GROUP DYNAMICS SPORT; Cohen J., 1988, STAT POWER ANAL BEHA; Tena JD, 2007, EUR J OPER RES, V181, P362, DOI 10.1016/j.ejor.2006.05.024; Dobson S., 2001, EC FOOTBALL, V1st ed.; Frick B, 2010, EUR J OPER RES, V200, P151, DOI 10.1016/j.ejor.2008.11.048; GAMSON WA, 1964, AM J SOCIOL, V70, P69, DOI 10.1086/223739; Heuer A, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/38007; Heuer A, 2009, EUR PHYS J B, V67, P445, DOI 10.1140/epjb/e2009-00024-8; Koning RH, 2003, APPL ECON, V35, P555, DOI 10.1080/0003684022000015946; Simmons R., 2004, INT SPORTS EC COMP, P123; TIPPENHAUER A, 2003, SPORT GOES MEDIA; Van Dalen H. P., 1994, EC STAT BERICHTEN, V79, P1089	18	28	28	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17664	10.1371/journal.pone.0017664	http://dx.doi.org/10.1371/journal.pone.0017664			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	740QI	21445335	Green Submitted, gold, Green Published			2022-12-27	WOS:000288809100006
J	Hojyo, S; Fukada, T; Shimoda, S; Ohashi, W; Bin, BH; Koseki, H; Hirano, T				Hojyo, Shintaro; Fukada, Toshiyuki; Shimoda, Shinji; Ohashi, Wakana; Bin, Bum-Ho; Koseki, Haruhiko; Hirano, Toshio			The Zinc Transporter SLC39A14/ZIP14 Controls G-Protein Coupled Receptor-Mediated Signaling Required for Systemic Growth	PLOS ONE			English	Article							HORMONE (PTH)/PTH-RELATED PEPTIDE; LIV-1 SUBFAMILY; ACRODERMATITIS-ENTEROPATHICA; CHONDROCYTE DIFFERENTIATION; PLATE; GENE; HOMEOSTASIS; EXPRESSION; BONE; INSULIN	Aberrant zinc (Zn) homeostasis is associated with abnormal control of mammalian growth, although the molecular mechanisms of Zn's roles in regulating systemic growth remain to be clarified. Here we report that the cell membrane-localized Zn transporter SLC39A14 controls G-protein coupled receptor (GPCR)-mediated signaling. Mice lacking Slc39a14 (Slc39a14-KO mice) exhibit growth retardation and impaired gluconeogenesis, which are attributable to disrupted GPCR signaling in the growth plate, pituitary gland, and liver. The decreased signaling is a consequence of the reduced basal level of cyclic adenosine monophosphate ( cAMP) caused by increased phosphodiesterase (PDE) activity in Slc39a14-KO cells. We conclude that SLC39A14 facilitates GPCR-mediated cAMP-CREB signaling by suppressing the basal PDE activity, and that this is one mechanism for Zn's involvement in systemic growth processes. Our data highlight SLC39A14 as an important novel player in GPCR-mediated signaling. In addition, the Slc39a14-KO mice may be useful for studying the GPCR-associated regulation of mammalian systemic growth.	[Hojyo, Shintaro; Fukada, Toshiyuki; Ohashi, Wakana; Bin, Bum-Ho; Hirano, Toshio] RIKEN Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Kanagawa, Japan; [Hojyo, Shintaro; Fukada, Toshiyuki] Osaka Univ, Grad Sch Med, Dept Allergy & Immunol, Osaka, Japan; [Shimoda, Shinji] Tsurumi Univ, Sch Dent Med, Dept Anat 1, Kanagawa, Japan; [Koseki, Haruhiko] RIKEN Res Ctr Allergy & Immunol, Lab Dev Genet, Kanagawa, Japan; [Bin, Bum-Ho; Hirano, Toshio] Osaka Univ, JST CREST, Grad Sch Med, Lab Dev Immunol,Grad Sch Frontier Biosci, Osaka, Japan; [Bin, Bum-Ho; Hirano, Toshio] Osaka Univ, WPI Immunol Frontier Res Ctr, Osaka, Japan	RIKEN; Osaka University; Tsurumi University; RIKEN; Osaka University; Osaka University	Hojyo, S (corresponding author), RIKEN Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Kanagawa, Japan.	hirano@molonc.med.osaka-u.ac.jp	Koseki, Haruhiko/I-3825-2014	Koseki, Haruhiko/0000-0001-8424-5854	KAKENHI [20249030]; JST-CREST	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by KAKENHI (#20249030) and the JST-CREST program (http://www.jst.go.jp/kisoken/crest/en/area03/2-05.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GJ, 2005, SEMIN LIVER DIS, V25, P420, DOI 10.1055/s-2005-923314; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; Brand IA, 1996, J BIOL CHEM, V271, P1941, DOI 10.1074/jbc.271.4.1941; Bruinsma JJ, 2002, DEV CELL, V2, P567, DOI 10.1016/S1534-5807(02)00151-X; Chung UI, 1998, P NATL ACAD SCI USA, V95, P13030, DOI 10.1073/pnas.95.22.13030; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Cousins RJ, 1996, PRESENT KNOWLEDGE NU, V7th, P293; Dufner-Beattie J, 2006, GENESIS, V44, P239, DOI 10.1002/dvg.20211; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Georgiev P, 2010, CELL METAB, V12, P386, DOI 10.1016/j.cmet.2010.08.012; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; GUO J, 1995, ENDOCRINOLOGY, V136, P3884, DOI 10.1210/en.136.9.3884; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hirano T, 2008, ADV IMMUNOL, V97, P149, DOI 10.1016/S0065-2776(08)00003-5; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Huang LP, 2005, J BIOL CHEM, V280, P15456, DOI 10.1074/jbc.M412188200; Ionescu AM, 2001, J BIOL CHEM, V276, P11639, DOI 10.1074/jbc.M006564200; Joyner AL, 2000, GENE TARGETING PRACT; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kasper G, 2005, INT J CANCER, V117, P961, DOI 10.1002/ijc.21235; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; MAYO KE, 1995, RECENT PROG HORM RES, V50, P35; Milon B, 2001, FEBS LETT, V507, P241, DOI 10.1016/S0014-5793(01)02950-7; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; Nishida K, 2009, J EXP MED, V206, P1351, DOI 10.1084/jem.20082533; Ohlsson C, 1998, ENDOCR REV, V19, P55, DOI 10.1210/er.19.1.55; Ovesen J., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P428; Percival MD, 1997, BIOCHEM BIOPH RES CO, V241, P175, DOI 10.1006/bbrc.1997.7542; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; PRASAD AS, 1995, NUTRITION, V11, P93; Procter AM, 1998, HUM GENET, V103, P255, DOI 10.1007/s004390050815; Rossi L, 2001, J NUTR, V131, P1142, DOI 10.1093/jn/131.4.1142; Sakharova AA, 2008, J CLIN ENDOCR METAB, V93, P2755, DOI 10.1210/jc.2008-0079; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; STRUTHERS RS, 1991, NATURE, V350, P622, DOI 10.1038/350622a0; Taylor KM, 2005, FEBS LETT, V579, P427, DOI 10.1016/j.febslet.2004.12.006; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183; Taylor KM, 2003, BIOCHEM J, V375, P51, DOI 10.1042/BJ20030478; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; VALLEE BL, 1995, NEUROCHEM INT, V27, P23, DOI 10.1016/0197-0186(94)00165-Q; VALLEE BL, 1993, BIOCHEMISTRY-US, V32, P6493, DOI 10.1021/bi00077a001; von Bulow V, 2005, J IMMUNOL, V175, P4697, DOI 10.4049/jimmunol.175.7.4697; Wang FD, 2004, HUM MOL GENET, V13, P563, DOI 10.1093/hmg/ddh049; Wang J, 1999, FASEB J, V13, P1985, DOI 10.1096/fasebj.13.14.1985; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yoshida E, 2001, EXP CELL RES, V265, P64, DOI 10.1006/excr.2001.5161; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	60	122	123	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18059	10.1371/journal.pone.0018059	http://dx.doi.org/10.1371/journal.pone.0018059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445361	gold, Green Published, Green Submitted			2022-12-27	WOS:000288809100026
J	Giret, MTM; Miraglia, JL; Sucupira, MCA; Nishiya, A; Levi, JE; Diaz, RS; Sabino, EC; Kallas, EG				Giret, Maria Teresa M.; Miraglia, Joao Luiz; Araripe Sucupira, Maria Cecilia; Nishiya, Anna; Levi, Jose Eduardo; Diaz, Ricardo S.; Sabino, Ester C.; Kallas, Esper G.			Prevalence, Incidence Density, and Genotype Distribution of GB Virus C Infection in a Cohort of Recently HIV-1-Infected Subjects in Sao Paulo, Brazil	PLOS ONE			English	Article							HEPATITIS-G VIRUS; C/HEPATITIS-G-VIRUS; EARLY HIV-1 INFECTION; ANTIRETROVIRAL THERAPY; PHYLOGENETIC ANALYSIS; DISEASE PROGRESSION; REGION SEQUENCES; NONCODING REGION; BLOOD-DONORS; NO INFLUENCE	Background: The results of previous studies elsewhere have indicated that GB virus C (GBV-C) infection is frequent in patients infected with the human immunodeficiency virus type 1 (HIV-1) due to similar transmission routes of both viruses. The aim of this study was to determine the prevalence, incidence density and genotypic characteristics of GBV-C in this population. Methodology/Principal Findings: The study population included 233 patients from a cohort primarily comprised of homosexual men recently infected with HIV-1 in Sao Paulo, Brazil. The presence of GBV-C RNA was determined in plasma samples by reverse transcriptase-nested polymerase chain reaction and quantified by real-time PCR. GBV-C genotypes were determined by direct sequencing. HIV viral load, CD4+ T lymphocyte and CD8+ T lymphocyte count were also tested in all patients. The overall prevalence of GBV-C infection was 0.23 (95% CI: 0.18 to 0.29) in the study group. There was no significant difference between patients with and without GBV-C infection and Glycoprotein E2 antibody presence regarding age, sex, HIV-1 viral load, CD4+ and CD8+ T cell counts and treatment with antiretroviral drugs. An inverse correlation was observed between GBV-C and HIV-1 loads at enrollment and after one year. Also, a positive but not significant correlation was observed between GBV-C load and CD4+ T lymphocyte. Phylogenetic analysis of the GBV-C isolates revealed the presence of genotype 1 and genotype 2, these sub classified into subtype 2a and 2b. Conclusion/Significance: GBV-C infection is common in recently HIV -1 infected patients in Sao Paulo, Brazil and the predominant genotype is 2b. This study provides the first report of the GBV-C prevalence at the time of diagnosis of HIV-1 and the incidence density of GBV-C infection in one year.	[Giret, Maria Teresa M.; Miraglia, Joao Luiz; Kallas, Esper G.] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Araripe Sucupira, Maria Cecilia; Diaz, Ricardo S.] Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil; [Nishiya, Anna; Sabino, Ester C.] Sao Paulo Blood Bank, Sao Paulo, Brazil; [Levi, Jose Eduardo] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Giret, MTM (corresponding author), Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil.	esper.kallas@gmail.com	Kallas, Esper G/C-9539-2012; Sabino, Ester C/F-7750-2010; Araripe Sucupira, Maria Cecilia/K-1931-2012; Nishiya, Anna/Q-8156-2016; Diaz, Ricardo/K-3978-2012; Miraglia, Joao/H-5294-2013	Sabino, Ester C/0000-0003-2623-5126; Araripe Sucupira, Maria Cecilia/0000-0002-1114-5382; Kallas, Esper/0000-0003-2026-6925; Miraglia, Joao Luiz/0000-0002-4788-6254	Ministry of Health [914/BRA/3014-UNESCO/Kallas]; Sao Paulo City Health Department [2004-0.168.922-7/Kallas]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [04/15856-9/Diaz, Sabino Kallas, 05/01072-9/Levi]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazilian Ministry of Education	Ministry of Health; Sao Paulo City Health Department; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazilian Ministry of Education(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported with funding from the Brazilian Program for STD and AIDS, Ministry of Health (914/BRA/3014-UNESCO/Kallas), the Sao Paulo City Health Department (2004-0.168.922-7/Kallas), and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (04/15856-9/Diaz, Sabino & Kallas; and 05/01072-9/Levi). T.M.G. was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazilian Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1997, NEW ENGL J MED, V336, P741, DOI 10.1056/NEJM199703133361101; Barbosa AD, 2009, REV SOC BRAS MED TRO, V42, P591, DOI 10.1590/S0037-86822009000500021; Barbour JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001080; Berzsenyi MD, 2007, GASTROENTEROLOGY, V133, P1821, DOI 10.1053/j.gastro.2007.08.076; Berzsenyi MD, 2005, J CLIN VIROL, V33, P257, DOI 10.1016/j.jcv.2005.04.002; Birk M, 2002, AIDS, V16, P2482, DOI 10.1097/00002030-200212060-00017; Bjorkman P, 2004, AIDS, V18, P877, DOI [10.1097/01.aids.0000125908.52357.4c, 10.1097/00002030-200404090-00005]; Branco C, 2010, J MED VIROL, V82, P452, DOI 10.1002/jmv.21703; Brumme ZL, 2002, AIDS, V16, P1929, DOI 10.1097/00002030-200209270-00010; Compston LI, 2009, J MED VIROL, V81, P1860, DOI 10.1002/jmv.21614; Gallian P, 1998, J MED VIROL, V56, P310, DOI 10.1002/(SICI)1096-9071(199812)56:4&lt;310::AID-JMV4&gt;3.0.CO;2-4; George SL, 2006, J INFECT DIS, V193, P451, DOI 10.1086/499435; Hammad AM, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-36; Handajani R, 2000, J CLIN MICROBIOL, V38, P662, DOI 10.1128/JCM.38.2.662-668.2000; Heringlake S, 1998, J INFECT DIS, V177, P1723, DOI 10.1086/517431; Hosseini-Moghaddam SM, 2008, J MED VIROL, V80, P1260, DOI 10.1002/jmv.21161; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Jarvis LM, 1996, LANCET, V348, P1352, DOI 10.1016/S0140-6736(96)04041-X; Kallas Esper Georges, 2004, Braz J Infect Dis, V8, P399, DOI 10.1590/S1413-86702004000600003; Katayama K, 1998, ARCH VIROL, V143, P1063, DOI 10.1007/s007050050356; Lampe E, 1998, J MED VIROL, V56, P39, DOI 10.1002/(SICI)1096-9071(199809)56:1&lt;39::AID-JMV7&gt;3.0.CO;2-O; Lampe E, 1997, J MED VIROL, V52, P61, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;61::AID-JMV10&gt;3.0.CO;2-3; Lau DTY, 1999, J INFECT DIS, V180, P1334, DOI 10.1086/315031; Leao GC, 2007, JPN J CLIN ONCOL, V37, P632, DOI 10.1093/jjco/hym063; Levi José Eduardo, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P75, DOI 10.1590/S0036-46652003000200004; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; Loureiro CL, 2002, J MED VIROL, V68, P357, DOI 10.1002/jmv.10211; Lyra AC, 2005, BRAZ J MED BIOL RES, V38, P767, DOI 10.1590/S0100-879X2005000500015; Maidana Maria Teresa, 2005, Braz J Infect Dis, V9, P122, DOI 10.1590/S1413-86702005000200001; Maidana-Giret MT, 2009, AIDS, V23, P2277, DOI 10.1097/QAD.0b013e32832d7a11; Massud I, 2002, MEDICINA-BUENOS AIRE, V62, P173; *MIN SAUD SECR VIG, ANT THER REC HIV INF; Muerhoff AS, 2006, J MED VIROL, V78, P105, DOI 10.1002/jmv.20510; Muerhoff AS, 2003, J MED VIROL, V70, P141, DOI 10.1002/jmv.10375; MUERHOFF AS, 1995, J VIROL, V69, P5621, DOI 10.1128/JVI.69.9.5621-5630.1995; Muerhoff AS, 1996, J HEPATOL, V25, P379, DOI 10.1016/S0168-8278(96)80125-5; Muerhoff AS, 1997, J VIROL, V71, P6501, DOI 10.1128/JVI.71.9.6501-6508.1997; Mukaide M, 1997, FEBS LETT, V407, P51, DOI 10.1016/S0014-5793(97)00136-1; Naito H, 1999, J CLIN MICROBIOL, V37, P1217, DOI 10.1128/JCM.37.4.1217-1220.1999; Naito H, 2001, J VIROL METHODS, V91, P3, DOI 10.1016/S0166-0934(00)00207-X; Nishiya Anna S., 2003, Rev. Inst. Med. trop. S. Paulo, V45, P213, DOI 10.1590/S0036-46652003000400007; Okamoto H, 1997, J GEN VIROL, V78, P737, DOI 10.1099/0022-1317-78-4-737; Oliveira LA, 2002, MEM I OSWALDO CRUZ, V97, P953, DOI 10.1590/S0074-02762002000700005; Pereira LMMB, 2002, J MED VIROL, V67, P27, DOI 10.1002/jmv.2188; Pinho J. R. R., 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P243, DOI 10.1590/S0036-46651996000300016; Pinho Joao Renato Rebello, 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P441, DOI 10.1590/S0036-46651996000600010; Pinho JRR, 1999, J CLIN MICROBIOL, V37, P1634, DOI 10.1128/JCM.37.5.1634-1637.1999; Quiros-Roldan E, 2002, AIDS, V16, P1430, DOI 10.1097/00002030-200207050-00019; Ramezani A, 2008, J GASTROINTEST LIVER, V17, P269; Ramezani A, 2008, INT J INFECT DIS, V12, P57, DOI 10.1016/j.ijid.2007.04.010; Ramos R, 2004, MEM I OSWALDO CRUZ, V99, P639, DOI 10.1590/S0074-02762004000600019; Rey D, 2000, EUR J CLIN MICROBIOL, V19, P721, DOI 10.1007/s100960000352; Ribeiro-dos-Santos G, 2002, EUR J CLIN MICROBIOL, V21, P438, DOI 10.1007/s10096-002-0752-y; Ryt-Hansen R, 2006, AIDS RES HUM RETROV, V22, P496, DOI 10.1089/aid.2006.22.496; Sa D, 2007, AIDS RES HUM RETROV, V23, P1087, DOI 10.1089/aid.2006.0173; Sathar MA, 2004, CLIN INFECT DIS, V38, P405, DOI 10.1086/381092; SCHLAUDER GG, 1995, LANCET, V346, P447, DOI 10.1016/S0140-6736(95)92821-9; Schwarze-Zander C, 2006, J INFECT DIS, V194, P410, DOI 10.1086/505713; SIMONS JN, 1995, P NATL ACAD SCI USA, V92, P3401, DOI 10.1073/pnas.92.8.3401; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Smith DB, 1997, J GEN VIROL, V78, P1533, DOI 10.1099/0022-1317-78-7-1533; Souza IE, 2006, HIV MED, V7, P25, DOI 10.1111/j.1468-1293.2005.00339.x; STAPLETON JT, 2010, J GEN VIROL; Supapol WB, 2008, J INFECT DIS, V197, P1369, DOI 10.1086/587488; Supapol WB, 2011, J MED VIROL, V83, P33, DOI 10.1002/jmv.21946; Thomas DL, 1998, J INFECT DIS, V177, P539, DOI 10.1086/514245; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; Tucker TJ, 1999, J MED VIROL, V59, P52, DOI 10.1002/(SICI)1096-9071(199909)59:1&lt;52::AID-JMV9&gt;3.0.CO;2-D; Van der Bij AK, 2005, J INFECT DIS, V191, P678, DOI 10.1086/427559; Watanabe MAE, 2003, RENAL FAILURE, V25, P67, DOI 10.1081/JDI-120017469; Weng HY, 2009, AM J EPIDEMIOL, V169, P1182, DOI 10.1093/aje/kwp035; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Xiang JH, 2000, J VIROL, V74, P9125, DOI 10.1128/JVI.74.19.9125-9133.2000	74	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18407	10.1371/journal.pone.0018407	http://dx.doi.org/10.1371/journal.pone.0018407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483671	gold, Green Submitted, Green Published			2022-12-27	WOS:000289191300021
J	Ma, ZH; Lavebratt, C; Almgren, M; Portwood, N; Forsberg, LE; Branstrom, R; Berglund, E; Falkmer, S; Sundler, F; Wierup, N; Bjorklund, A				Ma, Zuheng; Lavebratt, Catharina; Almgren, Malin; Portwood, Neil; Forsberg, Lars E.; Branstrom, Robert; Berglund, Erik; Falkmer, Sture; Sundler, Frank; Wierup, Nils; Bjorklund, Anneli			Evidence for Presence and Functional Effects of Kv1.1 Channels in beta-Cells: General Survey and Results from mceph/mceph Mice	PLOS ONE			English	Article							GATED POTASSIUM CHANNEL; K+ CHANNELS; EXPRESSION; SECRETION; BRAIN; MOUSE	Background: Voltage-dependent K+ channels (Kv) mediate repolarisation of beta-cell action potentials, and thereby abrogate insulin secretion. The role of the Kv1.1 K+ channel in this process is however unclear. We tested for presence of Kv1.1 in different species and tested for a functional role of Kv1.1 by assessing pancreatic islet function in BALB/cByJ (wild-type) and megencephaly (mceph/mceph) mice, the latter having a deletion in the Kv1.1 gene. Methodology/Principal Findings: Kv1.1 expression was detected in islets from wild-type mice, SD rats and humans, and expression of truncated Kv1.1 was detected in mceph/mceph islets. Full-length Kv1.1 protein was present in islets from wildtype mice, but, as expected, not in those from mceph/mceph mice. Kv1.1 expression was localized to the beta-cell population and also to alpha-and delta-cells, with evidence of over-expression of truncated Kv1.1 in mceph/mceph islets. Blood glucose, insulin content, and islet morphology were normal in mceph/mceph mice, but glucose-induced insulin release from batch-incubated islets was (moderately) higher than that from wild-type islets. Reciprocal blocking of Kv1.1 by dendrotoxin-K increased insulin secretion from wild-type but not mceph/mceph islets. Glucose-induced action potential duration, as well as firing frequency, was increased in mceph/mceph mouse beta-cells. This duration effect on action potential in beta-cells from mceph/mceph mice was mimicked by dendrotoxin-K in beta-cells from wild-type mice. Observations concerning the effects of both the mceph mutation, and of dendrotoxin-K, on glucose-induced insulin release were confirmed in pancreatic islets from Kv1.1 null mice. Conclusion/Significance: Kv1.1 channels are expressed in the beta-cells of several species, and these channels can influence glucose-stimulated insulin release.	[Ma, Zuheng; Lavebratt, Catharina; Almgren, Malin; Portwood, Neil; Forsberg, Lars E.; Branstrom, Robert; Berglund, Erik; Bjorklund, Anneli] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Falkmer, Sture] Ryhov Hosp, Lab Pathol & Clin Cytol, Jonkoping, Sweden; [Sundler, Frank; Wierup, Nils] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Karolinska Institutet; Karolinska University Hospital; Lund University	Ma, ZH (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	anneli.bjorklund@ki.se		Berglund, Erik/0000-0001-7049-7348; Ma, Zuheng/0000-0003-1186-9396; Branstrom, Robert/0000-0001-6245-7223; Lavebratt, Catharina/0000-0003-4987-2718	Swedish Research Council; Swedish Society of Medicine; Karolinska Institutet; Magnus Bergwall Foundation; Fredrik and Ingrid Thuring Foundation; Ragnhild and Einar Lundstrom Foundation; Ake Wiberg Foundation; Loo Foundation and Hans Osterman Foundation; NovoNordisk Foundation; Royal Physiographic Society in Lund; Gyllenstiernska Krapperup Foundation; Tore Nilsson Foundation; Albert Pahlson Foundation; Ahlen Foundation; Foundation for Clinical Cancer Research in Jokoping	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Karolinska Institutet(Karolinska Institutet); Magnus Bergwall Foundation; Fredrik and Ingrid Thuring Foundation; Ragnhild and Einar Lundstrom Foundation; Ake Wiberg Foundation; Loo Foundation and Hans Osterman Foundation; NovoNordisk Foundation(Novo Nordisk Foundation); Royal Physiographic Society in Lund; Gyllenstiernska Krapperup Foundation; Tore Nilsson Foundation; Albert Pahlson Foundation; Ahlen Foundation; Foundation for Clinical Cancer Research in Jokoping	The authors thank the Swedish Research Council, the Swedish Society of Medicine, Funds of Karolinska Institutet, the Magnus Bergwall, the Fredrik and Ingrid Thuring, the Ragnhild and Einar Lundstrom, Ake Wiberg, the Loo and Hans Osterman Foundations, the NovoNordisk Foundation, the Royal Physiographic Society in Lund, the Gyllenstiernska Krapperup, the Tore Nilsson, Albert Pahlson, Ahlen Foundations as well as the Foundation for Clinical Cancer Research in Jokoping. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETSHOLTZ C, 1990, FEBS LETT, V263, P121, DOI 10.1016/0014-5793(90)80719-Y; BJORKLUND A, 1993, ENDOCRINOLOGY, V132, P1319, DOI 10.1210/en.132.3.1319; Diez M, 2003, EUR J NEUROSCI, V18, P3218, DOI 10.1111/j.1460-9568.2003.02994.x; Donahue LR, 1996, MAMM GENOME, V7, P871, DOI 10.1007/s003359900259; Escobar LI, 2004, AM J PHYSIOL-CELL PH, V286, pC965, DOI 10.1152/ajpcell.00074.2003; GRILL V, 1981, DIABETOLOGIA, V20, P495, DOI 10.1007/BF00253414; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hatton WJ, 2001, J PHYSIOL-LONDON, V533, P315, DOI 10.1111/j.1469-7793.2001.0315a.x; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; London B, 1998, P NATL ACAD SCI USA, V95, P2926, DOI 10.1073/pnas.95.6.2926; MacDonald PE, 2003, DIABETOLOGIA, V46, P1046, DOI 10.1007/s00125-003-1159-8; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; Misonou H, 2004, CRIT REV BIOCHEM MOL, V39, P125, DOI 10.1080/10409230490475417; Ozmen L, 2002, DIABETES, V51, P1779, DOI 10.2337/diabetes.51.6.1779; Persson AS, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-10; Persson AS, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-65; Petersson S, 2003, EUR J NEUROSCI, V18, P3231, DOI 10.1111/j.1460-9568.2003.03044.x; Robertson B, 1996, FEBS LETT, V383, P26, DOI 10.1016/0014-5793(96)00211-6; Roe MW, 1996, J BIOL CHEM, V271, P32241, DOI 10.1074/jbc.271.50.32241; Yan LZ, 2004, DIABETES, V53, P597, DOI 10.2337/diabetes.53.3.597	22	5	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18213	10.1371/journal.pone.0018213	http://dx.doi.org/10.1371/journal.pone.0018213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483673	Green Submitted, Green Published, gold			2022-12-27	WOS:000289191300012
J	Brauer, PM; Zheng, Y; Evans, MD; Dominguez-Brauer, C; Peehl, DM; Tyner, AL				Brauer, Patrick M.; Zheng, Yu; Evans, Mark D.; Dominguez-Brauer, Carmen; Peehl, Donna M.; Tyner, Angela L.			The Alternative Splice Variant of Protein Tyrosine Kinase 6 Negatively Regulates Growth and Enhances PTK6-Mediated Inhibition of beta-Catenin	PLOS ONE			English	Article							BREAST-TUMOR KINASE; PROSTATE-CANCER; GASTROINTESTINAL-TRACT; ANDROGEN RECEPTOR; OXIDATIVE STRESS; DISTINCT FAMILY; SMALL-INTESTINE; CELL FACTOR; BRK; EXPRESSION	Protein tyrosine kinase 6 (PTK6), also called breast tumor kinase (BRK), is expressed in epithelial cells of various tissues including the prostate. Previously it was shown that PTK6 is localized to epithelial cell nuclei in normal prostate, but becomes cytoplasmic in human prostate tumors. PTK6 is also primarily cytoplasmic in the PC3 prostate adenocarcinoma cell line. Sequencing revealed expression of wild type full-length PTK6 transcripts in addition to an alternative transcript lacking exon 2 in PC3 cells. The alternative transcript encodes a 134 amino acid protein, referred to here as ALT-PTK6, which shares the first 77 amino acid residues including the SH3 domain with full length PTK6. RT-PCR was used to show that ALT-PTK6 is coexpressed with full length PTK6 in established human prostate and colon cell lines, as well as in primary cell lines derived from human prostate tissue and tumors. Although interaction between full-length PTK6 and ALT-PTK6 was not detected, ALT-PTK6 associates with the known PTK6 substrates Sam68 and beta-catenin in GST pull-down assays. Coexpression of PTK6 and ALT-PTK6 led to suppression of PTK6 activity and reduced association of PTK6 with tyrosine phosphorylated proteins. While ALT-PTK6 alone did not influence beta-catenin/TCF transcriptional activity in a luciferase reporter assay, it enhanced PTK6-mediated inhibition of beta-catenin/TCF transcription by promoting PTK6 nuclear functions. Ectopic expression of ALT-PTK6 led to reduced expression of the beta-catenin/TCF targets Cyclin D1 and c-Myc in PC3 cells. Expression of tetracycline-inducible ALT-PTK6 blocked the proliferation and colony formation of PC3 cells. Our findings suggest that ALT-PTK6 is able to negatively regulate growth and modulate PTK6 activity, protein-protein associations and/or subcellular localization. Fully understanding functions of ALT-PTK6 and its impact on PTK6 signaling will be critical for development of therapeutic strategies that target PTK6 in cancer.	[Brauer, Patrick M.; Zheng, Yu; Evans, Mark D.; Dominguez-Brauer, Carmen; Tyner, Angela L.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Peehl, Donna M.] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Stanford University	Brauer, PM (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.	atyner@uic.edu		Tyner, Angela/0000-0001-7448-8625	National Institutes of Health [DK044525, DK068503]; Department of Defense (DOD) [81XWH-05-1-0111, W81XWH-06-1-000]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK044525, R01DK044525, R01DK068503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DOD)(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK044525 and DK068503 (A.L.T.), and Department of Defense (DOD) grant 81XWH-05-1-0111 (D.P.). P.M.B. was supported by a DOD Predoctoral Traineeship Award, Army W81XWH-06-1-000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; Beildeck ME, 2010, EXP CELL RES, V316, P1763, DOI 10.1016/j.yexcr.2010.02.001; Brauer PM, 2010, CELL CYCLE, V9, P4190, DOI 10.4161/cc.9.20.13518; Brauer PM, 2010, BBA-REV CANCER, V1806, P66, DOI 10.1016/j.bbcan.2010.02.003; Brignatz C, 2009, MOL CELL BIOL, V29, P6438, DOI 10.1128/MCB.00398-09; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; CHAN E, 2010, INT J CANC; Chen TP, 1999, MOL BIOL CELL, V10, P3015, DOI 10.1091/mbc.10.9.3015; Cohen CD, 2005, J AM SOC NEPHROL, V16, P1958, DOI 10.1681/ASN.2005020204; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; Derry JJ, 2003, ONCOGENE, V22, P4212, DOI 10.1038/sj.onc.1206465; Dominguez-Brauer C, 2009, EMBO REP, V10, P1036, DOI 10.1038/embor.2009.139; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Greco-Stewart VS, 2006, VIROLOGY, V356, P35, DOI 10.1016/j.virol.2006.06.040; Haegebarth A, 2005, CELL CYCLE, V4, P1239, DOI 10.4161/cc.4.9.1965; Haegebarth A, 2004, J BIOL CHEM, V279, P54398, DOI 10.1074/jbc.M409579200; Haegebarth A, 2006, MOL CELL BIOL, V26, P4949, DOI 10.1128/MCB.01901-05; Haegebarth A, 2009, GASTROENTEROLOGY, V137, P945, DOI 10.1053/j.gastro.2009.05.054; Harvey AJ, 2009, AM J PATHOL, V175, P1226, DOI 10.2353/ajpath.2009.080811; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; IRIE HY, PLOS ONE, V5; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Kasprzycka M, 2006, AM J PATHOL, V168, P1631, DOI 10.2353/ajpath.2006.050521; Kim HI, 2007, BIOCHEM BIOPH RES CO, V362, P829, DOI 10.1016/j.bbrc.2007.08.055; Kim HI, 2009, J BIOCHEM, V146, P133, DOI 10.1093/jb/mvp050; Ko S, 2009, BIOCHEM BIOPH RES CO, V384, P236, DOI 10.1016/j.bbrc.2009.04.103; Lee HY, 1998, MOL CELLS, V8, P401; LEE ST, 1993, ONCOGENE, V8, P3403; Llor X, 1999, CLIN CANCER RES, V5, P1767; Lukong KE, 2009, CELL SIGNAL, V21, P1415, DOI 10.1016/j.cellsig.2009.04.008; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Mitchell PJ, 1997, ONCOGENE, V15, P1497, DOI 10.1038/sj.onc.1201292; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; OSTRANDER JH, 2010, CURR OPIN PHARM; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Palka-Hamblin HL, 2010, J CELL SCI, V123, P236, DOI 10.1242/jcs.053264; Paronetto MP, 2010, CANCER RES, V70, P229, DOI 10.1158/0008-5472.CAN-09-2788; PASCO MY, 2010, NEUROBIOL DIS; Peehl DM, 2005, ENDOCR-RELAT CANCER, V12, P19, DOI 10.1677/erc.1.00795; PEEHL DM, 1992, CULTURE EPITHELIAL C, P159; Petro BJ, 2004, ORAL ONCOL, V40, P1040, DOI 10.1016/j.oraloncology.2004.05.010; Playford MP, 2000, P NATL ACAD SCI USA, V97, P12103, DOI 10.1073/pnas.210394297; Qiu HQ, 2005, ONCOGENE, V24, P5656, DOI 10.1038/sj.onc.1208721; Qiu HQ, 2002, J BIOL CHEM, V277, P34634, DOI 10.1074/jbc.M203877200; Rasband W., 2006, IMAGEJ; Robertson BW, 2010, EXP CELL RES, V316, P1, DOI 10.1016/j.yexcr.2009.10.012; Robinson DR, 2008, CURR DRUG TARGETS, V9, P571; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; Serfas MS, 2003, ONCOL RES, V13, P409; SIYANOVA EY, 1994, ONCOGENE, V9, P2053; Takahashi-Yanaga F, CLIN CANC RES, V16, P3153; Vasioukhin V, 1997, P NATL ACAD SCI USA, V94, P14477, DOI 10.1073/pnas.94.26.14477; VASIOUKHIN V, 1995, ONCOGENE, V10, P349; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Verras M, 2005, MOL ENDOCRINOL, V19, P391, DOI 10.1210/me.2004-0208; Wai PY, 2008, CANCER METAST REV, V27, P103, DOI 10.1007/s10555-007-9104-9; Wang G, 2008, CANCER RES, V68, P9918, DOI 10.1158/0008-5472.CAN-08-1718; Wang TC, 2005, BRIT J DERMATOL, V153, P282, DOI 10.1111/j.1365-2133.2005.06604.x; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Zhang P, 2005, J BIOL CHEM, V280, P1982, DOI 10.1074/jbc.M412038200; Zheng Y, 2010, MOL CELL BIOL, V30, P4280, DOI 10.1128/MCB.00024-10	64	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e14789	10.1371/journal.pone.0014789	http://dx.doi.org/10.1371/journal.pone.0014789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479203	Green Published, gold			2022-12-27	WOS:000289055700002
J	Laayouni, H; Montanucci, L; Sikora, M; Mele, M; Dall'Olio, GM; Lorente-Galdos, B; McGee, KM; Graffelman, J; Awadalla, P; Bosch, E; Comas, D; Navarro, A; Calafell, F; Casals, F; Bertranpetit, J				Laayouni, Hafid; Montanucci, Ludovica; Sikora, Martin; Mele, Marta; Marco Dall'Olio, Giovanni; Lorente-Galdos, Belen; McGee, Kate M.; Graffelman, Jan; Awadalla, Philip; Bosch, Elena; Comas, David; Navarro, Arcadi; Calafell, Francesc; Casals, Ferran; Bertranpetit, Jaume			Similarity in Recombination Rate Estimates Highly Correlates with Genetic Differentiation in Humans	PLOS ONE			English	Article							CELL-LINE PANEL; HUMAN GENOME; HUMAN-POPULATIONS; LINKAGE DISEQUILIBRIUM; MEIOTIC RECOMBINATION; HAPLOTYPE MAP; PATTERNS; HOTSPOTS; ASSOCIATION; CHIMPANZEES	Recombination varies greatly among species, as illustrated by the poor conservation of the recombination landscape between humans and chimpanzees. Thus, shorter evolutionary time frames are needed to understand the evolution of recombination. Here, we analyze its recent evolution in humans. We calculated the recombination rates between adjacent pairs of 636,933 common single-nucleotide polymorphism loci in 28 worldwide human populations and analyzed them in relation to genetic distances between populations. We found a strong and highly significant correlation between similarity in the recombination rates corrected for effective population size and genetic differentiation between populations. This correlation is observed at the genome-wide level, but also for each chromosome and when genetic distances and recombination similarities are calculated independently from different parts of the genome. Moreover, and more relevant, this relationship is robustly maintained when considering presence/absence of recombination hotspots. Simulations show that this correlation cannot be explained by biases in the inference of recombination rates caused by haplotype sharing among similar populations. This result indicates a rapid pace of evolution of recombination, within the time span of differentiation of modern humans.	[Laayouni, Hafid; Montanucci, Ludovica; Sikora, Martin; Mele, Marta; Marco Dall'Olio, Giovanni; Lorente-Galdos, Belen; Bosch, Elena; Comas, David; Navarro, Arcadi; Calafell, Francesc; Casals, Ferran; Bertranpetit, Jaume] CEXS UPF PRBB, Inst Evolutionary Biol UPF CSIC, IBE, Barcelona, Catalonia, Spain; [McGee, Kate M.] NCI, NIH, Frederick, MD 21701 USA; [Graffelman, Jan] Univ Politecn Cataluna, Dept Stat & Operat Res, Barcelona, Spain; [Awadalla, Philip; Casals, Ferran] Univ Montreal, Fac Med, Ste Justine Hosp, Res Ctr, Montreal, PQ H3C 3J7, Canada; [Navarro, Arcadi] Inst Catalana Recerca & Estudis Avancats, Barcelona, Catalonia, Spain; [Navarro, Arcadi] Natl Inst Bioinformat INB, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universitat Politecnica de Catalunya; Universite de Montreal; ICREA	Laayouni, H (corresponding author), CEXS UPF PRBB, Inst Evolutionary Biol UPF CSIC, IBE, Barcelona, Catalonia, Spain.	jaume.bertranpetit@upf.edu	Comas, David/D-5382-2014; Laayouni, Hafid/AAA-9254-2019; Bertranpetit, Jaume/F-8550-2012; Calafell, Francesc/C-8595-2014; Sikora, Martin/C-8609-2015; Graffelman, Jan/L-8056-2014; Bosch, Elena/N-7603-2019; Navarro, Arcadi/F-1592-2011; Bosch, Elena/D-8681-2014; Awadalla, Philip/AAC-4896-2021; Casals, Ferran/H-4347-2015	Comas, David/0000-0002-5075-0956; Laayouni, Hafid/0000-0003-1297-5078; Bertranpetit, Jaume/0000-0003-0100-0590; Calafell, Francesc/0000-0002-1083-9438; Sikora, Martin/0000-0003-2818-8319; Graffelman, Jan/0000-0003-3900-0780; Bosch, Elena/0000-0003-2848-103X; Navarro, Arcadi/0000-0003-2162-8246; Bosch, Elena/0000-0003-2848-103X; Casals, Ferran/0000-0002-8941-0369; mele, marta/0000-0001-8874-6453; Dall'Olio, Giovanni Marco/0000-0001-9057-2480; MONTANUCCI, LUDOVICA/0000-0003-2375-7359; Lorente-Galdos, Belen/0000-0001-5390-2452	Ministerio de Educacion y Ciencia (Spain) [BFU2007-63657, BFU2009-13409-C02-02, SAF-2007-63171]; Direccio General de Recerca of Generalitat de Catalunya (Grup de Recerca Consolidat) [2005SGR/00608, 2009 SGR 1101]; National Institute for Bioinformatics; ICREA Funding Source: Custom	Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Direccio General de Recerca of Generalitat de Catalunya (Grup de Recerca Consolidat)(Generalitat de Catalunya); National Institute for Bioinformatics; ICREA(ICREA)	This research was funded by grants BFU2007-63657, BFU2009-13409-C02-02 and SAF-2007-63171 awarded by Ministerio de Educacion y Ciencia (Spain), by the Direccio General de Recerca of Generalitat de Catalunya (Grup de Recerca Consolidat 2005SGR/00608 and 2009 SGR 1101), and by the National Institute for Bioinformatics (www.inab.org), a platform of Genoma Espana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Auton A, 2007, GENOME RES, V17, P1219, DOI 10.1101/gr.6386707; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Bertranpetit J, 2003, COLD SPRING HARB SYM, V68, P79, DOI 10.1101/sqb.2003.68.79; Cann HM, 2002, SCIENCE, V296, P261; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Evans DM, 2005, AM J HUM GENET, V76, P681, DOI 10.1086/429274; Fearnhead P, 2001, GENETICS, V159, P1299; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gardner M, 2006, MOL PSYCHIATR, V11, P66, DOI 10.1038/sj.mp.4001749; Graffelman J, 2007, HUM GENET, V122, P301, DOI 10.1007/s00439-007-0391-6; GROSSMAN SR, SCIENCE, V327, P883; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jeffreys AJ, 2005, NAT GENET, V37, P601, DOI 10.1038/ng1565; Khil PP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000831; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Serre D, 2005, GENOME RES, V15, P1547, DOI 10.1101/gr.4211905; Smith NGC, 2005, GENETICS, V171, P2051, DOI 10.1534/genetics.104.036293; Sokal RR, 1995, BIOMETRY; Stajich JE, 2005, MOL BIOL EVOL, V22, P63, DOI 10.1093/molbev/msh252; Stumpf MPH, 2003, NAT REV GENET, V4, P959, DOI 10.1038/nrg1227; The International HapMap Consortium, 2005, NATURE, V437, P1299, DOI DOI 10.1038/NATURE04226; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	37	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17913	10.1371/journal.pone.0017913	http://dx.doi.org/10.1371/journal.pone.0017913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464928	gold, Green Published, Green Submitted			2022-12-27	WOS:000289053800005
J	Yotoko, KSC; Dornelas, MC; Togni, PD; Fonseca, TC; Salzano, FM; Bonatto, SL; Freitas, LB				Yotoko, Karla S. C.; Dornelas, Marcelo C.; Togni, Pakisa D.; Fonseca, Tamara C.; Salzano, Francisco M.; Bonatto, Sandro L.; Freitas, Loreta B.			Does Variation in Genome Sizes Reflect Adaptive or Neutral Processes? New Clues from Passiflora	PLOS ONE			English	Article							NUCLEAR-DNA CONTENT; PHYLOGENETIC ANALYSIS; METABOLIC-RATE; CELL-VOLUME; JUNK DNA; EVOLUTION; RECOMBINATION; SELECTION; AMPLIFICATION; GENERATION	One of the long-standing paradoxes in genomic evolution is the observation that much of the genome is composed of repetitive DNA which has been typically regarded as superfluous to the function of the genome in generating phenotypes. In this work, we used comparative phylogenetic approaches to investigate if the variations in genome sizes (GS) should be considered as adaptive or neutral processes by the comparison between GS and flower diameters (FD) of 50 Passiflora species, more specifically, within its two most species-rich subgenera, Passiflora and Decaloba. For this, we have constructed a phylogenetic tree of these species, estimated GS and FD of them, inferred the tempo and mode of evolution of these traits and their correlations, using both current and phylogenetically independent contrasted values. We found significant correlations among the traits, when considering the complete set of data or only the subgenus Passiflora, whereas no correlations were observed within Decaloba. Herein, we present convincing evidence of adaptive evolution of GS, as well as clues that this pattern is limited by a minimum genome size, which could reduce both the possibilities of changes in GS and the possibility of phenotypic responses to environment changes.	[Yotoko, Karla S. C.] Univ Fed Vicosa, Dept Biol Geral, Lab Bioinformat & Evolucao, Vicosa, MG, Brazil; [Dornelas, Marcelo C.; Fonseca, Tamara C.] Univ Estadual Campinas, Inst Biol, Dept Biol Vegetal, Campinas, Brazil; [Togni, Pakisa D.; Salzano, Francisco M.; Freitas, Loreta B.] Univ Fed Rio Grande do Sul, Dept Genet, Lab Evolucao Mol, Porto Alegre, RS, Brazil; [Bonatto, Sandro L.] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Lab Biol Genom & Mol, Porto Alegre, RS, Brazil	Universidade Federal de Vicosa; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Yotoko, KSC (corresponding author), Univ Fed Vicosa, Dept Biol Geral, Lab Bioinformat & Evolucao, Vicosa, MG, Brazil.	dornelas@unicamp.br	Dornelas, Marcelo C/A-6104-2013; Yotoko, Karla/G-5151-2010; Salzano, Francisco M/L-7916-2015; Freitas, Loreta B/D-9948-2013; Freitas, Loreta B/E-7366-2010; Bonatto, Sandro L/A-1240-2010	Dornelas, Marcelo C/0000-0002-6710-3050; Yotoko, Karla/0000-0003-2051-4204; Freitas, Loreta B/0000-0002-0728-4945; Freitas, Loreta B/0000-0002-0728-4945; Bonatto, Sandro L/0000-0002-0064-467X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Institutos do Milenio, Programa de Apoio a Nucleos de Excelencia (PRONEX); Programa Especial de Taxonomia (CNPq-PROTAX); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Pro-Reitoria de Pesquisa da Universidade Federal do Rio Grande do Sul (PROPESQ-UFRGS)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Institutos do Milenio, Programa de Apoio a Nucleos de Excelencia (PRONEX)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Programa Especial de Taxonomia (CNPq-PROTAX)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Pro-Reitoria de Pesquisa da Universidade Federal do Rio Grande do Sul (PROPESQ-UFRGS)	This project was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Institutos do Milenio, Programa de Apoio a Nucleos de Excelencia (PRONEX), Programa Especial de Taxonomia (CNPq-PROTAX), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), and Pro-Reitoria de Pesquisa da Universidade Federal do Rio Grande do Sul (PROPESQ-UFRGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achigan-Dako EG, 2008, PLANT SYST EVOL, V276, P9, DOI 10.1007/s00606-008-0075-2; ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9; Ashman TL, 2004, P ROY SOC B-BIOL SCI, V271, P553, DOI 10.1098/rspb.2003.2642; Ashman TL, 2006, HEREDITY, V96, P343, DOI 10.1038/sj.hdy.6800815; Beaulieu JM, 2007, ANN BOT-LONDON, V99, P495, DOI 10.1093/aob/mcl271; BEBENEK K, 1990, P NATL ACAD SCI USA, V87, P4946, DOI 10.1073/pnas.87.13.4946; Bennett MD, 2005, ANN BOT-LONDON, V95, P1, DOI 10.1093/aob/mci001; BENNETT MD, 1977, PHILOS T R SOC B, V277, P201, DOI 10.1098/rstb.1977.0012; BENNETT MD, 1976, PHILOS T R SOC B, V274, P227, DOI 10.1098/rstb.1976.0044; BENNETT MD, 1972, PROC R SOC SER B-BIO, V181, P109, DOI 10.1098/rspb.1972.0042; Bennetzen JL, 2002, GENETICA, V115, P29, DOI 10.1023/A:1016015913350; CAVALIERSMITH T, 1978, J CELL SCI, V34, P247; Chung J, 1998, THEOR APPL GENET, V96, P1064, DOI 10.1007/s001220050840; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Dolezel J, 2005, ANN BOT-LONDON, V95, P99, DOI 10.1093/aob/mci005; DUNN IS, 1987, NUCLEIC ACIDS RES, V15, P2677; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Garland T, 1999, AM ZOOL, V39, P374; GARLAND T, 2006, PDAP PHENOTYPIC DIVE; Gaut BS, 2008, SCIENCE, V320, P484, DOI 10.1126/science.1153586; Gregory TR, 2005, ANN BOT-LONDON, V95, P133, DOI 10.1093/aob/mci009; Gregory TR, 2004, PALEOBIOLOGY, V30, P179, DOI 10.1666/0094-8373(2004)030<0179:MHTATC>2.0.CO;2; Hansen AK, 2006, SYST BOT, V31, P138, DOI 10.1600/036364406775971769; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JASIENSKI M, 1995, NATURE, V376, P559, DOI 10.1038/376559b0; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Knight CA, 2002, ECOL LETT, V5, P66, DOI 10.1046/j.1461-0248.2002.00283.x; Knight CA, 2008, ANN BOT-LONDON, V101, P759, DOI 10.1093/aob/mcm321; Kozlowski J, 2003, P NATL ACAD SCI USA, V100, P14080, DOI 10.1073/pnas.2334605100; KUNKEL TA, 1990, BIOCHEMISTRY-US, V29, P8003, DOI 10.1021/bi00487a001; Meagher TR, 2008, GENET RES, V90, P111, DOI 10.1017/S001667230700897X; MEAGHER TR, 1994, AM J BOT, V81, P1198, DOI 10.2307/2445482; Muschner VC, 2003, AM J BOT, V90, P1229, DOI 10.3732/ajb.90.8.1229; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; OHNO S, 1972, BROOKHAVEN SYM BIOL, P366; Oliver MJ, 2007, GENOME RES, V17, P594, DOI 10.1101/gr.6096207; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Otto F, 1990, Methods Cell Biol, V33, P105; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Petrov DA, 2002, THEOR POPUL BIOL, V61, P531, DOI 10.1006/tpbi.2002.1605; Price H. James, 1996, P115; PRICE HJ, 1973, EXPERIENTIA, V29, P1028, DOI 10.1007/BF01930444; Rambaut A., 2003, TRACER MCMC TRACE AN; Ross-Ibarra J, 2007, J EVOLUTION BIOL, V20, P800, DOI 10.1111/j.1420-9101.2006.01275.x; ROY A, 1992, THEOR APPL GENET, V85, P173, DOI 10.1007/BF00222856; Savolainen V, 2000, SYST BIOL, V49, P306, DOI 10.1093/sysbio/49.2.306; Smarda P, 2008, ANN BOT-LONDON, V102, P599, DOI 10.1093/aob/mcn133; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; SouzaChies TT, 1997, PLANT SYST EVOL, V204, P109, DOI 10.1007/BF00982535; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMAS CA, 1971, ANNU REV GENET, V5, P237, DOI 10.1146/annurev.ge.05.120171.001321; Ulmer T., 2004, PASSIFLORA PASSIONFL; Vinogradov AE, 1995, EVOLUTION, V49, P1249, DOI 10.1111/j.1558-5646.1995.tb04451.x; Vinogradov AE, 1997, EVOLUTION, V51, P220, DOI 10.1111/j.1558-5646.1997.tb02403.x; WAKAMIYA I, 1993, AM J BOT, V80, P1235, DOI 10.2307/2445706; Wendel JF, 2002, GENETICA, V115, P37, DOI 10.1023/A:1016020030189; Wyman J, 1997, AM J BOT, V84, P1351, DOI 10.2307/2446133	62	41	45	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18212	10.1371/journal.pone.0018212	http://dx.doi.org/10.1371/journal.pone.0018212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464897	Green Published, Green Submitted, gold			2022-12-27	WOS:000289053800029
J	Chesnokova, V; Zonis, S; Zhou, CQ; Ben-Shlomo, A; Wawrowsky, K; Toledano, Y; Tong, YG; Kovacs, K; Scheithauer, B; Melmed, S				Chesnokova, Vera; Zonis, Svetlana; Zhou, Cuiqi; Ben-Shlomo, Anat; Wawrowsky, Kolja; Toledano, Yoel; Tong, Yunguang; Kovacs, Kalman; Scheithauer, Bernd; Melmed, Shlomo			Lineage-Specific Restraint of Pituitary Gonadotroph Cell Adenoma Growth	PLOS ONE			English	Article							TUMOR-TRANSFORMING GENE; TRANSCRIPTION FACTORS; CYCLE PROGRESSION; EPITHELIAL-CELLS; PTTG EXPRESSION; TRANSGENIC MICE; C/EBP-DELTA; DNA-DAMAGE; FACTOR-I; SENESCENCE	Although pituitary adenomas are usually benign, unique trophic mechanisms restraining cell proliferation are unclear. As GH-secreting adenomas are associated with p53/p21-dependent senescence, we tested mechanisms constraining non-functioning pituitary adenoma growth. Thirty six gonadotroph-derived non-functioning pituitary adenomas all exhibited DNA damage, but undetectable p21 expression. However, these adenomas all expressed p16, and > 90% abundantly expressed cytoplasmic clusterin associated with induction of the Cdk inhibitor p15 in 70% of gonadotroph and in 26% of somatotroph lineage adenomas (p = 0.006). Murine L beta T2 and alpha T3 gonadotroph pituitary cells, and alpha GSU.PTTG transgenic mice with targeted gonadotroph cell adenomas also abundantly expressed clusterin and exhibited features of oncogene-induced senescence as evidenced by C/EBP beta and C/EBP delta induction. In turn, C/EBPs activated the clusterin promoter similar to 5 fold, and elevated clusterin subsequently elicited p15 and p16 expression, acting to arrest murine gonadotroph cell proliferation. In contrast, specific clusterin suppression by RNAis enhanced gonadotroph proliferation. FOXL2, a tissue-specific gonadotroph lineage factor, also induced the clusterin promoter similar to 3 fold in alpha T3 pituitary cells. As nine of 12 pituitary carcinomas were devoid of clusterin expression, this protein may limit proliferation of benign adenomatous pituitary cells. These results point to lineage-specific pathways restricting uncontrolled murine and human pituitary gonadotroph adenoma cell growth.	[Chesnokova, Vera; Zonis, Svetlana; Zhou, Cuiqi; Ben-Shlomo, Anat; Wawrowsky, Kolja; Toledano, Yoel; Tong, Yunguang; Melmed, Shlomo] Cedars Sinai Med Ctr, Dept Med, Pituitary Ctr, Los Angeles, CA 90048 USA; [Tong, Yunguang; Kovacs, Kalman] St Michaels Hosp, Dept Pathol, Toronto, ON M5B 1W8, Canada; [Tong, Yunguang; Scheithauer, Bernd] Mayo Clin, Rochester, MN USA	Cedars Sinai Medical Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Mayo Clinic	Chesnokova, V (corresponding author), Cedars Sinai Med Ctr, Dept Med, Pituitary Ctr, Los Angeles, CA 90048 USA.	Melmed@csmc.edu	Ben-Shlomo, Anat/AAH-6009-2021; Chesnokova, Vera/AAI-4168-2020		National Institutes of Health [CA75979, T32 DK07770]; Doris Factor Molecular Endocrinology Laboratory; NATIONAL CANCER INSTITUTE [R01CA075979, K99CA138914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007770] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Factor Molecular Endocrinology Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health, CA75979 (SM) and T32 DK07770 (SM to YT), and the Doris Factor Molecular Endocrinology Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbud RA, 2005, MOL ENDOCRINOL, V19, P1383, DOI 10.1210/me.2004-0403; Alarid ET, 1996, DEVELOPMENT, V122, P3319; Bernal JA, 2008, CELL DEATH DIFFER, V15, P202, DOI 10.1038/sj.cdd.4402254; Bettuzzi S, 2002, ONCOGENE, V21, P4328, DOI 10.1038/sj.onc.1205594; Bettuzzi S, 2009, ONCOGENE, V28, P4344, DOI 10.1038/onc.2009.286; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chayka O, 2009, JNCI-J NATL CANCER I, V101, P663, DOI 10.1093/jnci/djp063; Chen TG, 2004, CANCER RES, V64, P7412, DOI 10.1158/0008-5472.CAN-04-2077; Chesnokova V, 2008, P NATL ACAD SCI USA, V105, P17498, DOI 10.1073/pnas.0804810105; Chesnokova V, 2007, CANCER RES, V67, P10564, DOI 10.1158/0008-5472.CAN-07-0974; Chi KN, 2008, EXPERT OPIN INV DRUG, V17, P1955, DOI [10.1517/13543780802528609, 10.1517/13543780802528609 ]; Chou TY, 2009, CELL SIGNAL, V21, P704, DOI 10.1016/j.cellsig.2009.01.008; Ciccone NA, 2010, MOL CELL BIOL, V30, P1028, DOI 10.1128/MCB.00848-09; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Criswell T, 2005, J BIOL CHEM, V280, P14212, DOI 10.1074/jbc.M412569200; Cuadrado M, 2009, CANCER RES, V69, P8726, DOI 10.1158/0008-5472.CAN-09-0729; Donangelo I, 2006, ENDOCRINOLOGY, V147, P4781, DOI 10.1210/en.2006-0544; EGASHIRA N, 2010, MODERN PATHOLOGY, P1; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; Fernandez A, 2010, CLIN ENDOCRINOL, V72, P377, DOI 10.1111/j.1365-2265.2009.03667.x; Filippella M, 2006, CLIN ENDOCRINOL, V65, P536, DOI 10.1111/j.1365-2265.2006.02630.x; Flanagan L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-107; Frost SJ, 2001, MOL CELL ENDOCRINOL, V176, P29, DOI 10.1016/S0303-7207(01)00477-4; Gery S, 2005, ONCOGENE, V24, P1589, DOI 10.1038/sj.onc.1208393; Goffin V, 2002, ANNU REV PHYSIOL, V64, P47, DOI 10.1146/annurev.physiol.64.081501.131049; Heaney AP, 1999, NAT MED, V5, P1317, DOI 10.1038/15275; Hsu YH, 2010, J BIOL CHEM, V285, P22630, DOI 10.1074/jbc.M109.096255; Janovick JA, 2010, P NATL ACAD SCI USA, V107, P4454, DOI 10.1073/pnas.0914261107; JENNE DE, 1989, P NATL ACAD SCI USA, V86, P7123, DOI 10.1073/pnas.86.18.7123; Kim HJ, 2009, ARTERIOSCL THROM VAS, V29, P1558, DOI 10.1161/ATVBAHA.109.190058; KIRSZBAUM L, 1992, FEBS LETT, V297, P70, DOI 10.1016/0014-5793(92)80330-J; Kleinberg DL, 2009, ENDOCR REV, V30, P51, DOI 10.1210/er.2008-0022; Kovacs K, 2001, J NEURO-ONCOL, V54, P121, DOI 10.1023/A:1012945129981; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI200320401; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Nam JS, 2008, CANCER RES, V68, P3915, DOI 10.1158/0008-5472.CAN-08-0206; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Panico F, 2009, ADV CANCER RES, V105, P63, DOI 10.1016/S0065-230X(09)05004-0; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rizzi F, 2010, ENDOCR-RELAT CANCER, V17, pR1, DOI 10.1677/ERC-09-0140; Rizzi F, 2009, J CELL PHYSIOL, V219, P314, DOI 10.1002/jcp.21671; Salehi F, 2008, ENDOCR-RELAT CANCER, V15, P721, DOI 10.1677/ERC-08-0012; Scheithauer BW, 2006, NEUROSURGERY, V59, P341, DOI 10.1227/01.NEU.0000223437.51435.6E; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Shen KC, 2005, CANCER RES, V65, P8747, DOI 10.1158/0008-5472.CAN-05-1471; Sivamurthy N, 2001, J VASC SURG, V34, P716, DOI 10.1067/mva.2001.116301; SWANSON SM, 2007, SCI STKE, pPE69; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; Thomas-Tikhonenko A, 2004, CANCER RES, V64, P3126, DOI 10.1158/0008-5472.CAN-03-1953; Trougakos IP, 2009, CANCER RES, V69, P403, DOI 10.1158/0008-5472.CAN-08-2912; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; Zhang X, 1999, J CLIN ENDOCR METAB, V84, P761, DOI 10.1210/jc.84.2.761; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	64	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17924	10.1371/journal.pone.0017924	http://dx.doi.org/10.1371/journal.pone.0017924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464964	gold, Green Submitted, Green Published			2022-12-27	WOS:000288813900018
J	Oelemann, MC; Gomes, HM; Willery, E; Possuelo, L; Lima, KVB; Allix-Beguec, C; Locht, C; de la Salmoniere, YOLG; Gutierrez, MC; Suffys, P; Supply, P				Oelemann, Maranibia Cardoso; Gomes, Harrison M.; Willery, Eve; Possuelo, Lia; Batista Lima, Karla Valeria; Allix-Beguec, Caroline; Locht, Camille; de la Salmoniere, Yves-Olivier L. Goguet; Gutierrez, Maria Cristina; Suffys, Philip; Supply, Philip			The Forest behind the Tree: Phylogenetic Exploration of a Dominant Mycobacterium tuberculosis Strain Lineage from a High Tuberculosis Burden Country	PLOS ONE			English	Article							RIO-DE-JANEIRO; TANDEM-REPEAT; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; BEIJING GENOTYPE; REPETITIVE UNITS; VARIABLE NUMBERS; DRUG-RESISTANCE; MIRU-VNTRPLUS; POPULATION	Background: Genotyping of Mycobacterium tuberculosis isolates is a powerful tool for epidemiological control of tuberculosis (TB) and phylogenetic exploration of the pathogen. Standardized PCR-based typing, based on 15 to 24 mycobacterial interspersed repetitive unit-variable number of tandem repeat (MIRU-VNTR) loci combined with spoligotyping, has been shown to have adequate resolution power for tracing TB transmission and to be useful for predicting diverse strain lineages in European settings. Its informative value needs to be tested in high TB-burden countries, where the use of genotyping is often complicated by dominance of geographically specific, genetically homogeneous strain lineages. Methodology/Principal Findings: We tested this genotyping system for molecular epidemiological analysis of 369 M. tuberculosis isolates from 3 regions of Brazil, a high TB-burden country. Deligotyping, targeting 43 large sequence polymorphisms (LSPs), and the MIRU-VNTRplus identification database were used to assess phylogenetic predictions. High congruence between the different typing results consistently revealed the countrywide supremacy of the Latin-American-Mediterranean (LAM) lineage, comprised of three main branches. In addition to an already known RDRio branch, at least one other branch characterized by a phylogenetically informative LAM3 spoligo-signature seems to be globally distributed beyond Brazil. Nevertheless, by distinguishing 321 genotypes in this strain population, combined MIRU-VNTR typing and spoligotyping demonstrated the presence of multiple distinct clones. The use of 15 to 24 loci discriminated 21 to 25% more strains within the LAM lineage, compared to a restricted lineage-specific locus set suggested to be used after SNP analysis. Noteworthy, 23 of the 28 molecular clusters identified were exclusively composed of patient isolates from a same region, consistent with expected patterns of mostly local TB transmission. Conclusions/Significance: Standard MIRU-VNTR typing combined with spoligotyping can reveal epidemiologically meaningful clonal diversity behind a dominant M. tuberculosis strain lineage in a high TB-burden country and is useful to explore international phylogenetical ramifications.	[Oelemann, Maranibia Cardoso; Gomes, Harrison M.; Suffys, Philip] Fiocruz MS, Inst Oswaldo Cruz, Lab Mol Biol Appl Mycobacteria, BR-21045900 Rio De Janeiro, Brazil; [Willery, Eve; Allix-Beguec, Caroline; Locht, Camille; Gutierrez, Maria Cristina; Supply, Philip] INSERM, U1019, F-59045 Lille, France; [Willery, Eve; Allix-Beguec, Caroline; Locht, Camille; Gutierrez, Maria Cristina; Supply, Philip] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR 8204, F-59019 Lille, France; [Willery, Eve; Allix-Beguec, Caroline; Locht, Camille; Gutierrez, Maria Cristina; Supply, Philip] Univ Lille Nord France, Lille, France; [Willery, Eve; Allix-Beguec, Caroline; Locht, Camille; Gutierrez, Maria Cristina; Supply, Philip] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Possuelo, Lia] Fundaco Estadual Prod & Pesquisa Saude, Ctr Sci & Technol Dev, Porto Alegre, RS, Brazil; [Batista Lima, Karla Valeria] Inst Evandro Chagas, Belem, Para, Brazil; [de la Salmoniere, Yves-Olivier L. Goguet; Gutierrez, Maria Cristina] Inst Pasteur, Dept Infect & Epidemiol, Paris, France	Fundacao Oswaldo Cruz; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Instituto Evandro Chagas; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Oelemann, MC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Mol Biol Appl Mycobacteria, BR-21045900 Rio De Janeiro, Brazil.	philip.supply@ibl.fr	Gomes, Harrison M/E-2942-2013; Locht, Camille/L-3516-2018; Lima, Karla Valéria/AAF-8256-2021; Gutierrez, Cristina/B-5597-2012; POSSUELO, LIA G/K-6695-2014; suffys, philip/E-3009-2013; Allix-Béguec, Caroline/AAI-4645-2021; Supply, Philip/A-9580-2019	Gomes, Harrison M/0000-0002-6489-8003; Lima, Karla Valéria/0000-0001-5807-0392; Gutierrez, Cristina/0000-0002-5567-5908; POSSUELO, LIA G/0000-0002-6425-3678; Allix-Béguec, Caroline/0000-0001-7642-4844; Supply, Philip/0000-0003-3690-3853; Locht, Camille/0000-0001-7295-7336	CAPES, Brazil	CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	MCO held a fellowship from the CAPES (www.capes.gov.br), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajoj SAM, 2010, J CLIN MICROBIOL, V48, P3813, DOI 10.1128/JCM.00556-10; Allix C, 2004, CLIN INFECT DIS, V39, P783, DOI 10.1086/423383; Allix-Beguec C, 2008, EUR RESPIR J, V31, P1077, DOI 10.1183/09031936.00053307; Allix-Beguec C, 2010, EUR RESPIR J, V35, P692, DOI 10.1183/09031936.00137309; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Alonso-Rodriguez N, 2009, J CLIN MICROBIOL, V47, P2026, DOI 10.1128/JCM.02308-08; Aminian M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S4; Baptista IMFD, 2002, MEM I OSWALDO CRUZ, V97, P1147, DOI 10.1590/S0074-02762002000800015; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cafrune PI, 2006, J INFECTION, V53, P370, DOI 10.1016/j.jinf.2005.12.027; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; Cowan LS, 2002, EMERG INFECT DIS, V8, P1294, DOI 10.3201/eid0811.020313; de la Salmoniere YOLG, 2004, J CLIN MICROBIOL, V42, P2913, DOI 10.1128/JCM.42.7.2913-2918.2004; Evans JT, 2010, EMERG INFECT DIS, V16, P542, DOI 10.3201/eid1603.090813; Ferrazoli L, 2000, INT J TUBERC LUNG D, V4, P18; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gibson AL, 2008, J CLIN MICROBIOL, V46, P1259, DOI 10.1128/JCM.02231-07; Gutierrez MC, 2006, EMERG INFECT DIS, V12, P1367, DOI 10.3201/eid1209.050017; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Han H, 2007, J MED MICROBIOL, V56, P1219, DOI 10.1099/jmm.0.47005-0; Hanekom M, 2008, J CLIN MICROBIOL, V46, P3338, DOI 10.1128/JCM.00770-08; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Ivens-de-Araujo ME, 1998, BRAZ J MED BIOL RES, V31, P369, DOI 10.1590/S0100-879X1998000300006; Jiao WW, 2008, J CLIN MICROBIOL, V46, P1045, DOI 10.1128/JCM.01869-07; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Mokrousov I, 2006, J CLIN MICROBIOL, V44, P2851, DOI 10.1128/JCM.00705-06; Nikolayevskyy V, 2006, EMERG INFECT DIS, V12, P1406, DOI 10.3201/eid1209.041623; Niobe-Eyangoh SN, 2004, J CLIN MICROBIOL, V42, P5029, DOI 10.1128/JCM.42.11.5029-5035.2004; Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06; Oelemann MC, 2007, MEM I OSWALDO CRUZ, V102, P455, DOI 10.1590/S0074-02762007005000034; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Organization WH, 2006, GLOB TUB CONTR WHO R; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Ritacco V, 2008, MEM I OSWALDO CRUZ, V103, P489, DOI 10.1590/S0074-02762008000500014; Savine E, 2002, J CLIN MICROBIOL, V40, P4561, DOI 10.1128/JCM.40.12.4561-4566.2002; Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99; Shamputa IC, 2010, J CLIN MICROBIOL, V48, P387, DOI 10.1128/JCM.02167-09; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2003, MOL MICROBIOL, V47, P529, DOI 10.1046/j.1365-2958.2003.03315.x; Supply P, 1997, MOL MICROBIOL, V26, P991, DOI 10.1046/j.1365-2958.1997.6361999.x; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Telles MAS, 2005, INT J TUBERC LUNG D, V9, P970; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; van Deutekom H, 2005, J CLIN MICROBIOL, V43, P4473, DOI 10.1128/JCM.43.9.4473-4479.2005; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Velji P, 2009, EMERG INFECT DIS, V15, P1609, DOI 10.3201/eid1510.090463; Wada T, 2007, J MED MICROBIOL, V56, P1052, DOI 10.1099/jmm.0.46990-0; Warren RM, 2004, J CLIN MICROBIOL, V42, P5774, DOI 10.1128/JCM.42.12.5774-5782.2004; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160	62	45	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18256	10.1371/journal.pone.0018256	http://dx.doi.org/10.1371/journal.pone.0018256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464915	Green Submitted, Green Published, gold			2022-12-27	WOS:000288813900056
J	van Gent, M; van Loo, IHM; Heuvelman, KJ; de Neeling, AJ; Teunis, P; Mooi, FR				van Gent, Marjolein; van Loo, Inge H. M.; Heuvelman, Kees J.; de Neeling, Albert J.; Teunis, Peter; Mooi, Frits R.			Studies on Prn Variation in the Mouse Model and Comparison with Epidemiological Data	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS STRAINS; FIELD GEL-ELECTROPHORESIS; VIRULENCE FACTORS; FILAMENTOUS HEMAGGLUTININ; ANTIGENIC DIVERGENCE; SEQUENCE VARIATION; TEMPORAL TRENDS; VACCINE STRAINS; PERTACTIN; TOXIN	The virulence factor pertactin (Prn) is a component of pertussis vaccines and one of the most polymorphic Bordetella pertussis antigens. After the introduction of vaccination shifts in predominant Prn types were observed and strains with the Prn vaccine type (Prn1) were replaced by strains carrying non-vaccine types (Prn2 and Prn3), suggesting vaccine-driven selection. The aim of this study was to elucidate the shifts observed in Prn variants. We show that, although Prn2 and Prn3 circulated in similar frequencies in the 1970s and 1980s, in the 1990s Prn2 strains expanded and Prn3 strains disappeared, suggesting that in vaccinated populations Prn2 strains are fitter than Prn3 strains. We established a role for Prn in the mouse model by showing that a Prn knock-out (Prn-ko) mutation reduced colonization in trachea and lungs. Restoration of the mutation resulted in a significant increase in colonization compared to the knock-out mutant. The ability of clinical isolates with different Prn variants to colonize the mouse lung was compared. Although these isolates were also polymorphic at other loci, only variation in the promoter for pertussis toxin (ptxP) and Prn were found to contribute significantly to differences in colonization. Analysis of a subset of strains with the same ptxP allele revealed that the ability to colonize mice decreased in the order Prn1. Prn2 and Prn3. Our results are consistent with the predominance of Prn1 strains in unvaccinated populations. Our results show that ability to colonize mice is practically the same for Prn2 and Prn3. Therefore other factors may have contributed to the predominance of Prn2 in vaccinated populations. The mouse model may be useful to assess and predict changes in the B. pertussis population due to vaccination.	[van Gent, Marjolein; Heuvelman, Kees J.; de Neeling, Albert J.; Mooi, Frits R.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands; [van Loo, Inge H. M.] Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands; [Teunis, Peter] Natl Inst Publ Hlth & Environm, Expertise Ctr Methodol & Informat Serv, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Maastricht University; Netherlands National Institute for Public Health & the Environment	van Gent, M (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands.	frits.mooi@rivm.nl		de Neeling, Albert Johannes/0000-0001-8578-1990	Ministry of Public Health, Welfare and Sport [247221]	Ministry of Public Health, Welfare and Sport	This work was supported by a grant (nr. 247221) from the Ministry of Public Health, Welfare and Sport (VWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2007, APMIS, V115, P299, DOI 10.1111/j.1600-0463.2007.apm_556.x; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Berbers GAM, 2009, HUM VACCINES, V5, P497, DOI 10.4161/hv.8112; Borisova O, 2007, CLIN VACCINE IMMUNOL, V14, P234, DOI 10.1128/CVI.00294-06; Bottero D, 2007, CLIN VACCINE IMMUNOL, V14, P1490, DOI 10.1128/CVI.00177-07; Bouchez V, 2009, VACCINE, V27, P6034, DOI 10.1016/j.vaccine.2009.07.074; Carbonetti NH, 2003, INFECT IMMUN, V71, P6358, DOI 10.1128/IAI.71.11.6358-6366.2003; Cassiday P, 2000, J INFECT DIS, V182, P1402, DOI 10.1086/315881; de Melker HE, 2006, J INFECTION, V53, P106, DOI 10.1016/j.jinf.2005.10.020; Elomaa A, 2005, J CLIN MICROBIOL, V43, P3681, DOI 10.1128/JCM.43.8.3681-3687.2005; Fry NK, 2001, INFECT IMMUN, V69, P5520, DOI 10.1128/IAI.69.9.5520-5528.2001; Gzyl A, 2004, VACCINE, V22, P2122, DOI 10.1016/j.vaccine.2003.12.006; Gzyl A, 2001, VACCINE, V20, P299, DOI 10.1016/S0264-410X(01)00356-5; Hallander HO, 2005, J CLIN MICROBIOL, V43, P2856, DOI 10.1128/JCM.43.6.2856-2865.2005; Halperin SA, 2007, NEW ENGL J MED, V356, P110, DOI 10.1056/NEJMp068288; HAZENBOS WLW, 1994, INFECT IMMUN, V62, P4818, DOI 10.1128/IAI.62.11.4818-4824.1994; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; Hozbor D, 2009, J INFECTION, V59, P225, DOI 10.1016/j.jinf.2009.07.014; Inatsuka CS, 2010, INFECT IMMUN, V78, P2901, DOI 10.1128/IAI.00188-10; Kallonen T, 2009, EXPERT REV VACCINES, V8, P863, DOI [10.1586/erv.09.46, 10.1586/ERV.09.46]; KHELEF N, 1994, INFECT IMMUN, V62, P2893, DOI 10.1128/IAI.62.7.2893-2900.1994; King AJ, 2001, MICROBIOL-SGM, V147, P2885, DOI 10.1099/00221287-147-11-2885; Kodama A, 2004, J CLIN MICROBIOL, V42, P5453, DOI 10.1128/JCM.42.12.5453-5457.2004; Komatsu E, 2010, CLIN VACCINE IMMUNOL, V17, P807, DOI 10.1128/CVI.00449-09; LEININGER E, 1992, INFECT IMMUN, V60, P2380, DOI 10.1128/IAI.60.6.2380-2385.1992; LEININGER E, 1991, P NATL ACAD SCI USA, V88, P345, DOI 10.1073/pnas.88.2.345; Mastrantonio P, 1999, MICROBIOL-UK, V145, P2069, DOI 10.1099/13500872-145-8-2069; McGuirk P, 2000, EUR J IMMUNOL, V30, P415, DOI 10.1002/1521-4141(200002)30:2<415::AID-IMMU415>3.3.CO;2-O; Mooi FR, 1999, INFECT IMMUN, V67, P3133, DOI 10.1128/IAI.67.6.3133-3134.1999; Mooi FR, 1998, INFECT IMMUN, V66, P670, DOI 10.1128/IAI.66.2.670-675.1998; Mooi FR, 2000, EUR J CLIN MICROBIOL, V19, P174, DOI 10.1007/s100960050455; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Nicholson TL, 2009, INFECT IMMUN, V77, P2136, DOI 10.1128/IAI.01379-08; Njamkepo E, 2008, MICROBES INFECT, V10, P1582, DOI 10.1016/j.micinf.2008.09.012; Octavia S., 2010, MOL BIOL EVOL; Packard ER, 2004, J MED MICROBIOL, V53, P355, DOI 10.1099/jmm.0.05515-0; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Peppler MS, 2003, J CLIN MICROBIOL, V41, P3344, DOI 10.1128/JCM.41.7.3344-3347.2003; Poynten M, 2004, EPIDEMIOL INFECT, V132, P185, DOI 10.1017/S095026880300164X; ROBERTS M, 1991, MOL MICROBIOL, V5, P1393, DOI 10.1111/j.1365-2958.1991.tb00786.x; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Stefanelli P, 2009, NEW MICROBIOL, V32, P159; STIBITZ S, 1986, GENE, V50, P133, DOI 10.1016/0378-1119(86)90318-5; STIBITZ S, 1991, J BACTERIOL, V173, P4288, DOI 10.1128/JB.173.14.4288-4296.1991; van Loo IHM, 2002, MICROBIOL-SGM, V148, P2011, DOI 10.1099/00221287-148-7-2011; VERWEY WF, 1949, J BACTERIOL, V58, P127, DOI 10.1128/JB.58.2.127-134.1949; Watanabe M, 2002, J HEALTH SCI, V48, P560, DOI 10.1248/jhs.48.560; Weber C, 2001, J CLIN MICROBIOL, V39, P4396, DOI 10.1128/JCM.39.12.4396-4403.2001; Yao SM, 2005, J CLIN MICROBIOL, V43, P5457, DOI 10.1128/JCM.43.11.5457-5461.2005	50	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18014	10.1371/journal.pone.0018014	http://dx.doi.org/10.1371/journal.pone.0018014			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464955	gold, Green Published, Green Submitted			2022-12-27	WOS:000288813900028
J	Barragan, F; Moreno, CE; Escobar, F; Halffter, G; Navarrete, D				Barragan, Felipe; Moreno, Claudia E.; Escobar, Federico; Halffter, Gonzalo; Navarrete, Dario			Negative Impacts of Human Land Use on Dung Beetle Functional Diversity	PLOS ONE			English	Article							ECOSYSTEM SERVICES; FOREST; BIODIVERSITY; FRAGMENTATION; SCARABAEINAE; CONSEQUENCES; CONSERVATION; ASSEMBLAGES; MECHANISMS; FRAMEWORK	The loss of biodiversity caused by human activity is assumed to alter ecosystem functioning. However our understanding of the magnitude of the effect of these changes on functional diversity and their impact on the dynamics of ecological processes is still limited. We analyzed the functional diversity of copro-necrophagous beetles under different conditions of land use in three Mexican biosphere reserves. In Montes Azules pastures, forest fragments and continuous rainforest were analyzed, in Los Tuxtlas rainforest fragments of different sizes were analyzed and in Barranca de Metztitlan two types of xerophile scrub with different degrees of disturbance from grazing were analyzed. We assigned dung beetle species to functional groups based on food relocation, beetle size, daily activity period and food preferences, and as measures of functional diversity we used estimates based on multivariate methods. In Montes Azules functional richness was lower in the pastures than in continuous rainforest and rainforest fragments, but fragments and continuous forest include functionally redundant species. In small rainforest fragments (< 5 ha) in Los Tuxtlas, dung beetle functional richness was lower than in large rainforest fragments (> 20 ha). Functional evenness and functional dispersion did not vary among habitat types or fragment size in these reserves. In contrast, in Metztitlan, functional richness and functional dispersion were different among the vegetation types, but differences were not related to the degree of disturbance by grazing. More redundant species were found in submontane than in crassicaule scrub. For the first time, a decrease in the functional diversity in communities of copro-necrophagous beetles resulting from changes in land use is documented, the potential implications for ecosystem functioning are discussed and a series of variables that could improve the evaluation of functional diversity for this biological group is proposed.	[Barragan, Felipe; Moreno, Claudia E.] Univ Autonoma Estado Hidalgo, Ctr Invest Biol, Pachuca, Hidalgo, Mexico; [Escobar, Federico; Halffter, Gonzalo] AC, Inst Ecol, Xalapa, Veracruz, Mexico; [Navarrete, Dario] El Colegio Frontera Sur, San Cristobal Casas, Chiapas, Mexico	Universidad Autonoma del Estado de Hidalgo; Instituto de Ecologia - Mexico; El Colegio de la Frontera Sur (ECOSUR)	Barragan, F (corresponding author), Univ Autonoma Estado Hidalgo, Ctr Invest Biol, Pachuca, Hidalgo, Mexico.	cmoreno@uaeh.edu.mx	Moreno, Claudia E./B-2733-2013; Barragán, Felipe/AAR-9806-2021; Moreno, Claudia/GRJ-1036-2022; Escobar, Federico/C-1396-2011; Halffter, Gonzalo/R-3652-2018	Moreno, Claudia E./0000-0002-9584-2619; Barragán, Felipe/0000-0001-5658-6192; Escobar, Federico/0000-0003-0179-7528; 	FOMIX CONACYT-HIDALGO [95828]; SEP-CONACYT Basic Science [84127]; CONACYT [168898]	FOMIX CONACYT-HIDALGO; SEP-CONACYT Basic Science; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This paper is a result of projects 95828 of FOMIX CONACYT-HIDALGO, and 84127 of SEP-CONACYT Basic Science. F. Barragan received a scholarship from CONACYT (168898). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo-Rodriguez V, 2009, CONSERV BIOL, V23, P729, DOI 10.1111/j.1523-1739.2008.01120.x; Batalha MA, 2010, NAT CONSERVACAO, V8, P34, DOI 10.4322/natcon.00801005; Castillo-Campos G., 2004, TUXTLAS PAISAJE SIER, P231; CHAO A, 1984, SCAND J STAT, V11, P265; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; CONANP [Comision Nacional de Areas Naturales Protegidas], 2003, PROGR MAN RES BIOSF; Davis ALV, 2004, S AFR J SCI, V100, P415; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; DIRZO R, 1992, CONSERV BIOL, V6, P84, DOI 10.1046/j.1523-1739.1992.610084.x; DOF, 2000, RES PROGR MAN RES BI; Escobar F, 2007, ECOGRAPHY, V30, P193, DOI [10.1111/j.2007.0906-7590.04818.x, 10.1111/j.0906-7590.2007.04818.x]; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Giraldo C, 2011, INSECT CONSERV DIVER, V4, P115, DOI 10.1111/j.1752-4598.2010.00112.x; GUEVARA S, 1997, HIST NATURAL TUXTLAS, P44; Halffter G., 1982, NESTING BEHAV DUNG B; Halffter Gonzalo, 2009, Boletin de la SEA, V45, P1; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Hanski I., 1991, P305; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; *INE, 1993, PROGR MAN RES INT BI; KLEIN BC, 1989, ECOLOGY, V70, P1715, DOI 10.2307/1938106; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Laborde J, 2004, TUXTLAS PAISAJE SIER, P271; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Larsen TH, 2008, CONSERV BIOL, V22, P1288, DOI 10.1111/j.1523-1739.2008.00969.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Moreno CE, 2006, OECOLOGIA, V149, P133, DOI 10.1007/s00442-006-0417-0; Navarrete D, 2008, BIODIVERS CONSERV, V17, P2869, DOI 10.1007/s10531-008-9402-8; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Pavon N. P, 2009, CAMBIO CLIMATICO EST; Perrings C, 2010, SCIENCE, V330, P323, DOI 10.1126/science.1196431; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2007, OIKOS, V116, P1422, DOI 10.1111/j.2007.0030-1299.15894.x; Pineda E, 2005, CONSERV BIOL, V19, P400, DOI 10.1111/j.1523-1739.2005.00531.x; PUIC H., 1991, VEGETACION HUASTECA; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; RICKLEFS RE, 1993, SPECIES DIVERSITY EC, P416; Santos BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012625; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Spector S, 2006, COLEOPTS BULL, V60, P71, DOI 10.1649/0010-065X(2006)60[71:SDBCSS]2.0.CO;2; Tilman D., 2001, ENCY BIODIVERSITY, P109, DOI DOI 10.1016/B0-12-226865-2/00132-2; Verdu JR, 2007, BIOL CONSERV, V140, P308, DOI 10.1016/j.biocon.2007.08.015; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Vulinec K, 2008, TROP CONSERV SCI, V1, P111, DOI 10.1177/194008290800100204; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	47	141	145	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17976	10.1371/journal.pone.0017976	http://dx.doi.org/10.1371/journal.pone.0017976			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448292	Green Published, gold			2022-12-27	WOS:000288810500026
J	Kim, CH; Jeon, HM; Lee, SY; Ju, MK; Moon, JY; Park, HG; Yoo, MA; Choi, BT; Yook, JI; Lim, SC; Han, SI; Kang, HS				Kim, Cho Hee; Jeon, Hyun Min; Lee, Su Yeon; Ju, Min Kyung; Moon, Ji Young; Park, Hye Gyeong; Yoo, Mi-Ae; Choi, Byung Tae; Yook, Jong In; Lim, Sung-Chul; Han, Song Iy; Kang, Ho Sung			Implication of Snail in Metabolic Stress-Induced Necrosis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MITOCHONDRIAL PERMEABILITY TRANSITION; TRANSCRIPTIONAL REPRESSOR SNAIL; SUPPRESSES TUMOR-GROWTH; MOBILITY GROUP BOX-1; BREAST-CANCER CELLS; PROTEIN AGGREGATION; E-CADHERIN; GLUCOSE DEPRIVATION; HEPATOCELLULAR-CARCINOMA	Background: Necrosis, a type of cell death accompanied by the rupture of the plasma membrane, promotes tumor progression and aggressiveness by releasing the pro-inflammatory and angiogenic cytokine high mobility group box 1. It is commonly found in the core region of solid tumors due to hypoxia and glucose depletion (GD) resulting from insufficient vascularization. Thus, metabolic stress-induced necrosis has important clinical implications for tumor development; however, its regulatory mechanisms have been poorly investigated. Methodology/Principal Findings: Here, we show that the transcription factor Snail, a key regulator of epithelial-mesenchymal transition, is induced in a reactive oxygen species (ROS)-dependent manner in both two-dimensional culture of cancer cells, including A549, HepG2, and MDA-MB-231, in response to GD and the inner regions of a multicellular tumor spheroid system, an in vitro model of solid tumors and of human tumors. Snail short hairpin (sh) RNA inhibited metabolic stress-induced necrosis in two-dimensional cell culture and in multicellular tumor spheroid system. Snail shRNA-mediated necrosis inhibition appeared to be linked to its ability to suppress metabolic stress-induced mitochondrial ROS production, loss of mitochondrial membrane potential, and mitochondrial permeability transition, which are the primary events that trigger necrosis. Conclusions/Significance: Taken together, our findings demonstrate that Snail is implicated in metabolic stress-induced necrosis, providing a new function for Snail in tumor progression.	[Kim, Cho Hee; Jeon, Hyun Min; Lee, Su Yeon; Ju, Min Kyung; Moon, Ji Young; Yoo, Mi-Ae; Kang, Ho Sung] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan 609735, South Korea; [Park, Hye Gyeong] Pusan Natl Univ, Nanobiotechnol Ctr, Pusan 609735, South Korea; [Choi, Byung Tae] Pusan Natl Univ, Sch Oriental Med, Div Meridian & Struct Med, Pusan 609735, South Korea; [Yook, Jong In] Yonsei Univ, Dept Oral Pathol, Oral Canc Res Inst, Coll Dent, Seoul 120749, South Korea; [Lim, Sung-Chul; Han, Song Iy] Chosun Univ, Coll Med, Res Ctr Resistant Cells, Kwangju, South Korea; [Lim, Sung-Chul] Chosun Univ, Coll Med, Dept Pathol, Kwangju, South Korea	Pusan National University; Pusan National University; Pusan National University; Yonsei University; Yonsei University Health System; Chosun University; Chosun University	Kim, CH (corresponding author), DNA Identificat Ctr, Natl Forens Serv, Seoul, South Korea.	hspkang@pusan.ac.kr		Yook, Jong In/0000-0002-7318-6112	Ministry of Health & Welfare, Republic of Korea [0620010]; NRF, MEST [2009-0059210]; Korean government (MEST) through the Research Center for Resistant Cells [R13-2003-009]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); NRF, MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean government (MEST) through the Research Center for Resistant Cells(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (0620010), and Mid-career Researcher Program through NRF grant funded by the MEST (2009-0059210), and the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) through the Research Center for Resistant Cells (R13-2003-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Ahmad IM, 2005, J BIOL CHEM, V280, P4254, DOI 10.1074/jbc.M411662200; Alirol E, 2006, ONCOGENE, V25, P4706, DOI 10.1038/sj.onc.1209600; Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Choi YR, 2003, CANCER RES, V63, P2188; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Escriva M, 2008, MOL CELL BIOL, V28, P1528, DOI 10.1128/MCB.02061-07; Evans AJ, 2007, MOL CELL BIOL, V27, P157, DOI 10.1128/MCB.00892-06; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Ge PF, 2007, STROKE, V38, P3230, DOI 10.1161/STROKEAHA.107.487108; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Hippert MM, 2006, CANCER RES, V66, P9349, DOI 10.1158/0008-5472.CAN-06-1597; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Hu BR, 2001, J CEREBR BLOOD F MET, V21, P865, DOI 10.1097/00004647-200107000-00012; Hu BR, 2000, J NEUROSCI, V20, P3191, DOI 10.1523/JNEUROSCI.20-09-03191.2000; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; Ishiguro H, 2005, PROSTATE, V64, P92, DOI 10.1002/pros.20219; Ivascu A, 2007, INT J ONCOL, V31, P1403; Jeong EK, 2010, INT J ONCOL, V37, P655, DOI 10.3892/ijo_00000714; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kim CH, 2007, J CELL PHYSIOL, V211, P371, DOI 10.1002/jcp.20941; Kim CH, 2010, INT J ONCOL, V37, P97, DOI 10.3892/ijo_00000657; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; LaRue KEA, 2004, CANCER RES, V64, P1621, DOI 10.1158/0008-5472.CAN-2902-2; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Lim SO, 2008, GASTROENTEROLOGY, V135, P2128, DOI 10.1053/j.gastro.2008.07.027; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Mancera PA, 2005, HUM MOL GENET, V14, P3449, DOI 10.1093/hmg/ddi373; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Schlueter C, 2005, AM J PATHOL, V166, P1259, DOI 10.1016/S0002-9440(10)62344-9; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Spitz DR, 2000, ANN NY ACAD SCI, V899, P349, DOI 10.1111/j.1749-6632.2000.tb06199.x; Sugimachi K, 2003, CLIN CANCER RES, V9, P2657; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tomes L, 2003, BREAST CANCER RES TR, V81, P61, DOI 10.1023/A:1025476722493; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	64	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18000	10.1371/journal.pone.0018000	http://dx.doi.org/10.1371/journal.pone.0018000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448462	gold, Green Published, Green Submitted			2022-12-27	WOS:000288810500027
J	Carlisle, EM; Poroyko, V; Caplan, MS; Alverdy, JA; Liu, D				Carlisle, Erica M.; Poroyko, Valeriy; Caplan, Michael S.; Alverdy, John A.; Liu, Donald			Gram Negative Bacteria Are Associated with the Early Stages of Necrotizing Enterocolitis	PLOS ONE			English	Article							INTESTINAL INJURY; PRETERM INFANTS; RAT MODEL; PATHOGENESIS; REPERFUSION; DIVERSITY; ISCHEMIA; FLORA; TLR4; MICE	Introduction: Necrotizing enterocolitis (NEC) affects 5- 10% of infants born weighing less than 1500 g. Most models of NEC recapitulate late- stage disease with gut necrosis and elevated inflammatory mediators. Evaluation of NEC at earlier, less lethal stages of disease will allow investigation of initial disease triggers and may advance our understanding of temporal relationships between factors implicated in NEC pathogenesis. In this manuscript, we describe our investigation of early NEC and test the hypothesis that bacteria and inflammatory mediators differ between animals with early NEC and disease free animals. Methods: On DOL7 C3HeB/FeJ pups were fed liquid formula with 1610 4 Streptococcus thoraltensis, Serratia marcescens, and Pseudomonas aeruginosa every 3 h. To initiate NEC, pups underwent asphyxia (100% N2 for 90 s) and hypothermia (4uC for 10 min) after feeding. Pups were euthanized at 72 h. Intestines were collected for histologic NEC scoring and DNA/RNA extraction. Bacterial populations were identified by 16S rRNA pyrosequencing and principal component analysis (PCA). RNA isolates underwent QRT- PCR for Toll- like Receptor 4 (TLR4) and inducible nitric oxide synthase (iNOS). Results: Despite histologic, intestinal damage in mice with NEC, no gross necrosis was observed suggesting early disease. QRT- PCR yielded no difference between groups in TLR4 or iNOS mRNA levels. PCA demonstrated relative clustering of microbial communities based on presence or absence of NEC. 16S pyrosequencing demonstrated similar phyla between groups (Firmicutes and Proteobacteria predominated in all animals). However, the colonic microbiota of animals with NEC had more Citrobacter (p < 0.01), Klebsiella (p < 0.05), and Tatumella (p < 0.05), while that of animals without NEC had more Streptococcus (p < 0.01) and Enterococcus (p < 0.01). Conclusion: Citrobacter, Klebsiella, and Tatumella are associated with NEC. Differential colonic bacteria were identified despite the lack of inflammatory mediator elevation traditionally associated with NEC. This suggests a temporal relationship between bacteria and inflammatory mediators such that alterations in gut microbiota are associated with early NEC, while inflammatory mediator elevation is associated with advanced NEC.	[Carlisle, Erica M.; Poroyko, Valeriy; Alverdy, John A.; Liu, Donald] Univ Chicago, Med Ctr, Dept Surg, Chicago, IL 60637 USA; [Caplan, Michael S.] Northshore Univ Hlth Syst, Dept Pediat, Chicago, IL USA	University of Chicago; University of Chicago Medical Center; NorthShore University Health System	Carlisle, EM (corresponding author), Univ Chicago, Med Ctr, Dept Surg, Chicago, IL 60637 USA.	dliu@surgery.bsd.uchicago.edu		Carlisle, Erica/0000-0002-3884-9793	University of Chicago	University of Chicago(University of Chicago)	This work was supported by an internal grant from the University of Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand RJ, 2007, SHOCK, V27, P124, DOI 10.1097/01.shk.0000239774.02904.65; BARLOW B, 1975, SURGERY, V77, P687; BELL MJ, 1979, AM J SURG, V138, P629, DOI 10.1016/0002-9610(79)90333-7; Caplan Michael S, 2005, Semin Pediatr Surg, V14, P145, DOI 10.1053/j.sempedsurg.2005.05.002; CAPLAN MS, 1994, PEDIATR PATHOL, V14, P1017, DOI 10.3109/15513819409037698; Carrasco R, 2004, J PEDIATR SURG, V39, P1693, DOI 10.1016/j.jpedsurg.2004.07.017; Ceylan H, 2005, EUR J PEDIATR SURG, V15, P325, DOI 10.1055/s-2005-865820; Cintra AESU, 2008, TRANSPL P, V40, P830, DOI 10.1016/j.transproceed.2008.02.044; Cordero L, 2004, AM J INFECT CONTROL, V32, P189, DOI 10.1016/j.ajic.2003.07.004; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Halpern MD, 2008, AM J PHYSIOL-GASTR L, V294, pG20, DOI 10.1152/ajpgi.00168.2007; Jilling T, 2004, PEDIATR RES, V55, P622, DOI 10.1203/01.PDR.0000113463.70435.74; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; KLIEGMAN RM, 1990, J PEDIATR-US, V117, pS2, DOI 10.1016/S0022-3476(05)81123-0; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Lee Jane S, 2003, Semin Neonatol, V8, P449, DOI 10.1016/S1084-2756(03)00123-4; Magne F, 2006, FEMS MICROBIOL ECOL, V57, P128, DOI 10.1111/j.1574-6941.2006.00097.x; Millar MR, 1996, J CLIN MICROBIOL, V34, P2506, DOI 10.1128/JCM.34.10.2506-2510.1996; Morowitz MJ, 2010, PEDIATRICS, V125, P777, DOI 10.1542/peds.2009-3149; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Nadler EP, 2000, J SURG RES, V92, P71, DOI 10.1006/jsre.2000.5877; Poroyko V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012459; RADULESCU A, 1933, J PEDIAT SURG, V45; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sodhi C, 2008, DIS MODEL MECH, V1, P94, DOI 10.1242/dmm.000315; Tian RL, 2010, INT J CLIN EXP MED, V3, P293; Tudehope DI, 2005, J PAEDIATR CHILD H, V41, P167, DOI 10.1111/j.1440-1754.2005.00581.x; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Young C, 2009, PEDIATR RES, V65, p91R, DOI 10.1203/PDR.0b013e31819dba7d	30	42	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18084	10.1371/journal.pone.0018084	http://dx.doi.org/10.1371/journal.pone.0018084			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445365	Green Published, Green Submitted, gold			2022-12-27	WOS:000288809100029
J	Liu, JX; Pinnock, SB; Herbert, J				Liu, Jian Xin; Pinnock, Scarlett B.; Herbert, Joe			Novel Control by the CA3 Region of the Hippocampus on Neurogenesis in the Dentate Gyrus of the Adult Rat	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; MOSSY FIBERS; KAINIC ACID; ADRENAL-STEROIDS; BRAIN; CORTICOSTERONE; EXPRESSION; CELLS; FLUOXETINE; SURVIVAL	The dentate gyrus is a site of continued neurogenesis in the adult brain. The CA3 region of the hippocampus is the major projection area from the dentate gyrus. CA3 sends reciprocal projections back to the dentate gyrus. Does this imply that CA3 exerts some control over neurogenesis? We studied the effects of lesions of CA3 on neurogenesis in the dentate gyrus, and on the ability of fluoxetine to stimulate mitotic activity in the progenitor cells. Unilateral ibotenic-acid generated lesions were made in CA3. Four days later there was no change on the number of either BrdU or Ki67-positive progenitor cells in the dentate gyrus. However, after 15 or 28 days, there was a marked reduction in surviving BrdU-labelled cells on the lesioned side (but no change in Ki-67+ cells). pCREB or Wnt3a did not co-localise with Ki-67 but with NeuN, a marker of mature neurons. Lesions had no effect on the basal expression of either pCREB or Wnt3a. Subcutaneous fluoxetine (10 mg/kg/day) for 14 days increased the number of Ki67+ cells as expected on the control (non-lesioned) side but not on that with a CA3 lesion. Nevertheless, the expected increase in BDNF, pCREB and Wnt3a still occurred on the lesioned side following fluoxetine treatment. Fluoxetine has been reported to decrease the number of "mature" calbindin-positive cells in the dentate gyrus; we found this still occurred on the side of a CA3 lesion. We then showed that the expression GAP-43 was reduced in the dentate gyrus on the lesioned side, confirming the existence of a synaptic connection between CA3 and the dentate gyrus. These results show that CA3 has a hitherto unsuspected role in regulating neurogenesis in the dentate gyrus of the adult rat.	[Liu, Jian Xin] Xi An Jiao Tong Univ, Inst Neurobiol, Sch Med, Xian, Peoples R China; [Pinnock, Scarlett B.; Herbert, Joe] Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England; [Pinnock, Scarlett B.; Herbert, Joe] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	Xi'an Jiaotong University; University of Cambridge; University of Cambridge	Liu, JX (corresponding author), Xi An Jiao Tong Univ, Inst Neurobiol, Sch Med, Xian, Peoples R China.	jh24@cam.ac.uk	Herbert, Joe/K-5877-2013		Wellcome Trust; Institute of Neurobiology, Xi'an Jiaotong University, P.R. China	Wellcome Trust(Wellcome TrustEuropean Commission); Institute of Neurobiology, Xi'an Jiaotong University, P.R. China	Work was supported by a grant from the Wellcome Trust. Dr. J. Liu is supported by the Institute of Neurobiology, Xi'an Jiaotong University, P.R. China. The authors declare that they have no financial or other matters to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Adlard PA, 2004, NEUROSCIENCE, V124, P985, DOI 10.1016/j.neuroscience.2003.12.039; ALME MN, 2007, NEURAL PLAST, V2007; Balu DT, 2009, NEUROSCI BIOBEHAV R, V33, P232, DOI 10.1016/j.neubiorev.2008.08.007; Bendotti C, 2000, EXP NEUROL, V161, P317, DOI 10.1006/exnr.1999.7262; BENDOTTI C, 1994, EUR J NEUROSCI, V6, P509, DOI 10.1111/j.1460-9568.1994.tb00294.x; Bendotti C, 1997, EUR J NEUROSCI, V9, P93, DOI 10.1111/j.1460-9568.1997.tb01357.x; Cameron H, 1996, J COMP NEUROL, V369, P56, DOI 10.1002/(SICI)1096-9861(19960520)369:1<56::AID-CNE4>3.0.CO;2-J; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; CASTREN E, DEV NEUROBIOL, V70, P289; CRONIN J, 1988, BRAIN RES, V474, P181, DOI 10.1016/0006-8993(88)90681-6; DAVENPORT CJ, 1990, EXP NEUROL, V109, P180, DOI 10.1016/0014-4886(90)90072-Z; Dias BG, 2003, NEUROPHARMACOLOGY, V45, P553, DOI 10.1016/S0028-3908(03)00198-9; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gold AE, 2005, HIPPOCAMPUS, V15, P808, DOI 10.1002/hipo.20103; GOULD E, 1991, J COMP NEUROL, V313, P486, DOI 10.1002/cne.903130309; HANSON ND, 2011, J PHARM EXP THER; Herbert J, 2006, J NEUROENDOCRINOL, V18, P393, DOI 10.1111/j.1365-2826.2006.01429.x; Huang GJ, 2008, MOL PSYCHIATR, V13, P119, DOI 10.1038/sj.mp.4002104; Huang GJ, 2006, BIOL PSYCHIAT, V59, P619, DOI 10.1016/j.biopsych.2005.09.016; Karishma KK, 2002, EUR J NEUROSCI, V16, P445, DOI 10.1046/j.1460-9568.2002.02099.x; KNEISLER TB, 1995, J PHYSIOL-LONDON, V487, P125, DOI 10.1113/jphysiol.1995.sp020866; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P8434, DOI 10.1073/pnas.0912690107; Lucassen PJ, 2010, EUR NEUROPSYCHOPHARM, V20, P1, DOI 10.1016/j.euroneuro.2009.08.003; Marlatt MW, 2010, BRAIN RES, V1341, P93, DOI 10.1016/j.brainres.2010.03.086; Nair A, 2006, J BIOSCIENCES, V31, P423, DOI 10.1007/BF02704114; Navailles S, 2008, J COMP NEUROL, V509, P372, DOI 10.1002/cne.21775; Oestreicher AB, 1997, PROG NEUROBIOL, V53, P627, DOI 10.1016/S0301-0082(97)00043-9; Paxinos G, 1998, RAT BRAIN STEROTAXIC; Pinnock SB, 2008, EUR J NEUROSCI, V27, P2493, DOI 10.1111/j.1460-9568.2008.06250.x; Pinnock SB, 2007, NEUROPSYCHOPHARMACOL, V32, P493, DOI 10.1038/sj.npp.1301245; Pinnock SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013652; Prickaerts J, 2004, NEUROBIOL LEARN MEM, V81, P1, DOI 10.1016/j.nlm.2003.09.001; Scharfman HE, 2007, PROG BRAIN RES, V163, P627, DOI 10.1016/S0079-6123(07)63034-9	34	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17562	10.1371/journal.pone.0017562	http://dx.doi.org/10.1371/journal.pone.0017562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21464973	Green Submitted, Green Published, gold			2022-12-27	WOS:000288545100017
J	Villalonga-Planells, R; Coll-Mulet, L; Martinez-Soler, F; Castano, E; Acebes, JJ; Gimenez-Bonafe, P; Gil, J; Tortosa, A				Villalonga-Planells, Ruth; Coll-Mulet, Llorenc; Martinez-Soler, Fina; Castano, Esther; Acebes, Juan-Jose; Gimenez-Bonafe, Pepita; Gil, Joan; Tortosa, Avelina			Activation of p53 by Nutlin-3a Induces Apoptosis and Cellular Senescence in Human Glioblastoma Multiforme	PLOS ONE			English	Article							SMALL-MOLECULE ANTAGONISTS; IN-VITRO; GENETIC ALTERATIONS; SIGNALING PATHWAYS; MDM2; CANCER; CELLS; SURVIVIN; VIVO; QUIESCENCE	Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor in adults. Despite concerted efforts to improve current therapies and develop novel clinical approaches, patient survival remains poor. As such, increasing attention has focused on developing new therapeutic strategies that specifically target the apoptotic pathway in order to improve treatment responses. Recently, nutlins, small-molecule antagonists of MDM2, have been developed to inhibit p53-MDM2 interaction and activate p53 signaling in cancer cells. Glioma cell lines and primary cultured glioblastoma cells were treated with nutlin-3a. Nutlin-3a induced p53-dependent G1- and G2-M cell cycle arrest and apoptosis in glioma cell lines with normal TP53 status. In addition, nutlin-arrested glioma cells show morphological features of senescence and persistent induction of p21 protein. Furthermore, senescence induced by nutlin-3a might be depending on mTOR pathway activity. In wild-type TP53 primary cultured cells, exposure to nutlin-3a resulted in variable degrees of apoptosis as well as cellular features of senescence. Nutlin-3a-induced apoptosis and senescence were firmly dependent on the presence of functional p53, as revealed by the fact that glioblastoma cells with knockdown p53 with specific siRNA, or cells with mutated or functionally impaired p53 pathway, were completely insensitive to the drug. Finally, we also found that nutlin-3a increased response of glioma cells to radiation therapy. The results provide a basis for the rational use of MDM2 antagonists as a novel treatment option for glioblastoma patients.	[Villalonga-Planells, Ruth; Coll-Mulet, Llorenc; Martinez-Soler, Fina; Gimenez-Bonafe, Pepita; Gil, Joan] Bellvitge Univ Barcelona, Inst Invest Biomed, Dept Ciencies Fisiol 2, Barcelona, Spain; [Martinez-Soler, Fina; Tortosa, Avelina] Bellvitge Univ Barcelona, Inst Invest Biomed, Dept Basic Nursing, Barcelona, Spain; [Castano, Esther] Univ Barcelona, Unitat Biol Bellvitge, Serv Cientificotecn, Barcelona, Spain; [Acebes, Juan-Jose] Bellvitge Hosp Bellvitge, Inst Invest Biomed, Serv Neurocirurgia, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital	Villalonga-Planells, R (corresponding author), Bellvitge Univ Barcelona, Inst Invest Biomed, Dept Ciencies Fisiol 2, Barcelona, Spain.	atortosa@ub.edu	Tortosa, Avelina/O-7788-2016	Tortosa, Avelina/0000-0002-9080-2976; Castano, Esther/0000-0002-7140-2272; Gil, Joan/0000-0002-3686-3903; Gimenez-Bonafe, Pepita/0000-0002-4713-903X	Spanish Ministry of Health [FIS 05/0689, FIS 08/1085]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC); Instituto de Salud Carlos III (ISCIII); Spanish Ministry of Science and Innovation [ISCIII-RETIC RD06/0020/0097]; Fundacion Medica Mutua Madrilena; Spanish Ministry of Education and Science; FEDER [SAF2007-60964]; Catalonia regional government [2005SGR00549]; IDIBELL; Jose Carreras International Leukemia Foundation; ISCIII-RETIC [RD06/0020/0097]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Red Tematica de Investigacion Cooperativa en Cancer (RTICC)(European Commission); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Medica Mutua Madrilena(Instituto de Salud Carlos III); Spanish Ministry of Education and Science(Spanish Government); FEDER(European Commission); Catalonia regional government; IDIBELL; Jose Carreras International Leukemia Foundation; ISCIII-RETIC(Instituto de Salud Carlos III)	This study was supported by grants from the Spanish Ministry of Health (FIS 05/0689; FIS 08/1085), Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation (ISCIII-RETIC RD06/0020/0097), Fundacion Medica Mutua Madrilena 2007, Spanish Ministry of Education and Science and FEDER (SAF2007-60964), and Catalonia regional government (2005SGR00549). RV and LCM are the recipients of fellowships from IDIBELL and the Jose Carreras International Leukemia Foundation, respectively. FMS has a research scientist position funded by ISCIII-RETIC RD06/0020/0097. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Brell M, 2005, CLIN CANCER RES, V11, P5167, DOI 10.1158/1078-0432.CCR-05-0230; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coll-Mulet L, 2006, BLOOD, V107, P4109, DOI 10.1182/blood-2005-08-3273; Demidenko ZN, 2010, P NATL ACAD SCI USA, V107, P9660, DOI 10.1073/pnas.1002298107; Drakos E, 2007, CLIN CANCER RES, V13, P3380, DOI 10.1158/1078-0432.CCR-06-2581; Eldering E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng153; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Hofseth LJ, 2004, TRENDS PHARMACOL SCI, V25, P177, DOI 10.1016/j.tips.2004.02.009; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Itahana K, 2001, EUR J BIOCHEM, V268, P2784, DOI 10.1046/j.1432-1327.2001.02228.x; Kitagawa M, 2008, ONCOGENE, V27, P5303, DOI 10.1038/onc.2008.164; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Korotchkina LG, 2009, CELL CYCLE, V8, P3777, DOI 10.4161/cc.8.22.10121; Krakstad C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-135; Logan IR, 2007, PROSTATE, V67, P900, DOI 10.1002/pros.20568; Long JS, 2010, CELL CYCLE, V9, P4050, DOI 10.4161/cc.9.20.13747; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Poyurovsky MV, 2010, AGING-US, V2, P380, DOI 10.18632/aging.100179; Serrano M, 2010, CELL CYCLE, V9, P4256, DOI 10.4161/cc.9.21.13785; Siegelin MD, 2009, NEURO-ONCOLOGY, V11, P122, DOI 10.1215/15228517-2008-085; Stuhmer T, 2005, BLOOD, V106, P3609, DOI 10.1182/blood-2005-04-1489; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2007, J CLIN ONCOL, V25, P4127, DOI 10.1200/JCO.2007.11.8554; Sullivan A, 2004, ONCOGENE, V23, P3328, DOI 10.1038/sj.onc.1207428; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; The WHO, 2020, CLASSIFICATION TUMOU; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Uchida H, 2004, MOL THER, V10, P162, DOI 10.1016/j.ymthe.2004.05.006; VanderBorght A, 2006, ONCOGENE, V25, P6672, DOI 10.1038/sj.onc.1209667; Vassilev LT, 2004, CELL CYCLE, V3, P419; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584	44	88	91	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18588	10.1371/journal.pone.0018588	http://dx.doi.org/10.1371/journal.pone.0018588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483692	Green Published, gold			2022-12-27	WOS:000289191300030
J	Caspers, S; Heim, S; Lucas, MG; Stephan, E; Fischer, L; Amunts, K; Zilles, K				Caspers, Svenja; Heim, Stefan; Lucas, Marc G.; Stephan, Egon; Fischer, Lorenz; Amunts, Katrin; Zilles, Karl			Moral Concepts Set Decision Strategies to Abstract Values	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; POSTERIOR PARIETAL CORTEX; MEDIAL PREFRONTAL CORTEX; HUMAN AMYGDALA; FUNCTIONAL ACTIVATION; NEURAL MECHANISMS; PROBABILITY MAPS; SOCIAL COGNITION; FMRI; REPRESENTATIONS	Persons have different value preferences. Neuroimaging studies where value-based decisions in actual conflict situations were investigated suggest an important role of prefrontal and cingulate brain regions. General preferences, however, reflect a superordinate moral concept independent of actual situations as proposed in psychological and socioeconomic research. Here, the specific brain response would be influenced by abstract value systems and moral concepts. The neurobiological mechanisms underlying such responses are largely unknown. Using functional magnetic resonance imaging (fMRI) with a forced-choice paradigm on word pairs representing abstract values, we show that the brain handles such decisions depending on the person's superordinate moral concept. Persons with a predominant collectivistic (altruistic) value system applied a "balancing and weighing" strategy, recruiting brain regions of rostral inferior and intraparietal, and midcingulate and frontal cortex. Conversely, subjects with mainly individualistic (egocentric) value preferences applied a "fight-and-flight" strategy by recruiting the left amygdala. Finally, if subjects experience a value conflict when rejecting an alternative congruent to their own predominant value preference, comparable brain regions are activated as found in actual moral dilemma situations, i.e., midcingulate and dorsolateral prefrontal cortex. Our results demonstrate that superordinate moral concepts influence the strategy and the neural mechanisms in decision processes, independent of actual situations, showing that decisions are based on general neural principles. These findings provide a novel perspective to future sociological and economic research as well as to the analysis of social relations by focusing on abstract value systems as triggers of specific brain responses.	[Caspers, Svenja; Heim, Stefan; Amunts, Katrin; Zilles, Karl] Forschungszentrum Julich, Inst Neurosci & Med INM 1 INM 2, D-52425 Julich, Germany; [Heim, Stefan; Amunts, Katrin; Zilles, Karl] JARA BRAIN, Julich, Germany; [Heim, Stefan; Amunts, Katrin] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Heim, Stefan] Rhein Westfal TH Aachen, Sect Neurol Cognit Res, Dept Neurol, Aachen, Germany; [Lucas, Marc G.; Stephan, Egon] Univ Cologne, Dept Psychol, INEKO, Cologne, Germany; [Lucas, Marc G.] FernUniv Hagen, Dept Business Studies Leadership & Org, Hagen, Germany; [Fischer, Lorenz] Univ Cologne, Inst Econ & Social Psychol, Cologne, Germany; [Zilles, Karl] Univ Dusseldorf, C & O Vogt Inst Brain Res, Dusseldorf, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University; RWTH Aachen University; University of Cologne; Fern University Hagen; University of Cologne; Heinrich Heine University Dusseldorf	Caspers, S (corresponding author), Forschungszentrum Julich, Inst Neurosci & Med INM 1 INM 2, D-52425 Julich, Germany.	s.caspers@fz-juelich.de	Caspers, Svenja/H-9346-2013; Zilles, Karl/Y-3784-2019; Amunts, Katrin/I-3470-2013; Zilles, Karl/J-9704-2013; Heim, Stefan/G-6348-2013	Caspers, Svenja/0000-0001-5083-4669; Zilles, Karl/0000-0002-4705-4175; Amunts, Katrin/0000-0001-5828-0867; Zilles, Karl/0000-0001-9296-9959; Heim, Stefan/0000-0002-5818-8355	Helmholtz Association within the Helmholtz Alliance on Systems Biology; Helmholtz Alliance for Mental Health in an Aging Society; German Federal Ministry of Education and Research ('Bundesministerium fur Bildung und Forschung', BMBF) [01GW0613]	Helmholtz Association within the Helmholtz Alliance on Systems Biology; Helmholtz Alliance for Mental Health in an Aging Society; German Federal Ministry of Education and Research ('Bundesministerium fur Bildung und Forschung', BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (Human Brain Model; KZ), the Helmholtz Alliance for Mental Health in an Aging Society (HelMA; KZ, KA), and a grant of the German Federal Ministry of Education and Research ('Bundesministerium fur Bildung und Forschung', BMBF; No: 01GW0613; KA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2003, ANN NY ACAD SCI, V985, P326; Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Amaro E, 2006, BRAIN COGNITION, V60, P220, DOI 10.1016/j.bandc.2005.11.009; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Aycan Z, 2000, APPL PSYCHOL-INT REV, V49, P192, DOI 10.1111/1464-0597.00010; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Barbey AK, 2009, TRENDS NEUROSCI, V32, P603, DOI 10.1016/j.tins.2009.09.001; Barbey AK, 2009, PHILOS T R SOC B, V364, P1291, DOI 10.1098/rstb.2008.0315; Barch DM, 2001, CEREB CORTEX, V11, P837, DOI 10.1093/cercor/11.9.837; Berthoz S, 2006, NEUROIMAGE, V31, P945, DOI 10.1016/j.neuroimage.2005.12.039; *BIBL I AG, 2009, DUD WORT SYN; BLAIR RJR, 1995, COGNITION, V57, P1, DOI 10.1016/0010-0277(95)00676-P; BORKENAU P, 1993, NEO 5 FACTORIAL INVE; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Caspers S, 2008, BRAIN STRUCT FUNCT, V212, P481, DOI 10.1007/s00429-008-0195-z; Caspers S, 2006, NEUROIMAGE, V33, P430, DOI 10.1016/j.neuroimage.2006.06.054; Chatman JA, 1998, ADMIN SCI QUART, V43, P749, DOI 10.2307/2393615; Choi HJ, 2006, J COMP NEUROL, V495, P53, DOI 10.1002/cne.20849; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Derbyshire S W, 2000, Curr Rev Pain, V4, P467; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9; Faymonville ME, 2000, ANESTHESIOLOGY, V92, P1257, DOI 10.1097/00000542-200005000-00013; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Funk CM, 2009, CURR OPIN NEUROBIOL, V19, P678, DOI 10.1016/j.conb.2009.09.011; Fusar-Poli P, 2009, NEUROSCI LETT, V452, P262, DOI 10.1016/j.neulet.2009.01.065; Goossens L, 2009, HUM BRAIN MAPP, V30, P3332, DOI 10.1002/hbm.20755; GRAVES CW, 1970, J HUMANIST PSYCHOL, V10, P131, DOI 10.1177/002216787001000205; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Harenski CL, 2006, NEUROIMAGE, V30, P313, DOI 10.1016/j.neuroimage.2005.09.034; Heim S, 2008, ACTA NEUROBIOL EXP, V68, P73; Heim S, 2006, NEUROREPORT, V17, P1097, DOI 10.1097/01.wnr.0000224775.05023.42; Hofstede G., 1980, CULTURES CONSEQUENCE; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Hurlemann R, 2008, J NEUROSCI METH, V172, P13, DOI 10.1016/j.jneumeth.2008.04.004; Kluckhohn F. R., 1961, VARIATIONS VALUE ORI, P450; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Kohlberg L., 1969, HDB SOCIALIZATION TH, P347, DOI DOI 10.12691/EDUCATION-3-9-16; Loevinger J., 1970, MEASURING EGO DEV; Maslow A.H., 1962, PSYCHOL BEING; Mevorach C, 2006, NAT NEUROSCI, V9, P740, DOI 10.1038/nn1709; Mevorach C, 2006, NEUROPSYCHOLOGIA, V44, P307, DOI 10.1016/j.neuropsychologia.2005.04.015; Mevorach C, 2009, J COGNITIVE NEUROSCI, V21, P1204, DOI 10.1162/jocn.2009.21088; Mitchell JP, 2005, NEUROIMAGE, V26, P251, DOI 10.1016/j.neuroimage.2005.01.031; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Moll J, 2008, ANN NY ACAD SCI, V1124, P161, DOI 10.1196/annals.1440.005; Palomero-Gallagher N, 2009, HUM BRAIN MAPP, V30, P2336, DOI 10.1002/hbm.20667; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Platek SM, 2004, COGNITIVE BRAIN RES, V19, P114, DOI 10.1016/j.cogbrainres.2003.11.014; Price CJ, 1999, NEUROIMAGE, V10, P36, DOI 10.1006/nimg.1999.0447; Raine A, 2006, SOC COGN AFFECT NEUR, V1, P203, DOI 10.1093/scan/nsl033; Richardson FM, 2009, BRAIN STRUCT FUNCT, V213, P511, DOI 10.1007/s00429-009-0211-y; Riddoch MJ, 2010, ANN NY ACAD SCI, V1191, P156, DOI 10.1111/j.1749-6632.2010.05448.x; Rokeach M., 1973, NATURE HUMAN VALUES; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schlaggar BL, 2007, ANNU REV NEUROSCI, V30, P475, DOI 10.1146/annurev.neuro.28.061604.135645; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; SCHWARTZ SH, 1987, J PERS SOC PSYCHOL, V53, P550, DOI 10.1037/0022-3514.53.3.550; Shenhav A, 2010, NEURON, V67, P667, DOI 10.1016/j.neuron.2010.07.020; Sommer M, 2010, NEUROPSYCHOLOGIA, V48, P2018, DOI 10.1016/j.neuropsychologia.2010.03.023; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Stackman RW, 2000, HDB ORG CULTURE CLIM, P37; Vogt BA, 2003, J CHEM NEUROANAT, V26, P301, DOI 10.1016/j.jchemneu.2003.09.004; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Weiss RH, 1998, TEST BASIC INTELLIGE; Winston JS, 2005, J NEUROSCI, V25, P8903, DOI 10.1523/JNEUROSCI.1569-05.2005; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	82	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18451	10.1371/journal.pone.0018451	http://dx.doi.org/10.1371/journal.pone.0018451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743ZB	21483767	Green Published, gold, Green Submitted			2022-12-27	WOS:000289058300017
J	Pathak, A; Kumar, S				Pathak, Amit; Kumar, Sanjay			From Molecular Signal Activation to Locomotion: An Integrated, Multiscale Analysis of Cell Motility on Defined Matrices	PLOS ONE			English	Article							MIGRATION; MODEL; ADHESIONS; SUBSTRATE; RIGIDITY; MUSCLE; ACTIN; FIBROBLASTS; PROTRUSION; MECHANICS	The adhesion, mechanics, and motility of eukaryotic cells are highly sensitive to the ligand density and stiffness of the extracellular matrix (ECM). This relationship bears profound implications for stem cell engineering, tumor invasion and metastasis. Yet, our quantitative understanding of how ECM biophysical properties, mechanotransductive signals, and assembly of contractile and adhesive structures collude to control these cell behaviors remains extremely limited. Here we present a novel multiscale model of cell migration on ECMs of defined biophysical properties that integrates local activation of biochemical signals with adhesion and force generation at the cell-ECM interface. We capture the mechanosensitivity of individual cellular components by dynamically coupling ECM properties to the activation of Rho and Rac GTPases in specific portions of the cell with actomyosin contractility, cell-ECM adhesion bond formation and rupture, and process extension and retraction. We show that our framework is capable of recreating key experimentally-observed features of the relationship between cell migration and ECM biophysical properties. In particular, our model predicts for the first time recently reported transitions from filopodial to "stick-slip" to gliding motility on ECMs of increasing stiffness, previously observed dependences of migration speed on ECM stiffness and ligand density, and high-resolution measurements of mechanosensitive protrusion dynamics during cell motility we newly obtained for this study. It also relates the biphasic dependence of cell migration speed on ECM stiffness to the tendency of the cell to polarize. By enabling the investigation of experimentally-inaccessible microscale relationships between mechanotransductive signaling, adhesion, and motility, our model offers new insight into how these factors interact with one another to produce complex migration patterns across a variety of ECM conditions.	[Pathak, Amit; Kumar, Sanjay] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Pathak, A (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	skumar@berkeley.edu	Pathak, Amit/H-3049-2013	Pathak, Amit/0000-0003-4006-5119	Arnold and Mabel Beckman Young Investigator Award; NSF [CMMI 0727420]; Army Research Office [W911NF-09-1-0507]; NIH Physical Sciences Oncology Center [1U54CA143836]; NIH [1DP2OD004213]; NATIONAL CANCER INSTITUTE [U54CA143836] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004213] Funding Source: NIH RePORTER	Arnold and Mabel Beckman Young Investigator Award; NSF(National Science Foundation (NSF)); Army Research Office; NIH Physical Sciences Oncology Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Arnold and Mabel Beckman Young Investigator Award, the NSF (CMMI 0727420), a PECASE award from the Army Research Office (W911NF-09-1-0507), an NIH Physical Sciences Oncology Center Grant (1U54CA143836), and an NIH Director's New Innovator Award (1DP2OD004213), a part of the NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Dokukina IV, 2010, BIOPHYS J, V98, P2794, DOI 10.1016/j.bpj.2010.03.026; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Herant M, 2003, BIOPHYS J, V84, P3389, DOI 10.1016/S0006-3495(03)70062-9; Herant M, 2010, BIOPHYS J, V98, P1408, DOI 10.1016/j.bpj.2009.12.4303; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Nicolas A, 2004, P NATL ACAD SCI USA, V101, P12520, DOI 10.1073/pnas.0403539101; Nishimura SI, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000310; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002; Walcott S, 2010, P NATL ACAD SCI USA, V107, P7757, DOI 10.1073/pnas.0912739107; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zemel A., 2010, NAT PHYS	35	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18423	10.1371/journal.pone.0018423	http://dx.doi.org/10.1371/journal.pone.0018423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483802	gold, Green Submitted, Green Published			2022-12-27	WOS:000289057200073
J	Crumbley, C; Burris, TP				Crumbley, Christine; Burris, Thomas P.			Direct Regulation of CLOCK Expression by REV-ERB	PLOS ONE			English	Article							CIRCADIAN TRANSCRIPTION; NUCLEAR RECEPTORS; TARGET GENE; ALPHA; LIGAND; CLONING; NPAS2; HEME	Circadian rhythms are regulated at the cellular level by transcriptional feedback loops leading to oscillations in expression of key proteins including CLOCK, BMAL1, PERIOD (PER), and CRYPTOCHROME (CRY). The CLOCK and BMAL1 proteins are members of the bHLH class of transcription factors and form a heterodimer that regulates the expression of the PER and CRY genes. The nuclear receptor REV-ERB alpha plays a key role in regulation of oscillations in BMAL1 expression by directly binding to the BMAL1 promoter and suppressing its expression at certain times of day when REV-ERB alpha expression levels are elevated. We recently demonstrated that REV-ERB alpha also regulates the expression of NPAS2, a heterodimer partner of BMAL1. Here, we show that REV-ERB alpha also regulates the expression another heterodimer partner of BMAL1, CLOCK. We identified a REV-ERB alpha binding site within the 1(st) intron of the CLOCK gene using a chromatin immunoprecipitation microarray screen. Suppression of REV-ERB alpha expression resulted in elevated CLOCK mRNA expression consistent with REV-ERB alpha's role as a transcriptional repressor. A REV-ERB response element (RevRE) was identified within this region of the CLOCK gene and was conserved between humans and mice. Additionally, the CLOCK RevRE conferred REV-ERB responsiveness to a heterologous reporter gene. Our data suggests that REV-ERB alpha plays a dual role in regulation of the activity of the BMAL1/CLOCK heterodimer by regulation of expression of both the BMAL1 and CLOCK genes.	[Crumbley, Christine; Burris, Thomas P.] Scripps Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute	Crumbley, C (corresponding author), Scripps Res Inst, Jupiter, FL 33458 USA.	tburris@scripps.edu	Burris, Thomas/H-5078-2011; Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449	National Institutes of Health (NIH) [R01DK080201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092769] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health (NIH) R01DK080201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolucci C, 2008, MOL CELL BIOL, V28, P3070, DOI 10.1128/MCB.01931-07; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; GRANT D, ACS CHEM BIOL, V5, P925; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; KOJETIN D, ACS CHEM BIOL; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; Meng QJ, 2008, J CELL SCI, V121, P3629, DOI 10.1242/jcs.035048; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Rogers PM, 2008, BIOCHEM BIOPH RES CO, V368, P955, DOI 10.1016/j.bbrc.2008.02.031; Stayrook KR, 2008, MOL PHARMACOL, V73, P607, DOI 10.1124/mol.107.039099; Steeves TDL, 1999, GENOMICS, V57, P189, DOI 10.1006/geno.1998.5675; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wang YJ, 2008, MOL PHARMACOL, V74, P1716, DOI 10.1124/mol.108.048538; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200	20	112	116	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17290	10.1371/journal.pone.0017290	http://dx.doi.org/10.1371/journal.pone.0017290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479263	Green Submitted, gold, Green Published			2022-12-27	WOS:000289054600008
J	Carvalho, FA; de Oliveira, S; Freitas, T; Goncalves, S; Santos, NC				Carvalho, Filomena A.; de Oliveira, Sofia; Freitas, Teresa; Goncalves, Sonia; Santos, Nuno C.			Variations on Fibrinogen-Erythrocyte Interactions during Cell Aging	PLOS ONE			English	Article							RED-BLOOD-CELLS; MOLECULAR RECOGNITION; GOLD NANOPARTICLES; FORCE SPECTROSCOPY; BINDING-SITES; SIALIC-ACID; MEMBRANE; CENTRIFUGATION; AGGREGATION; POPULATIONS	Erythrocyte hyperaggregation, a cardiovascular risk factor, is considered to be caused by an increase in plasma adhesion proteins, particularly fibrinogen. We have recently reported a specific binding between fibrinogen and an erythrocyte integrin receptor with a beta(3) or beta(3)-like subunit. In this study we evaluate the influence of erythrocyte aging on the fibrinogen binding. By atomic force microscopy-based force spectroscopy measurements we found that increasing erythrocyte age, there is a decrease of the binding to fibrinogen by decreasing the frequency of its occurrence but not its force. This observation is reinforced by zeta-potential and fluorescence spectroscopy measurements. We conclude that upon erythrocyte aging the number of fibrinogen molecules bound to each cell decreases significantly, due to the progressive impairment of the specific fibrinogen-erythrocyte receptor interaction. Knowing that younger erythrocytes bind more to fibrinogen, we could presume that this population is the main contributor to the cardiovascular diseases associated with increased fibrinogen content in blood, which could disturb the blood flow. Our data also show that the sialic acids exposed on the erythrocyte membrane contribute for the interaction with fibrinogen, possibly by facilitating its binding to the erythrocyte membrane receptor.	[Carvalho, Filomena A.; de Oliveira, Sofia; Freitas, Teresa; Goncalves, Sonia; Santos, Nuno C.] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal	Universidade de Lisboa	Carvalho, FA (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.	nsantos@fm.ul.pt	de Oliveira, Sofia/AAV-4304-2020; Gonçalves, Sónia/H-9482-2017; Pieper, Maja/AAN-8539-2020; Santos, Nuno/N-7248-2013; Carvalho, Filomena A./M-9202-2013	de Oliveira, Sofia/0000-0003-0893-111X; Gonçalves, Sónia/0000-0003-2903-4282; Santos, Nuno/0000-0002-0580-0475; Carvalho, Filomena A./0000-0001-6088-3894	Fundacao para a Ciencia e a Tecnologia - Ministerio da Ciencia, Tecnologia e Ensino Superior (FCT-MCTES, Portugal) [CONC-REEQ/140/2001, PTDC/SAU-OSM/73449/2006]; Fundacao Calouste Gulbenkian (Portugal)	Fundacao para a Ciencia e a Tecnologia - Ministerio da Ciencia, Tecnologia e Ensino Superior (FCT-MCTES, Portugal)(Portuguese Foundation for Science and Technology); Fundacao Calouste Gulbenkian (Portugal)	This work was supported by Fundacao para a Ciencia e a Tecnologia - Ministerio da Ciencia, Tecnologia e Ensino Superior (FCT-MCTES, Portugal; grants CONC-REEQ/140/2001 and PTDC/SAU-OSM/73449/2006) and by Fundacao Calouste Gulbenkian (Portugal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERMAN EM, 1980, BLOOD, V55, P817; Barattin R, 2008, CHEM COMMUN, P1513, DOI 10.1039/b614328h; BOSCH FH, 1992, BLOOD, V79, P254; Bratosin D, 1998, BIOCHIMIE, V80, P173, DOI 10.1016/S0300-9084(98)80024-2; Brewer SH, 2005, LANGMUIR, V21, P9303, DOI 10.1021/la050588t; Carvalho FA, 2010, ACS NANO, V4, P4609, DOI 10.1021/nn1009648; CHEN XY, 2007, CURRENT APPL PHYS, V7, pE94, DOI DOI 10.1016/J.CAP.2006.11.024; Chtcheglova LA, 2008, BIOPOLYMERS, V89, P292, DOI 10.1002/bip.20910; CLARK MR, 1988, PHYSIOL REV, V68, P503, DOI 10.1152/physrev.1988.68.2.503; Corsi D, 1999, EUR J BIOCHEM, V261, P775, DOI 10.1046/j.1432-1327.1999.00336.x; DANON D, 1988, BLOOD CELLS, V14, P7; Dimitrova MN, 2000, INT J BIOL MACROMOL, V27, P187, DOI 10.1016/S0141-8130(00)00123-9; Domingues MM, 2008, J PEPT SCI, V14, P394, DOI 10.1002/psc.1007; Domingues MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008385; Goncalves S, 2007, J PHOTOCH PHOTOBIO B, V86, P170, DOI 10.1016/j.jphotobiol.2006.09.001; Hadengue AL, 1998, HYPERTENSION, V32, P324, DOI 10.1161/01.HYP.32.2.324; Kaufman ED, 2007, LANGMUIR, V23, P6053, DOI 10.1021/la063725a; KAY MMB, 1985, GERONTOLOGY, V31, P215, DOI 10.1159/000212706; KOSOWER NS, 1993, AM J HEMATOL, V42, P241, DOI 10.1002/ajh.2830420302; Lominadze D, 2002, FEBS LETT, V517, P41, DOI 10.1016/S0014-5793(02)02575-9; Lominadze D, 2002, CLIN EXP HYPERTENS, V24, P397, DOI 10.1081/CEH-120005376; MAEDA N, 1987, BIOCHIM BIOPHYS ACTA, V904, P81, DOI 10.1016/0005-2736(87)90089-7; MARIKOVS.Y, 1969, J CELL BIOL, V43, P1, DOI 10.1083/jcb.43.1.1; Matos PM, 2008, J PEPT SCI, V14, P407, DOI 10.1002/psc.1005; Matos PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009830; Racca A, 1999, MEDICINA-BUENOS AIRE, V59, P33; Ratto TV, 2006, LANGMUIR, V22, P1749, DOI 10.1021/la052087d; TERAYAMA K, 1993, IND HEALTH, V31, P113, DOI 10.2486/indhealth.31.113; Venerando B, 2002, BLOOD, V99, P1064, DOI 10.1182/blood.V99.3.1064; WALLACH DFH, 1974, BIOCHIM BIOPHYS ACTA, V356, P68, DOI 10.1016/0005-2736(74)90294-6; WARREN L, 1959, J BIOL CHEM, V234, P1971; Zawisza I, 2003, BIOPHYS J, V85, P4055, DOI 10.1016/S0006-3495(03)74819-X	33	34	36	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18167	10.1371/journal.pone.0018167	http://dx.doi.org/10.1371/journal.pone.0018167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464904	Green Published, gold			2022-12-27	WOS:000289053800024
J	Couvreur, O; Ferezou, J; Gripois, D; Serougne, C; Crepin, D; Aubourg, A; Gertler, A; Vacher, CM; Taouis, M				Couvreur, Odile; Ferezou, Jacqueline; Gripois, Daniel; Serougne, Colette; Crepin, Delphine; Aubourg, Alain; Gertler, Arieh; Vacher, Claire-Marie; Taouis, Mohammed			Unexpected Long-Term Protection of Adult Offspring Born to High-Fat Fed Dams against Obesity Induced by a Sucrose-Rich Diet	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; LEPTIN RESISTANCE; MATERNAL OBESITY; BIRTH-WEIGHT; RATS; SUSCEPTIBILITY; LACTATION; PREGNANCY; ORIGINS	Background: Metabolic and endocrine environment during early life is crucial for metabolic imprinting. When dams were fed a high fat diet (HF diet), rat offspring developed hypothalamic leptin resistance with lean phenotype when weaned on a normal diet. Interestingly, when grown on the HF diet, they appeared to be protected against the effects of HF diet as compared to offspring of normally fed dams. The mechanisms involved in the protective effect of maternal HF diet are unclear. Methodology/Principal Findings: We thus investigated the impact of maternal high fat diet on offspring subjected to normal or high palatable diet (P diet) on metabolic and endocrine parameters. We compared offspring born to dams fed P or HF diet. Offspring born to dams fed control or P diet, when fed P diet exhibited a higher body weight, altered hypothalamic leptin sensitivity and metabolic parameters suggesting that maternal P diet has no protective effect on offspring. Whereas, maternal HF diet reduces body weight gain and circulating triglycerides, and ameliorates corpulence index of offspring, even when subjected to P diet. Interestingly, this protective effect is differently expressed in male and female offspring. Male offspring exhibited higher energy expenditure as mirrored by increased hypothalamic UCP-2 and liver AdipoR1/R2 expression, and a profound change in the arcuate nucleus astrocytic organization. In female offspring, the most striking impact of maternal HF diet is the reduced hypothalamic expression of NPY and POMC. Conclusions/Significance: HF diet given during gestation and lactation protects, at least partially, offspring from excessive weight gain through several mechanisms depending upon gender including changes in arcuate nucleus astrocytic organization and increased hypothalamic UCP-2 and liver AdipoR1/2 expression in males and reduced hypothalamic expression of NPY and POMC in females. Taken together our results reveal new mechanisms involved in the protective effect of maternal HF diet.	[Couvreur, Odile; Ferezou, Jacqueline; Gripois, Daniel; Serougne, Colette; Crepin, Delphine; Aubourg, Alain; Vacher, Claire-Marie; Taouis, Mohammed] Univ Paris 11, UMR 8195, Orsay, France; [Couvreur, Odile; Ferezou, Jacqueline; Gripois, Daniel; Serougne, Colette; Crepin, Delphine; Aubourg, Alain; Vacher, Claire-Marie; Taouis, Mohammed] Ctr Neurosci Paris Sud, CNRS, UMR8195, Orsay, France; [Gertler, Arieh] Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; Hebrew University of Jerusalem	Couvreur, O (corresponding author), Univ Paris 11, UMR 8195, Orsay, France.	mohammed.taouis@u-psud.fr	Taouis, Mohammed/CAA-1797-2022	Taouis, Mohammed/0000-0002-4101-691X; Crepin, Delphine/0000-0003-1224-3926; Vacher, Claire-Marie/0000-0002-2966-8149	University of Paris-Sud 11; Groupe Lipide et Nutrition [GLN 2009-2010]	University of Paris-Sud 11; Groupe Lipide et Nutrition	The funding for this work came from University of Paris-Sud 11 and Groupe Lipide et Nutrition (GLN 2009-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amateau SK, 2002, J NEUROENDOCRINOL, V14, P904, DOI 10.1046/j.1365-2826.2002.00858.x; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; Attig L, 2008, INT J OBESITY, V32, P1153, DOI 10.1038/ijo.2008.39; Benomar Y, 2005, MOL CELL ENDOCRINOL, V242, P59, DOI 10.1016/j.mce.2005.07.003; Bouret SG, 2007, J NEUROENDOCRINOL, V19, P575, DOI 10.1111/j.1365-2826.2007.01563.x; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Cripps RL, 2007, BIOCHEM SOC T, V35, P1203, DOI 10.1042/BST0351203; Davidowa H, 2007, NEUROREPORT, V18, P521, DOI 10.1097/WNR.0b013e32805dfb93; Degasperi GR, 2008, FEBS LETT, V582, P3103, DOI 10.1016/j.febslet.2008.08.006; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Gallou-Kabani C, 2005, DIABETES, V54, P1899, DOI 10.2337/diabetes.54.7.1899; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Harder T, 2007, LANCET, V369, P1859, DOI 10.1016/S0140-6736(07)60847-2; Holemans K, 2004, AM J OBSTET GYNECOL, V190, P858, DOI 10.1016/j.ajog.2003.09.025; Ikenasio-Thorpe BA, 2007, J ENDOCRINOL, V193, P31, DOI 10.1677/joe.1.07017; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Khan IY, 2005, AM J PHYSIOL-REG I, V288, pR127, DOI 10.1152/ajpregu.00354.2004; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Levin BE, 2006, PHILOS T R SOC B, V361, P1107, DOI 10.1098/rstb.2006.1851; Lins MC, 2005, REGUL PEPTIDES, V127, P197, DOI 10.1016/j.regpep.2004.12.005; McMillen IC, 2009, ADV EXP MED BIOL, V646, P71, DOI 10.1007/978-1-4020-9173-5_8; Mong JA, 1999, J NEUROSCI, V19, P1464; Nohr EA, 2009, AM J CLIN NUTR, V90, P1288, DOI 10.3945/ajcn.2009.27919; Phillips DIW, 2006, ANN NY ACAD SCI, V1083, P28, DOI 10.1196/annals.1367.027; Salomon G, 2006, PROTEIN EXPRES PURIF, V47, P128, DOI 10.1016/j.pep.2005.09.016; Shankar K, 2008, AM J PHYSIOL-REG I, V294, pR528, DOI 10.1152/ajpregu.00316.2007; Shapiro A, 2008, AM J PHYSIOL-REG I, V295, pR1370, DOI 10.1152/ajpregu.00195.2008; Stocker C, 2004, INT J OBESITY, V28, P129, DOI 10.1038/sj.ijo.0802476; Stocker CJ, 2007, AM J PHYSIOL-REG I, V292, pR1810, DOI 10.1152/ajpregu.00676.2006; TURNER RC, 1993, FRONT DIABETES, V12, P66; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	37	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18043	10.1371/journal.pone.0018043	http://dx.doi.org/10.1371/journal.pone.0018043			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464991	Green Published, gold, Green Submitted			2022-12-27	WOS:000288813900029
J	Warren, JP; Santello, M; Tillery, SIH				Warren, Jay P.; Santello, Marco; Tillery, Stephen I. Helms			Effects of Fusion between Tactile and Proprioceptive Inputs on Tactile Perception	PLOS ONE			English	Article							PRIMARY SOMATOSENSORY CORTEX; CUTANEOUS RABBIT; SALTATION ILLUSION; ELECTROTACTILE STIMULI; VISUAL SALTATION; DIGIT SOMATOTOPY; AREA 3B; POSTURE; ORGANIZATION; FINGERTIP	Tactile perception is typically considered the result of cortical interpretation of afferent signals from a network of mechanical sensors underneath the skin. Yet, tactile illusion studies suggest that tactile perception can be elicited without afferent signals from mechanoceptors. Therefore, the extent that tactile perception arises from isomorphic mapping of tactile afferents onto the somatosensory cortex remains controversial. We tested whether isomorphic mapping of tactile afferent fibers onto the cortex leads directly to tactile perception by examining whether it is independent from proprioceptive input by evaluating the impact of different hand postures on the perception of a tactile illusion across fingertips. Using the Cutaneous Rabbit Effect, a well studied illusion evoking the perception that a stimulus occurs at a location where none has been delivered, we found that hand posture has a significant effect on the perception of the illusion across the fingertips. This finding emphasizes that tactile perception arises from integration of perceived mechanical and proprioceptive input and not purely from tactile interaction with the external environment.	[Warren, Jay P.; Santello, Marco; Tillery, Stephen I. Helms] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA; [Tillery, Stephen I. Helms] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Warren, JP (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.	jaypwarren@gmail.com	Warren, Jay/ABA-9424-2020		NIH/NINDS [RO1 NS050256]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050256] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The National Institutes of Health supported this research (NIH.gov) through NIH/NINDS RO1 NS050256. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Blankenburg F, 2006, PLOS BIOL, V4, P459, DOI 10.1371/journal.pbio.0040069; Bobich LR, 2007, SOMATOSENS MOT RES, V24, P179, DOI 10.1080/08990220701637232; BREMER CD, 1977, AM J PSYCHOL, V90, P645, DOI 10.2307/1421738; Brodmann K., 1909, LOCALIZATION CEREBRA; Chen LM, 2003, SCIENCE, V302, P881, DOI 10.1126/science.1087846; CRAIG JC, 2003, CURR BIOL, V18, P1044; CUSICK CG, 1989, J COMP NEUROL, V282, P169, DOI 10.1002/cne.902820203; Eimer M, 2005, PERCEPT PSYCHOPHYS, V67, P458, DOI 10.3758/BF03193324; Flach R, 2006, J EXP PSYCHOL HUMAN, V32, P717, DOI 10.1037/0096-1523.32.3.717; GELDARD FA, 1985, J ACOUST SOC AM, V77, P233, DOI 10.1121/1.392264; GELDARD FA, 1975, B PSYCHONOMIC SOC, V6, P433; GELDARD FA, 1984, B PSYCHONOMIC SOC, V22, P279; GELDARD FA, 1982, AM J PSYCHOL, V95, P529, DOI 10.2307/1422152; GELDARD FA, 1981, B PSYCHONOMIC SOC, V18, P55; GELDARD FA, 1980, B PSYCHONOMIC SOC, V16, P178; GELDARD FA, 1983, PERCEPT PSYCHOPHYS, V33, P299, DOI 10.3758/BF03205876; GELDARD FA, 1972, SCIENCE, V178, P178, DOI 10.1126/science.178.4057.178; GELDARD FA, 1982, PSYCHOL BULL, V92, P136, DOI 10.1037/0033-2909.92.1.136; GELDARD FA, 1977, J INVEST DERMATOL, V69, P83, DOI 10.1111/1523-1747.ep12497890; Gelnar PA, 1998, NEUROIMAGE, V7, P261, DOI 10.1006/nimg.1998.0341; Gescheider G, 1997, PSYCHOPHYSICS FUNDAM; Getzmann S, 2008, EXP PSYCHOL, V55, P64, DOI 10.1027/1618-3169.55.1.64; Getzmann S, 2009, J EXP PSYCHOL HUMAN, V35, P289, DOI 10.1037/a0013026; Goldreich D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000333; HYVARINEN J, 1978, J PHYSIOL-LONDON, V283, P539, DOI 10.1113/jphysiol.1978.sp012518; Iguchi Y, 2005, CLIN NEUROPHYSIOL, V116, P1077, DOI 10.1016/j.clinph.2004.12.005; KAAS JH, 1983, PHYSIOL REV, V63, P206, DOI 10.1152/physrev.1983.63.1.206; Kaas JH, 1981, ORG CEREBRAL CORTEX, P237; Kandel E., 2000, PRINCIPLES NEURAL SC; Kidd J, 2003, AUST J PSYCHOL, V55, P83; Krause T, 2001, BRAIN RES, V899, P36, DOI 10.1016/S0006-8993(01)02147-3; Kurth R, 1998, NEUROREPORT, V9, P207, DOI 10.1097/00001756-199801260-00006; MELLER DM, 2010, J NEUROPHYSIOLOGY; Montgomery D.C., 2009, DESIGN ANAL EXPT, V7th; Moradi F, 2004, PERCEPTION, V33, P84; Nelson AJ, 2008, CEREB CORTEX, V18, P2341, DOI 10.1093/cercor/bhm257; Overduin SA, 2004, NEUROIMAGE, V23, P462, DOI 10.1016/j.neuroimage.2004.06.024; Overvliet KE, 2011, EXP BRAIN RES, V208, P245, DOI 10.1007/s00221-010-2475-0; Phillips DP, 2002, PERCEPTION, V31, P875, DOI 10.1068/p3293; Phillips DP, 2001, J ACOUST SOC AM, V110, P1539, DOI 10.1121/1.1396329; PRUDHOMME MJL, 1994, J NEUROPHYSIOL, V72, P2280, DOI 10.1152/jn.1994.72.5.2280; PRUDHOMME MJL, 1994, J NEUROPHYSIOL, V71, P173, DOI 10.1152/jn.1994.71.1.173; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; REES G, 2003, NAT NEUROSCI, V6, P414; Roberts RD, 2010, PSYCHOL SCI, V21, P476, DOI 10.1177/0956797610363405; Ruben J, 2006, CEREB CORTEX, V16, P819, DOI 10.1093/cercor/bhj025; Sarrazin JC, 2007, PSYCHOL RES-PSYCH FO, V71, P201, DOI 10.1007/s00426-005-0019-1; Schaefer M, 2006, NEUROIMAGE, V29, P67, DOI 10.1016/j.neuroimage.2005.07.001; Schweizer R, 2008, NEUROIMAGE, V42, P28, DOI 10.1016/j.neuroimage.2008.04.184; Soto-Faraco S, 2004, PERCEPT PSYCHOPHYS, V66, P1077, DOI 10.3758/BF03196837; Tillery SIH, 1996, J NEUROPHYSIOL, V76, P2423, DOI 10.1152/jn.1996.76.4.2423; van Westen D, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-28; Warren JP, 2008, IEEE T NEUR SYS REH, V16, P410, DOI 10.1109/TNSRE.2008.925072; Warren JP, 2010, EXP BRAIN RES, V206, P419, DOI 10.1007/s00221-010-2422-0; Zampini M, 2005, EXP BRAIN RES, V166, P498, DOI 10.1007/s00221-005-2390-y	55	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18073	10.1371/journal.pone.0018073	http://dx.doi.org/10.1371/journal.pone.0018073			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464943	Green Published, gold, Green Submitted			2022-12-27	WOS:000288813900035
J	Botlagunta, M; Krishnamachary, B; Vesuna, F; Winnard, PT; Bol, GM; Patel, AH; Raman, V				Botlagunta, Mahendran; Krishnamachary, Balaji; Vesuna, Farhad; Winnard, Paul T., Jr.; Bol, Guus M.; Patel, Arvind H.; Raman, Venu			Expression of DDX3 Is Directly Modulated by Hypoxia Inducible Factor-1 Alpha in Breast Epithelial Cells	PLOS ONE			English	Article							BOX RNA HELICASE; FACTOR (HIF)-1-ALPHA; MOLECULAR-MECHANISMS; DEAD; CANCER; GENE; HIF-2-ALPHA; REQUIREMENT; SUPPRESSOR; PROTEIN-3	DEAD box protein, DDX3, is aberrantly expressed in breast cancer cells ranging from weakly invasive to aggressive phenotypes and functions as an important regulator of cancer cell growth and survival. Here, we demonstrate that hypoxia inducible factor-1 alpha is a transcriptional activator of DDX3 in breast cancer cells. Within the promoter region of the human DDX3 gene, we identified three putative hypoxia inducible factor-1 responsive elements. By luciferase reporter assays in combination with mutated hypoxia inducible factor-1 responsive elements, we determined that the hypoxia inducible factor-1 responsive element at position -153 relative to the translation start site is essential for transcriptional activation of DDX3 under hypoxic conditions. We also demonstrated that hypoxia inducible factor-1 binds to the DDX3 promoter and that the binding is specific, as revealed by siRNA against hypoxia inducible factor-1 and chromatin immunoprecipitation assays. Thus, the activation of DDX3 expression during hypoxia is due to the direct binding of hypoxia inducible factor-1 to hypoxia responsive elements in the DDX3 promoter. In addition, we observed a significant overlap in the protein expression pattern of hypoxia inducible factor-1 alpha and DDX3 in MDA-MB-231 xenograft tumors. Taken together, our results demonstrate, for the first time, the role of DDX3 as a hypoxia-inducible gene that exhibits enhanced expression through the interaction of hypoxia inducible factor-1 with hypoxia inducible factor-1 responsive elements in its promoter region.	[Botlagunta, Mahendran; Krishnamachary, Balaji; Vesuna, Farhad; Winnard, Paul T., Jr.; Bol, Guus M.; Raman, Venu] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Patel, Arvind H.] Univ Glasgow, Med Res Council Virol Unit, Glasgow, Lanark, Scotland; [Raman, Venu] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; University of Glasgow; Johns Hopkins University	Botlagunta, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	vraman2@jhmi.edu	Vesuna, Farhad/G-3179-2010; Botlagunta, Mahendran/R-5140-2018	Vesuna, Farhad/0000-0002-0356-5096; Botlagunta, Mahendran/0000-0002-0490-2832; Bol, Guus/0000-0002-4021-3823	FAMRI; MRC [MC_U130184144] Funding Source: UKRI; Medical Research Council [MC_U130184144] Funding Source: researchfish	FAMRI; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by FAMRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus AGN, 2010, J GEN VIROL, V91, P122, DOI 10.1099/vir.0.015909-0; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; Baranwal S, 2009, BIOCHEM BIOPH RES CO, V384, P6, DOI 10.1016/j.bbrc.2009.04.051; Blancher C, 2000, CANCER RES, V60, P7106; Botlagunta M, 2008, ONCOGENE, V27, P3912, DOI 10.1038/onc.2008.33; Bracken CP, 2005, J BIOL CHEM, V280, P14240, DOI 10.1074/jbc.M409987200; Brizel DM, 1996, CANCER RES, V56, P941; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Dougherty GJ, 2009, CANCER GENE THER, V16, P279, DOI 10.1038/cgt.2008.72; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Guo X, 2007, BIOCHEM BIOPH RES CO, V364, P145, DOI 10.1016/j.bbrc.2007.09.108; GURURAJAN R, 1991, NATURE, V349, P717, DOI 10.1038/349717a0; Han ZB, 2008, CARCINOGENESIS, V29, P1853, DOI 10.1093/carcin/bgn066; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; JAMIESON DJ, 1991, MOL MICROBIOL, V5, P805, DOI 10.1111/j.1365-2958.1991.tb00753.x; Johnstone O, 2005, DEV BIOL, V277, P92, DOI 10.1016/j.ydbio.2004.09.009; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Knowles HJ, 2001, BREAST CANCER RES, V3, P318, DOI 10.1186/bcr314; Lahiri S, 2006, PROG BIOPHYS MOL BIO, V91, P249, DOI 10.1016/j.pbiomolbio.2005.07.001; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; LEROY P, 1989, CELL, V57, P549, DOI 10.1016/0092-8674(89)90125-6; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Mamiya N, 1999, J BIOL CHEM, V274, P15751, DOI 10.1074/jbc.274.22.15751; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Niquet J, 2006, NEUROSCIENCE, V141, P77, DOI 10.1016/j.neuroscience.2006.03.073; Noueiry AO, 2000, P NATL ACAD SCI USA, V97, P12985, DOI 10.1073/pnas.240460897; Owsianka AM, 1999, VIROLOGY, V257, P330, DOI 10.1006/viro.1999.9659; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Reynolds TY, 1996, CANCER RES, V56, P5754; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Schroder M, 2010, BIOCHEM PHARMACOL, V79, P297, DOI 10.1016/j.bcp.2009.08.032; Sekiguchi T, 2004, EXP CELL RES, V300, P213, DOI 10.1016/j.yexcr.2004.07.005; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Sowter HM, 2003, CANCER RES, V63, P6130; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; Teicher B A, 1994, In Vivo, V8, P125; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Wenger RH, 1997, BIOL CHEM, V378, P609; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029	52	35	37	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17563	10.1371/journal.pone.0017563	http://dx.doi.org/10.1371/journal.pone.0017563			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448281	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000288810500008
J	Lagendijk, DDG; Mackey, RL; Page, BR; Slotow, R				Lagendijk, D. D. Georgette; Mackey, Robin L.; Page, Bruce R.; Slotow, Rob			The Effects of Herbivory by a Mega- and Mesoherbivore on Tree Recruitment in Sand Forest, South Africa	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; PRIVATE GAME RESERVE; WOODLAND REGENERATION; SPECIES COMPOSITION; WOODY VEGETATION; RANGING PATTERNS; ELEPHANT; SIZE; DYNAMICS; POPULATION	Herbivory by megaherbivores on woody vegetation in general is well documented; however studies focusing on the individual browsing effects of both mega- and mesoherbivore species on recruitment are scarce. We determined these effects for elephant Loxodonta africana and nyala Tragelaphus angasii in the critically endangered Sand Forest, which is restricted to east southern Africa, and is conserved mainly in small reserves with high herbivore densities. Replicated experimental treatments (400 m(2)) in a single forest patch were used to exclude elephant, or both elephant and nyala. In each treatment, all woody individuals were identified to species and number of stems, diameter and height were recorded. Results of changes after two years are presented. Individual tree and stem densities had increased in absence of nyala and elephant. Seedling recruitment (based on height and diameter) was inhibited by nyala, and by elephant and nyala in combination, thereby preventing recruitment into the sapling stage. Neither nyala or elephant significantly reduced sapling densities. Excluding both elephant and nyala in combination enhanced recruitment of woody species, as seedling densities increased, indicating that forest regeneration is impacted by both mega-and mesoherbivores. The Sand Forest tree community approached an inverse J-shaped curve, with the highest abundance in the smaller size classes. However, the larger characteristic tree species in particular, such as Newtonia hildebrandtii, were missing cohorts in the middle size classes. When setting management goals to conserve habitats of key importance, conservation management plans need to consider the total herbivore assemblage present and the resulting browsing effects on vegetation. Especially in Africa, where the broadest suite of megaherbivores still persists, and which is currently dealing with the 'elephant problem', the individual effects of different herbivore species on recruitment and dynamics of forests and woodlands are important issues which need conclusive answers.	[Lagendijk, D. D. Georgette; Mackey, Robin L.; Page, Bruce R.; Slotow, Rob] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Amarula Elephant Res Programme, Durban, South Africa	University of Kwazulu Natal	Lagendijk, DDG (corresponding author), Univ KwaZulu Natal, Sch Biol & Conservat Sci, Amarula Elephant Res Programme, Durban, South Africa.	georgette.lagendijk@gmail.com	Page, Bruce R/G-1245-2010; Slotow, Rob/AAM-9053-2020	Page, Bruce R/0000-0001-7979-5229; Slotow, Rob/0000-0001-9469-1508	University of KwaZulu-Natal; Amarula Elephant Research Programme; South African National Research Foundation [FA2006032300024]	University of KwaZulu-Natal; Amarula Elephant Research Programme; South African National Research Foundation(National Research Foundation - South Africa)	This study was supported by the Amarula Elephant Research Programme, University of KwaZulu-Natal, and the South African National Research Foundation ( Grant FA2006032300024 to RS) http://www.nrf.ac.za/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine DJ, 2004, J APPL ECOL, V41, P45, DOI 10.1111/j.1365-2664.2004.00864.x; BELSKY AJ, 1984, AFR J ECOL, V22, P271, DOI 10.1111/j.1365-2028.1984.tb00701.x; Ben-Shahar R, 1998, PLANT ECOL, V136, P189, DOI 10.1023/A:1009708021735; Bergquist J, 1999, FOREST ECOL MANAG, V115, P171, DOI 10.1016/S0378-1127(98)00397-1; Biggs Harry C., 2008, P537; Bond WJ, 2003, INT J WILDLAND FIRE, V12, P381, DOI 10.1071/WF03024; Botes A, 2006, BIOL CONSERV, V130, P573, DOI 10.1016/j.biocon.2006.01.020; Burke A, 1997, BIODIVERS CONSERV, V6, P1203, DOI 10.1023/A:1018308907241; Cadenasso ML, 2002, J TORREY BOT SOC, V129, P228, DOI 10.2307/3088773; CAUGHLEY G, 1976, E AFR WILDL J, V14, P265; Clarke K. R., 2001, CHANGES MARINE COMMU; Condit R, 1998, AM NAT, V152, P495, DOI 10.1086/286186; de Garine-Wichatitsky M, 2004, OECOLOGIA, V141, P66, DOI 10.1007/s00442-004-1630-3; Druce Heleen, 2006, Koedoe, V49, P77; Druce HC, 2008, BIOL CONSERV, V141, P3127, DOI 10.1016/j.biocon.2008.09.024; DUBLIN HT, 1990, J ANIM ECOL, V59, P1147, DOI 10.2307/5037; Eckhardt HC, 2000, AFR J ECOL, V38, P108, DOI 10.1046/j.1365-2028.2000.00217.x; Everard DA, 1995, S AFR J BOT, V61, P283, DOI 10.1016/S0254-6299(15)30548-2; Fenner M., 2005, ECOLOGY SEEDS; Fritz H, 2002, OECOLOGIA, V131, P620, DOI 10.1007/s00442-002-0919-3; Gadd ME, 2002, AFR J ECOL, V40, P328, DOI 10.1046/j.1365-2028.2002.00385.x; Gaugris JY, 2008, S AFR J BOT, V74, P85, DOI 10.1016/j.sajb.2007.09.001; Gaugris J, 2007, S AFR J BOT, V73, P611, DOI 10.1016/j.sajb.2007.06.004; Goheen JR, 2007, J ECOL, V95, P129, DOI 10.1111/j.1365-2745.2006.01196.x; Goheen JR, 2004, ECOLOGY, V85, P1555, DOI 10.1890/03-3060; Grant C.C., 2008, P329; HAGENAH N, 2006, THESIS WAGENINGEN U; Hawthorne WD, 2000, J TROP ECOL, V16, P133, DOI 10.1017/S0266467400001310; Jacobs OS, 2002, S AFR J WILDL RES, V32, P13; Kellerman MJS, 2007, BOTHALIA, V37, P249, DOI 10.4102/abc.v37i2.323; Kerley Graham I.H., 2008, P146; Kirby Taryn, 2008, Acta Zoologica Sinica, V54, P561; Kirkwood D, 1999, BOTHALIA, V29, P293, DOI 10.4102/abc.v29i2.602; KYLE R, 2004, INDIGENOUS FORESTS W, P713; LAGENDIJK DDG, 2003, THESIS WAGENINGEN U; LAGENDIJK G, 2011, SHORT TERM IN PRESS; Lawes MJ, 2004, INDIGENOUS FORESTS W, P227; Levick S, 2008, BIOL CONSERV, V141, P489, DOI 10.1016/j.biocon.2007.11.001; Lykke AM, 1998, BIODIVERS CONSERV, V7, P1261, DOI 10.1023/A:1008877819286; MATTHEWS W. S, 2005, THESIS U PRETORIA; Matthews WS, 2001, S AFR J BOT, V67, P573, DOI 10.1016/S0254-6299(15)31188-1; Merrill Evelyn H., 2003, Journal for Nature Conservation (Jena), V10, P221, DOI 10.1078/1617-1381-00022; MIDGLEY JJ, 1995, S AFR J SCI, V91, P7; Moe SR, 2009, J APPL ECOL, V46, P223, DOI 10.1111/j.1365-2664.2008.01595.x; Moll E.J., 1980, STUDIES ECOLOGY MAPU, P52; Mucina L., 2006, VEGETATION S AFRICA; Obiri J, 2002, FOREST ECOL MANAG, V166, P131, DOI 10.1016/S0378-1127(01)00665-X; Owen-Smith N, 2006, S AFR J SCI, V102, P389; Owen-Smith R.N., 1988, P1; Pickett S. T. A., 2003, KRUGER EXPERIENCE EC, P22; PRINS HHT, 1993, J ECOL, V81, P305, DOI 10.2307/2261500; REPTON M, 2007, THESIS U KWAZULU NAT; Riginos C, 2007, OECOLOGIA, V153, P985, DOI 10.1007/s00442-007-0799-7; Shannon G, 2008, J TROP ECOL, V24, P281, DOI 10.1017/S0266467408004951; Shannon G, 2009, DIVERS DISTRIB, V15, P776, DOI 10.1111/j.1472-4642.2009.00581.x; Shaw MT, 2002, OIKOS, V98, P385, DOI 10.1034/j.1600-0706.2002.980303.x; Siebert Frances, 2008, Koedoe, V50, P126; Siebert SJ, 2004, BOTHALIA, V34, P61, DOI 10.4102/abc.v34i1.414; Smallie JJ, 2000, AFR J ECOL, V38, P352, DOI 10.1046/j.1365-2028.2000.00258.x; TURNER IM, 1990, BIOTROPICA, V22, P146, DOI 10.2307/2388407; vanWyk GF, 1996, S AFR J BOT, V62, P133, DOI 10.1016/S0254-6299(15)30612-8; WALKER BH, 1986, S AFR J BOT, V52, P397, DOI 10.1016/S0254-6299(16)31502-2	62	24	24	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17983	10.1371/journal.pone.0017983	http://dx.doi.org/10.1371/journal.pone.0017983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445345	Green Published, gold, Green Submitted			2022-12-27	WOS:000288809100022
J	Poulsen, L; Soe, MJ; Moller, LB; Dufva, M				Poulsen, Lena; Soe, Martin Jensen; Moller, Lisbeth Birk; Dufva, Martin			Investigation of Parameters that Affect the Success Rate of Microarray-Based Allele-Specific Hybridization Assays	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; OLIGONUCLEOTIDE MICROARRAYS; DNA MICROARRAYS; MOLECULAR-INTERACTIONS; PROBE SELECTION; CHIP; SURFACE; ARRAYS; OPTIMIZATION; ALGORITHMS	Background: The development of microarray-based genetic tests for diseases that are caused by known mutations is becoming increasingly important. The key obstacle to developing functional genotyping assays is that such mutations need to be genotyped regardless of their location in genomic regions. These regions include large variations in G+C content, and structural features like hairpins. Methods/Findings: We describe a rational, stable method for screening and combining assay conditions for the genetic analysis of 42 Phenylketonuria-associated mutations in the phenylalanine hydroxylase gene. The mutations are located in regions with large variations in G+C content (20-75%). Custom-made microarrays with different lengths of complementary probe sequences and spacers were hybridized with pooled PCR products of 12 exons from each of 38 individual patient DNA samples. The arrays were washed with eight buffers with different stringencies in a custom-made microfluidic system. The data were used to assess which parameters play significant roles in assay development. Conclusions: Several assay development methods found suitable probes and assay conditions for a functional test for all investigated mutation sites. Probe length, probe spacer length, and assay stringency sufficed as variable parameters in the search for a functional multiplex assay. We discuss the optimal assay development methods for several different scenarios.	[Poulsen, Lena; Soe, Martin Jensen; Dufva, Martin] Tech Univ Denmark, DTU Nanotech, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark; [Moller, Lisbeth Birk] Kennedy Ctr, Dept Appl Human Mol Genet, Glostrup, Denmark	Technical University of Denmark	Poulsen, L (corresponding author), Tech Univ Denmark, DTU Nanotech, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark.	martin.dufva@nanotech.dtu.dk	Dufva, Martin/V-9469-2019; Dufva, Martin/D-1873-2012; Søe, Martin J/F-7736-2014	Dufva, Martin/0000-0001-5449-0189; Søe, Martin J/0000-0002-0386-6294; Moller, Lisbeth/0000-0002-9524-4301	DTU	DTU	LP was funded by a DTU PhD stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RM, 2003, BIOTECHNIQUES, V34, P1082, DOI 10.2144/03345dd05; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; Dorris DR, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-6; GULDBERG P, 1993, GENOMICS, V17, P141, DOI 10.1006/geno.1993.1295; Hahnke K, 2007, J BIOTECHNOL, V128, P1, DOI 10.1016/j.jbiotec.2006.09.003; Halperin A, 2006, LANGMUIR, V22, P11290, DOI 10.1021/la0616606; Hong BJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni109; HOWELL WM, 1999, NAT BIOTECHNOL, P1787; Hu ZY, 2005, BIOTECHNIQUES, V38, P121, DOI 10.2144/05381MT02; Iwasaki H, 2002, DNA RES, V9, P59, DOI 10.1093/dnares/9.2.59; Jobs M, 2003, GENOME RES, V13, P916, DOI 10.1101/gr.801103; Kajiyama T, 2003, GENOME RES, V13, P467, DOI 10.1101/gr.790603; Lee HH, 2006, LAB CHIP, V6, P1163, DOI 10.1039/b605507a; Liu WM, 2003, BIOINFORMATICS, V19, P2397, DOI 10.1093/bioinformatics/btg332; Mao HB, 2002, ANAL CHEM, V74, P5071, DOI 10.1021/ac025851z; Mei R, 2003, P NATL ACAD SCI USA, V100, P11237, DOI 10.1073/pnas.1534744100; Noerholm M, 2004, LAB CHIP, V4, P28, DOI 10.1039/b311991b; Petersen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004808; Petersen J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1081; Poulsen L, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn600; Pozhitkov A, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl133; Pullat J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-282; Russom A, 2006, ANAL CHEM, V78, P2220, DOI 10.1021/ac051771u; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; Shchepinov MS, 1997, NUCLEIC ACIDS RES, V25, P1155, DOI 10.1093/nar/25.6.1155; Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429; Suzuki S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-373; Wick LM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj024; Wu HX, 2008, BIOTECHNIQUES, V45, P573, DOI 10.2144/000112952; Yershov G, 1996, P NATL ACAD SCI USA, V93, P4913, DOI 10.1073/pnas.93.10.4913; Zhang L, 2003, NAT BIOTECHNOL, V21, P818, DOI 10.1038/nbt836; Zhang XX, 2009, ANAL BIOCHEM, V386, P222, DOI 10.1016/j.ab.2008.12.008	33	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e14777	10.1371/journal.pone.0014777	http://dx.doi.org/10.1371/journal.pone.0014777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445337	gold, Green Submitted, Green Published			2022-12-27	WOS:000288809100004
J	Villani, M; Barbieri, A; Serra, R				Villani, Marco; Barbieri, Alessia; Serra, Roberto			A Dynamical Model of Genetic Networks for Cell Differentiation	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; NOISE; EXPRESSION; STOCHASTICITY; FIBROBLASTS; COMMITMENT	A mathematical model is proposed which is able to describe the most important features of cell differentiation, without requiring specific detailed assumptions concerning the interactions which drive the phenomenon. On the contrary, cell differentiation is described here as an emergent property of a generic model of the underlying gene regulatory network, and it can therefore be applied to a variety of different organisms. The model points to a peculiar role of cellular noise in differentiation and leads to non trivial predictions which could be subject to experimental testing. Moreover, a single model proves able to describe several different phenomena observed in various differentiation processes.	[Villani, Marco; Barbieri, Alessia; Serra, Roberto] Univ Modena & Reggio Emilia, Modelling & Simulat Lab, Dept Commun & Econ, Reggio Emilia, Italy; [Villani, Marco; Serra, Roberto] European Ctr Living Technol, Venice, Italy	Universita di Modena e Reggio Emilia	Serra, R (corresponding author), Univ Modena & Reggio Emilia, Modelling & Simulat Lab, Dept Commun & Econ, Reggio Emilia, Italy.	roberto.serra@unimore.it	Villani, Marco/K-9733-2016; Serra, Roberto/L-5084-2016	Villani, Marco/0000-0002-5991-5470; Serra, Roberto/0000-0002-1417-5106	Italian Miur [2982/Ric]; Fondazione di Venezia	Italian Miur(Ministry of Education, Universities and Research (MIUR)); Fondazione di Venezia	This work has been supported in part by the Italian Miur Project MITICA (FISR nr. 2982/Ric) and by the DICE project of the Fondazione di Venezia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDANA M, 2003, APPL MATH SCI SERIES; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; [Anonymous], 1995, HOME UNIVERSE SEARCH; Baron MH, 1993, CURR OPIN CELL BIOL, V5, P1050, DOI 10.1016/0955-0674(93)90091-4; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Furusawa C, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-17; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kaneko K, 2006; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Kauffman S. A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL; KUPIEC JJ, 1983, SPECULAT SCI TECHNOL, V6, P471; Kuznetsov VA, 2002, GENETICS, V161, P1321; LANGTON CG, 1992, SFI S SCI C, V10, P41; Lestas I, 2008, IEEE T AUTOMAT CONTR, V53, P189, DOI 10.1109/TAC.2007.911347; Maduro MF, 2010, DEV DYNAM, V239, P1315, DOI 10.1002/dvdy.22233; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Musashi M, 1991, Rinsho Ketsueki, V32, P439; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Ramo P, 2006, J THEOR BIOL, V242, P164, DOI 10.1016/j.jtbi.2006.02.011; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Ribeiro AS, 2007, J THEOR BIOL, V247, P743, DOI 10.1016/j.jtbi.2007.04.020; Serra R, 2007, J THEOR BIOL, V246, P449, DOI 10.1016/j.jtbi.2007.01.012; Serra R, 2004, J THEOR BIOL, V227, P149, DOI 10.1016/j.jtbi.2003.10.018; Serra R, 2010, J THEOR BIOL, V265, P185, DOI 10.1016/j.jtbi.2010.04.012; Shmulevich I, 2005, P NATL ACAD SCI USA, V102, P13439, DOI 10.1073/pnas.0506771102; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; VILLANI M, 2010, P 7 EUR C COMPL SYST, P24; WOLPERT L, 1994, SCIENCE, V266, P571, DOI 10.1126/science.7939707; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180	47	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17703	10.1371/journal.pone.0017703	http://dx.doi.org/10.1371/journal.pone.0017703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21464974	gold, Green Published			2022-12-27	WOS:000288545100026
J	Louie, JK; Jean, C; Acosta, M; Samuel, MC; Matyas, BT; Schechter, R				Louie, Janice K.; Jean, Cynthia; Acosta, Meileen; Samuel, Michael C.; Matyas, Bela T.; Schechter, Robert			A Review of Adult Mortality Due to 2009 Pandemic (H1N1) Influenza A in California	PLOS ONE			English	Article							INFECTION; VACCINE; DEATH	Background: While children and young adults had the highest attack rates due to 2009 pandemic (H1N1) influenza A (2009 H1N1), studies of hospitalized cases noted high fatality in older adults. We analyzed California public health surveillance data to better characterize the populations at risk for dying due to 2009 H1N1. Methods and Findings: A case was an adult >= 20 years who died with influenza-like symptoms and laboratory results indicative of 2009 H1N1. Demographic and clinical data were abstracted from medical records using a standardized case report form. From April 3, 2009 - August 10, 2010, 541 fatal cases >= 20 years with 2009 H1N1 were reported. Influenza fatality rates per 100,000 population were highest in persons 50-59 years (3.5; annualized rate = 2.6) and 60-69 years (2.3; annualized rate = 1.7) compared to younger and older age groups (0.4-1.9; annualized rates = 0.3-1.4). Of 486 cases hospitalized prior to death, 441 (91%) required intensive care unit (ICU) admission. ICU admission rates per 100,000 population were highest in adults 50-59 years (8.6). ICU case-fatality ratios among adults ranged from 24-42%, with the highest ratios in persons 70-79 years. A total of 425 (80%) cases had co-morbid conditions associated with severe seasonal influenza. The prevalence of most co-morbid conditions increased with increasing age, but obesity, pregnancy and obstructive sleep apnea decreased with age. Rapid testing was positive in 97 (35%) of 276 tested. Of 482 cases with available data, 384 (80%) received antiviral treatment, including 49 (15%) of 328 within 48 hours of symptom onset. Conclusions: Adults aged 50-59 years had the highest fatality due to 2009 H1N1; older adults may have been spared due to pre-existing immunity. However, once infected and hospitalized in intensive care, case-fatality ratios were high for all adults, especially in those over 60 years. Vaccination of adults older than 50 years should be encouraged.	[Louie, Janice K.; Jean, Cynthia; Acosta, Meileen; Samuel, Michael C.; Matyas, Bela T.; Schechter, Robert] Calif Dept Publ Hlth, Richmond, CA USA	California Department of Public Health	Louie, JK (corresponding author), Calif Dept Publ Hlth, Richmond, CA USA.	Janice.louie@cdph.ca.gov			California Department of Public Health	California Department of Public Health	This work was funded by the California Department of Public Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009360; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fiore Anthony E., 2010, Morbidity and Mortality Weekly Report, V59, P993; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Ikonen N, 2010, EURO SURVEILL, V15; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; 2000, PRACT GUID ID EV TRE; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Pebody RG, 2010, EUROSURVEILLANCE, V15; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	15	46	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18221	10.1371/journal.pone.0018221	http://dx.doi.org/10.1371/journal.pone.0018221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483677	Green Published, Green Submitted, gold			2022-12-27	WOS:000289191300013
J	Onnela, JP; Arbesman, S; Gonzalez, MC; Barabasi, AL; Christakis, NA				Onnela, Jukka-Pekka; Arbesman, Samuel; Gonzalez, Marta C.; Barabasi, Albert-Laszlo; Christakis, Nicholas A.			Geographic Constraints on Social Network Groups	PLOS ONE			English	Article								Social groups are fundamental building blocks of human societies. While our social interactions have always been constrained by geography, it has been impossible, due to practical difficulties, to evaluate the nature of this restriction on social group structure. We construct a social network of individuals whose most frequent geographical locations are also known. We also classify the individuals into groups according to a community detection algorithm. We study the variation of geographical span for social groups of varying sizes, and explore the relationship between topological positions and geographic positions of their members. We find that small social groups are geographically very tight, but become much more clumped when the group size exceeds about 30 members. Also, we find no correlation between the topological positions and geographic positions of individuals within network communities. These results suggest that spreading processes face distinct structural and spatial constraints.	[Onnela, Jukka-Pekka; Arbesman, Samuel; Christakis, Nicholas A.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Gonzalez, Marta C.] MIT, Dept Civil & Environm Engn & Engn Syst, Cambridge, MA 02139 USA; [Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys Biol & Comp Sci, Ctr Complex Network Res, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Christakis, Nicholas A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Christakis, Nicholas A.] Harvard Fac Arts & Sci, Dept Sociol, Cambridge, MA USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Northeastern University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Onnela, JP (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.	onnela@med.harvard.edu	Barabasi, Albert-Laszlo/S-6474-2017; Gonzalez, Marta C./E-9456-2011	Gonzalez, Marta C./0000-0002-8482-0318; Barabasi, Albert/0000-0002-4028-3522	National Institute on Aging [P01 AG-031093]; Office of Naval Research [ONR N000141010968]; Network Science Collaborative Technology Alliance [ARL NS-CTA W911NF-09-2-0053]; Defense Threat Reduction Agency [DTRA BRBAA08-Per4-C-2-0033, DTRA WMD BRBAA07-J-2-0035]; National Science Foundation [NSF BCS-0826958]; James S. McDonnell Foundation [JSMF 220020084]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Office of Naval Research(Office of Naval Research); Network Science Collaborative Technology Alliance; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); National Science Foundation(National Science Foundation (NSF)); James S. McDonnell Foundation	JPO, SA, and NAC are supported by the National Institute on Aging (grant P01 AG-031093); ALB and MCG by the Office of Naval Research (grant ONR N000141010968), the Network Science Collaborative Technology Alliance (grant ARL NS-CTA W911NF-09-2-0053), the Defense Threat Reduction Agency (grants DTRA BRBAA08-Per4-C-2-0033 and DTRA WMD BRBAA07-J-2-0035), the National Science Foundation (grant NSF BCS-0826958), and the James S. McDonnell Foundation (grant JSMF 220020084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brandes U, 2008, IEEE T KNOWL DATA EN, V20, P172, DOI 10.1109/TKDE.2007.190689; Caldarelli G., 2007, SCALE FREE NETWORKS; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Freeman LC, 2004, DEV SOCIAL NETWORK A; Gan G, 2007, ASA SIAM SER STAT AP, V20, P1, DOI 10.1137/1.9780898718348; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Lambiotte R, 2008, PHYSICA A, V387, P5317, DOI 10.1016/j.physa.2008.05.014; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Newman M, 2008, PHYS TODAY, V61, P33, DOI 10.1063/1.3027989; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ., 2006, STRUCTURE DYNAMICS N; NOBLE JV, 1974, NATURE, V250, P726, DOI 10.1038/250726a0; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; PARK S, IMPORTANCE PROTEIN S; Porter MA., 2009, NOT AM MATH SOC, V56, P1082, DOI DOI 10.1103/PHYSREVE.69.066133; Skyrms B., 2004, STAG HUNT EVOLUTION, DOI DOI 10.1017/CBO9781139165228; Szolnoki A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057101; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053	28	195	198	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e16939	10.1371/journal.pone.0016939	http://dx.doi.org/10.1371/journal.pone.0016939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483665	Green Submitted, Green Published, gold			2022-12-27	WOS:000289191300004
J	Ma, L; Zhang, GD; Doyle, MP				Ma, Li; Zhang, Guodong; Doyle, Michael P.			Green Fluorescent Protein Labeling of Listeria, Salmonella, and Escherichia coli O157:H7 for Safety-Related Studies	PLOS ONE			English	Article							SPECIES-SPECIFIC MARKER; VECTORS; EXPRESSION; SURVIVAL; MUTANTS; MEDIA; GENE; DNA	Many food safety-related studies require tracking of introduced foodborne pathogens to monitor their fate in complex environments. The green fluorescent protein (GFP) gene (gfp) provides an easily detectable phenotype so has been used to label many microorganisms for ecological studies. The objectives of this study were to label major foodborne pathogens and related bacteria, including Listeria monocytogenes, Listeria innocua, Salmonella, and Escherichia coli O157:H7 strains, with GFP and characterize the labeled strains for stability of the GFP plasmid and the plasmid's effect on bacterial growth. GFP plasmids were introduced into these strains by a CaCl2 procedure, conjugation or electroporation. Stability of the label was determined through sequential propagation of labeled strains in the absence of selective pressure, and rates of plasmid-loss were calculated. Stability of the GFP plasmid varied among the labeled species and strains, with the most stable GFP label observed in E. coli O157:H7. When grown in nonselective media for two consecutive subcultures (ca. 20 generations), the rates of plasmid loss among labeled E. coli O157:H7, Salmonella and Listeria strains ranged from 0%-30%, 15.8%-99.9% and 8.1%-93.4%, respectively. Complete loss (>99.99%) of the plasmid occurred in some labeled strains after five consecutive subcultures in the absence of selective pressure, whereas it remained stable in others. The GFP plasmid had an insignificant effect on growth of most labeled strains. E. coli O157:H7, Salmonella and Listeria strains can be effectively labeled with the GFP plasmid which can be stable in some isolates for many generations without adversely affecting growth rates.	[Ma, Li] Oklahoma State Univ, Dept Entomol & Plant Pathol, Natl Inst Microbial Forens & Food & Agr Biosecur, Stillwater, OK 74078 USA; [Zhang, Guodong] Ctr Food Safety & Appl Nutr, College Pk, MD USA; [Doyle, Michael P.] Univ Georgia, Ctr Food Safety, Griffin, GA USA	Oklahoma State University System; Oklahoma State University - Stillwater; US Food & Drug Administration (FDA); University System of Georgia; University of Georgia	Ma, L (corresponding author), Oklahoma State Univ, Dept Entomol & Plant Pathol, Natl Inst Microbial Forens & Food & Agr Biosecur, Stillwater, OK 74078 USA.	mdoyle@uga.edu		ma, li/0000-0002-9778-6032	University of Georgia Center for Food Safety	University of Georgia Center for Food Safety	The University of Georgia Center for Food Safety supported this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DG, 2007, J APPL MICROBIOL, V103, P318, DOI 10.1111/j.1365-2672.2006.03243.x; Aspiras MB, 2000, APPL ENVIRON MICROB, V66, P4074, DOI 10.1128/AEM.66.9.4074-4083.2000; Bloemberg GV, 1997, APPL ENVIRON MICROB, V63, P4543, DOI 10.1128/AEM.63.11.4543-4551.1997; Cabello AE, 2005, J EXP MAR BIOL ECOL, V327, P157, DOI 10.1016/j.jembe.2005.06.009; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cho JC, 1999, J MICROBIOL METH, V36, P227, DOI 10.1016/S0167-7012(99)00038-X; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Dandie CE, 2001, LETT APPL MICROBIOL, V32, P26, DOI 10.1046/j.1472-765x.2001.00848.x; Erickson MC, 2010, BIORESOURCE TECHNOL, V101, P1014, DOI 10.1016/j.biortech.2009.08.105; Fortineau N, 2000, RES MICROBIOL, V151, P353, DOI 10.1016/S0923-2508(00)00158-3; Gandhi M, 2001, J FOOD PROTECT, V64, P1891, DOI 10.4315/0362-028X-64.12.1891; JIN DJ, 1989, J BACTERIOL, V171, P5229, DOI 10.1128/jb.171.9.5229-5231.1989; Kornacki JL, 2003, J FOOD PROTECT, V66, P1727, DOI 10.4315/0362-028X-66.9.1727; Leff LG, 1996, APPL ENVIRON MICROB, V62, P3486, DOI 10.1128/AEM.62.9.3486-3488.1996; MORISE H, 1974, BIOCHEMISTRY-US, V13, P2656, DOI 10.1021/bi00709a028; MOSSEL DAA, 1980, J APPL BACTERIOL, V49, P439, DOI 10.1111/j.1365-2672.1980.tb04719.x; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Qazi SNA, 2001, MICROBIAL ECOL, V41, P301; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SIMON FP, 1990, GENE, V94, P129; Skillman LC, 1998, MICROBIOL-SGM, V144, P2095, DOI 10.1099/00221287-144-8-2095; Tombolini R, 1997, FEMS MICROBIOL ECOL, V22, P17, DOI 10.1111/j.1574-6941.1997.tb00352.x; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; Zhang G, 2007, J FOOD PROTECT, V70, P1857, DOI 10.4315/0362-028X-70.8.1857; Zhang GD, 2009, J FOOD PROTECT, V72, P2028, DOI 10.4315/0362-028X-72.10.2028	26	50	50	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18083	10.1371/journal.pone.0018083	http://dx.doi.org/10.1371/journal.pone.0018083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483738	gold, Green Submitted, Green Published			2022-12-27	WOS:000289058700008
J	Baines, KJ; Simpson, JL; Gibson, PG				Baines, Katherine Joanne; Simpson, Jodie Louise; Gibson, Peter Gerard			Innate Immune Responses Are Increased in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; CIRCULATING NEUTROPHILS; AIRWAY INFLAMMATION; ADHESION MOLECULES; INDUCED SPUTUM; ONCOSTATIN-M; EXPRESSION; ACTIVATION; INTERLEUKIN-8; PATHOGENESIS	Background: Chronic obstructive pulmonary disease (COPD) is characterised by irreversible airflow obstruction, neutrophilic airway inflammation and chronic bacterial colonisation, however the role of the innate immune response in the pathogenesis of COPD remains unclear. Methods: Induced sputum was obtained from adults with COPD (n = 22), and healthy controls (n = 29) and was processed for differential cell counts. The sputum supernatant was assayed for innate immune mediators using ELISA, whilst sputum gene expression was measured using real-time PCR. Peripheral blood neutrophils were isolated and their response to lipopolysaccaride (LPS) stimulation was assessed in a subgroup of participants with COPD (n = 13) and healthy controls (n = 21). Results: Participants with COPD had significantly higher protein levels of interleukin (IL)-8, and neutrophil elastase (NE) and detection of oncostatin M (OSM) compared to healthy controls. Gene expression for toll-like receptor (TLR) 2, IL-8 and OSM were also significantly higher in COPD participants. The level of IL-1 beta, surfactant protein (SP)-A, matrix metalloproteinase (MMP)-9 and TLR4 mRNA was not significantly different between groups. The level of innate immune response markers were highly associated with the presence of sputum neutrophils, each other and the degree of airflow limitation (FEV1/FVC). Peripheral blood neutrophils from participants with COPD had an increased response to stimulation by LPS; with a greater fold increase in the production of IL-8 and MMP-9 protein, and gene expression of IL-8, TLR2 and TLR4. Conclusions: The innate immune response is increased in the airways and circulating neutrophils in COPD, and may be an important mechanism involved in disease pathogenesis.	[Baines, Katherine Joanne; Simpson, Jodie Louise; Gibson, Peter Gerard] Univ Newcastle, Prior Res Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia; [Baines, Katherine Joanne; Simpson, Jodie Louise; Gibson, Peter Gerard] John Hunter Hosp, Dept Resp & Sleep Med, Hunter Med Res Inst, New Lambton, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle	Baines, KJ (corresponding author), Univ Newcastle, Prior Res Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia.	katherine.baines@newcastle.edu.au	BAINES, KATHERINE JOANNE/G-7654-2013; SIMPSON, JODIE LOUISE/G-7639-2013; gibson, peter/G-6194-2014	BAINES, KATHERINE JOANNE/0000-0002-4240-6581; SIMPSON, JODIE LOUISE/0000-0002-3626-680X; gibson, peter/0000-0001-5865-489X	National Health and Medical Research Council; Hunter Medical Research Institute; NHMRC Centre for Respiratory and Sleep Medicine	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Hunter Medical Research Institute; NHMRC Centre for Respiratory and Sleep Medicine(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a project grant from the National Health and Medical Research Council and Hunter Medical Research Institute. Katherine Baines holds an HMRI Xstrata Coal Asthma Research Fellowship, Jodie Simpson is supported by the NHMRC Centre for Respiratory and Sleep Medicine and Professor Peter Gibson holds an NHMRC Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2001, AM J RESP CRIT CARE, V163, P349, DOI 10.1164/ajrccm.163.2.2003122; Baines KJ, 2009, EXP LUNG RES, V35, P554, DOI 10.1080/01902140902777490; BAINES KJ, 2009, EUR RESP J       SEP; Beeh KM, 2003, RESP MED, V97, P634, DOI 10.1053/rmed.2003.1493; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Di Stefano A, 1998, AM J RESP CRIT CARE, V158, P1277, DOI 10.1164/ajrccm.158.4.9802078; Di Stefano A, 2002, EUR RESPIR J, V20, P556, DOI 10.1183/09031936.02.00272002; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Gibson PG, 1998, AM J RESP CRIT CARE, V158, P36, DOI 10.1164/ajrccm.158.1.9705031; Grissell TV, 2005, AM J RESP CRIT CARE, V172, P433, DOI 10.1164/rccm.200412-1621OC; Hansel TT, 2009, LANCET, V374, P744, DOI 10.1016/S0140-6736(09)61342-8; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; KENT LM, 2009, INT IMMUNOPHARM 1007; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; MacNee William, 2005, Proc Am Thorac Soc, V2, P258, DOI 10.1513/pats.200504-045SR; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; MORTAZ E, 2009, EUR RESP J      1019; Noguera A, 1998, AM J RESP CRIT CARE, V158, P1664, DOI 10.1164/ajrccm.158.5.9712092; Noguera A, 2004, CHEST, V125, P1837, DOI 10.1378/chest.125.5.1837; Noguera A, 2001, THORAX, V56, P432, DOI 10.1136/thorax.56.6.432; O'Hara KA, 2003, CLIN EXP ALLERGY, V33, P1026, DOI 10.1046/j.1365-2222.2003.01714.x; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Oudijk EJD, 2005, THORAX, V60, P538, DOI 10.1136/thx.2004.034009; Oudijk EJD, 2003, EUR RESPIR J, V22, p5S, DOI 10.1183/09031936.03.00004603a; Parr DG, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-136; Peleman RA, 1999, EUR RESPIR J, V13, P839, DOI 10.1034/j.1399-3003.1999.13d24.x; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Reed CE, 2001, J ALLERGY CLIN IMMUN, V108, P157, DOI 10.1067/mai.2001.116862; Sabroe I, 2007, BIOCHEM SOC T, V35, P1492, DOI 10.1042/BST0351492; Sabroe I, 2005, IMMUNOLOGY, V115, P90, DOI 10.1111/j.1365-2567.2005.02133.x; Sabroe I, 2002, EUR RESPIR J, V19, P350, DOI 10.1183/09031936.02.00253602; Simpson JL, 2005, AM J RESP CRIT CARE, V172, P559, DOI 10.1164/rccm.200503-369OC; Simpson JL, 2007, THORAX, V62, P211, DOI 10.1136/thx.2006.061358; Simpson JL, 2009, EXP LUNG RES, V35, P781, DOI 10.3109/01902140902906412; Simpson JL, 2009, PHARMACOL THERAPEUT, V124, P86, DOI 10.1016/j.pharmthera.2009.06.004; SOCIETY AT, 1995, AM J RESP CRIT CARE, V152, P2185; Stockley RA, 2002, CHEST, V121, p151S, DOI 10.1378/chest.121.5_suppl.151S; YAMAMOTO C, 1997, AIRWAY INFLAMMATION, V8	40	60	63	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18426	10.1371/journal.pone.0018426	http://dx.doi.org/10.1371/journal.pone.0018426			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483784	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200075
J	Veraart, AJ; de Klein, JJM; Scheffer, M				Veraart, Annelies J.; de Klein, Jeroen J. M.; Scheffer, Marten			Warming Can Boost Denitrification Disproportionately Due to Altered Oxygen Dynamics	PLOS ONE			English	Article							NITROUS-OXIDE; ESTUARINE SEDIMENTS; GASEOUS NITROGEN; FRESH-WATER; TEMPERATURE; NITRATE; NITRIFICATION; ECOSYSTEMS; SOILS; MODEL	Background: Global warming and the alteration of the global nitrogen cycle are major anthropogenic threats to the environment. Denitrification, the biological conversion of nitrate to gaseous nitrogen, removes a substantial fraction of the nitrogen from aquatic ecosystems, and can therefore help to reduce eutrophication effects. However, potential responses of denitrification to warming are poorly understood. Although several studies have reported increased denitrification rates with rising temperature, the impact of temperature on denitrification seems to vary widely between systems. Methodology/Principal Findings: We explored the effects of warming on denitrification rates using microcosm experiments, field measurements and a simple model approach. Our results suggest that a three degree temperature rise will double denitrification rates. By performing experiments at fixed oxygen concentrations as well as with oxygen concentrations varying freely with temperature, we demonstrate that this strong temperature dependence of denitrification can be explained by a systematic decrease of oxygen concentrations with rising temperature. Warming decreases oxygen concentrations due to reduced solubility, and more importantly, because respiration rates rise more steeply with temperature than photosynthesis. Conclusions/Significance: Our results show that denitrification rates in aquatic ecosystems are strongly temperature dependent, and that this is amplified by the temperature dependencies of photosynthesis and respiration. Our results illustrate the broader phenomenon that coupling of temperature dependent reactions may in some situations strongly alter overall effects of temperature on ecological processes.	[Veraart, Annelies J.; de Klein, Jeroen J. M.; Scheffer, Marten] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, Wageningen, Netherlands	Wageningen University & Research	Veraart, AJ (corresponding author), Wageningen Univ, Dept Aquat Ecol & Water Qual Management, Wageningen, Netherlands.	annelies.veraart@wur.nl	Veraart, Annelies J/E-1927-2014; Scheffer, Marten/C-1852-2012; Veraart, Annelies/AFR-8009-2022	Veraart, Annelies J/0000-0001-6286-7484; 	STOWA (Dutch Foundation for Applied Water Research); 14 Dutch water boards	STOWA (Dutch Foundation for Applied Water Research); 14 Dutch water boards	Funding for this project was provided by STOWA (Dutch Foundation for Applied Water Research) and 14 Dutch water boards (project PLONS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2005, FUNCT ECOL, V19, P202, DOI 10.1111/j.1365-2435.2005.00952.x; Anderson-Teixeira KJ, 2008, P NATL ACAD SCI USA, V105, P228, DOI 10.1073/pnas.0710214104; Bachand PAM, 2000, ECOL ENG, V14, P17; Barnard R, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002282; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; Castaldi S, 2000, BIOL FERT SOILS, V32, P67, DOI 10.1007/s003740000218; Dalsgaard T, 2000, PROTOCOL HDB NICE NI; DAWSON RN, 1972, WATER RES, V6, P71, DOI 10.1016/0043-1354(72)90174-1; FOCHT DD, 1974, SOIL SCI, V118, P173, DOI 10.1097/00010694-197409000-00007; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GOREAU TJ, 1980, APPL ENVIRON MICROB, V40, P526, DOI 10.1128/AEM.40.3.526-532.1980; GRANELI W, 1978, OIKOS, V30, P7, DOI 10.2307/3543519; Gruca-Rokosz R, 2009, ENVIRON PROT ENG, V35, P5; Holtan-Hartwig L, 2002, SOIL BIOL BIOCHEM, V34, P1797, DOI 10.1016/S0038-0717(02)00169-4; JENKINS MC, 1984, LIMNOL OCEANOGR, V29, P609, DOI 10.4319/lo.1984.29.3.0609; Jeppesen E, 2011, HYDROBIOLOGIA, V663, P1, DOI 10.1007/s10750-010-0547-6; Kadlec RH, 2001, WATER ENVIRON RES, V73, P543, DOI 10.2175/106143001X139614; KEENEY DR, 1979, SOIL SCI SOC AM J, V43, P1124, DOI 10.2136/sssaj1979.03615995004300060012x; KING D, 1984, J GEN MICROBIOL, V130, P2935; Maag M, 1996, APPL SOIL ECOL, V4, P5, DOI 10.1016/0929-1393(96)00106-0; NIELSEN LP, 1992, FEMS MICROBIOL ECOL, V86, P357, DOI 10.1016/0378-1097(92)90800-4; Ogilvie BG, 1997, FEMS MICROBIOL ECOL, V23, P11, DOI 10.1016/S0168-6496(97)00004-4; Pina-Ochoa E, 2006, BIOGEOCHEMISTRY, V81, P111, DOI 10.1007/s10533-006-9033-7; SEITZINGER SP, 1988, LIMNOL OCEANOGR, V33, P702, DOI 10.4319/lo.1988.33.4_part_2.0702; Smith KA, 1997, GLOBAL CHANGE BIOL, V3, P327, DOI 10.1046/j.1365-2486.1997.00100.x; SORRELL BK, 1987, AQUAT BOT, V28, P63, DOI 10.1016/0304-3770(87)90056-8; Spellman F. R., 1996, STREAM ECOLOGY SELF; STANFORD G, 1975, SOIL SCI SOC AM J, V39, P867, DOI 10.2136/sssaj1975.03615995003900050024x; Thomann R.V., 1987, PRINCIPLES SURFACE W; TIEDJE JM, 1982, A VAN LEEUW J MICROB, V48, P569, DOI 10.1007/BF00399542; Tscherko D, 2001, SOIL BIOL BIOCHEM, V33, P491, DOI 10.1016/S0038-0717(00)00190-5; Van Luijn F, 1999, WATER RES, V33, P33, DOI 10.1016/S0043-1354(98)00201-2; Veraart AJ, 2011, BIOGEOCHEMISTRY, V104, P267, DOI 10.1007/s10533-010-9500-z; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431	34	106	108	6	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18508	10.1371/journal.pone.0018508	http://dx.doi.org/10.1371/journal.pone.0018508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483809	Green Submitted, Green Published, gold			2022-12-27	WOS:000289057200087
J	Harrison, F; Sciberras, J; James, R				Harrison, Freya; Sciberras, James; James, Richard			Strength of Social Tie Predicts Cooperative Investment in a Human Social Network	PLOS ONE			English	Article							INTERACTION PATTERNS; INDIRECT RECIPROCITY; EVOLUTION; EMERGENCE; KINSHIP; FRIENDSHIP; ALTRUISM; BEHAVIOR; ECOLOGY; NICHES	Social networks - diagrams which reflect the social structure of animal groups - are increasingly viewed as useful tools in behavioural ecology and evolutionary biology. Network structure may be especially relevant to the study of cooperation, because the action of mechanisms which affect the cost: benefit ratio of cooperating (e. g. reciprocity, punishment, image scoring) is likely to be mediated by the relative position of actor and recipient in the network. Social proximity could thus affect cooperation in a similar manner to biological relatedness. To test this hypothesis, we recruited members of a real-world social group and used a questionnaire to reveal their network. Participants were asked to endure physical discomfort in order to earn money for themselves and other group members, allowing us to explore relationships between willingness to suffer a cost on another's behalf and the relative social position of donor and recipient. Cost endured was positively correlated with the strength of the social tie between donor and recipient. Further, donors suffered greater costs when a relationship was reciprocated. Interestingly, participants regularly suffered greater discomfort for very close peers than for themselves. Our results provide new insight into the effect of social structure on the direct benefits of cooperation.	[Harrison, Freya; Sciberras, James] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Harrison, Freya] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [James, Richard] Univ Bath, Dept Phys, Bath BA2 7AY, Avon, England	University of Oxford; University of Bath; University of Bath	Harrison, F (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	freya.andersdottir@gmail.com	James, Richard/E-5061-2013		University of Oxford; European Commission [043318]	University of Oxford; European Commission(European CommissionEuropean Commission Joint Research Centre)	The study was funded by the University of Oxford via a contribution to JS's dissertation project (MSc in Integrative Bioscience); preliminary work was funded by the European Commission coordination action project Integrating Cooperation Research Across Europe (INCORE, FP6 NEST contract no. 043318; www.incore.ich.ucl.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Borgatti S., 2002, UCINET WINDOWS SOFTW; Borgatti S.P., 2002, NETDRAW NETWORK VISU; Branas-Garza P, 2010, GAME ECON BEHAV, V69, P249, DOI 10.1016/j.geb.2009.10.014; Cardenas JC, 2000, WORLD DEV, V28, P1719, DOI 10.1016/S0305-750X(00)00055-3; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Croft DP, 2009, BEHAV ECOL SOCIOBIOL, V63, P1495, DOI 10.1007/s00265-009-0802-x; Croft DP, 2006, BEHAV ECOL SOCIOBIOL, V59, P644, DOI 10.1007/s00265-005-0091-y; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Csanyi G, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036131; De Lange D., 2004, METODOLOSKI ZVEZKI, V1, P351; Dekker D, 2007, PSYCHOMETRIKA, V72, P563, DOI 10.1007/s11336-007-9016-1; Drea CM, 2009, ANIM BEHAV, V78, P967, DOI 10.1016/j.anbehav.2009.06.030; Dunbar RIM, 2008, GROUP DYN-THEOR RES, V12, P7, DOI 10.1037/1089-2699.12.1.7; Eames KTD, 2009, EPIDEMICS-NETH, V1, P70, DOI 10.1016/j.epidem.2008.12.001; ESTRADA A, 1978, Primates, V19, P401, DOI 10.1007/BF02382809; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Fowler JH, 2009, P NATL ACAD SCI USA, V106, P1720, DOI 10.1073/pnas.0806746106; FOWLER JH, 2010, PNAS, V104, P5334; Frank, 1998, FDN SOCIAL EVOLUTION; Franks DW, 2008, ADAPT BEHAV, V16, P264, DOI 10.1177/1059712308090536; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gardner Andy, 2008, P1, DOI 10.1007/978-3-540-75957-7_1; Gero S, 2008, BEHAV ECOL SOCIOBIOL, V63, P143, DOI 10.1007/s00265-008-0645-x; Gibbons D, 2003, J PERS SOC PSYCHOL, V84, P340, DOI 10.1037/0022-3514.84.2.340; GUPTA S, 1989, AIDS, V3, P807, DOI 10.1097/00002030-198912000-00005; HAAN M, 2006, IZL DISCUSSION PAPER, V2108; Hakansson H., 1989, CORPORATE TECHNOLOGI; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hammerstein P, 2006, J EVOLUTION BIOL, V19, P1400, DOI 10.1111/j.1420-9101.2006.01160.x; HANSEN WB, NETWORK GENIE; HEMELRIJK CK, 1990, ANIM BEHAV, V39, P1013, DOI 10.1016/S0003-3472(05)80775-4; HEMELRIJK CK, 1990, J THEOR BIOL, V143, P405, DOI 10.1016/S0022-5193(05)80036-0; Hruschka DJ, 2006, J THEOR BIOL, V239, P1, DOI 10.1016/j.jtbi.2005.07.006; James R, 2009, BEHAV ECOL SOCIOBIOL, V63, P989, DOI 10.1007/s00265-009-0742-5; Jones B, 2006, PSYCHOL SCI, V17, P283, DOI 10.1111/j.1467-9280.2006.01699.x; KRACKHARDT D, 1988, SOC NETWORKS, V10, P359, DOI 10.1016/0378-8733(88)90004-4; Krause J, 2002, LIVING GROUPS; Krause J, 2009, BEHAV ECOL SOCIOBIOL, V63, P967, DOI 10.1007/s00265-009-0747-0; Lehmann L, 2007, J EVOLUTION BIOL, V20, P2284, DOI 10.1111/j.1420-9101.2007.01414.x; Leider S, 2009, Q J ECON, V124, P1815, DOI 10.1162/qjec.2009.124.4.1815; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Madden JR, 2009, BEHAV ECOL SOCIOBIOL, V64, P81, DOI 10.1007/s00265-009-0820-8; Madsen EA, 2007, BRIT J PSYCHOL, V98, P339, DOI 10.1348/000712606X129213; McDonald DB, 2007, P NATL ACAD SCI USA, V104, P10910, DOI 10.1073/pnas.0701159104; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Milinski M, 2001, P ROY SOC B-BIOL SCI, V268, P2495, DOI 10.1098/rspb.2001.1809; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pastor-Nieto R, 2001, ZOO BIOL, V20, P293, DOI 10.1002/zoo.1029; Pike TW, 2008, P ROY SOC B-BIOL SCI, V275, P2515, DOI 10.1098/rspb.2008.0744; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; QUELLER DC, 1985, NATURE, V318, P366, DOI 10.1038/318366a0; Ruch J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-257; Russell AF, 2001, P ROY SOC B-BIOL SCI, V268, P2169, DOI 10.1098/rspb.2001.1790; Santos FC, 2006, P ROY SOC B-BIOL SCI, V273, P51, DOI 10.1098/rspb.2005.3272; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Scott J., 2000, SOCIAL STRUCTURE, V2nd; SEYFARTH RM, 1980, ANIM BEHAV, V28, P798, DOI 10.1016/S0003-3472(80)80140-0; SEYFARTH RM, 1976, ANIM BEHAV, V24, P917, DOI 10.1016/S0003-3472(76)80022-X; Sih A, 2009, BEHAV ECOL SOCIOBIOL, V63, P975, DOI 10.1007/s00265-009-0725-6; Sommerfeld RD, 2007, P NATL ACAD SCI USA, V104, P17435, DOI 10.1073/pnas.0704598104; Tomochi M, 2004, SOC NETWORKS, V26, P309, DOI 10.1016/j.socnet.2004.08.003; Voelkl B, 2009, BIOL LETTERS, V5, P462, DOI 10.1098/rsbl.2009.0204; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wolf JBW, 2008, P ROY SOC B-BIOL SCI, V275, P2063, DOI 10.1098/rspb.2008.0356; Wolf JBW, 2007, ANIM BEHAV, V74, P1293, DOI 10.1016/j.anbehav.2007.02.024; YAMAGISHI T, 1993, SOC PSYCHOL QUART, V56, P235, DOI 10.2307/2786661	74	44	44	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18338	10.1371/journal.pone.0018338	http://dx.doi.org/10.1371/journal.pone.0018338			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YK	21479173	Green Published, gold, Green Submitted			2022-12-27	WOS:000289055700049
J	Matheron, E; Kapoula, Z				Matheron, Eric; Kapoula, Zoi			Vertical Heterophoria and Postural Control in Nonspecific Chronic Low Back Pain	PLOS ONE			English	Article							WEIGHT DISTRIBUTION; SPECTACLE LENSES; HEALTHY-YOUNG; ADAPTATION; STABILITY; BALANCE; STANCE; PRISM; PROPRIOCEPTION; REHABILITATION	The purpose of this study was to test postural control during quiet standing in nonspecific chronic low back pain (LBP) subjects with vertical heterophoria (VH) before and after cancellation of VH; also to compare with healthy subjects with, and without VH. Fourteen subjects with LBP took part in this study. The postural performance was measured through the center of pressure displacements with a force platform while the subjects fixated on a target placed at either 40 or 200 cm, before and after VH cancellation with an appropriate prism. Their postural performance was compared to that of 14 healthy subjects with VH and 12 without VH (i.e. vertical orthophoria) studied previously in similar conditions. For LBP subjects, cancellation of VH with a prism improved postural performance. With respect to control subjects (with or without VH), the variance of speed of the center of pressure was higher, suggesting more energy was needed to stabilize their posture in quiet upright stance. Similarly to controls, LBP subjects showed higher postural sway when they were looking at a target at a far distance than at a close distance. The most important finding is that LBP subjects with VH can improve their performance after prism-cancellation of their VH. We suggest that VH reflects mild conflict between sensory and motor inputs involved in postural control i.e. a non optimal integration of the various signals. This could affect the performance of postural control and perhaps lead to pain. Nonspecific chronic back pain may results from such prolonged conflict.	[Matheron, Eric; Kapoula, Zoi] Hop Europeen Georges Pompidou, Serv Ophtalmol ORL Stomatol, CNRS, Grp IRIS,FRE 3375, Paris, France; [Matheron, Eric; Kapoula, Zoi] Hop Robert Debre, ORL, Serv Ophtalmol, F-75019 Paris, France; [Matheron, Eric] Univ Paris 05, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Matheron, E (corresponding author), Hop Europeen Georges Pompidou, Serv Ophtalmol ORL Stomatol, CNRS, Grp IRIS,FRE 3375, Paris, France.	matheron@wanadoo.fr			Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This study is funded by the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KM, 1998, J ORTHOP SPORT PHYS, V28, P378, DOI 10.2519/jospt.1998.28.6.378; Allison Christine L, 2007, Optometry, V78, P644, DOI 10.1016/j.optm.2007.05.012; Amiridis IG, 2003, NEUROSCI LETT, V350, P137, DOI 10.1016/S0304-3940(03)00878-4; AMOS FJ, 1987, DIAGNOSIS MANAGEMENT, P515; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; ANDERSSON HI, 1993, CLIN J PAIN, V9, P174, DOI 10.1097/00002508-199309000-00004; [Anonymous], 2004, EUROPEAN GUIDELINES; Atlas SJ, 2003, MUSCLE NERVE, V27, P265, DOI 10.1002/mus.10311; BARON J, 1952, Trans Am Acad Ophthalmol Otolaryngol, V56, P916; BERGIN PS, 1995, J NEUROL NEUROSUR PS, V58, P335, DOI 10.1136/jnnp.58.3.335; BLES W, 1980, ACTA OTO-LARYNGOL, V89, P534, DOI 10.3109/00016488009127171; Bloem BR, 2000, EXP BRAIN RES, V130, P375, DOI 10.1007/s002219900259; Brandt T., 1986, DISORDERS POSTURE, P157; Brumagne S, 2004, NEUROSCI LETT, V366, P63, DOI 10.1016/j.neulet.2004.05.013; Brumagne S, 2000, SPINE, V25, P989, DOI 10.1097/00007632-200004150-00015; Brumagne S, 2008, GAIT POSTURE, V28, P657, DOI 10.1016/j.gaitpost.2008.04.015; BYL NN, 1991, SPINE, V16, P325, DOI 10.1097/00007632-199103000-00012; Casillas EC, 2006, OPTOMETRY VISION SCI, V83, P237, DOI 10.1097/01.opx.0000214316.50270.24; CATSBARIL WL, 1991, SPINE, V16, P605, DOI 10.1097/00007632-199106000-00001; Cheeseman EW, 1999, ARCH OPHTHALMOL-CHIC, V117, P1188; Croft PR, 1998, BRIT MED J, V316, P1356, DOI 10.1136/bmj.316.7141.1356; DACUNHA HM, 1986, J FR OPHTALMOL, V9, P747; DAUM KM, 1991, CLIN PROCEDURES OPTO, P72; della Volpe R, 2006, GAIT POSTURE, V24, P349, DOI 10.1016/j.gaitpost.2005.10.009; Demer JL, 2008, PROG BRAIN RES, V171, P21, DOI 10.1016/S0079-6123(08)00604-3; DEYO RA, 1988, ARCH PHYS MED REHAB, V69, P1044; DIENER HC, 1989, PROG BRAIN RES, V80, P481; Doble JE, 2010, PM&R, V2, P244, DOI 10.1016/j.pmrj.2010.01.011; Ebenbichler GR, 2001, MED SCI SPORT EXER, V33, P1889, DOI 10.1097/00005768-200111000-00014; Gagey P M, 1987, Agressologie, V28, P925; Gagey P M, 1999, POSTUROLOGIE REGULAT, P45; GAGEY PM, 1980, DISORDERS POSTURE GA, P253; Hagen EM, 2006, SPINE, V31, P1491, DOI 10.1097/01.brs.0000219947.71168.08; Hamaoui A, 2004, NEUROSCI LETT, V357, P135, DOI 10.1016/j.neulet.2003.12.047; Harris AJ, 1999, LANCET, V354, P1464, DOI 10.1016/S0140-6736(99)05003-5; Henry SM, 2006, CLIN BIOMECH, V21, P881, DOI 10.1016/j.clinbiomech.2006.04.016; Hestbaek L, 2003, J MANIP PHYSIOL THER, V26, P243, DOI 10.1016/S0161-4754(03)00003-4; Huang MA, 2006, OPTOMETRY VISION SCI, V83, P242, DOI 10.1097/01.opx.0000214298.73085.b5; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Jones KE, 2001, NEUROREPORT, V12, P4029, DOI 10.1097/00001756-200112210-00035; Jonsson E, 2005, CLIN BIOMECH, V20, P202, DOI 10.1016/j.clinbiomech.2004.09.008; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kapoula Z, 2006, EXP BRAIN RES, V173, P438, DOI 10.1007/s00221-006-0382-1; Kertesz AE., 1983, VERGENCE EYE MOVEMEN, P317; Kono R, 2002, INVEST OPHTH VIS SCI, V43, P673; Le TT, 2006, VISION RES, V46, P3586, DOI 10.1016/j.visres.2006.06.018; Maniadakis N, 2000, PAIN, V84, P95, DOI 10.1016/S0304-3959(99)00187-6; MARUCCHI C, 1988, Agressologie, V29, P693; MATHERON E, 2007, POSTUROLOGIE CLIN DY, P44; MATHERON E, 2005, GAIT POSTURE S1, V21, pS132, DOI DOI 10.1016/S0966-6362(05)80437-0; Matheron E, 2000, KINESITHER SCI, V34, P23; Matheron E, 2008, CLIN NEUROPHYSIOL, V119, P2314, DOI 10.1016/j.clinph.2008.06.016; Matheron E, 2008, NEUROSCI LETT, V444, P176, DOI 10.1016/j.neulet.2008.08.025; Matheron E, 2007, NEUROSCI LETT, V423, P236, DOI 10.1016/j.neulet.2007.07.016; Mazzocchio R, 2001, BMC Musculoskelet Disord, V2, P4, DOI 10.1186/1471-2474-2-4; Mazzocchio R, 2000, J SPINAL DISORD, V13, P487, DOI 10.1097/00002517-200012000-00004; McCabe CS, 2007, RHEUMATOLOGY, V46, P1587, DOI 10.1093/rheumatology/kem204; McCabe CS, 2005, RHEUMATOLOGY, V44, P509, DOI 10.1093/rheumatology/keh529; Mientjes MIV, 1999, CLIN BIOMECH, V14, P710, DOI 10.1016/S0268-0033(99)00025-X; Missaoui B, 2008, NEUROPHYSIOL CLIN, V38, P447, DOI 10.1016/j.neucli.2008.09.004; Mok NW, 2004, SPINE, V29, pE107, DOI 10.1097/01.BRS.0000115134.97854.C9; Padula WV, 2009, BRAIN INJURY, V23, P566, DOI 10.1080/02699050902926283; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; PAULUS W, 1989, EXP BRAIN RES, V78, P243; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Pisella L, 2006, CURR OPIN NEUROL, V19, P534, DOI 10.1097/WCO.0b013e328010924b; Popa T, 2007, EXP BRAIN RES, V177, P411, DOI 10.1007/s00221-006-0683-4; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; SCATTERGOOD KD, 1983, AM J OPHTHALMOL, V96, P439, DOI 10.1016/S0002-9394(14)77906-1; SCHEIMAN M, 1994, CLIN MANAGEMENT BINO, P405; Speers RA, 2002, GAIT POSTURE, V16, P20, DOI 10.1016/S0966-6362(02)00003-6; Stokes IAF, 2006, EUR SPINE J, V15, P658, DOI 10.1007/s00586-005-0893-7; SUCHOFF IB, 2004, J AM OPTOM ASSOC, V75, P305; Sunartpin Peenaraya, 2005, Journal of the Medical Association of Thailand, V88, P1905; Takagi A., 1985, VESTIBULAR VISUAL CO, P74; Thomas E, 1999, BRIT MED J, V318, P1662, DOI 10.1136/bmj.318.7199.1662; USHIO N, 1980, AGRESSOLOGIE, V21, P143; USHIO N, 1980, AGRESSOLOGIE, V21, P153; van Rijn LJ, 1998, VISION RES, V38, P2973, DOI 10.1016/S0042-6989(98)00079-0; Von Korff M, 2005, PAIN, V113, P331, DOI 10.1016/j.pain.2004.11.010; Von Noorden GK, 2002, BINOCULAR VISION OCU, V6th; Vuillerme N, 2006, GAIT POSTURE, V24, P169, DOI 10.1016/j.gaitpost.2005.07.011; WADDELL G, 1987, SPINE, V12, P632, DOI 10.1097/00007632-198709000-00002; WADDELL G, 1993, ANN RHEUM DIS, V52, P317, DOI 10.1136/ard.52.5.317; Waddell G, 1996, SPINE, V21, P2820, DOI 10.1097/00007632-199612150-00002; Walker BF, 2000, J SPINAL DISORD, V13, P205, DOI 10.1097/00002517-200006000-00003; Wang Y, 2006, CLIN NEUROPHYSIOL, V117, P41, DOI 10.1016/j.clinph.2005.09.002; *WHO, 1992, HLTH PROM CHRON ILLN, P141; Wong AMF, 2002, OPHTHALMOLOGY, V109, P1315, DOI 10.1016/S0161-6420(02)01067-9; YGGE J, 1995, VISION RES, V35, P3169, DOI 10.1016/0042-6989(95)00125-J	90	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18110	10.1371/journal.pone.0018110	http://dx.doi.org/10.1371/journal.pone.0018110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479210	Green Published, Green Submitted, gold			2022-12-27	WOS:000289055700027
J	Wang, W; Ackermann, D; Mehlich, AM; Konig, S				Wang, Weiqun; Ackermann, Doreen; Mehlich, Anna-Maria; Koenig, Simone			Impact of Quenching Failure of Cy Dyes in Differential Gel Electrophoresis	PLOS ONE			English	Article							TECHNOLOGY	Background: Differential gel electrophoresis (DIGE) is a technology widely used for protein expression analysis. It is based on labelling with fluorescent Cy dyes. In comparative fluorescence gel electrophoresis experiments, however, unspecific labelling using N-hydroxy-succinimide-ester-based labelling protocols was recently detected. Cross-talk was observed due to failure of the quenching process. Here, the impact of this effect for DIGE experiments was investigated. Methodology/Principal Findings: Experiments to test quenching efficiency were performed in replicate using Escherichia coli lysate. Parameters such as the amount of dye and quencher were varied. Labelling and quenching were reversed in one experiment. Differences in protein spot volumes due to limited quenching were determined. For some spots twice the volume was detected underscoring the importance of proper control of silencing of active dye. Conclusions/Significance: It could be demonstrated that uncontrolled labelling increased protein spot volume, even doubling it in some cases. Moreover, proteins responded differently to the protocol. Such unpredictable and unspecific processes are not acceptable in protein regulation studies so that it is necessary to validate the correct amount of quencher for individual samples before the DIGE experiment is performed. Increase of the concentration of lysine, which is used as quencher, from 10 mM to 2500 mM, was sufficient to silence the dye. Alternatively, active dye molecules can be removed by filtration.	[Wang, Weiqun; Ackermann, Doreen; Mehlich, Anna-Maria; Koenig, Simone] Univ Munster, Fac Med, Clin Res Ctr, Core Unit Interdisciplinary, Munster, Germany	University of Munster	Wang, W (corresponding author), Univ Munster, Fac Med, Clin Res Ctr, Core Unit Interdisciplinary, Munster, Germany.	koenigs@uni-muenster.de	König, Simone/B-6504-2008	König, Simone/0000-0003-0672-7246	BMWi ProINNO II; BMWi	BMWi ProINNO II; BMWi(Federal Ministry for Economic Affairs and Energy (BMWi))	Funding from the BMWi ProINNO II project DALLImag is gratefully acknowledged. http://www.forschungskoop.de/10_proinno/10_start.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BMWi is a federal funding source which funds collaborative research projects of universities with small industry. None of the authors is employed in this company or dependent on it. This collaboration does not alter the authors' adherence to all PLoS ONE policies sharing data and materials.	*GE HEALTHC, 2003, ETT DIGE US MAN; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Tonge R, 2001, PROTEOMICS, V1, P377; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Viswanathan S, 2006, NAT PROTOC, V1, P1351, DOI 10.1038/nprot.2006.234; Wang WQ, 2010, PROTEOMICS, V10, P1525, DOI 10.1002/pmic.200900679	6	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18098	10.1371/journal.pone.0018098	http://dx.doi.org/10.1371/journal.pone.0018098			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479167	gold, Green Published, Green Submitted			2022-12-27	WOS:000289055700025
J	Goldman, SJ; Chen, E; Taylor, R; Zhang, S; Petrosky, W; Reiss, M; Jin, SK				Goldman, Scott J.; Chen, Elizabeth; Taylor, Robert; Zhang, Sheng; Petrosky, Whitney; Reiss, Michael; Jin, Shengkan			Use of the ODD-Luciferase Transgene for the Non-Invasive Imaging of Spontaneous Tumors in Mice	PLOS ONE			English	Article							BREAST-CANCER; MOUSE MODELS; SUPPRESSOR; HYPOXIA; GROWTH	Background: In humans, imaging of tumors provides rapid, accurate assessment of tumor growth and location. In laboratory animals, however, the imaging of spontaneously occurring tumors continues to pose many technical and logistical problems. Recently a mouse model was generated in which a chimeric protein consisting of HIF-1 alpha oxygen-dependent degradation domain (ODD) fused to luciferase was ubiquitously expressed in all tissues. Hypoxic stress leads to the accumulation of ODD-luciferase in the tissues of this mouse model which can be identified by non-invasive bioluminescence measurement. Since solid tumors often contain hypoxic regions, we performed proof-of-principle experiments testing whether this transgenic mouse model may be used as a universal platform for non-invasive imaging analysis of spontaneous solid tumors. Methods and Materials: ODD-luciferase transgenic mice were bred with MMTV-neu/beclin1+/- mice. Upon injection of luciferin, bioluminescent background of normal tissues in the transgenic mice and bioluminescent signals from spontaneously mammary carcinomas were measured non-invasively with an IVIS Spectrum imaging station. Tumor volumes were measured manually and the histology of tumor tissues was analyzed. Conclusion: Our results show that spontaneous mammary tumors in ODD-luciferase transgenic mice generate substantial bioluminescent signals, which are clearly discernable from background tissue luminescence. Moreover, we demonstrate a strong quantitative correlation between the bioluminescent tumor contour and the volume of palpable tumors. We further demonstrate that shrinkage of the volume of spontaneous tumors in response to chemotherapeutic treatment can be determined quantitatively using this system. Finally, we show that the growth and development of spontaneous tumors can be monitored longitudinally over several weeks. Thus, our results suggest that this model could potentially provide a practical, reliable, and cost-effective non-invasive quantitative method for imaging spontaneous solid tumors in mice.	[Goldman, Scott J.; Chen, Elizabeth; Taylor, Robert] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Petrosky, Whitney; Reiss, Michael; Jin, Shengkan] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08903 USA; [Zhang, Sheng] Cent S Univ, Dept Oral & Maxillofacial Surg, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Goldman, Scott J.; Chen, Elizabeth; Taylor, Robert; Petrosky, Whitney; Reiss, Michael; Jin, Shengkan] CINJ, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Central South University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Goldman, SJ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	jinsh@umdnj.edu		Reiss, Michael/0000-0001-8543-8092	National Institutes of Health [1R01CA116088]; Department of Defense [BC060538]; NATIONAL CANCER INSTITUTE [R01CA116088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research is funded by National Institutes of Health (1R01CA116088) and Department of Defense (BC060538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanell J, 1999, J MAMMARY GLAND BIOL, V4, P337, DOI 10.1023/A:1018762216147; Dennis C, 2006, NATURE, V442, P739, DOI 10.1038/442739a; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Dewhirst MW, 2009, RADIAT RES, V172, P653, DOI 10.1667/RR1926.1; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Gross S, 2005, CANCER CELL, V7, P5, DOI 10.1016/j.ccr.2004.12.011; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Jonkers J, 2002, NAT REV CANCER, V2, P251, DOI 10.1038/nrc777; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; KIM JB, PLOS ONE, V5, pE9364; KYRIAZI S, NAT REV CLIN ONCOL, V7, P381; MULLER WJ, 1991, CANCER METAST REV, V10, P217, DOI 10.1007/BF00050793; Muller WJ, 1996, MOL CELL BIOL, V16, P5726; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Oyen WJG, 2009, NAT REV CLIN ONCOL, V6, P609, DOI 10.1038/nrclinonc.2009.139; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; SCHETTER AJ, CARCINOGENESIS, V31, P37; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Stern DF, 2008, J MAMMARY GLAND BIOL, V13, P215, DOI 10.1007/s10911-008-9083-7; TENNANT DA, NAT REV CANC, V10, P267; Tuveson DA, 2002, CURR OPIN GENET DEV, V12, P105, DOI 10.1016/S0959-437X(01)00272-6; Waldman AD, 2009, NAT REV CLIN ONCOL, V6, P445, DOI 10.1038/nrclinonc.2009.92; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	26	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18269	10.1371/journal.pone.0018269	http://dx.doi.org/10.1371/journal.pone.0018269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479246	Green Published, gold, Green Submitted			2022-12-27	WOS:000289054600041
J	Hollis, KL; Cogswell, H; Snyder, K; Guillette, LM; Nowbahari, E				Hollis, Karen L.; Cogswell, Heather; Snyder, Kenzie; Guillette, Lauren M.; Nowbahari, Elise			Specialized Learning in Antlions (Neuroptera: Myrmeleontidae), Pit-Digging Predators, Shortens Vulnerable Larval Stage	PLOS ONE			English	Article							JAPANESE-QUAIL; BEHAVIOR; HOST; CONSTRUCTION; SELECTION; PATTERNS; SUCCESS; NEURONS; CONTEXT; PREY	Unique in the insect world for their extremely sedentary predatory behavior, pit-dwelling larval antlions dig pits, and then sit at the bottom and wait, sometimes for months, for prey to fall inside. This sedentary predation strategy, combined with their seemingly innate ability to detect approaching prey, make antlions unlikely candidates for learning. That is, although scientists have demonstrated that many species of insects possess the capacity to learn, each of these species, which together represent multiple families from every major insect order, utilizes this ability as a means of navigating the environment, using learned cues to guide an active search for food and hosts, or to avoid noxious events. Nonetheless, we demonstrate not only that sedentary antlions can learn, but also, more importantly, that learning provides an important fitness benefit, namely decreasing the time to pupate, a benefit not yet demonstrated in any other species. Compared to a control group in which an environmental cue was presented randomly vis-a-vis daily prey arrival, antlions given the opportunity to associate the cue with prey were able to make more efficient use of prey and pupate significantly sooner, thus shortening their long, highly vulnerable larval stage. Whereas "median survival time," the point at which half of the animals in each group had pupated, was 46 days for antlions receiving the Learning treatment, that point never was reached in antlions receiving the Random treatment, even by the end of the experiment on Day 70. In addition, we demonstrate a novel manifestation of antlions' learned response to cues predicting prey arrival, behavior that does not match the typical "learning curve" but which is well-adapted to their sedentary predation strategy. Finally, we suggest that what has long appeared to be instinctive predatory behavior is likely to be highly modified and shaped by learning.	[Hollis, Karen L.; Cogswell, Heather; Snyder, Kenzie; Guillette, Lauren M.] Mt Holyoke Coll, Interdisciplinary Program Neurosci & Behav, S Hadley, MA 01075 USA; [Hollis, Karen L.; Cogswell, Heather; Snyder, Kenzie; Guillette, Lauren M.] Mt Holyoke Coll, Dept Psychol, S Hadley, MA 01075 USA; [Nowbahari, Elise] Univ Paris 13, Lab Ethol Expt & Comparee, EA 4443, F-93430 Villetaneuse, France	Mount Holyoke College; Mount Holyoke College; Universite Paris 13	Hollis, KL (corresponding author), Mt Holyoke Coll, Interdisciplinary Program Neurosci & Behav, S Hadley, MA 01075 USA.	khollis@mtholyoke.edu	Guillette, Lauren/K-8154-2013	Guillette, Lauren/0000-0002-8777-6543	Harap Fund; Mount Holyoke College; University of Alberta	Harap Fund; Mount Holyoke College; University of Alberta(University of Alberta)	The Harap Fund (http://www.mtholyoke.edu/acad/psychology/resources.html) and Mount Holyoke College (http://www.mtholyoke.edu/) provided financial support. LMG is supported by an Izaak Walton Killam Memorial Scholarship at the University of Alberta. Website at: http://www.gradstudies.ualberta.ca/killam/izaakmemorial.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 2003, P ROY SOC B-BIOL SCI, V270, P1685, DOI 10.1098/rspb.2003.2421; Bernays Elizabeth A., 1993, P1; Crowley PH, 1999, ECOLOGY, V80, P2271, DOI 10.1890/0012-9658(1999)080[2271:AFTPAS]2.0.CO;2; DEVETAK D, 1985, Bioloski Vestnik, V33, P11; Devetak D, 2007, PHYSIOL ENTOMOL, V32, P268, DOI 10.1111/j.1365-3032.2007.00580.x; Domjan M.P, 2009, PRINCIPLES LEARNING; Dukas R, 2000, BEHAV ECOL, V11, P536, DOI 10.1093/beheco/11.5.536; Dukas R, 2000, P NATL ACAD SCI USA, V97, P2637, DOI 10.1073/pnas.050461497; Dukas R, 2008, ANNU REV ENTOMOL, V53, P145, DOI 10.1146/annurev.ento.53.103106.093343; Dukas R, 2006, ANIM BIOL, V56, P125, DOI 10.1163/157075606777304258; Dunlap AS, 2009, P ROY SOC B-BIOL SCI, V276, P3201, DOI 10.1098/rspb.2009.0602; Fertin A, 2006, J EXP BIOL, V209, P3510, DOI 10.1242/jeb.02401; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; GOTELLI NJ, 1993, ECOLOGY, V74, P226, DOI 10.2307/1939517; Gotelli NJ, 1997, ECOLOGY, V78, P1761, DOI 10.1890/0012-9658(1997)078[1761:CACOLA]2.0.CO;2; Greenspan RJ, 2007, COLD SPRING HARB MON, V49, P647; GRIFFITHS D, 1985, J ANIM ECOL, V54, P573, DOI 10.2307/4499; GRIFFITHS D, 1986, J ANIM ECOL, V55, P39, DOI 10.2307/4691; HOLLIS KL, 1982, ADV STUD BEHAV, V12, P1, DOI 10.1016/S0065-3454(08)60045-5; Hollis KL, 1997, J COMP PSYCHOL, V111, P219, DOI 10.1037/0735-7036.111.3.219; Hollis KL, 2004, ANIM BEHAV, V68, P1155, DOI 10.1016/j.anbehav.2003.11.022; LEWIS WJ, 1990, NATURE, V348, P635, DOI 10.1038/348635a0; London KB, 2005, J KANSAS ENTOMOL SOC, V78, P134, DOI 10.2317/0405.06.1; LUCAS JR, 1982, ANIM BEHAV, V30, P651, DOI 10.1016/S0003-3472(82)80135-8; Mahometa MJ, 2005, ANIM BEHAV, V69, P983, DOI 10.1016/j.anbehav.2004.06.023; Mansell M.W., 1999, STAPFIA, V60, P49; Mansell M. W., 1992, PHOENIX, V5, P20; Mansell MV, 1996, PURE AND APPLIED RESEARCH IN NEUROPTEROLOGY, P161; MATSURA T, 1987, RES POPUL ECOL, V29, P17, DOI 10.1007/BF02515422; Mencinger Bojana, 1998, Acta Zoologica Fennica, V209, P157; Mencinger-Vracko B, 2008, ZOOLOGY, V111, P2, DOI 10.1016/j.zool.2007.05.002; Menzel R., 1974, P195; MUENCHOW G, 1986, ECOLOGY, V67, P246, DOI 10.2307/1938524; Nicolaidis S., 1977, The chemical senses and nutrition, P123; North G, 2007, COLD SPRING HARB MON, V49, pIX; Papaj D. R., 2003, ENCY INSECTS, P624; Papaj D.R., 1993, INSECT LEARNING ECOL; Pszczolkowski MA, 2005, PHYSIOL BEHAV, V86, P168, DOI 10.1016/j.physbeh.2005.07.007; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Raine NE, 2009, CURR BIOL, V19, pR486, DOI 10.1016/j.cub.2009.04.047; Sakura M, 2001, ZOOL SCI, V18, P21, DOI 10.2108/zsj.18.21; Scharf I, 2006, J INSECT BEHAV, V19, P197, DOI 10.1007/s10905-006-9017-4; Shettleworth S. J., 2009, COGNITION EVOLUTION; SIMPSON SJ, 1990, ANIM BEHAV, V40, P506, DOI 10.1016/S0003-3472(05)80531-7; Skiri HT, 2005, J EXP BIOL, V208, P787, DOI 10.1242/jeb.01431; Snell-Rood EC, 2009, AM NAT, V173, P615, DOI 10.1086/597609; Stephens David W., 1993, P195; TOPOFF H, 1977, NAT HIST, V86, P64; Watanabe H, 2006, J EXP BIOL, V209, P766, DOI 10.1242/jeb.02049	50	33	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17958	10.1371/journal.pone.0017958	http://dx.doi.org/10.1371/journal.pone.0017958			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479229	Green Published, gold, Green Submitted			2022-12-27	WOS:000289054600023
J	Suh, YH; Yoshimoto-Furusawa, A; Weih, KA; Tessarollo, L; Roche, KW; Mackem, S; Roche, PA				Suh, Young Ho; Yoshimoto-Furusawa, Aki; Weih, Karis A.; Tessarollo, Lino; Roche, Katherine W.; Mackem, Susan; Roche, Paul A.			Deletion of SNAP-23 Results in Pre-Implantation Embryonic Lethality in Mice	PLOS ONE			English	Article							PANCREATIC ACINAR-CELLS; REGULATED EXOCYTOSIS; KNOCKOUT MICE; MAST-CELLS; STEM-CELLS; SNARE; TRAFFICKING; SURFACE; MECHANISMS; SYNTAXIN	SNARE-mediated membrane fusion is a pivotal event for a wide-variety of biological processes. SNAP-25, a neuron-specific SNARE protein, has been well-characterized and mouse embryos lacking Snap25 are viable. However, the phenotype of mice lacking SNAP-23, the ubiquitously expressed SNAP-25 homolog, remains unknown. To reveal the importance of SNAP-23 function in mouse development, we generated Snap23-null mice by homologous recombination. We were unable to obtain newborn SNAP-23-deficient mice, and analysis of pre-implantation embryos from Snap23(Delta/wt) matings revealed that Snap23-null blastocysts were dying prior to implantation at embryonic day E3.5. Thus these data reveal a critical role for SNAP-23 during embryogenesis.	[Suh, Young Ho; Weih, Karis A.; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Suh, Young Ho; Roche, Katherine W.] NINDS, Receptor Biol Sect, NIH, Bethesda, MD 20892 USA; [Suh, Young Ho] Ajou Univ, Sch Med, Dept Pharmacol, Grad Program Neurosci, Suwon 441749, South Korea; [Tessarollo, Lino] NCI, Mouse Canc Genet Program, CCR, NIH, Frederick, MD 21701 USA; [Yoshimoto-Furusawa, Aki; Mackem, Susan] NCI, Canc & Dev Biol Lab, CCR, NIH, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Ajou University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Suh, YH (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	paul.roche@nih.gov	Suh, Young Ho/AAJ-6405-2021; Roche, Katherine/W-9893-2019	Suh, Young Ho/0000-0003-3979-1615; Roche, Paul/0000-0002-8949-9172; Roche, Katherine/0000-0001-7282-6539	NCI; NINDS; Integrative Neural Immune Program; NATIONAL CANCER INSTITUTE [ZIABC011035, ZICBC011265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002994] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Integrative Neural Immune Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the NCI Intramural Research Program (Y.H.S., A.Y.-F., L.T, S.M. and P.A.R.), the NINDS Intramural Research Program (Y.H.S., and K.W.R.), and the Integrative Neural Immune Program (Y.H.S. fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Chen D, 2000, BLOOD, V95, P921, DOI 10.1182/blood.V95.3.921.003k17_921_929; DOOLEY TP, 1989, DEVELOPMENT, V107, P945; Ferguson GD, 2000, P NATL ACAD SCI USA, V97, P5598, DOI 10.1073/pnas.100104597; Fournier KM, 2006, NEUROCHEM INT, V48, P596, DOI 10.1016/j.neuint.2005.12.030; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Hepp G, 2005, J BIOL CHEM, V280, P6610, DOI 10.1074/jbc.M412126200; Holzenberger M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e92; Huang XH, 2001, PANCREAS, V23, P125, DOI 10.1097/00006676-200108000-00002; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Leung SM, 1998, J BIOL CHEM, V273, P17732, DOI 10.1074/jbc.273.28.17732; Nagy A, 2002, MANIPULATING MOUSE E, P800; PURI N, 2008, P NATL ACAD SCI US; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Rea S, 1998, J BIOL CHEM, V273, P18784, DOI 10.1074/jbc.273.30.18784; Reid Susan W., 2009, V530, P269, DOI 10.1007/978-1-59745-471-1_14; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Southon Eileen, 2009, V530, P165, DOI 10.1007/978-1-59745-471-1_9; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Tessarollo Lino, 2009, V530, P141, DOI 10.1007/978-1-59745-471-1_8; Vaidyanathan VV, 2000, GENE, V247, P181, DOI 10.1016/S0378-1119(00)00100-1; Vaidyanathan VV, 2001, J BIOL CHEM, V276, P25101, DOI 10.1074/jbc.M103536200; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; Yang CM, 2001, J CLIN INVEST, V107, P1311, DOI 10.1172/JCI12274; Yang CM, 2001, MOL CELL BIOL, V21, P1573, DOI 10.1128/MCB.21.5.1573-1580.2001	32	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18444	10.1371/journal.pone.0018444	http://dx.doi.org/10.1371/journal.pone.0018444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479242	Green Published, Green Submitted, gold			2022-12-27	WOS:000289054600052
J	Scarisbrick, IA; Epstein, B; Cloud, BA; Yoon, H; Wu, JM; Renner, DN; Blaber, SI; Blaber, M; Vandell, AG; Bryson, AL				Scarisbrick, Isobel A.; Epstein, Benjamin; Cloud, Beth A.; Yoon, Hyesook; Wu, Jianmin; Renner, Danielle N.; Blaber, Sachiko I.; Blaber, Michael; Vandell, Alexander G.; Bryson, Alexandra L.			Functional Role of Kallikrein 6 in Regulating Immune Cell Survival	PLOS ONE			English	Article							PROTEINASE-ACTIVATED RECEPTORS; FAMILY-MEMBER BIM; INDUCED APOPTOSIS; DIFFERENTIAL EXPRESSION; MULTIPLE-SCLEROSIS; TISSUE KALLIKREINS; SERINE-PROTEASE; CANCER CELLS; SPINAL-CORD; DEATH	Background: Kallikrein 6 (KLK6) is a newly identified member of the kallikrein family of secreted serine proteases that prior studies indicate is elevated at sites of central nervous system (CNS) inflammation and which shows regulated expression with T cell activation. Notably, KLK6 is also elevated in the serum of multiple sclerosis (MS) patients however its potential roles in immune function are unknown. Herein we specifically examine whether KLK6 alters immune cell survival and the possible mechanism by which this may occur. Methodology/Principal Findings: Using murine whole splenocyte preparations and the human Jurkat T cell line we demonstrate that KLK6 robustly supports cell survival across a range of cell death paradigms. Recombinant KLK6 was shown to significantly reduce cell death under resting conditions and in response to camptothecin, dexamethasone, staurosporine and Fas-ligand. Moreover, KLK6-over expression in Jurkat T cells was shown to generate parallel pro-survival effects. In mixed splenocyte populations the vigorous immune cell survival promoting effects of KLK6 were shown to include both T and B lymphocytes, to occur with as little as 5 minutes of treatment, and to involve up regulation of the pro-survival protein B-cell lymphoma-extra large (Bcl-XL), and inhibition of the pro-apoptotic protein Bcl-2-interacting mediator of cell death (Bim). The ability of KLK6 to promote survival of splenic T cells was also shown to be absent in cell preparations derived from PAR1 deficient mice. Conclusion/Significance: KLK6 promotes lymphocyte survival by a mechanism that depends in part on activation of PAR1. These findings point to a novel molecular mechanism regulating lymphocyte survival that is likely to have relevance to a range of immunological responses that depend on apoptosis for immune clearance and maintenance of homeostasis.	[Scarisbrick, Isobel A.; Epstein, Benjamin; Yoon, Hyesook; Wu, Jianmin; Renner, Danielle N.; Vandell, Alexander G.; Bryson, Alexandra L.] Mayo Med & Grad Sch, Neurobiol Dis Program, Rochester, MN 55905 USA; [Scarisbrick, Isobel A.; Cloud, Beth A.; Vandell, Alexander G.] Mayo Med & Grad Sch, Dept Phys Med & Rehabil, Rochester, MN USA; [Scarisbrick, Isobel A.] Mayo Med & Grad Sch, Dept Neurol, Rochester, MN USA; [Blaber, Sachiko I.; Blaber, Michael] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; State University System of Florida; Florida State University	Scarisbrick, IA (corresponding author), Mayo Med & Grad Sch, Neurobiol Dis Program, Rochester, MN 55905 USA.	Scarisbrick.Isobel@Mayo.edu	Blaber, Michael/E-7478-2011; Blaber, Michael/ABA-5031-2021; Blaber, Michael/N-1083-2019	Blaber, Michael/0000-0002-6856-1643; Cloud-Biebl, Beth/0000-0001-9121-1820	Mayo Collaborative MS [CA1060A11-02]; Christopher and Dana Reeve Foundation; NCI [P50CA108961]; National Institutes of Health [NS052741, R15NS057771]; National Multiple Sclerosis Society [RG3367]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052741, R15NS057771] Funding Source: NIH RePORTER	Mayo Collaborative MS; Christopher and Dana Reeve Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Mayo Collaborative MS Research Award CA1060A11-02, the Christopher and Dana Reeve Foundation and NCI P50CA108961, National Institutes of Health Grants NS052741 and R15NS057771 (http://www.nih.gov/) and the National Multiple Sclerosis Society Grants RG3367 (http://www.nationalmssociety.org/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTIERI DC, 1994, CELL IMMUNOL, V155, P372, DOI 10.1006/cimm.1994.1130; Angelo PF, 2006, J BIOL CHEM, V281, P3116, DOI 10.1074/jbc.M510096200; Anisowicz A, 1996, MOL MED, V2, P624, DOI 10.1007/BF03401646; ASHWELL JD, 1987, J EXP MED, V165, P173, DOI 10.1084/jem.165.1.173; Bernett MJ, 2002, J BIOL CHEM, V277, P24562, DOI 10.1074/jbc.M202392200; Blaber SI, 2004, FASEB J, V18, P920, DOI 10.1096/fj.03-1212fje; Blaber SI, 2002, BIOCHEMISTRY-US, V41, P1165, DOI 10.1021/bi015781a; Borgono CA, 2004, MOL CANCER RES, V2, P257; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; BROWN DG, 1993, J BIOL CHEM, V268, P3037; Chae HJ, 2000, PHARMACOL RES, V42, P373, DOI 10.1006/phrs.2000.0700; Chalmers CJ, 2003, BIOCHEM J, V375, P99, DOI 10.1042/BJ20030346; Chen D, 2004, P NATL ACAD SCI USA, V101, P1235, DOI 10.1073/pnas.0308050100; Christophi GP, 2004, J NEUROCHEM, V91, P1439, DOI 10.1111/j.1471-4159.2004.02826.x; Clements J, 2001, BIOL CHEM, V382, P5, DOI 10.1515/BC.2001.002; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Colognato R, 2003, BLOOD, V102, P2645, DOI 10.1182/blood-2002-08-2497; Coughlin SR, 2003, J CLIN INVEST, V111, P25, DOI 10.1172/JCI200317564; Cunningham MA, 2000, J EXP MED, V191, P455, DOI 10.1084/jem.191.3.455; Diamandis EP, 2000, CLIN BIOCHEM, V33, P579, DOI 10.1016/S0009-9120(00)00182-X; Eischen CM, 1997, BLOOD, V90, P935, DOI 10.1182/blood.V90.3.935.935_935_943; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; Ferraro C, 2000, CELL DEATH DIFFER, V7, P197, DOI 10.1038/sj.cdd.4400595; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; Fields RC, 2003, AM J PATHOL, V162, P1817, DOI 10.1016/S0002-9440(10)64316-7; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kawagoe J, 2002, JPN J PHARMACOL, V88, P77, DOI 10.1254/jjp.88.77; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Laxmikanthan G, 2005, PROTEINS, V58, P802, DOI 10.1002/prot.20368; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li T, 2006, SCAND J IMMUNOL, V64, P10, DOI 10.1111/j.1365-3083.2006.01772.x; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Malamud V, 2003, J NEUROIMMUNOL, V138, P115, DOI 10.1016/S0165-5728(03)00090-0; Mitsui S, 2002, ANN NY ACAD SCI, V977, P216, DOI 10.1111/j.1749-6632.2002.tb04818.x; Noorbakhsh F, 2006, J EXP MED, V203, P425, DOI 10.1084/jem.20052148; Oikonomopoulou K, 2006, BIOL CHEM, V387, P817, DOI 10.1515/BC.2006.104; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; Ruckert F, 2008, BRIT J CANCER, V99, P1484, DOI 10.1038/sj.bjc.6604717; Scarisbrick IA, 2006, J NEUROIMMUNOL, V178, P167, DOI 10.1016/j.jneuroim.2006.05.022; Scarisbrick IA, 2006, EUR J NEUROSCI, V24, P1457, DOI 10.1111/j.1460-9568.2006.05021.x; Scarisbrick IA, 2002, BRAIN, V125, P1283, DOI 10.1093/brain/awf142; Scarisbrick IA, 1997, J NEUROSCI, V17, P8156; Scarisbrick IA, 2008, BIOL CHEM, V389, P739, DOI 10.1515/BC.2008.085; Shpacovitch V, 2008, J LEUKOCYTE BIOL, V83, P1309, DOI 10.1189/jlb.0108001; Song Q, 1996, CLIN EXP HYPERTENS, V18, P975, DOI 10.3109/10641969609081030; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Tantivejkul K, 2005, J CELL BIOCHEM, V96, P641, DOI 10.1002/jcb.20533; Vandell AG, 2008, J NEUROCHEM, V107, P855, DOI 10.1111/j.1471-4159.2008.05658.x; Vergnolle N, 2004, J CLIN INVEST, V114, P1444, DOI 10.1172/JCI200421689; Wang YF, 2006, J NEUROCHEM, V98, P1046, DOI 10.1111/j.1471-4159.2006.03950.x; WEE JL, 2009, GASTROENTEROLOGY; White NMA, 2009, BRIT J CANCER, V101, P1107, DOI 10.1038/sj.bjc.6605280; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187; Yang YH, 2005, ARTHRITIS RHEUM-US, V52, P1325, DOI 10.1002/art.21001; ZACHARCHUK CM, 1990, J IMMUNOL, V145, P4037; Zarghooni M, 2002, CLIN BIOCHEM, V35, P225, DOI 10.1016/S0009-9120(02)00292-8; Zhang XD, 2004, MOL CANCER THER, V3, P187; Zilman A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012775	63	39	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18376	10.1371/journal.pone.0018376	http://dx.doi.org/10.1371/journal.pone.0018376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464892	Green Published, gold, Green Submitted			2022-12-27	WOS:000289053800044
J	den Hartog, G; Savelkoul, HFJ; Schoemaker, R; Tijhaar, E; Westphal, AH; de Ruiter, T; van de Weg-Schrijver, E; van Neerven, RJJ				den Hartog, Gerco; Savelkoul, Huub F. J.; Schoemaker, Ruud; Tijhaar, Edwin; Westphal, Adrie H.; de Ruiter, Talitha; van de Weg-Schrijver, Elise; van Neerven, R. J. Joost			Modulation of Human Immune Responses by Bovine Interleukin-10	PLOS ONE			English	Article							T-CELL PROLIFERATION; DENDRITIC CELLS; IFN-GAMMA; NECROTIZING ENTEROCOLITIS; SUBLINGUAL IMMUNOTHERAPY; CYTOKINE PRODUCTION; INTERFERON-GAMMA; AUTOCRINE IL-10; HUMAN-MILK; TGF-BETA	Cytokines can be functionally active across species barriers. Bovine IL-10 has an amino acid sequence identity with human IL-10 of 76.8%. Therefore, the aim of this study was to evaluate whether bovine IL-10 has immunomodulatory activities on human monocytes and dendritic cells. Peripheral blood monocytes were isolated from healthy donors, and used directly or allowed to differentiate to dendritic cells under the influence of IL-4 and GM-CSF. Recombinant bovine IL-10 inhibited TLR induced activation of monocytes, and dose-dependently inhibited LPS-induced activation of monocyte-derived DCs comparable to human IL-10. By using blocking antibodies to either bovine IL-10 or the human IL-10 receptor it was demonstrated that inhibition of monocyte activation by bovine IL-10 was dependent on binding of bovine IL-10 to the human IL-10R. These data demonstrate that bovine IL-10 potently inhibits the activation of human myeloid cells in response to TLR activation. Bovine IL-10 present in dairy products may thus potentially contribute to the prevention of necrotizing enterocolitis and allergy, enhance mucosal tolerance induction and decrease intestinal inflammation and may therefore be applicable in infant foods and in immunomodulatory diets.	[den Hartog, Gerco; Savelkoul, Huub F. J.; Tijhaar, Edwin] Wageningen Univ, Cell Biol & Immunol Grp, Wageningen, Netherlands; [Schoemaker, Ruud; de Ruiter, Talitha; van de Weg-Schrijver, Elise; van Neerven, R. J. Joost] Royal FrieslandCampina Res, Deventer, Netherlands; [Westphal, Adrie H.] Wageningen Univ, Biochem Lab, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	den Hartog, G (corresponding author), Wageningen Univ, Cell Biol & Immunol Grp, Wageningen, Netherlands.	joost.vanneerven@frieslandcampina.com	Savelkoul, Huub FJ/F-6026-2012; Westphal, Adrie Herman/L-3517-2019; van Neerven, Joost/GWZ-3214-2022; Hartog, Gerco den/AAB-6329-2019	Westphal, Adrie Herman/0000-0003-4264-6267; Hartog, Gerco den/0000-0002-2103-6315; Schoemaker, Ruud/0000-0003-4651-8406; van Neerven, R.J.Joost/0000-0002-3991-5297				Akdis M, 2009, CURR OPIN IMMUNOL, V21, P700, DOI 10.1016/j.coi.2009.07.012; Ando T, 2007, J ALLERGY CLIN IMMUN, V120, P916, DOI 10.1016/j.jaci.2007.05.023; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; BERNSTEIN ZP, 1995, BLOOD, V86, P3287, DOI 10.1182/blood.V86.9.3287.bloodjournal8693287; Bohle B, 2007, J ALLERGY CLIN IMMUN, V120, P707, DOI 10.1016/j.jaci.2007.06.013; COLLINS RA, 1994, VET IMMUNOL IMMUNOP, V40, P313, DOI 10.1016/0165-2427(94)90042-6; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; DELPRETE G, 1993, J IMMUNOL, V150, P353; Demangel C, 2002, EUR J IMMUNOL, V32, P994, DOI 10.1002/1521-4141(200204)32:4<994::AID-IMMU994>3.3.CO;2-Y; Denning TL, 2000, INT IMMUNOL, V12, P133, DOI 10.1093/intimm/12.2.133; DeSmedt T, 1997, EUR J IMMUNOL, V27, P1229, DOI 10.1002/eji.1830270526; Donnelly RP, 1999, J INTERF CYTOK RES, V19, P563, DOI 10.1089/107999099313695; Dvorak B, 2003, PEDIATR RES, V53, P426, DOI 10.1203/01.PDR.0000050657.56817.E0; Enrique E, 2005, J ALLERGY CLIN IMMUN, V116, P1073, DOI 10.1016/j.jaci.2005.08.027; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fayette J, 1997, J EXP MED, V185, P1909, DOI 10.1084/jem.185.11.1909; Field CJ, 2005, J NUTR, V135, P1; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Fituch CC, 2004, ACTA PAEDIATR, V93, P1496, DOI 10.1080/08035250410022314; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Frossard CP, 2007, J ALLERGY CLIN IMMUN, V119, P952, DOI 10.1016/j.jaci.2006.12.615; GAROFALO R, 1995, PEDIATR RES, V37, P444, DOI 10.1203/00006450-199504000-00010; Gill HS, 2000, BRIT J NUTR, V84, pS111; Halpern MD, 2006, AM J PHYSIOL-GASTR L, V290, pG757, DOI 10.1152/ajpgi.00408.2005; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Hirano T, 2003, IMMUNOL LETT, V89, P251, DOI 10.1016/S0165-2478(03)00156-1; Joetham A, 2007, J IMMUNOL, V178, P1433, DOI 10.4049/jimmunol.178.3.1433; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; Kaiser P, 1998, J INTERF CYTOK RES, V18, P711, DOI 10.1089/jir.1998.18.711; Kalinski P, 1999, J IMMUNOL, V162, P3231; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawson S, 2001, DEV COMP IMMUNOL, V25, P69, DOI 10.1016/S0145-305X(00)00044-6; Lawson S, 2000, J INTERF CYTOK RES, V20, P161, DOI 10.1089/107999000312568; Li YH, 2006, J IMMUNOL, V177, P1679, DOI 10.4049/jimmunol.177.3.1679; MACATONIA SE, 1993, J IMMUNOL, V150, P3755; MALEFYT RD, 1991, J EXP MED, V174, P1209; MALEFYT RD, 1993, J IMMUNOL, V150, pA180; Morar D, 2007, VET IMMUNOL IMMUNOP, V115, P146, DOI 10.1016/j.vetimm.2006.10.016; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; Ozturk H, 2002, J PEDIATR SURG, V37, P1330, DOI 10.1053/jpsu.2002.35002; Reineke U, 1998, PROTEIN SCI, V7, P951; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rigotti E, 2006, CLIN EXP ALLERGY, V36, P614, DOI 10.1111/j.1365-2222.2006.02483.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Schottelius AJG, 1999, J BIOL CHEM, V274, P31868, DOI 10.1074/jbc.274.45.31868; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Steinbrink K, 2002, BLOOD, V99, P2468, DOI 10.1182/blood.V99.7.2468; TAGA K, 1992, J IMMUNOL, V148, P1143; TAN JC, 1995, J BIOL CHEM, V270, P12906, DOI 10.1074/jbc.270.21.12906; TAN JC, 1993, J BIOL CHEM, V268, P21053; Untalan PB, 2009, BREASTFEED MED, V4, P138, DOI 10.1089/bfm.2008.0145; van der Aa LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012384; van Odijk J, 2003, ALLERGY, V58, P833, DOI 10.1034/j.1398-9995.2003.00264.x; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2	63	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18188	10.1371/journal.pone.0018188	http://dx.doi.org/10.1371/journal.pone.0018188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464967	Green Published, Green Submitted, gold			2022-12-27	WOS:000288813900049
J	Huynh, H; Zheng, JK; Umikawa, M; Silvany, R; Xie, XJ; Wu, CJ; Holzenberger, M; Wang, QM; Zhang, CC				Huynh, HoangDinh; Zheng, Junke; Umikawa, Masato; Silvany, Robert; Xie, Xian-Jin; Wu, Catherine J.; Holzenberger, Martin; Wang, Qianming; Zhang, Cheng Cheng			Components of the Hematopoietic Compartments in Tumor Stroma and Tumor-Bearing Mice	PLOS ONE			English	Article							EX-VIVO EXPANSION; STEM-CELLS; GROWTH-FACTOR; PROGENITOR CELLS; NICHE; POPULATION; CANCER; LIVER; IGF-1	Solid tumors are composed of cancerous cells and non-cancerous stroma. A better understanding of the tumor stroma could lead to new therapeutic applications. However, the exact compositions and functions of the tumor stroma are still largely unknown. Here, using a Lewis lung carcinoma implantation mouse model, we examined the hematopoietic compartments in tumor stroma and tumor-bearing mice. Different lineages of differentiated hematopoietic cells existed in tumor stroma with the percentage of myeloid cells increasing and the percentage of lymphoid and erythroid cells decreasing over time. Using bone marrow reconstitution analysis, we showed that the tumor stroma also contained functional hematopoietic stem cells. All hematopoietic cells in the tumor stroma originated from bone marrow. In the bone marrow and peripheral blood of tumor-bearing mice, myeloid populations increased and lymphoid and erythroid populations decreased and numbers of hematopoietic stem cells markedly increased with time. To investigate the function of hematopoietic cells in tumor stroma, we co-implanted various types of hematopoietic cells with cancer cells. We found that total hematopoietic cells in the tumor stroma promoted tumor development. Furthermore, the growth of the primary implanted Lewis lung carcinomas and their metastasis were significantly decreased in mice reconstituted with IGF type I receptor-deficient hematopoietic stem cells, indicating that IGF signaling in the hematopoietic tumor stroma supports tumor outgrowth. These results reveal that hematopoietic cells in the tumor stroma regulate tumor development and that tumor progression significantly alters the host hematopoietic compartment.	[Huynh, HoangDinh; Zheng, Junke; Umikawa, Masato; Silvany, Robert; Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Huynh, HoangDinh; Zheng, Junke; Umikawa, Masato; Silvany, Robert; Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Xie, Xian-Jin] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Wu, Catherine J.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Holzenberger, Martin] Hop St Antoine, INSERM, U515, F-75571 Paris, France; [Wang, Qianming] S China Normal Univ, Sch Chem & Environm, Guangzhou, Guangdong, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; South China Normal University	Huynh, H (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	Alec.Zhang@UTSouthwestern.edu	Zhang, Cheng/GRS-8698-2022; Holzenberger, Martin/N-9732-2018	Holzenberger, Martin/0000-0003-4869-725X	American Cancer Society [ACS-IRG-02-196]; NIH [K01CA120099]; Welch Foundation [I-1701]; March of Dimes Foundation; DOD [PR093256]; Cancer Prevention and Research Institute of Texas [RP100402]; NATIONAL CANCER INSTITUTE [K01CA120099] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); March of Dimes Foundation(March of Dimes); DOD(United States Department of Defense); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	American Cancer Society grant ACS-IRG-02-196 (http://www.cancer.org/), NIH grant K01CA120099 (http://grants1.nih.gov/grants/funding/funding.htm), Welch Foundation I-1701 ( http://www.welch1.org/), Basil O'Connor Award from the March of Dimes Foundation (http://www.marchofdimes.com/research/research.html), DOD Peer Reviewed Medical Research Program PR093256 (https://cdmrp.org/), and Cancer Prevention and Research Institute of Texas RP100402 (http://www.cprit.state.tx.us/funding-opportunities/) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Dziadziuszko R, 2008, J THORAC ONCOL, V3, P815, DOI 10.1097/JTO.0b013e31818180f5; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Huynh HD, 2008, STEM CELLS, V26, P1628, DOI 10.1634/stemcells.2008-0064; Jaiswal S, 2009, ANN NY ACAD SCI, V1174, P118, DOI 10.1111/j.1749-6632.2009.04930.x; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kaplan RN, 2007, TRENDS MOL MED, V13, P72, DOI 10.1016/j.molmed.2006.12.003; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kotton DN, 2005, BLOOD, V106, P1574, DOI 10.1182/blood-2005-03-1017; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Zheng J, 2010, BLOOD	21	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18054	10.1371/journal.pone.0018054	http://dx.doi.org/10.1371/journal.pone.0018054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464968	Green Published, gold, Green Submitted			2022-12-27	WOS:000288813900030
J	Won, HY; Lee, JA; Park, ZS; Song, JS; Kim, HY; Jang, SM; Yoo, SE; Rhee, Y; Hwang, ES; Bae, MA				Won, Hee Yeon; Lee, Jin-Ah; Park, Zong Sik; Song, Jin Sook; Kim, Hee Yun; Jang, Su-Min; Yoo, Sung-Eun; Rhee, Youmi; Hwang, Eun Sook; Bae, Myung Ae			Prominent Bone Loss Mediated by RANKL and IL-17 Produced by CD4+T Cells in TallyHo/JngJ Mice	PLOS ONE			English	Article							T-CELLS; ESTROGEN DEFICIENCY; ENERGY-METABOLISM; SERUM OSTEOCALCIN; GROWTH-FACTORS; MOUSE MODEL; DUAL ROLE; OSTEOPROTEGERIN; OSTEOPOROSIS; BETA	Increasing evidence that decreased bone density and increased rates of bone fracture are associated with abnormal metabolic states such as hyperglycemia and insulin resistance indicates that diabetes is a risk factor for osteoporosis. In this study, we observed that TallyHo/JngJ (TH) mice, a polygenic model of type II diabetes, spontaneously developed bone deformities with osteoporotic features. Female and male TH mice significantly gained more body weight than control C57BL/6 mice upon aging. Interestingly, bone density was considerably decreased in male TH mice, which displayed hyperglycemia. The osteoblast-specific bone forming markers osteocalcin and osteoprotegerin were decreased in TH mice, whereas osteoclast-driven bone resorption markers such as IL-6 and RANKL were significantly elevated in the bone marrow and blood of TH mice. In addition, RANKL expression was prominently increased in CD4+ T cells of TH mice upon T cell receptor stimulation, which was in accordance with enhanced IL-17 production. IL-17 production in CD4+ T cells was directly promoted by treatment with leptin while IFN-gamma production was not. Moreover, blockade of IFN-gamma further increased RANKL expression and IL-17 production in TH-CD4+ T cells. In addition, the osteoporotic phenotype of TH mice was improved by treatment with alendronate. These results strongly indicate that increased leptin in TH mice may act in conjunction with IL-6 to preferentially stimulate IL-17 production in CD4+ T cells and induce RANKL-mediated osteoclastogenesis. Accordingly, we propose that TH mice could constitute a beneficial model for osteoporosis.	[Won, Hee Yeon; Lee, Jin-Ah; Hwang, Eun Sook] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Coll Pharm, Div Life & Pharmaceut Sci, Seoul, South Korea; [Park, Zong Sik; Song, Jin Sook; Kim, Hee Yun; Jang, Su-Min; Yoo, Sung-Eun; Bae, Myung Ae] Korea Res Inst Chem Technol, Korea Bioorgan Sci Div, Taejon 305606, South Korea; [Rhee, Youmi] Yonsei Univ, Sch Med, Seoul 120749, South Korea	Ewha Womans University; Korea Research Institute of Chemical Technology (KRICT); Yonsei University	Won, HY (corresponding author), Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Coll Pharm, Div Life & Pharmaceut Sci, Seoul, South Korea.	eshwang@ewha.ac.kr; mbae@krict.re.kr	Rhee, Yumie/L-8020-2019	Rhee, Yumie/0000-0003-4227-5638	Ministry of Knowledge Economy [10033674]; Center for Biological Modulators of the 21st Century Frontier RD program; MEST [R15-2006-020]	Ministry of Knowledge Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Center for Biological Modulators of the 21st Century Frontier RD program(Ministry of Education, Science & Technology (MEST), Republic of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Ministry of Knowledge Economy (10033674) and the Center for Biological Modulators of the 21st Century Frontier R&D program and partly by the NCRC program (R15-2006-020) of KOSEF funded by MEST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchard F, 2009, CYTOKINE GROWTH F R, V20, P19, DOI 10.1016/j.cytogfr.2008.11.004; Botolin S, 2005, ENDOCRINOLOGY, V146, P3622, DOI 10.1210/en.2004-1677; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Chilton PM, 2004, DIABETES, V53, P1995, DOI 10.2337/diabetes.53.8.1995; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001; HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665; Hofbauer LC, 2007, J BONE MINER RES, V22, P1317, DOI 10.1359/JBMR.070510; Jiang J, 2006, BONE, V39, P494, DOI 10.1016/j.bone.2006.02.068; Jilka RL, 1998, BONE, V23, P75, DOI 10.1016/S8756-3282(98)00077-5; Kim JH, 2005, PHYSIOL GENOMICS, V22, P171, DOI 10.1152/physiolgenomics.00197.2004; Kim JH, 2001, GENOMICS, V74, P273, DOI 10.1006/geno.2001.6569; Kim JH, 2006, J ENDOCRINOL, V191, P437, DOI 10.1677/joe.1.06647; Kindblom JM, 2009, J BONE MINER RES, V24, P785, DOI [10.1359/jbmr.081234, 10.1359/JBMR.081234]; Kobayashi Y, 2000, J BONE MINER RES, V15, P1924, DOI 10.1359/jbmr.2000.15.10.1924; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee NK, 2008, TRENDS ENDOCRIN MET, V19, P161, DOI 10.1016/j.tem.2008.02.006; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; LORENTZON R, 1986, Diabetes Research and Clinical Practice, V2, P157, DOI 10.1016/S0168-8227(86)80017-1; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Fernandez-Real JM, 2009, J CLIN ENDOCR METAB, V94, P237, DOI 10.1210/jc.2008-0270; MATSUSHITA M, 1986, AM J PATHOL, V125, P276; Matter CM, 2009, CIRC RES, V104, P928, DOI 10.1161/CIRCRESAHA.109.197004; MCSHEEHY PMJ, 1986, ENDOCRINOLOGY, V119, P1654, DOI 10.1210/endo-119-4-1654; Melton LJ, 2008, J BONE MINER RES, V23, P1334, DOI 10.1359/JBMR.080323; MUNDY GR, 1993, J BONE MINER RES, V8, pS505, DOI 10.1002/jbmr.5650081315; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Page G, 2005, ARTHRITIS RHEUM-US, V52, P2307, DOI 10.1002/art.21211; PFEILSCHIFTER J, 1987, P NATL ACAD SCI USA, V84, P2024, DOI 10.1073/pnas.84.7.2024; Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422; Qaseem A, 2008, ANN INTERN MED, V148, P680, DOI 10.7326/0003-4819-148-9-200805060-00008; RHEE SD, 2010, EXP CLIN ENDOCRINOL; Schett G, 2010, NAT REV ENDOCRINOL, V6, P698, DOI 10.1038/nrendo.2010.190; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Stein NC, 2008, J BONE MINER RES, V23, P750, DOI 10.1359/JBMR.080203; Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; THOMSON BM, 1987, J IMMUNOL, V138, P775; Totsuka T, 2009, J IMMUNOL, V182, P6079, DOI 10.4049/jimmunol.0711823; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Weitzmann MN, 2007, ANN NY ACAD SCI, V1116, P360, DOI 10.1196/annals.1402.068	45	60	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18168	10.1371/journal.pone.0018168	http://dx.doi.org/10.1371/journal.pone.0018168			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464945	Green Submitted, Green Published, gold			2022-12-27	WOS:000288813900045
J	Malik, S; Khalique, H; Buch, S; Seth, P				Malik, Shaily; Khalique, Hena; Buch, Shilpa; Seth, Pankaj			A Growth Factor Attenuates HIV-1 Tat and Morphine Induced Damage to Human Neurons: Implication in HIV/AIDS-Drug Abuse Cases	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; ACTIVE ANTIRETROVIRAL THERAPY; CELL-DEATH; MEMBRANE PERMEABILIZATION; COGNITIVE IMPAIRMENT; OXIDATIVE STRESS; CYTOCHROME-C; TNF-ALPHA; IN-VITRO	The neuropathological abnormalities of human immunodeficiency virus (HIV)-1 patients abusing illicit drugs suggest extensive interactions between the two agents, thereby leading to increased rate of progression to neurodegeneration. The role of HIV-1 transactivating protein, Tat has been elucidated in mediating neuronal damage via apoptosis, a hallmark of HIV-associated dementia (HAD), however the underlying mechanisms involved in enhanced neurodegeneration by illicit drugs remain elusive. In this study, we demonstrated that morphine enhances HIV-Tat induced toxicity in human neurons and neuroblastoma cells. Enhanced toxicity by Tat and morphine was accompanied by increased numbers of TUNEL positive apoptotic neurons, elevated caspase-3 levels and decreased ratio of anti- and pro-apoptotic proteins, Bcl2/Bax. Tat and morphine together elicited high levels of reactive oxygen species that were NADPH dependent. Significant alterations in mitochondrial membrane homeostasis were also observed with co-exposure of these agents. Extensive studies of mitogen activated protein kinase (MAPK) signaling pathways revealed the involvement of c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase-1/2 (ERK1/2) pathways in enhanced toxicity of Tat and morphine. In addition to this, we found that pre-treatment of cells with platelet derived growth factor (PDGF-BB) protected neurons from HIV-Tat and morphine induced damage. PDGF-BB alleviated ROS production, maintained mitochondrial membrane potential, decreased caspase-3 activation and hence protected the cells from undergoing apoptosis. PDGF-BB mediated protection against Tat and morphine involved the phosphatidylinositol-3 kinase (PI3K) pathway, as specific inhibitor of PI3K abrogated the protection conferred by PDGF-BB. This study demonstrates the mechanism of enhanced toxicity in human neurons subjected to co-exposure of HIV protein Tat and morphine, thus implying its importance in HIV positive drug abusers, where damage to the brain is reported to be more severe than non-drug abusers. We have also showed for the first time that PDGF-BB can protect against simultaneous exposure of Tat and morphine, strengthening its role as a neuroprotective agent that could be considered for therapeutic intervention.	[Malik, Shaily; Khalique, Hena; Seth, Pankaj] Natl Brain Res Ctr, Gurgaon, Haryana, India; [Buch, Shilpa] Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); University of Nebraska System; University of Nebraska Medical Center	Malik, S (corresponding author), Natl Brain Res Ctr, Gurgaon, Haryana, India.	pseth@nbrc.ac.in		Seth, Pankaj/0000-0003-1021-7839; Buch, Shilpa/0000-0002-3103-6685	Department of Biotechnology, India [BT/PR6615/MED/14/857/2005]; National Brain Research Centre, India; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024442] Funding Source: NIH RePORTER	Department of Biotechnology, India(Department of Biotechnology (DBT) India); National Brain Research Centre, India; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a research grant (BT/PR6615/MED/14/857/2005) from Department of Biotechnology, India and intramural support from National Brain Research Centre, Manesar, India to P. Seth, and DA024442 from the National Institutes of Health to S. Buch. S. Malik and H. Khalique were supported by Integrated MS-PhD fellowship and Project Assistant-ship, respectively, from National Brain Research Centre, India. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov MY, 2001, NEUROSCI LETT, V305, P5, DOI 10.1016/S0304-3940(01)01786-4; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bachis A, 2005, ANN NY ACAD SCI, V1053, P247, DOI 10.1196/annals.1344.022; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Bell JE, 1998, BRAIN, V121, P2043, DOI 10.1093/brain/121.11.2043; Bokhari SM, 2009, J NEUROVIROL, V15, P219, DOI 10.1080/13550280902913628; Boscia F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006486; Bouwman FH, 1998, NEUROLOGY, V50, P1814, DOI 10.1212/WNL.50.6.1814; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chen Quan, 2003, Korean Journal of Biological Sciences, V7, P1; Cherner M, 2005, NEUROLOGY, V64, P1343, DOI 10.1212/01.WNL.0000158328.26897.0D; Corasaniti MT, 2005, CELL DEATH DIFFER, V12, P999, DOI 10.1038/sj.cdd.4401644; Crews L, 2008, J NEUROVIROL, V14, P327, DOI 10.1080/13550280802132840; Dey S, 2007, J NEUROCHEM, V103, P542, DOI 10.1111/j.1471-4159.2007.04750.x; Donovan M, 2004, BBA-MOL CELL RES, V1644, P133, DOI 10.1016/j.bbamcr.2003.08.011; Dore GJ, 2003, AIDS, V17, P1539, DOI 10.1097/00002030-200307040-00015; Dussmann H, 2003, J CELL SCI, V116, P525, DOI 10.1242/jcs.00236; El-Hage N, 2006, GLIA, V53, P132, DOI 10.1002/glia.20262; Ferri KF, 2000, ANN NY ACAD SCI, V926, P149; Gandhi N, 2010, J NEUROVIROL, V16, P294, DOI 10.3109/13550284.2010.499891; GIACOBINI MMJ, 1993, NEUROSCIENCE, V57, P923, DOI 10.1016/0306-4522(93)90038-H; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; Gurwell JA, 2001, NEUROSCIENCE, V102, P555, DOI 10.1016/S0306-4522(00)00461-9; Hauser KF, 2009, GLIA, V57, P194, DOI 10.1002/glia.20746; Hu SX, 2002, NEUROPHARMACOLOGY, V42, P829, DOI 10.1016/S0028-3908(02)00030-8; Jiao HY, 2007, J NEUROCHEM, V103, P840, DOI 10.1111/j.1471-4159.2007.04840.x; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; Lemasters JJ, 2002, ANTIOXID REDOX SIGN, V4, P769, DOI 10.1089/152308602760598918; Li Y, 2010, BIOCHEM BIOPH RES CO, V391, P426, DOI 10.1016/j.bbrc.2009.11.074; Lin X, 2009, FEBS J, V276, P2022, DOI 10.1111/j.1742-4658.2009.06938.x; Mahajan SD, 2008, J CLIN IMMUNOL, V28, P528, DOI 10.1007/s10875-008-9208-1; Mallon PWG, 2007, CURR OPIN HIV AIDS, V2, P282, DOI 10.1097/COH.0b013e3281e72ca0; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; McArthur JC, 2004, ARCH NEUROL-CHICAGO, V61, P1687, DOI 10.1001/archneur.61.11.1687; Mellon RD, 1998, BRAIN RES, V789, P56, DOI 10.1016/S0006-8993(97)01529-1; Mishra M, 2008, ANN NEUROL, V63, P366, DOI 10.1002/ana.21292; Mishra M, 2010, J NEUROVIROL, V16, P355, DOI 10.3109/13550284.2010.513028; Moore DJ, 2006, AIDS, V20, P879, DOI 10.1097/01.aids.0000218552.69834.00; NAKAJIMA M, 1994, BRAIN RES, V641, P350, DOI 10.1016/0006-8993(94)90165-1; Nath A, 2001, J NEUROVIROL, V7, P66; Nath A, 1999, SEMIN NEUROL, V19, P113, DOI 10.1055/s-2008-1040830; NIKKHAH G, 1993, EXP BRAIN RES, V92, P516; Noel RJ, 2006, VIROLOGY, V349, P440, DOI 10.1016/j.virol.2006.03.032; NUGENT AL, 2010, J NEUROIMMU IN PRESS; Peng FW, 2008, EUR J NEUROSCI, V28, P1255, DOI 10.1111/j.1460-9568.2008.06444.x; Peng FW, 2008, J NEUROVIROL, V14, P62, DOI 10.1080/13550280701809084; Perry W, 2005, AIDS, V19, pS79, DOI 10.1097/01.aids.0000192074.18691.31; Persidsky Y, 2002, J NEUROVIROL, V8, P49, DOI 10.1080/13550280290167993; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; Sacktor NC, 2000, J NEUROVIROL, V6, P84, DOI 10.3109/13550280009006385; Sanders VJ, 2000, J NEUROSCI RES, V59, P671, DOI 10.1002/(SICI)1097-4547(20000301)59:5<671::AID-JNR10>3.0.CO;2-B; Schifitto G, 2007, AIDS, V21, P1877, DOI 10.1097/QAD.0b013e32813384e8; Seth P, 2005, NEUROTOX RES, V8, P83, DOI 10.1007/BF03033821; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; Siddappa NB, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-53; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Subramaniam S, 2004, J CELL BIOL, V165, P357, DOI 10.1083/jcb.200403028; Svensson AL, 2008, P NATL ACAD SCI USA, V105, P7304, DOI 10.1073/pnas.0802531105; Turchan-Cholewo J, 2006, NEUROBIOL DIS, V23, P109, DOI 10.1016/j.nbd.2006.02.005; Turchan-Cholewo J, 2009, ANTIOXID REDOX SIGN, V11, P193, DOI [10.1089/ars.2008.2097, 10.1089/ARS.2008.2097]; Valcour VG, 2004, AIDS, V18, pS79, DOI 10.1097/00002030-200401001-00012; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Williams KC, 2002, ANNU REV NEUROSCI, V25, P537, DOI 10.1146/annurev.neuro.25.112701.142822; Williams R, 2008, J NEUROVIROL, V14, P292, DOI 10.1080/13550280802074539; Williams R, 2010, GLIA, V58, P611, DOI 10.1002/glia.20949; Wright KM, 2007, CELL DEATH DIFFER, V14, P625, DOI 10.1038/sj.cdd.4402024; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yao HH, 2009, J NEUROVIROL, V15, P164, DOI 10.1080/13550280902755375; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhu XH, 2009, TOXICOL APPL PHARM, V240, P286, DOI 10.1016/j.taap.2009.06.020	75	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18116	10.1371/journal.pone.0018116	http://dx.doi.org/10.1371/journal.pone.0018116			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21483469	Green Published, Green Submitted, gold			2022-12-27	WOS:000288811500024
J	Tchou-Wong, KM; Kiok, K; Tang, ZJ; Kluz, T; Arita, A; Smith, PR; Brown, S; Costa, M				Tchou-Wong, Kam-Meng; Kiok, Kathrin; Tang, Zuojian; Kluz, Thomas; Arita, Adriana; Smith, Phillip R.; Brown, Stuart; Costa, Max			Effects of Nickel Treatment on H3K4 Trimethylation and Gene Expression	PLOS ONE			English	Article							HISTONE DEMETHYLASE JMJD1A; LYSINE METHYLATION; ACTIVE GENES; HYPOXIA; TRANSFORMATION; NUCLEOSOME; PARTICLE; COMPASS; GROWTH; CELLS	Occupational exposure to nickel compounds has been associated with lung and nasal cancers. We have previously shown that exposure of the human lung adenocarcinoma A549 cells to NiCl2 for 24 hr significantly increased global levels of trimethylated H3K4 (H3K4me3), a transcriptional activating mark that maps to the promoters of transcribed genes. To further understand the potential epigenetic mechanism(s) underlying nickel carcinogenesis, we performed genome-wide mapping of H3K4me3 by chromatin immunoprecipitation and direct genome sequencing (ChIP-seq) and correlated with transcriptome genome-wide mapping of RNA transcripts by massive parallel sequencing of cDNA (RNA-seq). The effect of NiCl2 treatment on H3K4me3 peaks within 5,000 bp of transcription start sites (TSSs) on a set of genes highly induced by nickel in both A549 cells and human peripheral blood mononuclear cells were analyzed. Nickel exposure increased the level of H3K4 trimethylation in both the promoters and coding regions of several genes including CA9 and NDRG1 that were increased in expression in A549 cells. We have also compared the extent of the H3K4 trimethylation in the absence and presence of formaldehyde crosslinking and observed that crosslinking of chromatin was required to observe H3K4 trimethylation in the coding regions immediately downstream of TSSs of some nickel-induced genes including ADM and IGFBP3. This is the first genome-wide mapping of trimethylated H3K4 in the promoter and coding regions of genes induced after exposure to NiCl2. This study may provide insights into the epigenetic mechanism(s) underlying the carcinogenicity of nickel compounds.	[Tchou-Wong, Kam-Meng; Kiok, Kathrin; Kluz, Thomas; Arita, Adriana; Costa, Max] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA; [Tang, Zuojian; Smith, Phillip R.; Brown, Stuart] NYU, Sch Med, Dept Cell Biol, Tuxedo Pk, NY USA; [Tang, Zuojian; Smith, Phillip R.; Brown, Stuart] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, Tuxedo Pk, NY USA	New York University; New York University; New York University	Tchou-Wong, KM (corresponding author), NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA.	tchouk02@nyumc.org	costa, max/H-1754-2012; Brown, Stuart M./A-9880-2016	Brown, Stuart M./0000-0002-0906-9907; Smith, Phillip/0000-0002-7850-8440	National Institutes of Environmental Health Sciences [ES000260, ES010344, ES014454, ES005512]; National Cancer Institute [CA16087]; National Center for Research Resources [RR029893]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005512, P30ES000260, P42ES010344, R01ES014454] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grant numbers ES000260, ES010344, ES014454, ES005512 from the National Institutes of Environmental Health Sciences, and support from grant number CA16087 from National Cancer Institute and RR029893 from National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon AL, 2004, ANN MED, V36, P530, DOI 10.1080/07853890410018231; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Becker PB, 2002, EMBO J, V21, P4749, DOI 10.1093/emboj/cdf486; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Chen HB, 2006, MOL CELL BIOL, V26, P3728, DOI 10.1128/MCB.26.10.3728-3737.2006; Chen HB, 2010, CARCINOGENESIS, V31, P2136, DOI 10.1093/carcin/bgq197; Chen HB, 2010, J BIOL CHEM, V285, P7374, DOI 10.1074/jbc.M109.058503; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; Deville JL, 2010, EXPERT OPIN THER TAR, V14, P1059, DOI 10.1517/14728222.2010.522328; DOLL R, 1970, BRIT J CANCER, V24, P623, DOI 10.1038/bjc.1970.76; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kang J, 2003, TOXICOL SCI, V74, P279, DOI 10.1093/toxsci/kfg137; Ke QD, 2006, CARCINOGENESIS, V27, P1481, DOI 10.1093/carcin/bgl004; Kerckaert GA, 1996, FUND APPL TOXICOL, V34, P67, DOI 10.1006/faat.1996.0176; Kim A, 2007, MOL CELL BIOL, V27, P1271, DOI 10.1128/MCB.01684-06; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; KORNBERG RD, 1974, SCIENCE, V184, P865, DOI 10.1126/science.184.4139.865; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuper CF, 1997, MUTAT RES-FUND MOL M, V380, P19, DOI 10.1016/S0027-5107(97)00123-1; LEE YW, 1995, MOL CELL BIOL, V15, P2547; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Miller AC, 2001, CARCINOGENESIS, V22, P115, DOI 10.1093/carcin/22.1.115; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Wood A, 2007, MOL CELL BIOL, V27, P709, DOI 10.1128/MCB.01627-06; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou X, 2010, CANCER RES, V70, P4214, DOI 10.1158/0008-5472.CAN-09-2942; Zhou X, 2009, TOXICOL APPL PHARM, V236, P78, DOI 10.1016/j.taap.2009.01.009	36	23	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17728	10.1371/journal.pone.0017728	http://dx.doi.org/10.1371/journal.pone.0017728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455298	Green Published, Green Submitted, gold			2022-12-27	WOS:000288811500008
J	Luukkonen, J; Liimatainen, A; Hoyto, A; Juutilainen, J; Naarala, J				Luukkonen, Jukka; Liimatainen, Anu; Hoyto, Anne; Juutilainen, Jukka; Naarala, Jonne			Pre-Exposure to 50 Hz Magnetic Fields Modifies Menadione-Induced Genotoxic Effects in Human SH-SY5Y Neuroblastoma Cells	PLOS ONE			English	Article							SINGLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; ELECTROMAGNETIC-FIELDS; MAMMALIAN-CELLS; IN-VITRO; REPAIR; LYMPHOCYTES; FREQUENCY; EXPOSURE; METAANALYSIS	Background: Extremely low frequency (ELF) magnetic fields (MF) are generated by power lines and various electric appliances. They have been classified as possibly carcinogenic by the International Agency for Research on Cancer, but a mechanistic explanation for carcinogenic effects is lacking. A previous study in our laboratory showed that pre-exposure to ELF MF altered cancer-relevant cellular responses (cell cycle arrest, apoptosis) to menadione-induced DNA damage, but it did not include endpoints measuring actual genetic damage. In the present study, we examined whether pre-exposure to ELF MF affects chemically induced DNA damage level, DNA repair rate, or micronucleus frequency in human SH-SY5Y neuroblastoma cells. Methodology/Principal Findings: Exposure to 50 Hz MF was conducted at 100 mu T for 24 hours, followed by chemical exposure for 3 hours. The chemicals used for inducing DNA damage and subsequent micronucleus formation were menadione and methyl methanesulphonate (MMS). Pre-treatment with MF enhanced menadione-induced DNA damage, DNA repair rate, and micronucleus formation in human SH-SY5Y neuroblastoma cells. Although the results with MMS indicated similar effects, the differences were not statistically significant. No effects were observed after MF exposure alone. Conclusions: The results confirm our previous findings showing that pre-exposure to MFs as low as 100 mu T alters cellular responses to menadione, and show that increased genotoxicity results from such interaction. The present findings also indicate that complementary data at several chronological points may be critical for understanding the MF effects on DNA damage, repair, and post-repair integrity of the genome.	[Luukkonen, Jukka; Liimatainen, Anu; Hoyto, Anne; Juutilainen, Jukka; Naarala, Jonne] Univ Eastern Finland, Dept Environm Sci, Kuopio, Finland	University of Eastern Finland	Luukkonen, J (corresponding author), Univ Eastern Finland, Dept Environm Sci, Kuopio, Finland.	Jukka.Luukkonen@uef.fi	Höytö, Anne/G-5970-2012	Höytö, Anne/0000-0002-3152-534X	Finnish Ministry of Education (Graduate School in Environmental Health SYTYKE); University of Eastern Finland	Finnish Ministry of Education (Graduate School in Environmental Health SYTYKE); University of Eastern Finland	This work was supported by the Finnish Ministry of Education (Graduate School in Environmental Health SYTYKE) and University of Eastern Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akudugu JM, 2004, INT J RADIAT BIOL, V80, P93, DOI 10.1080/09553002310001655449; Andreoli C, 1999, MUTAGENESIS, V14, P497, DOI 10.1093/mutage/14.5.497; Brocklehurst B, 1996, INT J RADIAT BIOL, V69, P3, DOI 10.1080/095530096146147; Bryce SM, 2007, MUTAT RES-GEN TOX EN, V630, P78, DOI 10.1016/j.mrgentox.2007.03.002; Cantoni O, 1996, BIOCHEM MOL BIOL INT, V38, P527; Chow KC, 2000, FEBS LETT, V478, P133, DOI 10.1016/S0014-5793(00)01822-6; COSSARIZZA A, 1989, RADIAT RES, V118, P161, DOI 10.2307/3577431; FISCHERNIELSEN A, 1995, BIOCHEM PHARMACOL, V49, P1469, DOI 10.1016/0006-2952(94)00525-Q; FRAZIER ME, 1990, BIOELECTROMAGNETICS, V11, P229, DOI 10.1002/bem.2250110304; *GARS GD NCSU, LIN MIX MOD RAND EFF; Halliwell B., 2007, FREE RADICAL BIO MED, P46; Iarmarcovai G, 2008, MUTAT RES-REV MUTAT, V659, P274, DOI 10.1016/j.mrrev.2008.05.006; International Agency for Research of Cancer (IARC), 2002, IARC MON EV CARC RIS, V80; Jeggo PA, 2009, HEALTH PHYS, V97, P416, DOI 10.1097/HP.0b013e3181aff9c8; Juutilainen J, 2006, INT J RADIAT BIOL, V82, P1, DOI 10.1080/09553000600577839; Juutilainen J, 2000, BIOELECTROMAGNETICS, V21, P122, DOI 10.1002/(SICI)1521-186X(200002)21:2<122::AID-BEM7>3.0.CO;2-D; Kumlin T, 1998, INT J RADIAT BIOL, V73, P113, DOI 10.1080/095530098142761; Luukkonen J, 2009, MUTAT RES-FUND MOL M, V662, P54, DOI 10.1016/j.mrfmmm.2008.12.005; Markkanen A, 2008, INT J RADIAT BIOL, V84, P742, DOI 10.1080/09553000802360836; MCCONKEY DJ, 1988, TOXICOL LETT, V42, P123, DOI 10.1016/0378-4274(88)90069-0; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Robison JG, 2002, BIOELECTROMAGNETICS, V23, P106, DOI 10.1002/bem.103; Rothfuss A, 2000, CANCER RES, V60, P390; Terradas M, 2010, MUTAT RES-REV MUTAT, V705, P60, DOI 10.1016/j.mrrev.2010.03.004; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; World Health Organization (WHO), 2007, ENV HLTH CRIT, P347	26	49	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18021	10.1371/journal.pone.0018021	http://dx.doi.org/10.1371/journal.pone.0018021			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448285	Green Submitted, Green Published, gold			2022-12-27	WOS:000288810500028
J	Seghier, ML; Kolanko, MA; Leff, AP; Jager, HR; Gregoire, SM; Werring, DJ				Seghier, Mohamed L.; Kolanko, Magdalena A.; Leff, Alexander P.; Jaeger, Hans R.; Gregoire, Simone M.; Werring, David J.			Microbleed Detection Using Automated Segmentation (MIDAS): A New Method Applicable to Standard Clinical MR Images	PLOS ONE			English	Article							CEREBRAL AMYLOID ANGIOPATHY; BRAIN MICROBLEEDS; UNIFIED SEGMENTATION; PREVALENCE; AGREEMENT; RISK	Background: Cerebral microbleeds, visible on gradient-recalled echo (GRE) T2* MRI, have generated increasing interest as an imaging marker of small vessel diseases, with relevance for intracerebral bleeding risk or brain dysfunction. Methodology/Principal Findings: Manual rating methods have limited reliability and are time-consuming. We developed a new method for microbleed detection using automated segmentation (MIDAS) and compared it with a validated visual rating system. In thirty consecutive stroke service patients, standard GRE T2* images were acquired and manually rated for microbleeds by a trained observer. After spatially normalizing each patient's GRE T2* images into a standard stereotaxic space, the automated microbleed detection algorithm (MIDAS) identified cerebral microbleeds by explicitly incorporating an "extra" tissue class for abnormal voxels within a unified segmentation-normalization model. The agreement between manual and automated methods was assessed using the intraclass correlation coefficient (ICC) and Kappa statistic. We found that MIDAS had generally moderate to good agreement with the manual reference method for the presence of lobar microbleeds (Kappa = 0.43, improved to 0.65 after manual exclusion of obvious artefacts). Agreement for the number of microbleeds was very good for lobar regions: (ICC = 0.71, improved to ICC = 0.87). MIDAS successfully detected all patients with multiple (>= 2) lobar microbleeds. Conclusions/Significance: MIDAS can identify microbleeds on standard MR datasets, and with an additional rapid editing step shows good agreement with a validated visual rating system. MIDAS may be useful in screening for multiple lobar microbleeds.	[Seghier, Mohamed L.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Kolanko, Magdalena A.; Jaeger, Hans R.; Gregoire, Simone M.; Werring, David J.] UCL, Inst Neurol, Stroke Res Grp, Dept Brain Repair & Rehabil, London, England; [Leff, Alexander P.] UCL, Inst Cognit Neurosci, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Seghier, ML (corresponding author), UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England.	d.werring@ion.ucl.ac.uk	Jäger, Hans Rolf/K-1868-2013; Seghier, Mohamed L/C-6314-2009; Seghier, Mohamed/O-8634-2019; Leff, Alexander P/C-1502-2008; Werring, David/Q-8435-2019	Jäger, Hans Rolf/0000-0002-6403-4184; Seghier, Mohamed L/0000-0002-1146-8800; Seghier, Mohamed/0000-0002-1146-8800; Werring, David/0000-0003-2074-1861; Kolanko, Magdalena/0000-0002-0058-5884; Leff, Alexander/0000-0002-0831-3541	Wellcome Trust; The Stroke Association; Department of Health and Higher Educational and Funding Council; UK Department of Health's National Institute for Health Research Biomedical Research Center (UCLH/UCL Comprehensive Biomedical Research Trust); Stroke Association [TSABHF2009/01] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); The Stroke Association; Department of Health and Higher Educational and Funding Council; UK Department of Health's National Institute for Health Research Biomedical Research Center (UCLH/UCL Comprehensive Biomedical Research Trust); Stroke Association	Mohamed Seghier and Alex Leff were funded by the Wellcome Trust. Simone Gregoire was supported by a grant from The Stroke Association. David Werring is supported by a Department of Health and Higher Educational and Funding Council for England Clinical Senior Lectureship Award. This work was undertaken at UCLH/UCL, which received a proportion of funding from the UK Department of Health's National Institute for Health Research Biomedical Research Centers funding scheme (UCLH/UCL Comprehensive Biomedical Research Trust). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; Evans A.C., 1993, NUCL SCI S MED IM C, P1813, DOI DOI 10.1109/NSSMIC.1993.373602; Filippi M, 1995, BRAIN, V118, P1593, DOI 10.1093/brain/118.6.1593; Ghazel M, 2006, 2006 IEEE INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND INFORMATION TECHNOLOGY, VOLS 1 AND 2, P6, DOI 10.1109/ISSPIT.2006.270760; Greenberg SM, 2009, STROKE, V40, P2382, DOI 10.1161/STROKEAHA.109.548974; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Gregoire SM, 2010, J NEUROL NEUROSUR PS, V81, P679, DOI 10.1136/jnnp.2009.198994; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Rosand J, 2005, ANN NEUROL, V58, P459, DOI 10.1002/ana.20596; Rouainia M, 2006, PROC WRLD ACAD SCI E, V17, P301; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Seghier ML, 2008, NEUROIMAGE, V41, P1253, DOI 10.1016/j.neuroimage.2008.03.028; Soille P., 2004, MORPHOLOGICAL IMAGE, DOI [10.1007/978-3-662-05088-0, DOI 10.1007/978-3-662-05088-0]; Soo YOY, 2008, J NEUROL, V255, P1679, DOI 10.1007/s00415-008-0967-7; Stehling C, 2008, ACAD RADIOL, V15, P895, DOI 10.1016/j.acra.2008.01.013; VERMERSCH P, 1992, CLIN NEUROL NEUROSUR, V94, P213, DOI 10.1016/0303-8467(92)90091-G; Viswanathan A, 2006, STROKE, V37, P550, DOI 10.1161/01.STR.0000199847.96188.12; Werring DJ, 2004, BRAIN, V127, P2265, DOI 10.1093/brain/awh253	25	51	56	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17547	10.1371/journal.pone.0017547	http://dx.doi.org/10.1371/journal.pone.0017547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448456	gold, Green Submitted, Green Published			2022-12-27	WOS:000288810500007
J	Van Dorsselaer, A; Carapito, C; Delalande, F; Schaeffer-Reiss, C; Thierse, D; Diemer, H; McNair, DS; Krewski, D; Cashman, NR				Van Dorsselaer, Alain; Carapito, Christine; Delalande, Francois; Schaeffer-Reiss, Christine; Thierse, Daniele; Diemer, Helene; McNair, Douglas S.; Krewski, Daniel; Cashman, Neil R.			Detection of Prion Protein in Urine-Derived Injectable Fertility Products by a Targeted Proteomic Approach	PLOS ONE			English	Article							TRUNCATED FORMS; JAKOB-DISEASE; BLOOD; RECOMBINANT; INFECTIVITY; EXCRETION; RISK	Background: Iatrogenic transmission of human prion disease can occur through medical or surgical procedures, including injection of hormones such as gonadotropins extracted from cadaver pituitaries. Annually, more than 300,000 women in the United States and Canada are prescribed urine-derived gonadotropins for infertility. Although menopausal urine donors are screened for symptomatic neurological disease, incubation of Creutzfeldt-Jakob disease (CJD) is impossible to exclude by non-invasive testing. Risk of carrier status of variant CJD (vCJD), a disease associated with decades-long peripheral incubation, is estimated to be on the order of 100 per million population in the United Kingdom. Studies showing infectious prions in the urine of experimental animals with and without renal disease suggest that prions could be present in asymptomatic urine donors. Several human fertility products are derived from donated urine; recently prion protein has been detected in preparations of human menopausal gonadotropin (hMG). Methodology/Principal Findings: Using a classical proteomic approach, 33 and 34 non-gonadotropin proteins were identified in urinary human chorionic gonadotropin (u-hCG) and highly-purified urinary human menopausal gonadotropin (hMG-HP) products, respectively. Prion protein was identified as a major contaminant in u-hCG preparations for the first time. An advanced prion protein targeted proteomic approach was subsequently used to conduct a survey of gonadotropin products; this approach detected human prion protein peptides in urine-derived injectable fertility products containing hCG, hMG and hMG-HP, but not in recombinant products. Conclusions/Significance: The presence of protease-sensitive prion protein in urinary-derived injectable fertility products containing hCG, hMG, and hMG-HP suggests that prions may co-purify in these products. Intramuscular injection is a relatively efficient route of transmission of human prion disease, and young women exposed to prions can be expected to survive an incubation period associated with a minimal inoculum. The risks of urine-derived fertility products could now outweigh their benefits, particularly considering the availability of recombinant products.	[Van Dorsselaer, Alain; Carapito, Christine; Delalande, Francois; Schaeffer-Reiss, Christine; Thierse, Daniele; Diemer, Helene] Univ Strasbourg, Lab Spectrometrie Masse Bioorgan, IPHC, CNRS,UMR7178, Strasbourg, France; [McNair, Douglas S.] Cerner Corp, Kansas City, MO USA; [Krewski, Daniel] Univ Ottawa, McLaughlin Ctr Populat Hlth Risk Assessment, Ottawa, ON K1N 6N5, Canada; [Cashman, Neil R.] Univ British Columbia, Brain Res Ctr, Dept Med Neurol, Vancouver, BC V5Z 1M9, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Ottawa; University of British Columbia	Van Dorsselaer, A (corresponding author), Univ Strasbourg, Lab Spectrometrie Masse Bioorgan, IPHC, CNRS,UMR7178, Strasbourg, France.	vandors@unistra.fr; neil.cashman@vch.ca	McNair, Douglas/GSJ-0611-2022	Carapito, Christine/0000-0002-0079-319X; Delalande, Francois/0000-0003-3590-9874; McNair, Douglas/0000-0003-0965-883X	Merck Serono; PrioNet Canada; Natural Sciences and Engineering Research Council of Canada	Merck Serono(Merck & Company); PrioNet Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The Laboratoire de Spectrometrie de Masse Bio-Organique (AVD) received an unrestricted financial support from Merck Serono for the development of new characterization strategies of therapeutic proteins. Other background grants not directly related to this urinary pharmaceuticals project came from PrioNet Canada (http://www.prionetcanada.ca/) and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/). Dr. McNair is Vice-President of Cerner Corporation, which had no role in the initiation or conduct of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, VARIANT CREUTZFELDT; Balen AH, 2005, HUM REPROD, V20, P2994, DOI 10.1093/humrep/dei209; Bassett R, 2009, REPROD BIOMED ONLINE, V19, P300, DOI 10.1016/S1472-6483(10)60163-0; Boyd A, 2001, Commun Dis Intell Q Rep, V25, P248; Brown P, 2006, NEUROLOGY, V67, P389, DOI 10.1212/01.wnl.0000231528.65069.3f; Bruce ME, 2001, LANCET, V358, P208, DOI 10.1016/S0140-6736(01)05411-3; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Dagdanova A, 2010, J BIOL CHEM, V285, P30489, DOI 10.1074/jbc.M110.161794; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; Gerber Scott A, 2007, Methods Mol Biol, V359, P71; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Gregori L, 2008, EMERG INFECT DIS, V14, P1406, DOI 10.3201/eid1409.080259; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Kariv-Inbal Z, 2006, NEURODEGENER DIS, V3, P123, DOI 10.1159/000094770; Krewski D, 2009, ENV FORUM, V26, P50; Kuwabara Y, 2009, J REPROD MED, V54, P459; Leiss William, 2010, International Journal of Risk Assessment & Management, V14, P381, DOI 10.1504/IJRAM.2010.035935; Leiss W, 2008, TRANSFUS MED REV, V22, P35, DOI 10.1016/j.tmrv.2007.09.002; Murayama Y, 2007, J GEN VIROL, V88, P2890, DOI 10.1099/vir.0.82786-0; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; O'Brien SF, 2007, TRANSFUSION, V47, P316, DOI 10.1111/j.1537-2995.2007.01108.x; Reichl H, 2002, HUM REPROD, V17, P2501, DOI 10.1093/humrep/17.10.2501; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Siso S, 2008, J PATHOL, V215, P126, DOI 10.1002/path.2336; World Health Organization, WHO TABL TISS INF DI	27	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17815	10.1371/journal.pone.0017815	http://dx.doi.org/10.1371/journal.pone.0017815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448279	Green Published, Green Submitted, gold			2022-12-27	WOS:000288810500013
J	De, DD; Bhattacharjya, S; Maitra, M; Datta, A; Choudhury, A; Dhali, GK; Roychoudhury, S				De, Dipanjana Datta; Bhattacharjya, Sumana; Maitra, Meenakshi; Datta, Arindam; Choudhury, Abhijit; Dhali, G. K.; Roychoudhury, Susanta			IL1B Induced Smad 7 Negatively Regulates Gastrin Expression	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; GROWTH FACTOR-BETA/SMAD; TGF-BETA; DUODENAL-ULCER; ACID-SECRETION; MESSENGER-RNA; PROMOTER; MUCOSA; POLYMORPHISMS; INTERLEUKIN-1	Background: Helicobacter pylori elicited IL1B is one of the various modulators responsible for perturbation of acid secretion in gut. We have earlier reported that IL1B activated NFkB downregulates gastrin, a major modulator of acid secretion. However, we hypothesized that regulation of gastrin by IL1B would depend on the cell's ability to integrate inputs from multiple signaling pathways to generate appropriate biological response. Principal Finding: In this study, we report that IL1B induces Smad 7 expression by about 4.5 fold in gastric carcinoma cell line, AGS. Smad 7 resulted in transcriptional repression of gastrin promoter by about 6.5 fold when co-transfected with Smad 7 expression vector and gastrin-promoter luciferase in AGS cells. IL1B inhibited phosphorylation of Smad 3 and subsequently interfered with nuclear translocation of the positive Smad complex, thus occluding it off the gastrin promoter. IL1B promoter polymorphisms (-511T/-31C IL1B) are known to be associated with H. pylori associated gastro-duodenal ulcer. We observed that IL1B expressed from -31T promoter driven IL1B cDNA elicited 3.5 fold more Smad 7 than that expressed from the IL1B-31C variant in AGS cells. This differential activation of Smad 7 by IL1B promoter variants translated into differential downregulation of gastrin expression. We further analyzed Smad 7, NFkB, IL1B and gastrin expression in antral gut biopsy samples of patients with H. pylori associated duodenal ulcer and normal individuals. We observed that individuals with duodenal ulcer had significantly lower levels of IL1B, Smad 7, NFkB and corresponding higher level of gastrin expression. Conclusion: Pro-inflammatory cytokine IL1B repress gastrin expression by activating Smad 7 and subsequent inhibition of nuclear localization of Smad 3/4 complex. Polymorphic promoter variants of IL1B gene can modulate the IL1B expression which resulted in differential activation Smad 7 and consequent repression of gastrin expression, respectively. Analysis of H. pylori infected duodenal ulcer patient's gut biopsy samples also supported this observation.	[De, Dipanjana Datta; Bhattacharjya, Sumana; Datta, Arindam; Roychoudhury, Susanta] CSIR, Indian Inst Chem Biol, Mol & Human Genet Div, Kolkata, India; [Maitra, Meenakshi] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Choudhury, Abhijit; Dhali, G. K.] Inst Postgrad Med & Expt Res, Dept Med, Kolkata, India; [Choudhury, Abhijit; Dhali, G. K.] Inst Postgrad Med & Expt Res, Dept Gastroenterol, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of Texas System; University of Texas Southwestern Medical Center Dallas; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	De, DD (corresponding author), CSIR, Indian Inst Chem Biol, Mol & Human Genet Div, Kolkata, India.	susanta@iicb.res.in	Datta, Arindam/ADR-8763-2022; Dhali, Gopal Krishna/AAE-5331-2022; Roychoudhury, Susanta/AAD-7946-2021	Datta, Arindam/0000-0002-0617-9908; Dhali, Gopal Krishna/0000-0002-6759-5067; 	Indian Council of Medical Research [63/147/2001-BMS]; Council of Scientific and Industrial Research, India [IAP 001]; Council of Medical Research, India [5/8-1(161)/H.pylori/2000-ECD-II]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Medical Research, India	This study was partially supported by research grants from the Indian Council of Medical Research (63/147/2001-BMS) and the Council of Scientific and Industrial Research, India (IAP 001), awarded to S. Roychoudhury; and the Council of Medical Research, India (5/8-1(161)/H.pylori/2000-ECD-II), awarded to A. Choudhury. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON JH, 1998, CLIN TESTS GASTRIC S; Beales ILP, 2000, DIGEST DIS SCI, V45, P289, DOI 10.1023/A:1005452307860; Bitzer M, 2000, GENE DEV, V14, P187; Chakravorty M, 2006, HUM MUTAT, V27, P411, DOI 10.1002/humu.20299; Chakravorty M, 2009, INT J BIOCHEM CELL B, V41, P1502, DOI 10.1016/j.biocel.2008.12.017; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; FIGURA N, 1987, J CLIN MICROBIOL, V25, P1341, DOI 10.1128/JCM.25.7.1341-1342.1987; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Harris AW, 1996, GUT, V38, P663, DOI 10.1136/gut.38.5.663; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; KONDO S, 1994, AM J PHYSIOL-GASTR L, V267, pG966, DOI 10.1152/ajpgi.1994.267.6.G966; Lei S, 2004, J BIOL CHEM, V279, P42492, DOI 10.1074/jbc.M404025200; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Monteleone G, 2004, TRENDS IMMUNOL, V25, P513, DOI 10.1016/j.it.2004.07.008; Monteleone G, 2004, GASTROENTEROLOGY, V126, P674, DOI 10.1053/j.gastro.2003.11.048; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nedrud JG, 1997, GASTROENTEROLOGY, V112, P670, DOI 10.1053/gast.1997.v112.agast970670a; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Tanigawa T, 2005, J PHYSIOL PHARMACOL, V56, P3; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; WALLACE JL, 1991, AM J PHYSIOL, V261, pG559, DOI 10.1152/ajpgi.1991.261.4.G559; Wang MC, 1999, J GASTROENTEROL, V34, P10; Yamaoka Y, 1999, J CLIN MICROBIOL, V37, P2274, DOI 10.1128/JCM.37.7.2274-2279.1999; Yamaoka Y, 1996, GASTROENTEROLOGY, V110, P1744, DOI 10.1053/gast.1996.v110.pm8964399; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zavros Y, 2003, P NATL ACAD SCI USA, V100, P12944, DOI 10.1073/pnas.2135193100	29	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e14775	10.1371/journal.pone.0014775	http://dx.doi.org/10.1371/journal.pone.0014775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445336	gold, Green Published, Green Submitted			2022-12-27	WOS:000288809100002
J	Choo, SW; White, R; Russell, S				Choo, Siew Woh; White, Robert; Russell, Steven			Genome-Wide Analysis of the Binding of the Hox Protein Ultrabithorax and the Hox Cofactor Homothorax in Drosophila	PLOS ONE			English	Article							HOMEOTIC GENE ULTRABITHORAX; POLYCOMB GROUP PROTEINS; BITHORAX COMPLEX; DNA-BINDING; TRANSCRIPTION FACTORS; HOMEODOMAIN PROTEIN; HALTERE DEVELOPMENT; IMAGINAL DISC; TARGET GENE; NEGATIVE REGULATION	Hox genes encode a family of transcription factors that are key developmental regulators with a highly conserved role in specifying segmental diversity along the metazoan body axis. Although they have been shown to regulate a wide variety of downstream processes, direct transcriptional targets have been difficult to identify and this has been a major obstacle to our understanding of Hox gene function. We report the identification of genome-wide binding sites for the Hox protein Ultrabithorax (Ubx) using a YFP-tagged Drosophila protein-trap line together with chromatin immunoprecipitation and microarray analysis. We identify 1,147 genes bound by Ubx at high confidence in chromatin from the haltere imaginal disc, a prominent site of Ubx function where it specifies haltere versus wing development. The functional relevance of these genes is supported by their overlap with genes differentially expressed between wing and haltere imaginal discs. The Ubx-bound gene set is highly enriched in genes involved in developmental processes and contains both high-level regulators as well as genes involved in more basic cellular functions. Several signalling pathways are highly enriched in the Ubx target gene set and our analysis supports the view that Hox genes regulate many levels of developmental pathways and have targets distributed throughout the gene network. We also performed genome-wide analysis of the binding sites for the Hox cofactor Homothorax (Hth), revealing a striking similarity with the Ubx binding profile. We suggest that these binding profiles may be strongly influenced by chromatin accessibility and provide evidence of a link between Ubx/Hth binding and chromatin state at genes regulated by Polycomb silencing. Overall, we define a set of direct Ubx targets in the haltere imaginal disc and suggest that chromatin accessibility has important implications for Hox target selection and for transcription factor binding in general.	[Choo, Siew Woh; Russell, Steven] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Choo, Siew Woh; White, Robert] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EH, England; [Russell, Steven] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 3EH, England	University of Cambridge; University of Cambridge; University of Cambridge	Choo, SW (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	rw108@cam.ac.uk	Russell, Steve/A-4072-2011; Choo, Siew Woh/E-3406-2010; White, Rob A H/G-4835-2012	Russell, Steve/0000-0003-0546-3031; 	Malaysian Government; University of Malaya	Malaysian Government; University of Malaya(Universiti Malaya)	SWC was supported by a scholarship from the Malaysian Government and the University of Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abu-Shaar M, 1998, DEVELOPMENT, V125, P3821; Adryan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r167; Akam M, 1998, CURR BIOL, V8, pR676, DOI 10.1016/S0960-9822(98)70433-6; Azpiazu N, 2000, DEVELOPMENT, V127, P2685; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; BENDER W, 1983, SCIENCE, V221, P23, DOI 10.1126/science.221.4605.23; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Beuchle D, 2001, DEVELOPMENT, V128, P993; Biggin MD, 1997, DEVELOPMENT, V124, P4425; Birch-Machin I, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r63; BODMER R, 1993, DEVELOPMENT, V118, P719; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; CAPOVILLA M, 1994, CELL, V76, P461, DOI 10.1016/0092-8674(94)90111-2; CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0; CASANOVA J, 1985, J EMBRYOL EXP MORPH, V90, P179; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; Casares F, 2000, DEVELOPMENT, V127, P1499; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; Chan SK, 1996, P NATL ACAD SCI USA, V93, P5223, DOI 10.1073/pnas.93.11.5223; Chan SK, 1997, DEVELOPMENT, V124, P2007; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Chopra VS, 2009, CURR BIOL, V19, P688, DOI 10.1016/j.cub.2009.02.055; CHRISTEN B, 1994, MECH DEVELOP, V48, P255, DOI 10.1016/0925-4773(94)90064-7; Costello JC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r97; Crickmore MA, 2006, SCIENCE, V313, P63, DOI 10.1126/science.1128650; Curtiss J, 1997, DEV BIOL, V190, P129, DOI 10.1006/dbio.1997.8659; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Down TA, 2005, NUCLEIC ACIDS RES, V33, P1445, DOI 10.1093/nar/gki282; EKKER SC, 1991, EMBO J, V10, P1179, DOI 10.1002/j.1460-2075.1991.tb08058.x; Fitzgerald DP, 2001, MOL CELL BIOL, V21, P6585, DOI 10.1128/MCB.21.19.6585-6597.2001; Galant R, 2002, DEVELOPMENT, V129, P3115; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; GONZALEZCRESPO S, 1995, DEVELOPMENT, V121, P2117; GOULD AP, 1990, NATURE, V348, P308, DOI 10.1038/348308a0; Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402; Hersh BM, 2007, DEV BIOL, V302, P717, DOI 10.1016/j.ydbio.2006.11.011; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Hueber SD, 2007, DEVELOPMENT, V134, P381, DOI 10.1242/dev.02746; Huen DS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-359; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kurant E, 1998, DEVELOPMENT, V125, P1037; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; LEVINE M, 1983, EMBO J, V2, P2037, DOI 10.1002/j.1460-2075.1983.tb01697.x; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LEWIS EB, 1964, ROLE CHROMOSOMES DEV, P231; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Lovegrove B, 2006, CURR BIOL, V16, P2206, DOI 10.1016/j.cub.2006.09.029; Lu Q, 1996, MOL CELL BIOL, V16, P1632; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Maeda RK, 2006, DEVELOPMENT, V133, P1413, DOI 10.1242/dev.02323; Makhijani K, 2007, DEV BIOL, V302, P243, DOI 10.1016/j.ydbio.2006.09.029; MANAK JR, 1994, DEVELOPMENT, V120, P3605; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; McCall K, 1996, EMBO J, V15, P569, DOI 10.1002/j.1460-2075.1996.tb00389.x; MCCORMICK AM, 1995, DEVELOPMENT, V121, P2799; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Mihaly J, 2006, DEVELOPMENT, V133, P2983, DOI 10.1242/dev.02451; Mohit P, 2006, DEV BIOL, V291, P356, DOI 10.1016/j.ydbio.2005.12.022; Molnar C, 2006, GENETICS, V174, P1635, DOI 10.1534/genetics.106.061283; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Pai CY, 1998, GENE DEV, V12, P435, DOI 10.1101/gad.12.3.435; Pallavi SK, 2006, DEV BIOL, V296, P340, DOI 10.1016/j.ydbio.2006.05.035; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; PAVLOPOULOS A, 2011, P NATL ACAD IN PRESS; Pinsonneault J, 1997, EMBO J, V16, P2032, DOI 10.1093/emboj/16.8.2032; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; Roch F, 2000, DEVELOPMENT, V127, P97; Ryder E, 2009, BIOINFORMATICS, V25, P548, DOI 10.1093/bioinformatics/btp012; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; SCHLOSSHERR J, 1994, MOL GEN GENET, V243, P453; Shashidhara LS, 1999, DEV BIOL, V212, P491, DOI 10.1006/dbio.1999.9341; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C; VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6; Walsh CM, 2007, DEVELOPMENT, V134, P3585, DOI 10.1242/dev.009522; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; White RAH, 2000, MECH DEVELOP, V91, P217, DOI 10.1016/S0925-4773(99)00306-8; WHITE RAH, 1985, NATURE, V318, P567, DOI 10.1038/318567a0; WHITE RAH, 1985, EMBO J, V4, P2035, DOI 10.1002/j.1460-2075.1985.tb03889.x; WIRZ J, 1986, EMBO J, V5, P3327, DOI 10.1002/j.1460-2075.1986.tb04647.x; Wu J, 1999, DEVELOPMENT, V126, P109	89	45	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e14778	10.1371/journal.pone.0014778	http://dx.doi.org/10.1371/journal.pone.0014778			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483667	Green Submitted, Green Published, gold			2022-12-27	WOS:000289191300002
J	Kaplan, NA; Colosimo, PF; Liu, XP; Tolwinski, NS				Kaplan, Nicole A.; Colosimo, Pamela F.; Liu, Xiaoping; Tolwinski, Nicholas S.			Complex Interactions between GSK3 and aPKC in Drosophila Embryonic Epithelial Morphogenesis	PLOS ONE			English	Article							ASYMMETRIC CELL-DIVISION; PROTEIN-KINASE-C; PLANAR POLARITY; CDC42; POLARIZATION; ARMADILLO; PATHWAYS; BAZOOKA; SIGNAL; AXIN	Generally, epithelial cells must organize in three dimensions to form functional tissue sheets. Here we investigate one such sheet, the Drosophila embryonic epidermis, and the morphogenetic processes organizing cells within it. We report that epidermal morphogenesis requires the proper distribution of the apical polarity determinant aPKC. Specifically, we find roles for the kinases GSK3 and aPKC in cellular alignment, asymmetric protein distribution, and adhesion during the development of this polarized tissue. Finally, we propose a model explaining how regulation of aPKC protein levels can reorganize both adhesion and the cytoskeleton.	[Kaplan, Nicole A.; Colosimo, Pamela F.; Liu, Xiaoping; Tolwinski, Nicholas S.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Dev Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Kaplan, NA (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Dev Biol, 1275 York Ave, New York, NY 10021 USA.	tolwinsn@mskcc.org	Tolwinski, Nicholas/D-1481-2014; Tolwinski, Nicholas/Q-5782-2019	Tolwinski, Nicholas/0000-0002-8507-2737				Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Blankenship JT, 2007, J CELL SCI, V120, P3099, DOI 10.1242/jcs.004770; CHOU TB, 1992, GENETICS, V131, P643; Colosimo PF, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000009; Colosimo PF, 2010, DEV DYNAM, V239, P115, DOI 10.1002/dvdy.21963; Djiane A, 2005, CELL, V121, P621, DOI 10.1016/j.cell.2005.03.014; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Harris TJC, 2007, DEV CELL, V12, P727, DOI 10.1016/j.devcel.2007.02.011; Hatini V, 2001, TRENDS GENET, V17, P574, DOI 10.1016/S0168-9525(01)02448-9; HILLMAN R, 1970, J MORPHOL, V131, P383, DOI 10.1002/jmor.1051310403; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Kaplan NA, 2010, J CELL SCI, V123, P3157, DOI 10.1242/jcs.069898; Kaplan NA, 2009, GENETICS, V183, P897, DOI 10.1534/genetics.109.108878; KIM NG, 2009, P NATL ACAD SCI US; MARTINEZ ARIAS A., 1993, DEV PATTERNING LARVA; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Payre F, 2004, INT J DEV BIOL, V48, P207, DOI 10.1387/ijdb.15272387; PEIFER M, 1994, DEVELOPMENT, V120, P369; PRICE MH, 2006, J CELL SCI; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Sanson B, 2001, EMBO REP, V2, P1083, DOI 10.1093/embo-reports/kve255; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Simone RP, 2010, DEVELOPMENT, V137, P1385, DOI 10.1242/dev.048520; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Tolwinski NS, 2009, GENETICS, V181, P1169, DOI 10.1534/genetics.108.098236; Tolwinski NS, 2004, PLOS BIOL, V2, P486, DOI 10.1371/journal.pbio.0020095; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Tolwinski NS, 2001, DEVELOPMENT, V128, P2107; Walters JW, 2006, DEV BIOL, V297, P323, DOI 10.1016/j.ydbio.2006.04.454; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7; Zallen JA, 2008, SEMIN CELL DEV BIOL, V19, P263, DOI 10.1016/j.semcdb.2008.01.005; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603	40	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18616	10.1371/journal.pone.0018616	http://dx.doi.org/10.1371/journal.pone.0018616			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483653	Green Submitted, Green Published, gold			2022-12-27	WOS:000289191300033
J	Mutsaers, HAM; van den Heuvel, LP; Ringens, LHJ; Dankers, ACA; Russel, FGM; Wetzels, JFM; Hoenderop, JG; Masereeuw, R				Mutsaers, Henricus A. M.; van den Heuvel, Lambertus P.; Ringens, Lauke H. J.; Dankers, Anita C. A.; Russel, Frans G. M.; Wetzels, Jack F. M.; Hoenderop, Joost G.; Masereeuw, Rosalinde			Uremic Toxins Inhibit Transport by Breast Cancer Resistance Protein and Multidrug Resistance Protein 4 at Clinically Relevant Concentrations	PLOS ONE			English	Article							ORGANIC ANION TRANSPORTER; RENAL-FAILURE; INDOXYL SULFATE; EFFLUX PUMP; KIDNEY; EXPRESSION; MEMBRANE; ABCG2; ACID; MRP4/ABCC4	During chronic kidney disease (CKD), there is a progressive accumulation of toxic solutes due to inadequate renal clearance. Here, the interaction between uremic toxins and two important efflux pumps, viz. multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP) was investigated. Membrane vesicles isolated from MRP4- or BCRP-overexpressing human embryonic kidney cells were used to study the impact of uremic toxins on substrate specific uptake. Furthermore, the concentrations of various uremic toxins were determined in plasma of CKD patients using high performance liquid chromatography and liquid chromatography/tandem mass spectrometry. Our results show that hippuric acid, indoxyl sulfate and kynurenic acid inhibit MRP4-mediated [(3)H]-methotrexate ([(3)H]-MTX) uptake (calculated Ki values: 2.5 mM, 1 mM, 25 mu M, respectively) and BCRP-mediated [(3)H]-estrone sulfate ([(3)H]-E1S) uptake (Ki values: 4 mM, 500 mu M and 50 mu M, respectively), whereas indole-3-acetic acid and phenylacetic acid reduce [(3)H]-MTX uptake by MRP4 only (Ki value: 2 mM and IC(50) value: 7 mM, respectively). In contrast, p-cresol, p-toluenesulfonic acid, putrescine, oxalate and quinolinic acid did not alter transport mediated by MRP4 or BCRP. In addition, our results show that hippuric acid, indole-3-acetic acid, indoxyl sulfate, kynurenic acid and phenylacetic acid accumulate in plasma of end-stage CKD patients with mean concentrations of 160 mu M, 4 mu M, 129 mu M, 1 mu M and 18 mu M, respectively. Moreover, calculated Ki values are below the maximal plasma concentrations of the tested toxins. In conclusion, this study shows that several uremic toxins inhibit active transport by MRP4 and BCRP at clinically relevant concentrations.	[Mutsaers, Henricus A. M.; Ringens, Lauke H. J.; Dankers, Anita C. A.; Russel, Frans G. M.; Masereeuw, Rosalinde] Radboud Univ Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Pharmacol & Toxicol, Nijmegen, Netherlands; [Mutsaers, Henricus A. M.; Hoenderop, Joost G.] Radboud Univ Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Physiol, Nijmegen, Netherlands; [van den Heuvel, Lambertus P.] Radboud Univ Nijmegen Med Ctr, Dept Pediat, Nijmegen, Netherlands; [Wetzels, Jack F. M.] Radboud Univ Nijmegen Med Ctr, Dept Nephrol, Nijmegen, Netherlands; [van den Heuvel, Lambertus P.] Catholic Univ Louvain, Dept Pediat, B-3000 Louvain, Belgium	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Universite Catholique Louvain	Mutsaers, HAM (corresponding author), Radboud Univ Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Pharmacol & Toxicol, Nijmegen, Netherlands.	r.masereeuw@pharmtox.umcn.nl	Masereeuw, Roos/I-5276-2016; van den Heuvel, Lambertus/AAM-1772-2021; Mutsaers, Henricus/AAK-6321-2020; Hoenderop, Joost G.J./H-8047-2014; Wetzels, Jack F.M./A-1720-2014; Russel, Frans G.M./B-3184-2014; Masereeuw, Roos/N-3582-2014; van den Heuvel, L.P.W.J./H-8044-2014	Masereeuw, Roos/0000-0002-1560-1074; van den Heuvel, Lambertus/0000-0003-3917-6727; Mutsaers, Henricus/0000-0002-9553-8860; Hoenderop, Joost G.J./0000-0002-1816-8544; Wetzels, Jack F.M./0000-0002-0650-6921; Russel, Frans G.M./0000-0002-7959-2314; van den Heuvel, L.P.W.J./0000-0003-3917-6727	Dutch Kidney Foundation [IK08.03]; European Science Foundation	Dutch Kidney Foundation; European Science Foundation(European Science Foundation (ESF)European Commission)	This work was supported by the Dutch Kidney Foundation (grant number IK08.03; www.nierstichting.nl). J.G. Hoenderop was supported by an EURYI award from the European Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; Brener ZZ, 2010, AM J MED SCI, V339, P453, DOI 10.1097/MAJ.0b013e3181cf7d5b; Burckhardt BC, 2003, REV PHYSIOL BIOCH P, V146, P95, DOI 10.1007/s10254-002-0003-8; Cohen G, 2007, NEPHROL DIAL TRANSPL, V22, P3381, DOI 10.1093/ndt/gfm210; Deguchi T, 2004, KIDNEY INT, V65, P162, DOI 10.1111/j.1523-1755.2004.00354.x; Deguchi T, 2002, KIDNEY INT, V61, P1760, DOI 10.1046/j.1523-1755.2002.00318.x; El-Sheikh AAK, 2008, MOL PHARMACOL, V74, P964, DOI 10.1124/mol.107.043661; El-Sheikh AAK, 2007, J PHARMACOL EXP THER, V320, P229, DOI 10.1124/jpet.106.110379; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Hazai E, 2008, J STRUCT BIOL, V162, P63, DOI 10.1016/j.jsb.2007.12.001; Huang ZH, 2000, EUR J PHARMACOL, V406, P453, DOI 10.1016/S0014-2999(00)00699-3; Huls M, 2008, KIDNEY INT, V73, P220, DOI 10.1038/sj.ki.5002645; Huls M, 2006, KIDNEY INT, V69, P2186, DOI 10.1038/sj.ki.5000407; Imai Y, 2003, MOL PHARMACOL, V64, P610, DOI 10.1124/mol.64.3.610; Jankowski J, 2003, J CLIN INVEST, V112, P256, DOI 10.1172/JCI200315524; Jourde-Chiche N, 2009, SEMIN DIALYSIS, V22, P334, DOI 10.1111/j.1525-139X.2009.00576.x; Laouari D, 2001, AM J PHYSIOL-RENAL, V280, pF636, DOI 10.1152/ajprenal.2001.280.4.F636; Lee CT, 2010, PERITON DIALYSIS INT, V30, P456, DOI 10.3747/pdi.2009.00092; Lopez-Novoa JM, 2010, PHARMACOL THERAPEUT, V128, P61, DOI 10.1016/j.pharmthera.2010.05.006; Lu H, 2008, DRUG METAB DISPOS, V36, P16, DOI 10.1124/dmd.107.014845; Masereeuw R, 1998, J PHARM PHARMACOL, V50, P1397, DOI 10.1111/j.2042-7158.1998.tb03366.x; Masereeuw R, 1996, J PHARM PHARMACOL, V48, P560, DOI 10.1111/j.2042-7158.1996.tb05974.x; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Nakagawa T, 2006, BLOOD PURIFICAT, V24, P67, DOI 10.1159/000089440; Pick A, 2010, CHEMMEDCHEM, V5, P1498, DOI 10.1002/cmdc.201000216; Rhee EP, 2010, J AM SOC NEPHROL, V21, P1041, DOI 10.1681/ASN.2009111132; Schepers E, 2010, BLOOD PURIFICAT, V29, P130, DOI 10.1159/000245639; SMITH HW, 1945, J CLIN INVEST, V24, P388, DOI 10.1172/JCI101618; Toyohara T, 2009, J AM SOC NEPHROL, V20, P2546, DOI 10.1681/ASN.2009070696; Van Aubel RAMH, 2005, AM J PHYSIOL-RENAL, V288, pF327, DOI 10.1152/ajprenal.00133.2004; Van Aubel RAMH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133595; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 2008, PEDIATR NEPHROL, V23, P1211, DOI 10.1007/s00467-008-0762-9; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106	34	102	106	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18438	10.1371/journal.pone.0018438	http://dx.doi.org/10.1371/journal.pone.0018438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483698	gold, Green Published, Green Submitted			2022-12-27	WOS:000289058700028
J	Sola, S; Xavier, JM; Santos, DM; Aranha, MM; Morgado, AL; Jepsen, K; Rodrigues, CMP				Sola, Susana; Xavier, Joana M.; Santos, Daniela M.; Aranha, Marcia M.; Morgado, Ana L.; Jepsen, Kristen; Rodrigues, Cecilia M. P.			p53 Interaction with JMJD3 Results in Its Nuclear Distribution during Mouse Neural Stem Cell Differentiation	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; SELF-RENEWAL; PATHWAY; DEMETHYLASE; PLURIPOTENT; CONTRIBUTES; METHYLATION; REPRESSION; GENERATION; APOPTOSIS	Conserved elements of apoptosis are also integral components of cellular differentiation. In this regard, p53 is involved in neurogenesis, being required for neurite outgrowth in primary neurons and for axonal regeneration in mice. Interestingly, demethylases regulate p53 activity and its interaction with co-activators by acting on non-histone proteins. In addition, the histone H3 lysine 27-specific demethylase JMJD3 induces ARF expression, thereby stabilizing p53 in mouse embryonic fibroblasts. We hypothesized that p53 interacts with key regulators of neurogenesis to redirect stem cells to differentiation, as an alternative to cell death. Specifically, we investigated the potential cross-talk between p53 and JMJD3 during mouse neural stem cell (NSC) differentiation. Our results demonstrated that JMJD3 mRNA and protein levels were increased early in mouse NSC differentiation, when JMJD3 activity was readily detected. Importantly, modulation of JMJD3 in NSCs resulted in changes of total p53 protein, coincident with increased ARF mRNA and protein expression. ChIP analysis revealed that JMJD3 was present at the promoter and exon 1 regions of ARF during neural differentiation, although without changes in H3K27me3. Immunoprecipitation assays demonstrated a direct interaction between p53 and JMJD3, independent of the C-terminal region of JMJD3, and modulation of p53 methylation by JMJD3-demethylase activity. Finally, transfection of mutant JMJD3 showed that the demethylase activity of JMJD3 was crucial in regulating p53 cellular distribution and function. In conclusion, JMJD3 induces p53 stabilization in mouse NSCs through ARF-dependent mechanisms, directly interacts with p53 and, importantly, causes nuclear accumulation of p53. This suggests that JMJD3 and p53 act in a common pathway during neurogenesis.	[Sola, Susana; Xavier, Joana M.; Santos, Daniela M.; Aranha, Marcia M.; Morgado, Ana L.; Rodrigues, Cecilia M. P.] Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal; [Jepsen, Kristen] Univ Calif San Diego, Dept Med, Howard Hughes Med Inst, San Diego, CA 92103 USA	Universidade de Lisboa; Howard Hughes Medical Institute; University of California System; University of California San Diego	Sola, S (corresponding author), Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal.	susana.sola@ff.ul.pt	Morgado, Ana Luísa/A-8683-2015; iMed.ULisboa, CellFun/A-4244-2014; Solá, Susana/M-5251-2013; Solá, Susana/AAI-4580-2021; Santos, Daniela/W-3903-2019; Aranha, Marcia/AAO-7240-2021; Rodrigues, Cecilia MP/M-3572-2013	Morgado, Ana Luísa/0000-0003-3153-4665; Solá, Susana/0000-0003-2036-797X; Solá, Susana/0000-0003-2036-797X; Rodrigues, Cecilia MP/0000-0002-4829-754X; Moutinho Dos Santos, Daniela/0000-0002-3740-1305; Aranha, Marcia/0000-0001-9842-4335	Fundacao para a Ciencia e a Tecnologia (FCT), Lisbon, Portugal [PTDC/BIA-BCM/67922/2006]; FCT [SFRH/BD/42008/2007, SFRH/BD/28429/2006]	Fundacao para a Ciencia e a Tecnologia (FCT), Lisbon, Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by grant PTDC/BIA-BCM/67922/2006 from Fundacao para a Ciencia e a Tecnologia (FCT), Lisbon, Portugal. Santos DM and Aranha MA were recipients of PhD fellowships from FCT (SFRH/BD/42008/2007 and SFRH/BD/28429/2006, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Allison SJ, 2003, CANCER RES, V63, P6674; Amaral JD, 2010, CURR PHARM DESIGN, V16, P2493; Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Aranha MM, 2009, J CELL BIOCHEM, V107, P748, DOI 10.1002/jcb.22172; Armesilla-Diaz A, 2009, NEUROSCIENCE, V158, P1378, DOI 10.1016/j.neuroscience.2008.10.052; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Ferecatu I, 2009, FRONT BIOSCI-LANDMRK, V14, P4214, DOI 10.2741/3524; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; HE J, 2010, MED ONCOL       0817; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jones RS, 2007, NATURE, V450, P357, DOI 10.1038/450357a; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Nagao M, 2008, J CELL BIOL, V183, P1243, DOI 10.1083/jcb.200807130; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sawarkar R, 2010, DEV CELL, V19, P651, DOI 10.1016/j.devcel.2010.10.012; Scoumanne A, 2008, HISTOL HISTOPATHOL, V23, P1143, DOI 10.14670/HH-23.1143; Selvaraj V, 2010, TRENDS BIOTECHNOL, V28, P214, DOI 10.1016/j.tibtech.2010.01.002; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Tedeschi A, 2009, EMBO REP, V10, P576, DOI 10.1038/embor.2009.89; Tsai WW, 2008, MOL CELL BIOL, V28, P5139, DOI 10.1128/MCB.00287-08; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Zhao TBA, 2010, TRENDS CELL BIOL, V20, P170, DOI 10.1016/j.tcb.2009.12.004; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	47	45	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18421	10.1371/journal.pone.0018421	http://dx.doi.org/10.1371/journal.pone.0018421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483786	gold, Green Submitted, Green Published			2022-12-27	WOS:000289057200072
J	Burger, C; Both, C				Burger, Claudia; Both, Christiaan			Translocation as a Novel Approach to Study Effects of a New Breeding Habitat on Reproductive Output in Wild Birds	PLOS ONE			English	Article							GLOBAL CLIMATE-CHANGE; DISPERSAL; FAMILIARITY; DISTANCE; CONSEQUENCES; SELECTION; SURVIVAL; FITNESS	Environmental conditions under which species reproduce have major consequences on breeding success and subsequent fitness. Therefore breeding habitat choice is ultimately important. Studies rarely address the potential fitness pay-offs of alternative natural breeding habitats by experimental translocation. Here we present a new tool to study fitness consequences of free living birds in different habitats. We translocated a migratory passerine, the pied flycatcher (Ficedula hypoleuca), to a novel site, where pairs were subjected to a short stay (2-4 days) in a nest box-equipped aviary before being released. We show that it is technically possible to retain birds in the new area for breeding, allowing the study of reproductive consequences of dispersal under natural conditions. The translocation resulted in an extension of the interval between arrival and egg laying of four days, highlighting the importance of having an adequate control group. Clutch size and nestling parameters did not differ significantly between translocated and unmanipulated females, which suggests that the procedure did not affect birds in their reproductive performance later on. This method could be applied broadly in evolutionary and ecological research, e. g., to study the potential fitness benefits and costs for dispersing to more northern latitudes as a way of adapting to climate change.	[Burger, Claudia; Both, Christiaan] Univ Groningen, Ctr Life Sci, Anim Ecol Grp, Groningen, Netherlands	University of Groningen	Burger, C (corresponding author), Univ Groningen, Ctr Life Sci, Anim Ecol Grp, Groningen, Netherlands.	c.burger@rug.nl	Both, Christiaan/E-6459-2011	Both, Christiaan/0000-0001-7099-9831	Dutch Science Foundation (N.W.O.)	Dutch Science Foundation (N.W.O.)(Netherlands Organization for Scientific Research (NWO))	The study was funded by a VIDI grant of the Dutch Science Foundation (N.W.O.) awarded to C. Both. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1963, ANIMAL SPECIES EVOLU; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; ARMSTRONG DP, 1995, BIOL CONSERV, V71, P133, DOI 10.1016/0006-3207(94)00027-N; ARTEMYEV AV, 2004, TERRITORIAL BEHAV BI, P28; BERNDT R, 1969, Journal fuer Ornithologie, V110, P22, DOI 10.1007/BF01671133; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; Brouwer L, 2009, ECOLOGY, V90, P729, DOI 10.1890/07-1437.1; Brown CR, 2008, ANIM BEHAV, V76, P1201, DOI 10.1016/j.anbehav.2008.03.028; Chernetsov N, 2006, CONDOR, V108, P711, DOI 10.1650/0010-5422(2006)108[711:sndopf]2.0.co;2; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Doligez B, 2002, SCIENCE, V297, P1168, DOI 10.1126/science.1072838; Doligez B, 2008, J ANIM ECOL, V77, P1199, DOI 10.1111/j.1365-2656.2008.01446.x; DRENT PJ, 1987, ARDEA, V75, P59; Fretwell S.D., 1970, ACTA BIOTHEOR, V19, P16, DOI DOI 10.1007/BF01601953; Garant D, 2005, NATURE, V433, P60, DOI 10.1038/nature03051; Hansson B, 2004, EVOLUTION, V58, P2546, DOI 10.1111/j.0014-3820.2004.tb00883.x; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; JAENIKE J, 1991, AM NAT, V137, pS67, DOI 10.1086/285140; KOMDEUR J, 1994, BIOL CONSERV, V67, P143, DOI 10.1016/0006-3207(94)90360-3; Lambrechts MM, 1999, P ROY SOC B-BIOL SCI, V266, P1311, DOI 10.1098/rspb.1999.0780; Lundberg A, 1992, PIED FLYCATCHER; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Nichols J., 2001, DISPERSAL; Part T, 2007, J ORNITHOL, V148, pS327, DOI 10.1007/s10336-007-0226-1; PARTRIDGE L, 1974, NATURE, V247, P573, DOI 10.1038/247573a0; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Schoech SJ, 2008, OECOLOGIA, V157, P369, DOI 10.1007/s00442-008-1091-1; Shields WM, 1982, PHILOPATRY INBREEDIN; SIIKAMAKI P, 1995, ECOLOGY, V76, P308, DOI 10.2307/1940652; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; Winkel Wolfgang, 1993, Vogelwarte, V37, P50; Yoder JM, 2004, BEHAV ECOL, V15, P469, DOI 10.1093/beheco/arh037	38	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18143	10.1371/journal.pone.0018143	http://dx.doi.org/10.1371/journal.pone.0018143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479183	Green Published, Green Submitted, gold			2022-12-27	WOS:000289055700032
J	Dmitriew, C; Rowe, L				Dmitriew, Caitlin; Rowe, Locke			The Effects of Larval Nutrition on Reproductive Performance in a Food-Limited Adult Environment	PLOS ONE			English	Article							DEVELOPMENTAL TRADE-OFFS; EARLY GROWTH-CONDITIONS; COMPENSATORY GROWTH; PHYSIOLOGICAL COSTS; THRIFTY PHENOTYPE; BODY-SIZE; FLIGHT; EVOLUTION; CRICKETS; AGE	It is often assumed that larval food stress reduces lifetime fitness regardless of the conditions subsequently faced by adults. However, according to the environment-matching hypothesis, a plastic developmental response to poor nutrition results in an adult phenotype that is better adapted to restricted food conditions than one having developed in high food conditions. Such a strategy might evolve when current conditions are a reliable predictor of future conditions. To test this hypothesis, we assessed the effects of larval food conditions (low, improving and high food) on reproductive fitness in both low and high food adults environments. Contrary to this hypothesis, we found no evidence that food restriction in larval ladybird beetles produced adults that were better suited to continuing food stress. In fact, reproductive rate was invariably lower in females that were reared at low food, regardless of whether adults were well fed or food stressed. Juveniles that encountered improving conditions during the larval stage compensated for delayed growth by accelerating subsequent growth, and thus showed no evidence of a reduced reproductive rate. However, these same individuals lost more mass during the period of starvation in adults, which indicates that accelerated growth results in an increased risk of starvation during subsequent periods of food stress.	[Dmitriew, Caitlin] Univ Zurich, Inst Evolutionary Biol & Environm Sci, Zurich, Switzerland; [Rowe, Locke] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of Zurich; University of Toronto	Dmitriew, C (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Sci, Zurich, Switzerland.	c.dmitriew@utoronto.ca			Natural Sciences and Engineering Research Council (NSERC); Canada Research Chairs program	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs)	This research was funded by a Natural Sciences and Engineering Research Council (NSERC) PGS-D scholarship to C. D. and by grants from NSERC (http://www.nserc-crsng.gc.ca/) and the Canada Research Chairs program (http://www.chairs-chaires.gc.ca/) to L.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, EVOLUTION, V50, P1052, DOI 10.1111/j.1558-5646.1996.tb02346.x; Ali M, 2003, FISH FISH, V4, P147, DOI 10.1046/j.1467-2979.2003.00120.x; Andersson Malte, 1994; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; BARKER DJP, 1989, J EPIDEMIOL COMMUN H, V43, P237, DOI 10.1136/jech.43.3.237; Barrett ELB, 2009, P ROY SOC B-BIOL SCI, V276, P3257, DOI 10.1098/rspb.2009.0725; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bauerfeind SS, 2005, OIKOS, V111, P514, DOI 10.1111/j.0030-1299.2005.13888.x; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Boggs CL, 2005, OECOLOGIA, V144, P353, DOI 10.1007/s00442-005-0076-6; Braendle C, 2006, HEREDITY, V97, P192, DOI 10.1038/sj.hdy.6800863; Coll M, 2004, ENVIRON ENTOMOL, V33, P1471, DOI 10.1603/0046-225X-33.5.1471; Day T, 2002, AM NAT, V159, P338, DOI 10.1086/338989; De Block M, 2005, ECOLOGY, V86, P185, DOI 10.1890/04-0116; Dingle Hugh, 2001, Symposia of the Royal Entomological Society of London, V20, P159, DOI 10.1079/9780851994567.0159; Dmitriew C, 2007, J EVOLUTION BIOL, V20, P1298, DOI 10.1111/j.1420-9101.2007.01349.x; Dmitriew C, 2009, CAN J ZOOL, V87, P175, DOI 10.1139/Z09-001; Dmitriew CM, 2011, BIOL REV, V86, P97, DOI 10.1111/j.1469-185X.2010.00136.x; Fischer K, 2004, EVOL ECOL, V18, P343, DOI 10.1007/s10682-004-2004-3; GOTTHARD K, 1994, OECOLOGIA, V99, P281, DOI 10.1007/BF00627740; Hahn DA, 2005, J INSECT PHYSIOL, V51, P1210, DOI 10.1016/j.jinsphys.2005.06.011; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Jones RH, 2009, MOL CELL ENDOCRINOL, V297, P4, DOI 10.1016/j.mce.2008.06.020; Karlsson B, 2008, P ROY SOC B-BIOL SCI, V275, P2131, DOI 10.1098/rspb.2008.0404; Koch RL, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.32; Lorenz MW, 2007, J INSECT PHYSIOL, V53, P819, DOI 10.1016/j.jinsphys.2007.03.011; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Ozanne SE, 2005, MECH AGEING DEV, V126, P852, DOI 10.1016/j.mad.2005.03.005; Pellegroms B, 2009, ECOL ENTOMOL, V34, P387, DOI 10.1111/j.1365-2311.2009.01090.x; Prasad NG, 2003, J GENET, V82, P45, DOI 10.1007/BF02715881; ROFF DA, 1990, ECOL MONOGR, V60, P389, DOI 10.2307/1943013; Roseboom TJ, 2000, HEART, V84, P595, DOI 10.1136/heart.84.6.595; ROWE L, 1991, ECOLOGY, V72, P413, DOI 10.2307/2937184; Saglam IK, 2008, J EVOLUTION BIOL, V21, P997, DOI 10.1111/j.1420-9101.2008.01548.x; Scharf I, 2009, OECOLOGIA, V160, P453, DOI 10.1007/s00442-009-1316-y; Scott DE, 2007, OECOLOGIA, V153, P521, DOI 10.1007/s00442-007-0755-6; Stevens DJ, 1999, P ROY SOC B-BIOL SCI, V266, P1049, DOI 10.1098/rspb.1999.0742; Stoks R, 2006, ECOLOGY, V87, P1566, DOI 10.1890/0012-9658(2006)87[1566:PCOCGI]2.0.CO;2; Zajitschek F, 2009, FUNCT ECOL, V23, P602, DOI 10.1111/j.1365-2435.2008.01520.x; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zera AJ, 2006, AM NAT, V167, P889, DOI 10.1086/503578	44	87	89	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17399	10.1371/journal.pone.0017399	http://dx.doi.org/10.1371/journal.pone.0017399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479211	Green Published, gold, Green Submitted			2022-12-27	WOS:000289055700011
J	Owen, AD; Hayward, RD; Koenig, HG; Steffens, DC; Payne, ME				Owen, Amy D.; Hayward, R. David; Koenig, Harold G.; Steffens, David C.; Payne, Martha E.			Religious Factors and Hippocampal Atrophy in Late Life	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; TEMPORAL-LOBE EPILEPSY; MAJOR DEPRESSION; CHRONIC STRESS; ALZHEIMER NEUROPATHOLOGY; GERIATRIC DEPRESSION; NEGATIVE INTERACTION; SYNAPTIC PLASTICITY; GESCHWIND-SYNDROME; PRELIMINARY SPECT	Despite a growing interest in the ways spiritual beliefs and practices are reflected in brain activity, there have been relatively few studies using neuroimaging data to assess potential relationships between religious factors and structural neuroanatomy. This study examined prospective relationships between religious factors and hippocampal volume change using high-resolution MRI data of a sample of 268 older adults. Religious factors assessed included life-changing religious experiences, spiritual practices, and religious group membership. Hippocampal volumes were analyzed using the GRID program, which is based on a manual point-counting method and allows for semi-automated determination of region of interest volumes. Significantly greater hippocampal atrophy was observed for participants reporting a life-changing religious experience. Significantly greater hippocampal atrophy was also observed from baseline to final assessment among born-again Protestants, Catholics, and those with no religious affiliation, compared with Protestants not identifying as born-again. These associations were not explained by psychosocial or demographic factors, or baseline cerebral volume. Hippocampal volume has been linked to clinical outcomes, such as depression, dementia, and Alzheimer's Disease. The findings of this study indicate that hippocampal atrophy in late life may be uniquely influenced by certain types of religious factors.	[Owen, Amy D.; Koenig, Harold G.] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA; [Hayward, R. David; Koenig, Harold G.; Steffens, David C.; Payne, Martha E.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Hayward, R. David; Payne, Martha E.] Duke Univ, Med Ctr, Neuropsychiat Imaging Res Lab, Durham, NC 27710 USA; [Koenig, Harold G.; Steffens, David C.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Owen, AD (corresponding author), Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA.	david.hayward@duke.edu	Hayward, R. David/A-8654-2009; Koenig, Harold G/F-7379-2011	Hayward, R. David/0000-0002-9845-6131; 	National Institutes of Health [MH54846, MH60451, MH70027]; John Templeton Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054846, P50MH060451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Templeton Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was funded by National Institutes of Health grants MH54846, MH60451, and MH70027, and the John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbotts J, 1997, SOC SCI MED, V45, P3, DOI 10.1016/S0277-9536(96)00302-4; Ai AL, 2004, J HEALTH PSYCHOL, V9, P435, DOI 10.1177/1359105304042352; Ai AL, 2010, J HEALTH PSYCHOL, V15, P186, DOI 10.1177/1359105309345556; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 2000, INT J PSYCHOL RELIG, DOI DOI 10.1207/S15327582IJPR1004_04; [Anonymous], 2008, US REL LANDSC SURV; Azari N.P., 2005, INT J PSYCHOL RELIG, V15, P263, DOI [10.1207/s15327582ijpr1504_1, DOI 10.1207/S15327582IJPR1504_]; Bast T, 2007, REV NEUROSCIENCE, V18, P253; Beauregard M, 2006, NEUROSCI LETT, V405, P186, DOI 10.1016/j.neulet.2006.06.060; Borg J, 2003, AM J PSYCHIAT, V160, P1965, DOI 10.1176/appi.ajp.160.11.1965; Britton WB, 2004, PSYCHOL SCI, V15, P254, DOI 10.1111/j.0956-7976.2004.00661.x; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Caetano SC, 2004, PSYCHIAT RES-NEUROIM, V132, P141, DOI 10.1016/j.psychresns.2004.08.002; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Collins M.L., 2008, HDB DEV COGNITIVE NE; Conrad CD, 2008, REV NEUROSCIENCE, V19, P395; Davidson RJ, 2000, PSYCHOL BULL, V126, P890, DOI 10.1037/0033-2909.126.6.890; DEWHURST K, 1970, BRIT J PSYCHIAT, V117, P497, DOI 10.1192/bjp.117.540.497; GEORGE LK, 1989, BRIT J PSYCHIAT, V154, P478, DOI 10.1192/bjp.154.4.478; GOLD PW, 1988, NEW ENGL J MED, V319, P348, DOI 10.1056/NEJM198808113190606; Gosche KM, 2002, NEUROLOGY, V58, P1476, DOI 10.1212/WNL.58.10.1476; Hampel H, 2008, ALZHEIMERS DEMENT, V4, P38, DOI 10.1016/j.jalz.2007.08.006; Han SH, 2008, SOC NEUROSCI-UK, V3, P1, DOI 10.1080/17470910701469681; Harris S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007272; Hays JC, 2001, AM J PSYCHIAT, V158, P1850, DOI 10.1176/appi.ajp.158.11.1850; HERZOG H, 1991, NEUROPSYCHOBIOLOGY, V23, P182, DOI 10.1159/000119450; Hickie I, 2005, BRIT J PSYCHIAT, V186, P197, DOI 10.1192/bjp.186.3.197; Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038; Idler EL, 2009, J GERONTOL B-PSYCHOL, V64, P528, DOI 10.1093/geronb/gbp028; Jack CR, 2000, NEUROLOGY, V55, P484, DOI 10.1212/WNL.55.4.484; Jarrard LE, 1995, BEHAV BRAIN RES, V71, P1, DOI 10.1016/0166-4328(95)00034-8; Jevning R, 1996, PHYSIOL BEHAV, V59, P399, DOI 10.1016/0031-9384(95)02006-3; Joels M, 2004, STRESS, V7, P221, DOI 10.1080/10253890500070005; Kapogiannis D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007180; Koenig HG, 2004, J AM GERIATR SOC, V52, P554, DOI 10.1111/j.1532-5415.2004.52161.x; Koenig HG, 2001, INT REV PSYCHIATR, V13, P67; Krause N, 2000, REV RELIG RES, V41, P510, DOI 10.2307/3512318; Krause N, 1998, J SCI STUD RELIG, V37, P725, DOI 10.2307/1388153; LANDFIELD PW, 1978, SCIENCE, V202, P1098, DOI 10.1126/science.715460; Lazar SW, 2000, NEUROREPORT, V11, P1581, DOI 10.1097/00001756-200005150-00041; Lou HC, 1999, HUM BRAIN MAPP, V7, P98; Luders E, 2009, NEUROIMAGE, V45, P672, DOI 10.1016/j.neuroimage.2008.12.061; Lupien SJ, 2005, J PSYCHIATR NEUROSCI, V30, P328; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; MACFALL JR, 1994, PSYCHIAT RES-NEUROIM, V55, P167, DOI 10.1016/0925-4927(94)90024-8; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Miller WR, 2003, AM PSYCHOL, V58, P24, DOI 10.1037/0003-066X.58.1.24; Model S, 2002, INT MIGR REV, V36, P1061; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Mortimer JA, 2004, NEUROLOGY, V62, P428, DOI 10.1212/01.WNL.0000106463.66966.65; Muller MB, 2001, EUR J NEUROSCI, V14, P1603, DOI 10.1046/j.0953-816x.2001.01784.x; Newberg A, 2003, PERCEPT MOTOR SKILL, V97, P625, DOI 10.2466/PMS.97.6.625-630; Newberg A, 2001, PSYCHIAT RES-NEUROIM, V106, P113, DOI 10.1016/S0925-4927(01)00074-9; Newberg AB, 2006, PSYCHIAT RES-NEUROIM, V148, P67, DOI 10.1016/j.pscychresns.2006.07.001; O'Brien JT, 2004, AM J PSYCHIAT, V161, P2081, DOI 10.1176/appi.ajp.161.11.2081; O'Reilly D, 2008, SOC SCI MED, V66, P1637, DOI 10.1016/j.socscimed.2007.12.004; Pargament KI, 2002, PSYCHOL INQ, V13, P168, DOI 10.1207/S15327965PLI1303_02; Pargament KI, 2001, ARCH INTERN MED, V161, P1881, DOI 10.1001/archinte.161.15.1881; Payne ME, 2002, PSYCHIAT RES-NEUROIM, V115, P63, DOI 10.1016/S0925-4927(02)00009-4; Pham K, 2003, EUR J NEUROSCI, V17, P879, DOI 10.1046/j.1460-9568.2003.02513.x; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Resnick SM, 2003, J NEUROSCI, V23, P3295; Rosenbrock H, 2005, BRAIN RES, V1040, P55, DOI 10.1016/j.brainres.2005.01.065; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Schjodt U, 2008, NEUROSCI LETT, V443, P165, DOI 10.1016/j.neulet.2008.07.068; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Steffens DC, 2000, BIOL PSYCHIAT, V48, P301, DOI 10.1016/S0006-3223(00)00829-5; Steffens DC, 2002, AM J GERIAT PSYCHIAT, V10, P62, DOI 10.1176/appi.ajgp.10.1.62; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; Trimble M, 2006, EPILEPSY BEHAV, V9, P407, DOI 10.1016/j.yebeh.2006.05.006; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; UNO H, 1989, J NEUROSCI, V9, P1705, DOI 10.1523/jneurosci.09-05-01705.1989; van Elst LT, 2003, EPILEPSY BEHAV, V4, P291, DOI 10.1016/S1525-5050(03)00084-2; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Wuerfel J, 2004, J NEUROL NEUROSUR PS, V75, P640, DOI 10.1136/jnnp.2003.06973	81	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17006	10.1371/journal.pone.0017006	http://dx.doi.org/10.1371/journal.pone.0017006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YK	21479219	Green Published, Green Submitted, gold			2022-12-27	WOS:000289055700008
J	Xia, X; Li, YW; Huang, DQ; Wang, ZY; Luo, LY; Song, Y; Zhao, LA; Wen, R				Xia, Xin; Li, Yiwen; Huang, Deqiang; Wang, Zhengying; Luo, Lingyu; Song, Ying; Zhao, Lian; Wen, Rong			Oncostatin M Protects Rod and Cone Photoreceptors and Promotes Regeneration of Cone Outer Segment in a Rat Model of Retinal Degeneration	PLOS ONE			English	Article							LEUKEMIA-INHIBITORY FACTOR; CILIARY NEUROTROPHIC FACTOR; PHOTOTRANSDUCTION MACHINERY; GROWTH-REGULATOR; TRANSGENIC RATS; EXPRESSION; CYTOKINES; RECEPTORS; CELLS; CARDIOTROPHIN-1	Retinitis pigmentosa (RP) is a group of photoreceptor degenerative disorders that lead to loss of vision. Typically, rod photoreceptors degenerate first, resulting in loss of night and peripheral vision. Secondary cone degeneration eventually affects central vision, leading to total blindness. Previous studies have shown that photoreceptors could be protected from degeneration by exogenous neurotrophic factors, including ciliary neurotrophic factor (CNTF), a member of the IL-6 family of cytokines. Using a transgenic rat model of retinal degeneration (the S334-ter rat), we investigated the effects of Oncostatin M (OSM), another member of the IL-6 family of cytokines, on photoreceptor protection. We found that exogenous OSM protects both rod and cone photoreceptors. In addition, OSM promotes regeneration of cone outer segments in early stages of cone degeneration. Further investigation showed that OSM treatment induces STAT3 phosphorylation in Muller cells but not in photoreceptors, suggesting that OSM not directly acts on photoreceptors and that the protective effects of OSM on photoreceptors are mediated by Muller cells. These findings support the therapeutic strategy using members of IL-6 family of cytokines for retinal degenerative disorders. They also provide evidence that activation of the STAT3 pathway in Muller cells promotes photoreceptor survival. Our work highlights the importance of Muller cell-photoreceptor interaction in the retina, which may serve as a model of glia-neuron interaction in general.	[Xia, Xin; Li, Yiwen; Huang, Deqiang; Wang, Zhengying; Luo, Lingyu; Wen, Rong] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Xia, Xin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Xia, Xin] Shanghai Key Lab Ocular Fundus Dis, Shanghai, Peoples R China; [Song, Ying; Zhao, Lian] Univ Penn, Sch Med, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Wen, Rong] Univ Miami, Miller Sch Med, Neurosci Program, Miami, FL 33136 USA	Bascom Palmer Eye Institute; University of Miami; Shanghai Jiao Tong University; University of Pennsylvania; University of Miami	Xia, X (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	rwen@med.miami.edu			National Institutes of Health [R01EY018586, P30EY14801]; Hope for Vision; James and Esther King Biomedical Research Program of the State of Florida; Department of Defense [W81XWH-09-1-0674]; Shanghai First People's Hospital; Shanghai Key Laboratory for Ocular Fundus Diseases; Chinese Scholarship Council; Research to Prevent Blindness Inc.; NATIONAL EYE INSTITUTE [R01EY018586, P30EY014801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Vision; James and Esther King Biomedical Research Program of the State of Florida; Department of Defense(United States Department of Defense); Shanghai First People's Hospital; Shanghai Key Laboratory for Ocular Fundus Diseases; Chinese Scholarship Council(China Scholarship Council); Research to Prevent Blindness Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from National Institutes of Health (R01EY018586 to RW, P30EY14801 to Bascom Palmer Eye Institute), Hope for Vision (RW), the James and Esther King Biomedical Research Program of the State of Florida (YL), and the Department of Defense (W81XWH-09-1-0674 to RW). Xin Xia was supported in part by grants and scholarships from Shanghai First People's Hospital, Shanghai Key Laboratory for Ocular Fundus Diseases, and Chinese Scholarship Council. Additional support was provided by an unrestricted grant from Research to Prevent Blindness Inc. to Bascom Palmer Eye Institute. The above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Bruce A. Gregory, 1992, Progress in Growth Factor Research, V4, P157, DOI 10.1016/0955-2235(92)90029-H; BRUCE AG, 1992, J IMMUNOL, V149, P1271; Chen SH, 2004, CYTOKINE GROWTH F R, V15, P379, DOI 10.1016/j.cytogfr.2004.06.002; Delyfer MN, 2004, BIOL CELL, V96, P261, DOI 10.1016/j.biolcel.2004.01.006; Ensoli F, 1999, J IMMUNOL, V162, P6268; Ensoli F, 2002, MULT SCLER J, V8, P284, DOI 10.1191/1352458502ms817oa; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; GEISTERFER M, 1995, CYTOKINE, V7, P503, DOI 10.1006/cyto.1995.0068; Grant SL, 1999, MOL MED TODAY, V5, P406, DOI 10.1016/S1357-4310(99)01540-3; Grotzinger J, 2002, BBA-MOL CELL RES, V1592, P215, DOI 10.1016/S0167-4889(02)00316-6; Hanisch A, 2000, J CLIN ENDOCR METAB, V85, P4411, DOI 10.1210/jc.85.11.4411; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Ito Y, 2000, NEUROCHEM RES, V25, P1113, DOI 10.1023/A:1007674113440; Jankowsky JL, 1999, EXP NEUROL, V159, P333, DOI 10.1006/exnr.1999.7137; Joly S, 2008, J NEUROSCI, V28, P13765, DOI 10.1523/JNEUROSCI.5114-08.2008; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; Li YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009495; Liu CD, 1999, J NEUROSCI, V19, P4778; Loy JK, 1999, TOXICOL PATHOL, V27, P151, DOI 10.1177/019262339902700201; MALIK N, 1989, MOL CELL BIOL, V9, P2847, DOI 10.1128/MCB.9.7.2847; Mata NL, 2010, CURR OPIN OPHTHALMOL, V21, P190, DOI 10.1097/ICU.0b013e32833866c8; Miyajima A, 2000, CYTOKINE GROWTH F R, V11, P177, DOI 10.1016/S1359-6101(00)00003-4; Moidunny S, 2010, J NEUROCHEM, V114, P1667, DOI 10.1111/j.1471-4159.2010.06881.x; Morikawa Y, 2004, J NEUROSCI, V24, P1941, DOI 10.1523/JNEUROSCI.4975-03.2004; RICHARDS CD, 1992, J IMMUNOL, V148, P1731; ROSE TM, 1991, P NATL ACAD SCI USA, V88, P8641, DOI 10.1073/pnas.88.19.8641; Rosell DR, 2003, NEUROSCIENCE, V122, P329, DOI 10.1016/S0306-4522(03)00593-1; Ruprecht K, 2001, J NEUROPATH EXP NEUR, V60, P1087, DOI 10.1093/jnen/60.11.1087; Sarup V, 2004, BRAIN RES, V1013, P152, DOI 10.1016/j.brainres.2004.03.030; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Song Y, 2003, INVEST OPHTH VIS SCI, V44, P4069, DOI 10.1167/iovs.02-1130; SPORENO E, 1994, CYTOKINE, V6, P255, DOI 10.1016/1043-4666(94)90021-3; TALCOTT KE, 2010, INVEST OPHTHALMOL VI; Wallace PM, 1999, J IMMUNOL, V162, P5547; Weiss TW, 2006, FASEB J, V20, P2369, DOI 10.1096/fj.06-5850fje; Wen R, 2008, ADV EXP MED BIOL, V613, P407, DOI 10.1007/978-0-387-74904-4_48; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739; Znoyko I, 2005, ANAT REC PART A, V283A, P182, DOI 10.1002/ar.a.20159	40	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18282	10.1371/journal.pone.0018282	http://dx.doi.org/10.1371/journal.pone.0018282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479182	Green Published, gold, Green Submitted			2022-12-27	WOS:000289055700043
J	Fujita, H; Toyokura, K; Okada, K; Kawaguchi, M				Fujita, Hironori; Toyokura, Koichi; Okada, Kiyotaka; Kawaguchi, Masayoshi			Reaction-Diffusion Pattern in Shoot Apical Meristem of Plants	PLOS ONE			English	Article							STEM-CELL HOMEOSTASIS; LASER-ABLATION ANALYSIS; ARABIDOPSIS; WUSCHEL; CLAVATA3; KINASE; GROWTH; MODEL; CLV3; GENE	A fundamental question in developmental biology is how spatial patterns are self-organized from homogeneous structures. In 1952, Turing proposed the reaction-diffusion model in order to explain this issue. Experimental evidence of reaction-diffusion patterns in living organisms was first provided by the pigmentation pattern on the skin of fishes in 1995. However, whether or not this mechanism plays an essential role in developmental events of living organisms remains elusive. Here we show that a reaction-diffusion model can successfully explain the shoot apical meristem (SAM) development of plants. SAM of plants resides in the top of each shoot and consists of a central zone (CZ) and a surrounding peripheral zone (PZ). SAM contains stem cells and continuously produces new organs throughout the lifespan. Molecular genetic studies using Arabidopsis thaliana revealed that the formation and maintenance of the SAM are essentially regulated by the feedback interaction between WUSHCEL (WUS) and CLAVATA (CLV). We developed a mathematical model of the SAM based on a reaction-diffusion dynamics of the WUS-CLV interaction, incorporating cell division and the spatial restriction of the dynamics. Our model explains the various SAM patterns observed in plants, for example, homeostatic control of SAM size in the wild type, enlarged or fasciated SAM in clv mutants, and initiation of ectopic secondary meristems from an initial flattened SAM in wus mutant. In addition, the model is supported by comparing its prediction with the expression pattern of WUS in the wus mutant. Furthermore, the model can account for many experimental results including reorganization processes caused by the CZ ablation and by incision through the meristem center. We thus conclude that the reaction-diffusion dynamics is probably indispensable for the SAM development of plants.	[Fujita, Hironori; Kawaguchi, Masayoshi] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Symbiot Syst, Okazaki, Aichi 4448585, Japan; [Toyokura, Koichi; Okada, Kiyotaka] Natl Inst Nat Sci, Natl Inst Basic Biol, Lab Plant Organ Dev, Okazaki, Aichi 4448585, Japan; [Toyokura, Koichi] Kyoto Univ, Dept Bot, Grad Sch Sci, Kyoto, Japan; [Kawaguchi, Masayoshi] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Sch Life Sci, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Kyoto University; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Fujita, H (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Div Symbiot Syst, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	hfujita@nibb.ac.jp		Kawaguchi, Masayoshi/0000-0002-1032-6261; Fujita, Hironori/0000-0003-4916-2994; Toyokura, Koichi/0000-0001-7775-7886	Ministry of Education, Culture, Sports, Science and Technology of Japan [21027011]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid Science Research on Priority Areas (Grant No. 21027011) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; CLARK SE, 1993, DEVELOPMENT, V119, P397; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, PLANT CELL, V9, P1067, DOI 10.1105/tpc.9.7.1067; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; Gross-Hardt R, 2002, GENE DEV, V16, P1129, DOI 10.1101/gad.225202; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Hohm T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009189; Holloway DM, 2010, BIOCHEM SOC T, V38, P645, DOI 10.1042/BST0380645; Jonsson H, 2005, BIOINFORMATICS, V21, pI232, DOI 10.1093/bioinformatics/bti1036; Kinoshita A, 2010, DEVELOPMENT, V137, P3911, DOI 10.1242/dev.048199; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Kondo S, 2009, INT J DEV BIOL, V53, P851, DOI 10.1387/ijdb.072502sk; Laux T, 1996, DEVELOPMENT, V122, P87; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lenhard M, 2003, DEVELOPMENT, V130, P3163, DOI 10.1242/dev.00525; Lyndon RF, 1998, SHOOT APICAL MERISTE; Madzvamuse A, 2003, J COMPUT PHYS, V190, P478, DOI 10.1016/S0021-9991(03)00294-8; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Meinhardt H., 1995, ALGORITHMIC BEAUTY S; Meinhardt H., 1982, MODELS BIOL PATTERN; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Mordhorst AP, 1998, GENETICS, V149, P549; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Murray JD, 2003, MATH BIOL, V3; Nikolaev S. V., 2007, Russian Journal of Developmental Biology, V38, P383, DOI 10.1134/S1062360407060069; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Reddy GV, 2008, CURR OPIN PLANT BIOL, V11, P88, DOI 10.1016/j.pbi.2007.10.012; Reddy GV, 2005, SCIENCE, V310, P663, DOI 10.1126/science.1116261; Reinhardt D, 2005, DEVELOPMENT, V132, P15, DOI 10.1242/dev.01544; Reinhardt D, 2003, DEVELOPMENT, V130, P4073, DOI 10.1242/dev.00596; Rieu I, 2009, SEMIN CELL DEV BIOL, V20, P1083, DOI 10.1016/j.semcdb.2009.09.013; Sablowski R, 2007, CURR OPIN PLANT BIOL, V10, P639, DOI 10.1016/j.pbi.2007.07.001; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Shoji H, 2003, J THEOR BIOL, V224, P339, DOI 10.1016/S0022-5193(03)00170-X; Stahl Y, 2010, CURR OPIN PLANT BIOL, V13, P53, DOI 10.1016/j.pbi.2009.09.008; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vidaurre DP, 2007, DEVELOPMENT, V134, P2561, DOI 10.1242/dev.006759; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Wu XL, 2005, CURR BIOL, V15, P436, DOI 10.1016/j.cub.2004.12.079; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Zhao Z, 2010, NATURE, V465, P1089, DOI 10.1038/nature09126	47	36	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18243	10.1371/journal.pone.0018243	http://dx.doi.org/10.1371/journal.pone.0018243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479227	Green Published, gold, Green Submitted			2022-12-27	WOS:000289054600036
J	Vial, F; Johnston, WT; Donnelly, CA				Vial, Flavie; Johnston, W. Thomas; Donnelly, Christl A.			Local Cattle and Badger Populations Affect the Risk of Confirmed Tuberculosis in British Cattle Herds	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS INFECTIONS; REPUBLIC-OF-IRELAND; HUSBANDRY PRACTICES; WILD BOAR; ENGLAND; ASSOCIATION; BREAKDOWNS; FARMS; EPIDEMIOLOGY; STRATEGIES	Background: The control of bovine tuberculosis (bTB) remains a priority on the public health agenda in Great Britain, after launching in 1998 the Randomised Badger Culling Trial (RBCT) to evaluate the effectiveness of badger (Meles meles) culling as a control strategy. Our study complements previous analyses of the RBCT data (focusing on treatment effects) by presenting analyses of herd-level risks factors associated with the probability of a confirmed bTB breakdown in herds within each treatment: repeated widespread proactive culling, localized reactive culling and no culling (survey-only). Methodology/Principal Findings: New cases of bTB breakdowns were monitored inside the RBCT areas from the end of the first proactive badger cull to one year after the last proactive cull. The risk of a herd bTB breakdown was modeled using logistic regression and proportional hazard models adjusting for local farm-level risk factors. Inside survey-only and reactive areas, increased numbers of active badger setts and cattle herds within 1500 m of a farm were associated with an increased bTB risk. Inside proactive areas, the number of M. bovis positive badgers initially culled within 1500 m of a farm was the strongest predictor of the risk of a confirmed bTB breakdown. Conclusions/Significance: The use of herd-based models provide insights into how local cattle and badger populations affect the bTB breakdown risks of individual cattle herds in the absence of and in the presence of badger culling. These measures of local bTB risks could be integrated into a risk-based herd testing programme to improve the targeting of interventions aimed at reducing the risks of bTB transmission.	[Vial, Flavie; Donnelly, Christl A.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England; [Johnston, W. Thomas] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	Imperial College London; University of York - UK	Vial, F (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England.	f.vial@imperial.ac.uk		Vial, Flavie/0000-0003-3603-4694; Johnston, Tom/0000-0002-5204-0966; Donnelly, Christl/0000-0002-0195-2463	U.K. Department of Environment, Food and Rural Affairs (Defra); U.K. Medical Research Council (MRC); Medical Research Council [G0600719B] Funding Source: researchfish	U.K. Department of Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); U.K. Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors gratefully acknowledge the support of the U.K. Department of Environment, Food and Rural Affairs (Defra; http://www.defra.gov.uk/index.htm) for this work. CAD thanks the U.K. Medical Research Council (MRC; http://www.mrc.ac.uk/index.htm) for Centre funding. The funders had no role in the design of the analyses, data analysis, decision to publish, or preparation (drafting, editing or finalizing) of the manuscript. The Randomised Badger Culling Trial (RBCT) was implemented by the staff of Defra and its associated agencies. Defra funds the ongoing collection and storage of routine surveillance data which were utilized in this study. Defra officials commented on a near-final draft of this manuscript.	Allen AR, 2010, P ROY SOC B-BIOL SCI, V277, P2737, DOI 10.1098/rspb.2010.0830; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Bourne F., 2007, BOVINE TUBERCULOSIS; CHEESEMAN CL, 1989, EPIDEMIOL INFECT, V103, P113, DOI 10.1017/S0950268800030417; COLEMAN J, 2000, BRUSHTAIL POSSUM BIO; Defra, 2010, BOV TUB GOV APPR TAC; *DEFRA, 2009, BOV TB STAT GREAT BR; Denny GO, 1999, VET REC, V144, P305, DOI 10.1136/vr.144.12.305; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; DONNELLY CA, 2010, PLOS ONE COMMENT; Donnelly CA, 2007, INT J INFECT DIS, V11, P300, DOI 10.1016/j.ijid.2007.04.001; Etter E, 2006, ANN NY ACAD SCI, V1081, P61, DOI 10.1196/annals.1373.006; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Gopal R, 2006, VET REC, V159, P265, DOI 10.1136/vr.159.9.265; Green LE, 2005, PREV VET MED, V70, P293, DOI 10.1016/j.prevetmed.2005.05.005; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; GRIFFIN JM, 1993, PREV VET MED, V17, P145, DOI 10.1016/0167-5877(93)90025-O; Griffin JM, 1996, PREV VET MED, V27, P217, DOI 10.1016/0167-5877(95)00571-4; Hone J, 2008, J APPL ECOL, V45, P1660, DOI 10.1111/j.1365-2664.2008.01556.x; Humblet MF, 2009, VET RES, V40, DOI 10.1051/vetres/2009033; Jenkins HE, 2007, J APPL ECOL, V44, P897, DOI 10.1111/j.1365-2664.2007.01372.x; Jenkins HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009090; Johnston WT, 2005, BIOL LETT-UK, V1, P53, DOI 10.1098/rsbl.2004.0249; Kaneene JB, 2002, J AM VET MED ASSOC, V221, P837, DOI 10.2460/javma.2002.221.837; Krebs J., 1997, PB3423 HMSO; LEFEVRE AM, 2005, IMPACT LOCALISED REA; Marangon S, 1998, PREV VET MED, V34, P87, DOI 10.1016/S0167-5877(97)00087-1; Martin SW, 1997, PREV VET MED, V31, P113, DOI 10.1016/S0167-5877(96)01111-7; Menzies FD, 2000, VET J, V160, P92, DOI 10.1053/tvjl.2000.0482; Michel AL, 2007, BMC VET RES, V3, P23, DOI DOI 10.1186/1746-6148-3-23; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Nishi JS, 2006, VET MICROBIOL, V112, P325, DOI 10.1016/j.vetmic.2005.11.013; Olea-Popelka FJ, 2004, PREV VET MED, V63, P163, DOI 10.1016/j.prevetmed.2004.03.001; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Payeur JB, 2002, ANN NY ACAD SCI, V969, P259, DOI 10.1111/j.1749-6632.2002.tb04389.x; Porphyre T, 2008, PREV VET MED, V86, P93, DOI 10.1016/j.prevetmed.2008.03.008; PROUD AJ, 2006, GOVT VET J, V16; Ramirez-Villaescusa AM, 2010, PREV VET MED, V95, P224, DOI 10.1016/j.prevetmed.2010.03.009; Reilly LA, 2007, PREV VET MED, V80, P129, DOI 10.1016/j.prevetmed.2007.02.002; Richomme C, 2010, J WILDLIFE DIS, V46, P627, DOI 10.7589/0090-3558-46.2.627; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Thoen C, 2006, VET MICROBIOL, V112, P339, DOI 10.1016/j.vetmic.2005.11.047; White PCL, 2004, PREV VET MED, V63, P1, DOI 10.1016/j.prevetmed.2004.02.003; Woodroffe R, 2008, J ZOOL, V274, P28, DOI 10.1111/j.1469-7998.2007.00353.x; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x; WOODROFFE R, 2003, CONSERVATION CONFLIC; Woodroffe R, 2006, P NATL ACAD SCI USA, V103, P14713, DOI 10.1073/pnas.0606251103; Woodroffe R, 2009, J WILDLIFE DIS, V45, P128, DOI 10.7589/0090-3558-45.1.128	49	26	26	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18058	10.1371/journal.pone.0018058	http://dx.doi.org/10.1371/journal.pone.0018058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464920	Green Published, Green Submitted, gold			2022-12-27	WOS:000289053800019
J	Fraser, ON; Bugnyar, T				Fraser, Orlaith N.; Bugnyar, Thomas			Ravens Reconcile after Aggressive Conflicts with Valuable Partners	PLOS ONE			English	Article							POSTCONFLICT AFFILIATION; CONVERGENT EVOLUTION; CORVUS-FRUGILEGUS; SCRUB-JAYS; CHIMPANZEES; PRIMATES; RESOLUTION; INTELLIGENCE; CONSOLATION; CORVIDS	Reconciliation, a post-conflict affiliative interaction between former opponents, is an important mechanism for reducing the costs of aggressive conflict in primates and some other mammals as it may repair the opponents' relationship and reduce post-conflict distress. Opponents who share a valuable relationship are expected to be more likely to reconcile as for such partners the benefits of relationship repair should outweigh the risk of renewed aggression. In birds, however, post-conflict behavior has thus far been marked by an apparent absence of reconciliation, suggested to result either from differing avian and mammalian strategies or because birds may not share valuable relationships with partners with whom they engage in aggressive conflict. Here, we demonstrate the occurrence of reconciliation in a group of captive subadult ravens (Corvus corax) and show that it is more likely to occur after conflicts between partners who share a valuable relationship. Furthermore, former opponents were less likely to engage in renewed aggression following reconciliation, suggesting that reconciliation repairs damage caused to their relationship by the preceding conflict. Our findings suggest not only that primate-like valuable relationships exist outside the pair bond in birds, but that such partners may employ the same mechanisms in birds as in primates to ensure that the benefits afforded by their relationships are maintained even when conflicts of interest escalate into aggression. These results provide further support for a convergent evolution of social strategies in avian and mammalian species.	[Fraser, Orlaith N.; Bugnyar, Thomas] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Bugnyar, Thomas] Konrad Lorenz Forschungstelle, Grunau, Austria	University of Vienna	Fraser, ON (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	orlaith.fraser@univie.ac.at			European Science Fund [ESF-COCOR: I-105-G11]; Austrian Science Fund [FWF-START: Y366-B17]; FWF-Erwin-Schrodinger [J2064, J2225, R31-B03]; Austrian Science Fund (FWF) [Y 366] Funding Source: researchfish	European Science Fund; Austrian Science Fund(Austrian Science Fund (FWF)); FWF-Erwin-Schrodinger(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by grants from the European Science Fund (ESF-COCOR: I-105-G11) and the Austrian Science Fund (FWF-START: Y366-B17; FWF-Erwin-Schrodinger J2064, J2225 and R31-B03) to TB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, LME4 LINEAR MIXED EF; Arnold K., 2010, PRIMATES PERSPECTIVE, V2, P608; Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; Aureli F., 2000, NATURAL CONFLICT RES; Boarman W. I., 1999, BIRDS N AM, V476; Bugnyar T, 2002, ANIM BEHAV, V64, P185, DOI 10.1006/anbe.2002.3056; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Colmenares F, 2006, INT J PRIMATOL, V27, P1311, DOI 10.1007/s10764-006-9080-x; Cools AKA, 2008, ETHOLOGY, V114, P53, DOI 10.1111/j.1439-0310.2007.01443.x; Cordoni G, 2008, ETHOLOGY, V114, P298, DOI 10.1111/j.1439-0310.2008.01474.x; Cords M., 2000, NATURAL CONFLICT RES, P177; COZZI A, 2010, BEHAV PROCESS; De Waal, 1989, PEACEMAKING PRIMATES; de Waal F.B.M., 1986, P341; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Dunbar RIM, 2010, BEHAVIOUR, V147, P775, DOI 10.1163/000579510X501151; Emery N. J., 2004, COMP ANAL MINDS, P181, DOI DOI 10.1098/RSTB.2006.1991; Emery NJ, 2007, PHILOS T R SOC B, V362, P489, DOI 10.1098/rstb.2006.1991; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Fraser ON, 2008, AM J PRIMATOL, V70, P1114, DOI 10.1002/ajp.20608; Fraser ON, 2008, ETHOLOGY, V114, P834, DOI 10.1111/j.1439-0310.2008.01527.x; Fraser ON, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010605; Fraser ON, 2010, ANIM BEHAV, V79, P927, DOI 10.1016/j.anbehav.2010.01.008; KAPPELER PM, 1992, ETHOLOGY, V92, P51; Raby CR, 2007, NATURE, V445, P919, DOI 10.1038/nature05575; Ratcliffe DA., 1997, RAVEN; Schino Gabriele, 2000, P225; Seed A, 2009, ETHOLOGY, V115, P401, DOI 10.1111/j.1439-0310.2009.01644.x; Seed AM, 2008, P ROY SOC B-BIOL SCI, V275, P1421, DOI 10.1098/rspb.2008.0111; Seed AM, 2007, CURR BIOL, V17, P152, DOI 10.1016/j.cub.2006.11.025; Silk JB, 2000, NATURAL CONFLICT RES, P179; VEENEMA HC, 1994, BEHAV PROCESS, V31, P29, DOI 10.1016/0376-6357(94)90035-3; VONBLOTZHEIM UNG, 1993, HDB VOGEL MITTELEURO, V13, P600; Wahaj SA, 2001, ETHOLOGY, V107, P1057, DOI 10.1046/j.1439-0310.2001.00717.x; Watts DP, 2006, INT J PRIMATOL, V27, P1337, DOI 10.1007/s10764-006-9081-9; WEIR AAS, 2002, SHAPING HOOKS NEW CA, P981	40	67	68	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18118	10.1371/journal.pone.0018118	http://dx.doi.org/10.1371/journal.pone.0018118			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464962	Green Submitted, Green Published, gold			2022-12-27	WOS:000288813900039
J	Piras, F; Coull, JT				Piras, Federica; Coull, Jennifer T.			Implicit, Predictive Timing Draws upon the Same Scalar Representation of Time as Explicit Timing	PLOS ONE			English	Article							TEMPORAL INFORMATION; DURATION DISCRIMINATION; NEURONAL-ACTIVITY; NEURAL-NETWORK; MOTOR CONTROL; HUMAN BRAIN; INTERVALS; PERCEPTION; ATTENTION; TASKS	It is not yet known whether the scalar properties of explicit timing are also displayed by more implicit, predictive forms of timing. We investigated whether performance in both explicit and predictive timing tasks conformed to the two psychophysical properties of scalar timing: the Psychophysical law and Weber's law. Our explicit temporal generalization task required overt estimation of the duration of an empty interval bounded by visual markers, whereas our temporal expectancy task presented visual stimuli at temporally predictable intervals, which facilitated motor preparation thus speeding target detection. The Psychophysical Law and Weber's Law were modeled, respectively, by (1) the functional dependence between mean subjective time and real time (2) the linearity of the relationship between timing variability and duration. Results showed that performance for predictive, as well as explicit, timing conformed to both psychophysical properties of interval timing. Both tasks showed the same linear relationship between subjective and real time, demonstrating that the same representational mechanism is engaged whether it is transferred into an overt estimate of duration or used to optimise sensorimotor behavior. Moreover, variability increased with increasing duration during both tasks, consistent with a scalar representation of time in both predictive and explicit timing. However, timing variability was greater during predictive timing, at least for durations greater than 200 msec, and ascribable to temporal, rather than non-temporal, mechanisms engaged by the task. These results suggest that although the same internal representation of time was used in both tasks, its external manifestation varied as a function of temporal task goals.	[Piras, Federica] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, D-72074 Tubingen, Germany; [Piras, Federica] Santa Lucia Fdn, Rome, Italy; [Coull, Jennifer T.] CNRS, Lab Neurobiol Cognit, Marseille, France; [Coull, Jennifer T.] Univ Aix Marseille 1, Marseille, France	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; IRCCS Santa Lucia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Piras, F (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, D-72074 Tubingen, Germany.	PirasFPhD@gmail.com	Coull, Jennifer T/M-4243-2015; Piras, Federica/AAC-4768-2022; Piras, Fabrizio/M-7902-2016	Coull, Jennifer T/0000-0002-8790-5835; Piras, Federica/0000-0002-9546-7038; Piras, Fabrizio/0000-0003-3566-5494	European Commission [PITN-G-2008-214570, ANR-07-NEURO-033-01]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by a European Commission three-year fellowship (PITN-G-2008-214570) awarded to FP and by grant ANR-07-NEURO-033-01 awarded to JTC. The funders had no role in study design, data collection and analysis, decision to publush, or preparation of the manuscript.	ALEGRIA J, 1975, ATTENTION PERFORMANC; ALLAN LG, 1979, PERCEPT PSYCHOPHYS, V26, P340, DOI 10.3758/BF03204158; ALLAN LG, 1983, PERCEPT PSYCHOPHYS, V33, P29, DOI 10.3758/BF03205863; ALLAN LG, 1994, FECHNER DAY 94 P 19, P24; Barnes R, 2000, COGNITIVE PSYCHOL, V41, P254, DOI 10.1006/cogp.2000.0738; Bausenhart KM, 2010, VISION RES, V50, P1025, DOI 10.1016/j.visres.2010.03.011; Bengtsson SL, 2005, EUR J NEUROSCI, V22, P3255, DOI 10.1111/j.1460-9568.2005.04517.x; Beudel M, 2009, NEUROIMAGE, V44, P1032, DOI 10.1016/j.neuroimage.2008.09.028; Block RA, 1997, PSYCHON B REV, V4, P184, DOI 10.3758/BF03209393; Bueti D, 2008, J COGNITIVE NEUROSCI, V20, P1054, DOI 10.1162/jocn.2008.20060; Bueti D, 2010, J NEUROSCI, V30, P4343, DOI 10.1523/JNEUROSCI.2254-09.2010; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; CHURCH RM, 1984, ANN NY ACAD SCI, V423, P566, DOI 10.1111/j.1749-6632.1984.tb23459.x; Correa A, 2006, EXP BRAIN RES, V169, P58, DOI 10.1007/s00221-005-0131-x; Correa A, 2005, PSYCHON B REV, V12, P328, DOI 10.3758/BF03196380; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Coull JT, 2001, CEREB CORTEX, V11, P73, DOI 10.1093/cercor/11.1.73; Coull JT, 1998, J NEUROSCI, V18, P7426; CREELMAN CD, 1962, J ACOUST SOC AM, V34, P582, DOI 10.1121/1.1918172; Dreher JC, 2002, NEUROIMAGE, V17, P95, DOI 10.1006/nimg.2002.1169; Durstewitz D, 2004, NEUROREPORT, V15, P745, DOI 10.1097/00001756-200404090-00001; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Ferrara A, 1997, Q J EXP PSYCHOL-B, V50, P217; Fraisse P, 1963, PSYCHOL TIME; Gallistel C. R., 1990, ORG LEARNING; GETTY DJ, 1975, PERCEPT PSYCHOPHYS, V18, P1, DOI 10.3758/BF03199358; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; GIBBON J, 1986, PSYCHOL LEARN MOTIV, V20, P105; GIBBON J, 1991, LEARN MOTIV, V22, P3, DOI 10.1016/0023-9690(91)90015-Z; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; GIBBON J, 1992, J MATH PSYCHOL, V36, P283, DOI 10.1016/0022-2496(92)90041-5; GOLDSTONE S, 1979, PSYCHOPHARMACOLOGY, V65, P119, DOI 10.1007/BF00433037; Grondin S., 2001, Acoustical Science and Technology, V22, P370, DOI 10.1250/ast.22.370; Grondin S, 2001, PERCEPT PSYCHOPHYS, V63, P1214, DOI 10.3758/BF03194535; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Hazeltine E, 1997, BRAIN, V120, P123, DOI 10.1093/brain/120.1.123; IVRY R, 1993, VARIABILITY AND MOTOR CONTROL, P415; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Jantzen KJ, 2005, NEUROIMAGE, V25, P1031, DOI 10.1016/j.neuroimage.2004.12.029; Jantzen KJ, 2004, P NATL ACAD SCI USA, V101, P6815, DOI 10.1073/pnas.0401300101; Joiner WM, 2009, J COMPUT NEUROSCI, V26, P119, DOI 10.1007/s10827-008-0102-x; Jones CRG, 2008, BRAIN COGNITION, V68, P30, DOI 10.1016/j.bandc.2008.02.121; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; KARLIN L, 1959, J EXP PSYCHOL, V58, P185, DOI 10.1037/h0049152; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; Kilavik BE, 2010, J NEUROPHYSIOL, V104, P2338, DOI 10.1152/jn.00250.2010; KILLEEN PR, 1992, NATO ADV SCI INST SE, V66, P203; KRISTOFFERSON AB, 1980, PERCEPT PSYCHOPHYS, V27, P300, DOI 10.3758/BF03206118; KRISTOFFERSON AB, 1977, PERCEPT PSYCHOPHYS, V21, P105, DOI 10.3758/BF03198714; Lange K, 2003, PSYCHOPHYSIOLOGY, V40, P806, DOI 10.1111/1469-8986.00081; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Macar F, 1999, EXP BRAIN RES, V125, P271, DOI 10.1007/s002210050683; Merchant H, 2008, J NEUROPHYSIOL, V99, P939, DOI 10.1152/jn.01225.2007; Merchant H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003169; Muller-Gethmann H, 2003, PSYCHOPHYSIOLOGY, V40, P597, DOI 10.1111/1469-8986.00061; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Nobre AC, 2001, NEUROPSYCHOLOGIA, V39, P1317; O'Reilly JX, 2008, J NEUROSCI, V28, P2252, DOI 10.1523/JNEUROSCI.2742-07.2008; Olson IR, 2001, J EXP PSYCHOL LEARN, V27, P1299, DOI 10.1037/0278-7393.27.5.1299; Pfeuty M, 2003, EXP BRAIN RES, V151, P372, DOI 10.1007/s00221-003-1505-6; Pouthas V, 2000, HUM BRAIN MAPP, V10, P49, DOI 10.1002/(SICI)1097-0193(200006)10:2<49::AID-HBM10>3.0.CO;2-8; Praamstra P, 2006, J NEUROSCI, V26, P5448, DOI 10.1523/JNEUROSCI.0440-06.2006; RAMMSAYER TH, 1991, PERCEPT PSYCHOPHYS, V50, P565, DOI 10.3758/BF03207541; Rammsayer TH, 2004, PSYCHOL RES-PSYCH FO, V69, P115, DOI 10.1007/s00426-003-0164-3; Rammsayer TH, 1999, Q J EXP PSYCHOL-B, V52, P273; Renoult L, 2006, EUR J NEUROSCI, V23, P3098, DOI 10.1111/j.1460-9568.2006.04824.x; Reutimann J, 2004, J NEUROSCI, V24, P3295, DOI 10.1523/JNEUROSCI.4098-03.2004; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; RUCHKIN DS, 1977, PSYCHOPHYSIOLOGY, V14, P451, DOI 10.1111/j.1469-8986.1977.tb01311.x; Sanders A.F., 1998, ELEMENTS HUMAN PERFO, DOI 10.4324/9780203774250; Shih LYL, 2009, NEUROREPORT, V20, P897, DOI 10.1097/WNR.0b013e3283270b6e; Snedecor G.W., 1989, AMES IOWA STATE U PR; Spencer RMC, 2003, J MOTOR BEHAV, V35, P371, DOI 10.1080/00222890309603157; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; Tandonnet C, 2003, CLIN NEUROPHYSIOL, V114, P2376, DOI 10.1016/S1388-2457(03)00253-0; TREISMAN M, 1963, PSYCHOL MONGR, V77; Vidalaki VN, 1999, NEUROPSYCHOLOGIA, V37, P1061, DOI 10.1016/S0028-3932(98)00155-9; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Wearden JH, 2008, Q J EXP PSYCHOL, V61, P569, DOI 10.1080/17470210701282576; Wearden JH, 2003, BEHAV PROCESS, V61, P47, DOI 10.1016/S0376-6357(02)00159-6; Wiener M, 2010, NEUROPSYCHOLOGIA, V48, P3967, DOI 10.1016/j.neuropsychologia.2010.09.014; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Zelaznik HN, 2000, J MOTOR BEHAV, V32, P193, DOI 10.1080/00222890009601370; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575	93	48	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18203	10.1371/journal.pone.0018203	http://dx.doi.org/10.1371/journal.pone.0018203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	740SE	21464972	Green Published, Green Submitted, gold			2022-12-27	WOS:000288813900051
J	Arizono, N; Yamada, M; Tegoshi, T; Takaoka, Y; Ohta, M; Sakaeda, T				Arizono, Naoki; Yamada, Minoru; Tegoshi, Tatsuya; Takaoka, Yutaka; Ohta, Mika; Sakaeda, Toshiyuki			Hsp12.6 Expression Is Inducible by Host Immunity in Adult Worms of the Parasitic Nematode Nippostrongylus brasiliensis	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; MAST-CELLS; INDEPENDENT EXPRESSION; INTESTINAL EPITHELIUM; C-ELEGANS; INFECTION; LONGEVITY; DAF-16; GENE; MIGRATION	Heat shock proteins (Hsp) are a family of stress-inducible molecular chaperones that play multiple roles in a wide variety of animals. However, the roles of Hsps in parasitic nematodes remain largely unknown. To elucidate the roles of Hsps in the survival and longevity of nematodes, particularly at the 2 most critical stages in their lifecycle, the infective-L3 stage and adult stage, which is subjected to host-derived immunological pressure, we examined the temporal gene transcription patterns of Hsp12.6, Hsp20, Hsp70, and Hsp90 throughout the developmental course of the nematode Nippostrongylus brasiliensis by reverse transcriptase real-time PCR. Nb-Hsp70 and Nb-Hsp90 expression were observed throughout the nematode's lifecycle, while the expression of Nb-Hsp20 was restricted to adults. Interestingly, Nb-Hsp12.6 showed a biphasic temporal expression pattern; i.e., it was expressed in infective-L3 larvae and in adults during worm expulsion from immunocompetent rats. However, the activation of Nb-Hsp12.6 in adult worms was aborted when they infected permissive athymic-rnu/rnu rats and was only marginal when they infected mast-cell-deficient Ws/Ws rats, which exhibited a low response of rat mast cell protease (RMCP) II and resistin-like molecule (Relm)- beta expression compared to those observed in immunocompetent rats. Moreover, the activation of Nb-Hsp12.6 was reversed when adult worms were transplanted into the naive rat intestine. These features of Nb-Hsp12.6, the expression of which is not only stage-specific in infective-L3, but is also inducible by mucosal immunity in adults, have implications for the survival strategies of parasitic nematodes in deleterious environmental conditions both outside and inside the host.	[Arizono, Naoki; Yamada, Minoru; Tegoshi, Tatsuya] Kyoto Prefectural Univ Med, Dept Med Zool, Kyoto, Japan; [Takaoka, Yutaka; Ohta, Mika] Kobe Univ, Div Appl Genome Sci & Bioinformat, Grad Sch Med, Kobe, Hyogo 657, Japan; [Sakaeda, Toshiyuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Frontier Educ Ctr, Ctr Integrat Educ Pharm Frontier, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kobe University; Kyoto University	Arizono, N (corresponding author), Kyoto Prefectural Univ Med, Dept Med Zool, Kyoto, Japan.	arizonon@koto.kpu-m.ac.jp			Japan Society for the Promotion of Science [20659064]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research #20659064 from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	ARIZONO N, 1993, BLOOD, V81, P2572; Artis D, 2008, MUCOSAL IMMUNOL, V1, P252, DOI 10.1038/mi.2008.21; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; BLAXTER ML, 1994, MOL BIOCHEM PARASIT, V68, P1, DOI 10.1016/0166-6851(94)00127-8; Castelletto ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000370; Cherkasova V, 2000, J MOL BIOL, V300, P433, DOI 10.1006/jmbi.2000.3880; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; Devaney E, 2005, INT J PARASITOL, V35, P627, DOI 10.1016/j.ijpara.2005.01.007; Eswar N., 2006, CURR PROT BIOINF, V15, P1, DOI [10.1002/0471250953.bi0506s15, DOI 10.1002/0471250953.BI0506S15]; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Gao X, 2009, INT J PARASITOL, V39, P407, DOI 10.1016/j.ijpara.2008.09.005; Gnanasekar M, 2008, MOL BIOCHEM PARASIT, V159, P98, DOI 10.1016/j.molbiopara.2008.02.010; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Hartman D, 2003, EXP PARASITOL, V104, P96, DOI 10.1016/S0014-4894(03)00138-3; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Hu M, 2010, INT J PARASITOL, V40, P405, DOI 10.1016/j.ijpara.2009.09.005; Huot J, 1996, CANCER RES, V56, P273; JAKOB U, 1994, TRENDS BIOCHEM SCI, V19, P205, DOI 10.1016/0968-0004(94)90023-X; Jones LM, 2010, J PROTEOME RES, V9, P2871, DOI 10.1021/pr9009639; Jones SJM, 2001, GENOME RES, V11, P1346, DOI 10.1101/gr.184401; Kawai Y, 2007, APMIS, V115, P210, DOI 10.1111/j.1600-0463.2007.apm_510.x; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KITAMURA Y, 1993, AM J MED SCI, V306, P185, DOI 10.1097/00000441-199309000-00011; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Lawrence CE, 2003, PARASITE IMMUNOL, V25, P271, DOI 10.1046/j.1365-3024.2003.00630.x; Leroux MR, 1997, J BIOL CHEM, V272, P24646, DOI 10.1074/jbc.272.39.24646; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Massey HC, 2006, INT J PARASITOL, V36, P347, DOI 10.1016/j.ijpara.2005.11.007; NAWA Y, 1994, PARASITE IMMUNOL, V16, P333, DOI 10.1111/j.1365-3024.1994.tb00358.x; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Newton-Howes J, 2006, INT J PARASITOL, V36, P467, DOI 10.1016/j.ijpara.2005.12.001; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Nishida M, 1999, APMIS, V107, P929, DOI 10.1111/j.1699-0463.1999.tb01493.x; Ogawa A, 2009, CURR BIOL, V19, P67, DOI 10.1016/j.cub.2008.11.063; OGILVIE BM, 1971, EXP PARASITOL, V29, P138, DOI 10.1016/0014-4894(71)90021-X; Raghavan N, 1999, MOL BIOCHEM PARASIT, V104, P233, DOI 10.1016/S0166-6851(99)00150-4; ROTHSTEIN NM, 1989, MOL BIOCHEM PARASIT, V33, P229, DOI 10.1016/0166-6851(89)90084-4; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sasaki Y, 2005, J EXP MED, V202, P607, DOI 10.1084/jem.20042202; TWEEDIE S, 1993, MOL BIOCHEM PARASIT, V61, P149, DOI 10.1016/0166-6851(93)90168-W; TWOHY DW, 1956, AM J HYG, V63, P165, DOI 10.1093/oxfordjournals.aje.a119801; Uchikawa R, 1996, PARASITOLOGY, V112, P339, DOI 10.1017/S0031182000065860; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; VANLEEUWEN MAW, 1995, PARASITOL RES, V81, P706, DOI 10.1007/BF00931852; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; WEINSTEIN PP, 1956, J PARASITOL, V42, P215, DOI 10.2307/3274846; Winter AD, 2007, J BIOL CHEM, V282, P12813, DOI 10.1074/jbc.M700274200; Yamauchi J, 2006, APMIS, V114, P270, DOI 10.1111/j.1600-0463.2006.apm_353.x; Yokogawa S., 1922, Parasitology Cambridge, V14, P127; Yu H, 2001, J MOL BIOL, V314, P1017, DOI 10.1006/jmbi.2000.5210	53	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18141	10.1371/journal.pone.0018141	http://dx.doi.org/10.1371/journal.pone.0018141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448458	Green Published, gold, Green Submitted			2022-12-27	WOS:000288810500045
J	Sousa, AP; Amaral, A; Baptista, M; Tavares, R; Campo, PC; Peregrin, PC; Freitas, A; Paiva, A; Almeida-Santos, T; Ramalho-Santos, J				Sousa, Ana Paula; Amaral, Alexandra; Baptista, Marta; Tavares, Renata; Caballero Campo, Pedro; Caballero Peregrin, Pedro; Freitas, Albertina; Paiva, Artur; Almeida-Santos, Teresa; Ramalho-Santos, Joao			Not All Sperm Are Equal: Functional Mitochondria Characterize a Subpopulation of Human Sperm with Better Fertilization Potential	PLOS ONE			English	Article							DENSITY GRADIENT CENTRIFUGATION; HUMAN-SPERMATOZOA; SWIM-UP; DNA FRAGMENTATION; INTRACYTOPLASMIC INJECTION; TYROSINE PHOSPHORYLATION; NONAPOPTOTIC SPERMATOZOA; MEMBRANE TRANSLOCATION; APOPTOTIC MARKERS; HEPARAN-SULFATE	Human sperm samples are very heterogeneous and include a low amount of truly functional gametes. Distinct strategies have been developed to characterize and isolate this specific subpopulation. In this study we have used fluorescence microscopy and fluorescence-activated cell sorting to determine if mitochondrial function, as assessed using mitochondrial-sensitive probes, could be employed as a criterion to obtain more functional sperm from a given ejaculate. We first determined that mitochondrial activity correlated with the quality of distinct human samples, from healthy donors to patients with decreased semen quality. Furthermore, using fluorescence-activated cell sorting to separate sperm with active and inactive mitochondria we found that this was also true within samples. Indeed, sperm with active mitochondria defined a more functional subpopulation, which contained more capacitated and acrosome intact cells, sperm with lower chromatin damage, and, crucially, sperm more able to decondense and participate in early development using both chemical induction and injection into mature bovine oocytes. Furthermore, cell sorting using mitochondrial activity produced a more functional sperm subpopulation than classic swim-up, both in terms of improvement in a variety of functional sperm parameters and in statistical significance. In conclusion, whatever the true biological role of sperm mitochondria in fertilization, mitochondrial activity is a clear hallmark of human sperm functionality.	[Sousa, Ana Paula; Amaral, Alexandra; Baptista, Marta; Tavares, Renata; Ramalho-Santos, Joao] Univ Coimbra, Dept Life Sci, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Sousa, Ana Paula; Almeida-Santos, Teresa] Univ Hosp Coimbra, Human Reprod Serv, Coimbra, Portugal; [Caballero Campo, Pedro; Caballero Peregrin, Pedro] Tambre Clin, Human Reprod Unit, Madrid, Spain; [Caballero Campo, Pedro; Caballero Peregrin, Pedro] Tambre Fdn, Madrid, Spain; [Freitas, Albertina; Paiva, Artur] Histocompatibil Ctr Coimbra, Coimbra, Portugal; [Almeida-Santos, Teresa] Univ Coimbra, Fac Med, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Universidade de Coimbra	Sousa, AP (corresponding author), Univ Coimbra, Dept Life Sci, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	jramalho@ci.uc.pt	Santos, João/HHZ-5595-2022; Paiva, Artur/AAH-2330-2022; Almeida-Santos, Teresa/M-7830-2016; Amaral, Alexandra/A-7521-2013; Paiva, Artur/AFM-0035-2022; Almeida Santos, Teresa/G-2000-2014; Ramalho-Santos, João/F-8641-2012	Paiva, Artur/0000-0002-6562-5859; Almeida-Santos, Teresa/0000-0001-7423-2996; Amaral, Alexandra/0000-0003-2354-8258; Paiva, Artur/0000-0002-6562-5859; Almeida Santos, Teresa/0000-0001-7423-2996; Ramalho-Santos, João/0000-0002-1172-4018; Sousa, Ana Paula/0000-0002-4190-6138; Tavares, Renata/0000-0002-4082-3701	Portuguese National Science Foundation (Fundacao para a Ciencia e Tecnologia) [POCTI/CVT/49102/2002]; Instituto de Investigacao Interdisciplinar of the University of Coimbra [III/BIO/50/2005]; Fundacao para a Ciencia e Tecnologia [SFRH/BD/23571/2005, SFRH/BPD/63120/2009, SFRH/BD/46002/2008, SFRH/BD/46078/2008]	Portuguese National Science Foundation (Fundacao para a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology); Instituto de Investigacao Interdisciplinar of the University of Coimbra; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by a Grant to J.R.-S. from the Portuguese National Science Foundation (Fundacao para a Ciencia e Tecnologia; POCTI/CVT/49102/2002), and by the Instituto de Investigacao Interdisciplinar of the University of Coimbra (III/BIO/50/2005). A.P.S., A.A., M.B. and R.T. are supported by Fundacao para a Ciencia e Tecnologia (SFRH/BD/23571/2005; SFRH/BPD/63120/2009; SFRH/BD/46002/2008; SFRH/BD/46078/2008). The funding entities had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ JG, 1992, J ANDROL, V13, P232; Amaral A, 2010, INT J ANDROL, V33, pE180, DOI 10.1111/j.1365-2605.2009.00987.x; Amaral A, 2007, HUM REPROD, V22, P1585, DOI 10.1093/humrep/dem030; Arrighi CD, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-1; AUGER J, 1993, J HISTOCHEM CYTOCHEM, V41, P1247, DOI 10.1177/41.8.8331289; AUSTIN CR, 1965, FERTILISATION FDN DE; Barroso G, 2006, FERTIL STERIL, V85, P149, DOI 10.1016/j.fertnstert.2005.06.046; Birkhead T, 2000, PROMISCUITY EVOLUTIO; Buffone MG, 2009, J ANDROL, V30, P552, DOI 10.2164/jandrol.108.006551; Buffone MG, 2004, HUM REPROD, V19, P139, DOI 10.1093/humrep/deh040; Chantler E, 2004, INT J ANDROL, V27, P350, DOI 10.1111/j.1365-2605.2004.00498.x; COHEN J, 1980, J REPROD FERTIL, V60, P213, DOI 10.1530/jrf.0.0600213; COHEN J, 1974, J REPROD FERTIL, V39, P297, DOI 10.1530/jrf.0.0390297; Dirican EK, 2008, J ASSIST REPROD GEN, V25, P375, DOI 10.1007/s10815-008-9250-1; Donnelly ET, 2000, HUM REPROD, V15, P1552, DOI 10.1093/humrep/15.7.1552; Gallon F, 2006, FERTIL STERIL, V86, P1526, DOI 10.1016/j.fertnstert.2006.03.055; Garner DL, 2006, THERIOGENOLOGY, V65, P943, DOI 10.1016/j.theriogenology.2005.09.009; GORUS FK, 1981, FERTIL STERIL, V35, P662; Grunewald Sonja, 2006, Cell and Tissue Banking, V7, P99, DOI 10.1007/s10561-005-1367-1; Grunewald Sonja, 2001, Cell and Tissue Banking, V2, P127, DOI 10.1023/A:1020188913551; Grunewald S, 2009, FERTIL STERIL, V92, P572, DOI 10.1016/j.fertnstert.2008.07.1705; Henkel Ralf R, 2003, Reprod Biol Endocrinol, V1, P108, DOI 10.1186/1477-7827-1-108; Holt WV, 2005, HUM REPROD, V20, P2983, DOI 10.1093/humrep/dei189; Holt WV, 2004, REPRODUCTION, V127, P527, DOI 10.1530/rep.1.00134; Hoogendijk CF, 2009, FERTIL STERIL, V91, P1285, DOI 10.1016/j.fertnstert.2008.01.042; Kasai T, 2002, ASIAN J ANDROL, V4, P97; KATZ DF, 1982, J REPROD FERTIL, V65, P171; Kotwicka M, 2008, REPROD BIOMED ONLINE, V16, P657, DOI 10.1016/S1472-6483(10)60479-8; Lee TH, 2010, HUM REPROD, V25, P839, DOI 10.1093/humrep/deq009; LOPATA A, 1976, FERTIL STERIL, V27, P677, DOI 10.1016/S0015-0282(16)41899-6; Marchetti C, 2004, HUM REPROD, V19, P2267, DOI 10.1093/humrep/deh416; Marchetti C, 2002, HUM REPROD, V17, P1257, DOI 10.1093/humrep/17.5.1257; Paasch U, 2004, BIOL REPROD, V71, P1828, DOI 10.1095/biolreprod.103.025627; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; PERREAULT SD, 1988, DEV BIOL, V125, P181, DOI 10.1016/0012-1606(88)90070-X; Piomboni P, 2006, ARCH ANDROLOGY, V52, P51, DOI 10.1080/01485010500203741; POUSETTE A, 1986, INT J ANDROL, V9, P1, DOI 10.1111/j.1365-2605.1986.tb00862.x; Ramalho-Santos J, 2004, FERTIL STERIL, V82, P1654, DOI 10.1016/j.fertnstert.2004.05.086; Ramalho-Santos J, 2007, MODERN RES ED TOPICS, V1, P394; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Ricci G, 2009, FERTIL STERIL, V91, P632, DOI 10.1016/j.fertnstert.2007.11.068; Romanato M, 2008, HUM REPROD, V23, P1145, DOI 10.1093/humrep/den028; Romanato M, 2003, HUM REPROD, V18, P1868, DOI 10.1093/humrep/deg354; RYBOUCHKIN A, 1995, HUM REPROD, V10, P1130, DOI 10.1093/oxfordjournals.humrep.a136105; Said T, 2006, BIOL REPROD, V74, P530, DOI 10.1095/biolreprod.105.046607; Said TM, 2005, REPROD BIOMED ONLINE, V10, P740, DOI 10.1016/S1472-6483(10)61118-2; Sakkas D, 2000, HUM REPROD, V15, P1112, DOI 10.1093/humrep/15.5.1112; Sousa APM, 2009, HUM REPROD, V24, P28, DOI 10.1093/humrep/den365; Spano M, 1999, MOL HUM REPROD, V5, P29, DOI 10.1093/molehr/5.1.29; Sutovsky P, 2000, INT REV CYTOL, V195, P1; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Tomlinson MJ, 2001, HUM REPROD, V16, P2160, DOI 10.1093/humrep/16.10.2160; Turner RMO, 1999, MOL HUM REPROD, V5, P816, DOI 10.1093/molehr/5.9.816; Varum S, 2007, FERTIL STERIL, V87, P572, DOI 10.1016/j.fertnstert.2006.07.1528; World Health Organization, 2010, LAB MAN EX PROC HUM; YANAGIMACHI R, 1976, BIOL REPROD, V15, P471, DOI 10.1095/biolreprod15.4.471; Younglai EV, 2001, HUM REPROD, V16, P1950, DOI 10.1093/humrep/16.9.1950; Zini A, 1999, FERTIL STERIL, V72, P496, DOI 10.1016/S0015-0282(99)00295-2; Zini A, 2000, UROLOGY, V56, P1081, DOI 10.1016/S0090-4295(00)00770-6	59	101	108	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18112	10.1371/journal.pone.0018112	http://dx.doi.org/10.1371/journal.pone.0018112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448461	Green Published, Green Submitted, gold			2022-12-27	WOS:000288810500036
J	Cohen-Or, I; Katz, C; Ron, EZ				Cohen-Or, Ifat; Katz, Chen; Ron, Eliora Z.			AGEs Secreted by Bacteria Are Involved in the Inflammatory Response	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; MULTIDRUG EFFLUX; PATHOGENESIS; COMPLICATIONS; INHIBITORS; INSIGHTS; RECEPTOR; SEPSIS	Advanced Glycated End Products (AGEs) are formed by non-enzymatic protein glycation and are implicated in several physiological aspects including cell aging and diseases. Recent data indicate that bacteria - although short lived - produce, metabolize and accumulate AGEs. Here we show that Escherichia coli cells secret AGEs by the energy-dependent efflux pump systems. Moreover, we show that in the presence of these AGEs there is an upshift of pro-inflammatory cytokins by mammalian cells. Thus, we propose that secretion of AGEs by bacteria is a novel avenue of bacterial-induced inflammation which is potentially important in the pathophysiology of bacterial infections. Moreover, the sensing of AGEs by the host cells may constitute a warning system for the presence of bacteria.	[Cohen-Or, Ifat; Katz, Chen; Ron, Eliora Z.] Tel Aviv Univ, Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Cohen-Or, I (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	eliora@post.tau.ac.il			Alfried Krupp Wissenschaftskolleg Greifswald	Alfried Krupp Wissenschaftskolleg Greifswald	CK was supported by a fellowship of the Alfried Krupp Wissenschaftskolleg Greifswald. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anas AA, 2010, NETH J MED, V68, P147; Augustus AM, 2004, J BACTERIOL, V186, P1851, DOI 10.1128/JB.186.6.1851-1860.2004; Baynes J W, 1989, Prog Clin Biol Res, V304, P43; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Horvat S, 2004, J PEPT SCI, V10, P119, DOI 10.1002/psc.519; Huang SM, 2006, MOL NUTR FOOD RES, V50, P1129, DOI 10.1002/mnfr.200600075; Hyogo H, 2008, CURR PHARM DESIGN, V14, P969, DOI 10.2174/138161208784139701; Jandeleit-Dahm K, 2008, CURR PHARM DESIGN, V14, P979, DOI 10.2174/138161208784139684; Katz C, 2010, MBIO, V1, DOI 10.1128/mBio.00195-10; Lehman TD, 2001, BBA-MOL BASIS DIS, V1535, P110, DOI 10.1016/S0925-4439(00)00087-9; Levy SB, 2002, J APPL MICROBIOL, V92, p65S, DOI 10.1046/j.1365-2672.92.5s1.4.x; Lutterloh EC, 2007, EXPERT OPIN PHARMACO, V8, P1193, DOI 10.1517/14656566.8.9.1193; Mironova R, 2001, MOL MICROBIOL, V39, P1061, DOI 10.1046/j.1365-2958.2001.02304.x; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nikaido H, 1998, CLIN INFECT DIS, V27, pS32, DOI 10.1086/514920; Njoroge F G, 1989, Prog Clin Biol Res, V304, P85; Pages JM, 2005, TRENDS MOL MED, V11, P382, DOI 10.1016/j.molmed.2005.06.006; Pertynska-Marczewska M, 2004, CYTOKINE, V28, P35, DOI 10.1016/j.cyto.2004.06.006; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; Sharff A, 2001, EUR J BIOCHEM, V268, P5011, DOI 10.1046/j.0014-2956.2001.02442.x; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Takeuchi M, 2008, CURR PHARM DESIGN, V14, P973, DOI 10.2174/138161208784139693; Takeuchi M, 2009, J ALZHEIMERS DIS, V16, P845, DOI 10.3233/JAD-2009-0974; Turk N, 2004, DIABETES METAB, V30, P187, DOI 10.1016/S1262-3636(07)70106-4; Unoshima Masako, 2004, Nihon Rinsho, V62, P2323; Van Nguyen C, 2006, MOL NUTR FOOD RES, V50, P1140, DOI 10.1002/mnfr.200600144; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; WHITNEY EN, 1971, GENETICS, V67, P39; Wynn J, 2010, PEDIATRICS, V125, P1031, DOI 10.1542/peds.2009-3301	32	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17974	10.1371/journal.pone.0017974	http://dx.doi.org/10.1371/journal.pone.0017974			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445354	gold, Green Published, Green Submitted			2022-12-27	WOS:000288809100019
J	Macadangdang, B; Zhang, N; Lund, PE; Marple, AH; Okabe, M; Gottesman, MM; Appella, DH; Kimchi-Sarfaty, C				Macadangdang, Benjamin; Zhang, Ning; Lund, Paul E.; Marple, Andrew H.; Okabe, Mitsunori; Gottesman, Michael M.; Appella, Daniel H.; Kimchi-Sarfaty, Chava			Inhibition of Multidrug Resistance by SV40 Pseudovirion Delivery of an Antigene Peptide Nucleic Acid (PNA) in Cultured Cells	PLOS ONE			English	Article							P-GLYCOPROTEIN; GENE-EXPRESSION; IN-VITRO; SV40-DERIVED VECTORS; LOCALIZATION SIGNAL; CELLULAR DELIVERY; ANTICANCER DRUGS; CHROMOSOMAL DNA; CANCER-CELLS; SEQUENCE	Peptide nucleic acid (PNA) is known to bind with extraordinarily high affinity and sequence-specificity to complementary nucleic acid sequences and can be used to suppress gene expression. However, effective delivery into cells is a major obstacle to the development of PNA for gene therapy applications. Here, we present a novel method for the in vitro delivery of antigene PNA to cells. By using a nucleocapsid protein derived from Simian virus 40, we have been able to package PNA into pseudovirions, facilitating the delivery of the packaged PNA into cells. We demonstrate that this system can be used effectively to suppress gene expression associated with multidrug resistance in cancer cells, as shown by RT-PCR, flow cytometry, Western blotting, and cell viability under chemotherapy. The combination of PNA with the SV40-based delivery system is a method for suppressing a gene of interest that could be broadly applied to numerous targets.	[Macadangdang, Benjamin; Lund, Paul E.; Marple, Andrew H.; Okabe, Mitsunori; Gottesman, Michael M.] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Zhang, Ning; Appella, Daniel H.] NIDDK, Bioorgan Chem Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Kimchi-Sarfaty, Chava] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); US Food & Drug Administration (FDA)	Macadangdang, B (corresponding author), NCI, Cell Biol Lab, NIH, Bldg 37, Bethesda, MD 20892 USA.	appellad@niddk.nih.gov; chava.kimchi-sarfaty@fda.hhs.gov		Kimchi-Sarfaty, Chava/0000-0002-9355-8585	National Institutes of Health; National Cancer InstituteNational Institute of Diabetes and Digestive and Kidney Diseases; Food and Drug Administration; NATIONAL CANCER INSTITUTE [ZIABC005598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer InstituteNational Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Food and Drug Administration(United States Department of Health & Human Services); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, and the National Institute of Diabetes and Digestive and Kidney Diseases, and the Food and Drug Administration. The findings and conclusions in this article have not been formally disseminated by the Food and Drug Administration and should not be construed to represent an Agency determination or policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abes S, 2006, J CONTROL RELEASE, V110, P595, DOI 10.1016/j.jconrel.2005.10.026; AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Bendifallah N, 2006, BIOCONJUGATE CHEM, V17, P750, DOI 10.1021/bc050283q; BOEKHORST PAW, 1993, BLOOD, V82, P3157; Braun K, 2002, J MOL BIOL, V318, P237, DOI 10.1016/S0022-2836(02)00031-1; Chiarantini L, 2005, J CONTROL RELEASE, V109, P24, DOI 10.1016/j.jconrel.2005.09.013; Chiarantini L, 2002, BIOCHEMISTRY-US, V41, P8471, DOI 10.1021/bi020079f; CHITNIS M, 1991, SELECT CANCER THER, V7, P165, DOI 10.1089/sct.1991.7.165; Cogoi S, 2005, BIOCHEMISTRY-US, V44, P10510, DOI 10.1021/bi0505215; Cordelier P, 2003, OLIGONUCLEOTIDES, V13, P281, DOI 10.1089/154545703322616961; Corradini R, 2007, CURR TOP MED CHEM, V7, P681, DOI 10.2174/156802607780487759; Cutrona G, 2000, NAT BIOTECHNOL, V18, P300, DOI 10.1038/73745; DEMIDOV VV, 1994, BIOCHEM PHARMACOL, V48, P1310, DOI 10.1016/0006-2952(94)90171-6; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Dragulescu-Andrasi A, 2006, J AM CHEM SOC, V128, P16104, DOI 10.1021/ja063383v; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; FOJO AT, 1987, J CLIN ONCOL, V5, P1922, DOI 10.1200/JCO.1987.5.12.1922; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guo Hua, 2005, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V27, P300; Hille S, 2006, ANTI-CANCER DRUG, V17, P1041, DOI 10.1097/01.cad.0000231480.07654.b5; Hotta T, 1999, SURG TODAY, V29, P591, DOI 10.1007/BF02482982; Hu JX, 2007, BIOCHEMISTRY-US, V46, P7581, DOI 10.1021/bi700230a; Janowski BA, 2005, NAT CHEM BIOL, V1, P210, DOI 10.1038/nchembio724; Kaihatsu K, 2004, BIOCHEMISTRY-US, V43, P14340, DOI 10.1021/bi048519l; Kimchi-Sarfaty C, 2006, CANCER GENE THER, V13, P648, DOI 10.1038/sj.cgt.7700943; Kimchi-Sarfaty C, 2005, HUM GENE THER, V16, P1110, DOI 10.1089/hum.2005.16.1110; Kimchi-Sarfaty C, 2004, BIOTECHNIQUES, V37, P270, DOI 10.2144/04372RR04; Kimchi-Sarfaty C, 2002, HUM GENE THER, V13, P299, DOI 10.1089/10430340252769815; Koppelhus U, 2003, ADV DRUG DELIVER REV, V55, P267, DOI 10.1016/S0169-409X(02)00182-5; Larsen HJ, 1999, BBA-GENE STRUCT EXPR, V1489, P159, DOI 10.1016/S0167-4781(99)00145-1; Miyake K, 1999, CANCER RES, V59, P8; Mukherjee S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000765; Nielsen P. E., 2004, PEPTIDE NUCL ACIDS P, V2nd, P37; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Pokorski JK, 2004, J AM CHEM SOC, V126, P15067, DOI 10.1021/ja046280q; SALUNKE DM, 1986, CELL, V46, P895, DOI 10.1016/0092-8674(86)90071-1; Shen F, 2008, J PHARMACOL EXP THER, V324, P95, DOI 10.1124/jpet.107.127704; Shiraishi T, 2006, BIOCONJUGATE CHEM, V17, P189, DOI 10.1021/bc050246z; Shiraishi T, 2005, CHEM BIOL, V12, P923, DOI 10.1016/j.chembiol.2005.06.009; Strayer DS, 2000, GENE THER, V7, P886, DOI 10.1038/sj.gt.3301159; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Turner JJ, 2005, NUCLEIC ACIDS RES, V33, P6837, DOI 10.1093/nar/gki991; UEDA K, 1987, J BIOL CHEM, V262, P17432; WARNER E, 1995, AM J CLIN ONCOL-CANC, V18, P251, DOI 10.1097/00000421-199506000-00013; Wei HL, 2003, ACTA PHARMACOL SIN, V24, P805; WITTUNG P, 1995, FEBS LETT, V365, P27, DOI 10.1016/0014-5793(95)00409-3	48	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17981	10.1371/journal.pone.0017981	http://dx.doi.org/10.1371/journal.pone.0017981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445346	Green Published, gold, Green Submitted			2022-12-27	WOS:000288809100021
J	Sugiura, Y; Taguchi, R; Setou, M				Sugiura, Yuki; Taguchi, Ryo; Setou, Mitsutoshi			Visualization of Spatiotemporal Energy Dynamics of Hippocampal Neurons by Mass Spectrometry during a Kainate-Induced Seizure	PLOS ONE			English	Article							ASSISTED-LASER-DESORPTION/IONIZATION; RAT-HEART MITOCHONDRIA; ACID CYCLE ACTIVITY; KAINIC ACID; CELL-DEATH; REGULATORY PROTEINS; APOPTOSIS; TISSUE; BRAIN; SUSCEPTIBILITY	We report the use of matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry combined with capillary electrophoresis (CE) mass spectrometry to visualize energy metabolism in the mouse hippocampus by imaging energy-related metabolites. We show the distribution patterns of ATP, ADP, and AMP in the hippocampus as well as changes in their amounts and distribution patterns in a murine model of limbic, kainate-induced seizure. As an acute response to kainate administration, we found massive and moderate reductions in ATP and ADP levels, respectively, but no significant changes in AMP levels-especially in cells of the CA3 layer. The results suggest the existence of CA3 neuron-selective energy metabolism at the anhydride bonds of ATP and ADP in the hippocampal neurons during seizure. In addition, metabolome analysis of energy synthesis pathways indicates accelerated glycolysis and possibly TCA cycle activity during seizure, presumably due to the depletion of ATP. Consistent with this result, the observed energy depletion significantly recovered up to 180 min after kainate administration. However, the recovery rate was remarkably low in part of the data-pixel population in the CA3 cell layer region, which likely reflects acute and CA3-selective neural death. Taken together, the present approach successfully revealed the spatiotemporal energy metabolism of the mouse hippocampus at a cellular resolution-both quantitatively and qualitatively. We aim to further elucidate various metabolic processes in the neural system.	[Sugiura, Yuki; Setou, Mitsutoshi] Hamamatsu Med Sch, Dept Mol Anat, Higashi Ku, Shizuoka, Japan; [Taguchi, Ryo] Univ Tokyo, Grad Sch Med, Dept Metabolome, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Sugiura, Y (corresponding author), Hamamatsu Med Sch, Dept Mol Anat, Higashi Ku, Shizuoka, Japan.	setou@hama-med.ac.jp		Sugiura, Yuki/0000-0002-6983-8958	Human Metabolomics Technology; SENTAN	Human Metabolomics Technology; SENTAN(Japan Science & Technology Agency (JST))	This research, particularly of CE-MS metabolomic research, was supported by a grant for leading metabolome research 2010 provided by Human Metabolomics Technology (http://humanmetabolome.com/?p=921=en) to YS. A Grant-in-Aid for Scientific Research (WAKATE-S:20670004, http://www.jsps.go.jp) to MS, and SENTAN program-P to KO (http://www.jst.go.jp/sentan/en/) support conducting other parts of this research. Shimazdu Corp. and Eisai contributed data analysis and manuscript preparation. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Benabdellah F, 2009, ANAL CHEM, V81, P5557, DOI 10.1021/ac9005364; BIZIERE K, 1978, J NEUROCHEM, V31, P513, DOI 10.1111/j.1471-4159.1978.tb02666.x; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Fujikawa DG, 2000, NEUROSCIENCE, V98, P41, DOI 10.1016/S0306-4522(00)00085-3; GARRETT TJ, 2006, INT J MASS SPECTROM, V260, P11; GRIFFITHS T, 1984, NEUROSCIENCE, V12, P557, DOI 10.1016/0306-4522(84)90073-3; Harada T, 2009, ANAL CHEM, V81, P9153, DOI 10.1021/ac901872n; HATTORI K, ANTIOXID REDOX SIGNA; Hayasaka T, 2008, RAPID COMMUN MASS SP, V22, P3415, DOI 10.1002/rcm.3751; HILLENKAMP F, 1975, NATURE, V256, P119, DOI 10.1038/256119a0; Jackson SN, 2007, J MASS SPECTROM, V42, P1093, DOI 10.1002/jms.1245; Konishi Y, 2003, J NEUROSCI, V23, P1649; KUPKA K-D, 1980, Scanning Electron Microscopy, P635; LANOUE K, 1970, J BIOL CHEM, V245, P102; LANOUE KF, 1972, J BIOL CHEM, V247, P667; LEBOVITZ R M, 1971, International Journal of Neuroscience, V2, P99, DOI 10.3109/00207457109146996; LEVY DE, 1977, J NEUROCHEM, V28, P63, DOI 10.1111/j.1471-4159.1977.tb07709.x; LOTHMAN EW, 1981, BRAIN RES, V218, P299, DOI 10.1016/0006-8993(81)91308-1; Lust W., 1989, CARBOHYDRATES ENERGY; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MORITA Y, 2010, CANC SCI IN PRESS; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791; Padmanabhan J, 1999, J NEUROSCI, V19, P8747, DOI 10.1523/JNEUROSCI.19-20-08747.1999; PINARD E, 1984, NEUROSCIENCE, V13, P1039, DOI 10.1016/0306-4522(84)90287-2; POLLARD H, 1994, NEUROSCIENCE, V63, P7, DOI 10.1016/0306-4522(94)90003-5; Ratzliff ADH, 2002, TRENDS NEUROSCI, V25, P140, DOI 10.1016/S0166-2236(00)02122-6; Ridenour WB, 2010, ANAL CHEM, V82, P1881, DOI 10.1021/ac9026115; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Schwartz SA, 2003, J MASS SPECTROM, V38, P699, DOI 10.1002/jms.505; Shimma S, 2008, ANAL CHEM, V80, P878, DOI 10.1021/ac071301v; Shimma S, 2007, J CHROMATOGR B, V855, P98, DOI 10.1016/j.jchromb.2007.02.037; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2007, J CHROMATOGR A, V1159, P125, DOI 10.1016/j.chroma.2007.05.054; SUGIURA Y, 2006, J MASS SPECTROM SOC, V54, P4; SUGIURA Y, 2009, J NEUROIMMUNE PHARM; Sugiura Y, 2006, ANAL CHEM, V78, P8227, DOI 10.1021/ac060974v; Sugiura Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003232; Tomita S, 2007, P NATL ACAD SCI USA, V104, P18784, DOI 10.1073/pnas.0708970104; TREMBLAY E, 1983, NEUROSCIENCE, V8, P299, DOI 10.1016/0306-4522(83)90068-4; Wang XQ, 2003, J CELL SCI, V116, P2099, DOI 10.1242/jcs.00420; Yao I, 2008, PROTEOMICS, V8, P3692, DOI 10.1002/pmic.200701121	46	57	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17952	10.1371/journal.pone.0017952	http://dx.doi.org/10.1371/journal.pone.0017952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445350	Green Published, Green Submitted, gold			2022-12-27	WOS:000288809100018
J	Verkuyl, DA; van Goor, GM; Hanssen, MJ; Miedema, MT; Koppe, M				Verkuyl, Douwe A.; van Goor, Gerda M.; Hanssen, Marjo J.; Miedema, Margreet T.; Koppe, Marnix			The Right to Informed Choice. A Study and Opinion Poll of Women Who Were or Were Not Given the Option of a Sterilisation with Their Caesarean Section	PLOS ONE			English	Article							TUBAL-STERILIZATION; UNITED-STATES; FOLLOW-UP; REGRET; RISK; CONTRACEPTION; PREGNANCY; LIGATION; BARRIERS; ABORTION	Background: In the Netherlands, caesarean sections (CSs) are rarely combined with tubal occlusion (TO), partly because discussing CS/TO near delivery is considered unethical and earlier hypothetical counselling - i.e. suppose you happen to need a CS - is rare. This results in more unintended pregnancies and is inconsistent with informed choice. We explored whether TO should indeed not be made routinely available to eligible women. Methods and Findings: A questionnaire was mailed to 515 Para >= 2 who underwent in the past >= 1 CS. 498 (96.7%) responded. They were on average 35.3 years old, had 2.5 children, had undergone 1.6 CSs, and 3.3 years had passed since their index delivery, either a CS (393) or vaginal birth (105) after a previous CS. 87% of the 498 believed that pregnant mothers with >= 1 children should be routinely counselled about CS/TO. Indeed, 58% and 85% respectively, thought women/couples expecting their second or third child should still be given the TO option days before delivery, if omitted earlier. Counselled women, 138/498 (27.8%), were far more often satisfied than those without CS/TO option. 33/393 had a CS/TO. None indicated regret in the questionnaire. Another 119 also would have elected a CS/TO if given that option. Therefore, 152 (38.7%) of 393 Para >= 2 had or would have liked a concurrent TO. 118/119 wrote they still regretted missing this opportunity. The exception's husband had had a vasectomy. 100/119 were good TO candidates: they were >= 28 years when they delivered an apparently healthy baby of >= 37 weeks. The current contraceptive use of these 100 suggests that this group will have at least 8 unintended pregnancies before age 50. Conclusion: The experiences and opinions of previous potential candidates for a CS/TO do not support the reluctance of Dutch obstetricians to counsel pregnant Para >= 1 about the TO option for a (potential) CS.	[Verkuyl, Douwe A.; van Goor, Gerda M.; Hanssen, Marjo J.; Miedema, Margreet T.; Koppe, Marnix] Bethesda Ziekenhuis, Dept Obstet & Gynaecol, Hoogeveen, Netherlands		Verkuyl, DA (corresponding author), Bethesda Ziekenhuis, Dept Obstet & Gynaecol, Hoogeveen, Netherlands.	verkuyl@freeler.nl	Potter, Joseph E/A-3122-2008					Billari FC, 2011, HUM REPROD, V26, P616, DOI 10.1093/humrep/deq360; Borrero S, 2011, FERTIL STERIL, V95, P17, DOI 10.1016/j.fertnstert.2010.05.031; Bury L., 2009, CONDOM BROKE WHY WOM; *CENTR BUR STAT, NETH; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; de Araujo FF, 2008, CONTRACEPTION, V78, P474, DOI 10.1016/j.contraception.2008.07.006; DEGRAAF A, 2005, ONGEPLANDE ZWANGERSC; Dohle G R, 2005, Ned Tijdschr Geneeskd, V149, P2728; Fernandes Arlete Maria Dos Santos, 2006, Rev Assoc Med Bras (1992), V52, P323; Gilliam M, 2008, CONTRACEPTION, V77, P44, DOI 10.1016/j.contraception.2007.09.011; Glazer AB, 2011, CONTRACEPTION, V83, P238, DOI 10.1016/j.contraception.2010.07.002; Goodman S, 2008, CONTRACEPTION, V78, P143, DOI 10.1016/j.contraception.2008.03.003; *GOVT NETH, 1995, WET GENEESKUNDIGE BE; Hillis SD, 1999, OBSTET GYNECOL, V93, P889, DOI 10.1016/S0029-7844(98)00539-0; Hubacher D, 2008, CONTRACEPTION, V78, P73, DOI 10.1016/j.contraception.2008.03.002; International Planned Parenthood Federation, 1996, CHART SEX REPR RIGHT; Kjaer SK, 2004, INT J EPIDEMIOL, V33, P596, DOI 10.1093/ije/dyh046; Kost K, 2008, CONTRACEPTION, V77, P10, DOI 10.1016/j.contraception.2007.09.013; KRUIJER H, 2009, LANDELIJKE ABORTUS R; Lipetz C, 2009, CONTRACEPTION, V79, P304, DOI 10.1016/j.contraception.2008.11.003; MacKay AP, 2001, FAM PLANN PERSPECT, V33, P161, DOI 10.2307/2673719; Moreno JM, 2001, EUR J OBSTET GYN R B, V97, P147, DOI 10.1016/S0301-2115(00)00522-4; *NICE, 2005, LONG ACT REV CONTR, P17; Peterson HB, 1996, AM J OBSTET GYNECOL, V174, P1161, DOI 10.1016/S0002-9378(96)70658-0; Peterson HB, 2008, OBSTET GYNECOL, V111, P189, DOI 10.1097/01.AOG.0000298621.98372.62; PLATZCHRISTENSEN JJ, 1992, INT J GYNECOL OBSTET, V38, P223, DOI 10.1016/0020-7292(82)90132-1; Qin L, 2009, INT J GYNECOL OBSTET, V104, P182, DOI 10.1016/j.ijgo.2008.12.002; Rasch V, 2008, EUR J PUBLIC HEALTH, V18, P144, DOI 10.1093/eurpub/ckm112; Ross JA, 2001, INT FAM PLAN PERSPEC, V27, P20, DOI 10.2307/2673801; *ROYAL COLL OBST G, 2004, MAL FEM STER EV BAS; Sannisto T, 2009, SCAND J PRIM HEALTH, V27, P244, DOI 10.3109/02813430903234914; Smith A, 2010, BJOG-INT J OBSTET GY, V117, P463, DOI 10.1111/j.1471-0528.2009.02469.x; Sonnenberg FA, 2004, CONTRACEPTION, V69, P447, DOI 10.1016/j.contraception.2004.03.008; TANNE JH, 2008, BRIT MED J, V336, P1095, DOI DOI 10.1136/BMJ.39576.554699; Trussell J, 2010, CONTRACEPTION, V82, P391, DOI 10.1016/j.contraception.2010.04.008; van Eygen L, 2008, TROP DOCT, V38, P36, DOI 10.1258/td.2007.005019; Vemer H M, 1986, Ned Tijdschr Geneeskd, V130, P410; VEMER HM, 1986, FERTIL STERIL, V46, P724; Verkuyl DAA, 2002, BJOG-INT J OBSTET GY, V109, P900, DOI 10.1016/S1470-0328(02)99427-9; Verkuyl DAA, 2009, CONTRACEPTION, V80, P234, DOI 10.1016/j.contraception.2009.03.002; Verkuyl DAA, 2007, PLOS MED, V4, P401, DOI 10.1371/journal.pmed.0040071; WILCOX LS, 1991, FERTIL STERIL, V55, P927; Zite N, 2006, CONTRACEPTION, V73, P404, DOI 10.1016/j.contraception.2005.10.014; 2005, PERINATALE ZORG NEDE	44	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e14776	10.1371/journal.pone.0014776	http://dx.doi.org/10.1371/journal.pone.0014776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445338	gold, Green Published, Green Submitted			2022-12-27	WOS:000288809100003
J	Zhu, X; Wang, F; Lin, MCM; Tian, LW; Fan, WG; Ng, SS; Liu, MJ; Huang, JQ; Xu, ZH; Li, DP; Kung, HF				Zhu, Xiao; Wang, Fang; Lin, Marie C. M.; Tian, Linwei; Fan, Wenguo; Ng, Samuel S.; Liu, Minjuan; Huang, Jianqing; Xu, Zhenhua; Li, Dongpei; Kung, Hsiangfu			The 3 ' UTR Variants in the GRP78 Are Not Associated with Overall Survival in Resectable Hepatocellular Carcinoma	PLOS ONE			English	Article							PROGNOSIS; RISK; GENE; SUSCEPTIBILITY; POLYMORPHISM	Background: Elevated glucose-regulated protein 78 (GRP78) levels in tissues have been known to be related with poor prognosis in hepatocellular carcinoma (HCC) patients. Though the variants in the 39 untranslated region (UTR) of GRP78 gene were not associated with HCC risk, we wonder whether these polymorphisms affect survival of HCC patients. Methodology/Principal Findings: Blood samples of HCC patients were maintained in our specimen bank between 1996 to 2003. DNA from 576 unrelated and resectable patients with HCC was typed for rs16927997 (T>C), rs1140763 (T>C) and rs12009 (T. C) by TaqMan assays. The Kaplan-Meier method and log-rank test were used to estimate overall survival. Linkage disequilibrium (LD) analysis identified a total of 3 haplotypes and 6 diplotypes in this region. The distribution of haplotype was not related to the clinical characteristics. Univariate analysis showed that the allele, genotype, haplotype and diplotype did not effect the survival. None of the clinical features show a significant association (P-correced > 0.05) with overall patient outcome in multiple comparisons. Conclusions/Significance: There is no noteworthy influence of 39 UTR variants in the GRP78 on prognosis of resectable HCC in the Chinese population.	[Zhu, Xiao; Wang, Fang; Kung, Hsiangfu] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Xiao; Liu, Minjuan; Huang, Jianqing] Affiliated Tumor Hosp, Guangzhou Med Coll, Guangzhou, Guangdong, Peoples R China; [Lin, Marie C. M.; Xu, Zhenhua] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Tian, Linwei] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Dept Epidemiol, Hong Kong, Hong Kong, Peoples R China; [Fan, Wenguo; Li, Dongpei] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Ng, Samuel S.] Univ Hong Kong, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Zhu, Xiao; Kung, Hsiangfu] Chinese Univ Hong Kong, Li Ka Shing Inst Med Sci, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Sun Yat Sen University; University of Hong Kong; Chinese University of Hong Kong	Zhu, X (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	bioxzhu@yahoo.com; lidp@mail.sysu.edu.cn	Tian, Linwei/A-9736-2009; wang, fang/GYD-4295-2022; Xu, Zhenhua/J-9200-2015	Tian, Linwei/0000-0002-4739-1534; Xu, Zhenhua/0000-0001-9481-5611; Tian, Linwei/0000-0003-2240-8886; Li, Dongpei/0000-0002-4734-6776	National Nature Science Foundation of China [81071697]; Research Project of Health Bureau of Guangzhou City [201102A213005]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Project of Health Bureau of Guangzhou City	This work was supported by the National Nature Science Foundation of China ( Grant No. 81071697) and the Research Project of Health Bureau of Guangzhou City (Grant No. 201102A213005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellavance EC, 2008, J GASTROINTEST SURG, V12, P1699, DOI 10.1007/s11605-008-0652-2; Clifford RJ, 2010, HEPATOLOGY, V52, P2034, DOI 10.1002/hep.23943; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Kew MC, 2002, TOXICOLOGY, V181, P35, DOI 10.1016/S0300-483X(02)00251-2; Kim KA, 2003, CLIN IMAG, V27, P340, DOI 10.1016/S0899-7071(02)00574-0; Li L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007765; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Nogueira JA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-204; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Su RJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-20; Tanabe KK, 2008, JAMA-J AM MED ASSOC, V299, P53, DOI 10.1001/jama.2007.65; Vormfelde SV, 2007, NAT REV GENET, V8, DOI 10.1038/nrg1916-c2; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Woodcock J, 2009, NEW ENGL J MED, V360, P811, DOI 10.1056/NEJMe0810630; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang XR, 2010, GUT, V59, P953, DOI 10.1136/gut.2008.176271; Yano M, 2007, EUR J CANCER, V43, P1092, DOI 10.1016/j.ejca.2007.01.032; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; ZHU X, HEPATOGASTR IN PRESS; Zhu X, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-83; Zhu X, 2009, INT J CANCER, V125, P1352, DOI 10.1002/ijc.24487	24	151	158	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17783	10.1371/journal.pone.0017783	http://dx.doi.org/10.1371/journal.pone.0017783			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445355	Green Published, Green Submitted, gold			2022-12-27	WOS:000288809100008
J	Chen, ZG; Phillips, LK; Gould, E; Campisi, J; Lee, SW; Ormerod, BK; Zwierzchoniewska, M; Martinez, OM; Palmer, TD				Chen, Zhiguo; Phillips, Lori K.; Gould, Elizabeth; Campisi, Jay; Lee, Star W.; Ormerod, Brandi K.; Zwierzchoniewska, Monika; Martinez, Olivia M.; Palmer, Theo D.			MHC Mismatch Inhibits Neurogenesis and Neuron Maturation in Stem Cell Allografts	PLOS ONE			English	Article							PROGENITOR CELLS; DOPAMINE NEURONS; TRANSPLANTATION; RAT; TISSUE; BRAIN; ANTIGENS; DIFFERENTIATION; IMMUNOGENICITY; RECOGNITION	Background: The role of histocompatibility and immune recognition in stem cell transplant therapy has been controversial, with many reports arguing that undifferentiated stem cells are protected from immune recognition due to the absence of major histocompatibility complex (MHC) markers. This argument is even more persuasive in transplantation into the central nervous system (CNS) where the graft rejection response is minimal. Methodology/Principal Findings: In this study, we evaluate graft survival and neuron production in perfectly matched vs. strongly mismatched neural stem cells transplanted into the hippocampus in mice. Although allogeneic cells survive, we observe that MHC-mismatch decreases surviving cell numbers and strongly inhibits the differentiation and retention of graft-derived as well as endogenously produced new neurons. Immune suppression with cyclosporine-A did not improve outcome but non-steroidal anti-inflammatory drugs, indomethacin or rosiglitazone, were able to restore allogeneic neuron production, integration and retention to the level of syngeneic grafts. Conclusions/Significance: These results suggest an important but unsuspected role for innate, rather than adaptive, immunity in the survival and function of MHC-mismatched cellular grafts in the CNS.	[Chen, Zhiguo; Gould, Elizabeth; Lee, Star W.; Ormerod, Brandi K.; Palmer, Theo D.] Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA; [Chen, Zhiguo; Gould, Elizabeth; Lee, Star W.; Ormerod, Brandi K.; Palmer, Theo D.] Dept Neurosurg, Stanford, CA USA; [Phillips, Lori K.; Campisi, Jay; Zwierzchoniewska, Monika; Martinez, Olivia M.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA	Stanford University	Chen, ZG (corresponding author), Merrimack Coll, N Andover, MA 01845 USA.	zchen1@stanford.edu	Palmer, Theo/GSI-6635-2022; Ormerod, Brandi/H-7037-2012; Whittaker, Anna/A-3577-2013	Ormerod, Brandi/0000-0003-0982-0788; , Olivia/0000-0002-2798-0251; Palmer, Theo/0000-0002-6266-1862; Chen, Zhiguo/0000-0003-1508-510X; Whittaker, Anna/0000-0002-5461-0598	National Institutes of Health [R01NS045113, R21NS050549, R01MH071472]; California Institute for Regenerative Medicine [RC1-00134-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045113, R21NS050549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by research grants from the National Institutes of Health (R01NS045113, R21NS050549, and R01MH071472) and the California Institute for Regenerative Medicine (RC1-00134-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker RA, 2000, J NEUROSCI, V20, P3415, DOI 10.1523/JNEUROSCI.20-09-03415.2000; Bechmann I, 1999, GLIA, V27, P62, DOI 10.1002/(SICI)1098-1136(199907)27:1<62::AID-GLIA7>3.0.CO;2-S; Burns TC, 2006, STEM CELLS, V24, P1121, DOI 10.1634/stemcells.2005-0463; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Chaturvedi RK, 2008, J NEUROCHEM, V106, P506, DOI 10.1111/j.1471-4159.2008.05388.x; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CORRY RJ, 1973, TRANSPLANT P, V5, P733; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; DUAN WM, 1995, NEUROSCIENCE, V64, P629, DOI 10.1016/0306-4522(94)00416-3; Duan WM, 1997, EXP NEUROL, V148, P334, DOI 10.1006/exnr.1997.6656; FEITOZA CQ, 2009, INFLAMM RES; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gould DS, 1999, IMMUNOL TODAY, V20, P77, DOI 10.1016/S0167-5699(98)01394-2; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Han Ruolan, 2008, J Biol, V7, P12, DOI 10.1186/jbiol69; Haskell CA, 2001, J CLIN INVEST, V108, P679, DOI 10.1172/JCI12976; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Hori J, 2003, STEM CELLS, V21, P405, DOI 10.1634/stemcells.21-4-405; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Imitola J, 2004, AM J PATHOL, V164, P1615, DOI 10.1016/S0002-9440(10)63720-0; Keohane A, 2010, MOL CELL NEUROSCI, V43, P127, DOI 10.1016/j.mcn.2009.10.003; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Landreth G, 2008, NEUROTHERAPEUTICS, V5, P481, DOI 10.1016/j.nurt.2008.05.003; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mammolenti M, 2004, STEM CELLS, V22, P1101, DOI 10.1634/stemcells.22-6-1101; MASON DW, 1986, NEUROSCIENCE, V19, P685, DOI 10.1016/0306-4522(86)90292-7; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Pan Y, 2005, EXP NEUROL, V192, P365, DOI 10.1016/j.expneurol.2004.11.011; RAO K, 1989, TRANSPLANTATION, V48, P1018, DOI 10.1097/00007890-198912000-00025; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Sayles M, 2004, TRANSPL IMMUNOL, V12, P321, DOI 10.1016/j.trim.2003.12.012; Schwarz SC, 2006, PARKINSONISM RELAT D, V12, P302, DOI 10.1016/j.parkreldis.2006.01.003; Shetty AK, 1999, J NEUROBIOL, V38, P391, DOI 10.1002/(SICI)1097-4695(19990215)38:3<391::AID-NEU8>3.0.CO;2-4; SLOAN DJ, 1990, PROG BRAIN RES, V82, P141; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TZE WJ, 1989, TRANSPLANTATION, V47, P1053, DOI 10.1097/00007890-198906000-00027; WIDNER H, 1993, CELL TRANSPLANT, V2, P307, DOI 10.1177/096368979300200413; WIDNER H, 1989, EXP BRAIN RES, V76, P187; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	49	105	109	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e14787	10.1371/journal.pone.0014787	http://dx.doi.org/10.1371/journal.pone.0014787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	22205957	gold, Green Submitted, Green Published			2022-12-27	WOS:000289055700001
J	Tseng, YC; Chen, RD; Lucassen, M; Schmidt, MM; Dringen, R; Abele, D; Hwang, PP				Tseng, Yung-Che; Chen, Ruo-Dong; Lucassen, Magnus; Schmidt, Maike M.; Dringen, Ralf; Abele, Doris; Hwang, Pung-Pung			Exploring Uncoupling Proteins and Antioxidant Mechanisms under Acute Cold Exposure in Brains of Fish	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; OXIDATIVE STRESS; GENE-EXPRESSION; NONSHIVERING THERMOGENESIS; SUPEROXIDE-DISMUTASE; ENERGY-METABOLISM; SKELETAL-MUSCLE; UP-REGULATION; HYPOXIA; ZEBRAFISH	Exposure to fluctuating temperatures accelerates the mitochondrial respiration and increases the formation of mitochondrial reactive oxygen species (ROS) in ectothermic vertebrates including fish. To date, little is known on potential oxidative damage and on protective antioxidative defense mechanisms in the brain of fish under cold shock. In this study, the concentration of cellular protein carbonyls in brain was significantly increased by 38% within 1 h after cold exposure (from 28 degrees C to 18 degrees C) of zebrafish (Danio rerio). In addition, the specific activity of superoxide dismutase (SOD) and the mRNA level of catalase (CAT) were increased after cold exposure by about 60% (6 h) and by 60%-90% (1 and 24 h), respectively, while the specific glutathione content as well as the ratio of glutathione disulfide to glutathione remained constant and at a very low level. In addition, cold exposure increased the protein level of hypoxia-inducible factor (HIF) by about 50% and the mRNA level of the glucose transporter zglut3 in brain by 50%-100%. To test for an involvement of uncoupling proteins (UCPs) in the cold adaptation of zebrafish, five UCP members were annotated and identified (zucp1-5). With the exception of zucp1, the mRNA levels of the other four zucps were significantly increased after cold exposure. In addition, the mRNA levels of four of the fish homologs (zppar) of the peroxisome proliferator-activated receptor (PPAR) were increased after cold exposure. These data suggest that PPARs and UCPs are involved in the alterations observed in zebrafish brain after exposure to 18 degrees C. The observed stimulation of the PPAR-UCP axis may help to prevent oxidative damage and to maintain metabolic balance and cellular homeostasis in the brains of ectothermic zebrafish upon cold exposure.	[Tseng, Yung-Che; Chen, Ruo-Dong; Hwang, Pung-Pung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Tseng, Yung-Che] Leibniz Inst Marine Sci, IFM GEOMAR, D-24105 Kiel, Germany; [Chen, Ruo-Dong] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Lucassen, Magnus; Abele, Doris] Alfred Wegener Inst Polar & Marine Res, D-2850 Bremerhaven, Germany; [Schmidt, Maike M.; Dringen, Ralf] Univ Bremen, Ctr Biomol Interact Bremen, Bremen, Germany	Academia Sinica - Taiwan; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Academia Sinica - Taiwan; National Taiwan University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen	Tseng, YC (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	pphwang@gate.sinica.edu.tw	Hwang, Pung-Pung/AEQ-4633-2022; hwang, pp/A-3641-2011; Tseng, Yung-Che/AAE-7509-2022; Lucassen, Magnus/E-8433-2011; Lucassen, Magnus/ABA-8396-2021; Hwang, Pung-Pung/AAH-1538-2022	Tseng, Yung-Che/0000-0001-7489-0403; Lucassen, Magnus/0000-0003-4276-4781; Lucassen, Magnus/0000-0003-4276-4781; Dringen, Ralf/0000-0001-7869-1305; Abele, Doris/0000-0002-5766-5017	Academia Sinica; Alfred-Wegener Institute for Polar and Marine Research; National Science of Council of Taiwan; International Bureau of the Germany Federal Ministry of Education and Research	Academia Sinica(Academia Sinica - Taiwan); Alfred-Wegener Institute for Polar and Marine Research; National Science of Council of Taiwan(Ministry of Science and Technology, Taiwan); International Bureau of the Germany Federal Ministry of Education and Research	This study was financially supported by Academia Sinica (P. P. Hwang) and Alfred-Wegener Institute for Polar and Marine Research (D. Abele). Y. C. Tseng was awarded the Postdoc Scholarship supported by both the National Science of Council of Taiwan and the Bilateral Cooperation in Science and Technology grant from International Bureau of the Germany Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2004, COMP BIOCHEM PHYS A, V138, P405, DOI 10.1016/j.cbpb.2004.05.013; Airaksinen S, 2003, COMP BIOCHEM PHYS B, V136, P275, DOI 10.1016/S1096-4959(03)00205-7; Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Benarroch EE, 2009, NEUROLOGY, V73, P560, DOI 10.1212/WNL.0b013e3181b2a719; Bermejo-Nogales A, 2010, J COMP PHYSIOL B, V180, P685, DOI 10.1007/s00360-009-0441-6; Blanquart C, 2003, J STEROID BIOCHEM, V85, P267, DOI 10.1016/S0960-0760(03)00214-0; Blomgren K, 2006, FREE RADICAL BIO MED, V40, P388, DOI 10.1016/j.freeradbiomed.2005.08.040; Bordet R, 2006, BIOCHEM SOC T, V34, P1341, DOI 10.1042/BST0341341; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Bugge A, 2010, J BIOL CHEM, V285, P17310, DOI 10.1074/jbc.M110.120584; Cannon B, 2006, BBA-BIOENERGETICS, V1757, P449, DOI 10.1016/j.bbabio.2006.05.016; CHAN PH, 1991, ANN NEUROL, V29, P482, DOI 10.1002/ana.410290506; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chavez A, 2008, ANN NY ACAD SCI, V1147, P312, DOI 10.1196/annals.1427.021; Chou MY, 2008, J EXP BIOL, V211, P3077, DOI 10.1242/jeb.019950; Cossins AR, 2002, BIOCHEM SOC T, V30, P1082, DOI 10.1042/bst0301082; CRAWSHAW L, 1985, PHARMACOL THERAPEUT, V30, P19, DOI 10.1016/0163-7258(85)90045-2; Dringen R, 1996, J NEUROCHEM, V67, P1375, DOI 10.1046/j.1471-4159.1996.67041375.x; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Fandrey J, 2006, CARDIOVASC RES, V71, P642, DOI 10.1016/j.cardiores.2006.05.005; FRIEDLANDER MJ, 1976, J COMP PHYSIOL, V112, P19, DOI 10.1007/BF00612674; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Heise K, 2007, J COMP PHYSIOL B, V177, P765, DOI 10.1007/s00360-007-0173-4; Heise K, 2006, J EXP BIOL, V209, P353, DOI 10.1242/jeb.01977; Hwang PP, 2010, FISH PHYSIOL, V29, P311, DOI 10.1016/S1546-5098(10)02908-0; JACOB RA, 1995, NUTR RES, V15, P755, DOI 10.1016/0271-5317(95)00041-G; Jastroch M, 2005, PHYSIOL GENOMICS, V22, P150, DOI 10.1152/physiolgenomics.00070.2005; Jastroch M, 2007, J COMP PHYSIOL B, V177, P743, DOI 10.1007/s00360-007-0171-6; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Katz LM, 2004, BRAIN RES, V1017, P85, DOI 10.1016/j.brainres.2004.05.020; Kern B, 2009, COMP BIOCHEM PHYS D, V4, P121, DOI 10.1016/j.cbd.2008.12.006; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389; Malek RL, 2004, COMP BIOCHEM PHYS C, V138, P363, DOI 10.1016/j.cca.2004.08.014; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; Mark FC, 2006, COMP BIOCHEM PHYS D, V1, P365, DOI 10.1016/j.cbd.2006.08.004; Portner H.-O., 2005, FISH PHYSIOL, V22, P79, DOI DOI 10.1016/S1546-5098(04)22003-9; Rial Eduardo, 2009, Journal of Biology (London), V8, P58, DOI 10.1186/jbiol155; Richardson SM, 2008, HISTOCHEM CELL BIOL, V129, P503, DOI 10.1007/s00418-007-0372-9; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Saito S, 2008, GENE, V408, P37, DOI 10.1016/j.gene.2007.10.018; Schwartz TS, 2008, P ROY SOC B-BIOL SCI, V275, P979, DOI 10.1098/rspb.2007.1761; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SHAKLEE JB, 1977, J EXP ZOOL, V201, P1, DOI 10.1002/jez.1402010102; Soitamo AJ, 2001, J BIOL CHEM, V276, P19699, DOI 10.1074/jbc.M009057200; Sokolova IM, 2005, FEBS LETT, V579, P313, DOI 10.1016/j.febslet.2004.11.103; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Thisse B, 2004, METHOD CELL BIOL, V77, P505; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Toyama T, 2004, BIOCHEM BIOPH RES CO, V324, P697, DOI 10.1016/j.bbrc.2004.09.110; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; TYLER S, 1984, J EXP ZOOL, V232, P1, DOI 10.1002/jez.1402320102; van den Burg EH, 2005, J NEUROPHYSIOL, V93, P2849, DOI 10.1152/jn.01113.2004; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Villarroya F, 2007, PPAR RES, V2007, DOI 10.1155/2007/74364; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wang PY, 2010, CIRC RES, V106, P911, DOI 10.1161/CIRCRESAHA.109.206185; WULLIMANN M, 1997, PHYSL FISHES, V2007, P245; Yoo HY, 1999, GENE, V234, P87, DOI 10.1016/S0378-1119(99)00176-6; Zhang X, 2007, TOXICOL APPL PHARM, V223, P10, DOI 10.1016/j.taap.2007.05.002	69	76	83	7	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18180	10.1371/journal.pone.0018180	http://dx.doi.org/10.1371/journal.pone.0018180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464954	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000288813900047
J	Shieh, JC; Schaar, BT; Srinivasan, K; Brodsky, FM; McConnell, SK				Shieh, Jennifer C.; Schaar, Bruce T.; Srinivasan, Karpagam; Brodsky, Frances M.; McConnell, Susan K.			Endocytosis Regulates Cell Soma Translocation and the Distribution of Adhesion Proteins in Migrating Neurons	PLOS ONE			English	Article							ALPHA-3-BETA-1 INTEGRIN; MEDIATED ENDOCYTOSIS; RADIAL MIGRATION; FOCAL ADHESIONS; MYOSIN-II; DYNAMIN; MEMBRANE; GROWTH; BETA-1-INTEGRINS; CONTRACTION	Newborn neurons migrate from their birthplace to their final location to form a properly functioning nervous system. During these movements, young neurons must attach and subsequently detach from their substrate to facilitate migration, but little is known about the mechanisms cells use to release their attachments. We show that the machinery for clathrin-mediated endocytosis is positioned to regulate the distribution of adhesion proteins in a subcellular region just proximal to the neuronal cell body. Inhibiting clathrin or dynamin function impedes the movement of migrating neurons both in vitro and in vivo. Inhibiting dynamin function in vitro shifts the distribution of adhesion proteins to the rear of the cell. These results suggest that endocytosis may play a critical role in regulating substrate detachment to enable cell body translocation in migrating neurons.	[Shieh, Jennifer C.; Srinivasan, Karpagam; McConnell, Susan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Shieh, Jennifer C.] Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; [Schaar, Bruce T.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Brodsky, Frances M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Brodsky, Frances M.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Brodsky, Frances M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shieh, JC (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	suemcc@stanford.edu		Brodsky, Frances/0000-0002-1334-9258	National Institutes of Health (NIH) [MH51864, GM038093]; National Defense Science and Engineering Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051864, R37MH051864] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded by National Institutes of Health (NIH) MH51864 (SKM) and NIH GM038093 (FMB). JCS was supported by a National Defense Science and Engineering Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Belvindrah R, 2007, J NEUROSCI, V27, P13854, DOI 10.1523/JNEUROSCI.4494-07.2007; Belvindrah R, 2007, J NEUROSCI, V27, P2704, DOI 10.1523/JNEUROSCI.2991-06.2007; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonanomi D, 2008, J CELL SCI, V121, P3757, DOI 10.1242/jcs.033803; Bretscher MS, 2008, J CELL SCI, V121, P2625, DOI 10.1242/jcs.031120; BRETSCHER MS, 1976, NATURE, V260, P21, DOI 10.1038/260021a0; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; BRODSKY FM, 1983, J MOL BIOL, V167, P197, DOI 10.1016/S0022-2836(83)80041-2; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; DAVIES PJA, 1984, DIABETES CARE, V7, P35; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; EDMONDSON JC, 1988, J CELL BIOL, V106, P505, DOI 10.1083/jcb.106.2.505; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Fletcher SJ, 2010, TRENDS CELL BIOL, V20, P71, DOI 10.1016/j.tcb.2009.11.006; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; GASSER UE, 1990, P NATL ACAD SCI USA, V87, P4543, DOI 10.1073/pnas.87.12.4543; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; GREGORY WA, 1988, J NEUROSCI, V8, P1728; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hawthorne AL, 2010, J NEUROSCI, V30, P420, DOI 10.1523/JNEUROSCI.2333-09.2010; He M, 2010, J NEUROSCI, V30, P10885, DOI 10.1523/JNEUROSCI.0240-10.2010; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hines JH, 2010, NAT NEUROSCI, V13, P829, DOI 10.1038/nn.2554; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Kamiguchi H, 2003, MOL NEUROBIOL, V28, P219, DOI 10.1385/MN:28:3:219; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Kirfel G, 2004, EUR J CELL BIOL, V83, P717, DOI 10.1078/0171-9335-00421; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Le Roy C, 2005, DEV CELL, V9, P167, DOI 10.1016/j.devcel.2005.07.007; Levecque C, 2009, AM J PHYSIOL-CELL PH, V297, pC160, DOI 10.1152/ajpcell.00630.2008; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; Marin O, 2006, TRENDS NEUROSCI, V29, P655, DOI 10.1016/j.tins.2006.10.001; Martini FJ, 2010, J NEUROSCI, V30, P8660, DOI 10.1523/JNEUROSCI.1962-10.2010; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McManus MF, 2005, J CHILD NEUROL, V20, P280, DOI 10.1177/08830738050200040301; Moskowitz HS, 2003, MOL BIOL CELL, V14, P4437, DOI 10.1091/mbc.e03-04-0230; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; NANDI PK, 1981, BIOCHEMISTRY-US, V20, P6706, DOI 10.1021/bi00526a028; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Palecek SP, 1996, J CELL SCI, V109, P941; Panicker AK, 2006, EXP CELL RES, V312, P299, DOI 10.1016/j.yexcr.2005.10.031; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; PHONPHOK Y, 1991, FEBS LETT, V281, P188, DOI 10.1016/0014-5793(91)80390-O; Pierini LM, 2000, BLOOD, V95, P2471; Quan A, 2007, MOL PHARMACOL, V72, P1425, DOI 10.1124/mol.107.034207; Rid R, 2005, CELL MOTIL CYTOSKEL, V61, P161, DOI 10.1002/cm.20076; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanada K, 2004, NEURON, V42, P197, DOI 10.1016/S0896-6273(04)00222-3; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schmid RS, 2004, DEVELOPMENT, V131, P6023, DOI 10.1242/dev.01532; Schneider IC, 2009, MOL BIOL CELL, V20, P3155, DOI 10.1091/mbc.E09-03-0219; Shan YL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000116; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shastry BS, 2007, J HUM GENET, V52, P104, DOI 10.1007/s10038-006-0088-z; Smilenov LB, 1999, SCIENCE, V286, P1172, DOI 10.1126/science.286.5442.1172; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Strachan LR, 2004, J CELL BIOL, V167, P545, DOI 10.1083/jcb.200405024; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160; Thelen K, 2002, J NEUROSCI, V22, P4918, DOI 10.1523/JNEUROSCI.22-12-04918.2002; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Ward Michael E., 2004, V294, P137; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010; Yuasa S, 1996, INT J DEV NEUROSCI, V14, P429, DOI 10.1016/S0736-5748(96)00021-4; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030	105	58	61	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17802	10.1371/journal.pone.0017802	http://dx.doi.org/10.1371/journal.pone.0017802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21573063	Green Published, Green Submitted, gold			2022-12-27	WOS:000288809100009
J	Holodniy, M; Brown, ST; Cameron, DW; Kyriakides, TC; Angus, B; Babiker, A; Singer, J; Owens, DK; Anis, A; Goodall, R; Hudson, F; Piaseczny, M; Russo, J; Schechter, M; Deyton, L; Darbyshire, J				Holodniy, Mark; Brown, Sheldon T.; Cameron, D. William; Kyriakides, Tassos C.; Angus, Brian; Babiker, Abdel; Singer, Joel; Owens, Douglas K.; Anis, Aslam; Goodall, Ruth; Hudson, Fleur; Piaseczny, Mirek; Russo, John; Schechter, Martin; Deyton, Lawrence; Darbyshire, Janet		OPTIMA Team	Results of Antiretroviral Treatment Interruption and Intensification in Advanced Multi-Drug Resistant HIV Infection from the OPTIMA Trial	PLOS ONE			English	Article							STRUCTURED TREATMENT INTERRUPTION; QUALITY-OF-LIFE; CROSS-RESISTANCE; CLINICAL PROGRESSION; VIROLOGICAL FAILURE; MEGA-HAART; COHORT; THERAPY; INHIBITORS; VIRUS	Background: Guidance is needed on best medical management for advanced HIV disease with multidrug resistance (MDR) and limited retreatment options. We assessed two novel antiretroviral (ARV) treatment approaches in this setting. Methods and Findings: We conducted a 262 factorial randomized open label controlled trial in patients with a CD4 count <= 300 cells/mu l who had ARV treatment (ART) failure requiring retreatment, to two options (a) re-treatment with either standard (<= 4 ARVs) or intensive (>= 5 ARVs) ART and b) either treatment starting immediately or after a 12-week monitored ART interruption. Primary outcome was time to developing a first AIDS-defining event (ADE) or death from any cause. Analysis was by intention to treat. From 2001 to 2006, 368 patients were randomized. At baseline, mean age was 48 years, 2% were women, median CD4 count was 106/mu l, mean viral load was 4.74 log(10) copies/ml, and 59% had a prior AIDS diagnosis. Median follow-up was 4.0 years in 1249 person-years of observation. There were no statistically significant differences in the primary composite outcome of ADE or death between re-treatment options of standard versus intensive ART (hazard ratio 1.17; CI 0.86-1.59), or between immediate retreatment initiation versus interruption before re-treatment (hazard ratio 0.93; CI 0.68-1.30), or in the rate of non-HIV associated serious adverse events between re-treatment options. Conclusions: We did not observe clinical benefit or harm assessed by the primary outcome in this largest and longest trial exploring both ART interruption and intensification in advanced MDR HIV infection with poor retreatment options.	[Holodniy, Mark; Owens, Douglas K.] VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Holodniy, Mark; Owens, Douglas K.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Brown, Sheldon T.] James J Peters VA Med Ctr, Bronx, NY USA; [Brown, Sheldon T.] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Cameron, D. William] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Cameron, D. William; Singer, Joel; Anis, Aslam; Piaseczny, Mirek; Schechter, Martin] St Pauls Hosp, Canadian HIV Trials Network, Vancouver, BC V6Z 1Y6, Canada; [Kyriakides, Tassos C.; Russo, John] VA Cooperat Studies Program Coordinating Ctr, West Haven, CT USA; [Angus, Brian] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England; [Babiker, Abdel; Goodall, Ruth; Hudson, Fleur; Darbyshire, Janet] MRC Clin Trials Unit, London, England; [Deyton, Lawrence] Off Publ Hlth & Environm Hazards, Dept Vet Affairs, Washington, DC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; University of Ottawa; Ottawa Hospital Research Institute; St. Paul's Hospital; University of Saskatchewan; University of Oxford; Medical Research Council Clinical Trials Unit	Holodniy, M (corresponding author), VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.	bcameron@ohri.ca	Kyriakides, Tassos/E-4980-2013; Angus, Brian/L-9246-2019; Cameron, Bill/E-9180-2010; Giongo, Adriana/P-8718-2015; Wasserfall, Clive/J-9078-2012	Kyriakides, Tassos/0000-0001-8913-108X; Angus, Brian/0000-0003-3598-7784; Cameron, Bill/0000-0002-0090-3539; Hyoty, Heikki/0000-0003-0370-4145; Kozal, Michael/0000-0002-3100-8254; Holodniy, Mark/0000-0002-6655-7982; Ilonen, Jorma/0000-0002-9973-2062; Knip, Mikael/0000-0003-0474-0033; Giongo, Adriana/0000-0002-1412-7040; Wasserfall, Clive/0000-0002-3522-8932; , Michael/0000-0002-7719-7396; Drew, Jennifer/0000-0002-4037-108X; Brown, Chris/0000-0002-7758-6447; Schechter, Martin/0000-0001-6063-2155; Goodall, Ruth/0000-0003-0622-5035	Ontario Ministry of Health/Ontario HIV Treatment Network; CIHR Canadian HIV Trials Network, Canada; MRC [MC_U122886352] Funding Source: UKRI; Medical Research Council [MC_U122886352] Funding Source: researchfish	Ontario Ministry of Health/Ontario HIV Treatment Network(Ministry of Health and Long-Term Care, Ontario); CIHR Canadian HIV Trials Network, Canada(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DWC is supported with a Career Scientist Award of the Ontario Ministry of Health/Ontario HIV Treatment Network. The study was supported in part in Canada through the CIHR Canadian HIV Trials Network. The study funders (MRC-UK, VACSP, CIHR) reviewed and approved the design and conduct of the trial, with external expert reviewers who were represented on the Trial Steering Committee. The OPTIMA Writing Committee and the OPTIMA team had full access to the statistical report and to the study data by request and the Writing Committee had final responsibility for the submitted manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anis AH, 2009, JAIDS-J ACQ IMM DEF, V51, P631, DOI 10.1097/QAI.0b013e3181a4f00d; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Antinori A, 2002, AIDS RES HUM RETROV, V18, P835, DOI 10.1089/08892220260190308; Bonnet F, 2007, HIV MED, V8, P547, DOI 10.1111/j.1468-1293.2007.00508.x; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Cozzi-Lepri A, 2008, AIDS, V22, P2187, DOI 10.1097/QAD.0b013e328310e04f; DARMINIO MA, 2005, ARCH INTERN MED, V0165; *DEP HLTH HUM SERV, PAN ANT GUID AD GUID; Hamers RL, 2008, ANTIVIR THER, V13, P625; Hughes A, 2008, J INFECTION, V57, P1, DOI 10.1016/j.jinf.2008.05.006; Joyce VR, 2009, JAIDS-J ACQ IMM DEF, V50, P27, DOI 10.1097/QAI.0b013e31818ce6f3; Katlama C, 2004, AIDS, V18, P217, DOI 10.1097/00002030-200401230-00011; KAUF TL, 2008, PREDICTIVE MODEL HLT; Kyriakides TC, 2003, CONTROL CLIN TRIALS, V24, P481, DOI 10.1016/S0197-2456(03)00029-1; Lawrence J, 2003, NEW ENGL J MED, V349, P837, DOI 10.1056/NEJMoa035103; LAWRENCE JKH, 2006, ANTIRETROVIRAL PHENO; Lawrence J, 2006, JAIDS-J ACQ IMM DEF, V43, P169, DOI 10.1097/01.qai.0000242450.74779.ee; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Lo Re V, 2008, CLIN LIVER DIS, V12, P587, DOI 10.1016/j.cld.2008.03.009; Miller V, 2000, ANTIVIR THER, V5, P49; Miller V, 2001, ANTIVIR THER, V6, P25; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Montaner JSG, 2001, AIDS, V15, P61, DOI 10.1097/00002030-200101050-00010; Morse CG, 2006, JAMA-J AM MED ASSOC, V296, P844, DOI 10.1001/jama.296.7.844; Pai N. P., 2006, COCHRANE DB SYST REV, V3; Perno CF, 2008, J MED VIROL, V80, P565, DOI 10.1002/jmv.21034; Race E, 1999, AIDS, V13, P2061, DOI 10.1097/00002030-199910220-00008; Reynolds SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010307; Rottmann C, 1999, ANTIVIR THER, V4, P93; Zaccarelli M, 2005, AIDS, V19, P1081, DOI 10.1097/01.aids.0000174455.01369.ad	30	445	452	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e14764	10.1371/journal.pone.0014764	http://dx.doi.org/10.1371/journal.pone.0014764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483491	gold, Green Submitted, Green Published			2022-12-27	WOS:000289057200001
J	Yu, ZY; Wang, R; Xu, LY; Xie, SW; Dong, JH; Jing, YK				Yu, Zhiying; Wang, Rui; Xu, Liying; Xie, Siwei; Dong, Jinhua; Jing, Yongkui			beta-Elemene Piperazine Derivatives Induce Apoptosis in Human Leukemia Cells through Downregulation of c-FLIP and Generation of ROS	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; LUNG-CANCER CELLS; PEROXIDE-DEPENDENT PATHWAY; ARSENIC TRIOXIDE; PROSTATE-CANCER; UP-REGULATION; PROTEIN; DEATH; EXPRESSION; TARGET	beta-Elemene is an active component of the herb medicine Curcuma Wenyujin with reported antitumor activity. To improve its antitumor ability, five novel piperazine derivatives of beta-elemene, 13-(3-methyl-1-piperazinyl)-beta-elemene (DX1), 13-(cis-3,5-dimethyl-1-piperazinyl)-beta-elemene (DX2), 13-(4-ethyl-1-piperazinyl)-beta-elemene (DX3), 13-(4-isopropyl-1-piperazinyl)-beta-elemene (DX4) and 13-piperazinyl-beta-elemene (DX5), were synthesized. The antiproliferative and apoptotic effects of these derivatives were determined in human leukemia HL-60, NB4, K562 and HP100-1 cells. DX1, DX2 and DX5, which contain a secondary amino moiety, were more active in inhibiting cell growth and in inducing apoptosis than DX3 and DX4. The apoptosis induction ability of DX1 was associated with the generation of hydrogen peroxide (H(2)O(2)), a decrease of mitochondrial membrane potential (MMP), and the activation of caspase-8. Pretreatment with the antioxidants N-acetylcysteine and catalase completely blocked DX1-induced H(2)O(2) production, but only partially its activation of caspase-8 and induction of apoptosis. HL-60 cells were more sensitive than its H(2)O(2)-resistant subclone HP100-1 cells to DX1-induced apoptosis. The activation of caspase-8 by these compounds was correlated with the decrease in the levels of cellular FLICE-inhibitory protein (c-FLIP). The proteasome inhibitor MG-132 augmented the decrease in c-FLIP levels and apoptosis induced by these derivatives. FADD-and caspase-8-deficient Jurkat subclones have a decreased response to DX1-induced apoptosis. Our data indicate that these novel beta-elemene piperazine derivatives induce apoptosis through the decrease in c-FLIP levels and the production of H(2)O(2) which leads to activation of both death receptor-and mitochondrial-mediated apoptotic pathways.	[Yu, Zhiying] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang, Peoples R China; [Xu, Liying; Xie, Siwei; Dong, Jinhua] Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang, Peoples R China; [Wang, Rui; Jing, Yongkui] Mt Sinai Sch Med, Dept Med, Tisch Canc Inst, New York, NY USA	Shenyang Pharmaceutical University; Shenyang Pharmaceutical University; Icahn School of Medicine at Mount Sinai	Yu, ZY (corresponding author), Guangdong Food & Drug Vocat Coll, Guangzhou, Guangdong, Peoples R China.	yongkui.jing@mssm.edu		Bonini, Nancy/0000-0003-0226-5291; Gitler, Aaron/0000-0001-8603-1526	National Natural Science Foundation of China [30328030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the past funding from National Natural Science Foundation of China (No. 30328030) (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external funding sources for this study.	Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Armstrong JS, 2006, BRIT J PHARMACOL, V147, P239, DOI 10.1038/sj.bjp.0706556; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dai J, 1999, BLOOD, V93, P268, DOI 10.1182/blood.V93.1.268.401a21_268_277; Day TW, 2006, BIOCHEM PHARMACOL, V71, P1551, DOI 10.1016/j.bcp.2006.02.015; Decaudin D, 1998, INT J ONCOL, V12, P141; Fukazawa T, 2001, ONCOGENE, V20, P5225, DOI 10.1038/sj.onc.1204673; Guseva NV, 2004, J CELL BIOCHEM, V91, P70, DOI 10.1002/jcb.10707; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; Kabore AF, 2006, APOPTOSIS, V11, P1175, DOI 10.1007/s10495-006-8048-9; KASUGAI I, 1992, LEUKEMIA RES, V16, P173, DOI 10.1016/0145-2126(92)90129-U; KAUH J, PLOS ONE, V5; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Kouhara J, 2007, INT J ONCOL, V30, P679; Kruidering M, 2000, IUBMB LIFE, V50, P85, DOI 10.1080/15216540050212088; Li WH, 2007, CANCER RES, V67, P2247, DOI 10.1158/0008-5472.CAN-06-3793; Li X, 2005, CELL MOL LIFE SCI, V62, P894, DOI 10.1007/s00018-005-5027-1; Lin YD, 2008, MOL CANCER THER, V7, P3556, DOI 10.1158/1535-7163.MCT-08-0648; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; Liu X, 2006, CANCER RES, V66, P11115, DOI 10.1158/0008-5472.CAN-06-2471; Lombard C, 2005, LEUKEMIA RES, V29, P915, DOI 10.1016/j.leukres.2005.01.014; Lu M, 2008, CANCER RES, V68, P1180, DOI 10.1158/0008-5472.CAN-07-2978; Nakazato T, 2005, CLIN CANCER RES, V11, P6040, DOI 10.1158/1078-0432.CCR-04-2273; Ozoren N, 2003, SEMIN CANCER BIOL, V13, P135, DOI 10.1016/S1044-579X(02)00131-1; Peter Marcus E, 2004, Biochem J, V382, pe1; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; Wang G, 2005, CELL MOL LIFE SCI, V62, P881, DOI 10.1007/s00018-005-5017-3; Wang YZ, 2005, DRUG DEV IND PHARM, V31, P769, DOI 10.1080/03639040500216329; Xia LJ, 2005, MOL CANCER THER, V4, P381; Xu LY, 2006, BIOORGAN MED CHEM, V14, P5351, DOI 10.1016/j.bmc.2006.03.041; YAMADA M, 1991, DNA CELL BIOL, V10, P735, DOI 10.1089/dna.1991.10.735; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Yu ZY, 2008, CANCER LETT, V269, P165, DOI 10.1016/j.canlet.2008.04.034; Zhang SY, 2005, MOL CANCER THER, V4, P1972, DOI 10.1158/1535-7163.MCT-05-0249	36	171	176	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15843	10.1371/journal.pone.0015843	http://dx.doi.org/10.1371/journal.pone.0015843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283566	Green Published, gold, Green Submitted			2022-12-27	WOS:000286661400015
J	Pawlowski, DR; Metzger, DJ; Raslawsky, A; Howlett, A; Siebert, G; Karalus, RJ; Garrett, S; Whitehouse, CA				Pawlowski, David R.; Metzger, Daniel J.; Raslawsky, Amy; Howlett, Amy; Siebert, Gretchen; Karalus, Richard J.; Garrett, Stephanie; Whitehouse, Chris A.			Entry of Yersinia pestis into the Viable but Nonculturable State in a Low-Temperature Tap Water Microcosm	PLOS ONE			English	Article							ESCHERICHIA-COLI; VIBRIO-VULNIFICUS; RESUSCITATION; SURVIVAL; CELLS; STARVATION; VIRULENCE; PERSISTENCE; POPULATION; RECOVERY	Yersinia pestis, the causative agent of plague, has caused several pandemics throughout history and remains endemic in the rodent populations of the western United States. More recently, Y. pestis is one of several bacterial pathogens considered to be a potential agent of bioterrorism. Thus, elucidating potential mechanisms of survival and persistence in the environment would be important in the event of an intentional release of the organism. One such mechanism is entry into the viable but non-culturable (VBNC) state, as has been demonstrated for several other bacterial pathogens. In this study, we showed that Y. pestis became nonculturable by normal laboratory methods after 21 days in a low-temperature tap water microcosm. We further show evidence that, after the loss of culturability, the cells remained viable by using a variety of criteria, including cellular membrane integrity, uptake and incorporation of radiolabeled amino acids, and protection of genomic DNA from DNase I digestion. Additionally, we identified morphological and ultrastructural characteristics of Y. pestis VBNC cells, such as cell rounding and large periplasmic spaces, by electron microscopy, which are consistent with entry into the VBNC state in other bacteria. Finally, we demonstrated resuscitation of a small number of the non-culturable cells. This study provides compelling evidence that Y. pestis persists in a low-temperature tap water microcosm in a viable state yet is unable to be cultured under normal laboratory conditions, which may prove useful in risk assessment and remediation efforts, particularly in the event of an intentional release of this organism.	[Pawlowski, David R.; Raslawsky, Amy; Howlett, Amy; Siebert, Gretchen; Karalus, Richard J.] CUBRC Inc, Buffalo, NY USA; [Garrett, Stephanie; Whitehouse, Chris A.] USA, Med Res Inst Infect Dis, Frederick, MD USA; [Pawlowski, David R.; Metzger, Daniel J.; Karalus, Richard J.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Pawlowski, DR (corresponding author), CUBRC Inc, Buffalo, NY USA.	pawlowski@cubrc.org		Guillou, Laure/0000-0003-1032-7958; Shahbazkia, Hamid Reza/0000-0002-5661-0612; Pawlowski, Jan/0000-0003-2421-388X; Christen, Richard/0000-0002-3396-4362	CUBRC [00291.01]; USAMRIID [114509]; Oak Ridge Institute for Science and Education	CUBRC; USAMRIID; Oak Ridge Institute for Science and Education(General Electric)	The authors acknowledge the CUBRC Internal Research and Development program (no. 00291.01) and the USAMRIID In-House Laboratory Research program (no. 114509) for financial support. This research was supported in part by an appointment to the Student Research Participation Program at USAMRIID by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the United States Army Medical Research and Materiel Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Albertini MC, 2006, CYTOM PART A, V69A, P260, DOI 10.1002/cyto.a.20263; Ayyadurai S, 2008, MICROBIOL-SGM, V154, P2865, DOI 10.1099/mic.0.2007/016154-0; Bjergbaek LA, 2005, J APPL MICROBIOL, V99, P1090, DOI 10.1111/j.1365-2672.2005.02706.x; Boaretti M, 2003, ENVIRON MICROBIOL, V5, P986, DOI 10.1046/j.1462-2920.2003.00497.x; Bogosian G, 2000, J BACTERIOL, V182, P5070, DOI 10.1128/JB.182.18.5070-5075.2000; Breneva N. V., 2006, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P7; Buzoleva LS, 2000, B EXP BIOL MED+, V129, P374, DOI 10.1007/BF02439275; Chaiyanan S, 2001, SYST APPL MICROBIOL, V24, P331, DOI 10.1078/0723-2020-00032; Chaiyanan S, 2007, ENVIRON MICROBIOL, V9, P393, DOI 10.1111/j.1462-2920.2006.01150.x; Czyzewska Izabela, 2003, Przegl Epidemiol, V57, P263; Du M, 2007, APPL ENVIRON MICROB, V73, P1349, DOI 10.1128/AEM.02243-06; Eisen RJ, 2008, EMERG INFECT DIS, V14, P941, DOI 10.3201/eid1406.080029; Forsman M, 2000, FEMS MICROBIOL ECOL, V31, P217, DOI 10.1111/j.1574-6941.2000.tb00686.x; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Garcia-Armisen T, 2004, J MICROBIOL METH, V58, P269, DOI 10.1016/j.mimet.2004.04.014; Halvorson HO, 1933, J BACTERIOL, V25, P101, DOI 10.1128/JB.25.2.101-121.1933; Heim S, 2002, J BACTERIOL, V184, P6739, DOI 10.1128/JB.184.23.6739-6745.2002; Jang KI, 2007, J MICROBIOL BIOTECHN, V17, P202; Keep NH, 2006, CELL MOL LIFE SCI, V63, P2555, DOI 10.1007/s00018-006-6188-2; LINDER K, 1989, APPL ENVIRON MICROB, V55, P2837, DOI 10.1128/AEM.55.11.2837-2842.1989; Lleo MM, 2001, J APPL MICROBIOL, V91, P1095, DOI 10.1046/j.1365-2672.2001.01476.x; Mizunoe Y, 1999, ARCH MICROBIOL, V172, P63, DOI 10.1007/s002030050741; MOLLARET H. H., 1963, BULL SOC PATHOL EXOTIQUE, V56, P1168; NOVITSKY JA, 1976, APPL ENVIRON MICROB, V32, P617, DOI 10.1128/AEM.32.4.617-622.1976; Oliver James D., 2005, Journal of Water and Health, V3, P249; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Oliver JD, 2005, J MICROBIOL, V43, P93; OLIVER JD, 2005, FOODBORNE PATHOGENS; RAHMAN I, 1994, APPL ENVIRON MICROB, V60, P3573, DOI 10.1128/AEM.60.10.3573-3578.1994; Rose LJ, 2007, APPL ENVIRON MICROB, V73, P3437, DOI 10.1128/AEM.00051-07; Rose LJ, 2003, APPL ENVIRON MICROB, V69, P2166, DOI 10.1128/AEM.69.4.2166-2171.2003; ROSZAK DB, 1987, APPL ENVIRON MICROB, V53, P2889, DOI 10.1128/AEM.53.12.2889-2893.1987; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; SMITH JJ, 1994, APPL ENVIRON MICROB, V60, P2977, DOI 10.1128/AEM.60.8.2977-2984.1994; Steinert M, 1997, APPL ENVIRON MICROB, V63, P2047, DOI 10.1128/AEM.63.5.2047-2053.1997; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Suchkov Iu G, 1997, Zh Mikrobiol Epidemiol Immunobiol, P42; Torosian SD, 2009, CAN J MICROBIOL, V55, P1125, DOI [10.1139/W09-061, 10.1139/w09-061]; Torosian SD, 2009, CAN J MICROBIOL, V55, P1119, DOI [10.1139/w09-060, 10.1139/W09-060]; Troitskaia V V, 1996, Zh Mikrobiol Epidemiol Immunobiol, P13; Whitesides MD, 1997, APPL ENVIRON MICROB, V63, P1002, DOI 10.1128/AEM.63.3.1002-1005.1997; WILM, 1897, HYGIENISCHE RUNDSCHA, V7, P285; Yersin Alexandre, 1894, ANN I PASTEUR PARIS, V8, P662	44	92	96	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2011	6	3							e17585	10.1371/journal.pone.0017585	http://dx.doi.org/10.1371/journal.pone.0017585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SI	21436885	Green Submitted, Green Published, gold			2022-12-27	WOS:000288514000003
